PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Engelmann, A; Speidel, D; Bornkamm, GW; Deppert, W; Stocking, C				Engelmann, A.; Speidel, D.; Bornkamm, G. W.; Deppert, W.; Stocking, C.			Gadd45 beta is a pro-survival factor associated with stress-resistant tumors	ONCOGENE			English	Article						B-cell lymphoma; MYC; p53; Bcl-x(L); retroviral insertional mutagenesis; stress-resistance	NF-KAPPA-B; MYC TRANSGENIC MICE; CELL-DEATH; INDUCED APOPTOSIS; INSERTIONAL MUTAGENESIS; HEMATOPOIETIC-CELLS; SIGNALING PATHWAYS; GROWTH-ARREST; IDENTIFICATION; FIBROBLASTS	Tumors that acquire resistance against death stimuli constitute a severe problem in the context of cancer therapy. To determine genetic alterations that favor the development of stress-resistant tumors in vivo, we took advantage of polyclonal tumors generated after retroviral infection of newborn E lambda-MYC mice, in which the retroviral integration acts as a mutagen to enhance tumor progression. Tumor cells were cultivated ex vivo and exposed to gamma-irradiation prior to their transplantation into syngenic recipients, thereby providing a strong selective pressure for pro-survival mutations. Secondary tumors developing from stress-resistant tumor stem cells were analysed for retroviral integration sites to reveal candidate genes whose dysregulation confer survival. In addition to the gene encoding the antiapoptotic Bcl-x(L) protein, we identified the gadd45b locus to be a novel common integration site in these tumors, leading to enhanced expression. In accord with a thus far undocumented role of Gadd45 beta in tumorigenesis, we showed that NIH3T3 cells overexpressing Gadd45 beta form tumors in NOD/SCID mice. Interestingly and differently to other known 'classical' antiapoptotic factors, high Gadd45b levels did not protect against MYC-, UV- or gamma-irradiation-induced apoptosis, but conferred a strong and specific survival advantage to serum withdrawal.	[Engelmann, A.; Speidel, D.; Deppert, W.; Stocking, C.] Heinrich Pette Inst, D-20206 Hamburg, Germany; [Bornkamm, G. W.] GSF Forschungszentrum Umwelt & Gesundheit, Inst Klin Mol Biol & Tumorgenet, Munich, Germany	Heinrich Pette Institute; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Stocking, C (corresponding author), Heinrich Pette Inst, POB 201652, D-20206 Hamburg, Germany.	stocking@hpi.uni-hamburg.de	Speidel, Daniel/I-4244-2012					Baxter EW, 1996, J VIROL, V70, P2095, DOI 10.1128/JVI.70.4.2095-2100.1996; Bernier J, 2004, NAT REV CANCER, V4, P737, DOI 10.1038/nrc1451; Blyth K, 2000, ONCOGENE, V19, P773, DOI 10.1038/sj.onc.1203321; Chabner BA, 2005, NAT REV CANCER, V5, P65, DOI 10.1038/nrc1529; Das S, 2005, J BIOL CHEM, V280, P23748, DOI 10.1074/jbc.M412837200; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Gupta M, 2005, ONCOGENE, V24, P7170, DOI 10.1038/sj.onc.1208847; Gupta M, 2006, J BIOL CHEM, V281, P17552, DOI 10.1074/jbc.M600950200; HAUPT Y, 1991, CELL, V65, P753, DOI 10.1016/0092-8674(91)90383-A; Heinrichs S, 2003, ONCOGENE, V22, P555, DOI 10.1038/sj.onc.1206138; Hwang HC, 2002, P NATL ACAD SCI USA, V99, P11293, DOI 10.1073/pnas.162356099; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Kovalchuk AL, 2000, J EXP MED, V192, P1183, DOI 10.1084/jem.192.8.1183; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Krug U, 2002, ONCOGENE, V21, P3475, DOI 10.1038/sj.onc.1205322; Kues Wilfried A., 2002, Cloning and Stem Cells, V4, P231, DOI 10.1089/15362300260339511; Leicht M, 2003, MOL CELL BIOCHEM, V251, P119, DOI 10.1023/A:1025446302759; Liebermann DA, 2002, ONCOGENE, V21, P3391, DOI 10.1038/sj.onc.1205312; Lindsten T, 2003, J NEUROSCI, V23, P11112; Mikkers H, 2003, ADV CANCER RES, V88, P53, DOI 10.1016/S0065-230X(03)88304-5; Mikkers H, 2002, NAT GENET, V32, P459, DOI 10.1038/ng1102-459b; Okada H, 2004, NAT REV CANCER, V4, P592, DOI 10.1038/nrc1412; Packham G, 1998, GENE DEV, V12, P2475, DOI 10.1101/gad.12.16.2475; Paddenberg R, 2001, EUR J CELL BIOL, V80, P366, DOI 10.1078/0171-9335-00166; POIRIER Y, 1988, J VIROL, V62, P3985, DOI 10.1128/JVI.62.11.3985-3992.1988; Schmidt M, 2001, HUM GENE THER, V12, P743, DOI 10.1089/104303401750148649; Schwieger M, 2002, J EXP MED, V196, P1227, DOI 10.1084/jem.20020824; SELVAKUMARAN M, 1994, MOL CELL BIOL, V14, P2352, DOI 10.1128/MCB.14.4.2352; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Simm A, 1997, J CELL SCI, V110, P819; Speidel D, 2006, ONCOGENE, V25, P940, DOI 10.1038/sj.onc.1209126; Stewart M, 2002, J VIROL, V76, P4364, DOI 10.1128/JVI.76.9.4364-4369.2002; Tsujimoto Y, 2003, J CELL PHYSIOL, V195, P158, DOI 10.1002/jcp.10254; VANDERLUGT NMT, 1995, EMBO J, V14, P2536, DOI 10.1002/j.1460-2075.1995.tb07251.x; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; Yoo JY, 2003, J BIOL CHEM, V278, P43001, DOI 10.1074/jbc.M307869200; Zazzeroni F, 2003, BLOOD, V102, P3270, DOI 10.1182/blood-2003-03-0689; Zerbini LF, 2004, P NATL ACAD SCI USA, V101, P13618, DOI 10.1073/pnas.0402069101	38	31	33	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 28	2008	27	10					1429	1438		10.1038/sj.onc.1210772	http://dx.doi.org/10.1038/sj.onc.1210772			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	267ZR	17891184				2022-12-25	WOS:000253548200010
J	Kauffmann, A; Rosselli, F; Lazar, V; Winnepenninckx, V; Mansuet-Lupo, A; Dessen, P; van den Oord, JJ; Spatz, A; Sarasin, A				Kauffmann, A.; Rosselli, F.; Lazar, V.; Winnepenninckx, V.; Mansuet-Lupo, A.; Dessen, P.; van den Oord, J. J.; Spatz, A.; Sarasin, A.			High expression of DNA repair pathways is associated with metastasis in melanoma patients	ONCOGENE			English	Article						melanoma; metastasis; DNA repair; microarray	TOPOISOMERASE-II; CUTANEOUS MELANOMA; P53 MUTATIONS; DAMAGE; CARCINOMA; GENETICS; CELLS; FOXM1	We have identified a gene-profile signature for human primary malignant melanoma associated with metastasis to distant sites and poor prognosis. We analyse the differential gene expression by looking at whole biological pathways rather than individual genes. Among the most significant pathways associated with progression to metastasis, we found the DNA replication (P = 10(-14)) and the DNA repair pathways (P = 10(-16)). We concentrated our analysis on DNA repair and found that 48 genes of this category, among a list of 234 genes, are associated with metastatic progression. These genes belong essentially to the pathways allowing recovery of stalled replication forks due to spontaneous blockage or induced DNA lesions. Because almost all these differentially expressed repair genes were overexpressed in primary tumors with bad prognosis, we speculate that primary melanoma cells that will metastasize try to replicate in a fast and error-free mode. In contrast to the progression from melanocytes to primary melanoma, genetic stability appears to be necessary for a melanoma cell to give rise to distant metastasis. This overexpression of repair genes explains nicely the extraordinary resistance of metastatic melanoma to chemo- and radio-therapy. Our results may open a new avenue for the discovery of drugs active on human metastatic melanoma.	[Kauffmann, A.; Rosselli, F.; Dessen, P.; Sarasin, A.] Inst Gustave Roussy, CNRS, Lab Genomes & Canc, FRE2939,PR2, F-94805 Villejuif, France; [Kauffmann, A.; Rosselli, F.; Dessen, P.; Sarasin, A.] Univ Paris Sud, Orsay, France; [Lazar, V.] Inst Gustave Roussy, Unit Funct Genom, F-94805 Villejuif, France; [Winnepenninckx, V.] Univ Hosp Maastricht, Dept Pathol, Maastricht, HX, Netherlands; [Mansuet-Lupo, A.; Spatz, A.] Inst Gustave Roussy, Dept Biopathol, F-94805 Villejuif, France; [van den Oord, J. J.] Katholieke Univ Leuven, Dept Morphol & Mol Pathol, Louvain, Belgium	Centre National de la Recherche Scientifique (CNRS); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Maastricht University; Maastricht University Medical Centre (MUMC); UNICANCER; Gustave Roussy; KU Leuven	Sarasin, A (corresponding author), Inst Gustave Roussy, CNRS, Lab Genomes & Canc, FRE2939,PR2, 39 Rue Camille Desmoulins, F-94805 Villejuif, France.	sarasin@igr.fr	Lazar, Vladimir/AAV-2087-2020; SPATZ, ALAN/B-8645-2009; Filippo, Rosselli/AAO-6393-2020; Lazar, Vladimir/AAQ-2086-2020	SPATZ, ALAN/0000-0003-3020-1420; Filippo, Rosselli/0000-0003-1080-5745; 				Armstrong BK, 2001, J PHOTOCH PHOTOBIO B, V63, P8, DOI 10.1016/S1011-1344(01)00198-1; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balch CM, 2001, J CLIN ONCOL, V19, P3622, DOI 10.1200/JCO.2001.19.16.3622; Bastian BC, 2003, AM J PATHOL, V163, P1765, DOI 10.1016/S0002-9440(10)63536-5; Bernal JA, 2002, NAT GENET, V32, P306, DOI 10.1038/ng997; Bradshaw PS, 2005, NAT GENET, V37, P193, DOI 10.1038/ng1506; Burden DA, 1998, BBA-GENE STRUCT EXPR, V1400, P139, DOI 10.1016/S0167-4781(98)00132-8; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Costa RH, 2005, NAT CELL BIOL, V7, P108, DOI 10.1038/ncb0205-108; Dyrskjot L, 2003, NAT GENET, V33, P90, DOI 10.1038/ng1061; EDER JP, 1995, CANCER RES, V55, P6109; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; Halazonetis TD, 2004, DNA REPAIR, V3, P1057, DOI 10.1016/j.dnarep.2004.03.036; Hamid T, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-3; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Howe HL, 2001, J NATL CANCER I, V93, P824, DOI 10.1093/jnci/93.11.824; Jemal A, 2001, JNCI-J NATL CANCER I, V93, P678, DOI 10.1093/jnci/93.9.678; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Munoz P, 2005, NAT GENET, V37, P1063, DOI 10.1038/ng1633; Niida H, 2006, MUTAGENESIS, V21, P3, DOI 10.1093/mutage/gei063; O'Donnell RK, 2005, ONCOGENE, V24, P1244, DOI 10.1038/sj.onc.1208285; Rosenquist TA, 2003, DNA REPAIR, V2, P581, DOI 10.1016/S1568-7864(03)00025-9; SCHUUR ER, 1995, CELL GROWTH DIFFER, V6, P219; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; Spatz A, 2001, CANCER RES, V61, P2480; Stary A, 2002, BIOCHIMIE, V84, P49, DOI 10.1016/S0300-9084(01)01358-X; Thompson JF, 2005, LANCET, V365, P687, DOI 10.1016/S0140-6736(05)17951-3; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang L, 2002, ENVIRON MOL MUTAGEN, V39, P348, DOI 10.1002/em.10072; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Warters RL, 2005, J INVEST DERMATOL, V124, P807, DOI 10.1111/j.0022-202X.2005.23674.x; Winnepenninckx VR, 2006, JNCI-J NATL CANCER I, V98, P472, DOI 10.1093/jnci/djj103	32	195	198	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 24	2008	27	5					565	573		10.1038/sj.onc.1210700	http://dx.doi.org/10.1038/sj.onc.1210700			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	255RK	17891185				2022-12-25	WOS:000252674900001
J	Carlson, EC; Lin, M; Liu, CY; Kao, WWY; Perez, VL; Pearlman, E				Carlson, Eric C.; Lin, Michelle; Liu, Chia-Yang; Kao, Winston W-Y.; Perez, Victor L.; Pearlman, Eric			Keratocan and lumican regulate neutrophil infiltration and corneal clarity in lipopolysaccharide-induced keratitis by direct interaction with CXCL1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; EXPRESSION; GENE; ACTIVATION; PROLIFERATION; VISUALIZATION; DELIVERY; OPACITY; PROTEIN; STROMA	Keratocan and lumican are keratan-sulfate proteoglycans (KSPG), which have a critical role in maintaining corneal clarity. To determine whether these KSPGs have a role in corneal inflammation, we examined Kera(-/-) and Lum(-/-) mice in a model of lipopolysaccharide (LPS)-induced keratitis in which wild-type mice develop increased corneal thickness and haze due to neutrophil infiltration to the corneal stroma. Corneal thickness increases caused by LPS mice were significantly lower in Kera(-/-) and Lum(-/-) than wild-type mice. Further, LPS-injected Lum(-/-) mice had elevated corneal haze levels compared with that of Kera(-/-) and wild-type. At 24 h post-injection, total enhanced green fluorescent protein-positive bone marrow-derived inflammatory cells in chimeric mice was significantly lower in Kera(-/-) mice and Lum(-/-) mice compared with wildtype mice. Neutrophil infiltration was inhibited in Kera(-/-) and Lum(-/-) mice at 6 and 24 h post-stimulation, with Lum(-/-) corneas having the most profound defect in neutrophil migration. Reconstitution of keratocan and lumican expression in corneas of Kera(-/-) and Lum(-/-) mice using adeno-keratocan and adeno-lumican viral vectors, respectively, resulted in normal neutrophil infiltration in response to LPS. Immunoprecipitation/Western blot analysis showed that lumican and keratocan core proteins bind the CXC chemokine KC during a corneal inflammatory response, indicating that corneal KSPGs mediate neutrophil recruitment to the cornea by regulating chemokine gradient formation. Together, these data support a significant role for lumican and keratocan in a corneal inflammatory response with respect to edema, corneal clarity, and cellular infiltration.	Case Western Reserve Univ, Dept Ophthalmol, Cleveland, OH 44106 USA; Univ Cincinnati, Dept Ophthalmol, Cincinnati, OH 45267 USA; Univ Miami, Dept Ophthalmol, Miami, FL 33136 USA	Case Western Reserve University; University System of Ohio; University of Cincinnati; University of Miami	Carlson, EC (corresponding author), Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, 10900 Euclid Ave, Cleveland, OH 44106 USA.	Eric.Carlson@case.edu	Perez, Victor L./AAY-8633-2020	Liu, Chia-yang/0000-0002-8398-5516; Lin, Michelle/0000-0001-5367-1930	NATIONAL EYE INSTITUTE [R01EY010320, K08EY014912, P30EY011373, R01EY014362, R01EY011845] Funding Source: NIH RePORTER; NEI NIH HHS [P30 EY011373, EY11845, EY11373, R01 EY010320, EY1032, R01 EY011845, K08 EY014912, R01 EY014362] Funding Source: Medline; PHS HHS [R01 12486] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Auletta JJ, 2004, BIOL BLOOD MARROW TR, V10, P834, DOI 10.1016/j.bbmt.2004.08.003; Carlson EC, 2006, INVEST OPHTH VIS SCI, V47, P241, DOI 10.1167/iovs.04-0741; Carlson EC, 2005, J BIOL CHEM, V280, P25541, DOI 10.1074/jbc.M500249200; Carlson EC, 2004, INVEST OPHTH VIS SCI, V45, P2194, DOI 10.1167/iovs.03-1224; Carlson EC, 2003, MOL VIS, V9, P615; Carlson EC, 2003, BIOCHEM J, V369, P461, DOI 10.1042/BJ20020593; Chakravarti S, 2000, INVEST OPHTH VIS SCI, V41, P3365; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; Chen J, 2001, J IMMUNOL, V167, P1297, DOI 10.4049/jimmunol.167.3.1297; Funderburgh JL, 1997, INVEST OPHTH VIS SCI, V38, P1159; Gueders MM, 2005, J IMMUNOL, V175, P2589, DOI 10.4049/jimmunol.175.4.2589; Johnson AC, 2005, INVEST OPHTH VIS SCI, V46, P589, DOI 10.1167/iovs.04-1077; Khan S, 2007, J LEUKOCYTE BIOL, V81, P315, DOI 10.1189/jlb.0506344; Khatri S, 2002, INVEST OPHTH VIS SCI, V43, P2278; Kozu T, 1996, BIOCHIMIE, V78, P1067, DOI 10.1016/S0300-9084(97)86731-4; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Lin M, 2007, J LEUKOCYTE BIOL, V81, P786, DOI 10.1189/jlb.0806502; Liu CY, 2003, J BIOL CHEM, V278, P21672, DOI 10.1074/jbc.M301169200; Liu CY, 2000, GENE, V250, P85, DOI 10.1016/S0378-1119(00)00165-7; Liu Y, 2007, BIOMATERIALS, V28, P1393, DOI 10.1016/j.biomaterials.2006.11.019; Oshima T, 2006, BRIT J OPHTHALMOL, V90, P218, DOI 10.1136/bjo.2005.077875; Pearlman E, 2000, PARASITE IMMUNOL, V22, P625, DOI 10.1046/j.1365-3024.2000.00345.x; PING LY, 2002, J PATHOL, V196, P324; Saika S, 2000, J BIOL CHEM, V275, P2607, DOI 10.1074/jbc.275.4.2607; Stechschulte SU, 2001, INVEST OPHTH VIS SCI, V42, P1975; Szliter E A, 2006, Eye Contact Lens, V32, P12, DOI 10.1097/01.icl.0000167611.03883.58; Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X; Vij N, 2005, INVEST OPHTH VIS SCI, V46, P88, DOI 10.1167/iovs.04-0833; Wu F, 2007, J BIOL CHEM, V282, P26409, DOI 10.1074/jbc.M702402200; Ying SX, 1997, J BIOL CHEM, V272, P30306, DOI 10.1074/jbc.272.48.30306	30	58	58	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35502	35509		10.1074/jbc.M705823200	http://dx.doi.org/10.1074/jbc.M705823200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17911102	hybrid, Green Accepted			2022-12-25	WOS:000251458100009
J	Lin, BC; Sullivan, R; Lee, Y; Moran, S; Glover, E; Bradfield, CA				Lin, Bernice C.; Sullivan, Ruth; Lee, Youngsook; Moran, Susan; Glover, Edward; Bradfield, Christopher A.			Deletion of the aryl hydrocarbon receptor-associated protein 9 leads to cardiac malformation and embryonic lethality	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-INTERACTING-PROTEIN; X-ASSOCIATED PROTEIN-2; CONGENITAL HEART-DISEASE; AH RECEPTOR; PITUITARY-ADENOMA; NUCLEAR-PROTEIN; GENE-MUTATIONS; OUTFLOW TRACT; PPAR-ALPHA; MICE	The aryl hydrocarbon receptor-associated protein 9, ARA9 ( also known as XAP2 or AIP1), is a chaperone that is found in complexes with certain xenobiotic receptors, such as the aryl hydrocarbon receptor (AHR) and the peroxisome proliferator-activated receptor alpha(PPAR alpha). In an effort to better understand the physiological role of ARA9 outside of its role in xenobiotic signal transduction, we generated a null allele at the Ara9 locus in mice. Mice with a homozygous deletion of this gene die at various time points throughout embryonic development. Embryonic lethality is accompanied by decreased blood flow to head and limbs, as well as a range of heart deformations, including double outlet right ventricle, ventricular-septal defects, and pericardial edema. The early cardiovascular defects observed in Ara9-null mice suggest an essential role for the ARA9 protein in cardiac development. The observation that the developmental aberrations in Ara9-null mice are distinct from those observed for disrupted alleles at Ahr or Ppar alpha indicates that the role of ARA9 in cardiac development is independent of its interactions with its known xenobiotic receptor partners.	Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA; Univ Wisconsin, Ctr Comprehens Canc, Madison, WI 53792 USA; Univ Wisconsin, Dept Anat, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Bradfield, CA (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, 1400 Univ Ave, Madison, WI 53706 USA.	bradfield@oncology.wisc.edu			NCI NIH HHS [P30-CA014520, T32-CA009135] Funding Source: Medline; NIEHS NIH HHS [R01-ES006883, R01 ES006883] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA014520, T32CA009135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES006883] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Adida C, 1998, AM J PATHOL, V152, P43; Bajolle F, 2006, CIRC RES, V98, P421, DOI 10.1161/01.RES.0000202800.85341.6e; Benson D. Woodrow, 2002, Cardiology Clinics, V20, P385, DOI 10.1016/S0733-8651(02)00009-7; BERNSTEIN D, 1996, CARDIOVASCULAR SYSTE, P1286; Bolger GB, 2003, J BIOL CHEM, V278, P33351, DOI 10.1074/jbc.M303269200; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Brand T, 2003, DEV BIOL, V258, P1, DOI 10.1016/S0012-1606(03)00112-X; BROACH JR, 1982, CELL, V29, P227, DOI 10.1016/0092-8674(82)90107-6; Broekhuizen MLA, 1999, ULTRASOUND OBST GYN, V13, P437, DOI 10.1046/j.1469-0705.1999.13060437.x; Bunger MK, 2003, J BIOL CHEM, V278, P17767, DOI 10.1074/jbc.M209594200; Campione M, 2002, COLD SPRING HARB SYM, V67, P89, DOI 10.1101/sqb.2002.67.89; Carver LA, 1997, J BIOL CHEM, V272, P11452; Carver LA, 1998, J BIOL CHEM, V273, P33580, DOI 10.1074/jbc.273.50.33580; Chen BB, 2000, NAT GENET, V24, P296, DOI 10.1038/73528; Chen J, 1998, DEVELOPMENT, V125, P1943; Christiansen JH, 2006, NUCLEIC ACIDS RES, V34, pD637, DOI 10.1093/nar/gkj006; Conway SJ, 2003, GENESIS, V35, P1, DOI 10.1002/gene.10152; Daly AF, 2007, J CLIN ENDOCR METAB, V92, P1891, DOI 10.1210/jc.2006-2513; de Oliveira SK, 2007, J BIOL CHEM, V282, P13656, DOI 10.1074/jbc.M610942200; Dees E, 2002, CURR OPIN PEDIATR, V14, P627, DOI 10.1097/00008480-200210000-00011; DICARLO J, 1994, PEDIATR CLIN N AM, V41, P525; DOLWICK KM, 1993, MOL PHARMACOL, V44, P911; Dymecki SM, 1996, P NATL ACAD SCI USA, V93, P6191, DOI 10.1073/pnas.93.12.6191; EISEN HJ, 1983, BIOCHEM ACTION HORM, V10, P227; FernandezSalguero PM, 1996, TOXICOL APPL PHARM, V140, P173, DOI 10.1006/taap.1996.0210; Fishman MC, 1997, DEVELOPMENT, V124, P2099; Franco D, 2003, TRENDS CARDIOVAS MED, V13, P157, DOI 10.1016/S1050-1738(03)00039-2; FUKUNAGA BN, 1995, J BIOL CHEM, V270, P29270, DOI 10.1074/jbc.270.49.29270; Georgitsi M, 2007, BRIT J CANCER, V96, P352, DOI 10.1038/sj.bjc.6603573; Georgitsi M, 2007, P NATL ACAD SCI USA, V104, P4101, DOI 10.1073/pnas.0700004104; HARDING MW, 1989, NATURE, V341, P758, DOI 10.1038/341758a0; Hemminki K, 2007, ENDOCR-RELAT CANCER, V14, P103, DOI 10.1677/ERC-06-0008; Hogers B, 1997, CIRC RES, V80, P473, DOI 10.1161/01.RES.80.4.473; Jain S, 1998, MECH DEVELOP, V73, P117, DOI 10.1016/S0925-4773(98)00038-0; Kang BH, 2006, J BIOL CHEM, V281, P24721, DOI 10.1074/jbc.M603175200; Kashuba E, 2000, ONCOGENE, V19, P1801, DOI 10.1038/sj.onc.1203501; Katz SG, 2003, P NATL ACAD SCI USA, V100, P14030, DOI 10.1073/pnas.1936250100; KURIHARA Y, 1995, J CLIN INVEST, V96, P293, DOI 10.1172/JCI118033; Kuzhandaivelu N, 1996, NUCLEIC ACIDS RES, V24, P4741, DOI 10.1093/nar/24.23.4741; LaPres JJ, 2000, J BIOL CHEM, V275, P6153, DOI 10.1074/jbc.275.9.6153; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Lee Y, 2000, CIRC RES, V86, P932, DOI 10.1161/01.RES.86.9.932; Lees MJ, 2003, J BIOL CHEM, V278, P35878, DOI 10.1074/jbc.M302430200; Lin CR, 1999, NATURE, V401, P279, DOI 10.1038/45803; Ma ACH, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-50; Ma Q, 1997, J BIOL CHEM, V272, P8878; Meyer BK, 1998, MOL CELL BIOL, V18, P978, DOI 10.1128/MCB.18.2.978; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Michalik L, 2001, J CELL BIOL, V154, P799, DOI 10.1083/jcb.200011148; MORRISONGRAHAM K, 1992, DEVELOPMENT, V115, P133; Motojima K, 2006, FEBS J, V273, P292, DOI 10.1111/j.1742-4658.2005.05060.x; Petrulis JR, 2000, J BIOL CHEM, V275, P37448, DOI 10.1074/jbc.M006873200; Sanford LP, 1997, DEVELOPMENT, V124, P2659; Schmidt JV, 1996, P NATL ACAD SCI USA, V93, P6731, DOI 10.1073/pnas.93.13.6731; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Su JL, 1998, HYBRIDOMA, V17, P47, DOI 10.1089/hyb.1998.17.47; Sumanasekera WK, 2003, J BIOL CHEM, V278, P4467, DOI 10.1074/jbc.M211261200; Vierimaa O, 2006, SCIENCE, V312, P1228, DOI 10.1126/science.1126100; Waldo K, 1998, DEV BIOL, V196, P129, DOI 10.1006/dbio.1998.8860; Watanabe S, 2005, AM J PHYSIOL-RENAL, V288, pF40, DOI 10.1152/ajprenal.00218.2004; Ya J, 1998, CIRC RES, V83, P986, DOI 10.1161/01.RES.83.10.986; Yanagisawa H, 1998, J CLIN INVEST, V102, P22, DOI 10.1172/JCI2698; ZWERTS F, 2007, BLOOD	64	67	69	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35924	35932		10.1074/jbc.M705471200	http://dx.doi.org/10.1074/jbc.M705471200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17916558	hybrid			2022-12-25	WOS:000251458100053
J	Mizuno, Y; Moorhead, GBG; Ng, KKS				Mizuno, Yutaka; Moorhead, Greg B. G.; Ng, Kenneth K. -S.			Structural basis for the regulation of N-acetylglutamate kinase by PII in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PROTEIN; L-GLUTAMATE KINASE; ARGININE-BIOSYNTHESIS; CRYSTAL-STRUCTURE; COMPLEX-FORMATION; PLASTID CARBON; NITROGEN; REVEALS; GLNK; AMTB	PII is a highly conserved regulatory protein found in organisms across the three domains of life. In cyanobacteria and plants, PII relieves the feedback inhibition of the rate-limiting step in arginine biosynthesis catalyzed by N-acetylglutamate kinase (NAGK). To understand the molecular structural basis of enzyme regulation by PII, we have determined a 2.5-angstrom resolution crystal structure of a complex formed between two homotrimers of PII and a single hexamer of NAGK from Arabidopsis thaliana bound to the metabolites N-acetylglutamate, ADP, ATP, and arginine. In PII, the T-loop and Trp(22) at the start of the alpha 1-helix, which are both adjacent to the ATP-binding site of PII, contact two beta-strands as well as the ends of two central helices (alpha E and alpha G) in NAGK, the opposing ends of which form major portions of the ATP and N-acetylglutamate substrate-binding sites. The binding of Mg2+ center dot ATP to PII stabilizes a conformation of the T-loop that favors interactions with both open and closed conformations of NAGK. Interactions between PII and NAGK appear to limit the degree of opening and closing of the active-site cleft in opposition to a domain-separating inhibitory effect exerted by arginine, thus explaining the stimulatory effect of PII on the kinetics of arginine-inhibited NAGK.	Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; Univ Calgary, Alberta Ingenu Ctr Carbohydrate Sci, Calgary, AB T2N 1N4, Canada	University of Calgary; University of Calgary	Ng, KKS (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	ngk@ucalgary.ca		Ng, Kenneth K.S./0000-0001-7280-8445				Arcondeguy T, 2001, MICROBIOL MOL BIOL R, V65, P80, DOI 10.1128/MMBR.65.1.80-105.2001; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burillo S, 2004, J BACTERIOL, V186, P3346, DOI 10.1128/JB.186.11.3346-3354.2004; Chen YM, 2006, J BIOL CHEM, V281, P5726, DOI 10.1074/jbc.M510945200; Conroy MJ, 2007, P NATL ACAD SCI USA, V104, P1213, DOI 10.1073/pnas.0610348104; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Ferrario-Mery S, 2006, FEBS LETT, V580, P2015, DOI 10.1016/j.febslet.2006.02.075; Ferrario-Mery S, 2005, PLANTA, V223, P28, DOI 10.1007/s00425-005-0063-5; Forchhammer K, 2004, FEMS MICROBIOL REV, V28, P319, DOI 10.1016/j.femsre.2003.11.001; Gil-Ortiz F, 2003, J MOL BIOL, V331, P231, DOI 10.1016/S0022-2836(03)00716-2; Gruswitz F, 2007, P NATL ACAD SCI USA, V104, P42, DOI 10.1073/pnas.0609796104; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; Heinrich A, 2004, MOL MICROBIOL, V52, P1303, DOI 10.1111/j.1365-2958.2004.04058.x; Hsieh MH, 1998, P NATL ACAD SCI USA, V95, P13965, DOI 10.1073/pnas.95.23.13965; Jiang P, 1997, J BACTERIOL, V179, P4342, DOI 10.1128/jb.179.13.4342-4353.1997; Maheswaran M, 2004, J BIOL CHEM, V279, P55202, DOI 10.1074/jbc.M410971200; MATTHEWS BW, 1985, METHOD ENZYMOL, V114, P176; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Mizuno Y, 2007, BIOCHEMISTRY-US, V46, P1477, DOI 10.1021/bi062149e; Moorhead GBG, 2003, PLANT PHYSIOL, V133, P492, DOI 10.1104/pp.103.025627; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ninfa AJ, 2000, TRENDS MICROBIOL, V8, P172, DOI 10.1016/S0966-842X(00)01709-1; Ninfa AJ, 2005, CURR OPIN MICROBIOL, V8, P168, DOI 10.1016/j.mib.2005.02.011; Osanai T, 2007, PLANT CELL PHYSIOL, V48, P908, DOI 10.1093/pcp/pcm072; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ramon-Maiques S, 2006, J MOL BIOL, V356, P695, DOI 10.1016/j.jmb.2005.11.079; Ramon-Maiques S, 2002, STRUCTURE, V10, P329, DOI 10.1016/S0969-2126(02)00721-9; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Sakai H, 2005, J STRUCT BIOL, V149, P99, DOI 10.1016/j.jsb.2004.08.007; Smith CS, 2004, BBA-PROTEINS PROTEOM, V1699, P145, DOI 10.1016/j.bbapap.2004.02.009; Smith CS, 2003, PLANT J, V33, P353, DOI 10.1046/j.1365-313X.2003.01634.x; Sugiyama K, 2004, PLANT CELL PHYSIOL, V45, P1768, DOI 10.1093/pcp/pch199; Xu YB, 1998, J MOL BIOL, V282, P149, DOI 10.1006/jmbi.1998.1979; Xu YB, 2001, EUR J BIOCHEM, V268, P2028, DOI 10.1046/j.1432-1327.2001.02074.x; Yildiz O, 2007, EMBO J, V26, P589, DOI 10.1038/sj.emboj.7601492	38	49	51	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35733	35740		10.1074/jbc.M707127200	http://dx.doi.org/10.1074/jbc.M707127200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17913711	hybrid			2022-12-25	WOS:000251458100034
J	Abbott, DW; Boraston, AB				Abbott, D. Wade; Boraston, Alisdair B.			A family 2 pectate lyase displays a rare fold and transition metal-assisted beta-elimination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERWINIA-CHRYSANTHEMI 3937; RETICULUM QUALITY-CONTROL; CRYSTAL-STRUCTURE; YERSINIA-ENTEROCOLITICA; PECTIN METHYLESTERASE; ASPERGILLUS-NIGER; ACTIVE-SITE; PORIN KDGM; IDENTIFICATION; ALPHA-1,2-MANNOSIDASES	The family 2 pectate lyase from Yersinia enterocolitica (YePL2A), solved to 1.5 angstrom, reveals it to be the first prokaryotic protein reported to display the rare (alpha/alpha)(7) barrel fold. In addition to its apo form, we have also determined the structure of a metal-bound form of YePL2A ( to 2.0 angstrom) and a trigalacturonic acid-bound substrate complex ( to 2.1 angstrom). Although its fold is rare, the catalytic center of YePL2A can be superimposed with structurally unrelated families, underlining the conserved catalytic amino acid architecture of the beta-elimination mechanism. In addition to its overall structure, YePL2A also has two other unique features: 1) it utilizes a metal atom other than calcium for catalysis, and 2) its Bronstead base is in an alternate conformation and directly interacts with the uronate group of the substrate.	Univ Victoria, Victoria, BC V8W 3P6, Canada	University of Victoria	Boraston, AB (corresponding author), Univ Victoria, PO Box 3055 STN CSC, Victoria, BC V8W 3P6, Canada.	boraston@uvic.ca		Abbott, Wade/0000-0003-4893-5799; Boraston, Alisdair/0000-0001-6417-0592				Abbott DW, 2007, J MOL BIOL, V367, P1023, DOI 10.1016/j.jmb.2007.01.030; ABBOTT DW, 2007, IN PRESS J MOL BIOL; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Benen JAE, 1999, EUR J BIOCHEM, V259, P577, DOI 10.1046/j.1432-1327.1999.00080.x; Blot N, 2002, J BIOL CHEM, V277, P7936, DOI 10.1074/jbc.M109193200; Boraston AB, 2001, BIOCHEMISTRY-US, V40, P6240, DOI 10.1021/bi0101695; BOWEN JH, 1979, AM J CLIN PATHOL, V72, P586; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Charnock SJ, 2002, P NATL ACAD SCI USA, V99, P12067, DOI 10.1073/pnas.182431199; Cocolin L, 2005, INT J FOOD MICROBIOL, V105, P71, DOI 10.1016/j.ijfoodmicro.2005.05.006; Coutinho PM, 1999, ROY SOC CH, P3; de Armas HN, 2004, ACTA CRYSTALLOGR D, V60, P999, DOI 10.1107/S090744490400602X; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Harding MM, 2006, ACTA CRYSTALLOGR D, V62, P678, DOI 10.1107/S0907444906014594; Herscovics A, 2001, BIOCHIMIE, V83, P757, DOI 10.1016/S0300-9084(01)01319-0; Hugouvieux-Cotte-Pattat N, 2001, MOL MICROBIOL, V41, P1125, DOI 10.1046/j.1365-2958.2001.02565.x; Hugouvieux-Cotte-Pattat N, 2001, MOL MICROBIOL, V41, P1113, DOI 10.1046/j.1365-2958.2001.02564.x; HugouvieuxCottePattat N, 1996, ANNU REV MICROBIOL, V50, P213, DOI 10.1146/annurev.micro.50.1.213; Jalava K, 2006, J INFECT DIS, V194, P1209, DOI 10.1086/508191; Jenkins J, 2004, J BIOL CHEM, V279, P9139, DOI 10.1074/jbc.M311390200; Jenkins J, 2001, PROG BIOPHYS MOL BIO, V77, P111, DOI 10.1016/S0079-6107(01)00013-X; Jenkins J, 2001, J MOL BIOL, V305, P951, DOI 10.1006/jmbi.2000.4324; Johansson K, 2002, FEBS LETT, V514, P243, DOI 10.1016/S0014-5793(02)02372-4; KARAPINAR M, 1992, INT J FOOD MICROBIOL, V16, P261, DOI 10.1016/0168-1605(92)90086-I; Karaveg K, 2005, J BIOL CHEM, V280, P16197, DOI 10.1074/jbc.M500119200; Liao CH, 1999, CAN J MICROBIOL, V45, P396, DOI 10.1139/cjm-45-5-396; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pellinen T, 2003, BIOCHEM J, V372, P329, DOI 10.1042/BJ20030027; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; PICKERSGILL R, 1994, NAT STRUCT BIOL, V1, P717, DOI 10.1038/nsb1094-717; Pickersgill R, 1998, J BIOL CHEM, V273, P24660, DOI 10.1074/jbc.273.38.24660; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Rodionov DA, 2004, MICROBIOL-SGM, V150, P3571, DOI 10.1099/mic.0.27041-0; Roy C, 1999, J BACTERIOL, V181, P3705, DOI 10.1128/JB.181.12.3705-3709.1999; Scavetta RD, 1999, PLANT CELL, V11, P1081, DOI 10.1105/tpc.11.6.1081; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Selma MV, 2006, J FOOD PROTECT, V69, P2357, DOI 10.4315/0362-028X-69.10.2357; Shevchik VE, 1999, J BACTERIOL, V181, P3912, DOI 10.1128/JB.181.13.3912-3919.1999; Shevchik VE, 1999, J BACTERIOL, V181, P1652, DOI 10.1128/JB.181.5.1652-1663.1999; Tempel W, 2004, J BIOL CHEM, V279, P29774, DOI 10.1074/jbc.M403065200; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Vallee F, 2000, EMBO J, V19, P581, DOI 10.1093/emboj/19.4.581; Van Petegem F, 2001, J MOL BIOL, V312, P157, DOI 10.1006/jmbi.2001.4946; van Santen Y, 1999, J BIOL CHEM, V274, P30474, DOI 10.1074/jbc.274.43.30474; YODER MD, 1993, STRUCTURE, V1, P241, DOI 10.1016/0969-2126(93)90013-7	46	28	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35328	35336		10.1074/jbc.M705511200	http://dx.doi.org/10.1074/jbc.M705511200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17881361	hybrid			2022-12-25	WOS:000251155200076
J	Versees, W; Spaepen, S; Wood, MDH; Leeper, FJ; Vanderleyden, J; Steyaert, J				Versees, Wim; Spaepen, Stijn; Wood, Martin D. H.; Leeper, Finian J.; Vanderleyden, Jos; Steyaert, Jan			Molecular mechanism of allosteric substrate activation in a thiamine diphosphate-dependent decarboxylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST PYRUVATE-DECARBOXYLASE; AZOSPIRILLUM-BRASILENSE; CRYSTAL-STRUCTURE; 1',4'-IMINOPYRIMIDINE TAUTOMER; PHENYLPYRUVATE DECARBOXYLASE; ZYMOMONAS-MOBILIS; STRUCTURAL BASIS; WILD-TYPE; ENZYMES; CATALYSIS	Thiamine diphosphate-dependent enzymes are involved in a wide variety of metabolic pathways. The molecular mechanism behind active site communication and substrate activation, observed in some of these enzymes, has since long been an area of debate. Here, we report the crystal structures of a phenylpyruvate decarboxylase in complex with its substrates and a covalent reaction intermediate analogue. These structures reveal the regulatory site and unveil the mechanism of allosteric substrate activation. This signal transduction relies on quaternary structure reorganizations, domain rotations, and a pathway of local conformational changes that are relayed from the regulatory site to the active site. The current findings thus uncover the molecular mechanism by which the binding of a substrate in the regulatory site is linked to the mounting of the catalytic machinery in the active site in this thiamine diphosphate-dependent enzyme.	Vrije Univ Brussels, Dept Ultrastruct, B-1050 Brussels, Belgium; VIB, Dept Mol & Cell Interact, B-1050 Brussels, Belgium; Katholieke Univ Leuven, Ctr Microbial & Plant Genet, INPAC, B-3001 Heverlee, Belgium; Univ Chem Lab, Cambridge CB2 1EW, England	Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); KU Leuven; University of Cambridge	Versees, W (corresponding author), Vrije Univ Brussels, Dept Ultrastruct, Pleinlaan 2, B-1050 Brussels, Belgium.	wversees@vub.ac.be	Leeper, Finian/B-4842-2012; steyaert, jan/GQP-7811-2022; Versées, Wim/H-5518-2015; Steyaert, Jan/H-4662-2011; Spaepen, Stijn/H-5646-2019	Steyaert, Jan/0000-0002-3825-874X; Spaepen, Stijn/0000-0001-5465-8287; Leeper, Finian James/0000-0003-3408-5199; Versees, Wim/0000-0002-4695-696X				Baburina I, 1998, BIOCHEMISTRY-US, V37, P1235, DOI 10.1021/bi970990+; Berthold CL, 2005, J BIOL CHEM, V280, P41645, DOI 10.1074/jbc.M509921200; BRESLOW R, 1958, J AM CHEM SOC, V80, P3719, DOI 10.1021/ja01547a064; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; COSTACURTA A, 1994, MOL GEN GENET, V243, P463, DOI 10.1007/BF00280477; DAVIES DD, 1967, BIOCHEM J, V104, pP50; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dobbelaere S, 1999, PLANT SOIL, V212, P155, DOI 10.1023/A:1004658000815; Dobritzsch D, 1998, J BIOL CHEM, V273, P20196, DOI 10.1074/jbc.273.32.20196; Duggleby RG, 2006, ACCOUNTS CHEM RES, V39, P550, DOI 10.1021/ar068022z; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fiedler E, 2002, P NATL ACAD SCI USA, V99, P591, DOI 10.1073/pnas.022510999; Frank RAW, 2004, SCIENCE, V306, P872, DOI 10.1126/science.1101030; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; Jordan F, 2003, NAT PROD REP, V20, P184, DOI 10.1039/b111348h; Jordan F, 2005, ACCOUNTS CHEM RES, V38, P755, DOI 10.1021/ar040244e; Jordan F, 2003, J AM CHEM SOC, V125, P12732, DOI 10.1021/ja0346126; Joseph E, 2006, BIOCHEMISTRY-US, V45, P13517, DOI 10.1021/bi0615588; Kern D, 1997, SCIENCE, V275, P67, DOI 10.1126/science.275.5296.67; Kluger R, 2006, J AM CHEM SOC, V128, P15856, DOI 10.1021/ja066249j; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Krieger F, 2002, EUR J BIOCHEM, V269, P3256, DOI 10.1046/j.1432-1033.2002.03006.x; Leeper FJ, 2005, BIOCHEM SOC T, V33, P772, DOI 10.1042/BST0330772; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lu GG, 2000, EUR J BIOCHEM, V267, P861, DOI 10.1046/j.1432-1327.2000.01070.x; Machius M, 2006, STRUCTURE, V14, P287, DOI 10.1016/j.str.2005.10.009; Mann S, 2004, ORG BIOMOL CHEM, V2, P1732, DOI 10.1039/b403619k; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MULLER YA, 1993, SCIENCE, V259, P965, DOI 10.1126/science.8438155; Nemeria N, 2004, BIOCHEMISTRY-US, V43, P6565, DOI 10.1021/bi049549r; Nemeria N, 2007, P NATL ACAD SCI USA, V104, P78, DOI 10.1073/pnas.0609973104; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Schenk G, 1997, EUR J BIOCHEM, V248, P63, DOI 10.1111/j.1432-1033.1997.t01-1-00063.x; Schowen RL, 1998, COMPREHENSIVE BIOL C, V2, P217; Schutz A, 2005, BIOCHEMISTRY-US, V44, P6164, DOI 10.1021/bi0473354; Sergienko EA, 2002, BIOCHEMISTRY-US, V41, P3952, DOI 10.1021/bi011860a; Somers E, 2005, APPL ENVIRON MICROB, V71, P1803, DOI 10.1128/AEM.71.4.1803-1810.2005; Spaepen S, 2007, J BACTERIOL, V189, P7626, DOI 10.1128/JB.00830-07; Versees W, 2007, FEBS J, V274, P2363, DOI 10.1111/j.1742-4658.2007.05771.x; Wang J, 2001, BIOCHEMISTRY-US, V40, P1755, DOI 10.1021/bi001003r; WEISS PM, 1988, BIOCHEMISTRY-US, V27, P2197, DOI 10.1021/bi00406a058; Wille G, 2006, NAT CHEM BIOL, V2, P324, DOI 10.1038/nchembio788	43	24	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35269	35278		10.1074/jbc.M706048200	http://dx.doi.org/10.1074/jbc.M706048200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17905741	Green Published, hybrid			2022-12-25	WOS:000251155200071
J	Gerevich, Z; Zadori, ZS; Koles, L; Kopp, L; Milius, D; Wirkner, K; Gyires, K; Illes, P				Gerevich, Zoltan; Zadori, Zoltan S.; Koeles, Laszlo; Kopp, Laurenz; Milius, Doreen; Wirkner, Kerstin; Gyires, Klara; Illes, Peter			Dual effect of acid pH on purinergic P2X(3) receptors depends on the histidine 206 residue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROOT GANGLION NEURONS; P2X(3) RECEPTOR-CHANNELS; ION-CHANNEL; EXTRACELLULAR PH; TISSUE ACIDOSIS; MOLECULAR PHYSIOLOGY; CAPSAICIN RECEPTOR; ATP-RESPONSES; P2Y RECEPTORS; PAIN	Whole cell patch clamp investigations were carried out to clarify the pH sensitivity of native and recombinant P2X(3) receptors. In HEK293 cells permanently transfected with human (h) P2X(3) receptors (HEK293- hP2X(3) cells), an acidic pH shifted the concentration-response curve for alpha,beta- methylene ATP (alpha,beta-meATP) to the right and increased its maximum. An alkalic pH did not alter the effect of alpha,beta-meATP. Further, a low pH value increased the activation time constant (tau(on)) of the alpha,beta-meATP current; the fast and slow time constants of desensitization (tau(des1), tau(des2)) were at the same time also increased. Finally, acidification accelerated the recovery of P2X(3) receptors from the desensitized state. Replacement of histidine 206, but not histidine 45, by alanine abolished the pH-induced effects on hP2X(3) receptors transiently expressed in HEK293 cells. Changes in the intracellular pH had no effect on the amplitude or time course of the alpha,beta-meATP currents. The voltage sensitivity and reversal potential of the currents activated by alpha,beta-meATP were unaffected by extracellular acidification. Similar effects were observed in a subpopulation of rat dorsal root ganglion neurons expressing homomeric P2X(3) receptor channels. It is suggested that acidification may have a dual effect on P2X(3) channels, by decreasing the current amplitude at low agonist concentrations (because of a decrease in the rate of activation) and increasing it at high concentrations (because of a decrease in the rate of desensitization). Thereby, a differential regulation of pain sensation during e.g. inflammation may occur at the C fiber terminals of small DRG neurons in peripheral tissues.	Univ Leipzig, Rudolf Boehm Inst Pharmacol & Toxicol, D-04107 Leipzig, Germany; Semmelweis Univ, Dept Pharmacol & Pharmacotherapy, H-1089 Budapest, Hungary	Leipzig University; Semmelweis University	Gerevich, Z (corresponding author), Univ Leipzig, Rudolf Boehm Inst Pharmacol & Toxicol, Haertelstr 16-18, D-04107 Leipzig, Germany.	gerz@medizin.uni-leipzig.de	Zádori, Zoltán S/J-9144-2017	Zádori, Zoltán S/0000-0001-7312-618X				[Anonymous], 1929, KLIN WOCHENSCHR; Burgard EC, 1999, J NEUROPHYSIOL, V82, P1590, DOI 10.1152/jn.1999.82.3.1590; Burnstock G, 1996, CIBA F SYMP, V198, P1; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chizh BA, 2001, PHARMACOL REV, V53, P553; Clarke CE, 2000, J PHYSIOL-LONDON, V523, P697, DOI 10.1111/j.1469-7793.2000.00697.x; Clyne JD, 2002, J PHYSIOL-LONDON, V539, P347, DOI 10.1113/jphysiol.2001.013244; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Garber K, 2003, J NATL CANCER I, V95, P770, DOI 10.1093/jnci/95.11.770; Gerevich Z, 2007, BRIT J PHARMACOL, V151, P226, DOI 10.1038/sj.bjp.0707217; Gerevich Z, 2005, EUR J PHARMACOL, V521, P34, DOI 10.1016/j.ejphar.2005.08.001; Gerevich Z, 2004, J NEUROSCI, V24, P797, DOI 10.1523/JNEUROSCI.4019-03.2004; Grote A, 2005, MOL MEMBR BIOL, V22, P497, DOI 10.1080/09687860500370638; Hubscher CH, 2001, NEUROREPORT, V12, P2995, DOI 10.1097/00001756-200109170-00048; Illes P, 2004, EUR J PHARMACOL, V483, P5, DOI 10.1016/j.ejphar.2003.10.030; Issberner U, 1996, NEUROSCI LETT, V208, P191, DOI 10.1016/0304-3940(96)12576-3; JACOBUS WE, 1977, NATURE, V265, P756, DOI 10.1038/265756a0; Kao YH, 2000, BIOPHYS J, V79, P1637, DOI 10.1016/S0006-3495(00)76414-9; King BF, 1997, BRIT J PHARMACOL, V121, P1445, DOI 10.1038/sj.bjp.0701286; Lalo U, 2007, J CELL PHYSIOL, V212, P473, DOI 10.1002/jcp.21043; Li CY, 1996, J NEUROPHYSIOL, V76, P3048, DOI 10.1152/jn.1996.76.5.3048; Li CY, 1997, PFLUG ARCH EUR J PHY, V433, P446, DOI 10.1007/s004240050299; Li CY, 1996, NEUROREPORT, V7, P2151, DOI 10.1097/00001756-199609020-00018; Ma Bei, 2006, Purinergic Signal, V2, P481, DOI 10.1007/s11302-006-9017-z; MacKenzie AB, 1999, ANN NY ACAD SCI, V868, P716, DOI 10.1111/j.1749-6632.1999.tb11351.x; North RA, 2004, J PHYSIOL-LONDON, V554, P301, DOI 10.1113/jphysiol.2003.048587; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Pan HL, 1999, J PHYSIOL-LONDON, V518, P857, DOI 10.1111/j.1469-7793.1999.0857p.x; Peer Lyndon., 1955, TRANSPLANTATION TISS; Reeh PW, 1996, PROG BRAIN RES, V113, P143, DOI 10.1016/S0079-6123(08)61085-7; Revici E., 1949, B I APPL BIOL, V1, P21; Skorinkin A, 2003, J GEN PHYSIOL, V122, P33, DOI 10.1085/jgp.200308825; Sokolova E, 2004, BRIT J PHARMACOL, V141, P1048, DOI 10.1038/sj.bjp.0705701; Sokolova E, 2006, MOL PHARMACOL, V70, P373, DOI 10.1124/mol.106.023564; STEEN KH, 1993, NEUROSCI LETT, V154, P113, DOI 10.1016/0304-3940(93)90184-M; STEEN KH, 1992, J NEUROSCI, V12, P86; Stoop R, 1997, J NEUROPHYSIOL, V78, P1837, DOI 10.1152/jn.1997.78.4.1837; Stubbs M, 2000, MOL MED TODAY, V6, P15, DOI 10.1016/S1357-4310(99)01615-9; Sutherland SP, 2001, P NATL ACAD SCI USA, V98, P711, DOI 10.1073/pnas.011404498; TANOKURA M, 1983, BIOCHIM BIOPHYS ACTA, V742, P576, DOI 10.1016/0167-4838(83)90276-5; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Vial C, 2004, TRENDS PHARMACOL SCI, V25, P487, DOI 10.1016/j.tips.2004.07.008; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Wildman SS, 1999, BRIT J PHARMACOL, V128, P486, DOI 10.1038/sj.bjp.0702802; Wildman SS, 1999, BRIT J PHARMACOL, V126, P762, DOI 10.1038/sj.bjp.0702325; Woo YC, 2004, ANESTHESIOLOGY, V101, P468, DOI 10.1097/00000542-200408000-00029; Xiang ZH, 1998, NEUROSCI LETT, V256, P105, DOI 10.1016/S0304-3940(98)00774-5; Yan ZH, 2006, J BIOL CHEM, V281, P32649, DOI 10.1074/jbc.M512791200; Zemkova H, 2004, J NEUROSCI, V24, P6968, DOI 10.1523/JNEUROSCI.1471-04.2004; Zhong Y, 2001, BRIT J PHARMACOL, V132, P221, DOI 10.1038/sj.bjp.0703778	50	30	30	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					33949	33957		10.1074/jbc.M705840200	http://dx.doi.org/10.1074/jbc.M705840200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17890225	hybrid			2022-12-25	WOS:000251145700008
J	Green, AK; Stratton, RC; Squires, PE; Simpson, AWM				Green, Anne K.; Stratton, Rebecca C.; Squires, Paul E.; Simpson, Alec W. M.			Atrial natriuretic peptide attenuates elevations in Ca2+ and protects hepatocytes by stimulating net plasma membrane Ca2+ efflux	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR SMOOTH-MUSCLE; ISCHEMIA-REPERFUSION INJURY; PARTICULATE GUANYLYL CYCLASE; ISOLATED RAT HEPATOCYTES; CGMP-INDUCED RELAXATION; FACTOR-KAPPA-B; INTRACELLULAR CALCIUM; CYTOSOLIC CALCIUM; NITRIC-OXIDE; BILE-ACIDS	Elevations in intracellular Ca2+ concentration and calpain activity are common early events in cellular injury, including that of hepatocytes. Atrial natriuretic peptide is a circulating hormone that has been shown to be hepatoprotective. The aim of this study was to examine the effects of atrial natriuretic peptide on potentially harmful elevations in cytosolic free Ca2+ and calpain activity induced by extracellular ATP in rat hepatocytes. We show that atrial natriuretic peptide, through protein kinase G, attenuated both the amplitude and duration of ATP-induced cytosolic Ca2+ rises in single hepatocytes. Atrial natriuretic peptide also prevented stimulation of calpain activity by ATP, taurolithocholate, or Ca2+ mobilization by thapsigargin and ionomycin. We therefore investigated the cellular Ca2+ handling mechanisms through which ANP attenuates this sustained elevation in cytosolic Ca2+. We show that atrial natriuretic peptide does not modulate the release from or re-uptake of Ca2+ into intracellular stores but, through protein kinase G, both stimulates plasma membrane Ca2+ efflux from and inhibits ATP-stimulated Ca2+ influx into hepatocytes. These findings suggest that stimulation of net plasma membrane Ca2+ efflux (to which both Ca2+ efflux stimulation and Ca2+ influx inhibition contribute) is the key process through which atrial natriuretic peptide attenuates elevations in cytosolic Ca2+ and calpain activity. Moreover we propose that plasma membrane Ca2+ efflux is a valuable, previously undiscovered, mechanism through which atrial natriuretic peptide protects rat hepatocytes, and perhaps other cell types, against Ca2+-dependent injury.	Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; Univ Liverpool, Dept Human Anat & Cell Biol, Liverpool L69 3GE, Merseyside, England	University of Warwick; University of Liverpool	Green, AK (corresponding author), Univ Warwick, Dept Biol Sci, Gibbet Hill Rd, Coventry CV4 7AL, W Midlands, England.	A.K.Green@warwick.ac.uk		Squires, Paul/0000-0003-4547-6777	Wellcome Trust [065845/Z/01] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aguilar HI, 1996, GASTROENTEROLOGY, V110, P558, DOI 10.1053/gast.1996.v110.pm8566604; Airhart N, 2003, J BIOL CHEM, V278, P38693, DOI 10.1074/jbc.M304098200; Ajamieh H, 2002, PHARMACOL RES, V45, P333, DOI 10.1006/phrs.2002.0952; ANWER MS, 1988, HEPATOLOGY, V8, P887, DOI 10.1002/hep.1840080430; Araujo IM, 2004, J NEUROCHEM, V91, P1322, DOI 10.1111/j.1471-4159.2004.02811.x; Arora AS, 1996, AM J PHYSIOL-GASTR L, V270, pG238, DOI 10.1152/ajpgi.1996.270.2.G238; Arundine M, 2003, CELL CALCIUM, V34, P325, DOI 10.1016/S0143-4160(03)00141-6; BALTENSPERGER K, 1988, EUR J BIOCHEM, V172, P7, DOI 10.1111/j.1432-1033.1988.tb13848.x; BELLOMO G, 1984, EUR J BIOCHEM, V144, P19, DOI 10.1111/j.1432-1033.1984.tb08425.x; Benitah JP, 2003, J MUSCLE RES CELL M, V24, P275; BERTHON B, 1984, FEBS LETT, V167, P19, DOI 10.1016/0014-5793(84)80824-8; BILZER M, 1994, GASTROENTEROLOGY, V106, P143, DOI 10.1016/S0016-5085(94)94961-1; Bilzer M, 1999, AM J PHYSIOL-GASTR L, V276, pG1137, DOI 10.1152/ajpgi.1999.276.5.G1137; Bilzer M, 2000, J HEPATOL, V32, P508, DOI 10.1016/S0168-8278(00)80404-3; BOKEMEYER D, 1994, CLIN SCI, V87, P383, DOI 10.1042/cs0870383; BOKEMEYER D, 1993, HYPERTENSION, V21, P166, DOI 10.1161/01.HYP.21.2.166; BOUSCAREL B, 1993, AM J PHYSIOL, V264, pG243, DOI 10.1152/ajpgi.1993.264.2.G243; BRENARD R, 1992, J HEPATOL, V14, P347, DOI 10.1016/0168-8278(92)90182-O; Calderone A, 1998, J CLIN INVEST, V101, P812, DOI 10.1172/JCI119883; CARAFOLI E, 1994, FASEB J, V8, P993, DOI 10.1096/fasebj.8.13.7926378; Carini R, 2003, HEPATOLOGY, V37, P277, DOI 10.1053/jhep.2003.50033; Castro LRV, 2006, CIRCULATION, V113, P2221, DOI 10.1161/CIRCULATIONAHA.105.599241; Cataliotti A, 2005, CIRCULATION, V112, P836, DOI 10.1161/CIRCULATIONAHA.105.538520; Chow SC, 1997, NEUROPHARMACOLOGY, V36, P1149, DOI 10.1016/S0028-3908(97)00123-8; COBBOLD P, 1988, J RECEPTOR RES, V8, P481, DOI 10.3109/10799898809049006; Colucci WS, 2000, NEW ENGL J MED, V343, P246, DOI 10.1056/NEJM200007273430403; COMBETTES L, 1988, J BIOL CHEM, V263, P2299; COQUIL JF, 1991, BIOCHEM J, V273, P153, DOI 10.1042/bj2730153; Cottart CH, 2003, NITRIC OXIDE-BIOL CH, V9, P57, DOI 10.1016/j.niox.2003.09.003; Crenesse D, 1999, PHARMACOLOGY, V58, P160, DOI 10.1159/000028278; De Vito P, 2003, MOL CELL BIOCHEM, V252, P353, DOI 10.1023/A:1025508828271; DEBOLD AJ, 1982, CAN J PHYSIOL PHARM, V60, P324, DOI 10.1139/y82-045; Dixon C. Jane, 2001, P65; Dixon CJ, 2005, J PHARMACOL EXP THER, V313, P1305, DOI 10.1124/jpet.104.082743; DIXON CJ, 1990, BIOCHEM J, V269, P499, DOI 10.1042/bj2690499; FERNANDO KC, 1995, BBA-MOL CELL RES, V1268, P97, DOI 10.1016/0167-4889(95)00041-P; FURUKAWA KI, 1988, J BIOL CHEM, V263, P8058; GASBARRINI A, 1993, BIOCHIM BIOPHYS ACTA, V1177, P1, DOI 10.1016/0167-4889(93)90149-J; Gerbes AL, 1998, HEPATOLOGY, V28, P1309, DOI 10.1002/hep.510280520; Gerwig T, 2003, J HEPATOL, V39, P341, DOI 10.1016/S0168-8278(03)00240-X; GLENNON MC, 1992, J BIOL CHEM, V267, P8230; Gorbig MN, 1999, HEPATOLOGY, V30, P501, DOI 10.1002/hep.510300201; GORES GJ, 1988, AM J PHYSIOL, V255, pC315, DOI 10.1152/ajpcell.1988.255.3.C315; Green AK, 2002, GASTROENTEROLOGY, V123, P1291, DOI 10.1053/gast.2002.35994; Green AK, 1997, CELL CALCIUM, V22, P99, DOI 10.1016/S0143-4160(97)90110-X; Haddad P, 1999, CRYOBIOLOGY, V39, P69, DOI 10.1006/cryo.1999.2186; Han YQ, 1999, J BIOL CHEM, V274, P787, DOI 10.1074/jbc.274.2.787; Hasegawa C, 2003, HEPATO-GASTROENTEROL, V50, P972; He L, 2000, AM J PHYSIOL-CELL PH, V278, pC845, DOI 10.1152/ajpcell.2000.278.4.C845; Hemmings SJ, 2002, CELL BIOCHEM FUNCT, V20, P47, DOI 10.1002/cbf.934; HOUCHI H, 1995, LIFE SCI, V57, pPL211, DOI 10.1016/0024-3205(95)02111-U; HOWARD A, 1994, BIOCHEM J, V303, P275, DOI 10.1042/bj3030275; Howarth FC, 2005, PEPTIDES, V26, P691, DOI 10.1016/j.peptides.2004.12.003; Ikari A, 1997, JPN J PHYSIOL, V47, P235, DOI 10.2170/jjphysiol.47.235; Ikeda Y, 2002, AM J PHYSIOL-HEART C, V282, pH1421, DOI 10.1152/ajpheart.00626.2001; Isozaki H, 2000, EUR J GASTROEN HEPAT, V12, P291, DOI 10.1097/00042737-200012030-00006; Jaeschke H, 2002, TOXICOL SCI, V65, P166, DOI 10.1093/toxsci/65.2.166; JOHANSSON JS, 1992, BIOCHIM BIOPHYS ACTA, V1105, P40, DOI 10.1016/0005-2736(92)90160-N; JOSEPH SK, 1985, J BIOL CHEM, V260, P2508; KESSLER F, 1990, J BIOL CHEM, V265, P16012; Kobayashi S, 1999, TRANSPLANTATION, V67, P451, DOI 10.1097/00007890-199902150-00019; KOGA T, 1994, J BIOL CHEM, V269, P11640; Kohli V, 1999, GASTROENTEROLOGY, V116, P168, DOI 10.1016/S0016-5085(99)70241-6; KWAN CY, 1990, AM J PHYSIOL, V258, pC1006, DOI 10.1152/ajpcell.1990.258.6.C1006; Land SC, 1997, J APPL PHYSIOL, V82, P776, DOI 10.1152/jappl.1997.82.3.776; Lehotsky J, 2002, GEN PHYSIOL BIOPHYS, V21, P31; LIDOFSKY SD, 1990, AM J PHYSIOL, V259, pG56, DOI 10.1152/ajpgi.1990.259.1.G56; Liu XL, 2004, ANNU REV PHARMACOL, V44, P349, DOI 10.1146/annurev.pharmtox.44.101802.121804; LONG RM, 1986, J PHARMACOL EXP THER, V238, P186; Marsault R, 1997, EMBO J, V16, P1575, DOI 10.1093/emboj/16.7.1575; McDonald MC, 2001, FASEB J, V15, P171, DOI 10.1096/fj.99-0645com; McNulty TJ, 1999, BIOCHEM J, V339, P555, DOI 10.1042/0264-6021:3390555; Mikami M, 1997, HEPATOL RES, V7, P48, DOI 10.1016/S0928-4346(97)00372-1; Mikawa K, 1997, CLIN EXP PHARMACOL P, V24, P175, DOI 10.1111/j.1440-1681.1997.tb01804.x; Miyoshi H, 1996, GASTROENTEROLOGY, V110, P1897, DOI 10.1053/gast.1996.v110.pm8964416; MONTEITH GR, 1995, CELL CALCIUM, V18, P459, DOI 10.1016/0143-4160(95)90009-8; MOORE M, 1985, J BIOL CHEM, V260, P3035; Munagala VK, 2004, CURR PROB CARDIOLOGY, V29, P707, DOI 10.1016/j.cpcardiol.2004.07.002; MURATA M, 1994, HEPATOLOGY, V19, P1223, DOI 10.1016/0270-9139(94)90870-2; Musa-Aziz R, 2005, PFLUG ARCH EUR J PHY, V450, P405, DOI 10.1007/s00424-005-1459-6; Nascimentogomes G, 1995, BRAZ J MED BIOL RES, V28, P609; Nathanson M H, 1996, Prog Liver Dis, V14, P1; Oliveira-Souza M, 2004, AM J PHYSIOL-RENAL, V286, pF402, DOI 10.1152/ajprenal.00121.2003; Oliveira-Souza M, 2002, KIDNEY INT, V62, P1693, DOI 10.1046/j.1523-1755.2002.00604.x; Oliveira-Souza M, 2001, KIDNEY INT, V60, P1800, DOI 10.1046/j.1523-1755.2001.00993.x; Ono Y, 1998, BIOCHEM BIOPH RES CO, V245, P289, DOI 10.1006/bbrc.1998.8085; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Pande J, 2006, AM J PHYSIOL-CELL PH, V290, pC1341, DOI 10.1152/ajpcell.00573.2005; Pandey KN, 2005, PEPTIDES, V26, P901, DOI 10.1016/j.peptides.2004.09.024; PANDOL SJ, 1990, CELL CALCIUM, V11, P477, DOI 10.1016/0143-4160(90)90080-E; PELLA R, 1991, BIOCHEM BIOPH RES CO, V174, P549, DOI 10.1016/0006-291X(91)91452-I; Petersen OH, 2006, TRENDS PHARMACOL SCI, V27, P113, DOI 10.1016/j.tips.2005.12.006; Piggott LA, 2006, J GEN PHYSIOL, V128, P3, DOI 10.1085/jgp.200509403; POPESCU LM, 1985, EUR J PHARMACOL, V107, P393, DOI 10.1016/0014-2999(85)90269-9; RASHATWAR SS, 1987, P NATL ACAD SCI USA, V84, P5685, DOI 10.1073/pnas.84.16.5685; Ray SK, 2003, BRAIN RES REV, V42, P169, DOI 10.1016/S0165-0173(03)00152-8; Rho EH, 2002, J APPL PHYSIOL, V92, P257, DOI 10.1152/jappl.2002.92.1.257; RodriguezPascual F, 1996, MOL PHARMACOL, V49, P1058; Roma MG, 1999, TOXICOL APPL PHARM, V161, P192, DOI 10.1006/taap.1999.8801; Rose S, 1997, HEPATOLOGY, V25, P379; ROSSER BG, 1993, J BIOL CHEM, V268, P23593; Rychkov GY, 2005, CELL CALCIUM, V37, P183, DOI 10.1016/j.ceca.2004.09.001; SAKAGUCHI S, 1993, BIOL PHARM BULL, V16, P808; SAKAIDA I, 1991, J BIOL CHEM, V266, P717; Sakon M, 2002, SURG TODAY, V32, P1, DOI 10.1007/s595-002-8105-8; SanchezBueno A, 1997, CELL CALCIUM, V21, P125, DOI 10.1016/S0143-4160(97)90036-1; Sansoe G, 2005, J HEPATOL, V43, P791, DOI 10.1016/j.jhep.2005.04.017; Schillinger KJ, 2005, P NATL ACAD SCI USA, V102, P13789, DOI 10.1073/pnas.0506807102; Schlosser SF, 1996, P NATL ACAD SCI USA, V93, P9948, DOI 10.1073/pnas.93.18.9948; Schofl C, 1999, AM J PHYSIOL-GASTR L, V276, pG164, DOI 10.1152/ajpgi.1999.276.1.G164; SPIVEY JR, 1993, J CLIN INVEST, V92, P17, DOI 10.1172/JCI116546; Squier MKT, 1996, CELL DEATH DIFFER, V3, P275; Stalker TJ, 2005, DIABETES, V54, P1132, DOI 10.2337/diabetes.54.4.1132; Stoyanovsky DA, 1999, TOXICOL LETT, V106, P23, DOI 10.1016/S0378-4274(99)00009-0; Su J, 2005, EXP BIOL MED, V230, P242; Suttner Stefan W, 2004, Curr Opin Crit Care, V10, P336, DOI 10.1097/01.ccx.0000135513.26376.4f; Tao JC, 1999, J BIOL CHEM, V274, P23761, DOI 10.1074/jbc.274.34.23761; THIBAULT N, 1991, J BIOCHEM TOXICOL, V6, P237, DOI 10.1002/jbt.2570060310; THIBAULT N, 1993, BIOCHEM PHARMACOL, V45, P289, DOI 10.1016/0006-2952(93)90063-3; Tinton SA, 1996, EUR J BIOCHEM, V238, P576, DOI 10.1111/j.1432-1033.1996.0576z.x; TRUMP BF, 1995, FASEB J, V9, P219, DOI 10.1096/fasebj.9.2.7781924; Vaandrager AB, 1996, MOL CELL BIOCHEM, V157, P23, DOI 10.1007/BF00227877; Vollmar AM, 1997, GUT, V40, P145, DOI 10.1136/gut.40.1.145; VONRUECKER AA, 1989, J CLIN CHEM CLIN BIO, V27, P531; VROLIX M, 1988, BIOCHEM J, V255, P855, DOI 10.1042/bj2550855; Wang CH, 2004, J BIOMED SCI, V11, P571, DOI 10.1159/000079668; Weber H, 2005, BIOCHEM PHARMACOL, V70, P1241, DOI 10.1016/j.bcp.2005.06.028; WOODS NM, 1987, CELL CALCIUM, V8, P79, DOI 10.1016/0143-4160(87)90038-8; Yoshida Y, 1999, MOL CELL BIOCHEM, V190, P157, DOI 10.1023/A:1006991032073; YOSHIDA Y, 1992, J BIOCHEM-TOKYO, V111, P559, DOI 10.1093/oxfordjournals.jbchem.a123796; Yoshioka A, 2000, J NEUROCHEM, V74, P633, DOI 10.1046/j.1471-4159.2000.740633.x; Yoshizumi M, 1997, FEBS LETT, V419, P255, DOI 10.1016/S0014-5793(97)01470-1; ZOETEWEIJ JP, 1992, BIOCHEM J, V288, P207, DOI 10.1042/bj2880207; Zolle O, 2000, J BIOL CHEM, V275, P25892, DOI 10.1074/jbc.M000786200	134	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34542	34554		10.1074/jbc.M707115200	http://dx.doi.org/10.1074/jbc.M707115200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17893148	hybrid			2022-12-25	WOS:000251145700069
J	Skaggs, HS; Xing, H; Wilkerson, DC; Murphy, LA; Hong, Y; Mayhew, CN; Sarge, KD				Skaggs, Hollie S.; Xing, Hongyan; Wilkerson, Donald C.; Murphy, Lynea A.; Hong, Yiling; Mayhew, Christopher N.; Sarge, Kevin D.			HSF1-TPR interaction facilitates export of stress-induced HSP70 mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-PORE COMPLEX; HEAT-SHOCK; GENE-EXPRESSION; PROTEIN TPR; TRANSCRIPTION; BINDING; CELLS; IDENTIFICATION; LOCALIZATION; METABOLISM	Stress conditions inhibit mRNA export, but mRNAs encoding heat shock proteins continue to be efficiently exported from the nucleus during stress. How HSP mRNAs bypass this stress-associated export inhibition was not known. Here, we show that HSF1, the transcription factor that binds HSP promoters after stress to induce their transcription, interacts with the nuclear pore-associating TPR protein in a stress-responsive manner. TPR is brought into proximity of the HSP70 promoter after stress and preferentially associates with mRNAs transcribed from this promoter. Disruption of the HSF1-TPR interaction inhibits the export of mRNAs expressed from the HSP70 promoter, both endogenous HSP70 mRNA and a luciferase reporter mRNA. These results suggest that HSP mRNA export escapes stress inhibition via HSF1-mediated recruitment of the nuclear pore-associating protein TPR to HSP genes, thereby functionally connecting the first and last nuclear steps of the gene expression pathway, transcription and mRNA export.	Univ Kentucky, Albert B Chandler Med Ctr, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA	University of Kentucky	Sarge, KD (corresponding author), Univ Kentucky, Albert B Chandler Med Ctr, Dept Mol & Cellular Biochem, 741 S Limestone St, Lexington, KY 40536 USA.	kdsarge@uky.edu	Mayhew, Christopher N/AGB-4929-2022		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD050043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061053, R01GM064606] Funding Source: NIH RePORTER; NICHD NIH HHS [HD 50043, F32 HD050043] Funding Source: Medline; NIEHS NIH HHS [T32 ES 007266] Funding Source: Medline; NIGMS NIH HHS [GM 61053, R01 GM064606-03, R01 GM064606-02, R01 GM061053-01A1, R01 GM061053-02, R01 GM061053-04, R01 GM064606-04, GM 64606, R01 GM061053, R01 GM061053-03, R01 GM064606, R01 GM064606-01A2] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bangs P, 1998, J CELL BIOL, V143, P1801, DOI 10.1083/jcb.143.7.1801; Bond U, 2006, FEMS YEAST RES, V6, P160, DOI 10.1111/j.1567-1364.2006.00032.x; Cordes VC, 1997, J CELL BIOL, V136, P515, DOI 10.1083/jcb.136.3.515; Cornett J, 2005, NAT GENET, V37, P198, DOI 10.1038/ng1503; Fontoura BMA, 2001, P NATL ACAD SCI USA, V98, P3208, DOI 10.1073/pnas.061014698; Frosst P, 2002, J CELL BIOL, V156, P617, DOI 10.1083/jcb.200106046; Gallouzi IE, 2000, P NATL ACAD SCI USA, V97, P3073, DOI 10.1073/pnas.97.7.3073; GIGUERE V, 1986, CELL, V46, P645, DOI 10.1016/0092-8674(86)90339-9; Green DM, 2003, P NATL ACAD SCI USA, V100, P1010, DOI 10.1073/pnas.0336594100; Hase ME, 2001, MOL BIOL CELL, V12, P2433, DOI 10.1091/mbc.12.8.2433; HOBBS MV, 1993, J IMMUNOL, V150, P3602; Holmberg CI, 2002, TRENDS BIOCHEM SCI, V27, P619, DOI 10.1016/S0968-0004(02)02207-7; Krebber H, 1999, GENE DEV, V13, P1994, DOI 10.1101/gad.13.15.1994; Krull S, 2004, MOL BIOL CELL, V15, P4261, DOI 10.1091/mbc.E04-03-0165; Liu Y, 1996, EMBO J, V15, P6750, DOI 10.1002/j.1460-2075.1996.tb01064.x; Saavedra C, 1996, GENE DEV, V10, P1608, DOI 10.1101/gad.10.13.1608; SADIS S, 1988, J CELL PHYSIOL, V135, P377, DOI 10.1002/jcp.1041350304; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; Shah S, 1998, J CELL BIOL, V141, P31, DOI 10.1083/jcb.141.1.31; Strambio-de-Castillia C, 1999, J CELL BIOL, V144, P839, DOI 10.1083/jcb.144.5.839; Tani T, 1996, MOL BIOL CELL, V7, P173, DOI 10.1091/mbc.7.1.173; Vinciguerra P, 2005, EMBO J, V24, P813, DOI 10.1038/sj.emboj.7600527; Voellmy R, 2004, CELL STRESS CHAPERON, V9, P122, DOI 10.1379/CSC-14R.1; Xing HY, 2005, SCIENCE, V307, P421, DOI 10.1126/science.1106478; Zimowska G, 1997, J CELL SCI, V110, P927	25	34	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					33902	33907		10.1074/jbc.M704054200	http://dx.doi.org/10.1074/jbc.M704054200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17897941	Green Accepted, hybrid			2022-12-25	WOS:000251145700002
J	Langergraber, KE; Siedel, H; Mitani, JC; Wrangham, RW; Reynolds, V; Hunt, K; Vigilant, L				Langergraber, Kevin E.; Siedel, Heike; Mitani, John C.; Wrangham, Richard W.; Reynolds, Vernon; Hunt, Kevin; Vigilant, Linda			The Genetic Signature of Sex-Biased Migration in Patrilocal Chimpanzees and Humans	PLOS ONE			English	Article								A large body of theoretical work suggests that analyses of variation at the maternally inherited mitochondrial (mt)DNA and the paternally inherited non-recombining portion of the Y chromosome (NRY) are a potentially powerful way to reveal the differing migratory histories of men and women across human societies. However, the few empirical studies comparing mtDNA and NRY variation and known patterns of sex-biased migration have produced conflicting results. Here we review some methodological reasons for these inconsistencies, and take them into account to provide an unbiased characterization of mtDNA and NRY variation in chimpanzees, one of the few mammalian taxa where males routinely remain in and females typically disperse from their natal groups. We show that patterns of mtDNA and NRY variation are more strongly contrasting in patrilocal chimpanzees compared with patrilocal human societies. The chimpanzee data we present here thus provide a valuable comparative benchmark of the patterns of mtDNA and NRY variation to be expected in a society with extremely female-biased dispersal.	[Langergraber, Kevin E.; Mitani, John C.] Univ Michigan, Dept Anthropol, Ann Arbor, MI 48109 USA; [Siedel, Heike; Vigilant, Linda] Max Planck Inst Evolutionary Anthropol, Primatol Dept, Leipzig, Germany; [Wrangham, Richard W.] Harvard Univ, Dept Anthropol, Cambridge, MA 02138 USA; [Reynolds, Vernon] Univ Oxford, Sch Anthropol, Oxford, England; [Hunt, Kevin] Indiana Univ, Dept Anthropol, Bloomington, IN 47405 USA	University of Michigan System; University of Michigan; Max Planck Society; Harvard University; University of Oxford; Indiana University System; Indiana University Bloomington	Langergraber, KE (corresponding author), Univ Michigan, Dept Anthropol, Ann Arbor, MI 48109 USA.	klangerg@umich.edu	Hunt, Kevin/L-6018-2019; Peng, Bo/A-6920-2009	Peng, Bo/0000-0001-8225-2284	U.S. National Science Foundation [BCS0215622, IOB-0516644, BCS-0416125]; National Sciences and Engineering Research Council of Canada; L.S.B. Leakey Foundation; Wenner-Gren Foundation; Max Planck Society; University of Michigan; Detroit Zoological Institute; Royal Zoological Society of Scotland; National Geographic Society	U.S. National Science Foundation(National Science Foundation (NSF)); National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); L.S.B. Leakey Foundation; Wenner-Gren Foundation; Max Planck Society(Max Planck SocietyFoundation CELLEX); University of Michigan(University of Michigan System); Detroit Zoological Institute; Royal Zoological Society of Scotland; National Geographic Society(National Geographic Society)	This study was funded by the U.S. National Science Foundation (BCS0215622, IOB-0516644, BCS-0416125), the National Sciences and Engineering Research Council of Canada, the L.S.B. Leakey Foundation, the Wenner-Gren Foundation, the Max Planck Society, the University of Michigan, the Detroit Zoological Institute, the Royal Zoological Society of Scotland, and the National Geographic Society. None of these funders were involved in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Altmann J, 1996, P NATL ACAD SCI USA, V93, P5797, DOI 10.1073/pnas.93.12.5797; Alvarez HP, 2004, KINSHIP AND BEHAVIOR IN PRIMATES, P420; [Anonymous], 1967, KINSHIP AND MARRIAGE; Chaix R, 2007, CURR BIOL, V17, P43, DOI 10.1016/j.cub.2006.10.058; Clutton-Brock T. H., 1988, REPROD SUCCESS; Eriksson J, 2006, MOL ECOL, V15, P939, DOI 10.1111/j.1365-294X.2006.02845.x; Eriksson J, 2004, MOL ECOL, V13, P3425, DOI 10.1111/j.1365-294X.2004.02332.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fenner JN, 2005, AM J PHYS ANTHROPOL, V128, P415, DOI 10.1002/ajpa.20188; Gagneux P, 2001, PHILOS T R SOC B, V356, P889, DOI 10.1098/rstb.2001.0865; Hammond RL, 2006, P ROY SOC B-BIOL SCI, V273, P479, DOI 10.1098/rspb.2005.3257; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Hill K., 1996, ACHE LIFE HIST; Howell Nancy, 1979, DEMOGRAPHY D KUNG; Irons William, 2000, ADAPTATION HUMAN BEH, P223; Kano T., 1992, LAST APE; Kayser M, 2003, AM J HUM GENET, V72, P281, DOI 10.1086/346065; Kumar V, 2006, PLOS GENET, V2, P420, DOI 10.1371/journal.pgen.0020053; Meirmans PG, 2006, EVOLUTION, V60, P2399, DOI 10.1111/j.0014-3820.2006.tb01874.x; Mitani JC, 2002, EVOL ANTHROPOL, V11, P9, DOI 10.1002/evan.10008; MULDER MB, 1988, REPROD SUCCESS, P419; MURDOCH GP, 1981, ATLAS WORLD CULTURES; Nei M., 1987, MOL EVOLUTIONARY GEN; Nishida T, 2003, AM J PRIMATOL, V59, P99, DOI 10.1002/ajp.10068; Oota H, 2001, NAT GENET, V29, P20, DOI 10.1038/ng711; Rhine RJ, 2000, AM J PRIMATOL, V51, P229, DOI 10.1002/1098-2345(200008)51:4<229::AID-AJP2>3.0.CO;2-C; Seielstad MT, 1998, NAT GENET, V20, P278, DOI 10.1038/3088; Strassmann Beverly I., 2003, P177; SWEDELL L, 2006, STRATEGIES SEX SURVI; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960; Wilder JA, 2004, MOL BIOL EVOL, V21, P2047, DOI 10.1093/molbev/msh214; Wilder JA, 2004, NAT GENET, V36, P1122, DOI 10.1038/ng1428; Wilkins JF, 2006, BIOESSAYS, V28, P290, DOI 10.1002/bies.20378; Won YJ, 2005, MOL BIOL EVOL, V22, P297, DOI 10.1093/molbev/msi017	34	72	72	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e973	10.1371/journal.pone.0000973	http://dx.doi.org/10.1371/journal.pone.0000973			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912352	gold, Green Published, Green Submitted			2022-12-25	WOS:000207455900011
J	Lee, WM; Kiesner, C; Pappas, T; Lee, I; Grindle, K; Jartti, T; Jakiela, B; Lemanske, RF; Shult, PA; Gern, JE				Lee, Wai-Ming; Kiesner, Christin; Pappas, Tressa; Lee, Iris; Grindle, Kris; Jartti, Tuomas; Jakiela, Bogdan; Lemanske, Robert F., Jr.; Shult, Peter A.; Gern, James E.			A Diverse Group of Previously Unrecognized Human Rhinoviruses Are Common Causes of Respiratory Illnesses in Infants	PLOS ONE			English	Article								Background. Human rhinoviruses (HRVs) are the most prevalent human pathogens, and consist of 101 serotypes that are classified into groups A and B according to sequence variations. HRV infections cause a wide spectrum of clinical outcomes ranging from asymptomatic infection to severe lower respiratory symptoms. Defining the role of specific strains in various HRV illnesses has been difficult because traditional serology, which requires viral culture and neutralization tests using 101 serotype-specific antisera, is insensitive and laborious. Methods and Findings. To directly type HRVs in nasal secretions of infants with frequent respiratory illnesses, we developed a sensitive molecular typing assay based on phylogenetic comparisons of a 260-bp variable sequence in the 5' noncoding region with homologous sequences of the 101 known serotypes. Nasal samples from 26 infants were first tested with a multiplex PCR assay for respiratory viruses, and HRV was the most common virus found (108 of 181 samples). Typing was completed for 101 samples and 103 HRVs were identified. Surprisingly, 54 (52.4%) HRVs did not match any of the known serotypes and had 12-35% nucleotide divergence from the nearest reference HRVs. Of these novel viruses, 9 strains (17 HRVs) segregated from HRVA, HRVB and human enterovirus into a distinct genetic group ("C''). None of these new strains could be cultured in traditional cell lines. Conclusions. By molecular analysis, over 50% of HRV detected in sick infants were previously unrecognized strains, including 9 strains that may represent a new HRV group. These findings indicate that the number of HRV strains is considerably larger than the 101 serotypes identified with traditional diagnostic techniques, and provide evidence of a new HRV group.	[Lee, Wai-Ming; Pappas, Tressa; Lee, Iris; Grindle, Kris; Jartti, Tuomas; Jakiela, Bogdan; Lemanske, Robert F., Jr.; Gern, James E.] Univ Wisconsin, Dept Pediat & Med, Madison, WI 53706 USA; [Kiesner, Christin; Shult, Peter A.] Univ Wisconsin, Wisconsin State Lab Hyg, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Lee, WM (corresponding author), Univ Wisconsin, Dept Pediat & Med, Madison, WI 53706 USA.	wlee5@wisc.edu	Jakiela, Bogdan/CAA-1861-2022	Jakiela, Bogdan/0000-0003-0444-981X	NIAID/NIH [NO1-AI-25496]; NHLBI [P01 HL070831]; NIAID [U19 AI070503-01]; NIH/NCRR University of Wisconsin General Clinical Research Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL070831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI025496, U19AI070503] Funding Source: NIH RePORTER	NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/NCRR University of Wisconsin General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIAID/NIH NO1-AI-25496, NHLBI P01 HL070831, NIAID U19 AI070503-01 and NIH/NCRR University of Wisconsin General Clinical Research Center Sponsors/ funders had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Andeweg AC, 1999, J CLIN MICROBIOL, V37, P524, DOI 10.1128/JCM.37.3.524-530.1999; Blomqvist S, 2002, J CLIN MICROBIOL, V40, P4218, DOI 10.1128/JCM.40.11.4218-4223.2002; CALLAHAN PL, 1985, P NATL ACAD SCI USA, V82, P732, DOI 10.1073/pnas.82.3.732; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; COUCH RB, 2001, FIELDS VIROLOGY, P777; Deffernez C, 2004, J CLIN MICROBIOL, V42, P3212, DOI 10.1128/JCM.42.7.3212-3218.2004; DUECHLER M, 1987, P NATL ACAD SCI USA, V84, P2605, DOI 10.1073/pnas.84.9.2605; Gern JE, 2002, PEDIAT ALLERG IMM-UK, V13, P386, DOI 10.1034/j.1399-3038.2002.01093.x; Gern JE, 2002, AM J MED, V112, p19S; Graat JM, 2003, J CLIN EPIDEMIOL, V56, P1218, DOI 10.1016/S0895-4356(03)00171-9; Gwaltney Jack M. Jr., 2002, P995; HAMPARIAN VV, 1987, VIROLOGY, V159, P191; Harris JR, 2005, J VIROL, V79, P5363, DOI 10.1128/JVI.79.9.5363-5373.2005; Heikkinen T, 2003, LANCET, V361, P51, DOI 10.1016/S0140-6736(03)12162-9; Hershenson MB, 2006, AM J RESP CRIT CARE, V174, P1284, DOI 10.1164/rccm.200609-1387ED; Holmes EC, 1998, BRIT MED BULL, V54, P533; HUGHES PJ, 1988, J GEN VIROL, V69, P49, DOI 10.1099/0022-1317-69-1-49; Johnston NW, 2005, J ALLERGY CLIN IMMUN, V115, P132, DOI 10.1016/j.jaci.2004.09.025; JOHNSTON SL, 1993, J CLIN MICROBIOL, V31, P111, DOI 10.1128/JCM.31.1.111-117.1993; KAPIKIAN A Z, 1971, Virology, V43, P524, DOI 10.1016/0042-6822(71)90329-1; KAPIKIAN A Z, 1967, Nature (London), V213, P761; Kistler AL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-40; KOPECKA H, 1995, VIRUS RES, V38, P125, DOI 10.1016/0168-1702(95)00055-U; Laine P, 2005, J GEN VIROL, V86, P697, DOI 10.1099/vir.0.80445-0; Lamson D, 2006, J INFECT DIS, V194, P1398, DOI 10.1086/508551; Ledford RM, 2004, J VIROL, V78, P3663, DOI 10.1128/JVI.78.7.3663-3674.2004; Lee WM, 2007, J CLIN MICROBIOL, V45, P2626, DOI 10.1128/JCM.02501-06; LEE WM, 1995, VIRUS GENES, V9, P177, DOI 10.1007/BF01702661; LEE WM, 1993, J VIROL, V67, P2110, DOI 10.1128/JVI.67.4.2110-2122.1993; Lemanske RF, 2005, J ALLERGY CLIN IMMUN, V116, P571, DOI 10.1016/j.jaci.2005.06.024; Loens K, 2003, J CLIN MICROBIOL, V41, P1971, DOI 10.1128/JCM.41.5.1971-1976.2003; Louie JK, 2005, CLIN INFECT DIS, V41, P262, DOI 10.1086/430915; McCormack GP, 2002, REV MED VIROL, V12, P221, DOI 10.1002/rmv.355; McErlean P, 2007, J CLIN VIROL, V39, P67, DOI 10.1016/j.jcv.2007.03.012; Monto AS, 2001, CLIN THER, V23, P1615, DOI 10.1016/S0149-2918(01)80133-8; Monto AS, 2002, AM J MED, V112, p4S; MONTO AS, 1987, J INFECT DIS, V156, P43, DOI 10.1093/infdis/156.1.43; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Oberste MS, 2004, J GEN VIROL, V85, P2577, DOI 10.1099/vir.0.79925-0; Oberste MS, 2003, J CLIN VIROL, V26, P375, DOI 10.1016/S1386-6532(03)00004-0; Oberste MS, 1999, J CLIN MICROBIOL, V37, P1288, DOI 10.1128/JCM.37.5.1288-1293.1999; Oberste MS, 1999, J VIROL, V73, P1941, DOI 10.1128/JVI.73.3.1941-1948.1999; Oberste MS, 2000, J CLIN MICROBIOL, V38, P1170, DOI 10.1128/JCM.38.3.1170-1174.2000; Palacios G, 2002, J CLIN MICROBIOL, V40, P182, DOI 10.1128/JCM.40.1.182-192.2002; PELON W, 1957, P SOC EXP BIOL MED, V94, P262; Pitkaranta A, 1998, ANN MED, V30, P529; PRICE WH, 1956, P NATL ACAD SCI USA, V42, P892, DOI 10.1073/pnas.42.12.892; Rotbart HA, 2000, ARCH FAM MED, V9, P913, DOI 10.1001/archfami.9.9.913; Rueckert RR, 1996, VIROLOGY, P609; Savolainen C, 2004, J GEN VIROL, V85, P2271, DOI 10.1099/vir.0.79897-0; Savolainen C, 2002, J GEN VIROL, V83, P333, DOI 10.1099/0022-1317-83-2-333; SKERN T, 1985, NUCLEIC ACIDS RES, V13, P2111, DOI 10.1093/nar/13.6.2111; STANWAY G, 1984, NUCLEIC ACIDS RES, V12, P7859, DOI 10.1093/nar/12.20.7859; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Turner RB, 2007, J INFECT DIS, V195, P765, DOI 10.1086/511829; van Benten I, 2003, PEDIAT ALLERG IMM-UK, V14, P363, DOI 10.1034/j.1399-3038.2003.00064.x; Winther B, 2006, J MED VIROL, V78, P644, DOI 10.1002/jmv.20588; Witwer C, 2001, NUCLEIC ACIDS RES, V29, P5079, DOI 10.1093/nar/29.24.5079	58	231	242	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e966	10.1371/journal.pone.0000966	http://dx.doi.org/10.1371/journal.pone.0000966			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912345	Green Published, gold			2022-12-25	WOS:000207455900004
J	Nittala, A; Ghosh, S; Wang, XJ				Nittala, Aparna; Ghosh, Soumitra; Wang, Xujing			Investigating the Role of Islet Cytoarchitecture in Its Oscillation Using a New beta-Cell Cluster Model	PLOS ONE			English	Article							PULSATILE INSULIN; ELECTRICAL-ACTIVITY; PANCREATIC-ISLETS; CA2+ OSCILLATIONS; IDENTIFIED ALPHA; GAP-JUNCTIONS; SECRETION; SYNCHRONIZATION; MODULATION; SINGLE	The oscillatory insulin release is fundamental to normal glycemic control. The basis of the oscillation is the intercellular coupling and bursting synchronization of beta cells in each islet. The functional role of islet beta cell mass organization with respect to its oscillatory bursting is not well understood. This is of special interest in view of the recent finding of islet cytoarchitectural differences between human and animal models. In this study we developed a new hexagonal closest packing (HCP) cell cluster model. The model captures more accurately the real islet cell organization than the simple cubic packing (SCP) cluster that is conventionally used. Using our new model we investigated the functional characteristics of beta-cell clusters, including the fraction of cells able to burst f(b), the synchronization index lambda of the bursting beta cells, the bursting period T-b, the plateau fraction p(f), and the amplitude of intracellular calcium oscillation [Ca]. We determined their dependence on cluster architectural parameters including number of cells n(beta), number of inter-beta cell couplings of each beta cell n(c), and the coupling strength g(c). We found that at low values of n(beta), n(c) and g(c), the oscillation regularity improves with their increasing values. This functional gain plateaus around their physiological values in real islets, at n(beta) similar to 100, n(c) similar to 6 and g(c) similar to 200 pS. In addition, normal beta-cell clusters are robust against significant perturbation to their architecture, including the presence of non-beta cells or dead beta cells. In clusters with n(beta) > similar to 100, coordinated beta-cell bursting can be maintained at up to 70% of beta-cell loss, which is consistent with laboratory and clinical findings of islets. Our results suggest that the bursting characteristics of a beta-cell cluster depend quantitatively on its architecture in a non-linear fashion. These findings are important to understand the islet bursting phenomenon and the regulation of insulin secretion, under both physiological and pathological conditions.	[Nittala, Aparna; Ghosh, Soumitra; Wang, Xujing] Med Coll Wisconsin, Childrens Hosp Wisconsin, Max McGee Natl Res Ctr Juvenile Diabet, Human & Mol Genet Ctr,Childrens Res Inst, Milwaukee, WI 53226 USA	Children's Hospital of Wisconsin; Medical College of Wisconsin	Wang, XJ (corresponding author), Med Coll Wisconsin, Childrens Hosp Wisconsin, Max McGee Natl Res Ctr Juvenile Diabet, Human & Mol Genet Ctr,Childrens Res Inst, Milwaukee, WI 53226 USA.	xwang@mcw.edu			Children's Hospital Foundation; Children's Research Institute of Wisconsin; Children's Hospital of Wisconsin	Children's Hospital Foundation; Children's Research Institute of Wisconsin; Children's Hospital of Wisconsin	This work is supported in part by a special fund from Children's Hospital Foundation, Children's Research Institute of Wisconsin and Children's Hospital of Wisconsin.	Aguirre J, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.041910; Allagnat F, 2005, J CELL SCI, V118, P5335, DOI 10.1242/jcs.02600; Allefeld C, 2004, INT J BIFURCAT CHAOS, V14, P417, DOI 10.1142/S0218127404009521; Andreu E, 1997, J PHYSIOL-LONDON, V498, P753, DOI 10.1113/jphysiol.1997.sp021899; Atwater I., 1996, DIABETES MELLITUS FU; Atwater I., 1989, INSULIN SECRETION; Bergsten P, 2000, DIABETES-METAB RES, V16, P179, DOI 10.1002/1520-7560(200005/06)16:3<179::AID-DMRR115>3.3.CO;2-3; Bertram R, 2004, BIOPHYS J, V87, P3074, DOI 10.1529/biophysj.104.049262; BERTRAM R, 1995, BIOPHYS J, V68, P2323, DOI 10.1016/S0006-3495(95)80414-5; Bertram R, 2000, BIOPHYS J, V79, P2880, DOI 10.1016/S0006-3495(00)76525-8; Bertuzzi F, 2007, DIABETES CARE, V30, P410, DOI 10.2337/dc06-1233; BINGLEY PJ, 1992, DIABETOLOGIA, V35, P32, DOI 10.1007/BF00400849; BRATUSCHMARRAIN PR, 1986, DIABETES, V35, P922, DOI 10.2337/diabetes.35.8.922; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; CHAY TR, 1988, BIOPHYS J, V54, P427, DOI 10.1016/S0006-3495(88)82976-X; CHAY TR, 1983, BIOPHYS J, V42, P181, DOI 10.1016/S0006-3495(83)84384-7; De Vries G, 2000, J THEOR BIOL, V207, P513, DOI 10.1006/jtbi.2000.2193; De Vries G, 2001, B MATH BIOL, V63, P371, DOI 10.1006/bulm.2001.0228; FALKE LC, 1989, FEBS LETT, V251, P167, DOI 10.1016/0014-5793(89)81448-6; FOULIS AK, 1987, J PATHOL, V152, P141, DOI 10.1002/path.1711520302; GEPTS W, 1965, DIABETES, V14, P619, DOI 10.2337/diab.14.10.619; Gylfe E, 2000, UPSALA J MED SCI, V105, P35, DOI 10.1517/03009734000000054; HELLMAN B, 1994, DIABETOLOGIA, V37, pS11, DOI 10.1007/BF00400821; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Inoguchi Toyoshi, 2001, Medical Electron Microscopy, V34, P86, DOI 10.1007/s007950170002; Jo J, 2005, BIOPHYS J, V89, P1534, DOI 10.1529/biophysj.104.053181; Jonkers FC, 1999, J PHYSIOL-LONDON, V520, P839, DOI 10.1111/j.1469-7793.1999.00839.x; Kinard TA, 1999, BIOPHYS J, V76, P1423, DOI 10.1016/S0006-3495(99)77303-0; Le Gurun S, 2003, J BIOL CHEM, V278, P37690, DOI 10.1074/jbc.M212382200; Lehmann R, 2007, DIABETES, V56, P594, DOI 10.2337/db06-0779; LINN T, 1991, IMMUN INFEKT, V19, P164; MacDonald PE, 2006, PLOS BIOL, V4, P167, DOI 10.1371/journal.pbio.0040049; MacDonald PE, 2005, PHILOS T R SOC B, V360, P2211, DOI 10.1098/rstb.2005.1762; MacGregor RR, 2006, AM J PHYSIOL-ENDOC M, V290, pE771, DOI 10.1152/ajpendo.00097.2005; MATTHEWS DR, 1983, DIABETES, V32, P617, DOI 10.2337/diabetes.32.7.617; MATTHEWS EK, 1975, J PHYSIOL-LONDON, V246, P421, DOI 10.1113/jphysiol.1975.sp010897; MEARS D, 1995, J MEMBRANE BIOL, V146, P163; MEISSNER HP, 1974, PFLUG ARCH EUR J PHY, V351, P195, DOI 10.1007/BF00586918; Nadal A, 1999, J PHYSIOL-LONDON, V517, P85, DOI 10.1111/j.1469-7793.1999.0085z.x; Nlend Rachel Nlend, 2006, Archives of Physiology and Biochemistry, V112, P74, DOI 10.1080/13813450600712019; ORAHILLY S, 1988, NEW ENGL J MED, V318, P1225, DOI 10.1056/NEJM198805123181902; PAOLISSO G, 1988, J CLIN ENDOCR METAB, V66, P1220, DOI 10.1210/jcem-66-6-1220; PAOLISSO G, 1988, ANN MED INTERNE, V139, P144; Pedersen MG, 2005, BIOPHYS J, V89, P107, DOI 10.1529/biophysj.104.055681; Pedersen MG, 2005, J THEOR BIOL, V235, P1, DOI 10.1016/j.jtbi.2005.01.025; PEREZARMENDARIZ M, 1991, BIOPHYS J, V59, P76, DOI 10.1016/S0006-3495(91)82200-7; Porksen N, 2002, DIABETES, V51, pS245, DOI 10.2337/diabetes.51.2007.S245; Quesada I, 2006, DIABETES, V55, P2463, DOI 10.2337/db06-0272; Ravier MA, 2005, DIABETES, V54, P1798, DOI 10.2337/diabetes.54.6.1798; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Rocheleau JV, 2006, PLOS BIOL, V4, P221, DOI 10.1371/journal.pbio.0040026; Rorsman P, 2003, DIABETOLOGIA, V46, P1029, DOI 10.1007/s00125-003-1153-1; Rosenblum M., 2001, HDB BIOL PHYS, V4, P279; SAMOLS E, 1990, METABOLISM, V39, P55, DOI 10.1016/0026-0495(90)90212-U; SANCHEZANDRES JV, 1995, J PHYSIOL-LONDON, V486, P223, DOI 10.1113/jphysiol.1995.sp020804; SANTOS RM, 1987, FEBS LETT, V220, P342, DOI 10.1016/0014-5793(87)80843-8; Sato T, 2002, DIABETES, V51, P1565, DOI 10.2337/diabetes.51.5.1565; Schafer C, 1999, PHYS REV E, V60, P857, DOI 10.1103/PhysRevE.60.857; Schmitz O, 1997, AM J PHYSIOL-ENDOC M, V272, pE218, DOI 10.1152/ajpendo.1997.272.2.E218; SHERMAN A, 1991, BIOPHYS J, V59, P547, DOI 10.1016/S0006-3495(91)82271-8; Sherman A, 1996, AM J PHYSIOL-ENDOC M, V271, pE362, DOI 10.1152/ajpendo.1996.271.2.E362; SHERMAN A, 1988, BIOPHYS J, V54, P411, DOI 10.1016/S0006-3495(88)82975-8; SMITH PA, 1990, FEBS LETT, V261, P187, DOI 10.1016/0014-5793(90)80667-8; SMOLEN P, 1993, BIOPHYS J, V64, P1668, DOI 10.1016/S0006-3495(93)81539-X; Sohl G, 2004, CARDIOVASC RES, V62, P228, DOI 10.1016/j.cardiores.2003.11.013; STAGNER JI, 1985, AM J PHYSIOL, V248, pE522, DOI 10.1152/ajpendo.1985.248.5.E522; Valdeolmillos M, 1996, J PHYSIOL-LONDON, V493, P9, DOI 10.1113/jphysiol.1996.sp021361; VELDHUIS JD, 1987, P NATL ACAD SCI USA, V84, P7686, DOI 10.1073/pnas.84.21.7686; WARD GM, 1987, DRUGS, V33, P156, DOI 10.2165/00003495-198733020-00004; Wierschem K, 2004, J THEOR BIOL, V228, P513, DOI 10.1016/j.jtbi.2004.02.022; YARIMIZU K, 1992, DIABETES RES CLIN PR, V17, P27, DOI 10.1016/0168-8227(92)90040-X; Zarkovic M, 2004, AM J PHYSIOL-ENDOC M, V287, pE340, DOI 10.1152/ajpendo.00069.2004; Zarkovic M, 1999, EUR J ENDOCRINOL, V141, P494, DOI 10.1530/eje.0.1410494; Zimliki CL, 2004, BIOPHYS J, V87, P193, DOI 10.1529/biophysj.103.038471	75	34	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e983	10.1371/journal.pone.0000983	http://dx.doi.org/10.1371/journal.pone.0000983			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912360	Green Published, Green Submitted, gold			2022-12-25	WOS:000207455900019
J	Sponner, A; Vater, W; Monajembashi, S; Unger, E; Grosse, F; Weisshart, K				Sponner, Alexander; Vater, Wolfram; Monajembashi, Shamci; Unger, Eberhard; Grosse, Frank; Weisshart, Klaus			Composition and Hierarchical Organisation of a Spider Silk	PLOS ONE			English	Article							SKIN-CORE STRUCTURE; DRAGLINE SILK; MECHANICAL-PROPERTIES; PROTEIN-COMPONENTS; MICROSTRUCTURE; MORPHOLOGY; SEQUENCE; GLYCOPROTEINS; ORIENTATION; FIBERS	Albeit silks are fairly well understood on a molecular level, their hierarchical organisation and the full complexity of constituents in the spun fibre remain poorly defined. Here we link morphological defined structural elements in dragline silk of Nephila clavipes to their biochemical composition and physicochemical properties. Five layers of different make-ups could be distinguished. Of these only the two core layers contained the known silk proteins, but all can vitally contribute to the mechanical performance or properties of the silk fibre. Understanding the composite nature of silk and its supra-molecular organisation will open avenues in the production of high performance fibres based on artificially spun silk material.	[Sponner, Alexander] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Sponner, Alexander; Vater, Wolfram; Monajembashi, Shamci; Unger, Eberhard; Grosse, Frank; Weisshart, Klaus] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany	University of Oxford; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Weisshart, K (corresponding author), Carl Zeiss MicroImaging GmbH, Jena, Germany.	weisshart@zeiss.de			Bundesministerium fur Forschung und Bildung [BMBF FKZ 0311130]; Bundesministerium fur Landwirtschaft [BML FKZ 98NR049]; Thueringer Ministerium fur Wissenschaft, Forschung und Kultur [TMWFK B307-99-001]; European Commission [MTKD-CT-2004-014533]	Bundesministerium fur Forschung und Bildung(Federal Ministry of Education & Research (BMBF)); Bundesministerium fur Landwirtschaft; Thueringer Ministerium fur Wissenschaft, Forschung und Kultur; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was funded by Bundesministerium fur Forschung und Bildung (BMBF FKZ 0311130), Bundesministerium fur Landwirtschaft (BML FKZ 98NR049), Thueringer Ministerium fur Wissenschaft, Forschung und Kultur (TMWFK B307-99-001) and European Commission (MTKD-CT-2004-014533).	Augsten K, 2000, SCANNING, V22, P12; Augsten K, 1999, SCANNING, V21, P77; Ayoub NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000514; Colgin MA, 1998, PROTEIN SCI, V7, P667, DOI 10.1002/pro.5560070315; CRAIG CC, 2003, TRACING EVOLUTION MO; Denny M.W., 1980, Symposia of the Society for Experimental Biology, P247; Dicko C, 2004, BIOMACROMOLECULES, V5, P704, DOI 10.1021/bm034307c; Garb JE, 2006, SCIENCE, V312, P1762, DOI 10.1126/science.1127946; Gosline J, 2002, PHILOS T R SOC B, V357, P121, DOI 10.1098/rstb.2001.1022; GOSLINE JM, 1984, NATURE, V309, P551, DOI 10.1038/309551a0; Gosline JM, 1999, J EXP BIOL, V202, P3295; Gould SAC, 1999, INT J BIOL MACROMOL, V24, P151, DOI 10.1016/S0141-8130(99)00003-3; Guerette PA, 1996, SCIENCE, V272, P112, DOI 10.1126/science.272.5258.112; Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0; Hayashi CY, 2004, MOL BIOL EVOL, V21, P1950, DOI 10.1093/molbev/msh204; Huemmerich D, 2004, CURR BIOL, V14, P2070, DOI 10.1016/j.cub.2004.11.005; Huemmerich D, 2004, BIOCHEMISTRY-US, V43, P13604, DOI 10.1021/bi048983q; Knight DP, 2001, BIOMACROMOLECULES, V2, P323, DOI 10.1021/bm0001446; Knight DP, 2000, INT J BIOL MACROMOL, V27, P205, DOI 10.1016/S0141-8130(00)00124-0; KNIGHT DP, 2001, BIOL LIQUID CRYSTAL, P302; KOVOOR J, 1986, Revue Arachnologique, V7, P15; Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780; LI SFY, 1994, J VAC SCI TECHNOL A, V12, P1891, DOI 10.1116/1.578978; LI SFY, 1994, BIOPHYS J, V66, P1209, DOI 10.1016/S0006-3495(94)80903-8; Liu Y, 2005, NAT MATER, V4, P901, DOI 10.1038/nmat1534; Miller LD, 1999, INT J BIOL MACROMOL, V24, P159, DOI 10.1016/S0141-8130(99)00024-0; Motriuk-Smith D, 2005, BIOMACROMOLECULES, V6, P3152, DOI 10.1021/bm050472b; Parkhe AD, 1997, J MOL RECOGNIT, V10, P1, DOI 10.1002/(SICI)1099-1352(199701/02)10:1<1::AID-JMR338>3.0.CO;2-7; PESCHKE T, 1989, J MICROSC-OXFORD, V156, P191, DOI 10.1111/j.1365-2818.1989.tb02918.x; Porter D, 2005, EUR PHYS J E, V16, P199, DOI 10.1140/epje/e2005-00021-2; Riekel C, 2000, BIOMACROMOLECULES, V1, P622, DOI 10.1021/bm000047c; Rousseau ME, 2007, J AM CHEM SOC, V129, P3897, DOI 10.1021/ja067471r; Scheller J, 2004, TRANSGENIC RES, V13, P51, DOI 10.1023/B:TRAG.0000017175.78809.7a; Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335; Schulz S, 2001, LIPIDS, V36, P637, DOI 10.1007/s11745-001-0768-7; SEEGER S, 1991, CYTOMETRY, V12, P497, DOI 10.1002/cyto.990120606; Shao Z, 1999, POLYMER, V40, P4709, DOI 10.1016/S0032-3861(99)00072-5; Simmons AH, 1996, SCIENCE, V271, P84, DOI 10.1126/science.271.5245.84; Sponner A, 2005, NAT MATER, V4, P772, DOI 10.1038/nmat1493; Sponner A, 2005, BIOCHEMISTRY-US, V44, P4727, DOI 10.1021/bi047671k; Sponner A, 2004, BIOMACROMOLECULES, V5, P840, DOI 10.1021/bm034378b; Thiel BL, 1997, BIOPOLYMERS, V41, P703, DOI 10.1002/(SICI)1097-0282(199706)41:7<703::AID-BIP1>3.0.CO;2-T; THIEL BL, 1994, BIOPOLYMERS, V34, P1089, DOI 10.1002/bip.360340812; Thiel BL, 1997, J MICROSC-OXFORD, V185, P179, DOI 10.1046/j.1365-2818.1997.d01-607.x; Tian MZ, 2005, BIOCHEMISTRY-US, V44, P8006, DOI 10.1021/bi050366u; van Beek JD, 2002, P NATL ACAD SCI USA, V99, P10266, DOI 10.1073/pnas.152162299; Vendrely C, 2007, MACROMOL BIOSCI, V7, P401, DOI 10.1002/mabi.200600255; Vollrath F, 1999, INT J BIOL MACROMOL, V24, P243, DOI 10.1016/S0141-8130(98)00095-6; Vollrath F, 1996, P ROY SOC B-BIOL SCI, V263, P147, DOI 10.1098/rspb.1996.0023; Vollrath F, 2005, WOODH PUBL TEXT, P245; Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000; Vollrath F, 2001, P ROY SOC B-BIOL SCI, V268, P2339, DOI 10.1098/rspb.2001.1590	52	133	135	6	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e998	10.1371/journal.pone.0000998	http://dx.doi.org/10.1371/journal.pone.0000998			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912375	Green Submitted, Green Published, gold			2022-12-25	WOS:000207455900034
J	Beckstrom-Sternberg, SM; Auerbach, RK; Godbole, S; Pearson, JV; Beckstrom-Sternberg, JS; Deng, ZM; Munk, C; Kubota, K; Zhou, Y; Bruce, D; Noronha, J; Scheuermann, RH; Wang, AH; Wei, XY; Wang, JJ; Hao, J; Wagner, DM; Brettin, TS; Brown, N; Gilna, P; Keim, PS				Beckstrom-Sternberg, Stephen M.; Auerbach, Raymond K.; Godbole, Shubhada; Pearson, John V.; Beckstrom-Sternberg, James S.; Deng, Zuoming; Munk, Christine; Kubota, Kristy; Zhou, Yan; Bruce, David; Noronha, Jyothi; Scheuermann, Richard H.; Wang, Aihui; Wei, Xianying; Wang, Jianjun; Hao, Jicheng; Wagner, David M.; Brettin, Thomas S.; Brown, Nancy; Gilna, Paul; Keim, Paul S.			Complete Genomic Characterization of a Pathogenic A.II Strain of Francisella tularensis Subspecies tularensis	PLOS ONE			English	Article							UNITED-STATES; VIRULENCE; SEQUENCE; PROTEIN; IDENTIFICATION; ALIGNMENT; GENES; ATTENUATION; TULAREMIA	Francisella tularensis is the causative agent of tularemia, which is a highly lethal disease from nature and potentially from a biological weapon. This species contains four recognized subspecies including the North American endemic F. tularensis subsp. tularensis (type A), whose genetic diversity is correlated with its geographic distribution including a major population subdivision referred to as A.I and A.II. The biological significance of the A.I - A.II genetic differentiation is unknown, though there are suggestive ecological and epidemiological correlations. In order to understand the differentiation at the genomic level, we have determined the complete sequence of an A.II strain (WY96-3418) and compared it to the genome of Schu S4 from the A.I population. We find that this A.II genome is 1,898,476 bp in size with 1,820 genes, 1,303 of which code for proteins. While extensive genomic variation exists between "WY96'' and Schu S4, there is only one whole gene difference. This one gene difference is a hypothetical protein of unknown function. In contrast, there are numerous SNPs (3,367), small indels (1,015), IS element differences (7) and large chromosomal rearrangements (31), including both inversions and translocations. The rearrangement borders are frequently associated with IS elements, which would facilitate intragenomic recombination events. The pathogenicity island duplicated regions (DR1 and DR2) are essentially identical in WY96 but vary relative to Schu S4 at 60 nucleotide positions. Other potential virulence-associated genes (231) varied at 559 nucleotide positions, including 357 non-synonymous changes. Molecular clock estimates for the divergence time between A.I and A.II genomes for different chromosomal regions ranged from 866 to 2131 years before present. This paper is the first complete genomic characterization of a member of the A.II clade of Francisella tularensis subsp. tularensis.	[Beckstrom-Sternberg, Stephen M.; Hao, Jicheng; Keim, Paul S.] Translat Genom Res Inst, Pathogen Genom Div, Phoenix, AZ USA; [Beckstrom-Sternberg, Stephen M.; Auerbach, Raymond K.; Beckstrom-Sternberg, James S.; Wagner, David M.; Keim, Paul S.] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA; [Godbole, Shubhada; Noronha, Jyothi; Scheuermann, Richard H.] Univ Texas SW Med Ctr Dallas, BioHlth Base, Dallas, TX 75390 USA; [Pearson, John V.] Translat Genom Res Inst, Neurogenom Div, Phoenix, AZ USA; [Deng, Zuoming; Wang, Aihui; Wei, Xianying; Wang, Jianjun] Northrop Grumman Informat Technol, BioHealthBase, Rockville, MD USA; [Munk, Christine; Bruce, David; Brettin, Thomas S.; Brown, Nancy; Gilna, Paul] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM USA; [Munk, Christine; Bruce, David; Brettin, Thomas S.; Brown, Nancy; Gilna, Paul] Joint Genome Inst, Dept Energy, Walnut Creek, CA USA; [Kubota, Kristy; Zhou, Yan] Ctr Dis Control & Prevent, Ft Collins, CO USA	Translational Genomics Research Institute; Northern Arizona University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Translational Genomics Research Institute; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Centers for Disease Control & Prevention - USA	Keim, PS (corresponding author), Translat Genom Res Inst, Pathogen Genom Div, Phoenix, AZ USA.	Paul.Keim@nau.edu	Pearson, John V/F-2249-2011; Keim, Paul S/A-2269-2010; Wagner, David M/A-5125-2010; Gilna, Paul/I-3608-2016	Pearson, John V/0000-0003-0904-4598; Gilna, Paul/0000-0002-6542-0191; Scheuermann, Richard H./0000-0003-1355-892X; Wagner, David/0000-0003-2684-6007	Cowden Endowment for Microbiology NAU; NIAID/NIH [HHSN266200400041C]; ADB [N01-AI-40041]	Cowden Endowment for Microbiology NAU; NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ADB	PSK was supported by The Cowden Endowment for Microbiology NAU. SG, ZD, JN, RS, AW, XW, and JW were supported by NIAID/NIH Contract Number: HHSN266200400041C, ADB Contract Number: N01-AI-40041. Genome sequencing was funded by the Intelligence Technology Innovation Center.	ACHTMAN M, 2004, YERSINIA MOL CELLULA; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AUERBACH RK, 2006, THESIS NO ARIZONA U, P72; Barns SM, 2005, APPL ENVIRON MICROB, V71, P5494, DOI 10.1128/AEM.71.9.5494-5500.2005; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Brotcke A, 2006, INFECT IMMUN, V74, P6642, DOI 10.1128/IAI.01250-06; *CDC, 2003, KEY FACTS TUL; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P2369, DOI 10.1093/nar/27.11.2369; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Farlow J, 2005, EMERG INFECT DIS, V11, P1835, DOI 10.3201/eid1112.050728; Forslund AL, 2006, MOL MICROBIOL, V59, P1818, DOI 10.1111/j.1365-2958.2006.05061.x; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Haft DH, 2001, NUCLEIC ACIDS RES, V29, P41, DOI 10.1093/nar/29.1.41; HARRIS S, 1991, CRIME LAW SOCIAL CH, V15, P171; Harris S., 1992, ANN N Y ACAD SCI, V666, P21; Johansson A, 2004, J BACTERIOL, V186, P5808, DOI 10.1128/JB.186.17.5808-5818.2004; Jordan IK, 2002, GENOME RES, V12, P962, DOI 10.1101/gr.87702; KEIM PS, 2007, ANN N Y ACAD SCI; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Larsson P, 2005, NAT GENET, V37, P153, DOI 10.1038/ng1499; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; LSUFJEV NG, 1983, INT J SYSTEMATIC BAC, V33, P872; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725, DOI 10.1128/MMBR.62.3.725-774.1998; Petrosino JF, 2006, J BACTERIOL, V188, P6977, DOI 10.1128/JB.00506-06; POLARD P, 1991, J MOL BIOL, V222, P465, DOI 10.1016/0022-2836(91)90490-W; Rohmer L, 2006, INFECT IMMUN, V74, P6895, DOI 10.1128/IAI.01006-06; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Staples JE, 2006, EMERG INFECT DIS, V12, P1113; Stothard P, 2005, BIOINFORMATICS, V21, P537, DOI 10.1093/bioinformatics/bti054; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Twine S, 2005, INFECT IMMUN, V73, P8345, DOI 10.1128/IAI.73.12.8345-8352.2005; Twine SM, 2006, MICROB PATHOGENESIS, V40, P133, DOI 10.1016/j.micpath.2005.12.004	40	41	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e947	10.1371/journal.pone.0000947	http://dx.doi.org/10.1371/journal.pone.0000947			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895988	Green Submitted, Green Published, gold			2022-12-25	WOS:000207455800026
J	Roure, A; Rothbacher, U; Robin, F; Kalmar, E; Ferone, G; Lamy, C; Missero, C; Mueller, F; Lemaire, P				Roure, Agnes; Rothbaecher, Ute; Robin, Francois; Kalmar, Eva; Ferone, Giustina; Lamy, Clement; Missero, Caterina; Mueller, Ferenc; Lemaire, Patrick			A Multicassette Gateway Vector Set for High Throughput and Comparative Analyses in Ciona and Vertebrate Embryos	PLOS ONE			English	Article							FUNCTIONAL-ANALYSIS; GENE-EXPRESSION; SONIC-HEDGEHOG; DNA CLONING; MESODERM; RECOMBINATION; TRANSCRIPTION; CHORDATE; ENHANCER; SYSTEM	Background. The past few years have seen a vast increase in the amount of genomic data available for a growing number of taxa, including sets of full length cDNA clones and cis-regulatory sequences. Large scale cross-species comparisons of protein function and cis-regulatory sequences may help to understand the emergence of specific traits during evolution. Principal Findings. To facilitate such comparisons, we developed a Gateway compatible vector set, which can be used to systematically dissect cis-regulatory sequences, and overexpress wild type or tagged proteins in a variety of chordate systems. It was developed and first characterised in the embryos of the ascidian Ciona intestinalis, in which large scale analyses are easier to perform than in vertebrates, owing to the very efficient embryo electroporation protocol available in this organism. Its use was then extended to fish embryos and cultured mammalian cells. Conclusion. This versatile vector set opens the way to the mid-to large-scale comparative analyses of protein function and cis-regulatory sequences across chordate evolution. A complete user manual is provided as supplemental material.	[Roure, Agnes; Rothbaecher, Ute; Robin, Francois; Lamy, Clement; Lemaire, Patrick] Univ Mediterranee, CNRS, Inst Biol Dev Marseille Luminy, UMR 6216, Marseille, France; [Kalmar, Eva; Mueller, Ferenc] Forschungszentrum Karlsruhe, Inst Toxicol & Genet, D-76021 Karlsruhe, Germany; [Ferone, Giustina; Missero, Caterina] CEINGE Biotecnol Avanzate SCarl Ctr Genet Engn, Naples, Italy	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Helmholtz Association; Karlsruhe Institute of Technology; CEINGE Biotecnologie Avanzate	Roure, A (corresponding author), Univ Mediterranee, CNRS, Inst Biol Dev Marseille Luminy, UMR 6216, Marseille, France.	roure@ibdm.univ-mrs.fr; lemaire@ibdm.univ-mrs.fr	Lemaire, Patrick/B-5560-2012; Robin, François/B-4784-2013; Robin, Francois B/ABI-2581-2020; Kalmár, Éva/AAD-6515-2022; Rothbächer, Ute/G-2688-2013; Rothbächer, Ute/AAB-6901-2022; Lemaire, Patrick/P-8228-2019; Muller, Ferenc/C-6426-2009	Lemaire, Patrick/0000-0003-4925-2009; Robin, François/0000-0002-2420-2593; Robin, Francois B/0000-0002-2420-2593; Kalmár, Éva/0000-0003-4616-8047; Rothbächer, Ute/0000-0002-9989-6139; Rothbächer, Ute/0000-0002-9989-6139; Lemaire, Patrick/0000-0003-4925-2009; Missero, Caterina/0000-0003-0905-5123; mueller, ferenc/0000-0002-0996-774X	CNRS; European commission; GIS de la Genomique Marine	CNRS(Centre National de la Recherche Scientifique (CNRS)); European commission(European CommissionEuropean Commission Joint Research Centre); GIS de la Genomique Marine	This work was supported by CNRS and by grants from the European commission (Transcode to PL, FM and CM; Embryos against cancer, Marine genomics Europe to PL) and the GIS de la Genomique Marine to PL.	Antonini D, 2006, MOL CELL BIOL, V26, P3308, DOI 10.1128/MCB.26.8.3308-3318.2006; Bertrand V, 2003, CELL, V115, P615, DOI 10.1016/S0092-8674(03)00928-0; Brand L, 2006, PLANT PHYSIOL, V141, P1194, DOI 10.1104/pp.106.081299; Brasch MA, 2004, GENOME RES, V14, P2001, DOI 10.1101/gr.2769804; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Cheo DL, 2004, GENOME RES, V14, P2111, DOI 10.1101/gr.2512204; Conklin E.G., 1905, J ACAD NAT SCI PHILA, V12, P1, DOI DOI 10.5962/BHL.TITLE.4801; Corbo JC, 1997, DEVELOPMENT, V124, P589; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Dupuy D, 2004, GENOME RES, V14, P2169, DOI 10.1101/gr.2497604; Erives A, 1998, DEV BIOL, V194, P213, DOI 10.1006/dbio.1997.8810; Ertzer R, 2007, DEV BIOL, V301, P578, DOI 10.1016/j.ydbio.2006.11.004; Fanelli A, 2003, DEV BIOL, V263, P12, DOI 10.1016/S0012-1606(03)00397-X; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Hinman VF, 2003, P NATL ACAD SCI USA, V100, P13356, DOI 10.1073/pnas.2235868100; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hope IA, 2004, GENOME RES, V14, P2070, DOI 10.1101/gr.2463804; Ikuta T, 2004, P NATL ACAD SCI USA, V101, P15118, DOI 10.1073/pnas.0401389101; Kim SH, 1998, DEVELOPMENT, V125, P4681; Koster RW, 2001, DEV BIOL, V233, P329, DOI 10.1006/dbio.2001.0242; Kusakabe T, 2005, ZOOL SCI, V22, P129, DOI 10.2108/zsj.22.129; Lamy C, 2006, DEVELOPMENT, V133, P2835, DOI 10.1242/dev.02448; LEMAIRE P, 1995, CELL, V81, P85, DOI 10.1016/0092-8674(95)90373-9; Lenart P, 2005, NATURE, V436, P812, DOI 10.1038/nature03810; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Locascio A, 1999, DEVELOPMENT, V126, P4737; Marcellini S, 2003, DEV BIOL, V260, P352, DOI 10.1016/S0012-1606(03)00244-6; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Moriyoshi K, 1996, NEURON, V16, P255, DOI 10.1016/S0896-6273(00)80044-6; Muller F, 1999, DEVELOPMENT, V126, P2103; MULLER F, 1993, FEBS LETT, V324, P27, DOI 10.1016/0014-5793(93)81525-5; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Oda H, 2001, J CELL SCI, V114, P493; Oda-Ishii I, 2005, DEVELOPMENT, V132, P1663, DOI 10.1242/dev.01707; Ohno M, 1999, MOL CELL BIOL, V19, P2051; Pasini A, 2006, PLOS BIOL, V4, P1173, DOI 10.1371/journal.pbio.0040225; Poulain M, 2006, DEVELOPMENT, V133, P2189, DOI 10.1242/dev.02387; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; Rottinger E, 2006, DEVELOPMENT, V133, P4341, DOI 10.1242/dev.02603; Ruvinsky I, 2003, DEVELOPMENT, V130, P5133, DOI 10.1242/dev.00711; Sasaki Y, 2004, J BIOTECHNOL, V107, P233, DOI 10.1016/j.jbiotec.2003.10.001; SASAKI Y, 2005, J BIOTECHNOL; Satou Y, 2002, GENESIS, V33, P153, DOI 10.1002/gene.10119; Simpson JC, 2000, EMBO REP, V1, P287, DOI 10.1093/embo-reports/kvd058; Tarsitano M, 2006, FASEB J, V20, P227, DOI 10.1096/fj.05-4147com; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Yahata K, 2005, J BIOTECHNOL, V118, P123, DOI 10.1016/j.jbiotec.2005.02.020	51	94	95	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2007	2	9							e916	10.1371/journal.pone.0000916	http://dx.doi.org/10.1371/journal.pone.0000916			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HS	17878951	Green Published, Green Submitted, gold			2022-12-25	WOS:000207455700024
J	Subramanian, S; Lui, WO; Lee, CH; Espinosa, I; Nielsen, TO; Heinrich, MC; Corless, CL; Fire, AZ; van de Rijn, M				Subramanian, S.; Lui, W. O.; Lee, C. H.; Espinosa, I.; Nielsen, T. O.; Heinrich, M. C.; Corless, C. L.; Fire, A. Z.; van de Rijn, M.			MicroRNA expression signature of human sarcomas	ONCOGENE			English	Article						miRNA; microarrays; sarcoma	GENE-EXPRESSION; KIT; MUTATIONS; TUMORS; REGIONS; MDM2; RNAS	MicroRNAs (miRNAs) are similar to 22 nucleotide-long noncoding RNAs involved in several biological processes including development, differentiation and proliferation. Recent studies suggest that knowledge of miRNA expression patterns in cancer may have substantial value for diagnostic and prognostic determinations as well as for eventual therapeutic intervention. We performed comprehensive analysis of miRNA expression profiles of 27 sarcomas, 5 normal smooth muscle and 2 normal skeletal muscle tissues using microarray technology and/or small RNA cloning approaches. The miRNA expression profiles are distinct among the tumor types as demonstrated by an unsupervised hierarchical clustering, and unique miRNA expression signatures were identified in each tumor class. Remarkably, the miRNA expression patterns suggested that two of the sarcomas had been misdiagnosed and this was confirmed by reevaluation of the tumors using histopathologic and molecular analyses. Using the cloning approach, we also identified 31 novel miRNAs or other small RNA effectors in the sarcomas and normal skeletal muscle tissues examined. Our data show that different histological types of sarcoma have distinct miRNA expression patterns, reflecting the apparent lineage and differentiation status of the tumors. The identification of unique miRNA signatures in each tumor type may indicate their role in tumorigenesis and may aid in diagnosis of soft tissue sarcomas.	[Subramanian, S.; Lui, W. O.; Lee, C. H.; Espinosa, I.; Fire, A. Z.; van de Rijn, M.] Stanford Univ, Med Ctr, Dept Pathol, Stanford, CA 94305 USA; [Lee, C. H.; Nielsen, T. O.] Univ British Columbia, Gen Pathol Evaluat Ctr, Vancouver, BC V5Z 1M9, Canada; [Heinrich, M. C.] Oregon Hlth & Sci Univ, Div Hematol Oncol, Portland, OR 97201 USA; [Corless, C. L.] Oregon Hlth & Sci Univ, Dept Pathol, Portland, OR 97201 USA; [Fire, A. Z.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA	Stanford University; University of British Columbia; Oregon Health & Science University; Oregon Health & Science University; Stanford University	van de Rijn, M (corresponding author), Stanford Univ, Med Ctr, Dept Pathol, 300 Pasteur Dr,L-235, Stanford, CA 94305 USA.	mrijn@stanford.edu	Heinrich, Michael/AAC-6745-2019; Lui, Weng-Onn/G-6703-2013; Lui, Weng-Onn/X-5957-2019	Lui, Weng-Onn/0000-0003-4717-4473; Lui, Weng-Onn/0000-0003-4717-4473; Subramanian, Subbaya/0000-0002-2544-480X; Fire, Andrew/0000-0001-6217-8312; Heinrich, Michael/0000-0003-3790-0478; van de Rijn, Matt/0000-0002-1909-9739	NCI NIH HHS [CA112270] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA112270] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Baer C, 2004, INT J CANCER, V110, P687, DOI 10.1002/ijc.20171; Binh MBN, 2005, AM J SURG PATHOL, V29, P1340, DOI 10.1097/01.pas.0000170343.09562.39; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; ESPINOSA I, 2007, IN PRESS AM J SURG; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; Fletcher JA, 2007, CURR OPIN GENET DEV, V17, P3, DOI 10.1016/j.gde.2006.12.010; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; HE L, 2004, NAT REV GENET, V5, P522; Heinrich MC, 2003, SCIENCE, V299, P708, DOI 10.1126/science.1079666; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lui WO, 2007, CANCER RES, V67, P6031, DOI 10.1158/0008-5472.CAN-06-0561; Mayanil CSK, 2001, J BIOL CHEM, V276, P49299, DOI 10.1074/jbc.M107933200; Michael MZ, 2003, MOL CANCER RES, V1, P882; Nielsen TO, 2002, LANCET, V359, P1301, DOI 10.1016/S0140-6736(02)08270-3; Politz JCR, 2006, P NATL ACAD SCI USA, V103, P18957, DOI 10.1073/pnas.0609466103; Pretto D, 2006, ONCOGENE, V25, P3661, DOI 10.1038/sj.onc.1209413; Shimada S, 2006, HUM PATHOL, V37, P1123, DOI 10.1016/j.humpath.2006.04.010; Subramanian S, 2004, ONCOGENE, V23, P7780, DOI 10.1038/sj.onc.1208056; WEISS SW, 2001, SOFT TISSUE TUMORS; West RB, 2004, AM J PATHOL, V165, P107, DOI 10.1016/S0002-9440(10)63279-8; Yan Z, 2003, J BIOL CHEM, V278, P8826, DOI 10.1074/jbc.M209879200; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	31	185	213	0	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 27	2008	27	14					2015	2026		10.1038/sj.onc.1210836	http://dx.doi.org/10.1038/sj.onc.1210836			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	279MK	17922033				2022-12-25	WOS:000254359100006
J	Xiao, W; Zhang, Q; Habermacher, G; Yang, X; Zhang, AY; Cai, X; Hahn, J; Liu, J; Pins, M; Doglio, L; Dhir, R; Gingrich, J; Wang, Z				Xiao, W.; Zhang, Q.; Habermacher, G.; Yang, X.; Zhang, A-y; Cai, X.; Hahn, J.; Liu, J.; Pins, M.; Doglio, L.; Dhir, R.; Gingrich, J.; Wang, Z.			U19/Eaf2 knockout causes lung adenocarcinoma, B-cell lymphoma, hepatocellular carcinoma and prostatic intraepithelial neoplasia	ONCOGENE			English	Article						U19/Eaf2; lung adenocarcinoma; B-cell lymphoma; hepatocellular carcinoma; prostate cancer; tumor suppressor	ELONGATION-FACTOR ELL; TUMOR-SUPPRESSOR; VASCULAR TUMORS; FACTOR-2 EAF2; CAJAL BODY; GENE; POLYMERASE; MLL; INACTIVATION; EXPRESSION	Upregulated gene 19 (U19)/ELL-associated factor 2 (Eaf2) is a potential human tumor suppressor that exhibits frequent allelic loss and downregulation in high-grade prostate cancer. U19/Eaf2, along with its homolog Eaf1, has been reported to regulate transcriptional elongation via interaction with the eleven-nineteen lysine-rich leukemia (ELL) family of proteins. To further explore the tumor-suppressive effects of U19/Eaf2, we constructed and characterized a murine U19/Eaf2-knockout model. Homozygous or heterozygous deletion of U19/Eaf2 resulted in high rates of lung adenocarcinoma, B-cell lymphoma, hepato cellular carcinoma and prostate intraepithelial neoplasia. Within the mouse prostate, U19/Eaf2 defficiency enhanced cell proliferation and increased epithelial cell size. The knockout mice also exhibited cardiac cell hypertrophy. These data indicate a role for U19/Eaf2 in growth suppression and cell size control as well as argue for U19/Eaf2 as a novel tumor suppressor in multiple mouse tissues. The U19/Eaf2 knockout mouse also provides a unique animal model for three important cancers: lung adenocarcinoma, B-cell lymphoma and hepatocellular carcinoma.	[Zhang, A-y; Liu, J.; Gingrich, J.; Wang, Z.] Univ Pittsburgh, Dept Urol, Shadyside Med Ctr, Inst Canc,Sch Med, Pittsburgh, PA 15232 USA; [Xiao, W.; Zhang, Q.; Habermacher, G.; Zhang, A-y; Cai, X.; Hahn, J.; Wang, Z.] Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA; [Xiao, W.] Chinese Acad Sci, Inst Hydrobiol, Wuhan, Peoples R China; [Yang, X.; Pins, M.] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA; [Yang, X.; Pins, M.; Wang, Z.] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Doglio, L.; Wang, Z.] Northwestern Univ, Feinberg Sch Med, Ctr Genet Med, Chicago, IL 60611 USA; [Dhir, R.] Univ Pittsburgh, Sch Med, Dept Pathol, Inst Canc, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Northwestern University; Feinberg School of Medicine; Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Feinberg School of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wang, Z (corresponding author), Univ Pittsburgh, Dept Urol, Shadyside Med Ctr, Inst Canc,Sch Med, Suite G40,5200 Ctr Ave, Pittsburgh, PA 15232 USA.	wangz2@upmc.edu	Xiao, Wuhan/GLU-7352-2022	Gingrich, Jeffrey/0000-0002-4516-2893	NATIONAL CANCER INSTITUTE [R01CA120386, P50CA090386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051193, R37DK051193] Funding Source: NIH RePORTER; NCI NIH HHS [P50 CA90386, R01 CA120386, P50 CA090386-06A25083, P50 CA090386, R01 CA120386-03] Funding Source: Medline; NIDDK NIH HHS [R01 DK51193, R01 DK051193, R37 DK051193-14, R37 DK051193] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Cioce M, 2005, ANNU REV CELL DEV BI, V21, P105, DOI 10.1146/annurev.cellbio.20.010403.103738; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; Gall JG, 2003, NAT REV MOL CELL BIO, V4, P975, DOI 10.1038/nrm1262; Haase VH, 2001, P NATL ACAD SCI USA, V98, P1583, DOI 10.1073/pnas.98.4.1583; Haber D, 1997, NAT GENET, V16, P320, DOI 10.1038/ng0897-320; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kong SE, 2005, P NATL ACAD SCI USA, V102, P10094, DOI 10.1073/pnas.0503017102; Li M, 2003, DEV DYNAM, V228, P273, DOI 10.1002/dvdy.10367; Luo RT, 2001, MOL CELL BIOL, V21, P5678, DOI 10.1128/MCB.21.16.5678-5687.2001; Ma WB, 2003, CANCER RES, V63, P5320; Maurus D, 2005, EMBO J, V24, P1181, DOI 10.1038/sj.emboj.7600603; Mitani K, 2000, BIOCHEM BIOPH RES CO, V279, P563, DOI 10.1006/bbrc.2000.3970; Polak PE, 2003, MOL BIOL CELL, V14, P1517, DOI 10.1091/mbc.E02-07-0394; SELFRIDGE J, 1992, SOMAT CELL MOLEC GEN, V18, P325, DOI 10.1007/BF01235756; Shappell SB, 2004, CANCER RES, V64, P2270, DOI 10.1158/0008-5472.CAN-03-0946; Shilatifard A, 1997, P NATL ACAD SCI USA, V94, P3639, DOI 10.1073/pnas.94.8.3639; Shilatifard A, 1996, SCIENCE, V271, P1873, DOI 10.1126/science.271.5257.1873; Shilatifard A, 1997, J BIOL CHEM, V272, P22355, DOI 10.1074/jbc.272.35.22355; Simone F, 2003, BLOOD, V101, P2355, DOI 10.1182/blood-2002-06-1664; Simone F, 2001, BLOOD, V98, P201, DOI 10.1182/blood.V98.1.201; THIRMAN MJ, 1994, P NATL ACAD SCI USA, V91, P12110, DOI 10.1073/pnas.91.25.12110; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Wang Z, 1997, P NATL ACAD SCI USA, V94, P12999, DOI 10.1073/pnas.94.24.12999; Xiao WH, 2003, CANCER RES, V63, P4698; Zhu N, 1999, CANCER RES, V59, P1896	26	54	56	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 6	2008	27	11					1536	1544		10.1038/sj.onc.1210786	http://dx.doi.org/10.1038/sj.onc.1210786			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	271VC	17873910	Green Accepted			2022-12-25	WOS:000253815800005
J	Ingram, WJ; Mccue, KI; Tran, TH; Hallahan, AR; Wainwright, BJ				Ingram, W. J.; McCue, K. I.; Tran, T. H.; Hallahan, A. R.; Wainwright, B. J.			Sonic Hedgehog regulates Hes1 through a novel mechanism that is independent of canonical Notch pathway signalling	ONCOGENE			English	Article						Sonic Hedgehog; Hes1; Notch; C3H/10T1/2; MNS70; gene expression profiling	GENE-EXPRESSION; HUMAN HOMOLOG; CELL DIFFERENTIATION; MICROARRAY ANALYSIS; NEURAL DEVELOPMENT; IDENTIFICATION; GROWTH; ROLES; MEDULLOBLASTOMAS; CERULOPLASMIN	Aberrant regulation of signalling mechanisms that normally orchestrate embryonic development, such as the Hedgehog, Wnt and Notch pathways, is a common feature of tumorigenesis. In order to better understand the neoplastic events mediated by Hedgehog signalling, we identified over 200 genes regulated by Sonic Hedgehog in multipotent mesodermal cells. Widespread crosstalk with other developmental signalling pathways is evident, suggesting a complex network of interactions that challenges the often over-simplistic representation of these pathways as simple linear entities. Hes1, a principal effector of the Notch pathway, was found to be a target of Sonic Hedgehog in both C3H/10T1/2 mesodermal and MNS70 neural cells. Desert Hedgehog also elicited a strong Hes1 response. While Smoothened function was found necessary for upregulation of Hes1 in response to Sonic Hedgehog, the mechanism does not require gamma-secretase-mediated cleavage of Notch receptors, and appears to involve transcription factors other than RBP-J kappa. Thus, we have defined a novel mechanism for Hes1 regulation in stem-like cells that is independent of canonical Notch signalling.	[Ingram, W. J.; McCue, K. I.; Tran, T. H.; Wainwright, B. J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Ingram, W. J.; Hallahan, A. R.] Univ Queensland, Royal Childrens Hosp, Dept Paediat & Child Hlth, Brisbane, Qld, Australia	University of Queensland; Royal Children's Hospital Brisbane; University of Queensland	Wainwright, BJ (corresponding author), Univ Queensland, Inst Mol Biosci, Bldg 80,St Lucia Campus, Brisbane, Qld 4072, Australia.	b.wainwright@imb.uq.edu.au	Hallahan, Andrew R/F-1757-2010; Ingram, Wendy J/F-7317-2010	Ingram, Wendy J/0000-0002-7063-1081; Wainwright, Brandon/0000-0003-0406-2092				Alexandre C, 1999, DEVELOPMENT, V126, P5689; Allenspach EJ, 2002, CANCER BIOL THER, V1, P466, DOI 10.4161/cbt.1.5.159; Amundson SA, 1998, ONCOGENE, V17, P3287, DOI 10.1038/sj.onc.1202576; Arias AM, 2002, CURR OPIN GENET DEV, V12, P524, DOI 10.1016/S0959-437X(02)00336-2; Baonza A, 2001, DEVELOPMENT, V128, P3889; Blokzijl A, 2003, J CELL BIOL, V163, P723, DOI 10.1083/jcb.200305112; Borzillo GV, 2005, CURR TOP MED CHEM, V5, P147, DOI 10.2174/1568026053507732; CHAKRABORTY PK, 1984, ACTA MED OKAYAMA, V38, P315; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Dakubo GD, 2006, J NEURO-ONCOL, V79, P221, DOI 10.1007/s11060-006-9132-2; Das I, 2004, J BIOL CHEM, V279, P30771, DOI 10.1074/jbc.M309252200; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Eichberger T, 2006, GENOMICS, V87, P616, DOI 10.1016/j.ygeno.2005.12.003; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Fan X, 2004, CANCER RES, V64, P7787, DOI 10.1158/0008-5472.CAN-04-1446; Frank-Kamenetsky Maria, 2002, J Biol, V1, P10, DOI 10.1186/1475-4924-1-10; Fu WM, 2003, DEVELOPMENT, V130, P5229, DOI 10.1242/dev.00764; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; Goodrich LV, 1998, NEURON, V21, P1243, DOI 10.1016/S0896-6273(00)80645-5; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Hallahan AR, 2004, CANCER RES, V64, P7794, DOI 10.1158/0008-5472.CAN-04-1813; Hansson EM, 2004, SEMIN CANCER BIOL, V14, P320, DOI 10.1016/j.semcancer.2004.04.011; Hays R, 1999, DEVELOPMENT, V126, P2891; Hegde P, 2000, BIOTECHNIQUES, V29, P548, DOI 10.2144/00293bi01; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Ingram WJ, 2002, ONCOGENE, V21, P8196, DOI 10.1038/sj.onc.1205975; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Iso T, 2001, MOL CELL BIOL, V21, P6071, DOI 10.1128/MCB.21.17.6071-6079.2001; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jia J, 2006, CELL MOL LIFE SCI, V63, P1249, DOI 10.1007/s00018-005-5519-z; Johansson FK, 2005, ONCOGENE, V24, P3896, DOI 10.1038/sj.onc.1208553; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Kageyama R, 2005, EXP CELL RES, V306, P343, DOI 10.1016/j.yexcr.2005.03.015; Kappler R, 2004, ONCOGENE, V23, P8785, DOI 10.1038/sj.onc.1208133; Kappler R, 2004, INT J ONCOL, V25, P113; Kato M, 2001, BIOCHEM BIOPH RES CO, V289, P472, DOI 10.1006/bbrc.2001.5976; Kinto N, 1997, FEBS LETT, V404, P319, DOI 10.1016/S0014-5793(97)00014-8; KUNAPULI SP, 1987, LIFE SCI, V40, P2225, DOI 10.1016/0024-3205(87)90057-9; Kwon C, 2004, DEVELOPMENT, V131, P2681, DOI 10.1242/dev.01127; Li XM, 2002, MICROCIRCULATION, V9, P13, DOI 10.1038/sj.mn.7800118; Lowndes SA, 2004, ONCOL RES, V14, P529, DOI 10.3727/0965040042707952; McGlinn E, 2005, MECH DEVELOP, V122, P1218, DOI 10.1016/j.mod.2005.06.012; Minoguchi S, 1997, MOL CELL BIOL, V17, P2679, DOI 10.1128/MCB.17.5.2679; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Murata K, 2005, MOL CELL BIOL, V25, P4262, DOI 10.1128/MCB.25.10.4262-4271.2005; Nakagawa Y, 1996, DEVELOPMENT, V122, P2449; Nakamura T, 1997, BIOCHEM BIOPH RES CO, V237, P465, DOI 10.1006/bbrc.1997.7156; Oliver TG, 2005, DEVELOPMENT, V132, P2425, DOI 10.1242/dev.01793; Oliver TG, 2003, P NATL ACAD SCI USA, V100, P7331, DOI 10.1073/pnas.0832317100; Pathi S, 2001, MECH DEVELOP, V106, P107, DOI 10.1016/S0925-4773(01)00427-0; Pietsch T, 1997, CANCER RES, V57, P2085; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; REZNIKOFF CA, 1973, CANCER RES, V33, P3231; Shawber C, 1996, DEVELOPMENT, V122, P3765; Solecki DJ, 2001, NEURON, V31, P557, DOI 10.1016/S0896-6273(01)00395-6; van den Boom J, 2003, AM J PATHOL, V163, P1033, DOI 10.1016/S0002-9440(10)63463-3; Varela AS, 1997, CANCER LETT, V121, P139, DOI 10.1016/S0304-3835(97)00340-6; Weng AP, 2003, MOL CELL BIOL, V23, P655, DOI 10.1128/MCB.23.2.655-664.2003; Woodward WA, 2005, J CELL SCI, V118, P3585, DOI 10.1242/jcs.02532; Yokota N, 2004, ONCOGENE, V23, P3444, DOI 10.1038/sj.onc.1207475; Yoon JW, 2002, J BIOL CHEM, V277, P5548, DOI 10.1074/jbc.M105708200; Zhao Q, 2002, P NATL ACAD SCI USA, V99, P5704, DOI 10.1073/pnas.082092399	62	129	135	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 28	2008	27	10					1489	1500		10.1038/sj.onc.1210767	http://dx.doi.org/10.1038/sj.onc.1210767			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	267ZR	17873912				2022-12-25	WOS:000253548200016
J	Rosenzweig, D; Smith, D; Opperdoes, F; Stern, S; Olafson, RW; Zilberstein, D				Rosenzweig, Doron; Smith, Derek; Opperdoes, Fred; Stern, Shay; Olafson, Robert W.; Zilberstein, Dan			Retooling Leishmania metabolism: from sand fly gut to human macrophage	FASEB JOURNAL			English	Article						proteomics; metabolomics; intracellular differentiation; gene expression	AXENIC AMASTIGOTES; ENZYME-ACTIVITIES; GENE-EXPRESSION; MEXICANA; PROMASTIGOTES; PARASITE; DONOVANI; PROTEIN; DIFFERENTIATION; IDENTIFICATION	To survive extremely different environments, intracellular parasites require highly adaptable physiological and metabolic systems. Leishmania donovani extracellular promastigotes reside in a glucose-rich, slightly alkaline environment in the sand fly vector alimentary tract. On entry into human macrophage phagolysosomes, promastigotes differentiate into intracellular amastigotes. These cope with an acidic milieu, where glucose is scarce while amino acids are abundant. Here, we use an axenic differentiation model and a novel high-coverage, comparative proteomic methodology to analyze in detail protein expression changes throughout the differentiation process. The analysis identified and quantified 21% of the parasite proteome across 7 time points during differentiation. The data reveal a delayed increase in gluconeogenesis enzymes, coinciding with a decrease in glycolytic capacity. At the same time, beta-oxidation, amino acid catabolism, tricarboxylic acid cycle, mitochondrial respiration chain, and oxidative phosphorylation capacities are all up-regulated. The results indicate that the differentiating parasite shifts from glucose to fatty acids and amino acids as its main energy source. Furthermore, glycerol and amino acids are used as precursors for sugar synthesis, compensating for lack of exogenous sugars. These changes occur while promastigotes undergo morphological transformation. Our findings provide new insight into changes occurring in single-cell organisms during a developmental process.	[Rosenzweig, Doron; Zilberstein, Dan] Technion Israel Inst Technol, Fac Biol, IL-32000 Haifa, Israel; [Stern, Shay; Olafson, Robert W.] Technion Israel Inst Technol, Fac Chem Engn, Haifa, Israel; [Smith, Derek] Univ Victoria, UVic Proteome Ctr, Victoria, BC V8W 2Y2, Canada; [Opperdoes, Fred] Catholic Univ Louvain, Brussels, Belgium; [Opperdoes, Fred] Christian Duve Inst Cellular Pathol, Trop Dis Res Unit, Brussels, Belgium	Technion Israel Institute of Technology; Technion Israel Institute of Technology; University of Victoria; Universite Catholique Louvain	Zilberstein, D (corresponding author), Technion Israel Inst Technol, Fac Biol, IL-32000 Haifa, Israel.	danz@tx.technion.ac.il	Opperdoes, Frederik R/C-8897-2018; Opperdoes, Fred/N-9922-2019	Opperdoes, Frederik R/0000-0003-1984-3764; Opperdoes, Fred/0000-0003-1984-3764				Akopyants NS, 2004, MOL BIOCHEM PARASIT, V136, P71, DOI 10.1016/j.molbiopara.2004.03.002; Almeida R, 2004, MOL BIOCHEM PARASIT, V136, P87, DOI 10.1016/j.molbiopara.2004.03.004; Barak E, 2005, MOL BIOCHEM PARASIT, V141, P99, DOI 10.1016/j.molbiopara.2005.02.004; BATES PA, 1993, FEMS MICROBIOL LETT, V107, P53, DOI 10.1111/j.1574-6968.1993.tb06003.x; Bente M, 2003, PROTEOMICS, V3, P1811, DOI 10.1002/pmic.200300462; Besteiro S, 2006, J BIOL CHEM, V281, P11384, DOI 10.1074/jbc.M512307200; Besteiro S, 2007, INT J PARASITOL, V37, P1063, DOI 10.1016/j.ijpara.2007.03.008; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Clayton CE, 2002, EMBO J, V21, P1881, DOI 10.1093/emboj/21.8.1881; COOMBS GH, 1982, MOL BIOCHEM PARASIT, V5, P199, DOI 10.1016/0166-6851(82)90021-4; Debrabant A, 2004, INT J PARASITOL, V34, P205, DOI 10.1016/j.ijpara.2003.10.011; Dillon RJ, 1997, COMP BIOCHEM PHYS B, V116, P35, DOI 10.1016/S0305-0491(96)00195-2; HART DT, 1982, EXP PARASITOL, V54, P397, DOI 10.1016/0014-4894(82)90049-2; HASSAN HF, 1985, COMP BIOCHEM PHYS B, V81, P1037, DOI 10.1016/0305-0491(85)90110-5; Herwaldt BL, 1999, LANCET, V354, P1191, DOI 10.1016/S0140-6736(98)10178-2; Holzer TR, 2006, MOL BIOCHEM PARASIT, V146, P198, DOI 10.1016/j.molbiopara.2005.12.009; Hubel A, 1997, MOL CELL BIOL, V17, P5987; HUBEL A, 1995, MOL BIOCHEM PARASIT, V70, P107, DOI 10.1016/0166-6851(95)00012-P; Huynh C, 2006, J EXP MED, V203, P2363, DOI 10.1084/jem.20060559; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; MCGARRY JD, 1977, J CLIN INVEST, V60, P265, DOI 10.1172/JCI108764; Melanson JE, 2006, PROTEOMICS, V6, P4466, DOI 10.1002/pmic.200600112; MOTTRAM JC, 1985, EXP PARASITOL, V59, P151, DOI 10.1016/0014-4894(85)90067-0; MUKKADA AJ, 1974, J PROTOZOOL, V21, P393, DOI 10.1111/j.1550-7408.1974.tb03676.x; MUKKADA AJ, 1985, SCIENCE, V229, P1099, DOI 10.1126/science.4035350; Naderer T, 2006, P NATL ACAD SCI USA, V103, P5502, DOI 10.1073/pnas.0509196103; Nugent PG, 2004, MOL BIOCHEM PARASIT, V136, P51, DOI 10.1016/j.molbiopara.2004.02.009; Onn I, 2006, J BIOL CHEM, V281, P37468, DOI 10.1074/jbc.M606374200; OPPERDOES FR, 2007, TRENDS PARASITOL; Saar Y, 1998, MOL BIOCHEM PARASIT, V95, P9, DOI 10.1016/S0166-6851(98)00062-0; Saxena A, 2007, MOL BIOCHEM PARASIT, V152, P53, DOI 10.1016/j.molbiopara.2006.11.011; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; VANSCHAFTINGEN E, 1985, EUR J BIOCHEM, V153, P403, DOI 10.1111/j.1432-1033.1985.tb09316.x; Walker J, 2006, MOL BIOCHEM PARASIT, V147, P64, DOI 10.1016/j.molbiopara.2006.01.008; Wiese M, 1998, EMBO J, V17, P2619, DOI 10.1093/emboj/17.9.2619; Zhang WW, 1996, MOL BIOCHEM PARASIT, V78, P79, DOI 10.1016/S0166-6851(96)02612-6	36	209	209	2	25	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2008	22	2					590	602		10.1096/fj.07-9254com	http://dx.doi.org/10.1096/fj.07-9254com			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	257TY	17884972				2022-12-25	WOS:000252822600029
J	Garvey, GS; McCormick, SP; Rayment, I				Garvey, Graeme S.; McCormick, Susan P.; Rayment, Ivan			Structural and functional characterization of the TRI101 trichothecene 3-O-acetyltransferase from Fusarium sporotrichioides and Fusarium graminearum - Kinetic insights to combating fusarium head blight	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYCOTOXIN DEOXYNIVALENOL; VINORINE SYNTHASE; CRYSTAL-STRUCTURE; GENE; BIOSYNTHESIS; EXPRESSION; ENCODES; PROTEIN; BAHD; ACETYLTRANSFERASE	Fusarium head blight (FHB) is a plant disease with serious economic and health impacts. It is caused by fungal species belonging to the genus Fusarium and the mycotoxins they produce. Although it has proved difficult to combat this disease, one strategy that has been examined is the introduction of an indigenous fungal protective gene into cereals such as wheat barley and rice. Thus far the gene of choice has been tri101 whose gene product catalyzes the transfer of an acetyl group from acetyl coenzyme A to the C3 hydroxyl moiety of several trichothecene mycotoxins. In vitro this has been shown to reduce the toxicity of the toxins by similar to 100-fold but has demonstrated limited resistance to FHB in transgenic cereal. To understand the molecular basis for the differences between in vitro and in vivo resistance the three-dimensional structures and kinetic properties of two TRI101 orthologs isolated from Fusarium sporotrichioides and Fusarium graminearum have been determined. The kinetic results reveal important differences in activity of these enzymes toward B-type trichothecenes such as deoxynivalenol. These differences in activity can be explained in part by the three-dimensional structures for the ternary complexes for both of these enzymes with coenzyme A and trichothecene mycotoxins. The structural and kinetic results together emphasize that the choice of an enzymatic resistance gene in transgenic crop protection strategies must take into account the kinetic profile of the selected protein.	[Garvey, Graeme S.; Rayment, Ivan] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [McCormick, Susan P.] USDA ARS, Natl Ctr Agr Utilizat Res, Mycotoxin Res Unit, Peoria, IL 61604 USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of Agriculture (USDA)	Rayment, I (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	ivan_rayment@biochem.wisc.edu	rayment, ivan/A-2720-2008	rayment, ivan/0000-0001-9279-7835; McCormick, Susan/0000-0002-7824-6372	NIAMS NIH HHS [AR 35186] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR035186] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Alexander NJ, 1999, MOL GEN GENET, V261, P977, DOI 10.1007/s004380051046; ANDERSON DW, 1989, J MED CHEM, V32, P555, DOI 10.1021/jm00123a008; Atlas RM., 1995, HDB MEDIA ENV MICROB; Bayer A, 2004, BIOORGAN MED CHEM, V12, P2787, DOI 10.1016/j.bmc.2004.02.029; Buglino J, 2004, J BIOL CHEM, V279, P30634, DOI 10.1074/jbc.M404011200; CUNDLIFFE E, 1974, P NATL ACAD SCI USA, V71, P30, DOI 10.1073/pnas.71.1.30; D'Auria JC, 2006, CURR OPIN PLANT BIOL, V9, P331, DOI 10.1016/j.pbi.2006.03.016; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; HOHN TM, 1986, ARCH BIOCHEM BIOPHYS, V251, P756, DOI 10.1016/0003-9861(86)90386-3; Kim HS, 2003, MYCOL RES, V107, P190, DOI 10.1017/S0953756203007317; Kimura M, 1998, J BIOL CHEM, V273, P1654, DOI 10.1074/jbc.273.3.1654; Kimura M, 1998, BIOSCI BIOTECH BIOCH, V62, P1033, DOI 10.1271/bbb.62.1033; Larsen JC, 2004, TOXICOL LETT, V153, P1, DOI 10.1016/j.toxlet.2004.04.020; Manoharan M, 2006, PLANT SCI, V171, P699, DOI 10.1016/j.plantsci.2006.07.004; McCormick SP, 1999, APPL ENVIRON MICROB, V65, P5252; McCormick SP, 2002, APPL ENVIRON MICROB, V68, P2959, DOI 10.1128/AEM.68.6.2959-2964.2002; McCormick SP, 2006, CAN J MICROBIOL, V52, P636, DOI 10.1139/W06-011; Muhitch MJ, 2000, PLANT SCI, V157, P201, DOI 10.1016/S0168-9452(00)00282-X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nganje WE, 2004, REV AGR ECON, V26, P332, DOI 10.1111/j.1467-9353.2004.00183.x; Ohsato S, 2007, PLANT CELL REP, V26, P531, DOI 10.1007/s00299-006-0251-1; Okubara PA, 2002, THEOR APPL GENET, V106, P74, DOI 10.1007/s00122-002-1066-2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pestka JJ, 2005, J TOXICOL ENV HEAL B, V8, P39, DOI 10.1080/10937400590889458; Poppenberger B, 2003, J BIOL CHEM, V278, P47905, DOI 10.1074/jbc.M307552200; Rynkiewicz MJ, 2001, P NATL ACAD SCI USA, V98, P13543, DOI 10.1073/pnas.231313098; Shih YP, 2005, PROTEIN SCI, V14, P936, DOI 10.1110/ps.041129605; Shima J, 1997, APPL ENVIRON MICROB, V63, P3825, DOI 10.1128/AEM.63.10.3825-3830.1997; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tokai T, 2005, MICROBIOL-SGM, V151, P509, DOI 10.1099/mic.0.27435-0; Tokai T, 2007, BIOCHEM BIOPH RES CO, V353, P412, DOI 10.1016/j.bbrc.2006.12.033; Tsodikov OV, 2002, J COMPUT CHEM, V23, P600, DOI 10.1002/jcc.10061; UENO Y, 1975, APPL MICROBIOL, V30, P4, DOI 10.1128/AEM.30.1.4-9.1975; Unno H, 2007, J BIOL CHEM, V282, P15812, DOI 10.1074/jbc.M700638200; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127	40	69	78	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1660	1669		10.1074/jbc.M705752200	http://dx.doi.org/10.1074/jbc.M705752200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17923480	hybrid			2022-12-25	WOS:000252282700053
J	Lundgren, S; Andersen, B; Piskur, J; Dobritzsch, D				Lundgren, Stina; Andersen, Birgit; Piskur, Jure; Dobritzsch, Doreen			Crystal structures of yeast beta-alanine synthase complexes reveal the mode of substrate binding and large scale domain closure movements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRIMIDINE DEGRADATION; UREIDOPROPIONASE; PURIFICATION; CARNOSINE; PROTEINS; CATALYSIS; ROTATION; ENZYMES; ERRORS; ACID	beta-Alanine synthase is the final enzyme of the reductive pyrimidine catabolic pathway, which is responsible for the breakdown of uracil and thymine in higher organisms. The fold of the homodimeric enzyme from the yeast Saccharomyces kluyveri identifies it as a member of the AcyI/M20 family of metallopeptidases. Its subunit consists of a catalytic domain harboring a di-zinc center and a smaller dimerization domain. The present site-directed mutagenesis studies identify Glu(159) and Arg(322) as crucial for catalysis and His(262) and His(397) as functionally important but not essential. We determined the crystal structures of wild-type beta-alanine synthase in complex with the reaction product beta-alanine, and of the mutant E159A with the substrate N-carbamyl-beta-alanine, revealing the closed state of a dimeric AcyI/M20 metallopeptidase-like enzyme. Subunit closure is achieved by a similar to 30 degrees rigid body domain rotation, which completes the active site by integration of substrate binding residues that belong to the dimerization domain of the same or the partner subunit. Substrate binding is achieved via a salt bridge, a number of hydrogen bonds, and coordination to one of the zinc ions of the di-metal center.	Karolinska Inst, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden; Lund Univ, Dept Cell & Organism Biol, SE-22362 Lund, Sweden	Karolinska Institutet; Lund University	Dobritzsch, D (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Tomtebodavagen 6, SE-17177 Stockholm, Sweden.	Doreen.Dobritzsch@ki.se	Dobritzsch, Doreen/H-7334-2018					Agarwal R, 2007, J MOL BIOL, V368, P450, DOI 10.1016/j.jmb.2007.02.028; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Biagini A, 2001, COMP BIOCHEM PHYS B, V128, P469, DOI 10.1016/S1096-4959(00)00341-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dobritzsch D, 2003, ACTA CRYSTALLOGR D, V59, P1267, DOI 10.1107/S0907444903009120; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Gojkovic Z, 2001, GENETICS, V158, P999; Hakansson K, 2002, EUR J BIOCHEM, V269, P443, DOI 10.1046/j.0014-2956.2001.02665.x; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; HEGGIE GD, 1987, CANCER RES, V47, P2203; HIGGINS JJ, 1994, NEUROLOGY, V44, P1728, DOI 10.1212/WNL.44.9.1728; Hipkiss AR, 1997, NEUROSCI LETT, V238, P135, DOI 10.1016/S0304-3940(97)00873-2; Janssen B, 2005, DIABETES, V54, P2320, DOI 10.2337/diabetes.54.8.2320; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jozic D, 2002, STRUCTURE, V10, P1097, DOI 10.1016/S0969-2126(02)00805-5; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lindner HA, 2005, BIOCHEMISTRY-US, V44, P15645, DOI 10.1021/bi051180y; Lindner HA, 2003, J BIOL CHEM, V278, P44496, DOI 10.1074/jbc.M304233200; Lohkamp B., 2005, CCP4 NEWSLETTER, V42; Lu GG, 2000, J APPL CRYSTALLOGR, V33, P176, DOI 10.1107/S0021889899012339; Lundgren S, 2003, J BIOL CHEM, V278, P51851, DOI 10.1074/jbc.M308674200; Martinez-Rodriguez S, 2006, BIOCHIMIE, V88, P837, DOI 10.1016/j.biochi.2006.01.012; Munch G, 1997, BBA-MOL BASIS DIS, V1360, P17, DOI 10.1016/S0925-4439(96)00062-2; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Rawlings ND, 2004, BIOCHEM J, V378, P705, DOI 10.1042/BJ20031825; Rowsell S, 1997, STRUCTURE, V5, P337, DOI 10.1016/S0969-2126(97)00191-3; SANDBERG M, 1981, J NEUROCHEM, V37, P1353, DOI 10.1111/j.1471-4159.1981.tb04691.x; SANNO Y, 1970, J BIOL CHEM, V245, P5668; Stvolinsky SL, 1999, CELL MOL NEUROBIOL, V19, P45, DOI 10.1023/A:1006960407008; TAMAKI N, 1987, EUR J BIOCHEM, V169, P21, DOI 10.1111/j.1432-1033.1987.tb13575.x; Traut TW, 1996, PROG NUCLEIC ACID RE, V53, P1, DOI 10.1016/S0079-6603(08)60142-7; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Van Kuilenburg ABP, 1999, ANAL BIOCHEM, V272, P250, DOI 10.1006/abio.1999.4181; vanGennip AH, 1997, J INHERIT METAB DIS, V20, P203, DOI 10.1023/A:1005356806329; Vistoli G, 2006, J MED CHEM, V49, P3269, DOI 10.1021/jm0602099; Waldmann G, 2005, PROTEIN PEPTIDE LETT, V12, P69, DOI 10.2174/0929866053405904; WASTERNACK C, 1979, BIOCHIM BIOPHYS ACTA, V570, P341, DOI 10.1016/0005-2744(79)90154-2; WASTERNACK C, 1980, PHARMACOL THERAPEUT, V8, P629, DOI 10.1016/0163-7258(80)90079-0; White WH, 2001, J BIOL CHEM, V276, P10794, DOI 10.1074/jbc.M009804200; Widemann BC, 2006, ONCOLOGIST, V11, P694, DOI 10.1634/theoncologist.11-6-694; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Ye QZ, 2006, P NATL ACAD SCI USA, V103, P9470, DOI 10.1073/pnas.0602433103	48	20	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					36037	36047		10.1074/jbc.M705517200	http://dx.doi.org/10.1074/jbc.M705517200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17916556	hybrid			2022-12-25	WOS:000251458100063
J	Saavedra, L; Mohamed, A; Ma, V; Kar, S; de Chaves, EP				Saavedra, Lucila; Mohamed, Amany; Ma, Victoria; Kar, Satyabrata; de Chaves, Elena Posse			Internalization of beta-amyloid peptide by primary neurons in the absence of apolipoprotein E	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN; NICOTINIC ACETYLCHOLINE-RECEPTOR; INTRANEURONAL A-BETA-42 ACCUMULATION; INTRACELLULAR A-BETA; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; COMPARTMENTALIZED CULTURES; ULTRASTRUCTURALLY LOCALIZE; SYMPATHETIC NEURONS; GM1 GANGLIOSIDE	Extracellular accumulation of beta-amyloid peptide (A beta) has been linked to the development of Alzheimer disease. The importance of intraneuronal A beta has been recognized more recently. Although considerable evidence indicates that extracellular A beta contributes to the intracellular pool of A beta, the mechanisms involved in A beta uptake by neurons are poorly understood. We examined the molecular mechanisms involved in A beta-(1-42) internalization by primary neurons in the absence of apolipoprotein E. We demonstrated that A beta-(1-42) is more efficiently internalized by axons than by cell bodies of sympathetic neurons, suggesting that A beta-(1 42) uptake might be mediated by proteins enriched in the axons. Although the acetylcholine receptor alpha 7nAChR, previously suggested to be involved in A beta internalization, is enriched in axons, our results indicate that it does not mediate A beta-(1-42) internalization. Moreover, receptors of the low density lipoprotein receptor family are not essential for A beta-(1-42) uptake in the absence of apolipoprotein E because receptor-associated protein had no effect on A beta uptake. By expressing the inactive dynamin mutant dynK44A and the clathrin hub we found that A beta-(1-42) internalization is independent of clathrin but dependent on dynamin, which suggests an endocytic pathway involving caveolae/lipid rafts. Confocal microscopy studies showing that A beta did not co-localize with the early endosome marker EEA1 further support a clathrin-independent mechanism. The lack of co-localization of A beta with caveolin in intracellular vesicles and the normal uptake of A beta by neurons that do not express caveolin indicate that A beta does not require caveolin either. Instead partial co-localization of A beta-(1-42) with cholera toxin subunit B and sensitivity to reduction of cellular cholesterol and sphingolipid levels suggest a caveolae-independent, raft-mediated mechanism. Understanding the molecular events involved in neuronal A beta internalization might identify potential therapeutic targets for Alzheimer disease.	Univ Alberta, Fac Med & Dent, Dept Pharmacol, Edmonton, AB T6G 2H7, Canada; Univ Alberta, Fac Med & Dent, Dept Med, Edmonton, AB T6G 2H7, Canada; Univ Alberta, Fac Med & Dent, Ctr Neurosci, Edmonton, AB T6G 2H7, Canada	University of Alberta; University of Alberta; University of Alberta	de Chaves, EP (corresponding author), Univ Alberta, Fac Med, Dept Pharmacol, 9-28 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	elena.chaves@ualberta.ca	Saavedra, Lucila/AAS-9970-2020					Altschuler Y, 1998, J CELL BIOL, V143, P1871, DOI 10.1083/jcb.143.7.1871; Arispe N, 2002, FASEB J, V16, P1526, DOI 10.1096/fj.02-0829com; Bahr BA, 1998, J COMP NEUROL, V397, P139; Bi X, 2002, NEUROSCIENCE, V112, P827, DOI 10.1016/S0306-4522(02)00132-X; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Breese CR, 1997, J COMP NEUROL, V387, P385, DOI 10.1002/(SICI)1096-9861(19971027)387:3<385::AID-CNE5>3.0.CO;2-X; Bu GJ, 1998, TRENDS CELL BIOL, V8, P272, DOI 10.1016/S0962-8924(98)01283-5; Bu GJ, 2000, TRENDS CARDIOVAS MED, V10, P148, DOI 10.1016/S1050-1738(00)00045-1; BURDICK D, 1992, J BIOL CHEM, V267, P546; Burdick D, 1997, BRAIN RES, V746, P275, DOI 10.1016/S0006-8993(96)01262-0; Busciglio J, 2002, NEURON, V33, P677, DOI 10.1016/S0896-6273(02)00604-9; CAMPENOT RB, 1982, DEV BIOL, V93, P13, DOI 10.1016/0012-1606(82)90233-0; CAMPENOT RB, 1982, DEV BIOL, V93, P1, DOI 10.1016/0012-1606(82)90232-9; Cuello AC, 2005, BRAIN PATHOL, V15, P66; D'Andrea MR, 2001, HISTOPATHOLOGY, V38, P120, DOI 10.1046/j.1365-2559.2001.01082.x; D'Andrea MR, 2002, NEUROSCI LETT, V333, P163, DOI 10.1016/S0304-3940(02)00875-3; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; de Chaves EIP, 1997, J BIOL CHEM, V272, P30766, DOI 10.1074/jbc.272.49.30766; de Chaves EIP, 2000, J BIOL CHEM, V275, P19883, DOI 10.1074/jbc.275.26.19883; deChaves EIP, 1997, J BIOL CHEM, V272, P3028, DOI 10.1074/jbc.272.5.3028; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Dineley KT, 2002, J BIOL CHEM, V277, P25056, DOI 10.1074/jbc.M200066200; Ditaranto K, 2001, NEUROBIOL DIS, V8, P19, DOI 10.1006/nbdi.2000.0364; Echeverria V, 2002, MOL NEUROBIOL, V26, P299, DOI 10.1385/MN:26:2-3:299; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098; Glabe C, 2001, J MOL NEUROSCI, V17, P137, DOI 10.1385/JMN:17:2:137; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Gouras GK, 2005, NEUROBIOL AGING, V26, P1235, DOI 10.1016/j.neurobiolaging.2005.05.022; Gylys KH, 2007, NEUROBIOL AGING, V28, P8, DOI 10.1016/j.neurobiolaging.2005.10.018; Gylys KH, 2003, J NEUROCHEM, V84, P1442, DOI 10.1046/j.1471-4159.2003.01643.x; Gyure KA, 2001, ARCH PATHOL LAB MED, V125, P489; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Harrison T, 2004, CURR OPIN DRUG DISC, V7, P709; Head BP, 2007, TRENDS CELL BIOL, V17, P51, DOI 10.1016/j.tcb.2006.11.008; Helguera P, 2005, J NEUROSCI, V25, P2295, DOI 10.1523/JNEUROSCI.5107-04.2005; HERZ J, 1991, J BIOL CHEM, V266, P21232; Ida N, 1996, FEBS LETT, V394, P174, DOI 10.1016/0014-5793(96)00948-9; Jhamandas JH, 2004, J NEUROSCI, V24, P5579, DOI 10.1523/JNEUROSCI.1051-04.2004; Jordan J, 1998, J NEUROSCI, V18, P195; Kang DE, 2000, J CLIN INVEST, V106, P1159, DOI 10.1172/JCI11013; Kawarabayashi T, 2004, J NEUROSCI, V24, P3801, DOI 10.1523/JNEUROSCI.5543-03.2004; Kirkham M, 2005, BBA-MOL CELL RES, V1745, P273, DOI 10.1016/j.bbamcr.2005.06.002; Kokubo H, 2005, BRAIN RES, V1045, P224, DOI 10.1016/j.brainres.2005.03.017; Kokubo H, 2005, BRAIN RES, V1031, P222, DOI 10.1016/j.brainres.2004.10.041; Kuner P, 1998, J NEUROSCI RES, V54, P798, DOI 10.1002/(SICI)1097-4547(19981215)54:6<798::AID-JNR7>3.3.CO;2-K; Kuruvilla R, 2004, CELL, V118, P243, DOI 10.1016/j.cell.2004.06.021; LaDu MJ, 2000, J BIOL CHEM, V275, P33974, DOI 10.1074/jbc.M000602200; LAFERLA FM, 1995, NAT GENET, V9, P21, DOI 10.1038/ng0195-21; Le PU, 2003, J CELL SCI, V116, P1059, DOI 10.1242/jcs.00327; Marsh M, 1999, SCIENCE, V285, P215, DOI 10.1126/science.285.5425.215; Matsuzaki K, 1999, BIOCHEMISTRY-US, V38, P4137, DOI 10.1021/bi982345o; Mori C, 2002, AMYLOID, V9, P88, DOI 10.3109/13506120208995241; Muresan Z, 2006, MOL CELL BIOL, V26, P4982, DOI 10.1128/MCB.00371-06; Nagele RG, 2002, NEUROSCIENCE, V110, P199, DOI 10.1016/S0306-4522(01)00460-2; NAMBA Y, 1991, BRAIN RES, V541, P163, DOI 10.1016/0006-8993(91)91092-F; Narita M, 1997, J NEUROCHEM, V68, P587; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Permanne B, 1997, BIOCHEM BIOPH RES CO, V240, P715, DOI 10.1006/bbrc.1997.7727; Qiu ZH, 1999, J NEUROCHEM, V73, P1393, DOI 10.1046/j.1471-4159.1999.0731393.x; Rubino M, 2000, J BIOL CHEM, V275, P3745, DOI 10.1074/jbc.275.6.3745; Samuel N, 1997, NEUROSCI LETT, V222, P179, DOI 10.1016/S0304-3940(97)13377-8; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schneider A, 2006, NEUROBIOL DIS, V23, P573, DOI 10.1016/j.nbd.2006.04.015; Selkoe DJ, 2001, J ALZHEIMERS DIS, V3, P75, DOI 10.3233/JAD-2001-3111; Selkoe DJ, 2004, ANN INTERN MED, V140, P627, DOI 10.7326/0003-4819-140-8-200404200-00047; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Shie FS, 2003, NEUROREPORT, V14, P123, DOI 10.1097/00001756-200301200-00023; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; Skovronsky DM, 1998, J CELL BIOL, V141, P1031, DOI 10.1083/jcb.141.4.1031; Small DH, 2007, J NEUROCHEM, V101, P1527, DOI 10.1111/j.1471-4159.2006.04444.x; Song MS, 2006, NEUROBIOL AGING, V27, P1224, DOI 10.1016/j.neurobiolaging.2005.06.007; Song MS, 2003, NEUROPHARMACOLOGY, V45, P1130, DOI 10.1016/S0028-3908(03)00284-3; Soriano S, 1999, J BIOL CHEM, V274, P32295, DOI 10.1074/jbc.274.45.32295; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Tienari PJ, 1997, P NATL ACAD SCI USA, V94, P4125, DOI 10.1073/pnas.94.8.4125; Tseng HC, 2002, FEBS LETT, V523, P58, DOI 10.1016/S0014-5793(02)02934-4; TUMER RS, 1996, J BIOL CHEM, V271, P8966; Vaucher E, 2002, EXP NEUROL, V175, P398, DOI 10.1006/exnr.2002.7915; Wakabayashi M, 2005, BIOCHEM BIOPH RES CO, V328, P1019, DOI 10.1016/j.bbrc.2005.01.060; Walsh DM, 2000, BIOCHEMISTRY-US, V39, P10831, DOI 10.1021/bi001048s; Wang HY, 2000, J BIOL CHEM, V275, P5626, DOI 10.1074/jbc.275.8.5626; Wang HY, 2000, J NEUROCHEM, V75, P1155, DOI 10.1046/j.1471-4159.2000.0751155.x; Wirths O, 2001, NEUROSCI LETT, V316, P145, DOI 10.1016/S0304-3940(01)02399-0; WISNIEWSKI T, 1993, BIOCHEM BIOPH RES CO, V192, P359, DOI 10.1006/bbrc.1993.1423; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Xia WM, 1998, BIOCHEMISTRY-US, V37, P16465, DOI 10.1021/bi9816195; Yamauchi K, 2002, ANN CLIN LAB SCI, V32, P65; Yanagisawa K, 2005, NEUROSCIENTIST, V11, P250, DOI 10.1177/1073858405275177; Yang DS, 1999, NEUROSCIENCE, V90, P1217, DOI 10.1016/S0306-4522(98)00561-2; Yip CM, 2001, J MOL BIOL, V311, P723, DOI 10.1006/jmbi.2001.4881; Zhang Y, 2002, J CELL BIOL, V156, P519, DOI 10.1083/jcb.200110119	93	99	103	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35722	35732		10.1074/jbc.M701823200	http://dx.doi.org/10.1074/jbc.M701823200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17911110	hybrid			2022-12-25	WOS:000251458100033
J	Liao, P; Yu, D; Li, G; Yong, TF; Soon, JL; Chua, YL; Soong, TW				Liao, Ping; Yu, Dejie; Li, Guang; Yong, Tan Fong; Soon, Jia Lin; Chua, Yeow Leng; Soong, Tuck Wah			A smooth muscle Ca(v)1.2 calcium channel splice variant underlies hyperpolarized window current and enhanced state-dependent inhibition by nifedipine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA(1C) SUBUNIT; ALPHA-1 SUBUNIT; CA2+ CHANNEL; FUNCTIONAL EXPRESSION; ISOFORM; INACTIVATION; SENSITIVITY; SELECTIVITY; ANTAGONISTS; ISRADIPINE	Native smooth muscle L-type Ca(v)1.2 calcium channels have been shown to support a fraction of Ca2+ currents with a window current that is close to resting potential. The smooth muscle L-type Ca2+ channels are also more susceptible to inhibition by dihydropyridines (DHPs) than the cardiac channels. It was hypothesized that smooth muscle Cav1.2 channels exhibiting hyperpolarized shift in steady-state inactivation would contribute to larger inhibition by DHP, in addition to structural differences of the channels generated by alternative splicing that modulate DHP sensitivities. In addition, it has also been shown that alternative splicing modulates DHP sensitivities by generating structural differences in the Cav1.2 channels. Here, we report a smooth muscle L-type Cav1.2 calcium channel splice variant, Ca(v)1.2SM (1/8/9*/32/Delta 33), that when expressed in HEK 293 cells display hyperpolarized shifts for steady-state inactivation and activation potentials when compared with the established Ca(v)1.2b clone ( 1/8/9*/32/Delta 33). This variant activates from more negative potentials and generates a window current closer to resting membrane potential. We also identified the predominant cardiac isoform Ca(v)1.2CM clone ( 1a/8a/Delta 9*/32/33) that is different from the established Ca(v)1.2a (1a/8a/Delta 9*/31/33). Importantly, Cav1.2SM channels were shown to be more sensitive to nifedipine blockade than Cav1.2b and cardiac Cav1.2CM channels when currents were recorded in either 5 mM Ba2+ or 1.8 mM Ca2+ external solutions. This is the first time that a smooth muscle Cav1.2 splice variant has been identified functionally to possess biophysical property that can be linked to enhanced state-dependent block by DHP.	Natl Univ Singapore, Dept Physiol, Yong Loo Lin Sch Med, Singapore 117597, Singapore; Natl Heart Ctr, Dept Cardiothorac Surg, Singapore 168752, Singapore; Natl Inst Neurosci, Singapore 308433, Singapore; Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA	National University of Singapore; National Heart Centre Singapore; National Neuroscience Institute (NNI); Johns Hopkins University	Soong, TW (corresponding author), Natl Univ Singapore, Dept Physiol, Yong Loo Lin Sch Med, Block MD9,2 Med Dr, Singapore 117597, Singapore.	phsstw@nus.edu.sg	Tuluc, Petronel/C-2527-2011					Abernethy DR, 2002, J PHARMACOL EXP THER, V300, P724, DOI 10.1124/jpet.300.3.724; BEAN BP, 1984, P NATL ACAD SCI-BIOL, V81, P6388, DOI 10.1073/pnas.81.20.6388; BIEL M, 1990, FEBS LETT, V269, P409, DOI 10.1016/0014-5793(90)81205-3; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chemin J, 2000, FEBS LETT, V478, P166, DOI 10.1016/S0014-5793(00)01832-9; Dai BS, 2002, BIOCHEM BIOPH RES CO, V296, P429, DOI 10.1016/S0006-291X(02)00894-X; DIEBOLD RJ, 1992, P NATL ACAD SCI USA, V89, P1497, DOI 10.1073/pnas.89.4.1497; FERON O, 1994, EUR J BIOCHEM, V222, P195, DOI 10.1111/j.1432-1033.1994.tb18857.x; FLEISCHMANN BK, 1994, P NATL ACAD SCI USA, V91, P11914, DOI 10.1073/pnas.91.25.11914; GIDHJAIN M, 1995, BIOCHEM BIOPH RES CO, V216, P892, DOI 10.1006/bbrc.1995.2705; HESS P, 1984, NATURE, V311, P538, DOI 10.1038/311538a0; HIRST GDS, 1989, PHYSIOL REV, V69, P546, DOI 10.1152/physrev.1989.69.2.546; Hu H, 1998, MOL PHARMACOL, V53, P902; Lacinova L, 2000, PFLUG ARCH EUR J PHY, V440, P50, DOI 10.1007/s004240051021; LANGTON PD, 1993, J PHYSIOL-LONDON, V469, P535, DOI 10.1113/jphysiol.1993.sp019828; Ledoux J, 2006, PHYSIOLOGY, V21, P69, DOI 10.1152/physiol.00040.2005; Liao P, 2005, CARDIOVASC RES, V68, P197, DOI 10.1016/j.cardiores.2005.06.024; Liao P, 2004, J BIOL CHEM, V279, P50329, DOI 10.1074/jbc.M409436200; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; Morel N, 1998, BRIT J PHARMACOL, V125, P1005, DOI 10.1038/sj.bjp.0702162; NELSON MT, 1988, NATURE, V336, P382, DOI 10.1038/336382a0; NELSON MT, 1990, AM J PHYSIOL, V259, pC3; Richard S, 2005, DRUGS, V65, P1; Saada N, 2003, BIOCHEM BIOPH RES CO, V302, P23, DOI 10.1016/S0006-291X(03)00097-4; Saada NI, 2005, CELL CALCIUM, V37, P301, DOI 10.1016/j.ceca.2004.11.003; Sanders KM, 2001, J APPL PHYSIOL, V91, P1438, DOI 10.1152/jappl.2001.91.3.1438; SANGUINETTI MC, 1984, CIRC RES, V55, P336, DOI 10.1161/01.RES.55.3.336; Scholz H, 1997, CARDIOVASC DRUG THER, V10, P869, DOI 10.1007/BF00051613; Shi CZ, 2002, J BIOL CHEM, V277, P6813, DOI 10.1074/jbc.M110524200; SLISH DF, 1989, FEBS LETT, V250, P509, DOI 10.1016/0014-5793(89)80786-0; Soong TW, 2002, J NEUROSCI, V22, P10142; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Splawski I, 2005, P NATL ACAD SCI USA, V102, P8089, DOI 10.1073/pnas.0502506102; Striessnig J, 1999, CELL PHYSIOL BIOCHEM, V9, P242, DOI 10.1159/000016320; SUN JP, 1995, J PHARMACOL EXP THER, V274, P419; Tang ZZ, 2007, CELL CALCIUM, V41, P417, DOI 10.1016/j.ceca.2006.08.002; Tang ZZ, 2004, J BIOL CHEM, V279, P44335, DOI 10.1074/jbc.M407023200; Triggle DJ, 2003, CELL MOL NEUROBIOL, V23, P293, DOI 10.1023/A:1023632419813; TRIGGLE DJ, 1991, J CARDIOVASC PHARM, V18, pS1; Welling A, 1997, CIRC RES, V81, P526, DOI 10.1161/01.RES.81.4.526; Yang YB, 2000, J MOL CELL CARDIOL, V32, P973, DOI 10.1006/jmcc.2000.1138; Zuhlke RD, 1998, FEBS LETT, V427, P220, DOI 10.1016/S0014-5793(98)00425-6; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	43	81	82	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35133	35142		10.1074/jbc.M705478200	http://dx.doi.org/10.1074/jbc.M705478200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17916557	hybrid			2022-12-25	WOS:000251155200058
J	Chang, YH; Chuang, LY; Hwang, CC				Chang, Yi-Hsun; Chuang, Lea-Yea; Hwang, Chi-Ching			Mechanism of proton transfer in the 3 alpha-hydroxysteroid dehydrogenase/carbonyl reductase from Comamonas testosteroni	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHORT-CHAIN DEHYDROGENASES/REDUCTASES; PSEUDOMONAS SP B-0831; ALCOHOL-DEHYDROGENASE; ENZYMATIC CATALYSIS; BRONSTED ANALYSIS; CHEMICAL RESCUE; HYDROGEN-BONDS; BASE CATALYSIS; ANHYDRASE-III; MUTANT	3 alpha-Hydroxysteroid dehydrogenase/carbonyl reductase from Comamonas testosteroni catalyzes the oxidation of androsterone with NAD(+) to form androstanedione and NADH with a concomitant releasing of protons to bulk solvent. To probe the proton transfer during the enzyme reaction, we used mutagenesis, chemical rescue, and kinetic isotope effects to investigate the release of protons. The kinetic isotope effects of V-D and V-D2O for wild-type enzyme are 1 and 2.1 at pL 10.4(where L represents H, H-2), respectively, and suggest a rate-limiting step in the intramolecular proton transfer. Substitution of alanine for Lys(159) changes therate-limiting step to the hydride transfer, evidenced by an equal deuterium isotope effect of 18 on V-max and V/K-androsterone and no solvent kinetic isotope effect at saturating 3-(cyclohexylamino)propanesulfonic acid (CAPS). However, a value of 4.4 on V-max is observed at 10mM CAPS at pL 10.4, indicating a rate-limiting proton transfer. The rate of the proton transfer is blocked in the K159A and K159M mutants but can be rescued using exogenous proton acceptors, such as buffers, small primary amines, and azide. The Bronsted relationship between the log( V/Kd-baseEt) of the external amine (corrected for molecular size effects) and pK(a) is linear for the K159A mutant-catalyzed reaction at pH 10.4 (beta = 0.85 +/- 0.09) at 5mM CAPS. These results show that proton transfer to the external base with a late transition state occurred in a rate-limiting step. Furthermore, a proton inventory on V/Et is bowl-shaped for both the wild-type and K159A mutant enzymes and indicates a two-proton transfer in the transition state from Tyr(155) to Lys(159) via 2'-OH of ribose.	Kaohsiung Med Univ, Coll Med, Fac Med, Dept Biochem, Kaohsiung 80731, Taiwan	Kaohsiung Medical University	Hwang, CC (corresponding author), Kaohsiung Med Univ, Coll Med, Fac Med, Dept Biochem, 100 Shih Chuan 1st Rd, Kaohsiung 80731, Taiwan.	cchwang@kmu.edu.tw	Chuang, Lea-Yea/C-7450-2009; Hwang, Chi-Ching/K-7933-2012	Hwang, Chi-Ching/0000-0002-8328-674X				An HQ, 2002, BBA-PROTEINS PROTEOM, V1599, P21, DOI 10.1016/S0167-4838(02)00374-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brzezinski P, 2000, BBA-BIOENERGETICS, V1458, P1, DOI 10.1016/S0005-2728(00)00056-6; CHOTHIA C, 1975, NATURE, V254, P304, DOI 10.1038/254304a0; Cleland W W, 1979, Methods Enzymol, V63, P103; CLELAND WW, 1994, SCIENCE, V264, P1887, DOI 10.1126/science.8009219; Cleland WW, 1998, J BIOL CHEM, V273, P25529, DOI 10.1074/jbc.273.40.25529; EHRIG T, 1991, BIOCHEMISTRY-US, V30, P1062, DOI 10.1021/bi00218a026; Faxen K, 2005, NATURE, V437, P286, DOI 10.1038/nature03921; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; Grimm C, 2000, J BIOL CHEM, V275, P41333, DOI 10.1074/jbc.M007559200; Hwang CC, 2005, J BIOL CHEM, V280, P3522, DOI 10.1074/jbc.M411751200; Jiang WJ, 2000, BIOCHEMISTRY-US, V39, P7990, DOI 10.1021/bi000630d; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Klimacek M, 2003, BIOCHEM J, V375, P141, DOI 10.1042/BJ20030733; Koumanov A, 2003, PROTEINS, V51, P289, DOI 10.1002/prot.10354; Maser E, 2001, CHEM-BIOL INTERACT, V130, P707, DOI 10.1016/S0009-2797(00)00302-1; Mobus E, 1998, J BIOL CHEM, V273, P30888, DOI 10.1074/jbc.273.47.30888; NAGLE JF, 1978, P NATL ACAD SCI USA, V75, P298, DOI 10.1073/pnas.75.1.298; Nakamura S, 2006, J BIOL CHEM, V281, P31876, DOI 10.1074/jbc.M604226200; Oppermann U, 2003, CHEM-BIOL INTERACT, V143, P247, DOI 10.1016/S0009-2797(02)00164-3; Pankhurst KL, 2006, J BIOL CHEM, V281, P20589, DOI 10.1074/jbc.M603077200; QUINN DM, 1991, ENZYME MECH ISOTOPE, P73; Relyea HA, 2005, BIOCHEMISTRY-US, V44, P6640, DOI 10.1021/bi047640p; Richard JP, 1998, BIOCHEMISTRY-US, V37, P4305, DOI 10.1021/bi972655r; ROSE IA, 1991, BIOCHEMISTRY-US, V30, P722, DOI 10.1021/bi00217a021; Schlieben NH, 2005, J MOL BIOL, V349, P801, DOI 10.1016/j.jmb.2005.04.029; Schlippe YVG, 2005, BIOCHEMISTRY-US, V44, P16695, DOI 10.1021/bi051603w; SCHOWEN KB, 1982, METHOD ENZYMOL, V87, P551; Schowen KB, 2000, BBA-BIOENERGETICS, V1458, P43, DOI 10.1016/S0005-2728(00)00059-1; SILVERMAN DN, 1988, ACCOUNTS CHEM RES, V21, P30, DOI 10.1021/ar00145a005; SKALHEGG BA, 1975, EUR J BIOCHEM, V50, P603, DOI 10.1111/j.1432-1033.1975.tb09901.x; TAOKA S, 1994, J BIOL CHEM, V269, P17988; TONEY MD, 1992, PROTEIN SCI, V1, P107; TONEY MD, 1989, SCIENCE, V243, P1485, DOI 10.1126/science.2538921; Tu C, 2001, J AM CHEM SOC, V123, P5861, DOI 10.1021/ja010301o; TU CK, 1990, BIOCHEMISTRY-US, V29, P6400, DOI 10.1021/bi00479a009; Ueda S, 2004, EUR J BIOCHEM, V271, P1774, DOI 10.1111/j.1432-1033.2004.04089.x; VIOLA RE, 1979, ANAL BIOCHEM, V96, P334, DOI 10.1016/0003-2697(79)90590-6; Zheng RJ, 2000, BIOCHEMISTRY-US, V39, P16244, DOI 10.1021/bi002134v	40	20	20	8	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34306	34314		10.1074/jbc.M706336200	http://dx.doi.org/10.1074/jbc.M706336200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17893142	hybrid			2022-12-25	WOS:000251145700046
J	Le Stunff, H; Giussani, P; Maceyka, M; Lepine, S; Milstien, S; Spiegel, S				Le Stunff, Herve; Giussani, Paola; Maceyka, Michael; Lepine, Sandrine; Milstien, Sheldon; Spiegel, Sarah			Recycling of sphingosine is regulated by the concerted actions of sphingosine-1-phosphate phosphohydrolase 1 and sphingosine kinase 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID PHOSPHATE PHOSPHATASES; EPIDERMAL-GROWTH-FACTOR; SPHINGOLIPID METABOLISM; GLUCOSYLCERAMIDE SYNTHASE; SACCHAROMYCES-CEREVISIAE; CERAMIDE GENERATION; MAMMALIAN-CELLS; KEY REGULATOR; RAT-LIVER; DE-NOVO	In yeast, the long-chain sphingoid base phosphate phosphohydrolase Lcb3p is required for efficient ceramide synthesis from exogenous sphingoid bases. Similarly, in this study, we found that incorporation of exogenous sphingosine into ceramide in mammalian cells was regulated by the homologue of Lcb3p, sphingosine-1-phosphate phosphohydrolase 1 (SPP-1), an endoplasmic reticulum resident protein. Sphingosine incorporation into endogenous long-chain ceramides was increased by SPP-1 overexpression, whereas recycling of C-6-ceramide into long-chain ceramides was not altered. The increase in ceramide was inhibited by fumonisin B-1, an inhibitor of ceramide synthase, but not by ISP-1, an inhibitor of serine palmitoyltransferase, the rate-limiting step in the de novo biosynthesis of ceramide. Mass spectrometry analysis revealed that SPP-1 expression increased the incorporation of sphingosine into all ceramide acyl chain species, particularly enhancing C16:0, C18:0, and C20:0 long-chain ceramides. The increased recycling of sphingosine into ceramide was accompanied by increased hexosylceramides and, to a lesser extent, sphingomyelins. Sphingosine kinase 2, but not sphingosine kinase 1, acted in concert with SPP-1 to regulate recycling of sphingosine into ceramide. Collectively, our results suggest that an evolutionarily conserved cycle of phosphorylation-dephosphorylation regulates recycling and salvage of sphingosine to ceramide and more complex sphingolipids.	Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; NIMH, Lab Cellular & Mol Regulat, Bethesda, MD 20892 USA	Virginia Commonwealth University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Spiegel, S (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, Med Coll Virginia Campus, Richmond, VA 23298 USA.	sspiegel@vcu.edu	Giussani, Paola/R-4268-2017; LE STUNFF, Hervé/AAA-6882-2019; Maceyka, Michael/B-9277-2008	Giussani, Paola/0000-0002-7793-1757; 	Intramural NIH HHS Funding Source: Medline; NIGMS NIH HHS [GM 069338, GM 43880] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043880, R37GM043880, U54GM069338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH001039] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ardail D, 2003, BIOCHEM J, V371, P1013, DOI 10.1042/BJ20021834; Becker KP, 2005, J BIOL CHEM, V280, P2606, DOI 10.1074/jbc.M409066200; Berdyshev EV, 2006, CELL SIGNAL, V18, P1779, DOI 10.1016/j.cellsig.2006.01.018; Brindley DN, 2002, BBA-MOL CELL BIOL L, V1582, P33, DOI 10.1016/S1388-1981(02)00135-X; Bu Shizhong, 2006, FASEB J, V20, P184; Cuvillier O, 2000, J BIOL CHEM, V275, P15691, DOI 10.1074/jbc.M000280200; Funato K, 2003, J BIOL CHEM, V278, P7325, DOI 10.1074/jbc.M209925200; Futerman AH, 2005, TRENDS CELL BIOL, V15, P312, DOI 10.1016/j.tcb.2005.04.006; FUTERMAN AH, 1991, BIOCHEM J, V280, P295, DOI 10.1042/bj2800295; Gillard BK, 1998, GLYCOBIOLOGY, V8, P885, DOI 10.1093/glycob/8.9.885; Giussani P, 2006, MOL CELL BIOL, V26, P5055, DOI 10.1128/MCB.02107-05; Gorska M, 2005, MED SCI MONITOR, V11, pCR35; Hait NC, 2005, J BIOL CHEM, V280, P29462, DOI 10.1074/jbc.M502922200; Hait NC, 2007, J BIOL CHEM, V282, P12058, DOI 10.1074/jbc.M609559200; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hanada K, 2007, BBA-MOL CELL BIOL L, V1771, P644, DOI 10.1016/j.bbalip.2007.01.009; Johnson KR, 2003, J BIOL CHEM, V278, P34541, DOI 10.1074/jbc.M301741200; Johnson KR, 2002, J BIOL CHEM, V277, P35257, DOI 10.1074/jbc.M203033200; Kohyama-Koganeya A, 2004, J BIOL CHEM, V279, P35995, DOI 10.1074/jbc.M400444200; Le Stunff H, 2002, J BIOL CHEM, V277, P8920, DOI 10.1074/jbc.M109968200; Le Stunff H, 2004, J BIOL CHEM, V279, P34290, DOI 10.1074/jbc.M404907200; Le Stunff H, 2004, J CELL BIOCHEM, V92, P882, DOI 10.1002/h=jcb.20097; Le Stunff H, 2002, J CELL BIOL, V158, P1039, DOI 10.1083/jcb.200203123; Maceyka M, 2005, J BIOL CHEM, V280, P37118, DOI 10.1074/jbc.M502207200; Maceyka M, 2005, PROSTAG OTH LIPID M, V77, P15, DOI 10.1016/j.prostaglandins.2004.09.010; Mandala SM, 2000, P NATL ACAD SCI USA, V97, P7859, DOI 10.1073/pnas.120146897; Mandala SM, 1998, P NATL ACAD SCI USA, V95, P150, DOI 10.1073/pnas.95.1.150; Mao CG, 1997, J BIOL CHEM, V272, P28690, DOI 10.1074/jbc.272.45.28690; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Milstien S, 2006, CANCER CELL, V9, P148, DOI 10.1016/j.ccr.2006.02.025; Ogawa C, 2003, J BIOL CHEM, V278, P1268, DOI 10.1074/jbc.M209514200; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Ogretmen B, 2002, J BIOL CHEM, V277, P12960, DOI 10.1074/jbc.M110699200; Okada T, 2005, J BIOL CHEM, V280, P36318, DOI 10.1074/jbc.M504507200; Olivera A, 1999, J CELL BIOL, V147, P545, DOI 10.1083/jcb.147.3.545; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Pitson SM, 2002, J BIOL CHEM, V277, P49545, DOI 10.1074/jbc.M206687200; Pyne S, 2005, BIOCHEM SOC T, V33, P1370, DOI 10.1042/BST0331370; Pyne S, 2002, BBA-MOL CELL BIOL L, V1582, P121, DOI 10.1016/S1388-1981(02)00146-4; Qie LX, 1997, J BIOL CHEM, V272, P16110, DOI 10.1074/jbc.272.26.16110; Reiss U, 2004, J BIOL CHEM, V279, P1281, DOI 10.1074/jbc.M309646200; Riebeling C, 2003, J BIOL CHEM, V278, P43452, DOI 10.1074/jbc.M307104200; Shayman JA, 2000, METHOD ENZYMOL, V311, P373; Sigal YJ, 2005, BIOCHEM J, V387, P281, DOI 10.1042/BJ20041771; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Stukey J, 1997, PROTEIN SCI, V6, P469; SULLARDS MC, 2001, SCI STKE, pL1; Sultan I, 2006, BIOCHEM J, V393, P513, DOI 10.1042/BJ20051083; Taha TA, 2006, J BIOCHEM MOL BIOL, V39, P113; vanEchtenDeckert G, 1997, J BIOL CHEM, V272, P15825, DOI 10.1074/jbc.272.25.15825; Venkataraman K, 2002, J BIOL CHEM, V277, P35642, DOI 10.1074/jbc.M205211200; Zhao YT, 2007, J BIOL CHEM, V282, P14165, DOI 10.1074/jbc.M701279200	52	77	81	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34372	34380		10.1074/jbc.M703329200	http://dx.doi.org/10.1074/jbc.M703329200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17895250	hybrid			2022-12-25	WOS:000251145700053
J	Nickerson, NN; Prasad, L; Jacob, L; Delbaere, LT; McGavin, MJ				Nickerson, Nicholas N.; Prasad, Lata; Jacob, Latha; Delbaere, Louis T.; McGavin, Martin J.			Activation of the SspA serine protease zymogen of Staphylococcus aureus proceeds through unique variations of a trypsinogen-like mechanism and is dependent on both autocatalytic and metalloprotease-specific processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOMYCES-GRISEUS; ANGSTROM RESOLUTION; INTRAMOLECULAR CHAPERONE; EPIDERMIDIS STRAIN; BOVINE TRYPSINOGEN; KINETIC STABILITY; CYSTEINE PROTEASE; CRYSTAL-STRUCTURE; V8 PROTEASE; BINDING	The serine and cysteine proteases SspA and SspB of Staphylococcus aureus are secreted as inactive zymogens, zSspA and zSspB. Mature SspA is a trypsin-like glutamyl endopeptidase and is required to activate zSspB. Although a metalloprotease Aureolysin (Aur) is in turn thought to contribute to activation of zSspA, a specific role has not been demonstrated. We found that pre-zSspA is processed by signal peptidase at ANA(29) down arrow, releasing a Leu(30) isoform that is first processed exclusively through autocatalytic intramolecular cleavage within a glutamine-rich propeptide segment, (40)QQTQSSKQQTPKIQ(53). The preferred site is Gln(43) with secondary processing at Gln(47) and Gln(53). This initial processing is necessary for optimal and subsequent Aur-dependent processing at Leu(58) and then Val(69) to release mature SspA. Although processing by Aur is rate-limiting in zSspA activation, the first active molecules of Val(69)SspA promote rapid intermolecular processing of remaining zSspA at Glu(65), producing an N-terminal (66)HANVILP isoform that is inactive until removal of the HAN tripeptide by Aur. Modeling indicated that His(66) of this penultimate isoform blocks the active site by hydrogen bonding to Ser(237) and occlusion of substrate. Binding of glutamate within the active site of zSspA is energetically unfavorable, but glutamine fits into the primary specificity pocket and is predicted to hydrogen bond to Thr(232) proximal to Ser(237), permitting autocatalytic cleavage of the glutamine-rich propeptide segment. These and other observations suggest that zSspA is activated through a trypsinogen-like mechanism where supplementary features of the propeptide must be sequentially processed in the correct order to allow efficient activation.	Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Lab Med & Pathobiol, Toronto, ON M4N 3M5, Canada; Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Saskatchewan	McGavin, MJ (corresponding author), Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Lab Med & Pathobiol, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	martin.mcgavin@sri.utoronto.ca		McGavin, Martin/0000-0001-5955-0689				Amagai M, 2000, NAT MED, V6, P1275, DOI 10.1038/81385; Archer GL, 1998, CLIN INFECT DIS, V26, P1179, DOI 10.1086/520289; Banbula A, 1998, STRUCTURE, V6, P1185, DOI 10.1016/S0969-2126(98)00118-X; Burlak C, 2007, CELL MICROBIOL, V9, P1172, DOI 10.1111/j.1462-5822.2006.00858.x; Chan PF, 1998, J BACTERIOL, V180, P6232; Chavakis T, 2005, THROMB HAEMOSTASIS, V94, P278, DOI 10.1160/TH05-05-0306; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DRAPEAU GR, 1978, J BACTERIOL, V136, P607, DOI 10.1128/JB.136.2.607-613.1978; FEHLHAMMER H, 1977, J MOL BIOL, V111, P415, DOI 10.1016/S0022-2836(77)80062-4; Filipek R, 2003, J BIOL CHEM, V278, P40959, DOI 10.1074/jbc.M302926200; Friedrich R, 2003, NATURE, V425, P535, DOI 10.1038/nature01962; Fu X, 2000, J BIOL CHEM, V275, P16871, DOI 10.1074/jbc.275.22.16871; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; GUY O, 1976, FEBS LETT, V62, P150, DOI 10.1016/0014-5793(76)80040-3; Hartleib J, 2000, BLOOD, V96, P2149; Hedstrom L, 1996, BIOCHEMISTRY-US, V35, P4515, DOI 10.1021/bi951928k; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; Jain SC, 1998, J MOL BIOL, V284, P137, DOI 10.1006/jmbi.1998.2161; Jaswal SS, 2002, NATURE, V415, P343, DOI 10.1038/415343a; Kato JY, 2005, J BACTERIOL, V187, P286, DOI 10.1128/JB.187.1.286-295.2005; Kawasaki K, 2002, ACTA CRYSTALLOGR D, V58, P1168, DOI 10.1107/S090744490200714X; KOSSIAKOFF AA, 1977, BIOCHEMISTRY-US, V16, P654, DOI 10.1021/bi00623a016; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Massimi I, 2002, J BIOL CHEM, V277, P41770, DOI 10.1074/jbc.M207162200; McAleese FM, 2001, J BIOL CHEM, V276, P29969, DOI 10.1074/jbc.M102389200; MCGAVIN MJ, 1993, J BIOL CHEM, V268, P23946; McGavin MJ, 1997, INFECT IMMUN, V65, P2621, DOI 10.1128/IAI.65.7.2621-2628.1997; McNamara PJ, 1998, J BACTERIOL, V180, P2609, DOI 10.1128/JB.180.10.2609-2615.1998; MOHAMADI F, 1990, J COMPUT CHEM, V11, P440, DOI 10.1002/jcc.540110405; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; NOVICK RP, 1991, METHOD ENZYMOL, V204, P587; Papageorgiou AC, 2000, PROTEIN SCI, V9, P610; Parry MAA, 1998, NAT STRUCT BIOL, V5, P917, DOI 10.1038/2359; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; Popowicz GM, 2006, J MOL BIOL, V358, P270, DOI 10.1016/j.jmb.2006.01.098; Potempa J, 2005, MOL MICROBIOL, V57, P605, DOI 10.1111/j.1365-2958.2005.04714.x; Prasad L, 2004, ACTA CRYSTALLOGR D, V60, P256, DOI 10.1107/S090744490302599X; Reed SB, 2001, INFECT IMMUN, V69, P1521, DOI 10.1128/IAI.69.3.1521-1527.2001; Rice K, 2001, INFECT IMMUN, V69, P159, DOI 10.1128/IAI.69.1.159-169.2001; Roussel A, 1992, TURBO FRODO BIOGRAPH; Rzychon M, 2003, MOL MICROBIOL, V49, P1051, DOI 10.1046/j.1365-2958.2003.03613.x; Sauter NK, 1998, NAT STRUCT BIOL, V5, P945, DOI 10.1038/2919; Shaw L, 2004, MICROBIOL-SGM, V150, P217, DOI 10.1099/mic.0.26634-0; Shaw LN, 2005, J BACTERIOL, V187, P1751, DOI 10.1128/JB.187.5.1751-1762.2005; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; STROUD RM, 1977, ANNU REV BIOPHYS BIO, V6, P177, DOI 10.1146/annurev.bb.06.060177.001141; SUZUKI Y, 1994, GENE, V150, P149; Truhlar SME, 2004, PROTEIN SCI, V13, P381, DOI 10.1110/ps.03336804; Vath GM, 1997, BIOCHEMISTRY-US, V36, P1559, DOI 10.1021/bi962614f; Yabuta Y, 2001, J BIOL CHEM, V276, P44427, DOI 10.1074/jbc.M107573200; Yokoi K, 2001, GENE, V281, P115, DOI 10.1016/S0378-1119(01)00782-X; YUEN SW, 1989, BIOTECHNIQUES, V7, P74; Zhang YQ, 2003, MOL MICROBIOL, V49, P1577, DOI 10.1046/j.1365-2958.2003.03671.x	53	43	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34129	34138		10.1074/jbc.M705672200	http://dx.doi.org/10.1074/jbc.M705672200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17878159	hybrid			2022-12-25	WOS:000251145700027
J	Sato, T; Diehl, TS; Narayanan, S; Funamoto, S; Ihara, Y; De Strooper, B; Steiner, H; Haass, C; Wolfe, MS				Sato, Toru; Diehl, Thekla S.; Narayanan, Saravanakumar; Funamoto, Satoru; Ihara, Yasuo; De Strooper, Bart; Steiner, Harald; Haass, Christian; Wolfe, Michael S.			Active gamma-secretase complexes contain only one of each component	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; SIGNAL PEPTIDE PEPTIDASE; PRESENILIN PROTEINS; ASPARTIC PROTEASE; NICASTRIN; APH-1; DISEASE; PEN-2; IDENTIFICATION; STABILIZATION	gamma-Secretase is an intramembrane aspartyl protease complex that cleaves type I integral membrane proteins, including the amyloid beta-protein precursor and the Notch receptor, and is composed of presenilin, Pen-2, nicastrin, and Aph-1. Although all four of these membrane proteins are essential for assembly and activity, the stoichiometry of the complex is unknown, with the number of presenilin molecules present being especially controversial. Here we analyze functional gamma-secretase complexes, isolated by immunoprecipitation from solubilized membrane fractions and able to produce amyloid beta-peptides and amyloid beta-protein precursor intracellular domain. We show that the active isolated protease contains only one presenilin per complex, which excludes certain models of the active site that require aspartate dyads formed between two presenilin molecules. We also quantified components in the isolated complexes by Western blot using protein standards and found that the amounts of Pen-2 and nicastrin were the same as that of presenilin. Moreover, we found that one Aph-1 was not co-immunoprecipitated with another in active complexes, evidence that Aph-1 is likewise present as a monomer. Taken together, these results demonstrate that the stoichiometry of gamma-components presenilin: Pen-2:nicastrin:Aph-1 is 1:1:1:1.	Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Univ Tokyo, Fac Med, Dept Neuropathol, Tokyo 1130033, Japan; Katholieke Univ Leuven VIB, Dept Mol & Dev Genet, B-3000 Louvain, Belgium; Katholieke Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium; Univ Munich, Adolf Butenandt Inst, Dept Biochem, Lab Alzheimers & Parkinsons Dis Res, D-80336 Munich, Germany; Univ Munich, Adolf Butenandt Inst, Dept Biochem, Ctr Integrated Prot Sci, D-80336 Munich, Germany	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Tokyo; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; University of Munich; University of Munich	Wolfe, MS (corresponding author), Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA.	mwolfe@rics.bwh.harvard.edu	De Strooper, Bart/F-6507-2012; de+Strooper, Bart/Z-1638-2019	De Strooper, Bart/0000-0001-5455-5819; 	NATIONAL INSTITUTE ON AGING [R01AG017574] Funding Source: NIH RePORTER; NIA NIH HHS [AG 17574] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Blum R, 1996, J BIOL CHEM, V271, P17183, DOI 10.1074/jbc.271.29.17183; Capell A, 1998, J BIOL CHEM, V273, P3205, DOI 10.1074/jbc.273.6.3205; Cervantes S, 2004, J BIOL CHEM, V279, P36519, DOI 10.1074/jbc.M404832200; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; Clarke EE, 2006, J BIOL CHEM, V281, P31279, DOI 10.1074/jbc.M605051200; Das C, 2003, J AM CHEM SOC, V125, P11794, DOI 10.1021/ja037131v; Deng Y, 2006, J NEUROSCI, V26, P3845, DOI 10.1523/JNEUROSCI.5384-05.2006; DeStrooper B, 1997, J BIOL CHEM, V272, P3590, DOI 10.1074/jbc.272.6.3590; Edbauer D, 2002, P NATL ACAD SCI USA, V99, P8666, DOI 10.1073/pnas.132277899; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Evin G, 2005, BIOCHEMISTRY-US, V44, P4332, DOI 10.1021/bi0481702; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P323, DOI 10.1021/bi035748j; Gu YJ, 2004, J BIOL CHEM, V279, P31329, DOI 10.1074/jbc.M401548200; Hebert SS, 2004, NEUROBIOL DIS, V17, P260, DOI 10.1016/j.nbd.2004.08.002; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Kimberly WT, 2005, J NEUROSCI, V25, P5533, DOI 10.1523/JNEUROSCI.4883-04.2005; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Kimberly WT, 2003, BIOCHEMISTRY-US, V42, P137, DOI 10.1021/bi026888g; Kornilova AY, 2003, J BIOL CHEM, V278, P16470, DOI 10.1074/jbc.C300019200; LaVoie MJ, 2003, J BIOL CHEM, V278, P37213, DOI 10.1074/jbc.M303941200; Lazarov VK, 2006, P NATL ACAD SCI USA, V103, P6889, DOI 10.1073/pnas.0602321103; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nakaya Y, 2005, J BIOL CHEM, V280, P19070, DOI 10.1074/jbc.M501130200; Narayanan S, 2007, J BIOL CHEM, V282, P20172, DOI 10.1074/jbc.M701536200; Niimura M, 2005, J BIOL CHEM, V280, P12967, DOI 10.1074/jbc.M409829200; Nyborg AC, 2004, J BIOL CHEM, V279, P15153, DOI 10.1074/jbc.M309305200; Ogura T, 2006, BIOCHEM BIOPH RES CO, V343, P525, DOI 10.1016/j.bbrc.2006.02.158; Onishi M, 1996, EXP HEMATOL, V24, P324; Podlisny MB, 1997, NEUROBIOL DIS, V3, P325, DOI 10.1006/nbdi.1997.0129; Prokop S, 2004, J BIOL CHEM, V279, P23255, DOI 10.1074/jbc.M401789200; Ratovitski T, 1997, J BIOL CHEM, V272, P24536, DOI 10.1074/jbc.272.39.24536; Sato T, 2003, J BIOL CHEM, V278, P24294, DOI 10.1074/jbc.M211161200; Sato T, 2006, BIOCHEMISTRY-US, V45, P8649, DOI 10.1021/bi060597g; Schroeter EH, 2003, P NATL ACAD SCI USA, V100, P13075, DOI 10.1073/pnas.1735338100; Seeger M, 1997, P NATL ACAD SCI USA, V94, P5090, DOI 10.1073/pnas.94.10.5090; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Shirotani K, 2004, J BIOL CHEM, V279, P41340, DOI 10.1074/jbc.M405768200; Shirotani K, 2004, J NEUROCHEM, V89, P1520, DOI 10.1111/j.1471-4159.2004.02447.x; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Wang R, 1996, J BIOL CHEM, V271, P31894, DOI 10.1074/jbc.271.50.31894; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wolfe MS, 2007, EMBO REP, V8, P136, DOI 10.1038/sj.embor.7400896; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yu G, 1998, J BIOL CHEM, V273, P16470, DOI 10.1074/jbc.273.26.16470	50	140	143	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					33985	33993		10.1074/jbc.M705248200	http://dx.doi.org/10.1074/jbc.M705248200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17911105	hybrid, Green Published			2022-12-25	WOS:000251145700012
J	Adamska, M; Degnan, SM; Green, KM; Adamski, M; Craigie, A; Larroux, C; Degnan, BM				Adamska, Maja; Degnan, Sandie M.; Green, Kathryn M.; Adamski, Marcin; Craigie, Alina; Larroux, Claire; Degnan, Bernard M.			Wnt and TGF-beta Expression in the Sponge Amphimedon queenslandica and the Origin of Metazoan Embryonic Patterning	PLOS ONE			English	Article							DEVELOPMENTAL EXPRESSION; SPEMANNS ORGANIZER; GENE FAMILY; EVOLUTION; PHYLOGENY; DEMOSPONGE; RECEPTOR; POLARITY; SUPERFAMILY; COMPLEXITY	Background. The origin of metazoan development and differentiation was contingent upon the evolution of cell adhesion, communication and cooperation mechanisms. While components of many of the major cell signalling pathways have been identified in a range of sponges (phylum Porifera), their roles in development have not been investigated and remain largely unknown. Here, we take the first steps toward reconstructing the developmental signalling systems used in the last common ancestor to living sponges and eumetazoans by studying the expression of genes encoding Wnt and TGF-beta signalling ligands during the embryonic development of a sponge. Methodology/Principal Findings. Using resources generated in the recent sponge Amphimedon queenslandica (Demospongiae) genome project, we have recovered genes encoding Wnt and TGF-beta signalling ligands that are critical in patterning metazoan embryos. Both genes are expressed from the earliest stages of Amphimedon embryonic development in highly dynamic patterns. At the time when the Amphimedon embryos begin to display anterior-posterior polarity, Wnt expression becomes localised to the posterior pole and this expression continues until the swimming larva stage. In contrast, TGF-beta expression is highest at the anterior pole. As in complex animals, sponge Wnt and TGF-beta expression patterns intersect later in development during the patterning of a sub-community of cells that form a simple tissue-like structure, the pigment ring. Throughout development, Wnt and TGF-beta are expressed radially along the anterior-posterior axis. Conclusions/Significance. We infer from the expression of Wnt and TGF-beta in Amphimedon that the ancestor that gave rise to sponges, cnidarians and bilaterians had already evolved the capacity to direct the formation of relatively sophisticated body plans, with axes and tissues. The radially symmetrical expression patterns of Wnt and TGF-beta along the anterior-posterior axis of sponge embryos and larvae suggest that these signalling pathways contributed to establishing axial polarity in the very first metazoans.	[Adamska, Maja; Degnan, Sandie M.; Green, Kathryn M.; Adamski, Marcin; Craigie, Alina; Larroux, Claire; Degnan, Bernard M.] Univ Queensland, Sch Integrat Biol, Brisbane, Qld, Australia	University of Queensland	Degnan, BM (corresponding author), Univ Queensland, Sch Integrat Biol, Brisbane, Qld, Australia.	b.degnan@uq.edu.au	Adamska, Maja/M-4128-2014; Degnan, Sandie/G-7338-2012; Larroux, Claire/U-7981-2017; Adamska, Maja/L-3306-2015	Degnan, Sandie/0000-0001-8003-0426; Larroux, Claire/0000-0002-3503-4150; Degnan, Bernard/0000-0001-7573-8518; Adamska, Maja/0000-0002-4223-8450	Australian Research Council	Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council. The ARC played no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	ADAMSKA M, 2007, CURR BIOL IN PRESS; Adell T, 2003, FEBS LETT, V554, P363, DOI 10.1016/S0014-5793(03)01190-6; Adell T, 2007, CELL BIOL INT, V31, P939, DOI 10.1016/j.cellbi.2007.03.003; Borchiellini C, 2001, J EVOLUTION BIOL, V14, P171, DOI 10.1046/j.1420-9101.2001.00244.x; Botting JP, 2005, P NATL ACAD SCI USA, V102, P1554, DOI 10.1073/pnas.0405867102; Broun M, 2005, DEVELOPMENT, V132, P2907, DOI 10.1242/dev.01848; Brusca RC, 2003, INVERTEBRATES; Cavalier-Smith T, 2003, J MOL EVOL, V56, P540, DOI 10.1007/s00239-002-2424-z; CavalierSmith T, 1996, CAN J ZOOL, V74, P2031, DOI 10.1139/z96-231; COHEN B, 1993, DEVELOPMENT, V117, P597; Davidson EH, 2006, REG GEN GEN REG; De Robertis EM, 2000, NAT REV GENET, V1, P171, DOI 10.1038/35042039; Degnan BM, 2005, INTEGR COMP BIOL, V45, P335, DOI 10.1093/icb/45.2.335; Erwin DH, 2002, DEVELOPMENT, V129, P3021; Flowers VL, 2004, DEV DYNAM, V231, P727, DOI 10.1002/dvdy.20194; Green J, 2002, DEV DYNAM, V225, P392, DOI 10.1002/dvdy.10170; Halanych KM, 2004, ANNU REV ECOL EVOL S, V35, P229, DOI 10.1146/annurev.ecolsys.35.112202.130124; Hayward DC, 2002, P NATL ACAD SCI USA, V99, P8106, DOI 10.1073/pnas.112021499; Holland LZ, 2000, DEV GENES EVOL, V210, P522, DOI 10.1007/s004270000089; Jackson DJ, 2007, SCIENCE, V316, P1893, DOI 10.1126/science.1141560; Kusserow A, 2005, NATURE, V433, P156, DOI 10.1038/nature03158; Larroux C, 2006, EVOL DEV, V8, P150, DOI 10.1111/j.1525-142X.2006.00086.x; Larroux C, 2007, CURR BIOL, V17, P706, DOI 10.1016/j.cub.2007.03.008; Lee PN, 2006, SEMIN CELL DEV BIOL, V17, P157, DOI 10.1016/j.semcdb.2006.05.002; Leys SP, 2002, INVERTEBR BIOL, V121, P171; Li CW, 1998, SCIENCE, V279, P879, DOI 10.1126/science.279.5352.879; Liu ZH, 1999, J COMB OPTIM, V3, P5, DOI 10.1023/A:1009841719644; Manuel M, 2003, SYST BIOL, V52, P311, DOI 10.1080/10635150390196966; Martindale MQ, 2005, NAT REV GENET, V6, P917, DOI 10.1038/nrg1725; Matus DQ, 2006, P NATL ACAD SCI USA, V103, P11195, DOI 10.1073/pnas.0601257103; Maves L, 1998, DEVELOPMENT, V125, P115; MCPHERRON AC, 1993, J BIOL CHEM, V268, P3444; Medina M, 2001, P NATL ACAD SCI USA, V98, P9707, DOI 10.1073/pnas.171316998; Miller DJ, 2005, TRENDS GENET, V21, P536, DOI 10.1016/j.tig.2005.08.002; Nichols SA, 2006, P NATL ACAD SCI USA, V103, P12451, DOI 10.1073/pnas.0604065103; Nishita M, 2000, NATURE, V403, P781, DOI 10.1038/35001602; NUSSE R, 1992, CELL, V69, P1073, DOI 10.1016/0092-8674(92)90630-U; OZKAYNAK E, 1992, J BIOL CHEM, V267, P25220; Peterson KJ, 2005, P NATL ACAD SCI USA, V102, P9547, DOI 10.1073/pnas.0503660102; Reinhardt B, 2004, DEV BIOL, V267, P43, DOI 10.1016/j.ydbio.2003.10.031; Rentzsch F, 2006, DEV BIOL, V296, P375, DOI 10.1016/j.ydbio.2006.06.003; Sakarya O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000506; Simionato E, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-33; Soshnikova N, 2003, GENE DEV, V17, P1963, DOI 10.1101/gad.263003; Suga H, 1999, FEBS LETT, V453, P346, DOI 10.1016/S0014-5793(99)00749-8; Watabe T, 1995, GENE DEV, V9, P3038, DOI 10.1101/gad.9.24.3038; Wolpert L, 1996, TRENDS GENET, V12, P359, DOI 10.1016/S0168-9525(96)80019-9; Zhou SH, 2004, J BONE MINER RES, V19, P463, DOI 10.1359/JBMR.0301239	48	154	159	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1031	10.1371/journal.pone.0001031	http://dx.doi.org/10.1371/journal.pone.0001031			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925879	Green Published, Green Submitted, gold			2022-12-25	WOS:000207456000030
J	Szulkin, M; Sheldon, BC				Szulkin, Marta; Sheldon, Ben C.			The Environmental Dependence of Inbreeding Depression in a Wild Bird Population	PLOS ONE			English	Article								Background. Inbreeding depression occurs when the offspring produced as a result of matings between relatives show reduced fitness, and is generally understood as a consequence of the elevated expression of deleterious recessive alleles. How inbreeding depression varies across environments is of importance for the evolution of inbreeding avoidance behaviour, and for understanding extinction risks in small populations. However, inbreeding-by-environment (IxE) interactions have rarely been investigated in wild populations. Methodology/Principal Findings. We analysed 41 years of breeding events from a wild great tit (Parus major) population and used 11 measures of the environment to categorise environments as relatively good or poor, testing whether these measures influenced inbreeding depression. Although inbreeding always, and environmental quality often, significantly affected reproductive success, there was little evidence for statistically significant IxE interactions at the level of individual analyses. However, point estimates of the effect of the environment on inbreeding depression were sometimes considerable, and we show that variation in the magnitude of the IxE interaction across environments is consistent with the expectation that this interaction is more marked across environmental axes with a closer link to overall fitness, with the environmental dependence of inbreeding depression being elevated under such conditions. Hence, our analyses provide evidence for an environmental dependence of the inbreeding x environment interaction: effectively an IxExE. Conclusions/Significance. Overall, our analyses suggest that IxE interactions may be substantial in wild populations, when measured across relevant environmental contrasts, although their detection for single traits may require very large samples, or high rates of inbreeding.	[Szulkin, Marta; Sheldon, Ben C.] Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England	University of Oxford	Szulkin, M (corresponding author), Univ Oxford, Dept Zool, Edward Grey Inst, S Parks Rd, Oxford OX1 3PS, England.	marta.szulkin@zoo.ox.ac.uk	Szulkin, Marta/J-8118-2012; Sheldon, Ben C/A-8056-2010	Szulkin, Marta/0000-0002-7355-5846; Sheldon, Ben C/0000-0002-5240-7828	Christopher Welch Trust; Queen's College	Christopher Welch Trust; Queen's College	Marta Szulkin was funded by the Christopher Welch Trust and The Queen's College.	Armbruster P, 2005, HEREDITY, V95, P235, DOI 10.1038/sj.hdy.6800721; Balloux F, 2004, MOL ECOL, V13, P3021, DOI 10.1111/j.1365-294X.2004.02318.x; Bijlsma R, 1999, J EVOLUTION BIOL, V12, P1125, DOI 10.1046/j.1420-9101.1999.00113.x; BLAKEY JK, 1994, IBIS, V136, P457, DOI 10.1111/j.1474-919X.1994.tb01122.x; Charlesworth B, 1999, GENET RES, V74, P329, DOI 10.1017/S0016672399004152; CLOBERT J, 1988, J ANIM ECOL, V57, P287, DOI 10.2307/4779; Crnokrak P, 1999, HEREDITY, V83, P260, DOI 10.1038/sj.hdy.6885530; Da Silva A, 2006, CONSERV GENET, V7, P371, DOI 10.1007/s10592-005-9048-y; Gardner M, 2001, EVOLUTION, V55, P1609, DOI 10.1111/j.0014-3820.2001.tb00680.x; Hauser TP, 1996, EVOLUTION, V50, P1119, DOI 10.2307/2410652; Husband BC, 1996, EVOLUTION, V50, P54, DOI [10.2307/2410780, 10.1111/j.1558-5646.1996.tb04472.x]; JIMENEZ JA, 1994, SCIENCE, V266, P271, DOI 10.1126/science.7939661; Joron M, 2003, NATURE, V424, P191, DOI 10.1038/nature01713; Keller LF, 2002, EVOLUTION, V56, P1229, DOI 10.1111/j.0014-3820.2002.tb01434.x; KONDRASHOV AS, 1994, P ROY SOC B-BIOL SCI, V258, P221, DOI 10.1098/rspb.1994.0166; Kristensen TN, 2003, CONSERV GENET, V4, P453, DOI 10.1023/A:1024763013798; Kruuk LEB, 2002, P ROY SOC B-BIOL SCI, V269, P1581, DOI 10.1098/rspb.2002.2049; Lynch M., 1998, GENETICS ANAL QUANTI; Marr AB, 2006, J ANIM ECOL, V75, P1406, DOI 10.1111/j.1365-2656.2006.01165.x; Marshall TC, 2002, P ROY SOC B-BIOL SCI, V269, P1533, DOI 10.1098/rspb.2002.2035; McCleery RH, 2004, AM NAT, V164, pE62, DOI 10.1086/422660; McCune AR, 2004, P ROY SOC B-BIOL SCI, V271, P2025, DOI 10.1098/rspb.2004.2787; Meagher S, 2000, P NATL ACAD SCI USA, V97, P3324, DOI 10.1073/pnas.060284797; MORTON NE, 1956, P NATL ACAD SCI USA, V42, P855, DOI 10.1073/pnas.42.11.855; NORMAN JK, 1995, EVOLUTION, V49, P297, DOI 10.1111/j.1558-5646.1995.tb02242.x; Pemberton J, 2004, TRENDS ECOL EVOL, V19, P613, DOI 10.1016/j.tree.2004.09.010; Perrins C.M., 1979, BRIT TITS; Reed DH, 2007, ANIM CONSERV, V10, P275, DOI 10.1111/j.1469-1795.2007.00120.x; Reed DH, 2007, CONSERV GENET, V8, P1061, DOI 10.1007/s10592-006-9260-4; Roff DA, 2002, EVOLUTION, V56, P768, DOI 10.1111/j.0014-3820.2002.tb01387.x; Roff DA, 2006, EVOLUTION, V60, P1981, DOI 10.1111/j.0014-3820.2006.tb01836.x; Slate J, 2004, HEREDITY, V93, P255, DOI 10.1038/sj.hdy.6800485; Szulkin M, 2007, J EVOLUTION BIOL, V20, P1531, DOI 10.1111/j.1420-9101.2007.01325.x; VANNOORDWIJK AJ, 1995, J ANIM ECOL, V64, P451, DOI 10.2307/5648; Wilkin TA, 2006, J ANIM ECOL, V75, P604, DOI 10.1111/j.1365-2656.2006.01078.x	35	31	31	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1027	10.1371/journal.pone.0001027	http://dx.doi.org/10.1371/journal.pone.0001027			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925875	gold, Green Published, Green Submitted			2022-12-25	WOS:000207456000026
J	Desy, MC; Theoret, H				Desy, Marie-Christine; Theoret, Hugo			Modulation of Motor Cortex Excitability by Physical Similarity with an Observed Hand Action	PLOS ONE			English	Article								The passive observation of hand actions is associated with increased motor cortex excitability, presumably reflecting activity within the human mirror neuron system (MNS). Recent data show that in-group ethnic membership increases motor cortex excitability during observation of culturally relevant hand gestures, suggesting that physical similarity with an observed body part may modulate MNS responses. Here, we ask whether the MNS is preferentially activated by passive observation of hand actions that are similar or dissimilar to self in terms of sex and skin color. Transcranial magnetic stimulation-induced motor evoked potentials were recorded from the first dorsal interosseus muscle while participants viewed videos depicting index finger movements made by female or male participants with black or white skin color. Forty-eight participants equally distributed in terms of sex and skin color participated in the study. Results show an interaction between self-attributes and physical attributes of the observed hand in the right motor cortex of female participants, where corticospinal excitability is increased during observation of hand actions in a different skin color than that of the observer. Our data show that specific physical properties of an observed action modulate motor cortex excitability and we hypothesize that in-group/out-group membership and self-related processes underlie these effects.	[Theoret, Hugo] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; Univ Montreal, Hop St Justine, Montreal, PQ H3T 1C5, Canada	Universite de Montreal; Universite de Montreal	Theoret, H (corresponding author), Univ Montreal, Dept Psychol, CP 6128, Montreal, PQ H3C 3J7, Canada.	hugo.theoret@umontreal.ca		Theoret, Hugo/0000-0002-7458-8797	National Sciences and Engineering Research of Canada; Fonds de Recherche en Sante du Quebec	National Sciences and Engineering Research of Canada; Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by grants from the National Sciences and Engineering Research of Canada and the Fonds de Recherche en Sante du Quebec.	Aziz-Zadeh L, 2002, EXP BRAIN RES, V144, P127, DOI 10.1007/s00221-002-1037-5; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Baron-Cohen S, 2005, SCIENCE, V310, P819, DOI 10.1126/science.1115455; Berlucchi G, 1997, TRENDS NEUROSCI, V20, P560, DOI 10.1016/S0166-2236(97)01136-3; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Buccino G, 2004, J COGNITIVE NEUROSCI, V16, P114, DOI 10.1162/089892904322755601; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Cheng YW, 2006, NEUROREPORT, V17, P1115, DOI 10.1097/01.wnr.0000223393.59328.21; Cheng YW, 2007, NEUROREPORT, V18, P887, DOI 10.1097/WNR.0b013e3280ebb486; Cross ES, 2006, NEUROIMAGE, V31, P1257, DOI 10.1016/j.neuroimage.2006.01.033; Cross SE, 1997, PSYCHOL BULL, V122, P5, DOI 10.1037/0033-2909.122.1.5; Cunningham WA, 2004, PSYCHOL SCI, V15, P806, DOI 10.1111/j.0956-7976.2004.00760.x; Eberhardt JL, 2005, AM PSYCHOL, V60, P181, DOI 10.1037/0003-066X.60.2.181; Fadiga L, 2005, CURR OPIN NEUROBIOL, V15, P213, DOI 10.1016/j.conb.2005.03.013; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Fourkas AD, 2006, EXP BRAIN RES, V168, P143, DOI 10.1007/s00221-005-0076-0; Gallese V, 2003, PSYCHOPATHOLOGY, V36, P171, DOI 10.1159/000072786; Gangitano M, 2001, NEUROREPORT, V12, P1489, DOI 10.1097/00001756-200105250-00038; Golby AJ, 2001, NAT NEUROSCI, V4, P845, DOI 10.1038/90565; Guimond S, 2006, J PERS SOC PSYCHOL, V90, P221, DOI 10.1037/0022-3514.90.2.221; Hardin EE, 2004, J CROSS CULT PSYCHOL, V35, P327, DOI 10.1177/0022022104264125; Hari R, 1998, P NATL ACAD SCI USA, V95, P15061, DOI 10.1073/pnas.95.25.15061; Hart AJ, 2000, NEUROREPORT, V11, P2351, DOI 10.1097/00001756-200008030-00004; Hewstone M, 2002, ANNU REV PSYCHOL, V53, P575, DOI 10.1146/annurev.psych.53.100901.135109; Hughes M, 2003, SOC PSYCHOL QUART, V66, P384, DOI 10.2307/1519836; Keenan JP, 2000, TRENDS COGN SCI, V4, P338, DOI 10.1016/S1364-6613(00)01521-7; Keenan JP, 2001, NATURE, V409, P305, DOI 10.1038/35053167; Maeda F, 2002, J NEUROPHYSIOL, V87, P1329, DOI 10.1152/jn.00773.2000; Mitchell JP, 2005, J COGNITIVE NEUROSCI, V17, P1306, DOI 10.1162/0898929055002418; Mitchell JP, 2006, NEURON, V50, P655, DOI 10.1016/j.neuron.2006.03.040; Molnar-Szakacs I, 2005, EUR J NEUROSCI, V21, P2000, DOI 10.1111/j.1460-9568.2005.04019.x; Molnar-Szakacs I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000626; Patuzzo S, 2003, NEUROPSYCHOLOGIA, V41, P1272, DOI 10.1016/S0028-3932(02)00293-2; Richeson JA, 2003, NAT NEUROSCI, V6, P1323, DOI 10.1038/nn1156; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Robbins JM, 2005, PERS SOC PSYCHOL REV, V9, P32, DOI 10.1207/s15327957pspr0901_3; Rossini PM, 1998, ELECTROEN CLIN NEURO, V106, P180, DOI 10.1016/S0013-4694(97)00097-7; Schutz-Bosbach S, 2006, CURR BIOL, V16, P1830, DOI 10.1016/j.cub.2006.07.048; Strafella AP, 2000, NEUROREPORT, V11, P2289, DOI 10.1097/00001756-200007140-00044; Theoret H, 2004, COGNITIVE BRAIN RES, V20, P54, DOI 10.1016/j.cogbrainres.2004.01.003; Uddin LQ, 2005, NEUROIMAGE, V25, P926, DOI 10.1016/j.neuroimage.2004.12.018; Uddin LQ, 2007, TRENDS COGN SCI, V11, P153, DOI 10.1016/j.tics.2007.01.001; Uddin LQ, 2006, SOC COGN AFFECT NEUR, V1, P65, DOI 10.1093/scan/nsl003; Urgesi C, 2006, EUR J NEUROSCI, V23, P2522, DOI 10.1111/j.1460-9568.2006.04772.x; van Baaren RB, 2003, J PERS SOC PSYCHOL, V84, P1093, DOI 10.1037/0022-3514.84.5.1093	46	44	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e971	10.1371/journal.pone.0000971	http://dx.doi.org/10.1371/journal.pone.0000971			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912350	Green Published, gold			2022-12-25	WOS:000207455900009
J	Gold, MC; Robinson, TL; Cook, MS; Byrd, LK; Ehlinger, HD; Lewinsohn, DM; Lewinsohn, DA				Gold, Marielle C.; Robinson, Tammie L.; Cook, Matthew S.; Byrd, Laura K.; Ehlinger, Heather D.; Lewinsohn, David M.; Lewinsohn, Deborah A.			Human Neonatal Dendritic Cells Are Competent in MHC Class I Antigen Processing and Presentation	PLOS ONE			English	Article								Neonates are clearly more susceptible to severe disease following infection with a variety of pathogens than are adults. However, the causes for this are unclear and are often attributed to immunological immaturity. While several aspects of immunity differ between adults and neonates, the capacity of dendritic cells in neonates to process and present antigen to CD8(+) T cells remains to be addressed. We used human CD8(+) T cell clones to compare the ability of neonatal and adult monocyte-derived dendritic cells to present or process and present antigen using the MHC class I pathway. Specifically, we assessed the ability of dendritic cells to present antigenic peptide, present an HLA-E-restricted antigen, process and present an MHC class I-restricted antigen through the classical MHC class I pathway, and cross present cell-associated antigen via MHC class I. We found no defect in neonatal dendritic cells to perform any of these processing and presentation functions and conclude that the MHC class I antigen processing and presentation pathway is functional in neonatal dendritic cells and hence may not account for the diminished control of pathogens.	[Gold, Marielle C.; Lewinsohn, David M.] Oregon Hlth & Sci Univ, Dept Pulm & Crit Care Med, Portland, OR 97201 USA; [Gold, Marielle C.; Lewinsohn, David M.] Portland VA Med Ctr, Portland, OR USA; [Robinson, Tammie L.; Cook, Matthew S.; Byrd, Laura K.; Ehlinger, Heather D.; Lewinsohn, Deborah A.] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97201 USA	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Oregon Health & Science University	Gold, MC (corresponding author), Oregon Hlth & Sci Univ, Dept Pulm & Crit Care Med, 3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.	goldm@ohsu.edu	; Lewinsohn, David/I-4936-2013	Slater, Marielle/0000-0003-2505-3291; Lewinsohn, David/0000-0001-9906-9494	NIH [5R01 AI054474]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054474] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIH 5R01 AI054474; The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; Aksoy E, 2007, BLOOD, V109, P2887, DOI 10.1182/blood-2006-06-027862; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Canaday DH, 2006, CELL IMMUNOL, V243, P96, DOI 10.1016/j.cellimm.2007.01.003; Dadaglio G, 2002, J IMMUNOL, V168, P2219, DOI 10.4049/jimmunol.168.5.2219; Fonteneau JF, 2003, BLOOD, V102, P4448, DOI 10.1182/blood-2003-06-1801; Goriely S, 2001, J IMMUNOL, V166, P2141, DOI 10.4049/jimmunol.166.3.2141; HARPER JMM, 1978, J VIROL, V26, P646, DOI 10.1128/JVI.26.3.646-659.1978; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; Heinzel AS, 2002, J EXP MED, V196, P1473, DOI 10.1084/jem.20020609; Kennedy PTF, 2006, HEPATOLOGY, V43, P602, DOI 10.1002/hep.21081; Levy O, 2006, J IMMUNOL, V177, P1956, DOI 10.4049/jimmunol.177.3.1956; Lewinsohn DA, 2003, AM J RESP CRIT CARE, V168, P1346, DOI 10.1164/rccm.200306-837OC; Lewinsohn DA, 2002, AM J RESP CRIT CARE, V166, P843, DOI 10.1164/rccm.2110094; Lewinsohn DM, 2000, J IMMUNOL, V165, P925, DOI 10.4049/jimmunol.165.2.925; Liu E, 2001, BRIT J HAEMATOL, V113, P240, DOI 10.1046/j.1365-2141.2001.02720.x; Marchant A, 1999, J IMMUNOL, V163, P2249; Marchant A, 2005, CLIN EXP IMMUNOL, V141, P10, DOI 10.1111/j.1365-2249.2005.02799.x; Marchant A, 2000, CURR OPIN INFECT DIS, V13, P241, DOI 10.1097/00001432-200006000-00007; RIDDELL SR, 1992, SCIENCE, V257, P238; ROMANI N, 1994, J EXP MED, V180, P83, DOI 10.1084/jem.180.1.83; Schibler KR, 2002, ACTA PAEDIATR, V91, P9, DOI 10.1080/080352502320764148; Shen LJ, 2006, CURR OPIN IMMUNOL, V18, P85, DOI 10.1016/j.coi.2005.11.003; Sun CM, 2005, IMMUNITY, V22, P467, DOI 10.1016/j.immuni.2005.02.008; Sun CM, 2003, BLOOD, V102, P585, DOI 10.1182/blood-2002-09-2966; Upham JW, 2002, INFECT IMMUN, V70, P6583, DOI 10.1128/IAI.70.12.6583-6588.2002; Vekemans J, 2001, EUR J IMMUNOL, V31, P1531, DOI 10.1002/1521-4141(200105)31:5<1531::AID-IMMU1531>3.0.CO;2-1; Velilla PA, 2006, CLIN IMMUNOL, V121, P251, DOI 10.1016/j.clim.2006.08.010; Wong OH, 2005, IMMUNOLOGY, V116, P13, DOI 10.1111/j.1365-2567.2005.02191.x; Wong P, 2003, ANNU REV IMMUNOL, V21, P29, DOI 10.1146/annurev.immunol.21.120601.141114; Wright PF, 1998, VACCINE, V16, P1355, DOI 10.1016/S0264-410X(98)00091-7	32	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e957	10.1371/journal.pone.0000957	http://dx.doi.org/10.1371/journal.pone.0000957			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895997	Green Published, gold, Green Submitted			2022-12-25	WOS:000207455800035
J	Dawson, WK; Fujiwara, K; Kawai, G				Dawson, Wayne K.; Fujiwara, Kazuya; Kawai, Gota			Prediction of RNA Pseudoknots Using Heuristic Modeling with Mapping and Sequential Folding	PLOS ONE			English	Article								Predicting RNA secondary structure is often the first step to determining the structure of RNA. Prediction approaches have historically avoided searching for pseudoknots because of the extreme combinatorial and time complexity of the problem. Yet neglecting pseudoknots limits the utility of such approaches. Here, an algorithm utilizing structure mapping and thermodynamics is introduced for RNA pseudoknot prediction that finds the minimum free energy and identifies information about the flexibility of the RNA. The heuristic approach takes advantage of the 5' to 3' folding direction of many biological RNA molecules and is consistent with the hierarchical folding hypothesis and the contact order model. Mapping methods are used to build and analyze the folded structure for pseudoknots and to add important 3D structural considerations. The program can predict some well known pseudoknot structures correctly. The results of this study suggest that many functional RNA sequences are optimized for proper folding. They also suggest directions we can proceed in the future to achieve even better results.	[Dawson, Wayne K.; Fujiwara, Kazuya; Kawai, Gota] Chiba Inst Technol, Dept Life & Environm Sci, Narashino, Chiba 275, Japan	Chiba Institute of Technology	Dawson, WK (corresponding author), Chiba Inst Technol, Dept Life & Environm Sci, Narashino, Chiba 275, Japan.	wayne.dawson@it-chiba.ac.jp	Dawson, Wayne/AAY-5576-2020	Dawson, Wayne/0000-0001-7751-7778	Ministry of Education, Culture, Sports, Science and Technology (Japan)	Ministry of Education, Culture, Sports, Science and Technology (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from Monbusho ( The Ministry of Education, Culture, Sports, Science and Technology ( Japan)). The sponsor played no role in the decisions, design, study, or interpretation of the results of this work.	Baird SD, 2006, RNA, V12, P1755, DOI 10.1261/rna.157806; BRUCCOLERI RE, 1988, COMPUT APPL BIOSCI, V4, P167; Cao S, 2006, NUCLEIC ACIDS RES, V34, P2634, DOI 10.1093/nar/gkl346; Cate JH, 1997, NAT STRUCT BIOL, V4, P553, DOI 10.1038/nsb0797-553; Dawson W, 2006, NUCLEOS NUCLEOT NUCL, V25, P171, DOI 10.1080/15257770500446915; Doshi KJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-105; Eddy SR, 2004, NAT BIOTECHNOL, V22, P1457, DOI 10.1038/nbt1104-1457; Felden B, 1996, RNA, V2, P201; Flory P. J, 1953, PRINCIPLES POLYM CHE; Hendrix DK, 2005, Q REV BIOPHYS, V38, P221, DOI 10.1017/S0033583506004215; Huttenhofer A, 2005, TRENDS GENET, V21, P289, DOI 10.1016/j.tig.2005.03.007; Kolk MH, 1998, SCIENCE, V280, P434, DOI 10.1126/science.280.5362.434; KUMAR PKR, 1992, NUCLEIC ACIDS RES, V20, P3919, DOI 10.1093/nar/20.15.3919; Lescoute A, 2006, NUCLEIC ACIDS RES, V34, P6587, DOI 10.1093/nar/gkl963; Lyngso RB, 2000, J COMPUT BIOL, V7, P409, DOI 10.1089/106652700750050862; Makarov DE, 2002, P NATL ACAD SCI USA, V99, P3535, DOI 10.1073/pnas.052713599; Mandal M, 2003, CELL, V113, P577, DOI 10.1016/S0092-8674(03)00391-X; Misra VK, 2001, P NATL ACAD SCI USA, V98, P12456, DOI 10.1073/pnas.221234598; Nameki N, 1999, NUCLEIC ACIDS RES, V27, P3667, DOI 10.1093/nar/27.18.3667; Plant EP, 2005, PLOS BIOL, V3, P1012, DOI 10.1371/journal.pbio.0030172; Reeder J, 2006, J BIOTECHNOL, V124, P41, DOI 10.1016/j.jbiotec.2006.01.034; Rivas E, 1999, J MOL BIOL, V285, P2053, DOI 10.1006/jmbi.1998.2436; Schlax PJ, 2001, J BIOL CHEM, V276, P38494, DOI 10.1074/jbc.M106934200; Schultes EA, 2005, NAT STRUCT MOL BIOL, V12, P1130, DOI 10.1038/nsmb1014; Sosnick TR, 2004, J MOL BIOL, V342, P1359, DOI 10.1016/j.jmb.2004.08.002; Su MC, 2005, NUCLEIC ACIDS RES, V33, P4265, DOI 10.1093/nar/gki731; Tinoco I, 1999, J MOL BIOL, V293, P271, DOI 10.1006/jmbi.1999.3001; Torres-Larios A, 2005, NATURE, V437, P584, DOI 10.1038/nature04074; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Xayaphoummine A, 2003, P NATL ACAD SCI USA, V100, P15310, DOI 10.1073/pnas.2536430100	30	37	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2007	2	9							e905	10.1371/journal.pone.0000905	http://dx.doi.org/10.1371/journal.pone.0000905			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HS	17878940	gold, Green Submitted, Green Published			2022-12-25	WOS:000207455700013
J	Gillet, L; May, JS; Stevenson, PG				Gillet, Laurent; May, Janet S.; Stevenson, Philip G.			Post-Exposure Vaccination Improves Gammaherpesvirus Neutralization	PLOS ONE			English	Article								Herpesvirus carriers transmit infection despite making virus-specific antibodies. Thus, their antibody responses are not necessarily optimal. An important question for infection control is whether vaccinating carriers might improve virus neutralization. The antibody response to murine gamma-herpesvirus-68 (MHV-68) blocks cell binding, but fails to block and even enhances an IgG Fc receptor-dependent infection of myeloid cells. Viral membrane fusion therefore remains intact. Although gH/gL-specific monoclonal antibodies can block infection at a post-binding step close to membrane fusion, gH/gL is a relatively minor antibody target in virus carriers. We show here that gH/gL-specific antibodies can block both Fc receptor-independent and Fc receptor-dependent infections, and that vaccinating virus carriers with a gH/gL fusion protein improves their capacity for virus neutralization both in vitro and in vivo. This approach has the potential to reduce herpesvirus transmission.	[Gillet, Laurent; May, Janet S.; Stevenson, Philip G.] Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Div Virol, Cambridge CB2 2QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Stevenson, PG (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Div Virol, Cambridge CB2 2QQ, England.	pgs27@cam.ac.uk	Stevenson, Philip/F-6651-2011; Stevenson, Philip g/F-9688-2014	Stevenson, Philip g/0000-0002-3520-5060; Gillet, Laurent/0000-0002-1047-2525	Wellcome Trust [GR076956MA]; Medical Research Council [G0400427, G9800903]; Cancer Research UK [C19612/A6189]; Fonds National Belge de la Recherche Scientifique (FNRS); MRC [G0400427] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Fonds National Belge de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Wellcome Trust ( Senior Clinical Fellow GR076956MA to PGS), the Medical Research Council (G0400427, G9800903) and Cancer Research UK (C19612/A6189). LG is a Postdoctoral Researcher of the Fonds National Belge de la Recherche Scientifique (FNRS).	Adler H, 2000, J VIROL, V74, P6964, DOI 10.1128/JVI.74.15.6964-6974.2000; BALACHANDRAN N, 1982, INFECT IMMUN, V37, P1132, DOI 10.1128/IAI.37.3.1132-1137.1982; Belz GT, 2000, P NATL ACAD SCI USA, V97, P2725, DOI 10.1073/pnas.040575197; Bitonti AJ, 2004, P NATL ACAD SCI USA, V101, P9763, DOI 10.1073/pnas.0403235101; Coleman HM, 2003, J VIROL, V77, P2410, DOI 10.1128/JVI.77.4.2410-2417.2003; DAVISON AJ, 1990, NUCLEIC ACIDS RES, V18, P4285, DOI 10.1093/nar/18.14.4285; De Lima BD, 2004, J VIROL, V78, P5103, DOI 10.1128/JVI.78.10.5103-5112.2004; DINGWELL KS, 1994, J VIROL, V68, P834, DOI 10.1128/JVI.68.2.834-845.1994; Gangappa S, 2002, J VIROL, V76, P11460, DOI 10.1128/JVI.76.22.11460-11468.2002; Gill MB, 2006, J GEN VIROL, V87, P1465, DOI 10.1099/vir.0.81760-0; Gillet L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000705; Gillet L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000347; Gillet L, 2007, J VIROL, V81, P280, DOI 10.1128/JVI.01616-06; Gillet L, 2006, J GEN VIROL, V87, P3515, DOI 10.1099/vir.0.82313-0; Huber VC, 2001, J IMMUNOL, V166, P7381, DOI 10.4049/jimmunol.166.12.7381; INADA T, 1985, J GEN VIROL, V66, P871, DOI 10.1099/0022-1317-66-4-871; Jiang R, 2006, J VIROL, V80, P7281, DOI 10.1128/JVI.00497-06; JOHNSON DC, 1987, J VIROL, V61, P2208, DOI 10.1128/JVI.61.7.2208-2216.1987; Kim IJ, 2002, J IMMUNOL, V168, P3958, DOI 10.4049/jimmunol.168.8.3958; KOHL S, 1986, J IMMUNOL, V137, P1688; Kraehenbuhl JP, 2000, ANNU REV CELL DEV BI, V16, P301, DOI 10.1146/annurev.cellbio.16.1.301; Lopes FB, 2004, J VIROL, V78, P13370, DOI 10.1128/JVI.78.23.13370-13375.2004; Maidji E, 2006, AM J PATHOL, V168, P1210, DOI 10.2353/ajpath.2006.050482; Marques S, 2003, J VIROL, V77, P7308, DOI 10.1128/JVI.77.13.7308-7318.2003; May JS, 2004, J GEN VIROL, V85, P137, DOI 10.1099/vir.0.19599-0; Mori Y, 2004, J VIROL, V78, P4609, DOI 10.1128/JVI.78.9.4609-4616.2004; Nagashunmugam T, 1998, J VIROL, V72, P5351, DOI 10.1128/JVI.72.7.5351-5359.1998; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; PEETERS B, 1993, J VIROL, V67, P170, DOI 10.1128/JVI.67.1.170-177.1993; RECTOR JT, 1982, INFECT IMMUN, V38, P168, DOI 10.1128/IAI.38.1.168-174.1982; Rosa GT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000560; ROTH MG, 1980, J VIROL, V35, P547, DOI 10.1128/JVI.35.2.547-550.1980; Sangster MY, 2000, J IMMUNOL, V164, P1820, DOI 10.4049/jimmunol.164.4.1820; Stevenson PG, 2004, CURR OPIN IMMUNOL, V16, P456, DOI 10.1016/j.coi.2004.05.002; Stevenson PG, 2002, NAT IMMUNOL, V3, P733, DOI 10.1038/ni818; Stevenson PG, 1999, P NATL ACAD SCI USA, V96, P9281, DOI 10.1073/pnas.96.16.9281; Stevenson PG, 1998, J VIROL, V72, P943, DOI 10.1128/JVI.72.2.943-949.1998; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; van Montfort T, 2007, J IMMUNOL, V178, P3177, DOI 10.4049/jimmunol.178.5.3177; Wang D, 2005, P NATL ACAD SCI USA, V102, P18153, DOI 10.1073/pnas.0509201102; Wang X, 1998, J VIROL, V72, P5552, DOI 10.1128/JVI.72.7.5552-5558.1998; Xu JK, 1996, J GEN VIROL, V77, P49, DOI 10.1099/0022-1317-77-1-49; Yewdell JW, 2002, NAT IMMUNOL, V3, P1019, DOI 10.1038/ni1102-1019	43	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2007	2	9							e899	10.1371/journal.pone.0000899	http://dx.doi.org/10.1371/journal.pone.0000899			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HS	17878934	Green Published, gold			2022-12-25	WOS:000207455700007
J	Siegmund, KD; Connor, CM; Campan, M; Long, TI; Weisenberger, DJ; Biniszkiewicz, D; Jaenisch, R; Laird, PW; Akbarian, S				Siegmund, Kimberly D.; Connor, Caroline M.; Campan, Mihaela; Long, Tiffany I.; Weisenberger, Daniel J.; Biniszkiewicz, Detlev; Jaenisch, Rudolf; Laird, Peter W.; Akbarian, Schahram			DNA Methylation in the Human Cerebral Cortex Is Dynamically Regulated throughout the Life Span and Involves Differentiated Neurons	PLOS ONE			English	Article							METHYLTRANSFERASES DNMT3A; SCHIZOPHRENIC-PATIENTS; GENE-EXPRESSION; PROMOTER; BRAIN; NEUROPATHOLOGY; REELIN; HYPERMETHYLATION; METHYLIGHT; PROTEIN	The role of DNA cytosine methylation, an epigenetic regulator of chromatin structure and function, during normal and pathological brain development and aging remains unclear. Here, we examined by MethyLight PCR the DNA methylation status at 50 loci, encompassing primarily 5' CpG islands of genes related to CNS growth and development, in temporal neocortex of 125 subjects ranging in age from 17 weeks of gestation to 104 years old. Two psychiatric disease cohorts-defined by chronic neurodegeneration (Alzheimer's) or lack thereof (schizophrenia)-were included. A robust and progressive rise in DNA methylation levels across the lifespan was observed for 8/50 loci (GABRA2, GAD1, HOXA1, NEUROD1, NEUROD2, PGR, STK11, SYK) typically in conjunction with declining levels of the corresponding mRNAs. Another 16 loci were defined by a sharp rise in DNA methylation levels within the first few months or years after birth. Disease-associated changes were limited to 2/50 loci in the Alzheimer's cohort, which appeared to reflect an acceleration of the age-related change in normal brain. Additionally, methylation studies on sorted nuclei provided evidence for bidirectional methylation events in cortical neurons during the transition from childhood to advanced age, as reflected by significant increases at 3, and a decrease at 1 of 10 loci. Furthermore, the DNMT3a de novo DNA methyl-transferase was expressed across all ages, including a subset of neurons residing in layers III and V of the mature cortex. Therefore, DNA methylation is dynamically regulated in the human cerebral cortex throughout the lifespan, involves differentiated neurons, and affects a substantial portion of genes predominantly by an age-related increase.	[Connor, Caroline M.; Akbarian, Schahram] Univ Massachusetts, Sch Med, Dept Psychiat, Worcester, MA 01655 USA; [Siegmund, Kimberly D.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Connor, Caroline M.] Univ Massachusetts, Sch Med, Grad Sch Biomed Sci, Program Neurobiol, Worcester, MA 01655 USA; [Campan, Mihaela; Long, Tiffany I.; Weisenberger, Daniel J.; Laird, Peter W.] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Biniszkiewicz, Detlev; Jaenisch, Rudolf] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Southern California; University of Massachusetts System; University of Massachusetts Worcester; University of Southern California; Massachusetts Institute of Technology (MIT); Whitehead Institute	Akbarian, S (corresponding author), Univ Massachusetts, Sch Med, Dept Psychiat, Worcester, MA 01655 USA.	Schahram.akbarian@umassmed.edu	Weisenberger, Daniel/AAA-8314-2020; feng, jian/G-9313-2011; Laird, Peter W/G-8683-2012	Weisenberger, Daniel/0000-0001-8303-2603; Laird, Peter W/0000-0001-9117-3641	National Institute of Mental Health	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported by grants from the National Institute of Mental Health.	Abdolmaleky HM, 2005, AM J MED GENET B, V134B, P60, DOI 10.1002/ajmg.b.30140; Ausio J, 2003, CLIN GENET, V64, P83, DOI 10.1034/j.1399-0004.2003.00124.x; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Braus DF, 2002, ARCH GEN PSYCHIAT, V59, P696, DOI 10.1001/archpsyc.59.8.696; Champagne FA, 2006, ENDOCRINOLOGY, V147, P2909, DOI 10.1210/en.2005-1119; Chen TP, 2002, J BIOL CHEM, V277, P38746, DOI 10.1074/jbc.M205312200; Debinski W, 2003, ANN NY ACAD SCI, V983, P232, DOI 10.1111/j.1749-6632.2003.tb05978.x; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Esteller M, 2005, ANNU REV PHARMACOL, V45, P629, DOI 10.1146/annurev.pharmtox.45.120403.095832; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Feng J, 2005, J NEUROSCI RES, V79, P734, DOI 10.1002/jnr.20404; Flanagan JM, 2006, AM J HUM GENET, V79, P67, DOI 10.1086/504729; Grayson DR, 2005, P NATL ACAD SCI USA, V102, P9341, DOI 10.1073/pnas.0503736102; Hakak Y, 2001, P NATL ACAD SCI USA, V98, P4746, DOI 10.1073/pnas.081071198; Heckers S, 1997, SCHIZOPHRENIA BULL, V23, P403, DOI 10.1093/schbul/23.3.403; Hoyaux D, 2000, BRAIN RES, V867, P280, DOI 10.1016/S0006-8993(00)02393-3; Huang HS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000809; Isles AR, 2006, PHILOS T R SOC B, V361, P2229, DOI 10.1098/rstb.2006.1942; Ito H, 2007, J NEUROCHEM, V100, P545, DOI 10.1111/j.1471-4159.2006.04222.x; Jakovcevski I, 2005, GLIA, V49, P480, DOI 10.1002/glia.20134; JELLINGER K, 1978, ACTA NEUROCHIR, V42, P5, DOI 10.1007/BF01406628; Kornack DR, 1998, P NATL ACAD SCI USA, V95, P1242, DOI 10.1073/pnas.95.3.1242; Kundakovic M, 2007, MOL PHARMACOL, V71, P644, DOI 10.1124/mol.106.030635; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Levenson JM, 2006, J BIOL CHEM, V281, P15763, DOI 10.1074/jbc.M511767200; Lipska BK, 2006, BIOL PSYCHIAT, V60, P650, DOI 10.1016/j.biopsych.2006.06.019; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Mirnics K, 2000, NEURON, V28, P53, DOI 10.1016/S0896-6273(00)00085-4; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nagarajan RP, 2006, EPIGENETICS-US, V1, P172, DOI 10.4161/epi.1.4.3514; Nguyen' S, 2007, DEV DYNAM, V236, P1663, DOI 10.1002/dvdy.21176; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; OKUSKY J, 1982, J COMP NEUROL, V210, P307, DOI 10.1002/cne.902100309; Petronis A, 2001, TRENDS GENET, V17, P142, DOI 10.1016/S0168-9525(00)02213-7; Polesskaya OO, 2006, J NEUROSCI RES, V83, P362, DOI 10.1002/jnr.20732; Prabakaran S, 2004, MOL PSYCHIATR, V9, P684, DOI 10.1038/sj.mp.4001511; Preusser M, 2006, WIEN MED WOCHENSCHR, V156, P332, DOI 10.1007/s10354-006-0304-7; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Sauvageot CM, 2002, CURR OPIN NEUROBIOL, V12, P244, DOI 10.1016/S0959-4388(02)00322-7; Scarpa S, 2003, FEBS LETT, V541, P145, DOI 10.1016/S0014-5793(03)00277-1; Selkoe DJ, 2002, ANNU REV GENOM HUM G, V3, P67, DOI 10.1146/annurev.genom.3.022502.103022; Song DL, 1996, DEVELOPMENT, V122, P627; Trinh BN, 2001, METHODS, V25, P456, DOI 10.1006/meth.2001.1268; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; WEINBERGER DR, 1995, LANCET, V346, P552, DOI 10.1016/S0140-6736(95)91386-6; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; Weisenberger DJ, 2002, GENE, V298, P91, DOI 10.1016/S0378-1119(02)00976-9; Widschwendter M, 2004, CANCER RES, V64, P3807, DOI 10.1158/0008-5472.CAN-03-3852; Wolf HK, 1996, J HISTOCHEM CYTOCHEM, V44, P1167, DOI 10.1177/44.10.8813082; Xie ZH, 2006, HUM MOL GENET, V15, P1375, DOI 10.1093/hmg/ddl059	55	328	339	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2007	2	9							e895	10.1371/journal.pone.0000895	http://dx.doi.org/10.1371/journal.pone.0000895			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HS	17878930	Green Published, gold, Green Submitted			2022-12-25	WOS:000207455700003
J	Viebig, NK; Levin, E; Dechavanne, S; Rogerson, SJ; Gysin, J; Smith, JD; Scherf, A; Gamain, B				Viebig, Nicola K.; Levin, Emily; Dechavanne, Sebastien; Rogerson, Stephen J.; Gysin, Jurg; Smith, Joseph D.; Scherf, Artur; Gamain, Benoit			Disruption of Var2csa Gene Impairs Placental Malaria Associated Adhesion Phenotype	PLOS ONE			English	Article								Infection with Plasmodium falciparum during pregnancy is one of the major causes of malaria related morbidity and mortality in newborn and mothers. The complications of pregnancy-associated malaria result mainly from massive adhesion of Plasmodium falciparum-infected erythrocytes (IE) to chondroitin sulfate A (CSA) present in the placental intervillous blood spaces. Var2CSA, a member of the P. falciparum erythrocyte membrane protein 1 (PfEMP1) family is the predominant parasite ligand mediating CSA binding. However, experimental evidence suggests that other host receptors, such as hyaluronic acid (HA) and the neonatal Fc receptor, may also support placental binding. Here we used parasites in which var2csa was genetically disrupted to evaluate the contribution of these receptors to placental sequestration and to identify additional adhesion receptors that may be involved in pregnancy-associated malaria. By comparison to the wild-type parasites, the FCR3 Delta var2csa mutants could not be selected for HA adhesion, indicating that var2csa is not only essential for IE cytoadhesion to the placental receptor CSA, but also to HA. However, further studies using different pure sources of HA revealed that the previously observed binding results from CSA contamination in the bovine vitreous humor HA preparation. To identify CSA-independent placental interactions, FCR3 Delta var2csa mutant parasites were selected for adhesion to the human placental trophoblastic BeWo cell line. BeWo selected parasites revealed a multi-phenotypic adhesion population expressing multiple var genes. However, these parasites did not cytoadhere specifically to the syncytiotrophoblast lining of placental cryosections and were not recognized by sera from malaria-exposed women in a parity dependent manner, indicating that the surface molecules present on the surface of the BeWo selected population are not specifically expressed during the course of pregnancy-associated malaria. Taken together, these results demonstrate that the placental malaria associated phenotype can not be restored in FCR3 Delta var2csa mutant parasites and highlight the key role of var2CSA in pregnancy malaria pathogenesis and for vaccine development.	[Viebig, Nicola K.; Scherf, Artur; Gamain, Benoit] Inst Pasteur, Unite Biol Interact Hote Parasite, Paris, France; [Viebig, Nicola K.; Scherf, Artur; Gamain, Benoit] CNRS, Paris, France; [Levin, Emily; Smith, Joseph D.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Dechavanne, Sebastien; Gysin, Jurg] Univ Aix Marseille 2, Unite Parasitol Expt, Marseille, France; [Rogerson, Stephen J.] Univ Melbourne, Dept Med, Royal Melbourne Hosp, Parkville, Vic 3052, Australia	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Center for Infectious Disease Research; UDICE-French Research Universities; Aix-Marseille Universite; Royal Melbourne Hospital; University of Melbourne	Scherf, A (corresponding author), Inst Pasteur, Unite Biol Interact Hote Parasite, Paris, France.	ascherf@pasteur.fr; bgamain@pasteur.fr	Gamain, Benoit/N-9985-2017; Scherf, Artur/A-9674-2014; Dechavanne, Sebastien/AAL-8108-2021	Gamain, Benoit/0000-0002-8255-2145; Rogerson, Stephen/0000-0003-4287-1982; Scherf, Artur/0000-0003-2411-3328; Dechavanne, Sebastien/0000-0001-9400-1976	Bill and Melinda Gates Foundation [ndegree 29202]; FP6 [LSHP-CT-2004-503578]; National Health and Medical Research Council of Australia; Pasteur-Sanofi Fonds Dedies [Ndegree 8]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); FP6(European Commission); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Pasteur-Sanofi Fonds Dedies	This work was supported by grants from the Bill and Melinda Gates Foundation ( grant n degrees 29202) as part of the Pregnancy Malaria vaccine consortium, the FP6-funded network of excellence BIOMALPAR program (LSHP-CT-2004-503578), the National Health and Medical Research Council of Australia and the Pasteur-Sanofi Fonds Dedies N degrees 8.	APLIN JD, 1992, J CELL SCI, V103, P435; Avril M, 2004, MICROBES INFECT, V6, P249, DOI 10.1016/j.micinf.2003.12.007; Baruch DI, 1997, BLOOD, V90, P3766, DOI 10.1182/blood.V90.9.3766; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Beeson JG, 2004, J INFECT DIS, V189, P169, DOI 10.1086/380975; Beeson JG, 2002, INT J PARASITOL, V32, P1245, DOI 10.1016/S0020-7519(02)00097-8; Beeson JG, 2000, NAT MED, V6, P86, DOI 10.1038/71582; Bockhorst J, 2007, MOL BIOCHEM PARASIT, V155, P103, DOI 10.1016/j.molbiopara.2007.06.007; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Brabin BJ, 2004, PLACENTA, V25, P359, DOI 10.1016/j.placenta.2003.10.019; BRABIN BJ, 1983, B WORLD HEALTH ORGAN, V61, P1005; Chai WG, 2001, INFECT IMMUN, V69, P420, DOI 10.1128/IAI.69.1.420-425.2001; Duffy MF, 2005, MOL MICROBIOL, V56, P774, DOI 10.1111/j.1365-2958.2005.04577.x; Duffy MF, 2006, MOL BIOCHEM PARASIT, V148, P117, DOI 10.1016/j.molbiopara.2006.03.006; Dzikowski R, 2006, PLOS PATHOG, V2, P184, DOI 10.1371/journal.ppat.0020022; Ellinger I, 1999, EUR J IMMUNOL, V29, P733, DOI 10.1002/(SICI)1521-4141(199903)29:03<733::AID-IMMU733>3.0.CO;2-C; Flick K, 2001, SCIENCE, V293, P2098, DOI 10.1126/science.1062891; Fried M, 2000, EXP PARASITOL, V95, P75, DOI 10.1006/expr.2000.4510; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; Fried M, 2006, EXP PARASITOL, V113, P36, DOI 10.1016/j.exppara.2005.12.003; Gamain B, 2005, J INFECT DIS, V191, P1010, DOI 10.1086/428137; Haase RN, 2006, INFECT IMMUN, V74, P3035, DOI 10.1128/IAI.74.5.3035-3038.2006; Kraemer SM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-45; Kristoffersen E K, 1996, APMIS Suppl, V64, P5; Kristoffersen EK, 1996, EUR J IMMUNOL, V26, P505, DOI 10.1002/eji.1830260234; Kyes S, 2000, MOL BIOCHEM PARASIT, V105, P311, DOI 10.1016/S0166-6851(99)00193-0; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lelievre J, 2005, EXP PARASITOL, V109, P195, DOI 10.1016/j.exppara.2004.11.012; Lucchi NW, 2006, PLACENTA, V27, P384, DOI 10.1016/j.placenta.2005.04.009; Lyden TW, 2001, J IMMUNOL, V166, P3882, DOI 10.4049/jimmunol.166.6.3882; MENENDEZ C, 1995, PARASITOL TODAY, V11, P178, DOI 10.1016/0169-4758(95)80151-0; Mount AM, 2004, LANCET, V363, P1860, DOI 10.1016/S0140-6736(04)16354-X; Muthusamy A, 2007, AM J PATHOL, V170, P1989, DOI 10.2353/ajpath.2007.061238; Noviyanti R, 2001, MOL BIOCHEM PARASIT, V114, P227, DOI 10.1016/S0166-6851(01)00266-3; Rasti N, 2006, P NATL ACAD SCI USA, V103, P13795, DOI 10.1073/pnas.0601519103; Ricke CH, 2000, J IMMUNOL, V165, P3309, DOI 10.4049/jimmunol.165.6.3309; Robinson BA, 2003, MOL MICROBIOL, V47, P1265, DOI 10.1046/j.1365-2958.2003.03378.x; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Trimnell AR, 2006, MOL BIOCHEM PARASIT, V148, P169, DOI 10.1016/j.molbiopara.2006.03.012; Valiyaveettil M, 2001, EXP PARASITOL, V99, P57, DOI 10.1006/expr.2001.4642; Viebig NK, 2006, EXP PARASITOL, V112, P121, DOI 10.1016/j.exppara.2005.09.007; Viebig NK, 2005, EMBO REP, V6, P775, DOI 10.1038/sj.embor.7400466; *WHO, 2003, B WORLD HEALTH ORGAN, V81, P472	47	60	61	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2007	2	9							e910	10.1371/journal.pone.0000910	http://dx.doi.org/10.1371/journal.pone.0000910			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HS	17878945	Green Published, gold			2022-12-25	WOS:000207455700018
J	Park, HJ; Wang, Z; Costa, RH; Tyner, A; Lau, LF; Raychaudhuri, P				Park, H. J.; Wang, Z.; Costa, R. H.; Tyner, A.; Lau, L. F.; Raychaudhuri, P.			An N-terminal inhibitory domain modulates activity of FoxM1 during cell cycle	ONCOGENE			English	Article						FoxM1; cell cycle regulation; FoxM1-inhibitory domain; transforming activity	TRANSCRIPTION FACTOR TRIDENT; S-PHASE; HEPATOCYTE ENTRY; FACTOR HFH-11B; LIVER; TRANSACTIVATION; PROLIFERATION; PROGRESSION; CARCINOMAS; EXPRESSION	The FoxM1 transcription factor plays critical roles in the expression of genes that are essential for cell proliferation. FoxM1 null or depleted cells fail to progress through mitosis, as expression of several mitotic genes depends upon FoxM1. The transcriptional activity of FoxM1 is stimulated by cyclin-cdk-mediated phosphorylation at a site within the transcriptional activation domain. Here, we characterize the role of an N-terminal inhibitory domain in the transcriptional activity of FoxM1. Deletion of the N-terminal 232 amino-acid residues increases the transcriptional and transforming activities of FoxM1. Moreover, while the activity of the full-length FoxM1 is stimulated by growth factors, the activity of the N-terminal deletion mutant is constitutively high in all phases of the cell cycle. The N-terminal deletion also eliminates the requirement for cyclin-cdk to activate FoxM1. We provide evidence that the N-terminal domain interacts with the C-terminal half of the transcription factor to attenuate its transcriptional activity. Moreover, the N-terminal fragment inhibits the transcriptional activity of FoxM1 in G(1)/S cells, but not in G(2)/M cells. Our results suggest that cyclin-cdk phosphorylates FoxM1 to counteract the inhibition by the N-terminal domain to fully activate FoxM1 in G(2)/M phase.	[Park, H. J.; Wang, Z.; Costa, R. H.; Tyner, A.; Lau, L. F.; Raychaudhuri, P.] Univ Illinois, Coll Med, Dept Biochem & Mol Genet M C 669, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Raychaudhuri, P (corresponding author), Univ Illinois, Coll Med, Dept Biochem & Mol Genet M C 669, 900 S Ashland Ave, Chicago, IL 60607 USA.	pradip@uic.edu		Lau, Lester/0000-0002-4364-2914; Tyner, Angela/0000-0001-7448-8625	NCI NIH HHS [R01 CA100035, CA46565, R01 CA046565, R01 CA124488, CA124488, R01 CA124488-02, R01 CA100035-04, CA100035] Funding Source: Medline; NIA NIH HHS [R01 AG021842, R01 AG021842-05] Funding Source: Medline; NIDDK NIH HHS [R01 DK044525, R01 DK054687-09, DK044525, R01 DK054687] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA046565, R01CA124488, R01CA100035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054687, R55DK044525, R01DK044525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021842] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Gusarova GA, 2007, J CLIN INVEST, V117, P99, DOI 10.1172/JCI27527; Kalin TV, 2006, CANCER RES, V66, P1712, DOI 10.1158/0008-5472.CAN-05-3138; Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704; Kim IM, 2006, CANCER RES, V66, P2153, DOI 10.1158/0008-5472.CAN-05-3003; Korver W, 1998, CURR BIOL, V8, P1327, DOI 10.1016/S0960-9822(07)00563-5; Korver W, 1997, NUCLEIC ACIDS RES, V25, P1715, DOI 10.1093/nar/25.9.1715; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Liu MG, 2006, CANCER RES, V66, P3593, DOI 10.1158/0008-5472.CAN-05-2912; Luscher-Firzlaff JM, 1999, ONCOGENE, V18, P5620, DOI 10.1038/sj.onc.1202967; Major ML, 2004, MOL CELL BIOL, V24, P2649, DOI 10.1128/MCB.24.7.2649-2661.2004; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Wang XH, 2002, P NATL ACAD SCI USA, V99, P16881, DOI 10.1073/pnas.252570299; Wang XH, 2001, P NATL ACAD SCI USA, V98, P11468, DOI 10.1073/pnas.201360898; Wang XH, 2001, HEPATOLOGY, V33, P1404, DOI 10.1053/jhep.2001.24666; Wierstra I, 2006, BIOCHEM BIOPH RES CO, V348, P99, DOI 10.1016/j.bbrc.2006.07.008; Wierstra I, 2006, BIOL CHEM, V387, P949, DOI 10.1515/BC.2006.119; Wierstra I, 2006, BIOL CHEM, V387, P963, DOI 10.1515/BC.2006.120; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059; Ye HG, 1999, MOL CELL BIOL, V19, P8570; Ye HG, 1997, MOL CELL BIOL, V17, P1626, DOI 10.1128/MCB.17.3.1626	20	58	60	2	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 13	2008	27	12					1696	1704		10.1038/sj.onc.1210814	http://dx.doi.org/10.1038/sj.onc.1210814			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	273WF	17891172	Green Submitted, Green Accepted			2022-12-25	WOS:000253962100005
J	Iwakuma, T; Tochigi, Y; Van Pelt, CS; Caldwell, LC; Terzian, T; Parant, JM; Chau, GP; Koch, JG; Eischen, CM; Lozano, G				Iwakuma, T.; Tochigi, Y.; Van Pelt, C. S.; Caldwell, L. C.; Terzian, T.; Parant, J. M.; Chau, G. P.; Koch, J. G.; Eischen, C. M.; Lozano, G.			Mtbp haploinsufficiency in mice increases tumor metastasis	ONCOGENE			English	Article						Mdm2; p53; MrpL13	MAMMALIAN MITOCHONDRIAL RIBOSOME; EMBRYONIC LETHALITY; S PHASE; MDM2; P53; EXPRESSION; SPECTRUM; RESCUE; SUPPRESSION; PROTEINS	Mdm2 inhibits the function of the p53 tumor suppressor. Mdm2 is overexpressed in many tumors with wild-type p53 suggesting an alternate mechanism of loss of p53 activity in tumors. An Mdm2-binding protein (MTBP) was identified using a yeast two-hybrid screen. In tissue culture, MTBP inhibits Mdm2 self-ubiquitination, leading to stabilization of Mdm2 and increased degradation of p53. To address the role of MTBP in the regulation of the p53 pathway in vivo, we deleted the Mtbp gene in mice. Homozygous disruption of Mtbp resulted in early embryonic lethality, which was not rescued by loss of p53. Mtbp(+/-) mice were not tumor prone. When mice were sensitized for tumor development by p53 heterozygosity, we found that the Mtbp(+/-)p53(+/-) mice developed significantly more metastatic tumors (18.2%) as compared to p53(+/-) mice (2.6%). Results of in vitro migration and invasion assays support the in vivo findings. Downmodulation of Mtbp in osteosarcoma cells derived from p53(+/-) mice resulted in increased invasiveness, and overexpression of Mtbp in Mtbp(+/-)p53(+/-) osteosarcoma cells inhibited invasiveness. These results suggest that MTBP is a metastasis suppressor. These results advance our understanding of the cellular roles of MTBP and raise the possibility that MTBP is a novel therapeutic target for metastasis.	[Iwakuma, T.; Terzian, T.; Parant, J. M.; Chau, G. P.; Koch, J. G.; Lozano, G.] Univ Texas MD Anderson Canc Ctr, Dept Canc Genet, Houston, TX 77030 USA; [Iwakuma, T.; Tochigi, Y.] Louisiana State Univ, Hlth Sci Ctr, Dept Genet, New Orleans, LA USA; [Van Pelt, C. S.] Univ Texas MD Anderson Canc Ctr, Dept Vet Med, Houston, TX USA; [Koch, J. G.] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX USA; [Eischen, C. M.] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37212 USA	University of Texas System; UTMD Anderson Cancer Center; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; Vanderbilt University	Lozano, G (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Genet, 1515 Holcombe Blvd, Houston, TX 77030 USA.	tiwaku@lsuhsc.edu; gglozano@mdanderson.org		Chau, Gilda/0000-0002-7907-3290	NATIONAL CANCER INSTITUTE [R01CA098139] Funding Source: NIH RePORTER; NCI NIH HHS [CA098139] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alt JR, 2003, EMBO J, V22, P1442, DOI 10.1093/emboj/cdg133; BARTEK J, 1991, ONCOGENE, V6, P1699; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Boyd MT, 2000, J BIOL CHEM, V275, P31883, DOI 10.1074/jbc.M004252200; Brady M, 2005, MOL CELL BIOL, V25, P545, DOI 10.1128/MCB.25.2.545-553.2005; Che G, 2006, NEOPLASMA, V53, P530; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Finch RA, 2002, CANCER RES, V62, P3221; Iwakuma T, 2004, ONCOGENE, V23, P7644, DOI 10.1038/sj.onc.1207793; Iwakuma T, 2003, MOL CANCER RES, V1, P993; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jee BK, 2006, BIOCHEM BIOPH RES CO, V342, P655, DOI 10.1016/j.bbrc.2006.01.153; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Jones SN, 1998, P NATL ACAD SCI USA, V95, P15608, DOI 10.1073/pnas.95.26.15608; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Koc EC, 2001, J BIOL CHEM, V276, P43958, DOI 10.1074/jbc.M106510200; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; LEVINE AJ, 2004, CELL, V69, pS67; LEVINE HB, 1993, PSYCHOANAL QUART, V62, P651; Lozano G, 2005, J PATHOL, V205, P206, DOI 10.1002/path.1704; LUNA RMD, 1995, NATURE, V378, P203; Lundgren K, 1997, GENE DEV, V11, P714, DOI 10.1101/gad.11.6.714; Mendrysa SM, 2006, GENE DEV, V20, P16, DOI 10.1101/gad.1378506; Migliorini D, 2002, MOL CELL BIOL, V22, P5527, DOI 10.1128/MCB.22.15.5527-5538.2002; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Parant J, 2001, NAT GENET, V29, P92, DOI 10.1038/ng714; PURDIE CA, 1994, ONCOGENE, V9, P603; Reinke V, 1999, CELL GROWTH DIFFER, V10, P147; Sharpless NE, 1999, CURR OPIN GENET DEV, V9, P22, DOI 10.1016/S0959-437X(99)80004-5; Sheng SJ, 1998, P NATL ACAD SCI USA, V95, P499, DOI 10.1073/pnas.95.2.499; Suzuki T, 2001, J BIOL CHEM, V276, P21724, DOI 10.1074/jbc.M100432200; TSUKADA T, 1993, ONCOGENE, V8, P3313; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991	34	24	25	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2008	27	13					1813	1820		10.1038/sj.onc.1210827	http://dx.doi.org/10.1038/sj.onc.1210827			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	276NZ	17906694				2022-12-25	WOS:000254150600001
J	Maynadier, M; Ramirez, JM; Cathiard, AM; Platet, N; Gras, D; Gleizes, M; Sheikh, MS; Nirde, P; Garcia, M				Maynadier, Marie; Ramirez, Jean-Marie; Cathiard, Ame-Marie; Platet, Nadine; Gras, Delphine; Gleizes, Michel; Sheikh, M. Saeed; Nirde, Philippe; Garcia, Marcel			Unliganded estrogen receptor alpha inhibits breast cancer cell growth through interaction with a cyclin-dependent kinase inhibitor (p21(WAF1))	FASEB JOURNAL			English	Article						cell cycle; steroid; proliferation	TRANSCRIPTIONAL ACTIVITY; PROGESTERONE-RECEPTOR; HORMONE RECEPTORS; DOWN-REGULATION; P53 EXPRESSION; ER-ALPHA; ACTIVATION; CARCINOMA; PROGNOSIS; P21	Estrogens are mitogenic in human breast cancer cells, but the presence of estrogen receptor alpha (ER alpha) is associated with a favorable prognosis in primary tumors and the molecular basis for this paradoxical relationship remains unknown. Here we show that ER alpha and ER alpha mutants devoid of ligand and DNA-binding domains inhibit cell growth in three-dimensional matrix as well as tumor formation in nude mice. Using in vitro and intracellular approaches, we have found that ER alpha, via its amino acids 184-283, interacts with cyclin-dependent kinase inhibitor p21(WAF1). Both proteins exhibit mutual interactions in the absence of estrogens or in the presence of pure antiestrogen ICI182,780, whereas estradiol treatment disrupts their interactions. Cross-linking experiments reveal that these proteins are present in a larger complex of similar to 200 kDa that also contains cdk2 and cyclin E. We further demonstrate that the unliganded full-length ER alpha or the variant having the p21(WAF1) interaction region significantly increases p21(WAF1) expression, whereas ER alpha silencing reduces p21(WAF1) levels and silencing of p21(WAF1) is sufficient to prevent ER alpha-induced growth inhibition. Taken together, our results point to an antiproliferative function of the unliganded ER alpha through its physical interactions with p21(WAF1) that may also explain the favorable prognosis of ER alpha-positive breast cancers.	[Maynadier, Marie; Ramirez, Jean-Marie; Cathiard, Ame-Marie; Platet, Nadine; Gras, Delphine; Nirde, Philippe; Garcia, Marcel] INSERM, U 826, CRLC, F-34298 Montpellier, France; [Maynadier, Marie; Ramirez, Jean-Marie; Cathiard, Ame-Marie; Platet, Nadine; Gras, Delphine; Gleizes, Michel; Nirde, Philippe; Garcia, Marcel] Univ Montpellier I, Montpellier, France; [Sheikh, M. Saeed] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Garcia, M (corresponding author), INSERM, U 826, CRLC, 208 Rue Apothicaires, F-34298 Montpellier, France.	marcel.garcia@valdorel.fnclcc.fr	Gras, Delphine/A-7062-2017; Gras, Delphine/AAP-7248-2020	Gras, Delphine/0000-0002-6630-2955				Allred DC, 1998, MODERN PATHOL, V11, P155; BERGER U, 1991, CANCER RES, V51, P239; Caffo O, 1996, CLIN CANCER RES, V2, P1591; Cariou S, 2000, P NATL ACAD SCI USA, V97, P9042, DOI 10.1073/pnas.160016897; Cayrol C, 1998, ONCOGENE, V17, P2437, DOI 10.1038/sj.onc.1202189; CHAMBRAUD B, 1990, J BIOL CHEM, V265, P20686; deMedeiros SRB, 1997, J BIOL CHEM, V272, P18250, DOI 10.1074/jbc.272.29.18250; DICKSON RB, 1995, ENDOCR REV, V16, P559, DOI 10.1210/er.16.5.559; Erenburg I, 1997, MOL ENDOCRINOL, V11, P2004, DOI 10.1210/me.11.13.2004; FISHER B, 1988, J CLIN ONCOL, V6, P1076, DOI 10.1200/JCO.1988.6.7.1076; Fritah A, 2005, MOL CELL BIOL, V25, P2419, DOI 10.1128/MCB.25.6.2419-2430.2005; GARCIA M, 1992, P NATL ACAD SCI USA, V89, P11538, DOI 10.1073/pnas.89.23.11538; GAUB MP, 1990, CELL, V63, P1267, DOI 10.1016/0092-8674(90)90422-B; Glondu M, 2002, ONCOGENE, V21, P5127, DOI 10.1038/sj.onc.1205657; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GU Y, 1993, NATURE, V366, P707, DOI 10.1038/366707a0; Gustafsson JA, 1999, J ENDOCRINOL, V163, P379, DOI 10.1677/joe.0.1630379; Hanrahan EO, 2006, J CLIN ONCOL, V24, P2113, DOI 10.1200/JCO.2005.02.8035; HARPER JW, 1993, CELL, V75, P805; HENDERSON BE, 1981, LANCET, V2, P363; Herynk MH, 2004, ENDOCR REV, V25, P869, DOI 10.1210/er.2003-0010; Jiang M, 1997, INT J CANCER, V74, P529, DOI 10.1002/(SICI)1097-0215(19971021)74:5<529::AID-IJC9>3.0.CO;2-5; Karaiskou A, 2001, J BIOL CHEM, V276, P36028, DOI 10.1074/jbc.M104722200; KELSEY JL, 1988, CANCER RES, V48, P5615; KORACH KS, 1994, SCIENCE, V266, P1524, DOI 10.1126/science.7985022; LIPPMAN M, 1976, CANCER RES, V36, P4595; MADER S, 1993, NUCLEIC ACIDS RES, V21, P1125, DOI 10.1093/nar/21.5.1125; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; MCCARTY KS, 1985, ARCH PATHOL LAB MED, V109, P716; MCGUIRE WL, 1978, SEMIN ONCOL, V5, P428; Oh YL, 2001, PATHOL INT, V51, P94, DOI 10.1046/j.1440-1827.2001.01173.x; OSBORNE CK, 1985, CANCER RES, V45, P584; Paech K, 1997, SCIENCE, V277, P1508, DOI 10.1126/science.277.5331.1508; PlanasSilva MD, 1997, MOL CELL BIOL, V17, P4059, DOI 10.1128/MCB.17.7.4059; Platet N, 2000, MOL ENDOCRINOL, V14, P999, DOI 10.1210/me.14.7.999; Prall OWJ, 1997, J BIOL CHEM, V272, P10882; Prall OWJ, 2001, J BIOL CHEM, V276, P45433, DOI 10.1074/jbc.M104752200; Sasano H, 1999, ENDOCR-RELAT CANCER, V6, P197, DOI 10.1677/erc.0.0060197; SHEIKH MS, 1995, ONCOGENE, V11, P1899; Sisci D, 2004, ONCOGENE, V23, P8920, DOI 10.1038/sj.onc.1208098; Skildum AJ, 2002, J BIOL CHEM, V277, P5145, DOI 10.1074/jbc.M109179200; STEIN B, 1995, MOL CELL BIOL, V15, P4971; Teyssier C, 2001, J BIOL CHEM, V276, P36361, DOI 10.1074/jbc.M101806200; THOMPSON EW, 1992, J CELL PHYSIOL, V150, P534, DOI 10.1002/jcp.1041500314; TORA L, 1989, EMBO J, V8, P1981, DOI 10.1002/j.1460-2075.1989.tb03604.x; Weigel NL, 1998, J MOL MED, V76, P469, DOI 10.1007/s001090050241; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; ZHANG H, 1994, GENE DEV, V8, P1750, DOI 10.1101/gad.8.15.1750	48	19	20	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2008	22	3					671	681		10.1096/fj.07-9322com	http://dx.doi.org/10.1096/fj.07-9322com			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	276LQ	17911387				2022-12-25	WOS:000254143700006
J	Frey, S; Leskovar, A; Reinstein, J; Buchner, J				Frey, Stephan; Leskovar, Adriane; Reinstein, Jochen; Buchner, Johannes			The ATPase cycle of the endoplasmic chaperone Grp94	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HSP90 MOLECULAR CHAPERONE; N-TERMINAL DOMAIN; BINDING-SITE; CRYSTAL-STRUCTURE; PEPTIDE BINDING; LIGAND-BINDING; IN-VIVO; PROTEIN; RETICULUM; NUCLEOTIDE	Grp94, the Hsp90 paralog of the endoplasmic reticulum, plays a crucial role in protein secretion. Like cytoplasmic Hsp90, Grp94 is regulated by nucleotide binding to its N-terminal domain. However, the question of whether Grp94 hydrolyzes ATP was controversial. This sets Grp94 apart from other members of the Hsp90 family where a slow but specific turnover of ATP has been unambiguously established. In this study we aimed at analyzing the nucleotide binding properties and the potential ATPase activity of Grp94. We show here that Grp94 has an ATPase activity comparable with that of yeast Hsp90 with a k(cat) of 0.36 min(-1) at 25 degrees C. Kinetic and equilibrium constants of the partial reactions of the ATPase cycle were determined using transient kinetic methods. Nucleotide binding appears to be tighter compared with other Hsp90s investigated, with dissociation constants (K-D) of similar to 4 mu M for ADP, ATP, and AMP-PCP. Interestingly, all nucleotides and inhibitors (radicicol, 5 '-N-ethylcarboxamidoadenosine) studied here bind with similar rate constants for association (0.2-0.3 x 10(6) M-1 s(-1) ). Furthermore, there is a marked difference from cytosolic Hsp90s in that after binding, the ATP molecule does not seem to become trapped by conformational changes in Grp94. Grp94 stays predominantly in the open state concerning the nucleotide-binding pocket as evidenced by kinetic analyses. Thus, Grp94 shows mechanistically important differences in the interaction with adenosine nucleotides, but the basic hydrolysis reaction seems to be conserved between cytosolic and endoplasmic members of the Hsp90 family.	Tech Univ Munich, Ctr Integrated Prot Sci, D-85747 Garching, Germany; Tech Univ Munich, Dept Chem, D-85747 Garching, Germany; Max Planck Inst Med Res, Dept Biomol Mech, D-69120 Heidelberg, Germany	Technical University of Munich; Technical University of Munich; Max Planck Society	Buchner, J (corresponding author), Lichtenbergstr 4, D-85747 Garching, Germany.	johannes.buchner@ch.tum.de	Buchner, Johannes/A-2651-2010	Buchner, Johannes/0000-0003-1282-7737				ALI JA, 1993, BIOCHEMISTRY-US, V32, P2717, DOI 10.1021/bi00061a033; Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; CALA SE, 1994, J BIOL CHEM, V269, P5926; CLAIRMONT CA, 1992, J BIOL CHEM, V267, P3983; CSERMELY P, 1995, J BIOL CHEM, V270, P6381, DOI 10.1074/jbc.270.11.6381; Descoteaux A, 2002, EMBO J, V21, P4458, DOI 10.1093/emboj/cdf447; Dollins DE, 2005, J BIOL CHEM, V280, P30438, DOI 10.1074/jbc.M503761200; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Gidalevitz T, 2004, J BIOL CHEM, V279, P16543, DOI 10.1074/jbc.M313060200; GUPTA RS, 1995, MOL BIOL EVOL, V12, P1063; GUTFREUND Y, 1995, J PHYSIOL-LONDON, V483, P621, DOI 10.1113/jphysiol.1995.sp020611; HUTCHISON KA, 1989, J BIOL CHEM, V264, P19898; HUTCHISON KA, 1990, BIOCHEMISTRY-US, V29, P5138, DOI 10.1021/bi00473a020; Immormino RM, 2004, J BIOL CHEM, V279, P46162, DOI 10.1074/jbc.M405253200; KANG HS, 1991, J BIOL CHEM, V266, P5643; KIM KS, 1990, DIFFERENTIATION, V42, P153, DOI 10.1111/j.1432-0436.1990.tb00756.x; LI ZH, 1993, EMBO J, V12, P3143, DOI 10.1002/j.1460-2075.1993.tb05983.x; McLaughlin SH, 2004, J MOL BIOL, V344, P813, DOI 10.1016/j.jmb.2004.09.055; McLaughlin SH, 2002, J MOL BIOL, V315, P787, DOI 10.1006/jmbi.2001.5245; MELNICK J, 1994, NATURE, V370, P373, DOI 10.1038/370373a0; Nieland TJF, 1996, P NATL ACAD SCI USA, V93, P6135, DOI 10.1073/pnas.93.12.6135; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; OBrien MC, 1996, J BIOL CHEM, V271, P15874, DOI 10.1074/jbc.271.27.15874; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Picard D, 2006, TRENDS ENDOCRIN MET, V17, P229, DOI 10.1016/j.tem.2006.06.003; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; Reed RC, 2002, J BIOL CHEM, V277, P25082, DOI 10.1074/jbc.M203195200; REINSTEIN J, 1990, BIOCHEMISTRY-US, V29, P7440, DOI 10.1021/bi00484a013; Richter K, 2006, J BIOL CHEM, V281, P11301, DOI 10.1074/jbc.M510142200; Richter K, 2002, J BIOL CHEM, V277, P44905, DOI 10.1074/jbc.M208457200; Richter K, 2001, J BIOL CHEM, V276, P33689, DOI 10.1074/jbc.M103832200; RICHTER K, 2005, PROTEIN FOLDING HDB, V2, P768; Riggs DL, 2004, CRIT REV BIOCHEM MOL, V39, P279, DOI 10.1080/10409230490892513; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; Rosser MFN, 2000, J BIOL CHEM, V275, P22798, DOI 10.1074/jbc.M001477200; Scheibel T, 1998, P NATL ACAD SCI USA, V95, P1495, DOI 10.1073/pnas.95.4.1495; SCHLEE S, 2005, PROTEIN FOLDING HDB, V2, P105; Schulte TW, 1999, MOL ENDOCRINOL, V13, P1435, DOI 10.1210/me.13.9.1435; Shiau AK, 2006, CELL, V127, P329, DOI 10.1016/j.cell.2006.09.027; SHIU RPC, 1977, P NATL ACAD SCI USA, V74, P3840, DOI 10.1073/pnas.74.9.3840; Soldano KL, 2003, J BIOL CHEM, V278, P48330, DOI 10.1074/jbc.M308661200; SORGER PK, 1987, J MOL BIOL, V194, P341, DOI 10.1016/0022-2836(87)90380-9; Srivastava P K, 1996, Semin Immunol, V8, P295, DOI 10.1006/smim.1996.0038; STANCATO LF, 1993, J BIOL CHEM, V268, P21711; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Theyssen H, 1996, J MOL BIOL, V263, P657, DOI 10.1006/jmbi.1996.0606; Thrall SH, 1996, BIOCHEMISTRY-US, V35, P4609, DOI 10.1021/bi9526387; Vogen S, 2002, J BIOL CHEM, V277, P40742, DOI 10.1074/jbc.M205323200; Wearsch PA, 1996, PROTEIN EXPRES PURIF, V7, P114, DOI 10.1006/prep.1996.0015; Wearsch PA, 1996, BIOCHEMISTRY-US, V35, P16760, DOI 10.1021/bi962068q; Wearsch PA, 1997, J BIOL CHEM, V272, P5152, DOI 10.1074/jbc.272.8.5152; Weikl T, 2000, J MOL BIOL, V303, P583, DOI 10.1006/jmbi.2000.4157	56	83	86	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35612	35620		10.1074/jbc.M704647200	http://dx.doi.org/10.1074/jbc.M704647200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17925398	hybrid			2022-12-25	WOS:000251458100021
J	Mene-Saffrane, L; Davoine, C; Stolz, S; Majcherczyk, P; Farmer, EE				Mene-Saffrane, Laurent; Davoine, Celine; Stolz, Stephanie; Majcherczyk, Paul; Farmer, Edward E.			Genetic removal of tri-unsaturated fatty acids suppresses - Developmental and molecular phenotypes of an Arabidopsis tocopherol-deficient mutant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATOGRAPHY-MASS-SPECTROMETRY; LIPID-PEROXIDATION; MALONDIALDEHYDE; EXPRESSION; DEFENSE; TEMPERATURE; LEAVES; ASSAY	Malondialdehyde (MDA) is a small, ubiquitous, and potentially toxic aldehyde that is produced in vivo by lipid oxidation and that is able to affect gene expression. Tocopherol deficiency in the vitamin E2 mutant vte2-1 of Arabidopsis thaliana leads to massive lipid oxidation and MDA accumulation shortly after germination. MDA accumulation correlates with a strong visual phenotype (growth reduction, cotyledon bleaching) and aberrant GST1 (glutathione (S) under bar-(t) under bar ransferase (1) under bar) expression. We suppressed MDA accumulation in the vte2-1 background by genetically removing tri-unsaturated fatty acids. The resulting quadruple mutant, fad3-2 fad7-2 fad8 vte2-1, did not display the visual phenotype or the aberrant GST1 expression observed in vte2-1. Moreover, cotyledon bleaching in vte2-1 was chemically phenocopied by treatment of wild-type plants with MDA. These data suggest that products of tri-unsaturated fatty acid oxidation underlie the vte2-1 seedling phenotype, including cellular toxicity and gene regulation properties. Generation of the quadruple mutant facilitated the development of an in situ fluorescence assay based on the formation of adducts of MDA with 2-thiobarbituric acid at 37 degrees C. Specificity was verified by measuring pentafluorophenylhydrazine derivatives of MDA and by liquid chromatography analysis of MDA-2-thiobarbituric acid adducts. Potentially applicable to other organisms, this method allowed the localization of MDA pools throughout the body of Arabidopsis and revealed an undiscovered pool of the compound unlikely to be derived from trienoic fatty acids in the vicinity of the root tip quiescent center.	Univ Lausanne, Dept Plant Mol Biol, CH-1015 Lausanne, Switzerland; Univ Lausanne, Dept Fundamental Microbiol, CH-1015 Lausanne, Switzerland	University of Lausanne; University of Lausanne	Farmer, EE (corresponding author), Univ Lausanne, Dept Plant Mol Biol, Batiment Biophore, CH-1015 Lausanne, Switzerland.	edward.farmer@unil.ch	Farmer, Edward E/H-1635-2011; Mène-Saffrané, Laurent/A-7440-2013	Mène-Saffrané, Laurent/0000-0002-1763-7871				Almeras E, 2003, PLANT J, V34, P202, DOI 10.1046/j.1365-313X.2003.01718.x; Alvarez ME, 1998, CELL, V92, P773, DOI 10.1016/S0092-8674(00)81405-1; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Falcone Deane L., 2004, BMC Plant Biology, V4, P17, DOI 10.1186/1471-2229-4-17; Farmer EE, 2007, CURR OPIN PLANT BIOL, V10, P380, DOI 10.1016/j.pbi.2007.04.019; Frankel E. N., 2005, OILY PRESS LIPID LIB, V18; HARWOOD JL, 1982, BIOCH PLANTS, V4, P1; JANERO DR, 1990, FREE RADICAL BIO MED, V9, P515, DOI 10.1016/0891-5849(90)90131-2; Jardine D, 2002, J AGR FOOD CHEM, V50, P1720, DOI 10.1021/jf011336a; Jiang K, 2003, DEVELOPMENT, V130, P1429, DOI 10.1242/dev.00359; Larkindale J, 2005, PLANT PHYSIOL, V138, P882, DOI 10.1104/pp.105.062257; Loeffler C, 2005, PLANT PHYSIOL, V137, P328, DOI 10.1104/pp.104.051714; Malkin R., 2000, BIOCH MOL BIOL PLANT, P568; McConn M, 1996, PLANT CELL, V8, P403, DOI 10.1105/tpc.8.3.403; MIQUEL M, 1992, J BIOL CHEM, V267, P1502; Muckenschnabel I, 2002, J EXP BOT, V53, P207, DOI 10.1093/jexbot/53.367.207; Mueller MJ, 2004, CURR OPIN PLANT BIOL, V7, P441, DOI 10.1016/j.pbi.2004.04.001; Sattler SE, 2006, PLANT CELL, V18, P3706, DOI 10.1105/tpc.106.044065; Sattler SE, 2004, PLANT CELL, V16, P1419, DOI 10.1105/tpc.021360; Scott IM, 2004, PLANT PHYSIOL, V135, P1040, DOI 10.1104/pp.104.041293; SINNHUBER RO, 1958, FOOD TECHNOL-CHICAGO, V12, P59; Vollenweider S, 2000, PLANT J, V24, P467, DOI 10.1046/j.1365-313x.2000.00897.x; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; Weber H, 2004, PLANT J, V37, P877, DOI 10.1111/j.1365-313X.2003.02013.x; WILBUR KM, 1949, ARCH BIOCHEM, V24, P305; YAGI K, 1976, BIOCHEM MED METAB B, V15, P212, DOI 10.1016/0006-2944(76)90049-1; Yeo HC, 1999, METHOD ENZYMOL, V300, P70	27	41	41	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35749	35756		10.1074/jbc.M706838200	http://dx.doi.org/10.1074/jbc.M706838200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17928299	hybrid			2022-12-25	WOS:000251458100036
J	Muller, H; Stitz, L; Wille, H; Prusiner, SB; Riesner, D				Mueller, Henrik; Stitz, Lothar; Wille, Holger; Prusiner, Stanley B.; Riesner, Detlev			Influence of water, fat, and glycerol on the mechanism of thermal prion inactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; SCRAPIE AGENT; MANUFACTURING PROCESS; RODS CONTAIN; PROTEIN; INFECTIVITY; RESISTANCE; DECONTAMINATION; STABILITY; SURVIVAL	Extending the recent analysis of the safety of industrial bovine fat-derived products for human consumption (Muller, H., Stitz, L., and Riesner, D. (2006) Eur. J. Lip. Sci. Technol. 108, 812 826), we investigated systematically the effects of fat, fatty acids, and glycerol on the heat destruction of prions. Prion destruction was qualitatively and quantitatively evaluated in PrP 27-30, or prion rods, by the inactivation of infectivity as well as by the degradation of the polypeptide backbone. Under all conditions analyzed, inactivation of prion infectivity was achieved more efficiently than backbone degradation by several orders of magnitude. The presence of fat enhanced prion inactivation and offers a mild treatment for prion decontamination. In contrast, the presence of fat, fatty acids, and especially glycerol protected the PrP 27-30 backbone against heat-induced degradation. Glycerol also protected against heat-induced inactivation of prion infectivity. A phase distribution analysis demonstrated that prions migrated to the interphase of a fat/water mixture at room temperature and accumulated in the water phase at higher temperatures. In a systematic study of the mechanism of prion destruction, we found an intermediate structure of PrP that has fewer fibrils in beta-sheet formation, lower resistance to protease digestion, greater aggregation, and reduced solubility compared with PrP 27-30 but retains residual infectivity. These findings suggest that prion infectivity depends on beta-sheet-rich fibrillar structure and that inactivation proceeds in a stepwise manner, which explains the tailing effect frequently observed during inactivation.	Univ Dusseldorf, Inst Phys Biol, D-40225 Dusseldorf, Germany; Bundesforschungsinst Tiergesundheit, Friedrich Loeffler Inst, D-72076 Tubingen, Germany; Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	Heinrich Heine University Dusseldorf; Friedrich Loeffler Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Riesner, D (corresponding author), Univ Dusseldorf, Inst Phys Biol, Gebaude 26-12-U1,Univ Str 1, D-40225 Dusseldorf, Germany.	riesner@biophys.uni-duesseldorf.de	Wille, Holger/C-2280-2008	Wille, Holger/0000-0001-5102-8706	NATIONAL INSTITUTE ON AGING [P01AG010770, P01AG002132] Funding Source: NIH RePORTER; NIA NIH HHS [AG10770, AG02132] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Appel TR, 2006, J GEN VIROL, V87, P1385, DOI 10.1099/vir.0.81426-0; Appel TR, 1999, BIOL CHEM, V380, P1295, DOI 10.1515/BC.1999.165; Appel TR, 2001, J GEN VIROL, V82, P465, DOI 10.1099/0022-1317-82-2-465; Bolton D C, 1991, Curr Top Microbiol Immunol, V172, P39; BROWN P, 1994, ANN NEUROL, V35, P513, DOI 10.1002/ana.410350504; BROWN P, 1990, J INFECT DIS, V161, P467, DOI 10.1093/infdis/161.3.467; Brown P, 2000, P NATL ACAD SCI USA, V97, P3418, DOI 10.1073/pnas.050566797; Cohen FE, 1999, J MOL BIOL, V293, P313, DOI 10.1006/jmbi.1999.2990; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; DICKINSO.AG, 1969, NATURE, V222, P892, DOI 10.1038/222892a0; DIMARTINO A, 1993, DEV BIOL STAND, V80, P187; Diringer H, 1997, INTERVIROLOGY, V40, P238, DOI 10.1159/000150553; Dumpitak C, 2005, BIOL CHEM, V386, P1149, DOI 10.1515/BC.2005.131; ERNST DR, 1993, J VIROL METHODS, V41, P193, DOI 10.1016/0166-0934(93)90126-C; Garcia AF, 2004, J GEN VIROL, V85, P261, DOI 10.1099/vir.0.19410-0; Golker CF, 1996, BIOLOGICALS, V24, P103; HJELMELAND LM, 1984, METHOD ENZYMOL, V104, P305; Hlodan R, 1991, Biotechnol Genet Eng Rev, V9, P47; Klein TR, 1998, BIOL CHEM, V379, P655, DOI 10.1515/bchm.1998.379.6.655; Krebs MRH, 2005, J STRUCT BIOL, V149, P30, DOI 10.1016/j.jsb.2004.08.002; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leffers KW, 2005, BIOL CHEM, V386, P569, DOI 10.1515/BC.2005.067; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; LeVine H, 1999, METHOD ENZYMOL, V309, P274; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; MCKINLEY MP, 1991, J VIROL, V65, P1340, DOI 10.1128/JVI.65.3.1340-1351.1991; MOULD DL, 1970, J COMP PATHOL, V80, P595, DOI 10.1016/0021-9975(70)90057-5; Muller H, 2006, EUR J LIPID SCI TECH, V108, P812, DOI 10.1002/ejlt.200600068; Muller H, 2005, EUR J LIPID SCI TECH, V107, P833, DOI 10.1002/ejlt.200501189; Oberthur RC, 2007, PRIONS IN HUMANS AND ANIMALS, P515; Peano S, 2000, INTENS CARE MED, V26, P608, DOI 10.1007/s001340051211; POCCHIARI M, 1991, DEV BIOLOGICALS, V75, P87; POCCHIARI M, 1991, HORM RES, V35, P161, DOI 10.1159/000181894; PRIOLA SA, 1995, J BIOL CHEM, V270, P3299, DOI 10.1074/jbc.270.7.3299; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; PRUSINER SB, 1999, PRION BIOL DIS; Riesner D, 2007, PRIONS IN HUMANS AND ANIMALS, P104; ROHWER RG, 1984, SCIENCE, V223, P600, DOI 10.1126/science.6420887; SAFAR J, 1993, PROTEIN SCI, V2, P2206, DOI 10.1002/pro.5560021220; SENDHAJI AF, 1977, J FOOD TECHNOL, V12, P203; SENDHAJI AF, 1977, J FOOD TECHNOL, V12, P216; Somerville RA, 2002, J BIOL CHEM, V277, P11084, DOI 10.1074/jbc.M111766200; Soto C, 2002, TRENDS NEUROSCI, V25, P390, DOI 10.1016/S0166-2236(02)02195-1; Spassov S, 2006, BBA-GEN SUBJECTS, V1760, P1138, DOI 10.1016/j.bbagen.2006.02.018; Taylor D M, 2004, Contrib Microbiol, V11, P136; TAYLOR DM, 1994, ARCH VIROL, V139, P313, DOI 10.1007/BF01310794; Taylor DM, 1999, J HOSP INFECT, V43, pS69, DOI 10.1016/S0195-6701(99)90067-1; Taylor DM, 1995, VET REC, V137, P605; Taylor DM, 1996, J GEN VIROL, V77, P811, DOI 10.1099/0022-1317-77-4-811; Taylor DM, 2000, VET J, V159, P10, DOI 10.1053/tvjl.1999.0406; Taylor DM, 1998, VET MICROBIOL, V64, P33, DOI 10.1016/S0378-1135(98)00257-0; TAYLOR DM, 1986, ANN NEUROL, V20, P749, DOI 10.1002/ana.410200621; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; WILESMITH JW, 1991, VET REC, V128, P199, DOI 10.1136/vr.128.9.199; Wille H, 1996, J MOL BIOL, V259, P608, DOI 10.1006/jmbi.1996.0343	56	16	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35855	35867		10.1074/jbc.M706883200	http://dx.doi.org/10.1074/jbc.M706883200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17878157	hybrid			2022-12-25	WOS:000251458100047
J	Nguyen, MTA; Favelyukis, S; Nguyen, AK; Reichart, D; Scott, PA; Jenn, A; Liu-Bryan, R; Glass, CK; Neels, JG; Olefsky, JM				Nguyen, M. T. Audrey; Favelyukis, Svetlana; Nguyen, Anh-Khoi; Reichart, Donna; Scott, Peter A.; Jenn, Alan; Liu-Bryan, Ru; Glass, Christopher K.; Neels, Jaap G.; Olefsky, Jerrold M.			A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via toll-like receptors 2 and 4 and JNK-dependent pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED INSULIN-RESISTANCE; DIET-INDUCED OBESITY; GENE-EXPRESSION; INFLAMMATION; TLR4; ACCUMULATION; RECEPTORS; MONOCYTES; MICE	Obesity and type 2 diabetes are characterized by decreased insulin sensitivity, elevated concentrations of free fatty acids (FFAs), and increased macrophage infiltration in adipose tissue ( AT). Here, we show that FFAs can cause activation of RAW264.7 cells primarily via the JNK signaling cascade and that TLR2 and TLR4 are upstream of JNK and help transduce FFA proinflammatory signals. We also demonstrate that F4/80(+/-) CD11b(+/-) CD11c(+/-) bone marrow-derived dendritic cells (BMDCs) have heightened proinflammatory activity compared with F4/80(+/-) CD11b(+) CD11c(+) bone marrow-derived macrophages and that the proinflammatory activity and JNK phosphorylation of BMDCs, but not bone marrow-derived macrophages, was further increased by FFA treatment. F4/80(+) CD11b(+) CD11c(+) cells were found in AT, and the proportion and number of these cells in AT is increased in ob/ob mice and by feeding wild type mice a high fat diet for 1 and 12 weeks. AT F4/80(+) CD11b(+) CD11c(+) cells express increased inflammatory markers compared with F4/80(+) CD11b(+) CD11c(-) cells, and FFA treatment increased inflammatory responses in these cells. In addition, we found that CD11c expression is increased in skeletal muscle of high fat diet-fed mice and that conditioned medium from FFA-treated wild type BMDCs, but not TLR2/4 DKO BMDCs, can induce insulin resistance in L6 myotubes. Together our results show that FFAs can activate CD11c(+) myeloid proinflammatory cells via TLR2/4 and JNK signaling pathways, thereby promoting inflammation and subsequent cellular insulin resistance.	Univ Calif San Diego, Div Endocrinol Metab, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Vet Affairs Med Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Nguyen, MTA (corresponding author), Univ Calif San Diego, Div Endocrinol Metab, 9500 Gilman Dr, La Jolla, CA 92093 USA.	m9nguyen@ucsd.edu	Glass, Christopher/AAI-3933-2021; Nguyen, Minh Tho/N-9582-2019; Scott, Peter/GYA-5335-2022; Neels, Jaap G/F-5534-2010	Glass, Christopher/0000-0003-4344-3592; Nguyen, Minh Tho/0000-0002-3803-0569; Neels, Jaap G/0000-0002-5900-8395; Jenn, Alan/0000-0003-4232-0697	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR049416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK033651, P01DK074868, R01DK033651] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR049416] Funding Source: Medline; NIDDK NIH HHS [DK33651, DK074868] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Boden G, 2002, CURR OPIN CLIN NUTR, V5, P545, DOI 10.1097/00075197-200209000-00014; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Boschmann M, 2005, HYPERTENSION, V46, P130, DOI 10.1161/01.HYP.0000171477.63859.b2; Bouloumie A, 2005, CURR OPIN CLIN NUTR, V8, P347, DOI 10.1097/01.mco.0000172571.41149.52; Brake DK, 2006, AM J PHYSIOL-CELL PH, V291, pC1232, DOI 10.1152/ajpcell.00008.2006; Bruun JM, 2006, AM J PHYSIOL-ENDOC M, V290, pE961, DOI 10.1152/ajpendo.00506.2005; Cancello R, 2005, DIABETES, V54, P2277, DOI 10.2337/diabetes.54.8.2277; Curat CA, 2006, DIABETOLOGIA, V49, P744, DOI 10.1007/s00125-006-0173-z; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; Daynes RA, 2002, NAT REV IMMUNOL, V2, P748, DOI 10.1038/nri912; Delerive P, 2001, J ENDOCRINOL, V169, P453, DOI 10.1677/joe.0.1690453; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Ghanim H, 2004, CIRCULATION, V110, P1564, DOI 10.1161/01.CIR.0000142055.53122.FA; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hoshino K, 1999, J IMMUNOL, V162, P3749; Kolb H, 2005, DIABETOLOGIA, V48, P1038, DOI 10.1007/s00125-005-1764-9; Kraegen EW, 2001, EXP CLIN ENDOCR DIAB, V109, pS189, DOI 10.1055/s-2001-18581; Lai L, 1998, J IMMUNOL, V160, P3861; Lee JY, 2004, J BIOL CHEM, V279, P16971, DOI 10.1074/jbc.M312990200; Lesniewski LA, 2007, NAT MED, V13, P455, DOI 10.1038/nm1550; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Mohanty P, 2004, J CLIN ENDOCR METAB, V89, P2728, DOI 10.1210/jc.2003-032103; Nguyen MTA, 2005, J BIOL CHEM, V280, P35361, DOI 10.1074/jbc.M504611200; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; SPECTOR AA, 1969, J LIPID RES, V10, P56; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Tripathy D, 2003, DIABETES, V52, P2882, DOI 10.2337/diabetes.52.12.2882; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620	37	733	759	0	51	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35279	35292		10.1074/jbc.M706762200	http://dx.doi.org/10.1074/jbc.M706762200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17916553	hybrid			2022-12-25	WOS:000251155200072
J	Pruliere-Escabasse, V; Planes, C; Escudier, E; Fanen, P; Coste, A; Clerici, C				Pruliere-Escabasse, Virginie; Planes, Carole; Escudier, Estelle; Fanen, Pascale; Coste, Andre; Clerici, Christine			Modulation of epithelial sodium channel trafficking and function by sodium 4-phenylbutyrate in human nasal epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; SURFACE EXPRESSION; APICAL MEMBRANE; CFTR EXPRESSION; REGULATES ENAC; NA+ ABSORPTION; PROTEIN; DEGRADATION; TRANSPORT; SUBUNITS	Sodium 4-phenylbutyrate (4-PBA) has been shown to correct the cellular trafficking of several mutant or nonmutant plasma membrane proteins such as cystic fibrosis transmembrane conductance regulator through the expression of 70-kDa heat shock proteins. The objective of the study was to determine whether 4-PBA may influence the functional expression of epithelial sodium channels (ENaC) in human nasal epithelial cells (HNEC). Using primary cultures of HNEC, we demonstrate that 4-PBA (5 mM for 6 h) markedly stimulated amiloridesensitive sodium channel activity and that this was related to an increased abundance of alpha-,beta-, and gamma- ENaC subunits in the apical membrane. The increase in ENaC cell surface expression (i) was due to insertion of newly ENaC subunits as determined by brefeldin A experiments and (ii) was not associated with cell surface retention of ENaC subunits because endocytosis of ENaC subunits was unchanged. In addition, we find that ENaC co-immunoprecipitated with the heat shock protein constituvely expressed Hsc70, that has been reported to modulate ENaC trafficking, and that 4-PBA decreased Hsc70 protein level. Finally, we report that in cystic fibrosis HNEC obtained from two cystic fibrosis patients, 4-PBA increased functional expression of ENaC as demonstrated by the increase in amiloride-sensitive sodium transport and in alpha-, beta-, and gamma- ENaC subunit expression in the apical membrane. Our results suggest that in HNEC, 4-PBA increases the functional expression of ENaC through the insertion of new alpha-, beta-, and gamma- ENaC subunits into the apical membrane and also suggest that 4-PBA could modify ENaC trafficking by reducing Hsc70 protein expression.	Hop Henri Mondor & Intercommunal, AP HP, Serv Otorhinolaryngol & Chirurg Cervicofaciale, F-94010 Creteil, France; INSERM, U 841, F-94000 Creteil, France; Univ Paris 12, F-94000 Creteil, France; Univ Versailles, F-78000 St Quentin en Yvelines, France; Hop Ambroise Pare, AP HP, Serv Physiol, F-92220 Boulogne, France; Univ Paris 07, INSERM, U 773, F-75018 Paris, France; Univ Paris 07, F-75013 Paris, France; Hop Bichat Claude Bernard, AP HP, Serv Physiol, F-75018 Paris, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Pruliere-Escabasse, V (corresponding author), Hop Henri Mondor & Intercommunal, AP HP, Serv Otorhinolaryngol & Chirurg Cervicofaciale, 51 Ave Marechal Lattre Tassigny, F-94010 Creteil, France.	virginie.pruliere@creteil.inserm.fr	Escabasse, virginie VPE Pruliere/R-1949-2018	Escabasse, virginie VPE Pruliere/0000-0003-0208-7544; Fanen, Pascale/0000-0002-3273-5349; planes, carole/0000-0003-2286-366X; COSTE, Andre/0000-0002-8386-3455				Bercovich B, 1997, J BIOL CHEM, V272, P9002; Brouard M, 1999, J CELL SCI, V112, P3343; Brown CR, 1997, J BIOENERG BIOMEMBR, V29, P491, DOI 10.1023/A:1022491124939; Butterworth MB, 2005, J GEN PHYSIOL, V125, P81, DOI 10.1085/jgp.2004.09124; CHIANG HL, 1989, SCIENCE, V246, P382, DOI 10.1126/science.2799391; Choo-Kang LR, 2001, AM J PHYSIOL-LUNG C, V281, pL58, DOI 10.1152/ajplung.2001.281.1.L58; de la Rosa DA, 2002, J GEN PHYSIOL, V119, P427, DOI 10.1085/jgp.20028559; DUC C, 1994, J CELL BIOL, V127, P1907, DOI 10.1083/jcb.127.6.1907; Ergonul Z, 2006, AM J PHYSIOL-RENAL, V291, pF683, DOI 10.1152/ajprenal.00422.2005; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Goldfarb SB, 2006, P NATL ACAD SCI USA, V103, P5817, DOI 10.1073/pnas.0507903103; Gonin S, 2001, MOL BIOL CELL, V12, P255, DOI 10.1091/mbc.12.2.255; Hanwell D, 2002, J BIOL CHEM, V277, P9772, DOI 10.1074/jbc.M110904200; Huang Pingbo, 2004, Proc Am Thorac Soc, V1, P33, DOI 10.1513/pats.2306012; Iordache C, 2007, EXP CELL RES, V313, P305, DOI 10.1016/j.yexcr.2006.10.012; KNOWLES MR, 1995, AM J RESP CRIT CARE, V151, pS65, DOI 10.1164/ajrccm/151.3_Pt_2.S65; Lim M, 2004, AM J RESP CELL MOL, V31, P351, DOI 10.1165/rcmb.2002-0086OC; Ling BN, 1997, J BIOL CHEM, V272, P594; Loffing J, 1999, AM J PHYSIOL-LUNG C, V277, pL700, DOI 10.1152/ajplung.1999.277.4.L700; LOW SH, 1992, J CELL BIOL, V118, P51, DOI 10.1083/jcb.118.1.51; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; MILLER SG, 1992, J CELL BIOL, V118, P267, DOI 10.1083/jcb.118.2.267; Moyer BD, 1999, AM J PHYSIOL-RENAL, V277, pF271, DOI 10.1152/ajprenal.1999.277.2.F271; Myerburg MM, 2006, J BIOL CHEM, V281, P27942, DOI 10.1074/jbc.M606449200; Nagel G, 2005, J PHYSIOL-LONDON, V564, P671, DOI 10.1113/jphysiol.2004.079046; Planes C, 2005, AM J PHYSIOL-LUNG C, V288, pL1099, DOI 10.1152/ajplung.00332.2004; Planes C, 2002, J BIOL CHEM, V277, P47318, DOI 10.1074/jbc.M209158200; Pruliere-Escabasse V, 2005, AM J PHYSIOL-LUNG C, V288, pL77, DOI 10.1152/ajplung.00048.2004; Riordan M, 2005, AM J PHYSIOL-RENAL, V288, pF1236, DOI 10.1152/ajprenal.00438.2004; Rochat T, 2004, J CELL PHYSIOL, V201, P106, DOI 10.1002/jcp.20066; Rubenstein RC, 2000, AM J PHYSIOL-CELL PH, V278, pC259, DOI 10.1152/ajpcell.2000.278.2.C259; Rubenstein RC, 2001, AM J PHYSIOL-LUNG C, V281, pL43, DOI 10.1152/ajplung.2001.281.1.L43; Rubenstein RC, 1997, J CLIN INVEST, V100, P2457, DOI 10.1172/JCI119788; Shimkets RA, 1997, J BIOL CHEM, V272, P25537, DOI 10.1074/jbc.272.41.25537; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; Snyder PM, 2004, J BIOL CHEM, V279, P5042, DOI 10.1074/jbc.M312477200; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; STUTTS MJ, 1995, SCIENCE, V269, P847, DOI 10.1126/science.7543698; Wade PA, 2001, HUM MOL GENET, V10, P693, DOI 10.1093/hmg/10.7.693; Weisz OA, 2000, J BIOL CHEM, V275, P39886, DOI 10.1074/jbc.M003822200; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	42	24	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34048	34057		10.1074/jbc.M702384200	http://dx.doi.org/10.1074/jbc.M702384200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17890229	hybrid			2022-12-25	WOS:000251145700019
J	Bochman, ML; Schwacha, A				Bochman, Matthew L.; Schwacha, Anthony			Differences in the single-stranded DNA binding activities of mcm2-7 and mcm467 - mcm2 and mcm5 define a slow atp-dependent step	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MINICHROMOSOME MAINTENANCE PROTEIN; REPRESSOR-OPERATOR INTERACTION; HELICASE ACTIVITY; REPLICATION ORIGINS; ARCHAEAL MCM; MCM4/6/7 HELICASE; CONSERVED MOTIFS; FISSION YEAST; COMPLEX; THERMOAUTOTROPHICUM	The MCM2-7 complex, a hexamer containing six distinct and essential subunits, is postulated to be the eukaryotic replicative DNA helicase. Although all six subunits function at the replication fork, only a specific subcomplex consisting of the MCM4, 6, and 7 subunits (MCM467) and not the MCM2-7 complex exhibits DNA helicase activity in vitro. To understand why MCM2-7 lacks helicase activity and to address the possible function of the MCM2, 3, and 5 subunits, we have compared the biochemical properties of the Saccharomyces cerevisiae MCM2-7 and MCM467 complexes. We demonstrate that both complexes are toroidal and possess a similar ATP-dependent single-stranded DNA (ssDNA) binding activity, indicating that the lack of helicase activity by MCM2-7 is not due to ineffective ssDNA binding. We identify two important differences between them. MCM467 binds dsDNA better than MCM2-7. In addition, we find that the rate of MCM2-7/ssDNA association is slow compared with MCM467; the association rate can be dramatically increased either by preincubation with ATP or by inclusion of mutations that ablate the MCM2/5 active site. We propose that the DNA binding differences between MCM2-7 and MCM467 correspond to a conformational change at the MCM2/5 active site with putative regulatory significance.	Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Schwacha, A (corresponding author), 4249 5th Ave,560 Crawford Hall, Pittsburgh, PA 15260 USA.	schwacha@pitt.edu	Bochman, Matthew L./I-2033-2019	Bochman, Matthew L./0000-0002-2807-0452				Adachi Y, 1997, GENES CELLS, V2, P467, DOI 10.1046/j.1365-2443.1997.1350333.x; Aladjem MI, 1998, SCIENCE, V281, P1005, DOI 10.1126/science.281.5379.1005; Aparicio T, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-18; Arlt MF, 2003, CYTOGENET GENOME RES, V100, P92, DOI 10.1159/000072843; Barry ER, 2007, NUCLEIC ACIDS RES, V35, P988, DOI 10.1093/nar/gkl1117; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Boulikas T, 1996, J CELL BIOCHEM, V60, P297, DOI 10.1002/(SICI)1097-4644(19960301)60:3<297::AID-JCB2>3.0.CO;2-R; Cha RS, 2002, SCIENCE, V297, P602, DOI 10.1126/science.1071398; Chen YJ, 2005, J MOL BIOL, V346, P389, DOI 10.1016/j.jmb.2004.11.076; Chong JPJ, 2000, P NATL ACAD SCI USA, V97, P1530, DOI 10.1073/pnas.030539597; Claycomb JM, 2002, J CELL BIOL, V159, P225, DOI 10.1083/jcb.200207046; Costa A, 2006, J STRUCT BIOL, V156, P210, DOI 10.1016/j.jsb.2006.04.001; Coue M, 1998, EXP CELL RES, V245, P282, DOI 10.1006/excr.1998.4271; Dai JL, 2005, P NATL ACAD SCI USA, V102, P337, DOI 10.1073/pnas.0408811102; Davey MJ, 2003, CURR BIOL, V13, pR594, DOI 10.1016/S0960-9822(03)00523-2; Davey MJ, 2003, J BIOL CHEM, V278, P4491, DOI 10.1074/jbc.M210511200; Edwards MC, 2002, J BIOL CHEM, V277, P33049, DOI 10.1074/jbc.M204438200; Fletcher RJ, 2005, J BIOL CHEM, V280, P42405, DOI 10.1074/jbc.M509773200; Fletcher RJ, 2003, NAT STRUCT BIOL, V10, P160, DOI 10.1038/nsb893; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; GARRETT NE, 1975, J BIOL CHEM, V250, P6640; Gomez EB, 2002, GENETICS, V160, P1305; HACKNEY DD, 1988, P NATL ACAD SCI USA, V85, P6314, DOI 10.1073/pnas.85.17.6314; Hardy CFJ, 1997, P NATL ACAD SCI USA, V94, P3151, DOI 10.1073/pnas.94.7.3151; Ishimi Y, 1996, J BIOL CHEM, V271, P24115, DOI 10.1074/jbc.271.39.24115; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Jenkinson ER, 2006, P NATL ACAD SCI USA, V103, P7613, DOI 10.1073/pnas.0509297103; Kaplan DL, 2004, MOL CELL, V15, P453, DOI 10.1016/j.molcel.2004.06.039; Kaplan DL, 2003, J BIOL CHEM, V278, P49171, DOI 10.1074/jbc.M308074200; Kawasaki Y, 2001, MOL CELLS, V12, P277; Kelman Z, 1999, P NATL ACAD SCI USA, V96, P14783, DOI 10.1073/pnas.96.26.14783; KOONIN EV, 1993, NUCLEIC ACIDS RES, V21, P2541, DOI 10.1093/nar/21.11.2541; Laskey RA, 2003, EMBO REP, V4, P26, DOI 10.1038/sj.embor.embor706; Lee JK, 2001, P NATL ACAD SCI USA, V98, P54, DOI 10.1073/pnas.98.1.54; Lei M, 1997, GENE DEV, V11, P3365, DOI 10.1101/gad.11.24.3365; Masai H, 2000, BIOCHEM BIOPH RES CO, V275, P228, DOI 10.1006/bbrc.2000.3281; MCMACKEN R, 1987, ESCHERICHIA COLI SAL, P564; Messer W, 2002, FEMS MICROBIOL REV, V26, P355, DOI 10.1016/S0168-6445(02)00127-4; Myllykallio H, 2000, TRENDS MICROBIOL, V8, P537, DOI 10.1016/S0966-842X(00)01881-3; Okuno Y, 1999, MOL CELL BIOL, V19, P6699; Pape T, 2003, EMBO REP, V4, P1079, DOI 10.1038/sj.embor.7400010; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Picha KM, 2000, BIOCHEMISTRY-US, V39, P6401, DOI 10.1021/bi992857i; Pucci B, 2004, J BIOL CHEM, V279, P49222, DOI 10.1074/jbc.M408967200; RIGGS AD, 1970, J MOL BIOL, V53, P401, DOI 10.1016/0022-2836(70)90074-4; SAENGER W, 1984, PRINCIPLES NUCLEIC A, P310; Sato M, 2000, J MOL BIOL, V300, P421, DOI 10.1006/jmbi.2000.3865; Schwacha A, 2001, MOL CELL, V8, P1093, DOI 10.1016/S1097-2765(01)00389-6; Shechter DF, 2000, J BIOL CHEM, V275, P15049, DOI 10.1074/jbc.M000398200; Shin JH, 2006, J BIOL CHEM, V281, P26914, DOI 10.1074/jbc.M605518200; Shin JH, 2003, J BIOL CHEM, V278, P49053, DOI 10.1074/jbc.M308599200; Spradling AC, 1999, GENE DEV, V13, P2619, DOI 10.1101/gad.13.20.2619; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; WINTER RB, 1981, BIOCHEMISTRY-US, V20, P6961, DOI 10.1021/bi00527a030; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; Yabuta N, 2003, GENES CELLS, V8, P413, DOI 10.1046/j.1365-2443.2003.00645.x; Ying CY, 2005, EMBO J, V24, P4334, DOI 10.1038/sj.emboj.7600892; You Z, 2005, NUCLEIC ACIDS RES, V33, P3033, DOI 10.1093/nar/gki607; You ZY, 2003, EMBO J, V22, P6148, DOI 10.1093/emboj/cdg576; You ZY, 1999, MOL CELL BIOL, V19, P8003	61	60	60	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33795	33804		10.1074/jbc.M703824200	http://dx.doi.org/10.1074/jbc.M703824200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17895243	hybrid			2022-12-25	WOS:000250840200062
J	Cohen, TJ; Waddell, DS; Barrientos, T; Lu, Z; Feng, G; Cox, GA; Bodine, SC; Yao, TP				Cohen, Todd J.; Waddell, David S.; Barrientos, Tomasa; Lu, Zhonghua; Feng, Guoping; Cox, Gregory A.; Bodine, Sue C.; Yao, Tso-Pang			The histone deacetylase HDAC4 connects neural activity to muscle transcriptional reprogramming	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBUNIT MESSENGER-RNA; CAM KINASE-II; SKELETAL-MUSCLE; INTRACELLULAR TRAFFICKING; GENE-EXPRESSION; IN-VIVO; IDENTIFICATION; MYOTUBES; MYOGENIN; CALCIUM	Neural activity actively regulates muscle gene expression. This regulation is crucial for specifying muscle functionality and synaptic protein expression. How neural activity is relayed into nuclei and connected to the muscle transcriptional machinery, however, is not known. Here we identify the histone deacetylase HDAC4 as the critical linker connecting neural activity to muscle transcription. We found that HDAC4 is normally concentrated at the neuromuscular junction (NMJ), where nerve innervates muscle. Remarkably, reduced neural input by surgical denervation or neuromuscular diseases dissociates HDAC4 from the NMJ and dramatically induces its expression, leading to robust HDAC4 nuclear accumulation. We present evidence that nuclear accumulated HDAC4 is responsible for the coordinated induction of synaptic genes upon denervation. Inactivation of HDAC4 prevents denervation-induced synaptic acetylcholine receptor ( nAChR) and MUSK transcription whereas forced expression of HDAC4 mimics denervation and activates ectopic nAChR transcription throughout myofibers. We determined that HDAC4 executes activity-dependent transcription by regulating the Dach2-myogenin transcriptional cascade where inhibition of the repressor Dach2 by HDAC4 permits the induction of the transcription factor myogenin, which in turn activates synaptic gene expression. Our findings establish HDAC4 as a neural activity-regulated deacetylase and a key signaling component that relays neural activity to the muscle transcriptional machinery.	Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Duke Univ, Dept Neurobiol, Durham, NC 27710 USA; Univ Calif Davis, Sect Neurobiol Physiol & Behav, Davis, CA 95616 USA; Jackson Lab, Bar Harbor, ME 04609 USA	Duke University; Duke University; University of California System; University of California Davis; Jackson Laboratory	Yao, TP (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Box 3813, Durham, NC 27710 USA.	yao00001@mc.duke.edu	Waddell, David/AAG-3774-2020; Feng, Guoping/Y-2827-2019; Waddell, David/J-7435-2015	Waddell, David/0000-0001-6749-4461; Waddell, David/0000-0001-6749-4461; Bodine, Sue/0000-0002-5742-9145				Adams L, 1998, J NEUROBIOL, V35, P245, DOI 10.1002/(SICI)1097-4695(19980605)35:3<245::AID-NEU2>3.0.CO;2-Z; Backs J, 2006, J CLIN INVEST, V116, P1853, DOI 10.1172/JCI27438; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; BESSEREAU JL, 1994, P NATL ACAD SCI USA, V91, P1304, DOI 10.1073/pnas.91.4.1304; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bolger TA, 2005, J NEUROSCI, V25, P9544, DOI 10.1523/JNEUROSCI.1826-05.2005; Cox GA, 1998, NEURON, V21, P1327, DOI 10.1016/S0896-6273(00)80652-2; Czubryt MP, 2003, P NATL ACAD SCI USA, V100, P1711, DOI 10.1073/pnas.0337639100; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Garvey SM, 2006, HUM MOL GENET, V15, P2348, DOI 10.1093/hmg/ddl160; HUANG CF, 1994, FEBS LETT, V338, P277, DOI 10.1016/0014-5793(94)80283-1; KLARSFELD A, 1985, P NATL ACAD SCI USA, V82, P4558, DOI 10.1073/pnas.82.13.4558; Macpherson PCD, 2006, MOL CELL NEUROSCI, V31, P649, DOI 10.1016/j.mcn.2005.12.005; Maddatu TP, 2004, HUM MOL GENET, V13, P1105, DOI 10.1093/hmg/ddh129; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Mejat A, 2005, NAT NEUROSCI, V8, P313, DOI 10.1038/nn1408; MERLIE JP, 1994, J BIOL CHEM, V269, P2461; NEVILLE C, 1991, NEUROREPORT, V2, P655, DOI 10.1097/00001756-199111000-00005; Ryu H, 2005, J NEUROCHEM, V93, P1087, DOI 10.1111/j.1471-4159.2005.03077.x; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Tang HB, 2006, P NATL ACAD SCI USA, V103, P16977, DOI 10.1073/pnas.0601565103; Zhao X, 2001, J BIOL CHEM, V276, P35042, DOI 10.1074/jbc.M105086200	22	139	154	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33752	33759		10.1074/jbc.M706268200	http://dx.doi.org/10.1074/jbc.M706268200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17873280	hybrid			2022-12-25	WOS:000250840200057
J	Gillespie, RF; Gudas, LJ				Gillespie, Robert F.; Gudas, Lorraine J.			Retinoic acid receptor isotype specificity in F9 teratocarcinoma stem cells results from the differential recruitment of coregulators to retinoic acid response elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONAL CARCINOMA-CELLS; UNION-OF-PHARMACOLOGY; GROUP PROTEIN SUZ12; NUCLEAR RECEPTORS; TARGET GENES; X-RECEPTOR; DEVELOPMENTAL REGULATORS; SIGNALING PATHWAY; HISTONE H3; RAR-ALPHA	The retinoic acid receptor (RAR) alpha, beta(2), and gamma isotypes each regulate specific subsets of target genes in F9 teratocarcinoma stem cells. We used chromatin immunoprecipitation assays to monitor the association of RAR gamma, retinoic X receptor (RXR) alpha, and coregulators with the RAR beta(2), Hoxa1, and Cyp26A1 retinoic acid response elements (RAREs) in F9 wild type and RAR alpha, -beta(2), and -gamma null cells. Additionally we quantitatively monitored expression of the corresponding mRNAs. We demonstrated that the association of RAR gamma and/ or RXR alpha with a RARE was not sufficient for retinoic acid (RA)-mediated transcription of the corresponding target gene. However, the ability of RAR alpha and/ or RXR alpha to recruit pCIP (AIB1/ACTR/RAC-3/TRAM-1/SRC-3) and p300 to a RARE did correlate with RA-associated transcription of target mRNAs. Therefore, the specific functions of the RAR isotypes do not manifest at the level of their DNA binding but rather from a differential ability to recruit specific components of the transcriptional machinery. We also demonstrated that RA-mediated displacement of the polycomb group protein SUZ12 from a RARE was inhibited in the absence of RAR gamma. Thus, transcriptional components of the RAR signaling pathway are specifically required for displacement of SUZ12 from RAREs during RA-mediated differentiation of F9 cells.	Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Program Mol Biol, New York, NY 10021 USA	Cornell University; Cornell University	Gudas, LJ (corresponding author), Cornell Univ, Weill Med Coll, Dept Pharmacol, 1300 York Ave,Rm E-409, New York, NY 10021 USA.	ljgudas@med.cornell.edu			NCI NIH HHS [R01CA043796] Funding Source: Medline; NIDDK NIH HHS [R01DK454560] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA043796] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abu-Abed SS, 1998, J BIOL CHEM, V273, P2409, DOI 10.1074/jbc.273.4.2409; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; BOYLAN JF, 1995, MOL CELL BIOL, V15, P843; BOYLAN JF, 1993, P NATL ACAD SCI USA, V90, P9601, DOI 10.1073/pnas.90.20.9601; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chambon P, 2005, MOL ENDOCRINOL, V19, P1418, DOI 10.1210/me.2005-0125; Chiba H, 1997, MOL CELL BIOL, V17, P3013, DOI 10.1128/MCB.17.6.3013; Chiba H, 1997, J CELL BIOL, V139, P735, DOI 10.1083/jcb.139.3.735; Clifford J, 1996, EMBO J, V15, P4142, DOI 10.1002/j.1460-2075.1996.tb00789.x; Dahlman-Wright K, 2006, PHARMACOL REV, V58, P773, DOI 10.1124/pr.58.4.8; DAMJANOV I, 1975, TERATOMAS DIFFERENTI, P209; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; DETHE H, 1989, EMBO J, V8, P429, DOI 10.1002/j.1460-2075.1989.tb03394.x; Dilworth FJ, 2000, MOL CELL, V6, P1049, DOI 10.1016/S1097-2765(00)00103-9; Dilworth FJ, 2001, ONCOGENE, V20, P3047, DOI 10.1038/sj.onc.1204329; Epping MT, 2005, CELL, V122, P835, DOI 10.1016/j.cell.2005.07.003; Espinosa JM, 2003, MOL CELL, V12, P1015, DOI 10.1016/S1097-2765(03)00359-9; Farboud B, 2003, MOL CELL BIOL, V23, P2844, DOI 10.1128/MCB.23.8.2844-2858.2003; Faria TN, 1999, J BIOL CHEM, V274, P26783, DOI 10.1074/jbc.274.38.26783; Germain P, 2006, PHARMACOL REV, V58, P712, DOI 10.1124/pr.58.4.4; Germain P, 2006, PHARMACOL REV, V58, P760, DOI 10.1124/pr.58.4.7; Gillespie RF, 2007, J MOL BIOL, V372, P298, DOI 10.1016/j.jmb.2007.06.079; Glass CK, 2000, GENE DEV, V14, P121; Goyette P, 2000, J BIOL CHEM, V275, P16497, DOI 10.1074/jbc.M909382199; Guenther MG, 2000, GENE DEV, V14, P1048; Hartman HB, 2005, EMBO REP, V6, P445, DOI 10.1038/sj.embor.7400391; Hauksdottir H, 2003, MOL ENDOCRINOL, V17, P373, DOI 10.1210/me.2002-0340; HU L, 1990, MOL CELL BIOL, V10, P391, DOI 10.1128/MCB.10.1.391; Hummasti S, 2006, MOL ENDOCRINOL, V20, P1261, DOI 10.1210/me.2006-0025; Kawasaki H, 1998, NATURE, V393, P284, DOI 10.1038/30538; LANGSTON AW, 1992, MECH DEVELOP, V38, P217, DOI 10.1016/0925-4773(92)90055-O; LAROSA GJ, 1988, P NATL ACAD SCI USA, V85, P329, DOI 10.1073/pnas.85.2.329; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lefebvre B, 2002, MOL CELL BIOL, V22, P1446, DOI 10.1128/MCB.22.5.1446-1459.2002; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Loudig O, 2005, BIOCHEM J, V392, P241, DOI 10.1042/BJ20050874; Loudig O, 2000, MOL ENDOCRINOL, V14, P1483, DOI 10.1210/me.14.9.1483; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; MEANS AL, 1995, ANNU REV BIOCHEM, V64, P201, DOI 10.1146/annurev.bi.64.070195.001221; Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; Olefsky JM, 2001, J BIOL CHEM, V276, P36863, DOI 10.1074/jbc.R100047200; Palancade B, 2003, EUR J BIOCHEM, V270, P3859, DOI 10.1046/j.1432-1033.2003.03794.x; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Pavri R, 2005, MOL CELL, V18, P83, DOI 10.1016/j.molcel.2005.02.034; Pirrotta V, 1998, CELL, V93, P333, DOI 10.1016/S0092-8674(00)81162-9; Rochette-Egly C, 2005, J BIOL CHEM, V280, P32565, DOI 10.1074/jbc.R500008200; Routledge EJ, 2000, J BIOL CHEM, V275, P35986, DOI 10.1074/jbc.M006777200; ROY DY, 1995, MOL CELL BIOL, V15, P6481; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; TANEJA R, 1995, P NATL ACAD SCI USA, V92, P7854, DOI 10.1073/pnas.92.17.7854; Taneja R, 1996, P NATL ACAD SCI USA, V93, P6197, DOI 10.1073/pnas.93.12.6197; Wong CW, 1998, MOL CELL BIOL, V18, P5724, DOI 10.1128/MCB.18.10.5724; Zhuang Y, 2003, MOL CANCER RES, V1, P619	58	58	59	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33421	33434		10.1074/jbc.M704845200	http://dx.doi.org/10.1074/jbc.M704845200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17875646	hybrid			2022-12-25	WOS:000250840200022
J	Makareeva, E; Leikin, S				Makareeva, Elena; Leikin, Sergey			Procollagen Triple Helix Assembly: An Unconventional Chaperone-Assisted Folding Paradigm	PLOS ONE			English	Article								Fibers composed of type I collagen triple helices form the organic scaffold of bone and many other tissues, yet the energetically preferred conformation of type I collagen at body temperature is a random coil. In fibers, the triple helix is stabilized by neighbors, but how does it fold? The observations reported here reveal surprising features that may represent a new paradigm for folding of marginally stable proteins. We find that human procollagen triple helix spontaneously folds into its native conformation at 30-34 degrees C but not at higher temperatures, even in an environment emulating Endoplasmic Reticulum (ER). ER-like molecular crowding by nonspecific proteins does not affect triple helix folding or aggregation of unfolded chains. Common ER chaperones may prevent aggregation and misfolding of procollagen C-propeptide in their traditional role of binding unfolded polypeptide chains. However, such binding only further destabilizes the triple helix. We argue that folding of the triple helix requires stabilization by preferential binding of chaperones to its folded, native conformation. Based on the triple helix folding temperature measured here and published binding constants, we deduce that HSP47 is likely to do just that. It takes over 20 HSP47 molecules to stabilize a single triple helix at body temperature. The required 50-200 mu M concentration of free HSP47 is not unusual for heat-shock chaperones in ER, but it is 100 times higher than used in reported in vitro experiments, which did not reveal such stabilization.	[Makareeva, Elena; Leikin, Sergey] NICHHD, Sect Phys Biochem, Dept Hlth & Human Serv, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Leikin, S (corresponding author), NICHHD, Sect Phys Biochem, Dept Hlth & Human Serv, NIH, Bethesda, MD 20892 USA.	leikins@mail.nih.gov	Makareeva, Elena/F-5183-2011; Leikin, Sergey/A-5518-2008	Makareeva, Elena/0000-0002-5815-0760; Leikin, Sergey/0000-0001-7095-0739	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000256] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000256] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BACHINGER HP, 1987, J BIOL CHEM, V262, P17144; Barnes AM, 2006, NEW ENGL J MED, V355, P2757, DOI 10.1056/NEJMoa063804; Beck K, 1996, J BIOL CHEM, V271, P21566, DOI 10.1074/jbc.271.35.21566; Bonfanti L, 1998, CELL, V95, P993, DOI 10.1016/S0092-8674(00)81723-7; Brooks DA, 1999, SEMIN CELL DEV BIOL, V10, P441, DOI 10.1006/scdb.1999.0314; BRUCKNER P, 1984, EUR J BIOCHEM, V140, P397, DOI 10.1111/j.1432-1033.1984.tb08115.x; BRUCKNER P, 1981, ANAL BIOCHEM, V110, P360, DOI 10.1016/0003-2697(81)90204-9; BRUCKNER P, 1984, EUR J BIOCHEM, V140, P391, DOI 10.1111/j.1432-1033.1984.tb08114.x; Byers PH, 2001, PHILOS T ROY SOC B, V356, P151, DOI 10.1098/rstb.2000.0760; Cabral WA, 2005, J BIOL CHEM, V280, P19259, DOI 10.1074/jbc.M414698200; Cabral WA, 2003, J BIOL CHEM, V278, P10006, DOI 10.1074/jbc.M212523200; CABRAL WA, 2007, HUM MUTAT; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; DAVIS JM, 1989, J BIOL CHEM, V264, P8956; DOLZ R, 1990, STRUCTURE MOL BIOL P; Du F, 2006, J MOL BIOL, V364, P469, DOI 10.1016/j.jmb.2006.09.018; Ellis RJ, 2006, BIOL CHEM, V387, P485, DOI 10.1515/BC.2006.064; Emerson RO, 2006, J CELL BIOCHEM, V98, P701, DOI 10.1002/jcb.20867; FESSLER L I, 1974, Journal of Supramolecular Structure, V2, P103, DOI 10.1002/jss.400020205; FIEDLERNAGY C, 1982, J BIOL CHEM, V257, P9181; FIEDLERNAGY C, 1981, ARCH BIOCHEM BIOPHYS, V212, P668, DOI 10.1016/0003-9861(81)90411-2; Fink AL, 1999, PHYSIOL REV, V79, P425, DOI 10.1152/physrev.1999.79.2.425; Ishida Y, 2006, MOL BIOL CELL, V17, P2346, DOI 10.1091/mbc.E05-11-1065; JAIN N, 1994, BIOCHEM J, V304, P61, DOI 10.1042/bj3040061; KOCH G, 1986, J CELL SCI, V86, P217; Koide T, 2006, J BIOL CHEM, V281, P3432, DOI 10.1074/jbc.M509707200; Koide T, 2006, J BIOL CHEM, V281, P11177, DOI 10.1074/jbc.M601369200; Koide T, 2000, J BIOL CHEM, V275, P27957; KUDO H, 1994, EXP CELL RES, V212, P219, DOI 10.1006/excr.1994.1137; KUIVANIEMI H, 1991, FASEB J, V5, P2052, DOI 10.1096/fasebj.5.7.2010058; KURKINEN M, 1984, J BIOL CHEM, V259, P5915; Lamande SR, 1999, SEMIN CELL DEV BIOL, V10, P455, DOI 10.1006/scdb.1999.0317; Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099; Macdonald JR, 2001, J BIOL CHEM, V276, P25399, DOI 10.1074/jbc.M102471200; Makareeva E, 2006, J BIOL CHEM, V281, P6463, DOI 10.1074/jbc.M511830200; Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429; Martin J, 1997, P NATL ACAD SCI USA, V94, P1107, DOI 10.1073/pnas.94.4.1107; Martinek N, 2007, J DENT RES, V86, P296, DOI 10.1177/154405910708600402; MCBRIDE DJ, 1992, MATRIX, V12, P256; Meldolesi J, 1998, TRENDS BIOCHEM SCI, V23, P10, DOI 10.1016/S0968-0004(97)01143-2; MILES CA, 1995, J MOL BIOL, V245, P437, DOI 10.1006/jmbi.1994.0035; Minton AP, 2006, J CELL SCI, V119, P2863, DOI 10.1242/jcs.03063; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Nagata K, 2003, SEMIN CELL DEV BIOL, V14, P275, DOI 10.1016/j.semcdb.2003.09.020; Persikov AV, 2002, P NATL ACAD SCI USA, V99, P1101, DOI 10.1073/pnas.042707899; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; Qu YX, 2002, BIOPHYS CHEM, V101, P155, DOI 10.1016/S0301-4622(02)00148-5; Satoh M, 1996, J CELL BIOL, V133, P469, DOI 10.1083/jcb.133.2.469; Sauk JJ, 2005, FRONT BIOSCI-LANDMRK, V10, P107, DOI 10.2741/1513; Tasab M, 2000, EMBO J, V19, P2204, DOI 10.1093/emboj/19.10.2204; Thomson CA, 2000, BIOCHEM J, V349, P877, DOI 10.1042/bj3490877; Thomson CA, 2003, PROTEIN SCI, V12, P1792, DOI 10.1110/ps.0236903; Tokuriki N, 2004, PROTEIN SCI, V13, P125, DOI 10.1110/ps.03288104; van den Berg B, 2000, EMBO J, V19, P3870, DOI 10.1093/emboj/19.15.3870; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492	56	45	45	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1029	10.1371/journal.pone.0001029	http://dx.doi.org/10.1371/journal.pone.0001029			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925877	gold, Green Published, Green Submitted			2022-12-25	WOS:000207456000028
J	Xiao, QZ; Kiechl, S; Patel, S; Oberhollenzer, F; Weger, S; Mayr, A; Metzler, B; Reindl, M; Hu, YH; Willeit, J; Xu, QB				Xiao, Qingzhong; Kiechl, Stefan; Patel, Seema; Oberhollenzer, Friedrich; Weger, Siegfried; Mayr, Agnes; Metzler, Bernhard; Reindl, Markus; Hu, Yanhua; Willeit, Johann; Xu, Qingbo			Endothelial Progenitor Cells, Cardiovascular Risk Factors, Cytokine Levels and Atherosclerosis - Results from a Large Population-Based Study	PLOS ONE			English	Article								Background. EPC number and functionality are assumed to reflect the endogenous vascular repair capacity with the EPC pool declining in higher ages and being exhausted by unfavorable life-style and risk factors. This intriguing and clinically highly relevant concept, however, has so far been derived from small case-control studies and patient series. Methodology and Principle Findings. In the population-based Bruneck Study EPC number and EPC-colony forming units (EPC-CFU) were assessed as part of the fourth follow-up evaluation (2005) in 571 and 542 subjects, respectively. EPC number declined with age (p = 0.013), was significantly lower in women (p = 0.006) and higher in subjects on statin, hormone replacement or ACE inhibitor/angiotensin-receptor blockers, and correlated positively with moderate alcohol consumption. Unexpectedly, a positive relation between EPC number and several vascular risk factors emerged. In a step forward multivariate linear regression analysis EPC number was independently related with SDF1 alpha, MMP-9, triglycerides, alcohol consumption, and Hba1c. EPC-CFU in turn was related to SDF1 alpha and diastolic blood pressure. Moreover, EPC number showed a significant positive association with the Framingham risk score (P = 0.001). Finally, there was an inverse association between EPC number and common carotid artery intima-media thickness (p = 0.02) and the carotid artery atherosclerosis score (p = 0.059). Conclusions. Our population-based data confirm the decline of EPC number with advancing age and lend first epidemiological support to a role of SDF-1 alpha and MMP9 in EPC differentiation, mobilization and homing, but are conflict with the view that EPC number is unfavorably affected by cardiovascular risk factors. EPC number increases with the cardiovascular risk estimated by the Framingham risk score (FRS), which in the absence of similar changes for EPC-CFU. Finally, we demonstrate a significant inverse association between EPC number and extent of carotid atherosclerosis even though this association was only of moderate strength and not entirely consistent in other vascular territories.	[Xiao, Qingzhong; Patel, Seema; Hu, Yanhua; Xu, Qingbo] Univ London, Kings Coll London, Div Cardiovasc, London, England; [Kiechl, Stefan; Weger, Siegfried; Reindl, Markus; Willeit, Johann] Med Univ Innsbruck, Dept Neurol, Innsbruck, Austria; [Oberhollenzer, Friedrich] Hosp Bruneck, Dept Internal Med, Brunico, Italy; [Mayr, Agnes] Hosp Bruneck, Dept Lab Med, Brunico, Italy; [Metzler, Bernhard] Med Univ Innsbruck, Dept Internal Med, Innsbruck, Austria	University of London; King's College London; Medical University of Innsbruck; Medical University of Innsbruck	Xu, QB (corresponding author), Univ London, Kings Coll London, Div Cardiovasc, London, England.	qingbo.xu@kcl.ac.uk	Reindl, Markus/ABE-5880-2020	Reindl, Markus/0000-0003-2817-1402	British Heart Foundation; Oak Foundation	British Heart Foundation(British Heart Foundation); Oak Foundation	This work was supported by grants from British Heart Foundation and Oak Foundation.	Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chavakis E, 2005, J EXP MED, V201, P63, DOI 10.1084/jem.20041402; Choi JH, 2004, ARTERIOSCL THROM VAS, V24, P1246, DOI 10.1161/01.ATV.0000133488.56221.4a; De Falco E, 2004, BLOOD, V104, P3472, DOI 10.1182/blood-2003-12-4423; Dimmeler S, 2001, J CLIN INVEST, V108, P391, DOI 10.1172/JCI200113152; George J, 2004, EUR HEART J, V25, P1003, DOI 10.1016/j.ehj.2004.03.026; George J, 2003, ARTERIOSCL THROM VAS, V23, pE57, DOI 10.1161/01.ATV.0000107029.65274.db; Ghani U, 2005, STROKE, V36, P151, DOI 10.1161/01.STR.0000149944.15406.16; Gill M, 2001, CIRC RES, V88, P167; Grisar J, 2005, CIRCULATION, V111, P204, DOI 10.1161/01.CIR.0000151875.21836.AE; Handgretinger R, 2003, ANN NY ACAD SCI, V996, P141, DOI 10.1111/j.1749-6632.2003.tb03242.x; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Imanishi T, 2005, J HYPERTENS, V23, P1831, DOI 10.1097/01.hjh.0000183524.73746.1b; Iwakura A, 2006, CIRCULATION, V113, P1605, DOI 10.1161/CIRCULATIONAHA.105.553925; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kawamoto A, 2001, CIRCULATION, V103, P634; Kiechl S, 1999, CIRCULATION, V99, P614, DOI 10.1161/01.CIR.99.5.614; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Kondo T, 2004, ARTERIOSCL THROM VAS, V24, P1442, DOI 10.1161/01.ATV.0000135655.52088.c5; Kong DL, 2004, CIRCULATION, V110, P2039, DOI 10.1161/01.CIR.0000143161.01901.BD; Kunz GA, 2006, AM HEART J, V152, P190, DOI 10.1016/j.ahj.2006.02.001; Laufs U, 2004, CIRCULATION, V109, P220, DOI 10.1161/01.CIR.0000109141.48980.37; Levy BI, 2005, HYPERTENSION, V45, P491, DOI 10.1161/01.HYP.0000159196.10515.b5; Powell TM, 2005, ARTERIOSCL THROM VAS, V25, P296, DOI 10.1161/01.ATV.0000151690.43777.e4; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Rauscher FM, 2003, CIRCULATION, V108, P457, DOI 10.1161/01.CIR.0000082924.75945.48; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Scheubel RJ, 2003, J AM COLL CARDIOL, V42, P2073, DOI 10.1016/j.jacc.2003.07.025; Seeger FH, 2005, CIRCULATION, V111, P1184, DOI 10.1161/01.CIR.0000157156.85397.A1; Spyridopoulos I, 2004, CIRCULATION, V110, P3136, DOI 10.1161/01.CIR.0000142866.50300.EB; Urbich C, 2003, CIRCULATION, V108, P2511, DOI 10.1161/01.CIR.0000096483.29777.50; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Vasa M, 2001, CIRCULATION, V103, P2885, DOI 10.1161/hc2401.092816; Verma S, 2004, CIRCULATION, V109, P2058, DOI 10.1161/01.CIR.0000127577.63323.24; Werner N, 2006, ARTERIOSCL THROM VAS, V26, P257, DOI 10.1161/01.ATV.0000198239.41189.5d; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Xu QB, 2000, CIRCULATION, V102, P14, DOI 10.1161/01.CIR.102.1.14; XU QB, 1993, LANCET, V341, P255, DOI 10.1016/0140-6736(93)92613-X; Yoon CH, 2005, CIRCULATION, V112, P1618, DOI 10.1161/CIRCULATIONAHA.104.503433; Young PP, 2002, P NATL ACAD SCI USA, V99, P11951, DOI 10.1073/pnas.182215799	43	130	136	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e975	10.1371/journal.pone.0000975	http://dx.doi.org/10.1371/journal.pone.0000975			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925881	Green Published, Green Submitted, gold			2022-12-25	WOS:000207456000001
J	Hasskarl, J; Mern, DS; Munger, K				Hasskarl, J.; Mern, D. S.; Muenger, K.			Interference of the dominant negative helix-loop-helix protein ID1 with the proteasomal subunit S5A causes centrosomal abnormalities	ONCOGENE			English	Article						ID1; centrosome; S5A; proteasome; cancer	CELL-CYCLE; RETINOBLASTOMA PROTEIN; MITOTIC DEFECTS; DNA-BINDING; DEGRADATION; ID-1; DUPLICATION; CANCER; DIFFERENTIATION; SENESCENCE	The inhibitor of DNA-binding (ID) proteins are dominant-negative inhibitors of basic helix-loop-helix transcription factors that have multiple functions d uring development and cellular differentiation. High-level expression of some ID family members has been observed in human malignancies, and in some cases was correlated with poor clinical prognosis. Ectopic ID1 expression extends the life span of primary human epithelial cells, inhibits cellular differentiation and induces centrosome duplication errors, thus suggesting that ID1 may have oncogenic activities. ID1 can bind to the proteasomal subunit S5A/Rpn10, but the biological consequences of the interaction have not been studied in detail. Here, we show that ID1' s ability to induce supernumerary centrosomes correlates with S5A binding. Similar to ID1, a fraction of the S5A protein localizes to centrosomal structures. Furthermore, partial depletion of S5A by RNA interference causes accumulation of cells with supernumerary centrosomes. These results are consistent with the model that ID1 dysregulates centrosome homeostasis at least in part by interfering with S5A activities at the centrosome.	[Hasskarl, J.; Mern, D. S.] Univ Freiburg, Med Ctr, Div Hematol & Oncol, D-79106 Freiburg, Freiburg Im Bre, Germany; [Muenger, K.] Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA	University of Freiburg; Harvard University; Brigham & Women's Hospital	Hasskarl, J (corresponding author), Univ Freiburg, Med Ctr, Div Hematol & Oncol, Hugstetter Str 55,Med 1, D-79106 Freiburg, Freiburg Im Bre, Germany.	jens.hasskarl@uniklinik-freiburg.de	Hasskarl, Jens/E-8980-2011	Shenegelegn Mern, Demissew/0000-0001-5893-981X; Munger, Karl/0000-0003-3288-9935	NCI NIH HHS [R01 CA066980] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA066980] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alani RM, 1999, P NATL ACAD SCI USA, V96, P9637, DOI 10.1073/pnas.96.17.9637; Anand G, 1997, J BIOL CHEM, V272, P19140, DOI 10.1074/jbc.272.31.19140; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Berse M, 2004, J MOL BIOL, V343, P361, DOI 10.1016/j.jmb.2004.08.043; Bloom J, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-5; Bounpheng MA, 1999, FASEB J, V13, P2257, DOI 10.1096/fasebj.13.15.2257; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; D'Assoro AB, 2001, MARC MALPIG SYMP SER, V7, P103; Deed RW, 1997, MOL CELL BIOL, V17, P6815, DOI 10.1128/MCB.17.12.6815; Doxsey SJ, 2001, NAT CELL BIOL, V3, pE105, DOI 10.1038/35074618; Duensing S, 2000, P NATL ACAD SCI USA, V97, P10002, DOI 10.1073/pnas.170093297; Duensing S, 2004, ONCOGENE, V23, P8206, DOI 10.1038/sj.onc.1208012; Duensing S, 2001, CANCER RES, V61, P2356; Duensing Stefan, 2003, Mol Cancer, V2, P30, DOI 10.1186/1476-4598-2-30; Fabunmi RP, 2000, J BIOL CHEM, V275, P409, DOI 10.1074/jbc.275.1.409; Fajerman I, 2004, BIOCHEM BIOPH RES CO, V314, P505, DOI 10.1016/j.bbrc.2003.12.116; Florio M, 1998, MOL CELL BIOL, V18, P5435, DOI 10.1128/MCB.18.9.5435; Fraidenraich D, 2004, SCIENCE, V306, P247, DOI 10.1126/science.1102612; Freed E, 1999, GENE DEV, V13, P2242, DOI 10.1101/gad.13.17.2242; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Hara E, 1996, DEV GENET, V18, P161; Hara E, 1997, EMBO J, V16, P332, DOI 10.1093/emboj/16.2.332; HASSKARL J, 2004, ONCOGENE, V63, P476; Hinchcliffe EH, 2001, GENE DEV, V15, P1167, DOI 10.1101/gad.894001; Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7; IAVARONE A, 1994, GENE DEV, V8, P1270, DOI 10.1101/gad.8.11.1270; JEN Y, 1992, GENE DEV, V6, P1466, DOI 10.1101/gad.6.8.1466; KREIDER BL, 1992, SCIENCE, V255, P1700, DOI 10.1126/science.1372755; Lasorella A, 2006, NATURE, V442, P471, DOI 10.1038/nature04895; Ling MT, 2003, ONCOGENE, V22, P4498, DOI 10.1038/sj.onc.1206693; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Meraldi P, 2002, FEBS LETT, V521, P9, DOI 10.1016/S0014-5793(02)02865-X; Nickoloff BJ, 2000, J BIOL CHEM, V275, P27501; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Roberts EC, 2001, MOL CELL BIOL, V21, P524, DOI 10.1128/MCB.21.2.524-533.2001; Stavropoulou V, 2005, CANCER RES, V65, P1361, DOI 10.1158/0008-5472.CAN-04-2085; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Szlanka T, 2003, J CELL SCI, V116, P1023, DOI 10.1242/jcs.00332; Tang J, 2002, LAB INVEST, V82, P1073, DOI 10.1097/01.LAB.0000022223.65962.3A; Trausch-Azar JS, 2004, J BIOL CHEM, V279, P32614, DOI 10.1074/jbc.M403794200; Wigley WC, 1999, J CELL BIOL, V145, P481; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	44	9	9	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 13	2008	27	12					1657	1664		10.1038/sj.onc.1210808	http://dx.doi.org/10.1038/sj.onc.1210808			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	273WF	17891176				2022-12-25	WOS:000253962100001
J	Nieto-Miguel, T; Gajate, C; Gonzalez-Camacho, F; Mollinedo, F				Nieto-Miguel, T.; Gajate, C.; Gonzalez-Camacho, F.; Mollinedo, F.			Proapoptotic role of Hsp90 by its interaction with c-Jun N-terminal kinase in lipid rafts in edelfosine-mediated antileukemic therapy	ONCOGENE			English	Article						Hsp90; JNK; lipid rafts; apoptosis; edelfosine; alkyl-lysophospholipid	HUMAN LEUKEMIC-CELLS; FAS/CD95 DEATH RECEPTOR; REGULATES AKT KINASE; COLON-CANCER CELLS; ET-18-OCH3 EDELFOSINE; INDUCED APOPTOSIS; HEAT-SHOCK-PROTEIN-90 FUNCTION; SELECTIVE INDUCTION; CYCLE ARREST; TUMOR-CELLS	Heat shock protein 90 (Hsp90) is a survival signaling chaperone and a cancer chemotherapeutic target. However, we have found that inhibitors of Hsp90 diminished the apoptotic response induced in leukemic cells by the antitumor alkyl-lysophospholipid analog edelfosine, which acts through lipid raft reorganization. Edelfosine treatment recruited Hsp90, c-Jun N-terminal kinase (JNK) and apoptotic molecules in lipid rafts, but not the JNK regulators apoptosis signal-regulating kinase 1 (ASK1) and Daxx, or the survival signaling molecules extracellular signal-regulated kinase (ERK) and Akt. Following edelfosine treatment, Hsp90 bound to JNK in lipid rafts and Hsp90-JNK clusters were identified at the plasma membrane by immunoelectron microscopy. Hsp90 inhibition reduced JNK protein level in lipid rafts and turned proapoptotic persistent JNK activation into a transient response in edelfosine-treated cells. Decrease in edelfosine-induced JNK activation and apoptosis by Hsp90 inhibition was prevented through proteasome inhibition, suggesting that Hsp90 inhibition diminishes apoptosis by promoting JNK protein degradation. Expression of ASK1 dominant negative mutant did not affect JNK activation and apoptosis following edelfosine treatment. These data indicate that lipid raft-recruited JNK is ASK1-independent and becomes a novel Hsp90 client protein. Our results reveal a new chaperoning role of Hsp90 on JNK-mediated apoptosis following its recruitment in lipid rafts.	[Nieto-Miguel, T.; Gajate, C.; Gonzalez-Camacho, F.; Mollinedo, F.] Univ Salamanca, Ctr Invest Canc, Inst Biol Mol & Celular Canc, CSIC, E-37007 Salamanca, Spain; [Gajate, C.] Hosp Univ Salamanca, Unidad Invest, Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Salamanca	Mollinedo, F (corresponding author), Univ Salamanca, Ctr Invest Canc, Inst Biol Mol & Celular Canc, CSIC, Campus Miguel Unamuno, E-37007 Salamanca, Spain.	fmollin@usal.es	2008, Ibsal/A-1268-2012; González-Camacho, Fernando/P-1610-2014; Nieto Miguel, Teresa/L-1496-2016	Gajate, Consuelo/0000-0003-0604-6459; Nieto Miguel, Teresa/0000-0002-8374-5379; Gonzalez-Camacho, Fernando/0000-0003-3175-9004				Chang HY, 1998, SCIENCE, V281, P1860, DOI 10.1126/science.281.5384.1860; Chen YR, 1996, J BIOL CHEM, V271, P31929, DOI 10.1074/jbc.271.50.31929; Chiosis G, 2001, BIOORG MED CHEM LETT, V11, P909, DOI 10.1016/S0960-894X(01)00099-3; Delmas D, 2003, J BIOL CHEM, V278, P41482, DOI 10.1074/jbc.M304896200; Gajate C, 2000, INT J CANCER, V85, P674, DOI 10.1002/(SICI)1097-0215(20000301)85:5<674::AID-IJC13>3.0.CO;2-Z; Gajate C, 2005, J BIOL CHEM, V280, P11641, DOI 10.1074/jbc.M411781200; Gajate C, 2000, CANCER RES, V60, P2651; Gajate C, 2004, J EXP MED, V200, P353, DOI 10.1084/jem.20040213; Gajate C, 2002, CURR DRUG METAB, V3, P491, DOI 10.2174/1389200023337225; Gajate C, 2001, BLOOD, V98, P3860, DOI 10.1182/blood.V98.13.3860; Gajate C, 1998, MOL PHARMACOL, V53, P602, DOI 10.1124/mol.53.4.602; Gajate C, 2007, BLOOD, V109, P711, DOI 10.1182/blood-2006-04-016824; Georgakis GV, 2006, CLIN CANCER RES, V12, P584, DOI 10.1158/1078-0432.CCR-05-1194; George P, 2005, BLOOD, V105, P1768, DOI 10.1182/blood-2004-09-3413; Lacour S, 2004, CANCER RES, V64, P3593, DOI 10.1158/0008-5472.CAN-03-2787; Mollinedo F, 2003, J IMMUNOL, V170, P1034, DOI 10.4049/jimmunol.170.2.1034; Mollinedo F, 1997, CANCER RES, V57, P1320; Mollinedo F, 2004, CURR MED CHEM, V11, P3163, DOI 10.2174/0929867043363703; MOLLINEDO F, 1993, BIOCHEM BIOPH RES CO, V192, P603, DOI 10.1006/bbrc.1993.1458; MOLLINEDO F, 1994, BIOCHEM J, V302, P325, DOI 10.1042/bj3020325; Mollinedo F, 2006, DRUG RESIST UPDATE, V9, P51, DOI 10.1016/j.drup.2006.04.002; Neckers L, 2002, TRENDS MOL MED, V8, pS55, DOI 10.1016/S1471-4914(02)02316-X; Nieto-Miguel T, 2006, J BIOL CHEM, V281, P14833, DOI 10.1074/jbc.M511251200; Ruiter GA, 1999, CANCER RES, V59, P2457; Solit DB, 2003, CANCER RES, V63, P2139; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; van der Luit AH, 2002, J BIOL CHEM, V277, P39541, DOI 10.1074/jbc.M203176200; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Yang XL, 1997, CELL, V89, P1067, DOI 10.1016/S0092-8674(00)80294-9; Zaremberg V, 2005, J BIOL CHEM, V280, P38047, DOI 10.1074/jbc.M502849200; Zhang H, 2004, J BIOL CHEM, V279, P19457, DOI 10.1074/jbc.M311377200; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024	32	44	45	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 13	2008	27	12					1779	1787		10.1038/sj.onc.1210816	http://dx.doi.org/10.1038/sj.onc.1210816			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	273WF	17891170				2022-12-25	WOS:000253962100013
J	Yao, L; Korteweg, C; Hsueh, W; Go, J				Yao, Lu; Korteweg, Christine; Hsueh, Wei; Go, Jiang			Avian influenza receptor expression in H5N1-infected and noninfected human tissues	FASEB JOURNAL			English	Article						sialic acid; human influenza virus receptors; lectin	HUMAN AIRWAY EPITHELIUM; LOWER RESPIRATORY-TRACT; A H5N1 INFECTION; SIALIC-ACID; BINDING SPECIFICITY; VIRUS; HEMAGGLUTININ; CELL; HOST; TRANSMISSION	Avian and human influenza viruses preferentially bind to alpha-2,3-linked and alpha-2,6-linked sialic acids, respectively. Until today, the distributions of these two receptor types had never been investigated in H5N1-infected human tissue samples. Here, the expression of avian (AIV-Rs) and human influenza receptors (HuIV-Rs) is studied in various organs (upper and lower respiratory tracts, brain, placenta, liver, kidney, heart, intestines, and spleen) of two H5N1 cases and 14 control cases. Histochemical stains using biotinylated Maackia amurensis lectin 11 and Sambucus nigra agglutinin were performed to localize AIV-Rs and HuIV-Rs, respectively. Immunohistochemical stainings were performed to identify the receptor-bearing cells. AIV-Rs were detected on type II pneumocytes; a limited number of epithelial cells of the upper respiratory tract; and the bronchi, bronchioli, and trachea; as well as on Kupffer cells, glomerular cells, splenic T cells, and neurons in the brain and intestines. HuIV-Rs were abundantly present in the respiratory tract and lungs. They were also detected on Hofbauer cells, glomerular cells, splenic B cells, and in the liver. Moreover, endothelial cells of all organs examined expressed both receptor types. In conclusion, the distribution pattern of AIV-Rs is partially inconsistent with the pattern of infected cells as detected in previous studies, which suggests there may be other receptors or mechanisms involved in H5N1 infection. In addition, the diffuse presence of receptors on endothelial cells may account for the multiple organ involvement in H5N1 influenza. Finally, the relative lack of AIV-Rs in the upper airway may be a one of the factors preventing efficient human-to-human transmission of H5N1 influenza.	[Yao, Lu; Korteweg, Christine; Go, Jiang] Peking Univ, Sch Basic Med Sci, Dept Pathol, Beijing 100083, Peoples R China; [Go, Jiang] Peking Univ, Ctr Infect Dis, Beijing 100871, Peoples R China; [Hsueh, Wei] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL USA	Peking University; Peking University; Northwestern University; Feinberg School of Medicine	Go, J (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Pathol, 38 Xuwyuan Rd, Beijing 100083, Peoples R China.	jianggu@bjmu.edu.cn		Yao, Lu/0000-0002-6430-8712; Gu, Jiang/0000-0002-0706-8329				BAUM LG, 1990, ACTA HISTOCHEM, P35; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Cerna A, 2002, ACTA HISTOCHEM, V104, P339, DOI 10.1078/0065-1281-00669; Chokephaibulkit K, 2005, PEDIATR INFECT DIS J, V24, P162, DOI 10.1097/01.inf.0000151037.25237.1e; de Jong MD, 2005, NEW ENGL J MED, V352, P686, DOI 10.1056/NEJMoa044307; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Eash S, 2004, AM J PATHOL, V164, P419, DOI 10.1016/S0002-9440(10)63132-X; Glaser L, 2005, J VIROL, V79, P11533, DOI 10.1128/JVI.79.17.11533-11536.2005; Gu J, 2007, LANCET, V370, P1137, DOI 10.1016/S0140-6736(07)61515-3; Harvey R, 2004, J VIROL, V78, P502, DOI 10.1128/JVI.78.1.502-507.2004; Ibricevic A, 2006, J VIROL, V80, P7469, DOI 10.1128/JVI.02677-05; Juckett G, 2006, AM FAM PHYSICIAN, V74, P783; KAWAOKA Y, 1989, J VIROL, V63, P4603, DOI 10.1128/JVI.63.11.4603-4608.1989; Matrosovich M, 2007, VIROLOGY, V361, P384, DOI 10.1016/j.virol.2006.11.030; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Muramoto Y, 2006, MICROBIOL IMMUNOL, V50, P73, DOI 10.1111/j.1348-0421.2006.tb03764.x; NELSON J, 1993, VIRUS RES, V29, P155, DOI 10.1016/0168-1702(93)90056-S; Nicholls JM, 2007, NAT MED, V13, P147, DOI 10.1038/nm1529; Ponnio M, 2004, MICROSC RES TECHNIQ, V65, P292, DOI 10.1002/jemt.20132; Reid AH, 2004, NAT REV MICROBIOL, V2, P909, DOI 10.1038/nrmicro1027; ROGERS GN, 1983, NATURE, V304, P76, DOI 10.1038/304076a0; SATA T, 1991, AM J PATHOL, V139, P1435; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Shu YL, 2006, NEW ENGL J MED, V354, P1421, DOI 10.1056/NEJMc053524; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Suzuki Y, 2005, BIOL PHARM BULL, V28, P399, DOI 10.1248/bpb.28.399; Thompson CI, 2006, J VIROL, V80, P8060, DOI 10.1128/JVI.00384-06; To KF, 2001, J MED VIROL, V63, P242, DOI 10.1002/1096-9071(200103)63:3&lt;242::AID-JMV1007&gt;3.0.CO;2-N; Uiprasertkul M, 2005, EMERG INFECT DIS, V11, P1036, DOI 10.3201/eid1107.041313; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; Zhang LQ, 2005, J VIROL, V79, P1113, DOI 10.1128/JVI.79.2.1113-1124.2005; Zhou Chao, 2006, Zhonghua Jiehe He Huxi Zazhi, V29, P9; 2007, CUMULATIVE NUMBER CO	37	103	108	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2008	22	3					733	740		10.1096/fj.06-7880com	http://dx.doi.org/10.1096/fj.06-7880com			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	276LQ	17925493				2022-12-25	WOS:000254143700012
J	Basting, D; Lorch, M; Lehner, I; Glaubitz, C				Basting, Daniel; Lorch, Mark; Lehner, Ines; Glaubitz, Clemens			Transport cycle intermediate in small multidrug resistance protein is revealed by substrate fluorescence	FASEB JOURNAL			English	Article						bacteriorhodopsin; EmrE; ethidium bromide; TBsmr	ESCHERICHIA-COLI; EMRE; BINDING; SITE; MODEL; H+; BACTERIORHODOPSIN; SECONDARY; GLUTAMATE; VESICLES	Efflux pumps of the small multidrug resistance family bind cationic, lipophilic antibiotics and transport them across the membrane in exchange for protons. The transport cycle must involve various conformational states of the protein needed for substrate binding, translocation, and release. A fluorescent substrate will therefore experience a significant change of environment while being transported, which influences its fluorescence properties. Thus the substrate itself can report intermediate states that form during the transport cycle. We show the existence of such a substrate-transporter complex for the EmrE homolog Mycobacterium tuberculosis TBsmr and its substrate ethidium bromide. The pH gradient needed for antiport has been generated by co-reconstituting TBsmr with bacteriorhodopsin. Sample illumination generates a Delta pH, which results in enhanced ethidium fluorescence intensity, which is abolished when Delta pH or Delta Psi is collapsed or when the essential residue Glu-13 in TBsmr is exchanged with Ala. This observation shows the formation of a pH-dependent, transient substrate-protein complex between binding and release of ethidium. We have further characterized this state by determining the K-d, by inhibiting ethidium transport through titration with nonfluorescent substrate and by fluorescence anisotropy measurements. Our findings support a model with a single occluded intermediate state in which the substrate is highly immobile.	[Basting, Daniel; Lorch, Mark; Lehner, Ines; Glaubitz, Clemens] Goethe Univ Frankfurt, Inst Biophys Chem, D-60438 Frankfurt, Germany; [Basting, Daniel; Lorch, Mark; Lehner, Ines; Glaubitz, Clemens] Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance, D-60438 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Glaubitz, C (corresponding author), Goethe Univ Frankfurt, Inst Biophys Chem, Max von Laue Str 9, D-60438 Frankfurt, Germany.	glaubitz@em.uni-frankfurt.de	Glaubitz, Clemens/D-5714-2011	Glaubitz, Clemens/0000-0002-3554-6586	Engineering and Physical Sciences Research Council [EP/C508912/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Arkin IT, 1996, BIOCHEMISTRY-US, V35, P7233, DOI 10.1021/bi960094i; Barth A, 2002, BIOPHYS J, V83, P2864, DOI 10.1016/S0006-3495(02)75295-8; BEAUGE LA, 1979, NATURE, V280, P510, DOI 10.1038/280510a0; De Rossi E, 1998, J BACTERIOL, V180, P6068, DOI 10.1128/JB.180.22.6068-6071.1998; GENEST D, 1985, NUCLEIC ACIDS RES, V13, P2603, DOI 10.1093/nar/13.7.2603; GRINIUS L, 1992, PLASMID, V27, P119, DOI 10.1016/0147-619X(92)90012-Y; Guan L, 2004, P NATL ACAD SCI USA, V101, P12148, DOI 10.1073/pnas.0404936101; GUENZA M, 1988, SPECTROCHIM ACTA A, V44, P1359, DOI 10.1016/0584-8539(88)80182-X; Kaback HR, 2007, P NATL ACAD SCI USA, V104, P491, DOI 10.1073/pnas.0609968104; Koteiche HA, 2003, BIOCHEMISTRY-US, V42, P6099, DOI 10.1021/bi0342867; Lorch M, 2005, BIOCHEM SOC T, V33, P873, DOI 10.1042/BST0330873; Luedtke NW, 2005, CHEM-EUR J, V11, P495, DOI 10.1002/chem.200400559; Mason AJ, 2005, FEBS J, V272, P2152, DOI 10.1111/j.1742-4658.2005.04633.x; MAYCOX PR, 1990, EMBO J, V9, P1465, DOI 10.1002/j.1460-2075.1990.tb08263.x; Muth TR, 2000, EMBO J, V19, P234, DOI 10.1093/emboj/19.2.234; Ninio S, 2003, J BIOL CHEM, V278, P12000, DOI 10.1074/jbc.M213119200; Ninio S, 2001, J BIOL CHEM, V276, P48250, DOI 10.1074/jbc.M108231200; Noguchi N, 1999, FEMS MICROBIOL LETT, V172, P247, DOI 10.1111/j.1574-6968.1999.tb13475.x; Oesterhelt D, 1974, Methods Enzymol, V31, P667; OLMSTED J, 1977, BIOCHEMISTRY-US, V16, P3647, DOI 10.1021/bi00635a022; PEROZO E, 1993, BIOCHEMISTRY-US, V32, P10471, DOI 10.1021/bi00090a025; RACKER E, 1974, J BIOL CHEM, V249, P662; Rapp M, 2007, SCIENCE, V315, P1282, DOI 10.1126/science.1135406; Rotem D, 2004, J BIOL CHEM, V279, P48787, DOI 10.1074/jbc.M408187200; Schuldiner S, 2007, TRENDS BIOCHEM SCI, V32, P252, DOI 10.1016/j.tibs.2007.04.002; Schwaiger M, 1998, EUR J BIOCHEM, V254, P610, DOI 10.1046/j.1432-1327.1998.2540610.x; Siarheyeva A, 2006, BIOCHEMISTRY-US, V45, P6203, DOI 10.1021/bi0524870; Soskine M, 2002, P NATL ACAD SCI USA, V99, P12043, DOI 10.1073/pnas.192392899; SUBCZYNSKI WK, 1994, BIOCHEMISTRY-US, V33, P7670, DOI 10.1021/bi00190a022; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Ubarretxena-Belandia I, 2003, EMBO J, V22, P6175, DOI 10.1093/emboj/cdg611; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Yerushalmi H, 2000, BIOCHEMISTRY-US, V39, P14711, DOI 10.1021/bi001892i; Yerushalmi H, 2000, FEBS LETT, V476, P93, DOI 10.1016/S0014-5793(00)01677-X; Yerushalmi H, 2000, J BIOL CHEM, V275, P5264, DOI 10.1074/jbc.275.8.5264; YERUSHALMI H, 1995, J BIOL CHEM, V270, P6856, DOI 10.1074/jbc.270.12.6856; Yin Y, 2006, BIOPHYS J, V91, P3972, DOI 10.1529/biophysj.106.085993	38	11	11	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2008	22	2					365	373		10.1096/fj.07-9162com	http://dx.doi.org/10.1096/fj.07-9162com			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	257TY	17873100				2022-12-25	WOS:000252822600006
J	Kemmner, W; Wan, KY; Ruttinger, S; Ebert, B; Macdonald, R; Klamm, U; MoestaO, KT				Kemmner, Wolfgang; Wan, Kayiu; Ruettinger, Steffen; Ebert, Bernd; Macdonald, Rainer; Klamm, Ursula; MoestaO, K. Thomas			Silencing of human ferrochelatase causes abundant protoporphyrin-IX accumulation in colon cancer	FASEB JOURNAL			English	Article						heme metabolism; gastrointestinal carcinomas; siRNA silencing; cytoplasmatic red fluorescence	HIGH-GRADE DYSPLASIA; ACID-INDUCED PROTOPORPHYRIN; 5-AMINOLEVULINIC ACID; PHOTODYNAMIC THERAPY; BARRETTS-ESOPHAGUS; RNA INTERFERENCE; GENE-EXPRESSION; FLUORESCENCE; PORPHYRINS; LESIONS	Hemes and heme proteins are vital components of essentially every cell of virtually every eukaryote organism. Previously, we demonstrated accumulation of the heme precursor protoporphyrin-IX (PpIX) in gastrointestinal tumor tissues. To elucidate the mechanisms of PpIX accumulation by quantitative reverse transcriptase-polymerase chain reaction (RTPCR), we studied expression of the relevant enzymes of the heme synthetic pathway. Here, we describe a significant down-regulation of ferrochelatase (FECH) mRNA expression in gastric, colonic, and rectal carcinomas. Accordingly, in an in vitro model of several carcinoma cell lines, ferrochelatase down-regulation and loss of enzymatic activity corresponded with an enhanced PpIX-dependent fluorescence. Direct detection of PpIX in minute amounts was achieved by a specifically developed pulsed solid-state laser dual delay fluorimetry setup. Silencing of FECH using small interfering RNA (siRNA) technology led to a maximum 50-fold increased PpIX accumulation, imageable by a specifically adapted two-photon microscopy unit. Our results show that in malignant tissue a transcriptional down-regulation of FECH occurs, which causes endogenous PpIX accumulation. Furthermore, accumulation of intracellular PpIX because of FECH siRNA silencing provides a small-molecule-based approach to molecular imaging and molecular therapy.	[Kemmner, Wolfgang; Wan, Kayiu] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Ruettinger, Steffen; Ebert, Bernd; Macdonald, Rainer] Phys Tech Bundesanstalt, Dept Biomed Opt, Berlin, Germany; [Klamm, Ursula; MoestaO, K. Thomas] Charite Univ Med Berlin, Clin Surg Oncol, Robert Roessle Clin, Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Physikalisch-Technische Bundesanstalt (PTB); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Kemmner, W (corresponding author), Max Delbruck Ctr Mol Med, Robert Roessle Str 10, D-13125 Berlin, Germany.	wkemmner@mdc-berlin.de						Barr H, 1996, LANCET, V348, P584, DOI 10.1016/S0140-6736(96)03054-1; Cardoso ALC, 2007, J GENE MED, V9, P170, DOI 10.1002/jgm.1006; DAILEY HA, 1984, BIOCHEM J, V223, P441, DOI 10.1042/bj2230441; Dailey HA, 2000, CELL MOL LIFE SCI, V57, P1909, DOI 10.1007/PL00000672; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Endlicher E, 2004, PHOTOCHEM PHOTOBIOL, V79, P189, DOI 10.1562/0031-8655(2004)079<0189:DODLBF>2.0.CO;2; Endlicher E, 2001, GUT, V48, P314, DOI 10.1136/gut.48.3.314; Gossner L, 1999, CANCER, V86, P1921, DOI 10.1002/(SICI)1097-0142(19991115)86:10<1921::AID-CNCR7>3.3.CO;2-E; Gupta S, 2004, P NATL ACAD SCI USA, V101, P1927, DOI 10.1073/pnas.0306111101; Hinnen P, 1998, BRIT J CANCER, V78, P679, DOI 10.1038/bjc.1998.559; HUA ZX, 1995, CANCER RES, V55, P1723; Koenig F, 2001, SCIENCE, V292, P1401, DOI 10.1126/science.292.5520.1401; Krieg RC, 2000, PHOTOCHEM PHOTOBIOL, V72, P226, DOI 10.1562/0031-8655(2000)072<0226:CTSPIM>2.0.CO;2; Liu YYL, 2004, LIFE SCI, V75, P2035, DOI 10.1016/j.lfs.2004.03.027; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magness ST, 2000, BLOOD, V95, P3568, DOI 10.1182/blood.V95.11.3568.011k40_3568_3577; Mahmood U, 2003, MOL CANCER THER, V2, P489; Moesta KT, 2001, CANCER RES, V61, P991; Mortelmaier M, 2002, SINGLE MOL, V3, P225, DOI 10.1002/1438-5171(200208)3:4<225::AID-SIMO225>3.0.CO;2-K; Rao AU, 2005, P NATL ACAD SCI USA, V102, P4270, DOI 10.1073/pnas.0500877102; Rozema DB, 2007, P NATL ACAD SCI USA, V104, P12982, DOI 10.1073/pnas.0703778104; Taketani S, 2000, EUR J BIOCHEM, V267, P4685, DOI 10.1046/j.1432-1327.2000.01519.x; VANHILLEGERSBERG R, 1992, GASTROENTEROLOGY, V103, P647, DOI 10.1016/0016-5085(92)90860-2; Walther W, 2006, HUM GENE THER, V17, P611, DOI 10.1089/hum.2006.17.611; Weissleder R, 2006, SCIENCE, V312, P1168, DOI 10.1126/science.1125949; Yuste R, 2005, NAT METHODS, V2, P902, DOI 10.1038/nmeth1205-902; Zender L, 2003, P NATL ACAD SCI USA, V100, P7797, DOI 10.1073/pnas.1330920100	27	77	83	0	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2008	22	2					500	509		10.1096/fj.07-8888com	http://dx.doi.org/10.1096/fj.07-8888com			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	257TY	17875605				2022-12-25	WOS:000252822600020
J	Tong, Y; Chugha, P; Hota, PK; Alviani, RS; Li, M; Tempel, W; Shen, L; Park, HW; Buck, M				Tong, Yufeng; Chugha, Preeti; Hota, Prasanta K.; Alviani, Rebecca S.; Li, Mei; Tempel, Wolfram; Shen, Limin; Park, Hee-Won; Buck, Matthias			Binding of Rac1, Rnd1, and RhoD to a novel Rho GTPase interaction motif destabilizes dimerization of the plexin-B1 effector domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE RAC; STRUCTURE VALIDATION; ACTIVATING PROTEIN; RECEPTOR PLEXIN-B1; LIGAND-BINDING; AXON GUIDANCE; R-RAS; SEMAPHORINS; GROWTH; RESOLUTION	Plexins are the first known transmembrane receptors that interact directly with small GTPases. On binding to certain Rho family GTPases, the receptor regulates the remodeling of the actin cytoskeleton and alters cell movement in response to semaphorin guidance cues. In a joint solution NMR spectroscopy and x-ray crystallographic study, we characterize a 120-residue cytoplasmic independent folding domain of plexin-B1 that directly binds three Rho family GTPases, Rac1, Rnd1, and RhoD. The NMR data show that, surprisingly, the Cdc42/Rac interactive binding-like motif of plexin-B1 is not involved in this interaction. Instead, all three GTPases interact with the same region, beta-strands 3 and 4 and a short alpha-helical segment of the plexin domain. The 2.0 angstrom resolution x-ray structure shows that these segments are brought together by the tertiary structure of the ubiquitin-like fold. In the crystal, the protein is dimerized with C2 symmetry through a four-stranded antiparallel beta-sheet that is formed outside the fold by a long loop between the monomers. This region is adjacent to the GTPase binding motifs identified by NMR. Destabilization of the dimer in solution by binding of any one of the three GTPases suggests a model for receptor regulation that involves bidirectional signaling. The model implies a multifunctional role for the GTPase-plexin interaction that includes conformational change and a localization of active receptors in the signaling mechanism.	[Tong, Yufeng; Chugha, Preeti; Hota, Prasanta K.; Alviani, Rebecca S.; Li, Mei; Buck, Matthias] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Buck, Matthias] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA; [Buck, Matthias] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Park, Hee-Won] Univ Toronto, Dept Pharmacol, Toronto, ON M5G 1L5, Canada; [Tong, Yufeng; Tempel, Wolfram; Shen, Limin; Park, Hee-Won] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L5, Canada	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University of Toronto; University of Toronto; Structural Genomics Consortium	Buck, M (corresponding author), Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, 10900 Euclid Ave, Cleveland, OH 44106 USA.	Matthias.Buck@case.edu	Hota, Prasanta Kumar/J-4319-2019; Buck, Matthias/B-2106-2017; Tong, Yufeng/D-2785-2011	Hota, Prasanta Kumar/0000-0002-4057-1831; Buck, Matthias/0000-0002-2958-0403; Tong, Yufeng/0000-0001-7740-1812	NHLBI NIH HHS [K02 HL084384-01, T32 HL007653, K02HL084384, K02 HL084384] Funding Source: Medline; NIGMS NIH HHS [R01GM73071, R01 GM073071-01, R01 GM073071] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007653, K02HL084384] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073071] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Antipenko A, 2003, NEURON, V39, P589, DOI 10.1016/S0896-6273(03)00502-6; Artigiani S, 1999, IUBMB LIFE, V48, P477, DOI 10.1080/713803563; Aspenstrom P, 2004, BIOCHEM J, V377, P327, DOI 10.1042/BJ20031041; Basile JR, 2004, CANCER RES, V64, P5212, DOI 10.1158/0008-5472.CAN-04-0126; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Bouguet-Bonnet S, 2006, J BIOMOL NMR, V36, P51, DOI 10.1007/s10858-006-9029-6; Buck M, 2004, J MOL BIOL, V338, P271, DOI 10.1016/j.jmb.2004.02.036; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Driessens MHE, 2001, CURR BIOL, V11, P339, DOI 10.1016/S0960-9822(01)00092-6; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fournier AE, 2000, J CELL BIOL, V149, P411, DOI 10.1083/jcb.149.2.411; Giordano S, 2002, NAT CELL BIOL, V4, P720, DOI 10.1038/ncb843; Gitler AD, 2004, DEV CELL, V7, P107, DOI 10.1016/j.devcel.2004.06.002; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Hu HL, 2001, NEURON, V32, P39, DOI 10.1016/S0896-6273(01)00453-6; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Love CA, 2003, NAT STRUCT BIOL, V10, P843, DOI 10.1038/nsb977; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Murphy C, 2001, EUR J CELL BIOL, V80, P391, DOI 10.1078/0171-9335-00173; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Oinuma I, 2004, J NEUROSCI, V24, P11473, DOI 10.1523/JNEUROSCI.3257-04.2004; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Oinuma I, 2003, J BIOL CHEM, V278, P25671, DOI 10.1074/jbc.M303047200; Patel BN, 2002, CURR OPIN CELL BIOL, V14, P221, DOI 10.1016/S0955-0674(02)00308-3; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Rohm B, 2000, FEBS LETT, V486, P68, DOI 10.1016/S0014-5793(00)02240-7; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P195, DOI 10.1107/S0907444901019291; Serini G, 2003, NATURE, V424, P391, DOI 10.1038/nature01784; Shimada I, 2005, METHOD ENZYMOL, V394, P483, DOI 10.1016/S0076-6879(05)94020-2; Swiercz JM, 2004, J CELL BIOL, V165, P869, DOI 10.1083/jcb.200312094; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; Takahashi H, 2000, NAT STRUCT BIOL, V7, P220; Takahashi T, 2001, NEURON, V29, P429, DOI 10.1016/S0896-6273(01)00216-1; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Tong YF, 2005, J BIOMOL NMR, V31, P369, DOI 10.1007/s10858-005-0943-9; Tong YF, 2005, STRUCTURE, V13, P7, DOI 10.1016/j.str.2004.10.018; Torres-Vazquez J, 2004, DEV CELL, V7, P117, DOI 10.1016/j.devcel.2004.06.008; Toyofuku T, 2004, GENE DEV, V18, P435, DOI 10.1101/gad.1167304; Tsubakimoto K, 1999, ONCOGENE, V18, P2431, DOI 10.1038/sj.onc.1202604; Turner LJ, 2004, J BIOL CHEM, V279, P33199, DOI 10.1074/jbc.M402943200; Vikis HG, 2000, P NATL ACAD SCI USA, V97, P12457, DOI 10.1073/pnas.220421797; Vikis HG, 2002, GENE DEV, V16, P836, DOI 10.1101/gad.966402; WANG BC, 1985, METHOD ENZYMOL, V115, P90; Wennerberg K, 2003, CURR BIOL, V13, P1106, DOI 10.1016/S0960-9822(03)00418-4; Wong AW, 2003, NAT IMMUNOL, V4, P891, DOI 10.1038/ni960; Zanata SM, 2002, J NEUROSCI, V22, P471, DOI 10.1523/JNEUROSCI.22-02-00471.2002	49	102	105	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37215	37224		10.1074/jbc.M703800200	http://dx.doi.org/10.1074/jbc.M703800200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17916560	Green Accepted, hybrid			2022-12-25	WOS:000251646000047
J	Diet, A; Abbas, K; Bouton, C; Guillon, B; Tomasello, F; Fourquet, S; Toledano, MB; Drapier, JC				Diet, Alexandre; Abbas, Kahina; Bouton, Cecile; Guillon, Blanche; Tomasello, Flora; Fourquet, Simon; Toledano, Michel B.; Drapier, Jean-Claude			Regulation of peroxiredoxins by nitric oxide in immunostimulated macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SULFINIC ACID; CELL-CYCLE ARREST; OXIDATIVE STRESS; REVERSIBLE OXIDATION; HYDROGEN-PEROXIDE; GENE-EXPRESSION; REACTIVE OXYGEN; ACTIVE-SITE; PEROXYNITRITE REDUCTASE; REDOX REGULATION	Reactive oxygen species and nitric oxide (NO) are capable of both mediating redox-sensitive signal transduction and eliciting cell injury. The interplay between these messengers is quite complex, and intersection of their signaling pathways as well as regulation of their fluxes requires tight control. In this regard, peroxiredoxins (Prxs), a recently identified family of six thiol peroxidases, are central because they reduce H2O2, organic peroxides, and peroxynitrite. Here we provide evidence that endogenously produced NO participates in protection of murine primary macrophages against oxidative and nitrosative stress by inducing Prx I and VI expression at mRNA and protein levels. We also show that NO prevented the sulfinylation-dependent inactivation of 2-Cys Prxs, a reversible overoxidation that controls H2O2 signaling. In addition, studies using macrophages from sulfiredoxin (Srx)-deficient mice indicated that regeneration of 2-Cys Prxs to the active form was dependent on Srx. Last, we show that NO increased Srx expression and hastened Srx-dependent recovery of 2-Cys Prxs. We therefore propose that modulation by NO of Prx expression and redox state, as well as up-regulation of Srx expression, constitutes a novel pathway that contributes to antioxidant response and control of H2O2 mediated signal transduction in mammals.	CNRS, ICSN, F-91190 Gif Sur Yvette, France; Commiss Energie Atom Saclay, Inst Biol & Technol Saclay, Lab Stress Oxydants & Canc, F-91190 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay	Drapier, JC (corresponding author), CNRS, ICSN, Bat 27,Ave Terrasse, F-91190 Gif Sur Yvette, France.	drapier@icsn.cnrs-gif.fr	Bouton, Cecile/J-8663-2013; Flora, Tomasello Marianna/E-9527-2018	Flora, Tomasello Marianna/0000-0001-6745-2181				Becker K, 1998, NAT STRUCT BIOL, V5, P267, DOI 10.1038/nsb0498-267; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Blanc A, 2003, INT J MOL MED, V11, P229; Bloodsworth A, 2000, ARTERIOSCL THROM VAS, V20, P1707, DOI 10.1161/01.ATV.20.7.1707; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; Bryk R, 2000, NATURE, V407, P211, DOI 10.1038/35025109; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Chang TS, 2004, J BIOL CHEM, V279, P50994, DOI 10.1074/jbc.M409482200; Chevallet M, 2003, J BIOL CHEM, V278, P37146, DOI 10.1074/jbc.M305161200; Cho SH, 2004, FEBS LETT, V560, P7, DOI 10.1016/S0014-5793(04)00112-7; Cordray P, 2007, J BIOL CHEM, V282, P32623, DOI 10.1074/jbc.M704369200; Dhakshinamoorthy S, 2004, J BIOL CHEM, V279, P20096, DOI 10.1074/jbc.M312492200; Dubuisson M, 2004, FEBS LETT, V571, P161, DOI 10.1016/j.febslet.2004.06.080; Espey MG, 2002, ANN NY ACAD SCI, V962, P195, DOI 10.1111/j.1749-6632.2002.tb04068.x; Fernandez-Tome P, 1999, NEUROPHARMACOLOGY, V38, P1307, DOI 10.1016/S0028-3908(99)00069-6; Finkel T, 1998, CURR OPIN CELL BIOL, V10, P248, DOI 10.1016/S0955-0674(98)80147-6; Forman Henry Jay, 2001, Molecular Aspects of Medicine, V22, P189; Forman HJ, 2002, MOL CELL BIOCHEM, V234, P49, DOI 10.1023/A:1015913229650; Gallagher BM, 2007, FREE RADICAL BIO MED, V42, P1270, DOI 10.1016/j.freeradbiomed.2007.01.023; Gorbunov NV, 1997, J BIOL CHEM, V272, P12328, DOI 10.1074/jbc.272.19.12328; Hogg N, 1999, BBA-BIOENERGETICS, V1411, P378, DOI 10.1016/S0005-2728(99)00027-4; Immenschuh S, 1999, HEPATOLOGY, V30, P118, DOI 10.1002/hep.510300142; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; KANNER J, 1991, ARCH BIOCHEM BIOPHYS, V289, P130, DOI 10.1016/0003-9861(91)90452-O; Kim YJ, 2007, CANCER RES, V67, P546, DOI 10.1158/0008-5472.CAN-06-2401; Klatt P, 2000, EUR J BIOCHEM, V267, P4928, DOI 10.1046/j.1432-1327.2000.01601.x; Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Leslie NR, 2003, EMBO J, V22, P5501, DOI 10.1093/emboj/cdg513; Moncada S, 2006, J NEUROCHEM, V97, P1676, DOI 10.1111/j.1471-4159.2006.03988.x; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Nathan C, 2004, SCI STKE, V2004, pe52; Noguchi T, 2003, BIOCHEMISTRY-US, V42, P11642, DOI 10.1021/bi035260i; Park EY, 2005, METHOD ENZYMOL, V396, P341, DOI 10.1016/S0076-6879(05)96028-X; Parsonage D, 2005, BIOCHEMISTRY-US, V44, P10583, DOI 10.1021/bi050448i; Pervin S, 2001, P NATL ACAD SCI USA, V98, P3583, DOI 10.1073/pnas.041603998; Peskin AV, 2007, J BIOL CHEM, V282, P11885, DOI 10.1074/jbc.M700339200; Phalen TJ, 2006, J CELL BIOL, V175, P779, DOI 10.1083/jcb.200606005; Rabilloud T, 2002, J BIOL CHEM, V277, P19396, DOI 10.1074/jbc.M106585200; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; Sun JH, 2006, ANTIOXID REDOX SIGN, V8, P1693, DOI 10.1089/ars.2006.8.1693; Thomas DD, 2002, METHOD ENZYMOL, V359, P84; Thomas DD, 2006, J BIOL CHEM, V281, P25984, DOI 10.1074/jbc.M602242200; West MB, 2006, FASEB J, V20, P1715, DOI 10.1096/fj.06-5843fje; WINK DA, 1993, P NATL ACAD SCI USA, V90, P9813, DOI 10.1073/pnas.90.21.9813; Woo HA, 2005, J BIOL CHEM, V280, P3125, DOI 10.1074/jbc.C400496200; Woo HA, 2003, J BIOL CHEM, V278, P47361, DOI 10.1074/jbc.C300428200; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200	52	81	84	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36199	36205		10.1074/jbc.M706420200	http://dx.doi.org/10.1074/jbc.M706420200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17921138	hybrid			2022-12-25	WOS:000251458300009
J	Grunberg, S; Bartlett, MS; Naji, S; Thomm, M				Grunberg, Sebastian; Bartlett, Michael S.; Naji, Souad; Thomm, Michael			Transcription factor E is a part of transcription elongation complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; ARCHAEAL TRANSCRIPTION; PREINITIATION COMPLEX; BASAL TRANSCRIPTION; INITIATION COMPLEX; TFIIE-ALPHA; PROMOTER CLEARANCE; CROSS-LINKING; DNA; REVEALS	A homologue of the N-terminal domain of the alpha subunit of the general eukaryotic transcription factor TFE is encoded in the genomes of all sequenced archaea, but the position of archaeal TFE in transcription complexes has not yet been defined. We show here that TFE binds nonspecifically to single-stranded DNA, and photochemical cross-linking revealed TFE binding to a preformed open transcription bubble. In preinitiation complexes, the N-terminal part of TFE containing a winged helix-turn-helix motif is cross-linked specifically to DNA of the non-template DNA strand at positions -9 and -11. In complexes stalled at +20, TFE cross-linked specifically to positions +9, +11, and +16 of the non-template strand. Analyses of transcription complexes stalled at position +20 revealed a TFE-dependent increase of the resumption efficiency of stalled RNA polymerase and a TFE-induced enhanced permanganate sensitivity of thymine residues in the transcription bubble. These results demonstrate the presence of TFE in early elongation complexes and suggest a role of TFE in stabilization of the transcription bubble during elongation.	Portland State Univ, Dept Biol, Portland, OR 97207 USA; Univ Regensburg, Lehrstuhl Mikrobiol, D-93053 Regensburg, Germany	Portland State University; University of Regensburg	Bartlett, MS (corresponding author), Portland State Univ, Dept Biol, POB 751, Portland, OR 97207 USA.	micb@pdx.edu		Grunberg, Sebastian/0000-0002-5694-0574				Bartholomew B, 1995, METHOD ENZYMOL, V262, P476; Bartlett MS, 2000, NAT STRUCT BIOL, V7, P782, DOI 10.1038/79020; Bartlett MS, 2005, CURR OPIN MICROBIOL, V8, P677, DOI 10.1016/j.mib.2005.10.016; Bartlett MS, 2004, J BIOL CHEM, V279, P5894, DOI 10.1074/jbc.M311429200; Bell SD, 2001, EMBO REP, V2, P133, DOI 10.1093/embo-reports/kve021; Chen HT, 2007, NAT STRUCT MOL BIOL, V14, P696, DOI 10.1038/nsmb1272; Dvir A, 1997, J BIOL CHEM, V272, P28175, DOI 10.1074/jbc.272.45.28175; Dvir A, 1997, P NATL ACAD SCI USA, V94, P9006, DOI 10.1073/pnas.94.17.9006; Dvir A, 2002, BBA-GENE STRUCT EXPR, V1577, P208, DOI 10.1016/S0167-4781(02)00453-0; Forget D, 2004, MOL CELL BIOL, V24, P1122, DOI 10.1128/MCB.24.3.1122-1131.2004; Geiduschek EP, 2005, MOL MICROBIOL, V56, P1397, DOI 10.1111/j.1365-2958.2005.04627.x; GOODRICH JA, 1994, CELL, V77, P145, DOI 10.1016/0092-8674(94)90242-9; Hanzelka BL, 2001, J BACTERIOL, V183, P1813, DOI 10.1128/JB.183.5.1813-1818.2001; Holstege FCP, 1996, EMBO J, V15, P1666, DOI 10.1002/j.1460-2075.1996.tb00512.x; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; Kuldell NH, 1997, MOL CELL BIOL, V17, P5288, DOI 10.1128/MCB.17.9.5288; MAXON ME, 1994, GENE DEV, V8, P515, DOI 10.1101/gad.8.5.515; Meinhart A, 2003, J BIOL CHEM, V278, P48267, DOI 10.1074/jbc.M307874200; Miller G, 2006, NAT STRUCT MOL BIOL, V13, P603, DOI 10.1038/nsmb1117; Naji S, 2007, J BIOL CHEM, V282, P11047, DOI 10.1074/jbc.M611674200; OHKUMA Y, 1994, NATURE, V368, P160, DOI 10.1038/368160a0; OHKUMA Y, 1990, P NATL ACAD SCI USA, V87, P9163, DOI 10.1073/pnas.87.23.9163; OHKUMA Y, 1995, MOL CELL BIOL, V15, P4856; Ohkuma Y, 1997, J BIOCHEM-TOKYO, V122, P481; Ouhammouch M, 2004, J BIOL CHEM, V279, P51719, DOI 10.1074/jbc.C400446200; PARVIN JD, 1993, CELL, V73, P53; Robert F, 1996, J BIOL CHEM, V271, P8517, DOI 10.1074/jbc.271.15.8517; Spitalny P, 2003, J BIOL CHEM, V278, P30497, DOI 10.1074/jbc.M303633200; Thomm M, 2007, ARCHAEA: MOLECULAR AND CELLULAR BIOLOGY, P139; Werner F, 2005, MOL CELL BIOL, V25, P8344, DOI 10.1128/MCB.25.18.8344-8355.2005; ZAWEL L, 1995, GENE DEV, V9, P1479, DOI 10.1101/gad.9.12.1479	31	41	41	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35482	35490		10.1074/jbc.M707371200	http://dx.doi.org/10.1074/jbc.M707371200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17921145	hybrid			2022-12-25	WOS:000251458100007
J	Zhang, J				Zhang, Jiandi			The direct involvement of SirT1 in insulin-induced insulin receptor substrate-2 tyrosine phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE-HOMEOSTASIS; INCREASED DOSAGE; CELL-SURVIVAL; LIFE-SPAN; IRS-2; TRANSCRIPTION; PROTEIN; ADIPOCYTES; REGULATOR; SECRETION	NAD(+)-dependent Sir2 family deacetylases and insulin signaling pathway are both conserved across species to regulate aging process. The interplay between these two genetic programs is investigated in this study. Protein deacetylase activity of SirT1, the mammalian homologue of Sir2, was suppressed through either nicotinamide treatment or RNA interference in several cell lines, and these cells displayed impaired insulin responses. Suppression of SirT1 activity also selectively inhibited insulin-induced tyrosine phosphorylation of insulin receptor substrate 2(IRS-2), whereas it had minimal effect on that of IRS-1. Further analyses showed that both IRS-1 and IRS-2 interacted with SirT1, and the acetylation level of IRS-2 was down-regulated by insulin treatment. Inhibition of SirT1 activity prevented deacetylation and insulin-induced tyrosine phosphorylation of IRS-2. Mutations of four lysine residues to alanine in IRS-2 protein, on the other hand, led to its reduced basal level acetylation and insulin-induced tyrosine phosphorylation. These results suggest a possible regulatory effect of SirT1 on insulin-induced tyrosine phosphorylation of IRS-2, a vital step in insulin signaling pathway, through deacetylation of IRS-2 protein. More importantly, this study may imply a pathway through which Sir2 family protein deacetylases and insulin signaling pathway jointly regulate various metabolic processes, including aging and diabetes.	Univ Texas SW Med Ctr Dallas, Ctr Human Nutr, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhang, J (corresponding author), Rigel Pharmaceut Co, 1180 Vet Blvd, San Francisco, CA 94080 USA.	jiandi.zhang@gmail.com		zhang, jiandi/0000-0002-9282-9443				Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Bouzakri K, 2006, CELL METAB, V4, P89, DOI 10.1016/j.cmet.2006.04.008; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Burks DJ, 2000, NATURE, V407, P377, DOI 10.1038/35030105; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Deng XQ, 2007, LIVER INT, V27, P708, DOI 10.1111/j.1478-3231.2007.01497.x; Dong XC, 2006, J CLIN INVEST, V116, P101, DOI 10.1172/JCI25735; Fontana L, 2004, P NATL ACAD SCI USA, V101, P6659, DOI 10.1073/pnas.0308291101; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Inoue G, 1998, J BIOL CHEM, V273, P11548, DOI 10.1074/jbc.273.19.11548; Kahn CR, 1996, ANNU REV MED, V47, P509; Kerouz NJ, 1997, J CLIN INVEST, V100, P3164, DOI 10.1172/JCI119872; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Neganova I, 2007, BIOL REPROD, V76, P1045, DOI 10.1095/biolreprod.106.059360; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Pagans S, 2005, PLOS BIOL, V3, P210, DOI 10.1371/journal.pbio.0030041; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rui LY, 2001, J BIOL CHEM, V276, P40362, DOI 10.1074/jbc.M105332200; Sommer M, 2006, CELL CYCLE, V5, P2005, DOI 10.4161/cc.5.17.3194; SUN XJ, 1995, NATURE, V377, P173, DOI 10.1038/377173a0; Taniguchi CM, 2005, J CLIN INVEST, V115, P718, DOI 10.1172/JCI200523187; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Wolkow CA, 2002, J BIOL CHEM, V277, P49591, DOI 10.1074/jbc.M207866200; Wong S, 2007, BIOCHEM J, V407, P451, DOI 10.1042/BJ20070151; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Zhang JD, 2006, BIOCHEM J, V397, P519, DOI 10.1042/BJ20050977	40	134	146	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34356	34364		10.1074/jbc.M706644200	http://dx.doi.org/10.1074/jbc.M706644200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17901049	hybrid			2022-12-25	WOS:000251145700051
J	Baek, JH; Liu, YV; McDonald, KR; Wesley, JB; Zhang, HF; Semenza, GL				Baek, Jin H.; Liu, Ye V.; McDonald, Karin R.; Wesley, Jacob B.; Zhang, Huafeng; Semenza, Gregg L.			Spermidine/spermine N-1-acetyltransferase-1 binds to hypoxia-inducible factor-1 alpha (HIF-1 alpha) and RACK1 and promotes ubiquitination and degradation of HIF-1 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN-DEPENDENT DEGRADATION; FACTOR-I; TRANSCRIPTIONAL ACTIVITY; GENE-EXPRESSION; FACTOR 1-ALPHA; CANCER CELLS; HIF-1; VHL; PROTEIN; HYPOXIA-INDUCIBLE-FACTOR-1-ALPHA	Hypoxia-inducible factor-1 (HIF-1) is a master regulator of oxygen homeostasis that controls the expression of genes encoding proteins that play key roles in angiogenesis, erythropoiesis, and glucose/energy metabolism. The stability of the HIF-1 alpha subunit is regulated by ubiquitination and proteasomal degradation. In aerobic cells, O-2-dependent prolyl hydroxylation of HIF-1 alpha is required for binding of the von Hippel-Lindau tumor suppressor protein VHL, which then recruits the Elongin C ubiquitin-ligase complex. SSAT2 (spermidine/spermine N-acetyltransferase-2) binds to HIF-1 alpha and promotes its ubiquitination/degradation by stabilizing the interaction of VHL and Elongin C. Treatment of cells with heat shock protein HSP90 inhibitors induces the degradation of HIF-1 alpha even under hypoxic conditions. HSP90 competes with RACK1 for binding to HIF-1 alpha, and HSP90 inhibition leads to increased binding of RACK1, which recruits the Elongin C ubiquitin-ligase complex to HIF-1 alpha in an O-2-independent manner. In this work, we demonstrate that SSAT1, which shares 46% amino acid identity with SSAT2, also binds to HIF-1 alpha and promotes its ubiquitination/degradation. However, in contrast to SSAT2, SSAT1 acts by stabilizing the interaction of HIF-1 alpha with RACK1. Thus, the paralogs SSAT1 and SSAT2 play complementary roles in promoting O-2-independent and O-2-dependent degradation of HIF-1 alpha.	Johns Hopkins Univ, Sch Med, Mckusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Inst Cell Engn, Vasc Program, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Radiat Oncol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Semenza, GL (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Vasc Program, 733 N Broadway,Suite 671, Baltimore, MD 21205 USA.	gsemenza@jhmi.edu	Zhang, Huafeng/A-7188-2012		DIVISION OF HEART AND VASCULAR DISEASES [N01HV028180] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HV-28180, R01-HL-553308] Funding Source: Medline	DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allen WL, 2007, MOL CANCER THER, V6, P128, DOI 10.1158/1535-7163.MCT-06-0303; Baek JH, 2005, MOL CELL, V17, P503, DOI 10.1016/j.molcel.2005.01.011; Baek JH, 2007, J BIOL CHEM, V282, P23572, DOI 10.1074/jbc.M703504200; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bewley MC, 2006, P NATL ACAD SCI USA, V103, P2063, DOI 10.1073/pnas.0511008103; Brahimi-Horn MC, 2007, BIOCHEM PHARMACOL, V73, P450, DOI 10.1016/j.bcp.2006.10.013; Chan DA, 2005, MOL CELL BIOL, V25, P6415, DOI 10.1128/MCB.25.15.6415-6426.2005; Chan DA, 2007, CANCER METAST REV, V26, P333, DOI 10.1007/s10555-007-9063-1; Coleman CS, 1996, BIOCHEM J, V316, P697, DOI 10.1042/bj3160697; Comerford KM, 2002, CANCER RES, V62, P3387; Ehrismann D, 2007, BIOCHEM J, V401, P227, DOI 10.1042/BJ20061151; Elvidge GP, 2006, J BIOL CHEM, V281, P15215, DOI 10.1074/jbc.M511408200; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Gillies RJ, 2007, CANCER METAST REV, V26, P311, DOI 10.1007/s10555-007-9065-z; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Jewell UR, 2001, FASEB J, V15, P1312, DOI 10.1096/fj.00-0732fje; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Jiang BH, 1997, J BIOL CHEM, V272, P19253, DOI 10.1074/jbc.272.31.19253; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kim JW, 2007, CANCER METAST REV, V26, P291, DOI 10.1007/s10555-007-9060-4; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Koivunen P, 2006, J BIOL CHEM, V281, P28712, DOI 10.1074/jbc.M604628200; Kong XG, 2006, MOL CELL BIOL, V26, P2019, DOI 10.1128/MCB.26.6.2019-2028.2006; Kong XG, 2007, J BIOL CHEM, V282, P15498, DOI 10.1074/jbc.M700704200; Kong XG, 2006, FEBS LETT, V580, P6182, DOI 10.1016/j.febslet.2006.10.019; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Lu L, 1996, J BIOL CHEM, V271, P18920, DOI 10.1074/jbc.271.31.18920; Mabjeesh NJ, 2002, CANCER RES, V62, P2478; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; McNeill LA, 2002, BIOORG MED CHEM LETT, V12, P1547, DOI 10.1016/S0960-894X(02)00219-6; Melillo G, 2007, CANCER METAST REV, V26, P341, DOI 10.1007/s10555-007-9059-x; Moeller BJ, 2007, CANCER METAST REV, V26, P241, DOI 10.1007/s10555-007-9056-0; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Poellinger L, 2004, CURR OPIN GENET DEV, V14, P81, DOI 10.1016/j.gde.2003.12.006; Pugh CW, 1997, J BIOL CHEM, V272, P11205; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Sullivan R, 2007, CANCER METAST REV, V26, P319, DOI 10.1007/s10555-007-9062-2; Unruh A, 2003, ONCOGENE, V22, P3213, DOI 10.1038/sj.onc.1206385; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Yu AY, 1998, AM J PHYSIOL-LUNG C, V275, pL818, DOI 10.1152/ajplung.1998.275.4.L818; Zagzag D, 2000, CANCER-AM CANCER SOC, V88, P2606, DOI 10.1002/1097-0142(20000601)88:11<2606::AID-CNCR25>3.0.CO;2-W; Zhong H, 1999, CANCER RES, V59, P5830	47	58	61	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33358	33366		10.1074/jbc.M705627200	http://dx.doi.org/10.1074/jbc.M705627200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17875644	hybrid			2022-12-25	WOS:000250840200015
J	Kanai, T; Akerboom, J; Takedomi, S; van de Werken, HJG; Blombach, F; van der Oost, J; Murakami, T; Atomi, H; Imanaka, T				Kanai, Tamotsu; Akerboom, Jasper; Takedomi, Shogo; van de Werken, Harmen J. G.; Blombach, Fabian; van der Oost, John; Murakami, Taira; Atomi, Haruyuki; Imanaka, Tadayuki			A global transcriptional regulator in Thermococcus kodakaraensis controls the expression levels of both glycolytic and gluconeogenic enzyme-encoding genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARCHAEON PYROCOCCUS-FURIOSUS; EMBDEN-MEYERHOF PATHWAY; ADP-DEPENDENT PHOSPHOFRUCTOKINASE; CENTRAL CARBOHYDRATE-METABOLISM; HYPERTHERMOPHILIC ARCHAEON; THERMOPROTEUS-TENAX; ESCHERICHIA-COLI; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; ABC TRANSPORTER; BINDING PROTEIN	We identified a novel regulator, Thermococcales glycolytic regulator (Tgr), functioning as both an activator and a repressor of transcription in the hyperthermophilic archaeon Thermococcus kodakaraensis KOD1. Tgr (TK1769) displays similarity (28% identical) to Pyrococcus furiosus TrmB (PF1743), a transcriptional repressor regulating the trehalose/maltose ATP-binding cassette transporter genes, but is more closely related (67%) to a TrmB paralog in P. furiosus (PF0124). Growth of a tgr disruption strain (Delta tgr) displayed a significant decrease in growth rate under gluconeogenic conditions compared with the wild-type strain, whereas comparable growth rates were observed under glycolytic conditions. A whole genome microarray analysis revealed that transcript levels of almost all genes related to glycolysis and maltodextrin metabolism were at relatively high levels in the Delta tgr mutant even under gluconeogenic conditions. The Delta tgr mutant also displayed defects in the transcriptional activation of gluconeogenic genes under these conditions, indicating that Tgr functions as both an activator and a repressor. Genes regulated by Tgr contain a previously identified sequence motif, the Thermococcales glycolytic motif (TGM). The TGM was positioned upstream of the Transcription factor B-responsive element (BRE)/TATA sequence in gluconeogenic promoters and downstream of it in glycolytic promoters. Electrophoretic mobility shift assay indicated that recombinant Tgr protein specifically binds to promoter regions containing a TGM. Tgr was released from the DNA when maltotriose was added, suggesting that this sugar is most likely the physiological effector. Our results strongly suggest that Tgr is a global transcriptional regulator that simultaneously controls, in response to sugar availability, both glycolytic and gluconeogenic metabolism in T. kodakaraensis via its direct binding to the TGM.	Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Nishikyo Ku, Kyoto 6158510, Japan; Wageningen Univ, Dept Agrotechnol & Food Sci, Microbiol Lab, NL-6703 HB Wageningen, Netherlands	Kyoto University; Wageningen University & Research	Imanaka, T (corresponding author), Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Nishikyo Ku, Kyoto 6158510, Japan.	imanaka@sbchem.kyoto-u.ac.jp	van+der+Oost, John/Y-2548-2019; Werken, Harmen van de/G-8979-2013; Kanai, Tamotsu/I-5842-2012; Blombach, Fabian/AAT-9241-2020	Werken, Harmen van de/0000-0002-9794-1477; Kanai, Tamotsu/0000-0003-3537-2114; Blombach, Fabian/0000-0001-5337-8662; Atomi, Haruyuki/0000-0001-9687-6426				Atomi Haruyuki, 2004, Archaea, V1, P263, DOI 10.1155/2004/204953; Baliga NS, 1999, J BACTERIOL, V181, P2513, DOI 10.1128/JB.181.8.2513-2518.1999; BLANGY D, 1968, J MOL BIOL, V31, P13, DOI 10.1016/0022-2836(68)90051-X; Brinkman AB, 2002, J BIOL CHEM, V277, P29537, DOI 10.1074/jbc.M203528200; Brunner NA, 1998, J BIOL CHEM, V273, P6149, DOI 10.1074/jbc.273.11.6149; Brunner NA, 2001, EXTREMOPHILES, V5, P101, DOI 10.1007/s007920100181; DiRuggiero J, 2000, MOL MICROBIOL, V38, P684, DOI 10.1046/j.1365-2958.2000.02161.x; FRAENKEL DG, 1966, ARCH BIOCHEM BIOPHYS, V114, P4, DOI 10.1016/0003-9861(66)90298-0; FRAENKEL DG, 1987, ESCHERICHIA COLI SAL, V1, P142; Fukui T, 2005, GENOME RES, V15, P352, DOI 10.1101/gr.3003105; Goncalves P, 1998, TRENDS MICROBIOL, V6, P314, DOI 10.1016/S0966-842X(98)01305-5; Imanaka H, 2006, MOL MICROBIOL, V61, P898, DOI 10.1111/j.1365-2958.2006.05287.x; Itoh T, 2003, J BIOSCI BIOENG, V96, P203, DOI 10.1263/jbb.96.203; Kanai T, 2005, J BIOTECHNOL, V116, P271, DOI 10.1016/j.jbiotec.2004.11.002; KENGEN SWM, 1994, J BIOL CHEM, V269, P17537; Kengen SWM, 1995, J BIOL CHEM, V270, P30453, DOI 10.1074/jbc.270.51.30453; Kletzin A, 1996, FEMS MICROBIOL REV, V18, P5, DOI 10.1016/0168-6445(95)00025-9; Koning Sonja M., 2002, Archaea, V1, P19, DOI 10.1155/2002/529610; Krug M, 2006, J BIOL CHEM, V281, P10976, DOI 10.1074/jbc.M512809200; Lee HS, 2006, J BACTERIOL, V188, P2115, DOI 10.1128/JB.188.6.2115-2125.2006; Lee SJ, 2005, MOL MICROBIOL, V57, P1797, DOI 10.1111/j.1365-2958.2005.04804.x; Lee SJ, 2003, J BIOL CHEM, V278, P983, DOI 10.1074/jbc.M210236200; Lee SJ, 2007, MOL MICROBIOL, V65, P305, DOI 10.1111/j.1365-2958.2007.05780.x; Lee SJ, 2007, MOL MICROBIOL, V64, P1499, DOI 10.1111/j.1365-2958.2007.05737.x; Lorentzen E, 2004, J MOL BIOL, V341, P815, DOI 10.1016/j.jmb.2004.05.032; Matsumi R, 2007, J BACTERIOL, V189, P2683, DOI 10.1128/JB.01692-06; MORIKAWA M, 1994, APPL ENVIRON MICROB, V60, P4559, DOI 10.1128/AEM.60.12.4559-4566.1994; MUKUND S, 1995, J BIOL CHEM, V270, P8389, DOI 10.1074/jbc.270.15.8389; Murakami T, 2006, J BACTERIOL, V188, P5915, DOI 10.1128/JB.00390-06; Oh MK, 2002, J BIOL CHEM, V277, P13175, DOI 10.1074/jbc.M110809200; Orita I, 2006, J BACTERIOL, V188, P4698, DOI 10.1128/JB.00492-06; Ouhammouch M, 2005, MOL MICROBIOL, V56, P625, DOI 10.1111/j.1365-2958.2005.04563.x; Ouhammouch M, 2004, J BIOL CHEM, V279, P51719, DOI 10.1074/jbc.C400446200; Ouhammouch M, 2003, P NATL ACAD SCI USA, V100, P5097, DOI 10.1073/pnas.0837150100; Rashid N, 2004, J BACTERIOL, V186, P6070, DOI 10.1128/jb.186.18.6070-6076.2004; Rashid N, 2002, J BIOL CHEM, V277, P30649, DOI 10.1074/jbc.M202868200; Robb Frank T., 1995, P167; Romeo T, 1998, MOL MICROBIOL, V29, P1321, DOI 10.1046/j.1365-2958.1998.01021.x; Ronimus RS, 1999, EXTREMOPHILES, V3, P121, DOI 10.1007/s007920050107; Saier MH, 1996, J BACTERIOL, V178, P3411, DOI 10.1128/jb.178.12.3411-3417.1996; Santangelo TJ, 2007, J MOL BIOL, V367, P344, DOI 10.1016/j.jmb.2006.12.069; Sato T, 2005, APPL ENVIRON MICROB, V71, P3889, DOI 10.1128/AEM.71.7.3889-3899.2005; Sato T, 2004, J BACTERIOL, V186, P5799, DOI 10.1128/JB.186.17.5799-5807.2004; Sato T, 2003, J BACTERIOL, V185, P210, DOI 10.1128/JB.185.1.210-220.2003; SCHAFER T, 1993, ARCH MICROBIOL, V159, P354, DOI 10.1007/BF00290918; Schut GJ, 2003, J BACTERIOL, V185, P3935, DOI 10.1128/JB.185.13.3935-3947.2003; Siebers B, 2005, CURR OPIN MICROBIOL, V8, P695, DOI 10.1016/j.mib.2005.10.014; Siebers B, 2004, J BACTERIOL, V186, P2179, DOI 10.1128/JB.186.7.2179-2194.2004; Siebers B, 2001, J BIOL CHEM, V276, P28710, DOI 10.1074/jbc.M103447200; Tjaden B, 2006, MOL MICROBIOL, V60, P287, DOI 10.1111/j.1365-2958.2006.05098.x; Tuininga JE, 1999, J BIOL CHEM, V274, P21023, DOI 10.1074/jbc.274.30.21023; van de Werken HJG, 2006, FEMS MICROBIOL LETT, V260, P69, DOI 10.1111/j.1574-6968.2006.00292.x; van der Oost J, 1998, J BIOL CHEM, V273, P28149, DOI 10.1074/jbc.273.43.28149; Verhees CH, 2003, BIOCHEM J, V375, P231, DOI 10.1042/BJ20021472; Verhees CH, 2001, J BIOL CHEM, V276, P40926, DOI 10.1074/jbc.M104603200; WAYGOOD EB, 1976, BIOCHEMISTRY-US, V15, P277, DOI 10.1021/bi00647a006	56	67	68	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46							33659	10.1074/jbc.M703424200	http://dx.doi.org/10.1074/jbc.M703424200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17875647	hybrid			2022-12-25	WOS:000250840200047
J	Goswami, A				Goswami, Anjali			Phylogeny, Diet, and Cranial Integration in Australodelphian Marsupials	PLOS ONE			English	Article							PHENOTYPIC COVARIANCE STRUCTURE; MORPHOLOGICAL INTEGRATION; DEVELOPMENTAL INTEGRATION; CRANIOFACIAL DEVELOPMENT; MATRIX CORRELATION; VARIATION PATTERNS; CLADISTIC-ANALYSIS; EVOLUTION; MODULARITY; HETEROCHRONY	Studies of morphological integration provide valuable information on the correlated evolution of traits and its relationship to long-term patterns of morphological evolution. Thus far, studies of morphological integration in mammals have focused on placentals and have demonstrated that similarity in integration is broadly correlated with phylogenetic distance and dietary similarity. Detailed studies have also demonstrated a significant correlation between developmental relationships among structures and adult morphological integration. However, these studies have not yet been applied to marsupial taxa, which differ greatly from placentals in reproductive strategy and cranial development and could provide the diversity necessary to assess the relationships among phylogeny, ecology, development, and cranial integration. This study presents analyses of morphological integration in 20 species of australodelphian marsupials, and shows that phylogeny is significantly correlated with similarity of morphological integration in most clades. Size-related correlations have a significant affect on results, particularly in Peramelia, which shows a striking decrease in similarity of integration among species when size is removed. Diet is not significantly correlated with similarity of integration in any marsupial clade. These results show that marsupials differ markedly from placental mammals in the relationships of cranial integration, phylogeny, and diet, which may be related to the accelerated development of the masticatory apparatus in marsupials.	[Goswami, Anjali] Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA; [Goswami, Anjali] Field Museum, Dept Geol, Chicago, IL USA	University of Chicago; Field Museum of Natural History (Chicago)	Goswami, A (corresponding author), Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England.	agos06@esc.cam.ac.uk	Goswami, Anjali/B-3440-2010		National Science Foundation [0308765]; Field Museum's Women-in-Science Fellowship; Society of Vertebrate Paleontology Predoctoral Fellowship; American Museum of Natural History; University of Chicago Hinds Fund	National Science Foundation(National Science Foundation (NSF)); Field Museum's Women-in-Science Fellowship; Society of Vertebrate Paleontology Predoctoral Fellowship; American Museum of Natural History; University of Chicago Hinds Fund	This research was supported by the National Science Foundation under Grant # 0308765, the Field Museum's Women-in-Science Fellowship, the Society of Vertebrate Paleontology Predoctoral Fellowship, the American Museum of Natural History collections study grant, and the University of Chicago Hinds Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann RR, 2000, AM J PHYS ANTHROPOL, V111, P489, DOI 10.1002/(SICI)1096-8644(200004)111:4<489::AID-AJPA5>3.0.CO;2-U; Ackermann RR, 2004, PHENOTYPIC INTEGRATION: STUDYING THE ECOLOGY AND EVOLUTION OF COMPLEX PHENOTYPES, P302; Amrine-Madsen H, 2003, MOL PHYLOGENET EVOL, V28, P186, DOI 10.1016/S1055-7903(03)00122-2; [Anonymous], 1999, WALKERS MAMMALS WORL; Asher RJ, 2004, MOL PHYLOGENET EVOL, V33, P240, DOI 10.1016/j.ympev.2004.05.004; Baker Michelle L., 2004, Journal of Mammalian Evolution, V11, P1, DOI 10.1023/B:JOMM.0000029143.39776.ec; Bolker JA, 2000, AM ZOOL, V40, P770, DOI 10.1668/0003-1569(2000)040[0770:MIDAWI]2.0.CO;2; CHEVERUD JM, 1982, EVOLUTION, V36, P499, DOI 10.1111/j.1558-5646.1982.tb05070.x; CHEVERUD JM, 1989, EVOLUTION, V43, P1737, DOI 10.1111/j.1558-5646.1989.tb02623.x; CHEVERUD JM, 1995, AM NAT, V145, P63, DOI 10.1086/285728; Cheverud JM, 1996, AM ZOOL, V36, P44; Emerson SB, 1998, Q REV BIOL, V73, P141, DOI 10.1086/420182; Goswami A, 2006, EVOLUTION, V60, P169; Goswami A, 2007, EVOL DEV, V9, P290, DOI 10.1111/j.1525-142X.2007.00161.x; Goswami A, 2006, AM NAT, V168, P270, DOI 10.1086/505758; Groves C.P., 1990, P1; Horovitz I, 2003, CLADISTICS, V19, P181, DOI 10.1016/S0748-3007(03)00045-8; Klingenberg CP, 2003, EVOL DEV, V5, P522, DOI 10.1046/j.1525-142X.2003.03057.x; Klingenberg CP, 1996, SYST BIOL, V45, P135, DOI 10.2307/2413611; KRAJEWSKI C, 2000, ZOOL J LINN SOC, V130; MANLY B, 1997, RANDOMIZATION BOOTST, P488; Marroig G, 2004, J EVOLUTION BIOL, V17, P144, DOI 10.1046/j.1420-9101.2003.00653.x; Marroig G, 2001, EVOLUTION, V55, P2576; MYERS P, 2000, CARNIVORA; Nilsson MA, 2004, GENE, V340, P189, DOI 10.1016/j.gene.2004.07.040; Nunn CL, 1998, AM NAT, V152, P82, DOI 10.1086/286151; Olson E. C., 1958, MORPHOLOGICAL INTEGR; Pigliucci M., 2004, PHENOTYPIC INTEGRATI; Ruedas LA, 2005, J MAMMAL, V86, P353, DOI 10.1644/BER-117.1; Schlosser G, 2004, MODULARITY IN DEVELOPMENT AND EVOLUTION, P1; Smith KK, 2006, DEV DYNAM, V235, P1181, DOI 10.1002/dvdy.20676; Smith KK, 2001, BIOL J LINN SOC, V73, P169, DOI 10.1006/bijl.2001.0535; Smith KK, 2001, J ANAT, V199, P121, DOI 10.1017/S0021878201008202; Smith KK, 1997, EVOLUTION, V51, P1663, DOI 10.1111/j.1558-5646.1997.tb01489.x; Steppan SJ, 2004, PHENOTYPIC INTEGRATION: STUDYING THE ECOLOGY AND EVOLUTION OF COMPLEX PHENOTYPES, P325; Steppan SJ, 1997, EVOLUTION, V51, P571, DOI 10.1111/j.1558-5646.1997.tb02444.x; Steppan SJ, 1997, EVOLUTION, V51, P587, DOI 10.1111/j.1558-5646.1997.tb02445.x; Szalay F. S., 1994, EVOLUTIONARY HIST MA; VERMEIJ GJ, 1973, SYST ZOOL, V22, P466, DOI 10.2307/2412953; Wagner GP, 1996, AM ZOOL, V36, P36; Wagner GP, 1995, LECT NOTES ARTIF INT, V929, P317; Wagner GP, 1996, EVOLUTION, V50, P967, DOI 10.1111/j.1558-5646.1996.tb02339.x; Westerman Michael, 1999, Journal of Mammalian Evolution, V6, P271, DOI 10.1023/A:1020565724799; Wroe S, 2000, J MAMMAL, V81, P1008, DOI 10.1644/1545-1542(2000)081<1008:CAODMP>2.0.CO;2; Wroe S, 2007, EVOLUTION, V61, P1251, DOI 10.1111/j.1558-5646.2007.00101.x; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR, P443; Zelditch ML, 2001, BEYOND HETEROCHRONY, P145; ZELDITCH ML, 1988, EVOLUTION, V42, P28, DOI 10.1111/j.1558-5646.1988.tb04105.x; Zelditch ML, 2004, PHENOTYPIC INTEGRATION: STUDYING THE ECOLOGY AND EVOLUTION OF COMPLEX PHENOTYPES, P274; ZELDITCH ML, 1989, EVOLUTION, V43, P814, DOI 10.1111/j.1558-5646.1989.tb05179.x; ZELDITCH ML, 1989, J MAMMAL, V70, P477, DOI 10.2307/1381419	51	29	29	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e995	10.1371/journal.pone.0000995	http://dx.doi.org/10.1371/journal.pone.0000995			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912372	gold, Green Published, Green Submitted			2022-12-25	WOS:000207455900031
J	Ni, M; Yu, JH				Ni, Min; Yu, Jae-Hyuk			A Novel Regulator Couples Sporogenesis and Trehalose Biogenesis in Aspergillus nidulans	PLOS ONE			English	Article								Trehalose is a compatible osmolyte produced by bacteria, fungi, insects and plants to protect the integrity of cells against various environmental stresses. Spores, the reproductive, survival and infection bodies of fungi require high amounts of trehalose for long-term survival. Here, via a gain-of-function genetic screen, we identify the novel regulator VosA that couples the formation of spores and focal trehalose biogenesis in the model fungus Aspergillus nidulans. The vosA gene is expressed specifically during the formation of both sexual and asexual spores (conidia). Levels of vosA mRNA and protein are high in both types of spore. The deletion of vosA results in the lack of trehalose in spores, a rapid loss of the cytoplasm, organelles and viability of spores, and a dramatic reduction in tolerance of conidia to heat and oxidative stress. Moreover, the absence of vosA causes uncontrolled activation of asexual development, whereas the enhanced expression of vosA blocks sporulation, suggesting that VosA also functions in negative-feedback regulation of sporogenesis. VosA localizes in the nucleus of mature conidia and its C-terminal region contains a potential transcription activation domain, indicating that it may function as a transcription factor primarily controlling the late process of sporulation including trehalose biogenesis. VosA is conserved in most fungi and may define a new fungus-specific transcription factor family.	[Ni, Min; Yu, Jae-Hyuk] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Ni, Min; Yu, Jae-Hyuk] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Yu, JH (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	jyu1@wisc.edu	Yu, Jae-Hyuk/A-2343-2008	Yu, Jae-Hyuk/0000-0002-6530-8407	Hatch [WIS04667]; National Science Foundation [MCB-0421863, IOS-0640067]	Hatch(United States Department of Agriculture (USDA)); National Science Foundation(National Science Foundation (NSF))	This work was supported by Hatch (WIS04667) and National Science Foundation grants (MCB-0421863 and IOS-0640067) to JHY. The sponsors or funders did not play any role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	ADAMS TH, 1988, CELL, V54, P353, DOI 10.1016/0092-8674(88)90198-5; Adams TH, 1998, MICROBIOL MOL BIOL R, V62, P35, DOI 10.1128/MMBR.62.1.35-54.1998; AGATEP R, 1998, TECHNICAL TIPS ONLIN, V1, P51; AGUIRRE J, 1990, EXP MYCOL, V14, P290, DOI 10.1016/0147-5975(90)90026-P; ANDRIANOPOULOS A, 1994, MOL CELL BIOL, V14, P2503, DOI 10.1128/MCB.14.4.2503; [Anonymous], 2003, J OCCUP ENVIRON MED, V45, P470; ARAMAYO R, 1990, NUCLEIC ACIDS RES, V18, P3415, DOI 10.1093/nar/18.11.3415; Borgia PT, 1996, MOL MICROBIOL, V20, P1287, DOI 10.1111/j.1365-2958.1996.tb02647.x; BOYLAN MT, 1987, MOL CELL BIOL, V7, P3113, DOI 10.1128/MCB.7.9.3113; Calvo AM, 2004, APPL ENVIRON MICROB, V70, P4733, DOI 10.1128/AEM.70.8.4733-4739.2004; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Crameri R, 2006, CHEM IMMUNOL ALLERGY, V91, P121; Crowe JH, 2007, ADV EXP MED BIOL, V594, P143; d'Enfert C, 1999, MOL MICROBIOL, V32, P471, DOI 10.1046/j.1365-2958.1999.01327.x; dEnfert C, 1997, MOL MICROBIOL, V24, P203, DOI 10.1046/j.1365-2958.1997.3131693.x; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Fernandes M, 1998, MOL MICROBIOL, V28, P1355, DOI 10.1046/j.1365-2958.1998.00907.x; Fillinger S, 2001, MICROBIOL-SGM, V147, P1851, DOI 10.1099/00221287-147-7-1851; Foster AJ, 2003, EMBO J, V22, P225, DOI 10.1093/emboj/cdg018; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; GWYNNE DI, 1987, GENE, V51, P205, DOI 10.1016/0378-1119(87)90309-X; Han KH, 2004, MOL MICROBIOL, V53, P529, DOI 10.1111/j.1365-2958.2004.04163.x; James P, 1996, GENETICS, V144, P1425; Kafer E, 1977, Adv Genet, V19, P33, DOI 10.1016/S0065-2660(08)60245-X; Kato N, 2003, EUKARYOT CELL, V2, P1178, DOI 10.1128/EC.2.6.1178-1186.2003; Kim HS, 2002, FUNGAL GENET BIOL, V37, P72, DOI 10.1016/S1087-1845(02)00029-4; Li SJ, 2006, MOL MICROBIOL, V62, P1418, DOI 10.1111/j.1365-2958.2006.05447.x; LINGAPPA BT, 1959, PLANT PHYSIOL, V34, P466, DOI 10.1104/pp.34.4.466; Mah JH, 2006, EUKARYOT CELL, V5, P1585, DOI 10.1128/EC.00192-06; MARSHALL MA, 1991, MOL CELL BIOL, V11, P55, DOI 10.1128/MCB.11.1.55; MAYORGA ME, 1992, MOL GEN GENET, V235, P205, DOI 10.1007/BF00279362; MIMS CW, 1988, PROTOPLASMA, V144, P132, DOI 10.1007/BF01637246; MIRABITO PM, 1989, CELL, V57, P859, DOI 10.1016/0092-8674(89)90800-3; Momany M, 2001, MOL CELLULAR BIOL FI, P119; Osherov N, 2000, FUNGAL GENET BIOL, V31, P181, DOI 10.1006/fgbi.2000.1236; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; PUNT PJ, 1991, J BIOTECHNOL, V17, P19, DOI 10.1016/0168-1656(91)90024-P; Seo JA, 2006, GENETICS, V172, P1535, DOI 10.1534/genetics.105.052258; Seo JA, 2003, GENETICS, V165, P1083; SEWALL TC, 1990, DEV BIOL, V138, P499, DOI 10.1016/0012-1606(90)90215-5; STRINGER MA, 1991, GENE DEV, V5, P1161, DOI 10.1101/gad.5.7.1161; Takeshita N, 2002, BIOCHEM BIOPH RES CO, V298, P103, DOI 10.1016/S0006-291X(02)02418-X; TIMBERLAKE WE, 1994, ASPERGILLUS 50 YEARS, P383; Ursic D, 2004, NUCLEIC ACIDS RES, V32, P2441, DOI 10.1093/nar/gkh561; WIESER J, 1995, GENE DEV, V9, P491, DOI 10.1101/gad.9.4.491; Yamada O, 1999, J BIOSCI BIOENG, V87, P424, DOI 10.1016/S1389-1723(99)80089-9; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; Yu JH, 1996, CURR GENET, V29, P549, DOI 10.1007/s002940050084	48	172	190	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e970	10.1371/journal.pone.0000970	http://dx.doi.org/10.1371/journal.pone.0000970			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912349	Green Submitted, gold, Green Published			2022-12-25	WOS:000207455900008
J	Richard, FJ; Tarpy, DR; Grozinger, CM				Richard, Freddie-Jeanne; Tarpy, David R.; Grozinger, Christina M.			Effects of Insemination Quantity on Honey Bee Queen Physiology	PLOS ONE			English	Article							APIS-MELLIFERA L; MANDIBULAR GLAND PHEROMONE; MATING FREQUENCY; GENE-EXPRESSION; BEHAVIOR; HYMENOPTERA; EVOLUTION; FLUID; POLYANDRY; PROTEINS	Mating has profound effects on the physiology and behavior of female insects, and in honey bee (Apis mellifera) queens, these changes are permanent. Queens mate with multiple males during a brief period in their early adult lives, and shortly thereafter they initiate egg-laying. Furthermore, the pheromone profiles of mated queens differ from those of virgins, and these pheromones regulate many different aspects of worker behavior and colony organization. While it is clear that mating causes dramatic changes in queens, it is unclear if mating number has more subtle effects on queen physiology or queen-worker interactions; indeed, the effect of multiple matings on female insect physiology has not been broadly addressed. Because it is not possible to control the natural mating behavior of queens, we used instrumental insemination and compared queens inseminated with semen from either a single drone (single-drone inseminated, or SDI) or 10 drones (multi-drone inseminated, or MDI). We used observation hives to monitor attraction of workers to SDI or MDI queens in colonies, and cage studies to monitor the attraction of workers to virgin, SDI, and MDI queen mandibular gland extracts (the main source of queen pheromone). The chemical profiles of the mandibular glands of virgin, SDI, and MDI queens were characterized using GC-MS. Finally, we measured brain expression levels in SDI and MDI queens of a gene associated with phototaxis in worker honey bees (Amfor). Here, we demonstrate for the first time that insemination quantity significantly affects mandibular gland chemical profiles, queen-worker interactions, and brain gene expression. Further research will be necessary to elucidate the mechanistic bases for these effects: insemination volume, sperm and seminal protein quantity, and genetic diversity of the sperm may all be important factors contributing to this profound change in honey bee queen physiology, queen behavior, and social interactions in the colony.	[Richard, Freddie-Jeanne; Tarpy, David R.; Grozinger, Christina M.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Richard, Freddie-Jeanne; Grozinger, Christina M.] N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA; [Richard, Freddie-Jeanne; Tarpy, David R.; Grozinger, Christina M.] N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Grozinger, CM (corresponding author), N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA.	cmgrozin@ncsu.edu		Richard, Freddie-Jeanne/0000-0002-2796-1181	USDA-NRI; DRT [200635607-16625]; Eastern Apiculture Society	USDA-NRI(United States Department of Agriculture (USDA)); DRT; Eastern Apiculture Society	This work was supported by a USDA-NRI grant to CMG and DRT (200635607-16625) and the Eastern Apiculture Society.	APSEGAITE V, 1999, PHEROMONES, V9, P27; Baer B, 2000, J CHEM ECOL, V26, P1869, DOI 10.1023/A:1005596707591; Baer B, 2001, P NATL ACAD SCI USA, V98, P3926, DOI 10.1073/pnas.061027998; Ben-Shahar Y, 2005, J COMP PHYSIOL A, V191, P987, DOI 10.1007/s00359-005-0025-1; Ben-Shahar Y, 2003, J EXP BIOL, V206, P2507, DOI 10.1242/jeb.00442; Ben-Shahar Y, 2002, SCIENCE, V296, P741, DOI 10.1126/science.1069911; BLUM MURRAY S., 1962, ANN ENTOMOL SOC AMER, V55, P135; Brockmann A, 2006, J CHEM ECOL, V32, P657, DOI 10.1007/s10886-005-9027-2; Butler C. G., 1963, Journal of Apicultural Research London, V2, P14; Chapman T, 2004, PEPTIDES, V25, P1477, DOI 10.1016/j.peptides.2003.10.023; Collins AM, 2004, INSECT MOL BIOL, V13, P141, DOI 10.1111/j.0962-1075.2004.00469.x; Crozier R.H., 1996, EVOLUTION SOCIAL INS; DADE HA, 1978, ANATOMY DISSECTION H; FAHRBACH SE, 1995, NEUROBIOL LEARN MEM, V63, P181, DOI 10.1006/nlme.1995.1019; Free J. B., 1987, PHEROMONES SOCIAL BE; GARY NE, 1962, SCIENCE, V136, P773, DOI 10.1126/science.136.3518.773; Gillott C, 2003, ANNU REV ENTOMOL, V48, P163, DOI 10.1146/annurev.ento.48.091801.112657; Grozinger CM, 2007, NATURWISSENSCHAFTEN, V94, P375, DOI 10.1007/s00114-006-0197-8; Grozinger CM, 2003, P NATL ACAD SCI USA, V100, P14519, DOI 10.1073/pnas.2335884100; Harano K, 2005, NATURWISSENSCHAFTEN, V92, P310, DOI 10.1007/s00114-005-0631-3; Heifetz Y, 2000, CURR BIOL, V10, P99, DOI 10.1016/S0960-9822(00)00288-8; HIGO HA, 1992, CAN ENTOMOL, V124, P409, DOI 10.4039/Ent124409-2; Hoover SER, 2005, INSECT SOC, V52, P6, DOI 10.1007/s00040-004-0772-y; Hoover SER, 2003, NATURWISSENSCHAFTEN, V90, P477, DOI 10.1007/s00114-003-0462-z; KAFTANOGLU O, 1982, J APICULT RES, V21, P3, DOI 10.1080/00218839.1982.11100508; KAMINSKI LA, 1990, J CHEM ECOL, V16, P841, DOI 10.1007/BF01016494; Keeling CI, 2003, P NATL ACAD SCI USA, V100, P4486, DOI 10.1073/pnas.0836984100; KELLER L, 1993, ANIM BEHAV, V45, P787, DOI 10.1006/anbe.1993.1092; Klenk M, 2004, APIDOLOGIE, V35, P371, DOI 10.1051/apido:2004029; Laidlaw HH., 1997, QUEEN REARING BEE BR; LAIDLAW HH, 1977, INSTRUMENTAL INSEMIN; LOBO JA, 1993, ETHOL ECOL EVOL, V5, P337, DOI 10.1080/08927014.1993.9523021; Melathopoulos AP, 1996, CAN ENTOMOL, V128, P263, DOI 10.4039/Ent128263-2; Morgan SM, 1998, BEHAV BRAIN RES, V91, P115, DOI 10.1016/S0166-4328(97)00118-6; Mueller JL, 2004, P NATL ACAD SCI USA, V101, P13542, DOI 10.1073/pnas.0405579101; NIJHOUT HF, 1984, J INSECT PHYSIOL, V30, P629, DOI 10.1016/0022-1910(84)90047-7; OLDROYD BP, 1992, ANN ENTOMOL SOC AM, V85, P335, DOI 10.1093/aesa/85.3.335; Oldroyd BP, 1997, BEHAV ECOL SOCIOBIOL, V40, P17, DOI 10.1007/s002650050311; Oldroyd BP, 1998, ANN ENTOMOL SOC AM, V91, P700, DOI 10.1093/aesa/91.5.700; Pankiw T, 1998, J INSECT PHYSIOL, V44, P685, DOI 10.1016/S0022-1910(98)00040-7; PANKIW T, 1995, INSECT SOC, V42, P371, DOI 10.1007/BF01242165; Pankiw T, 2000, NATURWISSENSCHAFTEN, V87, P487, DOI 10.1007/s001140050764; PANKIW T, 1994, J INSECT BEHAV, V7, P1, DOI 10.1007/BF01989823; PETTIS JS, 1995, INSECT SOC, V42, P113, DOI 10.1007/BF01242447; PETTIS JS, 1995, ANN ENTOMOL SOC AM, V88, P580, DOI 10.1093/aesa/88.4.580; Plettner E, 1997, J CHEM ECOL, V23, P363, DOI 10.1023/B:JOEC.0000006365.20996.a2; RIDDIFORD LM, 1973, BIOL BULL-US, V144, P162, DOI 10.2307/1540153; Ringo J, 1996, ANNU REV ENTOMOL, V41, P473, DOI 10.1146/annurev.en.41.010196.002353; ROTH LM, 1962, SCIENCE, V138, P1267, DOI 10.1126/science.138.3546.1267; Schluns H, 2005, ANIM BEHAV, V70, P125, DOI 10.1016/j.anbehav.2004.11.005; Seeley TD, 1985, HONEYBEE ECOLOGY STU; Seeley TD, 2007, P ROY SOC B-BIOL SCI, V274, P67, DOI 10.1098/rspb.2006.3702; Slessor KN, 2005, J CHEM ECOL, V31, P2731, DOI 10.1007/s10886-005-7623-9; SLESSOR KN, 1988, NATURE, V332, P354, DOI 10.1038/332354a0; SLESSOR KN, 1990, J CHEM ECOL, V16, P851, DOI 10.1007/BF01016495; SUGAWARA T, 1986, J INSECT PHYSIOL, V32, P485, DOI 10.1016/0022-1910(86)90010-7; Tanaka ED, 2004, ARTHROPOD STRUCT DEV, V33, P431, DOI 10.1016/j.asd.2004.06.006; Tarpy DR, 2002, ANN ENTOMOL SOC AM, V95, P513, DOI 10.1603/0013-8746(2002)095[0513:SEEPAE]2.0.CO;2; Tarpy DR, 2006, NATURWISSENSCHAFTEN, V93, P195, DOI 10.1007/s00114-006-0091-4; Tarpy DR, 2002, BEHAV ECOL SOCIOBIOL, V52, P143, DOI 10.1007/s00265-002-0498-7; Tarpy DR, 2000, AM NAT, V155, P820, DOI 10.1086/303358; Tomanek B, 1996, J APICULT RES, V35, P3, DOI 10.1080/00218839.1996.11100907; Tram U, 1998, P NATL ACAD SCI USA, V95, P4051, DOI 10.1073/pnas.95.7.4051; Whitfield CW, 2003, SCIENCE, V302, P296, DOI 10.1126/science.1086807; Winston M.L., 1991, BIOL HONEY BEE; Wolfner MF, 2002, HEREDITY, V88, P85, DOI 10.1038/sj.hdy.6800017; Wolfner MF, 1997, INSECT BIOCHEM MOLEC, V27, P179, DOI 10.1016/S0965-1748(96)00084-7; WOYCIECHOWSKI M, 1987, J THEOR BIOL, V128, P317, DOI 10.1016/S0022-5193(87)80074-7; Woyke J, 1995, J APICULT RES, V34, P105, DOI 10.1080/00218839.1995.11100895; WOYKE J, 1983, J APICULT RES, V22, P150, DOI 10.1080/00218839.1983.11100579; WOYKE J, 1966, WHICH IS MOST SUITAB, P12	71	77	77	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e980	10.1371/journal.pone.0000980	http://dx.doi.org/10.1371/journal.pone.0000980			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912357	Green Published, gold, Green Submitted			2022-12-25	WOS:000207455900016
J	Abbas, UL; Anderson, RM; Mellors, JW				Abbas, Ume L.; Anderson, Roy M.; Mellors, John W.			Potential Impact of Antiretroviral Chemoprophylaxis on HIV-1 Transmission in Resource-Limited Settings	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SUB-SAHARAN AFRICA; REVERSE-TRANSCRIPTASE; TENOFOVIR MONOTHERAPY; DEVELOPING-COUNTRIES; SENSITIVITY ANALYSIS; TYPE-1 POPULATIONS; INFECTED PATIENTS; NEWBORN MACAQUES; RESISTANT HIV-1	Background. The potential impact of pre-exposure chemoprophylaxis (PrEP) on heterosexual transmission of HIV-1 infection in resource-limited settings is uncertain. Methodology/Principle Findings. A deterministic mathematical model was used to simulate the effects of antiretroviral PrEP on an HIV-1 epidemic in sub-Saharan Africa under different scenarios (optimistic, neutral and pessimistic) both with and without sexual disinhibition. Sensitivity analyses were used to evaluate the effect of uncertainty in input parameters on model output and included calculation of partial rank correlations and standardized rank regressions. In the scenario without sexual disinhibition after PrEP initiation, key parameters influencing infections prevented were effectiveness of PrEP (partial rank correlation coefficient (PRCC) = 0.94), PrEP discontinuation rate (PRCC = -0.94), level of coverage (PRCC = 0.92), and time to achieve target coverage (PRCC = -0.82). In the scenario with sexual disinhibition, PrEP effectiveness and the extent of sexual disinhibition had the greatest impact on prevention. An optimistic scenario of PrEP with 90% effectiveness and 75% coverage of the general population predicted a 74% decline in cumulative HIV-1 infections after 10 years, and a 28.8% decline with PrEP targeted to the highest risk groups (16% of the population). Even with a 100% increase in at-risk behavior from sexual disinhibition, a beneficial effect (23.4%-62.7% decrease in infections) was seen with 90% effective PrEP across a broad range of coverage (25%-75%). Similar disinhibition led to a rise in infections with lower effectiveness of PrEP (<= 50%). Conclusions/Significance. Mathematical modeling supports the potential public health benefit of PrEP. Approximately 2.7 to 3.2 million new HIV-1 infections could be averted in southern sub-Saharan Africa over 10 years by targeting PrEP (having 90% effectiveness) to those at highest behavioral risk and by preventing sexual disinhibition. This benefit could be lost, however, by sexual disinhibition and by high PrEP discontinuation, especially with lower PrEP effectiveness (<= 50%).	[Abbas, Ume L.; Mellors, John W.] Univ Pittsburgh, Sch Med, Div Infect Dis, Pittsburgh, PA 15260 USA; [Anderson, Roy M.] Univ London, Fac Med, Imperial Coll, Dept Infect Dis Epidemiol, London, England	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Imperial College London; University of London	Abbas, UL (corresponding author), Univ Pittsburgh, Sch Med, Div Infect Dis, Pittsburgh, PA 15260 USA.	abbasu@dom.pitt.edu	Abbas, Ume/AAW-4590-2021	Anderson, Roy/0000-0002-9528-3175	National Institute of Allergy and Infectious Diseases [R21AI064092, U01AI38858]; Bristol Myers Squibb Research Foundation; National Cancer Institute [20XS190A]; Microbicide Trials Network [U01AI068633]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI038858, U01AI068633, R21AI064092] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bristol Myers Squibb Research Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Microbicide Trials Network; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the National Institute of Allergy and Infectious Diseases (R21AI064092). Ume L. Abbas acknowledges grant support from the National Institute of Allergy and Infectious Diseases ( R21AI064092). Roy M. Anderson acknowledges grant support from the Wellcome Trust. John W. Mellors acknowledges support from the Bristol Myers Squibb Research Foundation and grants from the National Institute of Allergy and Infectious Diseases (U01AI38858), the National Cancer Institute (SAIC contract 20XS190A) and the Microbicide Trials Network (U01AI068633).	Abbas UL, 2006, JAIDS-J ACQ IMM DEF, V41, P632, DOI 10.1097/01.qai.0000194234.31078.bf; ANDERSON R M, 1991; ANDERSON RM, 1992, PHILOS T R SOC B, V336, P135, DOI 10.1098/rstb.1992.0052; ANDERSON RM, 1989, ANN NY ACAD SCI, V569, P240, DOI 10.1111/j.1749-6632.1989.tb27374.x; Aral SO, 2000, SEX TRANSM DIS, V27, P327, DOI 10.1097/00007435-200007000-00005; Asamoah-Odei E, 2004, LANCET, V364, P35, DOI 10.1016/S0140-6736(04)16587-2; ATCHISON R, 2005, ANTIVIR THER S, V10, P45; Blower S, 2004, CLIN INFECT DIS, V39, pS240, DOI 10.1086/422361; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Brenner BG, 2002, J VIROL, V76, P1753, DOI 10.1128/JVI.76.4.1753-1761.2002; Brenner BG, 2006, AIDS, V20, pF9, DOI 10.1097/01.aids.0000232228.88511.0b; Brown AJL, 2003, J INFECT DIS, V187, P683, DOI 10.1086/367989; *CDCP, CDC TRIALS PREEXP PR; Charpentier C, 2004, J VIROL, V78, P4234, DOI 10.1128/JVI.78.8.4234-4247.2004; Clavel F, 2004, NEW ENGL J MED, V350, P1023, DOI 10.1056/NEJM2ra025195; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Cong ME, 2007, J VIROL, V81, P3037, DOI 10.1128/JVI.02712-06; Deeks SG, 2001, NEW ENGL J MED, V344, P472, DOI 10.1056/NEJM200102153440702; Deeks SG, 2005, J INFECT DIS, V192, P1537, DOI 10.1086/496892; Delaugerre C, 2001, AIDS, V15, P2189, DOI 10.1097/00002030-200111090-00016; *DEP EC SOC AFF PO, 2005, WORLD POP PROSP 2004; DESAI K, 2006, 16 INT AIDS C TOR CA; Deschamps MM, 1996, ANN INTERN MED, V125, P324, DOI 10.7326/0003-4819-125-4-199608150-00011; Doualla-Bell F, 2006, ANTIMICROB AGENTS CH, V50, P4182, DOI 10.1128/AAC.00714-06; Drummond MF., 2005, METHODS EC EVALUATIO, P55; EIGEN M, 1977, NATURWISSENSCHAFTEN, V64, P541, DOI 10.1007/BF00450633; FERRY B, 2001, AIDS S, V15, P41; Foss AM, 2003, AIDS, V17, P1227, DOI 10.1097/00002030-200305230-00015; Gandhi RT, 2003, CLIN INFECT DIS, V37, P1693, DOI 10.1086/379773; Garcia-Calleja JM, 2006, SEX TRANSM INFECT, V82, pIII64, DOI 10.1136/sti.2006.019901; Garcia-Lerma JG, 2006, ANTIVIR THER, V11, pS52; GARCIALERMA J, 2006, 13 C RETR OPP INF DE; GARNETT GP, 1993, PHILOS T R SOC B, V342, P137, DOI 10.1098/rstb.1993.0143; GARNETT GP, 1995, J ACQ IMMUN DEF SYND, V9, P500; GARNETT GP, 1994, IMA J MATH APPL MED, V11, P161; GENTLEMAN A, 2006, AIDS DRUG PROVOKES P; *GIL SCI, 2004, INV BROCH TEN DIS FU; *GIL SCI, 2005, INV BROCH EMTR TEN D; *GIL SCI INC, 2005, GIL RED PRIC VIR TRU; *GOV REP ZAMB MIN, 2005, ZAMB 2004 ANT CLIN S; GRANT R, 2006, 16 INT AIDS C TOR CA; Grant RM, 2005, SCIENCE, V309, P2170, DOI 10.1126/science.1116204; Grassly N. C., 2003, International Journal of Drug Policy, V14, P25, DOI 10.1016/S0955-3959(02)00224-4; Hance AJ, 2001, J VIROL, V75, P6410, DOI 10.1128/JVI.75.14.6410-6417.2001; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; Iman RL, 2002, RELIAB ENG SYST SAFE, V78, P131, DOI 10.1016/S0951-8320(02)00133-3; IMAN RL, 1981, J QUAL TECHNOL, V13, P232, DOI 10.1080/00224065.1981.11978763; IMAN RL, 1981, J QUAL TECHNOL, V13, P174, DOI 10.1080/00224065.1981.11978748; Izopet J, 2002, J INFECT DIS, V185, P1506, DOI 10.1086/340215; Kantor R, 2005, PLOS MED, V2, P325, DOI 10.1371/journal.pmed.0020112; Lifson JD, 2000, J VIROL, V74, P2584, DOI 10.1128/JVI.74.6.2584-2593.2000; Margot NA, 2006, ANTIMICROB AGENTS CH, V50, P4087, DOI 10.1128/AAC.00816-06; MAY RM, 1988, PHILOS T ROY SOC B, V321, P565, DOI 10.1098/rstb.1988.0108; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Miller MD, 2007, AIDS, V21, P265, DOI 10.1097/QAD.0b013e32801199ee; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Moatti JP, 2003, AIDS, V17, pS69, DOI 10.1097/00002030-200317003-00010; Morgan D, 2002, AIDS, V16, P597, DOI 10.1097/00002030-200203080-00011; Morgan D, 2000, SEX TRANSM INFECT, V76, P193, DOI 10.1136/sti.76.3.193; Morison L, 2001, AIDS, V15, pS61, DOI 10.1097/00002030-200108004-00007; Palmer S, 2006, AIDS, V20, P701, DOI 10.1097/01.aids.0000216370.69066.7f; *PREP WATCH, AIDS VACC ADV COAL P; Rosenwirth B, 2000, J VIROL, V74, P1704, DOI 10.1128/JVI.74.4.1704-1711.2000; SALTELLI A, 2000, SENSITIVITY ANAL, P475; Shelton JD, 2006, LANCET, V367, P1120, DOI 10.1016/S0140-6736(06)68436-5; SHISANA O, 2005, S AFRICAN NATL HIV P; Stover J, 2006, SCIENCE, V311, P1474, DOI 10.1126/science.1121176; STOVER J, 2002, EPIDEMIOLOGICAL IMPA, P1; Subbarao S, 2006, J INFECT DIS, V194, P904, DOI 10.1086/507306; *SURV SURV LAB WOR, 2006, INT REC US BED CAPT; TSAI CC, 1995, SCIENCE, V270, P1197, DOI 10.1126/science.270.5239.1197; Turner D, 2004, JAIDS-J ACQ IMM DEF, V37, P1627, DOI 10.1097/00126334-200412150-00017; UNAIDS, 2006, REP GLOB AIDS EP; *UNAIDS WHO, 2006, EST STAT AIDS EP COU; *UNAIDS WHO, EP UPD DEC 2006; *UNAIDS WHO WORK G, 2003, EST SIZ POP RISK HIV; *US AG INT DEV MAC, DEM HLTH SURV; *US BUR CENS, US CENS BUR INT DAT; Van Rompay KKA, 2001, J INFECT DIS, V184, P429, DOI 10.1086/322781; Van Rompay KKA, 2000, J VIROL, V74, P1767, DOI 10.1128/JVI.74.4.1767-1774.2000; Van Rompay KKA, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-25; Van Rompay KKA, 2006, J VIROL, V80, P6399, DOI 10.1128/JVI.02308-05; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Weber J, 2005, J CLIN MICROBIOL, V43, P1395, DOI 10.1128/JCM.43.3.1395-1400.2005; Wegbreit J, 2006, AIDS, V20, P1217, DOI 10.1097/01.aids.0000232229.96134.56; WEINSTEIN MC, 1989, CONFRONTING AIDS SEX, P471; White KL, 2002, ANTIMICROB AGENTS CH, V46, P3437, DOI 10.1128/AAC.46.11.3437-3446.2002; Williams BG, 2006, PLOS MED, V3, P1032, DOI 10.1371/journal.pmed.0030262; Yerly S, 2004, ANTIVIR THER, V9, P375	89	130	135	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2007	2	9							e875	10.1371/journal.pone.0000875	http://dx.doi.org/10.1371/journal.pone.0000875			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HS	17878928	Green Published, gold			2022-12-25	WOS:000207455700001
J	Akhras, MS; Unemo, M; Thiyagarajan, S; Nyren, P; Davis, RW; Fire, AZ; Pourmand, N				Akhras, Michael S.; Unemo, Magnus; Thiyagarajan, Sreedevi; Nyren, Pal; Davis, Ronald W.; Fire, Andrew Z.; Pourmand, Nader			Connector Inversion Probe Technology: A Powerful One-Primer Multiplex DNA Amplification System for Numerous Scientific Applications	PLOS ONE			English	Article							NEISSERIA-GONORRHOEAE; ISOTHERMAL AMPLIFICATION; CIPROFLOXACIN RESISTANCE; GYRASE GENE; QUANTIFICATION; SEQUENCES; OLIGONUCLEOTIDES; MUTATIONS; INDICATOR; RNA	We combined components of a previous assay referred to as Molecular Inversion Probe (MIP) with a complete gap filling strategy, creating a versatile powerful one-primer multiplex amplification system. As a proof-of-concept, this novel method, which employs a Connector Inversion Probe (CIPer), was tested as a genetic tool for pathogen diagnosis, typing, and antibiotic resistance screening with two distinct systems: i) a conserved sequence primer system for genotyping Human Papillomavirus (HPV), a cancer-associated viral agent and ii) screening for antibiotic resistance mutations in the bacterial pathogen Neisseria gonorrhoeae. We also discuss future applications and advances of the CIPer technology such as integration with digital amplification and next-generation sequencing methods. Furthermore, we introduce the concept of two-dimension informational barcodes, i. e. "multiplex multiplexing padlocks'' (MMPs). For the readers' convenience, we also provide an on-line tutorial with user-interface software application CIP creator 1.0.1, for custom probe generation from virtually any new or established primer-pairs.	[Akhras, Michael S.; Thiyagarajan, Sreedevi; Davis, Ronald W.; Pourmand, Nader] Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; [Akhras, Michael S.; Nyren, Pal] Royal Inst Technol, Dept Biotechnol, Stockholm, Sweden; [Unemo, Magnus] Orebro Univ Hosp, Dept Clin Microbiol, Natl Reference Lab Pathogen Neisseria, Orebro, Sweden; [Fire, Andrew Z.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Fire, Andrew Z.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Pourmand, Nader] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA	Stanford University; Royal Institute of Technology; Orebro University; Stanford University; Stanford University; University of California System; University of California Santa Cruz	Pourmand, N (corresponding author), Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA.	pourmand@stanford.edu	Unemo, Magnus/ABD-6653-2021	Fire, Andrew/0000-0001-6217-8312; Pourmand, Nader/0000-0003-0251-9060	National Institutes of Health [PO1-HG000205]; Hans Werthe'n Foundation; Sixten Gemzeus Scholarship Foundation; Foundation Blanceflor Boncompagni-Ludovisi, nee Bildt; Fulbright Commission; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000205] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hans Werthe'n Foundation; Sixten Gemzeus Scholarship Foundation; Foundation Blanceflor Boncompagni-Ludovisi, nee Bildt; Fulbright Commission; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This study was supported by a grant from National Institutes of Health (PO1-HG000205). Michael S. Akhras was supported by Hans Werthe'n Foundation; Sixten Gemzeus Scholarship Foundation; The Foundation Blanceflor Boncompagni-Ludovisi, nee Bildt; and the The Fulbright Commission.	ABRAVAYA K, 1995, NUCLEIC ACIDS RES, V23, P675, DOI 10.1093/nar/23.4.675; Akhras MS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000223; Alekshun MN, 2007, CELL, V128, P1037, DOI 10.1016/j.cell.2007.03.004; BARANY F, 1991, P NATL ACAD SCI USA, V88, P189, DOI 10.1073/pnas.88.1.189; Ben-Dov E, 2006, APPL ENVIRON MICROB, V72, P6902, DOI 10.1128/AEM.00849-06; Bennett ST, 2005, PHARMACOGENOMICS, V6, P373, DOI 10.1517/14622416.6.4.373; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Borodina TA, 2003, ANAL BIOCHEM, V318, P309, DOI 10.1016/S0003-2697(03)00250-1; Braslavsky I, 2003, P NATL ACAD SCI USA, V100, P3960, DOI 10.1073/pnas.0230489100; CHAMBERLAIN JS, 1988, NUCLEIC ACIDS RES, V16, P11141, DOI 10.1093/nar/16.23.11141; Chavali S, 2005, BIOINFORMATICS, V21, P3918, DOI 10.1093/bioinformatics/bti633; Csako G, 2006, CLIN CHIM ACTA, V363, P6, DOI 10.1016/j.cccn.2005.07.009; Dafforn A, 2004, BIOTECHNIQUES, V37, P854, DOI 10.2144/04375PF01; DAHL F, 2007, P NATL ACAD SCI US; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Doorbar J, 2006, CLIN SCI, V110, P525, DOI 10.1042/CS20050369; Dressman D, 2003, P NATL ACAD SCI USA, V100, P8817, DOI 10.1073/pnas.1133470100; Elnifro EM, 2000, CLIN MICROBIOL REV, V13, P559, DOI 10.1128/CMR.13.4.559-570.2000; FIRE A, 1995, P NATL ACAD SCI USA, V92, P4641, DOI 10.1073/pnas.92.10.4641; Fredriksson S, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm078; Gharizadeh B, 2005, INT J ANTIMICROB AG, V26, P486, DOI 10.1016/j.ijantimicag.2005.08.017; Gharizadeh B, 2006, J BIOTECHNOL, V124, P504, DOI 10.1016/j.jbiotec.2006.01.025; Gharizadeh B, 2006, MOL CELL PROBE, V20, P230, DOI 10.1016/j.mcp.2006.01.002; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; Hardenbol P, 2005, GENOME RES, V15, P269, DOI 10.1101/gr.3185605; Hardenbol P, 2003, NAT BIOTECHNOL, V21, P673, DOI 10.1038/nbt821; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057; Jarvius J, 2006, NAT METHODS, V3, P725, DOI 10.1038/NMETH916; Ji HL, 2006, CANCER RES, V66, P7910, DOI 10.1158/0008-5472.CAN-06-0595; Li M, 2006, NAT METHODS, V3, P95, DOI 10.1038/NMETH850; Lindback E, 2005, INT J STD AIDS, V16, P142, DOI 10.1258/0956462053057675; Lindback E, 2006, APMIS, V114, P837, DOI 10.1111/j.1600-0463.2006.apm_495.x; Lizardi PM, 1998, NAT GENET, V19, P225, DOI 10.1038/898; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mitani Y, 2007, NAT METHODS, V4, P257, DOI 10.1038/NMETH1007; NILSSON M, 1994, SCIENCE, V265, P2085, DOI 10.1126/science.7522346; Nilsson M, 2006, TRENDS BIOTECHNOL, V24, P83, DOI 10.1016/j.tibtech.2005.12.005; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; OKAZAKI R, 1968, P NATL ACAD SCI USA, V59, P598, DOI 10.1073/pnas.59.2.598; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Thiyagarajan S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-500; Unemo M, 2007, APMIS, V115, P231, DOI 10.1111/j.1600-0463.2007.apm_487.x; Wang YK, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni177	45	21	58	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2007	2	9							e915	10.1371/journal.pone.0000915	http://dx.doi.org/10.1371/journal.pone.0000915			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HS	17878950	Green Submitted, Green Published, gold			2022-12-25	WOS:000207455700023
J	Sahay, S; Pannucci, NL; Mahon, GM; Rodriguez, PL; Megjugorac, NJ; Kostenko, EV; Ozer, HL; Whitehead, IP				Sahay, S.; Pannucci, N. L.; Mahon, G. M.; Rodriguez, P. L.; Megjugorac, N. J.; Kostenko, E. V.; Ozer, H. L.; Whitehead, I. P.			The RhoGEF domain of p210 Bcr-Abl activates RhoA and is required for transformation	ONCOGENE			English	Article						chronic myelogenous leukemia; p210 Bcr-Abl; RhoA; RhoGEF domain; transformation	CHRONIC MYELOGENOUS LEUKEMIA; TYROSINE KINASE-ACTIVITY; POSITIVE HUMAN LEUKEMIAS; ADAPTER PROTEIN; ONCOGENE; FAMILY; ONCOPROTEIN; SEQUENCES; INTERACTS; GROWTH	The BCR-ABL oncogene encodes an in-frame fusion protein containing N-terminal sequences derived from Bcr and C-terminal sequences derived from Abl. Bcr contains a centrally located Rho-specific guanine nucleotide exchange factor (RhoGEF) domain that is retained within p210 Bcr-Abl. Although this domain is subject to autoinhibition in the context of Bcr, here we show that it is constitutively activated in p210 Bcr-Abl. p210 Bcr-Abl can stimulate RhoA activation independently of its tyrosine kinase activity, and mutations within the RhoGEF domain that are predicted to eliminate RhoGEF activity inhibit RhoA activation. The RhoGEF mutant of p210 Bcr-Abl does not affect the tyrosine kinase activity of the molecule, nor the ability of p210 Bcr-Abl to interact with XPB through the RhoGEF domain. Despite retaining normal levels of tyrosine kinase activity, the RhoGEF mutant of p210 Bcr-Abl is impaired in transforming activity as measured by anchorage-independent growth. However, the mutant is still able to confer the phenotype of growth factor independence in myeloid cells, suggesting that some, but not all parameters of p210 Bcr-Abl transformation, are dependent upon a catalytically active RhoGEF domain. Collectively, these observations identify a gain-of-function activity attributable to the RhoGEF domain of p210 Bcr-Abl that is required to support the transformed phenotype.	[Sahay, S.; Pannucci, N. L.; Mahon, G. M.; Rodriguez, P. L.; Megjugorac, N. J.; Kostenko, E. V.; Ozer, H. L.; Whitehead, I. P.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Microbiol & Mol Genet, Univ Hosp Canc Ctr, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Whitehead, IP (corresponding author), UMDNJ, NJMS Canc Ctr H Level, Dept Microbiol & Mol Genet, 205 S Orange Ave, Newark, NJ USA.	whiteip@umdnj.edu			NATIONAL CANCER INSTITUTE [R01CA097066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG004821] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA097066, CA097066, R01 CA097066-05A1] Funding Source: Medline; NIA NIH HHS [AG04821, R01 AG004821] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bassermann F, 2002, J BIOL CHEM, V277, P12437, DOI 10.1074/jbc.M112397200; CHUANG TH, 1995, P NATL ACAD SCI USA, V92, P10282, DOI 10.1073/pnas.92.22.10282; DALEY GQ, 1988, P NATL ACAD SCI USA, V85, P9312, DOI 10.1073/pnas.85.23.9312; Han JW, 1997, MOL CELL BIOL, V17, P1346, DOI 10.1128/MCB.17.3.1346; Harnois T, 2003, ONCOGENE, V22, P6445, DOI 10.1038/sj.onc.1206626; Korus M, 2002, ONCOGENE, V21, P4601, DOI 10.1038/sj.onc.1205678; LUGO TG, 1990, SCIENCE, V247, P1079, DOI 10.1126/science.2408149; LUGO TG, 1989, MOL CELL BIOL, V9, P1263, DOI 10.1128/MCB.9.3.1263; Mahon GM, 2003, CURR BIOL, V13, P437, DOI 10.1016/S0960-9822(03)00090-3; MCWHIRTER JR, 1993, EMBO J, V12, P1533, DOI 10.1002/j.1460-2075.1993.tb05797.x; MCWHIRTER JR, 1991, MOL CELL BIOL, V11, P1553, DOI 10.1128/MCB.11.3.1553; MULLER AJ, 1991, MOL CELL BIOL, V11, P1785, DOI 10.1128/MCB.11.4.1785; Olabisi OO, 2006, CANCER RES, V66, P6250, DOI 10.1158/0008-5472.CAN-06-0536; PENDERGAST AM, 1993, CELL, V75, P175, DOI 10.1016/S0092-8674(05)80094-7; PENDERGAST AM, 1991, CELL, V66, P161, DOI 10.1016/0092-8674(91)90148-R; Ramaraj P, 2004, CANCER RES, V64, P5322, DOI 10.1158/0008-5472.CAN-03-3656; RENSHAW MW, 1995, MOL CELL BIOL, V15, P1286; Salgia R, 1997, J CLIN INVEST, V100, P46, DOI 10.1172/JCI119520; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; Skorski T, 1998, P NATL ACAD SCI USA, V95, P11858, DOI 10.1073/pnas.95.20.11858; Takeda N, 1999, P NATL ACAD SCI USA, V96, P203, DOI 10.1073/pnas.96.1.203; TENHOEVE J, 1994, CANCER RES, V54, P2563; Wertheim JA, 2002, BLOOD, V99, P4122, DOI 10.1182/blood.V99.11.4122; Whitehead IP, 1997, BBA-REV CANCER, V1332, pF1, DOI 10.1016/S0304-419X(96)00040-6	24	27	28	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 27	2008	27	14					2064	2071		10.1038/sj.onc.1210841	http://dx.doi.org/10.1038/sj.onc.1210841			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	279MK	17922031	Green Accepted			2022-12-25	WOS:000254359100011
J	Kfoury, Y; Nasr, R; Favre-Bonvin, A; El-Sabban, M; Renault, N; Giron, ML; Setterblad, N; El Hajj, H; Chiari, E; Mikati, AG; Hermine, O; Saib, A; de The, H; Pique, C; Bazarbachi, A				Kfoury, Y.; Nasr, R.; Favre-Bonvin, A.; El-Sabban, M.; Renault, N.; Giron, M-L; Setterblad, N.; El Hajj, H.; Chiari, E.; Mikati, A. G.; Hermine, O.; Saib, A.; de The, H.; Pique, C.; Bazarbachi, A.			Ubiquitylated Tax targets and binds the IKK signalosome at the centrosome	ONCOGENE			English	Article						NF-kappa B; I kappa B kinase; centrosome; HTLV-I; Tax; ubiquitin	T-CELL LEUKEMIA; NF-KAPPA-B; VIRUS TYPE-1 TAX; I TAX; ACTIVATION; PROTEIN; UBIQUITINATION; ONCOPROTEIN; KINASE; AMPLIFICATION	Constitutive activation of the NF-kappa B pathway by the Tax oncoprotein plays a crucial role in the proliferation and transformation of HTLV-I infected T lymphocytes. We have previously shown that Tax ubiquitylation on C-terminal lysines is critical for binding of Tax to I kappa B kinase (IKK) and its subsequent activation. Here, we report that ubiquitylated Tax is not associated with active cytosolic IKK subunits, but binds endogenous IKK-alpha, -beta, -gamma, targeting them to the centrosome. K63-ubiquitylated Tax colocalizes at the centrosome with IKK-gamma, while K48-ubiquitylated Tax is stabilized upon proteasome inhibition. Altogether, these results support a model in which K63-ubiquitylated Tax activates IKK in a centrosome-associated signalosome, leading to the production of Tax-free active cytoplasmic IKK. These observations highlight an unsuspected link between Tax-induced IKK activation and the centrosome.	[Kfoury, Y.; Nasr, R.; El Hajj, H.; Mikati, A. G.; Bazarbachi, A.] Amer Univ Beirut, Med Ctr, Dept Internal Med, Beirut, Lebanon; [Nasr, R.; Renault, N.; Giron, M-L; Saib, A.; de The, H.] CNRS, UMR 7151, Lab Associe Comite Paris Ligue Canc, Paris, France; [Favre-Bonvin, A.; Chiari, E.; Pique, C.] Univ Paris 05, Univ Paris 07, CNRS,Fac Med Rene Descartes,UMR 7151, Inst Cochin,Dept Biol Cellulaire,UMR3,INSERM U567, Paris, France; [El-Sabban, M.] Amer Univ Beirut, Dept Human Morphol, Beirut, Lebanon; [Giron, M-L] Inst Univ Hematol IFR105, Imagery Dept, Paris, France; [Hermine, O.] Hop Necker Enfants Malad, Dept Hematol, Paris, France; [Hermine, O.] CNRS, UMR 8603, Paris, France	American University of Beirut; Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; American University of Beirut; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS)	Bazarbachi, A (corresponding author), Amer Univ Beirut, Med Ctr, Dept Internal Med, Hamra St,POB 1136044, Beirut, Lebanon.	bazarbac@aub.edu.lb	Pique, Claudine/O-6088-2017; Nasr, Rihab/AAF-1606-2020; Hermine, Olivier/Q-7072-2018; setterblad, niclas/GSN-1756-2022	Pique, Claudine/0000-0001-8690-2440; Hermine, Olivier/0000-0003-2574-3874; Bazarbachi, Ali/0000-0002-7171-4997; Mikati, Mohamad/0000-0003-0363-8715; Nasr, Rihab/0000-0003-1166-4999				Bex F, 1998, MOL CELL BIOL, V18, P2392, DOI 10.1128/MCB.18.4.2392; Cheng TS, 2006, LIFE SCI, V78, P1114, DOI 10.1016/j.lfs.2005.06.021; Chiari E, 2004, J VIROL, V78, P11823, DOI 10.1128/JVI.78.21.11823-11832.2004; Ching YP, 2006, NAT CELL BIOL, V8, P717, DOI 10.1038/ncb1432; Conaway RC, 2002, SCIENCE, V296, P1254, DOI 10.1126/science.1067466; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Harhaj NS, 2007, J BIOL CHEM, V282, P4185, DOI 10.1074/jbc.M611031200; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Lamsoul I, 2005, MOL CELL BIOL, V25, P10391, DOI 10.1128/MCB.25.23.10391-10406.2005; Nasr R, 2006, BLOOD, V107, P4021, DOI 10.1182/blood-2005-09-3572; Nawrocki ST, 2006, CANCER RES, V66, P3773, DOI 10.1158/0008-5472.CAN-05-2961; Nejmeddine M, 2005, J BIOL CHEM, V280, P29653, DOI 10.1074/jbc.M502639200; Nitta T, 2006, CANCER SCI, V97, P836, DOI 10.1111/j.1349-7006.2006.00254.x; Peloponese JM, 2004, J VIROL, V78, P11686, DOI 10.1128/JVI.78.21.11686-11695.2004; Pumfery A, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-50; Robek MD, 1999, J VIROL, V73, P4856, DOI 10.1128/JVI.73.6.4856-4865.1999; Sun SC, 2000, AIDS RES HUM RETROV, V16, P1591, DOI 10.1089/08892220050193001; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384	20	57	57	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 13	2008	27	12					1665	1676		10.1038/sj.onc.1210804	http://dx.doi.org/10.1038/sj.onc.1210804			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	273WF	17891179				2022-12-25	WOS:000253962100002
J	Khaleque, M; Bharti, A; Gong, J; Gray, PJ; Sachdev, V; Ciocca, DR; Stati, A; Fanelli, M; Calderwood, SK				Khaleque, Ma; Bharti, A.; Gong, J.; Gray, P. J.; Sachdev, V.; Ciocca, D. R.; Stati, A.; Fanelli, M.; Calderwood, S. K.			Heat shock factor 1 represses estrogen-dependent transcription through association with MTA1	ONCOGENE			English	Article						heat shock factor; metastasis; associated protein	METASTASIS-ASSOCIATED PROTEIN-1; C-FOS; GENE; CANCER; EXPRESSION; PHOSPHORYLATION; 14-3-3-EPSILON; CHAPERONES; COMPLEXES; APOPTOSIS	Heat shock factor 1 (HSF1), the transcriptional activator of the heat shock genes, is increasingly implicated in cancer. We have shown that HSF1 binds to the corepressor metastasis-associated protein 1 (MTA1) in vitro and in human breast carcinoma samples. HSF1-MTA1 complex formation was strongly induced by the transforming ligand heregulin and complexes incorporated a number of additional proteins including histone deacetylases (HDAC1 and 2) and Mi2 alpha, all components of the NuRD corepressor complex. These complexes were induced to assemble on the chromatin of MCF7 breast carcinoma cells and associated with the promoters of estrogen-responsive genes. Such HSF1 complexes participate in repression of estrogen-dependent transcription in breast carcinoma cells treated with heregulin and this effect was inhibited by MTA1 knockdown. Repression of estrogen-dependent transcription may contribute to the role of HSF1 in cancer.	[Khaleque, Ma; Gray, P. J.; Calderwood, S. K.] Harvard Univ, Sch Med, Dept Radiat Oncol, BIDMC, Boston, MA 02215 USA; [Khaleque, Ma] NS Univ, Dept Biochem, Dhaka, Bangladesh; [Bharti, A.; Gong, J.; Sachdev, V.; Calderwood, S. K.] Boston Univ, Dept Med, Mendoza, Argentina; [Ciocca, D. R.; Stati, A.; Fanelli, M.] Inst Expt Med & Biol Cuyo, Lab Oncol, Mendoza, Argentina	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Calderwood, SK (corresponding author), Harvard Univ, Sch Med, Dept Radiat Oncol, BIDMC, 21-27 Burlington Ave,5th Floor, Boston, MA 02215 USA.	scalderw@bidmc.harvard.edu		Khaleque, Md Abdul/0000-0002-6873-9165	NATIONAL CANCER INSTITUTE [R01CA077465] Funding Source: NIH RePORTER; NCI NIH HHS [CA077465] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bewick M, 1999, BONE MARROW TRANSPL, V24, P377, DOI 10.1038/sj.bmt.1701907; Bowen NJ, 2004, BBA-GENE STRUCT EXPR, V1677, P52, DOI 10.1016/j.bbaexp.2003.10.010; Cahill CM, 1996, J BIOL CHEM, V271, P24874; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Chen CM, 1997, J BIOL CHEM, V272, P26803, DOI 10.1074/jbc.272.43.26803; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Gago G, 2006, J BACTERIOL, V188, P477, DOI 10.1128/JB.188.2.477-486.2006; Hoang AT, 2000, AM J PATHOL, V156, P857, DOI 10.1016/S0002-9440(10)64954-1; Jones EL, 2004, INT J HYPERTHER, V20, P835, DOI 10.1080/02656730410001721807; Khaleque MA, 2005, ONCOGENE, V24, P6564, DOI 10.1038/sj.onc.1208798; Kumar R, 2003, SEMIN ONCOL, V30, P30, DOI 10.1053/j.seminoncol.2003.08.005; Mazumdar A, 2001, NAT CELL BIOL, V3, P30, DOI 10.1038/35050532; Mosser DD, 2004, ONCOGENE, V23, P2907, DOI 10.1038/sj.onc.1207529; Neubauer BL, 2003, CANCER RES, V63, P6056; Tang D, 2005, CELL STRESS CHAPERON, V10, P46, DOI 10.1379/CSC-44R.1; Toh Y, 2000, J EXP CLIN CANC RES, V19, P105; Wang XZ, 2006, J BIOL CHEM, V281, P782, DOI 10.1074/jbc.M505822200; Wang XZ, 2004, J BIOL CHEM, V279, P49460, DOI 10.1074/jbc.M406059200; Wang XZ, 2003, MOL CELL BIOL, V23, P6013, DOI 10.1128/MCB.23.17.6013-6026.2003; Wang YQ, 2004, J BIOL CHEM, V279, P32651, DOI 10.1074/jbc.M401475200; Xie Y, 2003, J BIOL CHEM, V278, P4687, DOI 10.1074/jbc.M210189200; Xie Y, 2002, J BIOL CHEM, V277, P11802, DOI 10.1074/jbc.M109296200; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Yao YL, 2003, J BIOL CHEM, V278, P42560, DOI 10.1074/jbc.M302955200	24	77	84	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2008	27	13					1886	1893		10.1038/sj.onc.1210834	http://dx.doi.org/10.1038/sj.onc.1210834			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	276NZ	17922035				2022-12-25	WOS:000254150600008
J	Akhavan, A; Crivelli, SN; Singh, M; Lingappa, VR; Muschler, JL				Akhavan, Armin; Crivelli, Silvia N.; Singh, Manisha; Lingappa, Vishwanath R.; Muschler, John L.			SEA domain proteolysis determines the functional composition of dystroglycan	FASEB JOURNAL			English	Article						mucin; laminin; autoproteolysis; muscular dystrophy	PROTEIN-STRUCTURE PREDICTION; DYSTROPHIN-GLYCOPROTEIN COMPLEX; SECONDARY STRUCTURE PREDICTION; MUSCULAR-DYSTROPHIES; ALPHA-DYSTROGLYCAN; BETA-DYSTROGLYCAN; EPITHELIAL-CELLS; LAMININ; GLYCOSYLATION; CLEAVAGE	Post-translational modifications of the extracellular matrix receptor dystroglycan (DG) determine its functional state, and defects in these modifications are linked to muscular dystrophies and cancers. A prominent feature of DG biosynthesis is a precursor cleavage that segregates the ligand-binding and transmembrane domains into the noncovalently attached alpha-and beta-subunits. We investigate here the structural determinants and functional significance of this cleavage. We show that cleavage of DG elicits a conspicuous change in its ligand-binding activity. Mutations that obstruct this cleavage result in increased capacity to bind laminin, in part, due to enhanced glycosylation of alpha-DG. Reconstitution of DG cleavage in a cell-free expression system demonstrates that cleavage takes place in the endoplasmic reticulum, providing a suitable regulatory point for later processing events. Sequence and mutational analyses reveal that the cleavage occurs within a full SEA (sea urchin, enterokinase, agrin) module with traits matching those ascribed to autoproteolysis. Thus, cleavage of DG constitutes a control point for the modulation of its ligand-binding properties, with therapeutic implications for muscular dystrophies. We provide a structural model for the cleavage domain that is validated by experimental analysis and discuss this cleavage in the context of mucin protein and SEA domain evolution.	[Akhavan, Armin; Singh, Manisha; Lingappa, Vishwanath R.; Muschler, John L.] Calif Pacific Med Ctr, Res Inst, San Francisco, CA 94107 USA; [Crivelli, Silvia N.] Lawrence Berkeley Natl Lab, Berkeley, CA USA	California Pacific Medical Center; California Pacific Medical Center Research Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Muschler, JL (corresponding author), Calif Pacific Med Ctr, Res Inst, 475 Brannan St,Ste 220, San Francisco, CA 94107 USA.	muschler@cpmcri.org		Lingappa, Vishwanath R./0000-0003-0962-6571; Muschler, John/0000-0001-9916-5937	NCI NIH HHS [R01 CA109579] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA109579] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Barresi R, 2004, NAT MED, V10, P696, DOI 10.1038/nm1059; Boffi A, 2001, BBA-PROTEIN STRUCT M, V1546, P114, DOI 10.1016/S0167-4838(01)00131-5; BORK P, 1995, PROTEIN SCI, V4, P1421, DOI 10.1002/pro.5560040716; Cohn RD, 2002, CELL, V110, P639, DOI 10.1016/S0092-8674(02)00907-8; Cohn RD, 2000, MUSCLE NERVE, V23, P1456, DOI 10.1002/1097-4598(200010)23:10<1456::AID-MUS2>3.0.CO;2-T; Crivelli S, 2004, J COMPUT AID MOL DES, V18, P271, DOI 10.1023/B:JCAM.0000046822.54719.4f; Cuff JA, 2000, PROTEINS, V40, P502, DOI 10.1002/1097-0134(20000815)40:3<502::AID-PROT170>3.0.CO;2-Q; Deng WM, 2003, DEVELOPMENT, V130, P173, DOI 10.1242/dev.00199; Dickens NJ, 2002, CURR BIOL, V12, pR197, DOI 10.1016/S0960-9822(02)00748-0; Duraisamy S, 2006, GENE, V373, P28, DOI 10.1016/j.gene.2005.12.021; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Esapa CT, 2003, FEBS LETT, V555, P209, DOI 10.1016/S0014-5793(03)01230-4; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Henry MD, 1998, CELL, V95, P859, DOI 10.1016/S0092-8674(00)81708-0; Holt KH, 2000, FEBS LETT, V468, P79, DOI 10.1016/S0014-5793(00)01195-9; Jayasinha V, 2003, NEUROMUSCULAR DISORD, V13, P365, DOI 10.1016/S0960-8966(03)00040-3; Johnson RP, 2006, DEVELOPMENT, V133, P1911, DOI 10.1242/dev.02363; Kanagawa M, 2004, CELL, V117, P953, DOI 10.1016/j.cell.2004.06.003; Karplus K, 2005, PROTEINS, V61, P135, DOI 10.1002/prot.20730; Levitin F, 2005, J BIOL CHEM, V280, P33374, DOI 10.1074/jbc.M506047200; Li S, 2002, J CELL BIOL, V157, P1279, DOI 10.1083/jcb.200203073; LIGTENBERG MJL, 1992, J BIOL CHEM, V267, P6171; Macao B, 2006, NAT STRUCT MOL BIOL, V13, P71, DOI 10.1038/nsmb1035; Maeda T, 2004, J BIOL CHEM, V279, P13174, DOI 10.1074/jbc.M309417200; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Molinari M, 1999, NATURE, V402, P90, DOI 10.1038/47062; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; Pereboev AV, 2001, BBA-GEN SUBJECTS, V1527, P54, DOI 10.1016/S0304-4165(01)00147-7; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; ROST B, 1994, COMPUT APPL BIOSCI, V10, P53; Saito F, 2003, NEURON, V38, P747, DOI 10.1016/S0896-6273(03)00301-5; Singh J, 2004, CANCER RES, V64, P6152, DOI 10.1158/0008-5472.CAN-04-1638; Tremblay MR, 2006, J BIOL CHEM, V281, P13365, DOI 10.1074/jbc.M600912200; Watanabe N, 2007, GENES CELLS, V12, P75, DOI 10.1111/j.1365-2443.2006.01033.x; Weir ML, 2006, J CELL SCI, V119, P4047, DOI 10.1242/jcs.03103; Wreschner DH, 2002, PROTEIN SCI, V11, P698, DOI 10.1110/ps.16502; Xu Jinbo, 2003, J Bioinform Comput Biol, V1, P95, DOI 10.1142/S0219720003000186; YOST CS, 1983, CELL, V34, P759; Zhang Y, 2005, P NATL ACAD SCI USA, V102, P1029, DOI 10.1073/pnas.0407152101	41	37	38	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	FEB	2008	22	2					612	621		10.1096/fj.07-8354com	http://dx.doi.org/10.1096/fj.07-8354com			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	257TY	17905726				2022-12-25	WOS:000252822600031
J	Wu, D; Huang, W; Richardson, PM; Priestley, JV; Liu, M				Wu, Dongsheng; Huang, Wenlong; Richardson, Peter M.; Priestley, John V.; Liu, Min			TRPC4 in rat dorsal root ganglion neurons is increased after nerve injury and is necessary for neurite outgrowth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY SENSORY NEURONS; RECEPTOR POTENTIAL CHANNELS; GROWTH CONES; NEUROTROPHIC FACTOR; CATION CHANNEL; CYCLIC-AMP; CA2+ ENTRY; IN-VITRO; EXPRESSION; REGENERATION	Canonical transient receptor potential (TRPC) receptors are Ca2+-permeable cation channels that have a variety of physiological functions and may be involved in neuronal development and plasticity. We investigated the expression profile of TRPC channels in adult rat dorsal root ganglia (DRG) after nerve injury and examined the role of TRPC4 in neurite outgrowth in cultured DRG neurons. Sciatic nerve transection and microinjection of dibutyryl cAMP were employed to induce axonal regeneration in vivo. TRPC4 mRNA was significantly increased whereas TRPC1, TRPC3, TRPC6, and TRPC7 remained unaltered after nerve injury or dibutyryl-cAMP microinjection. The increases in TRPC4 transcript and protein were transient with maximal levels reached at 2 or 7 days, respectively. In addition, TRPC4 transcript in ND7/23 and NDC cells, hybrid cell lines derived from neonatal DRG and neuroblastoma, was substantially increased on differentiation, characterized by neurite outgrowth. In adult DRG, TRPC4 immunoreactivity was found in small and large neurons, and nerve injury increased the number of TRPC4-immunoreactive cells, particularly in large neurons. TRPC4 immunoreactivity was present in growth cones at various stages of DRG neurite outgrowth in vitro. Suppression of TRPC4 by a specific small interfering RNA or antisense significantly reduced the length of neurites in cultured DRG neurons. Expression of short hairpin RNA significantly down-regulated TRPC4 protein level and shortened neurite lengths in differentiated ND7/23 cells. The reduction in neurite lengths in ND7/23 cells was rescued by overexpression of human TRPC4. Our results suggest that TRPC4 contributes to axonal regeneration after nerve injury.	[Wu, Dongsheng; Huang, Wenlong; Richardson, Peter M.; Priestley, John V.; Liu, Min] Queen Mary Univ London, Ctr Neurosci, Inst Cell & Mol Sci, London E1 2AT, England	University of London; Queen Mary University London	Liu, M (corresponding author), 4 Newark St, London E1 2AT, England.	m.liu@qmul.ac.uk	Huang, Wenlong/P-2025-2016					Agell N, 2002, CELL SIGNAL, V14, P649, DOI 10.1016/S0898-6568(02)00007-4; Alvarez VA, 2006, J NEUROSCI, V26, P7820, DOI 10.1523/JNEUROSCI.1957-06.2006; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Caroni P, 2001, EMBO J, V20, P4332, DOI 10.1093/emboj/20.16.4332; Costigan M, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-16; Fatherazi S, 2007, PFLUG ARCH EUR J PHY, V453, P879, DOI 10.1007/s00424-006-0156-4; Fukuchi M, 2005, J PHARMACOL SCI, V98, P212, DOI 10.1254/jphs.FMJ05001X4; Glazebrook PA, 2005, PFLUG ARCH EUR J PHY, V451, P125, DOI 10.1007/s00424-005-1468-5; Gomez TM, 2006, NAT REV NEUROSCI, V7, P115, DOI 10.1038/nrn1844; Greka A, 2003, NAT NEUROSCI, V6, P837, DOI 10.1038/nn1092; HARPER AA, 1985, J PHYSIOL-LONDON, V359, P31, DOI 10.1113/jphysiol.1985.sp015573; Haruta T, 1997, BIOCHEM J, V325, P455, DOI 10.1042/bj3250455; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Huang WC, 2007, CELL CALCIUM, V42, P1, DOI 10.1016/j.ceca.2006.11.002; Inada H, 2006, BIOCHEM BIOPH RES CO, V350, P762, DOI 10.1016/j.bbrc.2006.09.111; Kunert-Keil C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-159; Lautermilch NJ, 2000, J NEUROSCI, V20, P315, DOI 10.1523/JNEUROSCI.20-01-00315.2000; Laux T, 2000, J CELL BIOL, V149, P1455, DOI 10.1083/jcb.149.7.1455; Leclere PG, 2007, J NEUROSCI, V27, P1190, DOI 10.1523/JNEUROSCI.5089-06.2007; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Liu M, 2004, NEUROSCIENCE, V127, P659, DOI 10.1016/j.neuroscience.2004.05.041; Maroto R, 2005, NAT CELL BIOL, V7, P179, DOI 10.1038/ncb1218; Mehta D, 2003, J BIOL CHEM, V278, P33492, DOI 10.1074/jbc.M302401200; Michael GJ, 1999, EUR J NEUROSCI, V11, P3539, DOI 10.1046/j.1460-9568.1999.00767.x; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; MURPHY PG, 1995, J NEUROSCI, V15, P5130; Murphy PG, 2000, EUR J NEUROSCI, V12, P1891, DOI 10.1046/j.1460-9568.2000.00074.x; Neumann S, 2005, P NATL ACAD SCI USA, V102, P16848, DOI 10.1073/pnas.0508538102; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; Poteser M, 2006, J BIOL CHEM, V281, P13588, DOI 10.1074/jbc.M512205200; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Riccio A, 2002, MOL BRAIN RES, V109, P95, DOI 10.1016/S0169-328X(02)00527-2; RICHARDSON PM, 1984, NATURE, V309, P791, DOI 10.1038/309791a0; Shim S, 2005, NAT NEUROSCI, V8, P730, DOI 10.1038/nn1459; Singh I, 2007, J BIOL CHEM, V282, P7833, DOI 10.1074/jbc.M608288200; Strubing C, 2003, J BIOL CHEM, V278, P39014, DOI 10.1074/jbc.M306705200; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Tanabe K, 2003, J NEUROSCI, V23, P9675; Tonra JR, 1998, J NEUROSCI, V18, P4374; Wang GX, 2005, NATURE, V434, P898, DOI 10.1038/nature03478; Williams KL, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-24; WOOD JN, 1990, P ROY SOC B-BIOL SCI, V241, P187, DOI 10.1098/rspb.1990.0084; Wu DS, 2007, EXP NEUROL, V204, P66, DOI 10.1016/j.expneurol.2006.09.017; Wu XY, 2004, J BIOL CHEM, V279, P43392, DOI 10.1074/jbc.M408959200; Xiao HS, 2002, P NATL ACAD SCI USA, V99, P8360, DOI 10.1073/pnas.122231899; Yu Y, 2004, P NATL ACAD SCI USA, V101, P13861, DOI 10.1073/pnas.0405908101	49	66	69	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					416	426		10.1074/jbc.M703177200	http://dx.doi.org/10.1074/jbc.M703177200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17928298	hybrid			2022-12-25	WOS:000251940300046
J	Barron, RM; Campbell, SL; King, D; Bellon, A; Chapman, KE; Williamson, RA; Manson, JC				Barron, Rona M.; Campbell, Susan L.; King, Declan; Bellon, Anne; Chapman, Karen E.; Williamson, R. Anthony; Manson, Jean C.			High titers of transmissible spongiform encephalopathy infectivity associated with extremely low levels of PrPSc in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREUTZFELDT-JAKOB-DISEASE; ABNORMAL PRION PROTEIN; SINGLE AMINO-ACID; TRANSGENIC MICE; BLOOD-TRANSFUSION; INCUBATION-TIME; INSERTIONAL MUTATION; SCRAPIE AGENT; MUTANT PRP; BSE AGENT	Diagnosis of transmissible spongiform encephalopathy (TSE) disease in humans and ruminants relies on the detection in postmortem brain tissue of the protease-resistant form of the host glycoprotein PrP. The presence of this abnormal isoform (PrPSc) in tissues is taken as indicative of the presence of TSE infectivity. Here we demonstrate conclusively that high titers of TSE infectivity can be present in brain tissue of animals that show clinical and vacuolar signs of TSE disease but contain low or undetectable levels of PrPSc. This work questions the correlation between PrPSc level and the titer of infectivity and shows that tissues containing little or no proteinase K-resistant PrP can be infectious and harbor high titers of TSE infectivity. Reliance on protease-resistant PrPSc as a sole measure of infectivity may therefore in some instances significantly underestimate biological properties of diagnostic samples, thereby undermining efforts to contain and eradicate TSEs.	Roslin Inst, Neuropathogenesis Unit, Edinburgh EH9 3JF, Midlothian, Scotland; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Univ Edinburgh, Queens Med Res Inst, Ctr Cardiovasc Sci, Edinburgh EH16 4TJ, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; Scripps Research Institute; University of Edinburgh	Barron, RM (corresponding author), Roslin Inst, Neuropathogenesis Unit, Ogston Bldg,W Mains Rd, Edinburgh EH9 3JF, Midlothian, Scotland.	rona.barron@bbsrc.ac.uk	King, Declan/AAA-7145-2021; Barron, Rona M/C-7703-2013; Barron, Rona/AAP-9360-2020	manson, jean/0000-0002-0175-9890; King, Declan/0000-0002-2434-9317; Chapman, Karen/0000-0001-7777-6817; Barron, Rona/0000-0003-4512-9177	Biotechnology and Biological Sciences Research Council [BBS/E/I/00001155] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Barron RM, 2003, J GEN VIROL, V84, P3165, DOI 10.1099/vir.0.19147-0; Barron RM, 2001, EMBO J, V20, P5070, DOI 10.1093/emboj/20.18.5070; Beekes M, 1996, J GEN VIROL, V77, P1925, DOI 10.1099/0022-1317-77-8-1925; Bishop MT, 2006, LANCET NEUROL, V5, P393, DOI 10.1016/S1474-4422(06)70413-6; Brown P, 2000, NEUROLOGY, V55, P1075, DOI 10.1212/WNL.55.8.1075; Bruce ME, 2007, VET REC, V160, P665, DOI 10.1136/vr.160.19.665; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Buschmann A, 2004, J GEN VIROL, V85, P2727, DOI 10.1099/vir.0.79997-0; Buschmann A, 2004, J VIROL METHODS, V117, P27, DOI 10.1016/j.jviromet.2003.11.017; Chiesa R, 2000, P NATL ACAD SCI USA, V97, P5574, DOI 10.1073/pnas.97.10.5574; Chiesa R, 2001, NEUROBIOL DIS, V8, P743, DOI 10.1006/nbdi.2001.0433; Chiesa R, 1998, NEURON, V21, P1339, DOI 10.1016/S0896-6273(00)80653-4; DICKINSON AG, 1968, J COMP PATHOL, V78, P293, DOI 10.1016/0021-9975(68)90005-4; Hegde RS, 1999, NATURE, V402, P822, DOI 10.1038/45574; Hilton DA, 2004, J PATHOL, V203, P733, DOI 10.1002/path.1580; Houston F, 2000, LANCET, V356, P999, DOI 10.1016/S0140-6736(00)02719-7; HSIAO KK, 1994, P NATL ACAD SCI USA, V91, P9126, DOI 10.1073/pnas.91.19.9126; Hunter N, 2002, J GEN VIROL, V83, P2897, DOI 10.1099/0022-1317-83-11-2897; IRONSIDE J, 2006, BMJ-BRIT MED J, V332, P1164; Karber G., 1931, ARCH EXP PATHOL PH, V162, P480, DOI DOI 10.1007/BF01863914; KITAMOTO T, 1993, BIOCHEM BIOPH RES CO, V192, P525, DOI 10.1006/bbrc.1993.1447; Lasmezas CI, 1997, SCIENCE, V275, P402, DOI 10.1126/science.275.5298.402; Le Dur A, 2005, P NATL ACAD SCI USA, V102, P16031, DOI 10.1073/pnas.0502296102; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Ma JY, 2002, SCIENCE, V298, P1781, DOI 10.1126/science.1073725; Ma JY, 2002, SCIENCE, V298, P1785, DOI 10.1126/science.1073619; Manson JC, 1999, EMBO J, V18, P6855, DOI 10.1093/emboj/18.23.6855; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; Moroncini G, 2004, P NATL ACAD SCI USA, V101, P10404, DOI 10.1073/pnas.0403522101; Nazor KE, 2005, EMBO J, V24, P2472, DOI 10.1038/sj.emboj.7600717; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Pincock Stephen, 2004, BMJ, V329, P251, DOI 10.1136/bmj.329.7460.251-a; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1996, TRENDS BIOCHEM SCI, V21, P482, DOI 10.1016/S0968-0004(96)10063-3; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Safar JG, 2005, P NATL ACAD SCI USA, V102, P3501, DOI 10.1073/pnas.0409651102; Safar JG, 2002, NAT BIOTECHNOL, V20, P1147, DOI 10.1038/nbt748; Solforosi L, 2007, J BIOL CHEM, V282, P7465, DOI 10.1074/jbc.M610051200; Stewart RS, 2005, J NEUROSCI, V25, P3469, DOI 10.1523/JNEUROSCI.0105-05.2005; Tremblay P, 2004, J VIROL, V78, P2088, DOI 10.1128/JVI.78.4.2088-2099.2004; Wroe SJ, 2006, LANCET, V368, P2061, DOI 10.1016/S0140-6736(06)69835-8; Zanusso G, 1999, J BIOL CHEM, V274, P23396, DOI 10.1074/jbc.274.33.23396; Zanusso G, 1998, P NATL ACAD SCI USA, V95, P8812, DOI 10.1073/pnas.95.15.8812	43	135	140	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35878	35886		10.1074/jbc.M704329200	http://dx.doi.org/10.1074/jbc.M704329200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17923484	hybrid			2022-12-25	WOS:000251458100049
J	Cobb, N; Hemann, C; Polsinelli, GA; Ridge, JP; McEwan, AG; Hille, R				Cobb, Nathan; Hemann, Craig; Polsinelli, Gregory A.; Ridge, Justin P.; McEwan, Alastair G.; Hille, Russ			Spectroscopic and kinetic studies of Y114F and W116F mutants of Me2SO reductase from Rhodobacter capsulatus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIMETHYL-SULFOXIDE REDUCTASE; RAY-ABSORPTION SPECTROSCOPY; THALIANA SULFITE OXIDASE; F-SP DENITRIFICANS; DIMETHYLSULFOXIDE REDUCTASE; CRYSTAL-STRUCTURE; RAMAN-SPECTROSCOPY; DMSO REDUCTASE; MOLYBDENUM; SPHAEROIDES	Mutants of the active site residues Trp-116 and Tyr-114 of the molybdenum-containing Me2SO reductase from Rhodobacter capsulatus have been examined spectroscopically and kinetically. The Y114F mutant has an increased rate constant for oxygen atom transfer from Me2SO to reduced enzyme, the result of lower stability of the E-red center dot Me2SO complex. The absorption spectrum of this species ( but not that of either oxidized or reduced enzyme) is significantly perturbed in the mutant relative to wildtype enzyme, consistent with Tyr-114 interacting with bound Me2SO. The as-isolated W116F mutant is only five-coordinate, with one of the two equivalents of the pyranopterin cofactor found in the enzyme dissociated from the molybdenum and replaced by a second Mo=O group. Reduction of the mutant with sodium dithionite and reoxidation with Me2SO, however, regenerates the long-wavelength absorbance of functional enzyme, although the wavelength maximum is shifted to 670 nm from the 720 nm of wild-type enzyme. This "redox-cycled" mutant exhibits a Me2SO reducing activity and overall reaction mechanism similar to that of wild-type enzyme but rapidly reverts to the inactive five-coordinate form in the course of turnover.	Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA; Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; Univ Queensland, Sch Mol & Microbial Sci, St Lucia, Qld 4072, Australia	University of California System; University of California Riverside; University System of Ohio; Ohio State University; University of Queensland	Hille, R (corresponding author), Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.	russ.hille@ucr.edu	Ridge, Justin P/A-4994-2008	Hemann, Craig/0000-0002-7380-4072; McEwan, Alastair/0000-0002-2419-1003	NIEHS NIH HHS [ES 12658] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012658] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Adams B, 1999, BIOCHEMISTRY-US, V38, P8501, DOI 10.1021/bi9902034; BASTIAN NR, 1991, J BIOL CHEM, V266, P45; Baugh PE, 1997, J BIOL INORG CHEM, V2, P634, DOI 10.1007/s007750050178; Bell AF, 2001, BIOCHEMISTRY-US, V40, P440, DOI 10.1021/bi002065k; BENNETT B, 1994, EUR J BIOCHEM, V225, P321, DOI 10.1111/j.1432-1033.1994.00321.x; Bray RC, 2001, BIOCHEMISTRY-US, V40, P9810, DOI 10.1021/bi010559r; Bray RC, 2000, BIOCHEMISTRY-US, V39, P11258, DOI 10.1021/bi0000521; Cobb N, 2005, J BIOL CHEM, V280, P11007, DOI 10.1074/jbc.M412050200; Eilers T, 2001, J BIOL CHEM, V276, P46989, DOI 10.1074/jbc.M108078200; Garton SD, 1997, J AM CHEM SOC, V119, P12906, DOI 10.1021/ja972109l; George GN, 1996, J AM CHEM SOC, V118, P1113, DOI 10.1021/ja953317l; George GN, 1999, J AM CHEM SOC, V121, P1256, DOI 10.1021/ja982843k; Helton ME, 2001, J AM CHEM SOC, V123, P10389, DOI 10.1021/ja0100470; Hemann C, 2005, J AM CHEM SOC, V127, P16567, DOI 10.1021/ja0530873; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; Hille R, 2002, TRENDS BIOCHEM SCI, V27, P360, DOI 10.1016/S0968-0004(02)02107-2; Hilton JC, 1996, BBA-PROTEIN STRUCT M, V1294, P111, DOI 10.1016/0167-4838(96)00015-5; Johnson KE, 2001, J BIOL CHEM, V276, P13178, DOI 10.1074/jbc.M010965200; Li HK, 2000, J AM CHEM SOC, V122, P7673, DOI 10.1021/ja000643e; McAlpine AS, 1997, J BIOL INORG CHEM, V2, P690, DOI 10.1007/s007750050185; McAlpine AS, 1998, J MOL BIOL, V275, P613, DOI 10.1006/jmbi.1997.1513; MEWAN AG, 2002, GEOMICROBIOL J, V19, P1; Ridge JP, 2004, FEBS LETT, V563, P197, DOI 10.1016/S0014-5793(04)00301-1; Ridge JP, 2002, BIOCHEMISTRY-US, V41, P15762, DOI 10.1021/bi0266582; SATOH T, 1987, J BIOCHEM-TOKYO, V102, P191, DOI 10.1093/oxfordjournals.jbchem.a122032; Schindelin H, 1996, SCIENCE, V272, P1615, DOI 10.1126/science.272.5268.1615; Schneider F, 1996, J MOL BIOL, V263, P53, DOI 10.1006/jmbi.1996.0555; Shaw AL, 1996, BBA-BIOENERGETICS, V1276, P176, DOI 10.1016/0005-2728(96)00092-8; YAMAMOTO I, 1995, BIOSCI BIOTECH BIOCH, V59, P1850, DOI 10.1271/bbb.59.1850	29	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35519	35529		10.1074/jbc.M704458200	http://dx.doi.org/10.1074/jbc.M704458200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17921142	hybrid			2022-12-25	WOS:000251458100011
J	Gromadski, KB; Schummer, T; Stromgaard, A; Knudsen, CR; Kinzy, TG; Rodnina, MV				Gromadski, Kirill B.; Schuemmer, Tobias; Stromgaard, Anne; Knudsen, Charlotte R.; Kinzy, Terri Goss; Rodnina, Marina V.			Kinetics of the interactions between yeast elongation factors 1A and 1B alpha, guanine nucleotides, and aminoacyl-tRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELONGATION-FACTOR TU; SIGNAL RECOGNITION PARTICLE; CRYSTAL-STRUCTURE; EF-TU; TERNARY COMPLEX; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; FACTOR TS; GUANOSINE NUCLEOTIDES; EXCHANGE FACTOR	The interactions of elongation factor 1A (eEF1A) from Saccharomyces cerevisiae with elongation factor 1B alpha (eEF1B alpha), guanine nucleotides, and aminoacyl-tRNA were studied kinetically by fluorescence stopped-flow. eEF1A has similar affinities for GDP and GTP, 0.4 and 1.1 mu M, respectively. Dissociation of nucleotides from eEF1A in the absence of the guanine nucleotide exchange factor is slow ( about 0.1s(-1)) and is accelerated by eEF1B alpha by 320-fold and 250-fold for GDP and GTP, respectively. The rate constant of eEF1B alpha binding to eEF1A (10(7)-10(8) M-1 s(-1)) is independent of guanine nucleotides. At the concentrations of nucleotides and factors prevailing in the cell, the overall exchange rate is expected to be in the range of 6 s(-1), which is compatible with the rate of protein synthesis in the cell. eEF1A center dot GTP binds Phe-tRNA(Phe) with a K-d of 3 nM, whereas eEF1A center dot GDP shows no significant binding, indicating that eEF1A has similar tRNA binding properties as its prokaryotic homolog, EF-Tu.	Univ Witten Herdecke, Inst Phys Biochem, D-58448 Witten, Germany; Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus C, Denmark; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Microbiol Mol Genet & Immunol, Piscataway, NJ 08854 USA	Witten Herdecke University; Aarhus University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Rodnina, MV (corresponding author), Univ Witten Herdecke, Inst Phys Biochem, Stockumer Str 10, D-58448 Witten, Germany.	rodnina@uni-wh.de	Rodnina, Marina V./AAD-4667-2019	Rodnina, Marina V./0000-0003-0105-3879; Knudsen, Charlotte/0000-0003-2356-4821; Kinzy, Terri/0000-0003-1394-9226	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057483] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM057483, R01 GM057483-10] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abel K, 1996, STRUCTURE, V4, P1153, DOI 10.1016/S0969-2126(96)00123-2; Al-Karadaghi S, 1996, STRUCTURE, V4, P555, DOI 10.1016/S0969-2126(96)00061-5; Al-Maghrebi M, 2002, NUCLEIC ACIDS RES, V30, P5017, DOI 10.1093/nar/gkf656; Andersen GR, 2000, MOL CELL, V6, P1261, DOI 10.1016/S1097-2765(00)00122-2; Andersen GR, 2001, NAT STRUCT BIOL, V8, P531, DOI 10.1038/88598; BERCHTOLD H, 1993, NATURE, V365, P126, DOI 10.1038/365126a0; BOEHLKE KW, 1975, J BACTERIOL, V121, P429, DOI 10.1128/JB.121.2.429-433.1975; BONVEN B, 1979, MOL GEN GENET, V170, P225, DOI 10.1007/BF00337800; Clark BFC, 1997, CURR OPIN STRUC BIOL, V7, P110, DOI 10.1016/S0959-440X(97)80014-0; CRECHET JB, 1986, EUR J BIOCHEM, V161, P647, DOI 10.1111/j.1432-1033.1986.tb10489.x; Czworkowski J, 1997, BIOCHEMISTRY-US, V36, P10327, DOI 10.1021/bi970610k; CZWORKOWSKI J, 1994, EMBO J, V13, P3661, DOI 10.1002/j.1460-2075.1994.tb06675.x; Dahl LD, 2006, J BIOL CHEM, V281, P21139, DOI 10.1074/jbc.M602068200; Dale T, 2004, BIOCHEMISTRY-US, V43, P6159, DOI 10.1021/bi036290o; DELL VA, 1990, BIOCHEMISTRY-US, V29, P1757, DOI 10.1021/bi00459a014; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Gao HX, 2007, CELL, V129, P929, DOI 10.1016/j.cell.2007.03.050; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gromadski KB, 2002, BIOCHEMISTRY-US, V41, P162, DOI 10.1021/bi015712w; Hansson S, 2005, FEBS LETT, V579, P4492, DOI 10.1016/j.febslet.2005.07.016; Hemsath L, 2005, METHODS, V37, P173, DOI 10.1016/j.ymeth.2005.05.014; IKEMURA T, 1982, J MOL BIOL, V158, P573, DOI 10.1016/0022-2836(82)90250-9; JAGADISH MN, 1978, J CELL SCI, V31, P71; Jagath JR, 1998, BIOCHEMISTRY-US, V37, P15408, DOI 10.1021/bi981523a; JAMESON DM, 1987, BIOCHEMISTRY-US, V26, P3894, DOI 10.1021/bi00387a023; JANSSEN GMC, 1988, J BIOL CHEM, V263, P1773; JANSSEN GMC, 1988, EUR J BIOCHEM, V171, P119, DOI 10.1111/j.1432-1033.1988.tb13766.x; JOHN J, 1990, BIOCHEMISTRY-US, V29, P6058, DOI 10.1021/bi00477a025; Kapp LD, 2004, J MOL BIOL, V335, P923, DOI 10.1016/j.jmb.2003.11.025; Kawashima T, 1996, NATURE, V379, P511, DOI 10.1038/379511a0; KINZY TG, 1995, GENETICS, V141, P481; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P12543, DOI 10.1021/bi00039a008; Laurberg M, 2000, J MOL BIOL, V303, P593, DOI 10.1006/jmbi.2000.4168; Leibundgut M, 2005, EMBO J, V24, P11, DOI 10.1038/sj.emboj.7600505; Liu G, 1996, J CELL BIOL, V135, P953, DOI 10.1083/jcb.135.4.953; Merrick WC, 2000, COLD SPRING HARBOR M, V39, P89; Milon P, 2006, P NATL ACAD SCI USA, V103, P13962, DOI 10.1073/pnas.0606384103; Moser C, 1997, P NATL ACAD SCI USA, V94, P11339, DOI 10.1073/pnas.94.21.11339; Nissen P, 1999, STRUCTURE, V7, P143, DOI 10.1016/S0969-2126(99)80021-5; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Olarewaju Olubunmi, 2004, RNA Biol, V1, P89, DOI 10.4161/rna.1.2.1033; Pedersen L, 2001, ACTA CRYSTALLOGR D, V57, P159, DOI 10.1107/S0907444900015559; Perez JMJ, 1999, STRUCTURE, V7, P217, DOI 10.1016/S0969-2126(99)80027-6; Petrushenko ZM, 2002, EUR J BIOCHEM, V269, P4811, DOI 10.1046/j.1432-1033.2002.03178.x; Pisareva VP, 2007, BIOCHEMISTRY-US, V46, P2622, DOI 10.1021/bi062134g; Pisareva VP, 2006, J BIOL CHEM, V281, P40224, DOI 10.1074/jbc.M607461200; Pittman YR, 2006, J BIOL CHEM, V281, P19457, DOI 10.1074/jbc.M601076200; Polekhina G, 1996, STRUCTURE, V4, P1141, DOI 10.1016/S0969-2126(96)00122-0; RENSLAND H, 1995, BIOCHEMISTRY-US, V34, P593, DOI 10.1021/bi00002a026; RICHTER D, 1970, BIOCHEM BIOPH RES CO, V38, P864, DOI 10.1016/0006-291X(70)90800-4; Rodnina MV, 1996, J BIOL CHEM, V271, P646, DOI 10.1074/jbc.271.2.646; RODNINA MV, 1994, BIOCHEMISTRY-US, V33, P12267, DOI 10.1021/bi00206a033; SAHA SK, 1986, J BIOL CHEM, V261, P2599; Sanders J, 1996, J CELL SCI, V109, P1113; Schummer T, 2007, BIOCHEMISTRY-US, V46, P4977, DOI 10.1021/bi602486c; SCOPES RK, 1974, ANAL BIOCHEM, V59, P277, DOI 10.1016/0003-2697(74)90034-7; Thanbichler M, 2000, J BIOL CHEM, V275, P20458, DOI 10.1074/jbc.M002496200; TOMBS MP, 1959, BIOCHEM J, V73, P167, DOI 10.1042/bj0730167; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; WAGNER A, 1995, BIOCHEMISTRY-US, V34, P12535, DOI 10.1021/bi00039a007; WALDRON C, 1975, J BACTERIOL, V122, P855, DOI 10.1128/JB.122.3.855-865.1975; Wang Y, 1997, NAT STRUCT BIOL, V4, P650, DOI 10.1038/nsb0897-650; Wieden HJ, 2002, J BIOL CHEM, V277, P6032, DOI 10.1074/jbc.M110888200; Wilden B, 2006, P NATL ACAD SCI USA, V103, P13670, DOI 10.1073/pnas.0606099103; Wintermeyer W, 1974, Methods Enzymol, V29, P667; Zavialov AV, 2001, CELL, V107, P115, DOI 10.1016/S0092-8674(01)00508-6; Zhang YL, 1996, FEBS LETT, V391, P330, DOI 10.1016/0014-5793(96)00789-2; Zhang YL, 1998, J BIOL CHEM, V273, P4556, DOI 10.1074/jbc.273.8.4556	68	29	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35629	35637		10.1074/jbc.M707245200	http://dx.doi.org/10.1074/jbc.M707245200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17925388	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000251458100023
J	Hong, L; Fast, W				Hong, Lin; Fast, Walter			Inhibition of human dimethylarginine dimethylaminohydrolase-1 by S-nitroso-L-homocysteine and hydrogen peroxide - Analysis, quantification, and implications for hyperhomocysteinemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE-SITE CYSTEINE; NITRIC-OXIDE; ASYMMETRIC DIMETHYLARGININE; ENDOTHELIAL DYSFUNCTION; THIOL COMPOUNDS; BOVINE BRAIN; ADMA; MECHANISM; ANGIOGENESIS; KINETICS	The plasma concentrations of two cardiovascular risk factors, total homocysteine (tHcy) and asymmetric dimethylarginine (ADMA), correlate with decreased levels of endothelium-derived nitric oxide and subsequent endothelial dysfunction. Homocysteine has been proposed to inhibit the catabolic enzyme of ADMA, dimethylarginine dimethylaminohydrolase (DDAH), but the mechanism of this inhibition has not been fully elucidated. Here, the human DDAH isoform-1 (DDAH-1) is heterologously expressed and purified. Cys(274) and His(173) are identified as active site residues and the pH rate dependence is described. Because oxidation of the active site Cys has been suggested as an inhibitory mechanism in patients with hyperhomocysteinemia, the sensitivity of DDAH-1 to inhibition by L-homocysteine, H2O2, and S-nitroso-L-homocysteine is quantified. DDAH-1 is surprisingly insensitive to inactivation by the powerful oxidant, H2O2 (0.088 M-1 S-1), possibly because of a substrate-assisted mechanism that allows the active site cysteine to remain predominantly protonated and less reactive in the resting enzyme. In contrast, DDAH-1 is sensitive to inactivation by S-nitroso-L-homocysteine ( 3.79 M-1 S-1). This work illustrates how a particular catalytic mechanism can result in selective redox regulation and has possible implications for hyperhomocysteinemia.	Univ Texas, Coll Pharm, Texas Inst Drug & Diagnost Dev, Div Med Chem, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Fast, W (corresponding author), Univ Texas, Coll Pharm, Texas Inst Drug & Diagnost Dev, Div Med Chem, Austin, TX 78712 USA.	WaltFast@mail.utexas.edu						Achan V, 2005, VASC MED, V10, P7, DOI 10.1191/1358863x05vm580oa; Barrett WC, 1999, BIOCHEMISTRY-US, V38, P6699, DOI 10.1021/bi990240v; Boger RH, 2005, VASC MED, V10, pS19, DOI 10.1191/1358863x05vm602oa; Boger RH, 2001, CLIN SCI, V100, P161, DOI 10.1042/CS20000173; Bogumil R, 1998, BIOCHEMISTRY-US, V37, P4791, DOI 10.1021/bi972312t; Braun O, 2007, PROTEIN SCI, V16, P1522, DOI 10.1110/ps.062718507; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Claiborne A, 1999, BIOCHEMISTRY-US, V38, P15407, DOI 10.1021/bi992025k; Closs EI, 1997, NITRIC OXIDE-BIOL CH, V1, P65, DOI 10.1006/niox.1996.0106; Cooke JP, 2004, CIRCULATION, V109, P1813, DOI 10.1161/01.CIR.0000126823.07732.D5; Cooke JP, 2004, CAN J CARDIOL, V20, p7B; Cooke JP, 2005, VASC MED, V10, pS11, DOI 10.1191/1358863x05vm598oa; Dayal S, 2005, VASC MED, V10, pS27, DOI 10.1191/1358863x05vm599oa; DUERRE JA, 1966, ANAL BIOCHEM, V17, P310, DOI 10.1016/0003-2697(66)90209-0; FEELISCH M, 1996, METHODS NITRIC OXIDE, P521; Frey D, 2006, STRUCTURE, V14, P901, DOI 10.1016/j.str.2006.03.006; Geoghegan KF, 1999, ANAL BIOCHEM, V267, P169, DOI 10.1006/abio.1998.2990; Hampton MB, 2002, FEBS LETT, V517, P229, DOI 10.1016/S0014-5793(02)02629-7; Hogg N, 1999, ANAL BIOCHEM, V272, P257, DOI 10.1006/abio.1999.4199; Jacobi J, 2005, CIRCULATION, V111, P1431, DOI 10.1161/01.CIR.0000158487.80483.09; Jakubowski H, 2004, CELL MOL LIFE SCI, V61, P470, DOI 10.1007/s00018-003-3204-7; Jakubowski H, 2000, J BIOL CHEM, V275, P21813, DOI 10.1074/jbc.C000280200; Kimoto M, 1998, EUR J BIOCHEM, V258, P863, DOI 10.1046/j.1432-1327.1998.2580863.x; Knipp M, 2000, ANAL BIOCHEM, V286, P257, DOI 10.1006/abio.2000.4805; Knipp M, 2005, J AM CHEM SOC, V127, P2372, DOI 10.1021/ja0430200; Knipp M, 2001, J BIOL CHEM, V276, P40449, DOI 10.1074/jbc.M104056200; Knipp M, 2006, CHEMBIOCHEM, V7, P879, DOI 10.1002/cbic.200500527; Knuckley B, 2007, BIOCHEMISTRY-US, V46, P6578, DOI 10.1021/bi700095s; Kostourou V, 2002, BRIT J CANCER, V87, P673, DOI 10.1038/sj.bjc.6600518; Leiper J, 2007, NAT MED, V13, P198, DOI 10.1038/nm1543; Long LH, 2001, BIOCHEM BIOPH RES CO, V286, P991, DOI 10.1006/bbrc.2001.5514; Luo DY, 2005, J PHARM SCI-US, V94, P304, DOI 10.1002/jps.20253; Maas R, 2003, ATHEROSCLEROSIS SUPP, V4, P5, DOI 10.1016/S1567-5688(03)00028-X; Mitchell DA, 2005, NAT CHEM BIOL, V1, P154, DOI 10.1038/nchembio720; Murray-Rust J, 2001, NAT STRUCT BIOL, V8, P679, DOI 10.1038/90387; OGAWA T, 1989, J BIOL CHEM, V264, P10205; RADI R, 1991, J BIOL CHEM, V266, P4244; Rossiter S, 2005, J MED CHEM, V48, P4670, DOI 10.1021/jm050187a; Shirai H, 2001, TRENDS BIOCHEM SCI, V26, P465, DOI 10.1016/S0968-0004(01)01906-5; Shirai H, 2006, PROTEINS, V64, P1010, DOI 10.1002/prot.20863; SILVERMAN RB, 1995, METHOD ENZYMOL, V249, P240; Smith CV, 1996, TOXICOL APPL PHARM, V140, P1, DOI 10.1006/taap.1996.0191; Sohn J, 2003, BIOCHEMISTRY-US, V42, P10060, DOI 10.1021/bi0345081; STAMLER JS, 1993, J CLIN INVEST, V91, P308, DOI 10.1172/JCI116187; Stone EA, 2005, BIOCHEMISTRY-US, V44, P7069, DOI 10.1021/bi047407r; Stone EM, 2006, BIOCHEMISTRY-US, V45, P5618, DOI 10.1021/bi052595m; Stone EM, 2005, ANAL BIOCHEM, V343, P335, DOI 10.1016/j.ab.2005.05.006; Stuhlinger MC, 2005, CURR DRUG METAB, V6, P3, DOI 10.2174/1389200052997393; Stuhlinger MC, 2001, CIRCULATION, V104, P2569, DOI 10.1161/hc4601.098514; Subramaniam S, 1998, PROTEINS, V32, P1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vallance P, 2005, CHEM COMMUN, P5563, DOI 10.1039/b510709a; VALLANCE P, 1992, LANCET, V339, P572; Vallance P, 2002, NAT REV DRUG DISCOV, V1, P939, DOI 10.1038/nrd960; Wang K, 2001, BIOORG MED CHEM LETT, V11, P433, DOI 10.1016/S0960-894X(00)00688-0; Winterbourn CC, 1999, FREE RADICAL BIO MED, V27, P322, DOI 10.1016/S0891-5849(99)00051-9; Xian M, 2000, BIOCHEM BIOPH RES CO, V268, P310, DOI 10.1006/bbrc.2000.2117; Zhang YH, 2005, FREE RADICAL BIO MED, V38, P831, DOI 10.1016/j.freeradbiomed.2004.12.016; Zou CG, 2005, ANTIOXID REDOX SIGN, V7, P547, DOI 10.1089/ars.2005.7.547	59	46	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34684	34692		10.1074/jbc.M707231200	http://dx.doi.org/10.1074/jbc.M707231200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17895252	hybrid			2022-12-25	WOS:000251155200010
J	Jank, T; Giesemann, T; Aktories, K				Jank, Thomas; Giesemann, Torsten; Aktories, Klaus			Clostridium difficile glucosyltransferase toxin B-essential amino acids for substrate binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO-PROTEINS; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; GLYCOSYLTRANSFERASES; SITE; GLUCOSYLATION; CLEAVAGE; CELLS; MUTAGENESIS; MECHANISMS	Recently the crystal structure of the catalytic domain of Clostridium difficile toxin B was solved (Reinert, D. J., Jank, T., Aktories, K., and Schulz, G. E. (2005) J. Mol. Biol. 351, 973-981). On the basis of this structure, we studied the functional role of several amino acids located in the catalytic center of toxin B. Besides the (DXD288)-D-286 motif and Trp(102), which were shown to be necessary for Mn2+ and UDP binding, respectively, we identified by alanine scanning Asp(270), Arg(273), Tyr(284), Asn(384), and Trp(520) as being important for enzyme activity. The amino acids Arg(455), Asp(461), Lys(463), and Glu(472) and residues of helix alpha 17 (e. g. Glu(449)) of toxin B are essential for enzyme-protein substrate recognition. Introduction of helix alpha 17 of toxin B into Clostridium sordellii lethal toxin inhibited modification of Ras subfamily proteins but enabled glucosylation of RhoA, indicating that helix alpha 17 is involved in RhoA recognition by toxin B. The data allow the design of a model of the interaction of the glucosyltransferase domain of toxin B with its protein substrate RhoA.	Univ Freiburg, Inst Expt, D-79104 Freiburg, Germany; Univ Freiburg, Klin Pharmakol & Toxikol, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg	Aktories, K (corresponding author), Univ Freiburg, Inst Expt, Albertstr 25, D-79104 Freiburg, Germany.	Klaus.Aktories@pharmakol.uni-freiburg.de	Jank, Thomas/R-9627-2017; Aktories, Klaus/CAJ-5682-2022	Aktories, Klaus/0000-0002-5397-0436				Barth H, 2001, J BIOL CHEM, V276, P10670, DOI 10.1074/jbc.M009445200; Brayer GD, 2000, BIOCHEMISTRY-US, V39, P4778, DOI 10.1021/bi9921182; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; Busch C, 2000, J BIOL CHEM, V275, P13228, DOI 10.1074/jbc.275.18.13228; Busch C, 1998, J BIOL CHEM, V273, P19566, DOI 10.1074/jbc.273.31.19566; Davies G. J., 1998, INCOMPREHENSIVE BIOL, P119; Egerer M, 2007, J BIOL CHEM, V282, P25314, DOI 10.1074/jbc.M703062200; Gabb HA, 1997, J MOL BIOL, V272, P106, DOI 10.1006/jmbi.1997.1203; Gastinel LN, 2001, EMBO J, V20, P638, DOI 10.1093/emboj/20.4.638; Ho JGS, 2005, P NATL ACAD SCI USA, V102, P18373, DOI 10.1073/pnas.0506391102; Hofmann F, 1997, J BIOL CHEM, V272, P11074; Hurley TD, 2005, J BIOL CHEM, V280, P23892, DOI 10.1074/jbc.M502344200; Jank T, 2005, J BIOL CHEM, V280, P37833, DOI 10.1074/jbc.M506836200; Jank T, 2006, J BIOL CHEM, V281, P19527, DOI 10.1074/jbc.M600863200; Just I, 2005, REV PHYSIOL BIOCH P, V152, P23, DOI 10.1007/s10254-004-0033-5; JUST I, 1995, J BIOL CHEM, V270, P13932, DOI 10.1074/jbc.270.23.13932; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Lairson LL, 2004, J BIOL CHEM, V279, P28339, DOI 10.1074/jbc.M400451200; Mesmin B, 2004, J BIOL CHEM, V279, P49876, DOI 10.1074/jbc.M406903200; Negishi M, 2003, BIOCHEM BIOPH RES CO, V303, P393, DOI 10.1016/S0006-291X(03)00356-5; Persson K, 2001, NAT STRUCT BIOL, V8, P166, DOI 10.1038/84168; Pfeifer G, 2003, J BIOL CHEM, V278, P44535, DOI 10.1074/jbc.M307540200; Qasba PK, 2005, TRENDS BIOCHEM SCI, V30, P53, DOI 10.1016/j.tibs.2004.11.005; Reineke J, 2007, NATURE, V446, P415, DOI 10.1038/nature05622; Reinert DJ, 2005, J MOL BIOL, V351, P973, DOI 10.1016/j.jmb.2005.06.071; Ritchie DW, 2000, PROTEINS, V39, P178, DOI 10.1002/(SICI)1097-0134(20000501)39:2<178::AID-PROT8>3.3.CO;2-Y; Rupnik M, 2005, MICROBIOL-SGM, V151, P199, DOI 10.1099/mic.0.27474-0; Sehr P, 1998, BIOCHEMISTRY-US, V37, P5296, DOI 10.1021/bi972592c; Uitdehaag JCM, 1999, NAT STRUCT BIOL, V6, P432, DOI 10.1038/8235; vonEichelStreiber C, 1996, TRENDS MICROBIOL, V4, P375, DOI 10.1016/0966-842X(96)10061-5; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+	32	75	86	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35222	35231		10.1074/jbc.M703138200	http://dx.doi.org/10.1074/jbc.M703138200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17901056	hybrid			2022-12-25	WOS:000251155200067
J	Xiao, JM; Tian, XX; Jones, PP; Bolstad, J; Kong, HH; Wang, RW; Zhang, L; Duff, HJ; Gillis, AM; Fleischer, S; Kotlikoff, M; Copello, JA; Chen, SRW				Xiao, Jianmin; Tian, Xixi; Jones, Peter P.; Bolstad, Jeff; Kong, Huihui; Wang, Ruiwu; Zhang, Lin; Duff, Henry J.; Gillis, Anne M.; Fleischer, Sidney; Kotlikoff, Michael; Copello, Julio A.; Chen, S. R. Wayne			Removal of FKBP12.6 does not alter the conductance and activation of the cardiac ryanodine receptor or the susceptibility to stress-induced ventricular arrhythmias	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-RELEASE CHANNEL; FK506-BINDING PROTEIN FKBP12.6; FK-506 BINDING-PROTEIN; RETICULUM CA2+ CONTENT; SARCOPLASMIC-RETICULUM; SKELETAL-MUSCLE; IMMUNOSUPPRESSANT FK506; PHOSPHORYLATION SITE; CONTRACTION; MOUSE	The 12.6-kDa FK506-binding protein (FKBP12.6) is considered to be a key regulator of the cardiac ryanodine receptor (RyR2), but its precise role in RyR2 function is complex and controversial. In the present study we investigated the impact of FKBP12.6 removal on the properties of the RyR2 channel and the propensity for spontaneous Ca2(+) release and the occurrence of ventricular arrhythmias. Single channel recordings in lipid bilayers showed that FK506 treatment of recombinant RyR2 co-expressed with or without FKBP12.6 or native canine RyR2 did not induce long-lived subconductance states. [H-3] Ryanodine binding studies revealed that coexpression with or without FKBP12.6 or treatment with or without FK506 did not alter the sensitivity of RyR2 to activation by Ca2(+) or caffeine. Furthermore, single cell Ca2(+) imaging analyses demonstrated that HEK293 cells co-expressing RyR2 and FKBP12.6 or expressing RyR2 alone displayed the same propensity for spontaneous Ca2(+) release or store overload-induced Ca2(+) release (SOICR). FK506 increased the amplitude and decreased the frequency of SOICR in HEK293 cells expressing RyR2 with or without FKBP12.6, indicating that the action of FK506 on SOICR is independent of FKBP12.6. As with recombinant RyR2, the conductance and ligand-gating properties of single RyR2 channels from FKBP12.6-null mice were indistinguishable from those of single wild type channels. Moreover, FKBP12.6-null mice did not exhibit enhanced susceptibility to stress-induced ventricular arrhythmias, in contrast to previous reports. Collectively, our results demonstrate that the loss of FKBP12.6 has no significant effect on the conduction and activation of RyR2 or the propensity for spontaneous Ca2(+) release and stress-induced ventricular arrhythmias.	Univ Calgary, Libin Cardiovasc Inst Alberta, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada; Vanderbilt Univ, Dept Sci Biol, Nashville, TN 37240 USA; Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA; So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62794 USA	Libin Cardiovascular Institute Of Alberta; University of Calgary; Vanderbilt University; Cornell University; Southern Illinois University System; Southern Illinois University	Chen, SRW (corresponding author), Univ Calgary, Libin Cardiovasc Inst Alberta, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada.	swchen@ucalgary.ca	Kong, Huihui/F-9024-2012; Jones, Peter P/G-2618-2013	Jones, Pete/0000-0001-7977-1737; Duff, Henry/0000-0001-9292-5411	NHLBI NIH HHS [R01 HL075210-04, R01HL75210, R01 HL075210] Funding Source: Medline; PHS HHS [R01TM078665] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075210] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Barg S, 1997, AM J PHYSIOL-CELL PH, V272, pC1726, DOI 10.1152/ajpcell.1997.272.5.C1726; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bultynck G, 2000, J PHYSIOL-LONDON, V525, P681, DOI 10.1111/j.1469-7793.2000.t01-1-00681.x; Cerrone M, 2005, CIRC RES, V96, pE77, DOI 10.1161/01.RES.0000169067.51055.72; Chelu MG, 2004, TRENDS CARDIOVAS MED, V14, P227, DOI 10.1016/j.tcm.2004.06.003; Copello JA, 2001, CELL CALCIUM, V30, P269, DOI 10.1054/ceca.2001.0235; duBell WH, 1997, J PHYSIOL-LONDON, V501, P509, DOI 10.1111/j.1469-7793.1997.509bm.x; Eisner DA, 1998, CARDIOVASC RES, V38, P589, DOI 10.1016/S0008-6363(98)00062-5; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; George CH, 2007, J MOL CELL CARDIOL, V42, P34, DOI 10.1016/j.yjmcc.2006.08.115; Gomez AM, 2004, AM J PHYSIOL-HEART C, V287, pH1987, DOI 10.1152/ajpheart.00409.2004; Gomez AM, 1997, SCIENCE, V276, P800, DOI 10.1126/science.276.5313.800; GUO T, 2007, BIOPHYS J, V92, P2825; Hove-Madsen L, 2004, CIRCULATION, V110, P1358, DOI 10.1161/01.CIR.0000141296.59876.87; Hunt DJ, 2007, BIOCHEM J, V404, P431, DOI 10.1042/BJ20070135; Jiang DW, 2005, CIRC RES, V97, P1173, DOI 10.1161/01.RES.0000192146.85173.4b; Jiang MT, 2002, CIRC RES, V91, P1015, DOI 10.1161/01.RES.0000043663.08689.05; Kaftan E, 1996, CIRC RES, V78, P990, DOI 10.1161/01.RES.78.6.990; KANEKO N, 1994, DRUG DEVELOP RES, V33, P429, DOI 10.1002/ddr.430330406; Kumagai K, 2003, J CARDIOVASC ELECTR, V14, P880, DOI 10.1046/j.1540-8167.2003.03050.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAM E, 1995, J BIOL CHEM, V270, P26511, DOI 10.1074/jbc.270.44.26511; LEA JP, 1994, KIDNEY INT, V46, P647, DOI 10.1038/ki.1994.317; Li P, 2001, J GEN PHYSIOL, V118, P33, DOI 10.1085/jgp.118.1.33; Liu N, 2006, CIRC RES, V99, P292, DOI 10.1161/01.RES.0000235869.50747.e1; Loughrey CM, 2004, J PHYSIOL-LONDON, V556, P919, DOI 10.1113/jphysiol.2003.057166; Lukyanenko V, 1998, J PHYSIOL-LONDON, V507, P667, DOI 10.1111/j.1469-7793.1998.667bs.x; Lukyanenko V, 2001, BIOPHYS J, V81, P785, DOI 10.1016/S0006-3495(01)75741-4; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; MAYRLEITNER M, 1994, CELL CALCIUM, V15, P99, DOI 10.1016/0143-4160(94)90048-5; McCall E, 1996, CIRC RES, V79, P1110, DOI 10.1161/01.RES.79.6.1110; Milting H, 2001, EUR J PHARMACOL, V430, P299, DOI 10.1016/S0014-2999(01)01387-5; Mohamed U, 2007, J CARDIOVASC ELECTR, V18, P791, DOI 10.1111/j.1540-8167.2007.00766.x; Ono K, 2000, CARDIOVASC RES, V48, P323, DOI 10.1016/S0008-6363(00)00191-7; Overend CL, 1998, J PHYSIOL-LONDON, V507, P759, DOI 10.1111/j.1469-7793.1998.759bs.x; Prestle J, 2001, CIRC RES, V88, P188; Shimoni Y, 2004, J PHYSIOL-LONDON, V555, P345, DOI 10.1113/jphysiol.2003.055590; Stange M, 2003, J BIOL CHEM, V278, P51693, DOI 10.1074/jbc.M310406200; Su Z, 2003, J PHARMACOL EXP THER, V304, P334, DOI 10.1124/jpet.102.041210; Ter Keurs HEDJ, 2007, PHYSIOL REV, V87, P457, DOI 10.1152/physrev.00011.2006; Timerman AP, 1996, J BIOL CHEM, V271, P20385, DOI 10.1074/jbc.271.34.20385; TIMERMAN AP, 1993, J BIOL CHEM, V268, P22992; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vest JA, 2005, CIRCULATION, V111, P2025, DOI 10.1161/01.CIR.0000162461.67140.4C; Wehrens XHT, 2004, SCIENCE, V304, P292, DOI 10.1126/science.1094301; Wehrens XHT, 2003, CELL, V113, P829, DOI 10.1016/S0092-8674(03)00434-3; WITCHER DR, 1991, J BIOL CHEM, V266, P11144; Xiao BL, 2005, CIRC RES, V96, P847, DOI 10.1161/01.RES.0000163276.26083.e8; Xiao BL, 2004, CIRC RES, V94, P487, DOI 10.1161/01.RES.0000115945.89741.22; Xiao RP, 1997, J PHYSIOL-LONDON, V500, P343, DOI 10.1113/jphysiol.1997.sp022025; Xin HB, 2002, NATURE, V416, P334, DOI 10.1038/416334a; Yano M, 2000, CIRCULATION, V102, P2131, DOI 10.1161/01.CIR.102.17.2131; Yano M, 2006, NAT CLIN PRACT CARD, V3, P43, DOI 10.1038/ncpcardio0419; Yano M, 2003, CIRCULATION, V107, P477, DOI 10.1161/01.CIR.0000044917.74408.BE	54	78	84	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34828	34838		10.1074/jbc.M707423200	http://dx.doi.org/10.1074/jbc.M707423200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17921453	Green Accepted, hybrid			2022-12-25	WOS:000251155200025
J	Mandel, S; Gozes, I				Mandel, Shmuel; Gozes, Illana			Activity-dependent neuroprotective protein constitutes a novel element in the SWI/SNF chromatin remodeling complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDE; TUBULIN; BRG1; TRANSCRIPTION; NEUROGENESIS; EXPRESSION; INDUCTION; INTERACTS; GENES; CELLS	Complete deficiency in activity-dependent neuroprotective protein (ADNP), a heterochromatin 1-binding protein, results in dramatic changes in gene expression, neural tube closure defects, and death at gestation day 9 in mice. To further understand the cellular roles played by ADNP, the HEK293 human embryonic kidney cell line that allows efficient transfection with recombinant DNA was used as a model for the identification of ADNP-interacting proteins. Recombinant green fluorescent protein (GFP)-ADNP was localized to cell nuclei. When nuclear extracts were subjected to immunoprecipitation with specific GFP antibodies followed by polyacrylamide gel electrophoresis, several minor protein bands were observed in addition to GFP-ADNP. In-gel protein digests followed by mass spectrometry identified BRG1, BAF250a, and BAF170, all components of the SWI/SNF (mating type switching/sucrose nonfermenting) chromatin remodeling complex, as proteins that co-immunoprecipitate with ADNP. These results were verified utilizing BRG1 antibodies. ADNP short hairpin RNA down-regulation resulted in microtubule reorganization and changes in cell morphology including reduction in cell process formation and cell number. These morphological changes are closely associated with the SWI/SNF complex multifunctionality. Taken together, the current study uncovers a molecular basis for the essential function of the ADNP gene and protein.	Tel Aviv Univ, Sackler Fac Med, LEG fMRI Inst, Adams Super Ctr Brain Res,Dept Human Mol Genet &, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine	Gozes, I (corresponding author), Tel Aviv Univ, Sackler Fac Med, LEG fMRI Inst, Adams Super Ctr Brain Res,Dept Human Mol Genet &, IL-69978 Tel Aviv, Israel.	igozes@post.tau.ac.il						Bassan M, 1999, J NEUROCHEM, V72, P1283, DOI 10.1046/j.1471-4159.1999.0721283.x; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Divinski I, 2006, J NEUROCHEM, V98, P973, DOI 10.1111/j.1471-4159.2006.03936.x; Eroglu B, 2006, DEV DYNAM, V235, P2722, DOI 10.1002/dvdy.20911; Furman S, 2005, NEUROSCI LETT, V373, P73, DOI 10.1016/j.neulet.2004.09.077; Furman S, 2004, NEURON GLIA BIOL, V1, P193, DOI 10.1017/S1740925X05000013; GOZES I, 1977, FEBS LETT, V73, P109, DOI 10.1016/0014-5793(77)80027-6; Gozes I, 2004, J MOL NEUROSCI, V24, P67, DOI 10.1385/JMN:24:1:067; GOZES I, 1982, P NATL ACAD SCI-BIOL, V79, P2579, DOI 10.1073/pnas.79.8.2579; Gozes I, 2007, PHARMACOL THERAPEUT, V114, P146, DOI 10.1016/j.pharmthera.2007.01.004; Gozes I, 2005, CNS DRUG REV, V11, P353; Gozes Illana, 2005, Current Alzheimer Research, V2, P149, DOI 10.2174/1567205053585873; Hill DA, 2004, J CELL SCI, V117, P5847, DOI 10.1242/jcs.01502; Lee D, 2002, J BIOL CHEM, V277, P22330, DOI 10.1074/jbc.M111987200; Mandel S, 2007, DEV BIOL, V303, P814, DOI 10.1016/j.ydbio.2006.11.039; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Pinhasov A, 2003, DEV BRAIN RES, V144, P83, DOI 10.1016/S0165-3806(03)00162-7; Rosson GB, 2005, J CELL PHYSIOL, V205, P286, DOI 10.1002/jcp.20397; Roy S, 2005, ACTA NEUROPATHOL, V109, P5, DOI 10.1007/s00401-004-0952-x; Salma N, 2004, MOL CELL BIOL, V24, P4651, DOI 10.1128/MCB.24.11.4651-4663.2004; Seo S, 2005, DEVELOPMENT, V132, P105, DOI 10.1242/dev.01548; Siddiqui H, 2007, J CELL PHYSIOL, V211, P131, DOI 10.1002/jcp.20913; Simone C, 2006, J CELL PHYSIOL, V207, P309, DOI 10.1002/jcp.20514; Steingart RA, 2006, MOL CELL ENDOCRINOL, V252, P148, DOI 10.1016/j.mce.2006.03.029; Taylor TJ, 2004, J VIROL, V78, P5856, DOI 10.1128/JVI.78.11.5856-5866.2004; VULIHSHULTZMAN I, 2007, IN PRESS J PHARM EXP; Zaltzman R, 2004, J MOL NEUROSCI, V24, P181, DOI 10.1385/JMN:24:2:181; Zamostiano R, 2001, J BIOL CHEM, V276, P708, DOI 10.1074/jbc.M007416200	28	101	103	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34448	34456		10.1074/jbc.M704756200	http://dx.doi.org/10.1074/jbc.M704756200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17878164	hybrid			2022-12-25	WOS:000251145700060
J	Sun, YH; Rolan, HG; Tsolis, RM				Sun, Yao-Hui; Rolan, Hortensia Garcia; Tsolis, Renee M.			Injection of flagellin into the host cell cytosol by Salmonella enterica serotype Typhimurium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR-5; PHAGOSOME MATURATION; BACTERIAL FLAGELLIN; III SECRETION; LEGIONELLA; MACROPHAGES; EXPRESSION; CASPASE-1; INFLAMMASOME; RESTRICTION	Bacterial flagellins are potent inducers of innate immunity. Three signaling pathways have been implicated in the sensing of flagellins; these involve toll- like receptor 5 (TLR5) and the cytosolic proteins Bircle/Naip5 and Ipaf. Although the structural basis of TLR5-flagellin interaction is known, little is known about how flagellin enters the host cell cytosol to induce signaling via Bircle/Naip5 and Ipaf. Here we demonstrate for the first time the translocation of bacterial flagellin into the cytosol of host macrophages by the vacuolar pathogen, Salmonella enterica serotype Typhimurium. Translocation of flagellin into the host cell cytosol was directly demonstrated using beta-lactamase reporter constructs. Flagellin translocation required the Salmonella Pathogenicity Island 1 Type III secretion system ( SPI-1 T3SS) but not the flagellar T3SS.	Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA	University of California System; University of California Davis	Tsolis, RM (corresponding author), Univ Calif Davis, Dept Med Microbiol & Immunol, 1 Shields Ave, Davis, CA 95616 USA.	rmtsolis@ucdavis.edu		Tsolis, Renee/0000-0001-9131-6657	NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR012088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050553, R21AI065739] Funding Source: NIH RePORTER; NCRR NIH HHS [C06 RR 12088] Funding Source: Medline; NIAID NIH HHS [AI 065739, AI 50553] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Amer A, 2006, J BIOL CHEM, V281, P35217, DOI 10.1074/jbc.M604933200; Andersen-Nissen E, 2007, J EXP MED, V204, P393, DOI 10.1084/jem.20061400; Auvray F, 2001, J MOL BIOL, V308, P221, DOI 10.1006/jmbi.2001.4597; Baumler AJ, 1997, INFECT IMMUN, V65, P2254; Brennan MA, 2000, MOL MICROBIOL, V38, P31, DOI 10.1046/j.1365-2958.2000.02103.x; Chen LM, 1996, MOL MICROBIOL, V21, P1101, DOI 10.1046/j.1365-2958.1996.471410.x; Coers J, 2007, CELL MICROBIOL, V9, P2344, DOI 10.1111/j.1462-5822.2007.00963.x; Cookson BT, 2001, TRENDS MICROBIOL, V9, P113, DOI 10.1016/S0966-842X(00)01936-3; Cummings LA, 2005, J IMMUNOL, V174, P7929, DOI 10.4049/jimmunol.174.12.7929; Cummings LA, 2006, MOL MICROBIOL, V61, P795, DOI 10.1111/j.1365-2958.2006.05271.x; Fortier A, 2007, CELL MICROBIOL, V9, P910, DOI 10.1111/j.1462-5822.2006.00839.x; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; KUWAJIMA G, 1989, P NATL ACAD SCI USA, V86, P4953, DOI 10.1073/pnas.86.13.4953; Lara-Tejero M, 2006, J EXP MED, V203, P1407, DOI 10.1084/jem.20060206; Lindgren SW, 1996, P NATL ACAD SCI USA, V93, P4197, DOI 10.1073/pnas.93.9.4197; Lyons S, 2004, J CELL SCI, V117, P5771, DOI 10.1242/jcs.01500; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Miao EA, 2000, P NATL ACAD SCI USA, V97, P7539, DOI 10.1073/pnas.97.13.7539; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; Monack DM, 1996, P NATL ACAD SCI USA, V93, P9833, DOI 10.1073/pnas.93.18.9833; OBRIEN EJ, 1972, J MOL BIOL, V70, P133, DOI 10.1016/0022-2836(72)90168-4; Raffatellu M, 2005, INFECT IMMUN, V73, P3367, DOI 10.1128/IAI.73.6.3367-3374.2005; Raffatellu M, 2005, INFECT IMMUN, V73, P7817, DOI 10.1128/IAI.73.12.7817-7826.2005; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Schlumberger MC, 2005, P NATL ACAD SCI USA, V102, P12548, DOI 10.1073/pnas.0503407102; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998; STOJILJKOVIC I, 1995, J BACTERIOL, V177, P1357, DOI 10.1128/jb.177.5.1357-1366.1995; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; van der Velden AWM, 2003, J IMMUNOL, V171, P6742, DOI 10.4049/jimmunol.171.12.6742; Vegh BM, 2006, BIOCHEM BIOPH RES CO, V345, P93, DOI 10.1016/j.bbrc.2006.04.055; Vijay-Kumar M, 2006, AM J PATHOL, V169, P1686, DOI 10.2353/ajpath.2006.060345; Zamboni DS, 2006, NAT IMMUNOL, V7, P318, DOI 10.1038/ni1305; Zlokarnik G, 1998, SCIENCE, V279, P84, DOI 10.1126/science.279.5347.84	39	127	128	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					33897	33901		10.1074/jbc.C700181200	http://dx.doi.org/10.1074/jbc.C700181200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17911114	hybrid			2022-12-25	WOS:000251145700001
J	Wells, RC; Picton, LK; Williams, SCP; Tan, FJ; Hill, RB				Wells, Robert C.; Picton, Lora K.; Williams, Sarah C. P.; Tan, Frederick J.; Hill, R. Blake			Direct binding of the dynamin-like GTPase, dnm1, to mitochondrial dynamics protein fis1 is negatively regulated by the fis1 n-terminal arm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WD REPEAT PROTEIN; PEROXISOMAL FISSION; MAMMALIAN-CELLS; COMPONENT FIS1P; BUDDING YEAST; LIVING CELLS; DIVISION; APOPTOSIS; MACHINERY; INTERACTS	Recruitment of a dynamin-like GTPase (Drp1/Dlp1/Dnm1) to membranes requires the mitochondrial dynamics protein Fis1. Mdv1 has been proposed to act as an adaptor between Fis1 and Dnm1 in Saccharomyces cerevisiae. We show that S. cerevisiae Fis1 binds directly to Dnm1 and to Mdv1. Two Fis1 regions have been previously implicated in Mdv1 recruitment: an N-terminal "arm" and a concave surface formed by evolutionarily conserved residues in the tetratricopeptide repeat domain. Perturbing either Fis1 region does not affect Mdv1 binding, but both regions influence Dnm1 binding. Fis1 lacking its N-terminal arm binds tightly to Dnm1, and binding is abolished by mutations to the Fis1 concave surface. The Fis1-Dnm1 interaction decreases more than 100-fold in the presence of the Fis1 arm, suggesting that the arm acts in an autoinhibitory manner to restrict access to the Dnm1 binding site on Fis1. Our data indicate that the concave surface of the Fis1 tetratricopeptide repeat-like domain is evolutionarily conserved to bind the dynamin-like GTPase Dnm1 and not Mdv1 as previously predicted.	Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; Johns Hopkins Univ, Dept Chem, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University	Hill, RB (corresponding author), Johns Hopkins Univ, Dept Biol, Mudd Hall,3400 N Charles St, Baltimore, MD 21218 USA.	hill@jhu.edu		Hill, Blake/0000-0001-6228-3905	NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR020922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007231, R01GM067180] Funding Source: NIH RePORTER; NCRR NIH HHS [S10 RR020922, S10 RR020922-01] Funding Source: Medline; NIGMS NIH HHS [T32 GM007231, R01GM067180, R01 GM067180, R01 GM067180-04, T32GM007231] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; BEREITERHAHN J, 1994, MICROSC RES TECHNIQ, V27, P198, DOI 10.1002/jemt.1070270303; Bhar D, 2006, J BIOL CHEM, V281, P17312, DOI 10.1074/jbc.M513530200; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Bleazard W, 1999, NAT CELL BIOL, V1, P298, DOI 10.1038/13014; Cerveny KL, 2003, MOL BIOL CELL, V14, P4126, DOI 10.1091/mbc.E03-02-0092; Cerveny KL, 2001, MOL BIOL CELL, V12, P309, DOI 10.1091/mbc.12.2.309; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Delivani P, 2006, MOL CELL, V21, P761, DOI 10.1016/j.molcel.2006.01.034; Dohm JA, 2004, PROTEINS, V54, P153, DOI 10.1002/prot.10524; Fannjiang Y, 2004, GENE DEV, V18, P2785, DOI 10.1101/gad.1247904; Fekkes P, 2000, J CELL BIOL, V151, P333, DOI 10.1083/jcb.151.2.333; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Gatto GJ, 2000, NAT STRUCT BIOL, V7, P1091; Gorsich SW, 2004, MOL BIOL CELL, V15, P4369, DOI 10.1091/mbc.E03-12-0875; Griffin EE, 2005, J CELL BIOL, V170, P237, DOI 10.1083/jcb.200503148; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; Jagasia R, 2005, NATURE, V433, P754, DOI 10.1038/nature03316; Jakobs S, 2003, J CELL SCI, V116, P2005, DOI 10.1242/jcs.00423; James DI, 2003, J BIOL CHEM, V278, P36373, DOI 10.1074/jbc.M303758200; Jendrach M, 2005, MECH AGEING DEV, V126, P813, DOI 10.1016/j.mad.2005.03.002; JOHNSON LV, 1980, P NATL ACAD SCI-BIOL, V77, P990, DOI 10.1073/pnas.77.2.990; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Karren MA, 2005, J CELL BIOL, V171, P291, DOI 10.1083/jcb.200506158; Koch A, 2005, MOL BIOL CELL, V16, P5077, DOI 10.1091/mbc.E05-02-0159; Koch A, 2003, J BIOL CHEM, V278, P8597, DOI 10.1074/jbc.M211761200; Kuravi K, 2006, J CELL SCI, V119, P3994, DOI 10.1242/jcs.03166; Legesse-Miller A, 2003, MOL BIOL CELL, V14, P1953, DOI 10.1091/mbc.E02-10-0657; Leinninger GM, 2006, NAT CLIN PRACT NEURO, V2, P620, DOI 10.1038/ncpneuro0320; Li XL, 2003, J BIOL CHEM, V278, P17012, DOI 10.1074/jbc.M212031200; Mozdy AD, 2000, J CELL BIOL, V151, P367, DOI 10.1083/jcb.151.2.367; Naylor K, 2006, J BIOL CHEM, V281, P2177, DOI 10.1074/jbc.M507943200; Olichon A, 2006, BBA-MOL CELL RES, V1763, P500, DOI 10.1016/j.bbamcr.2006.04.003; Otsuga D, 1998, J CELL BIOL, V143, P333, DOI 10.1083/jcb.143.2.333; Parone PA, 2006, MOL CELL BIOL, V26, P7397, DOI 10.1128/MCB.02282-05; Sambrook J, 2001, MOL CLONING LAB MANU; Schauss AC, 2006, J CELL SCI, V119, P3098, DOI 10.1242/jcs.03026; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Scott SV, 2003, CURR OPIN CELL BIOL, V15, P482, DOI 10.1016/S0955-0674(03)00070-X; Sesaki H, 1999, J CELL BIOL, V147, P699, DOI 10.1083/jcb.147.4.699; Shaw JM, 2002, TRENDS CELL BIOL, V12, P178, DOI 10.1016/S0962-8924(01)02246-2; Stojanovski D, 2004, J CELL SCI, V117, P1201, DOI 10.1242/jcs.01058; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suzuki M, 2005, J BIOL CHEM, V280, P21444, DOI 10.1074/jbc.M414092200; Suzuki M, 2003, J MOL BIOL, V334, P445, DOI 10.1016/j.jmb.2003.09.064; Tieu Q, 2000, J CELL BIOL, V151, P353, DOI 10.1083/jcb.151.2.353; Tieu Q, 2002, J CELL BIOL, V158, P445, DOI 10.1083/jcb.200205031; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Yu TZ, 2005, J CELL SCI, V118, P4141, DOI 10.1242/jcs.02537	51	48	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33769	33775		10.1074/jbc.M700807200	http://dx.doi.org/10.1074/jbc.M700807200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17884824	hybrid, Green Accepted			2022-12-25	WOS:000250840200059
J	Qi, ZH; Song, M; Wallace, MJ; Wang, D; Newton, PM; Mcmahon, T; Chou, WH; Zhang, C; Shokat, KM; Messing, RO				Qi, Zhan-Heng; Song, Maengseok; Wallace, Melisa J.; Wang, Dan; Newton, Philip M.; Mcmahon, Thomas; Chou, Wen-Hai; Zhang, Chao; Shokat, Kevan M.; Messing, Robert O.			Protein kinase C epsilon regulates gamma-aminobutyrate type A receptor sensitivity to ethanol and benzodiazepines through phosphorylation of gamma 2 subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GABA(A) RECEPTORS; MICE LACKING; PKC-EPSILON; MAMMALIAN-CELLS; XENOPUS OOCYTES; WITHDRAWAL; RESPONSES; REQUIRES; SUBTYPES; BRAIN	Ethanol enhances gamma-aminobutyrate ( GABA) signaling in the brain, but its actions are inconsistent at GABA(A) receptors, especially at low concentrations achieved during social drinking. We postulated that the epsilon isoform of protein kinase C ( PKC epsilon) regulates the ethanol sensitivity of GABA(A) receptors, as mice lacking PKC epsilon show an increased behavioral response to ethanol. Here we developed an ATP analog-sensitive PKC epsilon mutant to selectively inhibit the catalytic activity of PKC epsilon. We used this mutant and PKC epsilon(-/-) mice to determine that PKC epsilon phosphorylates gamma 2 subunits at serine 327 and that reduced phosphorylation of this site enhances the actions of ethanol and benzodiazepines at alpha 1 beta 2 gamma 2 receptors, which is the most abundant GABA(A) receptor subtype in the brain. Our findings indicate that PKC epsilon phosphorylation of gamma 2 regulates the response of GABA(A) receptors to specific allosteric modulators, and, in particular, PKC epsilon inhibition renders these receptors sensitive to low intoxicating concentrations of ethanol.	Univ Calif San Francisco, Dept Neurol, Ernest Gallo Clin & Res Ctr, Emeryville, CA 94608 USA; Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco	Messing, RO (corresponding author), Univ Calif San Francisco, Dept Neurol, Ernest Gallo Clin & Res Ctr, 5858 Horton St,Suite 200, Emeryville, CA 94608 USA.	romes@gallo.ucsf.edu	Chou, Wen-Hai/H-1970-2016; Wallace, Melisa/C-5798-2009; Messing, Robert/D-3642-2015; Newton, Philip/C-5801-2009	Chou, Wen-Hai/0000-0002-7899-1129; Messing, Robert/0000-0002-5345-4431; Wallace, Melisa/0000-0001-7471-9833; Newton, Philip/0000-0002-5272-7979	NIAAA NIH HHS [AA 013588] Funding Source: Medline; NIAID NIH HHS [AI/CA 44009] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013588, R37AA013588] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		ALLAN AM, 1987, PHARMACOL BIOCHEM BE, V27, P665, DOI 10.1016/0091-3057(87)90192-4; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Borghese CM, 2006, J PHARMACOL EXP THER, V316, P1360, DOI 10.1124/jpet.105.092452; Brose N, 2002, J CELL SCI, V115, P4399, DOI 10.1242/jcs.00122; Brunig I, 2002, J NEUROSCI, V22, P4805, DOI 10.1523/JNEUROSCI.22-12-04805.2002; Choi DS, 2002, J NEUROSCI, V22, P9905; Criswell HE, 2005, NEUROPSYCHOPHARMACOL, V30, P1407, DOI 10.1038/sj.npp.1300750; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Glykys J, 2007, NAT NEUROSCI, V10, P40, DOI 10.1038/nn1813; Goslin K., 1998, CULTURING NERVE CELL, P339; HARRIS RA, 1995, ALCOHOL CLIN EXP RES, V19, P226, DOI 10.1111/j.1530-0277.1995.tb01496.x; Harris RA, 1997, ALCOHOL CLIN EXP RES, V21, P444; Hodge CW, 1999, NAT NEUROSCI, V2, P997, DOI 10.1038/14795; Homanics GE, 1999, NEUROPHARMACOLOGY, V38, P253, DOI 10.1016/S0028-3908(98)00177-4; Hood HM, 2000, ALCOHOL CLIN EXP RES, V24, P1327, DOI 10.1111/j.1530-0277.2000.tb02100.x; Hood HM, 2006, GENES BRAIN BEHAV, V5, P1, DOI 10.1111/j.1601-183X.2005.00122.x; Hosie AM, 2003, NAT NEUROSCI, V6, P362, DOI 10.1038/nn1030; Huang RQ, 1998, J PHARMACOL EXP THER, V286, P243; Johnson JA, 1996, J BIOL CHEM, V271, P24962, DOI 10.1074/jbc.271.40.24962; KELLENBERGER S, 1992, J BIOL CHEM, V267, P25660; Khasar SG, 1999, NEURON, V24, P253, DOI 10.1016/S0896-6273(00)80837-5; KRISHEK BJ, 1994, NEURON, V12, P1081, DOI 10.1016/0896-6273(94)90316-6; MARSZALEC W, 1994, J PHARMACOL EXP THER, V269, P157; McKernan RM, 1996, TRENDS NEUROSCI, V19, P139, DOI 10.1016/S0166-2236(96)80023-3; Mortensen M, 2006, J PHYSIOL-LONDON, V577, P841, DOI 10.1113/jphysiol.2006.117952; Olive MF, 2001, NEUROSCIENCE, V103, P171, DOI 10.1016/S0306-4522(00)00566-2; PRITCHETT DB, 1990, J NEUROCHEM, V54, P1802, DOI 10.1111/j.1471-4159.1990.tb01237.x; Proctor WR, 2003, J PHARMACOL EXP THER, V305, P264, DOI 10.1124/jpet.102.045450; Sapp DW, 1998, J PHARMACOL EXP THER, V284, P768; SIGEL E, 1993, FEBS LETT, V324, P140, DOI 10.1016/0014-5793(93)81380-I; Song M, 2005, CELL MOL LIFE SCI, V62, P119, DOI 10.1007/s00018-004-4339-x; Sundstrom-Poromaa I, 2002, NAT NEUROSCI, V5, P721, DOI 10.1038/nn888; SUZDAK PD, 1986, P NATL ACAD SCI USA, V83, P4071, DOI 10.1073/pnas.83.11.4071; WAFFORD KA, 1992, FEBS LETT, V313, P113, DOI 10.1016/0014-5793(92)81424-K; WAFFORD KA, 1991, NEURON, V7, P27, DOI 10.1016/0896-6273(91)90071-7; Wafford KA, 2005, CURR OPIN PHARMACOL, V5, P47, DOI 10.1016/j.coph.2004.08.006; Wallace MJ, 2007, NEUROPSYCHOPHARMACOL, V32, P127, DOI 10.1038/sj.npp.1301059; Wallner M, 2003, P NATL ACAD SCI USA, V100, P15218, DOI 10.1073/pnas.2435171100; Wang J, 2003, J NEUROSCI, V23, P826; Weiner JL, 2006, PHARMACOL THERAPEUT, V111, P533, DOI 10.1016/j.pharmthera.2005.11.002; Yamashita M, 2006, J PHARMACOL EXP THER, V319, P431, DOI 10.1124/jpet.106.106260; Zeidman R, 1999, J CELL BIOL, V145, P713, DOI 10.1083/jcb.145.4.713	43	78	80	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					33052	33063		10.1074/jbc.M707233200	http://dx.doi.org/10.1074/jbc.M707233200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17875639	hybrid			2022-12-25	WOS:000250625400054
J	Diaz, LA; Foss, CA; Thornton, K; Nimmagadda, S; Endres, CJ; Uzuner, O; Seyler, TM; Ulrich, SD; Conway, J; Bettegowda, C; Agrawal, N; Cheong, I; Zhang, XS; Ladenson, PW; Vogelstein, BN; Mont, MA; Zhou, SB; Kinzler, KW; Vogelstein, B; Pomper, MG				Diaz, Luis A., Jr.; Foss, Catherine A.; Thornton, Katherine; Nimmagadda, Sridhar; Endres, Christopher J.; Uzuner, Ovsev; Seyler, Thorsten M.; Ulrich, Slif D.; Conway, Janet; Bettegowda, Chetan; Agrawal, Nishant; Cheong, Ian; Zhang, Xiaosong; Ladenson, Paul W.; Vogelstein, Barry N.; Mont, Michael A.; Zhou, Shibin; Kinzler, Kenneth W.; Vogelstein, Bert; Pomper, Martin G.			Imaging of Musculoskeletal Bacterial Infections by [I-124]FIAU-PET/CT	PLOS ONE			English	Article								Background. Traditional imaging techniques for the localization and monitoring of bacterial infections, although reasonably sensitive, suffer from a lack of specificity. This is particularly true for musculoskeletal infections. Bacteria possess a thymidine kinase (TK) whose substrate specificity is distinct from that of the major human TK. The substrate specificity difference has been exploited to develop a new imaging technique that can detect the presence of viable bacteria. Methodology/Principal Findings. Eight subjects with suspected musculoskeletal infections and one healthy control were studied by a combination of [I-124]FIAU-positron emission tomography and CT ([I-124]FIAU-PET/CT). All patients with proven musculoskeletal infections demonstrated positive [I-124] FIAU-PET/CT signals in the sites of concern at two hours after radiopharmaceutical administration. No adverse reactions with FIAU were observed. Conclusions/Significance. [I-124]FIAU-PET/CT is a promising new method for imaging bacterial infections.	[Foss, Catherine A.; Nimmagadda, Sridhar; Endres, Christopher J.; Uzuner, Ovsev; Pomper, Martin G.] Johns Hopkins Univ, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21218 USA; [Diaz, Luis A., Jr.; Thornton, Katherine; Bettegowda, Chetan; Agrawal, Nishant; Cheong, Ian; Zhang, Xiaosong; Vogelstein, Barry N.; Zhou, Shibin; Kinzler, Kenneth W.; Vogelstein, Bert] Ludwig Ctr Canc Genet & Therapeut Johns Hopkins, Howard Hughes Med Inst, Baltimore, MD USA; [Seyler, Thorsten M.; Ulrich, Slif D.; Conway, Janet; Mont, Michael A.] Sinai Hosp, Rubin Inst Adv Orthoped, Ctr Joint Preservat & Reconstruct, Baltimore, MD 21215 USA; [Ladenson, Paul W.] Johns Hopkins Univ, Sch Med, Dept Med, Div Endocrinol & Metab, Baltimore, MD 21205 USA; [Diaz, Luis A., Jr.; Thornton, Katherine; Bettegowda, Chetan; Agrawal, Nishant; Cheong, Ian; Zhang, Xiaosong; Zhou, Shibin; Kinzler, Kenneth W.; Vogelstein, Bert; Pomper, Martin G.] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Sinai Hospital of Baltimore; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Pomper, MG (corresponding author), Johns Hopkins Univ, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21218 USA.	mpomper@jhmi.edu	Nimmagadda, Sridhar/D-6135-2011	Nimmagadda, Sridhar/0000-0002-6413-7191; Cheong, Ian/0000-0002-3062-6878; Diaz, Luis/0000-0002-7079-8914	NIH [CA62924, CA92871]; The Virginia and D. K. Ludwig Fund for Cancer Research; Johns Hopkins Alliance for Science and Technology Development; NATIONAL CANCER INSTITUTE [P50CA062924] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Virginia and D. K. Ludwig Fund for Cancer Research; Johns Hopkins Alliance for Science and Technology Development; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding: NIH grants CA62924, CA92871, The Virginia and D. K. Ludwig Fund for Cancer Research and the Johns Hopkins Alliance for Science and Technology Development	Agrawal N, 2004, P NATL ACAD SCI USA, V101, P15172, DOI 10.1073/pnas.0406242101; Akhtar MS, 2005, J NUCL MED, V46, P567; Bauer TW, 2006, J BONE JOINT SURG AM, V88A, P869, DOI 10.2106/JBJS.E.01149; Becker W, 2001, Lancet Infect Dis, V1, P326, DOI 10.1016/S1473-3099(01)00146-3; Benitez A, 2006, Q J NUCL MED MOL IM, V50, P147; Bettegowda C, 2005, P NATL ACAD SCI USA, V102, P1145, DOI 10.1073/pnas.0408861102; BRUCE A, 1980, SCAND J CLIN LAB INV, V40, P461, DOI 10.3109/00365518009101869; Buscombe JR, 2006, Q J NUCL MED MOL IM, V50, P99; Capriotti G, 2006, NUCL MED COMMUN, V27, P757, DOI 10.1097/01.mnm.0000230065.85705.b3; Crymes William B Jr, 2004, J Nucl Med Technol, V32, P12; Dang LH, 2001, P NATL ACAD SCI USA, V27, P27; De Winter F, 2004, EUR J NUCL MED MOL I, V31, P233, DOI 10.1007/s00259-003-1349-0; Diaz LA, 2005, TOXICOL SCI, V88, P562, DOI 10.1093/toxsci/kfi316; Dumarey N, 2002, EUR J NUCL MED MOL I, V29, P530, DOI 10.1007/s00259-001-0749-2; Fu DX, 2007, CLIN CANCER RES, V13, P1453, DOI 10.1158/1078-0432.CCR-06-2295; Gemmel F, 2004, NUCL MED COMMUN, V25, P277, DOI 10.1097/00006231-200403000-00011; Jacobs A, 2001, J NUCL MED, V42, P467; Johansson M, 1997, J BIOL CHEM, V272, P8454, DOI 10.1074/jbc.272.13.8454; Larikka MJ, 2003, J NUCL MED, V44, P1368; Love C, 2004, J NUCL MED, V45, P1864; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Machens HG, 1996, MICROSURG, V17, P272, DOI 10.1002/(SICI)1098-2752(1996)17:5<272::AID-MICR7>3.0.CO;2-L; MCKENZIE R, 1995, NEW ENGL J MED, V333, P1099, DOI 10.1056/NEJM199510263331702; Nimmagadda S, 2007, J NUCL MED, V48, P655, DOI 10.2967/jnumed.106.036830; PALESTRO CJ, 1990, J NUCL MED, V31, P1950; Parvizi J, 2006, J BONE JOINT SURG AM, V88A, P138, DOI 10.2106/JBJS.F.00609; Sarda L, 2003, J NUCL MED, V44, P920; Stumpe KDM, 2006, Q J NUCL MED MOL IM, V50, P131; Stumpe KDM, 2006, EUR J NUCL MED MOL I, V33, P1218, DOI 10.1007/s00259-006-0127-1; Toms AD, 2006, J BONE JOINT SURG BR, V88B, P149, DOI 10.1302/0301-620X.88B2.17058; Vinjamuri S, 1996, LANCET, V347, P233, DOI 10.1016/S0140-6736(96)90407-9; Wang JH, 1996, ANTIMICROB AGENTS CH, V40, P1555, DOI 10.1128/AAC.40.6.1555	32	71	73	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1007	10.1371/journal.pone.0001007	http://dx.doi.org/10.1371/journal.pone.0001007			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925855	gold, Green Published, Green Submitted			2022-12-25	WOS:000207456000006
J	Macri, S; Pasquali, P; Bonsignore, LT; Pieretti, S; Cirulli, F; Chiarotti, F; Laviola, G				Macri, Simone; Pasquali, Paolo; Bonsignore, Luca Tommaso; Pieretti, Stefano; Cirulli, Francesca; Chiarotti, Flavia; Laviola, Giovanni			Moderate Neonatal Stress Decreases Within-Group Variation in Behavioral, Immune and HPA Responses in Adult Mice	PLOS ONE			English	Article								Background. The significance of behavioral neuroscience and the validity of its animal models of human pathology largely depend on the possibility to replicate a given finding across different laboratories. Under the present test and housing conditions, this axiom fails to resist the challenge of experimental validation. When several mouse strains are tested on highly standardized behavioral test batteries in different laboratories, significant strain x lab interactions are often detected. This limitation, predominantly due to elevated within-group variability observed in control subjects, increases the number of animals needed to address fine experimental questions. Laboratory rodents display abnormal stress and fear reactions to experimental testing, which might depend on the discrepancy between the stability of the neonatal environment and the challenging nature of the adult test and housing conditions. Methodology/Principal Findings. Stimulating neonatal environments (e. g. brief maternal separations, increased foraging demands or maternal corticosterone supplementation) reduce stress and fear responses in adulthood. Here we tested whether reduced fearfulness associated with experimental testing would also reduce inter-individual variation. In line with our predictions, we show that a moderate elevation in neonatal corticosterone through maternal milk significantly reduces fear responses and inter-individual variability (average 44%) in adult mouse offspring. Conclusions/Significance. We observed reduced variation in pain perception, novelty preference, hormonal stress response and resistance to pathogen infection. This suggests that the results of this study may apply to a relatively broad spectrum of neuro-behavioral domains. Present findings encourage a reconsideration of the basic principles of neonatal housing systems to improve the validity of experimental models and reduce the number of animals used.	[Macri, Simone; Bonsignore, Luca Tommaso; Cirulli, Francesca; Chiarotti, Flavia; Laviola, Giovanni] Ist Super Sanita, Sect Behav Neurosci, Dept Cell Biol & Neurosci, I-00161 Rome, Italy; [Pasquali, Paolo] Ist Super Sanita, Dept Food Safety & Vet Publ Hlth, I-00161 Rome, Italy; [Pieretti, Stefano] Ist Super Sanita, Dept Drug Res & Evaluat, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS)	Laviola, G (corresponding author), Ist Super Sanita, Sect Behav Neurosci, Dept Cell Biol & Neurosci, Viale Regina Elena 299, I-00161 Rome, Italy.	giovanni.laviola@iss.it	Cirulli, Francesca/B-1581-2013; Bonsignore, Luca Tommaso/B-1594-2013; Laviola, Giovanni/K-4392-2016; Chiarotti, Flavia/K-7970-2016; Laviola, Giovanni/AAA-2391-2022; Pasquali, Paolo/C-1111-2008; Pieretti, Stefano/I-8634-2018	Cirulli, Francesca/0000-0001-9440-1873; Laviola, Giovanni/0000-0003-0388-0835; Chiarotti, Flavia/0000-0003-0084-6914; Laviola, Giovanni/0000-0003-0388-0835; Pasquali, Paolo/0000-0003-4704-0731; Pieretti, Stefano/0000-0001-5926-6194; Macri, Simone/0000-0003-2946-4784	ISSNIH [0F14]; NARSAD	ISSNIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD(NARSAD)	Funding: The study has been partly supported by the collaborative program ISSNIH 0F14 to Giovanni Laviola and Francesca Cirulli and by a NARSAD grant for young investigators to Simone Macri. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriani W, 1998, BEHAV NEUROSCI, V112, P1152, DOI 10.1037/0735-7044.112.5.1152; Bardo MT, 1993, EXP CLIN PSYCHOPHARM, V1, P101, DOI 10.1037/1064-1297.1.1-4.101; Barnard CJ, 1996, PHYSIOL BEHAV, V60, P1223, DOI 10.1016/S0031-9384(96)00174-6; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; BIGGERSTAFF S, 1992, PHYSIOL BEHAV, V52, P485, DOI 10.1016/0031-9384(92)90335-Y; Caldji C, 2000, NEUROPSYCHOPHARMACOL, V22, P219, DOI 10.1016/S0893-133X(99)00110-4; CALHOUN JB, 1962, SCI AM, V206, P139; Cameron NM, 2005, NEUROSCI BIOBEHAV R, V29, P843, DOI 10.1016/j.neubiorev.2005.03.022; CAPONE F, 2005, CURRENT PROTOCOLS TO; CARTER RB, 1991, PAIN, V47, P211, DOI 10.1016/0304-3959(91)90207-E; CATALANI A, 1993, BRAIN RES, V624, P209, DOI 10.1016/0006-8993(93)90079-3; Catalani A, 2000, NEUROSCIENCE, V100, P319, DOI 10.1016/S0306-4522(00)00277-3; Crabbe JC, 1999, SCIENCE, V284, P1670, DOI 10.1126/science.284.5420.1670; Visser L, 2006, GENES BRAIN BEHAV, V5, P458, DOI 10.1111/j.1601-183X.2005.00181.x; Fluttert M, 2000, LAB ANIM, V34, P372, DOI 10.1258/002367700780387714; Galsworthy MJ, 2005, BEHAV BRAIN RES, V157, P211, DOI 10.1016/j.bbr.2004.06.021; Garner JP, 2005, ILAR J, V46, P106, DOI 10.1093/ilar.46.2.106; GRIEBEL G, 1993, BEHAV PHARMACOL, V4, P637; Hager R, 2006, BIOL LETT-UK, V2, P253, DOI 10.1098/rsbl.2006.0457; Laviola G, 2003, NEUROSCI BIOBEHAV R, V27, P19, DOI 10.1016/S0149-7634(03)00006-X; Leonhardt M, 2007, HORM BEHAV, V51, P77, DOI 10.1016/j.yhbeh.2006.08.008; Macri S, 2004, EUR J NEUROSCI, V20, P1017, DOI 10.1111/j.1460-9568.2004.03541.x; Macri S, 2007, ANIM BEHAV, V73, P171, DOI 10.1016/j.anbehav.2006.03.029; Macri S, 2006, HORM BEHAV, V50, P667, DOI 10.1016/j.yhbeh.2006.06.015; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Pasquali P, 2003, INFECT IMMUN, V71, P2326, DOI 10.1128/IAI.71.5.2326-2330.2003; PIERETTI S, 1991, BEHAV NEUROSCI, V105, P215, DOI 10.1037/0735-7044.105.1.215; Pieretti S, 1999, LIFE SCI, V65, P1381, DOI 10.1016/S0024-3205(99)00377-X; Plone MA, 1996, PAIN, V66, P265, DOI 10.1016/0304-3959(96)03048-5; PLOTSKY PM, 1993, MOL BRAIN RES, V18, P195, DOI 10.1016/0169-328X(93)90189-V; Pryce CR, 2003, NEUROSCI BIOBEHAV R, V27, P57, DOI 10.1016/S0149-7634(03)00009-5; Roy V, 2004, BEHAV BRAIN RES, V154, P439, DOI 10.1016/j.bbr.2004.03.010; Sapolsky R.M., 2004, WHY ZEBRAS DONT GET, V3rd ed.; Schmidt M, 2003, INT J DEV NEUROSCI, V21, P125, DOI 10.1016/S0736-5748(03)00030-3; Smotherman W. P., 1980, MATERNAL INFLUENCES, P201; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Tsai PP, 2003, LAB ANIM-UK, V37, P314, DOI 10.1258/002367703322389889; Wahlsten D, 2006, P NATL ACAD SCI USA, V103, P16364, DOI 10.1073/pnas.0605342103; Wolfer DP, 2004, NATURE, V432, P821, DOI 10.1038/432821a; Wurbel H, 2001, TRENDS NEUROSCI, V24, P207, DOI 10.1016/S0166-2236(00)01718-5; Yorty JL, 2004, J NEUROIMMUNOL, V150, P48, DOI 10.1016/j.jneuroim.2004.01.012	42	52	53	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1015	10.1371/journal.pone.0001015	http://dx.doi.org/10.1371/journal.pone.0001015			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925863	Green Submitted, Green Published, gold			2022-12-25	WOS:000207456000014
J	Kent, C; Azanchi, R; Smith, B; Chu, A; Levine, J				Kent, Clement; Azanchi, Reza; Smith, Ben; Chu, Adrienne; Levine, Joel			A Model-Based Analysis of Chemical and Temporal Patterns of Cuticular Hydrocarbons in Male Drosophila melanogaster	PLOS ONE			English	Article								Drosophila Cuticular Hydrocarbons (CH) influence courtship behaviour, mating, aggregation, oviposition, and resistance to desiccation. We measured levels of 24 different CH compounds of individual male D. melanogaster hourly under a variety of environmental (LD/DD) conditions. Using a model-based analysis of CH variation, we developed an improved normalization method for CH data, and show that CH compounds have reproducible cyclic within-day temporal patterns of expression which differ between LD and DD conditions. Multivariate clustering of expression patterns identified 5 clusters of co-expressed compounds with common chemical characteristics. Turnover rate estimates suggest CH production may be a significant metabolic cost. Male cuticular hydrocarbon expression is a dynamic trait influenced by light and time of day; since abundant hydrocarbons affect male sexual behavior, males may present different pheromonal profiles at different times and under different conditions.	[Kent, Clement; Azanchi, Reza; Smith, Ben; Chu, Adrienne; Levine, Joel] Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada	University of Toronto; University Toronto Mississauga	Levine, J (corresponding author), Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada.	jlevine@utm.utoronto.ca	Kent, Clement F./B-9982-2008; Smith, Ben PC/GXZ-8778-2022	Kent, Clement F./0000-0003-4994-0098; Smith, Benjamin/0000-0003-0651-9420	Canada Research Chair award; CIHR [FRN 74665]	Canada Research Chair award(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by a Canada Research Chair award to JDL and by a grant from the CIHR (FRN 74665) to JDL.	Bartholomew DKM, 1999, LATENT VARIABLE MODE; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blows MW, 1998, AM NAT, V152, P826, DOI 10.1086/286211; Blows MW, 2004, AM NAT, V163, P329, DOI 10.1086/381941; Chertemps T, 2006, INSECT MOL BIOL, V15, P465, DOI 10.1111/j.1365-2583.2006.00658.x; Chertemps T, 2005, BIOCHEM BIOPH RES CO, V333, P1066, DOI 10.1016/j.bbrc.2005.06.015; Chertemps T, 2007, P NATL ACAD SCI USA, V104, P4273, DOI 10.1073/pnas.0608142104; CLARK AG, 1989, GENETICS, V123, P131; COBB M, 1990, ANIM BEHAV, V39, P1058, DOI 10.1016/S0003-3472(05)80778-X; Cox T. F, 1994, MULTIDIMENSIONAL SCA; Coyne JA, 1996, GENETICS, V143, P1689; COYNE JA, 1994, SCIENCE, V265, P1461, DOI 10.1126/science.8073292; Dallerac R, 2000, P NATL ACAD SCI USA, V97, P9449, DOI 10.1073/pnas.150243997; Dowse H.B., 1987, Journal of Biological Rhythms, V2, P65, DOI 10.1177/074873048700200106; Ejima A, 2005, CURR BIOL, V15, P194, DOI 10.1016/j.cub.2005.01.035; Ferveur JF, 1996, GENET RES, V67, P211, DOI 10.1017/S0016672300033693; Foley B, 2007, GENETICS, V175, P1465, DOI 10.1534/genetics.106.065771; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; GIBBS A, 1995, COMP BIOCHEM PHYS B, V112, P243, DOI 10.1016/0305-0491(95)00081-X; Ginzel MD, 2003, CHEMOECOLOGY, V13, P135, DOI 10.1007/s00049-003-0239-z; Grillet M, 2006, P ROY SOC B-BIOL SCI, V273, P315, DOI 10.1098/rspb.2005.3332; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; JALLON J, 1997, J INSECT PHYSL, V43, P1111; JALLON JM, 1984, BEHAV GENET, V14, P441, DOI 10.1007/BF01065444; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Labeur C, 2002, GENETICA, V114, P269, DOI 10.1023/A:1016223000650; Levine JD, 2002, SCIENCE, V298, P2010, DOI 10.1126/science.1076008; Loehlin JC, 2004, LATENT VARIABLE MODE; Marcillac F, 2005, GENETICS, V171, P1617, DOI 10.1534/genetics.104.033159; MARKOWITZ H, 1970, PORTOFOLIO SELECTION; Markowitz H, 1952, J FINANC, V7, P77, DOI 10.1111/j.1540-6261.1952.tb01525.x; Mas F, 2005, J CHEM ECOL, V31, P2747, DOI 10.1007/s10886-005-7570-5; Nicholls D.F., 1982, RANDOM COEFFICIENT A; R Development Core Team, 2006, R LANG ENV STAT COMP; Rouault J, 2000, GENETICA, V110, P117, DOI 10.1023/A:1017987220814; Rouault JD, 2004, GENETICA, V120, P195, DOI 10.1023/B:GENE.0000017641.75820.49; Skroblin A, 2006, J EVOLUTION BIOL, V19, P35, DOI 10.1111/j.1420-9101.2005.00986.x; Soroker V, 2000, J INSECT PHYSIOL, V46, P1097, DOI 10.1016/S0022-1910(99)00219-X; Takahashi A, 2001, P NATL ACAD SCI USA, V98, P3920, DOI 10.1073/pnas.061465098; THOMSON G, 1948, FACTORIAL ANAL HUMAN; Ueyama M, 2005, INSECT BIOCHEM MOLEC, V35, P911, DOI 10.1016/j.ibmb.2005.03.007; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967	45	26	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e962	10.1371/journal.pone.0000962	http://dx.doi.org/10.1371/journal.pone.0000962			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17896002	Green Published, gold, Green Submitted			2022-12-25	WOS:000207455800040
J	Parekkadan, B; van Poll, D; Suganuma, K; Carter, EA; Berthiaume, F; Tilles, AW; Yarmush, ML				Parekkadan, Biju; van Poll, Daan; Suganuma, Kazuhiro; Carter, Edward A.; Berthiaume, Francois; Tilles, Arno W.; Yarmush, Martin L.			Mesenchymal Stem Cell-Derived Molecules Reverse Fulminant Hepatic Failure	PLOS ONE			English	Article								Modulation of the immune system may be a viable alternative in the treatment of fulminant hepatic failure (FHF) and can potentially eliminate the need for donor hepatocytes for cellular therapies. Multipotent bone marrow-derived mesenchymal stem cells (MSCs) have been shown to inhibit the function of various immune cells by undefined paracrine mediators in vitro. Yet, the therapeutic potential of MSC-derived molecules has not been tested in immunological conditions in vivo. Herein, we report that the administration of MSC-derived molecules in two clinically relevant forms-intravenous bolus of conditioned medium (MSC-CM) or extracorporeal perfusion with a bioreactor containing MSCs (MSC-EB)-can provide a significant survival benefit in rats undergoing FHF. We observed a cell mass-dependent reduction in mortality that was abolished at high cell numbers indicating a therapeutic window. Histopathological analysis of liver tissue after MSC-CM treatment showed dramatic reduction of panlobular leukocytic infiltrates, hepatocellular death and bile duct duplication. Furthermore, we demonstrate using computed tomography of adoptively transferred leukocytes that MSC-CM functionally diverts immune cells from the injured organ indicating that altered leukocyte migration by MSC-CM therapy may account for the absence of immune cells in liver tissue. Preliminary analysis of the MSC secretome using a protein array screen revealed a large fraction of chemotactic cytokines, or chemokines. When MSC-CM was fractionated based on heparin binding affinity, a known ligand for all chemokines, only the heparin-bound eluent reversed FHF indicating that the active components of MSC-CM reside in this fraction. These data provide the first experimental evidence of the medicinal use of MSC-derived molecules in the treatment of an inflammatory condition and support the role of chemokines and altered leukocyte migration as a novel therapeutic modality for FHF.	[Parekkadan, Biju; van Poll, Daan; Suganuma, Kazuhiro; Carter, Edward A.; Berthiaume, Francois; Tilles, Arno W.; Yarmush, Martin L.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Engn Med & Surg Serv, Boston, MA 02115 USA; [Parekkadan, Biju; van Poll, Daan; Suganuma, Kazuhiro; Carter, Edward A.; Berthiaume, Francois; Tilles, Arno W.; Yarmush, Martin L.] Shriners Hosp Children, Boston, MA USA; [Parekkadan, Biju; Yarmush, Martin L.] Harvard Massachusetts Inst Technol, Div Hlth Sci & Technol, Cambridge, MA USA; [van Poll, Daan] Univ Utrecht, Univ Med Ctr, Dept Surg, Utrecht, Netherlands	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Utrecht University; Utrecht University Medical Center	Yarmush, ML (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Engn Med & Surg Serv, Boston, MA 02115 USA.	ireis@sbi.org	Berthiaume, Francois/ABD-2139-2020	Yarmush, Martin/0000-0003-4986-8444; Parekkadan, Biju/0000-0002-3408-8085	National Science Foundation; Michael van Vlooten foundation; National Institutes of Health [K08 DK66040, K18 DK076819, R01 DK43371]; Shriners Hospitals for Children; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043371, K18DK076819, K08DK066040] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Michael van Vlooten foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Hospitals for Children; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	BP was supported by a National Science Foundation predoctoral fellowship. DVP was supported by a fellowship from the Michael van Vlooten foundation. This work was partially supported by grants from the National Institutes of Health (K08 DK66040, K18 DK076819 and R01 DK43371) and the Shriners Hospitals for Children.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Beyth S, 2005, BLOOD, V105, P2214, DOI 10.1182/blood-2004-07-2921; Dazzi F, 2006, BLOOD REV, V20, P161, DOI 10.1016/j.blre.2005.11.002; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Gnecchi M, 2006, FASEB J, V20, P661, DOI 10.1096/fj.05-5211com; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Liechty KW, 2000, NAT MED, V6, P1282, DOI 10.1038/81395; Maitra B, 2004, BONE MARROW TRANSPL, V33, P597, DOI 10.1038/sj.bmt.1704400; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; PAREKKADAN B, 2007, BIOCH BIOPH IN PRESS; Shinoda M, 2007, J SURG RES, V137, P130, DOI 10.1016/j.jss.2006.08.009; Shinoda M, 2006, TISSUE ENG, V12, P1313, DOI 10.1089/ten.2006.12.1313; Shito M, 2001, DIGEST DIS SCI, V46, P1700, DOI 10.1023/A:1010653504568; Strain AJ, 2002, SCIENCE, V295, P1005, DOI 10.1126/science.1068660; Zhang YM, 2004, STEM CELLS, V22, P1256, DOI 10.1634/stemcells.2004-0173	15	402	486	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e941	10.1371/journal.pone.0000941	http://dx.doi.org/10.1371/journal.pone.0000941			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895982	Green Published, gold, Green Submitted			2022-12-25	WOS:000207455800020
J	Podtschaske, M; Benary, U; Zwinger, S; Hofer, T; Radbruch, A; Baumgrass, R				Podtschaske, Miriam; Benary, Uwe; Zwinger, Sandra; Hoefer, Thomas; Radbruch, Andreas; Baumgrass, Ria			Digital NFATc2 Activation per Cell Transforms Graded T Cell Receptor Activation into an All-or-None IL-2 Expression	PLOS ONE			English	Article								The expression of interleukin-2 (IL-2) is a key event in T helper (Th) lymphocyte activation, controlling both, the expansion and differentiation of effector Th cells as well as the activation of regulatory T cells. We demonstrate that the strength of TCR stimulation is translated into the frequency of memory Th cells expressing IL-2 but not into the amount of IL-2 per cell. This molecular switch decision for IL-2 expression per cell is located downstream of the cytosolic Ca(2+) level. Here we show that in a single activated Th cell, NFATc2 activation is digital but NF-kappa B activation is graded after graded T cell receptor (TCR) signaling. Subsequently, NFATc2 translocates into the nucleus in an all-or-none fashion per cell, transforming the strength of TCR-stimulation into the number of nuclei positive for NFATc2 and IL-2 transcription. Thus, the described NFATc2 switch regulates the number of Th cells actively participating in an immune response.	[Podtschaske, Miriam; Benary, Uwe; Radbruch, Andreas; Baumgrass, Ria] German Rheumatism Res Ctr, Berlin, Germany; [Zwinger, Sandra] Humboldt Univ, Charite, Inst Med Immunol, Berlin, Germany; [Hoefer, Thomas] Humboldt Univ, Dept Theoret Biophys, Berlin, Germany	Deutsches Rheuma-Forschungszentrum (DRFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin	Baumgrass, R (corresponding author), German Rheumatism Res Ctr, Berlin, Germany.	baumgrass@drfz.de	Höfer, Thomas/G-5665-2013	Höfer, Thomas/0000-0003-3560-8780; Baumgrass, Ria/0000-0002-3289-1608; Radbruch, Andreas/0000-0001-5753-0000; Benary, Uwe/0000-0001-7801-8639	State of Berlin; RB DRFZ Berlin; German Federal Ministry of Education and Research (BMBF) [NGFN II, SIPAGE, 01GS0413]; Deutsche Forschungsgemeinschaft [SFB650]	State of Berlin; RB DRFZ Berlin; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported by a grant of the State of Berlin to AR and RB DRFZ Berlin, by the German Federal Ministry of Education and Research (BMBF) (NGFN II, SIPAGE, 01GS0413), and by the Deutsche Forschungsgemeinschaft (SFB650).	Assenmacher M, 1998, EUR J IMMUNOL, V28, P1534, DOI 10.1002/(SICI)1521-4141(199805)28:05<1534::AID-IMMU1534>3.0.CO;2-R; Baumgrass R, 2004, J BIOL CHEM, V279, P2470, DOI 10.1074/jbc.M304754200; Biggar SR, 2001, EMBO J, V20, P3167, DOI 10.1093/emboj/20.12.3167; Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1038/ni887; Bueno OF, 2002, P NATL ACAD SCI USA, V99, P9398, DOI 10.1073/pnas.152665399; Castellanos MD, 2002, EUR J IMMUNOL, V32, P3108; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; de la Rosa M, 2004, EUR J IMMUNOL, V34, P2480, DOI 10.1002/eji.200425274; Diehn M, 2002, P NATL ACAD SCI USA, V99, P11796, DOI 10.1073/pnas.092284399; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; FIERING S, 1990, GENE DEV, V4, P1823, DOI 10.1101/gad.4.10.1823; GarciaSanz JA, 1996, J EXP MED, V184, P159, DOI 10.1084/jem.184.1.159; GARRITY PA, 1994, MOL CELL BIOL, V14, P2159, DOI 10.1128/MCB.14.3.2159; Gett AV, 2003, NAT IMMUNOL, V4, P355, DOI 10.1038/ni908; Harber M, 2000, Expert Rev Mol Med, V2, P1, DOI 10.1017/S1462399400002143; Kiani A, 2001, BLOOD, V98, P1480, DOI 10.1182/blood.V98.5.1480; Knoechel B, 2005, J EXP MED, V202, P1375, DOI 10.1084/jem.20050855; LOUIS M, 2002, SCI STKE, pPE33; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; Malek TR, 2004, NAT REV IMMUNOL, V4, P665, DOI 10.1038/nri1435; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; Pirone JR, 2004, J THEOR BIOL, V226, P111, DOI 10.1016/j.jtbi.2003.08.008; Powell JD, 1998, IMMUNOL REV, V165, P287, DOI 10.1111/j.1600-065X.1998.tb01246.x; Rachmilewitz J, 2002, TRENDS IMMUNOL, V23, P592, DOI 10.1016/S1471-4906(02)02342-6; Rao SH, 2001, J IMMUNOL, V167, P4494, DOI 10.4049/jimmunol.167.8.4494; ROONEY JW, 1995, MOL CELL BIOL, V15, P6299; Rothenberg EV, 1996, P NATL ACAD SCI USA, V93, P9358, DOI 10.1073/pnas.93.18.9358; Rudensky AY, 2006, CELL, V126, P253, DOI 10.1016/j.cell.2006.07.005; Salazar C, 2003, J MOL BIOL, V327, P31, DOI 10.1016/S0022-2836(03)00085-8; Saparov A, 1999, IMMUNITY, V11, P271, DOI 10.1016/S1074-7613(00)80102-8; Scheffold A, 1998, EUR CYTOKINE NETW, V9, P5; Schimpl A, 2002, CYTOKINE GROWTH F R, V13, P369, DOI 10.1016/S1359-6101(02)00022-9; Serfling E, 2004, INT J BIOCHEM CELL B, V36, P1166, DOI 10.1016/j.biocel.2003.07.002; SERFLING E, 1995, BBA-GENE STRUCT EXPR, V1263, P181, DOI 10.1016/0167-4781(95)00112-T; Serfling E, 2000, BBA-MOL CELL RES, V1498, P1, DOI 10.1016/S0167-4889(00)00082-3; Sojka DK, 2004, J IMMUNOL, V172, P6136, DOI 10.4049/jimmunol.172.10.6136; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; Viola A, 1996, SCIENCE, V273, P104, DOI 10.1126/science.273.5271.104; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Wulfing C, 1997, J EXP MED, V185, P1815, DOI 10.1084/jem.185.10.1815; Yamane H, 2005, J EXP MED, V202, P793, DOI 10.1084/jem.20051304; Zinkernagel RM, 2001, SCIENCE, V293, P251, DOI 10.1126/science.1063005; Zinkernagel RM, 2000, SEMIN IMMUNOL, V12, P163, DOI 10.1006/smim.2000.0253	44	52	53	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e935	10.1371/journal.pone.0000935	http://dx.doi.org/10.1371/journal.pone.0000935			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895976	Green Published, gold, Green Submitted			2022-12-25	WOS:000207455800014
J	Salemi, M; Burkhardt, BR; Gray, RR; Ghaffari, G; Sleasman, JW; Goodenow, MM				Salemi, Marco; Burkhardt, Brant R.; Gray, Rebecca R.; Ghaffari, Guity; Sleasman, John W.; Goodenow, Maureen M.			Phylodynamics of HIV-1 in Lymphoid and Non-Lymphoid Tissues Reveals a Central Role for the Thymus in Emergence of CXCR4-Using Quasispecies	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PERIPHERAL-BLOOD; CORECEPTOR USAGE; CELL TURNOVER; ENVELOPE GENE; ENV V1; EVOLUTION; RECOMBINATION; INFECTION; BRAIN	Background. During HIV-1 infection coreceptor switch from CCR5-(R5)-to CXCR4 (X4)-using viruses is associated with disease progression. X4 strains of HIV-1 are highly cytopathic to immature thymocytes. Virtually no studies have evaluated the HIV-1 quasispecies present in vivo within thymic and lymphoid tissues or the evolutionary relationship between R5 and X4 viruses in tissues and peripheral blood. Methodology/Principal Findings. High-resolution phylodynamic analysis was applied to virus envelope quasispecies in longitudinal peripheral blood mononuclear cells (PBMCs) and lymphoid and non-lymphoid tissues collected post mortem from therapy naive children with AIDS. There were three major findings. First, continued evolution of R5 viruses in PBMCs, spleen and lymph nodes involved multiple bottlenecks, independent of coreceptor switch, resulting in fitter quasispecies driven by positive selection. Second, evolution of X4 strains appeared to be a sequential process requiring the initial fixation of positively selected mutations in V1-V2 and C2 domains of R5 variants before the emergence of high charge V3 X4 variants. Third, R5 viruses persisted after the emergence of CXCR4-using strains, which were found predominantly but not exclusively in the thymus. Conclusions/Significance. Our data indicate that the evolution of X4 strains is a multi-step, temporally structured process and that the thymus may play an important role in the evolution/amplification of coreceptor variants. Development of new therapeutic protocols targeting virus in the thymus could be important to control HIV-1 infection prior to advanced disease.	[Salemi, Marco; Burkhardt, Brant R.; Gray, Rebecca R.; Ghaffari, Guity; Goodenow, Maureen M.] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32611 USA; [Gray, Rebecca R.] Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA; [Ghaffari, Guity; Goodenow, Maureen M.] Univ Florida, Dept Pediat, Div Immunol Rheumatol & Infect Dis, Gainesville, FL 32611 USA; [Sleasman, John W.] Univ S Florida, Dept Pediat, Div Rheumatol Allergy & Immunol, St Petersburg, FL 33701 USA; [Sleasman, John W.] Univ S Florida, All Childrens Hosp, St Petersburg, FL 33701 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Salemi, M (corresponding author), Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32611 USA.	salemi@pathology.ufl.edu; goodenow@ufl.edu			PHS R01 [HD032259, AI047723, AI065265]; General Clinical Research Center of the University of Florida [MO1-RR00082]; University of Florida Children's Miracle Network; Center for Research in Pediatric Immune Deficiency; Laura McClamma Research; Pediatric Clinical Research Center; University of South Florida; Maternal and Child Health Bureau [R60 MC 00003-01]; Department of Health and Human Services; Health Resources and Services Administration; Robert A. Good Chair for Immunology; Stephany W. Holloway University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032259] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065265, R01AI047723] Funding Source: NIH RePORTER	PHS R01; General Clinical Research Center of the University of Florida; University of Florida Children's Miracle Network; Center for Research in Pediatric Immune Deficiency; Laura McClamma Research; Pediatric Clinical Research Center; University of South Florida; Maternal and Child Health Bureau; Department of Health and Human Services; Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); Robert A. Good Chair for Immunology; Stephany W. Holloway University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research was supported by PHS R01 awards HD032259, AI047723, and AI065265; General Clinical Research Center of the University of Florida MO1-RR00082; University of Florida Children's Miracle Network; Center for Research in Pediatric Immune Deficiency; Laura McClamma Research Fellowship; Pediatric Clinical Research Center of All Children's Hospital, University of South Florida, and the Maternal and Child Health Bureau, R60 MC 00003-01, Department of Health and Human Services, Health Resources and Services Administration; Robert A. Good Chair for Immunology (JWS) and Stephany W. Holloway University Chair for AIDS Research (MMG).	Alves K, 2002, AIDS RES HUM RETROV, V18, P161, DOI 10.1089/08892220252779700; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Blankson JN, 2002, ANNU REV MED, V53, P557, DOI 10.1146/annurev.med.53.082901.104024; Bleul CC, 1997, P NATL ACAD SCI USA, V94, P1925, DOI 10.1073/pnas.94.5.1925; Briggs DR, 2000, AIDS, V14, P2937, DOI 10.1097/00002030-200012220-00016; Brooks DG, 2001, NAT MED, V7, P459, DOI 10.1038/86531; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; BURKHARDT B, 1999, PROMEGA NOTES, V71, P30; CANN AJ, 1992, J VIROL, V66, P305, DOI 10.1128/JVI.66.1.305-309.1992; Chang J, 1998, AIDS RES HUM RETROV, V14, P25, DOI 10.1089/aid.1998.14.25; Chene L, 1999, J VIROL, V73, P7533; Cho MW, 1998, J VIROL, V72, P2509, DOI 10.1128/JVI.72.3.2509-2515.1998; Chun TW, 2005, J CLIN INVEST, V115, P3250, DOI 10.1172/JCI26197; Clevestig P, 2005, AIDS RES HUM RETROV, V21, P371, DOI 10.1089/aid.2005.21.371; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; Craigo JK, 2004, AIDS RES HUM RETROV, V20, P1196, DOI 10.1089/aid.2004.20.1196; Dion ML, 2004, IMMUNITY, V21, P757, DOI 10.1016/j.immuni.2004.10.013; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Douek DC, 2001, J IMMUNOL, V167, P6663, DOI 10.4049/jimmunol.167.11.6663; Douek DC, 2000, VACCINE, V18, P1638, DOI 10.1016/S0264-410X(99)00499-5; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Edwards CTT, 2006, GENETICS, V174, P1441, DOI 10.1534/genetics.105.052019; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; FOUCHIER RAM, 1995, J CLIN MICROBIOL, V33, P906, DOI 10.1128/JCM.33.4.906-911.1995; Ghaffari G, 2005, J VIROL, V79, P13250, DOI 10.1128/JVI.79.21.13250-13261.2005; Goodenow MM, 2006, J LEUKOCYTE BIOL, V80, P965, DOI 10.1189/jlb.0306148; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Ho SH, 2007, J VIROL, V81, P8621, DOI 10.1128/JVI.00759-07; HOWELL RM, 1991, AIDS RES HUM RETROV, V7, P869, DOI 10.1089/aid.1991.7.869; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jensen MA, 2006, J VIROL, V80, P4698, DOI 10.1128/JVI.80.10.4698-4704.2006; Jensen MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003; KISELYEVA Y, 2007, J VIROL; Kitchen SG, 1997, J VIROL, V71, P6928, DOI 10.1128/JVI.71.9.6928-6934.1997; KOOT M, 1993, ANN INTERN MED, V118, P681, DOI 10.7326/0003-4819-118-9-199305010-00004; KORBER BTM, 1994, J VIROL, V68, P7467, DOI 10.1128/JVI.68.11.7467-7481.1994; Kourtis AP, 1996, NEW ENGL J MED, V335, P1431, DOI 10.1056/NEJM199611073351904; Lamers S, 2004, BIOINFORMATICS, V20, P436, DOI 10.1093/bioinformatics/btg445; LAMERS SL, 1993, J VIROL, V67, P3951, DOI 10.1128/JVI.67.7.3951-3960.1993; Lamers SL, 1996, AIDS RES HUM RETROV, V12, P1169, DOI 10.1089/aid.1996.12.1169; LEINO L, 1991, BONE MARROW TRANSPL, V8, P339; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; MACKALL CL, 1995, NEW ENGL J MED, V332, P143, DOI 10.1056/NEJM199501193320303; Margolis L, 2006, NAT REV MICROBIOL, V4, P312, DOI 10.1038/nrmicro1387; Messler W, 1997, NATURE, V385, P151, DOI 10.1038/385151a0; MEYERHANS A, 1990, NUCLEIC ACIDS RES, V18, P1687, DOI 10.1093/nar/18.7.1687; Mild M, 2007, J VIROL, V81, P3369, DOI 10.1128/JVI.01295-06; Milich L, 1997, VIROLOGY, V239, P108, DOI 10.1006/viro.1997.8821; Morris A, 1999, J VIROL, V73, P8720, DOI 10.1128/JVI.73.10.8720-8731.1999; Nickle DC, 2003, J VIROL, V77, P5540, DOI 10.1128/JVI.77.9.5540-5546.2003; Pastore C, 2006, J VIROL, V80, P750, DOI 10.1128/JVI.80.2.750-758.2006; PICKER LJ, 1992, ANNU REV IMMUNOL, V10, P561, DOI 10.1146/annurev.immunol.10.1.561; Pontow S, 2001, J VIROL, V75, P11503, DOI 10.1128/JVI.75.23.11503-11514.2001; Poss M, 1998, J VIROL, V72, P8240, DOI 10.1128/JVI.72.10.8240-8251.1998; Regoes RR, 2005, TRENDS MICROBIOL, V13, P269, DOI 10.1016/j.tim.2005.04.005; Ribeiro RM, 2006, J VIROL, V80, P802, DOI 10.1128/JVI.80.2.802-809.2006; ROSENZWEIG M, 1993, AIDS, V7, P1601, DOI 10.1097/00002030-199312000-00009; Salemi M, 2005, J VIROL, V79, P11343, DOI 10.1128/JVI.79.17.11343-11352.2005; Salminen M, 2003, PHYLOGENETIC HDB PRA, P348; Shah M, 2006, AIDS RES HUM RETROV, V22, P177, DOI 10.1089/aid.2006.22.177; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Shapshak P, 1999, AIDS RES HUM RETROV, V15, P811, DOI 10.1089/088922299310719; Shriner D, 2004, GENETICS, V166, P1155, DOI 10.1534/genetics.166.3.1155; Shriner D, 2004, GENETICS, V167, P1573, DOI 10.1534/genetics.103.023382; SIMPSON JG, 1975, CLIN EXP IMMUNOL, V19, P261; SLATKIN M, 1989, GENETICS, V123, P603; SMIT TK, 2004, INDEPENDENT EVOLUTIO; STAMATATOS L, 1993, J VIROL, V67, P5635, DOI 10.1128/JVI.67.9.5635-5639.1993; SWOFFORD D, 2003, PHYLOGENETIC HDB PRA, P160; Tuttle DL, 1998, J VIROL, V72, P4962, DOI 10.1128/JVI.72.6.4962-4969.1998; Tuttle DL, 2002, AIDS RES HUM RETROV, V18, P353, DOI 10.1089/088922202753519133; Uittenbogaart CH, 2000, AIDS, V14, P1317, DOI 10.1097/00002030-200007070-00003; VANTWOUT AB, 1994, J CLIN INVEST, V94, P2060, DOI 10.1172/JCI117560; Westby M, 2006, J VIROL, V80, P4909, DOI 10.1128/JVI.80.10.4909-4920.2006; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zaitseva MB, 1998, J IMMUNOL, V161, P3103; Zhang LQ, 1998, J VIROL, V72, P5035, DOI 10.1128/JVI.72.6.5035-5045.1998	79	44	45	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e950	10.1371/journal.pone.0000950	http://dx.doi.org/10.1371/journal.pone.0000950			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895991	Green Published, Green Submitted, gold			2022-12-25	WOS:000207455800029
J	Statnikov, A; Li, C; Aliferis, CF				Statnikov, Alexander; Li, Chun; Aliferis, Constantin F.			Effects of Environment, Genetics and Data Analysis Pitfalls in an Esophageal Cancer Genome-Wide Association Study	PLOS ONE			English	Article								Background. The development of new high-throughput genotyping technologies has allowed fast evaluation of single nucleotide polymorphisms (SNPs) on a genome-wide scale. Several recent genome-wide association studies employing these technologies suggest that panels of SNPs can be a useful tool for predicting cancer susceptibility and discovery of potentially important new disease loci. Methodology/Principal Findings. In the present paper we undertake a careful examination of the relative significance of genetics, environmental factors, and biases of the data analysis protocol that was used in a previously published genome-wide association study. That prior study reported a nearly perfect discrimination of esophageal cancer patients and healthy controls on the basis of only genetic information. On the other hand, our results strongly suggest that SNPs in this dataset are not statistically linked to the phenotype, while several environmental factors and especially family history of esophageal cancer (a proxy to both environmental and genetic factors) have only a modest association with the disease. Conclusions/Significance. The main component of the previously claimed strong discriminatory signal is due to several data analysis pitfalls that in combination led to the strongly optimistic results. Such pitfalls are preventable and should be avoided in future studies since they create misleading conclusions and generate many false leads for subsequent research.	[Statnikov, Alexander; Aliferis, Constantin F.] Vanderbilt Univ, Dept Biomed Informat, Discovery Syst Lab, Nashville, TN 37235 USA; [Li, Chun; Aliferis, Constantin F.] Vanderbilt Univ, Dept Biostat, Nashville, TN USA; [Li, Chun] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN USA; [Aliferis, Constantin F.] Vanderbilt Univ, Dept Canc Biol, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Aliferis, CF (corresponding author), Vanderbilt Univ, Dept Biomed Informat, Discovery Syst Lab, Nashville, TN 37235 USA.	constantin.aliferis@vanderbilt.edu	Li, Chun/B-8388-2012; Li, Chun/R-1095-2019	Li, Chun/0000-0002-8819-2443	 [R01 LM007948-01]; NATIONAL LIBRARY OF MEDICINE [R01LM007948] Funding Source: NIH RePORTER	; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The work was in part supported by grant R01 LM007948-01. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliferis CF, 2006, CANCER INFORM, V2, P133; [Anonymous], 2003, ROC GRAPHS NOTES PRA; Barrett JC, 2006, NAT GENET, V38, P659, DOI 10.1038/ng1801; Batista GEAPA, 2003, APPL ARTIF INTELL, V17, P519, DOI 10.1080/08839510390219309; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Braga-Neto UM, 2004, BIOINFORMATICS, V20, P374, DOI 10.1093/bioinformatics/btg419; Czene K, 2002, INT J CANCER, V99, P260, DOI 10.1002/ijc.10332; Dupuy A, 2007, JNCI-J NATL CANCER I, V99, P147, DOI 10.1093/jnci/djk018; Ellis NA, 2006, GENET EPIDEMIOL, V30, P48, DOI 10.1002/gepi.20101; Engle LJ, 2006, ONCOGENE, V25, P1594, DOI 10.1038/sj.onc.1209368; Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Hosking L, 2004, EUR J HUM GENET, V12, P395, DOI 10.1038/sj.ejhg.5201164; Hu N, 2005, CANCER RES, V65, P2542, DOI 10.1158/0008-5472.CAN-04-3247; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Ling C., 2003, P 18 INT JOINT C ART; Little R.J.A., 2002, STAT ANAL MISSING DA; Mitra N, 2004, CANCER RES, V64, P8116, DOI 10.1158/0008-5472.CAN-04-1411; Nicolae DL, 2006, PLOS GENET, V2, P665, DOI 10.1371/journal.pgen.0020067; Rudd MF, 2006, GENOME RES, V16, P693, DOI 10.1101/gr.5120106; Statnikov A, 2005, BIOINFORMATICS, V21, P631, DOI 10.1093/bioinformatics/bti033; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Vapnik V., 1998, STAT LEARNING THEORY; WADDELL M, 2005, P 5 ACM SIGKDD WORKS; Wagner M, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-26; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522	30	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e958	10.1371/journal.pone.0000958	http://dx.doi.org/10.1371/journal.pone.0000958			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895998	Green Published, gold, Green Submitted			2022-12-25	WOS:000207455800036
J	Zi, ZK; Klipp, E				Zi, Zhike; Klipp, Edda			Constraint-Based Modeling and Kinetic Analysis of the Smad Dependent TGF-beta Signaling Pathway	PLOS ONE			English	Article								Background. Investigation of dynamics and regulation of the TGF-beta signaling pathway is central to the understanding of complex cellular processes such as growth, apoptosis, and differentiation. In this study, we aim at using systems biology approach to provide dynamic analysis on this pathway. Methodology/Principal Findings. We proposed a constraint-based modeling method to build a comprehensive mathematical model for the Smad dependent TGF-beta signaling pathway by fitting the experimental data and incorporating the qualitative constraints from the experimental analysis. The performance of the model generated by constraint-based modeling method is significantly improved compared to the model obtained by only fitting the quantitative data. The model agrees well with the experimental analysis of TGF-beta pathway, such as the time course of nuclear phosphorylated Smad, the subcellular location of Smad and signal response of Smad phosphorylation to different doses of TGF-beta. Conclusions/Significance. The simulation results indicate that the signal response to TGF-beta is regulated by the balance between clathrin dependent endocytosis and non-clathrin mediated endocytosis. This model is useful to be built upon as new precise experimental data are emerging. The constraint-based modeling method can also be applied to quantitative modeling of other signaling pathways.	[Zi, Zhike; Klipp, Edda] Max Planck Inst Mol Genet, Berlin, Germany; [Klipp, Edda] Humboldt Univ, Inst Biol, Berlin, Germany	Max Planck Society; Humboldt University of Berlin	Klipp, E (corresponding author), Max Planck Inst Mol Genet, Berlin, Germany.	klipp@molgen.mpg.de	Zi, Zhike/B-4185-2012; Zi, Zhike/I-2756-2019	Zi, Zhike/0000-0002-7601-915X	IMPRS for Computational Biology and Scientific Computing; European Commission [LSHG-CT-2005-518254]	IMPRS for Computational Biology and Scientific Computing; European Commission(European CommissionEuropean Commission Joint Research Centre)	Z. Zi is supported by PhD program of the IMPRS for Computational Biology and Scientific Computing. This work was supported by ENFIN, a Network of Excellence funded by the European Commission within its FP6 Programme, under the thematic area "Life sciences, genomics and biotechnology for health", contract number LSHG-CT-2005-518254.	Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Clarke DC, 2006, IEE P SYST BIOL, V153, P412, DOI 10.1049/ip-syb:20050055; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Hayes S, 2002, J CELL BIOL, V158, P1239, DOI 10.1083/jcb.200204088; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Inman GJ, 2002, MOL CELL, V10, P283, DOI 10.1016/S1097-2765(02)00585-3; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Klipp E, 2005, NAT BIOTECHNOL, V23, P975, DOI 10.1038/nbt1114; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Melke P, 2006, BIOPHYS J, V91, P4368, DOI [10.1529/biophysj.105.080408, 10.1529/biophysj.106.080408]; Mitchell H, 2004, MOL BIOL CELL, V15, P4166, DOI 10.1091/mbc.E04-03-0245; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Pierreux CE, 2000, MOL CELL BIOL, V20, P9041, DOI 10.1128/MCB.20.23.9041-9054.2000; Price ND, 2003, TRENDS BIOTECHNOL, V21, P162, DOI 10.1016/S0167-7799(03)00030-1; Runarsson TP, 2000, IEEE T EVOLUT COMPUT, V4, P284, DOI 10.1109/4235.873238; Savini I, 2000, BIOCHEM J, V345, P665, DOI 10.1042/0264-6021:3450665; Schmierer B, 2005, MOL CELL BIOL, V25, P9845, DOI 10.1128/MCB.25.22.9845-9858.2005; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Swameye I, 2003, P NATL ACAD SCI USA, V100, P1028, DOI 10.1073/pnas.0237333100; Vilar JMG, 2006, PLOS COMPUT BIOL, V2, P36, DOI 10.1371/journal.pcbi.0020003; WAKEFIELD LM, 1987, J CELL BIOL, V105, P965, DOI 10.1083/jcb.105.2.965; WATT FM, 1988, P NATL ACAD SCI USA, V85, P5576, DOI 10.1073/pnas.85.15.5576; Xu L, 2002, MOL CELL, V10, P271, DOI 10.1016/S1097-2765(02)00586-5; Xu L, 2000, NAT CELL BIOL, V2, P559, DOI 10.1038/35019649; Zi Z, 2006, BIOINFORMATICS, V22, P2704, DOI 10.1093/bioinformatics/btl443	30	64	66	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e936	10.1371/journal.pone.0000936	http://dx.doi.org/10.1371/journal.pone.0000936			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895977	Green Submitted, Green Published, gold			2022-12-25	WOS:000207455800015
J	Borghans, JAM; Molgaard, A; de Boer, RJ; Kesmir, C				Borghans, Jose A. M.; Molgaard, Anne; de Boer, Rob J.; Kesmir, Can			HLA Alleles Associated with Slow Progression to AIDS Truly Prefer to Present HIV-1 p24	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CYTOTOXIC T-LYMPHOCYTES; CELL RESPONSES; GAG PROTEIN; VACCINIA VIRUS; TYPE-1 GAG; VIRAL LOAD; ESCAPE; SEQUENCE; EPITOPE	Background. The mechanism behind the association between human leukocyte antigen (HLA) molecules and the rate of HIV-1 disease progression is still poorly understood. Recent data suggest that "protective'' HLA molecules, i.e. those associated with a low HIV-1 viral load and relatively slow disease progression, tend to present epitopes from the Gag capsid protein. Although this suggests that preferential targeting of Gag delays disease progression, the apparent preference for Gag could also be a side-effect of the relatively high immunogenicity of the protein. Methods and Findings. To separate cause and effect, we predicted HIV-1 epitopes from the whole genome of HIV-1, and found that protective HLA alleles have a true preference for the p24 Gag protein, while non-protective HLA alleles preferentially target HIV-1 Nef. In line with this, we found a significant negative correlation between the predicted affinity of the best-binding p24 epitopes and the relative hazard of HIV-1 disease progression for a large number of HLA molecules. When the epitopes targeted by protective HLA alleles were mapped to the known p24 structure, we found that mutations in these epitopes are likely to disturb the p24 dimer structure, which is expected to severely reduce the fitness of the virus. Conclusions. Our results suggest that the intrinsic preference of different HLA molecules to present p24 peptides explains why some HLA molecules are more protective than others.	[Kesmir, Can] Univ Utrecht, Acad Biomed Ctr, Utrecht, Netherlands; [Borghans, Jose A. M.] Univ Med Ctr Utrecht, Dept Immunol, Utrecht, Netherlands; [Molgaard, Anne; Kesmir, Can] Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark	Utrecht University; Utrecht University; Utrecht University Medical Center; Technical University of Denmark	Kesmir, C (corresponding author), Univ Utrecht, Acad Biomed Ctr, Utrecht, Netherlands.	c.kesmir@uu.nl	Kesmir, Can/B-9410-2011; de Boer, Rob/B-6050-2011	de Boer, Rob/0000-0002-2130-691X	Netherlands Organization for Scientific Research (NWO) [050.50.202, 916.36.003, 016.048.603]; AIDS Fonds Netherlands [7011]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); AIDS Fonds Netherlands	This work was financially supported by the Netherlands Organization for Scientific Research (NWO, grants 050.50.202, 916.36.003 and 016.048.603), and by AIDS Fonds Netherlands (grant 7011).	Accola MA, 2000, J VIROL, V74, P5395, DOI 10.1128/JVI.74.12.5395-5402.2000; Altfeld M, 2003, AIDS, V17, P2581, DOI 10.1097/00002030-200312050-00005; Altfeld M, 2006, PLOS MED, V3, P1851, DOI 10.1371/journal.pmed.0030403; Assarsson E, 2007, J IMMUNOL, V178, P7890, DOI 10.4049/jimmunol.178.12.7890; Bailey JR, 2006, J EXP MED, V203, P1357, DOI 10.1084/jem.20052319; Balla-Jhagjhoorsingh SS, 1999, J IMMUNOL, V162, P2308; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Buseyne F, 2002, J INFECT DIS, V186, P1589, DOI 10.1086/345482; Buus S, 2003, TISSUE ANTIGENS, V62, P378, DOI 10.1034/j.1399-0039.2003.00112.x; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Crawford H, 2007, J VIROL, V81, P8346, DOI 10.1128/JVI.00465-07; Edwards BH, 2002, J VIROL, V76, P2298, DOI 10.1128/JVI.76.5.2298-2305.2002; Feeney ME, 2004, J VIROL, V78, P8927, DOI 10.1128/JVI.78.16.8927-8930.2004; Frahm N, 2006, NAT IMMUNOL, V7, P173, DOI 10.1038/ni1281; Frahm N, 2005, J VIROL, V79, P10218, DOI 10.1128/JVI.79.16.10218-10225.2005; Frahm N, 2004, J VIROL, V78, P2187, DOI 10.1128/JVI.78.5.2187-2200.2004; Frater AJ, 2007, J VIROL, V81, P6742, DOI 10.1128/JVI.00022-07; Friedrich TC, 2004, NAT MED, V10, P275, DOI 10.1038/nm998; Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849; Gao XJ, 2001, NEW ENGL J MED, V344, P1668, DOI 10.1056/NEJM200105313442203; Gillespie GMA, 2002, AIDS, V16, P961, DOI 10.1097/00002030-200205030-00002; Goulder PJR, 1997, AIDS, V11, P536; Honeyborne I, 2007, J VIROL, V81, P3667, DOI 10.1128/JVI.02689-06; Jansen CA, 2005, EUR J IMMUNOL, V35, P150, DOI 10.1002/eji.200425487; Johnson MC, 2002, J VIROL, V76, P11177, DOI 10.1128/JVI.76.22.11177-11185.2002; Kaul R, 2000, J IMMUNOL, V164, P1602, DOI 10.4049/jimmunol.164.3.1602; Kesmir C, 2002, PROTEIN ENG, V15, P287, DOI 10.1093/protein/15.4.287; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Klein MR, 1998, J GEN VIROL, V79, P2191, DOI 10.1099/0022-1317-79-9-2191; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Lichterfeld M, 2004, AIDS, V18, P1383, DOI 10.1097/01.aids.0000131329.51633.a3; Lund O, 2004, IMMUNOGENETICS, V55, P797, DOI 10.1007/s00251-004-0647-4; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; Masemola A, 2004, J VIROL, V78, P3233, DOI 10.1128/JVI.78.7.3233-3243.2004; Momany C, 1996, NAT STRUCT BIOL, V3, P763, DOI 10.1038/nsb0996-763; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; NIXON DF, 1988, NATURE, V336, P484, DOI 10.1038/336484a0; Novitsky V, 2003, J VIROL, V77, P882, DOI 10.1128/JVI.77.2.882-890.2003; Novitsky V, 2002, J VIROL, V76, P5435, DOI 10.1128/JVI.76.11.5435-5451.2002; Peters B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-132; Peters B, 2003, J IMMUNOL, V171, P1741, DOI 10.4049/jimmunol.171.4.1741; Peyerl FW, 2004, J VIROL, V78, P13901, DOI 10.1128/JVI.78.24.13901-13910.2004; Sacha JB, 2007, J IMMUNOL, V178, P2746, DOI 10.4049/jimmunol.178.5.2746; Scherer A, 2004, P NATL ACAD SCI USA, V101, P12266, DOI 10.1073/pnas.0404091101; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Sette A, 1999, IMMUNOGENETICS, V50, P201, DOI 10.1007/s002510050594; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Streeck H, 2007, J VIROL, V81, P7725, DOI 10.1128/JVI.00708-07; Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555, DOI 10.1038/9858; Trachtenberg E, 2003, NAT MED, V9, P928, DOI 10.1038/nm893; von Schwedler UK, 2003, J VIROL, V77, P5439, DOI 10.1128/JVI.77.9.5439-5450.2003; Wagner R, 1999, J IMMUNOL, V162, P3727; Zhang YQ, 1998, J VIROL, V72, P1782, DOI 10.1128/JVI.72.3.1782-1789.1998; Zuniga R, 2006, J VIROL, V80, P3122, DOI 10.1128/JVI.80.6.3122-3125.2006	60	77	78	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2007	2	9							e920	10.1371/journal.pone.0000920	http://dx.doi.org/10.1371/journal.pone.0000920			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HS	17878955	gold, Green Published			2022-12-25	WOS:000207455700028
J	Kauramaki, J; Jaaskelainen, IP; Sams, M				Kauramaki, Jaakko; Jaaskelainen, Iiro P.; Sams, Mikko			Selective Attention Increases Both Gain and Feature Selectivity of the Human Auditory Cortex	PLOS ONE			English	Article							LATERAL INTERACTIONS; UNEXPECTED TONES; MODULATION; FREQUENCY; PLASTICITY; SENSITIVITY; INHIBITION; ACTIVATION; STIMULUS; HEARING	Background. An experienced car mechanic can often deduce what's wrong with a car by carefully listening to the sound of the ailing engine, despite the presence of multiple sources of noise. Indeed, the ability to select task-relevant sounds for awareness, whilst ignoring irrelevant ones, constitutes one of the most fundamental of human faculties, but the underlying neural mechanisms have remained elusive. While most of the literature explains the neural basis of selective attention by means of an increase in neural gain, a number of papers propose enhancement in neural selectivity as an alternative or a complementary mechanism. Methodology/Principal Findings. Here, to address the question whether pure gain increase alone can explain auditory selective attention in humans, we quantified the auditory cortex frequency selectivity in 20 healthy subjects by masking 1000-Hz tones by continuous noise masker with parametrically varying frequency notches around the tone frequency (i.e., a notched-noise masker). The task of the subjects was, in different conditions, to selectively attend to either occasionally occurring slight increments in tone frequency (1020 Hz), tones of slightly longer duration, or ignore the sounds. In line with previous studies, in the ignore condition, the global field power (GFP) of event-related brain responses at 100 ms from the stimulus onset to the 1000-Hz tones was suppressed as a function of the narrowing of the notch width. During the selective attention conditions, the suppressant effect of the noise notch width on GFP was decreased, but as a function significantly different from a multiplicative one expected on the basis of simple gain model of selective attention. Conclusions/Significance. Our results suggest that auditory selective attention in humans cannot be explained by a gain model, where only the neural activity level is increased, but rather that selective attention additionally enhances auditory cortex frequency selectivity.	[Kauramaki, Jaakko; Jaaskelainen, Iiro P.; Sams, Mikko] Aalto Univ, Lab Computat Engn, FIN-02150 Espoo, Finland	Aalto University	Kauramaki, J (corresponding author), Aalto Univ, Lab Computat Engn, FIN-02150 Espoo, Finland.	Jaakko.Kauramaki@tkk.fi	Sams, Mikko E/G-7060-2012; Jaaskelainen, Iiro P/C-7392-2012; Kauramäki, Jaakko/G-6962-2012	Jaaskelainen, Iiro P/0000-0001-6001-6950; Kauramaki, Jaakko/0000-0002-6019-7920	Academy of Finland [206368, 212261, 213470]; National Institutes of Health [RO1-HD040712]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD040712] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was financially supported by the Academy of Finland ( grant nos. 206368, 212261, 213470) and by the National Institutes of Health ( grant no. RO1-HD040712).	Ahveninen J, 2006, P NATL ACAD SCI USA, V103, P14608, DOI 10.1073/pnas.0510480103; Alho K, 1999, COGNITIVE BRAIN RES, V7, P335, DOI 10.1016/S0926-6410(98)00036-6; Alho K, 2003, COGNITIVE BRAIN RES, V17, P201, DOI 10.1016/S0926-6410(03)00091-0; ARTHUR DL, 1991, ELECTROEN CLIN NEURO, V78, P348, DOI 10.1016/0013-4694(91)90097-N; BAKIN JS, 1990, BRAIN RES, V536, P271, DOI 10.1016/0006-8993(90)90035-A; Connor CE, 1996, J NEUROPHYSIOL, V75, P1306, DOI 10.1152/jn.1996.75.3.1306; DAI HP, 1991, J ACOUST SOC AM, V89, P2837, DOI 10.1121/1.400721; DAI HP, 1991, J ACOUST SOC AM, V89, P1816, DOI 10.1121/1.401015; Delano PH, 2007, J NEUROSCI, V27, P4146, DOI 10.1523/JNEUROSCI.3702-06.2007; Engelien A, 2000, BRAIN, V123, P532, DOI 10.1093/brain/123.3.532; Fishman YI, 2006, J NEUROPHYSIOL, V96, P1105, DOI 10.1152/jn.00124.2006; Freeman E, 2003, CURR BIOL, V13, P985, DOI 10.1016/S0960-9822(03)00333-6; Freeman E, 2001, NAT NEUROSCI, V4, P1032, DOI 10.1038/nn728; Fritz J, 2003, NAT NEUROSCI, V6, P1216, DOI 10.1038/nn1141; FRITZ JB, 2007, HEAR RES IN PRESS; Fujiki N, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-03-j0003.2002; Fujiwara N, 1998, COGNITIVE BRAIN RES, V7, P99, DOI 10.1016/S0926-6410(98)00014-7; Grady CL, 1997, NEUROREPORT, V8, P2511, DOI 10.1097/00001756-199707280-00019; Hillyard SA, 1998, PHILOS T ROY SOC B, V353, P1257, DOI 10.1098/rstb.1998.0281; HILLYARD SA, 1973, SCIENCE, V182, P177, DOI 10.1126/science.182.4108.177; Huang LQ, 2005, VISION RES, V45, P1201, DOI 10.1016/j.visres.2004.10.024; Hugdahl K, 1999, NEUROPSYCHOLOGIA, V37, P431, DOI 10.1016/S0028-3932(98)00101-8; Jaaskelainen IP, 2004, P NATL ACAD SCI USA, V101, P6809, DOI 10.1073/pnas.0303760101; Jancke L, 1999, NEUROSCI LETT, V266, P125, DOI 10.1016/S0304-3940(99)00288-8; LEHMANN D, 1980, ELECTROEN CLIN NEURO, V48, P609, DOI 10.1016/0013-4694(80)90419-8; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Lutkenhoner B, 2007, HEARING RES, V228, P188, DOI 10.1016/j.heares.2007.02.011; Martinez-Trujillo JC, 2002, NEURON, V35, P365, DOI 10.1016/S0896-6273(02)00778-X; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; Murray SO, 2004, NAT NEUROSCI, V7, P70, DOI 10.1038/nn1161; NAATANEN R, 1988, ELECTROEN CLIN NEURO, V69, P523, DOI 10.1016/0013-4694(88)90164-2; Naatanen R., 2018, ATTENTION BRAIN FUNC; Neelon MF, 2006, BRAIN RES, V1118, P94, DOI 10.1016/j.brainres.2006.08.006; Norena A, 2000, HEARING RES, V149, P24, DOI 10.1016/S0378-5955(00)00158-1; Ozaki I, 2004, CLIN NEUROPHYSIOL, V115, P1592, DOI 10.1016/j.clinph.2004.02.011; Pantev C, 1999, BRAIN RES, V842, P192, DOI 10.1016/S0006-8993(99)01835-1; PATTERSON RD, 1976, J ACOUST SOC AM, V59, P640, DOI 10.1121/1.380914; Pernier J, 1994, HUM BRAIN MAPP, V2, P159; Perrot X, 2006, CEREB CORTEX, V16, P941, DOI 10.1093/cercor/bhj035; Petkov CI, 2004, NAT NEUROSCI, V7, P658, DOI 10.1038/nn1256; Reynolds JH, 2003, NEURON, V37, P853, DOI 10.1016/S0896-6273(03)00097-7; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; RIF J, 1991, ELECTROEN CLIN NEURO, V79, P464, DOI 10.1016/0013-4694(91)90166-2; Rinne T, 2005, HUM BRAIN MAPP, V26, P94, DOI 10.1002/hbm.20123; SAMS M, 1994, HEARING RES, V75, P67, DOI 10.1016/0378-5955(94)90057-4; Slotnick SD, 2003, NEUROIMAGE, V19, P1602, DOI 10.1016/S1053-8119(03)00187-3; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; Suga N, 1997, J NEUROPHYSIOL, V77, P2098, DOI 10.1152/jn.1997.77.4.2098; TIITINEN H, 1993, NATURE, V364, P59, DOI 10.1038/364059a0; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Wang XQ, 2005, NATURE, V435, P341, DOI 10.1038/nature03565; Wiegrebe L, 1996, HEARING RES, V100, P171, DOI 10.1016/0378-5955(96)00111-6; WOLDORFF MG, 1993, P NATL ACAD SCI USA, V90, P8722, DOI 10.1073/pnas.90.18.8722; WOLDORFF MG, 1991, ELECTROEN CLIN NEURO, V79, P170, DOI 10.1016/0013-4694(91)90136-R; Wright BA, 2005, J ACOUST SOC AM, V117, P1299, DOI 10.1121/1.1855771; WRIGHT BA, 1994, J ACOUST SOC AM, V95, P939, DOI 10.1121/1.410011; Wright BA, 2004, PERCEPT PSYCHOPHYS, V66, P508, DOI 10.3758/BF03194897; WRIGHT BA, 1994, J ACOUST SOC AM, V95, P931, DOI 10.1121/1.410010; Xiao ZJ, 2002, NAT NEUROSCI, V5, P57, DOI 10.1038/nn786; Zatorre RJ, 1999, NEUROIMAGE, V10, P544, DOI 10.1006/nimg.1999.0491	61	63	65	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2007	2	9							e909	10.1371/journal.pone.0000909	http://dx.doi.org/10.1371/journal.pone.0000909			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HS	17878944	gold, Green Published, Green Submitted			2022-12-25	WOS:000207455700017
J	McDevitt, MR; Chattopadhyay, D; Jaggi, JS; Finn, RD; Zanzonico, PB; Villa, C; Rey, D; Mendenhall, J; Batt, CA; Njardarson, JT; Scheinberg, DA				McDevitt, Michael R.; Chattopadhyay, Debjit; Jaggi, Jaspreet S.; Finn, Ronald D.; Zanzonico, Pat B.; Villa, Carlos; Rey, Diego; Mendenhall, Juana; Batt, Carl A.; Njardarson, Jon T.; Scheinberg, David A.			PET Imaging of Soluble Yttrium-86-Labeled Carbon Nanotubes in Mice	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; IN-VIVO; BIODISTRIBUTION; PURIFICATION; CARCINOMA; CLEARANCE; IN-111	Background. The potential medical applications of nanomaterials are shaping the landscape of the nanobiotechnology field and driving it forward. A key factor in determining the suitability of these nanomaterials must be how they interface with biological systems. Single walled carbon nanotubes (CNT) are being investigated as platforms for the delivery of biological, radiological, and chemical payloads to target tissues. CNT are mechanically robust graphene cylinders comprised of sp(2)-bonded carbon atoms and possessing highly regular structures with defined periodicity. CNT exhibit unique mechanochemical properties that can be exploited for the development of novel drug delivery platforms. In order to evaluate the potential usefulness of this CNT scaffold, we undertook an imaging study to determine the tissue biodistribution and pharmacokinetics of prototypical DOTA-functionalized CNT labeled with yttrium-86 and indium-111 (Y-86-CNT and In-111-CNT, respectively) in a mouse model. Methodology and Principal Findings. The Y-86-CNT construct was synthesized from amine-functionalized, water-soluble CNT by covalently attaching multiple copies of DOTA chelates and then radiolabeling with the positron-emitting metal-ion, yttrium-86. A gamma-emitting In-111-CNT construct was similarly prepared and purified. The constructs were characterized spectroscopically, microscopically, and chromatographically. The whole-body distribution and clearance of yttrium-86 was characterized at 3 and 24 hours post-injection using positron emission tomography (PET). The yttrium-86 cleared the blood within 3 hours and distributed predominantly to the kidneys, liver, spleen and bone. Although the activity that accumulated in the kidney cleared with time, the whole-body clearance was slow. Differential uptake in these target tissues was observed following intraveneous or intraperitoneal injection. Conclusions. The whole-body PET images indicated that the major sites of accumulation of activity resulting from the administration of Y-86-CNT were the kidney, liver, spleen, and to a much less extent the bone. Blood clearance was rapid and could be beneficial in the use of short-lived radionuclides in diagnostic applications.	[McDevitt, Michael R.; Chattopadhyay, Debjit; Jaggi, Jaspreet S.; Finn, Ronald D.; Zanzonico, Pat B.; Villa, Carlos; Scheinberg, David A.] Mem Sloan Kettering Canc Ctr, Dept Med, Mol Pharmacol & Chem Dept, New York, NY 10021 USA; [McDevitt, Michael R.; Chattopadhyay, Debjit; Jaggi, Jaspreet S.; Finn, Ronald D.; Zanzonico, Pat B.; Villa, Carlos; Scheinberg, David A.] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10021 USA; [McDevitt, Michael R.; Chattopadhyay, Debjit; Jaggi, Jaspreet S.; Finn, Ronald D.; Zanzonico, Pat B.; Villa, Carlos; Scheinberg, David A.] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA; [Rey, Diego] Cornell Univ, Dept Biomed Engn, Ithaca, NY USA; [Mendenhall, Juana; Batt, Carl A.] Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA; [Njardarson, Jon T.] Cornell Univ, Dept Chem & Biol Chem, Ithaca, NY 14853 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University; Cornell University	McDevitt, MR (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, Mol Pharmacol & Chem Dept, 1275 York Ave, New York, NY 10021 USA.	m-mcdevitt@ski.mskcc.org; d-scheinberg@mskcc.org			NIH [CA55349, CA33049, 1R24CA83084]; Tudor and Glades Foundation; Commonwealth Cancer Foundation for Research; Experimental Therapeutics Center; Cornell University/Ludwig Institute for Cancer Research; Laurie Strauss Foundation; NATIONAL CANCER INSTITUTE [R01CA055349, R24CA083084, P01CA033049, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tudor and Glades Foundation; Commonwealth Cancer Foundation for Research; Experimental Therapeutics Center; Cornell University/Ludwig Institute for Cancer Research; Laurie Strauss Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The support of NIH CA55349, CA33049, 1R24CA83084, the Tudor and Glades Foundation, the Commonwealth Cancer Foundation for Research, the Experimental Therapeutics Center, The Cornell University/Ludwig Institute for Cancer Research Partnership, and the Laurie Strauss Foundation for funding.	Arnold K, 2006, PHYS STATUS SOLIDI B, V243, P3073, DOI 10.1002/pssb.200669196; Brouwers AH, 2004, J NUCL MED, V45, P327; BullardDillard R, 1996, BIOORG CHEM, V24, P376, DOI 10.1006/bioo.1996.0032; Cagle DW, 1999, P NATL ACAD SCI USA, V96, P5182, DOI 10.1073/pnas.96.9.5182; Cherukuri P, 2004, J AM CHEM SOC, V126, P15638, DOI 10.1021/ja0466311; Cherukuri P, 2006, P NATL ACAD SCI USA, V103, P18882, DOI 10.1073/pnas.0609265103; Dadachova E, 1999, NUCL MED BIOL, V26, P977, DOI 10.1016/S0969-8051(99)00054-2; Dresselhaus MS, 2001, TOP APPL PHYS, V80, P1; ESTEBAN JM, 1987, J NUCL MED, V28, P861; Finn RD, 1999, AIP CONF PROC, V475, P991; Georgakilas V, 2002, CHEM COMMUN, P3050, DOI 10.1039/b209843a; Hu H, 2003, J PHYS CHEM B, V107, P13838, DOI 10.1021/jp035719i; Huang WJ, 2002, NANO LETT, V2, P231, DOI [10.1021/nl010083x, 10.1021/n1010083x]; Itkis ME, 2005, J AM CHEM SOC, V127, P3439, DOI 10.1021/ja043061w; Kam NWS, 2004, J AM CHEM SOC, V126, P6850, DOI 10.1021/ja0486059; Lee CC, 2005, NAT BIOTECHNOL, V23, P1517, DOI 10.1038/nbt1171; Lin Y, 2005, J PHYS CHEM B, V109, P14779, DOI 10.1021/jp053073j; Lovqvist A, 2001, J NUCL MED, V42, P1281; LUI Z, 2007, NATURE NANOTECH, V2, P47; McDevitt MR, 2007, J NUCL MED, V48, P1180, DOI 10.2967/jnumed.106.039131; McDevitt MR, 2001, SCIENCE, V294, P1537, DOI 10.1126/science.1064126; MOFFAT DB, 1981, J CLIN PATHOL, V34, P1197, DOI 10.1136/jcp.34.11.1197; Ohlson M, 2001, AM J PHYSIOL-RENAL, V281, pF103, DOI 10.1152/ajprenal.2001.281.1.F103; Panhuis MIH, 2003, CHEM BIOL, V10, P897, DOI 10.1016/j.chembiol.2003.10.005; Pantarotto D, 2004, CHEM COMMUN, P16, DOI 10.1039/b311254c; Pantarotto D, 2003, J AM CHEM SOC, V125, P6160, DOI 10.1021/ja034342r; RUEGG CL, 1990, CANCER RES, V50, P4221; SARIN VK, 1981, ANAL BIOCHEM, V117, P147, DOI 10.1016/0003-2697(81)90704-1; Singh R, 2006, P NATL ACAD SCI USA, V103, P3357, DOI 10.1073/pnas.0509009103; von Schulthess GK, 2006, RADIOLOGY, V238, P405, DOI 10.1148/radiol.2382041977; Wang HF, 2004, J NANOSCI NANOTECHNO, V4, P1019, DOI 10.1166/jnn.2004.146; Yu ZH, 2001, J PHYS CHEM B, V105, P1123, DOI 10.1021/jp003081u; Zhao B, 2001, J AM CHEM SOC, V123, P11673, DOI 10.1021/ja010488j	33	143	149	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2007	2	9							e907	10.1371/journal.pone.0000907	http://dx.doi.org/10.1371/journal.pone.0000907			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HS	17878942	gold, Green Published, Green Submitted			2022-12-25	WOS:000207455700015
J	Proulx, SR; Nuzhdin, S; Promislow, DEL				Proulx, Stephen R.; Nuzhdin, Sergey; Promislow, Daniel E. L.			Direct Selection on Genetic Robustness Revealed in the Yeast Transcriptome	PLOS ONE			English	Article								Background. Evolutionary theory predicts that organisms should evolve the ability to produce high fitness phenotypes in the face of environmental disturbances (environmental robustness) or genetic mutations (genetic robustness). While several studies have uncovered mechanisms that lead to both environmental and genetic robustness, we have yet to understand why some components of the genome are more robust than others. According to evolutionary theory, environmental and genetic robustness will have different responses to selective forces. Selection on environmental robustness for a trait is expected to be strong and related to the fitness costs of altering that trait. In contrast to environmental robustness, selection on genetic robustness for a trait is expected to be largely independent of the fitness cost of altering the trait and instead should correlate with the standing genetic variation for the trait that can potentially be buffered. Several mechanisms that provide both environmental and genetic robustness have been described, and this correlation could be explained by direct selection on both forms of robustness (direct selection hypothesis), or through selection on environmental robustness and a correlated response in genetic robustness (congruence hypothesis). Methodology/Principal Findings. Using both published and novel data on gene expression in the yeast Saccharomyces cerevisiae, we find that genetic robustness is correlated with environmental robustness across the yeast genome as predicted by the congruence hypothesis. However, we also show that environmental robustness, but not genetic robustness, is related to per-gene fitness effects. In contrast, genetic robustness is significantly correlated with network position, suggesting that genetic robustness has been under direct selection. Conclusions/Significance. We observed a significant correlation between our measures of genetic and environmental robustness, in agreement with the congruence hypothesis. However, this correlation alone cannot explain the co-variance of genetic robustness with position in the protein interaction network. We therefore conclude that direct selection on robustness has played a role in the evolution of genetic robustness in the transcriptome.	[Proulx, Stephen R.] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA; [Nuzhdin, Sergey] Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA; [Nuzhdin, Sergey] Univ So Calif, Los Angeles, CA USA; [Promislow, Daniel E. L.] Univ Georgia, Dept Genet, Athens, GA 30602 USA	Iowa State University; University of California System; University of California Davis; University of Southern California; University System of Georgia; University of Georgia	Proulx, SR (corresponding author), Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA.	proulx@iastate.edu	Proulx, Stephen R/A-8160-2008; Proulx, Stephen/C-9213-2009	Proulx, Stephen/0000-0003-0307-1907; Promislow, Daniel/0000-0001-7088-4495	Ellison Medical Foundation; NIH [5R01GM076643]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076643] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	DP is funded by a Senior Scholar award from the Ellison Medical Foundation. SN was funded by NIH grant 5R01GM076643.	Ancel LW, 2000, J EXP ZOOL, V288, P242, DOI 10.1002/1097-010X(20001015)288:3<242::AID-JEZ5>3.0.CO;2-O; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Breitkreutz BJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r23; Burch CL, 2004, GENETICS, V167, P559, DOI 10.1534/genetics.103.021196; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; De Nooy W., 2005, EXPLORATORY SOCIAL N; de Visser JAGM, 2003, EVOLUTION, V57, P1959, DOI 10.1554/02-750R; Debat V, 2001, TRENDS ECOL EVOL, V16, P555, DOI 10.1016/S0169-5347(01)02266-2; DEMPSTER ER, 1955, COLD SPRING HARB SYM, V20, P25, DOI 10.1101/SQB.1955.020.01.005; Flatt T, 2005, Q REV BIOL, V80, P287, DOI 10.1086/432265; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; GAVRILETS S, 1994, EVOLUTION, V48, P1478, DOI [10.2307/2410242, 10.1111/j.1558-5646.1994.tb02190.x]; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Guldener U, 2005, NUCLEIC ACIDS RES, V33, pD364, DOI 10.1093/nar/gki053; Hahn MW, 2005, MOL BIOL EVOL, V22, P803, DOI 10.1093/molbev/msi072; Hansen TF, 2006, EVOLUTION, V60, P1523; Hazbun TR, 2003, MOL CELL, V12, P1353, DOI 10.1016/S1097-2765(03)00476-3; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Kawecki TJ, 2000, EVOLUTION, V54, P1, DOI 10.1111/j.0014-3820.2000.tb00001.x; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; LEVINS R, 1966, AM NAT, V100, P585, DOI 10.1086/282452; Meiklejohn CD, 2002, TRENDS ECOL EVOL, V17, P468, DOI 10.1016/S0169-5347(02)02596-X; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Promislow D, 2005, AM NAT, V165, P515, DOI 10.1086/429161; Proulx SR, 2005, AM NAT, V165, P147, DOI 10.1086/426873; Proulx SR, 2005, TRENDS ECOL EVOL, V20, P345, DOI 10.1016/j.tree.2005.04.004; Rice SH, 1998, EVOLUTION, V52, P647, DOI 10.1111/j.1558-5646.1998.tb03690.x; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; SCHMALHAUSEN H, 1949, FACTORS EVOLUTION; STEARNS SC, 1994, EVOLUTION, V48, P1438, DOI 10.1111/j.1558-5646.1994.tb02186.x; STEARNS SC, 1995, J EVOLUTION BIOL, V8, P539, DOI 10.1046/j.1420-9101.1995.8050539.x; Stearns SC, 2002, P NATL ACAD SCI USA, V99, P10229, DOI 10.1073/pnas.172388999; Steppan SJ, 2002, TRENDS ECOL EVOL, V17, P320, DOI 10.1016/S0169-5347(02)02505-3; THODAY JM, 1953, SYM SOC EXP BIOL, V7, P96; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; WADDINGTON C, 1961, ADV GENET, V10, P257, DOI 10.1016/S0065-2660(08)60119-4; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Wagner A, 1999, J EXP ZOOL, V285, P119; Wagner GP, 1997, EVOLUTION, V51, P329, DOI [10.2307/2411105, 10.1111/j.1558-5646.1997.tb02420.x]	49	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2007	2	9							e911	10.1371/journal.pone.0000911	http://dx.doi.org/10.1371/journal.pone.0000911			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HS	17878946	gold, Green Published, Green Submitted			2022-12-25	WOS:000207455700019
J	Honaramooz, A; Megee, S; Zeng, WX; Destrempes, MM; Overton, SA; Luo, JP; Galantino-Homer, H; Modelski, M; Chen, FP; Blash, S; Melican, DT; Gavin, WG; Ayres, S; Yang, F; Wang, PJ; Echelard, Y; Dobrinski, I				Honaramooz, Ali; Megee, Susan; Zeng, Wenxian; Destrempes, Margret M.; Overton, Susan A.; Luo, Jinping; Galantino-Homer, Hannah; Modelski, Mark; Chen, Fangping; Blash, Stephen; Melican, David T.; Gavin, William G.; Ayres, Sandra; Yang, Fang; Wang, P. Jeremy; Echelard, Yann; Dobrinski, Ina			Adeno-associated virus (AAV)-mediated transduction of male germ line stem cells results in transgene transmission after germ cell transplantation	FASEB JOURNAL			English	Article						transgenesis; testis; mouse; goat	LENTIVIRAL TRANSDUCTION; VECTOR TRANSDUCTION; GENE-TRANSFER; SELF-RENEWAL; AAV; INTEGRATION; EXPRESSION; MICE; PIGS; SPERMATOGENESIS	We explored whether exposure of mammalian germ line stem cells to adeno-associated virus (AAV), a gene therapy vector, would lead to stable transduction and transgene transmission. Mouse germ cells harvested from experimentally induced cryptorchid donor testes were exposed in vitro to AAV vectors carrying a GFP transgene and transplanted to germ cell-depleted syngeneic recipient testes, resulting in colonization of the recipient testes by transgenic donor cells. Mating of recipient males to wild-type females yielded 10% transgenic offspring. To broaden the approach to nonrodent species, AAV-transduced germ cells from goats were transplanted to recipient males in which endogenous germ cells had been depleted by fractionated testicular irradiation. Transgenic germ cells colonized recipient testes and produced transgenic sperm. When semen was used for in vitro fertilization (IVF), 10% of embryos were transgenic. Here, we report for the first time that AAV-mediated transduction of mammalian germ cells leads to transmission of the transgene through the male germ line. Equally important, this is also the first report of transgenesis via germ cell transplantation in a nonrodent species, a promising approach to generate transgenic large animal models for biomedical research.	[Honaramooz, Ali; Megee, Susan; Zeng, Wenxian; Luo, Jinping; Galantino-Homer, Hannah; Modelski, Mark; Chen, Fangping; Dobrinski, Ina] Univ Penn, Ctr Anim Transgenesis & Germ Cell Res, Dept Clin Sci, New Bolton Ctr, Kennett Sq, PA 19348 USA; [Yang, Fang; Wang, P. Jeremy] Univ Penn, Sch Vet Med, Dept Anim Biol, Kennett Sq, PA 19348 USA; [Ayres, Sandra] Tufts Univ, Cummings Sch Vet Med, North Grafton, MA USA; [Destrempes, Margret M.; Overton, Susan A.; Blash, Stephen; Melican, David T.; Gavin, William G.; Echelard, Yann] GTC Biotherapeutics, Framingham, MA USA	University of Pennsylvania; University of Pennsylvania; Tufts University	Dobrinski, I (corresponding author), Univ Penn, Ctr Anim Transgenesis & Germ Cell Res, Dept Clin Sci, New Bolton Ctr, 382 W State Rd, Kennett Sq, PA 19348 USA.	dobrinsk@vet.upenn.edu	Zeng, Wen/GPS-8058-2022	Galantino-Homer, Hannah/0000-0002-1435-100X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R42HD044780] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR017359] Funding Source: NIH RePORTER; NCRR NIH HHS [5 R01 RR17359-05] Funding Source: Medline; NICHD NIH HHS [2 R42 HD044780-02] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Arruda VR, 2001, MOL THER, V4, P586, DOI 10.1006/mthe.2001.0491; Bartlett JS, 1999, NAT BIOTECHNOL, V17, P181, DOI 10.1038/6185; Berns KI, 1996, CURR TOP MICROBIOL, V218, P1; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11303, DOI 10.1073/pnas.91.24.11303; Chen WY, 1997, P NATL ACAD SCI USA, V94, P5798, DOI 10.1073/pnas.94.11.5798; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Dobrinski I, 1999, MOL REPROD DEV, V53, P142, DOI 10.1002/(SICI)1098-2795(199906)53:2&lt;142::AID-MRD3&gt;3.0.CO;2-O; Dobrinski I, 2006, Soc Reprod Fertil Suppl, V62, P331; Donsante A, 2007, SCIENCE, V317, P477, DOI 10.1126/science.1142658; Echelard Y, 2006, BIOPHARM INT, V19, P36; Gordon JW, 1998, MOL MED TODAY, V4, P468, DOI 10.1016/S1357-4310(98)01323-9; Gordon JW, 2003, GENE THER, V10, P43, DOI 10.1038/sj.gt.3301850; Halbert CL, 2002, NAT BIOTECHNOL, V20, P697, DOI 10.1038/nbt0702-697; Hamra FK, 2005, P NATL ACAD SCI USA, V102, P17430, DOI 10.1073/pnas.0508780102; Hamra FK, 2002, P NATL ACAD SCI USA, V99, P14931, DOI 10.1073/pnas.222561399; Hendrie PC, 2005, MOL THER, V12, P9, DOI 10.1016/j.ymthe.2005.04.006; Hirata RK, 2004, CLONING STEM CELLS, V6, P31, DOI 10.1089/15362300460743817; Honaramooz A, 2005, J ANDROL, V26, P698, DOI 10.2164/jandrol.05032; Honaramooz A, 2003, BIOL REPROD, V69, P1260, DOI 10.1095/biolreprod.103.018788; Honaramooz A, 2003, MOL REPROD DEV, V64, P422, DOI 10.1002/mrd.10205; Jakob M, 2005, J GENE MED, V7, P630, DOI 10.1002/jgm.718; Jellerette T, 2006, THERIOGENOLOGY, V65, P1575, DOI 10.1016/j.theriogenology.2005.08.025; Kanatsu-Shinohara M, 2006, P NATL ACAD SCI USA, V103, P8018, DOI 10.1073/pnas.0601139103; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Lavitrano M, 2002, P NATL ACAD SCI USA, V99, P14230, DOI 10.1073/pnas.222550299; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; MCCARREY JR, 1992, DEV BIOL, V154, P160, DOI 10.1016/0012-1606(92)90056-M; McCarty DM, 2004, ANNU REV GENET, V38, P819, DOI 10.1146/annurev.genet.37.110801.143717; McEvoy TG, 2003, REPRODUCTION, P167; Mehrle S, 2004, VIRUS GENES, V28, P61, DOI 10.1023/B:VIRU.0000012264.54212.f5; Nagano M, 2002, FEBS LETT, V524, P111, DOI 10.1016/S0014-5793(02)03010-7; Nagano M, 2001, P NATL ACAD SCI USA, V98, P13090, DOI 10.1073/pnas.231473498; Nagano M, 2000, FEBS LETT, V475, P7, DOI 10.1016/S0014-5793(00)01606-9; Nagano MC, 2003, BIOL REPROD, V69, P701, DOI 10.1095/biolreprod.103.016352; Nakanishi T, 1999, FEBS LETT, V449, P277, DOI 10.1016/S0014-5793(99)00433-0; NICOLSON GL, 1975, J CELL BIOL, V66, P263, DOI 10.1083/jcb.66.2.263; NISHIMUNE Y, 1978, FERTIL STERIL, V29, P95; Ogawa T, 1997, INT J DEV BIOL, V41, P111; Orwig KE, 2002, BIOL REPROD, V67, P874, DOI 10.1095/biolreprod.102.005538; Park KW, 2002, BIOL REPROD, V66, P1001, DOI 10.1095/biolreprod66.4.1001; Russell DW, 1999, BLOOD, V94, P864, DOI 10.1182/blood.V94.3.864.415k34_864_874; Ryu BY, 2007, J ANDROL, V28, P353, DOI 10.2164/jandrol.106.001511; Seisenberger G, 2001, SCIENCE, V294, P1929, DOI 10.1126/science.1064103; Shinohara T, 2000, DEV BIOL, V220, P401, DOI 10.1006/dbio.2000.9655; Srivastava A, 2002, J CELL BIOCHEM, P39, DOI 10.1002/jcb.10053; Trobridge G, 2005, HUM GENE THER, V16, P522, DOI 10.1089/hum.2005.16.522; Villuendas G, 2001, INT J ANDROL, V24, P300, DOI 10.1046/j.1365-2605.2001.00302.x; XU KP, 1993, HUM REPROD, V8, P2206, DOI 10.1093/oxfordjournals.humrep.a138004	49	59	70	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2008	22	2					374	382		10.1096/fj.07-8935com	http://dx.doi.org/10.1096/fj.07-8935com			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	257TY	17873102				2022-12-25	WOS:000252822600007
J	Ong, PC; McGowan, S; Pearce, MC; Irving, JA; Kan, WT; Grigoryev, SA; Turk, B; Silverman, GA; Brix, K; Bottomley, SP; Whisstock, JC; Pike, RN				Ong, Poh Chee; McGowan, Sheena; Pearce, Mary C.; Irving, James A.; Kan, Wan-Ting; Grigoryev, Sergei A.; Turk, Boris; Silverman, Gary A.; Brix, Klaudia; Bottomley, Stephen P.; Whisstock, James C.; Pike, Robert N.			DNA accelerates the inhibition of human cathepsin V by serpins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE PROTEINASES; ENDOSOMAL PROTEOLYSIS; CHROMATIN-STRUCTURE; CRYSTAL-STRUCTURE; PAPAIN; MENT; HETEROCHROMATIN; CANCER; LOCALIZATION; PROTEASES	A balance between proteolytic activity and protease inhibition is crucial to the appropriate function of many biological processes. There is mounting evidence for the presence of both papain-like cysteine proteases and serpins with a corresponding inhibitory activity in the nucleus. Well characterized examples of cofactors fine tuning serpin activity in the extracellular milieu are known, but such modulation has not been studied for protease-serpin interactions within the cell. Accordingly, we present an investigation into the effect of a DNA-rich environment on the interaction between model serpins ( MENT and SCCA-1), cysteine proteases ( human cathepsin V and human cathepsin L), and cystatin A. DNA was indeed found to accelerate the rate at which MENT inhibited cathepsin V, a human orthologue of mammalian cathepsin L, up to 50-fold, but unexpectedly this effect was primarily effected via the protease and secondarily by the recruitment of the DNA as a "template" onto which cathepsin V and MENT are bound. Notably, the protease-mediated effect was found to correspond both with an altered substrate turnover and a conformational change within the protease. Consistent with this, cystatin inhibition, which relies on occlusion of the active site rather than the substrate-like behavior of serpins, was unaltered by DNA. This represents the first example of modulation of serpin inhibition of cysteine proteases by a cofactor and reveals a mechanism for differential regulation of cathepsin proteolytic activity in a DNA-rich environment.	[Ong, Poh Chee; McGowan, Sheena; Pearce, Mary C.; Irving, James A.; Kan, Wan-Ting; Bottomley, Stephen P.; Whisstock, James C.; Pike, Robert N.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Irving, James A.] Univ Oxford, Div Struct Biol, Wellcome Ctr Human Genet, Oxford OX3 7BN, England; [Grigoryev, Sergei A.] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; [Turk, Boris] Jozef Stefan Inst, Dept Biochem & Mol Biol, SI-1000 Ljubljana, Slovenia; [Silverman, Gary A.] Univ Pittsburgh, Sch Med, Newborn Med Program, Pittsburgh, PA 15261 USA; [Brix, Klaudia] Jacobs Univ Bremen, Sch Sci & Engn, D-28759 Bremen, Germany	Monash University; University of Oxford; Wellcome Centre for Human Genetics; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Jacobs University	Pike, RN (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.	rob.pike@med.monash.edu.au	Silverman, Gary/AAJ-1269-2020; Brix, Klaudia/F-5072-2013; Irving, James A/I-8467-2015; Irving, James/P-3860-2019; McGowan, Sheena/C-4797-2014	Brix, Klaudia/0000-0002-4476-0357; Irving, James/0000-0003-3204-6356; Pike, Robert/0000-0002-2083-0269; Turk, Boris/0000-0002-9007-5764; McGowan, Sheena/0000-0001-6863-1106; Whisstock, James/0000-0003-4200-5611	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059118] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-59118] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baici A, 2006, BIOL CHEM, V387, P1017, DOI 10.1515/BC.2006.125; BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535; Bird CH, 2001, MOL CELL BIOL, V21, P5396, DOI 10.1128/MCB.21.16.5396-5407.2001; Brix K, 2001, BIOL CHEM, V382, P717, DOI 10.1515/BC.2001.087; Bromme D, 1999, BIOCHEMISTRY-US, V38, P2377, DOI 10.1021/bi982175f; Bulynko YA, 2006, MOL CELL BIOL, V26, P4172, DOI 10.1128/MCB.00135-06; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Dehrmann FM, 1995, ARCH BIOCHEM BIOPHYS, V324, P93, DOI 10.1006/abbi.1995.9924; Estrada S, 1998, BIOCHEMISTRY-US, V37, P7551, DOI 10.1021/bi980026r; Friedrichs B, 2003, J CLIN INVEST, V111, P1733, DOI 10.1172/JCI200315990; Goulet B, 2004, MOL CELL, V14, P207, DOI 10.1016/S1097-2765(04)00209-6; GRIGORYEV SA, 1992, EXP CELL RES, V198, P268, DOI 10.1016/0014-4827(92)90379-M; Grigoryev SA, 1998, J BIOL CHEM, V273, P3082, DOI 10.1074/jbc.273.5.3082; Hagemann S, 2004, EUR J CELL BIOL, V83, P775, DOI 10.1078/0171-9335-00404; Huntington JA, 1999, J MOL BIOL, V293, P449, DOI 10.1006/jmbi.1999.3184; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Huntington JA, 2006, TRENDS BIOCHEM SCI, V31, P427, DOI 10.1016/j.tibs.2006.06.005; Irving JA, 2002, J BIOL CHEM, V277, P13192, DOI 10.1074/jbc.M108460200; Irving JA, 2002, BIOCHEMISTRY-US, V41, P4998, DOI 10.1021/bi0159985; JERALA R, 1994, PROTEIN ENG, V7, P977, DOI 10.1093/protein/7.8.977; Katagiri C, 2006, J CELL BIOL, V172, P983, DOI 10.1083/jcb.200508064; KATUNUMA N, 1995, METHOD ENZYMOL, V251, P382, DOI 10.1016/0076-6879(95)51142-3; LEHRER SS, 1971, BIOCHEMISTRY-US, V10, P3254, DOI 10.1021/bi00793a015; Li W, 2004, NAT STRUCT MOL BIOL, V11, P857, DOI 10.1038/nsmb811; LINDAHL P, 1988, BIOCHEMISTRY-US, V27, P5074, DOI 10.1021/bi00414a019; McGowan S, 2006, EMBO J, V25, P3144, DOI 10.1038/sj.emboj.7601201; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Olson ST, 2002, TRENDS CARDIOVAS MED, V12, P331, DOI 10.1016/S1050-1738(02)00183-4; Pike RN, 2005, FEBS J, V272, P4842, DOI 10.1111/j.1742-4658.2005.04880.x; Popova EY, 2006, EXP HEMATOL, V34, P453, DOI 10.1016/j.exphem.2006.01.003; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Qiu ZZ, 2006, J VIROL, V80, P5768, DOI 10.1128/JVI.00442-06; Reinheckel T, 2001, BIOL CHEM, V382, P735, DOI 10.1515/BC.2001.089; Rossi A, 2004, BIOL CHEM, V385, P363, DOI 10.1515/BC.2004.040; Schick C, 1998, BIOCHEMISTRY-US, V37, P5258, DOI 10.1021/bi972521d; Simmons G, 2005, P NATL ACAD SCI USA, V102, P11876, DOI 10.1073/pnas.0505577102; Somoza JR, 2000, BIOCHEMISTRY-US, V39, P12543, DOI 10.1021/bi000951p; Springhetti EM, 2003, J BIOL CHEM, V278, P43384, DOI 10.1074/jbc.M307635200; Szpaderska AM, 2001, CANCER RES, V61, P3493; Tepel C, 2000, J CELL SCI, V113, P4487; Turk B, 1997, BIOL CHEM, V378, P141; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; Vasiljeva O, 2006, CANCER RES, V66, P5242, DOI 10.1158/0008-5472.CAN-05-4463	44	33	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					36980	36986		10.1074/jbc.M706991200	http://dx.doi.org/10.1074/jbc.M706991200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17923478	hybrid			2022-12-25	WOS:000251646000024
J	Xiong, YL; Burton, ZF				Xiong, Yalin; Burton, Zachary F.			A tunable ratchet driving human RNA polymerase II translocation adjusted by accurately templated nucleoside triphosphates loaded at downstream sites and by elongation factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NTP-DRIVEN TRANSLOCATION; 3.3 ANGSTROM RESOLUTION; STATE KINETIC-ANALYSIS; STRUCTURAL BASIS; TRANSCRIPTION ELONGATION; DEPENDENT RNA-POLYMERASE-(3D(POL)); RIBONUCLEOTIDE INCORPORATION; ALLOSTERIC BINDING; ACTIVE-CENTER; TRIGGER LOOP	When nucleoside triphosphate (NTP) substrates and alpha-amanitin are added to a human RNA polymerase II elongation complex simultaneously, the reaction becomes stalled in the core of the bond synthesis mechanism. The mode of stalling is influenced by NTP substrates at the active site and at downstream sites and by transcription factor IIF (TFIIF) and TFIIS. NTP substrates templated at i + 2, i + 3, and i + 4 downstream DNA sites can reverse the previously stable binding of an NTP loaded at the i + 1 substrate site. Deoxy-(d)NTPs and NDPs (nucleoside diphosphates) do not substitute for NTPs at the i + 2 and i + 3 positions (considered together) or the i + 4, i + 5, and i + 6 positions (considered together). The mode of stalling is altered by changing the number of downstream template sites that are accurately occupied by NTPs and by changing NTP concentration. In the presence of the translocation blocker alpha-amanitin, a steady state condition is established in which RNA polymerase II stably loads an NTP substrate at i + 1 and forms a phosphodiester bond but cannot rapidly complete bond synthesis by releasing pyrophosphate. These observations support a role for incoming NTP substrates in stimulating translocation; results appear inconsistent with the secondary pore being the sole route of NTP entry for human RNA polymerase II, and results indicate mechanisms of dynamic error avoidance and error correction during rapid RNA synthesis.	Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University	Burton, ZF (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	burton@msu.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057461] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 057461] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Arnold JJ, 2004, BIOCHEMISTRY-US, V43, P5126, DOI 10.1021/bi035212y; Arnold JJ, 2004, BIOCHEMISTRY-US, V43, P5138, DOI 10.1021/bi035213q; Bar-Nahum G, 2005, CELL, V120, P183, DOI 10.1016/j.cell.2004.11.045; Batada NN, 2004, P NATL ACAD SCI USA, V101, P17361, DOI 10.1073/pnas.0408168101; Burton ZF, 2005, BIOCHEM CELL BIOL, V83, P486, DOI 10.1139/O05-059; Bushnell DA, 2002, P NATL ACAD SCI USA, V99, P1218, DOI 10.1073/pnas.251664698; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Foster JE, 2001, CELL, V106, P243, DOI 10.1016/S0092-8674(01)00420-2; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Gong XQ, 2005, MOL CELL, V18, P461, DOI 10.1016/j.molcel.2005.04.011; Gong XQ, 2004, J BIOL CHEM, V279, P27422, DOI 10.1074/jbc.M402163200; Holmes SF, 2003, J BIOL CHEM, V278, P35597, DOI 10.1074/jbc.M304496200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kahl BF, 2000, J MOL BIOL, V299, P75, DOI 10.1006/jmbi.2000.3743; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Landick R, 2005, TRENDS BIOCHEM SCI, V30, P651, DOI 10.1016/j.tibs.2005.10.001; Nedialkov YA, 2003, J BIOL CHEM, V278, P18303, DOI 10.1074/jbc.M301103200; Temiakov D, 2005, MOL CELL, V19, P655, DOI 10.1016/j.molcel.2005.07.020; Toulokhonov I, 2007, MOL CELL, V27, P406, DOI 10.1016/j.molcel.2007.06.008; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Trinh V, 2006, MICROBIOL MOL BIOL R, V70, P12, DOI 10.1128/MMBR.70.1.12-36.2006; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; WEILBAECHER R, 1994, GENE DEV, V8, P2913, DOI 10.1101/gad.8.23.2913; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; Westover KD, 2004, SCIENCE, V303, P1014, DOI 10.1126/science.1090839; ZAYCHIKOV E, 1995, P NATL ACAD SCI USA, V92, P1739, DOI 10.1073/pnas.92.5.1739; Zhang CF, 2005, MOL CELL BIOL, V25, P3583, DOI 10.1128/MCB.25.9.3583-3595.2005; Zhang CF, 2004, J MOL BIOL, V342, P1085, DOI 10.1016/j.jmb.2004.07.070; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	33	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36582	36592		10.1074/jbc.M707014200	http://dx.doi.org/10.1074/jbc.M707014200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17875640	hybrid			2022-12-25	WOS:000251458300051
J	Kozlov, G; Nguyen, L; Lin, T; De Crescenzo, G; Park, M; Gehring, K				Kozlov, Guennadi; Nguyen, Long; Lin, Tong; De Crescenzo, Gregory; Park, Morag; Gehring, Kalle			Structural basis of ubiquitin recognition by the ubiquitin-associated (UBA) domain of the ubiquitin ligase EDD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYS48-LINKED POLYUBIQUITIN CHAIN; TUMOR-SUPPRESSOR GENE; DNA-DAMAGE RESPONSE; HYPERPLASTIC-DISCS; MEDIATED DIMERIZATION; BINDING-PROTEIN; CUE DOMAIN; COMPLEX; PATHWAY; SURFACE	EDD (or HYD) is an E3 ubiquitin ligase in the family of HECT (homologous to E6-AP C terminus) ligases. EDD contains an N-terminal ubiquitin-associated (UBA) domain, which is present in a variety of proteins involved in ubiquitin-mediated processes. Here, we use isothermal titration calorimetry (ITC), NMR titrations, and pull-down assays to show that the EDD UBA domain binds ubiquitin. The 1.85 angstrom crystal structure of the complex with ubiquitin reveals the structural basis of ubiquitin recognition by UBA helices alpha 1 and alpha 3. The structure shows a larger number of intermolecular hydrogen bonds than observed in previous UBA/ubiquitin complexes. Two of these involve ordered water molecules. The functional importance of residues at the UBA/ubiquitin interface was confirmed using site-directed mutagenesis. Surface plasmon resonance (SPR) measurements show that the EDDUBA domain does not have a strong preference for polyubiquitin chains over monoubiquitin. This suggests that EDD binds to monoubiquitinated proteins, which is consistent with its involvement in DNA damage repair pathways.	McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Dept Med, Montreal, PQ H3A 1A1, Canada; McGill Univ, Dept Oncol, Montreal, PQ H3A 1A1, Canada; McGill Univ, Ctr Hlth, Mol Oncol Grp, Montreal, PQ H3A 1A1, Canada; Ecole Polytech, Dept Genie Chim, Montreal, PQ H3T 1J4, Canada	McGill University; McGill University; McGill University; McGill University; Universite de Montreal; Polytechnique Montreal	Gehring, K (corresponding author), McGill Univ, Dept Biochem, 3655 Promenade Sir William Osler, Montreal, PQ H3G 1Y6, Canada.	kalle.gehring@mcgill.ca	Gehring, Kalle/I-4403-2013; Gehring, Kalle/N-2945-2019	Gehring, Kalle/0000-0001-6500-1184; Gehring, Kalle/0000-0001-6500-1184; Nguyen, Long/0000-0002-3347-438X				BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Callaghan MJ, 1998, ONCOGENE, V17, P3479, DOI 10.1038/sj.onc.1202249; Chang YG, 2006, PROTEIN SCI, V15, P1248, DOI 10.1110/ps.051995006; Clancy JL, 2003, ONCOGENE, V22, P5070, DOI 10.1038/sj.onc.1206775; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dieckmann T, 1998, NAT STRUCT BIOL, V5, P1042, DOI 10.1038/4220; Eblen ST, 2003, J BIOL CHEM, V278, P14926, DOI 10.1074/jbc.M300485200; Fuja TJ, 2004, CANCER RES, V64, P942, DOI 10.1158/0008-5472.CAN-03-2100; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Henderson MJ, 2006, J BIOL CHEM, V281, P39990, DOI 10.1074/jbc.M602818200; Henderson MJ, 2002, J BIOL CHEM, V277, P26468, DOI 10.1074/jbc.M203527200; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/0968-0004(96)30015-7; Honda Y, 2002, J BIOL CHEM, V277, P3599, DOI 10.1074/jbc.M104347200; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; JONSSON U, 1991, BIOTECHNIQUES, V11, P620; Kang RS, 2003, CELL, V113, P621, DOI 10.1016/S0092-8674(03)00362-3; Kozlov G, 2007, J BIOL CHEM, V282, P27547, DOI 10.1074/jbc.M703333200; Kwon YT, 1998, P NATL ACAD SCI USA, V95, P7898, DOI 10.1073/pnas.95.14.7898; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lowe ED, 2006, ACTA CRYSTALLOGR D, V62, P177, DOI 10.1107/S0907444905037777; Makiniemi M, 2001, J BIOL CHEM, V276, P30399, DOI 10.1074/jbc.M102245200; MANSFIELD E, 1994, DEV BIOL, V165, P507, DOI 10.1006/dbio.1994.1271; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Mueller TD, 2004, J BIOL CHEM, V279, P11926, DOI 10.1074/jbc.M312865200; Mueller TD, 2002, J MOL BIOL, V319, P1243, DOI 10.1016/S0022-2836(02)00302-9; Ohno A, 2005, STRUCTURE, V13, P521, DOI 10.1016/j.str.2005.01.011; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peschard P, 2007, MOL CELL, V27, P474, DOI 10.1016/j.molcel.2007.06.023; Prag G, 2003, CELL, V113, P609, DOI 10.1016/S0092-8674(03)00364-7; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Ryu KS, 2003, J BIOL CHEM, V278, P36621, DOI 10.1074/jbc.M304628200; Schuberth C, 2004, EMBO REP, V5, P818, DOI 10.1038/sj.embor.7400203; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Swanson KA, 2006, J MOL BIOL, V358, P713, DOI 10.1016/j.jmb.2006.02.059; Tasaki T, 2005, MOL CELL BIOL, V25, P7120, DOI 10.1128/MCB.25.16.7120-7136.2005; Trempe JF, 2005, EMBO J, V24, P3178, DOI 10.1038/sj.emboj.7600797; Varadan R, 2004, J BIOL CHEM, V279, P7055, DOI 10.1074/jbc.M309184200; Varadan R, 2005, MOL CELL, V18, P687, DOI 10.1016/j.molcel.2005.05.013; Varadan R, 2002, J MOL BIOL, V324, P637, DOI 10.1016/S0022-2836(02)01198-1; Wang QH, 2003, BIOCHEMISTRY-US, V42, P13529, DOI 10.1021/bi035391j; Yoshida M, 2006, EMBO J, V25, P1934, DOI 10.1038/sj.emboj.7601079	47	44	44	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35787	35795		10.1074/jbc.M705655200	http://dx.doi.org/10.1074/jbc.M705655200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17897937	hybrid			2022-12-25	WOS:000251458100040
J	Sugimoto, I; Futakawa, S; Oka, R; Ogawa, K; Marth, JD; Miyoshi, E; Taniguchi, N; Hashimoto, Y; Kitazume, S				Sugimoto, Ichiro; Futakawa, Satoshi; Oka, Ritsuko; Ogawa, Kazuko; Marth, Jamey D.; Miyoshi, Eiji; Taniguchi, Naoyuki; Hashimoto, Yasuhiro; Kitazume, Shinobu			beta-galactoside alpha 2,6-sialyltransferase I cleavage by BACE1 enhances the sialylation of soluble glycoproteins - A novel regulatory mechanism for alpha 2,6-sialylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; HEREDITARY HEPATITIS; ASPARTYL PROTEASE; GOLGI-APPARATUS; KNOCKOUT MICE; ST6GAL I; SECRETASE; SIALYLTRANSFERASE; IDENTIFICATION	BACE1((beta) under bar -site (a) under bar myloid precursor protein-(c) under bar leaving (e) under bar nzyme-(1) under bar) is a membrane-bound aspartic protease that cleaves amyloid precursor protein to produce a neurotoxic peptide, amyloid beta-peptide, and has been implicated in triggering the pathogenesis of Alzheimer disease. We showed previously that BACE1 cleaves beta-galactoside alpha 2,6-sialyltransferase I (ST6Gal I) to initiate its secretion, but it remained unclear how BACE1 affects the cellular level of alpha 2,6-sialylation. Here, we found that BACE1 overexpression in Hep3B cells increased the sialylation of soluble secreted glycoproteins, but did not affect cell-surface sialylation. The sialylation of soluble glycoproteins was not increased by ST6Gal I overexpression alone, but was increased by co-overexpression of ST6Gal I and BACE1 or by expression of the soluble form of ST6Gal I, suggesting that soluble ST6Gal I produced by BACE1 plays, at least in part, a role in the sialylation of soluble glycoproteins. We also found that plasma glycoproteins from BACE1-deficient mice exhibited reduced levels of alpha 2,6-sialylation compared with those from wild-type mice. We propose a novel regulatory mechanism in which cleavage and secretion of ST6Gal I enhance the sialylation of soluble glycoprotein substrates.	RIKEN, Glyco Chain Funct Lab, Supra Biomol Syst Res Grp, Wako, Saitama 3510198, Japan; Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 5600082, Japan; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Osaka Univ, Grad Sch Med, Dept Biochem, Suita, Osaka 565871, Japan; Fukushima Med Univ, Sch Med, Dept Biochem, Fukushima 9601295, Japan	RIKEN; Japan Science & Technology Agency (JST); University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; Osaka University; Fukushima Medical University	Kitazume, S (corresponding author), RIKEN, Glyco Chain Funct Lab, Supra Biomol Syst Res Grp, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	shinobuk@riken.jp	Taniguchi, Naoyuki/A-7086-2016; Taniguchi, Naoyuki/I-4182-2014	Taniguchi, Naoyuki/0000-0001-5889-5968				ASHWELL G, 1974, ADV ENZYMOL RAMB, V41, P99; BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Colley KJ, 1997, GLYCOBIOLOGY, V7, P1, DOI 10.1093/glycob/7.1.1-b; COLLEY KJ, 1989, J BIOL CHEM, V264, P17619; Dalziel M, 1999, GLYCOBIOLOGY, V9, P1003, DOI 10.1093/glycob/9.10.1003; Dominguez D, 2005, J BIOL CHEM, V280, P30797, DOI 10.1074/jbc.M505249200; ELHAMMER A, 1986, J BIOL CHEM, V261, P5249; GERBER AC, 1979, EUR J BIOCHEM, V93, P453, DOI 10.1111/j.1432-1033.1979.tb12843.x; Harrison SM, 2003, MOL CELL NEUROSCI, V24, P646, DOI 10.1016/S1044-7431(03)00227-6; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; KAPLAN HA, 1983, J BIOL CHEM, V258, P1505; KITAGAWA H, 1994, J BIOL CHEM, V269, P17872; Kitazume S, 2005, J BIOL CHEM, V280, P8589, DOI 10.1074/jbc.M409417200; Kitazume S, 2003, J BIOL CHEM, V278, P14865, DOI 10.1074/jbc.M206262200; Kitazume S, 2001, P NATL ACAD SCI USA, V98, P13554, DOI 10.1073/pnas.241509198; Kitazume-Kawaguchi S, 1999, GLYCOBIOLOGY, V9, P1397; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lawrence CM, 1999, SCIENCE, V286, P779, DOI 10.1126/science.286.5440.779; Li QM, 2004, J BIOL CHEM, V279, P10542, DOI 10.1074/jbc.M310001200; LI Y, 1991, J CLIN INVEST, V87, P1858, DOI 10.1172/JCI115208; Lichtenthaler SF, 2003, J BIOL CHEM, V278, P48713, DOI 10.1074/jbc.M303861200; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Mori M., 1991, LEC RAT NEW MODEL HE; Petris MJ, 1996, EMBO J, V15, P6084, DOI 10.1002/j.1460-2075.1996.tb00997.x; Roberds SL, 2001, HUM MOL GENET, V10, P1317, DOI 10.1093/hmg/10.12.1317; SARNESTO A, 1990, J BIOL CHEM, V265, P15067; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; von Arnim CAF, 2005, J BIOL CHEM, V280, P17777, DOI 10.1074/jbc.M414248200; WEN DX, 1992, J BIOL CHEM, V267, P2512; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wong HK, 2005, J BIOL CHEM, V280, P23009, DOI 10.1074/jbc.M414648200; WU JS, 1994, NAT GENET, V7, P541, DOI 10.1038/ng0894-541; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; YOSHIDA MC, 1987, J HERED, V78, P361, DOI 10.1093/oxfordjournals.jhered.a110416	37	40	40	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34896	34903		10.1074/jbc.M704766200	http://dx.doi.org/10.1074/jbc.M704766200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17897958	hybrid			2022-12-25	WOS:000251155200032
J	Squires, RC; Muehlbauer, SM; Brojatsch, J				Squires, Raynal C.; Muehlbauer, Stefan M.; Brojatsch, Juergen			Proteasomes control caspase-1 activation in anthrax lethal toxin-mediated cell killing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE REPAIR; CA2+-REGULATED EXOCYTOSIS; INFLAMMATORY CASPASES; IMMUNE-RESPONSE; KINASE-KINASE; MACROPHAGES; PROTEIN; APOPTOSIS; INACTIVATION; PATHOGENESIS	Activation of caspase-1 through the inflammasome protein Nalp1b controls anthrax lethal toxin (LT)-induced necrosis in murine macrophages. In this study we analyzed physiological changes controlled by caspase-1 in LT-treated murine macrophages. The caspase-1 inhibitor Boc-D-cmk blocked caspase-1 activity and membrane impairment in LT-treated cells. To determine the relationship between caspase-1 activation and membrane integrity, we added Boc-D-cmk to J774A.1 macrophages at different time points following LT exposure. Remarkably, Boc-D-cmk rescued LT-treated macrophages, even when added at the peak of caspase-1 activation. Late addition of the caspase-1 inhibitor reversed the losses of plasma membrane integrity and metabolic activity in these cells. Similar results were obtained with the proteasome inhibitor MG132, one of the most potent inhibitors of LT toxicity. LT-treated macrophages displaying evidence of membrane impairment recovered upon the addition of MG132, mirroring the Boc-D-cmk response. Strikingly, late addition of proteasome inhibitors also abrogated caspase-1 activity in LT-treated macrophages. Proteasomal control of caspase-1 activity and membrane impairment, however, was restricted to LT-induced cytolysis, because proteasome inhibitors did not block caspase-1 activation and cell death triggered by lipopolysaccharide and nigericin. Our findings indicate that proteasome inhibitors do not target caspase-1 directly but instead control an upstream event in LT-treated macrophages leading to caspase-1 activation. Taken together, caspase-1-mediated necrosis appears to be tightly controlled and differentially regulated by proteasomes depending on the source of caspase-1 induction.	Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Brojatsch, J (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA.	brojatsc@aecom.yu.edu		brojatsch, jurgen/0000-0002-7424-365X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 057158] Funding Source: Medline; NIGMS NIH HHS [T32 GM 007288] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alileche A, 2006, CELL CYCLE, V5, P100, DOI 10.4161/cc.5.1.2283; Alileche A, 2005, PLOS PATHOG, V1, P150, DOI 10.1371/journal.ppat.0010019; Andrews NW, 2005, EMBO REP, V6, P826, DOI 10.1038/sj.embor.7400505; Bement WM, 2007, CURR OPIN CELL BIOL, V19, P95, DOI 10.1016/j.ceb.2006.12.001; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chopra AP, 2003, J BIOL CHEM, V278, P9402, DOI 10.1074/jbc.M211262200; CLARKE MSF, 1995, CIRC RES, V76, P927, DOI 10.1161/01.RES.76.6.927; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Fink SL, 2006, CELL MICROBIOL, V8, P1812, DOI 10.1111/j.1462-5822.2006.00751.x; FRIEDLANDER AM, 1986, J BIOL CHEM, V261, P7123; FRIEDLANDER AM, 1993, INFECT IMMUN, V61, P245, DOI 10.1128/IAI.61.1.245-252.1993; HANNA PC, 1992, MOL BIOL CELL, V3, P1269, DOI 10.1091/mbc.3.11.1269; HANNA PC, 1993, P NATL ACAD SCI USA, V90, P10198, DOI 10.1073/pnas.90.21.10198; Hanna PC, 1999, TRENDS MICROBIOL, V7, P180, DOI 10.1016/S0966-842X(99)01507-3; Hilbi H, 1998, J BIOL CHEM, V273, P32895, DOI 10.1074/jbc.273.49.32895; Huynh C, 2005, EMBO REP, V6, P843, DOI 10.1038/sj.embor.7400495; Huynh C, 2004, P NATL ACAD SCI USA, V101, P16795, DOI 10.1073/pnas.0405905101; Kahlenberg JM, 2005, J IMMUNOL, V175, P7611, DOI 10.4049/jimmunol.175.11.7611; Kim SO, 2003, J BIOL CHEM, V278, P7413, DOI 10.1074/jbc.M209279200; Kirby JE, 2004, INFECT IMMUN, V72, P430, DOI 10.1128/IAI.72.1.430-439.2004; KLIMPEL KR, 1994, MOL MICROBIOL, V13, P1093, DOI 10.1111/j.1365-2958.1994.tb00500.x; Koo HM, 2002, P NATL ACAD SCI USA, V99, P3052, DOI 10.1073/pnas.052707699; Lara-Tejero M, 2006, J EXP MED, V203, P1407, DOI 10.1084/jem.20060206; Le Feuvre RA, 2002, J BIOL CHEM, V277, P3210, DOI 10.1074/jbc.M104388200; Leitch V, 2001, P NATL ACAD SCI USA, V98, P2894, DOI 10.1073/pnas.041616498; Lin CG, 1996, CURR MICROBIOL, V33, P224, DOI 10.1007/s002849900104; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; McNeil PL, 2005, NAT REV MOL CELL BIO, V6, P499, DOI 10.1038/nrm1665; McNeil PL, 2003, ANNU REV CELL DEV BI, V19, P697, DOI 10.1146/annurev.cellbio.19.111301.140101; MCNEIL PL, 1992, AM J PATHOL, V140, P1097; McNeil PL, 2001, NAT CELL BIOL, V3, pE124, DOI 10.1038/35074652; Miyake K, 2003, CRIT CARE MED, V31, pS496, DOI 10.1097/01.CCM.0000081432.72812.16; Moayeri M, 2004, CURR OPIN MICROBIOL, V7, P19, DOI 10.1016/j.mib.2003.12.001; Moayeri M, 2003, J CLIN INVEST, V112, P670, DOI [10.1172/JCI200317991, 10.1172/JCI17991]; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Muehlbauer SM, 2007, CELL CYCLE, V6, P758, DOI 10.4161/cc.6.6.3991; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Roberts JE, 1998, MOL MICROBIOL, V29, P581, DOI 10.1046/j.1365-2958.1998.00953.x; Sadoul R, 1996, EMBO J, V15, P3845, DOI 10.1002/j.1460-2075.1996.tb00758.x; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; SINGH Y, 1989, J BIOL CHEM, V264, P11099; Sun GW, 2005, CELL MICROBIOL, V7, P1447, DOI 10.1111/j.1462-5822.2005.00569.x; Tang GQ, 1999, INFECT IMMUN, V67, P3055, DOI 10.1128/IAI.67.6.3055-3060.1999; Terasaki M, 1997, J CELL BIOL, V139, P63, DOI 10.1083/jcb.139.1.63; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Watters JW, 2001, CURR BIOL, V11, P1503, DOI 10.1016/S0960-9822(01)00476-6; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Yang YL, 2003, FASEB J, V17, P790, DOI 10.1096/fj.02-0654rev	60	66	67	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34260	34267		10.1074/jbc.M705687200	http://dx.doi.org/10.1074/jbc.M705687200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17878154	hybrid			2022-12-25	WOS:000251145700041
J	Wiznerowicz, M; Jakobsson, J; Szulc, J; Liao, S; Quazzola, A; Beermann, F; Aebischer, P; Trono, D				Wiznerowicz, Maciej; Jakobsson, Johan; Szulc, Jolanta; Liao, Shunyao; Quazzola, Alexandra; Beermann, Friedrich; Aebischer, Patrick; Trono, Didier			The Kruppel-associated box repressor domain can trigger de Novo promoter methylation during mouse early embryogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEINS; EMBRYONIC STEM-CELLS; GENE-EXPRESSION; TRANSCRIPTIONAL REPRESSION; MAMMALIAN DEVELOPMENT; LENTIVIRAL VECTORS; PATERNAL GENOME; KRAB; COREPRESSOR; TIF1-BETA	The Kruppel-associated box (KRAB) domain is a transcriptional repression module responsible for the DNA binding-dependent gene silencing activity of hundreds of vertebrate zinc finger proteins. We previously exploited KRAB-mediated repression within the context of a tet repressor-KRAB fusion protein and of lentiviral vectors to create a method of external gene control. We demonstrated that with this system transcriptional silencing was fully reversible in cell culture as well as in vivo. Here we reveal that, in sharp contrast, KRAB-mediated repression results in irreversible gene silencing through promoter DNA methylation if it acts during the first few days of mouse development.	Ecole Polytech Fed Lausanne, Frontier Genet Natl Ctr Competence Res, CH-1015 Lausanne, Switzerland; Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research	Trono, D (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, EPFL SV DO, Stn 15, Bldg AAB, CH-1015 Lausanne, Switzerland.	dider.trono@epfl.ch	Aebischer, Patrick/E-1387-2013; Liao, Shunyao/M-4123-2018; Jakobsson, Johan/E-7745-2014	Jakobsson, Johan/0000-0003-0669-7673				Ayyanathan K, 2003, GENE DEV, V17, P1855, DOI 10.1101/gad.1102803; Blancafort P, 2004, MOL PHARMACOL, V66, P1361, DOI 10.1124/mol.104.002758; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Cammas F, 2000, DEVELOPMENT, V127, P2955; Collins T, 2001, MOL CELL BIOL, V21, P3609, DOI 10.1128/MCB.21.11.3609-3615.2001; Cudre-Mauroux C, 2003, HUM GENE THER, V14, P1525, DOI 10.1089/104303403322495034; DEUSCHLE U, 1995, MOL CELL BIOL, V15, P1907; Fedorov LM, 2001, TRANSGENIC RES, V10, P247, DOI 10.1023/A:1016632110931; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gossen M, 2002, ANNU REV GENET, V36, P153, DOI 10.1146/annurev.genet.36.041002.120114; Ikeda R, 2007, MOL CELL BIOL, V27, P1665, DOI 10.1128/MCB.01500-06; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Ju HS, 2001, P NATL ACAD SCI USA, V98, P7469, DOI 10.1073/pnas.131147598; Kim SS, 1996, P NATL ACAD SCI USA, V93, P15299, DOI 10.1073/pnas.93.26.15299; Lei H, 1996, DEVELOPMENT, V122, P3195; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Looman C, 2002, MOL BIOL EVOL, V19, P2118, DOI 10.1093/oxfordjournals.molbev.a004037; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Moosmann P, 1996, NUCLEIC ACIDS RES, V24, P4859, DOI 10.1093/nar/24.24.4859; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Nagy A, 2003, MANIPULATING MOUSE E, P453; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Pfeifer A, 2002, P NATL ACAD SCI USA, V99, P2140, DOI 10.1073/pnas.251682798; Ponger L, 2001, GENOME RES, V11, P1854, DOI 10.1101/gr.174501; Sanchez JP, 2006, PLANT BIOTECHNOL J, V4, P103, DOI 10.1111/j.1467-7652.2005.00161.x; Sripathy SP, 2006, MOL CELL BIOL, V26, P8623, DOI 10.1128/MCB.00487-06; Szulc J, 2006, NAT METHODS, V3, P109, DOI 10.1038/NMETH846; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; Weber P, 2002, DEVELOPMENT, V129, P2329; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Zheng L, 2000, MOL CELL, V6, P757, DOI 10.1016/S1097-2765(00)00075-7; Zhu Z, 2002, SEMIN CELL DEV BIOL, V13, P121, DOI 10.1016/S1084-9521(02)00018-6; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	38	81	82	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34535	34541		10.1074/jbc.M705898200	http://dx.doi.org/10.1074/jbc.M705898200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17893143	hybrid			2022-12-25	WOS:000251145700068
J	Mosnier, LO; Yang, XV; Griffin, JH				Mosnier, Laurent O.; Yang, Xia V.; Griffin, John H.			Activated protein C mutant with minimal anticoagulant activity, normal cytoprotective activity, and preservation of thrombin activable fibrinolysis inhibitor-dependent cytoprotective functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COAGULATION-FACTOR VA; PROCARBOXYPEPTIDASE-B; CARBOXYPEPTIDASE-B; ENDOTHELIAL-CELLS; DISULFIDE BOND; BINDING-SITE; TAFI; EXOSITE; PLASMA; PLASMINOGEN	Activated protein C (APC) reduces mortality in severe sepsis patients and exhibits beneficial effects in multiple animal injury models. APC anticoagulant activity involves inactivation of factors Va and VIIIa, whereas APC cytoprotective activities involve the endothelial protein C receptor and protease-activated receptor-1 (PAR-1). The relative importance of the anticoagulant activity of APC versus the direct cytoprotective effects of APC on cells for the in vivo benefits is unclear. To distinguish cytoprotective from the anticoagulant activities of APC, a protease domain mutant, 5A-APC (RR229/230AA and KKK191 193AAA), was made and compared with recombinant wild-type (rwt)-APC. This mutant had minimal anticoagulant activity but normal cytoprotective activities that were dependent on endothelial protein C receptor and protease-activated receptor-1. Whereas anticoagulantly active rwt-APC inhibited secondary-extended thrombin generation and concomitant thrombin-dependent activation of thrombin activable fibrinolysis inhibitor (TAFI) in plasma, secondary-extended thrombin generation and the activation of TAFI were essentially unopposed by 5A-APC due to its low anticoagulant activity. Compared with rwt-APC, 5A-APC had minimal profibrinolytic activity and preserved TAFI-mediated anti-inflammatory carboxypeptidase activities toward bradykinin and presumably toward the anaphlatoxins, C3a and C5a, which are well known pathological mediators in sepsis. Thus, genetic engineering can selectively alter the multiple activities of APC and provide APC mutants that retain the beneficial cytoprotective effects of APC while diminishing bleeding risk due to reduction in APC's anticoagulant and APC-dependent profibrinolytic activities.	Scripps Res Inst, Dept Mol & Expt Med MEM 180, La Jolla, CA 92037 USA	Scripps Research Institute	Griffin, JH (corresponding author), Scripps Res Inst, Dept Mol & Expt Med MEM 180, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jgriffin@scripps.edu	Yang, Xia V/F-6911-2011	Griffin, John/0000-0002-4302-2547	NHLBI NIH HHS [HL 52246, HL 31950, HL 087618] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052246, R00HL087618, P01HL031950, R37HL052246, K99HL087618] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abraham E, 2005, NEW ENGL J MED, V353, P1332, DOI 10.1056/NEJMoa050935; Asai S, 2004, J IMMUNOL, V173, P4669, DOI 10.4049/jimmunol.173.7.4669; Bae JS, 2007, J BIOL CHEM, V282, P9251, DOI 10.1074/jbc.M610547200; Bajzar L, 1996, J BIOL CHEM, V271, P16603, DOI 10.1074/jbc.271.28.16603; Bajzar L, 1996, J BIOL CHEM, V271, P22949, DOI 10.1074/jbc.271.38.22949; BAJZAR L, 1995, J BIOL CHEM, V270, P14477, DOI 10.1074/jbc.270.24.14477; Bajzar L, 1996, BLOOD, V88, P2093, DOI 10.1182/blood.V88.6.2093.bloodjournal8862093; Bernard GR, 2004, CHEST, V125, P2206, DOI 10.1378/chest.125.6.2206; Bernard GR, 2003, CRIT CARE, V7, P155, DOI 10.1186/cc2167; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Bouma BN, 2006, ANN MED, V38, P378, DOI 10.1080/07853890600852898; BRANSON HE, 1983, LANCET, V2, P1165; CAMPBELL W, 1989, BIOCHEM BIOPH RES CO, V162, P933, DOI 10.1016/0006-291X(89)90762-6; Campbell WD, 2002, MICROBIOL IMMUNOL, V46, P131, DOI 10.1111/j.1348-0421.2002.tb02669.x; Cayla C, 2007, FASEB J, V21, P1689, DOI 10.1096/fj.06-7175com; CHASE T, 1967, BIOCHEM BIOPH RES CO, V29, P508, DOI 10.1016/0006-291X(67)90513-X; Cheng T, 2003, NAT MED, V9, P338, DOI 10.1038/nm826; Cheng T, 2006, NAT MED, V12, P1278, DOI 10.1038/nm1498; Dahlback B, 2005, ARTERIOSCL THROM VAS, V25, P1311, DOI 10.1161/01.ATV.0000168421.13467.82; EATON DL, 1991, J BIOL CHEM, V266, P21833; Esmon CT, 2003, CHEST, V124, p26S, DOI 10.1378/chest.124.3_suppl.26S; Fein AM, 1997, JAMA-J AM MED ASSOC, V277, P482, DOI 10.1001/jama.277.6.482; Feistritzer C, 2005, BLOOD, V105, P3178, DOI 10.1182/blood-2004-10-3985; Friedrich U, 2001, J BIOL CHEM, V276, P23105, DOI 10.1074/jbc.M103138200; Gale AJ, 1997, PROTEIN SCI, V6, P132; Gale AJ, 2000, BLOOD, V96, P585; Gale AJ, 2004, PROTEINS, V54, P433, DOI 10.1002/prot.10627; Gale AJ, 2002, PROTEIN SCI, V11, P2091, DOI 10.1110/ps.0210002; Gale AJ, 2002, J BIOL CHEM, V277, P28836, DOI 10.1074/jbc.M204363200; GRIFFIN JH, 1981, J CLIN INVEST, V68, P1370, DOI 10.1172/JCI110385; Guimaraes AHC, 2004, THROMB HAEMOSTASIS, V91, P473, DOI 10.1160/TH03-06-0377; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; HENDRIKS D, 1989, J CLIN CHEM CLIN BIO, V27, P277; Herwald H, 2003, SCAND J INFECT DIS, V35, P604, DOI 10.1080/00365540310016268; Kerschen EJ, 2006, BLOOD, V108, p5A; Kerschen EJ, 2005, BLOOD, V106, p12A; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; Mansilla S, 2006, EUR J PHARMACOL, V540, P34, DOI 10.1016/j.ejphar.2006.04.035; Mather T, 1996, EMBO J, V15, P6822, DOI 10.1002/j.1460-2075.1996.tb01073.x; Mattsson E, 2001, INFECT IMMUN, V69, P3877, DOI 10.1128/IAI.69.6.3877-3882.2001; Mosnier LO, 2007, BLOOD, V109, P3161, DOI 10.1182/blood-2006-09-003004; Mosnier LO, 2006, ARTERIOSCL THROM VAS, V26, P2445, DOI 10.1161/01.ATV.0000244680.14653.9a; Mosnier LO, 2006, FRONT BIOSCI-LANDMRK, V11, P2381, DOI 10.2741/1977; Mosnier LO, 2004, BLOOD, V104, P1740, DOI 10.1182/blood-2004-01-0110; Mosnier LO, 1998, THROMB HAEMOSTASIS, V80, P829; Mosnier LO, 2003, BIOCHEM J, V373, P65, DOI 10.1042/BJ20030341; Mosnier LO, 2001, THROMB HAEMOSTASIS, V85, P5; Myles T, 2003, J BIOL CHEM, V278, P51059, DOI 10.1074/jbc.M306977200; Nishimura T, 2007, BLOOD, V109, P1992, DOI 10.1182/blood-2006-03-012567; PATTERSON CE, 1992, J APPL PHYSIOL, V72, P865, DOI 10.1152/jappl.1992.72.3.865; Rezaie AR, 2003, TRENDS CARDIOVAS MED, V13, P8, DOI 10.1016/S1050-1738(02)00191-3; Riewald M, 2005, J BIOL CHEM, V280, P19808, DOI 10.1074/jbc.M500747200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scola AM, 2007, J BIOL CHEM, V282, P3664, DOI 10.1074/jbc.M609178200; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Wang W, 1998, J BIOL CHEM, V273, P27176, DOI 10.1074/jbc.273.42.27176; Ward PA, 2004, NAT REV IMMUNOL, V4, P133, DOI 10.1038/nri1269; Wilken HC, 1999, IMMUNOL LETT, V67, P141, DOI 10.1016/S0165-2478(99)00002-4; YAN SCB, 1990, BIO-TECHNOL, V8, P655, DOI 10.1038/nbt0790-655; Yang LK, 2007, J BIOL CHEM, V282, P25493, DOI 10.1074/jbc.M702131200; ZHANG L, 1990, BIOCHEMISTRY-US, V29, P10828, DOI 10.1021/bi00500a016	61	95	103	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					33022	33033		10.1074/jbc.M705824200	http://dx.doi.org/10.1074/jbc.M705824200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17872949	hybrid			2022-12-25	WOS:000250625400051
J	Romano, CM; de Melo, FL; Corsini, MAB; Holmes, EC; Zanotto, PMDA				Romano, Camila M.; de Melo, Fernando L.; Corsini, Marco Aurelio B.; Holmes, Edward C.; Zanotto, Paolo M. de A.			Demographic Histories of ERV-K in Humans, Chimpanzees and Rhesus Monkeys	PLOS ONE			English	Article								We detected 19 complete endogenous retroviruses of the K family in the genome of rhesus monkey (Macaca mulatta; RhERV-K) and 12 full length elements in the genome of the common chimpanzee (Pan troglodytes; CERV-K). These sequences were compared with 55 human HERV-K and 20 CERV-K reported previously, producing a total data set of 106 full-length ERV-K genomes. Overall, 61% of the human elements compared to 21% of the chimpanzee and 47% of rhesus elements had estimated integration times less than 4.5 million years before present (MYBP), with an average integration times of 7.8 MYBP, 13.4 MYBP and 10.3 MYBP for HERV-K, CERV-K and RhERV-K, respectively. By excluding those ERV-K sequences generated by chromosomal duplication, we used 63 of the 106 elements to compare the population dynamics of ERV-K among species. This analysis indicated that both HERV-K and RhERV-K had similar demographic histories, including markedly smaller effective population sizes, compared to CERV-K. We propose that these differing ERV-K dynamics reflect underlying differences in the evolutionary ecology of the host species, such that host ecology and demography represent important determinants of ERV-K dynamics.	[Romano, Camila M.; de Melo, Fernando L.; Corsini, Marco Aurelio B.; Zanotto, Paolo M. de A.] Univ Sao Paulo, Biomed Sci Inst ICBII, Dept Microbiol, Lab Mol Evolut & Bioinformat, BR-05508 Sao Paulo, Brazil; [Holmes, Edward C.] Penn State Univ, Dept Biol, Mueller Lab, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Holmes, Edward C.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	Universidade de Sao Paulo; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Zanotto, PMDA (corresponding author), Univ Sao Paulo, Biomed Sci Inst ICBII, Dept Microbiol, Lab Mol Evolut & Bioinformat, BR-05508 Sao Paulo, Brazil.	pzanotto@usp.br	Melo, Fernando Lucas/U-6535-2017; Holmes, Edward/Y-2789-2019; Romano, Camila M/C-8185-2013; de A. Zanotto, Paolo M./B-9286-2019; Holmes, Edward/GVR-9499-2022; Romano, Camila/ABC-2883-2020	Melo, Fernando Lucas/0000-0002-9591-0239; Holmes, Edward/0000-0001-9596-3552; de A. Zanotto, Paolo M./0000-0002-8167-0625; Romano, Camila/0000-0003-4550-1987	VGDN [00/04205-6]; CAPES; CNPq	VGDN; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding: This research was funded by VGDN program FAPESP (00/04205-6). CMR and FLM hold a CAPES doctorate fellowship (DO) and PMAZ holds a CNPq PQ Research Scholarship.	Barton NH, 1998, SCIENCE, V281, P1986, DOI 10.1126/science.281.5385.1986; Belshaw R, 2005, J VIROL, V79, P12507, DOI 10.1128/JVI.79.19.12507-12514.2005; Belshaw R, 2004, P NATL ACAD SCI USA, V101, P4894, DOI 10.1073/pnas.0307800101; Belshaw R, 2005, BIOINFORMATICS, V21, P122, DOI 10.1093/bioinformatics/bth459; Bernard J., 1988, EUKARYOTE GENOME DEV, DOI [10.1007/978-94-011-5991-3, DOI 10.1007/978-94-011-5991-3]; Boeke J. D., 1997, P343; Brandon-Jones D, 2004, INT J PRIMATOL, V25, P97, DOI 10.1023/B:IJOP.0000014647.18720.32; Crombach A, 2007, MOL BIOL EVOL, V24, P1130, DOI 10.1093/molbev/msm033; Deceliere G, 2005, GENETICS, V169, P467, DOI 10.1534/genetics.104.032243; DOOLITTLE WF, 1980, NATURE, V284, P601, DOI 10.1038/284601a0; DRUMMOND AJ, 2003, BEAST V1 0; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elango N, 2006, P NATL ACAD SCI USA, V103, P1370, DOI 10.1073/pnas.0510716103; GHERMAN A, 2007, PLOS GENETI IN PRESS; Johnson WE, 1999, P NATL ACAD SCI USA, V96, P10254, DOI 10.1073/pnas.96.18.10254; Kaessmann H, 2001, NAT GENET, V27, P155, DOI 10.1038/84773; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Le Rouzic A, 2005, GENETICS, V169, P1033, DOI 10.1534/genetics.104.031211; Li WH, 1996, MOL PHYLOGENET EVOL, V5, P182, DOI 10.1006/mpev.1996.0012; LOWER R, 1993, P NATL ACAD SCI USA, V90, P4480, DOI 10.1073/pnas.90.10.4480; MARTIN AP, 1993, P NATL ACAD SCI USA, V90, P4087, DOI 10.1073/pnas.90.9.4087; Medstrand P, 2002, GENOME RES, V12, P1483, DOI 10.1101/gr.388902; Medstrand P, 1998, J VIROL, V72, P9782, DOI 10.1128/JVI.72.12.9782-9787.1998; Nuzhdin SV, 1999, GENETICA, V107, P129, DOI 10.1023/A:1003957323876; OHTA T, 1986, GENETICS, V113, P145; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Promislow DEL, 1999, P ROY SOC B-BIOL SCI, V266, P1555, DOI 10.1098/rspb.1999.0815; PURVIS A, 1995, P ROY SOC B-BIOL SCI, V260, P329, DOI 10.1098/rspb.1995.0100; Romano CM, 2006, ARCH VIROL, V151, P2215, DOI 10.1007/s00705-006-0792-1; Sawyer SL, 2004, PLOS BIOL, V2, P1278, DOI 10.1371/journal.pbio.0020275; Schulte AM, 1996, P NATL ACAD SCI USA, V93, P14759, DOI 10.1073/pnas.93.25.14759; SEINO S, 1992, MOL BIOL EVOL, V9, P193; SMIT AFA, 1993, NUCLEIC ACIDS RES, V21, P1863, DOI 10.1093/nar/21.8.1863; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Tsitrone A, 1999, GENET RES, V74, P159, DOI 10.1017/S0016672399003997; Whitlock MC, 2003, GENETICS, V164, P767; Wisotzkey RG, 1997, CHROMOSOMA, V106, P465, DOI 10.1007/s004120050268	39	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1026	10.1371/journal.pone.0001026	http://dx.doi.org/10.1371/journal.pone.0001026			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925874	Green Submitted, Green Published, gold			2022-12-25	WOS:000207456000025
J	Wu, HQ; Neilson, JR; Kumar, P; Manocha, M; Shankar, P; Sharp, PA; Manjunath, N				Wu, Haoquan; Neilson, Joel R.; Kumar, Priti; Manocha, Monika; Shankar, Premlata; Sharp, Phillip A.; Manjunath, N.			miRNA Profiling of Naive, Effector and Memory CD8 T Cells	PLOS ONE			English	Article							MICRORNA EXPRESSION; RNA-INTERFERENCE; POSTTRANSCRIPTIONAL REGULATION; ENDOGENOUS SIRNAS; NUCLEAR EXPORT; DIFFERENTIATION; QUANTIFICATION; MATURATION; GENERATION; GENES	microRNAs have recently emerged as master regulators of gene expression during development and cell differentiation. Although profound changes in gene expression also occur during antigen-induced T cell differentiation, the role of miRNAs in the process is not known. We compared the miRNA expression profiles between antigen-specific naive, effector and memory CD8+ T cells using 3 different methods-small RNA cloning, miRNA microarray analysis and real-time PCR. Although many miRNAs were expressed in all the T cell subsets, the frequency of 7 miRNAs (miR-16, miR-21, miR-142-3p, miR-142-5p, miR-150, miR-15b and let-7f) alone accounted for similar to 60% of all miRNAs, and their expression was several fold higher than the other expressed miRNAs. Global downregulation of miRNAs (including 6/7 dominantly expressed miRNAs) was observed in effector T cells compared to naive cells and the miRNA expression levels tended to come back up in memory T cells. However, a few miRNAs, notably miR-21 were higher in effector and memory T cells compared to naive T cells. These results suggest that concomitant with profound changes in gene expression, miRNA profile also changes dynamically during T cell differentiation. Sequence analysis of the cloned mature miRNAs revealed an extensive degree of end polymorphism. While 3' end polymorphisms dominated, heterogeneity at both ends, resembling drosha/dicer processing shift was also seen in miR-142, suggesting a possible novel mechanism to generate new miRNA and/or to diversify miRNA target selection. Overall, our results suggest that dynamic changes in the expression of miRNAs may be important for the regulation of gene expression during antigen-induced T cell differentiation. Our study also suggests possible novel mechanisms for miRNA biogenesis and function.	[Wu, Haoquan; Kumar, Priti; Manocha, Monika; Shankar, Premlata; Manjunath, N.] Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA; [Wu, Haoquan; Kumar, Priti; Manocha, Monika; Shankar, Premlata; Manjunath, N.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Neilson, Joel R.; Sharp, Phillip A.] MIT, Ctr Canc Res, Cambridge, MA 02139 USA; [Sharp, Phillip A.] MIT, Dept Biol, Cambridge, MA 02139 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Manjunath, N (corresponding author), Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA.	swamy@cbrinstitute.org	Kumar, Priti/C-5699-2009	Wu, Haoquan/0000-0001-9386-3187; Kumar, Priti/0000-0002-6901-5601; Neilson, Joel R./0000-0002-3408-608X	NIH [U19 AI 056900, R21 AI 066197]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI066197, U19AI056900] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding: This work was supported by NIH grant U19 AI 056900 and R21 AI 066197 to N. M.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Antia R, 2005, NAT REV IMMUNOL, V5, P101, DOI 10.1038/nri1550; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berezikov E, 2006, GENOME RES, V16, P1289, DOI 10.1101/gr.5159906; Borkhardt A, 2006, NEW ENGL J MED, V354, P524; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; FULCI V, 2007, BLOOD; Gourley TS, 2004, SEMIN IMMUNOL, V16, P323, DOI 10.1016/j.smim.2004.08.013; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Haasch D, 2002, CELL IMMUNOL, V217, P78, DOI 10.1016/S0008-8749(02)00506-3; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; KRISHNA KM, 1998, IMMUNITY, V8, P177; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI13296; Monticelli S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r71; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Neilson JR, 2007, GENE DEV, V21, P578, DOI 10.1101/gad.1522907; Nelson PT, 2004, NAT METHODS, V1, P155, DOI 10.1038/NMETH717; Ro S, 2006, BIOCHEM BIOPH RES CO, V351, P756, DOI 10.1016/j.bbrc.2006.10.105; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Sontheimer EJ, 2005, CELL, V122, P9, DOI 10.1016/j.cell.2005.06.030; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953; Weninger W, 2002, IMMUNOL REV, V186, P221, DOI 10.1034/j.1600-065X.2002.18618.x; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zhou BY, 2007, P NATL ACAD SCI USA, V104, P7080, DOI 10.1073/pnas.0702409104	53	387	429	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1020	10.1371/journal.pone.0001020	http://dx.doi.org/10.1371/journal.pone.0001020			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925868	Green Published, Green Submitted, gold			2022-12-25	WOS:000207456000019
J	Um, SY; McDonald, TV				Um, Sung Yon; McDonald, Thomas V.			Differential Association between HERG and KCNE1 or KCNE2	PLOS ONE			English	Article							LONG-QT SYNDROME; CARDIAC POTASSIUM CURRENT; MINK-RELATED PEPTIDE-1; ENDOPLASMIC-RETICULUM; BREFELDIN-A; I-KS; LANGE-NIELSEN; MOLECULAR-INTERACTIONS; MEMBRANE-PROTEINS; GOLGI PROTEINS	The small proteins encoded by KCNE1 and KCNE2 have both been proposed as accessory subunits for the HERG channel. Here we report our investigation into the cell biology of the KCNE-HERG interaction. In a co-expression system, KCNE1 was more readily co-precipitated with co-expressed HERG than was KCNE2. When forward protein trafficking was prevented (either by Brefeldin A or engineering an ER-retention/retrieval signal onto KCNE cDNA) the intracellular abundance of KCNE2 and its association with HERG markedly increased relative to KCNE1. HERG co-localized more completely with KCNE1 than with KCNE2 in all the membrane-processing compartments of the cell (ER, Golgi and plasma membrane). By surface labeling and confocal immunofluorescence, KCNE2 appeared more abundant at the cell surface compared to KCNE1, which exhibited greater co-localization with the ER-marker calnexin. Examination of the extracellular culture media showed that a significant amount of KCNE2 was extracellular (both soluble and membrane-vesicle-associated). Taken together, these results suggest that during biogenesis of channels HERG is more likely to assemble with KCNE1 than KCNE2 due to distinctly different trafficking rates and retention in the cell rather than differences in relative affinity. The final channel subunit constitution, in vivo, is likely to be determined by a combination of relative cell-to-cell expression rates and differential protein processing and trafficking.	[Um, Sung Yon; McDonald, Thomas V.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Um, Sung Yon; McDonald, Thomas V.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	McDonald, TV (corresponding author), Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA.	mcdonald@aecom.yu.edu			NIH/NHLBI; AHA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075615] Funding Source: NIH RePORTER	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AHA(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	NIH/NHLBI (Funding source only), AHA (Funding source only)	Abbott G W, 2001, Mol Interv, V1, P95; Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Bendahhou S, 2005, CARDIOVASC RES, V67, P529, DOI 10.1016/j.cardiores.2005.02.014; Bianchi L, 1999, HUM MOL GENET, V8, P1499, DOI 10.1093/hmg/8.8.1499; BRETSCHER MS, 1993, SCIENCE, V261, P1280, DOI 10.1126/science.8362242; CHANDRASEKHAR KD, 2006, J BIOL CHEM; Chen HJ, 2003, NEURON, V40, P15, DOI 10.1016/S0896-6273(03)00570-1; Chen YH, 1997, J CELL BIOL, V138, P891, DOI 10.1083/jcb.138.4.891; DOMS RW, 1989, J CELL BIOL, V109, P61, DOI 10.1083/jcb.109.1.61; Duggal P, 1998, CIRCULATION, V97, P142, DOI 10.1161/01.CIR.97.2.142; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Finley MR, 2002, AM J PHYSIOL-HEART C, V283, pH126, DOI 10.1152/ajpheart.00622.2001; Franco D, 2001, CARDIOVASC RES, V52, P65, DOI 10.1016/S0008-6363(01)00349-2; Friederich P, 2004, BRIT J ANAESTH, V92, P93, DOI 10.1093/bja/aeh026; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; Grunnet M, 2002, J PHYSIOL-LONDON, V542, P119, DOI 10.1113/jphysiol.2002.017301; Jiang M, 2004, CIRCULATION, V109, P1783, DOI 10.1161/01.CIR.0000124225.43852.50; Johnstone RM, 2006, BLOOD CELL MOL DIS, V36, P315, DOI 10.1016/j.bcmd.2005.12.001; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Kosolapov A, 2003, J BIOL CHEM, V278, P4305, DOI 10.1074/jbc.M209422200; Kramer B, 2005, BLOOD CELL MOL DIS, V35, P136, DOI 10.1016/j.bcmd.2005.06.006; Krumerman A, 2004, AM J PHYSIOL-CELL PH, V286, pC1453, DOI 10.1152/ajpcell.00275.2003; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lewis A, 2004, J BIOL CHEM, V279, P7884, DOI 10.1074/jbc.M310501200; Li XB, 2006, J CELL MOL MED, V10, P364, DOI 10.1111/j.1582-4934.2006.tb00405.x; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Lu JL, 2001, BIOCHEMISTRY-US, V40, P10934, DOI 10.1021/bi010763e; Lu Y, 2003, J PHYSIOL-LONDON, V551, P253, DOI 10.1113/jphysiol.2003.046045; Lundquist AL, 2006, GENOMICS, V87, P119, DOI 10.1016/j.ygeno.2005.09.004; Lundquist Andrew L, 2005, J Mol Cell Cardiol, V38, P277, DOI 10.1016/j.yjmcc.2004.11.012; MASIBAY AS, 1993, J BIOL CHEM, V268, P9908; Mazhari R, 2001, CIRC RES, V89, P33, DOI 10.1161/hh1301.093633; McDonald TV, 1997, NATURE, V388, P289, DOI 10.1038/40882; Mitra K, 2004, P NATL ACAD SCI USA, V101, P4083, DOI 10.1073/pnas.0307332101; MUNRO S, 1995, EMBO J, V14, P4695, DOI 10.1002/j.1460-2075.1995.tb00151.x; Nagaya N, 1997, J BIOL CHEM, V272, P3022, DOI 10.1074/jbc.272.5.3022; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Neyroud N, 1997, NAT GENET, V15, P186, DOI 10.1038/ng0297-186; Oyadomari S, 2006, CELL, V126, P727, DOI 10.1016/j.cell.2006.06.051; Park KH, 2003, FASEB J, V17, DOI 10.1096/fj.03-0577fje; PELHAM HRB, 1993, CELL, V75, P603, DOI 10.1016/0092-8674(93)90479-A; Pilzer D, 2005, SPRINGER SEMIN IMMUN, V27, P375, DOI 10.1007/s00281-005-0004-1; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Porto-Carreiro I, 2005, BLOOD CELL MOL DIS, V35, P143, DOI 10.1016/j.bcmd.2005.06.013; Pourrier M, 2003, CIRC RES, V93, P189, DOI 10.1161/01.RES.0000084851.60947.B5; Qu JH, 2004, J BIOL CHEM, V279, P43497, DOI 10.1074/jbc.M405018200; ROEPKE TK, 2006, J BIOL CHEM; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Tinel N, 2000, EMBO J, V19, P6326, DOI 10.1093/emboj/19.23.6326; Tinel N, 2000, FEBS LETT, V480, P137, DOI 10.1016/S0014-5793(00)01918-9; Tu LW, 1999, BIOPHYS J, V76, P2004, DOI 10.1016/S0006-3495(99)77358-3; Tyson J, 1997, HUM MOL GENET, V6, P2179, DOI 10.1093/hmg/6.12.2179; van Niel G, 2001, GASTROENTEROLOGY, V121, P337, DOI 10.1053/gast.2001.26263; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128; WANG S, 1996, P 5 CHIN C GLAC GEOC, V1, P17; Watson RT, 2001, AM J PHYSIOL-CELL PH, V281, pC215, DOI 10.1152/ajpcell.2001.281.1.C215; Weerapura M, 2002, J PHYSIOL-LONDON, V540, P15, DOI 10.1113/jphysiol.2001.013296; Yu H, 2001, CIRC RES, V88, pE84, DOI 10.1161/hh1201.093511; Zerangue N, 2001, P NATL ACAD SCI USA, V98, P2431, DOI 10.1073/pnas.051630198; Zhang M, 2001, CIRC RES, V88, P1012, DOI 10.1161/hh1001.090839; Zhou ZF, 1998, J BIOL CHEM, V273, P21061, DOI 10.1074/jbc.273.33.21061	62	30	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e933	10.1371/journal.pone.0000933	http://dx.doi.org/10.1371/journal.pone.0000933			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895974	Green Submitted, Green Published, gold			2022-12-25	WOS:000207455800012
J	Caramel, J; Medjkane, S; Quignon, F; Delattre, O				Caramel, J.; Medjkane, S.; Quignon, F.; Delattre, O.			The requirement for SNF5/INI1 in adipocyte differentiation highlights new features of malignant rhabdoid tumors	ONCOGENE			English	Article						SNF5/INI1; rhabdoid tumor suppressor; differentiation; SWI/SNF; adipocyte	CHROMATIN-REMODELING COMPLEX; SWI/SNF COMPLEX; BETA ISOFORM; CELL-CYCLE; SNF5; HSNF5/INI1; SUPPRESSOR; MUTATIONS; TRANSCRIPTION; BINDING	ATP-dependent SWI/SNF chromatin remodeling complexes regulate cell-cycle and play critical roles in a variety of differentiation pathways. The core subunit SNF5/INI1 is a tumor suppressor that is inactivated in a highly aggressive childhood cancer of unknown cellular origin, termed malignant rhabdoid tumor (MRT). The highly undifferentiated phenotype of this tumor suggests that the loss-of-function of hSNF5/INI1 impairs specific differentiation programs of the MRT parental cell. Based on the hypothesis that these programs might be reinitialized upon hSNF5/INI1 re-expression in MRTs, we show that some MRT cell lines can differentiate toward the adipogenic lineage. We further show that the knock down of the SNF5/INI1 subunit abrogates adipocyte differentiation of murine 3T3-L1 preadipocytes and of human mesenchymal stem cells. Finally, we provide evidence that hSNF5/INI1 cooperates with C/EBP beta and PPAR gamma 2 transcriptional regulators to activate the expression of adipocyte-specific genes. These data indicate that not only the ATPase subunit of the SWI/SNF complex, but also SNF5/INI1 is required for adipocyte differentiation. They further show that MRT cell lines harbor an adipogenic differentiation potential and that the tumor suppressor role of the SNF5/INI1 subunit may rely on its ability to regulate the balance between cell proliferation and differentiation.	[Caramel, J.; Medjkane, S.; Quignon, F.; Delattre, O.] Inst Curie, INSERM, U830, Sect Rech,Unite Genet & Biol Canc, F-75248 Paris 05, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite	Delattre, O (corresponding author), Inst Curie, INSERM, U830, Sect Rech,Unite Genet & Biol Canc, 26 Rue Ulm, F-75248 Paris 05, France.	olivier.delattre@curie.fr	Quignon, Frédérique/P-4249-2017	Medjkane, Souhila/0000-0001-7973-7707; Caramel, Julie/0000-0002-8883-918X; delattre, olivier/0000-0002-8730-2276				Albanese P, 2006, EUR J CANCER, V42, P2326, DOI 10.1016/j.ejca.2006.03.028; Betz BL, 2002, ONCOGENE, V21, P5193, DOI 10.1038/sj.onc.1205706; Biegel JA, 1999, CANCER RES, V59, P74; CARLSON M, 1994, CURR OPIN CELL BIOL, V6, P396, DOI 10.1016/0955-0674(94)90032-9; Chai JJ, 2007, CANCER RES, V67, P3002, DOI 10.1158/0008-5472.CAN-06-4207; de la Serna IL, 2006, NAT REV GENET, V7, P461, DOI 10.1038/nrg1882; Dennis JE, 2002, STEM CELLS, V20, P205, DOI 10.1634/stemcells.20-3-205; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Gresh L, 2005, EMBO J, V24, P3313, DOI 10.1038/sj.emboj.7600802; Guidi CJ, 2001, MOL CELL BIOL, V21, P3598, DOI 10.1128/MCB.21.10.3598-3603.2001; Hata K, 2005, MOL CELL BIOL, V25, P1971, DOI 10.1128/MCB.25.5.1971-1979.2005; KALPANA GV, 1994, SCIENCE, V266, P2002, DOI 10.1126/science.7801128; Kashiwagi M, 2007, DEVELOPMENT, V134, P1571, DOI 10.1242/dev.001750; Klochendler-Yeivin A, 2006, MOL CELL BIOL, V26, P2661, DOI 10.1128/MCB.26.7.2661-2674.2006; Klochendler-Yeivin A, 2000, EMBO REP, V1, P500, DOI 10.1093/embo-reports/kvd129; Kowenz-Leutz E, 1999, MOL CELL, V4, P735, DOI 10.1016/S1097-2765(00)80384-6; Krabbe C, 2005, APMIS, V113, P831, DOI 10.1111/j.1600-0463.2005.apm_3061.x; Lane MD, 1999, BIOCHEM BIOPH RES CO, V266, P677, DOI 10.1006/bbrc.1999.1885; Lee MC, 2002, NEUROPATHOLOGY, V22, P252, DOI 10.1046/j.1440-1789.2002.00458.x; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Medjkane S, 2004, CANCER RES, V64, P3406, DOI 10.1158/0008-5472.CAN-03-3004; MUCHARDT C, 1995, NUCLEIC ACIDS RES, V23, P1127, DOI 10.1093/nar/23.7.1127; Pedersen TA, 2001, GENE DEV, V15, P3208, DOI 10.1101/gad.209901; Phelan ML, 1999, MOL CELL, V3, P247, DOI 10.1016/S1097-2765(00)80315-9; Roberts CWM, 2000, P NATL ACAD SCI USA, V97, P13796, DOI 10.1073/pnas.250492697; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; Roberts CWM, 2002, CANCER CELL, V2, P415, DOI 10.1016/S1535-6108(02)00185-X; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Saladin R, 1999, CELL GROWTH DIFFER, V10, P43; Salma N, 2004, MOL CELL BIOL, V24, P4651, DOI 10.1128/MCB.24.11.4651-4663.2004; Sevenet N, 1999, AM J HUM GENET, V65, P1342, DOI 10.1086/302639; Sif S, 2001, GENE DEV, V15, P603, DOI 10.1101/gad.872801; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Versteege I, 2002, ONCOGENE, V21, P6403, DOI 10.1038/sj.onc.1205841; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Vries RGJ, 2005, GENE DEV, V19, P665, DOI 10.1101/gad.335805; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Young DW, 2005, J CELL BIOCHEM, V94, P720, DOI 10.1002/jcb.20332; Zhang ZK, 2002, MOL CELL BIOL, V22, P5975, DOI 10.1128/MCB.22.16.5975-5988.2002	40	50	50	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 27	2008	27	14					2035	2044		10.1038/sj.onc.1210847	http://dx.doi.org/10.1038/sj.onc.1210847			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	279MK	17922027				2022-12-25	WOS:000254359100008
J	Gort, EH; van Haaften, G; Verlaan, I; Groot, AJ; Plasterk, RHA; Shvarts, A; Suijkerbuijk, KPM; van Laar, T; van der Wall, E; Raman, V; van Diest, PJ; Tijsterman, M; Vooijs, M				Gort, E. H.; van Haaften, G.; Verlaan, I.; Groot, A. J.; Plasterk, R. H. A.; Shvarts, A.; Suijkerbuijk, K. P. M.; van Laar, T.; van der Wall, E.; Raman, V.; van Diest, P. J.; Tijsterman, M.; Vooijs, M.			The TWIST1 oncogene is a direct target of hypoxia-inducible factor-2 alpha	ONCOGENE			English	Article						hypoxia; HIF-2 alpha; TWIST1; C. elegans; cancer	ENDOTHELIAL GROWTH-FACTOR; CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; C-ELEGANS; TRANSCRIPTIONAL RESPONSE; FUNCTIONAL-ANALYSIS; DROSOPHILA EMBRYO; FACTOR-1 HIF-1; UP-REGULATION; FACTOR-I	Hypoxia-inducible factors (HIFs) are highly conserved transcription factors that play a crucial role in oxygen homeostasis. Intratumoral hypoxia and genetic alterations lead to HIF activity, which is a hallmark of solid cancer and is associated with poor clinical outcome. HIF activity is regulated by an evolutionary conserved mechanism involving oxygen-dependent HIF alpha protein degradation. To identify novel components of the HIF pathway, we performed a genome-wide RNA interference screen in Caenorhabditis elegans, to suppress HIF-dependent phenotypes, like egg-laying defects and hypoxia survival. In addition to hif-1 (HIF alpha) and aha-1 (HIF beta), we identified hlh-8, gska-3 and spe-8. The hlh-8 gene is homologous to the human oncogene TWIST1. We show that TWIST1 expression in human cancer cells is enhanced by hypoxia in a HIF-2 alpha-dependent manner. Furthermore, intronic hypoxia response elements of TWIST1 are regulated by HIF-2 alpha, but not HIF-1 alpha. These results identify TWIST1 as a direct target gene of HIF-2 alpha, which may provide insight into the acquired metastatic capacity of hypoxic tumors.	[Gort, E. H.; Verlaan, I.; Groot, A. J.; Shvarts, A.; Suijkerbuijk, K. P. M.; van Laar, T.; van Diest, P. J.; Vooijs, M.] Univ Med Ctr Utrecht, Dept Pathol, NL-3508 GA Utrecht, Netherlands; [van Haaften, G.; Plasterk, R. H. A.; Tijsterman, M.] Ctr Biomed Genet, Hubrecht Lab, Utrecht, Netherlands; [van der Wall, E.] Univ Med Ctr Utrecht, Dept Med Oncol, NL-3508 GA Utrecht, Netherlands; [Raman, V.] Johns Hopkins Univ, Sch Med, Dept Radiol, Baltimore, MD 21205 USA	Utrecht University; Utrecht University Medical Center; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Johns Hopkins University	Vooijs, M (corresponding author), Univ Med Ctr Utrecht, Dept Pathol, Heidelberglaan 100, NL-3508 GA Utrecht, Netherlands.	m.vooijs@umcutrecht.nl	van Haaften, Gijs/G-7832-2012; Tijsterman, Marcel/H-5663-2018; Vooijs, Marc/K-3522-2019	van Haaften, Gijs/0000-0003-3033-0329; Tijsterman, Marcel/0000-0001-8465-9002; Suijkerbuijk, Karijn/0000-0003-3604-5430				Bardos JI, 2004, BIOESSAYS, V26, P262, DOI 10.1002/bies.20002; Bishop T, 2004, PLOS BIOL, V2, P1549, DOI 10.1371/journal.pbio.0020289; Bos R, 2003, CANCER, V97, P1573, DOI 10.1002/cncr.11246; Corsi AK, 2002, DEVELOPMENT, V129, P2761; Dekanty A, 2005, J CELL SCI, V118, P5431, DOI 10.1242/jcs.02648; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Erbel PJA, 2003, P NATL ACAD SCI USA, V100, P15504, DOI 10.1073/pnas.2533374100; Esteban MA, 2006, CANCER RES, V66, P3567, DOI 10.1158/0008-5472.CAN-05-2670; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Gort EH, 2006, ONCOGENE, V25, P6123, DOI 10.1038/sj.onc.1209643; Greijer AE, 2005, J PATHOL, V206, P291, DOI 10.1002/path.1778; Gu YZ, 1998, GENE EXPRESSION, V7, P205; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harfe BD, 1998, GENE DEV, V12, P2623, DOI 10.1101/gad.12.16.2623; Hockel M, 2001, SEMIN ONCOL, V28, P36, DOI 10.1016/S0093-7754(01)90211-8; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Ikeda M, 1997, BIOCHEM BIOPH RES CO, V233, P258, DOI 10.1006/bbrc.1997.6371; IP YT, 1992, GENE DEV, V6, P1728, DOI 10.1101/gad.6.9.1728; Jiang HQ, 2001, P NATL ACAD SCI USA, V98, P7916, DOI 10.1073/pnas.141234698; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Kress S, 1998, J CANCER RES CLIN, V124, P315, DOI 10.1007/s004320050175; Liao D, 2007, CANCER RES, V67, P563, DOI 10.1158/0008-5472.CAN-06-2701; Maestro R, 1999, GENE DEV, V13, P2207, DOI 10.1101/gad.13.17.2207; Mottet D, 2003, J BIOL CHEM, V278, P31277, DOI 10.1074/jbc.M300763200; Padilla PA, 2002, MOL BIOL CELL, V13, P1473, DOI 10.1091/mbc.01-12-0594; PUGH CW, 1991, P NATL ACAD SCI USA, V88, P10553, DOI 10.1073/pnas.88.23.10553; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Ravi R, 2000, GENE DEV, V14, P34; Salem Y, 2005, CELL SIGNAL, V17, P341, DOI 10.1016/j.cellsig.2004.08.001; Semenza GL, 2004, PHYSIOLOGY, V19, P176, DOI 10.1152/physiol.00001.2004; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shen C, 2005, J BIOL CHEM, V280, P20580, DOI 10.1074/jbc.M501894200; Shen C, 2003, ANN NY ACAD SCI, V995, P191, DOI 10.1111/j.1749-6632.2003.tb03222.x; Shen C, 2006, GENETICS, V174, P1205, DOI 10.1534/genetics.106.063594; Shibata T, 1998, INT J RADIAT ONCOL, V42, P913, DOI 10.1016/S0360-3016(98)00298-3; SZYMANSKI P, 1995, EMBO J, V14, P2229, DOI 10.1002/j.1460-2075.1995.tb07217.x; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; To KKW, 2005, J BIOL CHEM, V280, P38102, DOI 10.1074/jbc.M504342200; TRENT C, 1983, GENETICS, V104, P619; van Haaften G, 2004, P NATL ACAD SCI USA, V101, P12992, DOI 10.1073/pnas.0403131101; Vaupel P, 2005, TRANSFUS CLIN BIOL, V12, P5, DOI 10.1016/j.tracli.2004.11.005; Vaupel P, 2001, SEMIN ONCOL, V28, P29, DOI 10.1016/S0093-7754(01)90210-6; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang V, 2005, CANCER RES, V65, P3299, DOI 10.1158/0008-5472.CAN-04-4130; Wiesener MS, 2002, FASEB J, V16, P271, DOI 10.1096/fj.02-0445fje; Wilkie AOM, 2001, NAT REV GENET, V2, P458, DOI 10.1038/35076601; Woelfle U, 2003, CANCER RES, V63, P5679; Wood SM, 1996, J BIOL CHEM, V271, P15117, DOI 10.1074/jbc.271.25.15117; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006	54	107	117	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 6	2008	27	11					1501	1510		10.1038/sj.onc.1210795	http://dx.doi.org/10.1038/sj.onc.1210795			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	271VC	17873906				2022-12-25	WOS:000253815800001
J	Jiang, Y; Prunier, C; Howe, PH				Jiang, Y.; Prunier, C.; Howe, P. H.			The inhibitory effects of Disabled-2 (Dab2) on Wnt signaling are mediated through Axin	ONCOGENE			English	Article						disabled-2 (Dab2); axin; wnt; beta-catenin; differentiation	BETA-CATENIN; NEGATIVE REGULATOR; ENDOCYTOSIS; PROTEIN; DOMAIN; MOUSE; PHOSPHORYLATION; MECHANISM; PATHWAY; ADAPTER	beta-Catenin-mediated Wnt signaling is essential in embryonic development and in adult tissues. Recent studies have demonstrated that Axin not only plays an important inhibitory role in coordinating beta-catenin degradation, but is itself degraded by the low-density-lipoprotein receptor-related protein (LRP) 5/6 Wnt co-receptor. Here, we demonstrate that the endocytic adaptor molecule Disabled-2 (Dab2), which we have previously demonstrated to act as an inhibitor of beta-catenin signaling, interacts with Axin and prevents its interaction with and degradation by the LRP5 co-receptor, thereby increasingits half-life and stabilization. Dab2 levels induced during retinoic acid-induced differentiation of F9, or during transforming growth factor-beta-induced epithelial-mesenchymal transdifferentiation of mouse mammary epithelial cells result in the stabilization of Axin and concomitant inhibition of beta-catenin signaling. Ectopic expression of Dab2 in F9 cells as well as in transformed cell lines results in increased Axin expression and attenuation of Wnt-mediated signaling. We conclude that Dab2 may play an important role in the maintenance of the differentiated state and restrain Wnt- mediated proliferation through its association with and modulation of Axin.	[Jiang, Y.; Howe, P. H.] Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA; [Prunier, C.] Hop St Antoine, INSERM, U673, F-75571 Paris, France	Cleveland Clinic Foundation; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Howe, PH (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Canc Biol, NB4, Cleveland, OH 44195 USA.	howep@ccf.org	Frottier, Celine Prunier/G-8259-2017	Frottier, Celine Prunier/0000-0002-7784-0273	NCI NIH HHS [R01 CA080095, R01 CA055536-18, R01 CA055536, CA80095, CA55536] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA055536, R01CA055536, R01CA080095] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BILIC J, 2007, J CELL SCI, V119, P395; Cadigan KM, 2006, J CELL SCI, V119, P395, DOI 10.1242/jcs.02826; Capelluto DGS, 2002, NATURE, V419, P726, DOI 10.1038/nature01056; Chen W, 2003, SCIENCE, V301, P1391, DOI 10.1126/science.1082808; Cliffe A, 2003, CURR BIOL, V13, P960, DOI 10.1016/S0960-9822(03)00370-1; DANIEL JM, 1995, MOL CELL BIOL, V15, P4819; Fagotto F, 1999, J CELL BIOL, V145, P741, DOI 10.1083/jcb.145.4.741; Furuhashi M, 2001, MOL CELL BIOL, V21, P5132, DOI 10.1128/MCB.21.15.5132-5141.2001; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; HERBER B, 1994, ONCOGENE, V9, P1295; Hocevar BA, 2003, EMBO J, V22, P3084, DOI 10.1093/emboj/cdg286; Hocevar BA, 2001, EMBO J, V20, P2789, DOI 10.1093/emboj/20.11.2789; Ilyas M, 1997, P NATL ACAD SCI USA, V94, P10330, DOI 10.1073/pnas.94.19.10330; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; KAKIMURA DM, 2001, TRAFFIC, V7, P324; Kleeff J, 2002, DIS COLON RECTUM, V45, P1242, DOI 10.1007/s10350-004-6399-2; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Lickert H, 2005, DEVELOPMENT, V132, P2599, DOI 10.1242/dev.01842; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Mishra SK, 2002, EMBO J, V21, P4915, DOI 10.1093/emboj/cdf487; Morin PJ, 1996, P NATL ACAD SCI USA, V93, P7950, DOI 10.1073/pnas.93.15.7950; Morris SM, 2002, TRAFFIC, V3, P331, DOI 10.1034/j.1600-0854.2002.30503.x; Morris SM, 2001, TRAFFIC, V2, P111, DOI 10.1034/j.1600-0854.2001.020206.x; Polakis P, 2002, CURR BIOL, V12, pR499, DOI 10.1016/S0960-9822(02)00969-7; Prunier C, 2005, J BIOL CHEM, V280, P17540, DOI 10.1074/jbc.M500974200; Prunier C, 2004, GROWTH FACTORS, V22, P141, DOI 10.1080/08977190410001720860; Shibamoto S, 2004, EXP CELL RES, V292, P11, DOI 10.1016/j.yexcr.2003.08.009; Shibamoto S, 1998, GENES CELLS, V3, P659; Smith ER, 2001, J BIOL CHEM, V276, P47303, DOI 10.1074/jbc.M106158200; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tolwinski NS, 2004, TRENDS GENET, V20, P177, DOI 10.1016/j.tig.2004.02.003; WILES MV, 1988, DEVELOPMENT, V104, P403; Willert K, 1999, GENE DEV, V13, P1768, DOI 10.1101/gad.13.14.1768; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; XU XX, 1995, J BIOL CHEM, V270, P14184, DOI 10.1074/jbc.270.23.14184; Yamamoto H, 1999, J BIOL CHEM, V274, P10681, DOI 10.1074/jbc.274.16.10681; Yamamoto H, 2006, DEV CELL, V11, P213, DOI 10.1016/j.devcel.2006.07.003; Yu A, 2007, DEV CELL, V12, P129, DOI 10.1016/j.devcel.2006.10.015; Yun M, 2003, J BIOL CHEM, V278, P36572, DOI 10.1074/jbc.M304384200; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185	41	40	43	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2008	27	13					1865	1875		10.1038/sj.onc.1210829	http://dx.doi.org/10.1038/sj.onc.1210829			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	276NZ	17922036	Green Accepted			2022-12-25	WOS:000254150600006
J	Obiozo, UM; Brondijk, THC; White, AJ; van Boxel, G; Dafforn, TR; White, SA; Jackson, JB				Obiozo, U. Mirian; Brondijk, T. Harma C.; White, Andrew J.; van Boxel, Gijs; Dafforn, Tim R.; White, Scott A.; Jackson, J. Baz			Substitution of tyrosine 146 in the dI component of proton-translocating transhydrogenase leads to reversible dissociation of the active dimer into inactive monomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINAMIDE NUCLEOTIDE TRANSHYDROGENASE; MOBILE-LOOP REGION; AMINO-ACID-RESIDUES; RHODOSPIRILLUM-RUBRUM; DOMAIN-I; SUBUNIT STRUCTURE; HYDRIDE TRANSFER; NADP(H)-BINDING COMPONENT; NAD(H)-BINDING COMPONENT; CONFORMATIONAL-CHANGES	Transhydrogenase couples the redox reaction between NADH and NADP(+) to proton translocation across a membrane. The protein has three components:dI binds NADH, dIII binds NADP(+), and dII spans the membrane. Transhydrogenase is a "dimer" of two dI-dII-dIII "monomers"; x-ray structures suggested that the two catalytic sites alternate during turnover. Invariant Tyr(146) in recombinant dI of Rhodospirillum rubrum transhydrogenase was substituted with Phe and Ala (proteins designated dI.Y146F and dI.Y146A, respectively). Analytical ultracentrifuge experiments and differential scanning calorimetry show that dI.Y146A more readily dissociates into monomers than wild-type dI. Analytical ultracentrifuge and Trp fluorescence experiments indicate that the dI.Y146A monomers bind NADH much more weakly than dimers. Wild-type dI and dI.Y146F reconstituted activity to dI-depleted membranes with similar characteristics. However, dI.Y146A reconstituted activity in its dimeric form but not in its monomeric form, this despite monomers retaining their native fold and binding to the dI-depleted membranes. It is suggested that transhydrogenase reconstructed with monomers of dI.Y146A is catalytically compromised, at least partly as a consequence of the lowered affinity for NADH, and this results from lost interactions between the nucleotide binding site and the protein beta-hairpin upon dissociation of the dI dimer. The importance of these interactions and their coupling to dI domain rotation in the mechanism of action of transhydrogenase is emphasized. Two peaks in the H-1 NMR spectrum of wild-type dI are broadened in dI. Y146A and are tentatively assigned to S-methyl groups of Met resonances in the beta-hairpin, consistent with the segmental mobility of this feature in the structure.	Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Jackson, JB (corresponding author), Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.	j.b.jackson@bham.ac.uk	Brondijk, Harma/AAD-6485-2019; Dafforn, Tim/A-9072-2015	Brondijk, Harma/0000-0002-0234-673X; White, Scott/0000-0002-0202-6154; Dafforn, Tim/0000-0003-2257-6679				AMBARTSOUMIAN G, 1994, MICROBIOL-UK, V140, P1737, DOI 10.1099/13500872-140-7-1737; ANDERSON WM, 1981, BIOCHIM BIOPHYS ACTA, V635, P194, DOI 10.1016/0005-2728(81)90018-9; Arkblad EL, 2005, FREE RADICAL BIO MED, V38, P1518, DOI 10.1016/j.freeradbiomed.2005.02.012; BALBO A, 2006, OFFICE RES SERVICES; Bhakta T, 2007, BIOCHEMISTRY-US, V46, P3304, DOI 10.1021/bi061843r; Bizouarn T, 1996, EUR J BIOCHEM, V239, P737, DOI 10.1111/j.1432-1033.1996.0737u.x; Bizouarn T, 1997, BBA-BIOENERGETICS, V1320, P265, DOI 10.1016/S0005-2728(97)00030-3; Brondijk THC, 2006, J BIOL CHEM, V281, P13345, DOI 10.1074/jbc.M513230200; Broos J, 2003, J BIOL CHEM, V278, P47578, DOI 10.1074/jbc.M309287200; Buckley PA, 2000, STRUCTURE, V8, P809, DOI 10.1016/S0969-2126(00)00171-4; Chaillan-Huntington C, 2001, J MOL BIOL, V314, P465, DOI 10.1006/jmbi.2001.5136; CLAYTON RK, 1963, BIOCHIM BIOPHYS ACTA, V75, P312, DOI 10.1016/0006-3002(63)90618-8; Cotton NPJ, 2001, STRUCTURE, V9, P165, DOI 10.1016/S0969-2126(01)00571-8; CUNNINGHAM IJ, 1992, BIOCHIM BIOPHYS ACTA, V1100, P332, DOI 10.1016/0167-4838(92)90490-5; DIGGLE C, 1995, EUR J BIOCHEM, V232, P315, DOI 10.1111/j.1432-1033.1995.tb20814.x; DIGGLE C, 1995, EUR J BIOCHEM, V228, P719, DOI 10.1111/j.1432-1033.1995.0719m.x; Diggle C, 1996, EUR J BIOCHEM, V241, P162, DOI 10.1111/j.1432-1033.1996.0162t.x; FERSHT A, 1999, STRUCTURE MECH PROTE, P158; FISHER RR, 1971, J BIOL CHEM, V246, P4679; Freeman H, 2006, CELL METAB, V3, P35, DOI 10.1016/j.cmet.2005.10.008; Grimley RL, 1997, BIOCHEMISTRY-US, V36, P14762, DOI 10.1021/bi971832l; Gupta S, 1998, BBA-BIOENERGETICS, V1409, P25, DOI 10.1016/S0005-2728(98)00146-7; HANSON RL, 1980, J BACTERIOL, V141, P401, DOI 10.1128/JB.141.1.401-404.1980; Hickman JW, 2002, J BACTERIOL, V184, P400, DOI 10.1128/JB.184.2.400-409.2002; HOU C, 1990, BIOCHIM BIOPHYS ACTA, V1018, P61, DOI 10.1016/0005-2728(90)90110-P; Jackson JB, 2005, RSC BIOMOLEC SCI, P376; Jackson JB, 2003, FEBS LETT, V545, P18, DOI 10.1016/S0014-5793(03)00388-0; Jackson JB, 2002, BIOCHEMISTRY-US, V41, P4173, DOI 10.1021/bi012078d; Jeeves M, 1999, J BIOMOL NMR, V13, P305, DOI 10.1023/A:1008300609352; Johansson T, 2005, J MOL BIOL, V352, P299, DOI 10.1016/j.jmb.2005.07.022; JONES S, 1995, PROG BIOPHYS MOL BIO, V63, P31, DOI 10.1016/0079-6107(94)00008-W; Lian L. Y., 1993, NMR MACROMOLECULES P, P153; Mather OC, 2004, BIOCHEMISTRY-US, V43, P10952, DOI 10.1021/bi0497594; MEJBAUMKATZENELLENBOGEN W, 1959, CLIN CHIM ACTA, V4, P515, DOI 10.1016/0009-8981(59)90158-5; OSHINO N, 1977, BIOCHEM J, V162, P509, DOI 10.1042/bj1620509; PERSSON B, 1987, ARCH BIOCHEM BIOPHYS, V259, P341, DOI 10.1016/0003-9861(87)90500-5; PHELPS DC, 1984, BIOCHEMISTRY-US, V23, P4475, DOI 10.1021/bi00314a037; PHELPS DC, 1985, BIOCHEMISTRY-US, V24, P3503, DOI 10.1021/bi00335a017; Prasad GS, 2002, BIOCHEMISTRY-US, V41, P12745, DOI 10.1021/bi020251f; Quirk PG, 1999, FEBS LETT, V446, P127, DOI 10.1016/S0014-5793(99)00198-2; Quirk PG, 1999, BBA-BIOENERGETICS, V1412, P139, DOI 10.1016/S0005-2728(99)00057-2; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Singh A, 2003, J BIOL CHEM, V278, P33208, DOI 10.1074/jbc.M303061200; Sundaresan V, 2005, J MOL BIOL, V346, P617, DOI 10.1016/j.jmb.2004.11.070; van Boxel GI, 2003, BIOCHEMISTRY-US, V42, P1217, DOI 10.1021/bi027032e; Venning JD, 2001, J BIOL CHEM, V276, P30678, DOI 10.1074/jbc.M104429200; WILSON R, 2006, BIOCH BIOPHY ACTA, V1537, P215; WU LNY, 1983, J BIOL CHEM, V258, P7847	49	3	3	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36434	36443		10.1074/jbc.M705433200	http://dx.doi.org/10.1074/jbc.M705433200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17911104	hybrid			2022-12-25	WOS:000251458300035
J	Wang, B; Bisello, A; Yang, YM; Romero, GG; Friedman, PA				Wang, Bin; Bisello, Alessandro; Yang, Yanmei; Romero, Guillermo G.; Friedman, Peter A.			NHERF1 regulates parathyroid hormone receptor membrane retention without affecting recycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; KAPPA-OPIOID RECEPTOR; CHRONIC-RENAL-FAILURE; OPOSSUM KIDNEY-CELLS; PTH-PTHRP RECEPTOR; BETA-ARRESTIN; KINASE-C; DOWN-REGULATION; PDZ-DOMAIN; INTERNALIZATION	Na/H exchange regulatory factor-1 (NHERF1) is a PDZ protein that regulates trafficking of several G protein-coupled receptors. The phenotype of NHERF1-null mice suggests that the parathyroid hormone (PTH) receptor (PTH1R) is the principal GPCR interacting with NHERF1. The effect of NHERF1 on receptor recycling is unknown. Here, we characterized NHERF1 effects on PTH1R membrane tethering and recycling by radio-ligand binding and recovery after maximal receptor endocytosis. Using Chinese hamster ovary cells expressing the PTH1R, where NHERF1 expression could be induced by tetracycline, NHERF1 inhibited PTH1R endocytosis and delayed PTH1R recycling. NHERF1 also inhibited PTH-induced receptor internalization in MC4 osteoblast cells. Reducing constitutive NHERF1 levels in HEK-293 cells with short hairpin RNA directed against NHERF1 augmented PTH1R endocytosis in response to PTH. Mutagenesis of the PDZ-binding domains or deletion of the MERM domain of NHERF1 demonstrated that both are required for inhibition of endocytosis and recycling. Likewise, an intact COOH-terminal PDZ recognition motif in PTH1R is needed. The effect of NHERF1 on receptor internalization and recycling was not associated with altered receptor expression or binding, activation, or phosphorylation but involved beta-arrestin and dynamin. We conclude that NHERF1 inhibits endocytosis without affecting PTH1R recycling in MC4 and PTH1R-expressing HEK-293 cells. Such an effect may protect against PTH resistance or PTH1R down-regulation in certain cells harboring NHERF1.	Univ Pittsburgh, Sch Med, Dept Pharmacol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Friedman, PA (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol, E-1347 Biomed Sci Tower, Pittsburgh, PA 15261 USA.	paf10@pitt.edu		Wang, Bin/0000-0002-5396-6111	NIDDK NIH HHS [DK-54171, DK-69998] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054171, R01DK069998] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABOUSAMRA AB, 1992, P NATL ACAD SCI USA, V89, P2732, DOI 10.1073/pnas.89.7.2732; Bisello A, 1996, BIOCHEMISTRY-US, V35, P15890, DOI 10.1021/bi962111+; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Bretscher A, 2000, ANNU REV CELL DEV BI, V16, P113, DOI 10.1146/annurev.cellbio.16.1.113; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Chauvin S, 2002, MOL ENDOCRINOL, V16, P2720, DOI 10.1210/me.2002-0049; Conway RR, 2001, J CELL PHYSIOL, V189, P341, DOI 10.1002/jcp.10028; Dicker F, 1999, P NATL ACAD SCI USA, V96, P5476, DOI 10.1073/pnas.96.10.5476; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Ferrari SL, 1999, J BIOL CHEM, V274, P29968, DOI 10.1074/jbc.274.42.29968; Flannery PJ, 2001, BIOCHEM PHARMACOL, V62, P1047, DOI 10.1016/S0006-2952(01)00749-3; Friedman PA, 2006, AM J PHYSIOL-RENAL, V290, pF975, DOI 10.1152/ajprenal.00336.2005; Friedman PA, 1996, ENDOCRINOLOGY, V137, P13, DOI 10.1210/en.137.1.13; FUKAYAMA S, 1992, ENDOCRINOLOGY, V131, P1757, DOI 10.1210/en.131.4.1757; Gensure RC, 2005, BIOCHEM BIOPH RES CO, V328, P666, DOI 10.1016/j.bbrc.2004.11.069; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Heydorn A, 2004, J BIOL CHEM, V279, P54291, DOI 10.1074/jbc.M406169200; Krupnick JG, 1997, J BIOL CHEM, V272, P32507, DOI 10.1074/jbc.272.51.32507; Lazar CS, 2004, MOL BIOL CELL, V15, P5470, DOI 10.1091/mbc.E04-03-0239; LEE CW, 1994, ENDOCRINOLOGY, V135, P1488, DOI 10.1210/en.135.4.1488; LEE SK, 1994, J BONE MINER RES, V9, P781; Li JG, 2002, J BIOL CHEM, V277, P27545, DOI 10.1074/jbc.M200058200; Li JG, 1999, J BIOL CHEM, V274, P12087, DOI 10.1074/jbc.274.17.12087; Mahon MJ, 2003, MOL ENDOCRINOL, V17, P2355, DOI 10.1210/me.2003-0043; Mahon MJ, 2002, NATURE, V417, P858, DOI 10.1038/nature00816; Mahon MJ, 2004, J BIOL CHEM, V279, P23550, DOI 10.1074/jbc.M313229200; Malecz N, 1998, MOL ENDOCRINOL, V12, P1846, DOI 10.1210/me.12.12.1846; Menard L, 1997, MOL PHARMACOL, V51, P800, DOI 10.1124/mol.51.5.800; Shenolikar S, 2004, PHYSIOLOGY, V19, P362, DOI 10.1152/physiol.00020.2004; Shenolikar S, 2001, AM J PHYSIOL-RENAL, V280, pF389, DOI 10.1152/ajprenal.2001.280.3.F389; Sneddon WB, 2007, ENDOCRINOLOGY, V148, P4073, DOI 10.1210/en.2007-0343; Sneddon WB, 2004, ENDOCRINOLOGY, V145, P2815, DOI 10.1210/en.2003-1185; Sneddon WB, 2003, J BIOL CHEM, V278, P43787, DOI 10.1074/jbc.M306019200; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Stanasila L, 2006, J BIOL CHEM, V281, P4354, DOI 10.1074/jbc.M511989200; Syme CA, 2005, J BIOL CHEM, V280, P11281, DOI 10.1074/jbc.M413393200; Tan CM, 2004, ANNU REV PHARMACOL, V44, P559, DOI 10.1146/annurev.pharmtox.44.101802.121558; TIAN J, 1994, AM J NEPHROL, V14, P41, DOI 10.1159/000168684; URENA P, 1994, KIDNEY INT, V45, P605, DOI 10.1038/ki.1994.79; Vargas GA, 2004, J BIOL CHEM, V279, P37461, DOI 10.1074/jbc.M401034200; Vilardaga JP, 2002, J BIOL CHEM, V277, P8121, DOI 10.1074/jbc.M110433200; Voltz JW, 2001, ONCOGENE, V20, P6309, DOI 10.1038/sj.onc.1204774; Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893; Wang SS, 1998, FEBS LETT, V427, P103, DOI 10.1016/S0014-5793(98)00402-5; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050; Weinman EJ, 2003, BIOCHEMISTRY-US, V42, P12662, DOI 10.1021/bi035244l; Weinman EJ, 2001, J BIOL CHEM, V276, P42339, DOI 10.1074/jbc.M106153200; Wheeler D, 2007, J BIOL CHEM, V282, P25076, DOI 10.1074/jbc.M701544200; Zhang J, 1996, J BIOL CHEM, V271, P18302, DOI 10.1074/jbc.271.31.18302	49	76	77	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36214	36222		10.1074/jbc.M707263200	http://dx.doi.org/10.1074/jbc.M707263200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17884816	hybrid			2022-12-25	WOS:000251458300011
J	Defer, N; Azroyan, A; Pecker, F; Pavoine, C				Defer, Nicole; Azroyan, Anie; Pecker, Francoise; Pavoine, Catherine			TNFR1 and TNFR2 signaling interplay in cardiac myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; KINASE-C-ZETA; NF-KAPPA-B; FACTOR-ALPHA; PHOSPHOLAMBAN PHOSPHORYLATION; NEUTRAL SPHINGOMYELINASE; ACETYLCYSTEINE TREATMENT; PKC-ZETA; ACTIVATION; CONTRACTION	Tumor necrosis factor alpha(TNF alpha) plays a major role in chronic heart failure, signaling through two different receptor subtypes, TNFR1 and TNFR2. Our aim was to further delineate the functional role and signaling pathways related to TNFR1 and TNFR2 in cardiac myocytes. In cardiac myocytes isolated from control rats, TNF alpha induced ROS production, exerted a dual positive and negative action on [Ca2+] transient and cell fractional shortening, and altered cell survival. Neutralizing anti-TNFR2 antibodies exacerbated TNF alpha responses on ROS production and cell death, arguing for a major protective role of the TNFR2 pathway. Treatment with either neutralizing anti-TNFR1 antibodies or the glutathione precursor, N-acetylcysteine (NAC), favored the emergence of TNFR2 signaling that mediated a positive effect of TNF alpha on [Ca2+] transient and cell fractional shortening. The positive effect of TNF alpha relied on TNFR2-dependent activation of the cPLA(2) activity, independently of serine 505 phosphorylation of the enzyme. Together with cPLA2 redistribution and AA release, TNF alpha induced a time-dependent phosphorylation of ERK, MSK1, PKC zeta, CaMKII, and phospholamban on the threonine 17 residue. Taken together, our results characterized a TNFR2-dependent signaling and illustrated the close interplay between TNFR1 and TNFR2 pathways in cardiac myocytes. Although apparently predominant, TNFR1-dependent responses were under the yoke of TNFR2, acting as a critical limiting factor. In vivo NAC treatment proved to be a unique tool to selectively neutralize TNFR1-mediated effects of TNF alpha while releasing TNFR2 pathways.	Hop Henri Mondor, INSERM, Unite 841, Inst Mondor Rech Biomed,Equipe 19, F-94010 Creteil, France; Univ Paris 12, F-94010 Creteil, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Pavoine, C (corresponding author), Hop Henri Mondor, INSERM, Unite 841, Inst Mondor Rech Biomed,Equipe 19, F-94010 Creteil, France.	catherine.pavoine@creteil.inserm.fr	Pavoine, Catherine/N-4405-2018	Pavoine, Catherine/0000-0002-0598-5545				Adamy C, 2007, J MOL CELL CARDIOL, V43, P344, DOI 10.1016/j.yjmcc.2007.06.010; Aimond F, 2000, J BIOL CHEM, V275, P39110, DOI 10.1074/jbc.M008192200; Ait-Mamar B, 2005, J BIOL CHEM, V280, P18881, DOI 10.1074/jbc.M410305200; Amadou A, 2002, AM J PHYSIOL-CELL PH, V282, pC1339, DOI 10.1152/ajpcell.00471.2001; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Bourraindeloup M, 2004, CIRCULATION, V110, P2003, DOI 10.1161/01.CIR.0000143630.14515.7C; Cailleret M, 2004, CIRCULATION, V109, P406, DOI 10.1161/01.CIR.0000109499.00587.FF; Cingolani HE, 2006, HYPERTENSION, V47, P727, DOI 10.1161/01.HYP.0000208302.62399.68; Gullestad L, 2005, AM J CARDIOL, V95, p17C, DOI 10.1016/j.amjcard.2005.03.008; Hagemann D, 2002, TRENDS CARDIOVAS MED, V12, P51, DOI 10.1016/S1050-1738(01)00145-1; Haq S, 2003, NAT MED, V9, P944, DOI 10.1038/nm891; Hartshorne DJ, 2004, J BIOL CHEM, V279, P37211, DOI 10.1074/jbc.R400018200; Hayakawa M, 2003, EMBO J, V22, P3356, DOI 10.1093/emboj/cdg332; Higuchi Y, 2004, CIRCULATION, V109, P1892, DOI 10.1161/01.CIR.0000124227.00670.AB; Hirai T, 2003, J BIOCHEM, V133, P1, DOI 10.1093/jb/mvg017; Jupp OJ, 2003, BIOCHEM J, V374, P453, DOI 10.1042/BJ20030705; Kurrelmeyer KM, 2000, P NATL ACAD SCI USA, V97, P5456, DOI 10.1073/pnas.070036297; LaVallie ER, 2006, J BIOL CHEM, V281, P24124, DOI 10.1074/jbc.M601905200; LEVINE B, 1990, NEW ENGL J MED, V323, P236, DOI 10.1056/NEJM199007263230405; Liu B, 1998, J BIOL CHEM, V273, P11313, DOI 10.1074/jbc.273.18.11313; Mann D L, 1996, J Card Fail, V2, pS165, DOI 10.1016/S1071-9164(96)80073-X; Massion PB, 2003, CIRC RES, V93, P388, DOI 10.1161/01.RES.0000088351.58510.21; Mattiazzi A, 2005, CARDIOVASC RES, V68, P366, DOI 10.1016/j.cardiores.2005.08.010; Mehra VC, 2005, J LEUKOCYTE BIOL, V78, P805, DOI 10.1189/jlb.0405182; Meldrum DR, 1998, AM J PHYSIOL-REG I, V274, pR577, DOI 10.1152/ajpregu.1998.274.3.R577; Moscat J, 2006, CELL DEATH DIFFER, V13, P702, DOI 10.1038/sj.cdd.4401823; Pavoine C, 2005, CELL SIGNAL, V17, P141, DOI 10.1016/j.cellsig.2004.09.001; Phillipson A, 2005, AM J PHYSIOL-HEART C, V289, pH898, DOI 10.1152/ajpheart.00883.2003; Prabhu SD, 2004, CIRC RES, V95, P1140, DOI 10.1161/01.RES.0000150734.79804.92; Ramani R, 2004, AM J PHYSIOL-HEART C, V287, pH1369, DOI 10.1152/ajpheart.00641.2003; Sack MN, 2000, CARDIOVASC RES, V45, P688, DOI 10.1016/S0008-6363(99)00228-X; Sack MN, 2002, PHARMACOL THERAPEUT, V94, P123, DOI 10.1016/S0163-7258(02)00176-6; Sauvadet A, 1997, J BIOL CHEM, V272, P12437, DOI 10.1074/jbc.272.19.12437; Shen HM, 2006, FASEB J, V20, P1589, DOI 10.1096/fj.05-5603rev; TORREAMIONE G, 1995, CIRCULATION, V92, P1487, DOI 10.1161/01.CIR.92.6.1487; Vanderheyden M, 2005, HEART, V91, P926, DOI 10.1136/hrt.2004.035733; Xin MG, 2007, J BIOL CHEM, V282, P21268, DOI 10.1074/jbc.M701613200	37	72	79	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35564	35573		10.1074/jbc.M704003200	http://dx.doi.org/10.1074/jbc.M704003200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17913704	hybrid			2022-12-25	WOS:000251458100016
J	Lauberth, SM; Bilyeu, AC; Firulli, BA; Kroll, KL; Rauchman, M				Lauberth, Shannon M.; Bilyeu, Amy C.; Firulli, Beth A.; Kroll, Kristen L.; Rauchman, Michael			A phosphomimetic mutation in the Sall1 repression motif disrupts recruitment of the nucleosome remodeling and deacetylase complex and repression of Gbx2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOWNES-BROCKS-SYNDROME; RADIAL RAY SYNDROME; OKIHIRO-SYNDROME; TRANSCRIPTIONAL REPRESSOR; GENE-EXPRESSION; CAUSATIVE GENE; CELL FATE; HETEROCHROMATIN; NURD; PHOSPHOPROTEINS	The multizinc finger transcription factor Sall1 is a critical developmental regulator that mediates repression through the recruitment of the nucleosome remodeling and deacetylase ( NuRD) complex. Although a short conserved peptide motif in Sall1 is sufficient to recruit NuRD, its ability to regulate native Sall1 target genes in vivo has not been demonstrated. In this report, we demonstrate an in vivo role for the Sall1 repression motif and describe a novel direct target gene of Sall1, Gbx2, that is directly repressed in a NuRD-dependent fashion. The ability of Sall1 to repress Gbx2 was impaired in Xenopus embryos expressing mutant forms of Sall1 that are defective for NuRD binding. Finally, we demonstrate that protein kinase C phosphorylates serine 2 of the Sall1 repression motif and reveal that a phosphomimetic mutation of serine 2 disrupts the ability of Sall1 to repress Gbx2 in cell culture and Xenopus embryos. Together, these studies establish that Sall1 recruits NuRD via the Sall1 repression motif to mediate repression of a native target gene and suggest a model in which dynamic control of gene expression by Sall1 is modulated by serine phosphorylation of the Sall1 repression motif.	St Louis Univ, Dept Biochem, St Louis, MO 63106 USA; St Louis Univ, Dept Biol Mol, St Louis, MO 63106 USA; Vet Affairs Med Ctr, St Louis, MO 63106 USA; Washington Univ, Dept Mol Biol & Pharmacol, St Louis, MO 63106 USA; Indiana Univ, Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA	Saint Louis University; Saint Louis University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Washington University (WUSTL); Indiana University System; Indiana University-Purdue University Indianapolis	Rauchman, M (corresponding author), St Louis Vet Affairs Med Ctr, 657-111B-JC,915 N Grand Blvd, St Louis, MO 63106 USA.	rauchman@slu.edu		Kroll, Kristen/0000-0002-5450-6694; Lauberth, Shannon/0000-0003-4131-8536	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066815] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK067222] Funding Source: Medline; NIGMS NIH HHS [GM66815-01, R01 GM066815] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agrawal GK, 2006, MOL CELL PROTEOMICS, V5, P2044, DOI 10.1074/mcp.M600084-MCP200; Ahringer J, 2000, TRENDS GENET, V16, P351, DOI 10.1016/S0168-9525(00)02066-7; Al-Baradie R, 2002, AM J HUM GENET, V71, P1195, DOI 10.1086/343821; Borozdin W, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.019901; Boube M, 2000, MECH DEVELOP, V91, P271, DOI 10.1016/S0925-4773(99)00315-9; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Byrd NA, 2005, DEV BIOL, V284, P233, DOI 10.1016/j.ydbio.2005.05.023; Cismasiu VB, 2006, BLOOD, V108, P2695, DOI 10.1182/blood-2006-05-021790; Cismasiu VB, 2005, ONCOGENE, V24, P6753, DOI 10.1038/sj.onc.1208904; Cobb BS, 2000, GENE DEV, V14, P2146, DOI 10.1101/gad.816400; de Celis JF, 2000, MECH DEVELOP, V91, P31, DOI 10.1016/S0925-4773(99)00261-0; Firulli Beth A., 2004, Biol Proced Online, V6, P16, DOI 10.1251/bpo69; Garda AL, 2001, MECH DEVELOP, V101, P111, DOI 10.1016/S0925-4773(00)00567-0; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Hong W, 2005, EMBO J, V24, P2367, DOI 10.1038/sj.emboj.7600703; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; Katahira T, 2000, MECH DEVELOP, V91, P43, DOI 10.1016/S0925-4773(99)00262-2; Kehle J, 1998, SCIENCE, V282, P1897, DOI 10.1126/science.282.5395.1897; Kiefer SM, 2003, HUM MOL GENET, V12, P2221, DOI 10.1093/hmg/ddg233; Kohlhase J, 2002, HUM MOL GENET, V11, P2979, DOI 10.1093/hmg/11.23.2979; Kohlhase J, 2005, HUM MUTAT, V26, P176, DOI 10.1002/humu.20215; Kohlhase J, 2003, J MED GENET, V40; Kohlhase J, 1998, NAT GENET, V18, P81, DOI 10.1038/ng0198-81; Lauberth SM, 2006, J BIOL CHEM, V281, P23922, DOI 10.1074/jbc.M513461200; Lin ZS, 2005, DEVELOPMENT, V132, P2309, DOI 10.1242/dev.01804; Martin K, 2003, COMB CHEM HIGH T SCR, V6, P331; Mollereau B, 2001, NATURE, V412, P911, DOI 10.1038/35091076; Netzer C, 2006, BBA-MOL BASIS DIS, V1762, P386, DOI 10.1016/j.bbadis.2005.12.005; Netzer C, 2001, HUM MOL GENET, V10, P3017, DOI 10.1093/hmg/10.26.3017; NIEUWKOOP PD, 1967, NORMAL TABLE XENOPUS, P162; Nishioka K, 2002, GENE DEV, V16, P479, DOI 10.1101/gad.967202; Onai T, 2004, DEV CELL, V7, P95, DOI 10.1016/j.devcel.2004.06.004; Pal S, 2004, P NATL ACAD SCI USA, V101, P980, DOI 10.1073/pnas.0307612100; Sato A, 2004, BIOCHEM BIOPH RES CO, V319, P103, DOI 10.1016/j.bbrc.2004.04.156; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Solari F, 1999, DEVELOPMENT, V126, P2483; Stasyk T, 2005, ELECTROPHORESIS, V26, P2850, DOI 10.1002/elps.200500026; Steinberg TH, 2003, PROTEOMICS, V3, P1128, DOI 10.1002/pmic.200300434; Toker AS, 2003, DEVELOPMENT, V130, P3831, DOI 10.1242/dev.00398; von Zelewsky T, 2000, DEVELOPMENT, V127, P5277; Wang X, 2002, EMBO J, V21, P5225, DOI 10.1093/emboj/cdf527; Yamashita K, 2007, GENES CELLS, V12, P171, DOI 10.1111/j.1365-2443.2007.01042.x; Zegerman P, 2002, J BIOL CHEM, V277, P11621, DOI 10.1074/jbc.C200045200; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481	44	31	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34858	34868		10.1074/jbc.M703702200	http://dx.doi.org/10.1074/jbc.M703702200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17895244	Green Submitted, hybrid			2022-12-25	WOS:000251155200028
J	Duong, N; Osborne, S; Bustamante, VH; Tomljenovic, AM; Puente, JL; Coombes, BK				Duong, Nancy; Osborne, Suzanne; Bustamante, Victor H.; Tomljenovic, Ana M.; Puente, Jose L.; Coombes, Brian K.			Thermosensing coordinates a cis-regulatory module for transcriptional activation of the intracellular virulence system in salmonella enterica serovar typhimurium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN H-NS; III SECRETION SYSTEM; BACTERIAL GENE-REGULATION; IN-VIVO OLIGOMERIZATION; PATHOGENICITY ISLAND 2; ESCHERICHIA-COLI; EXPRESSION; IDENTIFICATION; SSRB; HHA	The expression of bacterial virulence genes is tightly controlled by the convergence of multiple extracellular signals. As a zoonotic pathogen, virulence gene regulation in Salmonella enterica serovar Typhimurium must be responsive to multiple cues from the general environment as well as from multiple niches within animal and human hosts. Previous work has identified combined magnesium and phosphate limitation as an environmental cue that activates genes required for intracellular virulence. One unanswered question is how virulence genes that are expressed within the host are inhibited in non-host environments that satisfy the phosphate and magnesium limitation cues. We report here that thermosensing is the major mechanism controlling incongruous activation of the intracellular virulence phenotype. Bacteria grown at 30 degrees C or lower were unable to activate the intracellular type III secretion system even under strong inducing signals such as synthetic medium, contact with macrophages, and exposure to the murine gut. Thermoregulation was fully recapitulated in a Salmonella bongori strain engineered to contain the intracellular virulence genes of S. enterica sv. Typhimurium, suggesting that orthologous thermoregulators were available. Accordingly, virulence gene repression at the nonpermissive temperature required Hha and H-NS, two nucleoid-like proteins involved in virulence gene control. The use of combined environmental cues to control transcriptional "logic gates" allows for transcriptional selectivity of virulence genes that would otherwise be superfluous if activated in the non-host environment. Thus, thermosensing by Salmonella provides integrated control of host niche-specific virulence factors.	McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Mol Microbiol, Cuernavaca 62251, Morelos, Mexico; Publ Hlth Agcy Canada, Lab Foodborne Zoonoses, Guelph, ON N1G 3W4, Canada	McMaster University; Universidad Nacional Autonoma de Mexico; Public Health Agency of Canada	Coombes, BK (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, 1200 Main St W,Hlth Sci Ctr 4H17, Hamilton, ON L8N 3Z5, Canada.	coombes@mcmaster.ca	Coombes, Brian K/A-1727-2009; Bustamante, Victor/GXF-0780-2022; Taylor, Graham/A-4027-2012	Coombes, Brian/0000-0001-9883-1010; Tomljenovic-Berube, Ana/0000-0003-4733-7164; Puente, Jose/0000-0002-8411-4974				Brown NF, 2005, PLOS PATHOG, V1, P252, DOI 10.1371/journal.ppat.0010032; Buchler NE, 2003, P NATL ACAD SCI USA, V100, P5136, DOI 10.1073/pnas.0930314100; Ceschini S, 2000, J BIOL CHEM, V275, P729, DOI 10.1074/jbc.275.2.729; Coombes BK, 2005, P NATL ACAD SCI USA, V102, P17460, DOI 10.1073/pnas.0505401102; Coombes BK, 2005, INFECT IMMUN, V73, P7161, DOI 10.1128/IAI.73.11.7161-7169.2005; Coombes BK, 2004, J BIOL CHEM, V279, P49804, DOI 10.1074/jbc.M404299200; Coombes BK, 2007, INFECT IMMUN, V75, P574, DOI 10.1128/IAI.00985-06; Deiwick J, 1999, ELECTROPHORESIS, V20, P813, DOI 10.1002/(SICI)1522-2683(19990101)20:4/5<813::AID-ELPS813>3.0.CO;2-Q; Deiwick J, 1999, MOL MICROBIOL, V31, P1759, DOI 10.1046/j.1365-2958.1999.01312.x; Dorman CJ, 2004, NAT REV MICROBIOL, V2, P391, DOI 10.1038/nrmicro883; Garmendia J, 2003, MICROBIOL-SGM, V149, P2385, DOI 10.1099/mic.0.26397-0; GORANSSON M, 1990, NATURE, V344, P682, DOI 10.1038/344682a0; Hansen-Wester I, 2004, INFECT IMMUN, V72, P2879, DOI 10.1128/IAI.72.5.2879-2888.2004; Hapfelmeier S, 2005, J IMMUNOL, V174, P1675, DOI 10.4049/jimmunol.174.3.1675; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; Hensel M, 1998, MOL MICROBIOL, V30, P163, DOI 10.1046/j.1365-2958.1998.01047.x; Hermsen R, 2006, PLOS COMPUT BIOL, V2, P1552, DOI 10.1371/journal.pcbi.0020164; Hurme R, 1997, CELL, V90, P55, DOI 10.1016/S0092-8674(00)80313-X; Hurme R, 1998, MOL MICROBIOL, V30, P1, DOI 10.1046/j.1365-2958.1998.01049.x; Knodler LA, 2002, MOL MICROBIOL, V43, P1089, DOI 10.1046/j.1365-2958.2002.02820.x; LEIMEISTERWACHTER M, 1992, J BACTERIOL, V174, P947, DOI 10.1128/jb.174.3.947-952.1992; Lucchini S, 2006, PLOS PATHOG, V2, P746, DOI 10.1371/journal.ppat.0020081; Madrid C, 2002, INT J MED MICROBIOL, V291, P425; Madrid C, 2007, J BACTERIOL, V189, P265, DOI 10.1128/JB.01124-06; MAYER MP, 1995, GENE, V163, P41, DOI 10.1016/0378-1119(95)00389-N; Mayo AE, 2006, PLOS BIOL, V4, P555, DOI 10.1371/journal.pbio.0040045; Morgan E, 2004, MOL MICROBIOL, V54, P994, DOI 10.1111/j.1365-2958.2004.04323.x; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Nieto JM, 2000, MOL GEN GENET, V263, P349, DOI 10.1007/s004380051178; Nieto JM, 2002, J BACTERIOL, V184, P629, DOI 10.1128/JB.184.3.629-635.2002; Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800; Ono S, 2005, BIOCHEM J, V391, P203, DOI 10.1042/BJ20050453; Paytubi S, 2004, MOL MICROBIOL, V54, P251, DOI 10.1111/j.1365-2958.2004.04268.x; Shea JE, 1996, P NATL ACAD SCI USA, V93, P2593, DOI 10.1073/pnas.93.6.2593; Silphaduang U, 2007, J BACTERIOL, V189, P3669, DOI 10.1128/JB.00002-07; Smyth CP, 2000, MOL MICROBIOL, V36, P962, DOI 10.1046/j.1365-2958.2000.01917.x; Stella S, 2006, J MOL BIOL, V355, P169, DOI 10.1016/j.jmb.2005.10.034; Stella S, 2005, EMBO J, V24, P2896, DOI 10.1038/sj.emboj.7600754; Tendeng C, 2003, TRENDS MICROBIOL, V11, P511, DOI 10.1016/j.tim.2003.09.005; Ueguchi C, 1996, J MOL BIOL, V263, P149, DOI 10.1006/jmbi.1996.0566; Umanski T, 2002, MICROBIOL-SGM, V148, P2735, DOI 10.1099/00221287-148-9-2735; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; Walthers D, 2007, MOL MICROBIOL, V65, P477, DOI 10.1111/j.1365-2958.2007.05800.x; *WHO, 2005, 139 WHO; Worley MJ, 2000, MOL MICROBIOL, V36, P749, DOI 10.1046/j.1365-2958.2000.01902.x; WRAY C, 1978, RES VET SCI, V25, P139, DOI 10.1016/S0034-5288(18)32968-0	46	36	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34077	34084		10.1074/jbc.M707352200	http://dx.doi.org/10.1074/jbc.M707352200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17895240	hybrid			2022-12-25	WOS:000251145700022
J	Nakamata, K; Kurita, T; Bhuiyan, MSA; Sato, K; Noda, Y; Yoda, K				Nakamata, Kosuke; Kurita, Tomokazu; Bhuiyan, M. Shah Alam; Sato, Keisuke; Noda, Yoichi; Yoda, Koji			KEG1/YFR042w encodes a novel Kre6-binding endoplasmic reticulum membrane protein responsible for beta-1,6-glucan synthesis in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GLUCAN SYNTHESIS; CELL-WALL; IN-VITRO; EXPLORATION; GENES; ACTIN; ROT1P	KEG1/YFR042w of Saccharomyces cerevisiae is an essential gene that encodes a 200-amino acid polypeptide with four predicted transmembrane domains. The green fluorescent protein or Myc(6)-tagged Keg1 protein showed the typical characteristics of an integral membrane protein and was found in the endoplasmic reticulum by fluorescence imaging. Immunoprecipitation from the Triton X-100-solubilized cell lysate revealed that Keg1 binds to Kre6, which has been known to participate in beta-1,6-glucan synthesis. To analyze the essential function of Keg1 in more detail, we constructed temperature-sensitive mutant alleles by error-prone polymerase chain reaction. The keg1-1 mutant cells showed a common phenotype with Delta kre6 mutant including hypersensitivity to Calcofluor white, reduced sensitivity to the K1 killer toxin, and reduced content of beta-1,6-glucan in the cell wall. These results suggest that Keg1 and Kre6 have a cooperative role in beta-1,6-glucan synthesis in S. cerevisiae.	Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan	University of Tokyo	Yoda, K (corresponding author), Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan.	asdfg@mail.ecc.u-tokyo.ac.jp	Kurita, Tomokazu/E-6346-2012					Azuma M, 2002, YEAST, V19, P783, DOI 10.1002/yea.873; Davierwala AP, 2005, NAT GENET, V37, P1147, DOI 10.1038/ng1640; Ecker M, 2006, J BIOL CHEM, V281, P11523, DOI 10.1074/jbc.M600314200; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hazbun TR, 2003, MOL CELL, V12, P1353, DOI 10.1016/S1097-2765(03)00476-3; Imai K, 2005, J BIOL CHEM, V280, P8275, DOI 10.1074/jbc.M409428200; Inadome H, 2005, MOL CELL BIOL, V25, P7696, DOI 10.1128/MCB.25.17.7696-7710.2005; Kagiwada S, 1998, J BACTERIOL, V180, P1700, DOI 10.1128/JB.180.7.1700-1708.1998; KILMARTIN JV, 1984, J CELL BIOL, V98, P922, DOI 10.1083/jcb.98.3.922; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; Li HJ, 2002, YEAST, V19, P1097, DOI 10.1002/yea.904; Machi K, 2004, MICROBIOL-SGM, V150, P3163, DOI 10.1099/mic.0.27292-0; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; MUHLRAD D, 1992, YEAST, V8, P79, DOI 10.1002/yea.320080202; ROEMER T, 1993, MOL CELL BIOL, V13, P4039, DOI 10.1128/MCB.13.7.4039; ROEMER T, 1991, P NATL ACAD SCI USA, V88, P11295, DOI 10.1073/pnas.88.24.11295; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Shahinian S, 2000, MOL MICROBIOL, V35, P477, DOI 10.1046/j.1365-2958.2000.01713.x; Takeuchi M, 2006, J BIOCHEM, V139, P597, DOI 10.1093/jb/mvj063; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Umeyama T, 2006, INFECT IMMUN, V74, P2373, DOI 10.1128/IAI.74.4.2373-2381.2006; Vashist S, 2002, MOL BIOL CELL, V13, P3955, DOI 10.1091/mbc.02-06-0090; Vink E, 2004, YEAST, V21, P1121, DOI 10.1002/yea.1156; Wooding S, 1998, MOL BIOL CELL, V9, P2667, DOI 10.1091/mbc.9.9.2667	26	17	19	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34315	34324		10.1074/jbc.M706486200	http://dx.doi.org/10.1074/jbc.M706486200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17893149	hybrid			2022-12-25	WOS:000251145700047
J	Wang, Y; Cipriano, DJ; Forgac, M				Wang, Yanru; Cipriano, Daniel J.; Forgac, Michael			Arrangement of subunits in the proteolipid ring of the V-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLAR H+-ATPASE; CROSS-LINKING; MUTATIONAL ANALYSIS; YEAST; ROTATION; BINDING; LOCALIZATION; SYNTHASE; MUTANTS; STALK	The vacuolar ATPases (V-ATPases) are multisubunit complexes containing two domains. The V-1 domain (subunits A-H) is peripheral and carries out ATP hydrolysis. The V-0 domain (subunits a, c, c', c '', d, and e) is membrane-integral and carries out proton transport. In yeast, there are three proteolipid subunits as follows: subunit c (Vma3p), subunit c' (Vma11p), and subunit c '' (Vma16p). The proteolipid subunits form a six-membered ring containing single copies of subunits c' and c '' and four copies of subunit c. To determine the possible arrangements of proteolipid subunits in V-0 that give rise to a functional V-ATPase complex, a series of gene fusions was constructed to constrain the arrangement of pairs of subunits in the ring. Fusions containing c '' employed a truncated version of this protein lacking the first putative transmembrane helix (which we have shown previously to be functional), to ensure that the N and C termini of all subunits were located on the luminal side of the membrane. Fusion constructs were expressed in strains disrupted in c', c '', or both but containing a wild copy of c to ensure the presence of the required number of copies of subunit c. The c-c ''(Delta TM1), c ''(Delta TM1)-c', and c'-c constructs all complemented the vma(-) phenotype and gave rise to complexes possessing greater than 25% of wild-type levels of activity. By contrast, neither the c-c', the c'-c ''(Delta TM1), nor the c ''(Delta TM1)-c constructs complemented the vma(-) phenotype. These results suggest that functionally assembled V-ATPase complexes contain the proteolipid subunits arranged in a unique order in the ring.	Tufts Univ, Sch Med, Dept Physiol, Boston, MA 02111 USA	Tufts University	Forgac, M (corresponding author), Tufts Univ, Sch Med, Dept Physiol, 136 Harrison Ave, Boston, MA 02111 USA.	michael.forgac@tufts.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034478, R01GM034478] Funding Source: NIH RePORTER; NIDDK NIH HHS [P30 DK034928, DK 34928] Funding Source: Medline; NIGMS NIH HHS [R37 GM034478-22, GM 34478, R37 GM034478-23, R37 GM034478-21, R37 GM034478, R01 GM034478] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abrami L, 2004, J CELL BIOL, V166, P645, DOI 10.1083/jcb.200312072; ARAI H, 1988, J BIOL CHEM, V263, P8796; Arata Y, 2002, BIOCHEMISTRY-US, V41, P11301, DOI 10.1021/bi0262449; Arata Y, 2002, J BIOL CHEM, V277, P3357, DOI 10.1074/jbc.M109967200; BAUERLE C, 1993, J BIOL CHEM, V268, P12749; Boekema EJ, 1999, NATURE, V401, P37, DOI 10.1038/43369; Dmitriev OY, 1999, P NATL ACAD SCI USA, V96, P7785, DOI 10.1073/pnas.96.14.7785; DOHERTY RD, 1993, J BIOL CHEM, V268, P16845; Fillingame RH, 2002, BBA-BIOENERGETICS, V1555, P29, DOI 10.1016/S0005-2728(02)00250-5; Flannery AR, 2004, J BIOL CHEM, V279, P39856, DOI 10.1074/jbc.M406767200; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Hirata R, 1997, J BIOL CHEM, V272, P4795, DOI 10.1074/jbc.272.8.4795; Hirata T, 2003, J BIOL CHEM, V278, P23714, DOI 10.1074/jbc.M302756200; Imamizu H, 2003, P NATL ACAD SCI USA, V100, P5461, DOI 10.1073/pnas.0835746100; Inoue T, 2005, J BIOENERG BIOMEMBR, V37, P393, DOI 10.1007/s10863-005-9478-8; Iwata M, 2004, P NATL ACAD SCI USA, V101, P59, DOI 10.1073/pnas.0305165101; Junge W, 1996, BER BUNSEN PHYS CHEM, V100, P2014, DOI 10.1002/bbpc.19961001215; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kawasaki-Nishi S, 2003, J BIOL CHEM, V278, P41908, DOI 10.1074/jbc.M308026200; Kawasaki-Nishi S, 2001, P NATL ACAD SCI USA, V98, P12397, DOI 10.1073/pnas.221291798; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li YP, 1999, NAT GENET, V23, P447, DOI 10.1038/70563; Liu JZ, 1996, BIOCHEMISTRY-US, V35, P10938, DOI 10.1021/bi9608065; MacLeod KJ, 1998, J BIOL CHEM, V273, P150, DOI 10.1074/jbc.273.1.150; Malkus P, 2004, MOL BIOL CELL, V15, P5075, DOI 10.1091/mbc.E04-06-0514; MANDEL M, 1988, P NATL ACAD SCI USA, V85, P5521, DOI 10.1073/pnas.85.15.5521; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; NELSON H, 1990, P NATL ACAD SCI USA, V87, P3503, DOI 10.1073/pnas.87.9.3503; Nelson N, 2003, J BIOENERG BIOMEMBR, V35, P281, DOI 10.1023/A:1025768529677; Nishi T, 2003, J BIOL CHEM, V278, P5821, DOI 10.1074/jbc.M209875200; PFEIFER K, 1987, CELL, V49, P9, DOI 10.1016/0092-8674(87)90750-1; Pietrement C, 2006, BIOL REPROD, V74, P185, DOI 10.1095/biolreprod.105.043752; Powell B, 2000, J BIOL CHEM, V275, P23654, DOI 10.1074/jbc.M004440200; Sambade M, 2004, J BIOL CHEM, V279, P17361, DOI 10.1074/jbc.M314104200; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Sun-Wada GH, 2004, BBA-BIOENERGETICS, V1658, P106, DOI 10.1016/j.bbabio.2004.04.013; SUPEK F, 1994, J BIOL CHEM, V269, P24102; UCHIDA E, 1985, J BIOL CHEM, V260, P1090; Vasilyeva E, 2000, J BIOL CHEM, V275, P255, DOI 10.1074/jbc.275.1.255; VIK SB, 1994, J BIOL CHEM, V269, P30364; Wagner CA, 2004, PHYSIOL REV, V84, P1263, DOI 10.1152/physrev.00045.2003; Wang YR, 2004, J BIOL CHEM, V279, P44628, DOI 10.1074/jbc.M407345200; Wilkens S, 2004, J BIOL CHEM, V279, P41942, DOI 10.1074/jbc.M407821200; ZHANG JM, 1992, J BIOL CHEM, V267, P9773	47	31	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34058	34065		10.1074/jbc.M704331200	http://dx.doi.org/10.1074/jbc.M704331200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17897940	Green Accepted, hybrid			2022-12-25	WOS:000251145700020
J	Geraghty, P; Greene, CM; O'Mahony, M; O'Neill, SJ; Taggart, CC; McElvaney, NG				Geraghty, Patrick; Greene, Catherine M.; O'Mahony, Michael; O'Neill, Shane J.; Taggart, Clifford C.; McElvaney, Noel G.			Secretory leucocyte protease inhibitor inhibits interferon-gamma-induced cathepsin S expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; SMOKE-INDUCED EMPHYSEMA; IFN-GAMMA; LEUCOPROTEASE INHIBITOR; DENDRITIC CELLS; MACROPHAGE ELASTASE; ANGSTROM RESOLUTION; CYSTEINE PROTEASE; T-LYMPHOCYTES; INFLAMMATION	We have demonstrated that bronchoalveolar lavage fluid from chronic obstructive pulmonary disease patients contains higher levels of interferon-gamma compared with controls. Interferon-gamma is a potent inducer of various cathepsins and matrix metalloproteases. Therefore, we postulated that interferon-gamma could induce protease expression by macrophages in acute and chronic lung disease. Chronic obstructive pulmonary disease patients had greater levels of cathepsin S and matrix metalloprotease-12 in their bronchoalveolar lavage fluid. Macrophages incubated with chronic obstructive pulmonary disease bronchoalveolar lavage fluid exhibited increased expression of cathepsin S and matrix metalloprotease-12, which was inhibited by the addition of interferon-gamma-neutralizing immunoglobulin. Human secretory leukocyte protease inhibitor is an 11.7-kDa cationic non-glycosylated antiprotease synthesized and secreted by cells at the site of inflammation. We have demonstrated that secretory leukocyte protease inhibitor can inhibit interferon-gamma-induced cathepsin S production by macrophages. Pretreatment of macrophages with secretory leukocyte protease inhibitor inhibited interferon-gamma-induced inhibitor kappa B beta degradation and activation of nuclear factor kappa B. Secretory leukocyte protease inhibitor may prove to be therapeutically important as a potential inhibitor of protease expression in chronic obstructive pulmonary disease.	Beaumont Hosp, RCSI Educ, Pulm Res Div, Dublin 9, Ireland	Royal College of Surgeons - Ireland	Taggart, CC (corresponding author), Beaumont Hosp, RCSI Educ, Pulm Res Div, Smurfit Bldg, Dublin 9, Ireland.	ctaggart@rcsi.ie	McElvaney, Noel/A-6809-2010; Taggart, Clifford C/G-4492-2014; Greene, Catherine M/D-3513-2012	Greene, Catherine M/0000-0003-2549-2569; Geraghty, Patrick/0000-0003-1647-5505; mcelvaney, Noel/0000-0002-0152-4370; Taggart, Clifford/0000-0002-9930-2978				ABE T, 1991, J CLIN INVEST, V87, P2207, DOI 10.1172/JCI115255; Churg A, 2007, AM J RESP CELL MOL, V37, P144, DOI 10.1165/rcmb.2006-0345OC; Fenton MJ, 1997, INFECT IMMUN, V65, P5149, DOI 10.1128/IAI.65.12.5149-5156.1997; Fiebiger E, 2001, J EXP MED, V193, P881, DOI 10.1084/jem.193.8.881; FINKELSTEIN R, 1995, AM J RESP CRIT CARE, V152, P1666, DOI 10.1164/ajrccm.152.5.7582312; Fukao T, 2001, J IMMUNOL, V166, P4446, DOI 10.4049/jimmunol.166.7.4446; FULTZ MJ, 1993, INT IMMUNOL, V5, P1383, DOI 10.1093/intimm/5.11.1383; GAUTHIER F, 1982, BIOCHIM BIOPHYS ACTA, V700, P178, DOI 10.1016/0167-4838(82)90095-4; Greene CM, 2004, INFECT IMMUN, V72, P3684, DOI 10.1128/IAI.72.6.3684-3687.2004; Grumelli S, 2004, PLOS MED, V1, P75, DOI 10.1371/journal.pmed.0010008; Guncar G, 1998, STRUCTURE, V6, P51; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Hiemstra PS, 2004, CURR PHARM DESIGN, V10, P2891, DOI 10.2174/1381612043383566; Hochrein H, 2001, J IMMUNOL, V166, P5448, DOI 10.4049/jimmunol.166.9.5448; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Jin FY, 1997, CELL, V88, P417, DOI 10.1016/S0092-8674(00)81880-2; Lams BEA, 2000, EUR RESPIR J, V15, P512, DOI 10.1034/j.1399-3003.2000.15.14.x; Lentsch AB, 1999, AM J PATHOL, V154, P239, DOI 10.1016/S0002-9440(10)65270-4; Ma B, 2005, J CLIN INVEST, V115, P3460, DOI 10.1172/JCI24858; Molet S, 2005, INFLAMM RES, V54, P31, DOI 10.1007/s00011-004-1319-4; Moriuchi H, 2000, J VIROL, V74, P6849, DOI 10.1128/JVI.74.15.6849-6855.2000; Nagler DK, 1999, BIOCHEMISTRY-US, V38, P12648, DOI 10.1021/bi991371z; Odaka C, 2003, J IMMUNOL, V171, P1507, DOI 10.4049/jimmunol.171.3.1507; Ohteki T, 1999, J EXP MED, V189, P1981, DOI 10.1084/jem.189.12.1981; OShaughnessy TC, 1997, AM J RESP CRIT CARE, V155, P852, DOI 10.1164/ajrccm.155.3.9117016; Pauwels R A, 2001, Respir Care, V46, P798; Puddu P, 1997, J IMMUNOL, V159, P3490; Punturieri A, 2000, J EXP MED, V192, P789, DOI 10.1084/jem.192.6.789; Rogan MP, 2004, J INFECT DIS, V190, P1245, DOI 10.1086/423821; Saeta M, 1999, AM J RESP CRIT CARE, V160, P711, DOI 10.1164/ajrccm.160.2.9812020; Saetta M, 1998, AM J RESP CRIT CARE, V157, P822, DOI 10.1164/ajrccm.157.3.9709027; Sandler NG, 2003, J IMMUNOL, V171, P3655, DOI 10.4049/jimmunol.171.7.3655; Schindler H, 2001, J IMMUNOL, V166, P3075, DOI 10.4049/jimmunol.166.5.3075; Schleicher U, 2005, BLOOD, V105, P1319, DOI 10.1182/blood-2004-05-1749; Schwarz G, 2002, J INVEST DERMATOL, V119, P44, DOI 10.1046/j.1523-1747.2002.01800.x; Taggart CC, 2005, J EXP MED, V202, P1659, DOI 10.1084/jem.20050768; Taggart CC, 2003, J IMMUNOL, V171, P931, DOI 10.4049/jimmunol.171.2.931; Taggart CC, 2002, J BIOL CHEM, V277, P33648, DOI 10.1074/jbc.M203710200; Taggart CC, 2001, J BIOL CHEM, V276, P33345, DOI 10.1074/jbc.M103220200; Turk D, 1996, FEBS LETT, V384, P211, DOI 10.1016/0014-5793(96)00309-2; Wang ZD, 2000, J EXP MED, V192, P1587, DOI 10.1084/jem.192.11.1587; Wiendl H, 2003, J NEUROIMMUNOL, V138, P132, DOI 10.1016/S0165-5728(03)00093-6; Zheng T, 2000, J CLIN INVEST, V106, P1081, DOI 10.1172/JCI10458; Zheng T, 2005, J IMMUNOL, V174, P8106, DOI 10.4049/jimmunol.174.12.8106	44	40	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33389	33395		10.1074/jbc.M706884200	http://dx.doi.org/10.1074/jbc.M706884200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17878156	hybrid			2022-12-25	WOS:000250840200018
J	Iwamoto, N; Sumi, D; Ishii, T; Uchida, K; Cho, AK; Froines, JR; Kumagai, Y				Iwamoto, Noriko; Sumi, Daigo; Ishii, Takeshi; Uchida, Koji; Cho, Arthur K.; Froines, John R.; Kumagai, Yoshito			Chemical knockdown of protein-tyrosine phosphatase 1B by 1,2-naphthoquinone through covalent modification causes persistent transactivation of epidermal growth factor receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIESEL EXHAUST PARTICLES; PARTICULATE MATTER; EPITHELIAL-CELLS; QUINONES; ROLES; REDOX; 9,10-PHENANTHRAQUINONE; PHENANTHRAQUINONE; PHOSPHORYLATION; INACTIVATION	1,2-Naphthoquinone (1,2-NQ), an atmospheric contaminant, causes the contraction of guinea pig trachea through the activation of epidermal growth factor receptor (EGFR) by inhibiting protein-tyrosine phosphatases (PTPs). Phosphorylation of EGFR is negatively regulated by PTPs, but details of the mechanism by which 1,2-NQ inhibits PTPs have not been elucidated. Results described in this report demonstrate that 1,2-NQ forms covalent bonds with PTP1B after exposure to human epithelial A431 cells. In this study, a concentration-dependent phosphorylation of EGFR was found to be coupled to the reduction of PTP activity in the cells. The reduction in PTP activity was due to the irreversible modification of PTP1B, and when PTP1B was overexpressed by the cells, the 1,2-NQ-mediated EGFR phosphorylation was suppressed. Studies with purified PTP1B and 1,2-NQ showed that the reduction in enzyme activity was due to a nucleophilic attack by the quinone on the enzyme, to form covalent bonds. Matrix-assisted laser desorption and ionization time-of-flight mass spectrometry analysis and mutation experiments revealed that PTP1B inactivation was primarily due to covalent attachment of the quinone to Cys-121 of the enzyme, with binding to His-25 and Cys-215 as well. Collectively, the results show that covalent attachment of 1,2-NQ to PTP1B is at least partially responsible for the reduction of PTP activity, which leads to prolonged transactivation of EGFR in the cells.	Univ Tsukuba, Grad Sch Comprehens Human Sci, Doctoral Programs Med Sci, Tsukuba, Ibaraki 3058575, Japan; Univ Shizuoka, Dept Food & Nutr Sci, Shizuoka 4228526, Japan; Univ Shizuoka, Global COE Program, Shizuoka 4228526, Japan; Nagoya Univ, Grad Sch Bioagr Sci, Lab Food & Biodynam, Nagoya, Aichi 4648601, Japan; Univ Calif Los Angeles, Inst Environm, So California Particle Ctr, Los Angeles, CA 90095 USA	University of Tsukuba; University of Shizuoka; University of Shizuoka; Nagoya University; University of California System; University of California Los Angeles	Kumagai, Y (corresponding author), Univ Tsukuba, Grad Sch Comprehens Human Sci, Doctoral Programs Med Sci, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058575, Japan.	yk-em-tu@md.tsukuba.ac.jp		Sumi, Daigo/0000-0002-1585-8013; Uchida, Koji/0000-0003-3894-5299				Abdelmohsen K, 2003, J BIOL CHEM, V278, P38360, DOI 10.1074/jbc.M306785200; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Ausubel F.M., 1992, SHORT PROTOCOLS MOL; BARFORD D, 1994, SCIENCE, V263, P1397, DOI 10.1126/science.8128219; BARFORD D, 1995, NAT STRUCT BIOL, V2, P1043, DOI 10.1038/nsb1295-1043; Barrett WC, 1999, J BIOL CHEM, V274, P34543, DOI 10.1074/jbc.274.49.34543; Bolton JL, 2000, CHEM RES TOXICOL, V13, P135, DOI 10.1021/tx9902082; Bonner JC, 2002, AM J PHYSIOL-LUNG C, V283, pL528, DOI 10.1152/ajplung.00126.2002; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUNMARK A, 1989, FREE RADICAL BIO MED, V7, P435, DOI 10.1016/0891-5849(89)90126-3; Caselli A, 1998, J BIOL CHEM, V273, P32554, DOI 10.1074/jbc.273.49.32554; Cho AK, 2004, AEROSOL SCI TECH, V38, P68, DOI 10.1080/02786820390229471; Chung MY, 2006, ENVIRON SCI TECHNOL, V40, P4880, DOI 10.1021/es0515957; Claiborne A, 1999, BIOCHEMISTRY-US, V38, P15407, DOI 10.1021/bi992025k; Haj FG, 2003, J BIOL CHEM, V278, P739, DOI 10.1074/jbc.M210194200; Hansen SK, 2005, BIOCHEMISTRY-US, V44, P7704, DOI 10.1021/bi047417s; Inoue K, 2007, EUR RESPIR J, V29, P259, DOI 10.1183/09031936.00033106; Kar S, 2003, BIOCHEMISTRY-US, V42, P10490, DOI 10.1021/bi027418p; Kikuno S, 2006, TOXICOL APPL PHARM, V210, P47, DOI 10.1016/j.taap.2005.06.015; KUMAGAI Y, 1994, MOL PHARMACOL, V45, P359; Kumagai Y, 2002, CHEM RES TOXICOL, V15, P483, DOI 10.1021/tx0100993; Kumagai Y, 2001, AM J PHYSIOL-REG I, V281, pR25, DOI 10.1152/ajpregu.2001.281.1.R25; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Lohse DL, 1997, BIOCHEMISTRY-US, V36, P4568, DOI 10.1021/bi963094r; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; Sugimoto R, 2005, FREE RADICAL BIO MED, V38, P388, DOI 10.1016/j.freeradbiomed.2004.11.003; Taguchi K, 2007, FREE RADICAL BIO MED, V43, P789, DOI 10.1016/j.freeradbiomed.2007.05.021; Tonks NK, 2003, FEBS LETT, V546, P140, DOI 10.1016/S0014-5793(03)00603-3; TONKS NK, 1988, J BIOL CHEM, V263, P6722; Urbanek RA, 2001, J MED CHEM, V44, P1777, DOI 10.1021/jm000447i; Valavanidis A, 2006, ENVIRON CHEM, V3, P118, DOI 10.1071/EN05089; Wu WD, 2001, AM J PHYSIOL-LUNG C, V281, pL483, DOI 10.1152/ajplung.2001.281.2.L483; Zhang ZY, 2002, ANNU REV PHARMACOL, V42, P209, DOI 10.1146/annurev.pharmtox.42.083001.144616; Zheng J, 1996, CHEM RES TOXICOL, V9, P904, DOI 10.1021/tx960014b	36	89	90	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33396	33404		10.1074/jbc.M705224200	http://dx.doi.org/10.1074/jbc.M705224200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17878162	hybrid			2022-12-25	WOS:000250840200019
J	Larkin, C; Haft, RJF; Harley, MJ; Traxler, B; Schildbach, JF				Larkin, Christopher; Haft, Rembrandt J. F.; Harley, Matthew J.; Traxler, Beth; Schildbach, Joel F.			Roles of active site residues and the HUH motif of the F plasmid TraI relaxase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; SEQUENCE-SPECIFIC BINDING; HELICASE-I CATALYZES; ESCHERICHIA-COLI; CONJUGATIVE RELAXASE; ORIGIN; PROTEINS; CLEAVAGE; DOMAIN; RECOGNITION	Bacterial conjugation, transfer of a single strand of a conjugative plasmid between bacteria, requires sequence-specific single-stranded DNA endonucleases called relaxases or nickases. Relaxases contain an HUH (His-hydrophobe-His) motif, part of a three-His cluster that binds a divalent cation required for the cleavage reaction. Crystal structures of the F plasmid TraI relaxase domain, with and without bound single-stranded DNA, revealed an extensive network of interactions involving HUH and other residues. Here we study the roles of these residues in TraI function. Whereas substitutions for the three His residues alter metal-binding properties of the protein, the same substitution at each position elicits different effects, indicating that the residues contribute asymmetrically to metal binding. Substitutions for a conserved Asp that interacts with one HUH His demonstrate that the Asp modulates metal affinity despite its distance from the metal. The bound metal enhances binding of ssDNA to the protein, consistent with a role for the metal in positioning the scissile phosphate for cleavage. Most substitutions tested caused significantly reduced in vitro cleavage activities and in vivo transfer efficiencies. In summary, the results suggest that the metal-binding His cluster in TraI is a finely tuned structure that achieves a sufficient affinity for metal while avoiding the unfavorable electrostatics that would result from placing an acidic residue near the scissile phosphate of the bound ssDNA.	Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	University of Washington; University of Washington Seattle; Johns Hopkins University	Schildbach, JF (corresponding author), Mudd Hall 235,3400 N Charles St, Baltimore, MD 21218 USA.	joel@jhu.edu		Schildbach, Joel/0000-0002-3038-9745	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270, R01GM061017] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM61017, T32 GM07270] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Boer R, 2006, J MOL BIOL, V358, P857, DOI 10.1016/j.jmb.2006.02.018; Byrd DR, 1997, MOL MICROBIOL, V25, P1011, DOI 10.1046/j.1365-2958.1997.5241885.x; Byrd DR, 2002, J BIOL CHEM, V277, P42645, DOI 10.1074/jbc.M205984200; Datta S, 2003, STRUCTURE, V11, P1369, DOI 10.1016/j.str.2003.10.001; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Draper O, 2005, P NATL ACAD SCI USA, V102, P16385, DOI 10.1073/pnas.0506081102; Dudev T, 2003, CHEM REV, V103, P773, DOI 10.1021/cr020467n; Fekete RA, 2000, J BACTERIOL, V182, P4022, DOI 10.1128/JB.182.14.4022-4027.2000; Galburt EA, 2002, BIOCHEMISTRY-US, V41, P13851, DOI 10.1021/bi020467h; Grandoso G, 2000, J MOL BIOL, V295, P1163, DOI 10.1006/jmbi.1999.3425; Guasch A, 2003, NAT STRUCT BIOL, V10, P1002, DOI 10.1038/nsb1017; Haft RJF, 2006, J BACTERIOL, V188, P6346, DOI 10.1128/JB.00462-06; Hickman AB, 2002, MOL CELL, V10, P327, DOI 10.1016/S1097-2765(02)00592-0; HOWARD MT, 1995, J BIOL CHEM, V270, P28381; ILYINA TV, 1992, NUCLEIC ACIDS RES, V20, P3279, DOI 10.1093/nar/20.13.3279; KOONIN EV, 1993, BIOSYSTEMS, V30, P241, DOI 10.1016/0303-2647(93)90074-M; Larkin C, 2005, STRUCTURE, V13, P1533, DOI 10.1016/j.str.2005.06.013; Lujan SA, 2007, P NATL ACAD SCI USA, V104, P12282, DOI 10.1073/pnas.0702760104; Mate MJ, 2004, J BIOL CHEM, V279, P34763, DOI 10.1074/jbc.M403719200; MATSON SW, 1991, J BIOL CHEM, V266, P16232; Monzingo AF, 2007, J MOL BIOL, V366, P165, DOI 10.1016/j.jmb.2006.11.031; NELSON WC, 1995, J BIOL CHEM, V270, P28374; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Reisner A, 2006, J BACTERIOL, V188, P3582, DOI 10.1128/JB.188.10.3582-3588.2006; REYGERS U, 1991, EMBO J, V10, P2689, DOI 10.1002/j.1460-2075.1991.tb07812.x; SHERMAN JA, 1994, J BIOL CHEM, V269, P26220; Stern JC, 2001, BIOCHEMISTRY-US, V40, P11586, DOI 10.1021/bi010877q; Stern JC, 2004, J BIOL CHEM, V279, P29155, DOI 10.1074/jbc.M402965200; Street LM, 2003, BBA-PROTEINS PROTEOM, V1646, P86, DOI 10.1016/S1570-9639(02)00553-8; Varsaki A, 2003, MOL MICROBIOL, V48, P481, DOI 10.1046/j.1365-2958.2003.03441.x; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Yoon-Robarts M, 2003, J BIOL CHEM, V278, P4912, DOI 10.1074/jbc.M209750200; Zechner E. L., 2000, HORIZONTAL GENE POOL, P87	34	23	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33707	33713		10.1074/jbc.M703210200	http://dx.doi.org/10.1074/jbc.M703210200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17890221	hybrid			2022-12-25	WOS:000250840200052
J	Elser, JJ; Kyle, MM; Smith, MS; Nagy, JD				Elser, James J.; Kyle, Marcia M.; Smith, Marilyn S.; Nagy, John D.			Biological Stoichiometry in Human Cancer	PLOS ONE			English	Article								Background. A growing tumor in the body can be considered a complex ecological and evolutionary system. A new eco-evolutionary hypothesis (the "Growth Rate Hypothesis'', GRH) proposes that tumors have elevated phosphorus (P) demands due to increased allocation to P-rich nucleic acids, especially ribosomal RNA, to meet the protein synthesis demands of accelerated proliferation. Methodology/Principal Findings. We determined the elemental (C, N, P) and nucleic acid contents of paired malignant and normal tissues from colon, lung, liver, or kidney for 121 patients. Consistent with the GRH, lung and colon tumors were significantly higher (by approximately two-fold) in P content (fraction of dry weight) and RNA content and lower in nitrogen (N): P ratio than paired normal tissue, and P in RNA contributed a significantly larger fraction of total biomass P in malignant relative to normal tissues. Furthermore, patient-specific differences for % P between malignant and normal tissues were positively correlated with such differences for % RNA, both for the overall data and within three of the four organ sites. However, significant differences in % P and % RNA between malignant and normal tissues were not seen in liver and kidney and, overall, RNA contributed only similar to 11% of total tissue P content. Conclusions/Significance. Data for lung and colon tumors provide support for the GRH in human cancer. The two-fold amplification of P content in colon and lung tumors may set the stage for potential P-limitation of their proliferation, as such differences often do for rapidly growing biota in ecosystems. However, data for kidney and liver do not support the GRH. To account for these conflicting observations, we suggest that local environments in some organs select for neoplastic cells bearing mutations increasing cell division rate ("r-selected,'' as in colon and lung) while conditions elsewhere may select for reduced mortality rate ("K-selected,'' as in liver and kidney).	[Elser, James J.; Kyle, Marcia M.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Smith, Marilyn S.] Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66103 USA; [Nagy, John D.] Scottsdale Community Coll, Dept Biol, Scottsdale, AZ USA	Arizona State University; Arizona State University-Tempe; University of Kansas; University of Kansas Medical Center	Elser, JJ (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	j.elser@asu.edu	Elser, James/A-7082-2008; Elser, James J/AAL-6199-2020	Elser, James/0000-0002-1460-2155; Elser, James J/0000-0002-1460-2155	National Science Foundation/National Institutes of Health [NSF DMS-0342388]; NIH [NSF DMS-0342325, NIH GM060792]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060792] Funding Source: NIH RePORTER	National Science Foundation/National Institutes of Health(National Science Foundation (NSF)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by a National Science Foundation/National Institutes of Health grant (NSF DMS-0342388) to JJE and JDN and by NSF/NIH and NIH grants (NSF DMS-0342325 and NIH GM060792) to MSS.	Amanzadeh J, 2006, NAT CLIN PRACT NEPHR, V2, P136, DOI 10.1038/ncpneph0124; APHA- American Public Health Association, 2005, AM PUBL HLTH ASS STA, V21; Cha YI, 2007, ANNU REV MED, V58, P239, DOI 10.1146/annurev.med.57.121304.131253; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; Ciarmatori S, 2001, MOL CELL BIOL, V21, P5806, DOI 10.1128/MCB.21.17.5806-5814.2001; Clegg LX, 2002, ARCH INTERN MED, V162, P1985, DOI 10.1001/archinte.162.17.1985; Elser JJ, 2003, ECOL LETT, V6, P936, DOI 10.1046/j.1461-0248.2003.00518.x; Elser JJ, 2003, BIOSCIENCE, V53, P1112, DOI 10.1641/0006-3568(2003)053[1112:BSAEPO]2.0.CO;2; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Gillooly JF, 2005, P NATL ACAD SCI USA, V102, P11923, DOI 10.1073/pnas.0504756102; Greaves M, 2007, NAT REV CANCER, V7, P213, DOI 10.1038/nrc2071; GU W, 1993, P NATL ACAD SCI USA, V90, P2935, DOI 10.1073/pnas.90.7.2935; JEWELL S, 2002, AM J CLIN PATHOL, V118, P1; Kumar R, 2000, BONE, V27, P333, DOI 10.1016/S8756-3282(00)00334-3; MAC ARTHUR ROBERT H., 1967; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Mutter GL, 2001, CANCER RES, V61, P4311; Nagata S, 1999, ANNU REV GENET, V33, P29, DOI 10.1146/annurev.genet.33.1.29; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Pitti RM, 1998, NATURE, V396, P699, DOI 10.1038/25387; Shu KX, 2007, COLLOID SURFACE B, V55, P10, DOI 10.1016/j.colsurfb.2006.11.003; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444	23	57	58	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1028	10.1371/journal.pone.0001028	http://dx.doi.org/10.1371/journal.pone.0001028			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925876	Green Published, Green Submitted, gold			2022-12-25	WOS:000207456000027
J	Schulz, TJ; Glaubitz, M; Kuhlow, D; Thierbach, R; Birringer, M; Steinberg, P; Pfeiffer, AFH; Ristow, M				Schulz, Tim J.; Glaubitz, Markus; Kuhlow, Doreen; Thierbach, Rene; Birringer, Marc; Steinberg, Pablo; Pfeiffer, Andreas F. H.; Ristow, Michael			Variable Expression of Cre Recombinase Transgenes Precludes Reliable Prediction of Tissue-Specific Gene Disruption by Tail-Biopsy Genotyping	PLOS ONE			English	Article								The Cre/loxP-system has become the system of choice for the generation of conditional so-called knockout mouse strains, i.e. the tissue-specific disruption of expression of a certain target gene. We here report the loss of expression of Cre recombinase in a transgenic mouse strain with increasing number of generations. This eventually led to the complete abrogation of gene expression of the inserted Cre cDNA while still being detectable at the genomic level. Conversely, loss of Cre expression caused an incomplete or even complete lack of disruption for the protein under investigation. As Cre expression in the tissue of interest in most cases cannot be addressed in vivo during the course of a study, our findings implicate the possibility that individual tail-biopsy genotypes may not necessarily indicate the presence or absence of gene disruption. This indicates that sustained post hoc analyses in regards to efficacy of disruption for every single study group member may be required.	[Schulz, Tim J.; Birringer, Marc; Ristow, Michael] Univ Jena, Inst Nutr, Jena, Germany; [Schulz, Tim J.; Glaubitz, Markus; Kuhlow, Doreen; Pfeiffer, Andreas F. H.; Ristow, Michael] German Inst Human Nutr, Potsdam, Germany; [Thierbach, Rene; Steinberg, Pablo] Univ Potsdam, Inst Nutr, Potsdam, Germany	Friedrich Schiller University of Jena; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); University of Potsdam	Ristow, M (corresponding author), Univ Jena, Inst Nutr, Jena, Germany.	mristow@mristow.org	Pfeiffer, Andreas F.H./AAJ-2311-2020; Ristow, Michael/O-9858-2014; Schulz, Tim/F-4842-2013	Pfeiffer, Andreas F.H./0000-0002-6887-0016; Ristow, Michael/0000-0003-2109-2453; Schulz, Tim/0000-0002-8413-3972; Birringer, Marc/0000-0003-0343-4704				BAKER WK, 1968, ADV GENET, V14, P133, DOI 10.1016/S0065-2660(08)60426-5; Dobie KW, 1996, P NATL ACAD SCI USA, V93, P6659, DOI 10.1073/pnas.93.13.6659; Feng YQ, 2001, MOL CELL BIOL, V21, P298, DOI 10.1128/MCB.21.1.298-309.2001; FLANAGAN JR, 1989, MOL CELL BIOL, V9, P739, DOI 10.1128/MCB.9.2.739; Garrick D, 1996, NUCLEIC ACIDS RES, V24, P4902, DOI 10.1093/nar/24.24.4902; Goldman IL, 2004, MED SCI MONITOR, V10, pRA274; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; HAMANAKA S, 2006, MOL THER; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Ristow M, 2003, J CLIN INVEST, V112, P527, DOI 10.1172/JCI200318107; Robertson G, 1996, NUCLEIC ACIDS RES, V24, P1465, DOI 10.1093/nar/24.8.1465; Shoichet SA, 2002, HUM MOL GENET, V11, P815, DOI 10.1093/hmg/11.7.815; SINGH PB, 1994, J CELL SCI, V107, P2653; Siomi MC, 2005, RNA, V11, P1004, DOI 10.1261/rna.2280105; SPOFFORD JB, 1959, P NATL ACAD SCI USA, V45, P1003, DOI 10.1073/pnas.45.7.1003; Swindle CS, 2004, J BIOL CHEM, V279, P34, DOI 10.1074/jbc.M309128200; Thierbach R, 2005, HUM MOL GENET, V14, P3857, DOI 10.1093/hmg/ddi410	22	23	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1013	10.1371/journal.pone.0001013	http://dx.doi.org/10.1371/journal.pone.0001013			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925861	Green Submitted, Green Published, gold			2022-12-25	WOS:000207456000012
J	Tarnopolsky, M; Zimmer, A; Paikin, J; Safdar, A; Aboud, A; Pearce, E; Roy, B; Doherty, T				Tarnopolsky, Mark; Zimmer, Andrew; Paikin, Jeremy; Safdar, Adeel; Aboud, Alissa; Pearce, Erin; Roy, Brian; Doherty, Timothy			Creatine Monohydrate and Conjugated Linoleic Acid Improve Strength and Body Composition Following Resistance Exercise in Older Adults	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; C-REACTIVE PROTEIN; FAT MASS; SATELLITE CELL; ELDERLY-MEN; LIPID-PEROXIDATION; ORAL CREATINE; INSULIN SENSITIVITY; METABOLIC SYNDROME; OXIDATIVE STRESS	Aging is associated with lower muscle mass and an increase in body fat. We examined whether creatine monohydrate (CrM) and conjugated linoleic acid (CLA) could enhance strength gains and improve body composition (i.e., increase fat-free mass (FFM); decrease body fat) following resistance exercise training in older adults (>65 y). Men (N = 19) and women (N = 20) completed six months of resistance exercise training with CrM (5g/d)+CLA (6g/d) or placebo with randomized, double blind, allocation. Outcomes included: strength and muscular endurance, functional tasks, body composition (DEXA scan), blood tests (lipids, liver function, CK, glucose, systemic inflammation markers (IL-6, C-reactive protein)), urinary markers of compliance (creatine/creatinine), oxidative stress (8-OH-2dG, 8-isoP) and bone resorption (N-telopeptides). Exercise training improved all measurements of functional capacity (P < 0.05) and strength (P < 0.001), with greater improvement for the CrM+CLA group in most measurements of muscular endurance, isokinetic knee extension strength, FFM, and lower fat mass (P < 0.05). Plasma creatinine (P < 0.05), but not creatinine clearance, increased for CrM+CLA, with no changes in serum CK activity or liver function tests. Together, this data confirms that supervised resistance exercise training is safe and effective for increasing strength in older adults and that a combination of CrM and CLA can enhance some of the beneficial effects of training over a six-month period.	[Tarnopolsky, Mark; Zimmer, Andrew; Paikin, Jeremy; Safdar, Adeel; Aboud, Alissa; Pearce, Erin] McMaster Univ, Dept Pediat & Med, Hamilton, ON, Canada; [Roy, Brian] Brock Univ, Dept Phys Educ & Kinesiol, St Catharines, ON L2S 3A1, Canada; [Doherty, Timothy] Univ Western Ontario, Dept Clin Neurol Sci, London, ON, Canada; [Doherty, Timothy] Univ Western Ontario, Dept Phys Med & Rehabil, London, ON, Canada	McMaster University; Brock University; Western University (University of Western Ontario); Western University (University of Western Ontario)	Tarnopolsky, M (corresponding author), McMaster Univ, Dept Pediat & Med, Hamilton, ON, Canada.	tarnopol@mcmaster.ca	Roy, Brian/V-6612-2019; Doherty, Timothy/H-3576-2015	Roy, Brian/0000-0003-4638-5586; Hatcher, Erin/0000-0002-3638-4742; Safdar, Adeel/0000-0003-2469-0467	Canadian Institute of Health Research	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This study was funded entirely by the Canadian Institute of Health Research.	Banz WJ, 2003, EXP BIOL MED, V228, P434, DOI 10.1177/153537020322800414; Basu S, 2000, CLIN SCI, V99, P511, DOI 10.1042/cs0990511; Belury MA, 2002, ANNU REV NUTR, V22, P505, DOI 10.1146/annurev.nutr.22.021302.121842; Bermon S, 1998, ACTA PHYSIOL SCAND, V164, P147, DOI 10.1046/j.1365-201X.1998.00427.x; Blankson H, 2000, J NUTR, V130, P2943, DOI 10.1093/jn/130.12.2943; Bluher M, 2006, J CLIN ENDOCR METAB, V91, P2310, DOI 10.1210/jc.2005-2556; Borst SE, 2004, AGE AGEING, V33, P548, DOI 10.1093/ageing/afh201; BOYDEN TW, 1993, ARCH INTERN MED, V153, P97, DOI 10.1001/archinte.153.1.97; Brose A, 2003, J GERONTOL A-BIOL, V58, P11; Bruun JM, 2006, AM J PHYSIOL-ENDOC M, V290, pE961, DOI 10.1152/ajpendo.00506.2005; Busetto L, 2001, NUTR METAB CARDIOVAS, V11, P195; Castaneda C, 2002, DIABETES CARE, V25, P2335, DOI 10.2337/diacare.25.12.2335; Castillo EM, 2003, AM J PREV MED, V25, P226, DOI 10.1016/S0749-3797(03)00197-1; CHARETTE SL, 1991, J APPL PHYSIOL, V70, P1912, DOI 10.1152/jappl.1991.70.5.1912; Chilibeck PD, 2002, CAN J PHYSIOL PHARM, V80, P941, DOI 10.1139/y02-126; Chrusch MJ, 2001, MED SCI SPORT EXER, V33, P2111, DOI 10.1097/00005768-200112000-00021; Dangott B, 2000, INT J SPORTS MED, V21, P13, DOI 10.1055/s-2000-8848; Dreyer HC, 2006, MUSCLE NERVE, V33, P242, DOI 10.1002/mus.20461; Dunstan DW, 2002, DIABETES CARE, V25, P1729, DOI 10.2337/diacare.25.10.1729; Eijnde BO, 2003, J APPL PHYSIOL, V95, P818, DOI 10.1152/japplphysiol.00891.2002; Fatouros IG, 2005, J CLIN ENDOCR METAB, V90, P5970, DOI 10.1210/jc.2005-0261; FIATARONE MA, 1994, NEW ENGL J MED, V330, P1769, DOI 10.1056/NEJM199406233302501; Gaullier JM, 2005, J NUTR, V135, P778; Gaullier JM, 2004, AM J CLIN NUTR, V79, P1118; Gerber I, 2005, Eur Cell Mater, V10, P8; Gillette-Goyonnet S, 2003, MECH AGEING DEV, V124, P311, DOI 10.1016/S0047-6374(02)00198-7; Green JS, 2004, METABOLISM, V53, P1192, DOI 10.1016/j.metabol.2004.04.008; Halbert JA, 1999, EUR J CLIN NUTR, V53, P514, DOI 10.1038/sj.ejcn.1600784; Hespel P, 2001, J PHYSIOL-LONDON, V536, P625, DOI 10.1111/j.1469-7793.2001.0625c.xd; Kelley DS, 2004, LIPIDS, V39, P135, DOI 10.1007/s11745-004-1211-9; Kim HK, 2005, J NUTR SCI VITAMINOL, V51, P8, DOI 10.3177/jnsv.51.8; Kohrt WM, 2001, INT J SPORT NUTR EXE, V11, pS137, DOI 10.1123/ijsnem.11.s1.s137; Kreider RB, 1998, MED SCI SPORT EXER, V30, P73, DOI 10.1097/00005768-199801000-00011; Kreider RB, 2002, J STRENGTH COND RES, V16, P325; Lambert CP, 2002, J CLIN ENDOCR METAB, V87, P2100, DOI 10.1210/jc.87.5.2100; Lau EMC, 2005, J GERONTOL A-BIOL, V60, P213, DOI 10.1093/gerona/60.2.213; Louis M, 2003, MUSCLE NERVE, V27, P604, DOI 10.1002/mus.10355; Luukinen H, 1997, J AM GERIATR SOC, V45, P1302, DOI 10.1111/j.1532-5415.1997.tb02928.x; Mackey AL, 2007, SCAND J MED SCI SPOR, V17, P34, DOI 10.1111/j.1600-0838.2006.00534.x; Marcell TJ, 2005, METABOLISM, V54, P533, DOI 10.1016/j.metabol.2004.11.008; McAnulty SR, 2005, FREE RADICAL RES, V39, P1219, DOI 10.1080/10725760500317536; Mihic S, 2000, MED SCI SPORT EXER, V32, P291, DOI 10.1097/00005768-200002000-00007; Monzillo LU, 2003, OBES RES, V11, P1048, DOI 10.1038/oby.2003.144; Mullins Nicole M, 2005, Nutr Metab (Lond), V2, P19, DOI 10.1186/1743-7075-2-19; NEWMAN AB, 2003, J AM GERIATR SOC, V51, P1602, DOI DOI 10.1046/J.1532-5415.2003.51534.X; O'Leary VB, 2006, J APPL PHYSIOL, V100, P1584, DOI 10.1152/japplphysiol.01336.2005; Olsen S, 2006, J PHYSIOL-LONDON, V573, P525, DOI 10.1113/jphysiol.2006.107359; Onat A, 2004, INT J OBESITY, V28, P1018, DOI 10.1038/sj.ijo.0802695; Parise G, 2005, FREE RADICAL BIO MED, V39, P289, DOI 10.1016/j.freeradbiomed.2005.03.024; Parise G, 2005, EXP GERONTOL, V40, P173, DOI 10.1016/j.exger.2004.09.002; Parise G, 2001, J APPL PHYSIOL, V91, P1041, DOI 10.1152/jappl.2001.91.3.1041; Poortmans JR, 1999, MED SCI SPORT EXER, V31, P1108, DOI 10.1097/00005768-199908000-00005; Poortmans JR, 1997, EUR J APPL PHYSIOL O, V76, P566, DOI 10.1007/s004210050291; Riserus U, 2004, AM J CLIN NUTR, V80, P279; Riserus U, 2002, CIRCULATION, V106, P1925, DOI 10.1161/01.CIR.0000033589.15413.48; RODRIGUEZ MC, 2006, MUSCLE NERVE; Sartorio A, 2001, J ENDOCRINOL INVEST, V24, P882, DOI 10.1007/BF03343946; Sebedio JL, 2001, LIPIDS, V36, P575, DOI 10.1007/s11745-001-0759-8; Shadid S, 2006, J CLIN ENDOCR METAB, V91, P3418, DOI 10.1210/jc.2006-0015; Short KR, 2003, DIABETES, V52, P1888, DOI 10.2337/diabetes.52.8.1888; SINGH B, 2006, CLIN CHIM ACTA; SKELTON DA, 1995, J AM GERIATR SOC, V43, P1081, DOI 10.1111/j.1532-5415.1995.tb07004.x; Sturnieks DL, 2004, J RHEUMATOL, V31, P2272; Taaffe DR, 1999, J AM GERIATR SOC, V47, P1208, DOI 10.1111/j.1532-5415.1999.tb05201.x; Takahashi Y, 2003, BBA-MOL CELL BIOL L, V1631, P265, DOI 10.1016/S1388-1981(03)00038-6; Tarnopolsky MA, 2004, NEUROLOGY, V62, P1771, DOI 10.1212/01.WNL.0000125178.18862.9D; Tarnopolsky MA, 1997, MUSCLE NERVE, V20, P1502, DOI 10.1002/(SICI)1097-4598(199712)20:12<1502::AID-MUS4>3.0.CO;2-C; Tarnopolsky MA, 2001, MED SCI SPORT EXER, V33, P2044, DOI 10.1097/00005768-200112000-00011; Tricon S, 2005, P NUTR SOC, V64, P171, DOI 10.1079/PNS2005418; Vierck JL, 2003, MED SCI SPORT EXER, V35, P769, DOI 10.1249/01.MSS.0000065005.96298.01; Vincent KR, 2002, MED SCI SPORT EXER, V34, P17, DOI 10.1097/00005768-200201000-00004; Volek JS, 1999, MED SCI SPORT EXER, V31, P1147, DOI 10.1097/00005768-199908000-00011; Wang YW, 2004, INT J OBESITY, V28, P941, DOI 10.1038/sj.ijo.0802641; Watson TA, 2005, INT J SPORT NUTR EXE, V15, P131, DOI 10.1123/ijsnem.15.2.131; Wendel AA, 2006, LIPIDS, V41, P241, DOI 10.1007/s11745-006-5093-7; Whigham LD, 2004, FOOD CHEM TOXICOL, V42, P1701, DOI 10.1016/j.fct.2004.06.008; Willoughby DS, 2001, MED SCI SPORT EXER, V33, P1674, DOI 10.1097/00005768-200110000-00010; Wilund KR, 2002, METABOLISM, V51, P774, DOI 10.1053/meta.2002.32730; Xu XF, 2003, J NUTR, V133, P663, DOI 10.1093/jn/133.3.663	79	107	110	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e991	10.1371/journal.pone.0000991	http://dx.doi.org/10.1371/journal.pone.0000991			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912368	Green Submitted, Green Published, gold			2022-12-25	WOS:000207455900027
J	Ortega, R; Cloetens, P; Deves, G; Carmona, A; Bohic, S				Ortega, Richard; Cloetens, Peter; Deves, Guillaume; Carmona, Asuncion; Bohic, Sylvain			Iron Storage within Dopamine Neurovesicles Revealed by Chemical Nano-Imaging	PLOS ONE			English	Article								Altered homeostasis of metal ions is suspected to play a critical role in neurodegeneration. However, the lack of analytical technique with sufficient spatial resolution prevents the investigation of metals distribution in neurons. An original experimental setup was developed to perform chemical element imaging with a 90 nm spatial resolution using synchrotron-based X-ray fluorescence. This unique spatial resolution, combined to a high brightness, enables chemical element imaging in subcellular compartments. We investigated the distribution of iron in dopamine producing neurons because iron-dopamine compounds are suspected to be formed but have yet never been observed in cells. The study shows that iron accumulates into dopamine neurovesicles. In addition, the inhibition of dopamine synthesis results in a decreased vesicular storage of iron. These results indicate a new physiological role for dopamine in iron buffering within normal dopamine producing cells. This system could be at fault in Parkinson's disease which is characterized by an increased level of iron in the substancia nigra pars compacta and an impaired storage of dopamine due to the disruption of vesicular trafficking. The re-distribution of highly reactive dopamine-iron complexes outside neurovesicles would result in an enhanced death of dopaminergic neurons.	[Ortega, Richard; Deves, Guillaume] Univ Bordeaux 1, CNRS, Cellular Chem Imaging & Speciat Grp, Gradignan, France; [Cloetens, Peter] European Synchrotron Radiat Facil, Xray Imaging Grp, F-38043 Grenoble, France; [Carmona, Asuncion] Univ Seville, Ctr Nacl Aceleradores, Seville, Spain; [Bohic, Sylvain] European Synchrotron Radiat Facil, Grenoble Inst Neurosci, INSERM, Equipe Rayonnement Synchrotron & Rech Med,U836, F-38043 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; European Synchrotron Radiation Facility (ESRF); Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC - Centro Nacional de Aceleradores (CNA); European Synchrotron Radiation Facility (ESRF); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Ortega, R (corresponding author), Univ Bordeaux 1, CNRS, Cellular Chem Imaging & Speciat Grp, Gradignan, France.	ortega@cenbg.in2p3.fr	Cloetens, Peter/AAJ-6131-2020; Guillaume, Devès/R-9727-2019; BOHIC, Sylvain/F-6464-2013	Cloetens, Peter/0000-0002-4129-9091; Guillaume, Devès/0000-0002-3401-8351; BOHIC, Sylvain/0000-0001-6355-7592; Ortega, Richard/0000-0003-1692-5406; Carmona, Asuncion/0000-0002-9253-4581	CNRS (Centre National de la Recherche Scientifique); ESRF (European Synchrotron Radiation Facility); European program of integrated action Picasso	CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); ESRF (European Synchrotron Radiation Facility); European program of integrated action Picasso	This work was supported by fundings from the CNRS (Centre National de la Recherche Scientifique); the ESRF (European Synchrotron Radiation Facility); and the European program of integrated action Picasso.	Ben Shachar D, 2004, NEUROPHARMACOLOGY, V46, P254, DOI 10.1016/j.neuropharm.2003.09.005; Bohic S, 2001, APPL PHYS LETT, V78, P3544, DOI 10.1063/1.1366362; Bossy-Wetzel E, 2004, NAT MED, V10, pS2, DOI 10.1038/nm1067; Clarke SJ, 2006, NAT MATER, V5, P409, DOI 10.1038/nmat1631; DEXTER DT, 1987, LANCET, V2, P1219; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; FALCK B, 1962, J HISTOCHEM CYTOCHEM, V10, P348, DOI 10.1177/10.3.348; Gaeta A, 2005, BRIT J PHARMACOL, V146, P1041, DOI 10.1038/sj.bjp.0706416; GALVANI P, 1995, TOXICOL IN VITRO, V9, P365, DOI 10.1016/0887-2333(95)00031-3; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Griffiths PD, 1999, BRAIN, V122, P667, DOI 10.1093/brain/122.4.667; Hignette O, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1928191; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; KASTNER A, 1993, BRAIN RES, V606, P341, DOI 10.1016/0006-8993(93)91005-D; Kaur D, 2003, NEURON, V37, P899, DOI 10.1016/S0896-6273(03)00126-0; Ke Y, 2003, LANCET NEUROL, V2, P246, DOI 10.1016/S1474-4422(03)00353-3; KIRKPATRICK P, 1948, J OPT SOC AM, V38, P766, DOI 10.1364/JOSA.38.000766; Lashuel HA, 2006, ACS CHEM BIOL, V1, P420, DOI 10.1021/cb600331e; Linert W, 2000, J INORG BIOCHEM, V79, P319, DOI 10.1016/S0162-0134(99)00238-X; LIU YJ, 1994, J CELL BIOL, V127, P1419, DOI 10.1083/jcb.127.5.1419; Lotharius J, 2002, NAT REV NEUROSCI, V3, P932, DOI 10.1038/nrn983; Mori F, 2006, J NEUROPATH EXP NEUR, V65, P808, DOI 10.1097/01.jnen.0000230520.47768.1a; Ortega R, 1996, CELL MOL BIOL, V42, P77; Ortega R, 2004, ANAL CHEM, V76, P309, DOI 10.1021/ac035037r; Paris I, 2005, CHEM RES TOXICOL, V18, P415, DOI 10.1021/tx0497144; Quintana C, 2006, J STRUCT BIOL, V153, P42, DOI 10.1016/j.jsb.2005.11.001; Reaney SH, 2005, TOXICOL APPL PHARM, V205, P271, DOI 10.1016/j.taap.2004.10.013; RIEDERER P, 1989, J NEUROCHEM, V52, P515, DOI 10.1111/j.1471-4159.1989.tb09150.x; Rouault TA, 2001, NAT GENET, V28, P299, DOI 10.1038/91036; Smythies J, 1999, NEUROTOX RES, V1, P27, DOI 10.1007/BF03033337; Sole VA, 2007, SPECTROCHIM ACTA B, V62, P63, DOI 10.1016/j.sab.2006.12.002; TISCHLER AS, 1978, LAB INVEST, V39, P77; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Zhang PJ, 2005, J STRUCT BIOL, V150, P144, DOI 10.1016/j.jsb.2005.01.007; ZIEROLD K, 1984, HISTOCHEMISTRY, V80, P333, DOI 10.1007/BF00495413	35	127	128	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e925	10.1371/journal.pone.0000925	http://dx.doi.org/10.1371/journal.pone.0000925			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895967	gold, Green Published			2022-12-25	WOS:000207455800005
J	Webb, TJ; Freckleton, RP				Webb, Thomas J.; Freckleton, Robert P.			Only Half Right: Species with Female-Biased Sexual Size Dimorphism Consistently Break Rensch's Rule	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; BODY-SIZE; WATER STRIDER; ALLOMETRY; EVOLUTION; PATTERNS; SELECTION; ECOLOGY; MASS	Background. Most animal species display Sexual Size Dimorphism (SSD): males and females consistently attain different sizes, most frequently with females being larger than males. However the selective mechanisms driving patterns of SSD remain controversial. 'Rensch's rule' proposes a general scaling phenomenon for all taxa, whereby SSD increases with average body size when males are larger than females, and decreases with body size when females are larger than males. Rensch's rule appears to be general in the former case, but there is little evidence for the rule when females are larger then males. Methodology/Principal Findings. Using comprehensive data for 1291 species of birds across 30 families, we find strong support for Rensch's rule in families where males are typically larger than females, but no overall support for the rule in families with female-biased SSD. Reviewing previous studies of a broad range of taxa (arthropods, reptiles, fish and birds) showing predominantly female-biased SSD, we conclude that Rensch's conjecture is the exception rather than the rule in such species. Conclusions/Significance. The absence of consistent scaling of SSD in taxa with female-biased SSD, the most prevalent direction of dimorphism, calls into question previous general evolutionary explanations for Rensch's rule. We propose that, unlike several other ecological scaling relationships, Rensch's rule does not exist as an independent scaling phenomenon.	[Webb, Thomas J.; Freckleton, Robert P.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Webb, TJ (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	t.j.webb@sheffield.ac.uk	Freckleton, Rob P/B-6455-2013; Webb, Tom/D-5224-2011	Webb, Tom/0000-0003-3183-8116; Freckleton, Robert/0000-0002-8338-864X	NERC [NE/C004167/1]	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by NERC grant NE/C004167/1 to RPF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouheif E, 1997, AM NAT, V149, P540, DOI 10.1086/286004; Andersen NM, 1997, BIOL J LINN SOC, V61, P345, DOI 10.1111/j.1095-8312.1997.tb01796.x; [Anonymous], 1994, SEXUAL SELECTION; Baker RH, 2001, EVOLUTION, V55, P1373; BENNETT PM, 2002, EVOLUTIONARY ECOLOGY; Blanckenhorn WU, 2007, AM NAT, V169, P245, DOI 10.1086/510597; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Catry P, 1999, AUK, V116, P158, DOI 10.2307/4089462; CLUTTONBROCK TH, 1977, NATURE, V269, P797, DOI 10.1038/269797a0; Colwell RK, 2000, AM NAT, V156, P495, DOI 10.1086/303406; COOK JR, 1994, J AM STAT ASSOC, V89, P1314, DOI 10.2307/2290994; FAIRBAIRN DJ, 1994, AM NAT, V144, P101, DOI 10.1086/285663; Fairbairn DJ, 1997, ANNU REV ECOL SYST, V28, P659, DOI 10.1146/annurev.ecolsys.28.1.659; Fairbairn DJ, 2005, AM NAT, V166, pS69, DOI 10.1086/444600; Fairbairn DJ, 2007, SEX SIZE GENDER ROLE; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Hormiga G, 2000, SYST BIOL, V49, P435, DOI 10.1080/10635159950127330; Huey RB, 2006, ZOOLOGY, V109, P318, DOI 10.1016/j.zool.2006.04.003; Jannot JE, 2003, CAN J ZOOL, V81, P1956, DOI 10.1139/Z03-194; Johansson F, 2005, BIOL J LINN SOC, V86, P507, DOI 10.1111/j.1095-8312.2005.00549.x; Kodric-Brown A, 2006, P NATL ACAD SCI USA, V103, P8733, DOI 10.1073/pnas.0602994103; Kratochvil L, 2002, BIOL J LINN SOC, V76, P303, DOI 10.1046/j.1095-8312.2002.00064.x; MUELLER HC, 1986, WILSON BULL, V98, P387; Orme CDL, 2006, PLOS BIOL, V4, P1276, DOI 10.1371/journal.pbio.0040208; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Phillimore AB, 2006, AM NAT, V168, P220, DOI 10.1086/505763; PITNICK S, 1995, P NATL ACAD SCI USA, V92, P10614, DOI 10.1073/pnas.92.23.10614; Pyron M, 1996, BIOL J LINN SOC, V57, P327; REISS MJ, 1986, J THEOR BIOL, V121, P163, DOI 10.1016/S0022-5193(86)80090-X; Rensch B., 1959, EVOLUTION SPECIES LE; Roff Derek A., 1992; Sibley CG, 1990, PHYLOGENY CLASSIFICA; SIVINSKI JM, 1992, J INSECT BEHAV, V5, P491, DOI 10.1007/BF01058194; Smith RJ, 1997, J HUM EVOL, V32, P523, DOI 10.1006/jhev.1996.0122; Smith RJ, 2002, INT J PRIMATOL, V23, P1095, DOI 10.1023/A:1019654100876; Smith RJ, 1999, J HUM EVOL, V36, P423, DOI 10.1006/jhev.1998.0281; Szekely T, 2004, P NATL ACAD SCI USA, V101, P12224, DOI 10.1073/pnas.0404503101; Tubaro PL, 2003, BIOL J LINN SOC, V80, P519, DOI 10.1046/j.1095-8312.2003.00252.x; WEBSTER MS, 1992, EVOLUTION, V46, P1621, DOI 10.1111/j.1558-5646.1992.tb01158.x; Whittingham MJ, 2006, J ANIM ECOL, V75, P1182, DOI 10.1111/j.1365-2656.2006.01141.x; [No title captured]; [No title captured]; [No title captured]; [No title captured]	44	89	95	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2007	2	9							e897	10.1371/journal.pone.0000897	http://dx.doi.org/10.1371/journal.pone.0000897			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HS	17878932	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000207455700005
J	Barbetti, V; Gozzini, A; Rovida, E; Morandi, A; Spinelli, E; Fossati, G; Mascagni, P; Lubbert, M; Dello Sbarba, P; Santini, V				Barbetti, V.; Gozzini, A.; Rovida, E.; Morandi, A.; Spinelli, E.; Fossati, G.; Mascagni, P.; Luebbert, M.; Dello Sbarba, P.; Santini, V.			Selective anti-leukaemic activity of low-dose histone deacetylase inhibitor ITF2357 on AML1/ETO-positive cells	ONCOGENE			English	Article						AML; AML1/ETO; HDAC inhibitors; gene expression	ACUTE MYELOID-LEUKEMIA; NF-KAPPA-B; TRANSCRIPTION FACTORS; FUSION PARTNER; HEPATOMA-CELLS; RETINOIC ACID; IN-VITRO; APOPTOSIS; TARGET; ACETYLATION	We analysed the in vitro effects of a new hydroxamate derivative, ITF2357, on AML cells. ITF2357 potently induced histone acetylation. ITF2357 0.1 mu M blocked proliferation and induced apoptosis in AML1/ETO-positive Kasumi-1 cells, while AML1/ETO-negative HL60, THP1 and NB4 cell lines were sensitive only to 1 mu M ITF2357. Apoptosis was induced by 0.1 mu M ITF2357 in AML1/ETO-positive primary blasts and U937-A/E cells induced to express AML1/ETO, but not in U937-A/E cells non-expressing AML1/ETO. In Kasumi-1 cells 0.1 mu M ITF2357 induced AML1/ETO degradation through a caspase-dependent mechanism. ITF2357 0.1 mu M also determined DNMT1 efflux from, and p300 influx to, the nucleus. Moreover, 0.1 mu M ITF2357 determined local H4 acetylation and release of DNMT1, HDAC1 and AML1/ETO, paralleled by recruitment of p300 to the IL-3 gene promoter. ITF2357 treatment, however, did not induce re-expression of IL-3 gene. Accordingly, the methylation level of IL-3 promoter, as well as of several other genes, was unmodified. In conclusion, ITF2357 emerged as an antileukaemic agent very potent on AML cells, and on AML1/ETO-positive cells in particular. More relevantly, clearly emerged from our results that ITF2357 could be an ideal agent to treat AML subtypes presenting AML1/ETO fusion protein which determine HDAC involvement in leukaemogenesis.	[Gozzini, A.; Spinelli, E.; Santini, V.] Univ Florence, UF Ematol, AOU Careggi, I-50134 Florence, Italy; [Barbetti, V.; Rovida, E.; Morandi, A.; Dello Sbarba, P.] Univ Florence, Dipartimento Patol Oncol Sperimentali, I-50134 Florence, Italy; [Luebbert, M.] Univ Freiburg, Dept Med, D-7800 Freiburg, Germany; [Fossati, G.; Mascagni, P.] Italfarmaco SpA, Milan, Italy	University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Florence; University of Freiburg; Italfarmaco	Santini, V (corresponding author), Univ Florence, UF Ematol, AOU Careggi, Viale GB Morgagni 85, I-50134 Florence, Italy.	santini@unifi.it	Rovida, Elisabetta/F-3565-2015; Dello Sbarba, Persio/AAX-9887-2020; SANTINI, VALERIA/AAL-3135-2020	Rovida, Elisabetta/0000-0002-5949-3239; SANTINI, VALERIA/0000-0002-5439-2172; Morandi, Andrea/0000-0002-9222-5332				Alcalay M, 2001, ONCOGENE, V20, P5680, DOI 10.1038/sj.onc.1204642; Altucci L, 2005, CANCER RES, V65, P8754, DOI 10.1158/0008-5472.CAN-04-3569; Armeanu S, 2005, J HEPATOL, V42, P210, DOI 10.1016/j.jhep.2004.10.020; ASOU H, 1991, BLOOD, V77, P2031; Atsumi A, 2006, BIOCHEM BIOPH RES CO, V345, P1471, DOI 10.1016/j.bbrc.2006.05.047; Carta S, 2006, BLOOD, V108, P1618, DOI 10.1182/blood-2006-03-014126; Dai Y, 2005, MOL CELL BIOL, V25, P5429, DOI 10.1128/MCB.25.13.5429-5444.2005; Davie JR, 1997, MOL BIOL REP, V24, P197, DOI 10.1023/A:1006811817247; Downing JR, 1999, BRIT J HAEMATOL, V106, P296, DOI 10.1046/j.1365-2141.1999.01377.x; Fazi F, 2005, ONCOGENE, V24, P1820, DOI 10.1038/sj.onc.1208286; Fliegauf M, 2004, ONCOGENE, V23, P9070, DOI 10.1038/sj.onc.1208042; Gelmetti V, 1998, MOL CELL BIOL, V18, P7185, DOI 10.1128/MCB.18.12.7185; Gozzini A, 2003, CANCER RES, V63, P8955; Kitabayashi I, 1998, EMBO J, V17, P2994, DOI 10.1093/emboj/17.11.2994; KLISOVIC MI, 2003, LEUKEMIA, V350; Leoni F, 2005, MOL MED, V11, P1, DOI 10.2119/2006-00005.Dinarello; Liu SJ, 2007, J PHARMACOL EXP THER, V321, P953, DOI 10.1124/jpet.106.118406; Liu SJ, 2005, CANCER RES, V65, P1277, DOI 10.1158/0008-5472.CAN-04-4532; Look AT, 1997, SCIENCE, V278, P1059, DOI 10.1126/science.278.5340.1059; Lu Y, 2006, LEUKEMIA, V20, P987, DOI 10.1038/sj.leu.2404218; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Mrozek K, 2001, J CLIN ONCOL, V19, P2482, DOI 10.1200/JCO.2001.19.9.2482; OGAWA E, 1993, P NATL ACAD SCI USA, V90, P6859, DOI 10.1073/pnas.90.14.6859; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Pasqualucci L, 2003, LEUKEMIA LYMPHOMA, V44, pS5, DOI 10.1080/10428190310001621588; Pathil A, 2006, HEPATOLOGY, V43, P425, DOI 10.1002/hep.21054; Raelson JV, 1996, BLOOD, V88, P2826, DOI 10.1182/blood.V88.8.2826.bloodjournal8882826; Rahmani M, 2005, CANCER RES, V65, P2422, DOI 10.1158/0008-5472.CAN-04-2440; Santini V, 2007, CURR DRUG METAB, V8, P383, DOI 10.2174/138920007780655397; Tan J, 2006, J BIOL CHEM, V281, P10508, DOI 10.1074/jbc.M512719200; Wang JX, 1998, P NATL ACAD SCI USA, V95, P10860, DOI 10.1073/pnas.95.18.10860; Wang L, 2007, CELL DEATH DIFFER, V14, P306, DOI 10.1038/sj.cdd.4401996; Yang G, 2007, ONCOGENE, V26, P91, DOI 10.1038/sj.onc.1209760	33	38	41	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 13	2008	27	12					1767	1778		10.1038/sj.onc.1210820	http://dx.doi.org/10.1038/sj.onc.1210820			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	273WF	17891169				2022-12-25	WOS:000253962100012
J	Thijs, L; Vinck, E; Bolli, A; Trandafir, F; Wan, XH; Hoogewijs, D; Coletta, M; Fago, A; Weber, RE; Van Doorslaer, S; Ascenzi, P; Alam, M; Moens, L; Dewilde, S				Thijs, Liesbet; Vinck, Evi; Bolli, Alessandro; Trandafir, Florin; Wan, Xuehua; Hoogewijs, David; Coletta, Massimiliano; Fago, Angela; Weber, Roy E.; Van Doorslaer, Sabine; Ascenzi, Paolo; Alam, Maqsudul; Moens, Luc; Dewilde, Sylvia			Characterization of a globin-coupled oxygen sensor with a gene-regulating function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							HEME-BASED SENSORS; ELECTRON-PARAMAGNETIC-RES; TRUNCATED HEMOGLOBIN-O; HYDROGEN-BOND NETWORK; CYCLIC DI-GMP; NITRIC-OXIDE; LIGAND-BINDING; BACILLUS-SUBTILIS; RESONANCE RAMAN; MYCOBACTERIUM-LEPRAE	Globin-coupled sensors (GCSs) are multiple-domain transducers, consisting of a regulatory globin-like heme-binding domain and a linked transducer domain(s). GCSs have been described in both Archaea and bacteria. They are generally assumed to bind O-2 (and perhaps other gaseous ligands) and to transmit a conformational change signal through the transducer domain in response to fluctuating O2 levels. In this study, the heme-binding domain, AvGReg178, and the full protein, AvGReg of the Azotobacter vinelandii GCS, were cloned, expressed, and purified. After purification, the heme iron of AvGReg178 was found to bind O2. This form was stable over many hours. In contrast, the predominant presence of a bis-histidinecoordinate heme in ferric AvGReg was revealed. Differences in the hemepocket structure were also observed for the deoxygenated ferrous state of these proteins. The spectra showed that the deoxygenated ferrous derivatives of AvGReg178 and AvGReg are characterized by a penta-coordinate and hexa-coordinate heme iron, respectively. O2 binding isotherms indicate that AvGReg178 and AvGReg show a high affinity for O-2 with P-50 values at 20 degrees C of 0.04 and 0.15 torr, respectively. Kinetics of CO binding indicate that AvGReg178 carbonylation conforms to a monophasic process, comparable with that of myoglobin, whereas AvGReg carbonylation conforms to a three-phasic reaction, as observed for several proteins with bis-histidine heme iron coordination. Besides sensing ligands, in vitro data suggest that AvGReg(178) may have a role in O-2-mediated NO-detoxification, yielding metAvGReg(178) and nitrate.	[Thijs, Liesbet; Dewilde, Sylvia] Univ Antwerp, Dept Biomed Sci, B-2610 Antwerp, Belgium; [Vinck, Evi; Trandafir, Florin; Van Doorslaer, Sabine] Univ Antwerp, Dept Phys, B-2610 Antwerp, Belgium; [Bolli, Alessandro; Ascenzi, Paolo] Univ Roma Tre, Dipartimento Biol, Lab Interdipartimentale Microscopia Elettron, I-00146 Rome, Italy; [Wan, Xuehua; Alam, Maqsudul] Univ Hawaii, Dept Microbiol, Honolulu, HI 96822 USA; [Hoogewijs, David] Univ Ghent, Ctr Mol Phylogeny & Evolut, Dept Biol, B-9000 Ghent, Belgium; [Coletta, Massimiliano] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00133 Rome, Italy; [Fago, Angela; Weber, Roy E.] Aarhus Univ, Dept Sci Biol, DK-8000 Aarhus, Denmark; [Ascenzi, Paolo] Ist Nazl Malattie infet Lazzaro spallanzani, I-00149 Rome, Italy	University of Antwerp; University of Antwerp; Roma Tre University; University of Hawaii System; Ghent University; University of Rome Tor Vergata; Aarhus University	Dewilde, S (corresponding author), Univ Antwerp, Dept Biomed Sci, Campus Drie Eiken,Universiteitsplein 1, B-2610 Antwerp, Belgium.	sylvia.dewilde@ua.ac.be	Hoogewijs, David/L-5144-2016; Van Doorslaer, Sabine/E-5050-2017; Coletta, Massimo/N-9049-2015; Coletta, Massimiliano/GSN-5927-2022; Wan, Xuehua/D-5433-2016; Fago, Angela/J-5946-2013	Van Doorslaer, Sabine/0000-0002-1685-9202; Wan, Xuehua/0000-0002-6367-848X; Fago, Angela/0000-0001-7315-2628; COLETTA, Massimiliano/0000-0002-5489-9467; Bolli, Alessandro/0000-0001-7259-5785; Vinck, Evi/0000-0001-6167-1068				AMIKAM D, 1989, J BACTERIOL, V171, P6649, DOI 10.1128/jb.171.12.6649-6655.1989; ANTONINI E, 1971, BIOCHIM BIOPHYS ACTA, V310, P309; Aono S, 2002, J BIOL CHEM, V277, P13528, DOI 10.1074/jbc.M112256200; ArredondoPeter R, 1997, PLANT PHYSIOL, V115, P1259, DOI 10.1104/pp.115.3.1259; Ascenzi P, 2006, BIOCHEM BIOPH RES CO, V339, P450, DOI 10.1016/j.bbrc.2005.11.031; ASCENZI P, 2008, IN PRESS METHODS ENZ; Ascenzi P, 2007, IUBMB LIFE, V59, P600, DOI 10.1080/15216540701308424; Ascenzi P, 2007, BIOCHEM BIOPH RES CO, V357, P809, DOI 10.1016/j.bbrc.2007.04.024; Blumberg WE, 1971, PROBES STRUCTURE FUN, V2, P215; Brucker EA, 1998, PROTEINS, V30, P352, DOI 10.1002/(SICI)1097-0134(19980301)30:4<352::AID-PROT2>3.0.CO;2-L; BRUNORI M, 1969, J BIOL CHEM, V244, P4046; Brunori M, 2005, P NATL ACAD SCI USA, V102, P8483, DOI 10.1073/pnas.0408766102; Brunori M, 2004, J STRUCT BIOL, V147, P223, DOI 10.1016/j.jsb.2004.04.008; Brunori M, 2001, TRENDS BIOCHEM SCI, V26, P209, DOI 10.1016/S0968-0004(01)01824-2; BRUNORI M, 1986, SUPERMOLECULES BIOL, P55; Chan MK, 2001, CURR OPIN CHEM BIOL, V5, P216, DOI 10.1016/S1367-5931(00)00193-9; Chan NL, 1998, BIOCHEMISTRY-US, V37, P16459, DOI 10.1021/bi9816711; Chang AL, 2001, BIOCHEMISTRY-US, V40, P3420, DOI 10.1021/bi0100236; Conrad R, 1996, MICROBIOL REV, V60, P609, DOI 10.1128/MMBR.60.4.609-640.1996; Copeland DM, 2003, PROTEINS, V53, P182, DOI 10.1002/prot.10495; Das TK, 1999, BIOCHEMISTRY-US, V38, P15360, DOI 10.1021/bi991237e; Das TK, 2000, BIOCHEMISTRY-US, V39, P14330, DOI 10.1021/bi001681d; de Sanctis D, 2004, IUBMB LIFE, V56, P643, DOI 10.1080/15216540500059640; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; Duff SMG, 1997, J BIOL CHEM, V272, P16746, DOI 10.1074/jbc.272.27.16746; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fago A, 2004, J BIOL CHEM, V279, P44417, DOI 10.1074/jbc.M407126200; Fasano M, 2006, BIOCHEM BIOPH RES CO, V345, P704, DOI 10.1016/j.bbrc.2006.04.154; Flogel U, 2001, P NATL ACAD SCI USA, V98, P735, DOI 10.1073/pnas.011460298; Frauenfelder H, 2003, P NATL ACAD SCI USA, V100, P8615, DOI 10.1073/pnas.1633688100; Freitas TAK, 2005, J INORG BIOCHEM, V99, P23, DOI 10.1016/j.jinorgbio.2004.10.024; Freitas TAK, 2003, FEBS LETT, V552, P99, DOI 10.1016/S0014-5793(03)00923-2; Frey AD, 2005, TRENDS BIOTECHNOL, V23, P69, DOI 10.1016/j.tibtech.2004.12.002; Galperin MY, 2001, FEMS MICROBIOL LETT, V203, P11, DOI 10.1111/j.1574-6968.2001.tb10814.x; Gardner AM, 2000, J BIOL CHEM, V275, P12581, DOI 10.1074/jbc.275.17.12581; Gardner PR, 2006, J INORG BIOCHEM, V100, P542, DOI 10.1016/j.jinorgbio.2005.12.012; Geuens E, 2003, J BIOL CHEM, V278, P30417, DOI 10.1074/jbc.C300203200; GIBSON QH, 1986, J BIOL CHEM, V261, P228; Gilles-Gonzalez MA, 2005, J INORG BIOCHEM, V99, P1, DOI 10.1016/j.jinorgbio.2004.11.006; Gow AJ, 1999, P NATL ACAD SCI USA, V96, P9027, DOI 10.1073/pnas.96.16.9027; Hargrove MS, 1997, J MOL BIOL, V266, P1032, DOI 10.1006/jmbi.1996.0833; HAYASHI A, 1973, BIOCHIM BIOPHYS ACTA, V310, P309, DOI 10.1016/0005-2795(73)90110-4; HECHT GB, 1995, EMBO J, V14, P3915, DOI 10.1002/j.1460-2075.1995.tb00063.x; Herold S, 2005, J BIOL INORG CHEM, V10, P935, DOI 10.1007/s00775-005-0046-9; Herold S, 2005, BIOCHEMISTRY-US, V44, P6223, DOI 10.1021/bi0475929; Herold S, 2001, BIOCHEMISTRY-US, V40, P3385, DOI 10.1021/bi002407m; Hoshino M, 1996, J AM CHEM SOC, V118, P5702, DOI 10.1021/ja953311w; Hou SB, 2000, NATURE, V403, P540, DOI 10.1038/35000570; Hu SZ, 1996, J AM CHEM SOC, V118, P12638, DOI 10.1021/ja962239e; Ilari A, 2002, J BIOL CHEM, V277, P23725, DOI 10.1074/jbc.M202228200; Jain R, 2003, J BIOL INORG CHEM, V8, P1, DOI 10.1007/s00775-002-0405-8; Kharitonov VG, 1997, BIOCHEMISTRY-US, V36, P6814, DOI 10.1021/bi970201o; Martin E, 2006, J BIOL CHEM, V281, P27836, DOI 10.1074/jbc.M601078200; Mendes P, 1997, TRENDS BIOCHEM SCI, V22, P361, DOI 10.1016/S0968-0004(97)01103-1; MENDES P, 1993, COMPUT APPL BIOSCI, V9, P563; Mendes P, 1998, BIOINFORMATICS, V14, P869, DOI 10.1093/bioinformatics/14.10.869; Milani M, 2005, J INORG BIOCHEM, V99, P97, DOI 10.1016/j.jinorgbio.2004.10.035; Milani M, 2003, P NATL ACAD SCI USA, V100, P5766, DOI 10.1073/pnas.1037676100; MOORE EG, 1976, J BIOL CHEM, V251, P2788; Nicholas K.B., 1997, EMBNEW NEWS, V4, P1; Ouellet H, 2003, BIOCHEMISTRY-US, V42, P5764, DOI 10.1021/bi0270337; Ouellett H, 2002, P NATL ACAD SCI USA, V99, P5902, DOI 10.1073/pnas.092017799; Paoli M, 1999, NAT STRUCT BIOL, V6, P926; PEISACH J, 1971, J BIOL CHEM, V246, P5877; Pesce A, 2003, STRUCTURE, V11, P1087, DOI 10.1016/S0969-2126(03)00166-7; Peterson ES, 1998, BIOCHEMISTRY-US, V37, P12301, DOI 10.1021/bi980752u; Poole RK, 2005, BIOCHEM SOC T, V33, P176, DOI 10.1042/BST0330176; QUINN R, 1987, J AM CHEM SOC, V109, P3301, DOI 10.1021/ja00245a019; Roberts GP, 2005, J INORG BIOCHEM, V99, P280, DOI 10.1016/j.jinorgbio.2004.10.032; Rodgers KR, 2005, J INORG BIOCHEM, V99, P963, DOI 10.1016/j.jinorgbio.2005.02.016; Rodgers KR, 1999, CURR OPIN CHEM BIOL, V3, P158, DOI 10.1016/S1367-5931(99)80028-3; Romling U, 2005, CELL MOL LIFE SCI, V62, P1234, DOI 10.1007/s00018-005-4557-x; ROSS P, 1991, MICROBIOL REV, V55, P35, DOI 10.1128/MMBR.55.1.35-58.1991; Ryjenkov DA, 2005, J BACTERIOL, V187, P1792, DOI 10.1128/JB.187.5.1792-1798.2005; SAGE JT, 1991, BIOCHEMISTRY-US, V30, P1227, DOI 10.1021/bi00219a010; Sawai H, 2005, BIOCHEMISTRY-US, V44, P13257, DOI 10.1021/bi050997o; Sawai H, 2003, BIOCHEMISTRY-US, V42, P5133, DOI 10.1021/bi027067e; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Smagghe BJ, 2006, BIOCHEMISTRY-US, V45, P561, DOI 10.1021/bi051902l; Sousa EHS, 2005, BIOCHEMISTRY-US, V44, P15359, DOI 10.1021/bi051661h; Spiro TG, 2001, CURR OPIN CHEM BIOL, V5, P715, DOI 10.1016/S1367-5931(01)00271-X; SPRINGER BA, 1994, CHEM REV, V94, P699, DOI 10.1021/cr00027a007; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Svistunenko DA, 2000, BIOCHEM J, V351, P595, DOI 10.1042/0264-6021:3510595; Tal R, 1998, J BACTERIOL, V180, P4416, DOI 10.1128/JB.180.17.4416-4425.1998; TAYLOR CPS, 1977, BIOCHIM BIOPHYS ACTA, V491, P137, DOI 10.1016/0005-2795(77)90049-6; Trent JT, 2001, BIOCHEMISTRY-US, V40, P6155, DOI 10.1021/bi0100790; Uchida T, 2005, ACCOUNTS CHEM RES, V38, P662, DOI 10.1021/ar030267d; Uzan J, 2004, BIOPHYS J, V87, P1196, DOI 10.1529/biophysj.104.042168; Vallone B, 2004, PROTEINS, V56, P85, DOI 10.1002/prot.20113; Vallone B, 2004, P NATL ACAD SCI USA, V101, P17351, DOI 10.1073/pnas.0407633101; Van Doorslaer S, 2003, J BIOL CHEM, V278, P4919, DOI 10.1074/jbc.M210617200; Vinogradov SN, 2005, P NATL ACAD SCI USA, V102, P11385, DOI 10.1073/pnas.0502103102; Visca P, 2002, BIOCHEM BIOPH RES CO, V294, P1064, DOI 10.1016/S0006-291X(02)00593-4; WALKER FA, 1986, J AM CHEM SOC, V108, P5288, DOI 10.1021/ja00277a038; WEBER RE, 1992, J APPL PHYSIOL, V72, P1611, DOI 10.1152/jappl.1992.72.4.1611; WHITE DK, 1979, J AM CHEM SOC, V101, P2443, DOI 10.1021/ja00503a034; Wright E, 2004, PROTEIN EXPRES PURIF, V35, P373, DOI 10.1016/j.pep.2004.02.003; YE RW, 1994, APPL ENVIRON MICROB, V60, P1053, DOI 10.1128/AEM.60.4.1053-1058.1994; Yoshimura H, 2006, BIOCHEMISTRY-US, V45, P8301, DOI 10.1021/bi060315c; Youn H, 2004, J BACTERIOL, V186, P1320, DOI 10.1128/JB.186.5.1320-1329.2004; Zhang W, 2005, BIOPHYS J, V88, P2801, DOI 10.1529/biophysj.104.047936; Zhang W, 2003, STRUCTURE, V11, P1097, DOI 10.1016/S0969-2126(03)00169-2	104	32	32	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37325	37340		10.1074/jbc.M705541200	http://dx.doi.org/10.1074/jbc.M705541200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17925395	hybrid			2022-12-25	WOS:000251833600007
J	Knapp, AM; Ramsey, JE; Wang, SX; Strauch, AR; Kelm, RJ				Knapp, Anna M.; Ramsey, Jon E.; Wang, Shu-Xia; Strauch, Arthur R.; Kelm, Robert J., Jr.			Structure-function analysis of mouse pur beta II - Conformation altering mutations disrupt single-stranded DNA and protein interactions crucial to smooth muscle alpha-actin gene repression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING PROTEIN; MYOSIN HEAVY-CHAIN; CELL-CYCLE; MESSENGER-RNA; NIH3T3 CELLS; IN-VITRO; EXPRESSION; ATHEROSCLEROSIS; MYOFIBROBLAST; FIBROBLASTS	Previous studies from our laboratories have implicated two members of the Pur family of single-stranded DNA/RNA-binding proteins, Pur alpha and Pur beta, in transcriptional repression of the smooth muscle alpha-actin gene in vascular cell types. Although Pur alpha and Pur beta share substantial sequence homology and nucleic acid binding properties, genomic promoter and cis-element occupancy studies reported herein suggest that Pur beta is the dominant factor in gene regulation. To dissect the molecular basis of Pur beta repressor activity, site-directed mutagenesis was used to map amino acids critical to the physical and functional interaction of Pur beta with the smooth muscle alpha-actin promoter. Of all the various acidic, basic, and aromatic residues studied, mutation of positionally conserved arginines in the class I or class II repeat modules significantly attenuated Pur beta repressor activity in transfected vascular smooth muscle cells and fibroblasts. DNA binding and protein-protein interaction assays were conducted with purified recombinant Pur beta and selected mutants to reveal the physical basis for loss-of-function. Mutants R57E, R57E/R96E, and R57A/R96A each exhibited reduced single-stranded DNA binding affinity for an essential promoter element and diminished interaction with corepressor YB-1/MSY1. Structural analyses of the R57A/R96A and R57E/R96E double mutants in comparison to the wildtype Pur beta homodimer revealed aberrant self-association into higher order oligomeric complexes, which correlated with decreased alpha-helical content and defective DNA and protein binding in vitro. These findings point to a previously unrecognized structural role for certain core arginine residues in forming a conformationally stable Pur beta protein capable of physical interactions necessary for smooth muscle alpha-actin gene repression.	Univ Vermont, Coll Med, Dept Biochem, Cardiovasc Res Inst, Burlington, VT 05405 USA; Univ Vermont, Coll Med, Dept Med, Cardiovasc Res Inst, Burlington, VT 05405 USA; Ohio State Univ, Dept Physiol & Cell Biol, Dorothy M Davis Heart & Lung Res Inst, Coll Med & Publ Hlth, Columbus, OH 43210 USA	University of Vermont; University of Vermont; University System of Ohio; Ohio State University	Kelm, RJ (corresponding author), Colchester Res Fac, 208 S Pk Dr, Colchester, VT 05446 USA.	Robert.Kelm@uvm.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007594, R01HL054281] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL054281, T32 HL007594] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Barr SM, 2001, J CELL BIOCHEM, V81, P621, DOI 10.1002/jcb.1099; Becker NA, 2000, J BIOL CHEM, V275, P15384, DOI 10.1074/jbc.M909687199; Brill SJ, 1998, MOL CELL BIOL, V18, P7225, DOI 10.1128/MCB.18.12.7225; Carlini LE, 2002, J BIOL CHEM, V277, P8682, DOI 10.1074/jbc.M109754200; Clement S, 2007, J CELL SCI, V120, P229, DOI 10.1242/jcs.03340; Darbinian N, 2001, J CELL BIOCHEM, V80, P589, DOI 10.1002/1097-4644(20010315)80:4<589::AID-JCB1013>3.0.CO;2-0; Darbinian N, 2001, J CELL PHYSIOL, V189, P334, DOI 10.1002/jcp.10029; Desmouliere A, 2005, WOUND REPAIR REGEN, V13, P7, DOI 10.1111/j.1067-1927.2005.130102.x; Ding Y, 1997, NEUROCHEM INT, V31, P45, DOI 10.1016/S0197-0186(96)00127-1; Falk E, 2006, J AM COLL CARDIOL, V47, pC7, DOI 10.1016/j.jacc.2005.09.068; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Gallia GL, 2001, J CELL BIOCHEM, V83, P355, DOI 10.1002/jcb.1247; Gallia GL, 2000, NUCLEIC ACIDS RES, V28, P3197, DOI 10.1093/nar/28.17.3197; Gaudreault I, 2004, NUCLEIC ACIDS RES, V32, P316, DOI 10.1093/nar/gkh170; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Gupta M, 2003, J BIOL CHEM, V278, P44935, DOI 10.1074/jbc.M307696200; Gupta M, 2007, CAN J PHYSIOL PHARM, V85, P349, DOI 10.1139/Y07-009; Hu YH, 2004, J CLIN INVEST, V113, P1258, DOI 10.1172/JCI200419628; Itoh H, 1998, CELL GROWTH DIFFER, V9, P651; Ji J, 2007, MOL CELL BIOL, V27, P1531, DOI 10.1128/MCB.00629-06; Johnson EM, 2003, ANTICANCER RES, V23, P2093; Johnson EM, 2006, J NEUROSCI RES, V83, P929, DOI 10.1002/jnr.20806; JOHNSON EM, 1995, J BIOL CHEM, V270, P24352, DOI 10.1074/jbc.270.41.24352; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kelm RJ, 2003, J BIOL CHEM, V278, P38749, DOI 10.1074/jbc.M306163200; Kelm RJ, 1999, J BIOL CHEM, V274, P14238, DOI 10.1074/jbc.274.20.14238; Kelm RJ, 1999, J BIOL CHEM, V274, P38268, DOI 10.1074/jbc.274.53.38268; Kelm RJ, 1997, J BIOL CHEM, V272, P26727, DOI 10.1074/jbc.272.42.26727; Khalili K, 2003, MOL CELL BIOL, V23, P6857, DOI 10.1128/MCB.23.19.6857-6875.2003; Knapp AM, 2006, J BIOL CHEM, V281, P7907, DOI 10.1074/jbc.M509682200; Kumar MS, 2003, ARTERIOSCL THROM VAS, V23, P737, DOI 10.1161/01.ATV.0000065197.07635.BA; Liu H, 2005, BIOCHEM BIOPH RES CO, V328, P851, DOI 10.1016/j.bbrc.2005.01.038; Liu H, 2002, NUCLEIC ACIDS RES, V30, P2417, DOI 10.1093/nar/30.11.2417; MACDONALD GH, 1995, J BIOL CHEM, V270, P3527, DOI 10.1074/jbc.270.8.3527; Rahmani M, 2006, CIRC RES, V99, P801, DOI 10.1161/01.RES.0000246086.93555.f3; Ramsey JE, 2007, J BIOL CHEM, V282, P1552, DOI 10.1074/jbc.M609356200; RonnovJessen L, 1996, J CELL BIOL, V134, P67, DOI 10.1083/jcb.134.1.67; ROSS R, 1995, ANNU REV PHYSIOL, V57, P791, DOI 10.1146/annurev.ph.57.030195.004043; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Sartore S, 2001, CIRC RES, V89, P1111, DOI 10.1161/hh2401.100844; Schildmeyer LA, 2000, FASEB J, V14, P2213, DOI 10.1096/fj.99-0927com; Serini G, 1999, EXP CELL RES, V250, P273, DOI 10.1006/excr.1999.4543; Shimotai Y, 2006, BIOCHEM BIOPH RES CO, V340, P517, DOI 10.1016/j.bbrc.2005.12.032; Stacey DW, 1999, ONCOGENE, V18, P4254, DOI 10.1038/sj.onc.1202795; Subramanian SV, 2004, MOL BIOL CELL, V15, P4532, DOI 10.1091/mbc.E04-04-0348; Subramanian SV, 2002, CARDIOVASC RES, V54, P539, DOI 10.1016/S0008-6363(02)00270-5; Takeji M, 2006, J BIOL CHEM, V281, P40193, DOI 10.1074/jbc.M602182200; Tomasek JJ, 2006, INVEST OPHTH VIS SCI, V47, P2693, DOI 10.1167/iovs.05-1297; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065; Wang JW, 1997, J CLIN INVEST, V100, P1425, DOI 10.1172/JCI119663; Wang SX, 2005, J BIOL CHEM, V280, P6204, DOI 10.1074/jbc.M409506200; Wortman MJ, 2005, BBA-MOL CELL RES, V1743, P64, DOI 10.1016/j.bbamcr.2004.08.010; Yoshida T, 2005, CIRC RES, V96, P280, DOI 10.1161/01.RES.0000155951.62152.2e	53	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35899	35909		10.1074/jbc.M706617200	http://dx.doi.org/10.1074/jbc.M706617200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17906292	hybrid			2022-12-25	WOS:000251458100051
J	Romero-Perez, L; Chen, L; Lambertson, D; Madura, K				Romero-Perez, Lizbeth; Chen, Li; Lambertson, David; Madura, Kiran			Sts1 can overcome the loss of Rad23 and Rpn10 and represents a novel regulator of the ubiquitin/proteasome pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEOLYTIC PATHWAY; PROTEIN-DEGRADATION; BINDING PROTEIN; PROTEASOME; UBIQUITIN; YEAST; DESTRUCTION; RECEPTORS; REPAIR	A rad23 Delta rpn10 Delta double mutant accumulates multi-Ub proteins, is deficient in proteolysis, and displays sensitivity to drugs that generate damaged proteins. Overexpression of Sts1 restored normal growth in rad23 Delta rpn10 Delta but did not overcome the DNA repair defect of rad23 Delta. To understand the nature of Sts1 suppression, we characterized sts1-2, a temperature-sensitive mutant. We determined that sts1-2 was sensitive to translation inhibitors, accumulated high levels of multi-Ub proteins, and caused stabilization of proteolytic substrates. Additionally, ubiquitinated proteins that were detected in proteasomes were inefficiently cleared in sts1-2. Despite these proteolytic defects, overall proteasome activity was increased in sts1-2. We propose that Sts1 is a new regulatory factor in the ubiquitin/proteasome pathway that controls the turnover of proteasome substrates.	Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Madura, K (corresponding author), Robert Wood Johnson Med Sch, Dept Biochem, 683 Hoes Ln,SPH-Rm 383, Piscataway, NJ 08854 USA.	maduraki@umdnj.edu			NCI NIH HHS [CA83875] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA083875] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amrani N, 1996, MOL GEN GENET, V252, P552, DOI 10.1007/BF02172401; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Chen L, 2002, MOL CELL BIOL, V22, P4902, DOI 10.1128/MCB.22.13.4902-4913.2002; Chuang SM, 2005, MOL CELL BIOL, V25, P403, DOI 10.1128/MCB.25.1.403-413.2005; Clarke DJ, 2001, MOL CELL BIOL, V21, P1997, DOI 10.1128/MCB.21.6.1997-2007.2001; Diaz-Martinez LA, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-28; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; Enenkel C, 1998, EMBO J, V17, P6144, DOI 10.1093/emboj/17.21.6144; Enenkel C, 1999, MOL BIOL REP, V26, P131, DOI 10.1023/A:1006973803960; Funakoshi M, 2002, P NATL ACAD SCI USA, V99, P745, DOI 10.1073/pnas.012585199; Ghaboosi N, 2007, MOL BIOL CELL, V18, P1953, DOI 10.1091/mbc.E06-10-0965; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Glickman MH, 1999, MOL BIOL REP, V26, P21, DOI 10.1023/A:1006928316738; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; HOUMAN F, 1994, MOL CELL BIOL, V14, P6350, DOI 10.1128/MCB.14.9.6350; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Kim I, 2004, MOL BIOL CELL, V15, P3357, DOI 10.1091/mbc.E03-11-0835; Lambertson D, 1999, GENETICS, V153, P69; Lehmann A, 2002, J MOL BIOL, V317, P401, DOI 10.1006/jmbi.2002.5443; LIANG S, 1993, EUR J CELL BIOL, V62, P270; LIU HP, 1992, GENETICS, V132, P665; Ortolan TG, 2004, NUCLEIC ACIDS RES, V32, P6490, DOI 10.1093/nar/gkh987; Prakash S, 2000, MUTAT RES-FUND MOL M, V451, P13, DOI 10.1016/S0027-5107(00)00037-3; Rao H, 2002, J BIOL CHEM, V277, P11691, DOI 10.1074/jbc.M200245200; Saeki Y, 2002, BIOCHEM BIOPH RES CO, V293, P986, DOI 10.1016/S0006-291X(02)00340-6; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; Tabb MM, 2000, MOL CELL BIOL, V20, P6062, DOI 10.1128/MCB.20.16.6062-6073.2000; Takeda K, 2005, CELL, V122, P393, DOI 10.1016/j.cell.2005.05.023; Tatebe H, 2000, CURR BIOL, V10, P1329, DOI 10.1016/S0960-9822(00)00773-9; Turner GC, 2000, SCIENCE, V289, P2117, DOI 10.1126/science.289.5487.2117; vanNocker S, 1996, MOL CELL BIOL, V16, P6020; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014	34	11	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35574	35582		10.1074/jbc.M704857200	http://dx.doi.org/10.1074/jbc.M704857200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17916559	hybrid			2022-12-25	WOS:000251458100017
J	Yan, AX; Guan, ZQ; Raetz, CRH				Yan, Aixin; Guan, Ziqiang; Raetz, Christian R. H.			An undecaprenyl phosphate-aminoarabinose flippase required for polymyxin resistance in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2-COMPONENT REGULATORY SYSTEM; SALMONELLA-TYPHIMURIUM; LIPID-A; INNER MEMBRANE; MULTIDRUG TRANSPORTER; PMRA-MUTANTS; TRANSBILAYER MOVEMENT; EFFLUX TRANSPORTER; ABC-TRANSPORTERS; 4-AMINO-4-DEOXY-L-ARABINOSE	Modification of lipid A with the 4-amino-4-deoxy-L-arabinose (L-Ara4N) moiety is required for resistance to polymyxin and cationic antimicrobial peptides in Escherichia coli and Salmonella typhimurium. An operon of seven genes (designated pmrHFIJKLM in S. typhimurium), which is regulated by the PmrA transcription factor and is also present in E. coli, is necessary for the maintenance of polymyxin resistance. We previously elucidated the roles of pmrHFIJK in the biosynthesis and attachment of L-Ara4N to lipid A and renamed these genes arn-BCADT, respectively. We now propose functions for the last two genes of the operon, pmrL and pmrM. Chromosomal inactivation of each of these genes in an E. coli pmrAc parent switched its phenotype from polymyxin-resistant to polymyxin-sensitive. Lipid A was no longer modified with L-Ara4N, even though the levels of the lipid-linked donor of the L-Ara4N moiety, undecaprenyl phosphate-alpha-L-Ara4N, were not reduced in the mutants. However, the undecaprenyl phosphate-alpha-L-Ara4N present in the mutants was less concentrated on the periplasmic surface of the inner membrane, as judged by 4-5-fold reduced labeling with the inner membrane-impermeable amine reagent N-hydroxysulfosuccin-imidobiotin. In an arnT mutant of the same pmrAc parent, which lacks the enzyme that transfers the L-Ara4N unit to lipid A but retains the same high levels of undecaprenyl phosphate-alpha-L-Ara4N as the parent, N-hydroxysulfosuccin-imidobiotin labeling was not reduced. These results implicate pmrL and pmrM, but not arnT, in transporting undecaprenyl phosphate-alpha-L-Ara4N across the inner membrane. PmrM and PmrL, now renamed ArnE and ArnF because of their involvement in L-Ara4N modification of lipid A, may be subunits of an undecaprenyl phosphate-alpha-L-Ara4N flippase.	Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University	Raetz, CRH (corresponding author), Duke Univ, Med Ctr, Dept Biochem, POB 3711, Durham, NC 27710 USA.	raetz@biochem.duke.edu	Guan, Ziqiang/AAE-5110-2019; /A-2734-2010	/0000-0003-0310-5492	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051310, U54GM069338] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-069338, R01 GM051310-13, U54 GM069338, R01 GM051310, GM-51310] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alaimo C, 2006, EMBO J, V25, P967, DOI 10.1038/sj.emboj.7601024; Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Bishop RE, 2000, EMBO J, V19, P5071, DOI 10.1093/emboj/19.19.5071; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Breazeale SD, 2005, J BIOL CHEM, V280, P14154, DOI 10.1074/jbc.M414265200; Breazeale SD, 2003, J BIOL CHEM, V278, P24731, DOI 10.1074/jbc.M304043200; Breazeale SD, 2002, J BIOL CHEM, V277, P2886, DOI 10.1074/jbc.M109377200; BRETSCHER MS, 1972, J MOL BIOL, V71, P523, DOI 10.1016/0022-2828(72)90028-4; CAROFF M, 1988, CARBOHYD RES, V175, P273, DOI 10.1016/0008-6215(88)84149-1; Chung Y J, 2001, Curr Opin Drug Discov Devel, V4, P237; Curnow P, 2004, J MOL BIOL, V343, P213, DOI 10.1016/j.jmb.2004.08.032; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; Derbise A, 2003, FEMS IMMUNOL MED MIC, V38, P113, DOI 10.1016/S0928-8244(03)00181-0; Doerrler WT, 2004, J BIOL CHEM, V279, P45102, DOI 10.1074/jbc.M408106200; Doerrler WT, 2002, J BIOL CHEM, V277, P36697, DOI 10.1074/jbc.M205857200; Doerrler WT, 2001, J BIOL CHEM, V276, P11461, DOI 10.1074/jbc.C100091200; DULBECCO R, 1954, J EXP MED, V99, P167, DOI 10.1084/jem.99.2.167; Esmon CT, 2000, BBA-PROTEIN STRUCT M, V1477, P349, DOI 10.1016/S0167-4838(99)00266-6; Feldman MF, 1999, J BIOL CHEM, V274, P35129, DOI 10.1074/jbc.274.49.35129; Gatzeva-Topalova PZ, 2005, STRUCTURE, V13, P929, DOI 10.1016/j.str.2005.03.018; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Gibbons HS, 2000, J BIOL CHEM, V275, P32940, DOI 10.1074/jbc.M005779200; Gibbons HS, 2005, MOL MICROBIOL, V55, P425, DOI 10.1111/j.1365-2958.2004.04409.x; Granseth E, 2005, J MOL BIOL, V352, P489, DOI 10.1016/j.jmb.2005.07.053; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Groisman EA, 1997, J BACTERIOL, V179, P7040, DOI 10.1128/jb.179.22.7040-7045.1997; Gummadi SN, 2002, J BIOL CHEM, V277, P25337, DOI 10.1074/jbc.M203809200; Gunn JS, 2000, INFECT IMMUN, V68, P6139, DOI 10.1128/IAI.68.11.6139-6146.2000; Gunn JS, 1996, J BACTERIOL, V178, P6857, DOI 10.1128/jb.178.23.6857-6864.1996; Gunn JS, 1998, MOL MICROBIOL, V27, P1171, DOI 10.1046/j.1365-2958.1998.00757.x; Guo L, 1997, SCIENCE, V276, P250, DOI 10.1126/science.276.5310.250; HELANDER IM, 1994, MOL MICROBIOL, V11, P481, DOI 10.1111/j.1365-2958.1994.tb00329.x; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Helenius J, 2002, NATURE, V415, P447, DOI 10.1038/415447a; Hvorup RN, 2003, EUR J BIOCHEM, V270, P799, DOI 10.1046/j.1432-1033.2003.03418.x; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kanjilal-Kolar S, 2006, J BIOL CHEM, V281, P12879, DOI 10.1074/jbc.M513865200; KORNBERG RD, 1971, BIOCHEMISTRY-US, V10, P1111; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lazar K, 2002, CURR OPIN CHEM BIOL, V6, P786, DOI 10.1016/S1367-5931(02)00355-1; Lee H, 2004, J BACTERIOL, V186, P4124, DOI 10.1128/JB.186.13.4124-4133.2004; Li XZ, 2003, ANTIMICROB AGENTS CH, V47, P27, DOI 10.1128/AAC.47.1.27-33.2003; Lien E, 2002, CRIT CARE MED, V30, pS1, DOI 10.1097/00003246-200201001-00001; Liu D, 1996, J BACTERIOL, V178, P2102, DOI 10.1128/jb.178.7.2102-2107.1996; Ma C, 2004, P NATL ACAD SCI USA, V101, P2852, DOI 10.1073/pnas.0400137101; Ma C, 2007, P NATL ACAD SCI USA, V104, P3668, DOI 10.1073/pnas.0700711104; Muller W A, 1994, Methods Mol Biol, V27, P31; NIKAIDO H, 1985, MICROBIOL REV, V49, P1; Noland BW, 2002, STRUCTURE, V10, P1569, DOI 10.1016/S0969-2126(02)00879-1; NUMMILA K, 1995, MOL MICROBIOL, V16, P271, DOI 10.1111/j.1365-2958.1995.tb02299.x; Ohl ME, 2001, ANNU REV MED, V52, P259, DOI 10.1146/annurev.med.52.1.259; Paulsen IT, 1996, MOL MICROBIOL, V19, P1167, DOI 10.1111/j.1365-2958.1996.tb02462.x; Pornillos O, 2005, SCIENCE, V310, P1950, DOI 10.1126/science.1119776; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rapp M, 2006, NAT STRUCT MOL BIOL, V13, P112, DOI 10.1038/nsmb1057; Rapp M, 2007, SCIENCE, V315, P1282, DOI 10.1126/science.1135406; Reeves PR, 1996, TRENDS MICROBIOL, V4, P495, DOI 10.1016/S0966-842X(97)82912-5; Reynolds CM, 2006, J BIOL CHEM, V281, P21974, DOI 10.1074/jbc.M603527200; Rick PD, 1998, GLYCOBIOLOGY, V8, P557, DOI 10.1093/glycob/8.6.557; Rick PD, 2003, J BIOL CHEM, V278, P16534, DOI 10.1074/jbc.M301750200; Riley M, 2006, NUCLEIC ACIDS RES, V34, P1, DOI 10.1093/nar/gkj405; ROLAND KL, 1993, J BACTERIOL, V175, P4154, DOI 10.1128/JB.175.13.4154-4164.1993; Rotem D, 2004, J BIOL CHEM, V279, P48787, DOI 10.1074/jbc.M408187200; ROTHMAN JE, 1977, P NATL ACAD SCI USA, V74, P1821, DOI 10.1073/pnas.74.5.1821; Sambrook J, 2001, MOL CLONING LAB MANU; Schmitz G, 2006, FEBS LETT, V580, P5597, DOI 10.1016/j.febslet.2006.08.014; Schuldiner S, 2007, TRENDS BIOCHEM SCI, V32, P252, DOI 10.1016/j.tibs.2007.04.002; SMIT JJM, 1993, CELL, V75, P451, DOI 10.1016/0092-8674(93)90380-9; STRAIN SM, 1985, J BIOL CHEM, V260, P6089; Tate CG, 2006, CURR OPIN STRUC BIOL, V16, P457, DOI 10.1016/j.sbi.2006.06.005; Trent M. Stephen, 2002, Journal of Endotoxin Research, V8, P158; Trent MS, 2001, J BIOL CHEM, V276, P43132, DOI 10.1074/jbc.M106962200; Trent MS, 2001, J BIOL CHEM, V276, P43122, DOI 10.1074/jbc.M106961200; Trent MS, 2001, J BIOL CHEM, V276, P9083, DOI 10.1074/jbc.M010730200; VAARA M, 1992, MICROBIOL REV, V56, P395, DOI 10.1128/MMBR.56.3.395-411.1992; VAARA M, 1981, FEBS LETT, V129, P145, DOI 10.1016/0014-5793(81)80777-6; VOLK WA, 1970, EUR J BIOCHEM, V17, P223; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Wang XY, 2004, J BIOL CHEM, V279, P49470, DOI 10.1074/jbc.M409078200; Williams GJ, 2005, J BIOL CHEM, V280, P23000, DOI 10.1074/jbc.M501534200; Winfield MD, 2004, P NATL ACAD SCI USA, V101, P17162, DOI 10.1073/pnas.0406038101; Yan AX, 2005, GLYCOBIOLOGY, V15, P1407, DOI 10.1093/glycob/cwj026; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zahringer U, 1999, ENDOTOXIN IN HEALTH AND DISEASE, P93; Zhang ZG, 2007, BIOCHEMISTRY-US, V46, P5218, DOI 10.1021/bi7001604; Zhou ZM, 2001, J BIOL CHEM, V276, P43111, DOI 10.1074/jbc.M106960200; Zhou ZM, 1999, J BIOL CHEM, V274, P18503, DOI 10.1074/jbc.274.26.18503; Zhou ZM, 2000, J BIOL CHEM, V275, P13542, DOI 10.1074/jbc.275.18.13542	95	96	108	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					36077	36089		10.1074/jbc.M706172200	http://dx.doi.org/10.1074/jbc.M706172200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17928292	Green Accepted, hybrid, Green Submitted			2022-12-25	WOS:000251458100067
J	Ren, Z; Schenk, D; Basi, GS; Shapiro, IP				Ren, Zhao; Schenk, Dale; Basi, Guriqbal S.; Shapiro, I. Paul			Amyloid beta-protein precursor juxtamembrane domain regulates specificity of gamma-secretase-dependent cleavages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE DOMAIN; ALZHEIMERS-DISEASE; A-BETA; PRESENILIN-1 MUTATIONS; INTRACELLULAR DOMAINS; TERMINAL FRAGMENTS; ASPARTYL PROTEASE; EPSILON-CLEAVAGE; ALPHA-SECRETASE; ZETA-CLEAVAGE	Amyloid beta-protein (A beta), the major component of cerebral plaques associated with Alzheimer disease, is derived from amyloid beta-protein precursor (APP) through sequential proteolytic cleavage involving beta- and gamma-secretase. The intramembrane cleavage of APP by gamma-secretase occurs at two major sites, gamma and epsilon, although the temporal and/or mechanistic relationships between these cleavages remain unknown. In our attempt to address this issue, we uncovered an important regulatory role for the APP luminal juxtamembrane domain. We demonstrated in cell-based assays that domain replacements in this region can greatly reduce secreted A beta resulting from gamma-cleavage without affecting the epsilon-cleavage product. This A beta reduction is likely due to impaired proteolysis at the gamma-cleavage site. Further analyses with site-directed mutagenesis identified two juxtamembrane residues, Lys-28 and Ser-26 ( A beta numbering), as the critical determinants for efficient intramembrane proteolysis at the gamma-site. Consistent with the growing evidence that epsilon-cleavage of APP precedes gamma- processing, longer A beta species derived from the gamma-cleavage-deficient substrates were detected intra-cellularly. These results indicate that the luminal juxtamembrane region of APP is an important regulatory domain that modulates gamma-secretase-dependent intramembrane proteolysis, particularly in differentiating beta- and gamma- cleavages.	Elan Pharmaceut Inc, San Francisco, CA 94080 USA		Shapiro, IP (corresponding author), Elan Pharmaceut Inc, San Francisco, CA 94080 USA.	paul.shapiro@elan.com						Berezovska O, 2005, J NEUROSCI, V25, P3009, DOI 10.1523/JNEUROSCI.0364-05.2005; Berezovska O, 2003, J NEUROSCI, V23, P4560; Cao XW, 2004, J BIOL CHEM, V279, P24601, DOI 10.1074/jbc.M402248200; Chandu D, 2006, J NEUROCHEM, V96, P228, DOI 10.1111/j.1471-4159.2005.03547.x; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; Chen FS, 2002, J BIOL CHEM, V277, P36521, DOI 10.1074/jbc.M205093200; CITRON M, 1995, NEURON, V14, P661, DOI 10.1016/0896-6273(95)90323-2; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; DYRKS T, 1992, FEBS LETT, V309, P20, DOI 10.1016/0014-5793(92)80730-5; Eckman EA, 2005, BIOCHEM SOC T, V33, P1101, DOI 10.1042/BST0331101; Eggert S, 2004, J BIOL CHEM, V279, P18146, DOI 10.1074/jbc.M311601200; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Funamoto S, 2004, BIOCHEMISTRY-US, V43, P13532, DOI 10.1021/bi049399k; Hartmann D, 2001, J MOL NEUROSCI, V17, P171, DOI 10.1385/JMN:17:2:171; Hecimovic S, 2004, NEUROBIOL DIS, V17, P205, DOI 10.1016/j.nbd.2004.04.018; Herranz H, 2006, EMBO REP, V7, P297, DOI 10.1038/sj.embor.7400617; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; Kaether C, 2006, TRAFFIC, V7, P408, DOI 10.1111/j.1600-0854.2006.00396.x; Kametani F, 2004, FEBS LETT, V570, P73, DOI 10.1016/j.febslet.2004.06.034; Karlstrom H, 2002, J BIOL CHEM, V277, P6763, DOI 10.1074/jbc.C100649200; Kimberly WT, 2000, J BIOL CHEM, V275, P3173, DOI 10.1074/jbc.275.5.3173; Lefranc-Jullien S, 2006, J NEUROCHEM, V97, P807, DOI 10.1111/j.1471-4159.2006.03748.x; Lichtenthaler SF, 1999, FEBS LETT, V453, P288, DOI 10.1016/S0014-5793(99)00730-9; Lichtenthaler SF, 1997, BIOCHEMISTRY-US, V36, P15396, DOI 10.1021/bi971071m; Lieber T, 2002, GENE DEV, V16, P209, DOI 10.1101/gad.942302; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Lleo A, 2004, NAT MED, V10, P1065, DOI 10.1038/nm1112; Lu DC, 2000, NAT MED, V6, P397, DOI 10.1038/74656; Milano J, 2004, TOXICOL SCI, V82, P341, DOI 10.1093/toxsci/kfh254; Moehlmann T, 2002, P NATL ACAD SCI USA, V99, P8025, DOI 10.1073/pnas.112686799; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Murphy MP, 1999, J BIOL CHEM, V274, P11914, DOI 10.1074/jbc.274.17.11914; Okochi M, 2006, J BIOL CHEM, V281, P7890, DOI 10.1074/jbc.M513250200; Okochi M, 2002, EMBO J, V21, P5408, DOI 10.1093/emboj/cdf541; Okochi M, 2000, J BIOL CHEM, V275, P40925, DOI 10.1074/jbc.M005254200; Passer Brent, 2000, Journal of Alzheimer's Disease, V2, P289; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Ramdya P, 2003, J NEUROCHEM, V87, P843, DOI 10.1046/j.1471-4159.2003.02030.x; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; Searfoss GH, 2003, J BIOL CHEM, V278, P46107, DOI 10.1074/jbc.M307757200; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Teplow DB, 2006, ACCOUNTS CHEM RES, V39, P635, DOI 10.1021/ar050063s; Tesco G, 2005, J NEUROCHEM, V95, P446, DOI 10.1111/j.1471-4159.2005.03381.x; Tian GC, 2002, J BIOL CHEM, V277, P31499, DOI 10.1074/jbc.M112328200; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Weidemann A, 2002, BIOCHEMISTRY-US, V41, P2825, DOI 10.1021/bi015794o; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200; Xia WM, 2000, P NATL ACAD SCI USA, V97, P9299, DOI 10.1073/pnas.97.16.9299; Yamasaki A, 2006, J NEUROSCI, V26, P3821, DOI 10.1523/JNEUROSCI.5354-05.2006; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Zhang JM, 2002, J BIOL CHEM, V277, P15069, DOI 10.1074/jbc.M105375200; Zhao GJ, 2005, J BIOL CHEM, V280, P37689, DOI 10.1074/jbc.M507993200; Zhao GJ, 2004, J BIOL CHEM, V279, P50647, DOI 10.1074/jbc.C400473200	60	43	45	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35350	35360		10.1074/jbc.M702739200	http://dx.doi.org/10.1074/jbc.M702739200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17890228	hybrid			2022-12-25	WOS:000251155200078
J	Wayne, N; Bolon, DN				Wayne, Natalie; Bolon, Daniel N.			Dimerization of Hsp90 is required for in vivo function: Design and analysis of monomers and dimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; N-TERMINAL DOMAIN; MOLECULAR CHAPERONE; STEROID-RECEPTOR; ATPASE ACTIVITY; SACCHAROMYCES-CEREVISIAE; PROGESTERONE-RECEPTOR; CRYSTAL-STRUCTURE; COCHAPERONE AHA1; CLIENT PROTEIN	Heat shock protein 90 (Hsp90) plays a central role in signal transduction and has emerged as a promising target for anticancer therapeutics, but its molecular mechanism is poorly understood. At physiological concentration, Hsp90 predominantly forms dimers, but the function of full-length monomers in cells is not clear. Hsp90 contains three domains: the N-terminal and middle domains contribute directly to ATP binding and hydrolysis and the C domain mediates dimerization. To study the function of Hsp90 monomers, we used a single-chain strategy that duplicated the C-terminal dimerization domain. This novel monomerization strategy had the dual effect of stabilizing the C domain to denaturation and hindering intermolecular association of the ATPase domain. The resulting construct was predominantly monomeric at physiological concentration and did not function to support yeast viability as the sole Hsp90. The monomeric construct was also defective at ATP hydrolysis and the activation of a kinase and steroid receptor substrate in yeast cells. The ability to support yeast growth was rescued by the addition of a coiled-coil dimerization domain, indicating that the parental single-chain construct is functionally defective because it is monomeric.	Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Bolon, DN (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.	Dan.Bolon@umassmed.edu		Bolon, Daniel/0000-0001-5857-6676				Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Arlander SJH, 2006, J BIOL CHEM, V281, P2989, DOI 10.1074/jbc.M508687200; Birnby DA, 2000, GENETICS, V155, P85; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; Bornberg-Bauer E, 1999, P NATL ACAD SCI USA, V96, P10689, DOI 10.1073/pnas.96.19.10689; BOWIE JU, 1989, BIOCHEMISTRY-US, V28, P7139, DOI 10.1021/bi00444a001; Cantor C.R., 1980, BIOPHYS CHEM; Chadli A, 2000, P NATL ACAD SCI USA, V97, P12524, DOI 10.1073/pnas.220430297; CHANG HCJ, 1994, J BIOL CHEM, V269, P24983; KANG KI, 1994, P NATL ACAD SCI USA, V91, P340, DOI 10.1073/pnas.91.1.340; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Larabell CA, 2004, MOL BIOL CELL, V15, P957, DOI 10.1091/mbc.E03-07-0522; Llauger-Bufi L, 2003, BIOORG MED CHEM LETT, V13, P3975, DOI 10.1016/j.bmcl.2003.08.065; Louvion JF, 1996, P NATL ACAD SCI USA, V93, P13937, DOI 10.1073/pnas.93.24.13937; Maroney AC, 2006, BIOCHEMISTRY-US, V45, P5678, DOI 10.1021/bi0524969; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; McLaughlin SH, 2006, J MOL BIOL, V356, P746, DOI 10.1016/j.jmb.2005.11.085; McLaughlin SH, 2004, J MOL BIOL, V344, P813, DOI 10.1016/j.jmb.2004.09.055; McLaughlin SH, 2002, J MOL BIOL, V315, P787, DOI 10.1006/jmbi.2001.5245; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Nathan DF, 1997, P NATL ACAD SCI USA, V94, P12949, DOI 10.1073/pnas.94.24.12949; NATHAN DF, 1995, MOL CELL BIOL, V15, P3917; NORBY JG, 1988, METHOD ENZYMOL, V156, P116; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; PICARD D, 1990, NATURE, V348, P166, DOI 10.1038/348166a0; Plescia J, 2005, CANCER CELL, V7, P457, DOI 10.1016/j.ccr.2005.03.035; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; Prodromou C, 1999, EMBO J, V18, P754, DOI 10.1093/emboj/18.3.754; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Prodromou C, 1997, NAT STRUCT BIOL, V4, P477, DOI 10.1038/nsb0697-477; Richter K, 2004, J MOL BIOL, V342, P1403, DOI 10.1016/j.jmb.2004.07.064; Richter K, 2001, J BIOL CHEM, V276, P33689, DOI 10.1074/jbc.M103832200; Robinson CR, 1998, P NATL ACAD SCI USA, V95, P5929, DOI 10.1073/pnas.95.11.5929; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; SMITH DF, 1992, J BIOL CHEM, V267, P1350; SMITH DF, 1990, MOL ENDOCRINOL, V4, P1704, DOI 10.1210/mend-4-11-1704; UEHARA Y, 1986, MOL CELL BIOL, V6, P2198, DOI 10.1128/MCB.6.6.2198; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Wegele H, 2003, J BIOL CHEM, V278, P39303, DOI 10.1074/jbc.M305751200; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; XU Y, 1993, P NATL ACAD SCI USA, V90, P7074, DOI 10.1073/pnas.90.15.7074; Yue L, 1999, GENETICS, V151, P1065; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024	49	71	71	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35386	35395		10.1074/jbc.M703844200	http://dx.doi.org/10.1074/jbc.M703844200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17908693	hybrid			2022-12-25	WOS:000251155200081
J	Dong, JJ; Bloom, JD; Goncharov, V; Chattopadhyay, M; Millhauser, GL; Lynn, DG; Scheibel, T; Lindquist, S				Dong, Jijun; Bloom, Jesse D.; Goncharov, Vladimir; Chattopadhyay, Madhuri; Millhauser, Glenn L.; Lynn, David G.; Scheibel, Thomas; Lindquist, Susan			Probing the role of PrP repeats in conformational conversion and amyloid assembly of chimeric yeast prions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN BINDS CU(II); IN-VITRO CONVERSION; SACCHAROMYCES-CEREVISIAE; OCTAREPEAT DOMAIN; OCTAPEPTIDE REPEATS; GENETIC-VARIATION; COPPER(II) IONS; TRANSGENIC MICE; FULL-LENGTH; BETA-SHEET	Oligopeptide repeats appear in many proteins that undergo conformational conversions to form amyloid, including the mammalian prion protein PrP and the yeast prion protein Sup35. Whereas the repeats in PrP have been studied more exhaustively, interpretation of these studies is confounded by the fact that many details of the PrP prion conformational conversion are not well understood. On the other hand, there is now a relatively good understanding of the factors that guide the conformational conversion of the Sup35 prion protein. To provide a general model for studying the role of oligopeptide repeats in prion conformational conversion and amyloid formation, we have substituted various numbers of the PrP octarepeats for the endogenous Sup35 repeats. The resulting chimeric proteins can adopt the [PSI+] prion state in yeast, and the stability of the prion state depends on the number of repeats. In vitro, these chimeric proteins form amyloid fibers, with more repeats leading to shorter lag phases and faster assembly rates. Both pH and the presence of metal ions modulate assembly kinetics of the chimeric proteins, and the extent of modulation is highly sensitive to the number of PrP repeats. This work offers new insight into the properties of the PrP octarepeats in amyloid assembly and prion formation. It also reveals new features of the yeast prion protein, and provides a level of control over yeast prion assembly that will be useful for future structural studies and for creating amyloid-based biomaterials.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Emory Univ, Dept Biol & Chem, Atlanta, GA 30322 USA; Univ Chicago, Howard Hughes Med Inst, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; Tech Univ Munich, Inst Organ Chem & Biochem, D-85747 Garching, Germany	Massachusetts Institute of Technology (MIT); Whitehead Institute; Emory University; Howard Hughes Medical Institute; University of Chicago; University of California System; University of California Santa Cruz; Technical University of Munich	Lindquist, S (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lindquist_admin@wi.mit.edu	Bloom, Jesse D/K-3695-2019; Bloom, Jesse D/C-6837-2013; Scheibel, Thomas/I-1170-2014	Bloom, Jesse D/0000-0003-1267-3408; Scheibel, Thomas/0000-0002-0457-2423	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025874, R37GM025874, R01GM065790] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM025874-27, GM 065790, R37 GM025874, R01 GM025874, GM 25874, R01 GM065790] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Bocharova OV, 2005, BIOCHEMISTRY-US, V44, P6776, DOI 10.1021/bi050251q; BORCHELT DR, 1992, J BIOL CHEM, V267, P16188; Burns CS, 2002, BIOCHEMISTRY-US, V41, P3991, DOI 10.1021/bi011922x; Burns CS, 2003, BIOCHEMISTRY-US, V42, P6794, DOI 10.1021/bi027138+; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Chattopadhyay M, 2005, J AM CHEM SOC, V127, P12647, DOI 10.1021/ja053254z; Chernoff YO, 2002, METHOD ENZYMOL, V351, P499; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Chien P, 2003, NATURE, V424, P948, DOI 10.1038/nature01894; Chiesa R, 1998, NEURON, V21, P1339, DOI 10.1016/S0896-6273(00)80653-4; del Pino P, 2007, EUR BIOPHYS J BIOPHY, V36, P239, DOI 10.1007/s00249-006-0124-0; Derkatch IL, 1996, GENETICS, V144, P1375; Flechsig E, 2000, NEURON, V27, P399, DOI 10.1016/S0896-6273(00)00046-5; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; GOLDFARB LG, 1991, P NATL ACAD SCI USA, V88, P10926, DOI 10.1073/pnas.88.23.10926; Goldmann W, 1998, J GEN VIROL, V79, P3173, DOI 10.1099/0022-1317-79-12-3173; Hutter G, 2003, BIOL CHEM, V384, P1279, DOI 10.1515/BC.2003.142; Jackson GS, 2001, P NATL ACAD SCI USA, V98, P8531, DOI 10.1073/pnas.151038498; Jones S, 2005, BIOCHEM J, V392, P309, DOI 10.1042/BJ20051236; Kessler JC, 2003, BIOCHEMISTRY-US, V42, P672, DOI 10.1021/bi020429y; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; Krebs MRH, 2005, J STRUCT BIOL, V149, P30, DOI 10.1016/j.jsb.2004.08.002; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Langella E, 2004, BIOPHYS J, V87, P3623, DOI [10.1529/biophysj.104.043448, 10.1529/biophysj.104.043449]; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Lehmann S, 2002, CURR OPIN CHEM BIOL, V6, P187, DOI 10.1016/S1367-5931(02)00295-8; Leliveld SR, 2006, J BIOL CHEM, V281, P3268, DOI 10.1074/jbc.M510606200; Liu JJ, 1999, NATURE, V400, P573, DOI 10.1038/23048; Millhauser GL, 2004, ACCOUNTS CHEM RES, V37, P79, DOI 10.1021/ar0301678; Millhauser GL, 2007, ANNU REV PHYS CHEM, V58, P299, DOI 10.1146/annurev.physchem.58.032806.104657; Moore RA, 2006, PROTEIN SCI, V15, P609, DOI 10.1110/ps.051822606; Mukhopadhyay S, 2007, P NATL ACAD SCI USA, V104, P2649, DOI 10.1073/pnas.0611503104; Orem NR, 2006, J NEUROCHEM, V96, P1409, DOI 10.1111/j.1471-4159.2006.03650.x; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Qin KF, 2002, J BIOL CHEM, V277, P1981, DOI 10.1074/jbc.M108744200; Salnikova AB, 2005, J BIOL CHEM, V280, P8808, DOI 10.1074/jbc.M410150200; Scheibel T, 2005, CURR OPIN BIOTECH, V16, P427, DOI 10.1016/j.copbio.2005.05.005; Scheibel T, 2003, P NATL ACAD SCI USA, V100, P4527, DOI 10.1073/pnas.0431081100; Scheibel T, 2001, CURR BIOL, V11, P366, DOI 10.1016/S0960-9822(01)00099-9; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Schirmer EC, 1997, P NATL ACAD SCI USA, V94, P13932, DOI 10.1073/pnas.94.25.13932; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Serio TR, 1999, ANNU REV CELL DEV BI, V15, P661, DOI 10.1146/annurev.cellbio.15.1.661; Shewmaker F, 2006, P NATL ACAD SCI USA, V103, P19754, DOI 10.1073/pnas.0609638103; Shiraishi N, 2000, BIOCHEM BIOPH RES CO, V267, P398, DOI 10.1006/bbrc.1999.1944; Shiraishi N, 2006, J BIOL CHEM, V281, P34880, DOI 10.1074/jbc.M606581200; Shkundina IS, 2006, GENETICS, V172, P827, DOI 10.1534/genetics.105.048660; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Sigurdsson EM, 2003, J BIOL CHEM, V278, P46199, DOI 10.1074/jbc.C300303200; SIKORSKI RS, 1989, GENETICS, V122, P19; Stockel J, 1998, BIOCHEMISTRY-US, V37, P7185, DOI 10.1021/bi972827k; Sumudhu W, 2001, CURR BIOL, V11, P519, DOI 10.1016/S0960-9822(01)00147-6; Supattapone S, 1999, CELL, V96, P869, DOI 10.1016/S0092-8674(00)80596-6; Swietnicki W, 1997, J BIOL CHEM, V272, P27517, DOI 10.1074/jbc.272.44.27517; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tanaka M, 2006, METHOD ENZYMOL, V412, P185, DOI 10.1016/S0076-6879(06)12012-1; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Tessier PM, 2007, NATURE, V447, P556, DOI 10.1038/nature05848; Treiber C, 2007, FEBS J, V274, P1304, DOI 10.1111/j.1742-4658.2007.05678.x; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; True HL, 2004, NATURE, V431, P184, DOI 10.1038/nature02885; Uptain SM, 2001, EMBO J, V20, P6236, DOI 10.1093/emboj/20.22.6236; van Rheede T, 2003, MOL BIOL EVOL, V20, P111, DOI 10.1093/molbev/msg014; Vital C, 1998, NEUROPATH APPL NEURO, V24, P125, DOI 10.1046/j.1365-2990.1998.00098.x; Watanabe Y, 2006, BIOCHEM BIOPH RES CO, V350, P549, DOI 10.1016/j.bbrc.2006.09.082; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Zou WQ, 2002, J BIOL CHEM, V277, P43942, DOI 10.1074/jbc.M203611200	74	26	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34204	34212		10.1074/jbc.M704952200	http://dx.doi.org/10.1074/jbc.M704952200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17893150	Green Accepted, hybrid			2022-12-25	WOS:000251145700035
J	Tsuboi, S; Meerloo, J				Tsuboi, Shigeru; Meerloo, Jennifer			Wiskott-Aldrich syndrome protein is a key regulator of the phagocytic cup formation in macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WASP-INTERACTING PROTEIN; B-CELL ACTIVATION; FC-GAMMA-R; N-WASP; ACTIN POLYMERIZATION; T-CELL; MEDIATED PHAGOCYTOSIS; FILOPODIUM FORMATION; TYROSINE KINASE; ARP2/3 COMPLEX	Phagocytosis is a vital first-line host defense mechanism against infection involving the ingestion and digestion of foreign materials such as bacteria by specialized cells, phagocytes. For phagocytes to ingest the foreign materials, they form an actin-based membrane structure called phagocytic cup at the plasma membranes. Formation of the phagocytic cup is impaired in phagocytes from patients with a genetic immunodeficiency disorder, Wiskott-Aldrich syndrome (WAS). The gene defective in WAS encodes Wiskott-Aldrich syndrome protein (WASP). Mutation or deletion of WASP causes impaired formation of the phagocytic cup, suggesting that WASP plays an important role in the phagocytic cup formation. However, the molecular details of its formation remain unknown. We have shown that the WASP C-terminal activity is critical for the phagocytic cup formation in macrophages. We demonstrated that WASP is phosphorylated on tyrosine 291 in macrophages, and the WASP phosphorylation is important for the phagocytic cup formation. In addition, we showed that WASP and WASP interacting protein (WIP) form a complex at the phagocytic cup and that the WASP center dot WIP complex plays a critical role in the phagocytic cup formation. Our results indicate that the phosphorylation of WASP and the complex formation of WASP with WIP are the essential molecular steps for the efficient formation of the phagocytic cup in macrophages, suggesting a possible disease mechanism underlying phagocytic defects and recurrent infections in WAS patients.	Burnham Inst Med Res, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA; Burnham Inst Med Res, Cell Imaging Facil, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute	Tsuboi, S (corresponding author), Burnham Inst Med Res, Infect & Inflammatory Dis Ctr, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	stsuboi@burnham.org			NICHD NIH HHS [R01 HD 042752] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042752] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; ALDRICH RA, 1954, PEDIATRICS, V13, P133; Anton IM, 2006, EUR J CELL BIOL, V85, P295, DOI 10.1016/j.ejcb.2005.08.004; Anton IM, 2002, IMMUNITY, V16, P193, DOI 10.1016/S1074-7613(02)00268-6; Aspenstrom P, 2002, EXP CELL RES, V279, P21, DOI 10.1006/excr.2002.5576; AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; Baba Y, 1999, BLOOD, V93, P2003, DOI 10.1182/blood.V93.6.2003.406k13_2003_2012; Badolato R, 1998, J IMMUNOL, V161, P1026; Badour K, 2007, P NATL ACAD SCI USA, V104, P1593, DOI 10.1073/pnas.0610543104; Barda-Saad M, 2005, NAT IMMUNOL, V6, P80, DOI 10.1038/ni1143; Bodour K, 2004, J EXP MED, V199, P99, DOI 10.1084/jem.20030976; Burns S, 2004, BLOOD, V104, P3454, DOI 10.1182/blood-2004-04-1678; Calle Y, 2004, BLOOD, V103, P3552, DOI 10.1182/blood-2003-04-1259; Calle Y, 2006, J CELL SCI, V119, P2375, DOI 10.1242/jcs.02939; Cannon JL, 2004, J IMMUNOL, V173, P1658, DOI 10.4049/jimmunol.173.3.1658; Carman CV, 2007, IMMUNITY, V26, P784, DOI 10.1016/j.immuni.2007.04.015; Caron E, 2002, CURR OPIN CELL BIOL, V14, P82, DOI 10.1016/S0955-0674(01)00298-8; Chellaiah MA, 2007, J BIOL CHEM, V282, P10104, DOI 10.1074/jbc.M608957200; Cianferoni A, 2005, J ALLERGY CLIN IMMUN, V116, P1364, DOI 10.1016/j.jaci.2005.09.006; Cory GOC, 2002, J BIOL CHEM, V277, P45115, DOI 10.1074/jbc.M203346200; de la Fuente MA, 2007, P NATL ACAD SCI USA, V104, P926, DOI 10.1073/pnas.0610275104; DERRY JMJ, 1994, CELL, V78, P635, DOI 10.1016/0092-8674(94)90528-2; Dreskin SC, 2001, J IMMUNOL, V166, P5646, DOI 10.4049/jimmunol.166.9.5646; Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; GREENBERG S, 1993, J EXP MED, V177, P529, DOI 10.1084/jem.177.2.529; Greenberg S, 2002, CURR OPIN IMMUNOL, V14, P136, DOI 10.1016/S0952-7915(01)00309-0; Gross BS, 1999, BLOOD, V94, P4166, DOI 10.1182/blood.V94.12.4166.424k36_4166_4176; Guinamard R, 1998, FEBS LETT, V434, P431, DOI 10.1016/S0014-5793(98)01016-3; Higgs HN, 2000, J CELL BIOL, V150, P1311, DOI 10.1083/jcb.150.6.1311; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Ho HYH, 2001, P NATL ACAD SCI USA, V98, P11306, DOI 10.1073/pnas.211420498; Humblet-Baron S, 2007, J CLIN INVEST, V117, P407, DOI 10.1172/JCI29539; Jones GE, 2002, INT J BIOCHEM CELL B, V34, P806, DOI 10.1016/S1357-2725(01)00162-5; Kato M, 2002, BIOCHEM BIOPH RES CO, V291, P41, DOI 10.1006/bbrc.2002.6406; Kay JG, 2006, J BIOL CHEM, V281, P11949, DOI 10.1074/jbc.M600857200; Kedzierska K, 2001, J LEUKOCYTE BIOL, V70, P322; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Konno A, 2007, INT IMMUNOL, V19, P185, DOI 10.1093/intimm/dxl135; Leverrier Y, 2001, J IMMUNOL, V166, P4831, DOI 10.4049/jimmunol.166.8.4831; Leverrier Y, 2001, CURR BIOL, V11, P195, DOI 10.1016/S0960-9822(01)00047-1; Linder S, 2000, J IMMUNOL, V165, P221, DOI 10.4049/jimmunol.165.1.221; Linder S, 1999, P NATL ACAD SCI USA, V96, P9648, DOI 10.1073/pnas.96.17.9648; Linder S, 2001, INFECT IMMUN, V69, P1739, DOI 10.1128/IAI.69.3.1739-1746.2001; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Lorenzi R, 2000, BLOOD, V95, P2943, DOI 10.1182/blood.V95.9.2943.009k17_2943_2946; Maillard MH, 2007, J EXP MED, V204, P381, DOI 10.1084/jem.20061338; Marangoni F, 2007, J EXP MED, V204, P369, DOI 10.1084/jem.20061334; Martinez-Quiles N, 2001, NAT CELL BIOL, V3, P484, DOI 10.1038/35074551; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Moreau V, 2000, NAT CELL BIOL, V2, P441, DOI 10.1038/35017080; Morrogh LM, 1999, EUR J IMMUNOL, V29, P2269; Ochs HD, 2006, J ALLERGY CLIN IMMUN, V117, P725, DOI 10.1016/j.jaci.2006.02.005; Oda A, 2001, BLOOD, V97, P2633, DOI 10.1182/blood.V97.9.2633; Olazabal IM, 2002, CURR BIOL, V12, P1413, DOI 10.1016/S0960-9822(02)01069-2; Park JY, 2004, CLIN EXP IMMUNOL, V136, P104, DOI 10.1111/j.1365-2249.2004.02409.x; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Ramesh N, 1997, P NATL ACAD SCI USA, V94, P14671, DOI 10.1073/pnas.94.26.14671; Rawlings SL, 1999, BLOOD, V94, P3872, DOI 10.1182/blood.V94.11.3872.423k37_3872_3882; Rebhun JF, 2000, J BIOL CHEM, V275, P34901, DOI 10.1074/jbc.M005327200; Rengan R, 2000, BLOOD, V95, P1283, DOI 10.1182/blood.V95.4.1283.004k44_1283_1292; Sasahara Y, 2002, MOL CELL, V10, P1269, DOI 10.1016/S1097-2765(02)00728-1; Sawa M, 2006, BIOCHEM BIOPH RES CO, V340, P709, DOI 10.1016/j.bbrc.2005.12.056; Schafer G, 2007, DEV BIOL, V304, P664, DOI 10.1016/j.ydbio.2007.01.015; Scott MP, 2002, J BIOL CHEM, V277, P28238, DOI 10.1074/jbc.M202783200; Silvin C, 2001, J BIOL CHEM, V276, P21450, DOI 10.1074/jbc.M010729200; Snapper SB, 1998, IMMUNITY, V9, P81, DOI 10.1016/S1074-7613(00)80590-7; Torres E, 2006, J BIOL CHEM, V281, P3513, DOI 10.1074/jbc.M509416200; Torres E, 2003, MOL CELL, V11, P1215, DOI 10.1016/S1097-2765(03)00139-4; Tsuboi S, 2006, EMBO REP, V7, P506, DOI 10.1038/sj.embor.7400665; Tsuboi S, 2007, J IMMUNOL, V178, P2987, DOI 10.4049/jimmunol.178.5.2987; Tsuboi S, 2006, J IMMUNOL, V176, P6576, DOI 10.4049/jimmunol.176.11.6576; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; Vaduva G, 1997, J CELL BIOL, V139, P1821, DOI 10.1083/jcb.139.7.1821; WISKOTT A, 1937, MONATSSCHR KINDERH, V68, P212; Zeng R, 2003, J IMMUNOL, V171, P1360, DOI 10.4049/jimmunol.171.3.1360; Zhang H, 2006, IMMUNITY, V25, P285, DOI 10.1016/j.immuni.2006.06.014; Zhang J, 1999, J EXP MED, V190, P1329, DOI 10.1084/jem.190.9.1329; Zicha D, 1998, BRIT J HAEMATOL, V101, P659, DOI 10.1046/j.1365-2141.1998.00767.x	78	55	55	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34194	34203		10.1074/jbc.M705999200	http://dx.doi.org/10.1074/jbc.M705999200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17890224	hybrid			2022-12-25	WOS:000251145700034
J	Wang, Y; Loo, TW; Bartlett, MC; Clarke, DM				Wang, Ying; Loo, Tip W.; Bartlett, M. Claire; Clarke, David M.			Correctors promote maturation of cystic fibrosis transmembrane conductance regulator (CFTR)-processing mutants by binding to the protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN P-GLYCOPROTEIN; DELTA-F508 MUTATION; SIDE-CHAIN; CFTR; RESCUE; IDENTIFICATION; SIGNATURE; SEGMENTS; DOMAIN	The most common cause of cystic fibrosis (CF) is defective folding of a cystic fibrosis transmembrane conductance regulator (CFTR) mutant lacking Phe(508) (Delta F508). The Delta F508 protein appears to be trapped in a prefolded state with incomplete packing of the transmembrane (TM) segments, a defect that can be repaired by expression in the presence of correctors such as corr-4a, VRT-325, and VRT-532. To determine whether the mechanism of correctors involves direct interactions with CFTR, our approach was to test whether correctors blocked disulfide cross-linking between cysteines introduced into the two halves of a Cys-less CFTR. Although replacement of the 18 endogenous cysteines of CFTR with Ser or Ala yields a Cys-less mutant that does not mature at 37 C, we found that maturation could be restored if Val(510) was changed to Ala, Cys, Ser, Thr, Gly, Ala, or Asp. The V510D mutation also promoted maturation of Delta F508 CFTR. The Cys-less/V510A mutant was used for subsequent cross-linking analysis as it yielded relatively high levels of mature protein that was functional in iodide efflux assays. We tested for cross-linking between cysteines introduced into TM6 and TM7 of Cys-less CFTR/V510A because cross-linking between TM6 and TM7 of P-glycoprotein, the sister protein of CFTR, was inhibited with the corrector VRT-325. Cys-less CFTR/V510A mutant containing cysteines at I340C(TM6) and S877C(TM7) could be cross-linked with a homobifunctional cross-linker. Correctors and the CFTR channel blocker benzbromarone, but not P-glycoprotein substrates, inhibited cross-linking of mutant I340C(TM6)/S877C(TM7). These results suggest that corrector molecules such as corr-4a interact directly with CFTR.	Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto	Clarke, DM (corresponding author), Univ Toronto, Dept Med, 100 Coll St, Toronto, ON M5S 1A8, Canada.	david.clarke@utoronto.ca	Clarke, David M./A-1112-2008	Clarke, David M./0000-0003-4335-7184; Loo, Tip W/0000-0003-2108-0188				Chen EY, 2004, J BIOL CHEM, V279, P39620, DOI 10.1074/jbc.M407887200; Cui L, 2006, J PHYSIOL-LONDON, V572, P347, DOI 10.1113/jphysiol.2005.099457; deCarvalho ACV, 2002, J BIOL CHEM, V277, P35896, DOI 10.1074/jbc.M205644200; Diena T, 2007, EUR J PHARMACOL, V560, P127, DOI 10.1016/j.ejphar.2007.01.051; HOOF T, 1994, J BIOL CHEM, V269, P20575; Kleizen B, 2005, MOL CELL, V20, P277, DOI 10.1016/j.molcel.2005.09.007; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Loo TW, 2005, MOL PHARMACEUT, V2, P407, DOI 10.1021/mp0500521; Loo TW, 1997, J BIOL CHEM, V272, P709, DOI 10.1074/jbc.272.2.709; Loo TW, 2003, J BIOL CHEM, V278, P39706, DOI 10.1074/jbc.M308559200; Loo TW, 1996, J BIOL CHEM, V271, P27482, DOI 10.1074/jbc.271.44.27482; Mense M, 2002, J GEN PHYSIOL, V120, p25A; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; RIORDAN JR, 1989, SCIENCE, V245, P1066; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; TEEM JL, 1993, CELL, V73, P335, DOI 10.1016/0092-8674(93)90233-G; Thibodeau PH, 2005, NAT STRUCT MOL BIOL, V12, P10, DOI 10.1038/nsmb881; Treharne KJ, 2007, J BIOL CHEM, V282, P10804, DOI 10.1074/jbc.M610956200; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Wang Y, 2007, BIOCHEM J, V406, P257, DOI 10.1042/BJ20070478; Wang Y, 2007, MOL PHARMACOL, V71, P751, DOI 10.1124/mol.106.029926; Wang Y, 2006, MOL PHARMACOL, V70, P297, DOI 10.1124/mol.106.023994; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Zhang H, 2006, J BIOL CHEM, V281, P11312, DOI 10.1074/jbc.M512013200	26	123	126	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33247	33251		10.1074/jbc.C700175200	http://dx.doi.org/10.1074/jbc.C700175200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17911111	hybrid			2022-12-25	WOS:000250840200003
J	Young, TM; Tsai, M; Tian, B; Mathews, MB; Pe'ery, T				Young, Tara M.; Tsai, Michael; Tian, Bin; Mathews, Michael B.; Pe'ery, Tsafi			Cellular mRNA Activates Transcription Elongation by Displacing 7SK RNA	PLOS ONE			English	Article								The positive transcription elongation factor P-TEFb is a pivotal regulator of gene expression in higher cells. Originally identified in Drosophila, attention was drawn to human P-TEFb by the discovery of its role as an essential cofactor for HIV-1 transcription. It is recruited to HIV transcription complexes by the viral transactivator Tat, and to cellular transcription complexes by a plethora of transcription factors. P-TEFb activity is negatively regulated by sequestration in a complex with the HEXIM proteins and 7SK RNA. The mechanism of P-TEFb release from the inhibitory complex is not known. We report that P-TEFb-dependent transcription from the HIV promoter can be stimulated by the mRNA encoding HIC, the human I-mfa domain-containing protein. The 3'-untranslated region of HIC mRNA is necessary and sufficient for this action. It forms complexes with P-TEFb and displaces 7SK RNA from the inhibitory complex in cells and cell extracts. A 314-nucleotide sequence near the 3' end of HIC mRNA has full activity and contains a predicted structure resembling the 3'-terminal hairpin of 7SK that is critical for P-TEFb binding. This represents the first example of a cellular mRNA that can regulate transcription via P-TEFb. Our findings offer a rationale for 7SK being an RNA transcriptional regulator and suggest a practical means for enhancing gene expression.	[Young, Tara M.; Tsai, Michael; Tian, Bin; Mathews, Michael B.; Pe'ery, Tsafi] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07103 USA; [Pe'ery, Tsafi] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Med, Newark, NJ 07103 USA; [Tian, Bin; Mathews, Michael B.; Pe'ery, Tsafi] Univ Med & Dent New Jersey, Grad Sch Biomed Sci, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Mathews, MB (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07103 USA.	mathews@umdnj.edu; peeryts@umdnj.edu		Tian, Bin/0000-0001-8903-8256	National Institutes of Health [AI055331, AI034552]; Foundation of UMDNJ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034552, R21AI055331] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation of UMDNJ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding: This work was supported by grants from the National Institutes of Health, AI055331 to Tsafi Pe'ery and AI034552 to Michael B. Mathews, and from the Foundation of UMDNJ to Tsafi Pe'ery. The funders had no role in study, design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagella L, 1998, J CELL PHYSIOL, V177, P206, DOI 10.1002/(SICI)1097-4652(199811)177:2<206::AID-JCP2>3.3.CO;2-W; Barboric M, 2005, PLOS BIOL, V3, P200, DOI 10.1371/journal.pbio.0030076; Barboric M, 2001, MOL CELL, V8, P327, DOI 10.1016/S1097-2765(01)00314-8; Barboric M, 2007, NUCLEIC ACIDS RES, V35, P2003, DOI 10.1093/nar/gkm063; Bird G, 2004, MOL CELL BIOL, V24, P8963, DOI 10.1128/MCB.24.20.8963-8969.2004; Bres V, 2005, GENE DEV, V19, P1211, DOI 10.1101/gad.1291705; Byers SA, 2005, J BIOL CHEM, V280, P16360, DOI 10.1074/jbc.M500424200; Condeelis J, 2005, BIOL CELL, V97, P97; Eberhardy SR, 2002, J BIOL CHEM, V277, P40156, DOI 10.1074/jbc.M207441200; Egloff S, 2006, MOL CELL BIOL, V26, P630, DOI 10.1128/MCB.26.2.630-642.2006; Flores OL, 1999, P NATL ACAD SCI USA, V96, P7208, DOI 10.1073/pnas.96.13.7208; Fong YW, 2001, NATURE, V414, P929, DOI 10.1038/414929a; Foskett SM, 2001, J VIROL, V75, P1220, DOI 10.1128/JVI.75.3.1220-1228.2001; Fraldi A, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-42; Garber ME, 1998, GENE DEV, V12, P3512, DOI 10.1101/gad.12.22.3512; Garriga J, 1998, ONCOGENE, V17, P3093, DOI 10.1038/sj.onc.1202548; Guiguen A, 2007, EMBO J, V26, P1552, DOI 10.1038/sj.emboj.7601627; Havgaard JH, 2005, BIOINFORMATICS, V21, P1815, DOI 10.1093/bioinformatics/bti279; Hogg JR, 2007, RNA, V13, P868, DOI 10.1261/rna.565207; Hoque M, 2003, MOL CELL BIOL, V23, P1688, DOI 10.1128/MCB.23.5.1688-1702.2003; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jeronimo C, 2007, MOL CELL, V27, P262, DOI 10.1016/j.molcel.2007.06.027; Kameoka S, 2004, EMBO J, V23, P1782, DOI 10.1038/sj.emboj.7600187; Kanazawa S, 2003, ONCOGENE, V22, P5707, DOI 10.1038/sj.onc.1206800; Kino T, 2002, J BIOL CHEM, V277, P2396, DOI 10.1074/jbc.M106312200; Kulkarni PA, 2004, RECENT PROG HORM RES, V59, P125, DOI 10.1210/rp.59.1.125; Kurosu T, 2004, CURR BIOL, V14, P1112, DOI 10.1016/j.cub.2004.06.020; Kusano S, 2002, MOL CELL BIOL, V22, P6393, DOI 10.1128/MCB.22.18.6393-6405.2002; Kyburz A, 2003, NUCLEIC ACIDS RES, V31, P3936, DOI 10.1093/nar/gkg478; Lee DK, 2001, J BIOL CHEM, V276, P9978, DOI 10.1074/jbc.M002285200; Li QT, 2007, NUCLEIC ACIDS RES, V35, P2503, DOI 10.1093/nar/gkm150; Licatalosi DD, 2002, MOL CELL, V9, P1101, DOI 10.1016/S1097-2765(02)00518-X; Lis JT, 2000, GENE DEV, V14, P792; Majello B, 1999, ONCOGENE, V18, P4598, DOI 10.1038/sj.onc.1202822; Mancebo HSY, 1997, GENE DEV, V11, P2633, DOI 10.1101/gad.11.20.2633; MARSHALL NF, 1995, J BIOL CHEM, V270, P12335, DOI 10.1074/jbc.270.21.12335; Michels AA, 2003, MOL CELL BIOL, V23, P4859, DOI 10.1128/MCB.23.14.4859-4869.2003; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Mizutani T, 2001, MOL ENDOCRINOL, V15, P1693, DOI 10.1210/me.15.10.1693; Nakamura T, 2003, P NATL ACAD SCI USA, V100, P5834, DOI 10.1073/pnas.0935626100; Neo SY, 2000, BIOCHEM BIOPH RES CO, V272, P144, DOI 10.1006/bbrc.2000.2751; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Ni ZY, 2004, MOL CELL, V13, P55, DOI 10.1016/S1097-2765(03)00526-4; Pan WJ, 2006, J CELL SCI, V119, P4850, DOI 10.1242/jcs.03257; Pan WJ, 2005, P NATL ACAD SCI USA, V102, P17378, DOI 10.1073/pnas.0505922102; Pei Y, 2006, MOL CELL BIOL, V26, P777, DOI 10.1128/MCB.26.3.777-788.2006; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Qiang Z, 2006, MICROBIOL MOL BIOL R, V70, P646, DOI 10.1128/MMBR.00011-06; Ramanathan Y, 1999, J VIROL, V73, P5448, DOI 10.1128/JVI.73.7.5448-5458.1999; Rosonina E, 2004, RNA, V10, P581, DOI 10.1261/rna.5207204; Sano M, 2002, NAT MED, V8, P1310, DOI 10.1038/nm778; Sano M, 2003, CELL CYCLE, V2, P99, DOI 10.4161/cc.2.2.332; Sedore SC, 2007, NUCLEIC ACIDS RES, V35, P4347, DOI 10.1093/nar/gkm443; Snider L, 2005, MOL CELL BIOL, V25, P5061, DOI 10.1128/MCB.25.12.5061-5072.2005; Snider L, 2001, MOL CELL BIOL, V21, P1866, DOI 10.1128/MCB.21.5.1866-1873.2001; Taube R, 2002, MOL CELL BIOL, V22, P321, DOI 10.1128/MCB.22.1.321-331.2002; Thebault S, 2000, EUR J CELL BIOL, V79, P834, DOI 10.1078/0171-9335-00111; Thebault S, 2000, J BIOL CHEM, V275, P4848, DOI 10.1074/jbc.275.7.4848; VANHERREWEGHE E, 2007, EMBO J; Wang Q, 2007, J MOL BIOL, V367, P630, DOI 10.1016/j.jmb.2007.01.020; WASSARMAN DA, 1991, MOL CELL BIOL, V11, P3432, DOI 10.1128/MCB.11.7.3432; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Wittmann BM, 2005, ONCOGENE, V24, P5576, DOI 10.1038/sj.onc.1208728; Yang XZ, 1997, P NATL ACAD SCI USA, V94, P12331, DOI 10.1073/pnas.94.23.12331; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575; Yik JHN, 2005, J BIOL CHEM, V280, P16368, DOI 10.1074/jbc.M500912200; Yik JHN, 2004, MOL CELL BIOL, V24, P5094, DOI 10.1128/MCB.24.12.5094-5105.2004; Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5; Young TM, 2003, MOL CELL BIOL, V23, P6373, DOI 10.1128/MCB.23.18.6373-6384.2003; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	72	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1010	10.1371/journal.pone.0001010	http://dx.doi.org/10.1371/journal.pone.0001010			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925858	Green Published, gold, Green Submitted			2022-12-25	WOS:000207456000009
J	Azuma, M; Embree, LJ; Sabaawy, H; Hickstein, DD				Azuma, Mizuki; Embree, Lisa J.; Sabaawy, Hatem; Hickstein, Dennis D.			Ewing Sarcoma Protein Ewsr1 Maintains Mitotic Integrity and Proneural Cell Survival in the Zebrafish Embryo	PLOS ONE			English	Article								Background. The Ewing sarcoma breakpoint region 1 gene (EWSR1), also known as EWS, is fused to a number of different partner genes as a result of chromosomal translocation in diverse sarcomas. Despite the involvement of EWSR1 in these diverse sarcomas, the in vivo function of wild type EWSR1 remains unclear. Principal Findings. We identified two zebrafish EWSR1 orthologues, ewsr1a and ewsr1b, and demonstrate that both genes are expressed maternally, and are expressed ubiquitously throughout zebrafish embryonic development. Morpholino induced knockdown of both zebrafish ewsr1 genes led to mitotic defects with multipolar or otherwise abnormal mitotic spindles starting from the bud stage (10 hour post-fertilization (hpf)). The abnormalities in mitotic spindles were followed by p53-mediated apoptosis in the developing central nervous system (CNS) leading to a reduction in the number of proneural cells, disorganization of neuronal networks, and embryonic lethality by 5 days post-fertilization. siRNA silencing of EWSR1 in Hela cells resulted in mitotic defects accompanied by apoptotic cell death, indicating that the role of EWSR1 is conserved between zebrafish and human. Conclusions. Ewsr1 maintains mitotic integrity and proneural cell survival in early zebrafish development.	[Azuma, Mizuki; Embree, Lisa J.; Sabaawy, Hatem; Hickstein, Dennis D.] NCI, Expt Transplantat & Immunol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Azuma, M (corresponding author), NCI, Expt Transplantat & Immunol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	azumam@mail.nih.gov			NIH, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [K22CA120626] Funding Source: NIH RePORTER	NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research	ALLENDE ML, 1994, DEV BIOL, V166, P509, DOI 10.1006/dbio.1994.1334; Aman P, 1996, GENOMICS, V37, P1, DOI 10.1006/geno.1996.0513; Andermann P, 2002, DEV BIOL, V251, P45, DOI 10.1006/dbio.2002.0820; Araya N, 2003, J BIOL CHEM, V278, P5427, DOI 10.1074/jbc.M210234200; Azuma M, 2006, J BIOL CHEM, V281, P13309, DOI 10.1074/jbc.M601892200; Bertolotti A, 1998, MOL CELL BIOL, V18, P1489, DOI 10.1128/MCB.18.3.1489; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Cole LK, 2001, DEV BIOL, V240, P123, DOI 10.1006/dbio.2001.0432; Concha ML, 1998, DEVELOPMENT, V125, P983; Ensor E, 2001, J BIOL CHEM, V276, P5204, DOI 10.1074/jbc.M007068200; Gascoyne DM, 2004, ONCOGENE, V23, P3830, DOI 10.1038/sj.onc.1207497; Geldmacher-Voss B, 2003, DEVELOPMENT, V130, P3767, DOI 10.1242/dev.00603; Gross A, 2005, J BIOENERG BIOMEMBR, V37, P113, DOI 10.1007/s10863-005-6222-3; Kawahara A, 2002, DEV BIOL, V248, P107, DOI 10.1006/dbio.2002.0709; Korzh V, 1998, DEV DYNAM, V213, P92, DOI 10.1002/(SICI)1097-0177(199809)213:1<92::AID-AJA9>3.0.CO;2-T; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Li HJ, 2007, J CLIN INVEST, V117, P1314, DOI 10.1172/JCI31222; McEvilly RJ, 1996, NATURE, V384, P574, DOI 10.1038/384574a0; OXTOBY E, 1993, NUCLEIC ACIDS RES, V21, P1087, DOI 10.1093/nar/21.5.1087; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; SCHULTEMERKER S, 1994, DEVELOPMENT, V120, P1009; Shepard JL, 2005, P NATL ACAD SCI USA, V102, P13194, DOI 10.1073/pnas.0506583102; Smith MD, 1998, J BIOL CHEM, V273, P16715, DOI 10.1074/jbc.273.27.16715; Smith MD, 2001, MOL CELL NEUROSCI, V17, P460, DOI 10.1006/mcne.2000.0927; Strahle U, 1996, INT J DEV BIOL, V40, P929; Vader G, 2006, J CELL BIOL, V173, P833, DOI 10.1083/jcb.200604032; Xia SJ, 2005, EUR J CANCER, V41, P2513, DOI 10.1016/j.ejca.2005.08.003; Yang L, 2000, J BIOL CHEM, V275, P37612, DOI 10.1074/jbc.M005739200; Zakaryan RP, 2006, J MOL BIOL, V363, P27, DOI 10.1016/j.jmb.2006.08.018	31	44	45	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e979	10.1371/journal.pone.0000979	http://dx.doi.org/10.1371/journal.pone.0000979			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912356	Green Published, Green Submitted, gold			2022-12-25	WOS:000207455900015
J	Pincet, F				Pincet, Frederic			Membrane Recruitment of Scaffold Proteins Drives Specific Signaling	PLOS ONE			English	Article								Cells must give the right response to each stimulus they receive. Scaffolding, a signaling process mediated by scaffold proteins, participates in the decoding of the cues by specifically directing signal transduction. The aim of this paper is to describe the molecular mechanisms of scaffolding, i.e. the principles by which scaffold proteins drive a specific response of the cell. Since similar scaffold proteins are found in many species, they evolved according to the purpose of each organism. This means they require adaptability. In the usual description of the mechanisms of scaffolding, scaffold proteins are considered as reactors where molecules involved in a cascade of reactions are simultaneously bound with the right orientation to meet and interact. This description is not realistic: (i) it is not verified by experiments and (ii) timing and orientation constraints make it complex which seems to contradict the required adaptability. A scaffold protein, Ste5, is used in the MAPK pathway of Saccharomyces Cerevisiae for the cell to provide a specific response to stimuli. The massive amount of data available for this pathway makes it ideal to investigate the actual mechanisms of scaffolding. Here, a complete treatment of the chemical reactions allows the computation of the distributions of all the proteins involved in the MAPK pathway when the cell receives various cues. These distributions are compared to several experimental results. It turns out that the molecular mechanisms of scaffolding are much simpler and more adaptable than previously thought in the reactor model. Scaffold proteins bind only one molecule at a time. Then, their membrane recruitment automatically drives specific, amplified and localized signal transductions. The mechanisms presented here, which explain how the membrane recruitment of a protein can produce a drastic change in the activity of cells, are generic and may be commonly used in many biological processes.	Ecole Normale Super, Phys Stat Lab, F-75231 Paris, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Pincet, F (corresponding author), Ecole Normale Super, Phys Stat Lab, 24 Rue Lhomond, F-75231 Paris, France.	pincet@lps.ens.fr		PINCET, FREDERIC/0000-0002-4243-2157				Bardwell L, 1996, MOL CELL BIOL, V16, P3637; Bardwell L, 2007, BIOPHYS J, V92, P3425, DOI 10.1529/biophysj.106.090084; Barnich N, 2005, J CELL BIOL, V170, P21, DOI 10.1083/jcb.200502153; Behrmann I, 2004, J BIOL CHEM, V279, P35486, DOI 10.1074/jbc.M404202200; Ben-Romano R, 2004, DIABETOLOGIA, V47, P1107, DOI 10.1007/s00125-004-1408-5; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; Breitkreutz A, 2002, TRENDS CELL BIOL, V12, P254, DOI 10.1016/S0962-8924(02)02284-5; Breitkreutz A, 2001, CURR BIOL, V11, P1266, DOI 10.1016/S0960-9822(01)00370-0; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; CHOI KY, 1994, CELL, V78, P499; Chou S, 2004, CELL, V119, P981, DOI 10.1016/j.cell.2004.11.053; Collins RN, 2003, MOL CELL, V12, P1064, DOI 10.1016/S1097-2765(03)00445-3; Colman-Lerner A, 2005, NATURE, V437, P699, DOI 10.1038/nature03998; Dard N, 2006, BIOESSAYS, V28, P146, DOI 10.1002/bies.20351; Das S, 2003, P NATL ACAD SCI USA, V100, P7491, DOI 10.1073/pnas.0932835100; Elion EA, 2005, SCIENCE, V307, P687, DOI 10.1126/science.1109500; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Ferrell JE, 1997, J BIOL CHEM, V272, P19008, DOI 10.1074/jbc.272.30.19008; FERRELL JE, 2000, SCI STKE, pPE1; Flatauer LJ, 2005, MOL CELL BIOL, V25, P1793, DOI 10.1128/MCB.25.5.1793-1803.2005; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Giorgione JR, 2006, J BIOL CHEM, V281, P1660, DOI 10.1074/jbc.M510251200; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; Harris K, 2001, CURR BIOL, V11, P1815, DOI 10.1016/S0960-9822(01)00567-X; Hemsath L, 2005, MOL CELL, V20, P313, DOI 10.1016/j.molcel.2005.08.036; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Hyvola N, 2006, EMBO J, V25, P3750, DOI 10.1038/sj.emboj.7601274; Inouye C, 1997, SCIENCE, V278, P103, DOI 10.1126/science.278.5335.103; Kawasaki M, 2005, CURR OPIN STRUC BIOL, V15, P681, DOI 10.1016/j.sbi.2005.10.015; Kholodenko BN, 2000, TRENDS CELL BIOL, V10, P173, DOI 10.1016/S0962-8924(00)01741-4; Kohler F, 2005, NAT IMMUNOL, V6, P204, DOI 10.1038/ni1163; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Komarova NL, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100031; Kurzbauer R, 2004, P NATL ACAD SCI USA, V101, P10984, DOI 10.1073/pnas.0403435101; Kusari AB, 2004, J CELL BIOL, V164, P267, DOI 10.1083/jcb.200310021; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; Li X, 2006, BIOCHEM J, V394, P427, DOI 10.1042/BJ20051560; Lundmark R, 2004, J BIOL CHEM, V279, P42694, DOI 10.1074/jbc.M407430200; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; Matsuoka S, 2006, J CELL SCI, V119, P1071, DOI 10.1242/jcs.02824; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; NODA Y, 2006, J CELL BIOCH; Padival AK, 2004, MOL CELL BIOCHEM, V258, P129, DOI 10.1023/B:MCBI.0000012847.86529.07; Paleotti O, 2005, J BIOL CHEM, V280, P21661, DOI 10.1074/jbc.m503099200; Park SH, 2003, SCIENCE, V299, P1061, DOI 10.1126/science.1076979; Philip F, 2004, BIOCHEMISTRY-US, V43, P11691, DOI 10.1021/bi049381+; Sabbagh W, 2001, MOL CELL, V8, P683, DOI 10.1016/S1097-2765(01)00322-7; Schwartz MA, 2004, ANNU REV GENET, V38, P725, DOI 10.1146/annurev.genet.39.073003.112634; Shiba T, 2006, P NATL ACAD SCI USA, V103, P15416, DOI 10.1073/pnas.0605357103; Stahelin RV, 2006, J BIOL CHEM, V281, P39396, DOI 10.1074/jbc.M607079200; ten Klooster JP, 2007, EMBO J, V26, P336, DOI 10.1038/sj.emboj.7601518; Urs NM, 2005, J CELL SCI, V118, P5291, DOI 10.1242/jcs.02634; Wang TL, 2006, BIOCHEM BIOPH RES CO, V350, P413, DOI 10.1016/j.bbrc.2006.09.064; Wang X, 2006, BIOPHYS J, V90, P1961, DOI 10.1529/biophysj.105.073874; Wang YQ, 2003, J BIOL CHEM, V278, P22284, DOI 10.1074/jbc.M301272200; WHITEWAY MS, 1995, SCIENCE, V269, P1572, DOI 10.1126/science.7667635; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527	58	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e977	10.1371/journal.pone.0000977	http://dx.doi.org/10.1371/journal.pone.0000977			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912354	gold, Green Published			2022-12-25	WOS:000207455900013
J	Roelle, S; Grosse, R; Buech, T; Chubanov, V; Gudermann, T				Roelle, S.; Grosse, R.; Buech, T.; Chubanov, V.; Gudermann, T.			Essential role of Pyk2 and Src kinase activation in neuropeptide-induced proliferation of small cell lung cancer cells	ONCOGENE			English	Article						Pyk2; Src; Ca2+; small cell lung cancer cells; neuropeptides	FOCAL ADHESION KINASE; RAS-BINDING DOMAIN; PROTEIN-KINASE; CA2+ MOBILIZATION; CLONAL GROWTH; RECEPTORS; GALANIN; PHOSPHORYLATION; RAFTK/PYK2; INVASION	Neuropeptide hormones like bombesin/gastrin-releasing peptide, galanin or bradykinin, acting via auto and paracrine growth loops, represent the principal mitogens of small cell lung cancer (SCLC). These mitogenic neuropeptides activate G(q/11)-coupled receptors which stimulate phospholipase C beta activity, followed by rises of the intracellular calcium concent ration ([Ca2+](i)) and activation of protein kinase C (PKC). We report here that proline-rich tyrosine kinase Pyk2 is highly expressed in SCLC cells and provides a functional link between neuropeptide-induced increases in [Ca2+](i) and tumor cell proliferation. Activation of Pyk2 and its association with Src kinases critically depends on the elevation of [Ca2+](i), but is independent of PKC. Src kinase activities are crucial for neuropeptide-mediated GTP-loading of Ras and activation of extracellular signal-regulated kinases in SCLC cells. Pyk2 and Src kinases essentially contribute to anchorage-independent proliferation of SCLC cells. Inhibition of either Pyk2 or Src kinases by lentiviral RNAi or pharmacological inhibition with PP2, respectively, attenuated basal and neuropeptide-elicited survival and proliferation of SCLC cells in liquid culture and in soft agar. Thus, neuropeptides stimulate anchorage-independent survival and proliferation of SCLC cells via pathways involving Pyk2 and Src kinases. Therefore, Ca2+-induced Pyk2/Src complex formation may be a rewarding molecular target for novel therapeutic strategies in SCLC cells.	[Roelle, S.; Buech, T.; Chubanov, V.; Gudermann, T.] Univ Marburg, Inst Pharmakol & Toxikol, D-35043 Marburg, Germany; [Grosse, R.] Univ Heidelberg, Inst Pharmakol, D-6900 Heidelberg, Germany	Philipps University Marburg; Ruprecht Karls University Heidelberg	Gudermann, T (corresponding author), Univ Marburg, Inst Pharmakol & Toxikol, Karl Von Frischstr 1, D-35043 Marburg, Germany.	guderman@staff.uni-marburg.de		Grosse, Robert/0000-0002-3380-5273				Avraham H, 2000, CELL SIGNAL, V12, P123, DOI 10.1016/S0898-6568(99)00076-5; Beekman A, 1998, CANCER RES, V58, P910; Blaukat A, 1999, J BIOL CHEM, V274, P14893, DOI 10.1074/jbc.274.21.14893; Cook SJ, 2006, CELL CALCIUM, V39, P101, DOI 10.1016/j.ceca.2005.10.014; Cullen PJ, 2002, NAT REV MOL CELL BIO, V3, P339, DOI 10.1038/nrm808; deRooij J, 1997, ONCOGENE, V14, P623, DOI 10.1038/sj.onc.1201005; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Fernandis AZ, 2004, ONCOGENE, V23, P157, DOI 10.1038/sj.onc.1206910; Grosse R, 2000, J BIOL CHEM, V275, P12251, DOI 10.1074/jbc.275.16.12251; Hatch WC, 1998, BLOOD, V91, P3967, DOI 10.1182/blood.V91.10.3967.3967_3967_3973; Heasley LE, 2001, ONCOGENE, V20, P1563, DOI 10.1038/sj.onc.1204183; HERRMANN C, 1995, J BIOL CHEM, V270, P2901, DOI 10.1074/jbc.270.7.2901; Jones K, 1999, TRENDS BIOTECHNOL, V17, P477, DOI 10.1016/S0167-7799(99)01379-7; Laskin J, 2003, JNCI-J NATL CANCER I, V95, P1099, DOI 10.1093/jnci/djg013; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Lipinski CA, 2005, NEOPLASIA, V7, P435, DOI 10.1593/neo.04712; MABRY M, 1989, J CLIN INVEST, V84, P194, DOI 10.1172/JCI114140; MacKinnon AC, 1999, BRIT J CANCER, V80, P1026, DOI 10.1038/sj.bjc.6690458; McMullen M, 2004, ONCOGENE, V23, P1275, DOI 10.1038/sj.onc.1207243; Moore SM, 1998, CANCER RES, V58, P5239; Parkin DM, 2001, EUR J CANCER, V37, pS4, DOI 10.1016/S0959-8049(01)00267-2; Ravi RK, 1998, J CLIN INVEST, V101, P153, DOI 10.1172/JCI831; Rintoul RC, 2001, LANCET ONCOL, V2, P437, DOI 10.1016/S1470-2045(00)00421-6; Rocic P, 2001, AM J PHYSIOL-CELL PH, V280, pC90, DOI 10.1152/ajpcell.2001.280.1.C90; RodriguezFernandez JL, 1996, J BIOL CHEM, V271, P27895, DOI 10.1074/jbc.271.44.27895; Rozengurt E, 2002, TRENDS ENDOCRIN MET, V13, P128, DOI 10.1016/S1043-2760(01)00544-6; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; SETHI T, 1991, CANCER RES, V51, P1674; SETHI T, 1992, CANCER RES, V52, pS2737; SETHI T, 1993, CANCER RES, V53, P5208; Seufferlein T, 1996, CANCER RES, V56, P3895; Seufferlein T, 1996, CANCER RES, V56, P5758; Sorokin A, 2001, J BIOL CHEM, V276, P21521, DOI 10.1074/jbc.M008869200; Teti A, 2002, CALCIFIED TISSUE INT, V71, P293, DOI 10.1007/s00223-001-2071-1; Tokiwa G, 1996, SCIENCE, V273, P792, DOI 10.1126/science.273.5276.792; Wei L, 2004, ONCOGENE, V23, P9052, DOI 10.1038/sj.onc.1208091; Wittau N, 2000, ONCOGENE, V19, P4199, DOI 10.1038/sj.onc.1203777; Zrihan-Licht S, 2000, ONCOGENE, V19, P1318, DOI 10.1038/sj.onc.1203422; Zwartkruis FJT, 1999, EXP CELL RES, V253, P157, DOI 10.1006/excr.1999.4695	39	46	51	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 13	2008	27	12					1737	1748		10.1038/sj.onc.1210819	http://dx.doi.org/10.1038/sj.onc.1210819			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	273WF	17906699				2022-12-25	WOS:000253962100009
J	Nakatani, M; Takehara, Y; Sugino, H; Matsumoto, M; Hashimoto, O; Hasegawa, Y; Murakami, T; Uezumi, A; Takeda, S; Noji, S; Sunada, Y; Tsuchida, K				Nakatani, Masashi; Takehara, Yuka; Sugino, Hiromu; Matsumoto, Mitsuru; Hashimoto, Osamu; Hasegawa, Yoshihisa; Murakami, Tatsuya; Uezumi, Akiyoshi; Takeda, Shin'ichi; Noji, Sumihare; Sunada, Yoshihide; Tsuchida, Kunihiro			Transgenic expression of a myostatin inhibitor derived from follistatin increases skeletal muscle mass and ameliorates dystrophic pathology in mdx mice	FASEB JOURNAL			English	Article						Duchenne muscular dystrophy; activin; therapy; myostatin blockade	MUSCULAR-DYSTROPHY; BINDING-PROTEIN; ACTIVIN; HYPERTROPHY; RECEPTOR; GROWTH; DIFFERENTIATION; HYPERPLASIA; MUTATIONS; SEVERITY	Myostatin is a potent negative regulator of skeletal muscle growth. Therefore, myostatin inhibition offers a novel therapeutic strategy for muscular dystrophy by restoring skeletal muscle mass and suppressing the progression of muscle degeneration. The known myostatin inhibitors include myostatin propeptide, follistatin, follistatin-related proteins, and myostatin antibodies. Although follistatin shows potent myostatin-inhibiting activities, it also acts as an efficient inhibitor of activins. Because activins are involved in multiple functions in various organs, their blockade by follistatin would affect multiple tissues other than skeletal muscles. In the present study, we report the characterization of a myostatin inhibitor derived from follistatin, which does not affect activin signaling. The dissociation constants (K-d) of follistatin to activin and myostatin are 1.72 nM and 12.3 nM, respectively. By contrast, the dissociation constants (K-d) of a follistatin-derived myostatin inhibitor, designated FS I-I, to activin and myostatin are 64.3 mu M and 46.8 nM, respectively. Transgenic mice expressing FS I-I, under the control of a skeletal muscle-specific promoter showed increased skeletal muscle mass and strength. Hyperplasia and hypertrophy were both observed. We crossed FS I-I transgenic mice with mdx mice, a model for Duchenne muscular dystrophy. Notably, the skeletal muscles in the mdx/FS I-I mice showed enlargement and reduced cell infiltration. Muscle strength is also recovered in the mdx/FS I-I mice. These results indicate that myostatin blockade by FS I-I has a therapeutic potential for muscular dystrophy.	[Nakatani, Masashi; Murakami, Tatsuya; Uezumi, Akiyoshi; Tsuchida, Kunihiro] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Therapies Against Intractable Dis, Toyoake, Aichi 4701192, Japan; [Nakatani, Masashi; Takehara, Yuka; Sugino, Hiromu; Matsumoto, Mitsuru] Univ Tokushima, Inst Enzyme Res, Tokushima 770, Japan; [Hashimoto, Osamu; Hasegawa, Yoshihisa] Kitasato Univ, Sch Vet Med & Anim Sci, Lab Expt Anim Sci, Towada, Aomori 034, Japan; [Takeda, Shin'ichi; Sunada, Yoshihide] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mol Therapy, Tokyo, Japan; [Noji, Sumihare] Univ Tokushima, Fac Engn, Dept Biol Sci & Technol, Tokushima 770, Japan; [Takeda, Shin'ichi; Sunada, Yoshihide] Kawasaki Med Sch, Dept Internal Med, Div Neurol, Okayama, Japan	Fujita Health University; Tokushima University; Kitasato University; National Center for Neurology & Psychiatry - Japan; Tokushima University; Kawasaki Medical School	Tsuchida, K (corresponding author), Fujita Hlth Univ, Inst Comprehens Med Sci, Div Therapies Against Intractable Dis, Toyoake, Aichi 4701192, Japan.	tsuchida@fujita-hu.ac.jp	Noji, Sumihare/E-3047-2010; Uezumi, Akiyoshi/ABF-7359-2020; Tsuchida, Kunihiro/A-4501-2012	Uezumi, Akiyoshi/0000-0003-4294-0116; Tsuchida, Kunihiro/0000-0002-3983-5756				Amthor H, 2007, P NATL ACAD SCI USA, V104, P1835, DOI 10.1073/pnas.0604893104; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Bartoli M, 2007, GENE THER, V14, P733, DOI 10.1038/sj.gt.3302928; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; Bogdanovich S, 2005, FASEB J, V19, P543, DOI 10.1096/fj.04-2796com; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; DONOGHUE MJ, 1991, P NATL ACAD SCI USA, V88, P5847, DOI 10.1073/pnas.88.13.5847; Engvall E, 2003, FASEB J, V17, P1579, DOI 10.1096/fj.02-1215rev; Grobet L, 2003, GENESIS, V35, P227, DOI 10.1002/gene.10188; Guo QX, 1998, MOL ENDOCRINOL, V12, P96, DOI 10.1210/mend.12.1.0053; Harrington AE, 2006, EMBO J, V25, P1035, DOI 10.1038/sj.emboj.7601000; Hashimoto O, 2000, CELL SIGNAL, V12, P565, DOI 10.1016/S0898-6568(00)00099-1; Hill JJ, 2002, J BIOL CHEM, V277, P40735, DOI 10.1074/jbc.M206379200; Hill JJ, 2003, MOL ENDOCRINOL, V17, P1144, DOI 10.1210/me.2002-0366; Holzbaur ELF, 2006, NEUROBIOL DIS, V23, P697, DOI 10.1016/j.nbd.2006.05.009; Kambadur R, 1997, GENOME RES, V7, P910, DOI 10.1101/gr.7.9.910; Khurana TS, 2003, NAT REV DRUG DISCOV, V2, P379, DOI 10.1038/nrd1085; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Li ZF, 2005, AM J PATHOL, V166, P491, DOI 10.1016/S0002-9440(10)62271-7; Liu D, 2001, GENE DEV, V15, P2950, DOI 10.1101/gad.925901; Liu ZH, 2006, J ENDOCRINOL, V189, P409, DOI 10.1677/joe.1.06420; MATZUK MM, 1995, NATURE, V374, P360, DOI 10.1038/374360a0; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; NAKAMURA T, 1992, J BIOL CHEM, V267, P16385; NAKAMURA T, 1990, SCIENCE, V247, P836, DOI 10.1126/science.2106159; Nishi M, 2002, BIOCHEM BIOPH RES CO, V293, P247, DOI 10.1016/S0006-291X(02)00209-7; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohsawa Y, 2006, J CLIN INVEST, V116, P2924, DOI 10.1172/JCI28520; Parsons SA, 2006, AM J PATHOL, V168, P1975, DOI 10.2353/ajpath.2006.051316; Rebbapragada A, 2003, MOL CELL BIOL, V23, P7230, DOI 10.1128/MCB.23.20.7230-7242.2003; ROSENTHAL N, 1989, P NATL ACAD SCI USA, V86, P7780, DOI 10.1073/pnas.86.20.7780; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; SHIMASAKI S, 1988, P NATL ACAD SCI USA, V85, P4218, DOI 10.1073/pnas.85.12.4218; Sugino Hiromu, 2000, P251; Thompson TB, 2005, DEV CELL, V9, P535, DOI 10.1016/j.devcel.2005.09.008; Tsuchida K, 2006, EXPERT OPIN BIOL TH, V6, P147, DOI 10.1517/14712598.6.2.147; Tsuchida K, 2000, J BIOL CHEM, V275, P40788, DOI 10.1074/jbc.M006114200; Tsuchida Kunihiro, 2004, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V4, P157, DOI 10.2174/1568008043339901; Wagner KR, 2002, ANN NEUROL, V52, P832, DOI 10.1002/ana.10385; Whittemore LA, 2003, BIOCHEM BIOPH RES CO, V300, P965, DOI 10.1016/S0006-291X(02)02953-4; Yamakawa N, 2002, EMBO J, V21, P1684, DOI 10.1093/emboj/21.7.1684; Yang JZ, 2001, MOL REPROD DEV, V60, P351, DOI 10.1002/mrd.1097; Zhu XL, 2000, FEBS LETT, V474, P71, DOI 10.1016/S0014-5793(00)01570-2	45	142	163	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2008	22	2					477	487		10.1096/fj.07-8673com	http://dx.doi.org/10.1096/fj.07-8673com			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	257TY	17893249				2022-12-25	WOS:000252822600018
J	Geders, TW; Gu, LC; Mowers, JC; Liu, HC; Gerwick, WH; Hakansson, K; Sherman, DH; Smith, JL				Geders, Todd W.; Gu, Liangcai; Mowers, Jonathan C.; Liu, Haichuan; Gerwick, William H.; Hakansson, Kristina; Sherman, David H.; Smith, Janet L.			Crystal structure of the ECH2 catalytic domain of CurF from Lyngbya majuscula - Insights into a decarboxylase involved in polyketide chain beta-branching	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1.8 ANGSTROM RESOLUTION; GENE-CLUSTER; CROTONASE SUPERFAMILY; COENZYME-A; CURACIN-A; PSEUDOMONAS-FLUORESCENS; NATURAL-PRODUCT; HIGH-THROUGHPUT; BIOSYNTHESIS; ENZYME	Curacin A is a mixed polyketide/nonribosomal peptide possessing anti-mitotic and anti-proliferative activity. In the biosynthesis of curacin A, the N-terminal domain of the CurF multifunctional protein catalyzes decarboxylation of 3-methylglutaconyl-acyl carrier protein (ACP) to 3-methyl-crotonyl-ACP, the postulated precursor of the cyclopropane ring of curacin A. This decarboxylase is encoded within an "HCS cassette" that is used by several other polyketide biosynthetic systems to generate chemical diversity by introduction of a beta-branch functional group to the natural product. The crystal structure of the CurF N-terminal ECH2 domain establishes that the protein is a crotonase superfamily member. Ala(78) and Gly(118) form an oxyanion hole in the active site that includes only three polar side chains as potential catalytic residues. Site-directed mutagenesis and a biochemical assay established critical functions for His(240) and Lys(86), whereas Tyr(82) was nonessential. A decarboxylation mechanism is proposed in which His(240) serves to stabilize the substrate carboxylate and Lys(86) donates a proton to C-4 of the acyl-ACP enolate intermediate to form the Delta(2) unsaturated isopentenoyl-ACP product. The CurF ECH2 domain showed a 20-fold selectivity for ACP-over CoA-linked substrates. Specificity for ACP-linked substrates has not been reported for any other crotonase superfamily decarboxylase. Tyr(73) may select against CoA-linked substrates by blocking a contact of Arg(38) with the CoA adenosine 5'-phosphate.	Univ Michigan, Inst Life Sci, Dept Biol Chem, Ann Arbor, MI 48109 USA; Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; Univ Michigan, Inst Life Sci, Dept Med Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Inst Life Sci, Dept Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Inst Life Sci, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	University of Michigan System; University of Michigan; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California San Diego; Scripps Institution of Oceanography	Sherman, DH (corresponding author), Univ Michigan, Inst Life Sci, Dept Biol Chem, 210 Washtenaw Ave, Ann Arbor, MI 48109 USA.	davidhs@umich.edu; JanetSmith@umich.edu	Gu, Liangcai/U-6908-2019; Gu, Liangcai/E-4600-2010; Hakansson, Kristina/G-9428-2016	Hakansson, Kristina/0000-0003-1926-0542	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK042303, R01DK042303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076477] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK42303] Funding Source: Medline; NIGMS NIH HHS [GM076477] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Benning MM, 1996, BIOCHEMISTRY-US, V35, P8103, DOI 10.1021/bi960768p; Benning MM, 2000, BIOCHEMISTRY-US, V39, P4630, DOI 10.1021/bi9928896; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Butcher RA, 2007, P NATL ACAD SCI USA, V104, P1506, DOI 10.1073/pnas.0610503104; Calderone CT, 2007, CHEM BIOL, V14, P835, DOI 10.1016/j.chembiol.2007.06.008; Calderone CT, 2006, P NATL ACAD SCI USA, V103, P8977, DOI 10.1073/pnas.0603148103; Chang ZX, 2004, J NAT PROD, V67, P1356, DOI 10.1021/np0499261; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Edwards DJ, 2004, CHEM BIOL, V11, P817, DOI 10.1016/j.chembiol.2004.03.030; El-Sayed AK, 2003, CHEM BIOL, V10, P419, DOI 10.1016/S1074-5521(03)00091-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engel CK, 1996, EMBO J, V15, P5135, DOI 10.1002/j.1460-2075.1996.tb00897.x; Fortman JL, 2005, CHEMBIOCHEM, V6, P960, DOI 10.1002/cbic.200400428; GERWICK WH, 1994, J ORG CHEM, V59, P1243, DOI 10.1021/jo00085a006; Gu LC, 2007, SCIENCE, V318, P970, DOI 10.1126/science.1148790; Gu LC, 2006, J AM CHEM SOC, V128, P9014, DOI 10.1021/ja0626382; Guerrero SA, 2001, APPL MICROBIOL BIOT, V56, P718, DOI 10.1007/s002530100690; Hill AM, 2006, NAT PROD REP, V23, P256, DOI 10.1039/b301028g; Holden HM, 2001, ACCOUNTS CHEM RES, V34, P145, DOI 10.1021/ar000053l; Holm L, 1998, PROTEINS, V33, P88, DOI 10.1002/(SICI)1097-0134(19981001)33:1<88::AID-PROT8>3.0.CO;2-H; Hubbard PA, 2005, PROTEIN SCI, V14, P1545, DOI 10.1110/ps.041303705; Ishikawa M, 2004, EMBO J, V23, P2745, DOI 10.1038/sj.emboj.7600298; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Leonard PM, 2006, ACTA CRYSTALLOGR D, V62, P1494, DOI 10.1107/S0907444906039199; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Mursula AM, 2001, J MOL BIOL, V309, P845, DOI 10.1006/jmbi.2001.4671; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Partanen ST, 2004, J MOL BIOL, V342, P1197, DOI 10.1016/j.jmb.2004.07.039; Piel J, 2005, J NAT PROD, V68, P472, DOI 10.1021/np049612d; Pulsawat N, 2007, GENE, V393, P31, DOI 10.1016/j.gene.2006.12.035; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Senko MW, 1996, RAPID COMMUN MASS SP, V10, P1839, DOI 10.1002/(SICI)1097-0231(199611)10:14<1839::AID-RCM718>3.0.CO;2-V; Sherman DH, 2006, ACS CHEM BIOL, V1, P505, DOI 10.1021/cb600376r; Simunovic V, 2007, CHEMBIOCHEM, V8, P497, DOI 10.1002/cbic.200700017; Sleeman MC, 2005, J BIOL CHEM, V280, P34956, DOI 10.1074/jbc.M507196200; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Sudek S, 2007, J NAT PROD, V70, P67, DOI 10.1021/np060361d; Tang GL, 2004, CHEM BIOL, V11, P33, DOI 10.1016/j.chembiol.2003.12.014; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Truglio JJ, 2003, J BIOL CHEM, V278, P42352, DOI 10.1074/jbc.M307399200; Verdier-Pinard P, 1999, ARCH BIOCHEM BIOPHYS, V370, P51, DOI 10.1006/abbi.1999.1363; Walsh CT, 2004, SCIENCE, V303, P1805, DOI 10.1126/science.1094318; Whittingham JL, 2003, J BIOL CHEM, V278, P1744, DOI 10.1074/jbc.M211188200	52	38	39	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35954	35963		10.1074/jbc.M703921200	http://dx.doi.org/10.1074/jbc.M703921200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17928301	hybrid			2022-12-25	WOS:000251458100056
J	Lee, SA; Belyaeva, OV; Popov, IK; Kedishvili, NY				Lee, Seung-Ah; Belyaeva, Olga V.; Popov, Ivan K.; Kedishvili, Natalia Y.			Overproduction of bioactive retinoic acid in cells expressing disease-associated mutants of retinol dehydrogenase 12	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEBER CONGENITAL AMAUROSIS; RETINOBLASTOMA CELLS; RDH12 MUTATIONS; PHOTORECEPTOR DEVELOPMENT; ALDEHYDE DEHYDROGENASES; RETINALDEHYDE-BINDING; VISUAL CYCLE; RAT RETINA; DEGENERATION; ORIENTATION	Retinol dehydrogenase 12 (RDH12) is an NADP(+)-dependent oxidoreductase that in vitro catalyzes the reduction of all-trans-retinaldehyde to all-trans-retinol or the oxidation of retinol to retinaldehyde depending on substrate and cofactor availability. Recent studies have linked the mutations in RDH12 to severe early-onset autosomal recessive retinal dystrophy. The biochemical basis of photoreceptor cell death caused by mutations in RDH12 is not clear because the physiological role of RDH12 is not yet fully understood. Here we demonstrate that, although bi-directional in vitro, in living cells, RDH12 acts exclusively as a retinaldehyde reductase, shifting the retinoid homeostasis toward the increased levels of retinol and decreased levels of bioactive retinoic acid. The retinaldehyde reductase activity of RDH12 protects the cells from retinaldehyde-induced cell death, especially at high retinaldehyde concentrations, and this protective effect correlates with the lower levels of retinoic acid in RDH12-expressing cells. Disease-associated mutants of RDH12, T49M and I51N, exhibit significant residual activity in vitro, but are unable to control retinoic acid levels in the cells because of their dramatically reduced affinity for NADPH and much lower protein expression levels. These results suggest that RDH12 acts as a regulator of retinoic acid biosynthesis and protects photoreceptors against overproduction of retinoic acid from all-trans-retinaldehyde, which diffuses into the inner segments of photoreceptors from illuminated rhodopsin. These results provide a novel insight into the mechanism of retinal degeneration associated with mutations in RDH12 and are consistent with the observation that RDH12-null mice are highly susceptible to light-induced retinal apoptosis in cone and rod photoreceptors.	Univ Alabama, Sch Med & Dent, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Kedishvili, NY (corresponding author), Univ Alabama, Sch Med, Dept Biochem & Mol Genet, 720 20th St S,440B Kaul Genet Bldg, Birmingham, AL 35294 USA.	nkedishvili@uab.edu		Kedishvili, Natalia/0000-0001-6917-4891; Beliaeva, Olga/0000-0003-2512-925X	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012153] Funding Source: NIH RePORTER; NIAAA NIH HHS [R01 AA012153-07, AA12153, R01 AA012153] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		BAULDRY SA, 1992, J BIOL CHEM, V267, P323; Belyaeva OV, 2005, BIOCHEMISTRY-US, V44, P7035, DOI 10.1021/bi050226k; Belyaeva OV, 2003, BIOCHEMISTRY-US, V42, P14838, DOI 10.1021/bi035288u; BIRNBACH CD, 1997, INVEST OPHTH VIS SCI, V38, pS311; Boatright JH, 2002, VISION RES, V42, P933, DOI 10.1016/S0042-6989(02)00037-8; Chen Y, 2003, MOL VIS, V9, P345; DELEEUW AM, 1990, J NEUROCYTOL, V19, P253, DOI 10.1007/BF01217303; Drager UC, 1998, J NUTR, V128, p463S, DOI 10.1093/jn/128.2.463S; GERLIER D, 1986, J IMMUNOL METHODS, V94, P57, DOI 10.1016/0022-1759(86)90215-2; Hyatt GA, 1996, P NATL ACAD SCI USA, V93, P13298, DOI 10.1073/pnas.93.23.13298; Hyatt GA, 1997, INVEST OPHTH VIS SCI, V38, P1471; Janecke AR, 2004, NAT GENET, V36, P850, DOI 10.1038/ng1394; KALTER H, 1959, PHYSIOL REV, V39, P69, DOI 10.1152/physrev.1959.39.1.69; Kastner P, 1997, DEVELOPMENT, V124, P313; Kurth I, 2007, MOL CELL BIOL, V27, P1370, DOI 10.1128/MCB.01486-06; Levine EM, 2000, CELL MOL LIFE SCI, V57, P224, DOI 10.1007/PL00000686; Li AM, 2003, INVEST OPHTH VIS SCI, V44, P996, DOI 10.1167/iovs.02-0434; Li AM, 2002, INVEST OPHTH VIS SCI, V43, P1375; Maeda A, 2006, J BIOL CHEM, V281, P37697, DOI 10.1074/jbc.M608375200; Mangelsdorf David J., 1994, P319; MATSCHINSKY FM, 1968, J NEUROCHEM, V15, P643, DOI 10.1111/j.1471-4159.1968.tb08963.x; Napoli JL, 1999, BBA-MOL CELL BIOL L, V1440, P139, DOI 10.1016/S1388-1981(99)00117-1; Odermatt A, 1999, J BIOL CHEM, V274, P28762, DOI 10.1074/jbc.274.40.28762; Perrault I, 2004, AM J HUM GENET, V75, P639, DOI 10.1086/424889; Pinazo-Duran MD, 2000, OPHTHALMIC RES, V32, P61, DOI 10.1159/000055591; Saari JC, 2000, INVEST OPHTH VIS SCI, V41, P337; Saari John C., 1994, P351; SMITH SB, 1995, INVEST OPHTH VIS SCI, V36, P2193; Soderpalm AK, 2000, INVEST OPHTH VIS SCI, V41, P937; Sun WY, 2007, VISION RES, V47, P2055, DOI 10.1016/j.visres.2007.04.005; Thompson DA, 2005, HUM MOL GENET, V14, P3865, DOI 10.1093/hmg/ddi411; VEECH RL, 1969, BIOCHEM J, V115, P609, DOI 10.1042/bj1150609a; Wagner E, 2000, DEV BIOL, V222, P460, DOI 10.1006/dbio.2000.9719	33	32	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35621	35628		10.1074/jbc.M706372200	http://dx.doi.org/10.1074/jbc.M706372200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17925390	hybrid			2022-12-25	WOS:000251458100022
J	Hyvonen, MT; Keinanen, TA; Cerrada-Gimenez, M; Sinervirta, R; Grigorenko, N; Khomutov, AR; Vepsalainen, J; Alhonen, L; Janne, J				Hyvonen, Mervi T.; Keinanen, Tuomo A.; Cerrada-Gimenez, Marc; Sinervirta, Riitta; Grigorenko, Nikolay; Khomutov, Alex R.; Vepsalainen, Jouko; Alhonen, Leena; Janne, Juhani			Role of hypusinated eukaryotic translation initiation factor 5A in polyamine depletion-induced cytostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-METHYL POLYAMINES; ACUTE-PANCREATITIS; DEOXYHYPUSINE SYNTHASE; LIVER-REGENERATION; CELL-PROLIFERATION; DNA-REPLICATION; TRANSGENIC RATS; IN-VIVO; OXIDASE; CATABOLISM	We have earlier shown that alpha-methylated spermidine and spermine analogues rescue cells from polyamine depletion-induced growth inhibition and maintain pancreatic integrity under severe polyamine deprivation. However, because alpha-methylspermidine can serve as a precursor of hypusine, an integral part of functional eukaryotic translation initiation factor 5A required for cell proliferation, and because alpha,omega-bismethylspermine can be converted to methylspermidine, it is not entirely clear whether the restoration of cell growth is actually attributable to hypusine formed from these polyamine analogues. Here, we have used optically active isomers of methylated spermidine and spermine and show that polyamine depletion-induced acute cytostasis in cultured cells could be reversed by all the isomers of the methylpolyamines irrespective of whether they served or not as precursors of hypusine. In transgenic rats with activated polyamine catabolism, all the isomers similarly restored liver regeneration and reduced plasma alpha-amylase activity associated with induced pancreatitis. Under the above experimental conditions, the (S,S)-but not the (R,R)-isomer of bismethylspermine was converted to methylspermidine apparently through the action of spermine oxidase strongly preferring the (S,S)-isomer. Of the analogues, however, only (S)-methylspermidine sustained cell growth during prolonged (more than 1 week) inhibition of polyamine biosynthesis. It was also the only isomer efficiently converted to hypusine, indicating that deoxyhypusine synthase likewise possesses hidden stereospecificity. Taken together, the results show that growth inhibition in response to polyamine depletion involves two phases, an acute and a late hypusine-dependent phase.	Univ Kuopio, AI Virtanen Inst Mol Sci, Dept Chem, FI-70211 Kuopio, Finland; Russian Acad Sci, Engelhardt Inst Mol Biol, R-117984 Moscow, Russia	University of Eastern Finland; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS	Janne, J (corresponding author), Univ Kuopio, AI Virtanen Inst Mol Sci, Dept Chem, PO Box 1627, FI-70211 Kuopio, Finland.	Juhani.Janne@uku.fi	Keinänen, Tuomo/AAC-5630-2019; Khomutov, Alex/G-2128-2015	Keinanen, Tuomo/0000-0002-0659-5573; Khomutov, Alex/0000-0001-6833-7855				Alhonen L, 2000, P NATL ACAD SCI USA, V97, P8290, DOI 10.1073/pnas.140122097; Alhonen L, 2002, BIOCHEM J, V362, P149, DOI 10.1042/0264-6021:3620149; Bergeron RJ, 1998, J MED CHEM, V41, P3901, DOI 10.1021/jm980390o; Bernacki RJ, 1995, CLIN CANCER RES, V1, P847; BYERS TL, 1992, BIOCHEM J, V287, P717, DOI 10.1042/bj2870717; BYERS TL, 1994, BIOCHEM J, V303, P363, DOI 10.1042/bj3030363; Chattopadhyay MK, 2003, P NATL ACAD SCI USA, V100, P13869, DOI 10.1073/pnas.1835918100; Fredlund JO, 1996, EUR J BIOCHEM, V237, P539, DOI 10.1111/j.1432-1033.1996.0539p.x; GALLO CJ, 1986, BIOCHEM J, V238, P37, DOI 10.1042/bj2380037; Grigorenko NA, 2007, TETRAHEDRON, V63, P2257, DOI 10.1016/j.tet.2006.12.065; Higgins GM, 1931, ARCH PATHOL, V12, P186; Huang YF, 2007, P NATL ACAD SCI USA, V104, P4194, DOI 10.1073/pnas.0611609104; Hyvonen MT, 2006, AM J PATHOL, V168, P115, DOI 10.2353/ajpath.2006.050518; HYVONEN T, 1992, J CHROMATOGR-BIOMED, V574, P17, DOI 10.1016/0378-4347(92)80093-6; JANNE J, 1971, J BIOL CHEM, V246, P1725; Janne J, 2006, J BIOCHEM, V139, P155, DOI 10.1093/jb/mvj035; Jao DLE, 2006, J CELL BIOCHEM, V97, P583, DOI 10.1002/jcb.20658; Jarvinen A, 2006, J BIOL CHEM, V281, P4589, DOI 10.1074/jbc.M509959200; Jarvinen A, 2005, J BIOL CHEM, V280, P6595, DOI 10.1074/jbc.M412788200; Jarvinen AJ, 2006, J MED CHEM, V49, P399, DOI 10.1021/jm050872h; Keinanen TA, 2007, MINI-REV MED CHEM, V7, P813; Kramer DL, 2001, CANCER RES, V61, P7754; LAKANEN JR, 1992, J MED CHEM, V35, P724, DOI 10.1021/jm00082a013; Lee YB, 1998, BIOORGAN MED CHEM, V6, P253, DOI 10.1016/S0968-0896(97)10030-X; Li AL, 2004, J BIOL CHEM, V279, P49251, DOI 10.1074/jbc.M407165200; Nishimura K, 2005, BIOCHEM J, V385, P779, DOI 10.1042/BJ20041477; PARK MH, 1994, J BIOL CHEM, V269, P27827; PARK MH, 1993, TRENDS BIOCHEM SCI, V18, P475, DOI 10.1016/0968-0004(93)90010-K; PARK MH, 1981, P NATL ACAD SCI-BIOL, V78, P2869, DOI 10.1073/pnas.78.5.2869; Rasanen TL, 2002, J BIOL CHEM, V277, P39867, DOI 10.1074/jbc.M205967200; Schrader R, 2006, J BIOL CHEM, V281, P35336, DOI 10.1074/jbc.M601460200; Taylor CA, 2007, EXP CELL RES, V313, P437, DOI 10.1016/j.yexcr.2006.09.030; Thomas T, 2003, J CELL MOL MED, V7, P113, DOI 10.1111/j.1582-4934.2003.tb00210.x; Varnado BL, 2000, BIOORG CHEM, V28, P395, DOI 10.1006/bioo.2000.1195; Vujcic S, 2002, BIOCHEM J, V367, P665, DOI 10.1042/BJ20020720; Wang YL, 2001, CANCER RES, V61, P5370	36	52	55	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34700	34706		10.1074/jbc.M704282200	http://dx.doi.org/10.1074/jbc.M704282200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17901051	hybrid			2022-12-25	WOS:000251155200012
J	Yamauchi, Y; Reid, PC; Sperry, JB; Furukawa, K; Takeya, M; Chang, CCY; Chang, TY				Yamauchi, Yoshio; Reid, Patrick C.; Sperry, Jeffrey B.; Furukawa, Koichi; Takeya, Motohiro; Chang, Catherine C. Y.; Chang, Ta-Yuan			Plasma membrane rafts complete cholesterol synthesis by participating in retrograde movement of precursor sterols	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; OVARY CELL MUTANTS; OXYSTEROL-BINDING-PROTEIN; PICK C1 PROTEIN; ENDOPLASMIC-RETICULUM; LIPID RAFTS; HUMAN FIBROBLASTS; TRANSPORT; TRAFFICKING; ENDOCYTOSIS	Mammalian cells synthesize significant amounts of precursor sterols, in addition to cholesterol, at the endoplasmic reticulum (ER). The newly synthesized sterols rapidly move to the plasma membrane (PM). The mechanism by which precursor sterols move back to the ER for their enzymatic processing to cholesterol is essentially unknown. Here we performed pulse-chase experiments and showed that the C29/C30 sterols rapidly move from the PM to the ER and are converted to cholesterol. The retrograde precursor sterol transport is largely independent of the Niemann-Pick type C proteins, which play important roles in late endosomal cholesterol transport. In contrast, disrupting lipid rafts significantly retards the conversion of C29/C30 and C28 sterols to cholesterol, causing the accumulation of precursor sterols at the PM. Our results reveal a previously undisclosed function of the PM lipid rafts: they bring cholesterol biosynthesis to completion by participating in the retrograde movement of precursor sterols back to the ER.	Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA; Dartmouth Med Sch, Dept Chem, Hanover, NH 03755 USA; Kumamoto Univ, Grad Sch Med Sci, Dept Cell Pathol, Kumamoto 8608556, Japan; Nagoya Univ, Grad Sch Med, Dept Biochem, Nagoya, Aichi 4668550, Japan	Dartmouth College; Dartmouth College; Kumamoto University; Nagoya University	Chang, TY (corresponding author), Dartmouth Med Sch, Dept Biochem, 7200 Vail Bldg,Rm 304, Hanover, NH 03755 USA.	Ta.Yuan.Chang@Dartmouth.edu	Yamauchi, Yoshio/I-7539-2014	Yamauchi, Yoshio/0000-0001-5559-4596; Chang, Ta-Yuan/0000-0002-3249-0468	NHLBI NIH HHS [HL36709] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL036709, R01HL036709] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; BERRY DJ, 1982, BIOCHEMISTRY-US, V21, P573, DOI 10.1021/bi00532a025; CADIGAN KM, 1990, J CELL BIOL, V110, P295, DOI 10.1083/jcb.110.2.295; CADIGAN KM, 1988, J BIOL CHEM, V263, P274; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; CHANG TY, 1980, J BIOL CHEM, V255, P7787; Cheng ZJ, 2006, MOL BIOL CELL, V17, P3197, DOI 10.1091/mbc.E05-12-1101; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Cruz JC, 2000, J BIOL CHEM, V275, P4013, DOI 10.1074/jbc.275.6.4013; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; ECHEVARRIA F, 1990, J BIOL CHEM, V265, P8484; Field FJ, 1998, J LIPID RES, V39, P333; Fielding CJ, 2004, BIOCHEM SOC T, V32, P65, DOI 10.1042/BST0320065; Frolov A, 2003, J BIOL CHEM, V278, P25517, DOI 10.1074/jbc.M302588200; Garver WS, 2002, J LIPID RES, V43, P579; GURR MI, 1991, LIPID BIOCH, P297; Hao MM, 2002, J BIOL CHEM, V277, P609, DOI 10.1074/jbc.M108861200; Heino S, 2000, P NATL ACAD SCI USA, V97, P8375, DOI 10.1073/pnas.140218797; Higaki K, 2001, J BIOCHEM-TOKYO, V129, P875, DOI 10.1093/oxfordjournals.jbchem.a002932; Hua XX, 1996, CELL, V87, P415, DOI 10.1016/S0092-8674(00)81362-8; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; KAMMEREC.R, 1967, J LIPID RES, V8, P282; KAPLAN MR, 1985, J CELL BIOL, V101, P446, DOI 10.1083/jcb.101.2.446; LANGE Y, 1991, J BIOL CHEM, V266, P21439; Li YF, 2004, J BIOL CHEM, V279, P45226, DOI 10.1074/jbc.M407600200; LIMANEK JS, 1978, P NATL ACAD SCI USA, V75, P5452, DOI 10.1073/pnas.75.11.5452; Metherall JE, 1996, J BIOL CHEM, V271, P2627, DOI 10.1074/jbc.271.5.2627; Metherall JE, 1996, J BIOL CHEM, V271, P2634, DOI 10.1074/jbc.271.5.2634; Ohgami N, 2004, P NATL ACAD SCI USA, V101, P12473, DOI 10.1073/pnas.0405255101; Olkkonen VM, 2004, CURR OPIN LIPIDOL, V15, P321, DOI 10.1097/00041433-200406000-00013; Pelkmans L, 2003, CURR OPIN CELL BIOL, V15, P414, DOI 10.1016/S0955-0674(03)00081-4; PENTCHEV PG, 1986, J BIOL CHEM, V261, P2772; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; Pipalia NH, 2007, TRAFFIC, V8, P130, DOI 10.1111/j.1600-0854.2006.00513.x; Porter FD, 2002, J CLIN INVEST, V110, P715, DOI 10.1172/JCI200216386; Puri V, 2001, J CELL BIOL, V154, P535, DOI 10.1083/jcb.200102084; Raychaudhuri S, 2006, J CELL BIOL, V173, P107, DOI 10.1083/jcb.200510084; Reid PC, 2003, J LIPID RES, V44, P1010, DOI 10.1194/jlr.M300009-JLR200; Smart EJ, 1996, J BIOL CHEM, V271, P29427, DOI 10.1074/jbc.271.46.29427; Soccio RE, 2003, J BIOL CHEM, V278, P22183, DOI 10.1074/jbc.R300003200; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; Sugii S, 2003, J BIOL CHEM, V278, P27180, DOI 10.1074/jbc.M300542200; SUGLI S, 2006, J BIOL CHEM, V281, P23191; TAVANI DM, 1982, J LIPID RES, V23, P774; Walter M, 2003, J LIPID RES, V44, P243, DOI 10.1194/jlr.M200230-JLR200; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Wojtanik KM, 2003, J BIOL CHEM, V278, P14850, DOI 10.1074/jbc.M300488200; Xu XL, 2000, BIOCHEMISTRY-US, V39, P843, DOI 10.1021/bi992543v; Yamauchi Y, 2004, J LIPID RES, V45, P1943, DOI 10.1194/jlr.M400264-JLR200; Yang CD, 2006, J BIOL CHEM, V281, P27816, DOI 10.1074/jbc.M603781200; Yang HY, 2006, TRENDS CELL BIOL, V16, P427, DOI 10.1016/j.tcb.2006.07.002	52	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34994	35004		10.1074/jbc.M703653200	http://dx.doi.org/10.1074/jbc.M703653200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17916561	hybrid			2022-12-25	WOS:000251155200044
J	Kim, SJ; Nian, C; McIntosh, CHS				Kim, Su-Jin; Nian, Cuilan; McIntosh, Christopher H. S.			Resistin is a key mediator of glucose-dependent insulinotropic polypeptide (GIP) stimulation of lipoprotein lipase (LPL) activity in adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTRIC-INHIBITORY POLYPEPTIDE; PROTEIN-KINASE-B; ADIPOSE-TISSUE; CELL-PROLIFERATION; EXPRESSION; RECEPTOR; SECRETION; OBESITY; LEPTIN; INFLAMMATION	Studies on the physiological roles of the incretin hormone, glucose-dependent insulinotropic polypeptide (GIP) have largely focused on its insulinotropic action and ability to regulate beta-cell mass. In previous studies on the stimulatory effect of GIP on adipocyte lipoprotein lipase (LPL), a pathway was identified involving increased phosphorylation of protein kinase B (PKB) and reduced phosphorylation of LKB1 and AMP-activated protein kinase ( AMPK). The slow time of onset of the responses suggested that GIP may have induced release of an intermediary molecule, and the current studies focused on the possible contribution of the adipokine resistin. In differentiated 3T3-L1 adipocytes, GIP, in the presence of insulin, increased resistin secretion through a pathway involving p38 mitogen-activated protein kinase (p38 MAPK) and the stress-activated protein kinase/Jun amino-terminal kinase (SAPK/JNK). The other major incretin hormone, glucagon-like peptide-1 (GLP-1), exhibited no significant effects. Chronic elevation of circulating GIP levels in the Vancouver Diabetic Fatty (VDF) Zucker rat resulted in increases in circulating resistin levels and activation of p38 MAPK or SAPK/JNK in epididymal fat tissue, suggesting the existence of identical pathways in vivo as well as in vitro. Administration of resistin to 3T3-L1 adipocytes mimicked the effects of GIP on the PKB/LKB1/AMPK/LPL pathway: increasing phosphorylation of PKB, reducing levels of phosphorylated LKB1 and AMPK, and increasing LPL activity. Knockdown of resistin using RNA interference attenuated the effect of GIP on the PKB/LKB1/AMPK/LPL pathway in 3T3-L1 adipocytes, supporting a role for resistin as a mediator.	Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Inst Life Sci, Diabet Res Grp, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	McIntosh, CHS (corresponding author), 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	mcintoch@interchange.ubc.ca						Alvarez E, 2005, J NEUROCHEM, V92, P798, DOI 10.1111/j.1471-4159.2004.02914.x; Banerjee RR, 2004, SCIENCE, V303, P1195, DOI 10.1126/science.1092341; Barr VA, 1997, ENDOCRINOLOGY, V138, P4463, DOI 10.1210/en.138.10.4463; BECK B, 1983, REGUL PEPTIDES, V7, P3, DOI 10.1016/0167-0115(83)90276-8; Bornstein SR, 2000, DIABETES, V49, P532, DOI 10.2337/diabetes.49.4.532; BROWN JC, 1989, HDB PHYSL 6, P403; Brubaker PL, 2004, ENDOCRINOLOGY, V145, P2653, DOI 10.1210/en.2004-0015; Calabro P, 2004, CIRCULATION, V110, P3335, DOI 10.1161/01.CIR.0000147825.97879.E7; Cammisotto PG, 2006, BIOCHEM CELL BIOL, V84, P207, DOI 10.1139/O06-032; Chen YH, 2005, AM J PHYSIOL-ENDOC M, V288, pE1019, DOI 10.1152/ajpendo.00325.2004; Drucker DJ, 2007, J CLIN INVEST, V117, P24, DOI 10.1172/JCI30076; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Gong HX, 2004, EUR J ENDOCRINOL, V150, P885, DOI 10.1530/eje.0.1500885; Hansotia T, 2007, J CLIN INVEST, V117, P143, DOI 10.1172/JCI25483; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Kim KM, 2001, J BIOL CHEM, V276, P37409, DOI 10.1074/jbc.M106728200; Kim SJ, 2005, J BIOL CHEM, V280, P22297, DOI 10.1074/jbc.M500540200; Kim SJ, 2007, J BIOL CHEM, V282, P8557, DOI 10.1074/jbc.M609088200; Lee MJ, 2006, J LIPID RES, V47, P1984, DOI 10.1194/jlr.M600065-JLR200; Maebuchi M, 2003, ARCH BIOCHEM BIOPHYS, V416, P164, DOI 10.1016/S0003-9861(03)00279-0; Mayo KE, 2003, PHARMACOL REV, V55, P167, DOI 10.1124/pr.55.1.6; McIntosh CHS, 1999, ENDOCRINOLOGY, V140, P398, DOI 10.1210/en.140.1.398; McTernan PG, 2006, CURR OPIN LIPIDOL, V17, P170, DOI 10.1097/01.mol.0000217899.59820.9a; Meier JJ, 2005, DIABETES-METAB RES, V21, P91, DOI 10.1002/dmrr.538; Minn AH, 2003, BIOCHEM BIOPH RES CO, V310, P641, DOI 10.1016/j.bbrc.2003.09.061; Miyawaki K, 2002, NAT MED, V8, P738, DOI 10.1038/nm727; MontroseRafizadeh C, 1997, J CELL PHYSIOL, V172, P275, DOI 10.1002/(SICI)1097-4652(199709)172:3<275::AID-JCP1>3.0.CO;2-L; Morgan LM, 1996, BIOCHEM SOC T, V24, P585, DOI 10.1042/bst0240585; Mu H, 2006, CARDIOVASC RES, V70, P146, DOI 10.1016/j.cardiores.2006.01.015; Muse ED, 2004, J CLIN INVEST, V114, P232, DOI 10.1172/JCI200421270; Nakata M, 2007, BIOCHEM BIOPH RES CO, V353, P1046, DOI 10.1016/j.bbrc.2006.12.134; Nyberg J, 2005, J NEUROSCI, V25, P1816, DOI 10.1523/jneurosci.4920-04.2005; OBEN J, 1991, J ENDOCRINOL, V130, P267, DOI 10.1677/joe.0.1300267; OHNEDA A, 1984, REGUL PEPTIDES, V8, P123, DOI 10.1016/0167-0115(84)90167-8; Ort T, 2005, ENDOCRINOLOGY, V146, P2200, DOI 10.1210/en.2004-1421; Palanivel R, 2005, FEBS LETT, V579, P5049, DOI 10.1016/j.febslet.2005.08.011; Pederson RA, 1993, GUT PEPTIDES, P217; PEDERSON RA, 2004, ENCY ENDOCRINE DIS, V2, P202; Pereira RI, 2005, METABOLISM, V54, P1636, DOI 10.1016/j.metabol.2005.07.002; Pravenec M, 2006, INT J OBESITY, V30, P1157, DOI 10.1038/sj.ijo.0803237; Rajala MW, 2004, DIABETES, V53, P1671, DOI 10.2337/diabetes.53.7.1671; Roh C, 2000, AM J PHYSIOL-ENDOC M, V279, pE893, DOI 10.1152/ajpendo.2000.279.4.E893; Savage DB, 2001, DIABETES, V50, P2199, DOI 10.2337/diabetes.50.10.2199; Shen YH, 2006, J BIOL CHEM, V281, P7727, DOI 10.1074/jbc.M511105200; SKURK T, 2007, ENDOCRINOLOGY, V92, P1023; Steppan CM, 2005, MOL CELL BIOL, V25, P1569, DOI 10.1128/MCB.25.4.1569-1575.2005; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Tappenden KA, 1996, JPEN-PARENTER ENTER, V20, P357, DOI 10.1177/0148607196020005357; Wang BH, 2006, PFLUG ARCH EUR J PHY, V452, P418, DOI 10.1007/s00424-006-0055-8; WASADA T, 1981, J CLIN INVEST, V68, P1106, DOI 10.1172/JCI110335; Way JM, 2001, J BIOL CHEM, V276, P25651, DOI 10.1074/jbc.C100189200; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yang RZ, 2003, BIOCHEM BIOPH RES CO, V310, P927, DOI 10.1016/j.bbrc.2003.09.093; Yip RGC, 1998, ENDOCRINOLOGY, V139, P4004, DOI 10.1210/en.139.9.4004; Zhong Q, 2002, BIOCHEM BIOPH RES CO, V296, P383, DOI 10.1016/S0006-291X(02)00882-3	56	94	97	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34139	34147		10.1074/jbc.M704896200	http://dx.doi.org/10.1074/jbc.M704896200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17890220	hybrid			2022-12-25	WOS:000251145700028
J	Chen, D; Gould, C; Garza, R; Gao, T; Hampton, RY; Newton, AC				Chen, Dan; Gould, Christine; Garza, Renee; Gao, Tianyan; Hampton, Randolph Y.; Newton, Alexandra C.			Amplitude control of protein kinase c by RINCK, a novel e3 ubiquitin ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHORBOL ESTER RECEPTORS; CELL LUNG-CANCER; DOWN-REGULATION; PKC ISOFORMS; BETA-II; DOMAIN; DEGRADATION; ALPHA; PHOSPHORYLATION; EPSILON	Protein kinase C (PKC) isozymes play a central role in cellular signaling. Levels of PKC control the amplitude of agonist-induced signaling and alterations in these levels are associated with disease states, most notably cancer, yet mechanisms that control the turnover of the protein are poorly understood. Here we identify an E3 ligase that catalyzes the ubiquitin-mediated degradation of PKC. Specifically, we identified a RING finger domain-containing protein, RINCK ( for RING-finger protein that interacts with C kinase) from a yeast two-hybrid screen using the amino terminus of PKC beta as bait. RINCK encodes a protein of 581 amino acids that contains a RING finger domain, a B-box, and two coiled-coil regions, the three domains that form the signature motif of the large family of diverse TRIM ( tripartite motif) proteins. Co-immunoprecipitation studies using tsA201 cells reveal that RINCK and PKC associate with each other in cells. Studies using fragments of PKC beta reveal that this interaction is mediated by the C1A domain of PKC. RINCK induces the ubiquitination of PKC both in vitro and in cells. Overexpression of RINCK reduces the levels of PKC in cells, whereas genetic knockdown of endogenous RINCK increases the levels of PKC. This increase was observed for all PKC isozymes examined ( including conventional, novel, and atypical). The RINCK-mediated degradation of PKC occurs independently of the classic phorbol ester-mediated down-regulation: genetic depletion of RINCK had no effect on the phorbol ester-mediated down-regulation and, additionally, up-regulated the levels of isozymes that cannot bind phorbol esters. Our data reveal a novel mechanism that provides amplitude control in PKC signaling through ubiquitination catalyzed by RINCK, an E3 ligase that specifically recognizes the C1 domain of PKC isoforms.	Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Mol Pathol Grad Program, La Jolla, CA 92093 USA; Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Newton, AC (corresponding author), 9500 Gilman Dr, La Jolla, CA 92093 USA.	anewton@csd.edu			NIDDK NIH HHS [P01 DK54441] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADACHI Y, 1990, ADV SEC MESS PHOSPH, V24, P478; Anan T, 1998, GENES CELLS, V3, P751, DOI 10.1046/j.1365-2443.1998.00227.x; Balendran A, 2000, FEBS LETT, V484, P217, DOI 10.1016/S0014-5793(00)02162-1; Borden KLB, 1996, CURR OPIN STRUC BIOL, V6, P395, DOI 10.1016/S0959-440X(96)80060-1; Clark AS, 2003, CANCER RES, V63, P780; D'Costa AM, 2006, ONCOGENE, V25, P378, DOI 10.1038/sj.onc.1209065; Gokmen-Polar Y, 2001, CANCER RES, V61, P1375; Hansra G, 1999, BIOCHEM J, V342, P337, DOI 10.1042/0264-6021:3420337; JAKEN S, 1981, CANCER RES, V41, P2175; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Junoy B, 2002, ENDOCRINOLOGY, V143, P1386, DOI 10.1210/en.143.4.1386; Kazanietz MG, 2002, MOL PHARMACOL, V61, P759, DOI 10.1124/mol.61.4.759; Keranen LM, 1995, CURR BIOL, V5, P1394, DOI 10.1016/S0960-9822(95)00277-6; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; Lee HW, 1996, J BIOL CHEM, V271, P20973, DOI 10.1074/jbc.271.35.20973; Lee HW, 1997, MOL PHARMACOL, V51, P439; Leontieva OV, 2004, J BIOL CHEM, V279, P5788, DOI 10.1074/jbc.M308375200; Lu ZM, 2002, MOL CELL, V9, P945, DOI 10.1016/S1097-2765(02)00519-1; Lu ZM, 1998, MOL CELL BIOL, V18, P839, DOI 10.1128/MCB.18.2.839; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; OHNO S, 1990, J BIOL CHEM, V265, P6296; ORR JW, 1994, J BIOL CHEM, V269, P27715; ORR JW, 1992, J BIOL CHEM, V267, P15263; Pan Q, 2005, CANCER RES, V65, P8366, DOI 10.1158/0008-5472.CAN-05-0553; PARKER PJ, 1995, BIOCHEM SOC T, V23, P153, DOI 10.1042/bst0230153; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Regala RP, 2005, CANCER RES, V65, P8905, DOI 10.1158/0008-5472.CAN-05-2372; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Saurin AJ, 1996, TRENDS BIOCHEM SCI, V21, P208, DOI 10.1016/S0968-0004(96)80017-X; SOLANKI V, 1981, P NATL ACAD SCI-BIOL, V78, P1722, DOI 10.1073/pnas.78.3.1722; SWERDLOW PS, 1986, ANAL BIOCHEM, V156, P147, DOI 10.1016/0003-2697(86)90166-1; Tanaka M, 2005, MOL BIOL REP, V32, P87, DOI 10.1007/s11033-004-6613-2; VOJTEK AB, 1995, METHOD ENZYMOL, V255, P331; Zhang J, 2004, J BIOL CHEM, V279, P22118, DOI 10.1074/jbc.M400774200	38	51	56	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33776	33787		10.1074/jbc.M703320200	http://dx.doi.org/10.1074/jbc.M703320200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17893151	hybrid			2022-12-25	WOS:000250840200060
J	Walsh, LA; Carere, DA; Cooper, CA; Damjanovski, S				Walsh, Logan A.; Carere, Deanna A.; Cooper, Colin A.; Damjanovski, Sashko			Membrane Type-1 Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases-2 RNA Levels Mimic Each Other during Xenopus laevis Metamorphosis	PLOS ONE			English	Article								Matrix metalloproteinases (MMPs) and their endogenous inhibitors TIMPs (tissue inhibitors of MMPs), are two protein families that work together to remodel the extracellular matrix (ECM). TIMPs serve not only to inhibit MMP activity, but also aid in the activation of MMPs that are secreted as inactive zymogens. Xenopus laevis metamorphosis is an ideal model for studying MMP and TIMP expression levels because all tissues are remodeled under the control of one molecule, thyroid hormone. Here, using RT-PCR analysis, we examine the metamorphic RNA levels of two membrane-type MMPs (MT1-MMP, MT3-MMP), two TIMPs (TIMP-2, TIMP-3) and a potent gelatinase (Gel-A) that can be activated by the combinatory activity of a MT-MMP and a TIMP. In the metamorphic tail and intestine the RNA levels of TIMP-2 and MT1-MMP mirror each other, and closely resemble that of Gel-A as all three are elevated during periods of cell death and proliferation. Conversely, MT3-MMP and TIMP-3 do not have similar RNA level patterns nor do they mimic the RNA levels of the other genes examined. Intriguingly, TIMP-3, which has been shown to have anti-apoptotic activity, is found at low levels in tissues during periods of apoptosis.	[Walsh, Logan A.; Carere, Deanna A.; Cooper, Colin A.; Damjanovski, Sashko] Univ Western Ontario, Dept Biol, London, ON, Canada	Western University (University of Western Ontario)	Damjanovski, S (corresponding author), Univ Western Ontario, Dept Biol, London, ON, Canada.	sdamjano@uwo.ca	Damjanovski, Sashko/N-8728-2015	Damjanovski, Sashko/0000-0002-3479-721X; Walsh, Logan/0000-0001-8771-2577; Carere, Deanna Alexis/0000-0003-3965-686X	NSERC; Ontario Graduate Scholarship	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This research was supported by an NSERC Discovery Grant to SD, and Ontario Graduate Scholarship funding to LW and CC. The research funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvelo Francisco, 2006, Invest. clín, V47, P185; Crump D, 2002, ENVIRON HEALTH PERSP, V110, P1199, DOI 10.1289/ehp.021101199; Damjanovski S, 1999, CELL RES, V9, P91, DOI 10.1038/sj.cr.7290009; Damjanovski S, 2000, FASEB J, V14, P503, DOI 10.1096/fasebj.14.3.503; Damjanovski S, 2001, DEV DYNAM, V221, P37, DOI 10.1002/dvdy.1123; Das B, 2006, DEV BIOL, V291, P342, DOI 10.1016/j.ydbio.2005.12.032; DODD MHI, 1976, BIOL METAMORPHOSIS, P467; FU L, 2006, J BIOL CHEM; GROSS J, 1965, P NATL ACAD SCI USA, V54, P1197, DOI 10.1073/pnas.54.4.1197; Hammoud L, 2006, BIOCHEM CELL BIOL, V84, P167, DOI 10.1139/O05-175; Hasebe T, 2006, CELL TISSUE RES, V324, P105, DOI 10.1007/s00441-005-0099-7; Hasebe T, 2007, MECH DEVELOP, V124, P11, DOI 10.1016/j.mod.2006.09.001; Ishizuya-Oka A, 2000, J CELL BIOL, V150, P1177, DOI 10.1083/jcb.150.5.1177; Ishizuya-Oka A, 2001, DIFFERENTIATION, V69, P27, DOI 10.1046/j.1432-0436.2001.690103.x; Jung JC, 2002, DEV DYNAM, V223, P402, DOI 10.1002/dvdy.10069; Kang TB, 2002, CANCER RES, V62, P675; Lambert E, 2004, CRIT REV ONCOL HEMAT, V49, P187, DOI 10.1016/j.critrevonc.2003.09.008; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nieuwkoop PD, 1956, NORMAL TABLE XENOPUS, P243; Pickard B, 2004, CELL RES, V14, P389, DOI 10.1038/sj.cr.7290239; Shi Y.-B., 1999, AMPHIBIAN METAMORPHO; Shi YB, 2001, PROG NUCLEIC ACID RE, V65, P53; Shi YB, 1998, INT J DEV BIOL, V42, P107; Somiari SB, 2006, CANCER LETT, V233, P98, DOI 10.1016/j.canlet.2005.03.003; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Walsh LA, 2007, INT J DEV BIOL, V51, P389, DOI 10.1387/ijdb.062253lw	26	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e1000	10.1371/journal.pone.0001000	http://dx.doi.org/10.1371/journal.pone.0001000			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912339	gold, Green Published, Green Submitted			2022-12-25	WOS:000207455900036
J	Kurakin, A; Swistowski, A; Wu, SC; Bredesen, DE				Kurakin, Alexei; Swistowski, Andrzej; Wu, Susan C.; Bredesen, Dale E.			The PDZ Domain as a Complex Adaptive System	PLOS ONE			English	Article							PROTEIN INTERACTIONS; PEPTIDE RECOGNITION; SELF-ORGANIZATION; SH3 DOMAINS; PROMISCUITY; SELECTIVITY; CLASSIFICATION; SPECIFICITY; DYNAMICS; MODULES	Specific protein associations define the wiring of protein interaction networks and thus control the organization and functioning of the cell as a whole. Peptide recognition by PDZ and other protein interaction domains represents one of the best-studied classes of specific protein associations. However, a mechanistic understanding of the relationship between selectivity and promiscuity commonly observed in the interactions mediated by peptide recognition modules as well as its functional meaning remain elusive. To address these questions in a comprehensive manner, two large populations of artificial and natural peptide ligands of six archetypal PDZ domains from the synaptic proteins PSD95 and SAP97 were generated by target-assisted iterative screening (TAIS) of combinatorial peptide libraries and by synthesis of proteomic fragments, correspondingly. A comparative statistical analysis of affinity-ranked artificial and natural ligands yielded a comprehensive picture of known and novel PDZ ligand specificity determinants, revealing a hitherto unappreciated combination of specificity and adaptive plasticity inherent to PDZ domain recognition. We propose a reconceptualization of the PDZ domain in terms of a complex adaptive system representing a flexible compromise between the rigid order of exquisite specificity and the chaos of unselective promiscuity, which has evolved to mediate two mutually contradictory properties required of such higher order sub-cellular organizations as synapses, cell junctions, and others - organizational structure and organizational plasticity/adaptability. The generalization of this reconceptualization in regard to other protein interaction modules and specific protein associations is consistent with the image of the cell as a complex adaptive macromolecular system as opposed to clockwork.	[Kurakin, Alexei; Swistowski, Andrzej; Wu, Susan C.; Bredesen, Dale E.] Buck Inst Age Res, Novato, CA USA	Buck Institute for Research on Aging	Kurakin, A (corresponding author), Buck Inst Age Res, Novato, CA USA.	ak@alexeikurakin.org			NIH [NS33376]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033376] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported in part by NS33376 from the NIH to D. E. B.	Appleton BA, 2006, J BIOL CHEM, V281, P22312, DOI 10.1074/jbc.M602901200; Basdevant N, 2006, J AM CHEM SOC, V128, P12766, DOI 10.1021/ja060830y; Bezprozvanny I, 2001, FEBS LETT, V509, P457, DOI 10.1016/S0014-5793(01)03214-8; Birrane G, 2003, J BIOL CHEM, V278, P1399, DOI 10.1074/jbc.C200571200; Castagnoli L, 2004, FEBS LETT, V567, P74, DOI 10.1016/j.febslet.2004.03.116; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Dev KK, 2004, NAT REV DRUG DISCOV, V3, P1047, DOI 10.1038/nrd1578; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Fujita A, 2000, BIOCHEM BIOPH RES CO, V269, P1, DOI 10.1006/bbrc.1999.1893; Gray NW, 2006, PLOS BIOL, V4, P2065, DOI 10.1371/journal.pbio.0040370; Harris BZ, 2001, J CELL SCI, V114, P3219; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Inoue A, 2003, CURR OPIN NEUROBIOL, V13, P332, DOI 10.1016/S0959-4388(03)00077-1; Kay BK, 2000, FEBS LETT, V480, P55, DOI 10.1016/S0014-5793(00)01778-6; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kurakin A, 2005, BIOL CHEM, V386, P247, DOI 10.1515/BC.2005.030; Kurakin A, 2002, J BIOMOL STRUCT DYN, V19, P1015, DOI 10.1080/07391102.2002.10506805; Kurakin A, 2007, J MOL RECOGNIT, V20, P205, DOI 10.1002/jmr.839; Kurakin A, 2007, J MOL RECOGNIT, V20, P39, DOI 10.1002/jmr.809; Kurakin Alexei, 2004, Methods Mol Biol, V264, P47; Kurakin AV, 2003, J BIOL CHEM, V278, P34102, DOI 10.1074/jbc.M305264200; Kuriyan J, 1997, ANNU REV BIOPH BIOM, V26, P259, DOI 10.1146/annurev.biophys.26.1.259; Ladbury JE, 2000, CHEM BIOL, V7, pR3, DOI 10.1016/S1074-5521(00)00067-3; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lim IA, 2002, J BIOL CHEM, V277, P21697, DOI 10.1074/jbc.M112339200; Mayer BJ, 2001, J CELL SCI, V114, P1253; Misteli T, 2001, J CELL BIOL, V155, P181, DOI 10.1083/jcb.200108110; Niethammer M, 1998, NEURON, V20, P693, DOI 10.1016/S0896-6273(00)81009-0; Piserchio A, 2002, J BIOL CHEM, V277, P6967, DOI 10.1074/jbc.M109453200; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Sparks AB, 1996, P NATL ACAD SCI USA, V93, P1540, DOI 10.1073/pnas.93.4.1540; Spector DL, 2003, ANNU REV BIOCHEM, V72, P573, DOI 10.1146/annurev.biochem.72.121801.161724; Sudol M, 1998, ONCOGENE, V17, P1469, DOI 10.1038/sj.onc.1202182; TAYLOR WR, 1986, J THEOR BIOL, V119, P205, DOI 10.1016/S0022-5193(86)80075-3; Vaccaro P, 2002, FEBS LETT, V512, P345, DOI 10.1016/S0014-5793(02)02220-2; Wiedemann U, 2004, J MOL BIOL, V343, P703, DOI 10.1016/j.jmb.2004.08.064; Zucconi A, 2000, FEBS LETT, V480, P49, DOI 10.1016/S0014-5793(00)01777-4	41	39	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e953	10.1371/journal.pone.0000953	http://dx.doi.org/10.1371/journal.pone.0000953			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895993	Green Published, Green Submitted, gold			2022-12-25	WOS:000207455800031
J	Costford, SR; Kavaslar, N; Ahituv, N; Chaudhry, SN; Schackwitz, WS; Dent, R; Pennacchio, LA; McPherson, R; Harper, ME				Costford, Sheila R.; Kavaslar, Nihan; Ahituv, Nadav; Chaudhry, Shehla N.; Schackwitz, Wendy S.; Dent, Robert; Pennacchio, Len A.; McPherson, Ruth; Harper, Mary-Ellen			Gain-of-Function R225W Mutation in Human AMPK gamma(3) Causing Increased Glycogen and Decreased Triglyceride in Skeletal Muscle	PLOS ONE			English	Article								Background. AMP-activated protein kinase (AMPK) is a heterotrimeric enzyme that is evolutionarily conserved from yeast to mammals and functions to maintain cellular and whole body energy homeostasis. Studies in experimental animals demonstrate that activation of AMPK in skeletal muscle protects against insulin resistance, type 2 diabetes and obesity. The regulatory gamma(3) subunit of AMPK is expressed exclusively in skeletal muscle; however, its importance in controlling overall AMPK activity is unknown. While evidence is emerging that gamma subunit mutations interfere specifically with AMP activation, there remains some controversy regarding the impact of gamma subunit mutations [1-3]. Here we report the first gain-of-function mutation in the muscle-specific regulatory gamma(3) subunit in humans. Methods and Findings. We sequenced the exons and splice junctions of the AMPK gamma(3) gene (PRKAG3) in 761 obese and 759 lean individuals, identifying 87 sequence variants including a novel R225W mutation in subjects from two unrelated families. The gamma(3) R225W mutation is homologous in location to the gamma(2)R302Q mutation in patients with Wolf-Parkinson-White syndrome and to the gamma(3)R225Q mutation originally linked to an increase in muscle glycogen content in purebred Hampshire Rendement Napole (RN-) pigs. We demonstrate in differentiated muscle satellite cells obtained from the vastus lateralis of R225W carriers that the mutation is associated with an approximate doubling of both basal and AMP-activated AMPK activities. Moreover, subjects bearing the R225W mutation exhibit a similar to 90% increase of skeletal muscle glycogen content and a similar to 30% decrease in intramuscular triglyceride (IMTG). Conclusions. We have identified for the first time a mutation in the skeletal muscle-specific regulatory gamma(3) subunit of AMPK in humans. The gamma(3)R225W mutation has significant functional effects as demonstrated by increases in basal and AMP-activated AMPK activities, increased muscle glycogen and decreased IMTG. Overall, these findings are consistent with an important regulatory role for AMPK gamma(3) in human muscle energy metabolism.	[Costford, Sheila R.; Chaudhry, Shehla N.; Harper, Mary-Ellen] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Kavaslar, Nihan; McPherson, Ruth] Univ Ottawa, Inst Heart, Atherosclerosis Res Grp, Ottawa, ON, Canada; [Kavaslar, Nihan; McPherson, Ruth] Univ Ottawa, Inst Heart, Div Cardiol, Ottawa, ON, Canada; [Dent, Robert] Ottawa Hosp, Weight Management Clin, Ottawa, ON, Canada; [Ahituv, Nadav; Schackwitz, Wendy S.; Pennacchio, Len A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, Berkeley, CA 94720 USA; [Schackwitz, Wendy S.] US DOE, Joint Genome Inst, Walnut Creek, CA USA	University of Ottawa; University of Ottawa; University of Ottawa Heart Institute; University of Ottawa; University of Ottawa Heart Institute; University of Ottawa; Ottawa Hospital Research Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI	Harper, ME (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.	Maryellen.Harper@uottawa.ca	Schackwitz, Wendy/GXH-9536-2022	Pennacchio, Len/0000-0002-8748-3732; Ahituv, Nadav/0000-0002-7434-8144; Harper, Mary-Ellen/0000-0003-3864-5886	Heart and Stroke Foundation of Ontario [NA-5413]; Department of Energy [DE-AC02-05CH11231]; University of California	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Department of Energy(United States Department of Energy (DOE)); University of California(University of California System)	This research was supported by a grant (# NA-5413) from the Heart and Stroke Foundation of Ontario ( to R. McPherson and M-E Harper) and was partially conducted at the E.O. Lawrence Berkeley National Laboratory, and performed under Department of Energy Contract DE-AC02-05CH11231, University of California.	Ahituv N, 2006, HUM MOL GENET, V15, P387, DOI 10.1093/hmg/ddi455; Ahituv N, 2007, AM J HUM GENET, V80, P779, DOI 10.1086/513471; Andersson L, 2003, BIOCHEM SOC T, V31, P232, DOI 10.1042/BST0310232; Arad M, 2002, J CLIN INVEST, V109, P357, DOI 10.1172/JCI200214571; Barnes BR, 2005, DIABETES, V54, P3484, DOI 10.2337/diabetes.54.12.3484; Barnes BR, 2004, J BIOL CHEM, V279, P38441, DOI 10.1074/jbc.M405533200; Bergeron R, 2001, DIABETES, V50, P1076, DOI 10.2337/diabetes.50.5.1076; Birk JB, 2006, J PHYSIOL-LONDON, V577, P1021, DOI 10.1113/jphysiol.2006.120972; Buhl ES, 2002, DIABETES, V51, P2199, DOI 10.2337/diabetes.51.7.2199; Buhl ES, 2001, DIABETES, V50, P12, DOI 10.2337/diabetes.50.1.12; Burwinkel B, 2005, AM J HUM GENET, V76, P1034, DOI 10.1086/430840; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Cheung PCF, 2000, BIOCHEM J, V346, P659, DOI 10.1042/0264-6021:3460659; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; Daniel T, 2002, J BIOL CHEM, V277, P51017, DOI 10.1074/jbc.M207093200; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; DYCK JRB, 2006, J PHYSIOL-LONDON; Frosig C, 2004, AM J PHYSIOL-ENDOC M, V286, pE411, DOI 10.1152/ajpendo.00317.2003; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Fujii N, 2006, AM J PHYSIOL-ENDOC M, V291, pE867, DOI 10.1152/ajpendo.00207.2006; Gollob MH, 2001, CIRCULATION, V104, P3030, DOI 10.1161/hc5001.102111; Gollob MH, 2001, NEW ENGL J MED, V344, P1823, DOI 10.1056/NEJM200106143442403; Hamilton SR, 2001, FEBS LETT, V500, P163, DOI 10.1016/S0014-5793(01)02602-3; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hardie DG, 2000, METH MOL B, V99, P63; Hardie DG, 2006, PHYSIOLOGY, V21, P48, DOI 10.1152/physiol.00044.2005; Hedegaard J, 2004, PROTEOMICS, V4, P2448, DOI 10.1002/pmic.200300761; INGHAM KC, 1990, METHOD ENZYMOL, V182, P301; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Lang TM, 2000, GENOMICS, V70, P258, DOI 10.1006/geno.2000.6376; Mahlapuu M, 2004, AM J PHYSIOL-ENDOC M, V286, pE194, DOI 10.1152/ajpendo.00147.2003; Milan D, 2000, SCIENCE, V288, P1248, DOI 10.1126/science.288.5469.1248; Musi N, 2002, DIABETES, V51, P2074, DOI 10.2337/diabetes.51.7.2074; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Nielsen JN, 2003, J APPL PHYSIOL, V94, P631, DOI 10.1152/japplphysiol.00642.2002; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Winder WW, 1999, AM J PHYSIOL-ENDOC M, V277, pE1, DOI 10.1152/ajpendo.1999.277.1.E1; Wojtaszewski JFP, 2005, J PHYSIOL-LONDON, V564, P563, DOI 10.1113/jphysiol.2005.082669; Yu HY, 2006, AM J PHYSIOL-ENDOC M, V291, pE557, DOI 10.1152/ajpendo.00073.2006; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	41	66	67	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2007	2	9							e903	10.1371/journal.pone.0000903	http://dx.doi.org/10.1371/journal.pone.0000903			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HS	17878938	Green Published, Green Submitted, gold			2022-12-25	WOS:000207455700011
J	Garcia, GE; Truong, LD; Li, P; Zhang, P; Du, J; Chen, JF; Feng, LL				Garcia, Gabriela E.; Truong, Luan D.; Li, Ping; Zhang, Ping; Du, Jie; Chen, Jiang-Fan; Feng, Lili			Adenosine A(2A) receptor activation and macrophage-mediated experimental glomerulonephritis	FASEB JOURNAL			English	Article						chemokines; anti-inflammatory cytokines; tissue injury protection	EXPERIMENTAL CRESCENTIC GLOMERULONEPHRITIS; HUMAN POLYMORPHONUCLEAR LEUKOCYTES; MESANGIAL CELL-PROLIFERATION; MARROW-DERIVED CELLS; TNF-ALPHA; WKY RATS; BLOOD-PRESSURE; NITRIC-OXIDE; MAJOR SOURCE; IN-VIVO	In immune-induced inflammation, leukocytes are key mediators of tissue damage. Since A(2A) adenosine receptors (A(2A)Rs) are endogenous suppressors of inflammation, we examined cellular and molecular mechanisms of kidney damage to determine if selective activation of A(2A)R would suppress inflammation in a rat model of glomerulonephritis. Activation of A(2A)R reduced the degree of kidney injury in both the acute inflammatory phase and the progressive phase of glomerulonephritis. This protection against acute and chronic inflammation was associated with suppression of the glomerular expression of the MDC/CCL22 chemokine and down-regulation of MIP-1 alpha/CCL3, RANTES/CCL5, MIP-1 beta/CCL4, and MCP-1/CCL2 chemokines. The expression of anti-inflammatory cytokines, interluekin (IL)-4 and IL-10, also increased. The mechanism for these anti-inflammatory responses to the A(2A)R agonist was suppression of macrophages function. A(2A)R expression was increased in macrophages, macrophage-derived chemokines were reduced in response to the A(2A)R agonist, and chemokines not expressed in macrophages did not respond to A(2A)R activation. Thus, activation of the A(2A)R on macrophages inhibits immune-associated inflammation. In glomerulonephritis, A(2A)R activation modulates inflammation and tissue damage even in the progressive phase of glomerulonephritis. Accordingly, pharmacological activation of A(2A)R could be developed into a novel treatment for glomerulonephritis and other macrophage-related inflammatory diseases.	[Garcia, Gabriela E.; Li, Ping; Zhang, Ping; Du, Jie; Feng, Lili] Baylor Coll Med, Dept Med, Nephrol Sect, Houston, TX 77030 USA; [Truong, Luan D.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Truong, Luan D.] Methodist Hosp, Houston, TX 77030 USA; [Chen, Jiang-Fan] Boston Univ, Sch Med, Dept Neurol, Mol Neuropharmacol Lab, Boston, MA 02118 USA	Baylor College of Medicine; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Boston University	Garcia, GE (corresponding author), Baylor Coll Med, Dept Med, Nephrol Sect, Alkek N520,1 Baylor Plaza, Houston, TX 77030 USA.	geg@bcm.tmc.edu		Chen, Jiang-Fan/0000-0002-0446-3956	NIDDK NIH HHS [P50 DK064233-010005, P50 DK064233, P50 DK064233-050010] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK064233] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALEXOPOULOS E, 1990, KIDNEY INT, V37, P100, DOI 10.1038/ki.1990.14; Anders HJ, 2003, KIDNEY INT, V63, P401, DOI 10.1046/j.1523-1755.2003.00750.x; Armstrong JM, 2001, BIOCHEM J, V354, P123, DOI 10.1042/0264-6021:3540123; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Bariety J, 2005, KIDNEY INT, V68, P1109, DOI 10.1111/j.1523-1755.2005.00503.x; BULLOUGH DA, 1995, J IMMUNOL, V155, P2579; CASATI C, 1994, J PHARMACOL EXP THER, V268, P1506; Chen SH, 1998, J EXP MED, V188, P193, DOI 10.1084/jem.188.1.193; Cheng P, 1999, J POROUS MEDIA, V2, P19, DOI 10.1615/JPorMedia.v2.i1.20; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Colasanti M, 2000, BRAIN RES BULL, V52, P155, DOI 10.1016/S0361-9230(00)00262-8; Conti A, 1997, PHARMACOL RES, V35, P123, DOI 10.1006/phrs.1996.0125; Cook HT, 1999, KIDNEY INT, V55, P1319, DOI 10.1046/j.1523-1755.1999.00354.x; CRONSTEIN BN, 1985, J IMMUNOL, V135, P1366; CRONSTEIN BN, 1994, J APPL PHYSIOL, V76, P5, DOI 10.1152/jappl.1994.76.1.5; Day YJ, 2005, J IMMUNOL, V174, P5040, DOI 10.4049/jimmunol.174.8.5040; Day YJ, 2003, J CLIN INVEST, V112, P883, DOI 10.1172/JCI200315483; El-Shemi AGA, 2004, KIDNEY INT, V65, P1280, DOI 10.1111/j.1523-1755.2004.00536.x; Feng LL, 2000, J CLIN INVEST, V105, P341, DOI 10.1172/JCI2869; FENG LL, 1995, J CLIN INVEST, V95, P1009, DOI 10.1172/JCI117745; Feng LL, 1999, KIDNEY INT, V56, P612, DOI 10.1046/j.1523-1755.1999.00604.x; Fredholm BB, 1996, N-S ARCH PHARMACOL, V354, P262, DOI 10.1007/BF00171056; Garcia GE, 2000, J LEUKOCYTE BIOL, V67, P577, DOI 10.1002/jlb.67.4.577; Garcia GE, 2003, AM J PATHOL, V162, P1061, DOI 10.1016/S0002-9440(10)63903-X; Garcia GE, 2003, KIDNEY INT, V64, P160, DOI 10.1046/j.1523-1755.2003.00077.x; Gessi S, 2000, BRIT J PHARMACOL, V129, P2, DOI 10.1038/sj.bjp.0703045; Hasko G, 2004, TRENDS IMMUNOL, V25, P33, DOI 10.1016/j.it.2003.11.003; Hasko G, 1996, J IMMUNOL, V157, P4634; Hasko G, 2000, FASEB J, V14, P2065, DOI 10.1096/fj.99-0508com; HOLDSWORTH SR, 1981, J CLIN INVEST, V68, P686, DOI 10.1172/JCI110304; Huang S, 1997, BLOOD, V90, P1600, DOI 10.1182/blood.V90.4.1600.1600_1600_1610; Ikezumi Y, 2003, KIDNEY INT, V63, P83, DOI 10.1046/j.1523-1755.2003.00717.x; Isome M, 2004, NEPHROL DIAL TRANSPL, V19, P2997, DOI 10.1093/ndt/gfh558; Javaid B, 2005, KIDNEY INT, V67, P1692, DOI 10.1111/j.1523-1755.2005.00266.x; JOHNSON RJ, 1991, J CLIN INVEST, V87, P847, DOI 10.1172/JCI115089; Kanellis J, 2004, AM J PATHOL, V165, P341, DOI 10.1016/S0002-9440(10)63301-9; KAWASAKI K, 1993, J IMMUNOL, V150, P1074; KAWASAKI K, 1992, KIDNEY INT, V41, P1517, DOI 10.1038/ki.1992.221; Khoa ND, 2003, J IMMUNOL, V171, P3991, DOI 10.4049/jimmunol.171.8.3991; Khoa ND, 2001, J IMMUNOL, V167, P4026, DOI 10.4049/jimmunol.167.7.4026; Kobashi C, 2005, CIRC RES, V97, P1245, DOI 10.1161/01.RES.0000194328.57164.36; KREGE JH, 1995, NATURE, V375, P146, DOI 10.1038/375146a0; Le Hir M, 2001, J AM SOC NEPHROL, V12, P2060, DOI 10.1681/ASN.V12102060; Ledent C, 1997, NATURE, V388, P674, DOI 10.1038/41771; Linden J, 2001, ANNU REV PHARMACOL, V41, P775, DOI 10.1146/annurev.pharmtox.41.1.775; Lloyd GM, 1997, J EXP MED, V185, P1371, DOI 10.1084/jem.185.7.1371; Moeller MJ, 2004, J AM SOC NEPHROL, V15, P61, DOI 10.1097/01.ASN.0000102468.37809.C6; Niemir ZI, 1997, KIDNEY INT, V52, P393, DOI 10.1038/ki.1997.346; NIKOLICPATERSON DJ, 1994, KIDNEY INT, V45, pS79; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; RAMKUMAR V, 1991, MOL PHARMACOL, V40, P639; RICHTER J, 1992, J LEUKOCYTE BIOL, V51, P270, DOI 10.1002/jlb.51.3.270; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; SCHREINER GF, 1978, J EXP MED, V147, P369, DOI 10.1084/jem.147.2.369; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; THIEL M, 1995, J LAB CLIN MED, V126, P275; Thiel M, 1996, J LEUKOCYTE BIOL, V59, P671, DOI 10.1002/jlb.59.5.671; Timoshanko JR, 2003, J AM SOC NEPHROL, V14, P1785, DOI 10.1097/01.ASN.0000073902.38428.33; Trincavelli ML, 2002, BIOCHEM PHARMACOL, V64, P625, DOI 10.1016/S0006-2952(02)01222-4; UNANUE ER, 1965, J EXP MED, V121, P697, DOI 10.1084/jem.121.5.697; Wada T, 1996, FASEB J, V10, P1418, DOI 10.1096/fasebj.10.12.8903512; WEBB RL, 1993, J PHARMACOL EXP THER, V267, P287; Willets JM, 1999, J NEUROCHEM, V73, P1781, DOI 10.1046/j.1471-4159.1999.0731781.x; Wu XB, 1997, J IMMUNOL, V158, P3917; Xia YY, 1997, AM J PATHOL, V151, P375; XIA YY, 1993, AM J PHYSIOL, V264, pF774, DOI 10.1152/ajprenal.1993.264.5.F774; Yu LQ, 2004, NAT MED, V10, P1081, DOI 10.1038/nm1103	67	35	46	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2008	22	2					445	454		10.1096/fj.07-8430com	http://dx.doi.org/10.1096/fj.07-8430com			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	257TY	17898087	Green Accepted			2022-12-25	WOS:000252822600015
J	Olichon, A; Surrey, T				Olichon, Aurelien; Surrey, Thomas			Selection of genetically encoded fluorescent single domain antibodies engineered for efficient expression in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAIN FV ANTIBODIES; FUSION PROTEIN; PHAGE DISPLAY; FRAGMENTS; LIBRARIES; DSBC; BINDING; CELLS	Genetically encoded fluorescent antibodies are desirable for many applications in biotechnology and proteomics. However, the efficient production of single chain antibodies fused to fluorescent proteins like green fluorescent protein is still a major challenge. This is due to the opposite redox requirements of recombinant antibodies and fluorescent proteins for proper folding. To overcome this obstacle, we designed a novel strategy to directly select functional fluorescent antibodies (fluobodies) engineered for efficient cytosolic expression in Escherichia coli, starting from a llama heavy chain antibody (VHH) library. We used this strategy to produce several VHH fluobodies directed against microtubules. After biochemical characterization in vitro, we used a selected fluobody as a convenient biomarker of the microtubule cytoskeleton in eukaryotic cells and engineered its properties. This work provides a reliable approach for the production of fluobodies in wild- type E. coli and furthermore suggests that fusions of recombinant VHH with other cytosolic proteins are now possible, creating new opportunities for biotechnology and biomedical research.	European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Surrey, T (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	surrey@embl.de	Olichon, Aurelien/M-3115-2014; Surrey, Thomas/AAC-4608-2021; Olichon, Aurelien/Q-5425-2019	Olichon, Aurelien/0000-0002-0821-3612; Surrey, Thomas/0000-0001-9082-1870				Bazl MR, 2007, HYBRIDOMA, V26, P1, DOI 10.1089/hyb.2006.037; BELL PB, 1995, SCANNING MICROSCOPY, V9, P843; Binz HK, 2003, J MOL BIOL, V332, P489, DOI 10.1016/S0022-2836(03)00896-9; Bradbury ARM, 2004, J IMMUNOL METHODS, V290, P29, DOI 10.1016/j.jim.2004.04.007; Casey JL, 2000, PROTEIN ENG, V13, P445, DOI 10.1093/protein/13.6.445; Conrath KE, 2001, ANTIMICROB AGENTS CH, V45, P2807, DOI 10.1128/AAC.45.10.2807-2812.2001; Conrath KE, 2001, J BIOL CHEM, V276, P7346, DOI 10.1074/jbc.M007734200; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Feilmeier BJ, 2000, J BACTERIOL, V182, P4068, DOI 10.1128/JB.182.14.4068-4076.2000; Frenken LGJ, 2000, J BIOTECHNOL, V78, P11, DOI 10.1016/S0168-1656(99)00228-X; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Griep RA, 1999, J IMMUNOL METHODS, V230, P121, DOI 10.1016/S0022-1759(99)00131-3; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Holt LJ, 2003, TRENDS BIOTECHNOL, V21, P484, DOI 10.1016/j.tibtech.2003.08.007; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; Jurado P, 2002, J MOL BIOL, V320, P1, DOI 10.1016/S0022-2836(02)00405-9; Liska AJ, 2004, PROTEOMICS, V4, P2707, DOI 10.1002/PMIC.200300813; MISSIAKAS D, 1994, EMBO J, V13, P2013, DOI 10.1002/j.1460-2075.1994.tb06471.x; Morino K, 2001, J IMMUNOL METHODS, V257, P175, DOI 10.1016/S0022-1759(01)00462-8; Muyldermans S, 1999, J MOL RECOGNIT, V12, P131, DOI 10.1002/(SICI)1099-1352(199903/04)12:2<131::AID-JMR454>3.0.CO;2-M; Muyldermans S, 2001, J Biotechnol, V74, P277; Muyldermans S, 2001, TRENDS BIOCHEM SCI, V26, P230, DOI 10.1016/S0968-0004(01)01790-X; Nizak C, 2003, SCIENCE, V300, P984, DOI 10.1126/science.1083911; Oelschlaeger P, 2002, ANAL BIOCHEM, V309, P27, DOI 10.1016/S0003-2697(02)00290-7; Olichon A, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-7; PLUCKTHUN A, 1989, METHOD ENZYMOL, V178, P497; Rondot S, 2001, NAT BIOTECHNOL, V19, P75, DOI 10.1038/83567; Rothbauer U, 2006, NAT METHODS, V3, P887, DOI 10.1038/NMETH953; Schwalbach G, 2000, PROTEIN EXPRES PURIF, V18, P121, DOI 10.1006/prep.1999.1185; Segatori L, 2004, P NATL ACAD SCI USA, V101, P10018, DOI 10.1073/pnas.0403003101; Sidhu SS, 2000, CURR OPIN BIOTECH, V11, P610, DOI 10.1016/S0958-1669(00)00152-X; SKERRA A, 1988, SCIENCE, V240, P1038, DOI 10.1126/science.3285470; Spinelli S, 1996, NAT STRUCT BIOL, V3, P752, DOI 10.1038/nsb0996-752; WALLIS KT, 1993, J BIOL CHEM, V268, P15158; Worn A, 1998, FEBS LETT, V427, P357, DOI 10.1016/S0014-5793(98)00463-3; Zarebski LM, 2005, J MOL BIOL, V349, P814, DOI 10.1016/j.jmb.2005.03.072; Zhang Z, 2002, PROTEIN EXPRES PURIF, V26, P218, DOI 10.1016/S1046-5928(02)00502-8	38	63	68	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36314	36320		10.1074/jbc.M704908200	http://dx.doi.org/10.1074/jbc.M704908200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17921141	hybrid			2022-12-25	WOS:000251458300022
J	Anantha, RW; Vassin, VM; Borowiec, JA				Anantha, Rachel W.; Vassin, Vitaly M.; Borowiec, James A.			Sequential and synergistic modification of human RPA stimulates chromosomal DNA repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION PROTEIN-A; SINGLE-STRANDED-DNA; NUCLEOTIDE EXCISION-REPAIR; CYCLIN-DEPENDENT KINASES; S-PHASE CHECKPOINT; IN-VITRO; INDUCED PHOSPHORYLATION; P34 SUBUNIT; CELL-CYCLE; HOMOLOGOUS RECOMBINATION	The activity of human replication protein A (RPA) in DNA replication and repair is regulated by phosphorylation of the middle RPA2 subunit. It has previously been shown that up to nine different N-terminal residues are modified in vivo and in response to genotoxic stress. Using a novel antibody against phospho-Ser(29), a moiety formed by cyclin-Cdk, we observed that RPA2 was phosphorylated during mitosis in nonstressed cells. Robust phosphorylation of Ser(29) was also seen in interphase cells following treatment with the DNA-damaging agent camptothecin, a rare example of stress stimulating the modification of a repair factor by cyclin-Cdk. RPA2 phosphorylation is regulated both in cis and trans. Cis-phosphorylation follows a preferred pathway. (That is, the initial modification of Ser(33) by ATR stimulates subsequent phosphorylation of Cdk sites Ser(23) and Ser29). These events then facilitate modification of Thr(21) and extreme N-terminal sites Ser(4) and Ser(8), probably by DNA-PK. Our data also indicate that the phosphorylation of one RPA molecule can influence the phosphorylation of other RPA molecules in trans. Cells in which endogenous RPA2 was "replaced" with a double S23A/S29A-RPA2 mutant were seen to have an abnormal cell cycle distribution both in normal and in stressed cells. Such cells also showed aberrant DNA damage-dependent RPA foci and had persistent staining of gamma H2AX following DNA damage. Our data indicate that RPA phosphorylation facilitates chromosomal DNA repair. We postulate that the RPA phosphorylation pattern provides a means to regulate the DNA repair pathway utilized.	NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; NYU, Sch Med, New York Univ Canc Inst, New York, NY USA	New York University; New York University	Borowiec, JA (corresponding author), NYU, Sch Med, Dept Biochem, 550 1st Ave, New York, NY 10016 USA.	james.borowiec@med.nyu.edu		Borowiec, James/0000-0003-4117-0826	NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029963] Funding Source: NIH RePORTER; NCI NIH HHS [P30CA16087] Funding Source: Medline; NIAID NIH HHS [AI29963] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abraham J, 2000, J MOL BIOL, V295, P853, DOI 10.1006/jmbi.1999.3415; Araujo SJ, 1999, MUTAT RES-DNA REPAIR, V435, P23, DOI 10.1016/S0921-8777(99)00042-7; Binz SK, 2004, DNA REPAIR, V3, P1015, DOI 10.1016/j.dnarep.2004.03.028; Blaydes JP, 2001, J BIOL CHEM, V276, P4699, DOI 10.1074/jbc.M003485200; Block WD, 2004, NUCLEIC ACIDS RES, V32, P997, DOI 10.1093/nar/gkh265; Bochkareva E, 2002, EMBO J, V21, P1855, DOI 10.1093/emboj/21.7.1855; Bochkareva E, 2005, P NATL ACAD SCI USA, V102, P15412, DOI 10.1073/pnas.0504614102; Bouquet F, 2006, CELL CYCLE, V5, P1116, DOI 10.4161/cc.5.10.2799; Chaudhuri J, 2004, NATURE, V430, P992, DOI 10.1038/nature02821; Chehab NH, 2000, GENE DEV, V14, P278; Dent P, 2003, ONCOGENE, V22, P5885, DOI 10.1038/sj.onc.1206701; Dodson GE, 2004, J BIOL CHEM, V279, P34010, DOI 10.1074/jbc.C400242200; DUTTA A, 1992, EMBO J, V11, P2189, DOI 10.1002/j.1460-2075.1992.tb05278.x; FANG F, 1993, J CELL SCI, V106, P983; FOTEDAR R, 1992, EMBO J, V11, P2177, DOI 10.1002/j.1460-2075.1992.tb05277.x; Gibbs E, 1996, J BIOL CHEM, V271, P22847, DOI 10.1074/jbc.271.37.22847; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P24203; Iftode C, 1999, CRIT REV BIOCHEM MOL, V34, P141, DOI 10.1080/10409239991209255; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Kim K, 2005, MOL CELL BIOL, V25, P2463, DOI 10.1128/MCB.25.6.2463-2474.2005; LEE SH, 1995, J BIOL CHEM, V270, P12801, DOI 10.1074/jbc.270.21.12801; LEESMILLER SP, 1995, SCIENCE, V267, P1183, DOI 10.1126/science.7855602; Lin YL, 1998, J BIOL CHEM, V273, P1453, DOI 10.1074/jbc.273.3.1453; McGowan CH, 2004, CURR OPIN CELL BIOL, V16, P629, DOI 10.1016/j.ceb.2004.09.005; McIlwraith MJ, 2000, J MOL BIOL, V304, P151, DOI 10.1006/jmbi.2000.4180; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Morgan SE, 1997, CANCER RES, V57, P3386; Namiki Y, 2006, P NATL ACAD SCI USA, V103, P580, DOI 10.1073/pnas.0510223103; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Niu HW, 1997, J BIOL CHEM, V272, P12634, DOI 10.1074/jbc.272.19.12634; Nuss JE, 2005, BIOCHEMISTRY-US, V44, P8428, DOI 10.1021/bi0480584; Oakley GG, 2003, BIOCHEMISTRY-US, V42, P3255, DOI 10.1021/bi026377u; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Olson E, 2006, J BIOL CHEM, V281, P39517, DOI 10.1074/jbc.M605121200; PAN ZQ, 1994, P NATL ACAD SCI USA, V91, P8343, DOI 10.1073/pnas.91.18.8343; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; POVIRK LF, 1977, NUCLEIC ACIDS RES, V4, P3573, DOI 10.1093/nar/4.10.3573; Prakash S, 2000, MUTAT RES-FUND MOL M, V451, P13, DOI 10.1016/S0027-5107(00)00037-3; Ramilo C, 2002, MOL CELL BIOL, V22, P2037, DOI 10.1128/MCB.22.7.2037-2046.2002; Shao RG, 1999, EMBO J, V18, P1397, DOI 10.1093/emboj/18.5.1397; Shinohara A, 1998, GENES CELLS, V3, P145, DOI 10.1046/j.1365-2443.1998.00176.x; Sugiyama T, 1998, P NATL ACAD SCI USA, V95, P6049, DOI 10.1073/pnas.95.11.6049; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Vassin VM, 2004, MOL CELL BIOL, V24, P1930, DOI 10.1128/MCB.24.5.1930-1943.2004; Wang HY, 2001, CANCER RES, V61, P8554; Wong JMS, 2003, ONCOGENE, V22, P28, DOI 10.1038/sj.onc.1206071; Yang HJ, 2005, NATURE, V433, P653, DOI 10.1038/nature03234; Yuzhakov A, 1999, EMBO J, V18, P6189, DOI 10.1093/emboj/18.21.6189; ZernikKobak M, 1997, J BIOL CHEM, V272, P23896, DOI 10.1074/jbc.272.38.23896; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	51	117	120	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35910	35923		10.1074/jbc.M704645200	http://dx.doi.org/10.1074/jbc.M704645200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17928296	hybrid			2022-12-25	WOS:000251458100052
J	Fujiwara, N; Nakano, M; Kato, S; Yoshihara, D; Ookawara, T; Eguchi, H; Taniguchi, N; Suzuki, K				Fujiwara, Noriko; Nakano, Miyako; Kato, Shinsuke; Yoshihara, Daisaku; Ookawara, Tomomi; Eguchi, Hironobu; Taniguchi, Naoyuki; Suzuki, Keiichiro			Oxidative modification to cysteine sulfonic acid of Cys(111) in human copper-zinc superoxide dismutase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CU,ZN-SUPEROXIDE DISMUTASE; HYDROGEN-PEROXIDE; SULFINIC ACID; RECOMBINANT HUMAN; WILD-TYPE; MOLECULAR EVOLUTION; FAMILIAL ALS; ACTIVE-SITE; MUTANT	Copper-zinc superoxide dismutase (SOD1) plays a protective role against oxidative stress. On the other hand, recent studies suggest that SOD1 itself is a major target of oxidative damage and has its own pathogenicity in various neurodegenerative diseases, including familial amyotrophic lateral sclerosis. Only human and great ape SOD1s among mammals have the highly reactive free cysteine residue, Cys(111), at the surface of the SOD1 molecule. The purpose of this study was to investigate the role of Cys(111) in the oxidative damage of the SOD1 protein, by comparing the oxidative susceptibility of recombinant human SOD1 modified with 2-mercaptoethanol at Cys(111) (2-ME-SOD1) to wild-type SOD1. Wild-type SOD1 was more sensitive to oxidation by hydrogen peroxide-generating fragments, oligomers, and charge isomers compared with 2-ME-SOD1. Moreover, wild-type SOD1, but not 2-ME-SOD1, generated an upper shifted band in reducing SDS-PAGE even by air oxidation. Using mass spectrometry and limited proteolysis, this upper band was identified as an oxidized subunit of SOD1; the sulfhydryl group (Cys-SH) of Cys(111) was selectively oxidized to cysteine sulfinic acid (Cys-SO2H) and to cysteine sulfonic acid (Cys-SO3H). The antibody raised against a synthesized peptide containing Cys(111)-SO3H reacted with only the Cys(111)-peroxidized SOD1 by Western blot analysis and labeled Lewy bodylike hyaline inclusions and vacuole rims in the spinal cord of human SOD1-mutated amyotrophic lateral sclerosis mice by immunohistochemical analysis. These results suggest that Cys(111) is a primary target for oxidative modification and plays an important role in oxidative damage to human SOD1, including familial amyotrophic lateral sclerosis mutants.	Hyogo Coll Med, Dept Biochem, Nishinomiya, Hyogo 6638501, Japan; Osaka Univ, Dept Biochem, Sch Med, Suita, Osaka 5650871, Japan; Grad Sch Med, Suita, Osaka 5650871, Japan; Tottori Univ, Fac Med, Dept Neuropathol, Inst Neurol Sci, Yonago, Tottori 6838504, Japan; Osaka Univ, Dept Dis Glycom, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan	Hyogo College of Medicine; Osaka University; Tottori University; Osaka University	Fujiwara, N (corresponding author), Hyogo Coll Med, Dept Biochem, Nishinomiya, Hyogo 6638501, Japan.	noriko-f@hyo-med.ac.jp	Yoshihara, Daisaku/L-6664-2019; Taniguchi, Naoyuki/A-7086-2016; Taniguchi, Naoyuki/I-4182-2014	Taniguchi, Naoyuki/0000-0001-5889-5968				Abou Ezzi S, 2007, J NEUROCHEM, V102, P170, DOI 10.1111/j.1471-4159.2007.04531.x; Basso M, 2006, J BIOL CHEM, V281, P33325, DOI 10.1074/jbc.M603489200; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Chang TS, 2004, J BIOL CHEM, V279, P50994, DOI 10.1074/jbc.M409482200; Choi J, 2005, J BIOL CHEM, V280, P11648, DOI 10.1074/jbc.M414327200; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; DE Beus MD, 2004, PROTEIN SCI, V13, P1347, DOI 10.1110/ps.03576904; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Ferri A, 2006, P NATL ACAD SCI USA, V103, P13860, DOI 10.1073/pnas.0605814103; Fink RC, 2002, ARCH BIOCHEM BIOPHYS, V399, P19, DOI 10.1006/abbi.2001.2739; Forman HJ, 2002, MOL CELL BIOCHEM, V234, P49, DOI 10.1023/A:1015913229650; Fujiwara N, 2005, J BIOL CHEM, V280, P5061, DOI 10.1074/jbc.M406106200; Fukuhara R, 2002, GENE, V296, P99, DOI 10.1016/S0378-1119(02)00837-5; Furukawa Y, 2005, J BIOL CHEM, V280, P17266, DOI 10.1074/jbc.M500482200; Furukawa Y, 2006, P NATL ACAD SCI USA, V103, P7148, DOI 10.1073/pnas.0602048103; GETZOFF ED, 1989, PROTEINS, V5, P322, DOI 10.1002/prot.340050408; Ghadge GD, 1997, J NEUROSCI, V17, P8756; Goto JJ, 1998, J BIOL CHEM, V273, P30104, DOI 10.1074/jbc.273.46.30104; HALLEWELL RA, 1991, BIOCHEM BIOPH RES CO, V181, P474, DOI 10.1016/S0006-291X(05)81443-3; HODGSON EK, 1975, BIOCHEMISTRY-US, V14, P5299, DOI 10.1021/bi00695a011; Jacob C, 2004, ORG BIOMOL CHEM, V2, P1953, DOI 10.1039/b406180b; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Julien JP, 2001, CELL, V104, P581, DOI 10.1016/S0092-8674(01)00244-6; KAJIHARA J, 1998, J BIOCHEM-TOKYO, V104, P851; KAJIHARA J, 1998, J BIOCHEM-TOKYO, V104, P638; Kato S, 2005, ACTA NEUROPATHOL, V110, P101, DOI 10.1007/s00401-005-1019-3; Kim JR, 2000, ANAL BIOCHEM, V283, P214, DOI 10.1006/abio.2000.4623; Kurahashi T, 2001, J AM CHEM SOC, V123, P9268, DOI 10.1021/ja015953r; Liu HB, 2000, BIOCHEMISTRY-US, V39, P8125, DOI 10.1021/bi000846f; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Okado-Matsumoto A, 2006, FREE RADICAL BIO MED, V41, P1837, DOI 10.1016/j.freeradbiomed.2006.09.011; OOKAWARA T, 1992, J BIOL CHEM, V267, P18505; PARGE HE, 1992, P NATL ACAD SCI USA, V89, P6109, DOI 10.1073/pnas.89.13.6109; Rakhit R, 2002, J BIOL CHEM, V277, P47551, DOI 10.1074/jbc.M207356200; RAKHIT R, 2006, BIOCHIM BIOPHYS ACTA, V1726, P1025; REPOCK JR, 1990, J BIOL CHEM, V265, P21612; Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748; RIPPS ME, 1995, P NATL ACAD SCI USA, V92, P689, DOI 10.1073/pnas.92.3.689; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; SALO DC, 1990, J BIOL CHEM, V265, P11919; Stanton JL, 1996, DNA SEQUENCE, V6, P357, DOI 10.3109/10425179609047575; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; TAINER JA, 1982, J MOL BIOL, V160, P181, DOI 10.1016/0022-2836(82)90174-7; UCHIDA K, 1994, J BIOL CHEM, V269, P2405; Valentine JS, 2003, P NATL ACAD SCI USA, V100, P3617, DOI 10.1073/pnas.0730423100; Watanabe S, 2007, FREE RADICAL BIO MED, V42, P1534, DOI 10.1016/j.freeradbiomed.2007.02.004; WiedauPazos M, 1996, SCIENCE, V271, P515, DOI 10.1126/science.271.5248.515; Woo HA, 2005, J BIOL CHEM, V280, P3125, DOI 10.1074/jbc.C400496200; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200; Yim MB, 1996, P NATL ACAD SCI USA, V93, P5709, DOI 10.1073/pnas.93.12.5709; Zhang H, 2003, J BIOL CHEM, V278, P24078, DOI 10.1074/jbc.M302051200	53	108	110	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35933	35944		10.1074/jbc.M702941200	http://dx.doi.org/10.1074/jbc.M702941200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17913710	Green Published, hybrid			2022-12-25	WOS:000251458100054
J	Jensen, M; Hansen, B; De Meyts, P; Schaffer, L; Urso, B				Jensen, Maja; Hansen, Bente; De Meyts, Pierre; Schaeffer, Lauge; Urso, Birgitte			Activation of the insulin receptor by insulin and a synthetic peptide leads to divergent metabolic and mitogenic signaling and responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-II; CELL-PROLIFERATION; PROTEIN-KINASE; ISOFORM-A; INTERNALIZATION; SHC; PHOSPHORYLATION; TRANSDUCTION; SUBSTRATE-1; EXPRESSION	Recently, single chain peptides have been designed that target the insulin receptor and mimic insulin action. The aim of this study is to explore if activation of the insulin receptor with such an optimized peptide (S597) leads to the same activation of signaling pathways and biological endpoints i.e. stimulation of glycogen synthesis and cell proliferation as stimulation with insulin. We find that surface activation of the insulin receptor A-isoform with S597 leads to activation of protein kinase B (PKB) and glycogen synthesis comparable to activation by insulin, even though the level of insulin receptor phosphorylation is lower. In contrast, both Src homology 2/alpha collagen-related (Shc) and extracellular signal-regulated kinase (ERK) 2 activation are virtually absent upon stimulation with S597. Cell proliferation is only stimulated slightly by S597, suggesting that it depends on signals from Shc and ERK. The differences in signaling response could explain both the earlier reported differences in gene expression, and the reported differences in cell proliferation and glycogen synthesis induced by insulin and S597. In conclusion, despite binding equipotency, insulin, and S597 initiate different signaling and biological responses through the same insulin receptor isoform. We show for the first time that it is possible to design insulin receptor ligand mimetics with metabolic equipotency but low mitogenicity.	Hagedorn Res Inst, Receptor Syst Biol Lab, DK-2820 Gentofte, Denmark; Novo Nordisk AS, Dept Canc & ImmunoBiol, DK-2760 Malov, Denmark; Novo Nordisk AS, Diabet Prot Engn, DK-2760 Malov, Denmark	Novo Nordisk; Hagedorn Research Institute; Novo Nordisk; Novo Nordisk	Jensen, M (corresponding author), Hagedorn Res Inst, Receptor Syst Biol Lab, Niels Steensensvej 6, DK-2820 Gentofte, Denmark.	mjjn@novonordisk.com		De Meyts, Pierre/0000-0001-6214-0824				Biener Y, 1996, J BIOL CHEM, V271, P29489, DOI 10.1074/jbc.271.46.29489; Ceresa BP, 1998, MOL CELL BIOL, V18, P3862, DOI 10.1128/MCB.18.7.3862; Chow JC, 1998, J BIOL CHEM, V273, P4672, DOI 10.1074/jbc.273.8.4672; EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4; Foti Michelangelo, 2004, Novartis Found Symp, V262, P125; Frasca F, 1999, MOL CELL BIOL, V19, P3278, DOI 10.1128/mcb.19.5.3278; Gousseva N, 2001, J CELL BIOCHEM, V81, P523, DOI 10.1002/1097-4644(20010601)81:3<523::AID-JCB1066>3.0.CO;2-E; Hamer I, 2002, DIABETOLOGIA, V45, P657, DOI 10.1007/s00125-002-0798-5; Hansen BF, 1996, BIOCHEM J, V315, P271; Harada S, 1996, J BIOL CHEM, V271, P30222, DOI 10.1074/jbc.271.47.30222; Kurtzhals P, 2000, DIABETES, V49, P999, DOI 10.2337/diabetes.49.6.999; Leof EB, 2000, TRENDS CELL BIOL, V10, P343, DOI 10.1016/S0962-8924(00)01795-5; Morrione A, 1997, P NATL ACAD SCI USA, V94, P3777, DOI 10.1073/pnas.94.8.3777; Olsen GS, 2002, AM J PHYSIOL-ENDOC M, V283, pE965, DOI 10.1152/ajpendo.00118.2002; Pandini G, 2003, J BIOL CHEM, V278, P42178, DOI 10.1074/jbc.M304980200; Pillutla RC, 2002, J BIOL CHEM, V277, P22590, DOI 10.1074/jbc.M202119200; Sasaoka T, 2000, ENDOCR J, V47, P373, DOI 10.1507/endocrj.47.373; Schaffer L, 2003, P NATL ACAD SCI USA, V100, P4435, DOI 10.1073/pnas.0830026100; Sciacca L, 2002, ONCOGENE, V21, P8240, DOI 10.1038/sj.onc.1206058; Thirone ACP, 2006, TRENDS ENDOCRIN MET, V17, P70, DOI 10.1016/j.tem.2006.01.005; Thirone ACP, 1998, FEBS LETT, V421, P191, DOI 10.1016/S0014-5793(97)01560-3; Uhles S, 2007, FASEB J, V21, P1609, DOI 10.1096/fj.06-7589com; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; White MF, 1997, DIABETOLOGIA, V40, pS2, DOI 10.1007/s001250051387; WILDEN PA, 1990, P NATL ACAD SCI USA, V87, P3358, DOI 10.1073/pnas.87.9.3358; WILDEN PA, 1992, J BIOL CHEM, V267, P13719; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Yamauchi T, 1996, MOL CELL BIOL, V16, P3074	28	55	58	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35179	35186		10.1074/jbc.M704599200	http://dx.doi.org/10.1074/jbc.M704599200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17925406	hybrid			2022-12-25	WOS:000251155200063
J	Jeudy, S; Schwartz, TU				Jeudy, Sandra; Schwartz, Thomas U.			Crystal structure of nucleoporin Nic96 reveals a novel, intricate helical domain architecture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-PORE COMPLEX; N-TERMINAL DOMAIN; NUCLEOCYTOPLASMIC TRANSPORT; CRYOELECTRON TOMOGRAPHY; MESSENGER-RNA; IN-VIVO; PROTEIN; YEAST; INTERACTS; RECONSTRUCTION	The nuclear pore complex (NPC) is an elaborate protein machine that mediates macromolecular transport across the nuclear envelope in all eukaryotes. The NPC is formed by nucleoporins that assemble in multiple copies around an 8-fold symmetry axis. Homology modeling suggests that most architectural nucleoporins are composed of simple beta- propeller and alpha- helical repeat domains. Here we present the crystal structure of Nic96, the Nup93 homolog in Saccharomyces cerevisiae, one of the major components of the NPC. This is the first structure of an alpha- helical nucleoporin domain. The protein folds into an elongated, mostly alpha- helical structure. Characteristically, non-canonical architectural features define the Nic96 structure. Sequence conservation among Nup93 homologs across all eukaryotes strongly suggests that the distinct topology is evolutionarily well maintained. We propose that the unique Nic96/Nup93 fold has a conserved function in all eukaryotes.	MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Schwartz, TU (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave,Rm 68-480, Cambridge, MA 02139 USA.	tus@mit.edu	Schwartz, Thomas/K-9029-2017; Schwartz, Thomas/ABA-1770-2021	Schwartz, Thomas/0000-0001-8012-1512; Schwartz, Thomas/0000-0001-8012-1512; jeudy, sandra/0000-0002-5297-0135	NIGMS NIH HHS [GM077537] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077537] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; Allende ML, 1996, GENE DEV, V10, P3141, DOI 10.1101/gad.10.24.3141; Aravind L, 2006, CURR OPIN STRUC BIOL, V16, P409, DOI 10.1016/j.sbi.2006.04.006; Bailer SM, 2001, MOL CELL BIOL, V21, P7944, DOI 10.1128/MCB.21.23.7944-7955.2001; Beck M, 2007, NATURE, V449, P611, DOI 10.1038/nature06170; Berke IC, 2004, J CELL BIOL, V167, P591, DOI 10.1083/jcb.200408109; BLOBEL G, 1985, P NATL ACAD SCI USA, V82, P8527, DOI 10.1073/pnas.82.24.8527; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Devos D, 2006, P NATL ACAD SCI USA, V103, P2172, DOI 10.1073/pnas.0506345103; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; Dujon B, 2006, TRENDS GENET, V22, P375, DOI 10.1016/j.tig.2006.05.007; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fahrenkrog B, 2000, MOL BIOL CELL, V11, P3885, DOI 10.1091/mbc.11.11.3885; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Galy V, 2003, MOL BIOL CELL, V14, P5104, DOI 10.1091/mbc.E03-04-0237; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gomez-Ospina N, 2000, J STRUCT BIOL, V132, P1, DOI 10.1006/jsbi.2000.4305; GRANDI P, 1993, EMBO J, V12, P3061, DOI 10.1002/j.1460-2075.1993.tb05975.x; GRANDI P, 1995, EMBO J, V14, P76, DOI 10.1002/j.1460-2075.1995.tb06977.x; Grandi P, 1997, MOL BIOL CELL, V8, P2017, DOI 10.1091/mbc.8.10.2017; Hawryluk-Gara LA, 2005, MOL BIOL CELL, V16, P2382, DOI 10.1091/mbc.e04-10-0857; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kobe B, 2000, TRENDS BIOCHEM SCI, V25, P509, DOI 10.1016/S0968-0004(00)01667-4; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; LAFORTELLE E, 1997, METHOD ENZYMOL, V276, P472; LAMB JR, 1995, TRENDS BIOCHEM SCI, V20, P257, DOI 10.1016/S0968-0004(00)89037-4; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; Miller BR, 2000, MOL BIOL CELL, V11, P3381, DOI 10.1091/mbc.11.10.3381; Napetschnig J, 2007, P NATL ACAD SCI USA, V104, P1783, DOI 10.1073/pnas.0610828104; Osmani AH, 2006, MOL BIOL CELL, V17, P4946, DOI 10.1091/mbc.E06-07-0657; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Rabut G, 2004, CURR OPIN CELL BIOL, V16, P314, DOI 10.1016/j.ceb.2004.04.001; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Ryan KJ, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-17; Schwartz TU, 2005, CURR OPIN STRUC BIOL, V15, P221, DOI 10.1016/j.sbi.2005.03.003; Stewart M, 2007, MOL CELL, V25, P327, DOI 10.1016/j.molcel.2007.01.016; Stoffler D, 2003, J MOL BIOL, V328, P119, DOI 10.1016/S0022-2836(03)00266-3; Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097; Suel KE, 2006, METHODS, V39, P342, DOI 10.1016/j.ymeth.2006.06.015; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; Weirich CS, 2004, MOL CELL, V16, P749, DOI 10.1016/j.molcel.2004.10.032; Weis K, 2002, CURR OPIN CELL BIOL, V14, P328, DOI 10.1016/S0955-0674(02)00337-X; Zabel U, 1996, J CELL BIOL, V133, P1141, DOI 10.1083/jcb.133.6.1141; Zeitler B, 2004, J CELL BIOL, V167, P583, DOI 10.1083/jcb.200407156	55	50	50	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34904	34912		10.1074/jbc.M705479200	http://dx.doi.org/10.1074/jbc.M705479200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17897938	hybrid			2022-12-25	WOS:000251155200033
J	Vasanthavada, K; Hu, X; Falick, AM; La Mattina, C; Moore, AMF; Jones, PR; Yee, R; Reza, R; Tuton, T; Vierra, C				Vasanthavada, Keshav; Hu, Xiaoyi; Falick, Arnold M.; La Mattina, Coby; Moore, Anne M. F.; Jones, Patrick R.; Yee, Russell; Reza, Ryan; Tuton, Tiffany; Vierra, Craig			Aciniform spidroin, a constituent of egg case sacs and wrapping silk fibers from the black widow spider Latrodectus hesperus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSERVED C-TERMINI; COB WEAVER; PROTEINS; DRAGLINE; FIBROIN; FLAGELLIFORM; PREDATORS; EVOLUTION; COCOONS; GENE	Spiders produce high performance fibers with diverse mechanical properties and biological functions. Molecular and biochemical studies of spider egg case silk have revealed that the main constituent of the large diameter fiber contains the fibroin TuSp1. Here we demonstrate by SDS-PAGE and protein silver staining the presence of a distinct similar to 300-kDa polypeptide that is found in solubilized egg case sacs. Combining matrix-assisted laser desorption ionization tandem time-of-flight mass spectrometry and reverse genetics, we have isolated a novel gene called AcSp1-like and demonstrate that its protein product is assembled into the small diameter fibers of egg case sacs and wrapping silks from the black widow spider, Latrodectus hesperus. BLAST searches of the NCBInr protein data base using the amino acid sequence of AcSp1-like revealed similarity to AcSp1, an inferred protein proposed to be a component of wrapping silk. However, the AcSp1-like protein was found to display more nonuniformity in its internal iterated repeat modules than the putative AcSp1 fibroin. Real time quantitative PCR analysis demonstrates that the AcSp1-like gene displays an aciniform gland-restricted pattern of expression. The amino acid composition of the fibroins extracted from the luminal contents of the aciniform glands was remarkably similar to the predicted amino acid composition of the AcSp1-like protein, which supports the assertion that AcSp1-like protein represents the major constituent stored within the aciniform gland. Collectively, our findings provide the first direct molecular evidence for the involvement of the aciniform gland in the production of a common fibroin that is assembled into the small diameter threads of egg case and wrapping silk of cob weavers.	Univ Pacific, Dept Biol Sci, Stockton, CA 95211 USA; Univ Pacific, Dept Chem, Stockton, CA 95211 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of the Pacific; University of the Pacific; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Vierra, C (corresponding author), Univ Pacific, Dept Biol Sci, 3601 Pacific Ave, Stockton, CA 95211 USA.	cvierra@pacific.edu						AUSTIN AD, 1985, J NAT HIST, V19, P359, DOI 10.1080/00222938500770261; Ayoub NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000514; Casem ML, 1999, INT J BIOL MACROMOL, V24, P103, DOI 10.1016/S0141-8130(98)00078-6; Challis RJ, 2006, INSECT MOL BIOL, V15, P45, DOI 10.1111/j.1365-2583.2005.00606.x; FOELIX RF, 1996, BIOL SPIDERS, P1; Garb JE, 2005, P NATL ACAD SCI USA, V102, P11379, DOI 10.1073/pnas.0502473102; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Hayashi CY, 2004, MOL BIOL EVOL, V21, P1950, DOI 10.1093/molbev/msh204; Hayashi CY, 1998, J MOL BIOL, V275, P773, DOI 10.1006/jmbi.1997.1478; HIEBER CS, 1985, J THERM BIOL, V10, P171, DOI 10.1016/0306-4565(85)90023-3; HIEBER CS, 1992, OECOLOGIA, V91, P530, DOI 10.1007/BF00650327; Hu X, 2006, CELL MOL LIFE SCI, V63, P1986, DOI 10.1007/s00018-006-6090-y; Hu XY, 2007, BIOCHEMISTRY-US, V46, P3294, DOI 10.1021/bi602507e; Hu XY, 2006, BIOCHEMISTRY-US, V45, P3506, DOI 10.1021/bi052105q; Hu XY, 2005, BIOCHEMISTRY-US, V44, P10020, DOI 10.1021/bi050494i; Hu XY, 2005, J BIOL CHEM, V280, P21220, DOI 10.1074/jbc.M412316200; Huemmerich D, 2004, BIOCHEMISTRY-US, V43, P13604, DOI 10.1021/bi048983q; JIMENEZ CR, 1998, IN GEL DIGESTION PRO; Mitchell B, 2000, BBA-GENE STRUCT EXPR, V1492, P320, DOI 10.1016/S0167-4781(00)00109-3; Moon Myung-Jin, 2003, Korean Journal of Biological Sciences, V7, P35; Motriuk-Smith D, 2005, BIOMACROMOLECULES, V6, P3152, DOI 10.1021/bm050472b; Nguyen L, 2001, NUCLEIC ACIDS RES, V29, P4423, DOI 10.1093/nar/29.21.4423; Rising A, 2006, BIOMACROMOLECULES, V7, P3120, DOI 10.1021/bm060693x; SHULTZ JW, 1987, BIOL REV, V62, P89, DOI 10.1111/j.1469-185X.1987.tb01263.x; Sponner A, 2005, BIOCHEM BIOPH RES CO, V338, P897, DOI 10.1016/j.bbrc.2005.10.048; Sponner A, 2005, NAT MATER, V4, P772, DOI 10.1038/nmat1493; Sponner A, 2004, BIOMACROMOLECULES, V5, P840, DOI 10.1021/bm034378b; Tian MZ, 2005, BIOCHEMISTRY-US, V44, P8006, DOI 10.1021/bi050366u; Zhao AC, 2006, BIOCHEMISTRY-US, V45, P3348, DOI 10.1021/bi052414g	29	56	62	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35088	35097		10.1074/jbc.M705791200	http://dx.doi.org/10.1074/jbc.M705791200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17921147	hybrid			2022-12-25	WOS:000251155200053
J	Cheng, JZ; Zhang, JQ; Merched, A; Zhang, LP; Zhang, P; Truong, L; Boriek, AM; Du, J				Cheng, Jizhong; Zhang, Jiqiang; Merched, Aksam; Zhang, Liping; Zhang, Ping; Truong, Luan; Boriek, Aladin M.; Du, Jie			Mechanical stretch inhibits oxidized low density lipoprotein-induced apoptosis in vascular smooth muscle cells by up-regulating integrin alpha V beta 3 and stablization of PINCH-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ATHEROSCLEROTIC PLAQUES; INTEGRIN-LINKED KINASE; SHAPE MODULATION; ATHEROGENESIS; ILK; SURVIVAL; LDL; BAX	To determine the mechanisms involved in regulating the balance between apoptosis and survival in vascular smooth muscle cells (VSMC), we studied anti-apoptotic stimuli that can counteract pro-apoptotic events in the process of early atherosclerotic lesions formation. Such a process involves VSMC accumulation even in the presence of oxidized low density lipoprotein (Ox-LDL). In the arch of the aorta, we find that integrin beta 3 is higher than in descending arteries. In the advanced atherosclerosis lesion, we found an inverse correlation between the level of integrin beta 3 and apoptosis (deoxynucleotidyltransferase- mediated dUTP nick end labeling-positive). We also found an increase in integrin alpha V beta 3 (but not integrin beta 1) expression in VSMC that are subjected to cyclic stretch. VSMC subjected to stretch as well as VSMC with forced expression of alpha V beta 3 were demonstrated to be resistant to Ox-LDL induced cytoskeleton disruption and apoptosis. The anti-apoptotic effect of stretch was abolished by treatment of VSMC with small interfering RNA against integrin beta 3 as well as VSMC isolated from integrin beta 3 knock-out mice. Disruption of the cytoskeleton abolished the protective effect of stretch or alpha V beta 3 overexpression on Ox-LDL-induced activation of Bax and apoptosis. We also demonstrated that stretch-mediated protection of Ox-LDL-induced apoptosis involved stabilization of PINCH-1; Ox-LDL decreased the level of PINCH-1, but the application of mechanical stretch or overexpression of either integrin beta 1 or integrin beta 3 prevented its down-regulation. In the arteries of integrin beta 3 null mice, there were lower levels of PINCH-1 and ILK-1. Moreover, deletion of integrin beta 3 in VSMC abolished the stretch protective effect on PINCH-1. Small interfering RNA-mediated knockdown of PINCH-1 disrupted the cytoskeleton and caused apoptosis of VSMC. These findings provided experimental evidence that mechanical stretch acted as a survival factor in the arches of aortas. Furthermore, mechanical stretch prevented VSMC from apoptosis via a mechanism that involves alpha V beta 3 integrin expression, stabilization of PINCH-1, and remodeling of the cytoskeleton.	Baylor Coll Med, Div Nephrol, Dept Internal Med, Houston, TX 77030 USA	Baylor College of Medicine	Du, J (corresponding author), Baylor Coll Med, Div Nephrol, Dept Internal Med, 1 Baylor Plaza,BCM N-520, Houston, TX 77030 USA.	jdu@bcm.edu	Zhang, Jiqiang/B-4488-2008	Zhang, Jiqiang/0000-0002-1905-8750; Merched, Aksam/0000-0003-4030-4538	NHLBI NIH HHS [R01 HL 70762, HL 63134] Funding Source: Medline; NIDDK NIH HHS [P50 DK 064233, R01 DK095867] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063134, R01HL070762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK064233] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CHENG J, 2007, ARTERIOSCLER THROMB; Cheng JZ, 2007, ENDOCRINOLOGY, V148, P2085, DOI 10.1210/en.2006-1709; CHIEN S, 1976, ANN NY ACAD SCI, V275, P10, DOI 10.1111/j.1749-6632.1976.tb43335.x; Choi ET, 2004, CIRCULATION, V109, P1564, DOI 10.1161/01.CIR.0000121733.68724.FF; Fukuda T, 2003, J BIOL CHEM, V278, P51324, DOI 10.1074/jbc.M309122200; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Gimbrone MA, 2000, ANN NY ACAD SCI, V902, P230; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Kockx MM, 1998, CIRCULATION, V97, P2307, DOI 10.1161/01.CIR.97.23.2307; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Merched AJ, 2004, CIRCULATION, V110, P3830, DOI 10.1161/01.CIR.0000148681.01282.89; Mollinedo F, 2003, APOPTOSIS, V8, P413, DOI 10.1023/A:1025513106330; Murase T, 1998, CIRC RES, V83, P328, DOI 10.1161/01.RES.83.3.328; Napoli C, 2003, ANN NY ACAD SCI, V1010, P698, DOI 10.1196/annals.1299.127; Okura Y, 2000, CIRCULATION, V102, P2680, DOI 10.1161/01.CIR.102.22.2680; Pereira JJ, 2004, CANCER RES, V64, P977, DOI 10.1158/0008-5472.CAN-03-3056; ROSS R, 1986, NEW ENGL J MED, V314, P488, DOI 10.1056/NEJM198602203140806; Salvayre R, 2002, BBA-MOL CELL BIOL L, V1585, P213, DOI 10.1016/S1388-1981(02)00343-8; SCHWARTZ SM, 1995, CIRC RES, V77, P445, DOI 10.1161/01.RES.77.3.445; Shaw Anthony, 2003, Current Vascular Pharmacology, V1, P41, DOI 10.2174/1570161033386745; VanderLaan PA, 2004, ARTERIOSCL THROM VAS, V24, P12, DOI 10.1161/01.ATV.0000105054.43931.f0; Wernig F, 2003, HYPERTENSION, V41, P903, DOI 10.1161/01.HYP.0000062882.42265.88; Wu CY, 2005, TRENDS CELL BIOL, V15, P460, DOI 10.1016/j.tcb.2005.07.002; Wu CY, 1999, J CELL SCI, V112, P4485; Xu QB, 2000, TRENDS CARDIOVAS MED, V10, P35, DOI 10.1016/S1050-1738(00)00042-6; Xu Z, 2005, J BIOL CHEM, V280, P27631, DOI 10.1074/jbc.M504189200	26	24	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34268	34275		10.1074/jbc.M703115200	http://dx.doi.org/10.1074/jbc.M703115200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17878168	hybrid			2022-12-25	WOS:000251145700042
J	Tang, MJ; Tai, IT				Tang, Michelle J.; Tai, Isabella T.			A novel interaction between procaspase 8 and SPARC enhances apoptosis and potentiates chemotherapy sensitivity in colorectal cancers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DRUG-INDUCED APOPTOSIS; CELL LUNG-CANCER; EXTRACELLULAR-MATRIX; 1ST-LINE TREATMENT; GROWTH-INHIBITION; DEATH RECEPTOR; TUMOR-GROWTH; EXPRESSION; PROTEIN; CASPASE-8	Chemotherapy resistance accounts for the high mortality rates in patients with advanced cancers. We previously used a genomics approach to determine novel genes associated with this phenomenon and identified (s) under bar ecreted (p) under bar rotein (a) under bar cidic and (r) under bar ich in (c) under bar ysteine (SPARC) as a chemosensitizer capable of reversing therapy resistance in colorectal cancer cells by enhancing apoptosis in vitro and tumor regression in vivo. Here, we examined the mechanisms by which SPARC enhances apoptosis in the presence of chemotherapy. We show that SPARC potentiates apoptosis by augmenting the signaling cascade in a caspase-8-dependent manner, because apoptosis can be abolished by caspase 8 small interfering RNA in the presence of SPARC. This occurs independently of death receptor activation and leads to downstream involvement of Bid and subsequent apoptosis. Interestingly, this results from an interaction between SPARC and the N terminus of the procaspase-8 DED-containing domain. These exciting findings provide an initial map of the apoptosis signaling events mediated by SPARC and how this can ultimately result in the reversal of chemotherapy resistance and enhanced tumor regression. This signaling cascade can be exploited therapeutically and may have potential clinical implications for patients with advanced and therapy-refractory cancers.	Univ British Columbia, Div Gastroenterol, Vancouver, BC V5Z 1M9, Canada; British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; British Columbia Cancer Agency	Tai, IT (corresponding author), Univ British Columbia, Div Gastroenterol, 2775 Laurel St, Vancouver, BC V5Z 1M9, Canada.	itai@bcgsc.ca	Tai, Isabella T/E-8035-2012					ARAKI S, 1990, BIOCHEM BIOPH RES CO, V168, P1194, DOI 10.1016/0006-291X(90)91155-L; Basu A, 2006, CANCER RES, V66, P4309, DOI 10.1158/0008-5472.CAN-05-2657; Boatright KM, 2003, BIOCHEM SOC SYMP, V70, P233, DOI 10.1042/bss0700233; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Chlenski A, 2006, INT J CANCER, V118, P310, DOI 10.1002/ijc.21357; De Ambrosis A, 2007, INT J CANCER, V120, P39, DOI 10.1002/ijc.22173; de Gramont A, 2000, J CLIN ONCOL, V18, P2938, DOI 10.1200/JCO.2000.18.16.2938; DiMartino JF, 2006, LEUKEMIA, V20, P426, DOI 10.1038/sj.leu.2404102; Douillard JY, 2000, LANCET, V355, P1041, DOI 10.1016/S0140-6736(00)02034-1; Eischen CM, 1997, BLOOD, V90, P935, DOI 10.1182/blood.V90.3.935.935_935_943; ENGLISH HF, 1989, PROSTATE, V15, P233, DOI 10.1002/pros.2990150304; Ferreira CG, 2000, CLIN CANCER RES, V6, P203; Framson PE, 2004, J CELL BIOCHEM, V92, P679, DOI 10.1002/jcb.20091; FRANCHIMONT C, 1980, J CUTAN PATHOL, V7, P387, DOI 10.1111/j.1600-0560.1980.tb01212.x; Friesen C, 1996, NAT MED, V2, P574, DOI 10.1038/nm0596-574; Fulda S, 2004, ANN NY ACAD SCI, V1028, P150, DOI 10.1196/annals.1322.016; Fulda S, 2002, ONCOGENE, V21, P2283, DOI 10.1038/sj.onc.1205258; FUNK SE, 1991, P NATL ACAD SCI USA, V88, P2648, DOI 10.1073/pnas.88.7.2648; Gilles C, 1998, CANCER RES, V58, P5529; Graf D, 2007, ARCH BIOCHEM BIOPHYS, V462, P162, DOI 10.1016/j.abb.2007.03.029; Hopkins-Donaldson S, 2003, CELL DEATH DIFFER, V10, P356, DOI 10.1038/sj.cdd.4401157; Jiang XJ, 2000, J BIOL CHEM, V275, P31199, DOI 10.1074/jbc.C000405200; Koukourakis MI, 2003, CANCER RES, V63, P5376; Longley DB, 2006, ONCOGENE, V25, P838, DOI 10.1038/sj.onc.1209122; Machover D, 1996, ANN ONCOL, V7, P95; MASON IJ, 1986, EMBO J, V5, P1465, DOI 10.1002/j.1460-2075.1986.tb04383.x; Mok SC, 1996, ONCOGENE, V12, P1895; Ott M, 2002, P NATL ACAD SCI USA, V99, P1259, DOI 10.1073/pnas.241655498; Poulaki V, 2001, CANCER RES, V61, P4864; Puolakkainen PA, 2004, MOL CANCER RES, V2, P215; Reed WP, 2004, SURG ENDOSC, V18, P11, DOI 10.1007/s00464-003-8913-3; Rempel SA, 1998, J NEUROPATH EXP NEUR, V57, P1112, DOI 10.1097/00005072-199812000-00002; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Ruiz-Ruiz C, 2004, J BIOL CHEM, V279, P19712, DOI 10.1074/jbc.M313023200; SAGE H, 1989, J CELL BIOL, V109, P341, DOI 10.1083/jcb.109.1.341; Saltz LB, 2000, NEW ENGL J MED, V343, P905, DOI 10.1056/NEJM200009283431302; Sato N, 2003, ONCOGENE, V22, P5021, DOI 10.1038/sj.onc.1206807; Schulze-Osthoff K, 1998, EUR J BIOCHEM, V254, P439, DOI 10.1046/j.1432-1327.1998.2540439.x; Seol DW, 2001, CANCER RES, V61, P1138; Sun XM, 1999, J BIOL CHEM, V274, P5053, DOI 10.1074/jbc.274.8.5053; Taghizadeh F, 2007, MOL CANCER THER, V6, P309, DOI 10.1158/1535-7163.MCT-06-0517; Tai IT, 2005, J CLIN INVEST, V115, P1492, DOI 10.1172/JCI23002; Toyozumi Y, 2004, INT J ONCOL, V25, P721; Tsujimoto Y, 2002, BIOSCIENCE REP, V22, P47, DOI 10.1023/A:1016061006256; Wang WJ, 2006, NEPHROL DIAL TRANSPL, V21, P1278, DOI 10.1093/ndt/gfk036; Yang LL, 2003, CANCER RES, V63, P831; Yiu GK, 2001, AM J PATHOL, V159, P609, DOI 10.1016/S0002-9440(10)61732-4	48	61	65	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34457	34467		10.1074/jbc.M704459200	http://dx.doi.org/10.1074/jbc.M704459200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17897953	hybrid			2022-12-25	WOS:000251145700061
J	Compagno, D; Merle, C; Morin, A; Gilbert, C; Mathieu, JRR; Bozec, A; Mauduit, C; Benahmed, M; Cabon, F				Compagno, Daniel; Merle, Carole; Morin, Aurelie; Gilbert, Cristele; Mathieu, Jacques R. R.; Bozec, Aline; Mauduit, Claire; Benahmed, Mohammed; Cabon, Florence			SIRNA-Directed In Vivo Silencing of Androgen Receptor Inhibits the Growth of Castration-Resistant Prostate Carcinomas	PLOS ONE			English	Article							CANCER CELLS; GENE-EXPRESSION; PANCREATIC ADENOCARCINOMA; ANGIOGENESIS INHIBITOR; INTERFERING RNA; SERTOLI-CELLS; LNCAP MODEL; ACTIVATION; THROMBOSPONDIN-1; TESTOSTERONE	Background. Prostate carcinomas are initially dependent on androgens, and castration or androgen antagonists inhibit their growth. After some time though, tumors become resistant and recur with a poor prognosis. The majority of resistant tumors still expresses a functional androgen receptor (AR), frequently amplified or mutated. Methodology/Principal Findings. To test the hypothesis that AR is not only expressed, but is still a key therapeutic target in advanced carcinomas, we injected siRNA targeting AR into mice bearing exponentially growing castration-resistant tumors. Quantification of siRNA into tumors and mouse tissues demonstrated their efficient uptake. This uptake silenced AR in the prostate, testes and tumors. AR silencing in tumors strongly inhibited their growth, and importantly, also markedly repressed the VEGF production and angiogenesis. Conclusions/Significance. Our results demonstrate that carcinomas resistant to hormonal manipulations still depend on the expression of the androgen receptor for their development in vivo. The siRNA-directed silencing of AR, which allows targeting overexpressed as well as mutated isoforms, triggers a strong antitumoral and antiangiogenic effect. siRNA-directed silencing of this key gene in advanced and resistant prostate tumors opens promising new therapeutic perspectives and tools.	[Compagno, Daniel; Merle, Carole; Morin, Aurelie; Gilbert, Cristele; Mathieu, Jacques R. R.; Cabon, Florence] Univ Paris Sud, CNRS, FRE2944, Inst Andre Lwoff, Villejuif, France; [Bozec, Aline; Mauduit, Claire; Benahmed, Mohammed] INSERM, U406, F-69008 Lyon, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm)	Cabon, F (corresponding author), Univ Paris Sud, CNRS, FRE2944, Inst Andre Lwoff, Villejuif, France.	fcabon@vjf.cnrs.fr		Compagno, Daniel/0000-0002-7589-7217	Fondation de l'Avenir; Association pour la Recherche sur les Tumeurs de la Prostate; Association pour la Recherche sur le Cancer; MJENR [03L270]	Fondation de l'Avenir; Association pour la Recherche sur les Tumeurs de la Prostate; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); MJENR	Funding: This work was supported by grants to FC from Fondation de l'Avenir, Association pour la Recherche sur les Tumeurs de la Prostate, Association pour la Recherche sur le Cancer and a grant 03L270 from the MJENR.	Bakin RE, 2003, CANCER RES, V63, P1975; Behlke MA, 2006, MOL THER, V13, P644, DOI 10.1016/j.ymthe.2006.01.001; BELTINGER C, 1995, J CLIN INVEST, V95, P1814, DOI 10.1172/JCI117860; Benbrahim-Tallaa L, 2002, BIOL REPROD, V66, P1734, DOI 10.1095/biolreprod66.6.1734; Braasch DA, 2004, BIOORG MED CHEM LETT, V14, P1139, DOI 10.1016/j.bmcl.2003.12.074; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen SY, 2006, P NATL ACAD SCI USA, V103, P15969, DOI 10.1073/pnas.0604193103; Cheng H, 2006, CANCER RES, V66, P10613, DOI 10.1158/0008-5472.CAN-06-0028; Colombel M, 2005, CANCER RES, V65, P300; Culig Z, 2005, ENDOCR-RELAT CANCER, V12, P229, DOI 10.1677/erc.1.00775a; de Fougerolles A, 2007, NAT REV DRUG DISCOV, V6, P443, DOI 10.1038/nrd2310; De Gendt K, 2004, P NATL ACAD SCI USA, V101, P1327, DOI 10.1073/pnas.0308114100; DEHM SM, 2006, J BIOL CHEM; Doll JA, 2001, PROSTATE, V49, P293, DOI 10.1002/pros.10025; Duxbury MS, 2005, BIOCHEM BIOPH RES CO, V331, P459, DOI 10.1016/j.bbrc.2005.03.199; Duxbury MS, 2004, BRIT J CANCER, V91, P1384, DOI 10.1038/sj.bjc.6602113; Duxbury MS, 2004, ONCOGENE, V23, P1448, DOI 10.1038/sj.onc.1207247; Filleur S, 2003, CANCER RES, V63, P3919; Florin A, 2005, ENDOCRINOLOGY, V146, P1532, DOI 10.1210/en.2004-0834; Furutani T, 2005, BIOSCI BIOTECH BIOCH, V69, P2236, DOI 10.1271/bbb.69.2236; Ghosh PM, 2005, ENDOCR-RELAT CANCER, V12, P119, DOI 10.1677/erc.1.00835; Gonzalez-Herrera IG, 2006, FASEB J, V20, P476, DOI 10.1096/fj.04-3314fje; Gregory CW, 2001, CANCER RES, V61, P2892; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Guo ZY, 2006, CANCER CELL, V10, P309, DOI 10.1016/j.ccr.2006.08.021; Haag P, 2005, J STEROID BIOCHEM, V96, P251, DOI 10.1016/j.jsbmb.2005.04.029; Heidel JD, 2004, NAT BIOTECHNOL, V22, P1579, DOI 10.1038/nbt1038; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Kariko K, 2004, J IMMUNOL, V172, P6545, DOI 10.4049/jimmunol.172.11.6545; Liao XB, 2005, MOL CANCER THER, V4, P505, DOI 10.1158/1535-7163.MCT-04-0313; Mabjeesh NJ, 2003, CLIN CANCER RES, V9, P2416; Marques JT, 2005, NAT BIOTECHNOL, V23, P1399, DOI 10.1038/nbt1161; Mendoza N, 2002, CANCER RES, V62, P5485; Mohler JL, 2004, CLIN CANCER RES, V10, P440, DOI 10.1158/1078-0432.CCR-1146-03; Mostaghel EA, 2007, CANCER RES, V67, P5033, DOI 10.1158/0008-5472.CAN-06-3332; Nakayama T, 2000, LAB INVEST, V80, P1789, DOI 10.1038/labinvest.3780190; Nupponen NN, 2004, GENE CHROMOSOME CANC, V39, P119, DOI 10.1002/gcc.10308; O'Dwyer PJ, 1999, CLIN CANCER RES, V5, P3977; Ocker M, 2005, GUT, V54, P1298, DOI 10.1136/gut.2004.056192; Persengiev SP, 2004, RNA, V10, P12, DOI 10.1261/rna5160904; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Sirotnak FM, 2004, MOL CARCINOGEN, V41, P150, DOI 10.1002/mc.20051; Sramkoski RM, 1999, IN VITRO CELL DEV-AN, V35, P403; Stewart RJ, 2001, J UROLOGY, V165, P688, DOI 10.1097/00005392-200102000-00095; THALMANN GN, 1994, CANCER RES, V54, P2577; Wegiel B, 2005, ONCOGENE, V24, P6385, DOI 10.1038/sj.onc.1208795; Zegarra-Moro OL, 2002, CANCER RES, V62, P1008; Zhang M, 2000, NAT MED, V6, P196, DOI 10.1038/72303	53	50	53	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1006	10.1371/journal.pone.0001006	http://dx.doi.org/10.1371/journal.pone.0001006			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925854	Green Submitted, Green Published, gold			2022-12-25	WOS:000207456000005
J	Lim, JH; Jono, H; Koga, T; Woo, CH; Ishinaga, H; Bourne, P; Xu, HD; Ha, UH; Xu, HD; Li, JD				Lim, Jae Hyang; Jono, Hirofumi; Koga, Tomoaki; Woo, Chang-Hoon; Ishinaga, Hajime; Bourne, Patricia; Xu, Haodong; Ha, Un-Hwan; Xu, Haidong; Li, Jian-Dong			Tumor Suppressor CYLD Acts as a Negative Regulator for Non-Typeable Haemophilus influenza-Induced Inflammation in the Middle Ear and Lung of Mice	PLOS ONE			English	Article								Non-typeable Haemophilus influenza (NTHi) is an important human pathogen causing respiratory tract infections in both adults and children. NTHi infections are characterized by inflammation, which is mainly mediated by nuclear transcription factor kappaB (NF-kappa B)-dependent production of inflammatory mediators. The deubiquitinating enzyme cylindromatosis (CYLD), loss of which was originally reported to cause a benign human syndrome called cylindromatosis, has been identified as a key negative regulator for NF-kappa B in vitro. However, little is known about the role of CYLD in bacteria-induced inflammation in vivo. Here, we provided direct evidence for the negative role of CYLD in NTHi-induced inflammation of the mice in vivo. Our data demonstrated that CYLD is induced by NTHi in the middle ear and lung of mice. NTHi-induced CYLD, in turn, negatively regulates NTHi-induced NF-kappa B activation through deubiquitinating TRAF6 and 7 and down-regulates inflammation. Our data thus indicate that CYLD acts as a negative regulator for NF-kappa B-dependent inflammation in vivo, hence protecting the host against detrimental inflammatory response to NTHi infection.	[Lim, Jae Hyang; Jono, Hirofumi; Koga, Tomoaki; Ishinaga, Hajime; Ha, Un-Hwan; Xu, Haidong; Li, Jian-Dong] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Woo, Chang-Hoon] Univ Rochester, Med Ctr, Cardiovasc Res Inst, Rochester, NY 14642 USA; [Bourne, Patricia; Xu, Haodong] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Li, JD (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA.	Jian-Dong_Li@urmc.rochester.edu	Ha, Un-Hwan/ABH-8017-2020; xu, hao/GWQ-7394-2022	Lim, Jae Hyang/0000-0003-0972-9271; Li, Jian-Dong/0000-0002-5593-050X; Ha, Un-Hwan/0000-0001-9182-7000	National Institute of Health [DC004562, DC005843]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004562, R01DC005843] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from National Institute of Health DC004562 and DC005843 to J. D. Li.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Ben-Neriah Y, 2002, NAT IMMUNOL, V3, P20, DOI 10.1038/ni0102-20; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; DUNNE A, 2003, SCI STKE, pRE3, DOI DOI 10.1126/STKE.2003.171.RE3; Foxwell AR, 1998, MICROBIOL MOL BIOL R, V62, P294, DOI 10.1128/MMBR.62.2.294-308.1998; Fukushima T, 2007, P NATL ACAD SCI USA, V104, P6371, DOI 10.1073/pnas.0700548104; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gutierrez PP, 2002, J INVEST DERMATOL, V119, P527, DOI 10.1046/j.1523-1747.2002.01839.x; Habelhah H, 2004, EMBO J, V23, P322, DOI 10.1038/sj.emboj.7600044; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Imasato A, 2002, J BIOL CHEM, V277, P47444, DOI 10.1074/jbc.M208140200; Inoue J, 2000, EXP CELL RES, V254, P14, DOI 10.1006/excr.1999.4733; Jono H, 2004, J BIOL CHEM, V279, P36171, DOI 10.1074/jbc.M406638200; Kim S, 2005, AM J PHYSIOL-LUNG C, V289, pL1049, DOI 10.1152/ajplung.00388.2004; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Kurt-Jones EA, 2004, P NATL ACAD SCI USA, V101, P1315, DOI 10.1073/pnas.0308057100; Kweon SM, 2006, BIOCHEM BIOPH RES CO, V351, P368, DOI 10.1016/j.bbrc.2006.10.052; Leonard N, 2001, J CLIN PATHOL, V54, P689, DOI 10.1136/jcp.54.9.689; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; Murphy T F, 2000, Semin Respir Infect, V15, P41; Murphy TF, 2006, CURR OPIN INFECT DIS, V19, P225, DOI 10.1097/01.qco.0000224815.89363.15; Rao VK, 1999, FEMS MICROBIOL REV, V23, P99, DOI 10.1016/S0168-6445(98)00039-4; Reiley W, 2004, J BIOL CHEM, V279, P55161, DOI 10.1074/jbc.M411049200; Reiley WW, 2007, J EXP MED, V204, P1475, DOI 10.1084/jem.20062694; Reiley WW, 2006, NAT IMMUNOL, V7, P411, DOI 10.1038/ni1315; Sakai A, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-2; Sethi S, 2000, NEW ENGL J MED, V343, P1969; Shuto T, 2001, P NATL ACAD SCI USA, V98, P8774, DOI 10.1073/pnas.151236098; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Watanabe T, 2004, P NATL ACAD SCI USA, V101, P3563, DOI 10.1073/pnas.0400557101; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Yoshida H, 2005, J BIOL CHEM, V280, P41111, DOI 10.1074/jbc.M509526200; Zhang J, 2006, J CLIN INVEST, V116, P3042, DOI 10.1172/JCI28746	40	72	76	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1032	10.1371/journal.pone.0001032	http://dx.doi.org/10.1371/journal.pone.0001032			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925880	gold, Green Submitted, Green Published			2022-12-25	WOS:000207456000031
J	Gabanella, F; Butchbach, MER; Saieva, L; Carissimi, C; Burghes, AHM; Pellizzoni, L				Gabanella, Francesca; Butchbach, Matthew E. R.; Saieva, Luciano; Carissimi, Claudia; Burghes, Arthur H. M.; Pellizzoni, Livio			Ribonucleoprotein Assembly Defects Correlate with Spinal Muscular Atrophy Severity and Preferentially Affect a Subset of Spliceosomal snRNPs	PLOS ONE			English	Article								Spinal muscular atrophy (SMA) is a motor neuron disease caused by reduced levels of the survival motor neuron (SMN) protein. SMN together with Gemins2-8 and unrip proteins form a macromolecular complex that functions in the assembly of small nuclear ribonucleoproteins (snRNPs) of both the major and the minor splicing pathways. It is not known whether the levels of spliceosomal snRNPs are decreased in SMA. Here we analyzed the consequence of SMN deficiency on snRNP metabolism in the spinal cord of mouse models of SMA with differing phenotypic severities. We demonstrate that the expression of a subset of Gemin proteins and snRNP assembly activity are dramatically reduced in the spinal cord of severe SMA mice. Comparative analysis of different tissues highlights a similar decrease in SMN levels and a strong impairment of snRNP assembly in tissues of severe SMA mice, although the defect appears smaller in kidney than in neural tissue. We further show that the extent of reduction in both Gemin proteins expression and snRNP assembly activity in the spinal cord of SMA mice correlates with disease severity. Remarkably, defective SMN complex function in snRNP assembly causes a significant decrease in the levels of a subset of snRNPs and preferentially affects the accumulation of U11 snRNP-a component of the minor spliceosome-in tissues of severe SMA mice. Thus, impairment of a ubiquitous function of SMN changes the snRNP profile of SMA tissues by unevenly altering the normal proportion of endogenous snRNPs. These findings are consistent with the hypothesis that SMN deficiency affects the splicing machinery and in particular the minor splicing pathway of a rare class of introns in SMA.	[Gabanella, Francesca; Saieva, Luciano; Carissimi, Claudia; Pellizzoni, Livio] Dulbecco Telethon Inst, Inst Cell Biol, Rome, Italy; [Butchbach, Matthew E. R.; Burghes, Arthur H. M.] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Saieva, Luciano; Pellizzoni, Livio] Columbia Univ, Med Ctr, Dept Pathol, Ctr Motor Neuron Biol & Dis, New York, NY USA	Fondazione Telethon; Dulbecco Telethon Institute (DTI); University System of Ohio; Ohio State University; Columbia University	Pellizzoni, L (corresponding author), Dulbecco Telethon Inst, Inst Cell Biol, Rome, Italy.	lp2284@columbia.edu	carissimi, claudia/AAU-7414-2021; Gabanella, Francesca/AAY-3290-2020	carissimi, claudia/0000-0002-9885-2855; Butchbach, Matthew/0000-0003-2912-6400; Gabanella, Francesca/0000-0001-5536-5160; Burghes, Arthur/0000-0001-9031-1555; Pellizzoni, Livio/0000-0002-9168-5628	Telethon-Italy [TCP 02011]; "Compagnia di San Paolo"; Muscular Dystrophy Association-USA; NINDS [NS038650]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038650] Funding Source: NIH RePORTER	Telethon-Italy(Fondazione Telethon); "Compagnia di San Paolo"(Compagnia di San Paolo); Muscular Dystrophy Association-USA(Muscular Dystrophy Association); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by funds from Telethon-Italy (TCP 02011), "Compagnia di San Paolo" and the Muscular Dystrophy Association-USA to LP, Families of SMA to MERB, and NINDS (NS038650) to AHMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander GM, 2004, MOL BRAIN RES, V130, P7, DOI 10.1016/j.molbrainres.2004.07.002; Alioto TS, 2007, NUCLEIC ACIDS RES, V35, pD110, DOI 10.1093/nar/gkl796; Avila AM, 2007, J CLIN INVEST, V117, P659, DOI 10.1172/JCI29562; Buhler D, 1999, HUM MOL GENET, V8, P2351, DOI 10.1093/hmg/8.13.2351; Butchbach M.E.R., 2004, DRUG DISCOV TODAY DI, V1, P151, DOI [10.1016/j.ddmod.2004.07.001, DOI 10.1016/j.ddmod.2004.07.001, DOI 10.1016/J.DDMOD.2004.07.001]; Butchbach MER, 2007, J NEUROSCI METH, V161, P285, DOI 10.1016/j.jneumeth.2006.11.002; Carissimi C, 2006, J BIOL CHEM, V281, P8126, DOI 10.1074/jbc.M512243200; Carissimi C, 2006, J BIOL CHEM, V281, P37009, DOI 10.1074/jbc.M607505200; Carrel TL, 2006, J NEUROSCI, V26, P11014, DOI 10.1523/JNEUROSCI.1637-06.2006; Charroux B, 2000, J CELL BIOL, V148, P1177, DOI 10.1083/jcb.148.6.1177; Coovert DD, 1997, HUM MOL GENET, V6, P1205, DOI 10.1093/hmg/6.8.1205; Crawford TO, 1996, NEUROBIOL DIS, V3, P97, DOI 10.1006/nbdi.1996.0010; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Feng WQ, 2005, HUM MOL GENET, V14, P1605, DOI 10.1093/hmg/ddi168; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; Flink MT, 2003, J BIOENERG BIOMEMBR, V35, P697, DOI 10.1023/B:JOBB.0000008033.02320.10; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Frugier T, 2002, CURR OPIN GENET DEV, V12, P294, DOI 10.1016/S0959-437X(02)00301-5; Frugier T, 2000, HUM MOL GENET, V9, P849, DOI 10.1093/hmg/9.5.849; Gabanella F, 2005, HUM MOL GENET, V14, P3629, DOI 10.1093/hmg/ddi390; George AL, 2005, J CLIN INVEST, V115, P1990, DOI 10.1172/JCI25505; Helmken C, 2003, HUM GENET, V114, P11, DOI 10.1007/s00439-003-1025-2; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Kuyumcu-Martinez NM, 2006, PROG MOLEC, V44, P133; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Levine A, 2001, NUCLEIC ACIDS RES, V29, P4006, DOI 10.1093/nar/29.19.4006; Licatalosi DD, 2006, NEURON, V52, P93, DOI 10.1016/j.neuron.2006.09.017; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lorson CL, 2000, HUM MOL GENET, V9, P259, DOI 10.1093/hmg/9.2.259; Lueck JD, 2007, AM J PHYSIOL-CELL PH, V292, pC1291, DOI 10.1152/ajpcell.00336.2006; Lueck JD, 2007, J GEN PHYSIOL, V129, P79, DOI 10.1085/jgp.200609635; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; McAndrew PE, 1997, AM J HUM GENET, V60, P1411, DOI 10.1086/515465; McWhorter ML, 2003, J CELL BIOL, V162, P919, DOI 10.1083/jcb.200303168; Meister G, 2002, TRENDS CELL BIOL, V12, P472, DOI 10.1016/S0962-8924(02)02371-1; Meister G, 2001, NAT CELL BIOL, V3, P945, DOI 10.1038/ncb1101-945; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Monani UR, 2003, J CELL BIOL, V160, P41, DOI 10.1083/jcb.200208079; Monani UR, 2005, NEURON, V48, P885, DOI 10.1016/j.neuron.2005.12.001; MONTZKA KA, 1988, P NATL ACAD SCI USA, V85, P8885, DOI 10.1073/pnas.85.23.8885; Mourelatos Z, 2001, EMBO J, V20, P5443, DOI 10.1093/emboj/20.19.5443; Ogawa C, 2007, J BIOL CHEM, V282, P11122, DOI 10.1074/jbc.M609297200; Patel AA, 2003, NAT REV MOL CELL BIO, V4, P960, DOI 10.1038/nrm1259; Patel AA, 2002, EMBO J, V21, P3804, DOI 10.1093/emboj/cdf297; Paushkin S, 2002, CURR OPIN CELL BIOL, V14, P305, DOI 10.1016/S0955-0674(02)00332-0; Pellizzoni L, 1999, P NATL ACAD SCI USA, V96, P11167, DOI 10.1073/pnas.96.20.11167; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Pellizzoni L, 2007, EMBO REP, V8, P340, DOI 10.1038/sj.embor.7400941; Rajendra TK, 2007, J CELL BIOL, V176, P831, DOI 10.1083/jcb.200610053; Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; Sendtner M, 2001, CURR OPIN NEUROL, V14, P629, DOI 10.1097/00019052-200110000-00012; Sheth N, 2006, NUCLEIC ACIDS RES, V34, P3955, DOI 10.1093/nar/gkl556; Shpargel KB, 2005, P NATL ACAD SCI USA, V102, P17372, DOI 10.1073/pnas.0508947102; Sumner Charlotte J, 2006, NeuroRx, V3, P235, DOI 10.1016/j.nurx.2006.01.010; Vincent A, 2006, NEURON, V52, P123, DOI 10.1016/j.neuron.2006.09.024; Wan LL, 2005, MOL CELL BIOL, V25, P5543, DOI 10.1128/MCB.25.13.5543-5551.2005; Winkler C, 2005, GENE DEV, V19, P2320, DOI 10.1101/gad.342005; Wu Q, 1999, MOL CELL BIOL, V19, P3225; Yong J, 2004, MOL CELL BIOL, V24, P2747, DOI 10.1128/MCB.24.7.2747-2756.2004; Zhang HLL, 2003, J NEUROSCI, V23, P6627; Zhang HL, 2006, J NEUROSCI, V26, P8622, DOI 10.1523/JNEUROSCI.3967-05.2006	67	246	250	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e921	10.1371/journal.pone.0000921	http://dx.doi.org/10.1371/journal.pone.0000921			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895963	Green Published, gold, Green Submitted			2022-12-25	WOS:000207455800001
J	Zhang, SL; Wang, JW; Tseng, H				Zhang, Shengliang; Wang, Junwen; Tseng, Hung			Basonuclin Regulates a Subset of Ribosomal RNA Genes in HaCaT Cells	PLOS ONE			English	Article							POLYMERASE-I TRANSCRIPTION; ZINC-FINGER PROTEIN; FACTOR TIF-IA; RDNA TRANSCRIPTION; FACTOR UBF; PHOSPHORYLATION; PROMOTER; DNA; KERATINOCYTES; RB	Basonuclin (Bnc1), a cell-type-specific ribosomal RNA (rRNA) gene regulator, is expressed mainly in keratinocytes of stratified epithelium and gametogenic cells of testis and ovary. Previously, basonuclin was shown in vitro to interact with rRNA gene (rDNA) promoter at three highly conserved sites. Basonuclin's high affinity binding site overlaps with the binding site of a dedicated and ubiquitous Pol I transcription regulator, UBF, suggesting that their binding might interfere with each other if they bind to the same promoter. Knocking-down basonuclin in mouse oocytes eliminated approximately one quarter of RNA polymerase I (Pol I) transcription foci, without affecting the BrU incorporation of the remaining ones, suggesting that basonuclin might regulate a subset of rDNA. Here we show, via chromatin immunoprecipitation (ChIP), that basonuclin is associated with rDNA promoters in HaCaT cells, a spontaneously established human keratinocyte line. Immunoprecipitation data suggest that basonuclin is in a complex that also contains the subunits of Pol I (RPA194, RPA116), but not UBF. Knocking-down basonuclin in HaCaT cells partially impairs the association of RPA194 to rDNA promoter, but not that of UBF. Basonuclin-deficiency also reduces the amount of 47S pre-rRNA, but this effect can be seen only after cell-proliferation related rRNA synthesis has subsided at a higher cell density. DNA sequence of basonuclin-bound rDNA promoters shows single nucleotide polymorphisms (SNPs) that differ from those associated with UBF-bound promoters, suggesting that basonuclin and UBF interact with different subsets of promoters. In conclusion, our results demonstrate basonuclin's functional association with rDNA promoters and its interaction with Pol I in vivo. Our data also suggest that basonuclin-Pol I complex transcribes a subset of rDNA.	[Zhang, Shengliang; Tseng, Hung] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA; [Wang, Junwen] Univ Penn, Dept Genet, Ctr Bioinformat, Philadelphia, PA 19104 USA; [Wang, Junwen] Univ Penn, Dept Comp & Informat Sci, Philadelphia, PA 19104 USA; [Tseng, Hung] Univ Penn, Ctr Res Reprod & Womens Hlth, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Tseng, H (corresponding author), Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA.	htsengpe@mail.med.upenn.edu	Wang, Junwen/C-4432-2009; Wang, Junwen/D-3700-2011	Wang, Junwen/0000-0002-4432-4707	NIH [AG14456]; NATIONAL INSTITUTE ON AGING [R01AG014456] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH grant AG14456 to HT. The funding agency played no role in the design, conduct and report of this study.	BECKMANN H, 1995, SCIENCE, V270, P1506, DOI 10.1126/science.270.5241.1506; BELL SP, 1990, GENE DEV, V4, P943, DOI 10.1101/gad.4.6.943; Bodem J, 2000, EMBO REP, V1, P171, DOI 10.1093/embo-reports/kvd032; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; BROWN DD, 1968, SCIENCE, V160, P272, DOI 10.1126/science.160.3825.272; BUTTGEREIT D, 1985, NUCLEIC ACIDS RES, V13, P8165, DOI 10.1093/nar/13.22.8165; CAVANAUGH AH, 1995, NATURE, V374, P177, DOI 10.1038/374177a0; Ciarmatori S, 2001, MOL CELL BIOL, V21, P5806, DOI 10.1128/MCB.21.17.5806-5814.2001; CONCONI A, 1989, CELL, V57, P753, DOI 10.1016/0092-8674(89)90790-3; COPENHAVER GP, 1994, NUCLEIC ACIDS RES, V22, P2651, DOI 10.1093/nar/22.13.2651; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; DECAPOA A, 1985, HUM GENET, V69, P212, DOI 10.1007/BF00293027; DECAPOA A, 1985, J CELL SCI, V74, P21; DECAPOA A, 1986, HORM METAB RES, V18, P574, DOI 10.1055/s-2007-1012376; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Green H, 2005, MOL B INT U, P207; Grummt I, 2003, NAT REV MOL CELL BIO, V4, P641, DOI 10.1038/nrm1171; HAAF T, 1991, EXP CELL RES, V193, P78, DOI 10.1016/0014-4827(91)90540-B; HALTINER MM, 1986, MOL CELL BIOL, V6, P227, DOI 10.1128/MCB.6.1.227; Hannan KM, 2000, ONCOGENE, V19, P3487, DOI 10.1038/sj.onc.1203690; Hannan KM, 2000, ONCOGENE, V19, P4988, DOI 10.1038/sj.onc.1203875; Iuchi S, 1997, P NATL ACAD SCI USA, V94, P7948, DOI 10.1073/pnas.94.15.7948; Iuchi S, 1999, P NATL ACAD SCI USA, V96, P9628, DOI 10.1073/pnas.96.17.9628; JONES MH, 1988, P NATL ACAD SCI USA, V85, P669, DOI 10.1073/pnas.85.3.669; LEARNED R M, 1982, Journal of Molecular and Applied Genetics, V1, P575; Lin CY, 2002, CURR BIOL, V12, P2142, DOI 10.1016/S0960-9822(02)01389-1; Ma J, 2006, DEVELOPMENT, V133, P2053, DOI 10.1242/dev.02371; Matsuzaki K, 1997, GENE, V195, P87, DOI 10.1016/S0378-1119(97)00176-5; Mayer C, 2005, GENE DEV, V19, P933, DOI 10.1101/gad.333205; MORRIS JF, 1991, ONCOGENE, V6, P2339; O'Sullivan AC, 2002, MOL CELL BIOL, V22, P657, DOI 10.1128/MCB.22.2.657-668.2002; PERKOWSKA E, 1968, NATURE, V217, P649, DOI 10.1038/217649a0; PIKAARD CS, 1990, MOL CELL BIOL, V10, P3810, DOI 10.1128/MCB.10.7.3810; RAUSCHER FJ, 1993, FASEB J, V7, P896, DOI 10.1096/fasebj.7.10.8393820; Russell J, 2005, TRENDS BIOCHEM SCI, V30, P87, DOI 10.1016/j.tibs.2004.12.008; Santoro R, 2001, MOL CELL, V8, P719, DOI 10.1016/S1097-2765(01)00317-3; Stefanovsky VY, 2001, MOL CELL, V8, P1063, DOI 10.1016/S1097-2765(01)00384-7; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tian QJ, 2001, DEVELOPMENT, V128, P407; Tseng H, 1998, Front Biosci, V3, pD985; TSENG H, 1994, J CELL BIOL, V126, P495, DOI 10.1083/jcb.126.2.495; Tseng H, 1999, J CELL SCI, V112, P3039; Tseng H, 2006, BIOESSAYS, V28, P719, DOI 10.1002/bies.20430; VOIT R, 1995, NUCLEIC ACIDS RES, V23, P2593, DOI 10.1093/nar/23.14.2593; Voit R, 1999, EMBO J, V18, P1891, DOI 10.1093/emboj/18.7.1891; Voit R, 1997, MOL CELL BIOL, V17, P4230, DOI 10.1128/MCB.17.8.4230; Voit R, 2001, P NATL ACAD SCI USA, V98, P13631, DOI 10.1073/pnas.231071698; Wang JW, 2006, BIOCHEM BIOPH RES CO, V348, P1261, DOI 10.1016/j.bbrc.2006.07.198; Young DW, 2007, NATURE, V445, P442, DOI 10.1038/nature05473; Yuan XJ, 2005, MOL CELL, V19, P77, DOI 10.1016/j.molcel.2005.05.023; Yuan XJ, 2002, EMBO REP, V3, P1082, DOI 10.1093/embo-reports/kvf212	51	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2007	2	9							e902	10.1371/journal.pone.0000902	http://dx.doi.org/10.1371/journal.pone.0000902			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HS	17878937	Green Submitted, gold, Green Published			2022-12-25	WOS:000207455700010
J	Montero-Conde, C; Martin-Campos, JM; Lerma, E; Gimenez, G; Martinez-Guitarte, JL; Combalia, N; Montaner, D; Matias-Guiu, X; Dopazo, J; de Leiva, A; Robledo, M; Mauricio, D				Montero-Conde, C.; Martin-Campos, J. M.; Lerma, E.; Gimenez, G.; Martinez-Guitarte, J. L.; Combalia, N.; Montaner, D.; Matias-Guiu, X.; Dopazo, J.; de Leiva, A.; Robledo, M.; Mauricio, D.			Molecular profiling related to poor prognosis in thyroid carcinoma. Combining gene expression data and biological information	ONCOGENE			English	Article						anaplastic thyroid cancer; functional profile; molecular signature	DIFFUSE SCLEROSING VARIANT; DIFFERENTIATED CARCINOMAS; MESENCHYMAL TRANSITION; PAPILLARY CARCINOMA; MICROARRAY DATA; BREAST-CANCER; TGF-BETA; METASTASIS; OVEREXPRESSION; CONTRIBUTES	Undifferentiated and poorly differentiated thyroid tumors are responsible for more than half of thyroid cancer patient deaths in spite of their low incidence. Conventional treatments do not obtain substantial benefits, and the lack of alternative approaches limits patient survival. Additionally, the absence of prognostic markers for well-differentiated tumors complicates patient-specific treatments and favors the progression of recurrent forms. In order to recognize the molecular basis involved in tumor dedifferentiation and identify potential markers for thyroid cancer prognosis prediction, we analysed the expression profile of 44 thyroid primary tumors with different degrees of dedifferentiation and aggressiveness using cDNA microarrays. Transcriptome comparison of dedifferentiated and well-differentiated thyroid tumors identified 1031 genes with > 2-fold difference in absolute values and false discovery rate of <0.15. According to known molecular interaction and reaction networks, the products of these genes were mainly clustered in the MAPkinase signaling pathway, the TGF-beta signaling pathway, focal adhesion and cell motility, activation of actin polymerization and cell cycle. An exhaustive search in several databases allowed us to identify various members of the matrix metalloproteinase, melanoma antigen A and collagen gene families within the upregulated gene set. We also identified a prognosis classifier comprising just 30 transcripts with an overall accuracy of 95%. These findings may clarify the molecular mechanisms involved in thyroid tumor dedifferentiation and provide a potential prognosis predictor as well as targets for new therapies.	[Montero-Conde, C.; Robledo, M.] Spanish Natl Canc Ctr, Hereditary Endocrine Canc Grp Leader, CNIO, E-28029 Madrid, Spain; [Mauricio, D.] Arnau Vilanova Hosp, Dept Endocrinol, IRBLLEIDA, E-25198 Lleida, Spain; [Martin-Campos, J. M.] Santa Creu & Sant Pau Hosp, Res Inst, Barcelona, Spain; [Martin-Campos, J. M.] Univ Autonoma Barcelona, Biochem & Mol Biol Dept, Barcelona, Spain; [Lerma, E.] Santa Creu & Sant Pau Hosp, Pathol Serv, Barcelona, Spain; [Martinez-Guitarte, J. L.; Matias-Guiu, X.] Arnau Vilanova Hosp, IRBLLEIDA, Dept Pathol & Mol Genet, Lleida, Spain; [Montaner, D.; Dopazo, J.] CIPF, Bioinformat Dept, Valencia, Spain; [Dopazo, J.; Robledo, M.] CIBERER, Ctr Biomed Res Rare Dis, ISCIII, Lleida, Spain; [de Leiva, A.; Mauricio, D.] Santa Creu & Sant Pau Hosp, Dept Endocrinol & Nutr, Barcelona, Spain; [de Leiva, A.] CIBER, BBN, ISCIII, Lleida, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); University Hospital Arnau de Vilanova; Autonomous University of Barcelona; Institut de Recerca Biomedica - IRB Lleida; University Hospital Arnau de Vilanova; Prince Felipe Research Center; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Instituto de Salud Carlos III	Robledo, M (corresponding author), Spanish Natl Canc Ctr, Hereditary Endocrine Canc Grp Leader, CNIO, Melchor Fernandez Almagro 3, E-28029 Madrid, Spain.	mrobledo@cnio.es	Montero-Conde, Cristina/K-7349-2014; Mauricio, Didac/B-7951-2009; Dopazo, Joaquin/A-9270-2014; matias-guiu, xavier/C-3039-2009; Martín-Campos, Jesús Maria/AGJ-2586-2022; Martinez-Guitarte, Jose-Luis/M-3990-2014; Lerma, Enrique/C-8498-2015; Robledo, Mercedes/O-2230-2013; Martín-Campos, Jesús M./AAQ-5478-2021; Montaner, David/A-9362-2014	Montero-Conde, Cristina/0000-0002-4452-4469; Mauricio, Didac/0000-0002-2868-0250; Dopazo, Joaquin/0000-0003-3318-120X; matias-guiu, xavier/0000-0002-7201-6605; Martín-Campos, Jesús Maria/0000-0003-0414-037X; Martinez-Guitarte, Jose-Luis/0000-0002-7722-864X; Robledo, Mercedes/0000-0001-6256-5902; de Leiva, Alberto/0000-0002-0419-6771; Montaner, David/0000-0002-2484-3278				Ain KB, 1999, SEMIN SURG ONCOL, V16, P64, DOI 10.1002/(SICI)1098-2388(199901/02)16:1<64::AID-SSU10>3.3.CO;2-L; Al-Shahrour F, 2006, NUCLEIC ACIDS RES, V34, pW472, DOI 10.1093/nar/gkl172; Alonso SR, 2007, CANCER RES, V67, P3450, DOI 10.1158/0008-5472.CAN-06-3481; Ambroise C, 2002, P NATL ACAD SCI USA, V99, P6562, DOI 10.1073/pnas.102102699; Benjamini Y, 2005, GENETICS, V171, P783, DOI 10.1534/genetics.104.036699; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Burgdorf SK, 2006, J EXP CLIN CANC RES, V25, P201; Chambers AF, 1997, J NATL CANCER I, V89, P1260, DOI 10.1093/jnci/89.17.1260; Croizet-Berger K, 2002, P NATL ACAD SCI USA, V99, P8277, DOI 10.1073/pnas.122187699; DELELLIS RA, 2004, WHO TUMORS ENDOCRINE; Duan ZF, 2003, CLIN CANCER RES, V9, P2778; FUJIMOTO Y, 1990, CANCER-AM CANCER SOC, V66, P2306, DOI 10.1002/1097-0142(19901201)66:11<2306::AID-CNCR2820661109>3.0.CO;2-P; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Glinsky GV, 2006, CELL CYCLE, V5, P1208, DOI 10.4161/cc.5.11.2796; Grunert S, 2003, NAT REV MOL CELL BIO, V4, P657, DOI 10.1038/nrm1175; Herrero J, 2001, BIOINFORMATICS, V17, P126, DOI 10.1093/bioinformatics/17.2.126; Huang E, 2003, LANCET, V361, P1590, DOI 10.1016/S0140-6736(03)13308-9; Lam AKY, 2006, ANN SURG ONCOL, V13, P176, DOI 10.1245/ASO.2006.03.062; Medina I, 2007, BIOINFORMATICS, V23, P390, DOI 10.1093/bioinformatics/btl602; Montaner D, 2006, NUCLEIC ACIDS RES, V34, pW486, DOI 10.1093/nar/gkl197; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Motti ML, 2005, CARCINOGENESIS, V26, P1021, DOI 10.1093/carcin/bgi050; Nikiforova MN, 2003, J CLIN ENDOCR METAB, V88, P5399, DOI 10.1210/jc.2003-030838; Onda M, 2004, ENDOCR-RELAT CANCER, V11, P843, DOI 10.1677/erc.1.00818; Pallante P, 2005, BRIT J CANCER, V93, P464, DOI 10.1038/sj.bjc.6602721; Randolph GW, 2002, THYROID, V12, P989, DOI 10.1089/105072502320908321; Rocha AS, 2003, HISTOPATHOLOGY, V42, P580, DOI 10.1046/j.1365-2559.2003.01642.x; SAKAMOTO A, 1983, CANCER, V52, P1849, DOI 10.1002/1097-0142(19831115)52:10<1849::AID-CNCR2820521015>3.0.CO;2-X; Sherman-Baust CA, 2003, CANCER CELL, V3, P377, DOI 10.1016/S1535-6108(03)00058-8; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Slettenaar VIF, 2006, ADV DRUG DELIVER REV, V58, P962, DOI 10.1016/j.addr.2006.03.012; Smith BR, 2006, THYROID, V16, P109, DOI 10.1089/thy.2006.16.109; Sobrinho-Simoes M, 2002, INT J SURG PATHOL, V10, P123, DOI 10.1177/106689690201000205; Sorrentino R, 2005, J CLIN ENDOCR METAB, V90, P928, DOI 10.1210/jc.2004-1518; Tang L, 2006, CLIN CANCER RES, V12, P3716, DOI 10.1158/1078-0432.CCR-06-0030; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Vasko V, 2007, P NATL ACAD SCI USA, V104, P2803, DOI 10.1073/pnas.0610733104; Vini L, 2002, LANCET ONCOL, V3, P407, DOI 10.1016/S1470-2045(02)00787-8; Voigt C, 2000, FEBS LETT, V486, P208, DOI 10.1016/S0014-5793(00)02302-4; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zou M, 2005, BRIT J CANCER, V93, P1277, DOI 10.1038/sj.bjc.6602856	43	67	76	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 6	2008	27	11					1554	1561		10.1038/sj.onc.1210792	http://dx.doi.org/10.1038/sj.onc.1210792			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	271VC	17873908				2022-12-25	WOS:000253815800007
J	Autio, KJ; Kastaniotis, AJ; Pospiech, H; Miinalainen, IJ; Schonauer, MS; Dieckmann, CL; Hiltunen, JK				Autio, Kaija J.; Kastaniotis, Alexander J.; Pospiech, Helmut; Miinalainen, Ilkka J.; Schonauer, Melissa S.; Dieckmann, Carol L.; Hiltunen, J. Kalervo			An ancient genetic link between vertebrate mitochondrial fatty acid synthesis and RNA processing	FASEB JOURNAL			English	Article						HsHTD2; RNase P	ACYL CARRIER PROTEIN; PEROXISOMAL MULTIFUNCTIONAL ENZYME; CELLULAR MESSENGER-RNA; HUMAN RIBONUCLEASE-P; SACCHAROMYCES-CEREVISIAE; INTERNAL INITIATION; ESCHERICHIA-COLI; YEAST; SUBUNITS; BIOSYNTHESIS	In bacteria, functionally related gene products are often encoded by a common transcript. Such polycistronic transcripts are rare in eukaryotes. Here we isolated several clones from human cDNA libraries, which rescued the respiratory-deficient phenotype of a yeast mitochondrial 3-hydroxyacyl thioester dehydratase 2 (htd2) mutant strain. All complementing cDNAs were derived from the RPP14 transcript previously described to encode the RPP14 subunit of the human ribonuclease P (RNase P) complex. We identified a second, 3' open reading frame (ORF) on the RPP14 transcript encoding a protein showing similarity to known dehydratases and hydratase 2 enzymes. The protein was localized in mitochondria, and the recombinant enzyme exhibited (3R)-specific hydratase 2 activity. Based on our results, we named the protein human 3-hydroxyacyl-thioester dehydratase 2 (HsHTD2), which is involved in mitochondrial fatty acid synthesis. The bicistronic arrangement of RPP14 and HsHTD2, as well as the general exon structure of the gene, is conserved in vertebrates from fish to humans, indicating a genetic link conserved for 400 million years between RNA processing and mitochondrial fatty acid synthesis.	[Autio, Kaija J.; Kastaniotis, Alexander J.; Pospiech, Helmut; Miinalainen, Ilkka J.; Hiltunen, J. Kalervo] Univ Oulu, Dept Biochem, FIN-90014 Oulu, Finland; [Autio, Kaija J.; Kastaniotis, Alexander J.; Pospiech, Helmut; Miinalainen, Ilkka J.; Hiltunen, J. Kalervo] Univ Oulu, Bioctr, Oulu, Finland; [Schonauer, Melissa S.; Dieckmann, Carol L.] Univ Arizona, Dept Biochem & Mol Biophys, Tucson, AZ USA; [Schonauer, Melissa S.; Dieckmann, Carol L.] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA	Finland National Institute for Health & Welfare; University of Oulu; University of Oulu; University of Arizona; University of Arizona	Hiltunen, JK (corresponding author), Univ Oulu, Dept Biochem, FIN-90014 Oulu, Finland.	kalervo.hiltunen@oulu.fi	Pospiech, Helmut/J-8598-2015	Autio, Kaija/0000-0001-9398-7649; Miinalainen, Ilkka/0000-0002-3922-3442; Kastaniotis, Alexander/0000-0003-3624-9214; Hiltunen, Kalervo/0000-0002-3073-9602				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Blumenthal Thomas, 2004, Briefings in Functional Genomics & Proteomics, V3, P199, DOI 10.1093/bfgp/3.3.199; Brody S, 1997, FEBS LETT, V408, P217, DOI 10.1016/S0014-5793(97)00428-6; CHEN DC, 1992, CURR GENET, V21, P83, DOI 10.1007/BF00318659; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Davis RE, 1997, MOL BIOCHEM PARASIT, V89, P25, DOI 10.1016/S0166-6851(97)00097-2; Felsenstein J, 2006, MOL BIOL EVOL, V23, P691, DOI 10.1093/molbev/msj079; FILPPULA SA, 1995, J BIOL CHEM, V270, P27453, DOI 10.1074/jbc.270.46.27453; FITCH WALTER M., 1967, BIOCHEM GENET, V1, P65, DOI 10.1007/BF00487738; Fukui T, 1997, J BACTERIOL, V179, P4821, DOI 10.1128/jb.179.15.4821-4830.1997; Ganot P, 2004, MOL CELL BIOL, V24, P7795, DOI 10.1128/MCB.24.17.7795-7805.2004; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Gray TA, 1999, P NATL ACAD SCI USA, V96, P5616, DOI 10.1073/pnas.96.10.5616; Hampsey M, 2006, NAT STRUCT MOL BIOL, V13, P564, DOI 10.1038/nsmb0706-564; Heath RJ, 1996, J BIOL CHEM, V271, P27795, DOI 10.1074/jbc.271.44.27795; Hiltunen JK, 2005, BIOCHEM SOC T, V33, P1162, DOI 10.1042/BST0331162; HILTUNEN JK, 1989, J BIOL CHEM, V264, P13536; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; Jarrous N, 1999, J CELL BIOL, V146, P559, DOI 10.1083/jcb.146.3.559; Jarrous N, 2002, RNA, V8, P1, DOI 10.1017/S1355838202011184; Jarrous N, 1999, RNA, V5, P153, DOI 10.1017/S135583829800185X; Kastaniotis AJ, 2004, MOL MICROBIOL, V53, P1407, DOI 10.1111/j.1365-2958.2004.04191.x; Koski MK, 2004, J BIOL CHEM, V279, P24666, DOI 10.1074/jbc.M400293200; Kozak M, 2005, NUCLEIC ACIDS RES, V33, P6593, DOI 10.1093/nar/gki958; LEE SJ, 1991, P NATL ACAD SCI USA, V88, P4250, DOI 10.1073/pnas.88.10.4250; MACEJAK DG, 1991, NATURE, V353, P90, DOI 10.1038/353090a0; Miinalainen IJ, 2003, J BIOL CHEM, V278, P20154, DOI 10.1074/jbc.M302851200; Park SJ, 2003, J BACTERIOL, V185, P5391, DOI 10.1128/JB.185.18.5391-5397.2003; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; Porras P, 2006, J BIOL CHEM, V281, P16551, DOI 10.1074/jbc.M600790200; Puranam RS, 2001, MOL CELL BIOL, V21, P548, DOI 10.1128/MCB.21.2.548-561.2001; Qin YM, 1999, J BIOL CHEM, V274, P28619, DOI 10.1074/jbc.274.40.28619; Qin YM, 2000, J BIOL CHEM, V275, P4965, DOI 10.1074/jbc.275.7.4965; Reiss J, 1999, AM J HUM GENET, V64, P706, DOI 10.1086/302296; Rosenblad MA, 2006, NUCLEIC ACIDS RES, V34, P5145, DOI 10.1093/nar/gkl626; ROSSMANITH W, 1995, J BIOL CHEM, V270, P12885, DOI 10.1074/jbc.270.21.12885; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SPIETH J, 1993, CELL, V73, P521, DOI 10.1016/0092-8674(93)90139-H; Stuible HP, 1998, J BIOL CHEM, V273, P22334, DOI 10.1074/jbc.273.35.22334; SUGINO H, 1992, J BACTERIOL, V174, P2485, DOI 10.1128/jb.174.8.2485-2492.1992; SULO P, 1993, J BIOL CHEM, V268, P17634; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wada H, 1997, P NATL ACAD SCI USA, V94, P1591, DOI 10.1073/pnas.94.4.1591; Xiao SH, 2002, ANNU REV BIOCHEM, V71, P165, DOI 10.1146/annurev.biochem.71.110601.135352; Zhang L, 2005, J BIOL CHEM, V280, P12422, DOI 10.1074/jbc.M413686200; Zhang L, 2003, J BIOL CHEM, V278, P40067, DOI 10.1074/jbc.M306121200; Zhang NS, 2003, GENE, V303, P121, DOI 10.1016/S0378-1119(02)01142-3	48	43	46	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	FEB	2008	22	2					569	578		10.1096/fj.07-8986	http://dx.doi.org/10.1096/fj.07-8986			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	257TY	17898086				2022-12-25	WOS:000252822600027
J	Zou, L; Yang, RX; Chai, JJ; Pei, G				Zou, Lin; Yang, Rongxi; Chai, Jingjing; Pei, Gang			Rapid xenograft tumor progression in beta-arrestin1 transgenic mice due to enhanced tumor angiogenesis	FASEB JOURNAL			English	Article						matrix metalloproteinase 9; MMP9; vascular endothelial growth factor; VEGF; phosphatidylinositol 3-kinase; PI3K	ARRESTIN-DEPENDENT ENDOCYTOSIS; PROTEASE-ACTIVATED RECEPTOR-2; GROWTH-FACTOR VEGF; BETA-ARRESTIN; MATRIX METALLOPROTEINASES; PHOSPHATIDYLINOSITOL 3-KINASE; OVARIAN-CARCINOMA; CANCER-THERAPY; GELATINASE-B; CELL-LINE	beta-arrestins (beta-Arrs) are known to be associated with tumor signaling pathways such as transforming growth factor-beta 1 (TGF-beta 1), P53/Murine double minute (MDM2) and NF-kappa B. To investigate the role of beta-Arr in tumor progression in vivo, we generated beta-Arr transgenic mice by subcutaneously inoculating tumor cells in them. We found that the xenograft tumor initiated earlier and grew more rapidly in beta-Arr1 transgenic mice than in both the beta-Arr2 transgenic and wild-type mice after inoculating murine liver cancer Hepa1-6 cells or lymphoma EL4 cells. Moreover, matrix metalloproteinase 9 (MMP9) activity, vascular endothelial growth factor ( VEGF) concentration in plasma and new small blood vessel formation in tumor tissues were enhanced in beta-Arr1 transgenic mice compared with those in control mice. In addition, injection of MMP9 inhibitors in beta-Arr1 transgenic mice abrogated all these effects and suppressed rapid tumor progression. Similar results were observed in human microvascular endothelial cells, where overexpressed beta-Arr1 did increase MMP9 activity and small blood vessel formation. Furthermore, phosphatidylinositol 3-kinase (PI3K) inhibitors could suppress beta-Arr1-enhanced MMP9 activity and the C-terminal 181-418 amino acids (aa) of beta-Arr1 was largely responsible for this effect. Our data reveal a functional role for beta-arrestin1 in tumor progression in vivo, in which overexpression of beta-Arr1 promotes MMP9 activity and tumor angiogenesis by providing a suitable microenvironment for tumor progression.	[Zou, Lin; Yang, Rongxi; Chai, Jingjing; Pei, Gang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, Shanghai 200031, Peoples R China; [Yang, Rongxi] Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China; [Zou, Lin] Chongqing Univ Med Sci, Childrens Hosp, Clin Mol Med Ctr, Chongqing, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Chongqing Medical University	Pei, G (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, Shanghai 200031, Peoples R China.	gpei@sibs.ac.cn	Xiao, Yang/B-5668-2012					ABECASSIS I, 2003, EXP CELL ERS, V291, P393; Belotti D, 2003, CANCER RES, V63, P5224; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Boudreau N, 1998, CURR OPIN CELL BIOL, V10, P640, DOI 10.1016/S0955-0674(98)80040-9; Bryja V, 2007, P NATL ACAD SCI USA, V104, P6690, DOI 10.1073/pnas.0611356104; Buchanan FG, 2006, P NATL ACAD SCI USA, V103, P1492, DOI 10.1073/pnas.0510562103; Byrne AM, 2005, J CELL MOL MED, V9, P777, DOI 10.1111/j.1582-4934.2005.tb00379.x; Carmeliet P, 2005, ONCOLOGY-BASEL, V69, P4, DOI 10.1159/000088478; Chen W, 2003, SCIENCE, V301, P1394, DOI 10.1126/science.1083195; Choi JH, 2006, CANCER RES, V66, P3912, DOI 10.1158/0008-5472.CAN-05-1785; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; Dery O, 1999, J BIOL CHEM, V274, P18524, DOI 10.1074/jbc.274.26.18524; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Dranoff G, 2004, NAT REV CANCER, V4, P11, DOI 10.1038/nrc1252; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; FIDLER IJ, 1995, J NATL CANCER I, V87, P1588, DOI 10.1093/jnci/87.21.1588; Fridman R, 2003, CANCER METAST REV, V22, P153, DOI 10.1023/A:1023091214123; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Girnita L, 2007, J BIOL CHEM, V282, P11329, DOI 10.1074/jbc.M611526200; Grimm CF, 2000, GASTROENTEROLOGY, V119, P1104, DOI 10.1053/gast.2000.18157; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hayward SW, 1998, INT J ONCOL, V13, P35; Huang SY, 2002, J NATL CANCER I, V94, P1134; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; Klein G, 2004, CRIT REV ONCOL HEMAT, V50, P87, DOI 10.1016/j.critevonc.2003.09.001; Ko HM, 2005, FEBS LETT, V579, P6451, DOI 10.1016/j.febslet.2005.10.027; Kroger A, 2001, CANCER RES, V61, P2609; Lefkowitz RJ, 2004, CURR OPIN CELL BIOL, V16, P162, DOI 10.1016/j.ceb.2004.01.001; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Ma YH, 2000, CELL RES, V10, P303, DOI 10.1038/sj.cr.7290057; Morris DR, 2006, CANCER RES, V66, P307, DOI 10.1158/0008-5472.CAN-05-1735; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; PAGET S, 1989, CANCER METAST REV, V8, P98; POVISC TJ, 2003, J BIOL CHEM, V278, P51334; Revankar CM, 2004, J BIOL CHEM, V279, P24578, DOI 10.1074/jbc.M402121200; Shenoy S.K., 2005, SCI STKE, V2005, pcm10; Sun Y, 2002, J BIOL CHEM, V277, P49212, DOI 10.1074/jbc.M207294200; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Wang B, 2003, CANCER CELL, V4, P19, DOI 10.1016/S1535-6108(03)00164-8; Wang P, 2003, J BIOL CHEM, V278, P11648, DOI 10.1074/jbc.M208109200; Wang P, 2003, J BIOL CHEM, V278, P6363, DOI 10.1074/jbc.M210350200; Wang P, 2006, BIOCHEMISTRY-US, V45, P9374, DOI 10.1021/bi0602617; Wang YY, 2006, NAT IMMUNOL, V7, P139, DOI 10.1038/ni1294	45	35	42	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2008	22	2					355	364		10.1096/fj.07-9046com	http://dx.doi.org/10.1096/fj.07-9046com			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	257TY	17890288				2022-12-25	WOS:000252822600005
J	Culyba, MJ; Minkah, N; Hwang, Y; Benhamou, OMJ; Bushman, FD				Culyba, Matthew J.; Minkah, Nana; Hwang, Young; Benhamou, Ori-Michael J.; Bushman, Frederic D.			DNA branch nuclease activity of vaccinia A22 resolvase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOLLIDAY JUNCTION RESOLVASE; CRYSTAL-STRUCTURE; VIRUS-DNA; HIV-1 INTEGRASE; SLICER ACTIVITY; VIRAL-DNA; IN-VITRO; L-CELLS; REPLICATION; ENDONUCLEASE	DNA replication, recombination, and repair can result in formation of diverse branched DNA structures. Many large DNA viruses are known to encode DNA branch nucleases, but several of the expected activities have not previously been found among poxvirus enzymes. Vaccinia encodes an enzyme, A22 resolvase, which is known to be active on four-stranded DNA junctions (Holliday junctions) or Holliday junction-like structures containing three of the four strands. Here we report that A22 resolvase in fact has a much wider substrate specificity than previously appreciated. A22 resolvase cleaves Y-junctions, single-stranded DNA flaps, transitions from double strands to unpaired single strands ("splayed duplexes"), and DNA bulges in vitro. We also report site-directed mutagenesis studies of candidate active site residues. The results identify the likely active site and support a model in which a single active site is responsible for cleavage on Holliday junctions and splayed duplexes. Lastly, we describe possible roles for the A22 resolvase DNA-branch nuclease activity in DNA replication and repair.	Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA	University of Pennsylvania	Bushman, FD (corresponding author), Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.	bushman@mail.med.upenn.edu		Bushman, Frederic/0000-0003-4740-4056	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057168, T32AI007324] Funding Source: NIH RePORTER; NIAID NIH HHS [T32 AI 07324, U54 AI057168] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BAROUDY BM, 1982, CELL, V28, P315, DOI 10.1016/0092-8674(82)90349-X; Ceschini S, 2001, EMBO J, V20, P6601, DOI 10.1093/emboj/20.23.6601; CONNOLLY B, 1991, P NATL ACAD SCI USA, V88, P6063, DOI 10.1073/pnas.88.14.6063; Culyba MJ, 2006, VIROLOGY, V352, P466, DOI 10.1016/j.virol.2006.05.007; DAVIES JF, 1991, SCIENCE, V252, P88, DOI 10.1126/science.1707186; Diamond TL, 2006, NUCLEIC ACIDS RES, V34, P6116, DOI 10.1093/nar/gkl862; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; ESTEBAN M, 1977, VIROLOGY, V83, P467, DOI 10.1016/0042-6822(77)90197-0; ESTEBAN M, 1977, VIROLOGY, V78, P57, DOI 10.1016/0042-6822(77)90078-2; ESTEBAN M, 1977, VIROLOGY, V82, P163, DOI 10.1016/0042-6822(77)90040-X; Gao K, 2004, J VIROL, V78, P6715, DOI 10.1128/JVI.78.13.6715-6722.2004; Garcia AD, 2000, P NATL ACAD SCI USA, V97, P8926, DOI 10.1073/pnas.150238697; Garcia AD, 2006, J BIOL CHEM, V281, P11618, DOI 10.1074/jbc.M600182200; Garcia AD, 2001, J VIROL, V75, P6460, DOI 10.1128/JVI.75.14.6460-6471.2001; Grinsztejn B, 2007, LANCET, V369, P1261, DOI 10.1016/S0140-6736(07)60597-2; Hamilton MD, 2007, NUCLEIC ACIDS RES, V35, P143, DOI 10.1093/nar/gkl1015; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; IWASAKI H, 1991, EMBO J, V10, P4381, DOI 10.1002/j.1460-2075.1991.tb05016.x; KLEFF S, 1992, EMBO J, V11, P699, DOI 10.1002/j.1460-2075.1992.tb05102.x; Kreuzer KN, 2000, TRENDS BIOCHEM SCI, V25, P165, DOI 10.1016/S0968-0004(00)01559-0; Lilley DMJ, 2000, P NATL ACAD SCI USA, V97, P9351, DOI 10.1073/pnas.97.17.9351; Maxam A M, 1980, Methods Enzymol, V65, P499; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; MERCHLINSKY M, 1988, J MOL BIOL, V199, P399, DOI 10.1016/0022-2836(88)90613-4; MIZUUCHI K, 1982, CELL, V29, P357, DOI 10.1016/0092-8674(82)90152-0; Moss B, 2001, VIROLOGY, P2637; MOYER RW, 1981, CELL, V27, P391, DOI 10.1016/0092-8674(81)90422-0; Parker JS, 2004, EMBO J, V23, P4727, DOI 10.1038/sj.emboj.7600488; PENNINGTON TH, 1974, J VIROL, V13, P488, DOI 10.1128/JVI.13.2.488-493.1974; POGO BGT, 1978, VIROLOGY, V84, P1, DOI 10.1016/0042-6822(78)90213-1; PRESCOTT DM, 1971, J MOL BIOL, V59, P505, DOI 10.1016/0022-2836(71)90313-5; Rice P, 1996, CURR OPIN STRUC BIOL, V6, P76, DOI 10.1016/S0959-440X(96)80098-4; SAITO A, 1995, P NATL ACAD SCI USA, V92, P7470, DOI 10.1073/pnas.92.16.7470; Schofield MJ, 1998, BIOCHEMISTRY-US, V37, P7733, DOI 10.1021/bi980399s; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sharples GJ, 2001, MOL MICROBIOL, V39, P823, DOI 10.1046/j.1365-2958.2001.02284.x; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Wardleworth BN, 2000, J BIOL CHEM, V275, P23725, DOI 10.1074/jbc.M002612200; YANG W, 1995, STRUCTURE, V3, P131, DOI 10.1016/S0969-2126(01)00142-3; Yang ZN, 2000, J MOL BIOL, V296, P535, DOI 10.1006/jmbi.1999.3463; Yao XD, 2001, J VIROL, V75, P6923, DOI 10.1128/JVI.75.15.6923-6932.2001	41	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34644	34652		10.1074/jbc.M705322200	http://dx.doi.org/10.1074/jbc.M705322200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17890227	Green Published, hybrid			2022-12-25	WOS:000251155200006
J	Zhang, T; Kohlhaas, M; Backs, J; Mishra, S; Phillips, W; Dybkova, N; Chang, S; Ling, H; Bers, DM; Maier, LS; Olson, EN; Brown, JH				Zhang, Tong; Kohlhaas, Michael; Backs, Johannes; Mishra, Shikha; Phillips, William; Dybkova, Nataliya; Chang, Shurong; Ling, Haiyun; Bers, Donald M.; Maier, Lars S.; Olson, Eric N.; Brown, Joan Heller			CaMKII delta isoforms differentially affect calcium handling but similarly regulate HDAC/MEF2 transcriptional responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-II; CARDIAC RYANODINE RECEPTOR; FACTOR GENE-EXPRESSION; HEART-FAILURE; SARCOPLASMIC-RETICULUM; TRANSGENIC MICE; DILATED CARDIOMYOPATHY; HISTONE DEACETYLASE-4; NUCLEAR CALCIUM; RELEASE CHANNEL	The delta(B) and delta(C) splice variants of Ca2+ /calmodulin-dependent protein kinase II (CaMKII), which differ by the presence of a nuclear localization sequence, are both expressed in cardiomyocytes. We used transgenic (TG) mice and CaMKII expression in cardiomyocytes to test the hypothesis that the CaMKII delta(C) isoform regulates cytosolic Ca2+ handling and the delta(B) isoform, which localizes to the nucleus, regulates gene transcription. Phosphorylation of CaMKII sites on the ryanodine receptor (RyR) and on phospholamban (PLB) were increased in CaMKII delta(C) TG. This was associated with markedly enhanced sarcoplasmic reticulum (SR) Ca2+ spark frequency and decreased SR Ca2+ content in cardiomyocytes. None of these parameters were altered in TG mice expressing the nuclear-targeted CaMKII delta(B). In contrast, cardiac expression of either CaMKII delta(B) or delta(C) induced transactivation of myocyte enhancer factor 2 (MEF2) gene expression and up-regulated hypertrophic marker genes. Studies using rat ventricular cardiomyocytes confirmed that CaMKII delta(B) and delta(C) both regulate MEF2-luciferase gene expression, increase histone deacetylase 4 (HDAC4) association with 14-3-3, and induce HDAC4 translocation from nucleus to cytoplasm, indicating that either isoform can stimulate HDAC4 phosphorylation. Finally, HDAC4 kinase activity was shown to be increased in cardiac homogenates from either CaMKII delta(B) or delta(C) TG mice. Thus CaMKII delta isoforms have similar effects on hypertrophic gene expression but disparate effects on Ca2+ handling, suggesting distinct roles for CaMKII delta isoform activation in the pathogenesis of cardiac hypertrophy versus heart failure.	Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; Univ Gottingen, Abt Kardiol, D-37075 Gottingen, Germany; Univ Gottingen, Pneumol Herzzentrum, D-37075 Gottingen, Germany; Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; Loyola Univ Chicago, Dept Physiol, Maywood, IL 60153 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Gottingen; University of Gottingen; University of Texas System; University of Texas Southwestern Medical Center Dallas; Loyola University Chicago	Brown, JH (corresponding author), Univ Calif San Diego, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jhbrown@ucsd.edu	Maier, Lars/AAQ-8313-2021; Bers, Donald M/C-4507-2012	Maier, Lars/0000-0001-9915-4429; Bers, Donald/0000-0002-2237-9483	NHLBI NIH HHS [HL46345, HL80101] Funding Source: Medline; NIGMS NIH HHS [GM007752, T32 GM007752] Funding Source: Medline; NINDS NIH HHS [NS047101] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL080101, P01HL046345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams JW, 1998, P NATL ACAD SCI USA, V95, P10140, DOI 10.1073/pnas.95.17.10140; Ai X, 2005, CIRC RES, V97, P1314, DOI 10.1161/01.RES.0000194329.41863.89; Backs J, 2006, J CLIN INVEST, V116, P1853, DOI 10.1172/JCI27438; Badminton MN, 1998, CELL CALCIUM, V23, P79, DOI 10.1016/S0143-4160(98)90105-1; BALTAS LG, 1995, FEBS LETT, V373, P71, DOI 10.1016/0014-5793(95)00981-E; Bare DJ, 2005, J BIOL CHEM, V280, P15912, DOI 10.1074/jbc.M414212200; BASSANI RA, 1995, AM J PHYSIOL-HEART C, V268, pH703, DOI 10.1152/ajpheart.1995.268.2.H703; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Colomer JM, 2000, MOL ENDOCRINOL, V14, P1125, DOI 10.1210/me.14.8.1125; Colomer JM, 2003, MOL ENDOCRINOL, V17, P183, DOI 10.1210/me.2002-0350; Davis FJ, 2003, J BIOL CHEM, V278, P20047, DOI 10.1074/jbc.M209998200; EDMAN CF, 1994, BBA-MOL CELL RES, V1221, P89, DOI 10.1016/0167-4889(94)90221-6; GRUVER CL, 1993, ENDOCRINOLOGY, V133, P376, DOI 10.1210/en.133.1.376; HAIN J, 1995, J BIOL CHEM, V270, P2074, DOI 10.1074/jbc.270.5.2074; Heist EK, 1998, CELL CALCIUM, V23, P103; KANASEKI T, 1991, J CELL BIOL, V115, P1049, DOI 10.1083/jcb.115.4.1049; Karczewski P, 1997, BASIC RES CARDIOL, V92, P37, DOI 10.1007/BF00794066; Kohlhaas M, 2006, CIRC RES, V98, P235, DOI 10.1161/01.RES.0000200739.90811.9f; Kolodziejczyk SM, 1999, CURR BIOL, V9, P1203, DOI 10.1016/S0960-9822(00)80027-5; Little GH, 2007, J BIOL CHEM, V282, P7219, DOI 10.1074/jbc.M604281200; Lu JR, 2000, P NATL ACAD SCI USA, V97, P4070, DOI 10.1073/pnas.080064097; Maier LS, 2003, CIRC RES, V92, P904, DOI 10.1161/01.RES.0000069685.20258.F1; Maier LS, 2002, J MOL CELL CARDIOL, V34, P919, DOI 10.1006/jmcc.2002.2038; Malviya AN, 1998, CELL, V92, P17, DOI 10.1016/S0092-8674(00)80895-8; Marks AR, 2001, J MOL CELL CARDIOL, V33, P615, DOI 10.1006/jmcc.2000.1343; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Mattiazzi A, 2005, CARDIOVASC RES, V68, P366, DOI 10.1016/j.cardiores.2005.08.010; MAYER P, 1995, BASIC RES CARDIOL, V90, P372, DOI 10.1007/BF00788498; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; MIYANO O, 1992, J BIOL CHEM, V267, P1198; Naya FJ, 1999, DEVELOPMENT, V126, P2045; Nelson TJ, 2005, J MOL CELL CARDIOL, V39, P479, DOI 10.1016/j.yjmcc.2005.05.004; Passier R, 2000, J CLIN INVEST, V105, P1395, DOI 10.1172/JCI8551; RAMIREZ MT, 1995, J BIOL CHEM, V270, P8446, DOI 10.1074/jbc.270.15.8446; Ramirez MT, 1997, J BIOL CHEM, V272, P31203, DOI 10.1074/jbc.272.49.31203; SRINIVASAN M, 1994, J CELL BIOL, V126, P839, DOI 10.1083/jcb.126.4.839; Wehrens XHT, 2005, ANNU REV PHYSIOL, V67, P69, DOI 10.1146/annurev.physiol.67.040403.114521; Wehrens XHT, 2004, CIRC RES, V94, pE61, DOI 10.1161/01.RES.0000125626.33738.E2; WITCHER DR, 1991, J BIOL CHEM, V266, P11144; Wu X, 2006, J CLIN INVEST, V116, P675, DOI 10.1172/JCI27374; Xu J, 2006, J BIOL CHEM, V281, P9152, DOI 10.1074/jbc.M510217200; Yano M, 2000, CIRCULATION, V102, P2131, DOI 10.1161/01.CIR.102.17.2131; Yano M, 2005, PHARMACOL THERAPEUT, V107, P377, DOI 10.1016/j.pharmthera.2005.04.003; Youn HD, 2000, J BIOL CHEM, V275, P22563, DOI 10.1074/jbc.C000304200; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhang T, 2003, CIRC RES, V92, P912, DOI 10.1161/01.RES.0000069686.31472.C5; Zhang T, 2002, J BIOL CHEM, V277, P1261, DOI 10.1074/jbc.M108525200; Zhang XM, 2001, AM J PHYSIOL-HEART C, V280, pH1782, DOI 10.1152/ajpheart.2001.280.4.H1782	49	157	174	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35078	35087		10.1074/jbc.M707083200	http://dx.doi.org/10.1074/jbc.M707083200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17923476	hybrid			2022-12-25	WOS:000251155200052
J	McCarthy, TL; Hochberg, RB; Labaree, DC; Centrella, M				McCarthy, Thomas L.; Hochberg, Richard B.; Labaree, David C.; Centrella, Michael			3-ketosteroid reductase activity and expression by fetal rat Osteoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; BINDING PROTEIN-DELTA; ESTROGEN-RECEPTOR MODULATORS; ALDO-KETO REDUCTASES; BONE CELL-CULTURES; DIHYDRODIOL DEHYDROGENASE; GENE-EXPRESSION; FACTOR-BETA; 3-ALPHA-HYDROXYSTEROID DEHYDROGENASE; HYDROXYSTEROID DEHYDROGENASES	In addition to reproductive tissue, sex hormones induce transcriptional events in many connective tissue cells, including osteoblasts. Some sex hormone receptor modulators with bone sparing effects selectively target estrogen or androgen receptors, whereas others appear more promiscuous, in part through enzymatic metabolism. Rat osteoblasts express significant oxidative 3 alpha-hydroxysteroid dehydrogenase activity, which can convert precursor substrates to potent androgen receptor agonists. Here we show that they also express 3-ketosteroid reductase activity, exemplified by 7-methyl-17ethynyl-19-norandrostan-5 (10)en-3-one (tibolone) conversion to potent estrogen receptor alpha agonists. Conversion was rapid and quantitative, with 3 alpha-hydroxytibolone as the primary metabolite. Consistently, tibolone induced estrogen receptor alpha-dependent gene promoter activity through cis-acting estrogen response elements, increased the stimulatory effect of TGF-beta on Smad-dependent gene promoter activity, and enhanced prostaglandin E2-induced activity of transcription factor Runx2. Rat osteoblasts express the 3-ketosteroid reductase AKR1C9, an aldo-keto reductase gene family member. Exposure to prostaglandin E2 increased AKR1C9 gene promoter activity and mRNA expression. AKR1C9 promoter activity was also enhanced by overexpression of protein kinase A catalytic subunit or transcription factor C/EBP delta, and the effect of PGE2 was reduced by dominant negative C/EBP delta competition or C/EBP delta antisense expression. Moreover, prostaglandin E2 increased the amount of functional endogenous nuclear C/EBP delta that could bind specifically to a distinct domain similar to 1.8-kb upstream from the start site of AKR1C9 transcription. In summary, in addition to 3 alpha-hydroxysteroid dehydrogenase, rat osteoblasts express significant and regulatable 3-ketosteroid reductase activity. Through these enzymes, they may selectively metabolize precursor compounds into potent steroid receptor agonists locally within bone.	Yale Univ, Sch Med, Dept Surg, Sect Plast Surg, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA	Yale University; Yale University	Centrella, M (corresponding author), 333 Cedar St,MS 208041, New Haven, CT 06520 USA.	michael.centrella@yale.edu			NATIONAL CANCER INSTITUTE [R01CA037799] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R29AR039201, R01AR039201] Funding Source: NIH RePORTER; NCI NIH HHS [CA 37799] Funding Source: Medline; NHLBI NIH HHS [HL 61432] Funding Source: Medline; NIAMS NIH HHS [AR 39201] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Agarwal AK, 2005, ENDOCRINOLOGY, V146, P2531, DOI 10.1210/en.2005-0061; Atalla A, 2000, XENOBIOTICA, V30, P755, DOI 10.1080/00498250050119826; Billiard J, 2001, J BIOL CHEM, V276, P15354, DOI 10.1074/jbc.M009973200; Bland R, 1999, J ENDOCRINOL, V161, P455, DOI 10.1677/joe.0.1610455; Blok LJ, 2003, J CLIN ENDOCR METAB, V88, P2327, DOI 10.1210/jc.2002-021737; Brann DW, 2007, STEROIDS, V72, P381, DOI 10.1016/j.steroids.2007.02.003; Carpenter TO, 1998, ENDOCRINOLOGY, V139, P35, DOI 10.1210/en.139.1.35; CENTRELLA M, 1994, ENDOCRINOLOGY, V135, P1611, DOI 10.1210/en.135.4.1611; Centrella M, 1996, ANN NY ACAD SCI, V785, P224, DOI 10.1111/j.1749-6632.1996.tb56267.x; Centrella M, 2004, MOL ENDOCRINOL, V18, P1120, DOI 10.1210/me.2003-0491; CENTRELLA M, 1987, J BIOL CHEM, V262, P2869; CENTRELLA M, 1995, MOL CELL BIOL, V15, P3273; Chang WZ, 2005, GENE, V345, P225, DOI 10.1016/j.gene.2004.11.017; Chang WZ, 2004, J BIOL CHEM, V279, P42438, DOI 10.1074/jbc.M405549200; Chen Y, 1998, J CELL BIOCHEM, V71, P351, DOI 10.1002/(SICI)1097-4644(19981201)71:3<351::AID-JCB4>3.0.CO;2-5; Cirigliano M, 2007, J WOMENS HEALTH, V16, P600, DOI 10.1089/jwh.2006.0311; CLEGG CH, 1987, J BIOL CHEM, V262, P13111; Col N F, 2005, Minerva Med, V96, P331; CORRELL LA, 1989, J BIOL CHEM, V264, P16672; Dufort I, 1999, ENDOCRINOLOGY, V140, P568, DOI 10.1210/en.140.2.568; Eyre LJ, 1998, J BONE MINER RES, V13, P996, DOI 10.1359/jbmr.1998.13.6.996; Gennari L, 2007, DRUG AGING, V24, P361, DOI 10.2165/00002512-200724050-00002; Glidewell-Kenney C, 2007, P NATL ACAD SCI USA, V104, P8173, DOI 10.1073/pnas.0611514104; HAKEDA Y, 1987, ENDOCRINOLOGY, V121, P1966, DOI 10.1210/endo-121-6-1966; Hou YT, 1998, MOL PHARMACOL, V53, P459, DOI 10.1124/mol.53.3.459; HOU YT, 1994, CANCER RES, V54, P247; Hung CF, 1999, MOL ENDOCRINOL, V13, P1704, DOI 10.1210/me.13.10.1704; Ishida Y, 2002, OSTEOPOROSIS INT, V13, P235, DOI 10.1007/s001980200020; Jakacka M, 2002, MOL ENDOCRINOL, V16, P2188, DOI 10.1210/me.2001-0174; Ji CH, 1996, J CELL BIOCHEM, V63, P478; Ji CH, 1997, J BIOL CHEM, V272, P21260, DOI 10.1074/jbc.272.34.21260; Ji CH, 2003, MOL ENDOCRINOL, V17, P1834, DOI 10.1210/me.2002-0235; Ji CH, 1998, J CELL BIOCHEM, V69, P353, DOI 10.1002/(SICI)1097-4644(19980601)69:3<353::AID-JCB12>3.3.CO;2-W; Kloosterboer HJ, 2004, MATURITAS, V48, pS30, DOI 10.1016/j.maturitas.2004.02.012; Kuwano Y, 1997, ENDOCR J, V44, P847, DOI 10.1507/endocrj.44.847; Lin HK, 1999, J STEROID BIOCHEM, V71, P29, DOI 10.1016/S0960-0760(99)00122-3; LIN HK, 1995, CANCER RES, V55, P4105; Manolagas SC, 2002, RECENT PROG HORM RES, V57, P385, DOI 10.1210/rp.57.1.385; Manolagas SC, 2004, KIDNEY INT, V66, pS41, DOI 10.1111/j.1523-1755.2004.09107.x; McCarthy TL, 2000, ENDOCRINOLOGY, V141, P127, DOI 10.1210/en.141.1.127; MCCARTHY TL, 1995, ENDOCRINOLOGY, V136, P3901, DOI 10.1210/en.136.9.3901; McCarthy TL, 2000, J BIOL CHEM, V275, P21746, DOI 10.1074/jbc.M002291200; McCarthy TL, 2003, J BIOL CHEM, V278, P43121, DOI 10.1074/jbc.M306531200; McCarthy TL, 1997, J BIOL CHEM, V272, P18132, DOI 10.1074/jbc.272.29.18132; MCCARTHY TL, 1988, J BONE MINER RES, V3, P401; McCarthy TL, 1998, J CELL BIOCHEM, V68, P446, DOI 10.1002/(SICI)1097-4644(19980315)68:4<446::AID-JCB5>3.0.CO;2-Q; MCCARTHY TL, 2007, IN PRESS ENDOCRINOL; Musa MA, 2007, CURR MED CHEM, V14, P1249, DOI 10.2174/092986707780598023; O'Brien JE, 2006, J BIOL CHEM, V281, P26683, DOI 10.1074/jbc.M601522200; Penning TM, 2000, BIOCHEM J, V351, P67, DOI 10.1042/0264-6021:3510067; Penning TM, 2004, MOL CELL ENDOCRINOL, V215, P63, DOI 10.1016/j.mce.2003.11.006; Penning TM, 2003, J STEROID BIOCHEM, V85, P247, DOI 10.1016/S0960-0760(03)00236-X; Penning TM, 2003, HUM REPROD UPDATE, V9, P193, DOI 10.1093/humupd/dmg022; Penning TM, 2007, ARCH BIOCHEM BIOPHYS, V464, P241, DOI 10.1016/j.abb.2007.04.024; Pierson-Mullany LK, 2004, MOL CELL BIOL, V24, P10542, DOI 10.1128/MCB.24.24.10542-10557.2004; Roesler WJ, 2001, ANNU REV NUTR, V21, P141, DOI 10.1146/annurev.nutr.21.1.141; Rosemond MJC, 2004, CHEM-BIOL INTERACT, V147, P129, DOI 10.1016/j.cbi.2003.12.001; SARTORIUS CA, 1994, CANCER RES, V54, P3868; Selvamurugan N, 2000, J BIOL CHEM, V275, P5037, DOI 10.1074/jbc.275.7.5037; Sherbet DP, 2007, MOL CELL ENDOCRINOL, V265, P83, DOI 10.1016/j.mce.2006.12.021; SMITHGALL TE, 1985, BIOCHEM PHARMACOL, V34, P831, DOI 10.1016/0006-2952(85)90763-4; Steckelbroeck S, 2006, J PHARMACOL EXP THER, V316, P1300, DOI 10.1124/jpet.105.091587; Steckelbroeck S, 2004, MOL PHARMACOL, V66, P1702, DOI 10.1124/mol.104.004515; STRAVITZ RT, 1994, J LIPID RES, V35, P239; Syed FA, 2005, J BONE MINER RES, V20, P1992, DOI 10.1359/JBMR.050713; Thomas MJ, 1996, J BIOL CHEM, V271, P21835, DOI 10.1074/jbc.271.36.21835; TOKUDA H, 1992, J CELL BIOCHEM, V48, P262, DOI 10.1002/jcb.240480306; Tsuruda L, 2001, CHEM RES TOXICOL, V14, P856, DOI 10.1021/tx0100035; Turgeon JL, 2006, ENDOCR REV, V27, P575, DOI 10.1210/er.2005-0020; UHLER MD, 1987, J BIOL CHEM, V262, P15202; Umayahara Y, 1997, J BIOL CHEM, V272, P31793, DOI 10.1074/jbc.272.50.31793; Wierman ME, 2007, ADV PHYSIOL EDUC, V31, P26, DOI 10.1152/advan.00086.2006	72	15	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34003	34012		10.1074/jbc.M707502200	http://dx.doi.org/10.1074/jbc.M707502200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17905737	hybrid			2022-12-25	WOS:000251145700014
J	Puri, V; Konda, S; Ranjit, S; Aouadi, M; Chawla, A; Chouinard, M; Chakladar, A; Czech, MP				Puri, Vishwajeet; Konda, Silvana; Ranjit, Srijana; Aouadi, Myriam; Chawla, Anil; Chouinard, My; Chakladar, Abhijit; Czech, Michael P.			Fat-specific protein 27, a novel lipid droplet protein that enhances triglyceride storage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; DNA-FRAGMENTATION-FACTOR; ADIPOCYTE-SPECIFIC GENE; TUMOR-NECROSIS-FACTOR; PERILIPIN-A; 3T3-L1 ADIPOCYTES; TRANSCRIPTIONAL REGULATION; LIPOLYTIC STIMULATION; OBESE GENE; EXPRESSION	Fat-specific protein (FSP)27/Cidec is most highly expressed in white and brown adipose tissues and increases in abundance by over 50-fold during adipogenesis. However, its function in adipocytes has remained elusive since its discovery over 15 years ago. Here we demonstrate that FSP27/Cidec localizes to lipid droplets in cultured adipocytes and functions to promote lipid accumulation. Ectopically expressed FSP27-GFP surrounds lipid droplets in 3T3-L1 adipocytes and colocalizes with the known lipid droplet protein perilipin. Immunostaining of endogenous FSP27 in 3T3-L1 adipocytes also confirmed its presence on lipid droplets. FSP27-GFP expression also markedly increases lipid droplet size and enhances accumulation of total neutral lipids in 3T3-L1 preadipocytes as well as other cell types such as COS cells. Conversely, RNA interference-based FSP27/Cidec depletion in mature adipocytes significantly stimulates lipolysis and reduces the size of lipid droplets. These data reveal FSP27/Cidec as a novel adipocyte lipid droplet protein that negatively regulates lipolysis and promotes triglyceride accumulation.	Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Czech, MP (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	Michael.Czech@umassmed.edu		Puri, Vishwajeet/0000-0002-0757-6067	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060837, R01DK030898, R37DK030898] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 60837, DK 30898] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Beckman M, 2006, SCIENCE, V311, P1232, DOI 10.1126/science.311.5765.1232; Bergeron R, 2006, ENDOCRINOLOGY, V147, P4252, DOI 10.1210/en.2005-1535; BLANCHETTEMACKIE EJ, 1995, J LIPID RES, V36, P1211; Boden G, 2006, EXPERT OPIN INV DRUG, V15, P243, DOI 10.1517/13543784.15.3.243; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Brasaemle DL, 2000, BBA-MOL CELL BIOL L, V1483, P251, DOI 10.1016/S1388-1981(99)00179-1; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Clifford GM, 1997, BIOCHEM SOC T, V25, pS672, DOI 10.1042/bst025s672; Clifford GM, 2000, J BIOL CHEM, V275, P5011, DOI 10.1074/jbc.275.7.5011; DANESCH U, 1992, J BIOL CHEM, V267, P7185; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; GREENBERG AS, 1993, P NATL ACAD SCI USA, V90, P12035, DOI 10.1073/pnas.90.24.12035; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Hickenbottom SJ, 2004, STRUCTURE, V12, P1199, DOI 10.1016/j.str.2004.04.021; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Inohara N, 1998, EMBO J, V17, P2526, DOI 10.1093/emboj/17.9.2526; Jiang ZY, 2003, P NATL ACAD SCI USA, V100, P7569, DOI 10.1073/pnas.1332633100; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Lazar HL, 2002, J THORAC CARDIOV SUR, V123, P842, DOI 10.1067/mtc.2002.121041; Liang L, 2003, BIOCHEM J, V370, P195, DOI 10.1042/BJ20020656; Londos C, 2005, BIOCHIMIE, V87, P45, DOI 10.1016/j.biochi.2004.12.010; Londos C, 1999, ANN NY ACAD SCI, V892, P155, DOI 10.1111/j.1749-6632.1999.tb07794.x; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Powelka AM, 2006, J CLIN INVEST, V116, P125, DOI 10.1172/JCI26040; Puri V, 2007, J LIPID RES, V48, P465, DOI 10.1194/jlr.D600033-JLR200; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Savkur Rajesh S, 2006, Expert Opin Investig Drugs, V15, P763, DOI 10.1517/13543784.15.7.763; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; SHILLABEER G, 1989, J CLIN INVEST, V84, P381, DOI 10.1172/JCI114177; Souza SC, 1998, J BIOL CHEM, V273, P24665, DOI 10.1074/jbc.273.38.24665; Souza SC, 2002, J BIOL CHEM, V277, P8267, DOI 10.1074/jbc.M108329200; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; TOBE K, 1987, FEBS LETT, V215, P345, DOI 10.1016/0014-5793(87)80175-8; TONTONOZ P, 1995, CURR OPIN GENET DEV, V5, P571, DOI 10.1016/0959-437X(95)80025-5; WILLIAMS PM, 1992, MOL ENDOCRINOL, V6, P1135, DOI 10.1210/me.6.7.1135; Wolins NE, 2006, FEBS LETT, V580, P5484, DOI 10.1016/j.febslet.2006.08.040; Wolins NE, 2005, J BIOL CHEM, V280, P19146, DOI 10.1074/jbc.M500978200; Yamada T, 2006, CELL METAB, V3, P223, DOI 10.1016/j.cmet.2006.02.001; Yu ST, 2003, J BIOL CHEM, V278, P498, DOI 10.1074/jbc.M210062200; Zhang HH, 2003, J BIOL CHEM, V278, P51535, DOI 10.1074/jbc.M309591200; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225	45	237	250	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34213	34218		10.1074/jbc.M707404200	http://dx.doi.org/10.1074/jbc.M707404200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17884815	hybrid			2022-12-25	WOS:000251145700036
J	Santamaria, L; Rodriguez-Perez, J; Larrinaga, AR; Pias, B				Santamaria, Luis; Rodriguez-Perez, Javier; Larrinaga, Asier R.; Pias, Beatriz			Predicting Spatial Patterns of Plant Recruitment Using Animal-Displacement Kernels	PLOS ONE			English	Article							BIRD-DISPERSED TREE; SEED DISPERSAL; GUT PASSAGE; SCALE; RAIN; ESTABLISHMENT; CONSEQUENCES; GERMINATION; LIMITATION; MODELS	For plants dispersed by frugivores, spatial patterns of recruitment are primarily influenced by the spatial arrangement and characteristics of parent plants, the digestive characteristics, feeding behaviour and movement patterns of animal dispersers, and the structure of the habitat matrix. We used an individual-based, spatially-explicit framework to characterize seed dispersal and seedling fate in an endangered, insular plant-disperser system: the endemic shrub Daphne rodriguezii and its exclusive disperser, the endemic lizard Podarcis lilfordi. Plant recruitment kernels were chiefly determined by the disperser's patterns of space utilization (i.e. the lizard's displacement kernels), the position of the various plant individuals in relation to them, and habitat structure (vegetation cover vs. bare soil). In contrast to our expectations, seed gut-passage rate and its effects on germination, and lizard speed-of-movement, habitat choice and activity rhythm were of minor importance. Predicted plant recruitment kernels were strongly anisotropic and fine-grained, preventing their description using one-dimensional, frequency-distance curves. We found a general trade-off between recruitment probability and dispersal distance; however, optimal recruitment sites were not necessarily associated to sites of maximal adult-plant density. Conservation efforts aimed at enhancing the regeneration of endangered plant-disperser systems may gain in efficacy by manipulating the spatial distribution of dispersers (e. g. through the creation of refuges and feeding sites) to create areas favourable to plant recruitment.	[Santamaria, Luis; Rodriguez-Perez, Javier; Larrinaga, Asier R.] CSIC UIB, IMEDEA, Mediterranean Inst Adv Studies, Esporles, Mallorca, Spain; [Pias, Beatriz] Univ Rey Juan Carlos, Area Biodiversidad & Conservac, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; University of Barcelona; Universidad Rey Juan Carlos	Santamaria, L (corresponding author), CSIC UIB, IMEDEA, Mediterranean Inst Adv Studies, Esporles, Mallorca, Spain.	luis.santamaria@uib.es	Larrinaga, Asier/B-3826-2013; Javier Rodríguez-Pérez, Ph.D. Biology/C-9773-2009; Santamaria, Luis/C-1438-2012; Traveset, Anna V/D-7802-2011; Pías, Beatriz/ABF-9948-2020	Larrinaga, Asier/0000-0001-6813-8784; Javier Rodríguez-Pérez, Ph.D. Biology/0000-0002-1292-9090; Santamaria, Luis/0000-0002-5072-2912; Pías, Beatriz/0000-0002-1136-8914	British Ecological Society [2272]; Spanish Ministry of Science and Technology [FP-2001-1819]	British Ecological Society; Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Funding: Funding to LSG by the British Ecological Society (Small Ecological Project Grant no. 2272) and to JRP by the Spanish Ministry of Science and Technology (FP-2001-1819) is gratefully acknowledged.	Alcantara JM, 2000, ECOLOGY, V81, P1937, DOI 10.1890/0012-9658(2000)081[1937:FSTSPA]2.0.CO;2; Alcantara JM, 2003, J EVOLUTION BIOL, V16, P1168, DOI 10.1046/j.1420-9101.2003.00618.x; BEYER HL, 2004, HAWTHS ANAL TOOLS; Clark CJ, 2005, ECOLOGY, V86, P2684, DOI 10.1890/04-1325; ERIKSSON O, 1992, OECOLOGIA, V91, P360, DOI 10.1007/BF00317624; Escudero A, 2005, J VEG SCI, V16, P383, DOI 10.1111/j.1654-1103.2005.tb02377.x; Figuerola J, 2005, AM J BOT, V92, P696, DOI 10.3732/ajb.92.4.696; Garcia D, 2005, J ECOL, V93, P693, DOI 10.1111/j.1365-2745.2005.01004.x; Gomez-Aparicio L, 2004, ECOL APPL, V14, P1128, DOI 10.1890/03-5084; Hardesty BD, 2006, ECOL LETT, V9, P516, DOI 10.1111/j.1461-0248.2006.00897.x; Harper J. L., 1977, Population biology of plants.; HERRERA CM, 1994, ECOL MONOGR, V64, P315, DOI 10.2307/2937165; Hickey JR, 1999, OIKOS, V87, P499, DOI 10.2307/3546814; Higgins SI, 2003, ECOLOGY, V84, P1945, DOI 10.1890/01-0616; Holbrook KM, 2000, OECOLOGIA, V125, P249, DOI 10.1007/s004420000445; Holbrook KM, 2002, ECOGRAPHY, V25, P745, DOI 10.1034/j.1600-0587.2002.250610.x; HOLBROOK KM, 2006, SEED DISPERSAL THEOR; Jones FA, 2005, AM NAT, V166, P543, DOI 10.1086/491661; Jordano P, 2000, ECOL MONOGR, V70, P591, DOI 10.1890/0012-9615(2000)070[0591:SDETQC]2.0.CO;2; Jordano Pedro, 2002, P305, DOI 10.1079/9780851995250.0305; Katul GG, 2005, AM NAT, V166, P368, DOI 10.1086/432589; Kollmann Johannes, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P29, DOI 10.1078/1433-8319-00003; Levine JM, 2003, ANNU REV ECOL EVOL S, V34, P549, DOI 10.1146/annurev.ecolsys.34.011802.132400; Maestre FT, 2003, ECOSYSTEMS, V6, P630, DOI 10.1007/s10021-002-0222-5; *MATHS INC, 1999, S PLUS 2000 GUID STA; Morales JM, 2006, ECOLOGY, V87, P1489, DOI 10.1890/0012-9658(2006)87[1489:TEOPDA]2.0.CO;2; MURRAY KG, 1988, ECOL MONOGR, V58, P271, DOI 10.2307/1942541; Nathan R, 2000, TRENDS ECOL EVOL, V15, P278, DOI 10.1016/S0169-5347(00)01874-7; Quinn G, 2002, EXPT DESIGN DATA ANA, P556; REYES T, 2003, OECOLOGIA, V136, P296; Riera N, 2002, J BIOGEOGR, V29, P713, DOI 10.1046/j.1365-2699.2002.00719.x; Robertson AW, 2006, FUNCT ECOL, V20, P58, DOI 10.1111/j.1365-2435.2005.01057.x; Rodgers A. R., 2005, HRT HOME RANGE TOOLS; RODRIGUEZPEREZ J, 2006, THESIS U BALEARIC IS; Saez Encarna, 1995, Herpetological Review, V26, P121; SAIN SR, 1994, THESIS RICE U TEXAS; SALVADOR A, 2006, LAGARTIJA BALEAR POD; Samuels IA, 2005, FUNCT ECOL, V19, P365, DOI 10.1111/j.1365-2435.2005.00973.x; SAS Institute, 2000, SAS STAT SOFTW US GU; SCHUPP EW, 1993, VEGETATIO, V108, P15; Seidler TG, 2006, PLOS BIOL, V4, P2132, DOI 10.1371/journal.pbio.0040344; Sun C, 1997, OECOLOGIA, V112, P94, DOI 10.1007/s004420050288; Travers C, 2005, J PERS DISORD, V19, P1, DOI 10.1521/pedi.19.1.1.62181; Traveset A, 1997, OECOLOGIA, V111, P241, DOI 10.1007/PL00008816; Traveset Anna, 1998, Perspectives in Plant Ecology Evolution and Systematics, V1, P151, DOI 10.1078/1433-8319-00057; Traveset Anna, 2002, P339, DOI 10.1079/9780851995250.0339; VENABLE DL, 1993, VEGETATIO, V108, P31; Verdu M, 2005, ECOLOGY, V86, P1385, DOI 10.1890/04-1647; Wehncke EV, 2003, J ECOL, V91, P677, DOI 10.1046/j.1365-2745.2003.00798.x; Wenny DG, 2000, ECOL MONOGR, V70, P331, DOI 10.1890/0012-9615(2000)070[0331:SDSPAS]2.0.CO;2; Wenny DG, 1998, P NATL ACAD SCI USA, V95, P6204, DOI 10.1073/pnas.95.11.6204; WESCOTT DA, 2000, OECOLOGIA, V102, P249; Westcott DA, 2005, OECOLOGIA, V146, P57, DOI 10.1007/s00442-005-0178-1; Westcott DA, 2000, OECOLOGIA, V122, P249, DOI 10.1007/PL00008853; WILLSON MF, 1993, VEGETATIO, V108, P261	55	28	29	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1008	10.1371/journal.pone.0001008	http://dx.doi.org/10.1371/journal.pone.0001008			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925856	gold, Green Published			2022-12-25	WOS:000207456000007
J	Wang, Q; Pang, YP				Wang, Qi; Pang, Yuan-Ping			Normal-Mode-Analysis-Monitored Energy Minimization Procedure for Generating Small-Molecule Bound Conformations	PLOS ONE			English	Article							DYNAMICS SIMULATIONS; SELECTION; PROTEIN; INDUCTION; PROGRAM; EUDOC	The energy minimization of a small molecule alone does not automatically stop at a local minimum of the potential energy surface of the molecule if the minimum is shallow, thus leading to folding of the molecule and consequently hampering the generation of the bound conformation of a guest in the absence of its host. This questions the practicality of virtual screening methods that use conformations at local minima of their potential energy surfaces (local minimum conformations) as potential bound conformations. Here we report a normal-mode-analysis-monitored energy minimization (NEM) procedure that generates local minimum conformations as potential bound conformations. Of 22 selected guest-host complex crystal structures with guest structures possessing up to four rotatable bonds, all complexes were reproduced, with guest mass-weighted root mean square deviations of <1.0 angstrom, through docking with the NEM-generated guest local minimum conformations. An analysis of the potential energies of these local minimum conformations showed that 22 (100%), 18 (82%), 16 (73%), and 12 (55%) of the 22 guest bound conformations in the crystal structures had conformational strain energies of less than or equal to 3.8, 2.0, 0.6, and 0.0 kcal/mol, respectively. These results suggest that (1) the NEM procedure can generate small-molecule bound conformations, and (2) guests adopt low-strain-energy conformations for complexation, thus supporting the virtual screening methods that use local minimum conformations.	[Wang, Qi; Pang, Yuan-Ping] Mayo Clin, Comp Aided Mol Design Lab, Rochester, MN 55905 USA	Mayo Clinic	Pang, YP (corresponding author), Mayo Clin, Comp Aided Mol Design Lab, Rochester, MN 55905 USA.	pang@mayo.edu		Pang, Yuan-Ping/0000-0003-0838-2560	U. S. Army Medical Research Acquisition Activity [W81XWH-04-2-0001]; National Institutes of Health [5R01AI054574-03, 5R01GM061300-06]; Mayo Graduate School; Mayo Foundation for Medical Education and Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061300] Funding Source: NIH RePORTER	U. S. Army Medical Research Acquisition Activity; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Graduate School; Mayo Foundation for Medical Education and Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: This work was supported by the U. S. Army Medical Research Acquisition Activity (W81XWH-04-2-0001), the National Institutes of Health (5R01AI054574-03 and 5R01GM061300-06), Mayo Graduate School, and the Mayo Foundation for Medical Education and Research.	Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; Beusen DD, 1996, J MOL STRUC-THEOCHEM, V370, P157, DOI 10.1016/S0166-1280(96)04565-4; Bostrom J, 1998, J COMPUT AID MOL DES, V12, P383, DOI 10.1023/A:1008007507641; Bruns RF, 1996, TRENDS PHARMACOL SCI, V17, P189, DOI 10.1016/0165-6147(96)20027-6; BURGEN ASV, 1981, FED PROC, V40, P2723; Case D.A, 1999, MOL BIOL+, V18, P329, DOI [10.1007/0-306-47089-6, DOI 10.1007/0-306-47089-6]; Caves LSD, 1998, PROTEIN SCI, V7, P649, DOI 10.1002/pro.5560070314; CIEPLAK P, 1995, J COMPUT CHEM, V16, P1357, DOI 10.1002/jcc.540161106; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Dammkoehler RA, 1995, J COMPUT AID MOL DES, V9, P491, DOI 10.1007/BF00124320; Frisch M J, 1999, GAUSSIAN 98 REVISION; Hinsen Konrad, 2006, P1; JENSEN F, 1998, INTRO COMPUTATIONAL, P312; Kenakin T, 1996, TRENDS PHARMACOL SCI, V17, P190, DOI 10.1016/0165-6147(96)20026-4; KOSHLAND DE, 1994, ANGEW CHEM INT EDIT, V33, P2375; LEACH AR, 1991, REV COMPUTATIONAL CH, V2, P1; Oelschlaeger P, 2003, BIOCHEMISTRY-US, V42, P8945, DOI 10.1021/bi0300332; Pang YP, 2007, CLIN PHARMACOL THER, V81, P30, DOI 10.1038/sj.clpt.6100030; Pang YP, 2001, J COMPUT CHEM, V22, P1750, DOI 10.1002/jcc.1129; Pang YP, 2004, PROTEINS, V57, P747, DOI 10.1002/prot.20249; Pang YP, 1997, J MOL MODEL, V3, P240, DOI 10.1007/s008940050036; PANG YP, 2007, IBM J RES D IN PRESS; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Smith LJ, 2002, PROTEINS, V48, P487, DOI 10.1002/prot.10144; Snow CD, 2002, NATURE, V420, P102, DOI 10.1038/nature01160; Wang Q, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000820; Wang Q, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000531; Zagrovic B, 2002, J MOL BIOL, V323, P927, DOI 10.1016/S0022-2836(02)00997-X	29	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1025	10.1371/journal.pone.0001025	http://dx.doi.org/10.1371/journal.pone.0001025			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925873	Green Published, gold, Green Submitted			2022-12-25	WOS:000207456000024
J	Dabney, AR; Storey, JD				Dabney, Alan R.; Storey, John D.			Optimality Driven Nearest Centroid Classification from Genomic Data	PLOS ONE			English	Article							VARIABLE SELECTION TECHNIQUES; DISCRIMINANT-ANALYSIS; GENE; CANCER; PREDICTION	Nearest-centroid classifiers have recently been successfully employed in high-dimensional applications, such as in genomics. A necessary step when building a classifier for high-dimensional data is feature selection. Feature selection is frequently carried out by computing univariate scores for each feature individually, without consideration for how a subset of features performs as a whole. We introduce a new feature selection approach for high-dimensional nearest centroid classifiers that instead is based on the theoretically optimal choice of a given number of features, which we determine directly here. This allows us to develop a new greedy algorithm to estimate this optimal nearest-centroid classifier with a given number of features. In addition, whereas the centroids are usually formed from maximum likelihood estimates, we investigate the applicability of high-dimensional shrinkage estimates of centroids. We apply the proposed method to clinical classification based on gene-expression microarrays, demonstrating that the proposed method can outperform existing nearest centroid classifiers.	[Dabney, Alan R.] Texas A&M Univ, Dept Stat, College Stn, TX 77843 USA; [Storey, John D.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Storey, John D.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Texas A&M University System; Texas A&M University College Station; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Dabney, AR (corresponding author), Texas A&M Univ, Dept Stat, College Stn, TX 77843 USA.	adabney@stat.tamu.edu; jstorey@u.washington.edu	Storey, John/B-5282-2011; Dabney, Alan/C-1171-2011	Storey, John/0000-0001-5992-402X	Cancer-Epidemiology and Biostatistics Training [5T32CA009168-29]; NIH [1 U54 GM2119]; NATIONAL CANCER INSTITUTE [T32CA009168] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002913] Funding Source: NIH RePORTER	Cancer-Epidemiology and Biostatistics Training; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research was supported in part by the Cancer-Epidemiology and Biostatistics Training Grant 5T32CA009168-29 and NIH grant 1 U54 GM2119.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Ambroise C, 2002, P NATL ACAD SCI USA, V99, P6562, DOI 10.1073/pnas.102102699; Bickel PJ, 2004, BERNOULLI, V10, P989, DOI 10.3150/bj/1106314847; Bo TH, 2002, GENOME BIOL, V3; Dabney AR, 2005, BIOINFORMATICS, V21, P4148, DOI 10.1093/bioinformatics/bti681; DABNEY AR, 2005, UW BIOSTATISTICS WOR; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Guo YQ, 2007, BIOSTATISTICS, V8, P86, DOI 10.1093/biostatistics/kxj035; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Lee JW, 2005, COMPUT STAT DATA AN, V48, P869, DOI 10.1016/j.csda.2004.03.017; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; MCKAY RJ, 1982, BRIT J MATH STAT PSY, V35, P1, DOI 10.1111/j.2044-8317.1982.tb00638.x; MCKAY RJ, 1982, BRIT J MATH STAT PSY, V35, P30, DOI 10.1111/j.2044-8317.1982.tb00639.x; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Schafer J, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1175; Shen RL, 2006, BIOINFORMATICS, V22, P2635, DOI 10.1093/bioinformatics/btl442; Stein C., 1955, P 3 BERK S MATH STAT, V1, P197, DOI DOI 10.1525/9780520313880-018; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299	21	26	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e1002	10.1371/journal.pone.0001002	http://dx.doi.org/10.1371/journal.pone.0001002			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912341	gold, Green Published, Green Submitted			2022-12-25	WOS:000207455900038
J	Nitta, RT; Smith, CL; Kennedy, BK				Nitta, Ryan T.; Smith, Catherine L.; Kennedy, Brian K.			Evidence that Proteasome-Dependent Degradation of the Retinoblastoma Protein in Cells Lacking A-Type Lamins Occurs Independently of Gankyrin and MDM2	PLOS ONE			English	Article							GENE-PRODUCT; TUMOR SUPPRESSORS; FAMILY PROTEINS; NUCLEAR LAMINA; RB FAMILY; ONCOPROTEIN; INHIBITION; P53; IDENTIFICATION; PHOSPHORYLATION	Background. A-type lamins, predominantly lamins A and C, are nuclear intermediate filaments believed to act as scaffolds for assembly of transcription factors. Lamin A/C is necessary for the retinoblastoma protein (pRB) stabilization through unknown mechanism(s). Two oncoproteins, gankyrin and MDM2, are known to promote pRB degradation in other contexts. Consequently, we tested the hypothesis that gankyrin and/or MDM2 are required for enhanced pRB degradation in Lmna(-/-) fibroblasts. Principal Findings. To determine if gankyrin promotes pRB destabilization in the absence of lamin A/C, we first analyzed its protein levels in Lmna(-/-) fibroblasts. Both gankyrin mRNA levels and protein levels are increased in these cells, leading us to further investigate its role in pRB degradation. Consistent with prior reports, overexpression of gankyrin in Lmna(+/+) cells destabilizes pRB. This decrease is functionally significant, since gankyrin overexpressing cells are resistant to p16(ink4a)-mediated cell cycle arrest. These findings suggest that lamin A-mediated degradation of pRB would be gankyrin-dependent. However, effective RNAi-enforced reduction of gankyrin expression in Lmna(-/-) cells was insufficient to restore pRB stability. To test the importance of MDM2, we disrupted the MDM2-pRB interaction by transfecting Lmna(-/-) cells with p14(arf). p14(arf) expression was also insufficient to stabilize pRB or confer cell cycle arrest, suggesting that MDM2 also does not mediate pRB degradation in Lmna(-/-) cells. Conclusions/Significance. Our findings suggest that pRB degradation in Lmna(-/-) cells occurs by gankyrin and MDM2-independent mechanisms, leading us to propose the existence of a third proteasome-dependent pathway for pRB degradation. Two findings from this study also increase the likelihood that lamin A/C functions as a tumor suppressor. First, protein levels of the oncoprotein gankyrin are elevated in Lmna(-/-) fibroblasts. Second, Lmna(-/-) cells are refractory to p14(arf)-mediated cell cycle arrest, as was previously shown with p16(ink4a). Potential roles of lamin A/C in the suppression of tumorigenesis are discussed.	[Nitta, Ryan T.; Smith, Catherine L.; Kennedy, Brian K.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Kennedy, BK (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	bkenn@u.washington.edu		Kennedy, Brian/0000-0002-5754-1874	National Institutes of Health [R01AG024287, AG013280]; NATIONAL INSTITUTE ON AGING [P30AG013280, R01AG024287] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the National Institutes of Health grant R01AG024287 to BKK. RTN. was supported by the NIH training grant AG013280.	Bakay M, 2006, BRAIN, V129, P996, DOI 10.1093/brain/awl023; Barbie DA, 2005, TRENDS CELL BIOL, V15, P378, DOI 10.1016/j.tcb.2005.05.005; Berezutskaya E, 1997, CELL GROWTH DIFFER, V8, P1277; Berezutskaya E, 1997, J BIOL CHEM, V272, P30135, DOI 10.1074/jbc.272.48.30135; Boyer SN, 1996, CANCER RES, V56, P4620; BRIDGER JM, 1993, J CELL SCI, V104, P297; Bridger JM, 2007, FEBS J, V274, P1354, DOI 10.1111/j.1742-4658.2007.05694.x; Bruce JL, 2000, MOL CELL, V6, P737, DOI 10.1016/S1097-2765(00)00072-1; Chang DLF, 2007, ONCOGENE, V26, P4627, DOI 10.1038/sj.onc.1210254; Chen TLL, 2001, EXP CELL RES, V263, P224, DOI 10.1006/excr.2000.5093; Dawson S, 2002, J BIOL CHEM, V277, P10893, DOI 10.1074/jbc.M107313200; Dawson S, 2006, TRENDS CELL BIOL, V16, P229, DOI 10.1016/j.tcb.2006.03.001; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Dimri GP, 1996, MOL CELL BIOL, V16, P2987; Dreuillet C, 2002, NUCLEIC ACIDS RES, V30, P4634, DOI 10.1093/nar/gkf587; Frock RL, 2006, GENE DEV, V20, P486, DOI 10.1101/gad.1364906; GERACE L, 1978, J CELL BIOL, V79, P546, DOI 10.1083/jcb.79.2.546; Goldman Robert D., 2005, V264, P3, DOI 10.1002/0470093765.ch2; Goldman Robert D., 2005, V264, P1, DOI 10.1002/0470093765.ch1; Goldman Robert D., 2005, V264, P279, DOI 10.1002/0470093765.ch19; GOODRICH DW, 1991, CELL, V67, P293, DOI 10.1016/0092-8674(91)90181-W; Higashitsuji H, 2005, CANCER CELL, V8, P75, DOI 10.1016/j.ccr.2005.06.006; Higashitsuji H, 2000, NAT MED, V6, P96, DOI 10.1038/71600; Higashitsuji H, 2005, CELL CYCLE, V4, P1335, DOI 10.4161/cc.4.10.2107; Hori T, 1998, GENE, V216, P113, DOI 10.1016/S0378-1119(98)00309-6; Horton LE, 1997, ONCOGENE, V14, P491, DOI 10.1038/sj.onc.1200851; Ivorra' C, 2006, GENE DEV, V20, P307, DOI 10.1101/gad.349506; Johnson BR, 2004, P NATL ACAD SCI USA, V101, P9677, DOI 10.1073/pnas.0403250101; Jones DL, 1997, VIROLOGY, V239, P97, DOI 10.1006/viro.1997.8851; Kalejta RF, 2003, P NATL ACAD SCI USA, V100, P3263, DOI 10.1073/pnas.0538058100; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Kennedy BK, 2000, GENE DEV, V14, P2855, DOI 10.1101/gad.842600; Knight JS, 2005, P NATL ACAD SCI USA, V102, P18562, DOI 10.1073/pnas.0503886102; Kudlow BA, 2005, AIDS, V19, P1565, DOI 10.1097/01.aids.0000186827.91408.90; Leduc C, 2006, ONCOGENE, V25, P4147, DOI 10.1038/sj.onc.1209446; Li JN, 2002, BIOCHEMISTRY-US, V41, P3977, DOI 10.1021/bi011550s; Lloyd DJ, 2002, HUM MOL GENET, V11, P769, DOI 10.1093/hmg/11.7.769; Macaluso M, 2006, ONCOGENE, V25, P5263, DOI 10.1038/sj.onc.1209680; MALLER JL, 1989, J CELL SCI, P53; MANCINI MA, 1994, P NATL ACAD SCI USA, V91, P418, DOI 10.1073/pnas.91.1.418; Markiewicz E, 2002, MOL BIOL CELL, V13, P4401, DOI 10.1091/mbc.E02-07-0450; MITTNACHT S, 1991, COLD SPRING HARB SYM, V56, P197; Naetar N, 2007, J CELL SCI, V120, P737, DOI 10.1242/jcs.03390; Nishiyama R, 1998, CELL STRUCT FUNCT, V23, P291, DOI 10.1247/csf.23.291; Nitta RT, 2006, MOL CELL BIOL, V26, P5360, DOI 10.1128/MCB.02464-05; OZAKI T, 1994, ONCOGENE, V9, P2649; Park TJ, 2001, MOL CARCINOGEN, V30, P138, DOI 10.1002/mc.1022; Pekovic V, 2007, J CELL BIOL, V176, P163, DOI 10.1083/jcb.200606139; Prokocimer M, 2006, J STRUCT BIOL, V155, P351, DOI 10.1016/j.jsb.2006.02.016; QIN XQ, 1992, GENE DEV, V6, P953, DOI 10.1101/gad.6.6.953; RABINOVITCH PS, 1989, LAB INVEST, V60, P65; RABINOVITCH PS, 1994, METHOD CELL BIOL, V41, P263; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.2005.10.017; SHAN B, 1992, MOL CELL BIOL, V12, P5620, DOI 10.1128/MCB.12.12.5620; Squatrito M, 2006, TRENDS CELL BIOL, V16, P433, DOI 10.1016/j.tcb.2006.07.007; Takano M, 2002, EUR J BIOCHEM, V269, P943, DOI 10.1046/j.0014-2956.2001.02730.x; Van Berlo JH, 2005, HUM MOL GENET, V14, P2839, DOI 10.1093/hmg/ddi316; Yang YL, 2004, ONCOGENE, V23, P2096, DOI 10.1038/sj.onc.1207411; Ying HQ, 2006, CELL CYCLE, V5, P506, DOI 10.4161/cc.5.5.2515	59	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e963	10.1371/journal.pone.0000963	http://dx.doi.org/10.1371/journal.pone.0000963			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17896003	gold, Green Submitted, Green Published			2022-12-25	WOS:000207455800041
J	Finckenstein, FG; Shahbazian, V; Davicioni, E; Ren, YX; Anderson, MJ				Finckenstein, F. Graf; Shahbazian, V.; Davicioni, E.; Ren, Y-X; Anderson, M. J.			PAX-FKHR function as pangenes by simultaneously inducing and inhibiting myogenesis	ONCOGENE			English	Article						rhabdomyosarcoma; PAX-FKHR; MyoD; pangene	DNA-BINDING DOMAIN; ALVEOLAR RHABDOMYOSARCOMAS; GENE-EXPRESSION; TRANSCRIPTION FACTOR; CELL-CYCLE; PAX3-FKHR; DIFFERENTIATION; MYOD; PROTEINS; IDENTIFICATION	Alveolar rhabdomyosarcomas (ARMS) escape terminal differentiation despite exhibiting a skeletal muscle phenotype. To understand the role of the ARMS-specific PAX-FKHR proteins in myogenesis, we characterized their regulation of MyoD expression and function. Reporter assays show that PAX-FKHR transactivate MyoD expression through its 258 bp core enhancer. Gel-shift assays confirm that PAX-FKHR bind to core enhancer sequences showing similarity to consensus PAX3/PAX-FKHR-binding sites. We show that while PAX3-FKHR activates the expression of endogenous MyoD and myogenin proteins in transduced NIH3T3 fibroblasts, it inhibits them from terminally differentiating as shown by low myogenin and myosin heavy chain expression, and lack of myotube formation. Attenuation of MyoD transcriptional activity via phosphorylation coupled to the lack of cell cycle arrest is the underlying mechanism for the differentiation block. Lastly, we show that fibroblast growth factor receptor signaling likely mediates the inhibition of differentiation by PAX3-FKHR. In a single experimental system we demonstrate that PAX3-FKHR can simultaneously induce myogenesis while preventing its completion. We propose a model whereby PAX-FKHR commit a yet undefined precursor cell to the myogenic lineage while at the same time inhibit terminal differentiation, thereby contributing to ARMS formation.	[Finckenstein, F. Graf; Shahbazian, V.; Ren, Y-X; Anderson, M. J.] Childrens Hosp Los Angeles, Dept Pathol, Los Angeles, CA 90027 USA; [Davicioni, E.; Anderson, M. J.] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA	Children's Hospital Los Angeles; University of Southern California	Anderson, MJ (corresponding author), Childrens Hosp Los Angeles, Saban Res Inst, Dept Pathol & Lab Med, 4650 Sunset Blvd,MS103, Los Angeles, CA 90027 USA.	manderson@chla.usc.edu		Davicioni, Elai/0000-0001-9136-099X				Anderson J, 2001, AM J PATHOL, V159, P1089, DOI 10.1016/S0002-9440(10)61784-1; Anderson MJ, 2001, P NATL ACAD SCI USA, V98, P1589, DOI 10.1073/pnas.98.4.1589; Barr FG, 2001, ONCOGENE, V20, P5736, DOI 10.1038/sj.onc.1204599; Bernasconi M, 1996, P NATL ACAD SCI USA, V93, P13164, DOI 10.1073/pnas.93.23.13164; CHALEPAKIS G, 1991, CELL, V66, P873, DOI 10.1016/0092-8674(91)90434-Z; Davicioni E, 2006, CANCER RES, V66, P6936, DOI 10.1158/0008-5472.CAN-05-4578; Davis RJ, 1997, P NATL ACAD SCI USA, V94, P8047, DOI 10.1073/pnas.94.15.8047; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Epstein JA, 1998, MOL CELL BIOL, V18, P4118, DOI 10.1128/MCB.18.7.4118; EPSTEIN JA, 1995, J BIOL CHEM, V270, P11719, DOI 10.1074/jbc.270.20.11719; FREDERICKS WJ, 1995, MOL CELL BIOL, V15, P1522; GOLDHAMER DJ, 1992, SCIENCE, V256, P538, DOI 10.1126/science.1315077; GOLDHAMER DJ, 1995, DEVELOPMENT, V121, P637; Keller C, 2004, GENE DEV, V18, P2614, DOI 10.1101/gad.1244004; Khan J, 1999, P NATL ACAD SCI USA, V96, P13264, DOI 10.1073/pnas.96.23.13264; Lam PYP, 1999, MOL CELL BIOL, V19, P594; Lang D, 2005, NATURE, V433, P884, DOI 10.1038/nature03292; LI L, 1992, CELL, V71, P1181, DOI 10.1016/S0092-8674(05)80066-2; Liu LN, 1998, CELL GROWTH DIFFER, V9, P699; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Novitch BG, 1999, CURR BIOL, V9, P449, DOI 10.1016/S0960-9822(99)80210-3; Novitch BG, 1996, J CELL BIOL, V135, P441, DOI 10.1083/jcb.135.2.441; Puri PL, 2000, J CELL PHYSIOL, V185, P155, DOI 10.1002/1097-4652(200011)185:2<155::AID-JCP1>3.0.CO;2-Z; Robson EJD, 2006, NAT REV CANCER, V6, P52, DOI 10.1038/nrc1778; SCHMIDT D, 1986, VIRCHOWS ARCH A, V409, P183, DOI 10.1007/BF00708327; TAPSCOTT SJ, 1992, MOL CELL BIOL, V12, P4994, DOI 10.1128/MCB.12.11.4994; Zhang L, 2007, ONCOGENE, V26, P1595, DOI 10.1038/sj.onc.1209958	27	38	38	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 27	2008	27	14					2004	2014		10.1038/sj.onc.1210835	http://dx.doi.org/10.1038/sj.onc.1210835			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	279MK	17922034				2022-12-25	WOS:000254359100005
J	Warnock, LJ; Adamson, R; Lynch, CJ; Milner, J				Warnock, L. J.; Adamson, R.; Lynch, C. J.; Milner, J.			Crosstalk between site-specific modifications on p53 and histone H3	ONCOGENE			English	Article						p53 protein; histone H3; phosphorylation; acetylation; methylation	TUMOR-SUPPRESSOR PROTEIN; POSTTRANSLATIONAL MODIFICATIONS; LYSINE METHYLATION; DNA-DAMAGE; PHOSPHORYLATION; ACTIVATION; ACETYLATION; BINDING; REPAIR; TRANSCRIPTION	Previously, we have observed a link between p53 expression and histone H3 post-translational modifications. Here, we ask if specific post-translational modifications of p53 impact upon histone H3 modi. cations in a selective manner. We have also screened for internal co-operative effects within the repertoire of p53 modi. cations. Exogenous p53 constructs were expressed in HCT116 p53(-/-) cells. Four mutant p53 constructs were used, with single 'phosphorylation' mutations at serines 15 and 37 (S15A, S15D, S37A and S37D) and compared with exogenously expressed wild-type p53. The results showed that the replacement of serine 15 with either alanine (S15A) or aspartic acid (S15D) induced phosphorylation at S33P, S37P and S46P. In contrast, phosphorylation mutants p53(S37A) and p53(S37D) were not phosphorylated on S33. S46 phosphorylation appeared specifically enhanced by p53(S37D) relative to p53(S37A). Distal induction of S392 phosphorylation was observed for each of the p53 N-terminal phosphorylation mutants. Analysis of endogenous histone H3 (from the transfected cells) revealed loss of di-methylated K9 following expression of wild type and mutant p53 constructs. Expression of p53 (S15A), (S15D) and (S37A) selectively induced acetylation at K9 and K14. In contrast, wt p53 and p53(S37D) had no effect upon K9 or K14 acetylation. K18 acetylation status was unaffected throughout.	[Warnock, L. J.; Adamson, R.; Lynch, C. J.; Milner, J.] Univ York, YCR P53 Res Grp, Dept Biol, York YO10 5DD, N Yorkshire, England	University of York - UK	Warnock, LJ (corresponding author), Univ York, YCR P53 Res Grp, Dept Biol, Zone 2, York YO10 5DD, N Yorkshire, England.	ljw7@york.ac.uk	Lynch, Cian/AIC-5510-2022; Lynch, Christopher J./E-6875-2010; Lynch, Cian J/K-2191-2017	Lynch, Cian/0000-0003-0187-3527; Lynch, Christopher J./0000-0003-2453-5838; Lynch, Cian J/0000-0003-0187-3527				Allison SJ, 2003, CANCER RES, V63, P6674; An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Espinosa JM, 2001, MOL CELL, V8, P57, DOI 10.1016/S1097-2765(01)00283-0; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kaeser MD, 2002, P NATL ACAD SCI USA, V99, P95, DOI 10.1073/pnas.012283399; Keller DM, 2001, MOL CELL, V7, P283, DOI 10.1016/S1097-2765(01)00176-9; Ljungman M, 2000, NEOPLASIA, V2, P208, DOI 10.1038/sj.neo.7900073; Morgunkova A, 2006, CELL CYCLE, V5, P1308, DOI 10.4161/cc.5.12.2820; Okorokov AL, 2002, CARCINOGENESIS, V23, P549, DOI 10.1093/carcin/23.4.549; Okorokov AL, 2006, EMBO J, V25, P5191, DOI 10.1038/sj.emboj.7601382; Rubbi CP, 2003, EMBO J, V22, P975, DOI 10.1093/emboj/cdg082; Saito S, 2003, J BIOL CHEM, V278, P37536, DOI 10.1074/jbc.M305135200; Saito S, 2002, J BIOL CHEM, V277, P12491, DOI 10.1074/jbc.C200093200; SCHAVOLT KL, 2007, ONCOGENE; Sengupta S, 2005, NAT REV MOL CELL BIO, V6, P44, DOI 10.1038/nrm1546; Sims RJ, 2006, GENE DEV, V20, P2779, DOI 10.1101/gad.1468206; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Vousden KH, 2006, J CELL SCI, V119, P5015, DOI 10.1242/jcs.03293; Vousden KH, 2002, BBA-REV CANCER, V1602, P47, DOI 10.1016/S0304-419X(02)00035-5; Warnock LJ, 2005, FEBS J, V272, P1669, DOI 10.1111/j.1742-4658.2005.04589.x; Yang XJ, 2005, ONCOGENE, V24, P1653, DOI 10.1038/sj.onc.1208173; Zhang K, 2005, J CELL BIOCHEM, V96, P1137, DOI 10.1002/jcb.20615; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Zhao RB, 2000, GENE DEV, V14, P981	28	12	13	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 6	2008	27	11					1639	1644		10.1038/sj.onc.1210787	http://dx.doi.org/10.1038/sj.onc.1210787			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	271VC	17891183				2022-12-25	WOS:000253815800016
J	Parvez, S; Beck, A; Peinelt, C; Soboloff, J; Lis, A; Monteilh-Zoller, M; Gill, DL; Fleig, A; Penner, R				Parvez, Suhel; Beck, Andreas; Peinelt, Christine; Soboloff, Jonathan; Lis, Annette; Monteilh-Zoller, Mahealani; Gill, Donald. L.; Fleig, Andrea; Penner, Reinhold			STIM2 protein mediates distinct store-dependent and store-independent modes of CRAC channel activation	FASEB JOURNAL			English	Article						STIM1; calmodulin; store-operated calcium entry	INOSITOL TRISPHOSPHATE RECEPTORS; OPERATED CA2+ ENTRY; PLASMA-MEMBRANE; 2-AMINOETHOXYDIPHENYL BORATE; CALCIUM INFLUX; RELEASE; ORAI1; CALMODULIN; DEPLETION; SENSOR	STIM1 and CRACM1 (or Orail) are essential molecular components mediating store-operated Ca2+ entry (SOCE) and Ca2+ release-activated Ca2+ (CRAC) currents. Although STIM1 acts as a luminal Ca2+ sensor in the endoplasmic reticulum (ER), the function of STIM2 remains unclear. Here we reveal that STIM2 has two distinct modes of activating CRAC channels: a store-operated mode that is activated through depletion of ER Ca2+ stores by inositol 1,4,5-trisphosphate (InsP(3)) and store-independent activation that is mediated by cell dialysis during whole-cell perfusion. Both modes are regulated by calmodulin (CaM). The store-operated mode is transient in intact cells, possibly reflecting recruitment of CaM, whereas loss of CaM in perfused cells accounts for the persistence of the store-independent mode. The inhibition by CaM can be reversed by 2-aminoethoxydiphenyl borate (2-APB), resulting in rapid, store-independent activation of CRAC channels. The aminoglycoside antibiotic G418 is a highly specific and potent inhibitor of STIM2-dependent CRAC channel activation. The results reveal a novel bimodal control of CRAC channels by STIM2, the store dependence and CaM regulation, which indicates that the STIM2/CRACM1 complex may be under the control of both luminal and cytoplasmic Ca2+ levels.	[Parvez, Suhel; Beck, Andreas; Peinelt, Christine; Lis, Annette; Monteilh-Zoller, Mahealani; Fleig, Andrea; Penner, Reinhold] Univ Hawaii, Queens Med Ctr, Ctr Biomed Res, Honolulu, HI 96813 USA; [Parvez, Suhel; Beck, Andreas; Peinelt, Christine; Lis, Annette; Monteilh-Zoller, Mahealani; Fleig, Andrea; Penner, Reinhold] Univ Hawaii, John A Burns Sch Med, Honolulu, HI 96822 USA; [Soboloff, Jonathan; Gill, Donald. L.] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19122 USA	The Queen's Medical Center; University of Hawaii System; University of Hawaii System; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Penner, R (corresponding author), Univ Hawaii, Queens Med Ctr, Ctr Biomed Res, 1301 Punchbowl St,UHT 8, Honolulu, HI 96813 USA.	rpenner@hawaii.edu	Parvez, Suhel/E-6778-2010; Peinelt, Christine/ABH-5292-2020; Soboloff, Jonathan/I-6995-2012	Parvez, Suhel/0000-0002-6318-6506; Soboloff, Jonathan/0000-0001-5192-1297; Fleig, Andrea/0000-0001-8396-7249; Penner, Reinhold/0000-0002-5366-1537; Peinelt, Christine/0000-0002-3474-6893	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058173, R01AI050200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040927] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI058173, R01-AI050200, R01 AI050200, AI058173] Funding Source: Medline; NINDS NIH HHS [R01-NS040927, R01 NS040927] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adkins CE, 2000, BIOCHEM J, V345, P357, DOI 10.1042/0264-6021:3450357; Braun FJ, 2001, J BIOL CHEM, V276, P1063, DOI 10.1074/jbc.M008348200; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Hermosura MC, 2002, J PHYSIOL-LONDON, V539, P445, DOI 10.1113/jphysiol.2001.013361; HOTH M, 1993, J PHYSIOL-LONDON, V465, P359, DOI 10.1113/jphysiol.1993.sp019681; Levitan IB, 1999, NEURON, V22, P645, DOI 10.1016/S0896-6273(00)80722-9; LI S, 2007, CURR BIOL, V17, P794; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Ma HT, 2002, J BIOL CHEM, V277, P6915, DOI 10.1074/jbc.M107755200; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Moreau B, 2005, J BIOL CHEM, V280, P8776, DOI 10.1074/jbc.M409619200; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Patel S, 1997, P NATL ACAD SCI USA, V94, P11627, DOI 10.1073/pnas.94.21.11627; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Prakriya M, 2001, J PHYSIOL-LONDON, V536, P3, DOI 10.1111/j.1469-7793.2001.t01-1-00003.x; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Soboloff J, 2006, CURR BIOL, V16, P1465, DOI 10.1016/j.cub.2006.05.051; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P4040, DOI 10.1073/pnas.0510050103; Vaca L, 1996, FEBS LETT, V390, P289, DOI 10.1016/0014-5793(96)00675-8; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Williams RT, 2001, BIOCHEM J, V357, P673, DOI 10.1042/0264-6021:3570673; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	33	127	134	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAR	2008	22	3					752	761		10.1096/fj.07-9449com	http://dx.doi.org/10.1096/fj.07-9449com			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	276LQ	17905723	Green Accepted			2022-12-25	WOS:000254143700014
J	Wang, X; Pan, L; Feng, Y; Wang, Y; Han, Q; Han, L; Han, S; Guo, J; Huang, B; Lu, J				Wang, X.; Pan, L.; Feng, Y.; Wang, Y.; Han, Q.; Han, L.; Han, S.; Guo, J.; Huang, B.; Lu, J.			p300 plays a role in p16(INK4a) expression and cell cycle arrest	ONCOGENE			English	Article						p16; p300; Sp1; transcriptional regulation	GENE-EXPRESSION; SP1; TRANSCRIPTION; INHIBITOR; BINDING; PROTEIN; PROLIFERATION; SENESCENCE; RECRUITMENT; LOCUS	As a cyclin-dependent kinase inhibitor, p16(INK4a) plays a key role in cell cycle progression and cellular differentiation, and its expression is frequently altered in human cancers through epigenetically mediated transcriptional silencing. In this report, we demonstrate that p300 was able to induce cell cycle arrest, and this process was reversed by p16(INK4a) silencing by RNA interference in HeLa cells. We also show that p300 was involved in activation of p16(INK4a) expression in 293T cells. Specifically, p300 cooperated with Sp1 to stimulate both p16(INK4a) promoter activity and mRNA expression. Co-immunoprecipitation and mammalian two-hybrid assays revealed that p300 and Sp1 formed a complex through interaction between the Q domain of p300 and the N-terminal domain of Sp1. The chromatin immunoprecipitation assays verified that p300 was recruited to p16(INK4a) promoter, and the histone acetyltransferase domain of p300 participated in p16(INK4a) activation through inducing hyperacetylation of histone H4 at p16(INK4a) gene. These data suggest that p300 plays a critical role in transcriptional regulation of p16(INK4a) and in cell cycle arrest.	[Wang, X.; Pan, L.; Feng, Y.; Wang, Y.; Han, Q.; Han, L.; Han, S.; Huang, B.; Lu, J.] NE Normal Univ, Inst Cytol & Genet, Changchun 130024, Peoples R China; [Guo, J.] NE Normal Univ, Key Lab Appl Stat MOS, Changchun, Peoples R China	Northeast Normal University - China; Northeast Normal University - China	Lu, J (corresponding author), NE Normal Univ, Inst Cytol & Genet, 5268 Renmin St, Changchun 130024, Peoples R China.	luj809@nenu.edu.cn	Han, Songyan/D-8351-2012					Bond J, 2004, EXP CELL RES, V292, P151, DOI 10.1016/j.yexcr.2003.09.021; Chan HM, 2001, J CELL SCI, V114, P2363; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; Deng QD, 2005, CANCER RES, V65, P8298, DOI 10.1158/0008-5472.CAN-05-0054; Gizard F, 2005, J CLIN INVEST, V115, P3228, DOI 10.1172/JCI22756; Han LP, 2006, BIOCHEM BIOPH RES CO, V348, P799, DOI 10.1016/j.bbrc.2006.07.147; Han SY, 2006, BIOCHEM J, V400, P439, DOI 10.1042/BJ20061085; Kivinen L, 1999, ONCOGENE, V18, P6252, DOI 10.1038/sj.onc.1203000; Kondo Y, 2003, MOL CELL BIOL, V23, P206, DOI 10.1128/MCB.23.1.206-215.2003; Lee CW, 1998, ONCOGENE, V16, P2695, DOI 10.1038/sj.onc.1201818; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2005, CYTOKINE, V31, P46, DOI 10.1016/j.cyto.2005.03.001; Magdinier F, 2001, P NATL ACAD SCI USA, V98, P4990, DOI 10.1073/pnas.101617298; MISSERO C, 1995, P NATL ACAD SCI USA, V92, P5451, DOI 10.1073/pnas.92.12.5451; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Owen GI, 1998, J BIOL CHEM, V273, P10696, DOI 10.1074/jbc.273.17.10696; Pore N, 2004, MOL BIOL CELL, V15, P4841, DOI 10.1091/mbc.E04-05-0374; Ray S, 2002, MOL ENDOCRINOL, V16, P824, DOI 10.1210/me.16.4.824; RUAS M, 1998, BIOCHIM BIOPHYS ACTA, V115, pF177; RUMI M, 2003, EXP HEMATOL, V31, P355; Ryu SJ, 1999, NATURE, V397, P446, DOI 10.1038/17141; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Suzuki T, 2000, GENES CELLS, V5, P29, DOI 10.1046/j.1365-2443.2000.00302.x; Voorhoeve PM, 2003, CANCER CELL, V4, P311, DOI 10.1016/S1535-6108(03)00223-X; Xiao HY, 2000, J BIOL CHEM, V275, P1371, DOI 10.1074/jbc.275.2.1371; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Zhao YM, 2005, J EXP BIOL, V208, P697, DOI 10.1242/jeb.01439	27	58	60	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR	2008	27	13					1894	1904		10.1038/sj.onc.1210821	http://dx.doi.org/10.1038/sj.onc.1210821			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	276NZ	17906698	Bronze			2022-12-25	WOS:000254150600009
J	Hinz, B; Cheremina, O; Brune, K				Hinz, Burkhard; Cheremina, Olga; Brune, Kay			Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man	FASEB JOURNAL			English	Article						cyclooxygenase isoenzymes; COX-2 selectivity; human whole blood assay; pharmacokinetics	NONSTEROIDAL ANTIINFLAMMATORY DRUGS; EXPRESSION; ASPIRIN; INFLAMMATION; MECHANISM; COX-3; DETERMINANTS; SYNTHASES; ARTHRITIS; THERAPY	For more than three decades, acetaminophen ( INN, paracetamol) has been claimed to be devoid of significant inhibition of peripheral prostanoids. Meanwhile, attempts to explain its action by inhibition of a central cyclooxygenase (COX)-3 have been rejected. The fact that acetaminophen acts functionally as a selective COX-2 inhibitor led us to investigate the hypothesis of whether it works via preferential COX-2 blockade. Ex vivo COX inhibition and pharmacokinetics of acetaminophen were assessed in 5 volunteers receiving single 1000 mg doses orally. Coagulation-induced thromboxane B-2 and lipopolysaccharideinduced prostaglandin E-2 were measured ex vivo and in vitro in human whole blood as indices of COX-1 and COX-2 activity. In vitro, acetaminophen elicited a 4.4-fold selectivity toward COX-2 inhibition (IC50 = 113.7 mu mol/L for COX-1; IC50 = 25.8 mu mol/L for COX-2). Following oral administration of the drug, maximal ex vivo inhibitions were 56% (COX-1) and 83% (COX-2). Acetaminophen plasma concentrations remained above the in vitro IC50 for COX-2 for at least 5 h postadministration. Ex vivo IC50 values ( COX-1: 105.2 mu mol/L; COX-2: 26.3 mu mol/L) of acetaminophen compared favorably with its in vitro IC50 values. In contrast to previous concepts, acetaminophen inhibited COX-2 by more than 80%, i.e., to a degree comparable to nonsteroidal antiinflammatory drugs ( NSAIDs) and selective COX-2 inhibitors. However, a > 95% COX-1 blockade relevant for suppression of platelet function was not achieved. Our data may explain acetaminophen's analgesic and antiinflammatory action as well as its superior overall gastrointestinal safety profile compared with NSAIDs. In view of its substantial COX-2 inhibition, recently defined cardiovascular warnings for use of COX-2 inhibitors should also be considered for acetaminophen.	[Hinz, Burkhard] Univ Rostock, Inst Pharmacol & Toxicol, D-18057 Rostock, Germany; [Cheremina, Olga; Brune, Kay] Univ Erlangen Nurnberg, Inst Expt & Clin Pharmacol & Toxicol, Erlangen, Germany	University of Rostock; University of Erlangen Nuremberg	Hinz, B (corresponding author), Univ Rostock, Inst Pharmacol & Toxicol, Schillingallee 70, D-18057 Rostock, Germany.	burkhard.hinz@med.uni-rostock.de						Abramson SB, 2002, ARTHRITIS RHEUM, V46, P2831, DOI 10.1002/art.10609; Bannwarth Bernard, 2004, Expert Opin Drug Saf, V3, P269, DOI 10.1517/14740338.3.4.269; Birmingham PK, 2001, ANESTHESIOLOGY, V94, P385; Bjornsson GA, 2003, BRIT J CLIN PHARMACO, V55, P405, DOI 10.1046/j.1365-2125.2003.01779.x; BOARDMAN PL, 1967, BMJ-BRIT MED J, V4, P264, DOI 10.1136/bmj.4.5574.264; Botting RM, 2000, CLIN INFECT DIS, V31, pS202, DOI 10.1086/317520; Boutaud O, 2002, P NATL ACAD SCI USA, V99, P7130, DOI 10.1073/pnas.102588199; Cannon CP, 2006, LANCET, V368, P1771, DOI 10.1016/S0140-6736(06)69666-9; Catella-Lawson F, 2001, NEW ENGL J MED, V345, P1809, DOI 10.1056/NEJMoa003199; Chan AT, 2006, CIRCULATION, V113, P1578, DOI 10.1161/CIRCULATIONAHA.105.595793; Chandrasekharan NV, 2002, P NATL ACAD SCI USA, V99, P13926, DOI 10.1073/pnas.162468699; Dinchuk JE, 2003, IMMUNOL LETT, V86, P121, DOI 10.1016/S0165-2478(02)00268-7; FERREIRA SH, 1978, POL J PHARMACOL PHAR, V30, P133; FLOWER RJ, 1972, NATURE, V240, P410, DOI 10.1038/240410a0; Forman JP, 2005, HYPERTENSION, V46, P500, DOI 10.1161/01.HYP.0000177437.07240.70; Graham Garry G, 2005, Am J Ther, V12, P46, DOI 10.1097/00045391-200501000-00008; Graham GG, 2005, DRUG SAFETY, V28, P227, DOI 10.2165/00002018-200528030-00004; HALLIWELL B, 1990, ARCH BIOCHEM BIOPHYS, V280, P1, DOI 10.1016/0003-9861(90)90510-6; Hinz B, 2000, BIOCHEM BIOPH RES CO, V278, P790, DOI 10.1006/bbrc.2000.3885; Hinz B, 2006, ARTHRITIS RHEUM-US, V54, P282, DOI 10.1002/art.21540; Honore P, 1995, PAIN, V63, P365, DOI 10.1016/0304-3959(95)00065-8; Jenkins C, 2004, BMJ-BRIT MED J, V328, P434, DOI 10.1136/bmj.328.7437.434; Kang KB, 2006, TRANSL RES, V148, P289, DOI 10.1016/j.trsl.2006.06.004; Kis B, 2005, J PHARMACOL EXP THER, V315, P1, DOI 10.1124/jpet.105.085431; LANGENBACH R, 1995, CELL, V83, P483, DOI 10.1016/0092-8674(95)90126-4; LANZ R, 1986, EUR J PHARMACOL, V130, P105, DOI 10.1016/0014-2999(86)90188-3; LAU GSN, 1994, J PHARMACEUT BIOMED, V12, P1563, DOI 10.1016/0731-7085(94)00859-0; Mantzke US, 2002, ANAESTHESIST, V51, P735, DOI 10.1007/s00101-002-0359-9; MCCORMACK K, 1987, ARCH TOXICOL, V60, P261, DOI 10.1007/BF01234664; MIELKE CH, 1981, ARCH INTERN MED, V141, P305, DOI 10.1001/archinte.141.3.305; MINERS JO, 1983, BRIT J CLIN PHARMACO, V16, P503, DOI 10.1111/j.1365-2125.1983.tb02207.x; Munsterhjelm E, 2005, ANESTHESIOLOGY, V103, P712, DOI 10.1097/00000542-200510000-00009; Niemi TT, 2000, ACTA ANAESTH SCAND, V44, P69, DOI 10.1034/j.1399-6576.2000.440113.x; Ouellet M, 2001, ARCH BIOCHEM BIOPHYS, V387, P273, DOI 10.1006/abbi.2000.2232; PATRIGNANI P, 1994, J PHARMACOL EXP THER, V271, P1705; Qin N, 2005, J PHARMACOL EXP THER, V315, P1298, DOI 10.1124/jpet.105.090944; Rahme E, 2002, ARTHRITIS RHEUM-US, V46, P3046, DOI 10.1002/art.10604; REILLY IAG, 1987, BLOOD, V69, P180; RING EFJ, 1974, ANN RHEUM DIS, V33, P353, DOI 10.1136/ard.33.4.353; Rodriguez LAG, 2001, EPIDEMIOLOGY, V12, P570; RUMACK BH, 1978, PEDIATRICS, V62, P943; Schnitzer TJ, 2002, J PAIN SYMPTOM MANAG, V23, pS24, DOI 10.1016/S0885-3924(02)00372-X; Schwab JM, 2003, FASEB J, V17, P2174, DOI 10.1096/fj.03-0595lte; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; SKJELBRED P, 1979, EUR J CLIN PHARMACOL, V15, P27, DOI 10.1007/BF00563555; Smith CJ, 1998, P NATL ACAD SCI USA, V95, P13313, DOI 10.1073/pnas.95.22.13313; Somasundaram S, 1997, GUT, V41, P344, DOI 10.1136/gut.41.3.344; Swierkosz Tomasz A, 2002, Med Sci Monit, V8, pBR496; TRIGGS EJ, 1975, J PHARMACOKINET BIOP, V3, P387, DOI 10.1007/BF01059473; Wallace JL, 1997, GASTROENTEROLOGY, V112, P1000, DOI 10.1053/gast.1997.v112.pm9041264; Warner TD, 2004, J PHARMACOL EXP THER, V310, P642, DOI 10.1124/jpet.103.063875	51	294	305	0	43	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2008	22	2					383	390		10.1096/fj.07-8506com	http://dx.doi.org/10.1096/fj.07-8506com			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	257TY	17884974				2022-12-25	WOS:000252822600008
J	Asano, Y; Czuwara, J; Trojanowska, M				Asano, Yoshihide; Czuwara, Joanna; Trojanowska, Maria			Transforming growth factor-beta regulates DNA binding activity of transcription factor fli1 by p300/CREB-binding protein-associated factor-dependent acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-2(I) COLLAGEN GENE; HUMAN DERMAL FIBROBLASTS; HISTONE ACETYLTRANSFERASES; ETS FAMILY; TGF-BETA; SCLERODERMA FIBROBLASTS; SIGNALING PATHWAY; FACTOR GATA-1; EXPRESSION; ACTIVATION	Fli1, a member of Ets transcriptional factors, has been shown to be a negative regulator of collagen gene expression in dermal fibroblasts. Although Fli1 down-regulation is implicated in pathological matrix remodeling such as cutaneous fibrosis in scleroderma, very little is known about the post-translational mechanisms regulating Fli1 function. The aim of this study was to investigate the role of acetylation, one of the main post-translational regulatory mechanisms, in regulating Fli1 activity. We initially demonstrated that Fli1 is acetylated by transforming growth factor (TGF)-beta 1 in dermal fibroblasts. An in vivo acetylation assay using 293T cells revealed that Fli1 is mainly acetylated by the histone acetyltransferase activity of p300/CBP- associated factor (PCAF) at lysine 380. Acetylation of Fli1 resulted in a decreased stability of Fli1 protein. More importantly, reduced binding of acetylated Fli1 to the human alpha 2( I) collagen (COL1A2) promoter was observed in DNA affinity precipitation and chromatin immunoprecipitation. Conversely, a Fli1 K380R mutant that is resistant to acetylation by PCAF showed increased DNA binding ability. Furthermore, PCAF overexpression reversed the inhibitory effect of Fli1 on TGF-beta 1-mediated COL1A2 promoter activity. In contrast, the Fli1 K380R mutant had a greater inhibitory effect on TGF-beta 1-induced COL1A2 promoter activity than wild-type Fli1, and PCAF failed to reverse this effect. These results indicate that PCAF-dependent acetylation of lysine 380 abrogates repressor function of Fli1 with respect to collagen gene expression. Furthermore, these data strongly suggest that the TGF-beta-dependent acetylation of Fli1 may represent the principal mechanism responsible for the TGF-beta-induced dissociation of Fli1 from the collagen promoter.	Med Univ S Carolina, Div Rheumatol & Immunol, Charleston, SC 29425 USA	Medical University of South Carolina	Trojanowska, M (corresponding author), Med Univ S Carolina, Div Rheumatol & Immunol, Charleston, SC 29425 USA.	trojanme@musc.edu	Czuwara, Joanna/AAK-4504-2020	Trojanowska, Maria/0000-0001-9550-7178	NCI NIH HHS [P01 CA78582] Funding Source: Medline; NIAMS NIH HHS [AR42334] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA078582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042334] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Asano Y, 2004, J CLIN INVEST, V113, P253, DOI 10.1172/JCI200416269; Bai YC, 2005, J IMMUNOL, V175, P5160, DOI 10.4049/jimmunol.175.8.5160; Bannister AJ, 2000, CURR BIOL, V10, P467, DOI 10.1016/S0960-9822(00)00445-0; Bannister AJ, 2000, CELL MOL LIFE SCI, V57, P1184, DOI 10.1007/PL00000758; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; Brown CE, 2000, TRENDS BIOCHEM SCI, V25, P15, DOI 10.1016/S0968-0004(99)01516-9; Chen HW, 2001, CURR OPIN CELL BIOL, V13, P218, DOI 10.1016/S0955-0674(00)00200-3; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Czuwara-Ladykowska J, 2002, J BIOL CHEM, V277, P20399, DOI 10.1074/jbc.M200206200; Czuwara-Ladykowska J, 2001, J BIOL CHEM, V276, P20839, DOI 10.1074/jbc.M010133200; Giandomenico V, 2003, MOL CELL BIOL, V23, P2587, DOI 10.1128/MCB.23.7.2587-2599.2003; Goel A, 2003, MOL CELL BIOL, V23, P6243, DOI 10.1128/MCB.23.17.6243-6254.2003; Graves BJ, 1998, ADV CANCER RES, V75, P1, DOI 10.1016/S0065-230X(08)60738-1; Gronroos E, 2002, MOL CELL, V10, P483, DOI 10.1016/S1097-2765(02)00639-1; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hart A, 2000, IMMUNITY, V13, P167, DOI 10.1016/S1074-7613(00)00017-0; Hollenhorst PC, 2004, NUCLEIC ACIDS RES, V32, P5693, DOI 10.1093/nar/gkh906; Hsu T, 2004, J CELL BIOCHEM, V91, P896, DOI 10.1002/jcb.20012; Hung HL, 1999, MOL CELL BIOL, V19, P3496; Inoue Y, 2007, ONCOGENE, V26, P500, DOI 10.1038/sj.onc.1209826; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Itoh S, 2000, NUCLEIC ACIDS RES, V28, P4291, DOI 10.1093/nar/28.21.4291; Jeong JW, 2002, CELL, V111, P709, DOI 10.1016/S0092-8674(02)01085-1; Jinnin M, 2006, J CELL PHYSIOL, V206, P718, DOI 10.1002/jcp.20527; Jinnin M, 2005, NUCLEIC ACIDS RES, V33, P3540, DOI 10.1093/nar/gki648; Jinnin M, 2005, NUCLEIC ACIDS RES, V33, P1337, DOI 10.1093/nar/gki275; Kiernan R, 2003, J BIOL CHEM, V278, P2758, DOI 10.1074/jbc.M209572200; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Kubo M, 2003, AM J PATHOL, V163, P571, DOI 10.1016/S0002-9440(10)63685-1; Mager AM, 1998, INT J DEV BIOL, V42, P561; Marmorstein R, 2001, CELL MOL LIFE SCI, V58, P693, DOI 10.1007/PL00000893; Marmorstein R, 2001, CURR OPIN GENET DEV, V11, P155, DOI 10.1016/S0959-437X(00)00173-8; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Masuya M, 2005, BLOOD, V105, P95, DOI 10.1182/blood-2003-12-4345; Munshi N, 1998, MOL CELL, V2, P457, DOI 10.1016/S1097-2765(00)80145-8; Nakerakanti SS, 2006, J BIOL CHEM, V281, P25259, DOI 10.1074/jbc.M600466200; Ogryzko VV, 2001, CELL MOL LIFE SCI, V58, P683, DOI 10.1007/PL00000892; Polesskaya A, 2000, J BIOL CHEM, V275, P34359, DOI 10.1074/jbc.M003815200; Rojas JR, 1999, NATURE, V401, P93, DOI 10.1038/43487; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Shirasaki F, 1999, ONCOGENE, V18, P7755, DOI 10.1038/sj.onc.1203360; Simonsson M, 2006, J BIOL CHEM, V281, P39870, DOI 10.1074/jbc.M607868200; Spyropoulos DD, 2000, MOL CELL BIOL, V20, P5643, DOI 10.1128/MCB.20.15.5643-5652.2000; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; TAMAKI T, 1995, J BIOL CHEM, V270, P4299, DOI 10.1074/jbc.270.9.4299; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Wang YQ, 2006, ARTHRITIS RHEUM-US, V54, P2271, DOI 10.1002/art.21948; Yao YL, 2001, MOL CELL BIOL, V21, P5979, DOI 10.1128/MCB.21.17.5979-5991.2001; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366; Zhang WJ, 1998, P NATL ACAD SCI USA, V95, P9855, DOI 10.1073/pnas.95.17.9855; Zhang WJ, 2001, MOL CELL BIOL, V21, P2413, DOI 10.1128/MCB.21.7.2413-2422.2001	51	75	76	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34672	34683		10.1074/jbc.M703907200	http://dx.doi.org/10.1074/jbc.M703907200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17884818	hybrid			2022-12-25	WOS:000251155200009
J	Bubenik, JL; Driscoll, DM				Bubenik, Jodi L.; Driscoll, Donna M.			Altered RNA binding activity underlies abnormal thyroid hormone metabolism linked to a mutation in selenocysteine insertion sequence-binding protein 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELENOPROTEIN-N GENE; MAMMALIAN SELENOCYSTEINE; MUSCULAR-DYSTROPHY; THIOREDOXIN REDUCTASE; SECONDARY STRUCTURE; RIGID SPINE; PROTEIN; RECOGNITION; SELENIUM; SECIS	The expression of selenoproteins requires the translational recoding of the UGA stop codon to selenocysteine. In eukaryotes, this requires an RNA stem loop structure in the 3' -untranslated region, termed a selenocysteine insertion sequence ( SECIS), and SECIS-binding protein 2 (SBP2). This study implicates SBP2 in dictating the hierarchy of selenoprotein expression, because it is the first to show that SBP2 distinguishes between SECIS elements in vitro. Using RNA electrophoretic mobility shift assays, we demonstrate that a naturally occurring mutation in SBP2, which correlates with abnormal thyroid hormone function in humans, lies within a novel, bipartite RNA-binding domain. This mutation alters the RNA binding affinity of SBP2 such that it no longer stably interacts with a subset of SECIS elements. Assays performed under competitive conditions to mimic intracellular conditions suggest that the differential affinity of SBP2 for various SECIS elements will determine the expression pattern of the selenoproteome. We hypothesize that the selective loss of a subset of selenoproteins, including some involved in thyroid hormone homeostasis, is responsible for the abnormal thyroid hormone metabolism previously observed in the affected individuals.	Case Western Reserve Univ, Coll Med, Lerner Res Inst, Cleveland Clin,Dept Cell Biol, Cleveland, OH 44195 USA; Case Western Reserve Univ, Coll Med, Cleveland Clin, Dept Mol Med, Cleveland, OH 44195 USA	Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Driscoll, DM (corresponding author), Case Western Reserve Univ, Coll Med, Lerner Res Inst, Cleveland Clin,Dept Cell Biol, Cleveland, OH 44195 USA.	driscod@ccf.org			NHLBI NIH HHS [HL29582] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL029582] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allamand V, 2006, EMBO REP, V7, P450, DOI 10.1038/sj.embor.7400648; Berry MJ, 2005, NAT GENET, V37, P1162, DOI 10.1038/ng1105-1162; BERRY MJ, 1991, NATURE, V353, P273, DOI 10.1038/353273a0; Bosl MR, 1997, P NATL ACAD SCI USA, V94, P5531, DOI 10.1073/pnas.94.11.5531; Caban K, 2007, MOL CELL BIOL, V27, P6350, DOI 10.1128/MCB.00632-07; Chavatte L, 2005, NAT STRUCT MOL BIOL, V12, P408, DOI 10.1038/nsmb922; Copeland PR, 2000, EMBO J, V19, P306, DOI 10.1093/emboj/19.2.306; Copeland PR, 1999, J BIOL CHEM, V274, P25447, DOI 10.1074/jbc.274.36.25447; Copeland PR, 2001, MOL CELL BIOL, V21, P1491, DOI 10.1128/MCB.21.5.1491-1498.2001; Driscoll DM, 2004, EMBO REP, V5, P140, DOI 10.1038/sj.embor.7400080; Dumitrescu AM, 2005, NAT GENET, V37, P1247, DOI 10.1038/ng1654; Fagegaltier D, 2000, EMBO J, V19, P4796, DOI 10.1093/emboj/19.17.4796; Ferreiro A, 2004, ANN NEUROL, V55, P676, DOI 10.1002/ana.20077; Ferreiro A, 2002, AM J HUM GENET, V71, P739, DOI 10.1086/342719; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Fletcher JE, 2001, RNA, V7, P1442; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; Gromer S, 2005, CELL MOL LIFE SCI, V62, P2414, DOI 10.1007/s00018-005-5143-y; Hatfield DL, 2002, MOL CELL BIOL, V22, P3565, DOI 10.1128/MCB.22.11.3565-3576.2002; Hoffmann PR, 2007, NUCLEIC ACIDS RES, V35, P3963, DOI 10.1093/nar/gkm355; Hoffmann PR, 2005, THYROID, V15, P769, DOI 10.1089/thy.2005.15.769; Jakupoglu C, 2005, MOL CELL BIOL, V25, P1980, DOI 10.1128/MCB.25.5.1980-1988.2005; Karplus K, 2003, PROTEINS, V53, P491, DOI 10.1002/prot.10540; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Kinzy SA, 2005, NUCLEIC ACIDS RES, V33, P5172, DOI 10.1093/nar/gki826; Kohrle J, 2000, CELL MOL LIFE SCI, V57, P1853, DOI 10.1007/PL00000667; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Lesoon A, 1997, MOL CELL BIOL, V17, P1977, DOI 10.1128/MCB.17.4.1977; Low SC, 2000, EMBO J, V19, P6882, DOI 10.1093/emboj/19.24.6882; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Mehta A, 2004, J BIOL CHEM, V279, P37852, DOI 10.1074/jbc.M404639200; Moghadaszadeh B, 2001, NAT GENET, V29, P17, DOI 10.1038/ng713; Okamoto Y, 2006, NEUROGENETICS, V7, P175, DOI 10.1007/s10048-006-0046-0; Ramos A, 2004, NUCLEIC ACIDS RES, V32, P1746, DOI 10.1093/nar/gkh331; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; SQUIRES JE, 2007, IN PRESS MOL CELL BI; Stefl R, 2005, EMBO REP, V6, P33, DOI 10.1038/sj.embor.7400325; Tajsharghi H, 2005, NEUROMUSCULAR DISORD, V15, P299, DOI 10.1016/j.nmd.2004.11.004; Tujebajeva RM, 2000, EMBO REP, V1, P158, DOI 10.1093/embo-reports/kvd033; Yant LJ, 2003, FREE RADICAL BIO MED, V34, P496, DOI 10.1016/S0891-5849(02)01360-6	41	56	57	2	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34653	34662		10.1074/jbc.M707059200	http://dx.doi.org/10.1074/jbc.M707059200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17901054	hybrid			2022-12-25	WOS:000251155200007
J	Dall'Osto, L; Fiore, A; Cazzaniga, S; Giuliano, G; Bassi, R				Dall'Osto, Luca; Fiore, Alessia; Cazzaniga, Stefano; Giuliano, Giovanni; Bassi, Roberto			Different roles of alpha- and beta-branch xanthophylls in photosystem assembly and photoprotection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING COMPLEX; CHLOROPHYLL-A FLUORESCENCE; TROPICAL TREE SEEDLINGS; ANTENNA PROTEIN CP26; ARABIDOPSIS-THALIANA; ENERGY-DISSIPATION; HIGHER-PLANTS; PHOTOOXIDATIVE STRESS; SINGLET OXYGEN; DELTA-PH	Xanthophylls ( oxygenated carotenoids) are essential components of the plant photosynthetic apparatus, where they act in photosystem assembly, light harvesting, and photoprotection. Nevertheless, the specific function of individual xanthophyll species awaits complete elucidation. In this work, we analyze the photosynthetic phenotypes of two newly isolated Arabidopsis mutants in carotenoid biosynthesis containing exclusively alpha-branch (chy1chy2lut5)or beta-branch (chy1chy2lut2) xanthophylls. Both mutants show complete lack of qE, the rapidly reversible component of nonphotochemical quenching, and high levels of photoinhibition and lipid peroxidation under photooxidative stress. Both mutants are much more photosensitive than npq1lut2, which contains high levels of viola- and neoxanthin and a higher stoichiometry of light-harvesting proteins with respect to photosystem II core complexes, suggesting that the content in light-harvesting complexes plays an important role in photoprotection. In addition, chy1chy2lut5, which has lutein as the only xanthophyll, shows unprecedented photosensitivity even in low light conditions, reduced electron transport rate, enhanced photobleaching of isolated LHCII complexes, and a selective loss of CP26 with respect to chy1chy2lut2, highlighting a specific role of beta-branch xanthophylls in photoprotection and in qE mechanism. The stronger photosystem II photoinhibition of both mutants correlates with the higher rate of singlet oxygen production from thylakoids and isolated light-harvesting complexes, whereas carotenoid composition of photosystem II core complex was not influential. In depth analysis of the mutant phenotypes suggests that alpha-branch ( lutein) and beta-branch ( zeaxanthin, violaxanthin, and neoxanthin) xanthophylls have distinct and complementary roles in antenna protein assembly and in the mechanisms of photoprotection.	Univ Verona, Dipartimento Sci & Tecnol, I-37134 Verona, Italy; Ctr Ric Casaccia, Dipartimento Biotecnol, I-00100 Rome, Italy	University of Verona; Italian National Agency New Technical Energy & Sustainable Economics Development	Bassi, R (corresponding author), Univ Verona, Dipartimento Sci & Tecnol, Strada Le Grazie 15, I-37134 Verona, Italy.	bassi@sci.univr.it	Cazzaniga, Stefano/ABG-3898-2021; Dall'Osto, Luca/A-9384-2010; Giuliano, Giovanni/A-2701-2012	Cazzaniga, Stefano/0000-0002-2824-7916; Dall'Osto, Luca/0000-0001-9497-5156; bassi, roberto/0000-0002-4140-8446; Giuliano, Giovanni/0000-0002-2486-0510				Andersson J, 2001, PLANT CELL, V13, P1193, DOI 10.1105/tpc.13.5.1193; ARO EM, 1994, PLANT PHYSIOL, V104, P1033, DOI 10.1104/pp.104.3.1033; Ballottari M, 2004, EUR J BIOCHEM, V271, P4659, DOI 10.1111/j.1432-1033.2004.04426.x; Ballottari M, 2007, J BIOL CHEM, V282, P8947, DOI 10.1074/jbc.M606417200; BARBER J, 1992, TRENDS BIOCHEM SCI, V17, P61, DOI 10.1016/0968-0004(92)90503-2; Baroli I, 2003, PLANT CELL, V15, P992, DOI 10.1105/tpc.010405; Baroli I, 2004, J BIOL CHEM, V279, P6337, DOI 10.1074/jbc.M312919200; Bassi R, 1999, P NATL ACAD SCI USA, V96, P10056, DOI 10.1073/pnas.96.18.10056; BASSI R, 1993, EUR J BIOCHEM, V212, P297, DOI 10.1111/j.1432-1033.1993.tb17662.x; Bellafiore S, 2005, NATURE, V433, P892, DOI 10.1038/nature03286; Caffarri S, 2001, J BIOL CHEM, V276, P35924, DOI 10.1074/jbc.M105199200; Casazza AP, 2001, PHOTOSYNTH RES, V68, P175, DOI 10.1023/A:1011818021875; Castelletti S, 2003, BIOCHEMISTRY-US, V42, P4226, DOI 10.1021/bi027398r; Connelly JP, 1997, BIOCHEMISTRY-US, V36, P281, DOI 10.1021/bi962467l; Croce R, 1999, J BIOL CHEM, V274, P29613, DOI 10.1074/jbc.274.42.29613; Croce R, 2002, BIOCHEMISTRY-US, V41, P7334, DOI 10.1021/bi0257437; Dall'Osto L, 2005, PLANT CELL, V17, P1217, DOI 10.1105/tpc.104.030601; Dall'Osto L, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-32; Dall'Osto L, 2007, PLANT CELL, V19, P1048, DOI 10.1105/tpc.106.049114; Davison PA, 2002, NATURE, V418, P203, DOI 10.1038/nature00861; DEMMIGADAMS B, 1992, ANNU REV PLANT PHYS, V43, P599, DOI 10.1146/annurev.pp.43.060192.003123; DEMMIGADAMS B, 1990, PLANT PHYSIOL, V92, P293, DOI 10.1104/pp.92.2.293; DEMMIGADAMS B, 1995, AUST J PLANT PHYSIOL, V22, P249, DOI 10.1071/PP9950249; Espineda CE, 1999, P NATL ACAD SCI USA, V96, P10507, DOI 10.1073/pnas.96.18.10507; Evron Y, 2000, PLANT PHYSIOL, V124, P407, DOI 10.1104/pp.124.1.407; Fiore A, 2006, FEBS LETT, V580, P4718, DOI 10.1016/j.febslet.2006.07.055; Flors C, 2006, J EXP BOT, V57, P1725, DOI 10.1093/jxb/erj181; Formaggio E, 2001, J MOL BIOL, V314, P1157, DOI 10.1006/jmbi.2000.5179; GILMORE AM, 1994, FEBS LETT, V350, P271, DOI 10.1016/0014-5793(94)00784-5; GILMORE AM, 1991, PLANT PHYSIOL, V96, P635, DOI 10.1104/pp.96.2.635; Gilmore AM, 2001, PHOTOCHEM PHOTOBIOL, V74, P291, DOI 10.1562/0031-8655(2001)074<0291:TROTAA>2.0.CO;2; Gilmore AM, 2001, PHOTOSYNTH RES, V67, P89, DOI 10.1023/A:1010657000548; Havaux M, 1999, P NATL ACAD SCI USA, V96, P8762, DOI 10.1073/pnas.96.15.8762; Havaux M, 2004, J BIOL CHEM, V279, P13878, DOI 10.1074/jbc.M311154200; Havaux M, 2005, PLANT CELL, V17, P3451, DOI 10.1105/tpc.105.037036; Havaux M, 2001, PLANTA, V213, P953, DOI 10.1007/s004250100572; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; Kim J, 2006, P NATL ACAD SCI USA, V103, P3474, DOI 10.1073/pnas.0511207103; Krause GH, 2004, FUNCT PLANT BIOL, V31, P743, DOI 10.1071/FP03239; Krause GH, 2001, PLANT CELL ENVIRON, V24, P1345, DOI 10.1046/j.0016-8025.2001.00786.x; Krieger-Liszkay A, 2005, J EXP BOT, V56, P337, DOI 10.1093/jxb/erh237; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Lokstein H, 2002, BBA-BIOENERGETICS, V1553, P309, DOI 10.1016/S0005-2728(02)00184-6; Lundin B, 2007, PLANT J, V49, P528, DOI 10.1111/j.1365-313X.2006.02976.x; MALKIN S, 1981, PLANT PHYSIOL, V67, P570, DOI 10.1104/pp.67.3.570; Matsubara S, 2005, J EXP BOT, V56, P461, DOI 10.1093/jxb/eri012; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Milborrow BV, 2001, J EXP BOT, V52, P1145, DOI 10.1093/jexbot/52.359.1145; Morosinotto T, 2003, PHYSIOL PLANTARUM, V119, P347, DOI 10.1034/j.1399-3054.2003.00213.x; Niyogi KK, 1997, P NATL ACAD SCI USA, V94, P14162, DOI 10.1073/pnas.94.25.14162; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.1105/tpc.10.7.1121; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Niyogi KK, 2001, PHOTOSYNTH RES, V67, P139, DOI 10.1023/A:1010661102365; op den Camp RGL, 2003, PLANT CELL, V15, P2320, DOI 10.1105/tpc.014662; Peterman EJG, 1997, BIOCHEMISTRY-US, V36, P12208, DOI 10.1021/bi9711689; PLUMLEY FG, 1987, P NATL ACAD SCI USA, V84, P146, DOI 10.1073/pnas.84.1.146; Pogson BJ, 1998, P NATL ACAD SCI USA, V95, P13324, DOI 10.1073/pnas.95.22.13324; Pogson BJ, 2000, PHILOS T ROY SOC B, V355, P1395, DOI 10.1098/rstb.2000.0701; Rissler HM, 2001, PHOTOSYNTH RES, V67, P127, DOI 10.1023/A:1010669404183; Sbarbati A, 2004, CHEM SENSES, V29, P683, DOI 10.1093/chemse/bjh071; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SIEFERMANNHARMS D, 1987, PHYSIOL PLANTARUM, V69, P561, DOI 10.1111/j.1399-3054.1987.tb09240.x; Sonoike K, 1996, PLANT CELL PHYSIOL, V37, P239, DOI 10.1093/oxfordjournals.pcp.a028938; Tian L, 2003, PLANT CELL, V15, P1320, DOI 10.1105/tpc.011403; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANKOOTEN O, 1990, PHOTOSYNTH RES, V25, P147, DOI 10.1007/BF00033156; Verhoeven AS, 1999, PLANT PHYSIOL, V120, P727, DOI 10.1104/pp.120.3.727; WALTERS RG, 1995, PLANTA, V197, P306, DOI 10.1007/BF00202652; Wollman FA, 2001, EMBO J, V20, P3623, DOI 10.1093/emboj/20.14.3623; YAMAMOTO HY, 1962, ARCH BIOCHEM BIOPHYS, V97, P168, DOI 10.1016/0003-9861(62)90060-7	71	115	120	4	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35056	35068		10.1074/jbc.M704729200	http://dx.doi.org/10.1074/jbc.M704729200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17913714	hybrid			2022-12-25	WOS:000251155200050
J	Ratner, GA; Hodel, AE; Powers, MA				Ratner, Gary A.; Hodel, Alec E.; Powers, Maureen A.			Molecular determinants of binding between gly-leu-phe-gly nucleoporins and the nuclear pore complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOGENESIS PATHWAY; TARGETING DOMAIN; NUP98; ARCHITECTURE; PROTEINS; LOCALIZATION; MECHANISMS; TRANSPORT; PRECURSOR; DYNAMICS	The vertebrate nucleoporin Nup98 can be expressed in two distinct forms from differentially spliced mRNAs, either as a 98-kDa protein or as the 195-kDa Nup98/Nup96 polyprotein. Both forms undergo autoproteolytic processing to generate the 90-kDa Nup98 and either an 8-kDa tail or the nucleoporin Nup96. An equivalent cleavage event occurs in one yeast ortholog, Nup145, to produce Nup145N and Nup145C. We previously proposed that Nup145N, and possibly the other orthologs Nup116 and Nup100, might bind to Nup145C as demonstrated for Nup98 and Nup96. Here we have further investigated the interaction of both yeast and vertebrate Gly-Leu-Phe-Gly nucleoporins with the nuclear pore. We find that dynamic Nup98 binding can be recapitulated in vitro and that simultaneous translation and folding as a polyprotein are not required to allow subsequent binding between Nup98 and Nup96. We show that Nup145N and Nup145C do indeed bind to each other, and we have determined the dissociation constants for these interactions in vitro. Additionally, we characterize two sites of molecular interaction for each binding pair. Of the yeast orthologs, Nup116 binds far less robustly to Nup145C than does Nup145N, and Nup100 binding is barely detectable. Thus, we conclude that Nup116 and Nup100 likely use means of incorporation into the nuclear pore complex that are distinct from those used by Nup145N.	Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Biochem Cell & Dev Biol Grad Program, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Powers, MA (corresponding author), Emory Univ, Sch Med, Dept Cell Biol, 615 Michael St, Atlanta, GA 30322 USA.	mpowers@cellbio.emory.edu			NIGMS NIH HHS [GM 59975, GM 58692] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058692, R01GM059975] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Boehmer T, 2003, P NATL ACAD SCI USA, V100, P981, DOI 10.1073/pnas.252749899; Bucci M, 1998, MOL BIOL CELL, V9, P2439, DOI 10.1091/mbc.9.9.2439; CHECOVICH WJ, 1995, NATURE, V375, P254, DOI 10.1038/375254a0; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Devos D, 2006, P NATL ACAD SCI USA, V103, P2172, DOI 10.1073/pnas.0506345103; Fontoura BMA, 1999, J CELL BIOL, V144, P1097, DOI 10.1083/jcb.144.6.1097; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Griffis ER, 2004, MOL BIOL CELL, V15, P1991, DOI 10.1091/mbc.e03-10-0743; Griffis ER, 2003, MOL BIOL CELL, V14, P600, DOI 10.1091/mbc.E02-09-0582; Griffis ER, 2002, MOL BIOL CELL, V13, P1282, DOI 10.1091/mbc.01-11-0538; Ho AK, 2000, MOL CELL BIOL, V20, P5736, DOI 10.1128/MCB.20.15.5736-5748.2000; Hodel AE, 2002, MOL CELL, V10, P347, DOI 10.1016/S1097-2765(02)00589-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MACAULAY C, 1995, J BIOL CHEM, V270, P254, DOI 10.1074/jbc.270.1.254; Osmani AH, 2006, MOL BIOL CELL, V17, P4946, DOI 10.1091/mbc.E06-07-0657; Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044; Perler FB, 1997, CURR OPIN CHEM BIOL, V1, P292, DOI 10.1016/S1367-5931(97)80065-8; Peters Reiner, 2006, V322, P235; PRASHER DC, 1992, GENE, V111, P229, DOI 10.1016/0378-1119(92)90691-H; Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184; RIIKONEN A, 1995, J BIOL CHEM, V270, P4903, DOI 10.1074/jbc.270.9.4903; Robinson MA, 2005, J BIOL CHEM, V280, P35723, DOI 10.1074/jbc.M505068200; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Schwartz TU, 2005, CURR OPIN STRUC BIOL, V15, P221, DOI 10.1016/j.sbi.2005.03.003; Stochaj U, 2006, EXP CELL RES, V312, P2490, DOI 10.1016/j.yexcr.2006.04.007; Suntharalingam M, 2003, DEV CELL, V4, P775, DOI 10.1016/S1534-5807(03)00162-X; Teixeira MT, 1999, J BIOL CHEM, V274, P32439, DOI 10.1074/jbc.274.45.32439; Teixeira MT, 1997, EMBO J, V16, P5086, DOI 10.1093/emboj/16.16.5086; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; Vasu S, 2001, J CELL BIOL, V155, P339, DOI 10.1083/jcb.200108007; Walther TC, 2003, CELL, V113, P195, DOI 10.1016/S0092-8674(03)00235-6; Xu QA, 1999, CELL, V98, P651, DOI 10.1016/S0092-8674(00)80052-5	34	14	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					33968	33976		10.1074/jbc.M707911200	http://dx.doi.org/10.1074/jbc.M707911200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17897945	hybrid			2022-12-25	WOS:000251145700010
J	Langer, M; Sniderhan, LF; Grossniklaus, U; Ray, A				Langer, Marybeth; Sniderhan, Lynn F.; Grossniklaus, Ueli; Ray, Animesh			Transposon Excision from an Atypical Site: A Mechanism of Evolution of Novel Transposable Elements	PLOS ONE			English	Article							ACTIVATOR TRANSPOSASE; MEIOTIC RECOMBINATION; MAIZE; GENE; REPAIR; ARABIDOPSIS; FREQUENCY; SEQUENCES; PATTERNS; HOMOLOG	The role of transposable elements in sculpting the genome is well appreciated but remains poorly understood. Some organisms, such as humans, do not have active transposons; however, transposable elements were presumably active in their ancestral genomes. Of specific interest is whether the DNA surrounding the sites of transposon excision become recombinogenic, thus bringing about homologous recombination. Previous studies in maize and Drosophila have provided conflicting evidence on whether transposon excision is correlated with homologous recombination. Here we take advantage of an atypical Dissociation (Ds) element, a maize transposon that can be mobilized by the Ac transposase gene in Arabidopsis thaliana, to address questions on the mechanism of Ds excision. This atypical Ds element contains an adjacent 598 base pairs (bp) inverted repeat; the element was allowed to excise by the introduction of an unlinked Ac transposase source through mating. Footprints at the excision site suggest a micro-homology mediated non-homologous end joining reminiscent of V(D)J recombination involving the formation of intra-helix 3' to 5' trans-esterification as an intermediate, a mechanism consistent with previous observations in maize, Antirrhinum and in certain insects. The proposed mechanism suggests that the broken chromosome at the excision site should not allow recombinational interaction with the homologous chromosome, and that the linked inverted repeat should also be mobilizable. To test the first prediction, we measured recombination of flanking chromosomal arms selected for the excision of Ds. In congruence with the model, Ds excision did not influence crossover recombination. Furthermore, evidence for correlated movement of the adjacent inverted repeat sequence is presented; its origin and movement suggest a novel mechanism for the evolution of repeated elements. Taken together these results suggest that the movement of transposable elements themselves may not directly influence linkage. Possibility remains, however, for novel repeated DNA sequences produced as a consequence of transposon movement to influence crossover in subsequent generations.	[Langer, Marybeth; Sniderhan, Lynn F.; Ray, Animesh] Univ Rochester, Dept Biol, Rochester, NY 14627 USA; [Grossniklaus, Ueli] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Ray, Animesh] Keck Grad Inst, Claremont, CA USA	University of Rochester; Cold Spring Harbor Laboratory; Claremont Colleges; Keck Graduate Institute	Ray, A (corresponding author), Univ Rochester, Dept Biol, Rochester, NY 14627 USA.	aray@kgi.edu	Grossniklaus, Ueli/A-2736-2012; Grossniklaus, Ueli/E-9995-2016	Grossniklaus, Ueli/0000-0002-0522-8974; Ray, Animesh/0000-0002-0120-5820	National Science Foundation [IBN-9982414, EIA-0130059, EIA-0205061]; Cold Spring Harbor Laboratory President's Council; European Molecular Biology Organization	National Science Foundation(National Science Foundation (NSF)); Cold Spring Harbor Laboratory President's Council; European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	Work in AR's laboratory was supported by National Science Foundation grants IBN-9982414, EIA-0130059, and EIA-0205061 to AR. Work in UG's laboratory was supported by the Cold Spring Harbor Laboratory President's Council and the European Molecular Biology Organization grants to UG.	Bai L, 2007, GENETICS, V175, P981, DOI 10.1534/genetics.106.066837; Becker HA, 1997, MOL GEN GENET, V254, P219, DOI 10.1007/s004380050410; COEN ES, 1986, CELL, V47, P285, DOI 10.1016/0092-8674(86)90451-4; Conrad LJ, 2005, GENETICS, V171, P1999, DOI 10.1534/genetics.105.046623; Dooner HK, 1997, PLANT CELL, V9, P1633, DOI 10.1105/tpc.9.9.1633; Dooner HK, 1997, GENETICS, V147, P1923; Eichler EE, 2003, SCIENCE, V301, P793, DOI 10.1126/science.1086132; ENGELS WR, 1990, CELL, V62, P515, DOI 10.1016/0092-8674(90)90016-8; FEDOROFF NV, 1993, PLANT J, V3, P273, DOI 10.1046/j.1365-313X.1993.t01-15-00999.x; Fischer SEJ, 2003, GENETICS, V164, P127; FRADKIN CMW, 1956, GENETICS, V41, P901; Fu HH, 2002, P NATL ACAD SCI USA, V99, P1082, DOI 10.1073/pnas.022635499; GLOOR GB, 1991, SCIENCE, V253, P1110, DOI 10.1126/science.1653452; Golden TA, 2002, PLANT PHYSIOL, V130, P808, DOI 10.1104/pp.003491; Gorbunova V, 2000, GENETICS, V155, P349; Grossniklaus U, 1998, SCIENCE, V280, P446, DOI 10.1126/science.280.5362.446; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; MCBLANE JF, 1995, CELL, V83, P387, DOI 10.1016/0092-8674(95)90116-7; McClintock B, 1953, CARNEGIE I WASH YB, V52, P227; Page DR, 2004, P NATL ACAD SCI USA, V101, P2969, DOI 10.1073/pnas.0400089101; Ray A, 1996, DEVELOPMENT, V122, P2631; Rinehart TA, 1997, PLANT J, V12, P1419, DOI 10.1046/j.1365-313x.1997.12061419.x; ROMMENS CMT, 1991, MOL GEN GENET, V228, P453, DOI 10.1007/BF00260639; Ros F, 2001, GENETICS, V157, P1723; ROTH DB, 1993, P NATL ACAD SCI USA, V90, P10788, DOI 10.1073/pnas.90.22.10788; SAEDLER H, 1985, EMBO J, V4, P585, DOI 10.1002/j.1460-2075.1985.tb03670.x; Scott L, 1996, GENETICS, V142, P237; SUNDARESAN V, 1995, GENE DEV, V9, P1797, DOI 10.1101/gad.9.14.1797; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; vanderBiezen EA, 1996, MOL GEN GENET, V251, P267, DOI 10.1007/BF02172517; Weil CF, 2000, NAT GENET, V26, P187, DOI 10.1038/82827; Wright SI, 2003, GENOME RES, V13, P1897, DOI 10.1101/gr.1281503; Xiao YL, 2002, MOL GENET GENOMICS, V266, P720, DOI 10.1007/s00438-001-0600-2; Xiao YL, 2000, GENETICS, V156, P2007; Yan XH, 1999, GENETICS, V152, P1733; Yao H, 2002, P NATL ACAD SCI USA, V99, P6157, DOI 10.1073/pnas.082562199; Yu JH, 2004, MOL CELL BIOL, V24, P1351, DOI 10.1128/MCB.24.3.1351-1364.2004; Zhou LQ, 2004, NATURE, V432, P995, DOI 10.1038/nature03157	39	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e965	10.1371/journal.pone.0000965	http://dx.doi.org/10.1371/journal.pone.0000965			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912344	gold, Green Published, Green Submitted			2022-12-25	WOS:000207455900003
J	de Jonge, HJM; Fehrmann, RSN; de Bont, ESJM; Hofstra, RMW; Gerbens, F; Kamps, WA; de Vries, EGE; van der Zee, AGJ; Meerman, GJT; ter Elst, A				de Jonge, Hendrik J. M.; Fehrmann, Rudolf S. N.; de Bont, Eveline S. J. M.; Hofstra, Robert M. W.; Gerbens, Frans; Kamps, Willem A.; de Vries, Elisabeth G. E.; van der Zee, Ate G. J.; Meerman, Gerard J. te; ter Elst, Arja			Evidence Based Selection of Housekeeping Genes	PLOS ONE			English	Article							EXPRESSION; RNA; PCR; QUANTIFICATION; MESSENGER	For accurate and reliable gene expression analysis, normalization of gene expression data against housekeeping genes (reference or internal control genes) is required. It is known that commonly used housekeeping genes (e. g. ACTB, GAPDH, HPRT1, and B2M) vary considerably under different experimental conditions and therefore their use for normalization is limited. We performed a meta-analysis of 13,629 human gene array samples in order to identify the most stable expressed genes. Here we show novel candidate housekeeping genes (e. g. RPS13, RPL27, RPS20 and OAZ1) with enhanced stability among a multitude of different cell types and varying experimental conditions. None of the commonly used housekeeping genes were present in the top 50 of the most stable expressed genes. In addition, using 2,543 diverse mouse gene array samples we were able to confirm the enhanced stability of the candidate novel housekeeping genes in another mammalian species. Therefore, the identified novel candidate housekeeping genes seem to be the most appropriate choice for normalizing gene expression data.	[de Jonge, Hendrik J. M.; de Bont, Eveline S. J. M.; Kamps, Willem A.; ter Elst, Arja] Univ Groningen, Dept Pediat, Univ Med Ctr Groningen, Div Pediat Oncol Hematol,Beatrix Childrens Hosp, NL-9700 AB Groningen, Netherlands; [Fehrmann, Rudolf S. N.; Hofstra, Robert M. W.; Gerbens, Frans; Meerman, Gerard J. te] Univ Groningen, Dept Genet, Univ Med Ctr Groningen, NL-9700 AB Groningen, Netherlands; [Fehrmann, Rudolf S. N.; van der Zee, Ate G. J.] Univ Groningen, Dept Gynecol, Univ Med Ctr Groningen, NL-9700 AB Groningen, Netherlands; [Fehrmann, Rudolf S. N.; de Vries, Elisabeth G. E.] Univ Groningen, Dept Med Oncol, Univ Med Ctr Groningen, NL-9700 AB Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	ter Elst, A (corresponding author), Univ Groningen, Dept Pediat, Univ Med Ctr Groningen, Div Pediat Oncol Hematol,Beatrix Childrens Hosp, NL-9700 AB Groningen, Netherlands.	a.ter.elst@med.umcg.nl	Fehrmann, Rudolf/E-2551-2011	Fehrmann, Rudolf/0000-0002-7516-315X; de Vries, Elisabeth/0000-0002-8949-7425; Hofstra, Robert/0000-0001-7498-3829	Dutch Cancer Society [3661]; Foundation for Pediatric Oncology	Dutch Cancer Society(KWF Kankerbestrijding); Foundation for Pediatric Oncology	This work was supported by a grant from the Dutch Cancer Society (grantnr 3661) to E.S.J.M. de B, a grant of the Foundation for Pediatric Oncology to H.J.M. de J and A ter E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Chuaqui RF, 2002, NAT GENET, V32, P509, DOI 10.1038/ng1034; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fink L, 1998, NAT MED, V4, P1329, DOI 10.1038/3327; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; JOHNSON ML, 1995, BIOTECHNIQUES, V19, P712; Lee SJ, 2002, CRIT REV EUKAR GENE, V12, P297, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i4.40; Novak JP, 2002, GENOMICS, V79, P104, DOI 10.1006/geno.2001.6675; Solanas M, 2001, ANAL BIOCHEM, V288, P99, DOI 10.1006/abio.2000.4889; SPANAKIS E, 1993, NUCLEIC ACIDS RES, V21, P3809, DOI 10.1093/nar/21.16.3809; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034	16	535	563	4	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2007	2	9							e898	10.1371/journal.pone.0000898	http://dx.doi.org/10.1371/journal.pone.0000898			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HS	17878933	Green Published, gold			2022-12-25	WOS:000207455700006
J	Freilinger, A; Rosner, M; Hanneder, M; Hengstschlager, M				Freilinger, A.; Rosner, M.; Hanneder, M.; Hengstschlaeger, M.			Ras mediates cell survival by regulating tuberin	ONCOGENE			English	Article						Ras; survival; tuberin; ERK; RSK	TUMOR-SUPPRESSOR GENE; RIBOSOMAL S6 KINASE; SCLEROSIS COMPLEX; 3-KINASE/AKT PATHWAY; HUMAN-DISEASE; TSC2; PRODUCT; GROWTH; PHOSPHORYLATION; APOPTOSIS	Mutational activation of Ras promotes oncogenesis by controlling cell cycle regulation and cell survival. Ras-mediated activation of both, the PI3K/AKT pathway and the MEK/ERK pathway, can trigger downregulation of the function of tuberin to block the activities of mTOR and p70S6K. Here we demonstrate that Ras-induced cell survival is accompanied by upregulation of p70S6K activity. Ras harbors the potential to negatively affect tuberin-induced apoptosis and p70S6K inactivation. These effects of Ras were found to depend on its potential to regulate the MEK/ERK pathway. Experiments using tuberin-negative fibroblasts revealed that the potential of Ras to counteract apoptosis depends on functional tuberin. Taken together, we provide evidence that the function of Ras to trigger inactivation of tuberin plays a major role in the regulation of cell survival upon mutational activation of the oncogene Ras. This is the first description of a functional interaction between the tumor suppressor tuberin and the oncogene Ras in regulating apoptosis.	[Hengstschlaeger, M.] Med Univ Vienna, Gen Hosp, A-1090 Vienna, Austria	Medical University of Vienna	Hengstschlager, M (corresponding author), Med Univ Vienna, Gen Hosp, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.	markus.hengstschlaeger@meduniwien.ac.at						Adachi H, 2003, J UROLOGY, V170, P601, DOI 10.1097/01.ju.0000074621.74361.10; Arrebola F, 2005, APOPTOSIS, V10, P1317, DOI 10.1007/s10495-005-2718-x; Astrinidis A, 2005, ONCOGENE, V24, P7475, DOI 10.1038/sj.onc.1209090; Ballif BA, 2005, P NATL ACAD SCI USA, V102, P667, DOI 10.1073/pnas.0409143102; Cox AD, 2003, ONCOGENE, V22, P8999, DOI 10.1038/sj.onc.1207111; Dan HC, 2002, J BIOL CHEM, V277, P35364, DOI 10.1074/jbc.M205838200; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Downward J, 2004, SEMIN CELL DEV BIOL, V15, P177, DOI 10.1016/j.semcdb.2004.01.002; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Freilinger A, 2006, ONCOGENE, V25, P6467, DOI 10.1038/sj.onc.1209660; Goncharova EA, 2002, J BIOL CHEM, V277, P30958, DOI 10.1074/jbc.M202678200; Harada H, 2001, P NATL ACAD SCI USA, V98, P9666, DOI 10.1073/pnas.171301998; Henry KW, 1998, J BIOL CHEM, V273, P20535, DOI 10.1074/jbc.273.32.20535; Hornigold N, 1999, ONCOGENE, V18, P2657, DOI 10.1038/sj.onc.1202854; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jiang WG, 2005, EUR J CANCER, V41, P1628, DOI 10.1016/j.ejca.2005.03.023; Kalejta RF, 1997, CYTOMETRY, V29, P286, DOI 10.1002/(SICI)1097-0320(19971201)29:4<286::AID-CYTO4>3.0.CO;2-8; Knowles MA, 2003, CANCER RES, V63, P7652; Knowles MA, 2003, BIOCHEM SOC T, V31, P597, DOI 10.1042/BST0310597; Kolb TM, 2005, TOXICOL SCI, V88, P331, DOI 10.1093/toxsci/kfi310; Kwiatkowski DJ, 2003, ANN HUM GENET, V67, P87, DOI 10.1046/j.1469-1809.2003.00012.x; Li Y, 2004, TRENDS BIOCHEM SCI, V29, P32, DOI 10.1016/j.tibs.2003.11.007; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Miloloza A, 2000, HUM MOL GENET, V9, P1721, DOI 10.1093/hmg/9.12.1721; Pan DJ, 2004, TRENDS CELL BIOL, V14, P78, DOI 10.1016/j.tcb.2003.12.006; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Rosner M, 2004, J BIOL CHEM, V279, P48707, DOI 10.1074/jbc.M405528200; Rosner M, 2003, ONCOGENE, V22, P4786, DOI 10.1038/sj.onc.1206776; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Soucek T, 1998, ONCOGENE, V16, P2197, DOI 10.1038/sj.onc.1201743; Soucek T, 1998, P NATL ACAD SCI USA, V95, P15653, DOI 10.1073/pnas.95.26.15653; Soucek T, 1997, J BIOL CHEM, V272, P29301, DOI 10.1074/jbc.272.46.29301; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Wohlfart S, 2004, AM J PATHOL, V164, P1081, DOI 10.1016/S0002-9440(10)63195-1; Xiao GH, 1997, J BIOL CHEM, V272, P6097, DOI 10.1074/jbc.272.10.6097	40	11	11	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 27	2008	27	14					2072	2083		10.1038/sj.onc.1210844	http://dx.doi.org/10.1038/sj.onc.1210844			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	279MK	17922028				2022-12-25	WOS:000254359100012
J	Katayama, K; Nakamura, A; Sugimoto, Y; Tsuruo, T; Fujita, N				Katayama, K.; Nakamura, A.; Sugimoto, Y.; Tsuruo, T.; Fujita, N.			FOXO transcription factor-dependent p15(INK4b) and p19(INK4d) expression	ONCOGENE			English	Article						Akt; FOXO; INK4	CYTOPLASMIC LOCALIZATION; GENE-EXPRESSION; CELL-LINES; PHOSPHORYLATION; AKT; INHIBITORS; P27(KIP1); BINDING; FKHR; INVOLVEMENT	FOXO (Forkhead box O) transcription factors are involved in cell-cycle arrest or apoptosis induction by transcripting cell-cycle inhibitor p27(KIP1) or apoptosis-related genes, respectively. Akt/protein kinase B promotes cell proliferation and suppresses apoptosis, in part, by phosphorylating FOXOs. Phosphorylated FOXOs could not exhibit transcriptional activity because of their nuclear export. Here we show that p15(INK4b) and p19(INK4d) transcription is associated with FOXO-mediated G(1) cell-cycle arrest. Inhibition of Akt signaling by PI3K inhibitors, a PDK1 inhibitor, or dominant-negative Akt transfection increased expression of p15(INK4b) and p19(INK4d) but not p16(INK4a) and p18(INK4c). Ectopic expression of wild type or active FOXO but not inactive form also increased p15(INK4b) and p19(INK4d) levels. FOXOs bound to promoter regions and induced transcription of these genes. No increase in the G1-arrested cell population, mediated by PI3K inhibitor LY294002, was observed in INK4b(-/-) or INK4d(-/-) murine embryonic fibroblasts. In summary, FOXOs are involved in G1 arrest caused by Akt inactivation via p15(INK4b) and p19(INK4d) transcription.	[Katayama, K.; Nakamura, A.; Sugimoto, Y.; Tsuruo, T.; Fujita, N.] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Div Expt Chemotherapy, Tokyo 1358550, Japan; [Katayama, K.; Sugimoto, Y.] Kyoritsu Univ Pharm, Dept Chemotherapy, Tokyo, Japan; [Nakamura, A.] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo, Japan	Japanese Foundation for Cancer Research; Keio University; University of Tokyo	Fujita, N (corresponding author), Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Div Expt Chemotherapy, Tokyo 1358550, Japan.	naoya.fujita@jfcr.or.jp	Katayama, Kazuhiro/AAH-2914-2019; Fujita, Naoya/A-7349-2010	Katayama, Kazuhiro/0000-0003-4232-7661; Fujita, Naoya/0000-0002-9631-9264				Bonneau D, 2000, HUM MUTAT, V16, P109, DOI 10.1002/1098-1004(200008)16:2<109::AID-HUMU3>3.0.CO;2-0; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cichy SB, 1998, J BIOL CHEM, V273, P6482, DOI 10.1074/jbc.273.11.6482; Collado M, 2000, J BIOL CHEM, V275, P21960, DOI 10.1074/jbc.M000759200; Fujita N, 2002, J BIOL CHEM, V277, P28706, DOI 10.1074/jbc.M203668200; Katayama K, 2005, MOL CELL BIOL, V25, P5725, DOI 10.1128/MCB.25.13.5725-5737.2005; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Latres E, 2000, EMBO J, V19, P3496, DOI 10.1093/emboj/19.13.3496; Matsushima-Nishiu M, 2001, CANCER RES, V61, P3741; Matsuura I, 2004, NATURE, V430, P226, DOI 10.1038/nature02650; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Ogasawara T, 2004, MOL CELL BIOL, V24, P6560, DOI 10.1128/mcb.24.15.6560-6568.2004; PUISIEUX A, 1993, FASEB J, V7, P1407, DOI 10.1096/fasebj.7.14.8224613; Rodier G, 2001, EMBO J, V20, P6672, DOI 10.1093/emboj/20.23.6672; Rokudai S, 2002, MOL CELL BIOL, V22, P8695, DOI 10.1128/MCB.22.24.8695-8708.2002; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Suhara T, 2002, MOL CELL BIOL, V22, P680, DOI 10.1128/MCB.22.2.680-691.2002; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Tsuruo T, 2003, CANCER SCI, V94, P15, DOI 10.1111/j.1349-7006.2003.tb01345.x; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Wells J, 2003, ONCOGENE, V22, P1445, DOI 10.1038/sj.onc.1206264; Woods YL, 2002, BIOCHEM SOC T, V30, P391, DOI 10.1042/bst0300391; Zariwala M, 1996, ONCOGENE, V12, P451; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032; Zindy F, 2000, MOL CELL BIOL, V20, P372, DOI 10.1128/MCB.20.1.372-378.2000	29	54	56	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 13	2008	27	12					1677	1686		10.1038/sj.onc.1210813	http://dx.doi.org/10.1038/sj.onc.1210813			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	273WF	17873901				2022-12-25	WOS:000253962100003
J	Zhu, S; Korzh, V; Gong, Z; Low, BC				Zhu, S.; Korzh, V.; Gong, Z.; Low, B. C.			RhoA prevents apoptosis during zebrafish embryogenesis through activation of Mek/Erk pathway	ONCOGENE			English	Article						RhoA; Mek/Erk; Bcl-2; apoptosis; embryogenesis; zebrafish	MAMMARY EPITHELIAL-CELLS; ACTIN DEPOLYMERIZATION; SIGNALING PATHWAY; BCL-2 EXPRESSION; PROTEIN-KINASE; SURVIVAL; DIFFERENTIATION; PROLIFERATION; METASTASIS; INHIBITION	RhoA small GTPase, as a key regulator for actin cytoskeletal rearrangement, plays pivotal roles during morphogenesis, cytokinesis, phagocytosis and cell migration, but little is known about its signaling mechanism that controls cell survival in vivo. Using zebrafish as a model, we show that non-overlapping antisense morpholinos that block either translation or splicing of rhoA lead to extensive apoptosis during embryogenesis, resulting in overall reduction of body size and body length. These defects are associated with reduced activation of growth-promoting Erk and decreased expression of anti-apoptotic bcl-2. Moreover, ectopic expression of rhoA, Mek or BCL-2 mRNA rescues such phenotypes. Consistently, combined suppression of RhoA and Mek/Erk or Bcl-2 pathways by sub-optimal dose of rhoA morpholino and pharmacological inhibitors for either Mek (U0126) or Bcl-2 (HA 14-1) can induce developmental abnormalities and enhanced apoptosis, similar to those caused by effective RhoA knockdown. Furthermore, U0126 abrogates the rescue by RhoA and MEK but not BCL-2. In contrast, HA 14-1 effectively abolishes all functional rescues by RhoA, MEK or BCL-2, supporting that RhoA prevents apoptosis by activation of Mek/ Erk pathway and requiring Bcl-2. These findings reveal an important genetic and functional relationship between RhoA with Mek/ Erk and Bcl-2 for cell survival control during embryogenesis.	[Zhu, S.; Korzh, V.; Low, B. C.] Natl Univ Singapore, Dept Biol Sci, Cell Signaling & Dev Biol Lab, Singapore 117543, Singapore; [Zhu, S.; Gong, Z.] Natl Univ Singapore, Dept Biol Sci, Mol Biol Lab, Singapore 117543, Singapore; [Korzh, V.] Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Low, BC (corresponding author), Natl Univ Singapore, Dept Biol Sci, Cell Signaling & Dev Biol Lab, 14 Sci Dr 4, Singapore 117543, Singapore.	dbslowbc@nus.edu.sg	Korzh, Vladimir P/H-1596-2011; Low, Boon Chuan/AAU-7685-2021; Low, Boon Chuan/H-8049-2012; Gong, Zhiyuan/H-8794-2012	Korzh, Vladimir P/0000-0002-6580-7986; Low, Boon Chuan/0000-0003-0756-096X; Low, Boon Chuan/0000-0003-0756-096X; Gong, Zhiyuan/0000-0002-9660-5260				Aznar S, 2001, CANCER LETT, V165, P1, DOI 10.1016/S0304-3835(01)00412-8; Beis D, 2006, TRENDS CELL BIOL, V16, P105, DOI 10.1016/j.tcb.2005.12.001; Bijian K, 2005, AM J PHYSIOL-RENAL, V289, pF1313, DOI 10.1152/ajprenal.00106.2005; Blanco-Colio LM, 2002, ATHEROSCLEROSIS, V161, P17, DOI 10.1016/S0021-9150(01)00613-X; Cole LK, 2001, DEV BIOL, V240, P123, DOI 10.1006/dbio.2001.0432; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Corson LB, 2003, DEVELOPMENT, V130, P4527, DOI 10.1242/dev.00669; Del Re DP, 2007, J BIOL CHEM, V282, P8069, DOI 10.1074/jbc.M604298200; Deng X, 2001, J Natl Cancer Inst Monogr, P30; Doshi JM, 2006, J MED CHEM, V49, P7731, DOI 10.1021/jm060968r; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fromigue O, 2006, CELL DEATH DIFFER, V13, P1845, DOI 10.1038/sj.cdd.4401873; Gabay L, 1997, SCIENCE, V277, P1103, DOI 10.1126/science.277.5329.1103; Giehl K, 2005, BIOL CHEM, V386, P193, DOI 10.1515/BC.2005.025; Gomez J, 1997, EUR J IMMUNOL, V27, P2793, DOI 10.1002/eji.1830271108; Harms C, 2004, MOL CELL NEUROSCI, V25, P69, DOI 10.1016/j.mcn.2003.09.012; Henning SW, 1997, EMBO J, V16, P2397, DOI 10.1093/emboj/16.9.2397; Hong CC, 2006, CURR BIOL, V16, P1366, DOI 10.1016/j.cub.2006.05.046; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Kobayashi K, 2004, J NEUROSCI, V24, P3480, DOI 10.1523/JNEUROSCI.0295-04.2004; Korichneva I, 1999, J CELL SCI, V112, P2521; Krens SFG, 2006, GENE EXPR PATTERNS, V6, P1019, DOI 10.1016/j.modgep.2006.04.008; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Li XW, 2002, J BIOL CHEM, V277, P15309, DOI 10.1074/jbc.M201253200; Martin S, 2001, MOL CELL BIOL, V21, P6529, DOI 10.1128/MCB.21.19.6529-6536.2001; McClintock JM, 2002, DEVELOPMENT, V129, P2339; McWhorter ML, 2003, J CELL BIOL, V162, P919, DOI 10.1083/jcb.200303168; Miyake H, 1999, BRIT J CANCER, V79, P1651, DOI 10.1038/sj.bjc.6690264; Navarro P, 1999, J BIOL CHEM, V274, P18857, DOI 10.1074/jbc.274.27.18857; Pinkas J, 2004, MOL CANCER RES, V2, P551; Posey SC, 1999, J BIOL CHEM, V274, P4259, DOI 10.1074/jbc.274.7.4259; Rikitake Y, 2000, ARTERIOSCL THROM VAS, V20, P1006, DOI 10.1161/01.ATV.20.4.1006; Rios-Munoz W, 2005, J NEUROCHEM, V93, P1422, DOI 10.1111/j.1471-4159.2005.03129.x; Tahinci E, 2003, DEV BIOL, V259, P318, DOI 10.1016/S0012-1606(03)00206-9; Wang JL, 2000, P NATL ACAD SCI USA, V97, P7124, DOI 10.1073/pnas.97.13.7124; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wick W, 1998, FEBS LETT, V440, P419, DOI 10.1016/S0014-5793(98)01494-X; Wullimann MF, 2000, ANAT EMBRYOL, V202, P385, DOI 10.1007/s004290000115; Yao Y, 2003, P NATL ACAD SCI USA, V100, P12759, DOI 10.1073/pnas.2134254100; Zhao M, 2006, MOL PHARMACOL, V69, P66, DOI 10.1124/mol.105.016923; Zhu SZ, 2006, CELL SIGNAL, V18, P359, DOI 10.1016/j.cellsig.2005.05.019	42	36	38	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 6	2008	27	11					1580	1589		10.1038/sj.onc.1210790	http://dx.doi.org/10.1038/sj.onc.1210790			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	271VC	17873909				2022-12-25	WOS:000253815800010
J	Choi, H; Aboulfatova, K; Pownall, HJ; Cook, R; Dong, JF				Choi, Hiuwan; Aboulfatova, Khatira; Pownall, Henry J.; Cook, Richard; Dong, Jing-fei			Shear-induced disulfide bond formation regulates adhesion activity of von Willebrand factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELET GLYCOPROTEIN IB; VONWILLEBRAND-FACTOR; ENDOTHELIAL-CELLS; ISOMERASE CATALYZES; VICINAL CYSTEINES; LINKED COMPLEXES; SELF-ASSOCIATION; VWF MULTIMERS; PROTEIN; VITRONECTIN	von Willebrand factor (VWF) is the largest multimeric adhesion ligand circulating in blood. Its adhesion activity is related to multimer size, with the ultra-large forms freshly released from the activated endothelial cells being most active, capable of spontaneously binding to platelets. In comparison, smaller plasma forms circulating in blood bind platelets only under high fluid shear stress or induced by modulators. The structure-function relationships that distinguish the two types of VWF multimers are not known. In this study, we demonstrate that some of the plasma VWF multimers contain surface-exposed free thiols. Physiological and pathological levels of shear stresses (50 and 100 dynes/cm(2)) promote the formation of disulfide bonds utilizing these free thiols. The shear-induced thiol-disulfide exchange increases VWF binding to platelets. The thiol-disulfide exchange involves some or all of nine cysteine residues (Cys(889), Cys(898), Cys(2448), Cys(2451), Cys(2490), Cys(2491), Cys(2453), Cys(2528), and Cys(2533)) in the D3 and C domains as determined by mass spectrometry of the tryptic VWF peptides. These results suggest that the thiol-disulfide state may serve as an important structural determinant of VWF adhesion activity and can be modified by fluid shear stress.	Baylor Coll Med, Dept Med, Thrombosis Res Sect, Houston, TX 77030 USA; Baylor Coll Med, Dept Med, Sect Atherosclerosis & Vasc Dis, Houston, TX 77030 USA; Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Dong, JF (corresponding author), Baylor Coll Med, Dept Med, Thrombosis Res Sect, BCM286,N1319,1 Baylor Plaza, Houston, TX 77030 USA.	jfdong@bcm.tmc.edu		Pownall, Henry/0000-0001-8412-506X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071895, R01HL030914] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL30914, HL71895] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arya M, 2002, BLOOD, V99, P3971, DOI 10.1182/blood-2001-11-0060; BRAAKMAN I, 1991, J CELL BIOL, V114, P401, DOI 10.1083/jcb.114.3.401; Brouland JP, 1999, ARTERIOSCL THROM VAS, V19, P3055, DOI 10.1161/01.ATV.19.12.3055; Burgess JK, 2000, J BIOL CHEM, V275, P9758, DOI 10.1074/jbc.275.13.9758; Carugo O, 2003, PROTEIN ENG, V16, P637, DOI 10.1093/protein/gzg088; Chen VM, 2006, BIOCHEMISTRY-US, V45, P12020, DOI 10.1021/bi061271a; Chiarugi P, 2001, J BIOL CHEM, V276, P33478, DOI 10.1074/jbc.M102302200; DEBOER HC, 1993, J BIOL CHEM, V268, P1279; Dong JF, 2002, BLOOD, V100, P4033, DOI 10.1182/blood-2002-05-1401; Dong JF, 2001, BLOOD, V97, P162, DOI 10.1182/blood.V97.1.162; Essex DW, 1999, BIOCHEMISTRY-US, V38, P10398, DOI 10.1021/bi990694s; Ganderton T, 2007, J THROMB HAEMOST, V5, P204, DOI 10.1111/j.1538-7836.2006.02292.x; HESSEL B, 1984, THROMB RES, V35, P637, DOI 10.1016/0049-3848(84)90267-6; ISAACS NW, 1995, CURR OPIN STRUC BIOL, V5, P391, DOI 10.1016/0959-440X(95)80102-2; Katsumi A, 2000, J BIOL CHEM, V275, P25585, DOI 10.1074/jbc.M002654200; Keuren JFW, 2004, BLOOD, V103, P1741, DOI 10.1182/blood-2003-07-2267; LOSCALZO J, 1985, BIOCHEMISTRY-US, V24, P4468, DOI 10.1021/bi00337a031; MARTI T, 1987, BIOCHEMISTRY-US, V26, P8099, DOI 10.1021/bi00399a013; MAYADAS TN, 1992, P NATL ACAD SCI USA, V89, P3531, DOI 10.1073/pnas.89.8.3531; MAYADAS TN, 1989, J BIOL CHEM, V264, P13497; MCCRARY JK, 1995, ANN BIOMED ENG, V23, P787, DOI 10.1007/BF02584477; Milev Y, 1999, ARCH BIOCHEM BIOPHYS, V361, P120, DOI 10.1006/abbi.1998.0963; MOAKE JL, 1988, BLOOD, V71, P1366; Moake JL, 1998, J CLIN APHERESIS, V13, P126, DOI 10.1002/(SICI)1098-1101(1998)13:3<126::AID-JCA6>3.0.CO;2-U; MOAKE JL, 1986, J CLIN INVEST, V78, P1456, DOI 10.1172/JCI112736; OHMORI K, 1982, J CELL BIOL, V95, P632, DOI 10.1083/jcb.95.2.632; Purvis AR, 2007, P NATL ACAD SCI USA, V104, P15647, DOI 10.1073/pnas.0705175104; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Savage B, 2002, P NATL ACAD SCI USA, V99, P425, DOI 10.1073/pnas.012459599; Schneppenheim R, 1996, P NATL ACAD SCI USA, V93, P3581, DOI 10.1073/pnas.93.8.3581; Shankaran H, 2003, BLOOD, V101, P2637, DOI 10.1182/blood-2002-05-1550; Siedlecki CA, 1996, BLOOD, V88, P2939, DOI 10.1182/blood.V88.8.2939.bloodjournal8882939; THORELL L, 1984, THROMB RES, V35, P431, DOI 10.1016/0049-3848(84)90235-4; TOMASINI BR, 1989, BIOCHEMISTRY-US, V28, P7617, DOI 10.1021/bi00445a017; TSAI HM, 1991, BRIT J HAEMATOL, V79, P239, DOI 10.1111/j.1365-2141.1991.tb04528.x; VERWEIJ CL, 1987, EMBO J, V6, P2885, DOI 10.1002/j.1460-2075.1987.tb02591.x; VOORBERG J, 1991, J CELL BIOL, V113, P195, DOI 10.1083/jcb.113.1.195; WAGNER DD, 1987, BLOOD, V69, P27; WAGNER DD, 1984, J CELL BIOL, V99, P2123, DOI 10.1083/jcb.99.6.2123; Wang SH, 2001, J CHROMATOGR A, V924, P345, DOI 10.1016/S0021-9673(01)00961-X; WISE RJ, 1988, CELL, V52, P229, DOI 10.1016/0092-8674(88)90511-9; Zhang JN, 2003, THROMB HAEMOSTASIS, V90, P672, DOI 10.1160/TH03-03-0145	42	88	88	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35604	35611		10.1074/jbc.M704047200	http://dx.doi.org/10.1074/jbc.M704047200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17925407	hybrid			2022-12-25	WOS:000251458100020
J	Kitago, Y; Karita, S; Watanabe, N; Kamiya, M; Aizawa, T; Sakka, K; Tanaka, I				Kitago, Yu; Karita, Shuichi; Watanabe, Nobuhisa; Kamiya, Masakatsu; Aizawa, Tomoyasu; Sakka, Kazuo; Tanaka, Isao			Crystal structure of Cel44A, a glycoside hydrolase family 44 endoglucanase from Clostridium thermocellum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-SCATTERING; CLAN GH-A; MACROMOLECULAR STRUCTURES; GLYCOSIDE HYDROLASES; BETA-GLUCOSIDASE; REFINEMENT; CELLULOSOME; CELJ; CLASSIFICATION; XYLOSIDASE	The crystal structure of Cel44A, which is one of the enzymatic components of the cellulosome of Clostridium thermocellum, was solved at a resolution of 0.96 angstrom. This enzyme belongs to glycoside hydrolase family (GH family) 44. The structure reveals that Cel44A consists of a TIM-like barrel domain and a beta-sandwich domain. The wild-type and the E186Q mutant structures complexed with substrates suggest that two glutamic acid residues, Glu(186) and Glu(359), are the active residues of the enzyme. Biochemical experiments were performed to confirm this idea. The structural features indicate that GH family 44 belongs to clan GH-A and that the reaction catalyzed by Cel44A is retaining type hydrolysis. The stereochemical course of hydrolysis was confirmed by a H-1 NMR experiment using the reduced cellooligosaccharide as a substrate.	Hokkaido Univ, Fac Adv Life Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan; Mie Univ, Grad Sch Bioresources, Tsu, Mie 5148507, Japan; Hokkaido Univ, Grad Sch Sci, Div Biol Sci, Sapporo, Hokkaido 0600810, Japan	Hokkaido University; Mie University; Hokkaido University	Watanabe, N (corresponding author), Hokkaido Univ, Fac Adv Life Sci, Kita Ku, N10W8, Sapporo, Hokkaido 0600810, Japan.	nobuhisa@sci.hokudai.ac.jp	Kamiya, Masakatsu/F-5274-2011; Watanabe, Nobuhisa/B-1187-2008; Aizawa, Tomoyasu/F-5278-2011	Watanabe, Nobuhisa/0000-0002-0118-5815; Aizawa, Tomoyasu/0000-0001-9134-7576; Kitago, Yu/0000-0003-2325-6917				Ahsan MM, 1997, BIOSCI BIOTECH BIOCH, V61, P427, DOI 10.1271/bbb.61.427; Ahsan MM, 1996, J BACTERIOL, V178, P5732, DOI 10.1128/jb.178.19.5732-5740.1996; Arai T, 2003, J BACTERIOL, V185, P504, DOI 10.1128/JB.185.2.504-512.2003; BAYER EA, 1986, J BACTERIOL, V167, P823; BEGUIN P, 1994, FEMS MICROBIOL REV, V13, P25, DOI 10.1016/0168-6445(94)90099-X; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Coutinho PM, 1999, ROY SOC CH, P3; Czjzek M, 2005, J MOL BIOL, V353, P838, DOI 10.1016/j.jmb.2005.09.003; Durand P, 1997, GLYCOBIOLOGY, V7, P277, DOI 10.1093/glycob/7.2.277; Dvir H, 2003, EMBO REP, V4, P704, DOI 10.1038/sj.embor.embor873; Hammel M, 2005, J BIOL CHEM, V280, P38562, DOI 10.1074/jbc.M503168200; Hammel M, 2004, J BIOL CHEM, V279, P55985, DOI 10.1074/jbc.M408979200; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Hovel K, 2003, EMBO J, V22, P4922, DOI 10.1093/emboj/cdg494; JENKINS J, 1995, FEBS LETT, V362, P281, DOI 10.1016/0014-5793(95)00252-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Larson SB, 2003, BIOCHEMISTRY-US, V42, P8411, DOI 10.1021/bi034144c; Madkour M, 2003, CELL BIOL INT, V27, P831, DOI 10.1016/S1065-6995(03)00166-5; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Najmudin S, 2006, J BIOL CHEM, V281, P8815, DOI 10.1074/jbc.M510559200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Ryttersgaard C, 2002, BIOCHEMISTRY-US, V41, P15135, DOI 10.1021/bi026238c; Sakon J, 1996, BIOCHEMISTRY-US, V35, P10648, DOI 10.1021/bi9604439; SCHOU C, 1993, EUR J BIOCHEM, V217, P947, DOI 10.1111/j.1432-1033.1993.tb18325.x; Shaw A, 2002, J MOL BIOL, V320, P303, DOI 10.1016/S0022-2836(02)00387-X; Sheldrick G.M, 2001, International Tables for Macromolecular Crystallography, P333; Sheldrick G.M., 2003, SHELXC; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Yang JK, 2004, J MOL BIOL, V335, P155, DOI 10.1016/j.jmb.2003.10.026; Yao M, 2006, ACTA CRYSTALLOGR D, V62, P189, DOI 10.1107/S0907444905038965; Zhou Y, 2006, J APPL CRYSTALLOGR, V39, P57, DOI 10.1107/S0021889805039270	35	36	40	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35703	35711		10.1074/jbc.M706835200	http://dx.doi.org/10.1074/jbc.M706835200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17905739	hybrid			2022-12-25	WOS:000251458100031
J	Pless, SA; Dibas, MI; Lester, HA; Lynch, JW				Pless, Stephan A.; Dibas, Mohammed I.; Lester, Henry A.; Lynch, Joseph W.			Conformational variability of the glycine receptor M2 domain in response to activation by different agonists	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; CHLORIDE CHANNEL; GATING MECHANISM; ION-CHANNEL; M2-M3 LOOP; OPEN STATE; PORE; BINDING; IDENTIFICATION; ACCESSIBILITY	Models describing the structural changes mediating Cys loop receptor activation generally give little attention to the possibility that different agonists may promote activation via distinct M2 pore-lining domain structural rearrangements. We investigated this question by comparing the effects of different ligands on the conformation of the external portion of the homomeric alpha 1 glycine receptor M2 domain. Conformational flexibility was assessed by tethering a rhodamine fluorophore to cysteines introduced at the 19' or 22' positions and monitoring fluorescence and current changes during channel activation. During glycine activation, fluorescence of the label attached to R19' C increased by similar to 20%, and the emission peak shifted to lower wavelengths, consistent with a more hydrophobic fluorophore environment. In contrast, ivermectin activated the receptors without producing a fluorescence change. Although taurine and beta-alanine were weak partial agonists at the alpha 1R19' C glycine receptor, they induced large fluorescence changes. Propofol, which drastically enhanced these currents, did not induce a glycine-like blue shift in the spectral emission peak. The inhibitors strychnine and picrotoxin elicited fluorescence and current changes as expected for a competitive antagonist and an open channel blocker, respectively. Glycine and taurine (or beta-alanine) also produced an increase and a decrease, respectively, in the fluorescence of a label attached to the nearby L22' C residue. Thus, results from two separate labeled residues support the conclusion that the glycine receptor M2 domain responds with distinct conformational changes to activation by different agonists.	Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; CALTECH, Div Biol, Pasadena, CA 91125 USA	University of Queensland; California Institute of Technology	Lynch, JW (corresponding author), Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia.	j.lynch@uq.edu.au	Lynch, Joseph/C-8636-2009	Pless, Stephan/0000-0001-6654-114X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS011756] Funding Source: NIH RePORTER; NINDS NIH HHS [NS-11756] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; Chang YC, 2002, NAT NEUROSCI, V5, P1163, DOI 10.1038/nn926; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; Cymes GD, 2002, BIOCHEMISTRY-US, V41, P5548, DOI 10.1021/bi011864f; Dahan DS, 2004, P NATL ACAD SCI USA, V101, P10195, DOI 10.1073/pnas.0301885101; England PM, 1999, CELL, V96, P89, DOI 10.1016/S0092-8674(00)80962-9; Gandhi CS, 2005, TRENDS NEUROSCI, V28, P472, DOI 10.1016/j.tins.2005.07.005; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; Han NLR, 2004, J BIOL CHEM, V279, P19559, DOI 10.1074/jbc.M400548200; Hawthorne R, 2005, J BIOL CHEM, V280, P35836, DOI 10.1074/jbc.M506645200; Hawthorne R, 2006, J NEUROCHEM, V98, P395, DOI 10.1111/j.1471-4159.2006.03875.x; Hemmings HC, 2005, TRENDS PHARMACOL SCI, V26, P503, DOI 10.1016/j.tips.2005.08.006; Kondratskaya EL, 2005, NEUROPHARMACOLOGY, V49, P945, DOI 10.1016/j.neuropharm.2005.07.001; Kondratskaya EL, 2002, NEUROCHEM INT, V40, P647, DOI 10.1016/S0197-0186(01)00109-7; Law RJ, 2000, PROTEINS, V39, P47, DOI 10.1002/(SICI)1097-0134(20000401)39:1<47::AID-PROT5>3.0.CO;2-A; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Lewis TM, 2003, J PHYSIOL-LONDON, V549, P361, DOI 10.1113/jphysiol.2002.037796; Lobo IA, 2004, J BIOL CHEM, V279, P33919, DOI 10.1074/jbc.M313941200; Lynch JW, 1997, EMBO J, V16, P110, DOI 10.1093/emboj/16.1.110; Lynch JW, 2001, J NEUROSCI, V21, P2589, DOI 10.1523/JNEUROSCI.21-08-02589.2001; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Muroi Y, 2006, BIOCHEMISTRY-US, V45, P7013, DOI 10.1021/bi060222v; O'Shea SM, 2004, J NEUROSCI, V24, P2322, DOI 10.1523/JNEUROSCI.4675-03.2004; Paas Y, 2005, P NATL ACAD SCI USA, V102, P15877, DOI 10.1073/pnas.0507599102; RAJENDRA S, 1995, NEURON, V14, P169, DOI 10.1016/0896-6273(95)90251-1; Shan Q, 2001, J BIOL CHEM, V276, P12556, DOI 10.1074/jbc.M011264200; UNWIN N, 1995, NATURE, V373, P37, DOI 10.1038/373037a0; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Webb TI, 2007, CURR PHARM DESIGN, V13, P2350; Wilson GG, 1998, NEURON, V20, P1269, DOI 10.1016/S0896-6273(00)80506-1	31	63	64	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					36057	36067		10.1074/jbc.M706468200	http://dx.doi.org/10.1074/jbc.M706468200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17911099	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000251458100065
J	Arokium, H; Ouerfelli, H; Velours, G; Camougrand, N; Vallette, FM; Manon, S				Arokium, Hubert; Ouerfelli, Hakim; Velours, Gisele; Camougrand, Nadine; Vallette, Francois M.; Manon, Stephen			Substitutions of potentially phosphorylatable serine residues of Bax reveal how they may regulate its interaction with mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; OUTER-MEMBRANE; DEPENDENT DEGRADATION; PROAPOPTOTIC FUNCTION; TERMINAL DOMAIN; ALPHA-HELIX; BCL-2; APOPTOSIS; PROTEIN; LOCALIZATION	During apoptosis, the pro-apoptotic protein Bax relocalizes from the cytosol to the mitochondrial outer membrane. This relocalization is associated to major conformational changes, namely at the N- and C- terminal ends of the protein. Substitution of residues located at critical positions within the protein potentially stimulates or inhibits this process. In the present study, we investigated the hypothesis that phosphorylation of serine residues might trigger these conformational changes, with a focus on Ser(163) and Ser(184), which have been shown to be phosphorylatable by protein kinases GSK3 beta and Akt/PKB, respectively, and on Ser(60), which is located in a consensus target sequence for PKA. Substitutions of these serine residues by alanine or aspartate were done in wild type or previously characterized Bax mutants, and the capacity of the resulting proteins to interact with mitochondria and to release cytochrome c was assayed in yeast, which provides a tool to study the function of Bax, independently of the rest of the apoptotic network. We conclude that sequential phosphorylation of these serine residues might participate in the triggering of the different conformational changes associated with Bax activation during apoptosis.	Univ Bordeaux 2, CNRS, UMR5095, F-33077 Bordeaux, France; Univ Nantes, INSERM, U601, F-44035 Nantes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite	Manon, S (corresponding author), Univ Bordeaux 2, CNRS, UMR5095, 1 Rue Camille St Saens, F-33077 Bordeaux, France.	stephen.manon@ibgc.cnrs.fr	Manon, Stéphen/C-7088-2017; Vallette, Francois M/K-9047-2015; Vallette, Francois/N-2361-2018	Vallette, Francois M/0000-0002-3296-8572; Vallette, Francois/0000-0003-0802-0519; Manon, Stephen/0000-0002-5792-1084				Adams JM, 2001, TRENDS BIOCHEM SCI, V26, P61, DOI 10.1016/S0968-0004(00)01740-0; Annis MG, 2005, EMBO J, V24, P2096, DOI 10.1038/sj.emboj.7600675; Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Arokium H, 2004, J BIOL CHEM, V279, P52566, DOI 10.1074/jbc.M408373200; Bellot G, 2007, CELL DEATH DIFFER, V14, P785, DOI 10.1038/sj.cdd.4402055; Brichese L, 2004, CELL CYCLE, V3, P1312, DOI 10.4161/cc.3.10.1166; Brichese L, 2002, EXP CELL RES, V278, P101, DOI 10.1006/excr.2002.5563; Cartron PF, 2003, J BIOL CHEM, V278, P11633, DOI 10.1074/jbc.M208955200; Cartron PF, 2002, FEBS LETT, V512, P95, DOI 10.1016/S0014-5793(02)02227-5; Cartron PF, 2004, MOL CELL, V16, P807, DOI 10.1016/j.molcel.2004.10.028; Cartron PF, 2005, J BIOL CHEM, V280, P10587, DOI 10.1074/jbc.M409714200; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dejean LM, 2006, CELL DEATH DIFFER, V13, P1387, DOI 10.1038/sj.cdd.4401949; Dejean LM, 2005, MOL BIOL CELL, V16, P2424, DOI 10.1091/mbc.E04-12-1111; Dimmeler S, 1999, J EXP MED, V189, P1815, DOI 10.1084/jem.189.11.1815; Garcia-Saez AJ, 2004, BIOCHEMISTRY-US, V43, P10930, DOI 10.1021/bi036044c; Gardai SJ, 2004, J BIOL CHEM, V279, P21085, DOI 10.1074/jbc.M400063200; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Guihard G, 2004, J BIOL CHEM, V279, P46542, DOI 10.1074/jbc.M405153200; Heimlich G, 2004, BIOCHEM J, V378, P247, DOI 10.1042/BJ20031152; JANIAK F, 1994, J BIOL CHEM, V269, P9842; Kissova I, 2006, J BIOL CHEM, V281, P36187, DOI 10.1074/jbc.M607444200; Lalier L, 2007, APOPTOSIS, V12, P887, DOI 10.1007/s10495-007-0749-1; Linseman DA, 2004, J NEUROSCI, V24, P9993, DOI 10.1523/JNEUROSCI.2057-04.2004; Madeo F, 2004, CURR OPIN MICROBIOL, V7, P655, DOI 10.1016/j.mib.2004.10.012; Makin GWJ, 2001, EMBO J, V20, P6306, DOI 10.1093/emboj/20.22.6306; Mancinelli F, 2006, J CELL BIOCHEM, V99, P305, DOI 10.1002/jcb.20893; Martinez-Senac MD, 2001, BIOCHEMISTRY-US, V40, P9983; Martinou JC, 2001, NAT REV MOL CELL BIO, V2, P63, DOI 10.1038/35048069; Marzo I, 1998, SCIENCE, V281, P2027, DOI 10.1126/science.281.5385.2027; Motz C, 2002, J MOL BIOL, V323, P729, DOI 10.1016/S0022-2836(02)00995-6; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; NGUYEN M, 1993, J BIOL CHEM, V268, P25265; Nomura M, 2003, J BIOL CHEM, V278, P2058, DOI 10.1074/jbc.M207880200; Oliver L, 2000, FEBS LETT, V487, P161, DOI 10.1016/S0014-5793(00)02330-9; Pavlov EV, 2001, J CELL BIOL, V155, P725, DOI 10.1083/jcb.200107057; Peyerl FW, 2007, CELL DEATH DIFFER, V14, P447, DOI 10.1038/sj.cdd.4402025; Pinson B, 1996, EUR J BIOCHEM, V239, P439, DOI 10.1111/j.1432-1033.1996.0439u.x; Poruchynsky MS, 1998, CANCER RES, V58, P3331; Priault M, 1999, FEBS LETT, V443, P225, DOI 10.1016/S0014-5793(98)01661-5; Priault M, 2003, CELL DEATH DIFFER, V10, P1068, DOI 10.1038/sj.cdd.4401270; Schendel SL, 1998, CELL DEATH DIFFER, V5, P372, DOI 10.1038/sj.cdd.4400365; Schinzel A, 2004, J CELL BIOL, V164, P1021, DOI 10.1083/jcb.200309013; Setoguchi K, 2006, EMBO J, V25, P5635, DOI 10.1038/sj.emboj.7601438; Sharpe JC, 2004, BBA-MOL CELL RES, V1644, P107, DOI 10.1016/j.bbamcr.2003.10.016; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Tremblais K, 1999, BIOCHEM BIOPH RES CO, V260, P582, DOI 10.1006/bbrc.1999.0904; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Xin MG, 2006, J BIOL CHEM, V281, P18859, DOI 10.1074/jbc.M512543200; Xin MG, 2005, J BIOL CHEM, V280, P10781, DOI 10.1074/jbc.M500084200; Yamaguchi H, 2001, ONCOGENE, V20, P7779, DOI 10.1038/sj.onc.1204984	54	49	49	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35104	35112		10.1074/jbc.M704891200	http://dx.doi.org/10.1074/jbc.M704891200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17911107	hybrid			2022-12-25	WOS:000251155200055
J	Mallette, FA; Gaumont-Leclerc, MF; Huot, G; Ferbeyre, G				Mallette, Frederick A.; Gaumont-Leclerc, Marie-France; Huot, Genevieve; Ferbeyre, Gerardo			Myc down-regulation as a mechanism to activate the Rb pathway in STAT5A-induced senescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONCOGENE-INDUCED SENESCENCE; C-MYC; MAMMARY-GLAND; IN-VIVO; SIGNAL TRANSDUCER; PROTEIN STABILITY; NULL FIBROBLASTS; MESSENGER-RNA; PML; STAT5	Senescence is a general antiproliferative program that avoids the expansion of cells bearing oncogenic mutations. We found that constitutively active STAT5A (ca-STAT5A) can induce a p53- and Rb-dependent cellular senescence response. However, ca-STAT5A did not induce p21 and p16(INK4a), which are responsible for inhibiting cyclin-dependent protein kinases and engaging the Rb pathway during the senescence response to oncogenic ras. Intriguingly, ca-STAT5A led to a down-regulation of Myc and Myc targets, including CDK4, a negative regulator of Rb. The down-regulation of Myc was in part proteasome-dependent and correlated with its localization to promyelocytic leukemia bodies, which were found to be highly abundant during STAT5-induced senescence. Introduction of CDK4 or Myc bypassed STAT5A-induced senescence in cells in which p53 was also inactivated. These results uncover a novel mechanism to engage the Rb pathway in oncogene-induced senescence and indicate the existence of oncogene-specific pathways that regulate senescence.	Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Ferbeyre, G (corresponding author), Univ Montreal, Dept Biochim, E-515,CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	g.ferbeyre@umontreal.ca	Mallette, Frédérick A./J-6646-2019; Ferbeyre, Gerardo/A-1569-2010	Mallette, Frédérick A./0000-0001-7932-0338; 				Barash I, 2006, J CELL PHYSIOL, V209, P305, DOI 10.1002/jcp.20771; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; Berns K, 2000, ONCOGENE, V19, P3330, DOI 10.1038/sj.onc.1203639; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Buck A, 2006, MOL CANCER RES, V4, P861, DOI 10.1158/1541-7786.MCR-06-0081; Buschbeck M, 2007, ONCOGENE, V26, P3415, DOI 10.1038/sj.onc.1210128; Cairo S, 2005, ONCOGENE, V24, P2195, DOI 10.1038/sj.onc.1208338; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; Cotarla I, 2004, INT J CANCER, V108, P665, DOI 10.1002/ijc.11619; DANI C, 1985, P NATL ACAD SCI USA, V82, P4896, DOI 10.1073/pnas.82.15.4896; de Stanchina E, 2004, MOL CELL, V13, P523, DOI 10.1016/S1097-2765(04)00062-0; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Fabunmi RP, 2001, J CELL SCI, V114, P29; Ferbeyre G, 2000, GENE DEV, V14, P2015; Fulop T, 2006, MECH AGEING DEV, V127, P526, DOI 10.1016/j.mad.2006.01.025; Gil J, 2005, CANCER RES, V65, P2179, DOI 10.1158/0008-5472.CAN-03-4030; Guney I, 2006, P NATL ACAD SCI USA, V103, P3645, DOI 10.1073/pnas.0600069103; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hermeking H, 2000, P NATL ACAD SCI USA, V97, P2229, DOI 10.1073/pnas.050586197; HIEBERT SW, 1989, P NATL ACAD SCI USA, V86, P3594, DOI 10.1073/pnas.86.10.3594; Huot TJ, 2002, MOL CELL BIOL, V22, P8135, DOI 10.1128/MCB.22.23.8135-8143.2002; JONES TR, 1987, MOL CELL BIOL, V7, P4513, DOI 10.1128/MCB.7.12.4513; Kato Y, 2005, J EXP MED, V202, P169, DOI 10.1084/jem.20042541; LAVAU C, 1995, ONCOGENE, V11, P871; LAW JC, 1993, LEUKEMIA RES, V17, P1045, DOI 10.1016/0145-2126(93)90161-D; Lawlor ER, 2006, CANCER RES, V66, P4591, DOI 10.1158/0008-5472.CAN-05-3826; Li HZ, 2004, CANCER RES, V64, P4774, DOI 10.1158/0008-5472.CAN-03-3499; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; Lord JD, 2000, J IMMUNOL, V164, P2533, DOI 10.4049/jimmunol.164.5.2533; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Mallette FA, 2004, ONCOGENE, V23, P91, DOI 10.1038/sj.onc.1206886; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; Malumbres M, 2000, MOL CELL BIOL, V20, P2915, DOI 10.1128/MCB.20.8.2915-2925.2000; Moriggl R, 2005, CANCER CELL, V7, P87, DOI 10.1016/j.ccr.2004.12.010; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Nevalainen MT, 2004, J CLIN ONCOL, V22, P2053, DOI 10.1200/JCO.2004.11.046; Onishi M, 1998, MOL CELL BIOL, V18, P3871, DOI 10.1128/MCB.18.7.3871; OTSUKI T, 1995, CANCER RES, V55, P1436; Ren SX, 2002, ONCOGENE, V21, P4335, DOI 10.1038/sj.onc.1205484; RUSTGI AK, 1991, NATURE, V352, P541, DOI 10.1038/352541a0; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; SCHWAB M, 1990, Critical Reviews in Oncogenesis, V2, P35; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sears R, 1999, MOL CELL, V3, P169, DOI 10.1016/S1097-2765(00)80308-1; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sillaber C, 2000, BLOOD, V95, P2118, DOI 10.1182/blood.V95.6.2118; Smith KP, 2004, J CELL BIOCHEM, V93, P1282, DOI 10.1002/jcb.20273; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; WAKAO H, 1994, EMBO J, V13, P2182, DOI 10.1002/j.1460-2075.1994.tb06495.x; Weniger MA, 2006, ONCOGENE, V25, P2679, DOI 10.1038/sj.onc.1209151; Wu CH, 2007, P NATL ACAD SCI USA, V104, P13028, DOI 10.1073/pnas.0701953104; Xi SC, 2003, CANCER RES, V63, P6763; Xi SC, 2003, J BIOL CHEM, V278, P31574, DOI 10.1074/jbc.M303499200; Yamashita Hiroko, 2002, Breast Cancer, V9, P312, DOI 10.1007/BF02967610; Yang HS, 2003, MOL CELL, V11, P1163, DOI 10.1016/S1097-2765(03)00135-7	56	38	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34938	34944		10.1074/jbc.M707074200	http://dx.doi.org/10.1074/jbc.M707074200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17913706	hybrid			2022-12-25	WOS:000251155200037
J	Lin, MT; Chang, CC; Lin, BR; Yang, HY; Chu, CY; Wu, MH; Kuo, ML				Lin, Ming-Tsan; Chang, Cheng-Chi; Lin, Been-Ren; Yang, Hsin-Yu; Chu, Chia-Yu; Wu, Ming-Hsun; Kuo, Min-Liang			Elevated expression of Cyr61 enhances peritoneal dissemination of gastric cancer cells through integrin alpha(2)beta(1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA(2)BETA(1) INTEGRIN; ALPHA-2-BETA-1 INTEGRIN; GENE-EXPRESSION; ACTIVATION; ADHESION; IDENTIFICATION; CARCINOMA; PROMOTES; ALPHA(1)BETA(1); ALPHA(6)BETA(1)	Cysteine-rich 61 (Cyr61/CCN1) is involved in human gastric cancer development and progression. Nonetheless, the role of Cyr61 as regards peritoneal dissemination of such cancers has not yet been completely characterized. We used liposome-mediated transfection to establish Cyr61, or antisense Cyr61, expression vectors into gastric cancer AGS or MKN45 cell lines. Transfectants were tested by means of a cancer-cell adhesion assay in vitro and ex vivo. Furthermore, a functional integrin fluorescence-activated cell sorting assay, reverse transcription-PCR, and an AP-1 reporter assay were performed to investigate the potential signaling pathway of Cyr61. It was shown that stable transfection of Cyr61 into the AGS cell line strongly enhanced its adhesion ability. The overexpression of Cyr61 within AGS cells significantly increased the functional expression of integrin alpha(2)beta(1). Function-neutralizing antibody to integrin alpha(2)beta(1) effectively suppressed the Cyr61-mediated enhanced adhesion of AGS cells to peritoneal tissue. Promoter assays of integrin alpha(2) gene further revealed that the AP-1 pathway was evidently activated within Cyr61-expressing AGS cells. Animal studies have revealed that mice injected with Cyr61-overexpressed AGS cells featured a greater number of peritoneal seeding nodules and a lower survival rate than the Neo control cell lines, and when such cells were treated with functional blocking antibody to integrin alpha(2)beta(1), they were able to elicit a decline in the peritoneal dissemination. The data suggest that Cyr61 may contribute to the peritoneal dissemination of gastric cancer by promoting tumor-cell adhesion ability through the up-regulation of the functional integrin alpha(2)beta(1) via an AP-1-dependent pathway.	Natl Taiwan Univ, Coll Med, Inst Toxicol, Lab Mol & Cellular Toxicol, Taipei 100, Taiwan; Natl Taiwan Univ, Angiogenesis Res Ctr, Taipei 100, Taiwan; Natl Taiwan Univ Hosp, Dept Primary Care Med, Taipei 100, Taiwan; Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; Natl Taiwan Univ Hosp, Dept Dermatol, Taipei 100, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Kuo, ML (corresponding author), Natl Taiwan Univ, Coll Med, Inst Toxicol, Lab Mol & Cellular Toxicol, 1,Sect 1,Jen Ai Rd, Taipei 100, Taiwan.	toxkml@ha.mc.ntu.edu.tw	wu, larry/AAV-5282-2021; Kuo, Min-Liang/C-4872-2009	wu, larry/0000-0002-8811-9203; CHU, CHIA-YU/0000-0002-9370-3279; KUO, MIN-LIANG/0000-0002-7139-0144; LIN, MING-TSAN/0000-0001-7313-7057; LIN, BEEN-REN/0000-0001-8354-1758				Ajisaka H, 2004, HEPATO-GASTROENTEROL, V51, P900; Aoyagi Keishiro, 2005, Gastric Cancer, V8, P155, DOI 10.1007/s10120-005-0329-4; ASAO T, 1994, CANCER LETT, V78, P57, DOI 10.1016/0304-3835(94)90031-0; Babic AM, 1998, P NATL ACAD SCI USA, V95, P6355, DOI 10.1073/pnas.95.11.6355; Brigstock DR, 1999, ENDOCR REV, V20, P189, DOI 10.1210/er.20.2.189; Chen NY, 2000, J BIOL CHEM, V275, P24953, DOI 10.1074/jbc.M003040200; Chiu SJ, 2002, J BIOMED SCI, V9, P261, DOI 10.1159/000059427; Cooper CR, 2002, CLIN EXP METASTAS, V19, P25, DOI 10.1023/A:1013849123736; Eriksson M, 2005, EXP CELL RES, V304, P175, DOI 10.1016/j.yexcr.2004.10.017; Gamble J, 1999, ENDOTHELIUM-NEW YORK, V7, P23, DOI 10.3109/10623329909165309; Grundstrom G, 2003, EXP CELL RES, V291, P463, DOI 10.1016/j.yexcr.2003.07.010; Grzeszkiewicz TM, 2002, ENDOCRINOLOGY, V143, P1441, DOI 10.1210/en.143.4.1441; Grzeszkiewicz TM, 2001, J BIOL CHEM, V276, P21943, DOI 10.1074/jbc.M100978200; HATHORN RW, 1994, CANCER, V74, P1904, DOI 10.1002/1097-0142(19941001)74:7<1904::AID-CNCR2820740713>3.0.CO;2-B; Holloway SE, 2005, J AM COLL SURGEONS, V200, P371, DOI 10.1016/j.jamcollsurg.2004.10.005; Horiuchi H, 2004, J EXP CLIN CANC RES, V23, P599; Jemal A, 2003, CA-CANCER J CLIN, V53, P5, DOI 10.3322/canjclin.53.1.5; Keely PJ, 1996, J BIOL CHEM, V271, P26668, DOI 10.1074/jbc.271.43.26668; Kobayashi Michiya, 2006, Gastric Cancer, V9, P114, DOI 10.1007/s10120-006-0364-9; LAU LF, 1985, EMBO J, V4, P3145, DOI 10.1002/j.1460-2075.1985.tb04057.x; Liang CC, 2001, J BIOL CHEM, V276, P21146, DOI 10.1074/jbc.M010669200; Lin CG, 2005, J BIOL CHEM, V280, P8229, DOI 10.1074/jbc.M404903200; Lin MT, 2005, CLIN CANCER RES, V11, P5809, DOI 10.1158/1078-0432.CCR-04-2639; Lin MT, 2004, J BIOL CHEM, V279, P24015, DOI 10.1074/jbc.M402305200; Lundberg S, 2006, INFLAMM BOWEL DIS, V12, P172, DOI 10.1097/01.MIB.0000217765.96604.83; Menendez JA, 2005, ONCOGENE, V24, P761, DOI 10.1038/sj.onc.1208238; Nishigaki R, 2005, PROTEOMICS, V5, P3205, DOI 10.1002/pmic.200401307; Paraskeva PA, 2005, TUMOR BIOL, V26, P94, DOI 10.1159/000085816; Park HB, 2004, BIOCHEM J, V378, P559, DOI 10.1042/BJ20031392; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Sakakura C, 2002, BRIT J CANCER, V87, P1153, DOI 10.1038/sj.bjc.6600580; Senger DR, 1997, P NATL ACAD SCI USA, V94, P13612, DOI 10.1073/pnas.94.25.13612; Takatsuki H, 2004, CANCER RES, V64, P6065, DOI 10.1158/0008-5472.CAN-04-0321; Tsai MS, 2002, ONCOGENE, V21, P8178, DOI 10.1038/sj.onc.1205682; Ura H, 1998, SURG TODAY, V28, P1001, DOI 10.1007/BF02483952; Xie D, 2004, CANCER RES, V64, P1987, DOI 10.1158/0008-5472.CAN-03-0666; Yokoyama F, 2005, BIOCHEMISTRY-US, V44, P9581, DOI 10.1021/bi050598t; Yokoyama T, 2004, CLIN EXP METASTAS, V21, P223, DOI 10.1023/B:CLIN.0000037704.72028.72; Yoo CH, 2000, BRIT J SURG, V87, P236, DOI 10.1046/j.1365-2168.2000.01360.x; Zhang WT, 2006, J CELL SCI, V119, P283, DOI 10.1242/jcs.02738; Zhang ZG, 2006, J CELL SCI, V119, P1886, DOI 10.1242/jcs.02921; Znoyko I, 2006, MOL CELL BIOCHEM, V282, P89, DOI 10.1007/s11010-006-1400-0; Zutter MM, 1997, BLOOD, V90, P678, DOI 10.1182/blood.V90.2.678.678_678_689; ZUTTER MM, 1994, J BIOL CHEM, V269, P463; ZUTTER MM, 1995, BLOOD, V86, P3006	45	43	50	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34594	34604		10.1074/jbc.M706600200	http://dx.doi.org/10.1074/jbc.M706600200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17905740	hybrid			2022-12-25	WOS:000251145700073
J	Slutsky-Leiderman, O; Marom, M; Iosefson, O; Levy, R; Maoz, S; Azem, A				Slutsky-Leiderman, Olga; Marom, Milit; Iosefson, Ohad; Levy, Ran; Maoz, Sharon; Azem, Abdussalam			The interplay between components of the mitochondrial protein translocation motor studied using purified components	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIM23 PREPROTEIN TRANSLOCASE; INNER MEMBRANE; IMPORT MOTOR; PRESEQUENCE TRANSLOCASE; J-DOMAIN; HSP70; TIM50; COCHAPERONE; COMPLEX; TIM44	The final step of protein translocation across the mitochondrial inner membrane is mediated by a translocation motor composed of 1) the matrix-localized, ATP-hydrolyzing, 70-kDa heat shock protein mHsp70; 2) its anchor to the import channel, Tim44; 3) the nucleotide exchange factor Mge1; and 4) a J-domain-containing complex of co-chaperones, Tim14/Pam18-Tim16/Pam16. Despite its essential role in the biogenesis of mitochondria, the mechanism by which the translocation motor functions is still largely unknown. The goal of this work was to carry out a structure-function analysis of the mitochondrial translocation motor utilizing purified components, with an emphasis on the formation of the Tim44-mHsp70 complex. To this end, we purified Tim44 and monitored its interaction with other components of the motor using cross-linking with bifunctional reagents. The effects of nucleotides, the J-domain-containing components, and the P5 peptide (CALLSAPRR, representing part of the mitochondrial targeting signal of aspartate aminotransferase) on the formation of the translocation motor were examined. Our results show that only the peptide and nucleotides, but not J-domain-containing proteins, affect the Tim44-mHsp70 interaction. Additionally, binding of Tim44 to mHsp70 prevents the formation of a complex between the latter and Tim14/Pam18-Tim16/Pam16. Thus, mutually exclusive interactions between various components of the motor with mHsp70 regulate its functional cycle. The results are discussed in light of known models for the function of the mitochondrial translocation motor.	Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69778 Tel Aviv, Israel	Tel Aviv University	Azem, A (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69778 Tel Aviv, Israel.	azema@tauex.tau.ac.il						Azem A, 1997, J BIOL CHEM, V272, P20901, DOI 10.1074/jbc.272.33.20901; Bauer MF, 1996, CELL, V87, P33, DOI 10.1016/S0092-8674(00)81320-3; D'Silva P, 2004, NAT STRUCT MOL BIOL, V11, P1084, DOI 10.1038/nsmb846; D'Silva PD, 2003, P NATL ACAD SCI USA, V100, P13839, DOI 10.1073/pnas.1936150100; D'Silva PR, 2005, P NATL ACAD SCI USA, V102, P12419, DOI 10.1073/pnas.0505969102; De los Rios P, 2006, P NATL ACAD SCI USA, V103, P6166, DOI 10.1073/pnas.0510496103; Deloche O, 1996, J BIOL CHEM, V271, P23960, DOI 10.1074/jbc.271.39.23960; Endo T, 2003, J CELL SCI, V116, P3259, DOI 10.1242/jcs.00667; Frazier AE, 2004, NAT STRUCT MOL BIOL, V11, P226, DOI 10.1038/nsmb735; Geissler A, 2002, CELL, V111, P507, DOI 10.1016/S0092-8674(02)01073-5; GLICK BS, 1995, CELL, V80, P11, DOI 10.1016/0092-8674(95)90444-1; Josyula R, 2006, J MOL BIOL, V359, P798, DOI 10.1016/j.jmb.2006.04.020; Kozany C, 2004, NAT STRUCT MOL BIOL, V11, P234, DOI 10.1038/nsmb734; KRONIDOU NG, 1994, P NATL ACAD SCI USA, V91, P12818, DOI 10.1073/pnas.91.26.12818; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li YF, 2004, J BIOL CHEM, V279, P38047, DOI 10.1074/jbc.M404319200; Liu QL, 2003, SCIENCE, V300, P139, DOI 10.1126/science.1083379; Liu QL, 2001, J BIOL CHEM, V276, P6112, DOI 10.1074/jbc.M009519200; LOSEFSON O, 2007, PROTEIN SCI, V16, P316; Matouschek A, 2000, EMBO REP, V1, P404, DOI 10.1093/embo-reports/kvd093; Meinecke M, 2006, SCIENCE, V312, P1523, DOI 10.1126/science.1127628; Mokranjac D, 2005, BIOCHEM SOC T, V33, P1019, DOI 10.1042/BST0331019; Mokranjac D, 2003, EMBO J, V22, P4945, DOI 10.1093/emboj/cdg485; Mokranjac D, 2003, EMBO J, V22, P816, DOI 10.1093/emboj/cdg090; Moro F, 2002, J BIOL CHEM, V277, P6874, DOI 10.1074/jbc.M107935200; Neupert W, 2002, NAT REV MOL CELL BIO, V3, P555, DOI 10.1038/nrm878; RASSOW J, 1994, J CELL BIOL, V127, P1547, DOI 10.1083/jcb.127.6.1547; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; SCHMID D, 1994, SCIENCE, V263, P971, DOI 10.1126/science.8310296; SCHNEIDER HC, 1994, NATURE, V371, P768, DOI 10.1038/371768a0; Stojanovski D, 2006, BBA-MOL CELL RES, V1763, P414, DOI 10.1016/j.bbamcr.2006.02.008; Truscott KN, 2003, J CELL BIOL, V163, P707, DOI 10.1083/jcb.200308004; VONAHSEN O, 1995, J BIOL CHEM, V270, P29848; Voos W, 2002, BBA-MOL CELL RES, V1592, P51, DOI 10.1016/S0167-4889(02)00264-1; Weiss C, 1999, P NATL ACAD SCI USA, V96, P8890, DOI 10.1073/pnas.96.16.8890; Weiss C, 2002, PROTEIN EXPRES PURIF, V24, P268, DOI 10.1006/prep.2001.1563; WESTERMANN B, 1995, EMBO J, V14, P3452, DOI 10.1002/j.1460-2075.1995.tb07351.x; Yamamoto H, 2002, CELL, V111, P519, DOI 10.1016/S0092-8674(02)01053-X	38	27	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					33935	33942		10.1074/jbc.M704435200	http://dx.doi.org/10.1074/jbc.M704435200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17881357	hybrid			2022-12-25	WOS:000251145700006
J	Hanover, JA; Love, DC; DeAngelis, N; O'Kane, ME; Lima-Miranda, R; Schulz, T; Yen, YM; Johnson, RC; Prinz, WA				Hanover, John A.; Love, Dona C.; DeAngelis, Nikki; O'Kane, Meghan E.; Lima-Miranda, Raquel; Schulz, Timothy; Yen, Yi-Meng; Johnson, Reid C.; Prinz, William A.			The high mobility group box transcription factor Nhp6Ap enters the nucleus by a calmodulin-dependent, ran-independent pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORE COMPLEX; SEX REVERSAL; PROTEIN IMPORT; TRANSPORT; BIOLOGY; SRY; RECOGNITION; INHIBITION; DOMAINS; SOX9	A gradient of Ran center dot GTP typically regulates traffic through the nuclear pore by modulating association of receptors with cargo. However, here we demonstrate that the yeast high mobility group box transcription factor Nhp6Ap enters the nucleus via a novel nuclear localization signal recognized by calcium calmodulin in a process that does not require Ran. Calmodulin is strictly required for the nondiffusional nuclear entry of Nhp6Ap. Calmodulin and DNA exhibit mutually exclusive binding to NHP6A, indicating that the directionality of Nhp6Ap nuclear accumulation may be driven by DNA-dependent dissociation of calmodulin. Our findings demonstrate that calmodulin can serve as a molecular switch triggering nuclear entry with subsequent dissociation of calmodulin binding upon interaction of cargo with chromatin. This pathway appears to be evolutionarily conserved; mammalian high mobility group box transcription factors often have two nuclear localization signals: one a classical Ran-dependent signal and a second that binds calmodulin. The finding that Nhp6Ap nuclear entry requires calmodulin but not Ran indicates that Nhp6Ap is a good model for studying this poorly understood but evolutionarily conserved calmodulin-dependent nuclear import pathway.	NIDDK, Lab Cell Biochem & Biol, NIH, Bethesda, MD 20892 USA; Univ Calif Los Angeles, Dept Biol Chem, Sch Med, Los Angeles, CA 90095 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Prinz, WA (corresponding author), NIDDK, Lab Cell Biochem & Biol, NIH, 8 Ctr Dr,MSC 0851, Bethesda, MD 20892 USA.	wprinz@helix.nih.gov			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK060001, ZIADK060106, Z01DK060106] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Argentaro A, 2003, J BIOL CHEM, V278, P33839, DOI 10.1074/jbc.M302078200; AU KT, 1998, PLANT PHYSIOL, V118, P965; Au TK, 2000, LIFE SCI, V67, P733, DOI 10.1016/S0024-3205(00)00668-8; Au TK, 2000, INT J BIOCHEM CELL B, V32, P1173, DOI 10.1016/S1357-2725(00)00058-3; CORNELIUSSEN B, 1994, NATURE, V368, P760, DOI 10.1038/368760a0; Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; Harley VR, 2003, P NATL ACAD SCI USA, V100, P7045, DOI 10.1073/pnas.1137864100; Harley VR, 2002, NOVART FDN SYMP, V244, P57; Koopman P, 2003, NATURE, V426, P241, DOI 10.1038/426241a; Larsson G, 2001, PROTEIN SCI, V10, P169, DOI 10.1110/ps.28401; Liao BR, 1999, P NATL ACAD SCI USA, V96, P6217, DOI 10.1073/pnas.96.11.6217; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Masse JE, 2002, J MOL BIOL, V323, P263, DOI 10.1016/S0022-2836(02)00938-5; Naim B, 2007, J BIOL CHEM, V282, P3881, DOI 10.1074/jbc.M608329200; Nef S, 2003, NATURE, V426, P291, DOI 10.1038/nature02059; Onions J, 1997, J BIOL CHEM, V272, P23930, DOI 10.1074/jbc.272.38.23930; Paschal BM, 1997, J BIOL CHEM, V272, P21534, DOI 10.1074/jbc.272.34.21534; Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044; PRUSCHY M, 1994, J CELL BIOL, V127, P1527, DOI 10.1083/jcb.127.6.1527; Sim H, 2005, MOL ENDOCRINOL, V19, P1884, DOI 10.1210/me.2004-0334; Sreenivasan A, 2003, SCIENCE, V302, P2050; Stochaj U, 1999, BIOESSAYS, V21, P579, DOI 10.1002/(SICI)1521-1878(199907)21:7<579::AID-BIES6>3.0.CO;2-E; Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097; Suntharalingam M, 2003, DEV CELL, V4, P775, DOI 10.1016/S1534-5807(03)00162-X; Sweitzer TD, 1996, P NATL ACAD SCI USA, V93, P14574, DOI 10.1073/pnas.93.25.14574; Wong DH, 1997, MOL CELL BIOL, V17, P3755, DOI 10.1128/MCB.17.7.3755; Yen YM, 2001, TRAFFIC, V2, P449, DOI 10.1034/j.1600-0854.2001.20703.x	28	23	23	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33743	33751		10.1074/jbc.M705875200	http://dx.doi.org/10.1074/jbc.M705875200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17878171	hybrid			2022-12-25	WOS:000250840200056
J	Oh, H; Ozkirimli, E; Shah, K; Harrison, ML; Geahlen, RL				Oh, Hyunju; Ozkirimli, Elif; Shah, Kavita; Harrison, Marietta L.; Geahlen, Robert L.			Generation of an analog-sensitive syk tyrosine kinase for the study of signaling dynamics from the B cell antigen receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; ACTIVATION; LYMPHOMA; CA2+; ENGAGEMENT; INHIBITORS; KINETICS; LOOP; LYN	The Syk protein-tyrosine kinase is an essential component of the signaling machinery that couples the B cell receptor for antigen to multiple downstream signal transduction pathways. Syk is phosphorylated and activated rapidly and transiently following receptor engagement, but many signaling events, such as the activation of transcription factors occur over the course of several minutes or hours. To investigate a role for the continued activation of Syk in these processes, we generated an analog-sensitive mutant with an engineered ATP-binding pocket to render the kinase uniquely sensitive to an orthogonal inhibitor. Mutation of the gatekeeper residue in Syk yielded an enzyme with very low activity. Second-site mutations, selected based on structural comparisons between Syk and Src, were introduced that restored catalytic activity to the mutant Syk. Syk-deficient DT40 B cells were prepared expressing the analog-sensitive Syk (Syk-AQL). Inhibition of the activity of Syk prior to, concomitant with or shortly following receptor engagement led to the rapid inhibition of receptor-mediated tyrosine phosphorylation and blocked the activation of extracellular signal-regulated kinase, NF-kappa B, and NFAT. The receptor-mediated activation of NF-kappa B required active Syk for a relatively short period of time, whereas the activation of NFAT required active kinase for a prolonged (> 1 h) period. Receptor cross-linking led to the recruitment of Syk to the clustered receptor. Retention of these receptor-kinase complexes on the cell surface was dependent on the continued activity of Syk. Thus, despite the apparent transient nature of the activation of Syk, the catalytic activity of the Syk was required for sustained signaling from ligated receptors.	Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; Purdue Univ, Purdue Canc Ctr, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Geahlen, RL (corresponding author), Purdue Univ, Dept Med Chem & Mol Pharmacol, Hansen Life Sci Res Bldg,201 S Univ St, W Lafayette, IN 47907 USA.	geahlen@purdue.edu	Shah, Kavita/Y-9755-2019; Ozkirimli, Elif/Q-1586-2015	Shah, Kavita/0000-0002-0451-1305; Ozkirimli, Elif/0000-0002-3206-8427; Geahlen, Robert/0000-0001-8400-2924	NCI NIH HHS [CA37372] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA037372] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Atwell S, 2004, J BIOL CHEM, V279, P55827, DOI 10.1074/jbc.M409792200; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Bishop AC, 1998, CURR BIOL, V8, P257, DOI 10.1016/S0960-9822(98)70198-8; Bishop AC, 1999, J AM CHEM SOC, V121, P627, DOI 10.1021/ja983267v; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dolmetsch RE, 1997, NATURE, V388, P308, DOI 10.1038/40912; Donahue AC, 2003, J IMMUNOL, V170, P5851, DOI 10.4049/jimmunol.170.12.5851; Fluckiger AC, 1998, EMBO J, V17, P1973, DOI 10.1093/emboj/17.7.1973; Gauld SB, 2005, NAT IMMUNOL, V6, P1160, DOI 10.1038/ni1256; Gururajan M, 2006, J IMMUNOL, V176, P5715, DOI 10.4049/jimmunol.176.10.5715; Hou P, 2006, PLOS BIOL, V4, P1147, DOI 10.1371/journal.pbio.0040200; Irish JM, 2006, BLOOD, V108, P3135, DOI 10.1182/blood-2006-02-003921; Irish JM, 2006, J IMMUNOL, V177, P1581, DOI 10.4049/jimmunol.177.3.1581; Ma H, 2001, J IMMUNOL, V166, P1507, DOI 10.4049/jimmunol.166.3.1507; PAGE DM, 1990, MOL CELL BIOL, V10, P3003, DOI 10.1128/MCB.10.6.3003; Rolli V, 2002, MOL CELL, V10, P1057, DOI 10.1016/S1097-2765(02)00739-6; SAOUAF SJ, 1994, P NATL ACAD SCI USA, V91, P9524, DOI 10.1073/pnas.91.20.9524; Singh DK, 2005, CELL, V121, P281, DOI 10.1016/j.cell.2005.02.036; Skaggs B.J., 2004, SIGNAL TRANSDUCT, V4, P173; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; Yamaguchi H, 1996, NATURE, V384, P484, DOI 10.1038/384484a0; Zhang C, 2005, NAT METHODS, V2, P435, DOI 10.1038/NMETH764	22	21	23	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33760	33768		10.1074/jbc.M704846200	http://dx.doi.org/10.1074/jbc.M704846200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17913708	hybrid			2022-12-25	WOS:000250840200058
J	Castelletti, E; Lo Caputo, S; Kuhn, L; Borelli, M; Gajardo, J; Sinkala, M; Trabattoni, D; Kankasa, C; Lauri, E; Clivio, A; Piacentini, L; Bray, DH; Aldrovandi, GM; Thea, DM; Veas, F; Nebuloni, M; Mazzotta, F; Clerici, M				Castelletti, Eleonora; Lo Caputo, Sergio; Kuhn, Louise; Borelli, Manuela; Gajardo, Johanna; Sinkala, Moses; Trabattoni, Daria; Kankasa, Chipepo; Lauri, Eleonora; Clivio, Alberto; Piacentini, Luca; Bray, Dorothy H.; Aldrovandi, Grace M.; Thea, Donald M.; Veas, Francisco; Nebuloni, Manuela; Mazzotta, Francesco; Clerici, Mario			The Mucosae-Associated Epithelial Chemokine (MEC/CCL28) Modulates Immunity in HIV Infection	PLOS ONE			English	Article								Background. CCL28 (MEC) binds to CCR3 and CCR10 and recruits IgA-secreting plasma cells (IgA-ASC) in the mucosal lamina propria (MLP). Mucosal HIV-specific IgA are detected in HIV-infection and exposure. The CCL28 circuit was analyzed in HIV-infected and-exposed individuals and in HIV-unexposed controls; the effect of CCL28 administration on gastrointestinal MLP IgA-ASC was verified in a mouse model. Methodology/Findings. CCL28 was augmented in breast milk (BM) plasma and saliva of HIV-infected and -exposed individuals; CCR3+ and CCR10+ B lymphocytes were increased in these same individuals. Additionally: 1) CCL28 concentration in BM was associated with longer survival in HIV vertically-infected children; and 2) gastro-intestinal mucosal IgA-ASC were significantly increased in VSV-immunized mice receiving CCL28. Conclusions. CCL28 mediates mucosal immunity in HIV exposure and infection. CCL28-including constructs should be considered in mucosal vaccines to prevent HIV infection of the gastro-intestinal MLP via modulation of IgA-ASC.	[Castelletti, Eleonora; Borelli, Manuela; Trabattoni, Daria; Clivio, Alberto; Piacentini, Luca; Thea, Donald M.; Clerici, Mario] Univ Milan, Dept Preclin Sci, Lab Interdisciplinare Technol Avanzate LITA Vialb, Milan, Italy; [Lo Caputo, Sergio; Mazzotta, Francesco] SS Annunziata Hosp, Infect Dis Clin, Florence, Italy; [Kuhn, Louise] Columbia Univ, Gertrude H Sergievsky Ctr, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA; [Gajardo, Johanna; Veas, Francisco] IRD UR178, Inst Dev Res, Lab Retroviral & Mol Immunol, Montpellier, France; [Sinkala, Moses] Lusaka Dist Hlth Management Team, Lusaka, Zambia; [Kankasa, Chipepo] Univ Zambia, Univ Teaching Hosp, Lusaka, Zambia; [Lauri, Eleonora; Nebuloni, Manuela] Univ Milan, Pathol Unit, Dept Clin Sci, Milan, Italy; [Bray, Dorothy H.] ImmunoClin, London, England; [Aldrovandi, Grace M.] Univ So Calif, Dept Pediat, Los Angeles, CA 90089 USA; Boston Univ, Sch Publ Hlth, Ctr Int Hlth & Dev, Boston, MA USA; Univ Milan, Dept Biomed Sci & Technol, I-20133 Milan, Italy	University of Milan; Columbia University; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Zambia; University of Milan; University of Southern California; Boston University; University of Milan	Clerici, M (corresponding author), Univ Milan, Dept Preclin Sci, Lab Interdisciplinare Technol Avanzate LITA Vialb, Milan, Italy.	mario.clerici@unimi.it	Trabattoni, Daria/G-7424-2012; Piacentini, Luca/K-8908-2016; CLIVIO, ALBERTO/S-9320-2017; NEBULONI, MANUELA/L-3969-2017	Trabattoni, Daria/0000-0001-9535-3359; Piacentini, Luca/0000-0003-1022-4481; Clerici, Mario/0000-0001-5920-6191; Lo Caputo, Sergio/0000-0002-4729-7548; Thea, Donald/0000-0002-6933-1030; CLIVIO, ALBERTO/0000-0002-1423-046X; NEBULONI, MANUELA/0000-0002-2773-734X	Istituto Superiore di Sanita; Tuscany Region; EMPRO; AVIP EC [WP6]; Japan Health Science Foundation; National Institutes of Child Health and Human Development [HD 39611, HD 40777]	Istituto Superiore di Sanita; Tuscany Region(Regione Toscana); EMPRO; AVIP EC; Japan Health Science Foundation; National Institutes of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Supported by grants from the Istituto Superiore di Sanita' "Programma Nazionale di Ricerca sull' AIDS''; Tuscany Region, DG Right to Health and Solidarity Policy; the EMPRO and AVIP EC WP6 Projects; the Japan Health Science Foundation; and from the National Institutes of Child Health and Human Development HD 39611 and HD 40777.	Belec L, 2001, J INFECT DIS, V184, P1412, DOI 10.1086/324375; Beyrer C, 1999, J INFECT DIS, V179, P59, DOI 10.1086/314556; Bomsel M, 1998, IMMUNITY, V9, P277, DOI 10.1016/S1074-7613(00)80610-X; Bomsel M, 2007, AIDS, V21, P13, DOI 10.1097/QAD.0b013e328011049b; Bourges D, 2004, SCAND J IMMUNOL, V60, P338, DOI 10.1111/j.0300-9475.2004.01479.x; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Cartry O, 1997, CLIN EXP IMMUNOL, V109, P47, DOI 10.1046/j.1365-2249.1997.4261320.x; Clerici M, 2002, AIDS, V16, P1731, DOI 10.1097/00002030-200209060-00004; Devito C, 2000, J IMMUNOL, V165, P5170, DOI 10.4049/jimmunol.165.9.5170; Devito C, 2000, AIDS, V14, P1917, DOI 10.1097/00002030-200009080-00006; Devito C, 2002, J ACQ IMMUN DEF SYND, V30, P413, DOI [10.1097/00042560-200208010-00007, 10.1097/01.QAI.0000021664.20213.5A]; Dorrell L, 2000, AIDS, V14, P1117, DOI 10.1097/00002030-200006160-00008; Eksteen B, 2006, J IMMUNOL, V177, P593, DOI 10.4049/jimmunol.177.1.593; Feng NG, 2006, J IMMUNOL, V176, P5749, DOI 10.4049/jimmunol.176.10.5749; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Hieshima K, 2004, J IMMUNOL, V173, P3668, DOI 10.4049/jimmunol.173.6.3668; Hieshima K, 2003, J IMMUNOL, V170, P1452, DOI 10.4049/jimmunol.170.3.1452; Hocini H, 1997, AIDS RES HUM RETROV, V13, P1179, DOI 10.1089/aid.1997.13.1179; JANOFF EN, 1995, J INFECT DIS, V172, P855, DOI 10.1093/infdis/172.3.855; John AE, 2005, AM J PATHOL, V166, P345, DOI 10.1016/S0002-9440(10)62258-4; Kaul R, 1999, AIDS, V13, P23, DOI 10.1097/00002030-199901140-00004; Kozlowski PA, 2003, CURR MOL MED, V3, P217, DOI 10.2174/1566524033479852; Kuhn L, 2005, JAIDS-J ACQ IMM DEF, V39, P138; Kunkel EJ, 2003, MICROCIRCULATION, V10, P313, DOI 10.1038/sj.mn.7800196; Kunkel EJ, 2003, J CLIN INVEST, V111, P1001, DOI 10.1172/JCI200317244; LAWSON ND, 1995, P NATL ACAD SCI USA, V92, P4477, DOI 10.1073/pnas.92.10.4477; Lazarus NH, 2003, J IMMUNOL, V170, P3799, DOI 10.4049/jimmunol.170.7.3799; Lehner T, 2005, VACCINE, V23, P5551, DOI 10.1016/j.vaccine.2005.07.009; Lehner T, 2002, AIDS, V16, pS125, DOI 10.1097/00002030-200216004-00017; Marinda E, 2007, PEDIATR INFECT DIS J, V26, P519, DOI 10.1097/01.inf.0000264527.69954.4c; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Mazzoli S, 1997, NAT MED, V3, P1250, DOI 10.1038/nm1197-1250; Nakayama T, 2003, J IMMUNOL, V170, P1136, DOI 10.4049/jimmunol.170.3.1136; Ogawa H, 2004, AM J PHYSIOL-GASTR L, V287, pG1062, DOI 10.1152/ajpgi.00162.2004; Oswald J, 2005, TISSUE ANTIGENS, V66, P373; Qin LZ, 2004, J VIROL, V78, P7016, DOI 10.1128/JVI.78.13.7016-7022.2004; Qin LZ, 2003, VIROLOGY, V308, P225, DOI [10.1016/S0042-6822(02)00088-0, 10.1016/S0042-3822(02)00088-0]; Schnell MJ, 1996, J VIROL, V70, P2318, DOI 10.1128/JVI.70.4.2318-2323.1996; Soderlund J, 2004, SCAND J INFECT DIS, V36, P663, DOI 10.1080/00365540410020857; Vincent N, 2004, AIDS, V18, P37, DOI 10.1097/00002030-200401020-00004; Wang W, 2000, J BIOL CHEM, V275, P22313, DOI 10.1074/jbc.M001461200; Williams IR, 2004, IMMUNOL RES, V29, P283, DOI 10.1385/IR:29:1-3:283; Wilson E, 2004, J EXP MED, V200, P805, DOI 10.1084/jem.20041069; Wu XL, 2003, AIDS RES HUM RETROV, V19, P275, DOI 10.1089/088922203764969474; Wu XL, 2002, J CLIN IMMUNOL, V22, P106, DOI 10.1023/A:1014435920321	46	29	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e969	10.1371/journal.pone.0000969	http://dx.doi.org/10.1371/journal.pone.0000969			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912348	Green Published, gold			2022-12-25	WOS:000207455900007
J	Enqvist, S; Sletten, K; Stevens, FJ; Hellman, U; Westermark, P				Enqvist, Stina; Sletten, Knut; Stevens, Fred J.; Hellman, Ulf; Westermark, Per			Germ Line Origin and Somatic Mutations Determine the Target Tissues in Systemic AL-Amyloidosis	PLOS ONE			English	Article								Background. Amyloid is insoluble aggregated proteins deposited in the extra cellular space. About 25 different proteins are known to form amyloid in vivo and are associated with severe diseases such as Alzheimers disease, prion diseases and type-2 diabetes. Light chain (AL) -amyloidosis is unique among amyloid diseases in that the fibril protein, a monoclonal immunoglobulin light chain, varies between individuals and that no two AL-proteins with identical primary structures have been described to date. The variability in tissue distribution of amyloid deposits is considerably larger in systemic AL-amyloidosis than in any other form of amyloidosis. The reason for this variation is believed to be based on the differences in properties of the amyloidogenic immunoglobulin light chain. However, there is presently no known relationship between the structure of an AL-protein and tissue distribution. Methodology/Principal Findings. We compared the pattern of amyloid deposition in four individuals with amyloid protein derived from variable light chain gene O18-O8, the source of a high proportion of amyloidogenic light chains, and in whom all or most of the fibril protein had been determined by amino acid sequencing. In spite of great similarities between the structures of the proteins, there was a pronounced variability in deposition pattern. We also compared the tissue distribution in these four individuals with that of four other patients with AL-amyloid derived from the L2-L16 gene. Although the interindividual variations were pronounced, liver and kidney involvement was much more evident in the latter four. Conclusions/Significance. We conclude that although the use of a specific gene influences the tissue distribution of amyloid, each light chain exhibits one or more determinants of organ-specificity, which originate from somatic mutations and post-translational modifications. Eventual identification of such determinants could lead to improved treatment of patients with AL amyloidosis.	[Enqvist, Stina; Westermark, Per] Uppsala Univ, Dept Genet & Pathol, Uppsala, Sweden; [Sletten, Knut] Univ Oslo, Biotechnol Ctr Oslo, Oslo, Norway; [Stevens, Fred J.] Argonne Natl Lab, Biosci Div, Argonne, IL 60439 USA; [Hellman, Ulf] Ludwig Inst Canc Res, S-75124 Uppsala, Sweden	Uppsala University; University of Oslo; United States Department of Energy (DOE); Argonne National Laboratory; Ludwig Institute for Cancer Research	Westermark, P (corresponding author), Uppsala Univ, Dept Genet & Pathol, Uppsala, Sweden.	Per.Westermark@genpat.uu.se			Research Council of Norway; Swedish Research Council [5941]; European Union	Research Council of Norway(Research Council of Norway); Swedish Research Council(Swedish Research CouncilEuropean Commission); European Union(European Commission)	The work was supported by the Research Council of Norway, the Swedish Research Council (Project No. 5941) and the European Union FP6 Program.	Abraham RS, 2003, BLOOD, V101, P3801, DOI 10.1182/blood-2002-09-2707; Bergstrom J, 2005, J PATHOL, V206, P224, DOI 10.1002/path.1759; Comenzo RL, 2001, BLOOD, V98, P714, DOI 10.1182/blood.V98.3.714; Decourt C, 1996, CLIN EXP IMMUNOL, V106, P357; Engvig JP, 1998, SCAND J IMMUNOL, V48, P92; EULITZ M, 1985, BIOL CHEM H-S, V366, P907, DOI 10.1515/bchm3.1985.366.2.907; Falk RH, 1997, NEW ENGL J MED, V337, P898, DOI 10.1056/NEJM199709253371306; Galea HR, 2002, CLIN EXP IMMUNOL, V129, P113, DOI 10.1046/j.1365-2249.2002.01896.x; Hamill SJ, 2000, J MOL BIOL, V295, P641, DOI 10.1006/jmbi.1999.3360; Hellman U, 2002, MASS SPECTROMETRY AND HYPHENATED TECHNIQUES IN NEUROPEPTIDE RESEARCH, P259; Hellman U, 2002, RAPID COMMUN MASS SP, V16, P1851, DOI 10.1002/rcm.805; ISOBE T, 1974, NEW ENGL J MED, V290, P473, DOI 10.1056/NEJM197402282900902; Karimi M, 2003, SCAND J IMMUNOL, V57, P319, DOI 10.1046/j.1365-3083.2003.01230.x; KLEIN R, 1993, EUR J IMMUNOL, V23, P3248, DOI 10.1002/eji.1830231231; KYLE RA, 1983, MAYO CLIN PROC, V58, P665; KYLE RA, 1992, BLOOD, V79, P1817; MERLINI G, 1995, SEMIN HEMATOL, V32, P60; NYQUIST J, 1993, AMYLOID AMYLOIDOSIS, P247; Olsen KE, 1998, BIOCHEM BIOPH RES CO, V251, P642, DOI 10.1006/bbrc.1998.9508; Olsen KE, 1998, BIOCHEM BIOPH RES CO, V245, P713, DOI 10.1006/bbrc.1998.8515; Pokkuluri PR, 2002, PROTEIN SCI, V11, P1687, DOI 10.1110/ps.4920102; Prado MJBA, 1997, BRAZ J MED BIOL RES, V30, P865, DOI 10.1590/S0100-879X1997000700008; PRAS M, 1982, ISRAEL J MED SCI, V18, P866; Samdal I, 1999, AMYLOID AND AMYLOIDOSIS 1998, P62; Samdal IA, 2001, AMYLOID, V8, P111, DOI 10.3109/13506120109007353; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SHINODA T, 1986, AMYLOIDOSIS, P151; SLETTEN K, 1986, AMYLOIDOSIS, P463; Solomon A, 1998, P NATL ACAD SCI USA, V95, P9547, DOI 10.1073/pnas.95.16.9547; SOLOMON A, 1982, J CLIN INVEST, V70, P453, DOI 10.1172/JCI110635; Stevens FJ, 2000, AMYLOID, V7, P200, DOI 10.3109/13506120009146835; Stevens FJ, 1999, PROTEIN STRUCTURE ST; Stevens FJ, 1999, ANTIBODIES, V5, P175; SYMMERS WSC, 1956, J CLIN PATHOL, V9, P187, DOI 10.1136/jcp.9.3.187; SYMMERS WSC, 1956, J CLIN PATHOL, V9, P212, DOI 10.1136/jcp.9.3.212; TERRY WD, 1973, J CLIN INVEST, V52, P1276, DOI 10.1172/JCI107295; TOFT KG, 1990, AMYLOID AMYLOIDOSIS, P169; Vidal R, 1999, AM J PATHOL, V155, P2009, DOI 10.1016/S0002-9440(10)65520-4; Wally J, 1999, BBA-MOL BASIS DIS, V1454, P49, DOI 10.1016/S0925-4439(99)00019-8; WESTERMARK GT, 1990, AM J PATHOL, V137, P377; Westermark P, 2005, AMYLOID, V12, P1, DOI 10.1080/13506120500032196	41	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e981	10.1371/journal.pone.0000981	http://dx.doi.org/10.1371/journal.pone.0000981			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912358	Green Published, gold, Green Submitted			2022-12-25	WOS:000207455900017
J	Fayard, E; Gill, J; Paolino, M; Hynx, D; Hollander, GA; Hemmings, BA				Fayard, Elisabeth; Gill, Jason; Paolino, Magdalena; Hynx, Debby; Hollaender, Georg A.; Hemmings, Brian A.			Deletion of PKB alpha/Akt1 Affects Thymic Development	PLOS ONE			English	Article								Background. The thymus constitutes the primary lymphoid organ for the majority of T cells. The phosphatidyl-inositol 3 kinase (PI3K) signaling pathway is involved in lymphoid development. Defects in single components of this pathway prevent thymocytes from progressing beyond early T cell developmental stages. Protein kinase B (PKB) is the main effector of the PI3K pathway. Methodology/Principal Findings. To determine whether PKB mediates PI3K signaling in the thymus, we characterized PKB knockout thymi. Our results reveal a significant thymic hypocellularity in PKB alpha(-/-) neonates and an accumulation of early thymocyte subsets in PKB alpha(-/-) adult mice. Using thymic grafting and fetal liver cell transfer experiments, the latter finding was specifically attributed to the lack of PKB alpha within the lymphoid component of the thymus. Microarray analyses show that the absence of PKB alpha in early thymocyte subsets modifies the expression of genes known to be involved in pre-TCR signaling, in T cell activation, and in the transduction of interferon-mediated signals. Conclusions/Significance. This report highlights the specific requirements of PKB alpha for thymic development and opens up new prospects as to the mechanism downstream of PKB alpha in early thymocytes.	[Fayard, Elisabeth; Paolino, Magdalena; Hynx, Debby; Hemmings, Brian A.] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Gill, Jason; Hollaender, Georg A.] Univ Basel, Univ Childrens Hosp, Ctr Biomed, Dept Clin Biol Sci, Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; University of Basel	Hemmings, BA (corresponding author), Friedrich Miescher Inst Biomed Res, Basel, Switzerland.	brian.hemmings@fmi.ch	Paolino, Magdalena/AAN-9417-2020	Hollander, Georg/0000-0002-8790-0874; Gill, Jason/0000-0003-0955-6470; Paolino, Magdalena/0000-0001-9724-9029	European Molecular Biology Organization (EMBO) [ALTF 506-2005]; Marie Curie Fellowship [MEIF-CT-2006-025075]; NHMRC of Australia [237036]; Swiss National Science Foundation [3100-68310.02]; European Community; National Institute of Health [RO1-A1057477]	European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Marie Curie Fellowship(European Commission); NHMRC of Australia(National Health and Medical Research Council (NHMRC) of Australia); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Community(European Commission); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	EF is supported by the European Molecular Biology Organization (EMBO) Long Term Fellowship ALTF 506-2005 and the Marie Curie Fellowship MEIF-CT-2006-025075. JG is supported by NHMRC of Australia, CJ Martin Fellowship 237036. This work has been in part supported by Swiss National Science Foundation (3100-68310.02), the European Community 6th Framework Program Euro-Thymaide Integrated Project and the National Institute of Health (RO1-A1057477). The Friedrich Miescher Institute for Biomedical Research is part of the Novartis Research Foundation.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Bellavia D, 2000, EMBO J, V19, P3337, DOI 10.1093/emboj/19.13.3337; Bellavia D, 2003, SEMIN IMMUNOL, V15, P107, DOI 10.1016/S1044-5323(03)00007-1; BLUNT T, 1995, CELL, V80, P813, DOI 10.1016/0092-8674(95)90360-7; Ceredig R, 2002, NAT REV IMMUNOL, V2, P888, DOI 10.1038/nri937; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; Dummler B, 2007, BIOCHEM SOC T, V35, P231, DOI 10.1042/BST0350231; Dummler B, 2006, MOL CELL BIOL, V26, P8042, DOI 10.1128/MCB.00722-06; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Fayard E, 2005, J CELL SCI, V118, P5675, DOI 10.1242/jcs.02724; Felli MP, 1999, INT IMMUNOL, V11, P1017, DOI 10.1093/intimm/11.7.1017; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Gill J, 2003, IMMUNOL REV, V195, P28, DOI 10.1034/j.1600-065X.2003.00077.x; Hagenbeek TJ, 2004, J EXP MED, V200, P883, DOI 10.1084/jem.20040495; Hinton HJ, 2006, FEBS LETT, V580, P5845, DOI 10.1016/j.febslet.2006.09.045; Hinton HJ, 2004, NAT IMMUNOL, V5, P539, DOI 10.1038/ni1062; Juntilla MM, 2007, P NATL ACAD SCI USA, V104, P12105, DOI 10.1073/pnas.0705285104; Kaur S, 2005, J INTERF CYTOK RES, V25, P780, DOI 10.1089/jir.2005.25.780; KIRCHGESSNER CU, 1995, SCIENCE, V267, P1178, DOI 10.1126/science.7855601; Kozma SC, 2002, BIOESSAYS, V24, P65, DOI 10.1002/bies.10031; Kurimasa A, 1999, P NATL ACAD SCI USA, V96, P1403, DOI 10.1073/pnas.96.4.1403; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Malstrom S, 2001, P NATL ACAD SCI USA, V98, P14967, DOI 10.1073/pnas.231467698; Mao CC, 2007, J IMMUNOL, V178, P5443, DOI 10.4049/jimmunol.178.9.5443; Nguyen H, 2001, J BIOL CHEM, V276, P33361, DOI 10.1074/jbc.M105070200; Norment AM, 2000, J IMMUNOL, V164, P639, DOI 10.4049/jimmunol.164.2.639; Okkenhaug K, 2003, NAT REV IMMUNOL, V3, P317, DOI 10.1038/nri1056; Parsons MJ, 2001, J IMMUNOL, V167, P42, DOI 10.4049/jimmunol.167.1.42; Patra AK, 2006, J IMMUNOL, V177, P4567, DOI 10.4049/jimmunol.177.7.4567; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; PETERSON SR, 1995, P NATL ACAD SCI USA, V92, P3171, DOI 10.1073/pnas.92.8.3171; Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Rathmell JC, 2003, EUR J IMMUNOL, V33, P2223, DOI 10.1002/eji.200324048; Rothenberg EV, 2005, ANNU REV IMMUNOL, V23, P601, DOI 10.1146/annurev.immunol.23.021704.115737; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; Shioi T, 2002, MOL CELL BIOL, V22, P2799, DOI 10.1128/MCB.22.8.2799-2809.2002; Shiroki F, 2007, J IMMUNOL, V178, P1349, DOI 10.4049/jimmunol.178.3.1349; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; Tschopp O, 2005, DEVELOPMENT, V132, P2943, DOI 10.1242/dev.01864; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Wagner DH, 2007, CLIN IMMUNOL, V123, P1, DOI 10.1016/j.clim.2006.08.006; WILSON A, 1995, INT IMMUNOL, V7, P1659, DOI 10.1093/intimm/7.10.1659; Yang ZZ, 2005, MOL CELL BIOL, V25, P10407, DOI 10.1128/MCB.25.23.10407-10418.2005; Yang ZZ, 2003, J BIOL CHEM, V278, P32124, DOI 10.1074/jbc.M302847200	53	26	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e992	10.1371/journal.pone.0000992	http://dx.doi.org/10.1371/journal.pone.0000992			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912369	Green Published, Green Submitted, gold			2022-12-25	WOS:000207455900028
J	Verra, F; Simpore, J; Warimwe, GM; Tetteh, KK; Howard, T; Osier, FHA; Bancone, G; Avellino, P; Blot, I; Fegan, G; Bull, PC; Williams, TN; Conway, DJ; Marsh, K; Modiano, D				Verra, Federica; Simpore, Jacques; Warimwe, George M.; Tetteh, Kevin K.; Howard, Tevis; Osier, Faith H. A.; Bancone, Germana; Avellino, Pamela; Blot, Isa; Fegan, Greg; Bull, Peter C.; Williams, Thomas N.; Conway, David J.; Marsh, Kevin; Modiano, David			Haemoglobin C and S Role in Acquired Immunity against Plasmodium falciparum Malaria	PLOS ONE			English	Article							ANTIBODY-RESPONSES; SURFACE-ANTIGENS; PROTECTION; ERYTHROCYTES; TRAIT	A recently proposed mechanism of protection for haemoglobin C (HbC; beta 6Glu -> Lys) links an abnormal display of PfEMP1, an antigen involved in malaria pathogenesis, on the surface of HbC infected erythrocytes together with the observation of reduced cytoadhesion of parasitized erythrocytes and impaired rosetting in vitro. We investigated the impact of this hypothesis on the development of acquired immunity against Plasmodium falciparum variant surface antigens (VSA) encoding PfEMP1 in HbC in comparison with HbA and HbS carriers of Burkina Faso. We measured: i) total IgG against a single VSA, A4U, and against a panel of VSA from severe malaria cases in human sera from urban and rural areas of Burkina Faso of different haemoglobin genotypes (CC, AC, AS, SC, SS); ii) total IgG against recombinant proteins of P. falciparum asexual sporozoite, blood stage antigens, and parasite schizont extract; iii) total IgG against tetanus toxoid. Results showed that the reported abnormal cell-surface display of PfEMP1 on HbC infected erythrocytes observed in vitro is not associated to lower anti-PfEMP1 response in vivo. Higher immune response against the VSA panel and malaria antigens were observed in all adaptive genotypes containing at least one allelic variant HbC or HbS in the low transmission urban area whereas no differences were detected in the high transmission rural area. In both contexts the response against tetanus toxoid was not influenced by the beta-globin genotype. These findings suggest that both HbC and HbS affect the early development of naturally acquired immunity against malaria. The enhanced immune reactivity in both HbC and HbS carriers supports the hypothesis that the protection against malaria of these adaptive genotypes might be at least partially mediated by acquired immunity against malaria.	[Verra, Federica; Bancone, Germana; Avellino, Pamela; Modiano, David] Univ Roma La Sapienza, Dipartimento Sci Sanita Pubbl, Sez Parassitol, Rome, Italy; [Verra, Federica; Tetteh, Kevin K.; Osier, Faith H. A.; Fegan, Greg; Conway, David J.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; [Simpore, Jacques] Ctr Med St Camille, Ouagadougou, Burkina Faso; [Warimwe, George M.; Howard, Tevis; Osier, Faith H. A.; Fegan, Greg; Bull, Peter C.; Williams, Thomas N.; Marsh, Kevin] Kilifi Dist Hosp, Ctr Geog Med Res, Wellcome Trust Programme, Kenya Med Res Inst, Kilifi, Kenya; [Blot, Isa] Ctr Natl Transfus Sanguine, Ouagadougou, Burkina Faso; [Conway, David J.] MRC Labs, Banjul, Gambia	Sapienza University Rome; University of London; London School of Hygiene & Tropical Medicine; Kenya Medical Research Institute; MRC Laboratory Molecular Biology	Verra, F (corresponding author), Univ Roma La Sapienza, Dipartimento Sci Sanita Pubbl, Sez Parassitol, Rome, Italy.	federica.verra@uniroma1.it	Tetteh, Kevin/GYQ-9704-2022; Fegan, Greg W/O-8079-2018; SIMPORE, Jacques/ABA-4873-2020	Tetteh, Kevin/0000-0003-2733-0037; Fegan, Greg W/0000-0002-2663-2765; SIMPORE, Jacques/0000-0002-0415-9161; Bull, Peter/0000-0002-7674-6752; Osier, Faith/0000-0001-7133-5375; Bancone, Germana/0000-0003-4550-0431; Conway, David/0000-0002-8711-3037	Wellcome Trust [071626]; European, Priority 1 Life Sciences, Genomics and Biotechnology for Health [LSH-CT-2004-503578]; malaria Network; Compagnia di San Paolo, Turin, Italy; MRC [MC_U190081993] Funding Source: UKRI; Medical Research Council [MC_U190081993] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); European, Priority 1 Life Sciences, Genomics and Biotechnology for Health; malaria Network; Compagnia di San Paolo, Turin, Italy(Compagnia di San Paolo); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This project was supported by the Wellcome Trust grant no 071626 (Advanced Training Fellowship in Tropical Medicine to FV). This work is also part of the activities of the BioMalPar European Network of Excellence supported by a European grant (LSH-CT-2004-503578) from the Priority 1 Life Sciences, Genomics and Biotechnology for Health in the 6th Framework Programme. FV is currently funded by the malaria Network sponsored by the Compagnia di San Paolo, Turin, Italy. The above mentioned funders had no role in the design and conduct of the study, in the collection, analysis, and interpretation, review, or approval of the manuscript.	Agarwal A, 2000, BLOOD, V96, P2358, DOI 10.1182/blood.V96.7.2358.h8002358_2358_2363; ALLISON AC, 1954, T ROY SOC TROP MED H, V48, P312, DOI 10.1016/0035-9203(54)90101-7; Ayi K, 2004, BLOOD, V104, P3364, DOI 10.1182/blood-2003-11-3820; Bull PC, 2002, J INFECT DIS, V185, P1688, DOI 10.1086/340420; Cabrera G, 2005, J INFECT DIS, V191, P1631, DOI 10.1086/429832; Cavanagh DR, 1997, MOL BIOCHEM PARASIT, V85, P197, DOI 10.1016/S0166-6851(96)02826-5; Cavanagh DR, 1998, J IMMUNOL, V161, P347; Fairhurst RM, 2005, NATURE, V435, P1117, DOI 10.1038/nature03631; Fairhurst RM, 2003, BLOOD, V101, P3309, DOI 10.1182/blood-2002-10-3105; Giha HA, 1999, INFECT IMMUN, V67, P4092, DOI 10.1128/IAI.67.8.4092-4098.1999; Haldane J. B. S., 1949, Ricerca Scientifica Suppl, P68; Kinyanjui SM, 2004, J INFECT DIS, V190, P1527, DOI 10.1086/424675; MARSH K, 1989, T ROY SOC TROP MED H, V83, P293, DOI 10.1016/0035-9203(89)90478-1; Mockenhaupt FP, 2004, J INFECT DIS, V190, P1006, DOI 10.1086/422847; Modiano D, 2001, NATURE, V414, P305, DOI 10.1038/35104556; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; VIRIYAKOSOL S, 1995, B WORLD HEALTH ORGAN, V73, P85; Weatherall DJ, 2001, NAT REV GENET, V2, P245, DOI 10.1038/35066048; Williams TN, 2005, PLOS MED, V2, P441, DOI 10.1371/journal.pmed.0020128; Williams TN, 2003, CYTOM PART A, V56A, P96, DOI 10.1002/cyto.a.10088	20	50	51	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e978	10.1371/journal.pone.0000978	http://dx.doi.org/10.1371/journal.pone.0000978			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912355	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000207455900014
J	Lodes, MJ; Suciu, D; Wilmoth, JL; Ross, M; Munro, S; Dix, K; Bernards, K; Stover, AG; Quintana, M; Iihoshi, N; Lyon, WJ; Danley, DL; McShea, A				Lodes, Michael J.; Suciu, Dominic; Wilmoth, Jodi L.; Ross, Marty; Munro, Sandra; Dix, Kim; Bernards, Karen; Stoever, Axel G.; Quintana, Miguel; Iihoshi, Naomi; Lyon, Wanda J.; Danley, David L.; McShea, Andrew			Identification of Upper Respiratory Tract Pathogens Using Electrochemical Detection on an Oligonucleotide Microarray	PLOS ONE			English	Article								Bacterial and viral upper respiratory infections (URI) produce highly variable clinical symptoms that cannot be used to identify the etiologic agent. Proper treatment, however, depends on correct identification of the pathogen involved as antibiotics provide little or no benefit with viral infections. Here we describe a rapid and sensitive genotyping assay and microarray for URI identification using standard amplification and hybridization techniques, with electrochemical detection (ECD) on a semiconductor-based oligonucleotide microarray. The assay was developed to detect four bacterial pathogens (Bordetella pertussis, Streptococcus pyogenes, Chlamydia pneumoniae and Mycoplasma pneumoniae) and 9 viral pathogens (adenovirus 4, coronavirus OC43, 229E and HK, influenza A and B, parainfluinza types 1, 2, and 3 and respiratory syncytial virus. This new platform forms the basis for a fully automated diagnostics system that is very flexible and can be customized to suit different or additional pathogens. Multiple probes on a flexible platform allow one to test probes empirically and then select highly reactive probes for further iterative evaluation. Because ECD uses an enzymatic reaction to create electrical signals that can be read directly from the array, there is no need for image analysis or for expensive and delicate optical scanning equipment. We show assay sensitivity and specificity that are excellent for a multiplexed format.	[Lodes, Michael J.; Suciu, Dominic; Wilmoth, Jodi L.; Ross, Marty; Munro, Sandra; Dix, Kim; Bernards, Karen; Stoever, Axel G.; Danley, David L.; McShea, Andrew] CombiMatrix Corp, Mukilteo, WA USA; [Quintana, Miguel; Iihoshi, Naomi] USA, Ctr Hlth Promot & Prevent Med W, Ft Lewis, WA USA; [Lyon, Wanda J.] USAF, Res Lab, Human Effectiveness Directorate, Appl Biotechnol Branch, Wright Patterson AFB, OH 45433 USA	United States Department of Defense; United States Air Force; US Air Force Research Laboratory	Lodes, MJ (corresponding author), CombiMatrix Corp, Mukilteo, WA USA.	mlodes@combimatrix.com	Munro, Sandra B/S-2611-2019	Munro, Sandra B/0000-0002-9643-0528	CombiMatrix Corporation	CombiMatrix Corporation	This is a research and development project funded by CombiMatrix Corporation (MJL, DS, JLW, AGS, MR, SM, KD, KB, DLD, and AM). MQ and NI are employees of CHPPM-West at Fort Lewis, Washington and WJL is an employee of the US Air Force Research Laboratory, Wright-Patterson AFB, OH.	Allwinn R, 2002, MED MICROBIOL IMMUN, V191, P157, DOI 10.1007/s00430-002-0137-y; Amano Y, 2005, ANAL BIOANAL CHEM, V381, P156, DOI 10.1007/s00216-004-2927-0; Baxi MK, 2006, VET J, V172, P473, DOI 10.1016/j.tvjl.2005.07.007; Bodrossy L, 2004, CURR OPIN MICROBIOL, V7, P245, DOI 10.1016/j.mib.2004.04.005; Boivin G, 2004, J CLIN MICROBIOL, V42, P45, DOI 10.1128/JCM.42.1.45-51.2004; Briese T, 2005, EMERG INFECT DIS, V11, P310, DOI 10.3201/eid1102.040492; Brook I, 2005, CHEST, V127, P2072, DOI 10.1378/chest.127.6.2072; Costa LF, 2006, MEM I OSWALDO CRUZ, V101, P301, DOI 10.1590/S0074-02762006000300014; Cram P, 1999, AM J MANAG CARE, V5, P1555; Dill K, 2004, BIOSENS BIOELECTRON, V20, P736, DOI 10.1016/j.bios.2004.06.049; Dosh SA, 2000, J FAM PRACTICE, V49, P407; Ecker DJ, 2005, P NATL ACAD SCI USA, V102, P8012, DOI 10.1073/pnas.0409920102; Ellis JS, 2002, REV MED VIROL, V12, P375, DOI 10.1002/rmv.370; Ghindilis AL, 2007, BIOSENS BIOELECTRON, V22, P1853, DOI 10.1016/j.bios.2006.06.024; Grondahl B, 1999, J CLIN MICROBIOL, V37, P1; Ivshina AV, 2004, J CLIN MICROBIOL, V42, P5793, DOI 10.1128/JCM.42.12.5793-5801.2004; Kessler N, 2004, J CLIN MICROBIOL, V42, P2173, DOI 10.1128/JCM.42.5.2173-2185.2004; Konno Masatoshi, 2006, Journal of Infection and Chemotherapy, V12, P83, DOI 10.1007/s10156-006-0433-3; Korimbocus J, 2005, J CLIN MICROBIOL, V43, P3779, DOI 10.1128/JCM.43.8.3779-3787.2005; Li JP, 2001, J CLIN MICROBIOL, V39, P696, DOI 10.1128/JCM.39.2.696-704.2001; Lin BC, 2006, GENOME RES, V16, P527, DOI 10.1101/gr.4337206; Lin BC, 2004, J CLIN MICROBIOL, V42, P3232, DOI 10.1128/JCM.42.7.3232-3239.2004; Liu HH, 1999, PHARMACOTHERAPY, V19, P371, DOI 10.1592/phco.19.6.371.31051; Liu RH, 2006, ANAL CHEM, V78, P4184, DOI 10.1021/ac060450v; Lodes MJ, 2006, J CLIN MICROBIOL, V44, P1209, DOI 10.1128/JCM.44.4.1209-1218.2006; Louie JK, 2005, CLIN INFECT DIS, V41, P822, DOI 10.1086/432800; Mainous AG, 1999, PHARMACOTHERAPY, V19, P388, DOI 10.1592/phco.19.6.388.31036; Makela MJ, 1998, J CLIN MICROBIOL, V36, P539; McDonough EA, 2005, MOL CELL PROBE, V19, P314, DOI 10.1016/j.mcp.2005.05.002; Mentel R, 2003, J MED MICROBIOL, V52, P893, DOI 10.1099/jmm.0.05290-0; Metzgar D, 2005, J CLIN MICROBIOL, V43, P5743, DOI 10.1128/JCM.43.11.5743-5752.2005; Mitterer G, 2004, J CLIN MICROBIOL, V42, P1048, DOI 10.1128/JCM.42.3.1048-1057.2004; Perkins SM, 2005, J CLIN MICROBIOL, V43, P2356, DOI 10.1128/JCM.43.5.2356-2362.2005; Roth SB, 2004, J CLIN MICROBIOL, V42, P4268, DOI 10.1128/JCM.42.9.4268-4274.2004; Schweiger B, 2000, J CLIN MICROBIOL, V38, P1552, DOI 10.1128/JCM.38.4.1552-1558.2000; Sengupta S, 2003, J CLIN MICROBIOL, V41, P4542, DOI 10.1128/JCM.41.10.4542-4550.2003; Stralin K, 2006, J CLIN MICROBIOL, V44, P643, DOI 10.1128/JCM.44.2.643-645.2006; Syrmis MW, 2004, J MOL DIAGN, V6, P125, DOI 10.1016/S1525-1578(10)60500-4; Taubenberger JK, 2001, MOL DIAGN, V6, P291, DOI 10.1054/modi.2001.28063; Templeton KE, 2004, J CLIN MICROBIOL, V42, P1564, DOI 10.1128/JCM.42.4.1564-1569.2004; Wang D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/pnas.242579699; Wang D, 2003, PLOS BIOL, V1, P257, DOI 10.1371/journal.pbio.0000002; Westin L, 2000, NAT BIOTECHNOL, V18, P199, DOI 10.1038/72658; Zou SM, 1997, J CLIN MICROBIOL, V35, P2623, DOI 10.1128/JCM.35.10.2623-2627.1997	44	49	52	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e924	10.1371/journal.pone.0000924	http://dx.doi.org/10.1371/journal.pone.0000924			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895966	Green Published, Green Submitted, gold			2022-12-25	WOS:000207455800004
J	Kidokoro, T; Tanikawa, C; Furukawa, Y; Katagiri, T; Nakamura, Y; Matsuda, K				Kidokoro, T.; Tanikawa, C.; Furukawa, Y.; Katagiri, T.; Nakamura, Y.; Matsuda, K.			CDC20, a potential cancer therapeutic target, is negatively regulated by p53	ONCOGENE			English	Article						CDC20; p53; p21; therapeutic target; spindle checkpoint	GENE-EXPRESSION PROFILES; WIDE CDNA MICROARRAY; WILD-TYPE P53; CELL LUNG CANCERS; DNA-DAMAGE; TRANSCRIPTIONAL REPRESSION; NEOADJUVANT CHEMOTHERAPY; P53-DEPENDENT APOPTOSIS; MYELOID-LEUKEMIA; BREAST-CANCER	The p53 protein inhibits malignant transformation through direct and indirect regulation of transcription of many genes related to cell cycle, apoptosis and cellular senescence. A number of genes induced by p53 have been well characterized, but biological significance of genes whose expression was suppressed by p53 is still largely undisclosed. To clarify the roles of p53-suppressive genes in carcinogenesis, we analysed two data sets of whole-genome expression profiles, one for cells in which wildtype p53 was exogenously introduced and the other for a large number of clinical cancer tissues. Here, we identified CDC20 that was frequently upregulated in many types of malignancies and remarkably suppressed by ectopic introduction of p53. CDC20 expression was suppressed by genotoxic stresses in p53- and p21-dependent manners through CDE-CHR elements in the CDC20 promoter. Furthermore, small interference RNA (siRNA)-mediated silencing of p53 induced CDC20 expression in normal human dermal. broblast cells. As we expected, treatment of cancer cells with siRNA against CDC20 induced G(2)/M arrest and suppressed cell growth. Our results indicate that p53 inhibits tumor cell growth through the indirect regulation of CDC20 and that CDC20 might be a good potential therapeutic target for a broad spectrum of human cancer.	[Kidokoro, T.; Tanikawa, C.; Katagiri, T.; Nakamura, Y.; Matsuda, K.] Univ Tokyo, Ctr Human Genome, Inst Med Sci, Mol Med Lab, Tokyo 1088639, Japan; [Furukawa, Y.] Univ Tokyo, Ctr Human Genome, Inst Med Sci, Promot Genome Based Med Project, Tokyo, Japan	University of Tokyo; University of Tokyo	Kidokoro, T (corresponding author), Univ Tokyo, Ctr Human Genome, Inst Med Sci, Mol Med Lab, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	koichima@ims.u-tokyo.ac.jp	Katagiri, Toyomasa/I-7344-2012; Matsuda, Koichi/D-4597-2011	Matsuda, Koichi/0000-0001-7292-2686; Tanikawa, Chizu/0000-0003-4759-4793				Ashida S, 2004, CANCER RES, V64, P5963, DOI 10.1158/0008-5472.CAN-04-0020; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Bykov VJN, 2002, NAT MED, V8, P282, DOI 10.1038/nm0302-282; El-Deiry WS, 1998, SEMIN CANCER BIOL, V8, P345, DOI 10.1006/scbi.1998.0097; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Fung TK, 2005, SEMIN CELL DEV BIOL, V16, P335, DOI 10.1016/j.semcdb.2005.02.014; Hasegawa S, 2002, CANCER RES, V62, P7012; Hirota E, 2006, INT J ONCOL, V29, P799; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; HOLLSTEIN M, 1994, NUCLEIC ACIDS RES, V22, P3551; Innocente SA, 2005, FEBS LETT, V579, P1001, DOI 10.1016/j.febslet.2004.12.073; Issaeva N, 2004, NAT MED, V10, P1321, DOI 10.1038/nm1146; Jinawath N, 2004, ONCOGENE, V23, P6830, DOI 10.1038/sj.onc.1207886; Kaneta Y, 2002, JPN J CANCER RES, V93, P849, DOI 10.1111/j.1349-7006.2002.tb01328.x; Kikuchi T, 2003, ONCOGENE, V22, P2192, DOI 10.1038/sj.onc.1206288; Kim JM, 2005, CLIN CANCER RES, V11, P473; Kitahara O, 2002, NEOPLASIA, V4, P295, DOI 10.1038/sj.neo.7900251; Kitahara O, 2001, CANCER RES, V61, P3544; MAITY SN, 1992, J BIOL CHEM, V267, P16574; Matsuda K, 2002, CANCER RES, V62, P2883; Mondal G, 2007, CARCINOGENESIS, V28, P81, DOI 10.1093/carcin/bgl100; Nagayama S, 2002, CANCER RES, V62, P5859; Nakamura T, 2004, ONCOGENE, V23, P2385, DOI 10.1038/sj.onc.1207392; Nakamura Y, 2004, CANCER SCI, V95, P7, DOI 10.1111/j.1349-7006.2004.tb03163.x; Nishidate T, 2004, INT J ONCOL, V25, P797; Obama K, 2005, HEPATOLOGY, V41, P1339, DOI 10.1002/hep.20718; Ochi K, 2004, INT J ONCOL, V24, P647; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Okabe H, 2001, CANCER RES, V61, P2129; Okada K, 2003, INT J ONCOL, V23, P1615; Okutsu J, 2002, MOL CANCER THER, V1, P1035; Ono K, 2000, CANCER RES, V60, P5007; Roth JA, 2006, EXPERT OPIN BIOL TH, V6, P55, DOI 10.1517/14712598.6.1.55; SETO E, 1992, P NATL ACAD SCI USA, V89, P12028, DOI 10.1073/pnas.89.24.12028; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Soussi T, 2006, CLIN CANCER RES, V12, P62, DOI 10.1158/1078-0432.CCR-05-0413; St Clair S, 2004, MOL CELL, V16, P725; Takata R, 2005, CLIN CANCER RES, V11, P2625, DOI 10.1158/1078-0432.CCR-04-1988; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; Tanikawa C, 2003, NAT CELL BIOL, V5, P216, DOI 10.1038/ncb943; Taniwaki M, 2006, INT J ONCOL, V29, P567; Taylor WR, 2001, J BIOL CHEM, V276, P1998, DOI 10.1074/jbc.M005101200; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wells J, 2000, MOL CELL BIOL, V20, P5797, DOI 10.1128/MCB.20.16.5797-5807.2000; Yamabuki T, 2006, INT J ONCOL, V28, P1375; Yi S, 2006, MOL CARCINOGEN, V45, P409, DOI 10.1002/mc.20231; Zaffaroni N, 2005, J CELL MOL MED, V9, P360, DOI 10.1111/j.1582-4934.2005.tb00361.x; ZHOU MX, 1995, BLOOD, V85, P1608, DOI 10.1182/blood.V85.6.1608.bloodjournal8561608; ZWICKER J, 1995, EMBO J, V14, P4514, DOI 10.1002/j.1460-2075.1995.tb00130.x	50	156	165	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 6	2008	27	11					1562	1571		10.1038/sj.onc.1210799	http://dx.doi.org/10.1038/sj.onc.1210799			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	271VC	17873905				2022-12-25	WOS:000253815800008
J	Knoops, L; Hornakova, T; Royer, Y; Constantinescu, SN; Renauld, JC				Knoops, L.; Hornakova, T.; Royer, Y.; Constantinescu, S. N.; Renauld, J-C			JAK kinases overexpression promotes in vitro cell transformation	ONCOGENE			English	Article						interleukin-9; Janus kinases; transforming gene; overexpression	SURFACE EXPRESSION; POLYCYTHEMIA-VERA; MYELOPROLIFERATIVE DISORDERS; CONSTITUTIVE ACTIVATION; ERYTHROPOIETIN RECEPTOR; CYTOKINE RECEPTOR; HODGKINS LYMPHOMA; STAT PROTEINS; INTERLEUKIN-9; MUTATION	Constitutive activation of the JAK-STAT pathway is frequent in cancer and contributes to oncogenesis. Here, we took advantage of the Ba/F3 cell line, a murine proB cell line dependent on IL-3 for growth, to analyse mechanisms of constitutive STAT activation in vitro. Cytokine-independent and tumorigenic Ba/F3 cell lines were derived from a two-step selection process. Cells transfected with a defective IL-9 receptor acquire IL-9 responsiveness during a first step of selection, and progress after a second selection step to autonomously growing tumorigenic cells. Microarray analysis pointed to JAK1 overexpression as a key genetic event in this transformation. Overexpression of JAK1 not only increased the sensitivity to IL-9 but also allowed a second selection step toward cytokine-independent growth with constitutive STAT activation. This progression was dependent on a functional FERM and kinase JAK1 domain. Similar results were observed after JAK2, JAK3 and TYK2 overexpression. All autonomous cell lines showed an activation of STAT5, ERK1-2 and AKT but only TYK2-overexpressing cell lines showed a constitutive activation of STAT3. Thus, JAK overexpression can be considered as one of the oncogenic events leading to the constitutive activation of the JAK-STAT pathway.	[Knoops, L.; Hornakova, T.; Royer, Y.; Constantinescu, S. N.; Renauld, J-C] Univ Catholique Louvain, Ludwig Inst Canc Res, Brussels Branch, B-1200 Brussels, Belgium; [Knoops, L.; Hornakova, T.; Royer, Y.; Constantinescu, S. N.; Renauld, J-C] Univ Catholique Louvain, Duve Inst, B-1200 Brussels, Belgium; [Knoops, L.] Clin Univ St Luc, Div Hematol, B-1200 Brussels, Belgium	Ludwig Institute for Cancer Research; Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Renauld, JC (corresponding author), Univ Catholique Louvain, Ludwig Inst Canc Res, Brussels Branch, Ave Hippocrate 74, B-1200 Brussels, Belgium.	renauld@bru.licr.org	Constantinescu, Stefan N/E-5277-2012; Renauld, Jean-Christophe/B-7268-2012	Renauld, Jean-Christophe/0000-0003-1736-2131; Constantinescu, Stefan N./0000-0002-8599-2699				Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Cochet O, 2006, CELL SIGNAL, V18, P449, DOI 10.1016/j.cellsig.2005.05.010; Demoulin JB, 2000, CANCER RES, V60, P3971; Demoulin JB, 1996, MOL CELL BIOL, V16, P4710; DRUEZ C, 1990, J IMMUNOL, V145, P2494; Fischer M, 2003, LEUKEMIA, V17, P2513, DOI 10.1038/sj.leu.2403123; Guiter C, 2004, BLOOD, V104, P543, DOI 10.1182/blood-2003-10-3545; Haan C, 2001, J BIOL CHEM, V276, P37451, DOI 10.1074/jbc.M106135200; He B, 2003, P NATL ACAD SCI USA, V100, P14133, DOI 10.1073/pnas.2232790100; Huang LJS, 2001, MOL CELL, V8, P1327, DOI 10.1016/S1097-2765(01)00401-4; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Joos S, 2000, CANCER RES, V60, P549; Joos S, 2003, INT J CANCER, V103, P489, DOI 10.1002/ijc.10845; KELLEHER K, 1991, BLOOD, V77, P1436; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Knoops L, 2004, GROWTH FACTORS, V22, P207, DOI 10.1080/08977190410001720879; Kohlhuber F, 1997, MOL CELL BIOL, V17, P695, DOI 10.1128/MCB.17.2.695; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kube D, 2001, BLOOD, V98, P762, DOI 10.1182/blood.V98.3.762; Lacronique V, 1997, SCIENCE, V278, P1309, DOI 10.1126/science.278.5341.1309; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Liu XD, 2000, ANAL BIOCHEM, V280, P20, DOI 10.1006/abio.2000.4478; Louahed J, 1999, BLOOD, V94, P1701, DOI 10.1182/blood.V94.5.1701.417k29_1701_1710; Lu XH, 2005, P NATL ACAD SCI USA, V102, P18962, DOI 10.1073/pnas.0509714102; MERZ H, 1991, BLOOD, V78, P1311; Nagai H, 2003, J HUM GENET, V48, P65, DOI 10.1007/s100380300008; PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2; Radtke S, 2002, J BIOL CHEM, V277, P11297, DOI 10.1074/jbc.M100822200; Ragimbeau J, 2003, EMBO J, V22, P537, DOI 10.1093/emboj/cdg038; Rawat R, 2000, BLOOD, V96, P3514; Renauld J.-C., 2003, CYTOKINE HDB, P347; RENAULD JC, 1994, ONCOGENE, V9, P1327; RENAULD JC, 1995, J LEUKOCYTE BIOL, V57, P353, DOI 10.1002/jlb.57.3.353; Rucker FG, 2006, J CLIN ONCOL, V24, P3887, DOI 10.1200/JCO.2005.04.5450; Seubert N, 2003, MOL CELL, V12, P1239, DOI 10.1016/S1097-2765(03)00389-7; Staerk J, 2005, J BIOL CHEM, V280, P41893, DOI 10.1074/jbc.C500358200; Trikha M, 2003, CLIN CANCER RES, V9, P4653; UYTTENHOVE C, 1991, J EXP MED, V173, P519, DOI 10.1084/jem.173.2.519; Zhou YJ, 2001, MOL CELL, V8, P959, DOI 10.1016/S1097-2765(01)00398-7	41	34	37	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 6	2008	27	11					1511	1519		10.1038/sj.onc.1210800	http://dx.doi.org/10.1038/sj.onc.1210800			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	271VC	17873904				2022-12-25	WOS:000253815800002
J	Cano, F; Drynan, LF; Pannell, R; Rabbitts, TH				Cano, F.; Drynan, L. F.; Pannell, R.; Rabbitts, T. H.			Leukaemia lineage specification caused by cell-specific Mll-Enl translocations	ONCOGENE			English	Article						MLL; leukaemia; translocation; translocator; mouse disease models	CHROMOSOMAL TRANSLOCATIONS; CRE-LOXP; GENE; 11Q23; RECOMBINATION	Chromosomal translocations involving the Mixed-Lineage Leukaemia (MLL) gene underlie many human leukaemias and MLL rearrangements are found in both acute myelogenous and acute lymphoblastic leukaemias. To assess the functionally relevant haematopoietic cell contexts for MLL fusions to be tumorigenic, we have generated different lines of mice in which de novo Mll-associated translocations occur. In these models, reciprocal chromosomal translocations occur by means of Cre-loxPmediated recombination (translocator mice) in different cells of the haematopoietic system (namely haematopoietic stem cells, semi-committed progenitors or committed T or B cells). Translocations between Mll and Enl cause myeloid neoplasias, initiating in stem cells or progenitors while no tumours arose when the translocation was restricted to the B-cell compartment. Despite the absence of tumorigenesis, Mll-Enl translocations did occur and Mll-Enl fusion mRNA was expressed in B-cell-restricted translocators. A permissive cellular environment is therefore required for oncogenicity of Mll-associated translocations since the occurrence of Mll-Enl does not promote unrestricted proliferation in all haematopoietic cellular contexts, consistent with a specific instructive role of the MLL-fusion proteins in leukaemogenesis.	[Rabbitts, T. H.] St James Univ Hosp, Leeds Inst Mol Med, Sect Expt Therapeut, Leeds LS9 7TF, W Yorkshire, England; [Cano, F.; Drynan, L. F.; Pannell, R.; Rabbitts, T. H.] MRC, Mol Biol Lab, Cambridge CB2 2QH, England	Saint James's University Hospital; University of Leeds; MRC Laboratory Molecular Biology	Rabbitts, TH (corresponding author), St James Univ Hosp, Leeds Inst Mol Med, Sect Expt Therapeut, Wellcome Trust Brenner Bldg, Leeds LS9 7TF, W Yorkshire, England.	thr@leeds.ac.uk	Drynan, Lesley/V-2984-2019; Rabbitts, Terence/D-6262-2016	Rabbitts, Terence/0000-0002-4982-2609	MRC [G0600914] Funding Source: UKRI; Medical Research Council [MC_U105178807, G0600914] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; Bloomfield CD, 2002, GENE CHROMOSOME CANC, V33, P362, DOI 10.1002/gcc.10046; Collins EC, 2000, EMBO REP, V1, P127, DOI 10.1093/embo-reports/kvd021; Corral J, 1996, CELL, V85, P853, DOI 10.1016/S0092-8674(00)81269-6; Cozzio A, 2003, GENE DEV, V17, P3029, DOI 10.1101/gad.1143403; Daser A, 2004, GENE DEV, V18, P965, DOI 10.1101/gad.1195504; Drynan LF, 2005, EMBO J, V24, P3136, DOI 10.1038/sj.emboj.7600760; Felix CA, 2001, MED PEDIATR ONCOL, V36, P525, DOI 10.1002/mpo.1125; Forster A, 2003, CANCER CELL, V3, P449, DOI 10.1016/S1535-6108(03)00106-5; Huret JL, 2001, LEUKEMIA, V15, P987, DOI 10.1038/sj.leu.2402135; Kogan SC, 2002, BLOOD, V100, P238, DOI 10.1182/blood.V100.1.238; McCormack MP, 2003, MOL CELL BIOL, V23, P9003, DOI 10.1128/MCB.23.24.9003-9013.2003; Metzler M, 2006, ONCOGENE, V25, P3093, DOI 10.1038/sj.onc.1209636; Milne TA, 2005, CANCER RES, V65, P11367, DOI 10.1158/0008-5472.CAN-05-1041; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Pui CH, 2007, LEUKEMIA, V21, P593, DOI 10.1038/sj.leu.2404598; Pui CH, 2002, LANCET, V359, P1909, DOI 10.1016/S0140-6736(02)08782-2; Pui Ching-Hon, 2002, Rev Clin Exp Hematol, V6, P161, DOI 10.1046/j.1468-0734.2002.00067.x; RABBITTS TH, 1991, CELL, V67, P641, DOI 10.1016/0092-8674(91)90057-6; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4	21	15	16	0	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2008	27	13					1945	1950		10.1038/sj.onc.1210818	http://dx.doi.org/10.1038/sj.onc.1210818			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	276NZ	17906700				2022-12-25	WOS:000254150600014
J	Shin, DH; Li, SH; Chun, YS; Huang, LE; Kim, MS; Park, JW				Shin, D. H.; Li, S. H.; Chun, Y-S; Huang, L. E.; Kim, M-S; Park, J-W			CITED2 mediates the paradoxical responses of HIF-1 alpha to proteasome inhibition	ONCOGENE			English	Article						hIF-1 alpha; CITED2; proteasome inhibition; p300 co-activator	HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; MELANOCYTE-SPECIFIC GENE; TRANSCRIPTIONAL ACTIVITY; PROTEIN; HIF-1; EXPRESSION; REGULATOR; P300/CBP; GROWTH; MRG1	Hypoxia-inducible factor-1 alpha (HIF-1 alpha) is destabilized via the ubiquitin-proteasome system. Thus HIF-1 alpha expression is robustly upregulated by proteasome inhibition, but paradoxically its activity is reduced. In the present study, we investigated the mechanism underlying the paradoxical response of HIF-1 alpha to proteasome inhibition. In both Hep3B and HEK293 cells, a proteasome inhibitor MG132 noticeably attenuated hypoxic induction of erythropoietin and VEGF mRNAs. MG132 inactivated HIF-1 alpha C-terminal transactivation domain (CAD), independently of factor inhibiting HIF-1 (FIH) and inhibited p300 recruitment by HIF-1 alpha. We next tested the possibility that CITED2 is involved in the HIF-1 inactivation. CITED2 was found to be degraded via the ubiquitin-proteasome system and thus was stabilized by proteasome inhibition. Both the activity and the p300 binding of HIF-1 alpha were inhibited by CITED2 expression and recovered by CITED2 siRNA in the presence of MG132. These results suggest that CITED2 is stabilized by proteasome inhibition and inactivates HIF-1 by interfering with the HIF-1 alpha-p300 interaction. This may be an important mode-of-action for proteasome inhibition-based cancer therapy.	[Shin, D. H.; Li, S. H.; Kim, M-S; Park, J-W] Seoul Natl Univ, Coll Med, Dept Pharmacol, Seoul 11079, South Korea; [Chun, Y-S] Seoul Natl Univ, Coll Med, Dept Physiol, Seoul 11079, South Korea; [Chun, Y-S] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Huang, L. E.] Univ Utah, Sch Med, Dept Neurosurg, Salt Lake City, UT USA	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Utah System of Higher Education; University of Utah	Park, JW (corresponding author), Seoul Natl Univ, Coll Med, Dept Pharmacol, 28 Yongon Dong, Seoul 11079, South Korea.	parkjw@snu.ac.kr	Park, Jong-Wan/J-2758-2012	Huang, Eric/0000-0002-6444-1708				Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; Bhattacharya S, 1999, GENE DEV, V13, P64, DOI 10.1101/gad.13.1.64; Birle DC, 2007, CANCER RES, V67, P1735, DOI 10.1158/0008-5472.CAN-06-2722; Braganca J, 2003, J BIOL CHEM, V278, P16021, DOI 10.1074/jbc.M208144200; Chou YT, 2006, J BIOL CHEM, V281, P18451, DOI 10.1074/jbc.M601720200; Chun YS, 2002, BIOCHEM J, V362, P71, DOI 10.1042/0264-6021:3620071; Dunwoodie SL, 1998, MECH DEVELOP, V72, P27, DOI 10.1016/S0925-4773(98)00011-2; Freedman SJ, 2003, NAT STRUCT BIOL, V10, P504, DOI 10.1038/nsb936; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Kallio PJ, 1999, J BIOL CHEM, V274, P6519, DOI 10.1074/jbc.274.10.6519; Kaluz S, 2006, MOL CELL BIOL, V26, P5895, DOI 10.1128/MCB.00552-06; Koshiji M, 2005, MOL CELL, V17, P793, DOI 10.1016/j.molcel.2005.02.015; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Liao D, 2007, CANCER RES, V67, P563, DOI 10.1158/0008-5472.CAN-06-2701; Sasabe E, 2007, INT J CANCER, V120, P268, DOI 10.1002/ijc.22294; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Shioda T, 1996, P NATL ACAD SCI USA, V93, P12298, DOI 10.1073/pnas.93.22.12298; Sun HB, 1998, P NATL ACAD SCI USA, V95, P13555, DOI 10.1073/pnas.95.23.13555; Xu B, 2007, DEV BIOL, V301, P130, DOI 10.1016/j.ydbio.2006.08.072; Yeo EJ, 2006, BLOOD, V107, P916, DOI 10.1182/blood-2005-06-2564; Yin Z, 2002, P NATL ACAD SCI USA, V99, P10488, DOI 10.1073/pnas.162371799	22	31	32	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR	2008	27	13					1939	1944		10.1038/sj.onc.1210826	http://dx.doi.org/10.1038/sj.onc.1210826			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	276NZ	17906695				2022-12-25	WOS:000254150600013
J	Wang, H; Mannava, S; Grachtchouk, V; Zhuang, D; Soengas, MS; Gudkov, AV; Prochownik, EV; Nikiforov, MA				Wang, H.; Mannava, S.; Grachtchouk, V.; Zhuang, D.; Soengas, M. S.; Gudkov, A. V.; Prochownik, E. V.; Nikiforov, M. A.			c-Myc depletion inhibits proliferation of human tumor cells at various stages of the cell cycle	ONCOGENE			English	Article						myc; cell cycle; shRNA	S-PHASE CHECKPOINT; NEOPLASTIC PHENOTYPE; MELANOMA-CELLS; TARGET GENES; APOPTOSIS; REVEALS; SKIN; TUMORIGENESIS; INACTIVATION; SUPPRESSION	A major role for c-Myc in the proliferation of normal cells is attributed to its ability to promote progression through G(1) and into S phase of the cell cycle. The absolute requirement of c-Myc for cell cycle progression in human tumor cells has not been comprehensively addressed. In the present work, we used a lentiviral-based short hairpin RNA (shRNA) expression vector to stably reduce c-Myc expression in a large number of human tumor cell lines and in three different types of normal human cells. In all cases, cell proliferation was severely inhibited, with normal cells ultimately undergoing G(0)/G(1) growth arrest. In contrast, tumor cells demonstrated a much more variable cell cycle response with cells from several lines accumulating in S or G(2)/M phases. Moreover, in some tumor lines, the phase of cell cycle arrest caused by inhibition of c-Myc could be altered by depleting tumor suppressor protein p53 or its transcriptional target p21(CIP/WAF). Our data suggest that, as in the case of normal cells, c-Myc is essential for sustaining proliferation of human tumor cells. However its rate-limiting role in cell cycle control is variable and is reliant upon the status of other cell cycle regulators.	[Mannava, S.; Grachtchouk, V.; Zhuang, D.; Soengas, M. S.; Nikiforov, M. A.] Univ Michigan, Dept Dermatol, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Wang, H.; Prochownik, E. V.] Childrens Hosp Pittsburgh, Hematol Oncol Sect, Rangos Res Ctr, Pittsburgh, PA 15213 USA; [Gudkov, A. V.] Cleveland Clin, Lerner Res Inst, Dept Mol Genet, Cleveland, OH 44106 USA	University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Cleveland Clinic Foundation	Nikiforov, MA (corresponding author), Univ Michigan, Dept Dermatol, Ctr Comprehens Canc, 1150 W Med Ctr Dr,MS1 Room 6427, Ann Arbor, MI 48109 USA.	mikhailn@umich.edu	Soengas, Maria S/H-6455-2015	Soengas, Maria S/0000-0003-0612-6299; Gudkov, Andrei/0000-0003-2548-0154	NCI NIH HHS [R01 CA107237, R01 CA120244-05, R01 CA105033, R01-CA105033, R01 CA140624, R01-CA120244-A1, R01 CA120244, R01-CA078259, R01 CA078259] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA105033, R01CA078259, R01CA140624, R01CA107237, R01CA120244] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Agarwal ML, 1998, P NATL ACAD SCI USA, V95, P14775, DOI 10.1073/pnas.95.25.14775; Arvanitis C, 2006, SEMIN CANCER BIOL, V16, P313, DOI 10.1016/j.semcancer.2006.07.012; Athar M, 2006, EXP DERMATOL, V15, P667, DOI 10.1111/j.1600-0625.2006.00473.x; Baena E, 2005, P NATL ACAD SCI USA, V102, P7286, DOI 10.1073/pnas.0409260102; Bernard Sandra, 2006, V42, P329, DOI 10.1007/004; Bettess MD, 2005, MOL CELL BIOL, V25, P7868, DOI 10.1128/MCB.25.17.7868-7878.2005; Boiko AD, 2006, GENE DEV, V20, P236, DOI 10.1101/gad.1372606; Boxer RB, 2004, CANCER CELL, V6, P577, DOI 10.1016/j.ccr.2004.10.013; Chen JP, 2001, J GASTROEN HEPATOL, V16, P22, DOI 10.1046/j.1440-1746.2001.02361.x; Citro G, 1998, CANCER RES, V58, P283; D'Agnano I, 2001, ONCOGENE, V20, P2814, DOI 10.1038/sj.onc.1204392; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Dang CV, 1999, MOL CELL BIOL, V19, P1; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; Denoyelle C, 2006, NAT CELL BIOL, V8, P1053, DOI 10.1038/ncb1471; Eisenman RN, 2001, GENE DEV, V15, P2023, DOI 10.1101/gad928101; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Fernandez Y, 2005, CANCER RES, V65, P6294, DOI 10.1158/0008-5472.CAN-05-0686; Gottifredi V, 2005, SEMIN CELL DEV BIOL, V16, P355, DOI 10.1016/j.semcdb.2005.02.011; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hermeking H, 2000, P NATL ACAD SCI USA, V97, P2229, DOI 10.1073/pnas.050586197; Hermeking H, 2003, CURR CANCER DRUG TAR, V3, P163, DOI 10.2174/1568009033481949; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; Li F, 2006, CANCER RES, V66, P5608, DOI 10.1158/0008-5472.CAN-05-4242; Lutz W, 2002, BBA-REV CANCER, V1602, P61, DOI 10.1016/S0304-419X(02)00036-7; Malynn BA, 2000, GENE DEV, V14, P1390; Mateyak MK, 1997, CELL GROWTH DIFFER, V8, P1039; McGuffie EM, 2000, CANCER RES, V60, P3790; Meyer N, 2006, SEMIN CANCER BIOL, V16, P275, DOI 10.1016/j.semcancer.2006.07.011; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Nikiforov MA, 2002, MOL CELL BIOL, V22, P5793, DOI 10.1128/MCB.22.16.5793-5800.2002; Patel JH, 2004, NAT REV CANCER, V4, P562, DOI 10.1038/nrc1393; Paz MF, 2003, CANCER RES, V63, P1114; Pelengaris S, 1999, MOL CELL, V3, P565, DOI 10.1016/S1097-2765(00)80350-0; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Ponzielli R, 2005, EUR J CANCER, V41, P2485, DOI 10.1016/j.ejca.2005.08.017; Prathapam T, 2006, P NATL ACAD SCI USA, V103, P2695, DOI 10.1073/pnas.0511186103; Prochownik Edward V, 2004, Expert Rev Anticancer Ther, V4, P289, DOI 10.1586/14737140.4.2.289; PROCHOWNIK EV, 1988, MOL CELL BIOL, V8, P3683, DOI 10.1128/MCB.8.9.3683; Rothermund K, 2005, CANCER RES, V65, P2097, DOI 10.1158/0008-5472.CAN-04-2928; Sharma SV, 2006, CLIN CANCER RES, V12, p4392S, DOI 10.1158/1078-0432.CCR-06-0096; Oskarsson T, 2006, GENE DEV, V20, P2024, DOI 10.1101/gad.381206; SKORSKI T, 1995, J EXP MED, V182, P1645, DOI 10.1084/jem.182.6.1645; Soengas MS, 2001, NATURE, V409, P207, DOI 10.1038/35051606; Stark GR, 2006, MOL BIOTECHNOL, V32, P227, DOI 10.1385/MB:32:3:227; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; VITA M, SEMIN CANC BIOL, V16, P318; Yin XY, 2002, J BIOL CHEM, V277, P19998, DOI 10.1074/jbc.M200860200; Zhou ZQ, 2001, TRENDS CELL BIOL, V11, pS10, DOI 10.1016/S0962-8924(01)02121-3	54	106	110	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2008	27	13					1905	1915		10.1038/sj.onc.1210823	http://dx.doi.org/10.1038/sj.onc.1210823			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	276NZ	17906696	Green Accepted			2022-12-25	WOS:000254150600010
J	Ji, ZY; Mei, FC; Johnson, BH; Thompson, EB; Cheng, XD				Ji, Zhenyu; Mei, Fang C.; Johnson, Betty H.; Thompson, E. Brad; Cheng, Xiaodong			Protein kinase a, not Epac, suppresses Hedgehog activity and regulates glucocorticoid sensitivity in acute lymphoblastic leukemia cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-MYC; INDUCED APOPTOSIS; LYMPHOID-CELLS; CEM CELLS; EVOKED APOPTOSIS; CYCLIC-AMP; T-CELLS; ACTIVATION; CAMP; PATHWAY	Cyclic AMP synergizes strongly with glucocorticoids (GC) to induce apoptosis in normal or malignant lymphoid cells. We examined the individual roles that cAMP-dependent protein kinase (PKA) and Epac (exchange protein directly activated by cAMP), two intracellular cAMP receptors, play in this synergistic effect. Our studies demonstrate that PKA is responsible for the observed synergism with GC, whereas Epac exerts a weak antagonistic effect against GC-induced apoptosis. We find that endogenous PKA activity is higher in the GC-sensitive clone than in the GC-resistant clone. In the GC-sensitive clone, higher PKA activity is associated with lower Hedgehog (Hh) activity. Moreover, inhibition of Hh activity by Hh pathway-specific inhibitors leads to cell cycle arrest and apoptosis in CEM (human acute lymphoblastic leukemia, T lineage) cells, and the GC-sensitive clone is more sensitive to Hh inhibition. These results suggest that Hh activity is critical for leukemia cell growth and survival and that the level of Hh activity is in part responsible for the synergism between cAMP and GC.	[Ji, Zhenyu; Mei, Fang C.; Cheng, Xiaodong] Univ Texas Med Branch, Sch Med, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA; [Johnson, Betty H.; Thompson, E. Brad] Univ Texas Med Branch, Sch Med, Dept Biochem & Mol Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Cheng, XD (corresponding author), Univ Texas Med Branch, Sch Med, Dept Pharmacol & Toxicol, 301 Univ Blvd, Galveston, TX 77555 USA.	xcheng@utmb.edu	Cheng, Xiaodong/O-8176-2019	Cheng, Xiaodong/0000-0002-3479-1694	NCI NIH HHS [CA041407] Funding Source: Medline; NIDDK NIH HHS [1 R90 DK071505-01, 1 T90 DK070109-01] Funding Source: Medline; NIEHS NIH HHS [ES06676] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA041407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R90DK071505, T90DK070109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bale AE, 2002, ANNU REV GENOM HUM G, V3, P47, DOI 10.1146/annurev.genom.3.022502.103031; Benazeraf B, 2006, DEV BIOL, V294, P133, DOI 10.1016/j.ydbio.2006.02.035; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Chen BY, 2006, J BIOMED SCI, V13, P373, DOI 10.1007/s11373-005-9050-x; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Cheng XD, 2001, J BIOL CHEM, V276, P4102, DOI 10.1074/jbc.M006447200; Coffino P, 1976, Recent Prog Horm Res, V32, P669; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; Duman-Scheel M, 2002, NATURE, V417, P299, DOI 10.1038/417299a; Erlacher M, 2005, BLOOD, V106, P4131, DOI 10.1182/blood-2005-04-1595; Feng YZ, 2007, CLIN CANCER RES, V13, P1389, DOI 10.1158/1078-0432.CCR-06-1407; Fuld S, 2005, EXP CELL RES, V309, P161, DOI 10.1016/j.yexcr.2005.05.016; He J, 2006, J BIOL CHEM, V281, P35598, DOI 10.1074/jbc.C600200200; Huang SH, 2006, CARCINOGENESIS, V27, P1334, DOI 10.1093/carcin/bgi378; Ji ZY, 2007, J BIOL CHEM, V282, P14048, DOI 10.1074/jbc.M611089200; Lau J, 2006, CELL MOL LIFE SCI, V63, P642, DOI 10.1007/s00018-005-5357-z; Lobjois V, 2004, DEV BIOL, V273, P195, DOI 10.1016/j.ydbio.2004.05.031; Lowrey JA, 2002, J IMMUNOL, V169, P1869, DOI 10.4049/jimmunol.169.4.1869; Lu JH, 2006, FEBS LETT, V580, P3539, DOI 10.1016/j.febslet.2006.05.031; Medh RD, 1998, CANCER RES, V58, P3684; Medh RD, 2003, GENOMICS, V81, P543, DOI 10.1016/S0888-7543(03)00045-4; Medh RD, 2001, ONCOGENE, V20, P4629, DOI 10.1038/sj.onc.1204680; Mei FC, 2005, MOL BIOSYST, V1, P325, DOI 10.1039/b511267b; Mei FC, 2005, FASEB J, V19, P497, DOI 10.1096/fj.05-4586fje; Mei FC, 2002, J BIOL CHEM, V277, P11497, DOI 10.1074/jbc.M110856200; Miller AL, 2007, CANCER CELL INT, V7, DOI 10.1186/1475-2867-7-3; Miller AL, 2005, MOL ENDOCRINOL, V19, P1569, DOI 10.1210/me.2004-0528; Molofsky AV, 2004, CURR OPIN CELL BIOL, V16, P700, DOI 10.1016/j.ceb.2004.09.004; Oancea Marcela, 2006, V129, P279; Pogoriler J, 2006, DEVELOPMENT, V133, P3929, DOI 10.1242/dev.02556; Qiao JB, 2002, J BIOL CHEM, V277, P26581, DOI 10.1074/jbc.M203571200; Regl G, 2004, CANCER RES, V64, P7724, DOI 10.1158/0008-5472.CAN-04-1085; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Sanchez P, 2004, P NATL ACAD SCI USA, V101, P12561, DOI 10.1073/pnas.0404956101; Sheng T, 2006, J BIOL CHEM, V281, P9, DOI 10.1074/jbc.C500300200; SIMONS SS, 1980, P NATL ACAD SCI-BIOL, V77, P5167, DOI 10.1073/pnas.77.9.5167; Stewart GA, 2002, J IMMUNOL, V169, P5451, DOI 10.4049/jimmunol.169.10.5451; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Thompson EB, 1999, J STEROID BIOCHEM, V69, P453, DOI 10.1016/S0960-0760(99)00063-1; Thompson EB, 1999, TRENDS ENDOCRIN MET, V10, P353, DOI 10.1016/S1043-2760(99)00187-3; THULASI R, 1993, J BIOL CHEM, V268, P18306; Trowbridge JJ, 2006, P NATL ACAD SCI USA, V103, P14134, DOI 10.1073/pnas.0604568103; Varas A, 2003, TRENDS IMMUNOL, V24, P197, DOI 10.1016/S1471-4906(03)00033-4; Wang Y, 2007, CURR OPIN CELL BIOL, V19, P159, DOI 10.1016/j.ceb.2007.02.005; Yu SN, 2006, BIOCHEMISTRY-US, V45, P15318, DOI 10.1021/bi061701x; ZAWYDIWSKI R, 1983, CANCER RES, V43, P3865; Zhang LZ, 2004, J BIOL CHEM, V279, P20858, DOI 10.1074/jbc.M310643200; Zhou F, 2000, J STEROID BIOCHEM, V73, P195, DOI 10.1016/S0960-0760(00)00080-7	49	42	51	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37370	37377		10.1074/jbc.M703697200	http://dx.doi.org/10.1074/jbc.M703697200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17895245	hybrid			2022-12-25	WOS:000251833600011
J	Chrencik, JE; Brooun, A; Recht, MI; Nicola, G; Davis, LK; Abagyan, R; Widmer, H; Pasquale, EB; Kuhn, P				Chrencik, Jill E.; Brooun, Alexei; Recht, Michael I.; Nicola, George; Davis, Leila K.; Abagyan, Ruben; Widmer, Hans; Pasquale, Elena B.; Kuhn, Peter			Three-dimensional structure of the EphB2 receptor in complex with an antagonistic peptide reveals a novel mode of inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; EPH RECEPTORS; EXPRESSION; MECHANISMS; EPHRIN-B2; MIGRATION; INVASION; MUTATION; LIGANDS; GROWTH	The Eph family of receptor tyrosine kinases has been implicated in tumorigenesis as well as pathological forms of angiogenesis. Understanding how to modulate the interaction of Eph receptors with their ephrin ligands is therefore of critical interest for the development of therapeutics to treat cancer. Previous work identified a set of 12-mer peptides that displayed moderate binding affinity but high selectivity for the EphB2 receptor. The SNEW antagonistic peptide inhibited the interaction of EphB2 with ephrinB2, with an IC50 of similar to 15 mu M. To gain a better molecular understanding of how to inhibit Eph/ephrin binding, we determined the crystal structure of the EphB2 receptor in complex with the SNEW peptide to 2.3-angstrom resolution. The peptide binds in the hydrophobic ligand-binding cleft of the EphB2 receptor, thus competing with the ephrin ligand for receptor binding. However, the binding interactions of the SNEW peptide are markedly different from those described for the TNYLRAW peptide, which binds to the ligand-binding cleft of EphB4, indicating a novel mode of antagonism. Nevertheless, we identified a conserved structural motif present in all known receptor/ligand interfaces, which may serve as a scaffold for the development of therapeutic leads. The EphB2-SNEW complex crystallized as a homodimer, and the residues involved in the dimerization interface are similar to those implicated in mediating tetramerization of EphB2-ephrinB2 complexes. The structure of EphB2 in complex with the SNEW peptide reveals novel binding determinants that could serve as starting points in the development of compounds that modulate Eph receptor/ephrin interactions and biological activities.	Scripps Res Inst, Dept Cellular Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Palo Alto Res Ctr, Scripps PARC, Inst Adv Biomed Sci, Palo Alto, CA 94304 USA; Novartis Inst BioMed Res, CH-4002 Basel, Switzerland; Burnham Inst Med Res, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Novartis; Sanford Burnham Prebys Medical Discovery Institute	Kuhn, P (corresponding author), 10550 N Torrey Pines Rd, San Diego, CA 92037 USA.	pkuhn@scripps.edu			NCI NIH HHS [Y1-CO-1020] Funding Source: Medline; NIAID NIH HHS [5T32/AI07354-16] Funding Source: Medline; NIGMS NIH HHS [GM074961, U54 GM074961, Y1-GM-1104] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074961] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; Alazzouzi H, 2005, CANCER RES, V65, P10170, DOI 10.1158/0008-5472.CAN-05-2580; [Anonymous], 1997, Cell, V90, P403; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Batlle E, 2005, NATURE, V435, P1126, DOI 10.1038/nature03626; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Brantley-Sieders Dana M., 2004, Angiogenesis, V7, P17, DOI 10.1023/B:AGEN.0000037340.33788.87; Carmeliet P, 1999, CURR TOP MICROBIOL, V237, P133; Chrencik JE, 2006, STRUCTURE, V14, P321, DOI 10.1016/j.str.2005.11.011; Chrencik JE, 2006, J BIOL CHEM, V281, P28185, DOI 10.1074/jbc.M605766200; Cowan CA, 2000, NEURON, V26, P417, DOI 10.1016/S0896-6273(00)81174-5; Dail M, 2006, J CELL SCI, V119, P1244, DOI 10.1242/jcs.02842; Davalos V, 2007, ONCOGENE, V26, P308, DOI 10.1038/sj.onc.1209780; Dong JT, 2006, J CELL BIOCHEM, V97, P433, DOI 10.1002/jcb.20696; Dravis C, 2004, DEV BIOL, V271, P272, DOI 10.1016/j.ydbio.2004.03.027; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; Guo DL, 2006, CARCINOGENESIS, V27, P454, DOI 10.1093/carcin/bgi259; Henkemeyer M, 2003, J CELL BIOL, V163, P1313, DOI 10.1083/jcb.200306033; Himanen JP, 2002, ACTA CRYSTALLOGR D, V58, P533, DOI 10.1107/S0907444902000264; Himanen JP, 1998, NATURE, V396, P486, DOI 10.1038/24904; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Himanen JP, 2001, NATURE, V414, P933, DOI 10.1038/414933a; Jubb AM, 2005, CLIN CANCER RES, V11, P5181, DOI 10.1158/1078-0432.CCR-05-0143; Kittles RA, 2006, J MED GENET, V43, P507, DOI 10.1136/jmg.2005.035790; Koolpe M, 2005, J BIOL CHEM, V280, P17301, DOI 10.1074/jbc.M500363200; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mao WG, 2004, CANCER RES, V64, P781, DOI 10.1158/0008-5472.CAN-03-1047; Nakada M, 2005, AM J PATHOL, V167, P565, DOI 10.1016/S0002-9440(10)62998-7; Nakada M, 2004, CANCER RES, V64, P3179, DOI 10.1158/0008-5472.CAN-03-3667; Noren NK, 2004, P NATL ACAD SCI USA, V101, P5583, DOI 10.1073/pnas.0401381101; Ogawa K, 2006, J CELL SCI, V119, P559, DOI 10.1242/jcs.02777; Orioli D, 1996, EMBO J, V15, P6035, DOI 10.1002/j.1460-2075.1996.tb00992.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pasquale EB, 2004, NAT NEUROSCI, V7, P417, DOI 10.1038/nn0504-417; Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006; Salvucci O, 2006, BLOOD, V108, P2914, DOI 10.1182/blood-2006-05-023341; Song JH, 2007, APMIS, V115, P164, DOI 10.1111/j.1600-0463.2007.apm_543.x; Totrov M, 2001, BIOPOLYMERS, V60, P124, DOI 10.1002/1097-0282(2001)60:2<124::AID-BIP1008>3.0.CO;2-S; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Wu QH, 2004, PATHOL ONCOL RES, V10, P26, DOI 10.1007/BF02893405; Wu QH, 2006, GYNECOL ONCOL, V102, P15, DOI 10.1016/j.ygyno.2005.11.034	44	48	53	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36505	36513		10.1074/jbc.M706340200	http://dx.doi.org/10.1074/jbc.M706340200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17897949	hybrid, Green Accepted			2022-12-25	WOS:000251458300043
J	Choi, SJ; Gustafson-Wagner, EA; Wang, QC; Harlan, SM; Sinn, HW; Lin, JLC; Lin, JJC				Choi, Sunju; Gustafson-Wagner, Elisabeth A.; Wang, Qinchuan; Harlan, Shannon M.; Sinn, Haley W.; Lin, Jenny L. -C.; Lin, Jim J. -C.			Loss of mXin alpha, an intercalated disk protein, results in cardiac hypertrophy and cardiomyopathy with conduction defects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; XIN-REPEATS; N-CADHERIN; ACTIN; COMPLEX; GENE; ASSOCIATION; ISOFORMS; WNT	Targeted deletion of mXin alpha results in cardiac hypertrophy and cardiomyopathy with conduction defects (Gustafson-Wagner, E., Sinn, H. W., Chen, Y.-L., Wang, D.-Z., Reiter, R. S., Lin, J.L.-C., Yang, B., Williamson, R. A., Chen, J.N., Lin, C.-I., and Lin, J.J.-C. ( 2007) Am. J. Physiol. 293, H2680 - H2692). To understand the underlying mechanisms leading to such cardiac defects, the functional domains of mXin alpha and its interacting proteins were investigated. Interaction studies using co-immunoprecipitation, pull-down, and yeast two-hybrid assays revealed that mXin alpha directly interacts with beta-catenin. The beta-catenin-binding site on mXin alpha was mapped to amino acids 535 - 636, which overlaps with the known actin-binding domains composed of the Xin repeats. The overlapping nature of these domains provides insight into the molecular mechanism for mXin alpha localization and function. Purified recombinant glutathione S-transferase- or His-tagged mXin alpha proteins are capable of binding and bundling actin filaments, as determined by co-sedimentation and electron microscopic studies. The binding to actin was saturated at an approximate stoichiometry of nine actin monomers to one mXin alpha. A stronger interaction was observed between mXin alpha C-terminal deletion and actin as compared with the interaction between full-length mXin alpha and actin. Furthermore, force expression of green fluorescent protein fused to an mXin alpha C-terminal deletion in cultured cells showed greater stress fiber localization compared with force-expressed GFP-mXin alpha. These results suggest a model whereby the C terminus of mXin alpha may prevent the full-length molecule from binding to actin, until the beta-catenin- binding domain is occupied by beta-catenin. The binding of mXin alpha to beta-catenin at the adherens junction would then facilitate actin binding. In support of this model, we found that the actin binding and bundling activity of mXin alpha was enhanced in the presence of beta-catenin.	Univ Iowa, Dept Biol Sci, Iowa City, IA 52242 USA	University of Iowa	Lin, JJC (corresponding author), Univ Iowa, Dept Biol Sci, 340 Biol Bldg E,210 E Iowa Ave, Iowa City, IA 52242 USA.	jim-lin@uiowa.edu	Wang, Qinchuan/AAH-5614-2021	Wang, Qinchuan/0000-0002-2359-3262	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075015] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL075015-04, HL075015, R01 HL075015] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Cherepanova O, 2006, J MOL BIOL, V356, P714, DOI 10.1016/j.jmb.2005.11.082; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; CHOU PY, 1990, PREDICTION PROTEIN S, P549; CLONTECH, 1999, MATCHMAKER 2 HYBRID; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Gates J, 2005, CELL, V123, P769, DOI 10.1016/j.cell.2005.11.009; Gonsior SM, 1998, J MUSCLE RES CELL M, V19, P225, DOI 10.1023/A:1005372915268; Gustafson-Wagner EA, 2007, AM J PHYSIOL-HEART C, V293, pH2680, DOI 10.1152/ajpheart.00806.2007; Hertig CM, 1996, J CELL SCI, V109, P11; Huang HT, 2006, J BIOL CHEM, V281, P39370, DOI 10.1074/jbc.M603244200; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; JI XH, 1992, BIOCHEMISTRY-US, V31, P10169, DOI 10.1021/bi00157a004; Jung-Ching Lin Jim, 2005, J Med Sci, V25, P215; Li Y, 2004, J CELL SCI, V117, P3593, DOI 10.1242/jcs.01216; Lin JJC, 2001, CARDIOVAS MOL MORPH, P75; Lukoyanova N, 2002, CURR BIOL, V12, P383, DOI 10.1016/S0960-9822(02)00678-4; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; NOVY RE, 1993, CELL MOTIL CYTOSKEL, V26, P248, DOI 10.1002/cm.970260308; Ong LL, 1998, DEV BIOL, V193, P1, DOI 10.1006/dbio.1997.8775; Pacholsky D, 2004, J CELL SCI, V117, P5257, DOI 10.1242/jcs.01406; Pokutta S, 2000, MOL CELL, V5, P533, DOI 10.1016/S1097-2765(00)80447-5; Pokutta S, 2002, CURR OPIN STRUC BIOL, V12, P255, DOI 10.1016/S0959-440X(02)00318-4; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Reynolds AB, 2004, ONCOGENE, V23, P7947, DOI 10.1038/sj.onc.1208161; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; Sadot E, 1998, P NATL ACAD SCI USA, V95, P15339, DOI 10.1073/pnas.95.26.15339; Shih IM, 2000, CANCER RES, V60, P1671; Sinn HW, 2002, DEV DYNAM, V225, P1, DOI 10.1002/dvdy.10131; Soll DR, 1998, TECH MOD B, P25; SOLL DR, 1995, INT REV CYTOL, V8, P439; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; van der Flier A, 2002, J CELL BIOL, V156, P361, DOI 10.1083/jcb.200103037; van der Ven PFM, 2006, EXP CELL RES, V312, P2154, DOI 10.1016/j.yexcr.2006.03.015; Wang DZ, 1999, DEVELOPMENT, V126, P1281; Xing Y, 2003, GENE DEV, V17, P2753, DOI 10.1101/gad.1142603; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020	40	35	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					36024	36036		10.1074/jbc.M707639200	http://dx.doi.org/10.1074/jbc.M707639200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17925400	Green Accepted, hybrid			2022-12-25	WOS:000251458100062
J	Jager, D; Schmalenbach, C; Prilla, S; Schrobang, J; Kebig, A; Sennwitz, M; Heller, E; Trankle, C; Holzgrabe, U; Holtje, HD; Mohr, K				Jaeger, Dorothea; Schmalenbach, Caroline; Prilla, Stefanie; Schrobang, Jasmin; Kebig, Anna; Sennwitz, Matthias; Heller, Eberhard; Traenkle, Christian; Holzgrabe, Ulrike; Hoeltje, Hans-Dieter; Mohr, Klaus			Allosteric small molecules unveil a role of an extracellular E2/transmembrane helix 7 junction for G protein-coupled receptor activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2ND EXTRACELLULAR LOOP; MUSCARINIC ACETYLCHOLINE-RECEPTORS; AMINO-ACIDS; SUBTYPE SELECTIVITIES; BINDING-SITES; MODULATION; STRYCHNINE; ENHANCERS; GALLAMINE; RESIDUES	G protein-coupled receptors represent the largest superfamily of cell membrane-spanning receptors. We used allosteric small molecules as a novel approach to better understand conformational changes underlying the inactive-to-active switch in native receptors. Allosteric molecules bind outside the orthosteric area for the endogenous receptor activator. The human muscarinic M-2 acetylcholine receptor is prototypal for the study of allosteric interactions. We measured receptor-mediated G protein activation, applied a series of structurally diverse muscarinic allosteric agents, and analyzed their cooperative effects with orthosteric receptor agonists. A strong negative cooperativity of receptor binding was observed with acetylcholine and other full agonists, whereas a pronounced negative cooperativity of receptor activation was observed with the partial agonist pilocarpine. Applying a newly synthesized allosteric tool, point mutated receptors, radioligand binding, and a three-dimensional receptor model, we found that the deviating allosteric/orthosteric interactions are mediated through the core region of the allosteric site. A key epitope is M(2)Trp(422) in position 7.35 that is located at the extracellular top of transmembrane helix 7 and that contacts, in the inactive receptor, the extracellular loop E2. Trp 7.35 is critically involved in the divergent allosteric/orthosteric cooperativities with acetylcholine and pilocarpine, respectively. In the absence of allosteric agents, Trp 7.35 is essential for receptor binding of the full agonist and for receptor activation by the partial agonist. This study provides first evidence for a role of an allosteric E2/transmembrane helix 7 contact region for muscarinic receptor activation by orthosteric agonists.	Univ Bonn, Pharmacol & Toxicol Sect, Inst Pharm, D-53121 Bonn, Germany; Univ Dusseldorf, Inst Pharmaceut & Med Chem, D-40225 Dusseldorf, Germany; Univ Wurzburg, Inst Pharm, Dept Pharmaceut Chem, D-97074 Wurzburg, Germany	University of Bonn; Heinrich Heine University Dusseldorf; University of Wurzburg	Mohr, K (corresponding author), Univ Bonn, Pharmacol & Toxicol Sect, Inst Pharm, Gerhard Domagk Str 3, D-53121 Bonn, Germany.	k.mohr@uni-bonn.de		Holzgrabe, Ulrike/0000-0002-0364-7278				Avlani VA, 2007, J BIOL CHEM, V282, P25677, DOI 10.1074/jbc.M702311200; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Baneres JL, 2005, J BIOL CHEM, V280, P20253, DOI 10.1074/jbc.M412009200; Brauner-Osborne H, 2007, CURR DRUG TARGETS, V8, P169, DOI 10.2174/138945007779315614; Buller S, 2002, MOL PHARMACOL, V61, P160, DOI 10.1124/mol.61.1.160; Christopoulos A, 2002, NAT REV DRUG DISCOV, V1, P198, DOI 10.1038/nrd746; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; EHLERT FJ, 1988, MOL PHARMACOL, V33, P187; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Grossmuller M, 2006, N-S ARCH PHARMACOL, V372, P267, DOI 10.1007/s00210-005-0023-4; Hall DA, 2000, MOL PHARMACOL, V58, P1412, DOI 10.1124/mol.58.6.1412; HILF G, 1989, EUR J BIOCHEM, V186, P725, DOI 10.1111/j.1432-1033.1989.tb15266.x; Huang XP, 2005, MOL PHARMACOL, V68, P769, DOI 10.1124/mol.105.014043; Jakubik J, 2005, J PHARMACOL EXP THER, V313, P688, DOI 10.1124/jpet.104.080358; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Klco JM, 2005, NAT STRUCT MOL BIOL, V12, P320, DOI 10.1038/nsmb913; Langmead CJ, 2006, TRENDS PHARMACOL SCI, V27, P475, DOI 10.1016/j.tips.2006.07.009; LAZARENO S, 1995, MOL PHARMACOL, V48, P362; Lazareno S, 1999, Methods Mol Biol, V106, P231; LEPPIK RA, 1994, MOL PHARMACOL, V45, P983; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Lu ZL, 2002, TRENDS PHARMACOL SCI, V23, P140, DOI 10.1016/S0165-6147(00)01973-8; MATSUI H, 1995, MOL PHARMACOL, V47, P88; Mohr M, 2004, J MED CHEM, V47, P3324, DOI 10.1021/jm031095t; Muth M, 2005, J MED CHEM, V48, P2212, DOI 10.1021/jm049616f; Muth M, 2003, J MED CHEM, V46, P1031, DOI 10.1021/jm021017q; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Prilla S, 2006, MOL PHARMACOL, V70, P181, DOI 10.1124/mol.106.023481; Scarselli M, 2007, J BIOL CHEM, V282, P7385, DOI 10.1074/jbc.M610394200; Schroter A, 2000, N-S ARCH PHARMACOL, V362, P512, DOI 10.1007/s002100000316; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Shi L, 2004, P NATL ACAD SCI USA, V101, P440, DOI 10.1073/pnas.2237265100; Vilardaga JP, 2003, NAT BIOTECHNOL, V21, P807, DOI 10.1038/nbt838; Voigtlander U, 2003, MOL PHARMACOL, V64, P21, DOI 10.1124/mol.64.1.21; Wess J, 2005, MOL PHARMACOL, V68, P1506, DOI 10.1124/mol.105.019141; Zahn K, 2002, J PHARMACOL EXP THER, V301, P720, DOI 10.1124/jpet.301.2.720	37	42	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34968	34976		10.1074/jbc.M705563200	http://dx.doi.org/10.1074/jbc.M705563200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17890226	hybrid			2022-12-25	WOS:000251155200041
J	Rampazzo, C; Fabris, S; Franzolin, E; Crovatto, K; Frangini, M; Bianchi, V				Rampazzo, Chiara; Fabris, Sonia; Franzolin, Elisa; Crovatto, Katia; Frangini, Miriam; Bianchi, Vera			Mitochondrial thymidine kinase and the enzymatic network regulating thymidine triphosphate pools in cultured human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBONUCLEOTIDE REDUCTASE GENE; NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY; DNA DEPLETION; EXPRESSION; P53; SUBSTRATE; TARGET; DEOXYRIBONUCLEOTIDES; 5'-NUCLEOTIDASES; IDENTIFICATION	In non-proliferating cells mitochondrial (mt) thymidine kinase (TK2) salvages thymidine derived from the extracellular milieu for the synthesis of mt dTTP. TK2 is a synthetic enzyme in a network of cytosolic and mt proteins with either synthetic or catabolic functions regulating the dTTP pool. In proliferating cultured cells the canonical cytosolic ribonucleotide reductase (R1-R2) is the prominent synthetic enzyme that by de novo synthesis provides most of dTTP for mt DNA replication. In non-proliferating cells p53R2 substitutes for R2. Catabolic enzymes safeguard the size of the dTTP pool: thymidine phosphorylase by degradation of thymidine and deoxyribonucleotidases by degradation of dTMP. Genetic deficiencies in three of the participants in the network, TK2, p53R2, or thymidine phosphorylase, result in severe mt DNA pathologies. Here we demonstrate the interdependence of the different enzymes of the network. We quantify changes in the size and turnover of the dTTP pool after inhibition of TK2 by RNA interference, of p53R2 with hydroxyurea, and of thymidine phosphorylase with 5-bromouracil. In proliferating cells the de novo pathway dominates, supporting large cytosolic and mt dTTP pools, whereas TK2 is dispensable, even in cells lacking the cytosolic thymidine kinase. In non-proliferating cells the small dTTP pools depend on the activities of both R1-p53R2 and TK2. The activity of TK2 is curbed by thymidine phosphorylase, which degrades thymidine in the cytoplasm, thus limiting the availability of thymidine for phosphorylation by TK2 in mitochondria. The dTTP pool shows an exquisite sensitivity to variations of thymidine concentrations at the nanomolar level.	Univ Padua, Dept Biol, I-35131 Padua, Italy	University of Padua	Bianchi, V (corresponding author), Univ Padua, Dept Biol, Via Ugo Bassi 58B, I-35131 Padua, Italy.	vbianchi@bio.unipd.it	Frangini, Miriam/I-3532-2013		Fondazione Telethon Funding Source: Custom; Telethon [GGP05001] Funding Source: Medline	Fondazione Telethon(Fondazione Telethon); Telethon(Fondazione Telethon)		ARNER ESJ, 1995, PHARMACOL THERAPEUT, V67, P155, DOI 10.1016/0163-7258(95)00015-9; BERK AJ, 1973, J BIOL CHEM, V248, P2722; BIANCHI V, 1986, J BIOL CHEM, V261, P6037; Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bridges EG, 1999, J BIOL CHEM, V274, P4620, DOI 10.1074/jbc.274.8.4620; Byun DS, 2002, INT J CANCER, V98, P718, DOI 10.1002/ijc.10253; Chabes AL, 2003, P NATL ACAD SCI USA, V100, P3925, DOI 10.1073/pnas.0330774100; Coller HA, 2006, PLOS BIOL, V4, P329, DOI 10.1371/journal.pbio.0040083; Ferraro P, 2005, J BIOL CHEM, V280, P24472, DOI 10.1074/jbc.M502869200; Ferraro P, 2006, P NATL ACAD SCI USA, V103, P18586, DOI 10.1073/pnas.0609020103; Franzolin E, 2006, BIOCHEM BIOPH RES CO, V344, P30, DOI 10.1016/j.bbrc.2006.03.147; Gazziola C, 2001, J BIOL CHEM, V276, P6185, DOI 10.1074/jbc.M007623200; Hakansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200; Itahana K, 2002, J BIOL CHEM, V277, P18206, DOI 10.1074/jbc.M201028200; Johansson M, 1997, J BIOL CHEM, V272, P8454, DOI 10.1074/jbc.272.13.8454; Johansson M, 1996, P NATL ACAD SCI USA, V93, P7258, DOI 10.1073/pnas.93.14.7258; Jordheim LP, 2005, MOL CANCER THER, V4, P1268, DOI 10.1158/1535-7163.MCT-05-0121; Ke PY, 2004, MOL CELL BIOL, V24, P514, DOI 10.1128/MCB.24.2.514-526.2004; Magnusson J, 2003, EXP CELL RES, V289, P133, DOI 10.1016/S0014-4827(03)00249-0; Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746; Marobbio CMT, 2006, BIOCHEM J, V393, P441, DOI 10.1042/BJ20051284; Marti R, 2004, CLIN CHEM, V50, P120, DOI 10.1373/clinchem.2003.026179; Matsukawa K, 1996, BBA-MOL CELL RES, V1314, P71, DOI 10.1016/S0167-4889(96)00078-X; Mrass P, 2004, CANCER RES, V64, P6542, DOI 10.1158/0008-5472.CAN-04-1129; MUNCHPETERSEN B, 1991, J BIOL CHEM, V266, P9032; Nakano K, 2000, ONCOGENE, V19, P4283, DOI 10.1038/sj.onc.1203774; Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pontarin G, 2007, J BIOL CHEM, V282, P16820, DOI 10.1074/jbc.M701310200; Pontarin G, 2006, J BIOL CHEM, V281, P22720, DOI 10.1074/jbc.M604498200; Rampazzo C, 2004, J BIOL CHEM, V279, P17019, DOI 10.1074/jbc.M313957200; Rampazzo C, 2002, BIOCHEM BIOPH RES CO, V293, P258, DOI 10.1016/S0006-291X(02)00206-1; Rylova SN, 2007, BIOCHEM PHARMACOL, V74, P169, DOI 10.1016/j.bcp.2007.03.029; Saada A, 2003, MOL GENET METAB, V79, P1, DOI 10.1016/S1096-7192(03)00063-5; Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751; SHERMAN PA, 1989, ANAL BIOCHEM, V180, P222, DOI 10.1016/0003-2697(89)90420-X; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vozza A, 2004, J BIOL CHEM, V279, P20850, DOI 10.1074/jbc.M313610200	41	38	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34758	34769		10.1074/jbc.M705923200	http://dx.doi.org/10.1074/jbc.M705923200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17913703	hybrid			2022-12-25	WOS:000251155200018
J	Saito, Y; Imazeki, H; Miura, S; Yoshimura, T; Okutsu, H; Harada, Y; Ohwaki, T; Nagao, O; Kamiya, S; Hayashi, R; Kodama, H; Handa, H; Yoshida, T; Fukai, F				Saito, Yohei; Imazeki, Hisae; Miura, Shogo; Yoshimura, Tomohisa; Okutsu, Hiroaki; Harada, Yosei; Ohwaki, Toshiyuki; Nagao, Osamu; Kamiya, Sadahiro; Hayashi, Ryo; Kodama, Hiroaki; Handa, Hiroshi; Yoshida, Toshimichi; Fukai, Fumio			A peptide derived from tenascin-C induces beta 1 integrin activation through syndecan-4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX; CELL-ADHESION; ANTIADHESIVE SITE; SPLICE VARIANTS; BINDING DOMAIN; FIBRONECTIN; EXPRESSION; PROTEINS; HEPARIN; DIFFERENTIATION	Tenascin-C (TN-C) is unique for its cell adhesion modulatory function. We have shown that TNIIIA2, a synthetic 22-mer peptide derived from TN-C, stimulated beta 1 integrin-mediated cell adhesion of nonadherent and adherent cell types, by inducing activation of beta 1 integrin. The active site of TNIIIA2 appeared cryptic in the TN-C molecule but was exposed by MMP-2 processing of TN-C. The following results suggest that cell surface heparan sulfate (HS) proteoglycan ( HSPG), including syndecan-4, participated in TNIIIA2-induced beta 1 integrin activation: 1) TNIIIA2 bound to cell surface HSPG via its HS chains, as examined by photoaffinity labeling; 2) heparitinase I treatment of cells abrogated beta 1 integrin activation induced by TNIIIA2; 3) syndecan-4 was isolated by affinity chromatography using TNIIIA2-immobilized beads; 4) small interfering RNA-based down-regulation of syndecan-4 expression reduced TNIIIA2-induced beta 1 integrin activation, and consequent cell adhesion to fibronectin; 5) overexpression of syndecan-4 core protein enhanced TNIIIA2-induced activation of beta 1 integrin. However, treatments that targeted the cytoplasmic region of syndecan-4, including ectopic expression of its mutant truncated with the cytoplasmic domains and treatment with protein kinase C alpha inhibitor Go6976, did not influence the TNIIIA2 activity. These results suggest that a TNIIIA2-related matricryptic site of the TN-C molecule, exposed by MMP-2 processing, may have bound to syndecan-4 via its HS chains and then induced conformational change in beta 1 integrin necessary for its functional activation. A lateral interaction of beta 1 integrin with the extracellular region of the syndecan-4 molecule may be involved in this conformation change.	Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Mol Pathophysiol, Chiba 2788510, Japan; Saga Univ, Fac Sci & Engn, Dept Biochem, Saga 8490922, Japan; Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 2268501, Japan; Mie Univ, Grad Sch Med, Dept Pathol & Matrix Biol, Tsu, Mie 5148507, Japan	Tokyo University of Science; Saga University; Tokyo Institute of Technology; Mie University	Fukai, F (corresponding author), Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Mol Pathophysiol, 2641 Yamazaki, Noda, Chiba 2788510, Japan.	fukai@rs.noda.tus.ac.jp	Yoshida, Toshimichi/H-6204-2013	Yoshida, Toshimichi/0000-0001-8935-8217				Adams JC, 2001, J CELL BIOL, V152, P1169, DOI 10.1083/jcb.152.6.1169; Beauvais DLM, 2004, J CELL BIOL, V167, P171, DOI 10.1083/jcb.200404171; BOURDON MA, 1989, J CELL BIOL, V108, P1149, DOI 10.1083/jcb.108.3.1149; CAREY DJ, 1994, J CELL BIOL, V124, P161, DOI 10.1083/jcb.124.1.161; Chiquet-Ehrismann R, 2003, J PATHOL, V200, P488, DOI 10.1002/path.1415; CHIQUETEHRISMANN R, 1988, CELL, V53, P383, DOI 10.1016/0092-8674(88)90158-4; Davis GE, 2000, AM J PATHOL, V156, P1489, DOI 10.1016/S0002-9440(10)65020-1; DORMAN G, 1994, BIOCHEMISTRY-US, V33, P5661, DOI 10.1021/bi00185a001; Erickson HP, 1993, CURR OPIN CELL BIOL, V5, P869, DOI 10.1016/0955-0674(93)90037-Q; Fukai F, 1997, J BIOCHEM-TOKYO, V121, P189; Fukai F, 1998, EXP CELL RES, V242, P92, DOI 10.1006/excr.1998.4076; FUKAI F, 1991, J BIOL CHEM, V266, P8807; Gallo R, 1996, J INVEST DERMATOL, V107, P676, DOI 10.1111/1523-1747.ep12365571; Ghert MA, 2001, ONCOLOGY-BASEL, V61, P306, DOI 10.1159/000055338; HAYASHI R, 2004, PEPTIDE SCI, V2003, P289; Hindermann W, 1999, J PATHOL, V189, P475; Hsia HC, 2005, J BIOL CHEM, V280, P26641, DOI 10.1074/jbc.R500005200; Huang WT, 2001, CANCER RES, V61, P8586; Ingham KC, 2004, J BIOL CHEM, V279, P28132, DOI 10.1074/jbc.M312785200; JOSHI P, 1993, J CELL SCI, V106, P389; Kamiya SL, 2002, BIOCHEMISTRY-US, V41, P3270, DOI 10.1021/bi015660a; Kato R, 2002, CLIN CANCER RES, V8, P2455; Keum E, 2004, BIOCHEM J, V378, P1007, DOI 10.1042/BJ20031734; Lee JW, 2000, MOL BIOL CELL, V11, P1973, DOI 10.1091/mbc.11.6.1973; LIGHTNER VA, 1990, ANN NY ACAD SCI, V580, P260, DOI 10.1111/j.1749-6632.1990.tb17935.x; Liu W, 1998, J BIOL CHEM, V273, P22825, DOI 10.1074/jbc.273.35.22825; Luque A, 1996, J BIOL CHEM, V271, P11067, DOI 10.1074/jbc.271.19.11067; MACKIE EJ, 1987, J CELL BIOL, V105, P2569, DOI 10.1083/jcb.105.6.2569; MACKIE EJ, 1992, J CELL SCI, V103, P765; McFall AJ, 1998, J BIOL CHEM, V273, P28270, DOI 10.1074/jbc.273.43.28270; Midwood KS, 2002, MOL BIOL CELL, V13, P3601, DOI 10.1091/mbc.E02-05-0292; Murphy-Ullrich JE, 2001, J CLIN INVEST, V107, P785, DOI 10.1172/JCI12609; Nishiuchi R, 2005, P NATL ACAD SCI USA, V102, P1939, DOI 10.1073/pnas.0409493102; OCKLIND G, 1993, J HISTOCHEM CYTOCHEM, V41, P1163, DOI 10.1177/41.8.7687262; Orend G, 2003, ONCOGENE, V22, P3917, DOI 10.1038/sj.onc.1206618; Sage EH, 1997, TRENDS CELL BIOL, V7, P182; Shimizu N, 2000, NAT BIOTECHNOL, V18, P877, DOI 10.1038/78496; SIRI A, 1995, J BIOL CHEM, V270, P8650, DOI 10.1074/jbc.270.15.8650; Sobel M, 2001, J VASC SURG, V33, P587, DOI 10.1067/mva.2001.112696; StetlerStevenson WG, 1996, AM J PATHOL, V148, P1345; Takagi J, 1997, J BIOCHEM, V121, P914; Thodeti CK, 2003, J BIOL CHEM, V278, P9576, DOI 10.1074/jbc.M208937200; Tsunoda T, 2003, AM J PATHOL, V162, P1857, DOI 10.1016/S0002-9440(10)64320-9; Watanabe K, 2000, BIOCHEMISTRY-US, V39, P7138, DOI 10.1021/bi992670r; Whiteford JR, 2006, J BIOL CHEM, V281, P32156, DOI 10.1074/jbc.M605553200; Yauch RL, 2000, J BIOL CHEM, V275, P9230, DOI 10.1074/jbc.275.13.9230	46	69	72	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34929	34937		10.1074/jbc.M705608200	http://dx.doi.org/10.1074/jbc.M705608200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17901052	hybrid			2022-12-25	WOS:000251155200036
J	Sundermeier, TR; Karzai, AW				Sundermeier, Thomas R.; Karzai, A. Wali			Functional SmpB-ribosome interactions require tmRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-MESSENGER-RNA; SMALL PROTEIN-B; MEDIATED TRANS-TRANSLATION; ESCHERICHIA-COLI; STALLED RIBOSOME; TAGGING ACTIVITY; DEGRADATION; BINDING; RESCUE; SYSTEM	Small protein B (SmpB) is a requisite component of the transfer messenger RNA (tmRNA)-mediated bacterial translational quality control system known as trans-translation. The initial binding of tmRNA and its subsequent accommodation into the ribosomal A-site are activities intimately linked to SmpB protein function. From a mechanistic perspective, two key unanswered questions that require further investigation are: 1) what constitutes a stalled ribosome recognition complex and 2) does SmpB pre-bind ribosomes to recruit tmRNA. We have assessed, both in vivo and in vitro, the nature and stability of free SmpB interactions with stalled ribosomes and examined whether these interactions are functionally relevant. We present evidence to demonstrate that interaction of free SmpB with ribosomes is salt sensitive and significantly more labile than interaction of the SmpB center dot tmRNA complex with ribosomes. Upon dissociation of 70 S ribosomes SmpB partitions primarily with tmRNA rather than ribosomal subunits. This finding is consistent with biochemical and structural data demonstrating that tmRNA is the high-affinity binding partner of SmpB. Moreover, we show that under normal physiological conditions roughly similar numbers of SmpB and tmRNA molecules are present in cells. Our investigations also reveal that upon induction of a nonstop mRNA, SmpB is enriched in stalled ribosome fractions only in the presence of tmRNA. Based on these findings, we conclude that SmpB does not pre-bind stalled ribosome and that functional SmpB-stalled ribosome interactions require tmRNA. We propose that a 1:1:1 complex of SmpB center dot tmRNA center dot EF-Tu(GTP) recognizes and binds a stalled ribosome to initiate trans-translation.	SUNY Stony Brook, Ctr Infect Dis, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Karzai, AW (corresponding author), SUNY Stony Brook, Ctr Infect Dis, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	akarzai@ms.cc.sunysb.edu			NIAID NIH HHS [AI055621, P01 AI055621-050003, P01 AI055621] Funding Source: Medline; NIGMS NIH HHS [R01 GM065319, R56 GM065319, GM65319, R01 GM065319-05] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI055621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM065319, R01GM065319] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barends S, 2000, BIOCHEMISTRY-US, V39, P2652, DOI 10.1021/bi992439d; Barends S, 2002, FEBS LETT, V514, P78, DOI 10.1016/S0014-5793(02)02306-2; Barends S, 2001, J MOL BIOL, V314, P9, DOI 10.1006/jmbi.2001.5114; Bessho Y, 2007, P NATL ACAD SCI USA, V104, P8293, DOI 10.1073/pnas.0700402104; BOREL F, 1993, FEBS LETT, V324, P162, DOI 10.1016/0014-5793(93)81385-D; Choy JS, 2007, J BACTERIOL, V189, P6564, DOI 10.1128/JB.00860-07; Culver GM, 1999, RNA, V5, P832, DOI 10.1017/S1355838299990714; Dulebohn D, 2007, BIOCHEMISTRY-US, V46, P4681, DOI 10.1021/bi6026055; Dulebohn DP, 2006, J BIOL CHEM, V281, P28536, DOI 10.1074/jbc.M605137200; Gillet R, 2007, J BIOL CHEM, V282, P6356, DOI 10.1074/jbc.M609658200; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Gutmann S, 2003, NATURE, V424, P699, DOI 10.1038/nature01831; Haebel PW, 2004, CURR OPIN STRUC BIOL, V14, P58, DOI 10.1016/j.sbi.2004.01.010; Hallier M, 2006, NUCLEIC ACIDS RES, V34, P1935, DOI 10.1093/nar/gkl097; Hallier M, 2004, J BIOL CHEM, V279, P25978, DOI 10.1074/jbc.M314086200; Hanawa-Suetsugu K, 2002, NUCLEIC ACIDS RES, V30, P1620, DOI 10.1093/nar/30.7.1620; Herman C, 1998, GENE DEV, V12, P1348, DOI 10.1101/gad.12.9.1348; Hong SJ, 2005, MOL MICROBIOL, V57, P565, DOI 10.1111/j.1365-2958.2005.04709.x; Ivanova N, 2005, NUCLEIC ACIDS RES, V33, P3529, DOI 10.1093/nar/gki666; Jacob Y, 2005, J BIOL CHEM, V280, P5503, DOI 10.1074/jbc.M409277200; Karzai AW, 2000, NAT STRUCT BIOL, V7, P449; Karzai AW, 1999, EMBO J, V18, P3793, DOI 10.1093/emboj/18.13.3793; Kaur S, 2006, P NATL ACAD SCI USA, V103, P16484, DOI 10.1073/pnas.0607438103; Keiler KC, 2003, J BACTERIOL, V185, P1825, DOI 10.1128/JB.185.6.1825-1830.2003; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; LEARN B, 1993, COLD SPRING HARB SYM, V58, P389, DOI 10.1101/SQB.1993.058.01.046; Mehta P, 2006, RNA, V12, P2187, DOI 10.1261/rna.247706; Metzinger L, 2005, NUCLEIC ACIDS RES, V33, P2384, DOI 10.1093/nar/gki534; Moore SD, 2005, MOL MICROBIOL, V58, P456, DOI 10.1111/j.1365-2958.2005.04832.x; Moore SD, 2007, ANNU REV BIOCHEM, V76, P101, DOI 10.1146/annurev.biochem.75.103004.142733; Nameki N, 2005, J BIOCHEM, V138, P729, DOI 10.1093/jb/mvi180; Okan Nihal A., 2006, PLoS Pathogens, V2, P50; Richards J, 2006, MOL MICROBIOL, V62, P1700, DOI 10.1111/j.1365-2958.2006.05472.x; RICHEY B, 1987, J BIOL CHEM, V262, P7157; Shimizu Y, 2002, FEBS LETT, V514, P74, DOI 10.1016/S0014-5793(02)02333-5; Shpanchenko OV, 2005, J BIOL CHEM, V280, P18368, DOI 10.1074/jbc.M409094200; Sundermeier TR, 2005, P NATL ACAD SCI USA, V102, P2316, DOI 10.1073/pnas.0409694102; TU GF, 1995, J BIOL CHEM, V270, P9322, DOI 10.1074/jbc.270.16.9322; Valle M, 2003, SCIENCE, V300, P127, DOI 10.1126/science.1081798; Withey JH, 2003, ANNU REV MICROBIOL, V57, P101, DOI 10.1146/annurev.micro.57.030502.090945; Wower IK, 2004, J BIOL CHEM, V279, P54202, DOI 10.1074/jbc.M410488200; Wower J, 2002, BIOCHEMISTRY-US, V41, P8826, DOI 10.1021/bi0201365; Yamamoto Y, 2003, RNA, V9, P408, DOI 10.1261/rna.2174803	43	25	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34779	34786		10.1074/jbc.M707256200	http://dx.doi.org/10.1074/jbc.M707256200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17911096	hybrid, Green Accepted			2022-12-25	WOS:000251155200020
J	Yamagishi, S; Koyama, Y; Katayama, T; Taniguchi, M; Hitomi, J; Kato, M; Aoki, M; Itoyama, Y; Kato, S; Tohyama, M				Yamagishi, Satoru; Koyama, Yoshihisa; Katayama, Taiichi; Taniguchi, Manabu; Hitomi, Junichi; Kato, Masaaki; Aoki, Masashi; Itoyama, Yasuto; Kato, Shinsuke; Tohyama, Masaya			An In Vitro Model for Lewy Body-Like Hyaline Inclusion/Astrocytic Hyaline Inclusion: Induction by ER Stress with an ALS-Linked SOD1 Mutation	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ENDOPLASMIC-RETICULUM STRESS; UNFOLDED-PROTEIN RESPONSE; EXPRESSING HUMAN SOD1; SUPEROXIDE-DISMUTASE; TRANSGENIC MICE; MUTANT SOD1; NEURODEGENERATIVE DISEASE; GENE-MUTATIONS; SPINAL-CORD	Neuronal Lewy body-like hyaline inclusions (LBHI) and astrocytic hyaline inclusions (Ast-HI) containing mutant Cu/Zn superoxide dismutase 1 (SOD1) are morphological hallmarks of familial amyotrophic lateral sclerosis (FALS) associated with mutant SOD1. However, the mechanisms by which mutant SOD1 contributes to formation of LBHI/Ast-HI in FALS remain poorly defined. Here, we report induction of LBHI/Ast-HI-like hyaline inclusions (LHIs) in vitro by ER stress in neuroblastoma cells. These LHI closely resemble LBHI/Ast-HI in patients with SOD1-linked FALS. LHI and LBHI/Ast-HI share the following features: 1) eosinophilic staining with a pale core, 2) SOD1, ubiquitin and ER resident protein (KDEL) positivity and 3) the presence of approximately 15-25 nm granule-coated fibrils, which are morphological hallmark of mutant SOD1-linked FALS. Moreover, in spinal cord neurons of L84V SOD1 transgenic mice at presymptomatic stage, we observed aberrant aggregation of ER and numerous free ribosomes associated with abnormal inclusion-like structures, presumably early stage neuronal LBHI. We conclude that the LBHI/Ast-HI seen in human patients with mutant SOD1-linked FALS may arise from ER dysfunction.	[Yamagishi, Satoru; Koyama, Yoshihisa; Katayama, Taiichi; Taniguchi, Manabu; Hitomi, Junichi; Tohyama, Masaya] Osaka Univ, Dept Anat & Neurosci, Grad Sch Med, Osaka, Japan; [Yamagishi, Satoru; Koyama, Yoshihisa; Katayama, Taiichi; Taniguchi, Manabu; Hitomi, Junichi; Tohyama, Masaya] Osaka Univ, 21st Century Ctr Excellence Program, Grad Sch Med, Osaka, Japan; [Kato, Masaaki; Aoki, Masashi; Itoyama, Yasuto] Tohoku Univ, Sch Med, Dept Neurol, Sendai, Miyagi 980, Japan; [Kato, Shinsuke] Tottori Univ, Sch Med, Inst Neurol Sci, Dept Neuropathol, Yonago, Tottori 683, Japan	Osaka University; Osaka University; Tohoku University; Tottori University	Yamagishi, S (corresponding author), Max Planck Inst Neurobiol, Munich, Germany.	yamagishi@neuro.mpg.de; kato@grape.med.tottori-u.ac.jp			Japan Society for the Promotion of Science [102-8471]; Ministry of Education, Culture, Sports, Science and Technology of Japan [17500229]; Research on Psychiatric and Neurological Disease and Mental Health; Ministry of Health, Labour and Welfare of Japan; European Molecular Biology Organization (EMBO)	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research on Psychiatric and Neurological Disease and Mental Health; Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO))	This work was supported in part by a grant from the 21st Century COE Program, Japan Society for the Promotion of Science, 6 Ichibancho, Chiyoda-ku, Tokyo 102-8471, Japan, a Grant-in-Aid for Scientific Research (c) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (S. K.: 17500229), a Grant from Research on Psychiatric and Neurological Disease and Mental Health (SK, MA, YI) and a Research Grant on Measures for Intractable Diseases from the Ministry of Health, Labour and Welfare of Japan (SK, YI). SY is supported by a longterm fellowship by European Molecular Biology Organization (EMBO) and Japan Society for the Promotion of Science (JSPS).	AOKI M, 1995, ANN NEUROL, V37, P676, DOI 10.1002/ana.410370518; Bassik MC, 2004, EMBO J, V23, P1207, DOI 10.1038/sj.emboj.7600104; Bonifacino JS, 1998, ANNU REV CELL DEV BI, V14, P19, DOI 10.1146/annurev.cellbio.14.1.19; Brown RH, 2001, SEMIN NEUROL, V21, P131; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Dickson KM, 2002, P NATL ACAD SCI USA, V99, P9852, DOI 10.1073/pnas.152621799; Forman MS, 2003, TRENDS NEUROSCI, V26, P407, DOI 10.1016/S0166-2236(03)00197-8; Gurney ME, 2000, BIOESSAYS, V22, P297, DOI 10.1002/(SICI)1521-1878(200003)22:3<297::AID-BIES12>3.0.CO;2-I; Higgins CMJ, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-06-j0001.2002; HIRANO A, 1967, ARCH NEUROL-CHICAGO, V16, P232, DOI 10.1001/archneur.1967.00470210008002; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Hyun DH, 2003, J NEUROCHEM, V86, P363, DOI 10.1046/j.1471-4159.2003.01841.x; Ishihara N, 1998, J BIOCHEM-TOKYO, V123, P722; Julien JP, 2001, CELL, V104, P581, DOI 10.1016/S0092-8674(01)00244-6; Kanaji S, 2000, J CELL BIOL, V151, P277, DOI 10.1083/jcb.151.2.277; Katayama T, 2001, J BIOL CHEM, V276, P43446, DOI 10.1074/jbc.M104096200; Katayama T, 1999, NAT CELL BIOL, V1, P479, DOI 10.1038/70265; Kato H, 2006, J CELL SCI, V119, P2342, DOI 10.1242/jcs.02951; Kato S, 1999, ACTA NEUROPATHOL, V97, P260, DOI 10.1007/s004010050983; Kato S, 2004, ACTA NEUROPATHOL, V107, P149, DOI 10.1007/s00401-003-0791-1; Kato S, 2001, NEUROPATHOLOGY, V21, P67, DOI 10.1046/j.1440-1789.2001.00359.x; Kato S, 2001, ACTA NEUROPATHOL, V102, P233; Kato S, 1999, HISTOL HISTOPATHOL, V14, P973, DOI 10.14670/HH-14.973; Kato S, 2000, AMYOTROPH LATERAL SC, V1, P163, DOI 10.1080/14660820050515160; Kato S, 2000, ACTA NEUROPATHOL, V100, P490, DOI 10.1007/s004010000226; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kikuchi H, 2006, P NATL ACAD SCI USA, V103, P6025, DOI 10.1073/pnas.0509227103; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Niwa J, 2002, J BIOL CHEM, V277, P36793, DOI 10.1074/jbc.M206559200; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Sasaki S, 2005, ACTA NEUROPATHOL, V110, P48, DOI 10.1007/s00401-005-1021-9; Shibata N, 1996, J NEUROPATH EXP NEUR, V55, P481, DOI 10.1097/00005072-199604000-00011; Takahashi R, 2003, J NEUROL, V250, P25, DOI 10.1007/s00415-003-1305-8; Takahashi R, 2003, ANN NY ACAD SCI, V991, P101; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Tobisawa S, 2003, BIOCHEM BIOPH RES CO, V303, P496, DOI 10.1016/S0006-291X(03)00353-X; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Urushitani M, 2004, J NEUROCHEM, V90, P231, DOI 10.1111/j.1471-4159.2004.02486.x; Wang B, 2003, J BIOL CHEM, V278, P14461, DOI 10.1074/jbc.M209684200; Wate R, 2005, ACTA NEUROPATHOL, V110, P557, DOI 10.1007/s00401-005-1080-y; Wootz H, 2004, BIOCHEM BIOPH RES CO, V322, P281, DOI 10.1016/j.bbrc.2004.07.118; Wootz H, 2006, EXP CELL RES, V312, P1890, DOI 10.1016/j.yexcr.2006.02.021	49	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1030	10.1371/journal.pone.0001030	http://dx.doi.org/10.1371/journal.pone.0001030			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925878	gold, Green Published, Green Submitted			2022-12-25	WOS:000207456000029
J	Ahmed, N; Saini, V; Raghuvanshi, S; Khurana, JP; Tyagi, AK; Tyagi, AK; Hasnain, SE				Ahmed, Niyaz; Saini, Vikram; Raghuvanshi, Saurabh; Khurana, Jitendra P.; Tyagi, Akhilesh K.; Tyagi, Anil K.; Hasnain, Seyed E.			Molecular Analysis of a Leprosy Immunotherapeutic Bacillus Provides Insights into Mycobacterium Evolution	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; TUBERCULOSIS COMPLEX; GENETIC-ANALYSIS; GYRB GENES; VACCINE; IDENTIFICATION; POLYMORPHISM; MULTIDRUG; SEQUENCES; BCG	Background. Evolutionary dynamics plays a central role in facilitating the mechanisms of species divergence among pathogenic and saprophytic mycobacteria. The ability of mycobacteria to colonize hosts, to proliferate and to cause diseases has evolved due to its predisposition to various evolutionary forces acting over a period of time. Mycobacterium indicus pranii (MIP), a taxonomically unknown 'generalist' mycobacterium, acts as an immunotherapeutic against leprosy and is approved for use as a vaccine against it. The large-scale field trials of this MIP based leprosy vaccine coupled with its demonstrated immunomodulatory and adjuvant property has led to human clinical evaluations of MIP in interventions against HIV-AIDS, psoriasis and bladder cancer. MIP, commercially available as 'Immuvac', is currently the focus of advanced phase III clinical trials for its antituberculosis efficacy. Thus a comprehensive analysis of MIP vis-a-vis evolutionary path, underpinning its immanent immunomodulating properties is of the highest desiderata. Principal Findings. Genome wide comparisons together with molecular phylogenetic analyses by fluorescent amplified fragment length polymorphism (FAFLP), enterobacterial repetitive intergenic consensus (ERIC) based genotyping and candidate orthologues sequencing revealed that MIP has been the predecessor of highly pathogenic Mycobacterium avium intracellulare complex (MAIC) that did not resort to parasitic adaptation by reductional gene evolution and therefore, preferred a free living life-style. Further analysis suggested a shared aquatic phase of MAIC bacilli with the early pathogenic forms of Mycobacterium, well before the latter diverged as 'specialists'. Conclusions/Significance. This evolutionary paradigm possibly affirms to marshal our understanding about the acquisition and optimization of virulence in mycobacteria and determinants of boundaries therein.	[Hasnain, Seyed E.] Univ Hyderabad, Hyderabad 500134, Andhra Pradesh, India; [Ahmed, Niyaz] Ctr DNA Fingerprinting & Diagnost CDFD, Pathogen Evolut Lab, Hyderabad, Andhra Pradesh, India; [Saini, Vikram; Raghuvanshi, Saurabh; Khurana, Jitendra P.; Tyagi, Akhilesh K.] Univ Delhi, Interdisciplinary Ctr Plant Gen, Dept Plant Mol Biol, New Delhi, India; [Saini, Vikram; Tyagi, Anil K.] Univ Delhi, Dept Biochem, New Delhi, India; [Hasnain, Seyed E.] Univ Hyderabad, Inst Life Sci, Hyderabad 500134, Andhra Pradesh, India; [Hasnain, Seyed E.] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560012, Karnataka, India	University of Hyderabad; Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); University of Delhi; University of Delhi; University of Hyderabad; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore	Hasnain, SE (corresponding author), Univ Hyderabad, Hyderabad 500134, Andhra Pradesh, India.	vc@uohyd.ernet.in	Saini, Vikram/B-4547-2009; Ahmed, Niyaz/D-2589-2010	Saini, Vikram/0000-0002-0258-2871; Ahmed, Niyaz/0000-0001-6425-7583; Hasnain, Seyed/0000-0002-2967-0791	Department of Biotechnology of the Indian Ministry of Science and Technology [BT/PR4127/MED/12/165/2003]; CSIR, India	Department of Biotechnology of the Indian Ministry of Science and Technology(Department of Biotechnology (DBT) India); CSIR, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by a research grant (BT/PR4127/MED/12/165/2003) to NA, JPK, AKT, AKT and SEH from the Department of Biotechnology of the Indian Ministry of Science and Technology. VS acknowledges CSIR, India for research studentship (CSIR JRF/SRF).	Ahmed N, 2003, INFECT GENET EVOL, V2, P193, DOI 10.1016/S1567-1348(02)00100-4; Akbar S, 1997, MOL MICROBIOL, V24, P567, DOI 10.1046/j.1365-2958.1997.3631732.x; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Chaudhuri Prabir, 2003, J Indian Med Assoc, V101, P559; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cousins DV, 2003, INT J SYST EVOL MICR, V53, P1305, DOI 10.1099/ijs.0.02401-0; Dagan T, 2006, MOL BIOL EVOL, V23, P310, DOI 10.1093/molbev/msj036; Danelishvili L, 2007, P NATL ACAD SCI USA, V104, P11038, DOI 10.1073/pnas.0610746104; de Bruyn G, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001166; Devulder G, 2005, INT J SYST EVOL MICR, V55, P293, DOI 10.1099/ijs.0.63222-0; Flint JL, 2004, P NATL ACAD SCI USA, V101, P12598, DOI 10.1073/pnas.0404892101; French MA, 2004, AIDS, V18, P1615, DOI 10.1097/01.aids.0000131375.21070.06; Gutierrez MC, 2005, PLOS PATHOG, V1, P55, DOI 10.1371/journal.ppat.0010005; Kaufmann SHE, 2005, NAT MED, V11, pS33, DOI 10.1038/nm1221; Kharkar Rajendra, 2002, J Indian Med Assoc, V100, P578; Kong Y, 2006, J CLIN MICROBIOL, V44, P3940, DOI 10.1128/JCM.01146-06; KUMAR S, 1994, COMPUT APPL BIOSCI, V10, P189; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Marri PR, 2006, CAN J MICROBIOL, V52, P560, DOI 10.1139/W06-001; Matte-Tailliez O, 2002, MOL BIOL EVOL, V19, P631, DOI 10.1093/oxfordjournals.molbev.a004122; Patel Naresh, 2002, J Indian Med Assoc, V100, P191; Rao KR, 2005, J CLIN MICROBIOL, V43, P5978, DOI 10.1128/JCM.43.12.5978-5982.2005; Rath N, 2003, INT J DERMATOL, V42, P756; Raviglione MC, 2007, NEW ENGL J MED, V356, P656, DOI 10.1056/NEJMp068273; REDDI PP, 1994, INT J LEPROSY, V62, P229; Rook GAW, 2007, IMMUNOBIOLOGY, V212, P461, DOI 10.1016/j.imbio.2007.03.003; Rosas-Magallanes V, 2006, MOL BIOL EVOL, V23, P1129, DOI 10.1093/molbev/msj120; Sechi LA, 1998, J CLIN MICROBIOL, V36, P128, DOI 10.1128/JCM.36.1.128-132.1998; Sharma P, 2005, LEPROSY REV, V76, P127; Siddiqi N, 1998, MEM I OSWALDO CRUZ, V93, P589, DOI 10.1590/S0074-02761998000500006; SINGH IG, 1992, INFECT IMMUN, V60, P257, DOI 10.1128/IAI.60.1.257-263.1992; SOINI H, 1994, J CLIN MICROBIOL, V32, P2944, DOI 10.1128/JCM.32.12.2944-2947.1994; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Stinear TP, 2000, J BACTERIOL, V182, P6322, DOI 10.1128/JB.182.22.6322-6330.2000; Talwar G P, 1999, Int Rev Immunol, V18, P229, DOI 10.3109/08830189909043027; TALWAR GP, 1990, VACCINE, V8, P121, DOI 10.1016/0264-410X(90)90134-8; Talwar GP, 2008, INFECT GENET EVOL, V8, P100, DOI 10.1016/j.meegid.2007.07.009; YADAVA A, 1991, SCAND J IMMUNOL, V34, P23, DOI 10.1111/j.1365-3083.1991.tb01517.x; Yamamoto S, 1996, INT J SYST BACTERIOL, V46, P506, DOI 10.1099/00207713-46-2-506; YAMAMOTO S, 1995, APPL ENVIRON MICROB, V61, P1104, DOI 10.1128/AEM.61.3.1104-1109.1995; ZAHEER SA, 1993, J INFECT DIS, V167, P401, DOI 10.1093/infdis/167.2.401	42	32	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e968	10.1371/journal.pone.0000968	http://dx.doi.org/10.1371/journal.pone.0000968			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912347	Green Submitted, gold, Green Published			2022-12-25	WOS:000207455900006
J	Hougardy, JM; Schepers, K; Place, S; Drowart, A; Lechevin, V; Verscheure, V; Debrie, AS; Doherty, TM; Van Vooren, JP; Locht, C; Mascart, F				Hougardy, Jean-Michel; Schepers, Kinda; Place, Sammy; Drowart, Annie; Lechevin, Veronique; Verscheure, Virginie; Debrie, Anne-Sophie; Doherty, T. Mark; Van Vooren, Jean-Paul; Locht, Camille; Mascart, Francoise			Heparin-Binding-Hemagglutinin-Induced IFN-gamma Release as a Diagnostic Tool for Latent Tuberculosis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; SKIN-TEST; T-CELL; IMMUNE-RESPONSES; INFECTION; TESTS; ASSAY; METAANALYSIS	Background. The detection of latent tuberculosis infection (LTBI) is a major component of tuberculosis (TB) control strategies. In addition to the tuberculosis skin test (TST), novel blood tests, based on in vitro release of IFN-gamma in response to Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 (IGRAs), are used for TB diagnosis. However, neither IGRAs nor the TST can separate acute TB from LTBI, and there is concern that responses in IGRAs may decline with time after infection. We have therefore evaluated the potential of the novel antigen heparin-binding hemagglutinin (HBHA) for in vitro detection of LTBI. Methodology and Principal Findings. HBHA was compared to purified protein derivative (PPD) and ESAT-6 in IGRAs on lymphocytes drawn from 205 individuals living in Belgium, a country with low TB prevalence, where BCG vaccination is not routinely used. Among these subjects, 89 had active TB, 65 had LTBI, based on well-standardized TST reactions and 51 were negative controls. HBHA was significantly more sensitive than ESAT-6 and more specific than PPD for the detection of LTBI. PPD-based tests yielded 90.00% sensitivity and 70.00% specificity for the detection of LTBI, whereas the sensitivity and specificity for the ESAT-6-based tests were 40.74% and 90.91%, and those for the HBHA-based tests were 92.06% and 93.88%, respectively. The QuantiFERON-TB Gold In-Tube (QFT-IT) test applied on 20 LTBI subjects yielded 50% sensitivity. The HBHA IGRA was not influenced by prior BCG vaccination, and, in contrast to the QFT-IT test, remote (. 2 years) infections were detected as well as recent (< 2 years) infections by the HBHA-specific test. Conclusions. The use of ESAT-6- and CFP-10-based IGRAs may underestimate the incidence of LTBI, whereas the use of HBHA may combine the operational advantages of IGRAs with high sensitivity and specificity for latent infection.	[Hougardy, Jean-Michel; Schepers, Kinda; Place, Sammy; Verscheure, Virginie; Mascart, Francoise] Univ Libre Bruxelles, Hop Erasme, Lab Vaccinol & Mucosal Immun, Brussels, Belgium; [Drowart, Annie] Univ Libre Bruxelles, Hop Brugmann, Dept Pneumol, Brussels, Belgium; [Drowart, Annie] Univ Libre Bruxelles, Hop Erasme, Dept Pneumol, Brussels, Belgium; [Lechevin, Veronique; Van Vooren, Jean-Paul] Univ Libre Bruxelles, Hop Erasme, Dept Immunodeficiency, Brussels, Belgium; [Lechevin, Veronique] Univ Libre Bruxelles, Hop Erasme, Dept Occupat Med, Brussels, Belgium; [Debrie, Anne-Sophie; Locht, Camille] INSERM, U629, F-59045 Lille, France; [Debrie, Anne-Sophie; Locht, Camille] Inst Pasteur, F-59019 Lille, France; [Doherty, T. Mark] Statens Serum Inst, Dept TB Immunol, DK-2300 Copenhagen, Denmark; [Mascart, Francoise] Free Univ Brussels, Hop Erasme, Immunobiol Clin, B-1070 Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Statens Serum Institut; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Mascart, F (corresponding author), Univ Libre Bruxelles, Hop Erasme, Lab Vaccinol & Mucosal Immun, Brussels, Belgium.	fmascart@ulb.ac.be	Locht, Camille/L-3516-2018	Debrie, Anne-Sophie/0000-0003-0570-4413; Locht, Camille/0000-0001-7295-7336; Hougardy, Jean-Michel/0000-0002-7769-5360	Fond de la Recherche Scientifique Medicale; European Commission [LSHP-CT-2003-503367]; Fond pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA); Fondation Erasme	Fond de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); European Commission(European CommissionEuropean Commission Joint Research Centre); Fond pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA)(Fonds de la Recherche Scientifique - FNRS); Fondation Erasme	This work was supported by a grant from the Fond de la Recherche Scientifique Medicale, by the European Commission, within the 6th Framework Program, contract Nu LSHP-CT-2003-503367, and by the "Region de Bruxelles-Capitale''. JMH was supported by a fellowship from the Fond pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA). KS and SP were supported by a fellowship from the Fondation Erasme. None of the organizations supporting the authors with grants had any role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in preparation, review or approval of the manuscript.	*AM THOR SOC CDC, 2000, J RESP CRIT CARE M 1, V161, P1376; Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; Arend SM, 2007, AM J RESP CRIT CARE, V175, P618, DOI 10.1164/rccm.200608-1099OC; Doherty TM, 2002, J CLIN MICROBIOL, V40, P704, DOI 10.1128/JCM.40.2.704-706.2002; Dye C, 2006, LANCET, V367, P938, DOI 10.1016/S0140-6736(06)68384-0; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; Ewer K, 2006, AM J RESP CRIT CARE, V174, P831, DOI 10.1164/rccm.200511-1783OC; Ferrara G, 2006, LANCET, V367, P1328, DOI 10.1016/S0140-6736(06)68579-6; Horsburgh CR, 2004, NEW ENGL J MED, V350, P2060, DOI 10.1056/NEJMsa031667; Hougardy JM, 2007, AM J RESP CRIT CARE, V176, P409, DOI 10.1164/rccm.200701-084OC; Jasmer RM, 2002, NEW ENGL J MED, V347, P1860, DOI 10.1056/NEJMcp021045; Jensen Paul A., 2005, Morbidity and Mortality Weekly Report, V54, P1; Kang YA, 2005, JAMA-J AM MED ASSOC, V293, P2756, DOI 10.1001/jama.293.22.2756; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Lalvani A, 2001, LANCET, V357, P2017, DOI 10.1016/S0140-6736(00)05115-1; Leyten EMS, 2007, CLIN VACCINE IMMUNOL, V14, P880, DOI 10.1128/CVI.00132-07; LOCHT C, 2007, MYCOBACTERI IN PRESS; Masungi C, 2002, J INFECT DIS, V185, P513, DOI 10.1086/338833; Mazurek Gerald H., 2005, Morbidity and Mortality Weekly Report, V54, P49; Menozzi FD, 1996, J EXP MED, V184, P993, DOI 10.1084/jem.184.3.993; Menzies D, 1999, AM J RESP CRIT CARE, V159, P15, DOI 10.1164/ajrccm.159.1.9801120; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; MENZIES R, 2006, TB COMPREHENSIVE INT, P251; Porsa E, 2006, CLIN VACCINE IMMUNOL, V13, P53, DOI 10.1128/CVI.13.1.53-58.2006; Richeldi L, 2006, AM J RESP CRIT CARE, V174, P736, DOI 10.1164/rccm.200509-1516PP; Sterling TR, 2006, NEW ENGL J MED, V355, P118, DOI 10.1056/NEJMp068015; Temmerman S, 2004, NAT MED, V10, P935, DOI 10.1038/nm1090; Wang L, 2002, THORAX, V57, P804, DOI 10.1136/thorax.57.9.804; Whalen CC, 1997, NEW ENGL J MED, V337, P801, DOI 10.1056/NEJM199709183371201; *WHO, 2007, 104 WHO	30	94	98	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e926	10.1371/journal.pone.0000926	http://dx.doi.org/10.1371/journal.pone.0000926			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912342	Green Submitted, Green Published, gold			2022-12-25	WOS:000207455900001
J	Komarova, NL; Wodarz, D				Komarova, Natalia L.; Wodarz, Dominik			Effect of Cellular Quiescence on the Success of Targeted CML Therapy	PLOS ONE			English	Article								Background. Similar to tissue stem cells, primitive tumor cells in chronic myelogenous leukemia have been observed to undergo quiescence; that is, the cells can temporarily stop dividing. Using mathematical models, we investigate the effect of cellular quiescence on the outcome of therapy with targeted small molecule inhibitors. Methods and Results. According to the models, the initiation of treatment can result in different patterns of tumor cell decline: a biphasic decline, a one-phase decline, and a reverse biphasic decline. A biphasic decline involves a fast initial phase (which roughly corresponds to the eradication of cycling cells by the drug), followed by a second and slower phase of exponential decline (corresponding to awakening and death of quiescent cells), which helps explain clinical data. We define the time when the switch to the second phase occurs, and identify parameters that determine whether therapy can drive the tumor extinct in a reasonable period of time or not. We further ask how cellular quiescence affects the evolution of drug resistance. We find that it has no effect on the probability that resistant mutants exist before therapy if treatment occurs with a single drug, but that quiescence increases the probability of having resistant mutants if patients are treated with a combination of two or more drugs with different targets. Interestingly, while quiescence prolongs the time until therapy reduces the number of cells to low levels or extinction, the therapy phase is irrelevant for the evolution of drug resistant mutants. If treatment fails as a result of resistance, the mutants will have evolved during the tumor growth phase, before the start of therapy. Thus, prevention of resistance is not promoted by reducing the quiescent cell population during therapy (e. g., by a combination of cell activation and drug-mediated killing). Conclusions. The mathematical models provide insights into the effect of quiescence on the basic kinetics of the response to targeted treatment of CML. They identify determinants of success in the absence of drug resistant mutants, and elucidate how quiescence influences the emergence of drug resistant mutants.	[Komarova, Natalia L.; Wodarz, Dominik] Univ Calif Irvine, Dept Math, Irvine, CA 92717 USA; [Komarova, Natalia L.; Wodarz, Dominik] Univ Calif Irvine, Dept Ecol & Evolut, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Wodarz, D (corresponding author), Univ Calif Irvine, Dept Math, Irvine, CA 92717 USA.	dwodarz@uci.edu			NIH [1R01AI058153-01A2]; Sloan Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058153] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sloan Fellowship(Alfred P. Sloan Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by NIH grant 1R01AI058153-01A2 (DW & NK), and a Sloan Fellowship (NK).	Al-Hajj M, 2004, CURR OPIN GENET DEV, V14, P43, DOI 10.1016/j.gde.2003.11.007; ARAI F, 2007, ANN N Y ACAD SCI; Barnes DJ, 2006, CELL CYCLE, V5, P2862, DOI 10.4161/cc.5.24.3573; Burkert J, 2006, J PATHOL, V209, P287, DOI 10.1002/path.2016; Calabretta B, 2004, BLOOD, V103, P4010, DOI 10.1182/blood-2003-12-4111; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; COLDMAN AJ, 1986, B MATH BIOL, V48, P279, DOI 10.1016/S0092-8240(86)90028-5; Cortes J, 2004, BLOOD, V104, P2204, DOI 10.1182/blood-2004-04-1335; Daley GQ, 2003, SEMIN HEMATOL, V40, P11, DOI 10.1053/shem.2003.50035; Daub H, 2004, NAT REV DRUG DISCOV, V3, P1001, DOI 10.1038/nrd1579; Deininger MWN, 2003, PHARMACOL REV, V55, P401, DOI 10.1124/pr.55.3.4; Druker BJ, 2004, ADV CANCER RES, V91, P1, DOI 10.1016/S0065-230X(04)91001-9; Druker BJ, 2003, MOL CANCER THER, V2, P225; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gambacorti-Passerini CB, 2003, LANCET ONCOL, V4, P75, DOI 10.1016/S1470-2045(03)00979-3; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; GYLLENBERG M, 1990, J MATH BIOL, V28, P671, DOI 10.1007/BF00160231; GYLLENBERG M, 1989, GROWTH DEVELOP AGING, V53, P25; GYLLENBERG M, 1987, MATH BIOSCI, V86, P67, DOI 10.1016/0025-5564(87)90064-2; Higashi T, 2004, AM J HEMATOL, V76, P275, DOI 10.1002/ajh.20096; Holyoake T, 1999, BLOOD, V94, P2056, DOI 10.1182/blood.V94.6.2056; Holyoake TL, 2001, BLOOD, V97, P720, DOI 10.1182/blood.V97.3.720; HOUGHTON J, 2006, SEMIN CANC BIOL; Jabbour E, 2007, SEMIN HEMATOL, V44, pS25, DOI 10.1053/seminhematol.2006.12.003; John AM, 2004, SEMIN CANCER BIOL, V14, P41, DOI 10.1016/j.semcancer.2003.11.006; Jones RJ, 2004, JNCI-J NATL CANCER I, V96, P583, DOI 10.1093/jnci/djh095; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Komarova NL, 2005, P NATL ACAD SCI USA, V102, P9714, DOI 10.1073/pnas.0501870102; Melo Junia V, 2003, Hematology Am Soc Hematol Educ Program, P132; Michor F, 2005, NATURE, V435, P1267, DOI 10.1038/nature03669; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Nardi V, 2004, CURR OPIN HEMATOL, V11, P35, DOI 10.1097/00062752-200401000-00006; O'Dwyer ME, 2002, ANNU REV MED, V53, P369, DOI 10.1146/annurev.med.53.082901.103853; Pelayo R, 2006, STEM CELLS, V24, P2703, DOI 10.1634/stemcells.2006-0217; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Roeder I, 2006, NAT MED, V12, P1181, DOI 10.1038/nm1487; ROUSSELOT P, 2006, BLOOD; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Shannon KM, 2002, CANCER CELL, V2, P99, DOI 10.1016/S1535-6108(02)00101-0; Shet AS, 2002, LEUKEMIA, V16, P1402, DOI 10.1038/sj.leu.2402577; Tauchi T, 2004, LEUKEMIA RES, V28, pS39, DOI 10.1016/j.leukres.2003.10.007; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Yee Karen W L, 2003, Expert Rev Anticancer Ther, V3, P295, DOI 10.1586/14737140.3.3.295; Yoshida C, 2004, INT J HEMATOL, V79, P420, DOI 10.1532/IJH97.04032	46	65	66	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e990	10.1371/journal.pone.0000990	http://dx.doi.org/10.1371/journal.pone.0000990			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912367	Green Published, gold, Green Submitted			2022-12-25	WOS:000207455900026
J	Letourneau, S; Im, EJ; Mashishi, T; Brereton, C; Bridgeman, A; Yang, HB; Dorrell, L; Dong, T; Korber, B; McMichael, AJ; Hanke, T				Letourneau, Sven; Im, Eung-Jun; Mashishi, Tumelo; Brereton, Choechoe; Bridgeman, Anne; Yang, Hongbing; Dorrell, Lucy; Dong, Tao; Korber, Bette; McMichael, Andrew J.; Hanke, Tomas			Design and Pre-Clinical Evaluation of a Universal HIV-1 Vaccine	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CYTOTOXIC T-LYMPHOCYTES; HIGHLY CONSERVED REGION; CELL RESPONSES; CROSS-CLADE; IMMUNE-RESPONSES; CTL EPITOPE; IMMUNOGENICITY EVALUATION; ENVELOPE GLYCOPROTEIN; PROTECTIVE IMMUNITY	Background. One of the big roadblocks in development of HIV-1/AIDS vaccines is the enormous diversity of HIV-1, which could limit the value of any HIV-1 vaccine candidate currently under test. Methodology and Findings. To address the HIV-1 variation, we designed a novel T cell immunogen, designated HIVCONSV, by assembling the 14 most conserved regions of the HIV-1 proteome into one chimaeric protein. Each segment is a consensus sequence from one of the four major HIV-1 clades A, B, C and D, which alternate to ensure equal clade coverage. The gene coding for the HIVCONSV protein was inserted into the three most studied vaccine vectors, plasmid DNA, human adenovirus serotype 5 and modified vaccine virus Ankara (MVA), and induced HIV-1-specific T cell responses in mice. We also demonstrated that these conserved regions prime CD8(+) and CD4(+) T cell to highly conserved epitopes in humans and that these epitopes, although usually subdominant, generate memory T cells in patients during natural HIV-1 infection. Significance. Therefore, this vaccine approach provides an attractive and testable alternative for overcoming the HIV-1 variability, while focusing T cell responses on regions of the virus that are less likely to mutate and escape. Furthermore, this approach has merit in the simplicity of design and delivery, requiring only a single immunogen to provide extensive coverage of global HIV-1 population diversity.	[Letourneau, Sven; Im, Eung-Jun; Mashishi, Tumelo; Brereton, Choechoe; Bridgeman, Anne; Yang, Hongbing; Dorrell, Lucy; Dong, Tao; McMichael, Andrew J.; Hanke, Tomas] Univ Oxford, MRC, Human Immunol Unit, Weatherall Inst Mol Med, Oxford, England; [Korber, Bette] Los Alamo Natl Lab, Los Alamos, NM USA; [Korber, Bette] Santa Fe Inst, Santa Fe, NM USA	University of Oxford; The Santa Fe Institute	Hanke, T (corresponding author), Univ Oxford, MRC, Human Immunol Unit, Weatherall Inst Mol Med, Oxford, England.	tomas.hanke@imm.ox.ac.uk		Korber, Bette/0000-0002-2026-5757; Dong, Tao/0000-0003-3545-3758; Bridgeman, Anne/0000-0002-9478-6125	MRC UK; Medical Research Council [G0502048, MC_U137884179, MC_U137884177, G0600520] Funding Source: researchfish; MRC [MC_U137884177, G0502048, MC_U137884179, G0600520] Funding Source: UKRI	MRC UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	TH is the Jenner Institute Investigator. The work was supported by MRC UK.	Allen TM, 1998, J IMMUNOL, V160, P6062; Altfeld M, 2003, J VIROL, V77, P7330, DOI 10.1128/JVI.77.13.7330-7340.2003; Amara RR, 2005, VIROLOGY, V334, P124; Andre S, 1998, J VIROL, V72, P1497; Basu D, 1998, P NATL ACAD SCI USA, V95, P14332, DOI 10.1073/pnas.95.24.14332; BERTOLETTI A, 1994, NATURE, V369, P407, DOI 10.1038/369407a0; Betts MR, 1997, J VIROL, V71, P8908, DOI 10.1128/JVI.71.11.8908-8911.1997; Bhattacharya T, 2007, SCIENCE, V315, P1583, DOI 10.1126/science.1131528; Blay WM, 2006, J VIROL, V80, P999, DOI 10.1128/JVI.80.2.999-1014.2006; BURROWS SR, 1995, J EXP MED, V182, P1703, DOI 10.1084/jem.182.6.1703; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Buseyne F, 1998, VIROLOGY, V250, P316, DOI 10.1006/viro.1998.9373; Cao HY, 1997, J VIROL, V71, P8615, DOI 10.1128/JVI.71.11.8615-8623.1997; Catanzaro AT, 2006, J INFECT DIS, V194, P1638, DOI 10.1086/509258; Dorrell L, 1999, J VIROL, V73, P1708, DOI 10.1128/JVI.73.2.1708-1714.1999; Dorrell L, 2001, EUR J IMMUNOL, V31, P1747, DOI 10.1002/1521-4141(200106)31:6<1747::AID-IMMU1747>3.3.CO;2-C; Dorrell L, 2006, J VIROL, V80, P4705, DOI 10.1128/JVI.80.10.4705-4716.2006; Duerr A, 2006, CLIN INFECT DIS, V43, P500, DOI 10.1086/505979; Ferrari G, 2000, AIDS RES HUM RETROV, V16, P1433, DOI 10.1089/08892220050140982; Ferrari G, 1997, P NATL ACAD SCI USA, V94, P1396, DOI 10.1073/pnas.94.4.1396; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; Frahm N, 2006, NAT IMMUNOL, V7, P173, DOI 10.1038/ni1281; Gallimore A, 1998, J EXP MED, V187, P1647; Gao F, 2005, J VIROL, V79, P1154, DOI 10.1128/JVI.79.2.1154-1163.2005; Gao Feng, 2004, Expert Rev Vaccines, V3, pS161, DOI 10.1586/14760584.3.4.S161; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; Gilbert SC, 2002, VACCINE, V20, P1039, DOI 10.1016/S0264-410X(01)00450-9; Gilbert SC, 1998, SCIENCE, V279, P1173, DOI 10.1126/science.279.5354.1173; Goonetilleke N, 2006, J VIROL, V80, P4717, DOI 10.1128/JVI.80.10.4717-4728.2006; GOTCH F, 1988, J EXP MED, V168, P2045, DOI 10.1084/jem.168.6.2045; Goulder PJR, 2004, NAT REV IMMUNOL, V4, P630, DOI 10.1038/nri1417; Goulder PJR, 2001, J EXP MED, V193, P181, DOI 10.1084/jem.193.2.181; Graham BS, 2006, J INFECT DIS, V194, P1650, DOI 10.1086/509259; Hanke T, 2000, NAT MED, V6, P951, DOI 10.1038/79626; Hanke T, 1998, VACCINE, V16, P426, DOI 10.1016/S0264-410X(97)00296-X; HANKE T, 1992, J GEN VIROL, V73, P653, DOI 10.1099/0022-1317-73-3-653; Hanke T, 1998, J GEN VIROL, V79, P83, DOI 10.1099/0022-1317-79-1-83; Hanke T, 2007, J GEN VIROL, V88, P1, DOI 10.1099/vir.0.82493-0; Harrer E, 1996, J INFECT DIS, V173, P476, DOI 10.1093/infdis/173.2.476; Hausmann S, 1999, J IMMUNOL, V162, P5389; Im EJ, 2007, AIDS RES HUM RETROV, V23, P857, DOI 10.1089/aid.2007.0009; JOHNSON RP, 1993, J VIROL, V67, P438, DOI 10.1128/JVI.67.1.438-445.1993; JOHNSON RP, 1992, J EXP MED, V175, P961, DOI 10.1084/jem.175.4.961; JOHNSON RP, 1991, J IMMUNOL, V147, P1512; JOHNSON RP, 1994, J VIROL, V68, P3145, DOI 10.1128/JVI.68.5.3145-3153.1994; Klenerman P, 2002, CURR OPIN MICROBIOL, V5, P408, DOI 10.1016/S1369-5274(02)00339-9; KLENERMAN P, 1994, NATURE, V369, P403, DOI 10.1038/369403a0; Kmieciak D, 1998, INT IMMUNOL, V10, P1789, DOI 10.1093/intimm/10.12.1789; Korber B, 2001, BRIT MED BULL, V58, P19, DOI 10.1093/bmb/58.1.19; Kothe DL, 2007, VIROLOGY, V360, P218, DOI 10.1016/j.virol.2006.10.017; Kothe DL, 2006, VIROLOGY, V352, P438, DOI 10.1016/j.virol.2006.05.011; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Larke N, 2007, EUR J IMMUNOL, V37, P566, DOI 10.1002/eji.200636711; Lau LL, 2005, J IMMUNOL, V174, P7970, DOI 10.4049/jimmunol.174.12.7970; Lee JK, 2004, J EXP MED, V200, P1455, DOI 10.1084/jem.20041251; Makki Amira, 2002, Cancer Immun, V2, P4; McMichael A, 2002, VACCINE, V20, P1918, DOI 10.1016/S0264-410X(02)00067-1; McMichael AJ, 2006, ANNU REV IMMUNOL, V24, P227, DOI 10.1146/annurev.immunol.24.021605.090605; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Nkolola JP, 2004, GENE THER, V11, P1068, DOI 10.1038/sj.gt.3302241; Plebanski M, 1999, NAT MED, V5, P565, DOI 10.1038/8444; ROLLAND M, 2007, PROTEINS J VIROL; Rowland-Jones SL, 1998, J CLIN INVEST, V102, P1758, DOI 10.1172/JCI4314; Seaman MS, 2005, J VIROL, V79, P2956, DOI 10.1128/JVI.79.5.2956-2963.2005; Slyker JA, 2005, VACCINE, V23, P4711, DOI 10.1016/j.vaccine.2005.01.145; STREECK H, 2007, J VIROL; TAKAHASHI H, 1988, P NATL ACAD SCI USA, V85, P3105, DOI 10.1073/pnas.85.9.3105; Walker BD, 2000, NATURE, V407, P313, DOI 10.1038/35030283; Weaver EA, 2006, J VIROL, V80, P6745, DOI 10.1128/JVI.02484-05; Williamson C, 2003, AIDS RES HUM RETROV, V19, P133, DOI 10.1089/088922203762688649; Wilson CC, 2003, J IMMUNOL, V171, P5611, DOI 10.4049/jimmunol.171.10.5611; Wilson CC, 2001, J VIROL, V75, P4195, DOI 10.1128/JVI.75.9.4195-4207.2001	72	225	235	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e984	10.1371/journal.pone.0000984	http://dx.doi.org/10.1371/journal.pone.0000984			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912361	Green Published, gold, Green Submitted			2022-12-25	WOS:000207455900020
J	Rogers, KL; Picaud, S; Roncali, E; Boisgard, R; Colasante, C; Stinnakre, J; Tavitian, B; Brulet, P				Rogers, Kelly L.; Picaud, Sandrine; Roncali, Emilie; Boisgard, Raphael; Colasante, Cesare; Stinnakre, Jacques; Tavitian, Bertrand; Brulet, Philippe			Non-Invasive In Vivo Imaging of Calcium Signaling in Mice	PLOS ONE			English	Article								Rapid and transient elevations of Ca2+ within cellular microdomains play a critical role in the regulation of many signal transduction pathways. Described here is a genetic approach for non-invasive detection of localized Ca2+ concentration ([Ca2+]) rises in live animals using bioluminescence imaging (BLI). Transgenic mice conditionally expressing the Ca2+-sensitive bioluminescent reporter GFP-aequorin targeted to the mitochondrial matrix were studied in several experimental paradigms. Rapid [Ca2+] rises inside the mitochondrial matrix could be readily detected during single-twitch muscle contractions. Whole body patterns of [Ca2+] were monitored in freely moving mice and during epileptic seizures. Furthermore, variations in mitochondrial [Ca2+] correlated to behavioral components of the sleep/wake cycle were observed during prolonged whole body recordings of newborn mice. This non-invasive imaging technique opens new avenues for the analysis of Ca2+ signaling whenever whole body information in freely moving animals is desired, in particular during behavioral and developmental studies.	[Rogers, Kelly L.; Picaud, Sandrine; Colasante, Cesare; Stinnakre, Jacques; Brulet, Philippe] Inst Pasteur, Unite Embryol Mol, CNRS, URA 2578, Paris, France; [Rogers, Kelly L.; Roncali, Emilie; Boisgard, Raphael; Tavitian, Bertrand] CEA, Serv Hosp Frederic Joliot, INSERM, U803, F-91406 Orsay, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Brulet, P (corresponding author), Inst Pasteur, Unite Embryol Mol, CNRS, URA 2578, Paris, France.	pbrulet@pasteur.fr	Roncali, Emilie/AAP-9701-2020; roncali, emilie/C-2130-2016; Tavitian, Bertrand M/P-6578-2018	Roncali, Emilie/0000-0002-2439-1064; Tavitian, Bertrand M/0000-0002-5349-8194; Rogers, Kelly L./0000-0002-6755-0221	Institut Pasteur; CNRS; AFM; E.U.; INSERM	Institut Pasteur(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); AFM(Association Francaise contre les Myopathies); E.U.(European Commission); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	The work was funded by Institut Pasteur, CNRS and AFM to PB and by E.U. support through the EMIL and DIMI European Networks to BT. KR received support from Institut Pasteur, CNRS and INSERM. Biospace Lab provided a PhD scholarship to ER. CC was supported by CNRS.	Abraham U, 2005, J NEUROSCI, V25, P8620, DOI 10.1523/JNEUROSCI.2225-05.2005; Adelsberger H, 2005, NAT NEUROSCI, V8, P988, DOI 10.1038/nn1502; Augustine GJ, 2003, NEURON, V40, P331, DOI 10.1016/S0896-6273(03)00639-1; Baubet V, 2000, P NATL ACAD SCI USA, V97, P7260, DOI 10.1073/pnas.97.13.7260; Bell CJ, 2006, J BIOL CHEM, V281, P28058, DOI 10.1074/jbc.M604540200; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bhaumik S, 2002, P NATL ACAD SCI USA, V99, P377, DOI 10.1073/pnas.012611099; Bizeau ME, 1998, J APPL PHYSIOL, V85, P1279, DOI 10.1152/jappl.1998.85.4.1279; Blumberg MS, 1996, DEV PSYCHOBIOL, V29, P1, DOI 10.1002/(SICI)1098-2302(199601)29:1<1::AID-DEV1>3.0.CO;2-Y; Blumberg MS, 2005, J SLEEP RES, V14, P91, DOI 10.1111/j.1365-2869.2004.00430_1.x; Blumberg MS, 2005, P NATL ACAD SCI USA, V102, P14860, DOI 10.1073/pnas.0506340102; Bronson SK, 1996, P NATL ACAD SCI USA, V93, P9067, DOI 10.1073/pnas.93.17.9067; Bruton J, 2003, J PHYSIOL-LONDON, V551, P179, DOI 10.1113/jphysiol.2003.043927; CLARK JB, 1970, J BIOL CHEM, V245, P4724; Curie T, 2007, MOL IMAGING, V6, P30, DOI 10.2310/7290.2006.00033; De A, 2005, FASEB J, V19, P2017, DOI 10.1096/fj.05-4628fje; De Sarro G, 2004, NEUROSCI RES, V50, P37, DOI 10.1016/j.neures.2004.05.007; Durand E, 2005, AM J RESP CRIT CARE, V172, P238, DOI 10.1164/rccm.200411-1528OC; Frank MG, 1997, AM J PHYSIOL-REG I, V272, pR1792, DOI 10.1152/ajpregu.1997.272.6.R1792; Garaschuk O, 2000, NAT NEUROSCI, V3, P452, DOI 10.1038/74823; Gorokhovatsky AY, 2004, BIOCHEM BIOPH RES CO, V320, P703, DOI 10.1016/j.bbrc.2004.06.014; GRAMSBERGEN A, 1970, Developmental Psychobiology, V3, P267, DOI 10.1002/dev.420030407; Hardy J, 2004, SCIENCE, V303, P851, DOI 10.1126/science.1092712; Hasan MT, 2004, PLOS BIOL, V2, P763, DOI 10.1371/journal.pbio.0020163; Hayashi M, 2003, J HISTOCHEM CYTOCHEM, V51, P1375, DOI 10.1177/002215540305101014; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; Karlsson KAE, 2005, PLOS BIOL, V3, P891, DOI 10.1371/journal.pbio.0030143; Karlsson KAE, 2004, NEUROSCIENCE, V123, P575, DOI 10.1016/j.neuroscience.2003.09.025; Karlsson KAE, 2002, BEHAV NEUROSCI, V116, P912, DOI 10.1037//0735-7044.116.5.912; KENDALL JM, 1992, BIOCHEM BIOPH RES CO, V187, P1091, DOI 10.1016/0006-291X(92)91309-E; Khazipov R, 2004, NATURE, V432, P758, DOI 10.1038/nature03132; Kovacs R, 2005, J NEUROSCI, V25, P4260, DOI 10.1523/JNEUROSCI.4000-04.2005; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; Lannergren J, 2001, J MUSCLE RES CELL M, V22, P265, DOI 10.1023/A:1012227009544; LOEW LM, 1994, P NATL ACAD SCI USA, V91, P12579, DOI 10.1073/pnas.91.26.12579; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Pfleger KDG, 2006, NAT METHODS, V3, P165, DOI 10.1038/nmeth841; Pichler A, 2004, P NATL ACAD SCI USA, V101, P1702, DOI 10.1073/pnas.0304326101; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Robb-Gaspers LD, 1998, EMBO J, V17, P4987, DOI 10.1093/emboj/17.17.4987; Robert V, 2001, EMBO J, V20, P4998, DOI 10.1093/emboj/20.17.4998; Rogers KL, 2005, EUR J NEUROSCI, V21, P597, DOI 10.1111/j.1460-9568.2005.03871.x; Roux S, 2005, MOL CELL NEUROSCI, V30, P572, DOI 10.1016/j.mcn.2005.05.009; Rudolf R, 2004, J CELL BIOL, V166, P527, DOI 10.1083/jcb.200403102; Schiavetta AM, 2003, CONTEMP TOP LAB ANIM, V42, P12; SHIMOMURA O, 1989, BIOCHEM J, V261, P913, DOI 10.1042/bj2610913; So MK, 2006, NAT BIOTECHNOL, V24, P339, DOI 10.1038/nbt1188; Zhao H, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2032388; Zhao Hui, 2004, Mol Imaging, V3, P43, DOI 10.1162/153535004773861714	52	65	66	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e974	10.1371/journal.pone.0000974	http://dx.doi.org/10.1371/journal.pone.0000974			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912353	Green Published, gold			2022-12-25	WOS:000207455900012
J	Makarova, KS; Omelchenko, MV; Gaidamakova, EK; Matrosova, VY; Vasilenko, A; Zhai, M; Lapidus, A; Copeland, A; Kim, E; Land, M; Mavromatis, K; Pitluck, S; Richardson, PM; Detter, C; Brettin, T; Saunders, E; Lai, B; Ravel, B; Kemner, KM; Wolf, YI; Sorokin, A; Gerasimova, AV; Gelfand, MS; Fredrickson, JK; Koonin, EV; Daly, MJ				Makarova, Kira S.; Omelchenko, Marina V.; Gaidamakova, Elena K.; Matrosova, Vera Y.; Vasilenko, Alexander; Zhai, Min; Lapidus, Alla; Copeland, Alex; Kim, Edwin; Land, Miriam; Mavromatis, Konstantinos; Pitluck, Samuel; Richardson, Paul M.; Detter, Chris; Brettin, Thomas; Saunders, Elizabeth; Lai, Barry; Ravel, Bruce; Kemner, Kenneth M.; Wolf, Yuri I.; Sorokin, Alexander; Gerasimova, Anna V.; Gelfand, Mikhail S.; Fredrickson, James K.; Koonin, Eugene V.; Daly, Michael J.			Deinococcus geothermalis: The Pool of Extreme Radiation Resistance Genes Shrinks	PLOS ONE			English	Article							ESCHERICHIA-COLI; IONIZING-RADIATION; DNA-POLYMERASE; TARGETED MUTAGENESIS; COMPARATIVE GENOMICS; CRYOELECTRON MICROSCOPY; SHEWANELLA-ONEIDENSIS; AROMATIC-COMPOUNDS; CRYSTAL-STRUCTURE; PROTEIN FAMILIES	Bacteria of the genus Deinococcus are extremely resistant to ionizing radiation (IR), ultraviolet light (UV) and desiccation. The mesophile Deinococcus radiodurans was the first member of this group whose genome was completely sequenced. Analysis of the genome sequence of D. radiodurans, however, failed to identify unique DNA repair systems. To further delineate the genes underlying the resistance phenotypes, we report the whole-genome sequence of a second Deinococcus species, the thermophile Deinococcus geothermalis, which at its optimal growth temperature is as resistant to IR, UV and desiccation as D. radiodurans, and a comparative analysis of the two Deinococcus genomes. Many D. radiodurans genes previously implicated in resistance, but for which no sensitive phenotype was observed upon disruption, are absent in D. geothermalis. In contrast, most D. radiodurans genes whose mutants displayed a radiation-sensitive phenotype in D. radiodurans are conserved in D. geothermalis. Supporting the existence of a Deinococcus radiation response regulon, a common palindromic DNA motif was identified in a conserved set of genes associated with resistance, and a dedicated transcriptional regulator was predicted. We present the case that these two species evolved essentially the same diverse set of gene families, and that the extreme stress-resistance phenotypes of the Deinococcus lineage emerged progressively by amassing cell-cleaning systems from different sources, but not by acquisition of novel DNA repair systems. Our reconstruction of the genomic evolution of the Deinococcus-Thermus phylum indicates that the corresponding set of enzymes proliferated mainly in the common ancestor of Deinococcus. Results of the comparative analysis weaken the arguments for a role of higher-order chromosome alignment structures in resistance; more clearly define and substantially revise downward the number of uncharacterized genes that might participate in DNA repair and contribute to resistance; and strengthen the case for a role in survival of systems involved in manganese and iron homeostasis.	[Makarova, Kira S.; Omelchenko, Marina V.; Wolf, Yuri I.; Sorokin, Alexander; Koonin, Eugene V.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA; [Gaidamakova, Elena K.; Matrosova, Vera Y.; Vasilenko, Alexander; Zhai, Min; Daly, Michael J.] Uniformed Serv Univ Hlth Sci, Dept Pathol, Bethesda, MD 20814 USA; [Lapidus, Alla; Copeland, Alex; Kim, Edwin; Land, Miriam; Mavromatis, Konstantinos; Pitluck, Samuel; Richardson, Paul M.] US DOE, Joint Genome Inst, Walnut Creek, CA USA; [Detter, Chris; Brettin, Thomas; Saunders, Elizabeth] Los Alamos Natl Lab, US Dept Energy, Joint Genome Inst, Los Alamos, NM USA; [Lai, Barry; Ravel, Bruce; Kemner, Kenneth M.] Argonne Natl Lab, Div Environm Res, Argonne, IL 60439 USA; [Lai, Barry; Ravel, Bruce; Kemner, Kenneth M.] Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA; [Gerasimova, Anna V.] Res Inst Genet & Select Ind Microorganisms, Moscow, Russia; [Gelfand, Mikhail S.] RAS, Inst Informat Transmiss Problems, Moscow 117901, Russia; [Gelfand, Mikhail S.] Moscow MV Lomonosov State Univ, Fac Bioengn & Bioinformat, Moscow, Russia; [Fredrickson, James K.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Uniformed Services University of the Health Sciences - USA; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; National Research Centre - Kurchatov Institute; Institute of Genetics & Selection of Industrial Microorganisms; Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences; Lomonosov Moscow State University; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Makarova, KS (corresponding author), NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA.	makarova@ncbi.nlm.nih.gov; mdaly@usuhs.mil	Matrosova, Vera/AAX-4125-2020; Lapidus, Alla L/I-4348-2013; Gelfand, Mikhail S/F-3425-2012; Land, Miriam L/A-6200-2011	Lapidus, Alla L/0000-0003-0427-8731; Land, Miriam L/0000-0001-7102-0031; Gelfand, Mikhail/0000-0003-4181-0846; Wolf, Yuri/0000-0002-0247-8708	National Institutes of Health; National Library of Medicine; USUHS [DE-FG02-04ER63918]; U.S. Department of Energy (DOE), Office of Science, Office of Biological and Environmental Research; Environmental Remediation Sciences Program (ERSP); Air Force Office of Scientific Research [FA9550-07-1-0218]; DOE Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Howard Hughes Medical Institute [55005610]; INTAS [05-8028]; Molecular and Cellular Virology program of the Russian Academy of Sciences; NATIONAL LIBRARY OF MEDICINE [Z01LM000073, ZIALM000061, Z01LM000061, ZIALM000073] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); USUHS; U.S. Department of Energy (DOE), Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Environmental Remediation Sciences Program (ERSP); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); DOE Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); INTAS(INTASEuropean Commission); Molecular and Cellular Virology program of the Russian Academy of Sciences; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The work of KSM, MVO, YIW, AS, and EVK was supported by the Intramural Research Program of the National Institutes of Health, National Library of Medicine. The work at USUHS was supported by grant DE-FG02-04ER63918 to MJD from the U.S. Department of Energy (DOE), Office of Science, Office of Biological and Environmental Research (BER), Environmental Remediation Sciences Program (ERSP); and by grant FA9550-07-1-0218 to MJD from the Air Force Office of Scientific Research. The work at the DOE-Joint Genome Institute was supported by the DOE Office of Science. Work at the Advanced Photon Source was supported by the DOE Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. The work of MSG and AVG was supported by grants from the Howard Hughes Medical Institute (55005610), INTAS (05-8028), and the Molecular and Cellular Virology program of the Russian Academy of Sciences. D. geothermalis was selected for genome sequencing by BER (http://www.science. doe.gov/ober/RFS-2.pdf) with MJD as the Principal Investigator.	Agostini HJ, 1996, J BACTERIOL, V178, P6759, DOI 10.1128/jb.178.23.6759-6765.1996; Albuquerque L, 2005, FEMS MICROBIOL LETT, V247, P161, DOI 10.1016/j.femsle.2005.05.002; Altschul SF, 1998, TRENDS BIOCHEM SCI, V23, P444, DOI 10.1016/S0968-0004(98)01298-5; AZEDDOUG H, 1994, CURR MICROBIOL, V29, P229, DOI 10.1007/BF01570159; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Battista JR, 2001, CRYOBIOLOGY, V43, P133, DOI 10.1006/cryo.2001.2357; Bearson SMD, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-13; Belyakov OV, 2005, P NATL ACAD SCI USA, V102, P14203, DOI 10.1073/pnas.0505020102; Bernstein DA, 2004, P NATL ACAD SCI USA, V101, P8575, DOI 10.1073/pnas.0401331101; Bhoo SH, 2001, NATURE, V414, P776, DOI 10.1038/414776a; Blasius M, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-69; BORDO D, 1994, J MOL BIOL, V238, P366, DOI 10.1006/jmbi.1994.1298; Bouchard JD, 2004, J BACTERIOL, V186, P3649, DOI 10.1128/JB.186.11.3649-3652.2004; Bowater R, 2006, PLOS GENET, V2, P93, DOI 10.1371/journal.pgen.0020008; BOYD A, 1995, J IND MICROBIOL, V15, P162, DOI 10.1007/BF01569821; Brim H, 2000, NAT BIOTECHNOL, V18, P85, DOI 10.1038/71986; Brim H, 2003, APPL ENVIRON MICROB, V69, P4575, DOI 10.1128/AEM.69.8.4575-4582.2003; Brim H, 2006, MICROBIOL-SGM, V152, P2469, DOI 10.1099/mic.0.29009-0; Brinkrolf K, 2006, GENET MOL RES, V5, P773; BRUCE AK, 1976, CAN J MICROBIOL, V22, P1336, DOI 10.1139/m76-197; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; Cabello P, 2004, J BIOL CHEM, V279, P45485, DOI 10.1074/jbc.M404417200; Carroll JD, 1996, J BACTERIOL, V178, P130, DOI 10.1128/jb.178.1.130-135.1996; CHASIN LA, 1968, J BIOL CHEM, V243, P5165; CHEO DL, 1991, J BACTERIOL, V173, P1696, DOI 10.1128/jb.173.5.1696-1703.1991; Courcelle J, 2001, GENETICS, V158, P41; Cox MM, 2005, NAT REV MICROBIOL, V3, P882, DOI 10.1038/nrmicro1264; Daly MJ, 2007, PLOS BIOL, V5, P769, DOI 10.1371/journal.pbio.0050092; Daly MJ, 2006, CLIN LAB MED, V26, P491, DOI 10.1016/j.cll.2006.03.009; Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185; DALY MJ, 1995, J BACTERIOL, V177, P5495, DOI 10.1128/jb.177.19.5495-5505.1995; Daly MJ, 1997, GENE, V187, P225, DOI 10.1016/S0378-1119(96)00755-X; DALY MJ, 1995, SCIENCE, V270, P1318, DOI 10.1126/science.270.5240.1318; Daly MJ, 2000, CURR OPIN BIOTECH, V11, P280, DOI 10.1016/S0958-1669(00)00096-3; DALY MJ, 1994, J BACTERIOL, V176, P3508, DOI 10.1128/JB.176.12.3508-3517.1994; DALY MJ, 1994, J BACTERIOL, V176, P7506, DOI 10.1128/JB.176.24.7506-7515.1994; Daly MJ, 1996, J BACTERIOL, V178, P4461, DOI 10.1128/jb.178.15.4461-4471.1996; Davis SJ, 1999, SCIENCE, V286, P2517, DOI 10.1126/science.286.5449.2517; Detter JC, 2002, GENOMICS, V80, P691, DOI 10.1006/geno.2002.7020; Du J, 2004, INT J BIOCHEM CELL B, V36, P2334, DOI 10.1016/j.biocel.2004.05.012; Earl AM, 2002, J BACTERIOL, V184, P6216, DOI 10.1128/JB.184.22.6216-6224.2002; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eisen JA, 2000, GENOME BIOL, V1; Eltsov M, 2005, J BACTERIOL, V187, P8047, DOI 10.1128/JB.187.23.8047-8054.2005; ELTSOV M, 2006, J BACTERIOL, V188, P6059; Eltsov M, 2006, J BACTERIOL, V188, P6053, DOI 10.1128/JB.00230-06; Englander J, 2004, J BACTERIOL, V186, P5973, DOI 10.1128/jb.186.18.5973-5977.2004; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fernandez de Henestrosa AR, 2000, MOL MICROBIOL, V35, P1560, DOI 10.1046/j.1365-2958.2000.01826.x; Ferreira AC, 1997, INT J SYST BACTERIOL, V47, P939, DOI 10.1099/00207713-47-4-939; Fisher DI, 2006, ARCH MICROBIOL, V186, P415, DOI 10.1007/s00203-006-0155-z; Fong SS, 2005, GENOME RES, V15, P1365, DOI 10.1101/gr.3832305; Frankenberg N, 2003, APPL MICROBIOL BIOT, V63, P115, DOI 10.1007/s00253-003-1432-2; Fredrickson JK, 2000, APPL ENVIRON MICROB, V66, P2006, DOI 10.1128/AEM.66.5.2006-2011.2000; Funayama T, 1999, MUTAT RES-DNA REPAIR, V435, P151, DOI 10.1016/S0921-8777(99)00044-0; Gacesa P, 1998, MICROBIOL-SGM, V144, P1133, DOI 10.1099/00221287-144-5-1133; Gallegos MT, 1997, MICROBIOL MOL BIOL R, V61, P393, DOI 10.1128/.61.4.393-410.1997; Galperin MY, 2006, MOL MICROBIOL, V59, P5, DOI 10.1111/j.1365-2958.2005.04950.x; Gao GJ, 2006, FEMS MICROBIOL LETT, V257, P195, DOI 10.1111/j.1574-6968.2006.00169.x; Gao GJ, 2007, SCI CHINA SER C, V50, P525, DOI 10.1007/s11427-007-0061-x; Gerard E, 2001, MOL GENET GENOMICS, V266, P72, DOI 10.1007/s004380100520; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Gerischer U, 2002, J MOL MICROB BIOTECH, V4, P111; Ghosal D, 2005, FEMS MICROBIOL REV, V29, P361, DOI 10.1016/j.fmrre.2004.12.007; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gupta RS, 1998, MICROBIOL MOL BIOL R, V62, P1435, DOI 10.1128/MMBR.62.4.1435-1491.1998; Gury J, 2004, APPL ENVIRON MICROB, V70, P2146, DOI 10.1128/AEM.70.4.2146-2153.2004; GUTMAN PD, 1994, GENE, V141, P31, DOI 10.1016/0378-1119(94)90124-4; GUTMAN PD, 1991, MUTAT RES, V254, P207, DOI 10.1016/0921-8777(91)90058-W; GUTMAN PD, 1993, J BACTERIOL, V175, P3581, DOI 10.1128/jb.175.11.3581-3590.1993; GUTMAN PD, 1994, MUTAT RES, V314, P87, DOI 10.1016/0921-8777(94)90064-7; HARBORNE NR, 1992, MOL MICROBIOL, V6, P2805, DOI 10.1111/j.1365-2958.1992.tb01460.x; Harris DR, 2004, PLOS BIOL, V2, P1629, DOI 10.1371/journal.pbio.0020304; Heinz K, 2007, J BIOL CHEM, V282, P10908, DOI 10.1074/jbc.M611404200; Hille R, 2002, TRENDS BIOCHEM SCI, V27, P360, DOI 10.1016/S0968-0004(02)02107-2; Hobman JL, 2005, BIOMETALS, V18, P429, DOI 10.1007/s10534-005-3717-7; Holland AD, 2006, APPL MICROBIOL BIOT, V72, P1074, DOI 10.1007/s00253-006-0399-1; Hou B, 2007, J RADIAT RES, V48, P57, DOI 10.1269/jrr.06067; Hua YJ, 2003, BIOCHEM BIOPH RES CO, V306, P354, DOI 10.1016/S0006-291X(03)00965-3; Huang Li-fen, 2006, Weishengwu Xuebao, V46, P205; Huang LF, 2007, DNA REPAIR, V6, P167, DOI 10.1016/j.dnarep.2006.09.006; Huillet E, 2006, FEMS MICROBIOL LETT, V254, P87, DOI 10.1111/j.1574-6968.2005.00014.x; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Iyer LM, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-8; JOBLING MG, 1988, GENE, V66, P245, DOI 10.1016/0378-1119(88)90361-7; Junemann S, 1997, BBA-BIOENERGETICS, V1321, P107, DOI 10.1016/S0005-2728(97)00046-7; Kannan K, 1998, FEMS MICROBIOL LETT, V161, P7, DOI 10.1016/S0378-1097(98)00043-3; Kemner KM, 2004, SCIENCE, V306, P686, DOI 10.1126/science.1103524; Kim JI, 2002, J BACTERIOL, V184, P1649, DOI 10.1128/JB.184.6.1649-1660.2002; Kimura H, 2003, APPL ENVIRON MICROB, V69, P644, DOI 10.1128/AEM.69.1.644-648.2003; Kitajima S, 1999, J BIOCHEM, V125, P1, DOI 10.1093/oxfordjournals.jbchem.a022244; Kitayama S, 1997, MUTAT RES-DNA REPAIR, V385, P151, DOI 10.1016/S0921-8777(97)00048-7; Kitayama S, 2000, MUTAT RES-DNA REPAIR, V461, P179, DOI 10.1016/S0921-8777(00)00044-6; Knofel T, 1999, NAT STRUCT BIOL, V6, P448; Kobayashi I, 2006, J BIOSCI BIOENG, V101, P315, DOI 10.1263/jbb.101.315; Kobayashi Yasuhiko, 2004, Biol Sci Space, V18, P134; Kolari M, 2003, J IND MICROBIOL BIOT, V30, P225, DOI 10.1007/s10295-003-0047-z; KOONIN EV, 2007, MOL SYST BI IN PRESS; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; LABIE C, 1989, J BACTERIOL, V171, P4315, DOI 10.1128/JB.171.8.4315-4319.1989; Lai WA, 2006, INT J SYST EVOL MICR, V56, P787, DOI 10.1099/ijs.0.64007-0; Lecointe F, 2004, MOL MICROBIOL, V53, P1721, DOI 10.1111/j.1365-2958.2004.04233.x; Levin-Zaidman S, 2003, SCIENCE, V299, P254, DOI 10.1126/science.1077865; Lin JY, 1999, SCIENCE, V285, P1558, DOI 10.1126/science.285.5433.1558; Lipton MS, 2002, P NATL ACAD SCI USA, V99, P11049, DOI 10.1073/pnas.172170199; LITTLE JW, 1981, P NATL ACAD SCI-BIOL, V78, P4199, DOI 10.1073/pnas.78.7.4199; Liu YQ, 2003, P NATL ACAD SCI USA, V100, P4191, DOI 10.1073/pnas.0630387100; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2000, GENETICA, V108, P25, DOI 10.1023/A:1004035424657; Makarova KS, 2005, NUCLEIC ACIDS RES, V33, P4626, DOI 10.1093/nar/gki775; Makarova KS, 1999, GENOME RES, V9, P608; Makarova KS, 2001, MICROBIOL MOL BIOL R, V65, P44, DOI 10.1128/MMBR.65.1.44-79.2001; Makarova KS, 1999, RES MICROBIOL, V150, P711, DOI 10.1016/S0923-2508(99)00121-7; Marchler-Bauer A, 2002, NUCLEIC ACIDS RES, V30, P281, DOI 10.1093/nar/30.1.281; Markillie LM, 1999, J BACTERIOL, V181, P666, DOI 10.1128/JB.181.2.666-669.1999; Marteinsson VT, 2001, APPL ENVIRON MICROB, V67, P4242, DOI 10.1128/AEM.67.9.4242-4248.2001; Mattimore V, 1996, J BACTERIOL, V178, P633, DOI 10.1128/jb.178.3.633-637.1996; Minton KW, 1996, MUTAT RES-DNA REPAIR, V363, P1, DOI 10.1016/0921-8777(95)00014-3; Mironov A. A., 2000, Molekulyarnaya Biologiya (Moscow), V34, P253; Mironov AA, 1999, NUCLEIC ACIDS RES, V27, P2981, DOI 10.1093/nar/27.14.2981; Miura S, 2000, APPL ENVIRON MICROB, V66, P4883, DOI 10.1128/AEM.66.11.4883-4889.2000; Mojica FJM, 2000, MOL MICROBIOL, V36, P244, DOI 10.1046/j.1365-2958.2000.01838.x; Molina-Henares AJ, 2006, FEMS MICROBIOL REV, V30, P157, DOI 10.1111/j.1574-6976.2005.00008.x; MOSELEY BEB, 1971, J BACTERIOL, V105, P976, DOI 10.1128/JB.105.3.976-983.1971; Nakamura K, 2003, FEBS LETT, V553, P239, DOI 10.1016/S0014-5793(03)01000-7; Narumi I, 2004, MOL MICROBIOL, V54, P278, DOI 10.1111/j.1365-2958.2004.04272.x; Narumi I, 2001, J BACTERIOL, V183, P6951, DOI 10.1128/JB.183.23.6951-6956.2001; Narumi I, 1999, MUTAT RES-DNA REPAIR, V435, P233, DOI 10.1016/S0921-8777(99)00048-8; Nurizzo D, 2003, J MOL BIOL, V327, P491, DOI 10.1016/S0022-2836(03)00121-9; Omelchenko MV, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-57; Pavlov AK, 2006, ASTROBIOLOGY, V6, P911, DOI 10.1089/ast.2006.6.911; Pennella MA, 2005, BIOMETALS, V18, P413, DOI 10.1007/s10534-005-3716-8; Pereira MM, 2001, BBA-BIOENERGETICS, V1505, P185, DOI 10.1016/S0005-2728(01)00169-4; Qiu XY, 2006, J BACTERIOL, V188, P1199, DOI 10.1128/JB.188.3.1199-1204.2006; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Saarimaa C, 2006, J BACTERIOL, V188, P7016, DOI 10.1128/JB.00608-06; Sandrini MPB, 2006, NUCLEOS NUCLEOT NUCL, V25, P1153, DOI 10.1080/15257770600894469; Satoh K, 2006, MICROBIOL-SGM, V152, P3217, DOI 10.1099/mic.0.29139-0; Schlesinger DJ, 2007, FEMS MICROBIOL LETT, V274, P342, DOI 10.1111/j.1574-6968.2007.00862.x; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; SETLOW JK, 1964, BIOCHIM BIOPHYS ACTA, V87, P664, DOI 10.1016/0926-6550(64)90284-1; Shallom D, 2003, CURR OPIN MICROBIOL, V6, P219, DOI 10.1016/S1369-5274(03)00056-0; Sheng DH, 2004, J BIOCHEM, V136, P787, DOI 10.1093/jb/mvh188; Singleton MR, 2002, P NATL ACAD SCI USA, V99, P13492, DOI 10.1073/pnas.212449899; Sorensen KI, 1996, J BACTERIOL, V178, P1003, DOI 10.1128/jb.178.4.1003-1011.1996; STERN S, 2007, MOL SYST BI IN PRESS; Tanaka M, 2004, GENETICS, V168, P21, DOI 10.1534/genetics.104.029249; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Touati E, 1996, MUTAT RES-FUND MOL M, V349, P193, DOI 10.1016/0027-5107(95)00178-6; UDUPA KS, 1994, J BACTERIOL, V176, P7439, DOI 10.1128/JB.176.24.7439-7446.1994; Vaisanen OM, 1998, J APPL MICROBIOL, V84, P1069; Venkateswaran A, 2000, APPL ENVIRON MICROB, V66, P2620, DOI 10.1128/AEM.66.6.2620-2626.2000; Von Sonntag C, 1987, CHEM BASIS RAD BIOL; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; Wolf YI, 2001, BMC EVOL BIOL, V1, DOI 10.1186/1471-2148-1-8; Wright EG, 2006, MUTAT RES-FUND MOL M, V597, P119, DOI 10.1016/j.mrfmmm.2005.03.035; Xi HL, 2000, J BACTERIOL, V182, P5332, DOI 10.1128/JB.182.19.5332-5341.2000; YASBIN RE, 1991, RES MICROBIOL, V142, P885, DOI 10.1016/0923-2508(91)90069-M; Yokoyama K, 2006, FEMS MICROBIOL REV, V30, P89, DOI 10.1111/j.1574-6976.2005.00005.x; Yun EJ, 2000, FEMS MICROBIOL LETT, V184, P155; Zahradka K, 2006, NATURE, V443, P569, DOI 10.1038/nature05160; Zhang YM, 2003, MOL MICROBIOL, V48, P1317, DOI 10.1046/j.1365-2958.2003.03486.x; Zimmerman JM, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-17; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	171	174	182	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e955	10.1371/journal.pone.0000955	http://dx.doi.org/10.1371/journal.pone.0000955			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895995	Green Submitted, gold, Green Published			2022-12-25	WOS:000207455800033
J	Girao, LC; Lopes, AV; Tabarelli, M; Bruna, EM				Girao, Luciana Coe; Lopes, Ariadna Valentina; Tabarelli, Marcelo; Bruna, Emilio M.			Changes in Tree Reproductive Traits Reduce Functional Diversity in a Fragmented Atlantic Forest Landscape	PLOS ONE			English	Article							RAIN-FOREST; HABITAT FRAGMENTATION; SEED DISPERSAL; POLLINATION; COMMUNITY; PATTERNS; EDGE; CONSERVATION; BIODIVERSITY; RECRUITMENT	Functional diversity has been postulated to be critical for the maintenance of ecosystem functioning, but the way it can be disrupted by human-related disturbances remains poorly investigated. Here we test the hypothesis that habitat fragmentation changes the relative contribution of tree species within categories of reproductive traits (frequency of traits) and reduces the functional diversity of tree assemblages. The study was carried out in an old and severely fragmented landscape of the Brazilian Atlantic forest. We used published information and field observations to obtain the frequency of tree species and individuals within 50 categories of reproductive traits (distributed in four major classes: pollination systems, floral biology, sexual systems, and reproductive systems) in 10 fragments and 10 tracts of forest interior (control plots). As hypothesized, populations in fragments and control plots differed substantially in the representation of the four major classes of reproductive traits (more than 50% of the categories investigated). The most conspicuous differences were the lack of three pollination systems in fragments-pollination by birds, flies and non-flying mammals-and that fragments had a higher frequency of both species and individuals pollinated by generalist vectors. Hermaphroditic species predominate in both habitats, although their relative abundances were higher in fragments. On the contrary, self-incompatible species were underrepresented in fragments. Moreover, fragments showed lower functional diversity (H' scores) for pollination systems (-30.3%), floral types (-23.6%), and floral sizes (-20.8%) in comparison to control plots. In contrast to the overwhelming effect of fragmentation, patch and landscape metrics such as patch size and forest cover played a minor role on the frequency of traits. Our results suggest that habitat fragmentation promotes a marked shift in the relative abundance of tree reproductive traits and greatly reduces the functional diversity of tree assemblages in fragmented landscapes.	[Girao, Luciana Coe] Univ Fed Pernambuco, Dept Bot, Programa Posgrad Biol Vegetal, Recife, PE, Brazil; [Bruna, Emilio M.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32611 USA	Universidade Federal de Pernambuco; State University System of Florida; University of Florida	Lopes, AV (corresponding author), Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32611 USA.	avflopes@ufpe.br	Bruna, Emilio M/H-2769-2012; Lopes, Ariadna V/E-8432-2010; Tabarelli, Marcelo/F-1088-2010	Bruna, Emilio M/0000-0003-3381-8477; Lopes, Ariadna V/0000-0001-5750-5913; Tabarelli, Marcelo/0000-0001-7573-7216	CAPES; CNPq; Fundacao O Boticario de Protecao a Natureza; Conservation International-Brazil	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao O Boticario de Protecao a Natureza; Conservation International-Brazil	Financial support was provided by CAPES (a Master's Thesis scholarship to L. Girao and a Research Grant to A. Lopes), CNPq ( Research Grants to A. Lopes and M. Tabarelli; and Research Funding via "Edital Universal''), Fundacao O Boticario de Protecao a Natureza, and Conservation International-Brazil.	Aguilar R, 2006, ECOL LETT, V9, P968, DOI 10.1111/j.1461-0248.2006.00927.x; AIZEN MA, 1994, ECOLOGY, V75, P330, DOI 10.2307/1939538; [Anonymous], 2004, MATA ATLANTICA ARVOR; BAWA KS, 1985, AM J BOT, V72, P346, DOI 10.2307/2443527; BAWA KS, 1990, ANNU REV ECOL SYST, V21, P399, DOI 10.1146/annurev.es.21.110190.002151; Bruna EM, 2002, CONSERV BIOL, V16, P1256, DOI 10.1046/j.1523-1739.2002.99494.x; Buchmann SL, 1996, FORGOTTEN POLLINATOR; Chambers JQ, 1998, NATURE, V391, P135, DOI 10.1038/34325; Chazdon RL, 2003, ECOL MONOGR, V73, P331, DOI 10.1890/02-4037; Chiarello AG, 1999, BIOL CONSERV, V89, P71, DOI 10.1016/S0006-3207(98)00130-X; Clark DB, 1998, J ECOL, V86, P101, DOI 10.1046/j.1365-2745.1998.00238.x; Clarke K.R., 2001, PRIMER V5 PLYMOUTH R, P91; COIMBRA F, 1996, LIMITES ORIGINAIS BI; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Cordeiro NJ, 2001, CONSERV BIOL, V15, P1733, DOI 10.1046/j.1523-1739.2001.99579.x; COSTA JBP, 2007, THESIS U FEDERAL PER; de Melo FPL, 2006, BIOL CONSERV, V132, P50, DOI 10.1016/j.biocon.2006.03.015; Endress P. K., 1994, DIVERSITY EVOLUTIONA; FAEGRI K, 1979, P244; Fontaine C, 2006, PLOS BIOL, V4, P129, DOI 10.1371/journal.pbio.0040001; Galetti M, 2006, BOT J LINN SOC, V151, P141, DOI 10.1111/j.1095-8339.2006.00529.x; Galindo-Leal C., 2005, MATA ATLANTICA BIOD, P3; Ghazoul J, 2005, BIOL REV, V80, P413, DOI 10.1017/S1464793105006731; Gorresen PM, 2004, J MAMMAL, V85, P688, DOI 10.1644/BWG-125; Grillo A, 2006, DIVERSIDADE BIOL CON, P191; GRILLO AS, 2005, THESIS U FEDERAL PER; Harper KA, 2005, CONSERV BIOL, V19, P768, DOI 10.1111/j.1523-1739.2005.00045.x; Harris L. Fabienne, 2004, International Journal of Tropical Insect Science, V24, P29; Hobbs RJ, 2003, AUST J BOT, V51, P471, DOI 10.1071/BT03037; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; IBGE, 1985, ATL NAC BRAS REG NOR; Jones MM, 2006, J ECOL, V94, P181, DOI 10.1111/j.1365-2745.2005.01071.x; Kang H, 2003, AM J BOT, V90, P865, DOI 10.3732/ajb.90.6.865; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; Kevan PG, 1999, AGR ECOSYST ENVIRON, V74, P373, DOI 10.1016/S0167-8809(99)00044-4; Krebs C.J., 1989, ECOLOGICAL METODOLOG; Laurance W. F., 2001, LESSONS AMAZONIA ECO, P158; Laurance WF, 1998, CONSERV BIOL, V12, P460, DOI 10.1046/j.1523-1739.1998.97175.x; Laurance WF, 2002, CONSERV BIOL, V16, P605, DOI 10.1046/j.1523-1739.2002.01025.x; Laurance WF, 2000, NATURE, V404, P836, DOI 10.1038/35009032; LAURANCE WF, 2006, EMERGING THREATS TRO; Laurance WF, 2006, P NATL ACAD SCI USA, V103, P19010, DOI 10.1073/pnas.0609048103; Laurance William F, 2006, Ecology, V87, P469, DOI 10.1890/05-0064; LOPES AV, 2006, DIVERSIDADE BIOL CON, P229; Melo FPL, 2007, ECOSCIENCE, V14, P124, DOI 10.2980/1195-6860(2007)14[124:EOLSFT]2.0.CO;2; Lorenzi H., 2002, ARVORES BRASILEIRAS, V1; Lorenzi H, 2002, ARVORES BRASILEIRAS, V2; Machado IC, 2004, ANN BOT-LONDON, V94, P365, DOI 10.1093/aob/mch152; MACHADO IC, 2002, DIAGNOSTICO BIODIVER, P583; Mason NWH, 2003, J VEG SCI, V14, P571, DOI 10.1111/j.1654-1103.2003.tb02184.x; Mayfield MM, 2005, ECOLOGY, V86, P2365, DOI 10.1890/05-0141; McCune B., 1999, MULTIVARIATE ANAL EC; Metzger JP, 2000, ECOL APPL, V10, P1147, DOI 10.1890/1051-0761(2000)010[1147:TFGRAL]2.0.CO;2; Michalski F, 2007, BIOTROPICA, V39, P691, DOI 10.1111/j.1744-7429.2007.00318.x; Murcia Carolina, 1996, P19; Oliveira MA, 2004, ORYX, V38, P389, DOI 10.1017/S0030605304000754; Oliveira PE, 2000, FLORA, V195, P311; Petchey OL, 2002, P ROY SOC B-BIOL SCI, V269, P1721, DOI 10.1098/rspb.2002.2073; Petchey OL, 2004, ECOLOGY, V85, P847, DOI 10.1890/03-0226; Pimentel DS, 2004, BIOTROPICA, V36, P74, DOI 10.1111/j.1744-7429.2004.tb00298.x; PORTO K, 2006, DIVERSIDADE BIOL CON; Prance G.T., 1982, BIOL DIVERSIFICATION, P137; Prieur-Richard AH, 2000, AUSTRAL ECOL, V25, P1; PRIMERS for Windows, 2001, PRIMER 5 WINDOWS; Proctor M., 1996, NATURAL HIST POLLINA; Ranta P, 1998, BIODIVERS CONSERV, V7, P385, DOI 10.1023/A:1008885813543; RATHCKE BJ, 1993, CURR SCI INDIA, V65, P273; Renner S.S., 1998, P339; Ribeiro J.E.L. da S., 1999, FLORA RESERVA DUCKE; Richards A. J., 1997; RICHARDS P. W., 1952, The tropical rain forest. An ecological study.; Ricotta C, 2005, BASIC APPL ECOL, V6, P479, DOI 10.1016/j.baae.2005.02.008; SANETO RJ, 2003, THESIS U FEDERAL PER, P29; SILVA JMC, 2000, NATURE, V404, P72, DOI DOI 10.1038/35003563; Sokal R. R., 2012, BIOMETRY; Tabarelli M, 1999, BIOL CONSERV, V91, P119, DOI 10.1016/S0006-3207(99)00085-3; Tabarelli M, 2004, BIODIVERS CONSERV, V13, P1419, DOI 10.1023/B:BIOC.0000019398.36045.1b; Tabarelli M, 2002, BIOL CONSERV, V106, P165, DOI 10.1016/S0006-3207(01)00243-9; ter Steege H, 2006, NATURE, V443, P444, DOI 10.1038/nature05134; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; The Angiosperm Phylogeny Group II, 2003, BOT J LINN SOC, V141, P399, DOI [DOI 10.1046/J.1095-8339.2003.T01-1-00158.X, 10.1046/j.1095-8339.2003.t01-1-00158.x]; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; TILMAN D, 1994, NATURE, V367, P363, DOI 10.1038/367363a0; Turner I.M., 2001, CAM TROP B, DOI 10.1017/CBO9780511542206; Vamosi JC, 2006, P NATL ACAD SCI USA, V103, P956, DOI 10.1073/pnas.0507165103; Veloso HP, 1991, CLASSIFICACAO VEGETA; Whitmore T.C, 1990, INTRO TROPICAL RAIN; Wilcock C, 2002, TRENDS PLANT SCI, V7, P270, DOI 10.1016/S1360-1385(02)02258-6; Wilkinson L, 1996, SYSTAT VERSION 6 0; WIRTH R, 2007, PROGR BOT, V69, P423	90	127	132	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2007	2	9							e908	10.1371/journal.pone.0000908	http://dx.doi.org/10.1371/journal.pone.0000908			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HS	17878943	Green Published, Green Submitted, gold			2022-12-25	WOS:000207455700016
J	Naguib, M; Nemitz, A				Naguib, Marc; Nemitz, Andrea			Living with the Past: Nutritional Stress in Juvenile Males Has Immediate Effects on their Plumage Ornaments and on Adult Attractiveness in Zebra Finches	PLOS ONE			English	Article							EARLY DEVELOPMENTAL STRESS; BROOD SIZE; MATE CHOICE; GREAT TITS; SONG; IMMUNOCOMPETENCE; REPRODUCTION; PHENOTYPE; SELECTION; SURVIVAL	The environmental conditions individuals experience during early development are well known to have fundamental effects on a variety of fitness-relevant traits. Although it is evident that the earliest developmental stages have large effects on fitness, other developmental stages, such as the period when secondary sexual characters develop, might also exert a profound effect on fitness components. Here we show experimentally in male zebra finches, Taeniopygia guttata, that nutritional conditions during this later period have immediate effects on male plumage ornaments and on their attractiveness as adults. Males that had received high quality food during the second month of life, a period when secondary sexual characteristics develop, were significantly more attractive as adults in mate choice tests than siblings supplied with standard food during this period. Preferred males that had experienced better nutritional conditions had larger orange cheek patches when nutritional treatments ended than did unpreferred males. Sexual plumage ornaments of young males thus are honest indicators of nutritional conditions during this period. The mate choice tests with adult birds indicate that nutritional conditions during the period of song learning, brain and gonad development, and moult into adult plumage have persisting effects on male attractiveness. This suggests that the developmental period following nutritional dependence from the parents is just as important in affecting adult attractiveness as are much earlier developmental periods. These findings thus contribute to understanding the origin and consequences of environmentally determined fitness components.	[Naguib, Marc; Nemitz, Andrea] Univ Bielefeld, Fac Biol, Bielefeld, Germany	University of Bielefeld	Naguib, M (corresponding author), Univ Bielefeld, Fac Biol, Bielefeld, Germany.	mnaguib@uni-bielefeld.de	Naguib, Marc/C-2650-2009	Naguib, Marc/0000-0003-0494-4888	German Science Foundation [NA335/6]	German Science Foundation(German Research Foundation (DFG))	The research was funded by the German Science Foundation NA335/6.	Andersson Malte, 1994; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Bottjer SW, 2002, J COMP PHYSIOL A, V188, P917, DOI 10.1007/s00359-002-0356-0; Brinkhof MWG, 1999, P ROY SOC B-BIOL SCI, V266, P2315, DOI 10.1098/rspb.1999.0925; Buchanan KL, 2003, P ROY SOC B-BIOL SCI, V270, P1149, DOI 10.1098/rspb.2003.2330; Catchpole C., 1995, BIRD SONG BIOL THEME; Charmantier A, 2006, TRENDS ECOL EVOL, V21, P417, DOI 10.1016/j.tree.2006.06.001; Cotton S, 2004, P ROY SOC B-BIOL SCI, V271, P771, DOI 10.1098/rspb.2004.2688; DeKogel CH, 1997, J ANIM ECOL, V66, P167; DeKogel CH, 1996, ANIM BEHAV, V51, P699, DOI 10.1006/anbe.1996.0073; Fisher MO, 2006, PLOS BIOL, V4, P1462, DOI 10.1371/journal.pbio.0040251; FORSTMEIER W, 2007, MOL ECOL IN PRESS; Gil D, 2004, J EXP BIOL, V207, P2215, DOI 10.1242/jeb.01013; Gil D, 2006, J NEUROBIOL, V66, P1602, DOI 10.1002/neu.20312; Griffith SC, 1999, NATURE, V400, P358, DOI 10.1038/22536; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P329, DOI 10.1016/j.neubiorev.2004.12.002; GUSTAFSSON L, 1988, NATURE, V335, P813, DOI 10.1038/335813a0; Hadfield JD, 2006, P ROY SOC B-BIOL SCI, V273, P1347, DOI 10.1098/rspb.2005.3459; Hill GE., 2006, BIRD COLOURATION, P507, DOI [10.4159/9780674273788, DOI 10.4159/9780674273788]; Hodes GE, 2005, HORM BEHAV, V48, P163, DOI 10.1016/j.yhbeh.2005.02.008; Jacot A, 2007, BEHAV ECOL, V18, P34, DOI 10.1093/beheco/arl054; Kaltiala-Heino R, 2003, SOC SCI MED, V57, P1055, DOI 10.1016/S0277-9536(02)00480-X; Leader N, 2006, ANIM BEHAV, V72, P113, DOI 10.1016/j.anbehav.2005.09.013; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Lummaa V, 2002, TRENDS ECOL EVOL, V17, P141, DOI 10.1016/S0169-5347(01)02414-4; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Naguib M, 2004, P ROY SOC B-BIOL SCI, V271, P833, DOI 10.1098/rspb.2003.2673; Naguib M, 2005, BIOL LETT-UK, V1, P95, DOI 10.1098/rsbl.2004.0277; Naguib M, 2006, P ROY SOC B-BIOL SCI, V273, P1901, DOI 10.1098/rspb.2006.3526; Nowicki S, 2002, J COMP PHYSIOL A, V188, P1003, DOI 10.1007/s00359-002-0361-3; Slater P.J.B., 1988, Advances in the Study of Behavior, V18, P1; SOSSINKA R, 1972, Journal fuer Ornithologie, V113, P29, DOI 10.1007/BF01647254; SOSSINKA R, 1980, J EXP ZOOL, V211, P225, DOI 10.1002/jez.1402110211; Spencer KA, 2005, BEHAV ECOL SOCIOBIOL, V58, P423, DOI 10.1007/s00265-005-0927-5; TINBERGEN JM, 1990, J ANIM ECOL, V59, P1113, DOI 10.2307/5035; Wells JCK, 2007, BIOL REV, V82, P143, DOI 10.1111/j.1469-185X.2006.00007.x; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3; ZANN R, 1994, IBIS, V136, P136, DOI 10.1111/j.1474-919X.1994.tb01077.x; Zann RA., 1996, ZEBRA FINCH SYNTHESI	39	53	54	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2007	2	9							e901	10.1371/journal.pone.0000901	http://dx.doi.org/10.1371/journal.pone.0000901			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HS	17878936	gold, Green Published, Green Submitted			2022-12-25	WOS:000207455700009
J	Weng, ZM; Barthelson, R; Gowda, S; Hilf, ME; Dawson, WO; Galbraith, DW; Xiong, ZG				Weng, Ziming; Barthelson, Roger; Gowda, Siddarame; Hilf, Mark E.; Dawson, William O.; Galbraith, David W.; Xiong, Zhongguo			Persistent Infection and Promiscuous Recombination of Multiple Genotypes of an RNA Virus within a Single Host Generate Extensive Diversity	PLOS ONE			English	Article								Recombination and reassortment of viral genomes are major processes contributing to the creation of new, emerging viruses. These processes are especially significant in long-term persistent infections where multiple viral genotypes co-replicate in a single host, generating abundant genotypic variants, some of which may possess novel host-colonizing and pathogenicity traits. In some plants, successive vegetative propagation of infected tissues and introduction of new genotypes of a virus by vector transmission allows for viral populations to increase in complexity for hundreds of years allowing co-replication and subsequent recombination of the multiple viral genotypes. Using a resequencing microarray, we examined a persistent infection by a Citrus tristeza virus (CTV) complex in citrus, a vegetatively propagated, globally important fruit crop, and found that the complex comprised three major and a number of minor genotypes. Subsequent deep sequencing analysis of the viral population confirmed the presence of the three major CTV genotypes and, in addition, revealed that the minor genotypes consisted of an extraordinarily large number of genetic variants generated by promiscuous recombination between the major genotypes. Further analysis provided evidence that some of the recombinants underwent subsequent divergence, further increasing the genotypic complexity. These data demonstrate that persistent infection of multiple viral genotypes within a host organism is sufficient to drive the large-scale production of viral genetic variants that may evolve into new and emerging viruses.	[Weng, Ziming; Barthelson, Roger; Galbraith, David W.; Xiong, Zhongguo] Univ Arizona, Dept Plant Sci, Tucson, AZ 85721 USA; [Gowda, Siddarame; Dawson, William O.] Univ Florida, Ctr Citrus Res & Educ, Lake Alfred, FL USA; [Hilf, Mark E.] ARS, USDA, US Hort Res Lab, Ft Pierce, FL USA	University of Arizona; State University System of Florida; University of Florida; United States Department of Agriculture (USDA)	Xiong, ZG (corresponding author), Univ Arizona, Dept Plant Sci, Tucson, AZ 85721 USA.	zxiong@email.arizona.edu	Galbraith, David/AAG-8891-2021	Xiong, Zhongguo/0000-0002-2999-0840	USDA [2003-34399-13764, 2005-34399-16070]	USDA(United States Department of Agriculture (USDA))	This work was supported by funding from USDA grants 2003-34399-13764 and 2005-34399-16070 to ZX and DWG.	Albiach-Marti MR, 2000, J VIROL, V74, P6856, DOI 10.1128/JVI.74.15.6856-6865.2000; BARJOSEPH M, 1989, ANNU REV PHYTOPATHOL, V27, P291, DOI 10.1146/annurev.py.27.090189.001451; Chare ER, 2006, ARCH VIROL, V151, P933, DOI 10.1007/s00705-005-0675-x; Cheng CP, 2005, VIROLOGY, V341, P107, DOI 10.1016/j.virol.2005.06.042; Cheng CP, 2003, J VIROL, V77, P12033, DOI 10.1128/JVI.77.22.12033-12047.2003; Cutler DJ, 2001, GENOME RES, V11, P1913, DOI 10.1101/gr.197201; Dzianott A, 2001, VIROLOGY, V289, P137, DOI 10.1006/viro.2001.1118; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Gibbs MJ, 1999, P NATL ACAD SCI USA, V96, P8022, DOI 10.1073/pnas.96.14.8022; Gibbs MJ, 2001, SCIENCE, V293, P1842, DOI 10.1126/science.1061662; Gowda S, 2000, VIROLOGY, V274, P246, DOI 10.1006/viro.2000.0413; Hilf ME, 2005, PHYTOPATHOLOGY, V95, P909, DOI 10.1094/PHYTO-95-0909; HILF ME, 1995, VIROLOGY, V208, P576, DOI 10.1006/viro.1995.1188; Holmes EC, 2005, PLOS BIOL, V3, P1579, DOI 10.1371/journal.pbio.0030300; KARASEV AV, 1995, VIROLOGY, V208, P511, DOI 10.1006/viro.1995.1182; Karasev AV, 1997, J VIROL, V71, P6233, DOI 10.1128/JVI.71.8.6233-6236.1997; Karasev AV, 2000, ANNU REV PHYTOPATHOL, V38, P293, DOI 10.1146/annurev.phyto.38.1.293; Kim MJ, 2001, P NATL ACAD SCI USA, V98, P4972, DOI 10.1073/pnas.081077198; Kong P, 2000, VIRUS GENES, V21, P139, DOI 10.1023/A:1008198311398; LAI MMC, 1992, MICROBIOL REV, V56, P61, DOI 10.1128/MMBR.56.1.61-79.1992; Lin BC, 2007, J CLIN MICROBIOL, V45, P443, DOI 10.1128/JCM.01870-06; Lin BC, 2006, GENOME RES, V16, P527, DOI 10.1101/gr.4337206; Lopez C, 1998, PHYTOPATHOLOGY, V88, P685, DOI 10.1094/PHYTO.1998.88.7.685; Lu R, 2004, P NATL ACAD SCI USA, V101, P15742, DOI 10.1073/pnas.0404940101; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Mawassi M, 1996, J GEN VIROL, V77, P2359, DOI 10.1099/0022-1317-77-9-2359; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pernas M, 2006, JAIDS-J ACQ IMM DEF, V42, P12, DOI 10.1097/01.qai.0000214810.65292.73; ROCHAPENA MA, 1995, PLANT DIS, V79, P437, DOI 10.1094/PD-79-0437; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roy A, 2004, ARCH VIROL, V149, P1911, DOI 10.1007/s00705-004-0355-2; Rubio L, 2001, J VIROL, V75, P8054, DOI 10.1128/JVI.75.17.8054-8062.2001; Ruiz-Ruiz S, 2006, ARCH VIROL, V151, P387, DOI 10.1007/s00705-005-0618-6; Satyanarayana T, 2004, P NATL ACAD SCI USA, V101, P799, DOI 10.1073/pnas.0307747100; Satyanarayana T, 2002, J VIROL, V76, P473, DOI 10.1128/JVI.76.2.473-483.2002; Satyanarayana T, 1999, P NATL ACAD SCI USA, V96, P7433, DOI 10.1073/pnas.96.13.7433; Shapka N, 2004, J VIROL, V78, P2288, DOI 10.1128/JVI.78.5.2288-2300.2004; Sulaiman IM, 2007, J CLIN MICROBIOL, V45, P358, DOI 10.1128/JCM.01848-06; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vives MC, 2005, VIROLOGY, V331, P232, DOI 10.1016/j.virol.2004.10.037; Vives MC, 1999, J GEN VIROL, V80, P811, DOI 10.1099/0022-1317-80-3-811; Wang Z, 2006, EMERG INFECT DIS, V12, P638, DOI 10.3201/eid1204.051441; Wong CW, 2004, GENOME RES, V14, P398, DOI 10.1101/gr.2141004; XIONG Z, 2006, P INT ORG CITRUS VIR, V16, P11; Yang GA, 1999, VIRUS GENES, V19, P5, DOI 10.1023/A:1008105004407; Yang ZN, 1999, VIRUS GENES, V19, P131, DOI 10.1023/A:1008127224147; Yu W, 2006, BIOTECHNIQUES, V40, P499, DOI 10.2144/000112124; Zwick ME, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r10	49	46	51	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2007	2	9							e917	10.1371/journal.pone.0000917	http://dx.doi.org/10.1371/journal.pone.0000917			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HS	17878952	Green Published, Green Submitted, gold			2022-12-25	WOS:000207455700025
J	Kadaja-Saarepuu, L; Laos, S; Jaeaeger, K; Viil, J; Balikova, A; Looke, M; Hansson, GC; Maimets, T				Kadaja-Saarepuu, L.; Laos, S.; Jaeaeger, K.; Viil, J.; Balikova, A.; Looke, M.; Hansson, G. C.; Maimets, T.			CD43 promotes cell growth and helps to evade FAS-mediated apoptosis in non-hematopoietic cancer cells lacking the tumor suppressors p53 or ARF	ONCOGENE			English	Article						leukosialin; sialophorin; FAS; colony formation; epithelial cell	NF-KAPPA-B; LYMPHOCYTE SURFACE SIALOGLYCOPROTEIN; ANTIBODY RECOGNIZING CD43; WISKOTT-ALDRICH SYNDROME; MONOCLONAL-ANTIBODY; COLON-CANCER; SIGNALING PATHWAYS; BETA-CATENIN; TF-1 CELLS; STEM-CELLS	CD43 is a highly glycosylated transmembrane protein expressed on the surface of most hematopoietic cells. Expression of CD43 has also been demonstrated in many human tumor tissues, including colon adenomas and carcinomas, but not in normal colon epithelium. The potential contribution of CD43 to tumor development is still not understood. Here, we show that overexpression of CD43 increases cell growth and colony formation in mouse and human cells lacking expression of either p53 or ARF (alternative reading frame) tumor-suppressor proteins. In addition, CD43 overexpression also lowers the detection of the FAS death receptor on the cell surface of human cancer cells, and thereby helps to evade FAS-mediated apoptosis. However, when both p53 and ARF proteins are present, CD43 overexpression activates p53 and suppresses colony formation due to induction of apoptosis. These observations suggest CD43 as a potential contributor to tumor development and the functional ARF-p53 pathway is required for the elimination of cells with aberrant CD43 expression.	[Kadaja-Saarepuu, L.; Jaeaeger, K.; Viil, J.; Balikova, A.; Looke, M.; Maimets, T.] Univ Tartu, Inst Mol & Cell Biol, Dept Cell Biol, EE-51010 Tartu, Estonia; [Laos, S.; Hansson, G. C.] Gothenburg Univ, Dept Med Biochem, Gothenburg, Sweden	University of Tartu; University of Gothenburg	Kadaja-Saarepuu, L (corresponding author), Univ Tartu, Inst Mol & Cell Biol, Dept Cell Biol, 23 Riia St, EE-51010 Tartu, Estonia.	lkadaja@ebc.ee	Hansson, Gunnar C./AAF-7324-2019; Hansson, Gunnar C/A-1236-2009; Maimets, Toivo/E-9268-2017; Jaager, Kersti/G-2786-2017	Hansson, Gunnar C./0000-0002-1900-1869; Hansson, Gunnar C/0000-0002-1900-1869; Maimets, Toivo/0000-0001-6461-3365; Jaager, Kersti/0000-0002-0503-9292				ABARZUA P, 1995, CANCER RES, V55, P3490; Andersson CX, 2004, BIOCHEM BIOPH RES CO, V316, P12, DOI 10.1016/j.bbrc.2004.02.011; ARDMAN B, 1992, P NATL ACAD SCI USA, V89, P5001, DOI 10.1073/pnas.89.11.5001; BAECKSTROM D, 1995, J BIOL CHEM, V270, P13688, DOI 10.1074/jbc.270.23.13688; Bazil V, 1996, BLOOD, V87, P1272, DOI 10.1182/blood.V87.4.1272.bloodjournal8741272; Bazil V, 1997, STEM CELLS, V15, P13, DOI 10.1002/stem.5530150804; BAZIL V, 1997, STEM CELLS, V15, P18; Brown TJ, 1996, J BIOL CHEM, V271, P27686, DOI 10.1074/jbc.271.44.27686; CARLSSON SR, 1986, J BIOL CHEM, V261, P2779; Cermak L, 2002, J BIOL CHEM, V277, P7955, DOI 10.1074/jbc.M108048200; Deng JO, 2002, CANCER CELL, V2, P323, DOI 10.1016/S1535-6108(02)00154-X; DRAGONE LL, 1995, P NATL ACAD SCI USA, V92, P626, DOI 10.1073/pnas.92.2.626; Esteller M, 2000, CANCER RES, V60, P129; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fernandez-Rodriguez J, 2002, TUMOR BIOL, V23, P193, DOI 10.1159/000067252; He YW, 1999, J EXP MED, V190, P1903, DOI 10.1084/jem.190.12.1903; Hewitt RE, 2000, J PATHOL, V192, P446; Ivanov VN, 2003, MOL CELL BIOL, V23, P3623, DOI 10.1128/MCB.23.10.3623-3635.2003; Kadaja L, 2004, ONCOGENE, V23, P2523, DOI 10.1038/sj.onc.1207359; Kyoizumi S, 2004, J IMMUNOL, V172, P7246, DOI 10.4049/jimmunol.172.12.7246; Laos S, 2006, INT J ONCOL, V28, P695; Layseca-Espinosa E, 2003, J LEUKOCYTE BIOL, V74, P1083, DOI 10.1189/jlb.0303095; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Mattioli I, 2004, BLOOD, V104, P3302, DOI 10.1182/blood-2004-04-1536; MAZARS R, 1991, ONCOGENE, V6, P1685; Misawa Y, 1996, EUR J IMMUNOL, V26, P2573, DOI 10.1002/eji.1830261106; Miura Y, 2001, BIOCHEM BIOPH RES CO, V288, P80, DOI 10.1006/bbrc.2001.5729; MOLLER P, 1994, INT J CANCER, V57, P371, DOI 10.1002/ijc.2910570314; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; O'Connell J, 2000, ANN NY ACAD SCI, V910, P178; Onami TM, 2002, J IMMUNOL, V168, P6022, DOI 10.4049/jimmunol.168.12.6022; Ostberg JR, 1998, IMMUNOL TODAY, V19, P546, DOI 10.1016/S0167-5699(98)01343-7; Ouaaz F, 1999, J EXP MED, V189, P999, DOI 10.1084/jem.189.6.999; PALLANT A, 1989, P NATL ACAD SCI USA, V86, P1328, DOI 10.1073/pnas.86.4.1328; Pimenidou A, 2004, ONCOL REP, V11, P327; REMOLDODONNELL E, 1984, J EXP MED, V159, P1705, DOI 10.1084/jem.159.6.1705; RODRIGUES NR, 1990, P NATL ACAD SCI USA, V87, P7555, DOI 10.1073/pnas.87.19.7555; Santamaria M, 1996, CANCER RES, V56, P3526; Santana MA, 2000, J BIOL CHEM, V275, P31460, DOI 10.1074/jbc.M005231200; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; SHELLEY CS, 1989, P NATL ACAD SCI USA, V86, P2819, DOI 10.1073/pnas.86.8.2819; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; Sikut R, 1999, INT J CANCER, V82, P52, DOI 10.1002/(SICI)1097-0215(19990702)82:1<52::AID-IJC10>3.0.CO;2-C; Sikut R, 1997, BIOCHEM BIOPH RES CO, V238, P612, DOI 10.1006/bbrc.1997.7334; von Reyher U, 1998, CANCER RES, V58, P526; Woodman RC, 1998, J EXP MED, V188, P2181, DOI 10.1084/jem.188.11.2181; Zhang K, 1997, CELL IMMUNOL, V176, P158, DOI 10.1006/cimm.1997.1085; Zheng Y, 2001, J IMMUNOL, V166, P4949, DOI 10.4049/jimmunol.166.8.4949; Ziprin P, 2004, BIOL CHEM, V385, P755, DOI 10.1515/BC.2004.092	51	17	20	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 13	2008	27	12					1705	1715		10.1038/sj.onc.1210802	http://dx.doi.org/10.1038/sj.onc.1210802			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	273WF	17891181				2022-12-25	WOS:000253962100006
J	Song, WL; Lawson, JA; Reilly, D; Rokach, J; Chang, CT; Giasson, B; FitzGerald, GA				Song, Wen-Liang; Lawson, John A.; Reilly, Dermot; Rokach, Joshua; Chang, Chih-Tsung; Giasson, Benoit; FitzGerald, Garret A.			Neurofurans, novel indices of oxidant stress derived from docosahexaenoic acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-3 FATTY-ACIDS; LIPID-PEROXIDATION; FISH-OIL; IN-VIVO; EICOSAPENTAENOIC ACID; ALZHEIMERS-DISEASE; DOUBLE-BLIND; F-2-ISOPROSTANES; BRAIN; ISOPROSTANES	Isoeicosanoids are free radical-catalyzed isomers of the enzymatic products of arachidonic acid. They are formed in situ in cell membranes, are cleaved, circulate, and are excreted in urine. Isomers of prostaglandin F-2 alpha, the F-2-isoprostanes, have emerged as sensitive indices of lipid peroxidation in vivo. Analogous compounds formed from docosahexaenoic acid (DHA) are termed neuroprostanes and are more abundant than isoprostanes (iPs) in brain. Isofurans are another class of isoeicosanoids characterized by a substituted tetrahydrofuran ring. They are preferentially formed, relative to iPs, under conditions of elevated oxygen tension. Here, we report the discovery of neurofurans (nFs), the analogous family of compounds formed from DHA. Formation of nFs is characterized by mass spectrometry and confirmed by oxidation of DHA in vitro and following CCl4 administration in liver in vivo. It is demonstrated that the levels of nFs are elevated in the brain cortex of a mouse model of Alzheimer disease and are depressed in mouse brain cortex by deletion of p47(phox), an essential component of the phagocyte NADPH oxidase. Measurement of the nFs may ultimately prove useful in diagnosis, timing, and selection of dose in the treatment and chemoprevention of neurodegenerative disease.	[Song, Wen-Liang; Lawson, John A.; Reilly, Dermot; FitzGerald, Garret A.] Univ Penn, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA; [Song, Wen-Liang; Lawson, John A.; Reilly, Dermot; Giasson, Benoit; FitzGerald, Garret A.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; [Rokach, Joshua; Chang, Chih-Tsung] Florida Inst Technol, Claude Pepper Inst, Dept Chem, Melbourne, FL 32901 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Florida Institute of Technology	FitzGerald, GA (corresponding author), Univ Penn, Sch Med, 153 Johnson Pavilion, Philadelphia, PA 19104 USA.	garret@spirit.gcrc.upenn.edu	FitzGerald, Garret A/A-4222-2010	Song, Wenliang/0000-0002-1866-0635; Rokach, Joshu/0000-0003-1814-7505	NHLBI NIH HHS [HL 81873, HL 62250] Funding Source: Medline; NINDS NIH HHS [P50 NS053488, P50 NS053488-01A20004] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL062250, R01HL081873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS053488] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Appleton KM, 2006, AM J CLIN NUTR, V84, P1308, DOI 10.1093/ajcn/84.6.1308; Birch EE, 2007, EARLY HUM DEV, V83, P279, DOI 10.1016/j.earlhumdev.2006.11.003; Brouwer IA, 2006, JAMA-J AM MED ASSOC, V295, P2613, DOI 10.1001/jama.295.22.2613; Brunton S, 2007, CURR MED RES OPIN, V23, P1139, DOI 10.1185/030079907X188017; Erkkila AT, 2006, J LIPID RES, V47, P2814, DOI 10.1194/jlr.P600005-JLR200; Fessel JP, 2003, J NEUROCHEM, V85, P645, DOI 10.1046/j.1471-4159.2003.01709.x; Fessel JP, 2002, P NATL ACAD SCI USA, V99, P16713, DOI 10.1073/pnas.252649099; Flood DG, 2002, NEUROBIOL AGING, V23, P335, DOI 10.1016/S0197-4580(01)00330-X; Freund-Levi Y, 2006, ARCH NEUROL-CHICAGO, V63, P1402, DOI 10.1001/archneur.63.10.1402; Hogyes E, 2003, NEUROSCIENCE, V119, P999, DOI 10.1016/S0306-4522(03)00198-2; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Kadiiska MB, 2005, FREE RADICAL BIO MED, V38, P711, DOI 10.1016/j.freeradbiomed.2004.10.024; KNAPP HR, 1986, NEW ENGL J MED, V314, P937, DOI 10.1056/NEJM198604103141501; KNAPP HR, 1989, NEW ENGL J MED, V320, P1037, DOI 10.1056/NEJM198904203201603; Lavigne MC, 2001, FASEB J, V15, P285; Lawson JA, 1999, J BIOL CHEM, V274, P24441, DOI 10.1074/jbc.274.35.24441; Makrides M, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003402.pub2; Montine KS, 2004, CHEM PHYS LIPIDS, V128, P117, DOI 10.1016/j.chemphyslip.2003.10.010; Montine TJ, 2002, ANN NEUROL, V52, P175, DOI 10.1002/ana.10272; Montine TJ, 1999, NEUROLOGY, V52, P562, DOI 10.1212/WNL.52.3.562; MOORE SA, 1991, J NEUROCHEM, V56, P518, DOI 10.1111/j.1471-4159.1991.tb08180.x; Mori Trevor A, 2004, Curr Atheroscler Rep, V6, P461, DOI 10.1007/s11883-004-0087-5; MORROW JD, 1992, P NATL ACAD SCI USA, V89, P10721, DOI 10.1073/pnas.89.22.10721; Murphy KJ, 2007, BRIT J NUTR, V97, P749, DOI 10.1017/S000711450747252X; Nourooz-Zadeh J, 1999, J NEUROCHEM, V72, P734, DOI 10.1046/j.1471-4159.1999.0720734.x; PHILLIPSON BE, 1985, NEW ENGL J MED, V312, P1210, DOI 10.1056/NEJM198505093121902; Pratico D, 1997, J CLIN INVEST, V100, P2028, DOI 10.1172/JCI119735; Pratico D, 1997, J CLIN INVEST, V100, P2637; Pratico D, 1998, FASEB J, V12, P1777, DOI 10.1096/fasebj.12.15.1777; Reich EE, 2001, AM J PATHOL, V158, P293, DOI 10.1016/S0002-9440(10)63968-5; Roberts LJ, 1998, J BIOL CHEM, V273, P13605, DOI 10.1074/jbc.273.22.13605; Schmidt EB, 2000, PUBLIC HEALTH NUTR, V3, P91, DOI 10.1017/S1368980000000112; Shaw LM, 2007, NAT REV DRUG DISCOV, V6, P295, DOI 10.1038/nrd2176; SKINNER ER, 1993, BRAIN, V116, P717, DOI 10.1093/brain/116.3.717; SODERBERG M, 1991, LIPIDS, V26, P421, DOI 10.1007/BF02536067; Wada M, 2007, J BIOL CHEM, V282, P22254, DOI 10.1074/jbc.M703169200; Wang CC, 2006, AM J CLIN NUTR, V84, P5, DOI 10.1093/ajcn/84.1.5; Xiao Y, 2006, BIOMED ENVIRON SCI, V19, P474; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3	39	67	68	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					6	16		10.1074/jbc.M706124200	http://dx.doi.org/10.1074/jbc.M706124200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17921521	hybrid			2022-12-25	WOS:000251940300003
J	Gunzburg, MJ; Perugini, MA; Howlett, GJ				Gunzburg, Menachem J.; Perugini, Matthew A.; Howlett, Geoffrey J.			Structural basis for the recognition and cross-linking of amyloid fibrils by human apolipoprotein E	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEDIMENTATION-VELOCITY ANALYSIS; RECEPTOR-BINDING DOMAIN; PROTEIN-PROTEIN DOCKING; ALZHEIMERS-DISEASE; SELF-ASSOCIATION; TERMINAL DOMAIN; AQUEOUS-SOLUTION; BETA-PEPTIDE; MOUSE MODEL; C-II	Apolipoprotein (apo) E is a well characterized lipid-binding protein in plasma that also exists as a common nonfibrillar component of both cerebral and systemic amyloid deposits. A genetic link between a common isoform of apoE, apoE4, and the incidence of late onset Alzheimer disease has drawn considerable attention to the potential roles of apoE in amyloid-related disease. We examined the interactions of apoE with amyloid fibrils composed of apoC-II and the amyloid-beta (A beta) peptide. Aggregates of apoE with A beta and apoC-II are found in Alzheimer and atherosclerotic plaques, respectively. Sedimentation velocity and fibril size distribution analysis showed that apoE3 and E4 isoforms bind and noncovalently cross-link apoC-II fibrils in a similar manner. This ability to cross-link apoC-II fibrils was abolished by the dissociation of the apoE tetramer to monomers or by thrombin cleavage to yield separate N- and C-terminal domains. Preparative ultracentrifuge binding studies indicated that apoE and the isolated N- and C-terminal domains of apoE bind with submicromolar affinities to both apoC-II and A beta fibrils. Fluorescence quenching and resonance energy transfer experiments confirmed that both domains of apoE interact with apoC-II fibrils and demonstrated that the binding of the isolated N-terminal domain of apoE to apoC-II or A beta fibrils is accompanied by a significant conformational change with helix three of the domain moving relative to helix one. We propose a model involving the interaction of apoE with patterns of aligned residues that could explain the general ability of apoE to bind to a diverse range of amyloid fibrils.	Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; Univ Melbourne, Bio Mol Sci & Biotechnol Inst 21, Parkville, Vic 3010, Australia	University of Melbourne; University of Melbourne	Howlett, GJ (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, 30 Flemington Rd, Parkville, Vic 3010, Australia.	ghowlett@unimelb.edu.au		Perugini, Matthew/0000-0001-8052-5584				AGGERBECK LP, 1988, J BIOL CHEM, V263, P6249; Breslow JL, 1996, SCIENCE, V272, P685, DOI 10.1126/science.272.5262.685; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Chen R, 2003, PROTEINS, V51, P397, DOI 10.1002/prot.10334; Chou CY, 2006, J BIOL CHEM, V281, P13333, DOI 10.1074/jbc.M511077200; Comeau SR, 2005, PROTEINS, V60, P239, DOI 10.1002/prot.20564; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; CORDER EH, 1993, SCIENCE, V261, P9921; De Meyer GRY, 2002, CIRC RES, V90, P1197, DOI 10.1161/01.RES.0000020017.84398.61; DELANO WL, 2002, PYMOL USERS MANUAL V; Fadika GO, 2002, AMYLOID, V9, P75, DOI 10.3109/13506120208995239; Findeis MA, 1999, BIOCHEMISTRY-US, V38, P6791, DOI 10.1021/bi982824n; Fisher CA, 1999, J LIPID RES, V40, P93; Harris FM, 2003, P NATL ACAD SCI USA, V100, P10966, DOI 10.1073/pnas.1434398100; Hatters DM, 2006, J MOL BIOL, V361, P932, DOI 10.1016/j.jmb.2006.06.080; Hatters DM, 2005, J BIOL CHEM, V280, P26477, DOI 10.1074/jbc.M503910200; Hatters DM, 2003, BIOPHYS J, V85, P3979, DOI 10.1016/S0006-3495(03)74812-7; Hatters DM, 2002, EUR BIOPHYS J BIOPHY, V31, P2, DOI 10.1007/s002490100172; Hatters DM, 2000, BIOCHEMISTRY-US, V39, P8276, DOI 10.1021/bi000002w; Hatters DM, 2005, J BIOL CHEM, V280, P34288, DOI 10.1074/jbc.M506044200; Holtzman DM, 1999, J CLIN INVEST, V103, pR15, DOI 10.1172/JCI6179; Holtzman DM, 2000, P NATL ACAD SCI USA, V97, P2892, DOI 10.1073/pnas.050004797; Howlett GJ, 2006, CURR OPIN LIPIDOL, V17, P541, DOI 10.1097/01.mol.0000245260.63505.4f; Hrncic R, 2000, AM J PATHOL, V157, P1239, DOI 10.1016/S0002-9440(10)64639-1; Huang YD, 2004, J MOL NEUROSCI, V23, P189, DOI 10.1385/JMN:23:3:189; HUDSON EN, 1973, BIOCHEMISTRY-US, V12, P4154, DOI 10.1021/bi00745a019; INNERARITY TL, 1983, J BIOL CHEM, V258, P2341; Kisilevsky R, 2000, AMYLOID, V7, P23, DOI 10.3109/13506120009146820; Lakowicz J R, 1999, PRINCIPLES FLUORESCE, P367, DOI 10.1007/978-1-4757-3061-6; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; LeVine H, 2000, AMYLOID, V7, P83, DOI 10.3109/13506120009146243; Lu B, 2000, J BIOL CHEM, V275, P20775, DOI 10.1074/jbc.M003508200; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; MacRaild CA, 2004, J BIOL CHEM, V279, P21038, DOI 10.1074/jbc.M314008200; MacRaild CA, 2003, BIOPHYS J, V84, P2562, DOI 10.1016/S0006-3495(03)75061-9; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; Medeiros LA, 2004, J BIOL CHEM, V279, P10643, DOI 10.1074/jbc.M311735200; Mok YF, 2006, METHOD ENZYMOL, V413, P199, DOI 10.1016/S0076-6879(06)13011-6; Morrow JA, 1999, PROTEIN EXPRES PURIF, V16, P224, DOI 10.1006/prep.1999.1069; Mucchiano GI, 2001, J PATHOL, V193, P270, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH753>3.0.CO;2-S; Mucchiano GI, 2001, AM J CLIN PATHOL, V115, P298; NAMBA Y, 1991, BRAIN RES, V541, P163, DOI 10.1016/0006-8993(91)91092-F; Narayanaswami V, 2001, J BIOL CHEM, V276, P37853; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pepys MB, 1997, AMYLOID, V4, P274, DOI 10.3109/13506129709003838; Perugini MA, 2000, J BIOL CHEM, V275, P36758, DOI 10.1074/jbc.M005565200; Peters-Libeu CA, 2006, J BIOL CHEM, V281, P1073, DOI 10.1074/jbc.M510851200; Peters-Libeu CA, 2007, J LIPID RES, V48, P1035, DOI 10.1194/jlr.M600545-JLR200; Ritter C, 2005, NATURE, V435, P844, DOI 10.1038/nature03793; Rocken C, 2006, ARTERIOSCL THROM VAS, V26, P676, DOI 10.1161/01.ATV.0000201930.10103.be; Saito H, 2001, J BIOL CHEM, V276, P40949, DOI 10.1074/jbc.M106337200; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221; Stewart CR, 2007, J LIPID RES, V48, P2162, DOI 10.1194/jlr.M700098-JLR200; Stratman NC, 2005, CHEM PHYS LIPIDS, V137, P52, DOI 10.1016/j.chemphyslip.2005.06.005; Tedgui A, 2002, CIRC RES, V90, P1145, DOI 10.1161/01.RES.0000023048.87638.92; VOLLMER E, 1991, VIRCHOWS ARCH A, V419, P79, DOI 10.1007/BF01600220; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; WESTERLUND JA, 1993, J BIOL CHEM, V268, P15745; WETTERAU JR, 1988, J BIOL CHEM, V263, P6240; WILSON C, 1991, SCIENCE, V252, P1817, DOI 10.1126/science.2063194; WISNIEWSKI T, 1992, NEUROSCI LETT, V135, P235, DOI 10.1016/0304-3940(92)90444-C; Yamaguchi I, 2001, BIOCHEMISTRY-US, V40, P8499, DOI 10.1021/bi0027128	68	20	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35831	35841		10.1074/jbc.M706425200	http://dx.doi.org/10.1074/jbc.M706425200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17916554	hybrid			2022-12-25	WOS:000251458100045
J	Odat, O; Matta, S; Khalil, H; Kampranis, SC; Pfau, R; Tsichlis, PN; Makris, AM				Odat, Osama; Matta, Samer; Khalil, Hadi; Kampranis, Sotirios C.; Pfau, Raymond; Tsichlis, Philip N.; Makris, Antonios M.			Old yellow enzymes, highly homologous FMN oxidoreductases with modulating roles in oxidative stress and programmed cell death in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETRACTED ARTICLE. SEE; SACCHAROMYCES-CEREVISIAE; ACTIN CYTOSKELETON; REGULATES APOPTOSIS; PROTEIN COMPLEXES; BAX LETHALITY; MITOCHONDRIAL; GLUTATHIONE; SUPPRESSES; EXPRESSION	In a genetic screen to identify modifiers of Bax-dependent lethality in yeast, the C terminus of OYE2 was isolated based on its capacity to restore sensitivity to a Bax-resistant yeast mutant strain. Overexpression of full-length OYE2 suppresses Bax lethality in yeast, lowers endogenous reactive oxygen species (ROS), increases resistance to H2O2-induced programmed cell death (PCD), and significantly lowers ROS levels generated by organic prooxidants. Reciprocally, Delta oye2 yeast strains are sensitive to prooxidant-induced PCD. Overexpression and knock-out analysis indicate these OYE2 antioxidant activities are opposed by OYE3, a highly homologous heterodimerizing protein, which functions as a prooxidant promoting H2O2-induced PCD in wild type yeast. To exert its effect OYE3 requires the presence of OYE2. Deletion of the 12 C-terminal amino acids and catalytic inactivation of OYE2 by a Y197F mutation enhance significantly survival upon H2O2-induced PCD in wild type cells, but accelerate PCD in Delta oye3 cells, implicating the oye2p-oye3p heterodimer for promoting cell death upon oxidative stress. Unexpectedly, a strain with a double knock-out of these genes (Delta oye2oye3) is highly resistant to H2O2-induced PCD, exhibits increased respiratory capacity, and undergoes less cell death during the adaptive response in chronological aging. Simultaneous deletion of OYE2 and other antioxidant genes hyperinduces endogenous levels of ROS, promoting H2O2-induced cell death: in Delta oye2glr1 yeast high levels of oxidized glutathione elicited gross morphological aberrations involving the actin cytoskeleton and defects in organelle partitioning. Altering the ratio of reduced to oxidized glutathione by exogenous addition of GSH fully reversed these alterations. Based on this work, OYE proteins are firmly placed in the signaling network connecting ROS generation, PCD modulation, and cytoskeletal dynamics in yeast.	Mediterranean Agron Inst Chania, Dept Nat Prod, Khania 73100, Greece; Tufts Univ New England Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA	CIHEAM; CIHEAM IAM Chania; Tufts Medical Center	Makris, AM (corresponding author), Alsyll Agrokepiou, Khania 73100, Greece.	antoniosmakris@yahoo.gr	Kampranis, Sotirios C/G-8374-2016	Kampranis, Sotirios C/0000-0001-6208-1684; Khalil, Hadi/0000-0003-3860-5331				Ahn SH, 2005, CELL, V120, P25, DOI 10.1016/j.cell.2004.11.016; Altmann K, 2005, MOL BIOL CELL, V16, P5410, DOI 10.1091/mbc.E05-07-0678; Beer SM, 2004, J BIOL CHEM, V279, P47939, DOI 10.1074/jbc.M408011200; Belhocine S, 2004, CELL DEATH DIFFER, V11, P946, DOI 10.1038/sj.cdd.4401422; Bellot G, 2007, CELL DEATH DIFFER, V14, P785, DOI 10.1038/sj.cdd.4402055; Braun RJ, 2006, J BIOL CHEM, V281, P25757, DOI 10.1074/jbc.M513699200; Breitenbach M, 2005, TRENDS CELL BIOL, V15, P637, DOI 10.1016/j.tcb.2005.09.011; Chae HJ, 2004, MOL CELL, V15, P355, DOI 10.1016/j.molcel.2004.06.038; COLLINSON LP, 1995, GENE, V156, P123, DOI 10.1016/0378-1119(95)00026-3; CORNILLON S, 1994, J CELL SCI, V107, P2691; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Del Carratore R, 2002, MUTAT RES-GEN TOX EN, V513, P183, DOI 10.1016/S1383-5718(01)00310-2; Dimitrova I, 2004, FEBS LETT, V566, P100, DOI 10.1016/j.febslet.2004.04.012; Fahrenkrog B, 2004, J CELL SCI, V117, P115, DOI 10.1242/jcs.00848; FOX KM, 1994, STRUCTURE, V2, P1089, DOI 10.1016/S0969-2126(94)00111-1; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gourlay CW, 2004, J CELL BIOL, V164, P803, DOI 10.1083/jcb.200310148; Grant CM, 1997, FEBS LETT, V410, P219, DOI 10.1016/S0014-5793(97)00592-9; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; Gross A, 2000, MOL CELL BIOL, V20, P3125, DOI 10.1128/MCB.20.9.3125-3136.2000; GUELMAN R, 2002, BONE, V30, P23; Haarer BK, 2004, MOL BIOL CELL, V15, P4522, DOI 10.1091/mbc.E04-06-0445; Herker E, 2004, J CELL BIOL, V164, P501, DOI 10.1083/jcb.200310014; Hill KL, 1996, J CELL BIOL, V135, P1535, DOI 10.1083/jcb.135.6.1535; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Jin C, 2002, NAT REV MOL CELL BIO, V3, P453, DOI 10.1038/nrm832; Kampranis SC, 2000, J BIOL CHEM, V275, P29207, DOI 10.1074/jbc.M002359200; KANE DJ, 1993, SCIENCE, V262, P1274, DOI 10.1126/science.8235659; Karplus PA, 1995, FASEB J, V9, P1518, DOI 10.1096/fasebj.9.15.8529830; Kilili KG, 2004, J BIOL CHEM, V279, P24540, DOI 10.1074/jbc.M309882200; Kohli RM, 1998, J BIOL CHEM, V273, P32763, DOI 10.1074/jbc.273.49.32763; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; LATTERICH M, 1995, CELL, V82, P885, DOI 10.1016/0092-8674(95)90268-6; Li W, 2006, MOL BIOL CELL, V17, P1802, DOI 10.1091/mbc.E05-04-0333; Ludovico P, 2001, MICROBIOL-SGM, V147, P3335, DOI 10.1099/00221287-147-12-3335; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Moon H, 2002, BIOCHEM BIOPH RES CO, V290, P457, DOI 10.1006/bbrc.2001.6208; Muller A, 2007, BIOTECHNOL BIOENG, V98, P22, DOI 10.1002/bit.21415; Niwa T, 2000, CLIN CHEM, V46, P82; Outten CE, 2004, J BIOL CHEM, V279, P7785, DOI 10.1074/jbc.M312421200; PALMER RE, 1992, J CELL BIOL, V119, P583, DOI 10.1083/jcb.119.3.583; Pastore A, 2003, J BIOL CHEM, V278, P42588, DOI 10.1074/jbc.M301872200; Pruyne D, 2004, ANNU REV CELL DEV BI, V20, P559, DOI 10.1146/annurev.cellbio.20.010403.103108; Reekmans R, 2005, FEMS YEAST RES, V5, P711, DOI 10.1016/j.femsyr.2004.12.010; SATO T, 1994, P NATL ACAD SCI USA, V91, P9238, DOI 10.1073/pnas.91.20.9238; Sawada M, 2003, NAT CELL BIOL, V5, P320, DOI 10.1038/ncb950; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Severin FF, 2002, CURR BIOL, V12, pR233, DOI 10.1016/S0960-9822(02)00776-5; Shirogane T, 1999, IMMUNITY, V11, P709, DOI 10.1016/S1074-7613(00)80145-4; Sinclair DA, 1998, TRENDS BIOCHEM SCI, V23, P131, DOI 10.1016/S0968-0004(98)01188-8; Skulachev VP, 2001, TRENDS BIOCHEM SCI, V26, P23, DOI 10.1016/S0968-0004(00)01735-7; STOTT K, 1993, J BIOL CHEM, V268, P6097; Trotter EW, 2006, APPL ENVIRON MICROB, V72, P4885, DOI 10.1128/AEM.00526-06; Vachova L, 2005, J CELL BIOL, V169, P711, DOI 10.1083/jcb.200410064; Wang J, 2001, J BIOL CHEM, V276, P47763, DOI 10.1074/jbc.C100415200; Westermann B, 2000, YEAST, V16, P1421, DOI 10.1002/1097-0061(200011)16:15<1421::AID-YEA624>3.3.CO;2-L; Wissing S, 2004, J CELL BIOL, V166, P969, DOI 10.1083/jcb.200404138; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	61	50	52	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					36010	36023		10.1074/jbc.M704058200	http://dx.doi.org/10.1074/jbc.M704058200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17897954	hybrid			2022-12-25	WOS:000251458100061
J	Gonzalez-Begne, M; Nakamoto, T; Nguyen, HV; Stewart, AK; Alper, SL; Melvin, JE				Gonzalez-Begne, Mireya; Nakamoto, Tetsuji; Nguyen, Ha-Van; Stewart, Andrew K.; Alper, Seth L.; Melvin, James E.			Enhanced formation of a HCO3- transport metabolon in exocrine cells of Nhe1(-/-) mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBONIC-ANHYDRASE-II; ANION-EXCHANGER AE1; ACINAR-CELLS; TARGETED DISRUPTION; NA+/H+ EXCHANGER; CL-/HCO3-EXCHANGER; CYTOPLASMIC CALCIUM; EPITHELIAL-CELLS; FLUID SECRETION; PLASMA-MEMBRANE	Cl- influx across the basolateral membrane is a limiting step in fluid production in exocrine cells and often involves functionally linked Cl-/HCO3- (Ae) and Na+/H+ (Nhe) exchange mechanisms. The dependence of this major Cl- uptake pathway on Na+/H+ exchanger expression was examined in the parotid acinar cells of Nhe1(-)/(-) and Nhe2(-)/(-) mice, both of which exhibited impaired fluid secretion. No change in Cl-/HCO3- exchanger activity was detected in Nhe2-deficient mice. Conversely, Cl-/HCO3- exchanger activity increased nearly 4-fold in Nhe1-deficient mice, despite only minimal or any change in mRNA and protein levels of the anion exchanger Ae2. Acetazolamide completely blocked the increase in Cl-/HCO3- exchanger activity in Nhe1-null mice suggesting that increased anion exchange required carbonic anhydrase activity. Indeed, the parotid glands of Nhe1(-)/(-) mice expressed higher levels of carbonic anhydrase 2 (Car2) polypeptide. Moreover, the enhanced Cl-/HCO3- exchange activity was accompanied by an increased abundance of Car2 center dot Ae2 complexes in the parotid plasma membranes of Nhe1(-)/(-) mice. Anion exchanger activity was also significantly reduced in Car2-deficient mice, consistent with an important role of a putative Car2 center dot Ae2HCO(3)(-) transport metabolon in parotid exocrine cell function. Increased abundance of this HCO3- transport metabolon is likely one of the multiple compensatory changes in the exocrine parotid gland of Nhe1(-)/(-) mice that together attenuate the severity of in vivo electrolyte and acid-base balance perturbations.	Univ Rochester, Med Ctr, Ctr Oral Biol, Rochester, NY 14642 USA; Beth Israel Deaconess Med Ctr, Mol & Vasc Med Unit, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Div Renal, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA	University of Rochester; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Melvin, JE (corresponding author), Univ Rochester, Med Ctr, Ctr Oral Biol, Box 611,601 Elmwood Ave, Rochester, NY 14642 USA.	james_melvin@urmc.rochester.edu			NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE008921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE009692, R37DE008921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK043495, R01DK043495] Funding Source: NIH RePORTER; NIDCR NIH HHS [DE08921, DE09692] Funding Source: Medline; NIDDK NIH HHS [DK43495] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alper SL, 2006, EXP PHYSIOL, V91, P153, DOI 10.1113/expphysiol.2005.031765; Alper SL, 2002, ANNU REV PHYSIOL, V64, P899, DOI 10.1146/annurev.physiol.64.092801.141759; Alper SL, 1997, AM J PHYSIOL-RENAL, V273, pF601, DOI 10.1152/ajprenal.1997.273.4.F601; Alvarez BV, 2003, BIOCHEMISTRY-US, V42, P12321, DOI 10.1021/bi0353124; Alvarez BV, 2005, EMBO J, V24, P2499, DOI 10.1038/sj.emboj.7600736; ARREOLA J, 1995, J MEMBRANE BIOL, V147, P95; Bell SM, 1999, AM J PHYSIOL-CELL PH, V276, pC788, DOI 10.1152/ajpcell.1999.276.4.C788; Brown DA, 2003, AM J PHYSIOL-GASTR L, V285, pG804, DOI 10.1152/ajpgi.00150.2003; Chernova MN, 2003, AM J PHYSIOL-CELL PH, V284, pC1235, DOI 10.1152/ajpcell.00522.2002; COUSIN JL, 1975, J PHYSIOL-LONDON, V253, P385, DOI 10.1113/jphysiol.1975.sp011195; Dahl NK, 2003, J BIOL CHEM, V278, P44949, DOI 10.1074/jbc.M308660200; DISSING S, 1990, AM J PHYSIOL, V259, pG1044, DOI 10.1152/ajpgi.1990.259.6.G1044; Evans RL, 1999, J BIOL CHEM, V274, P29025, DOI 10.1074/jbc.274.41.29025; Evans RL, 2000, J BIOL CHEM, V275, P26720; Gawenis LR, 2004, J BIOL CHEM, V279, P30531, DOI 10.1074/jbc.M403779200; GERBOTH GD, 1993, AM J PHYSIOL, V264, pL448, DOI 10.1152/ajplung.1993.264.5.L448; He XJ, 1997, PFLUG ARCH EUR J PHY, V433, P260; HUMPHREYS BD, 1994, AM J PHYSIOL-CELL PH, V267, pC1295, DOI 10.1152/ajpcell.1994.267.5.C1295; IKEDA K, 1991, AM J PHYSIOL, V261, pC231, DOI 10.1152/ajpcell.1991.261.2.C231; Kopito R R, 1990, Int Rev Cytol, V123, P177, DOI 10.1016/S0074-7696(08)60674-9; LEWIS SE, 1988, P NATL ACAD SCI USA, V85, P1962, DOI 10.1073/pnas.85.6.1962; Li XJ, 2002, J BIOL CHEM, V277, P36085, DOI 10.1074/jbc.M111952200; Melvin JE, 1999, J BIOL CHEM, V274, P22855, DOI 10.1074/jbc.274.32.22855; Melvin JE, 2005, ANNU REV PHYSIOL, V67, P445, DOI 10.1146/annurev.physiol.67.041703.084745; MELVIN JE, 1992, AM J PHYSIOL, V262, pG393, DOI 10.1152/ajpgi.1992.262.3.G393; NAUNTOFTE B, 1992, AM J PHYSIOL, V263, P823; Nguyen HV, 2004, AM J PHYSIOL-GASTR L, V286, pG312, DOI 10.1152/ajpgi.00158.2003; Nguyen HV, 2000, J PHYSIOL-LONDON, V523, P139, DOI 10.1111/j.1469-7793.2000.t01-2-00139.x; Park K, 2001, J BIOL CHEM, V276, P27042, DOI 10.1074/jbc.M102901200; PETERSEN OH, 1992, J PHYSIOL-LONDON, V448, P1; Piermarini PM, 2007, J BIOL CHEM, V282, P1409, DOI 10.1074/jbc.M608261200; Roussa E, 1999, AM J PHYSIOL-GASTR L, V277, pG1288, DOI 10.1152/ajpgi.1999.277.6.G1288; Schultheis PJ, 1998, J CLIN INVEST, V101, P1243, DOI 10.1172/JCI1249; Scozzafava A, 2002, BIOORG MED CHEM LETT, V12, P1177, DOI 10.1016/S0960-894X(02)00121-X; SNOWDOWNE KW, 1992, BIOCHIM BIOPHYS ACTA, V1108, P145, DOI 10.1016/0005-2736(92)90019-I; Sterling D, 2002, J BIOL CHEM, V277, P25239, DOI 10.1074/jbc.M202562200; Sterling D, 2001, JOP, V2, P165; Sterling D, 2001, J BIOL CHEM, V276, P47886, DOI 10.1074/jbc.M105959200; Sterling D, 2002, AM J PHYSIOL-CELL PH, V283, pC1522, DOI 10.1152/ajpcell.00115.2002; Stewart AK, 2002, J GEN PHYSIOL, V120, P707, DOI 10.1085/jgp.20028641; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; Turner RJ, 2002, ORAL DIS, V8, P3, DOI 10.1034/j.1601-0825.2002.10815.x; Vince JW, 2000, BIOCHEMISTRY-US, V39, P5527, DOI 10.1021/bi992564p; Vince JW, 2000, BIOCHEMISTRY-US, V39, P13344, DOI 10.1021/bi0015111; Vince JW, 1998, J BIOL CHEM, V273, P28430, DOI 10.1074/jbc.273.43.28430; Wu Q, 1998, J MEMBRANE BIOL, V162, P31, DOI 10.1007/s002329900339; Wu RY, 2004, INVEST OPHTH VIS SCI, V45, P3213, DOI 10.1167/iovs.03-1252; Zhao YX, 2004, ANAL CHEM, V76, P1817, DOI 10.1021/ac0354037; Zhao YX, 2003, ANAL CHEM, V75, P3751, DOI 10.1021/ac034184m	49	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35125	35132		10.1074/jbc.M707266200	http://dx.doi.org/10.1074/jbc.M707266200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17890222	hybrid			2022-12-25	WOS:000251155200057
J	Donato, H; Krupenko, NI; Tsybovsky, Y; Krupenko, SA				Donato, Henry; Krupenko, Natalia I.; Tsybovsky, Yaroslav; Krupenko, Sergey A.			10-formyltetrahydrofolate dehydrogenase requires a 4 '-phosphopantetheine prosthetic group for catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL CARRIER PROTEIN; CARBOXYL-TERMINAL DOMAIN; ALKALINE-PHOSPHATASE; PHOSPHODIESTERASE ACTIVITY; ALDEHYDE DEHYDROGENASE; ESCHERICHIA-COLI; HYDROLASE DOMAIN; PURIFICATION; EXPRESSION; ENZYMES	10- Formyltetrahydrofolate dehydrogenase (FDH) consists of two independent catalytic domains, N- and C-terminal, connected by a 100-amino acid residue linker (intermediate domain). Our previous studies on structural organization and enzymatic properties of rat FDH suggest that the overall enzyme reaction, i.e. NADP(+) -dependent conversion of 10-formyltetrahydrofolate to tetrahydrofolate and CO2, consists of two steps: (i) hydrolytic cleavage of the formyl group in the N-terminal catalytic domain, followed by (ii) NADP(+) -dependent oxidation of the formyl group to CO2 in the C-terminal aldehyde dehydrogenase domain. In this mechanism, it was not clear how the formyl group is transferred between the two catalytic domains after the first step. This study demonstrates that the intermediate domain functions similarly to an acyl carrier protein. A 4'-phosphopantetheine swinging arm bound through a phosphoester bond to Ser(354) of the intermediate domain transfers the formyl group between the catalytic domains of FDH. Thus, our study defines the intermediate domain of FDH as a novel carrier protein and provides the previously lacking component of the FDH catalytic mechanism.	Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; Coll Charleston, Dept Chem & Biochem, Charleston, SC 29424 USA	Medical University of South Carolina; College of Charleston	Krupenko, SA (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, 173 Ashley Ave, Charleston, SC 29425 USA.	krupenko@musc.edu			NIDDK NIH HHS [DK 54388] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054388] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anguera MC, 2006, J BIOL CHEM, V281, P18335, DOI 10.1074/jbc.M510623200; CHAMPION KM, 1994, P NATL ACAD SCI USA, V91, P11338, DOI 10.1073/pnas.91.24.11338; Chumanevich AA, 2004, J BIOL CHEM, V279, P14355, DOI 10.1074/jbc.M313934200; COOK RJ, 1991, J BIOL CHEM, V266, P4965; COOK RJ, 1982, BIOCHEMISTRY-US, V21, P4427, DOI 10.1021/bi00261a036; Crump MP, 1997, BIOCHEMISTRY-US, V36, P6000, DOI 10.1021/bi970006+; Guo SJ, 2001, J BACTERIOL, V183, P7120, DOI 10.1128/JB.183.24.7120-7125.2001; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; Huang XY, 2001, ANNU REV BIOCHEM, V70, P149, DOI 10.1146/annurev.biochem.70.1.149; Jitrapakdee S, 1999, BIOCHEM J, V340, P1, DOI 10.1042/bj3400001; Joshi AK, 2003, J BIOL CHEM, V278, P33142, DOI 10.1074/jbc.M305459200; KIM YM, 1990, PROTEINS, V8, P377, DOI 10.1002/prot.340080411; Krupenko SA, 1997, J BIOL CHEM, V272, P10266; Krupenko SA, 1997, J BIOL CHEM, V272, P10273; Krupenko SA, 2002, CELL GROWTH DIFFER, V13, P227; KRUPENKO SA, 1995, J BIOL CHEM, V270, P519, DOI 10.1074/jbc.270.2.519; Krupenko SA, 2001, J BIOL CHEM, V276, P24030, DOI 10.1074/jbc.M009257200; KRUPENKO SA, 1995, PROTEIN EXPRES PURIF, V6, P457, DOI 10.1006/prep.1995.1061; Krupenko SA, 1999, J BIOL CHEM, V274, P35777, DOI 10.1074/jbc.274.50.35777; Kursula P, 2006, ACTA CRYSTALLOGR D, V62, P1294, DOI 10.1107/S0907444906026849; KUTZBACH C, 1971, METHODS ENZYMOL B, V18, P793; La Clair JJ, 2004, CHEM BIOL, V11, P195, DOI 10.1016/j.chembiol.2004.02.010; Lai JR, 2006, BIOCHEMISTRY-US, V45, P14869, DOI 10.1021/bi061979p; Lamb AL, 1999, BIOCHEMISTRY-US, V38, P6003, DOI 10.1021/bi9900471; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Moore SA, 1998, STRUCTURE, V6, P1541, DOI 10.1016/S0969-2126(98)00152-X; O'Brien PJ, 2001, BIOCHEMISTRY-US, V40, P5691, DOI 10.1021/bi0028892; Oleinik NV, 2005, BIOCHEM J, V391, P503, DOI 10.1042/BJ20050533; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; Raushel FM, 2003, ACCOUNTS CHEM RES, V36, P539, DOI 10.1021/ar020047k; Reuland SN, 2006, PROTEIN SCI, V15, P1076, DOI 10.1110/ps.052062806; Reuland SN, 2003, J BIOL CHEM, V278, P22894, DOI 10.1074/jbc.M302948200; REZENDE AA, 1994, BIOCHEM J, V301, P517, DOI 10.1042/bj3010517; SCHIRCH D, 1994, J BIOL CHEM, V269, P24728; SCHLUMBOHM W, 1991, J BIOL CHEM, V266, P23135; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SCRUTTON MC, 1979, BIOCHEM J, V177, P833, DOI 10.1042/bj1770833; Thomas J, 2005, J BIOL CHEM, V280, P34675, DOI 10.1074/jbc.M505736200; Tsybovsky Y, 2007, BIOCHEMISTRY-US, V46, P2917, DOI 10.1021/bi0619573; Wagner C, 1995, FOLATE HLTH DIS, P23; Walsh C., 2006, POSTTRANSLATIONAL MO; Weber T, 2000, STRUCT FOLD DES, V8, P407, DOI 10.1016/S0969-2126(00)00120-9; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Zalatan JG, 2006, J AM CHEM SOC, V128, P1293, DOI 10.1021/ja056528r	45	33	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34159	34166		10.1074/jbc.M707627200	http://dx.doi.org/10.1074/jbc.M707627200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17884809	hybrid			2022-12-25	WOS:000251145700030
J	Hintze, KJ; Katoh, Y; Igarashi, K; Theil, EC				Hintze, Korry J.; Katoh, Yasutake; Igarashi, Kazuhiko; Theil, Elizabeth C.			Bach1 repression of ferritin and thioredoxin reductase1 is heme-sensitive in cells and in vitro and coordinates expression with heme oxygenase1, beta-globin, and NADP(H) quinone (oxido) reductase1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-RESPONSIVE ELEMENT; MESSENGER-RNA REGULATION; LOCUS-CONTROL REGION; HUMAN HEPATOMA-CELLS; COBALT-PROTOPORPHYRIN; GENE-EXPRESSION; ERYTHROID-DIFFERENTIATION; TRANSLATIONAL REGULATION; REGULATORY PROTEIN-2; OXIDATIVE STRESS	Ferritin gene transcription is regulated by heme as is ferritin mRNA translation, which is mediated by the well studied mRNA.IRE/IRP protein complex. The heme-sensitive DNA sequence in ferritin genes is the maf recognition/antioxidant response element present in several other genes that are induced by heme and repressed by Bach1. We now report that chromatin immunoprecipitated with Bach1 antiserum contains ferritin DNA sequences. In addition, overexpression of Bach1 protein in the transfected cells decreased ferritin expression, indicating insufficient endogenous Bach1 for full repression; decreasing Bach1 with antisense RNA increased ferritin expression. Thioredoxin reductase1, a gene that also contains a maf recognition/antioxidant response element but is less studied, responded similarly to ferritin, as did the positive controls heme oxygenase1 and NADP(H) quinone (oxido) reductase1. Bach1-DNA promoter interactions in cells were confirmed in vitro with soluble, recombinant Bach1 protein and revealed a quantitative range of Bach1/DNA stabilities: ferritin L similar to ferritin H similar to beta-globin, beta-globin similar to 2-fold > heme oxygenase1 = quinone reductase beta-globin similar to 4-fold > thioredoxin reductase1. Such results indicate the possibility that modulation of cellular Bach1 concentrations will have variable effects among the genes coordinately regulated by maf recognition/ antioxidant response elements in iron/oxygen/antioxidant metabolism.	Childrens Hosp Oakland, Res Inst, Council Bioiron, Oakland, CA 94609 USA; Tohoku Univ, Sch Med, Dept Biochem, Sendai, Miyagi 9808575, Japan; Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Tohoku University; University of California System; University of California Berkeley	Theil, EC (corresponding author), Childrens Hosp Oakland, Res Inst, Council Bioiron, 5700 Martin Luther King Jr Way, Oakland, CA 94609 USA.	etheil@chori.org	Hintze, Korry/A-7079-2008; Hintze, Korry/E-4619-2011	Igarashi, Kazuhiko/0000-0002-2470-2475; Hintze, Korry/0000-0003-0135-0478	NIDDK NIH HHS [DK 20251] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK020251, R37DK020251, R56DK020251] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alam J, 2004, ANTIOXID REDOX SIGN, V6, P924, DOI 10.1089/1523086041798114; BLACKWELL JR, 1991, FEBS LETT, V295, P10, DOI 10.1016/0014-5793(91)81372-F; Brand M, 2004, NAT STRUCT MOL BIOL, V11, P73, DOI 10.1038/nsmb713; CAREY J, 1988, P NATL ACAD SCI USA, V85, P975, DOI 10.1073/pnas.85.4.975; Clarke SL, 2006, EMBO J, V25, P544, DOI 10.1038/sj.emboj.7600954; DANDEKAR T, 1991, EMBO J, V10, P1903, DOI 10.1002/j.1460-2075.1991.tb07716.x; Dhakshinamoorthy S, 2005, J BIOL CHEM, V280, P16891, DOI 10.1074/jbc.M500166200; Erlitzki R, 2002, J BIOL CHEM, V277, P42579, DOI 10.1074/jbc.M207918200; Fletcher JE, 2001, RNA, V7, P1442; Ghaziani T, 2006, J HEPATOL, V45, P5, DOI 10.1016/j.jhep.2005.12.020; Goessling LS, 1998, J BIOL CHEM, V273, P12555, DOI 10.1074/jbc.273.20.12555; Gunshin H, 2001, FEBS LETT, V509, P309, DOI 10.1016/S0014-5793(01)03189-1; HARRELL CM, 1991, P NATL ACAD SCI USA, V88, P4166, DOI 10.1073/pnas.88.10.4166; HENTZE MW, 1987, SCIENCE, V238, P1570, DOI 10.1126/science.3685996; Hintze KJ, 2006, CELL MOL LIFE SCI, V63, P591, DOI 10.1007/s00018-005-5285-y; Hintze KJ, 2003, J NUTR, V133, P2721, DOI 10.1093/jn/133.9.2721; Hintze KJ, 2005, P NATL ACAD SCI USA, V102, P15048, DOI 10.1073/pnas.0505148102; Igarashi K, 1998, J BIOL CHEM, V273, P11783, DOI 10.1074/jbc.273.19.11783; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Iwasaki K, 2006, MOL CELL BIOL, V26, P2845, DOI 10.1128/MCB.26.7.2845-2856.2006; KATAOKA K, 1994, MOL CELL BIOL, V14, P700, DOI 10.1128/MCB.14.1.700; Ke YH, 1998, J BIOL CHEM, V273, P23637, DOI 10.1074/jbc.273.37.23637; Kitamuro T, 2003, J BIOL CHEM, V278, P9125, DOI 10.1074/jbc.M209939200; LEIBOLD EA, 1988, P NATL ACAD SCI USA, V85, P2171, DOI 10.1073/pnas.85.7.2171; LIN JJ, 1991, P NATL ACAD SCI USA, V88, P6068, DOI 10.1073/pnas.88.14.6068; LIN JJ, 1990, SCIENCE, V247, P74, DOI 10.1126/science.2294594; Liu XF, 2005, ACCOUNTS CHEM RES, V38, P167, DOI 10.1021/ar0302336; MASCOTTI DP, 1995, ANNU REV NUTR, V15, P239, DOI 10.1146/annurev.nu.15.070195.001323; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; Muckenthaler M, 1998, MOL CELL, V2, P383, DOI 10.1016/S1097-2765(00)80282-8; Omura S, 2005, GENES CELLS, V10, P277, DOI 10.1111/j.1365-2443.2005.00832.x; Otterbein LE, 2002, AM J RESP CELL MOL, V26, P161, DOI 10.1165/ajrcmb.26.2.f226; Pietsch EC, 2003, J BIOL CHEM, V278, P2361, DOI 10.1074/jbc.M210664200; Sawado T, 2001, P NATL ACAD SCI USA, V98, P10226, DOI 10.1073/pnas.181344198; Shan Y, 2004, J BIOL CHEM, V279, P51769, DOI 10.1074/jbc.M409463200; Shan Y, 2006, FASEB J, V20, P2651, DOI 10.1096/fj.06-6346fje; SMITH A, 1993, J BIOL CHEM, V268, P7365; SMITH TJ, 1991, BIOCHIM BIOPHYS ACTA, V1073, P221, DOI 10.1016/0304-4165(91)90206-V; Sun JY, 2004, P NATL ACAD SCI USA, V101, P1461, DOI 10.1073/pnas.0308083100; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; Sun JY, 2001, J BIOCHEM, V130, P385, DOI 10.1093/oxfordjournals.jbchem.a002997; Suzuki H, 2004, EMBO J, V23, P2544, DOI 10.1038/sj.emboj.7600248; Tahara T, 2004, J BIOL CHEM, V279, P5480, DOI 10.1074/jbc.M302733200; Theil EC, 2000, J BIOL CHEM, V275, P40659, DOI 10.1074/jbc.R000019200; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; Tsuji Y, 2000, MOL CELL BIOL, V20, P5818, DOI 10.1128/MCB.20.16.5818-5827.2000; Walden WE, 2006, SCIENCE, V314, P1903, DOI 10.1126/science.1133116; Yamanaka K, 2003, NAT CELL BIOL, V5, P336, DOI 10.1038/ncb952; Zenke-Kawasaki Y, 2007, MOL CELL BIOL, V27, P6962, DOI 10.1128/MCB.02415-06	49	86	87	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34365	34371		10.1074/jbc.M700254200	http://dx.doi.org/10.1074/jbc.M700254200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17901053	hybrid			2022-12-25	WOS:000251145700052
J	Muff, TJ; Ordal, GW				Muff, Travis J.; Ordal, George W.			The CheC phosphatase regulates chemotactic adaptation through CheD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; BACTERIAL CHEMOTAXIS; PROMOTES ADAPTATION; SIGNAL-TRANSDUCTION; METHYLATION; RECEPTOR; PROTEINS; REVEALS; MCPB	The bacterial chemotaxis system is one of the most extensively studied signal transduction systems in biology. The response regulator CheY controls flagellar rotation and is phosphorylated by the CheA histidine kinase to its active form. CheC is a CheY- P phosphatase, and this activity is enhanced in a CheC-CheD heterodimer. CheC is also critical for chemotactic adaptation, the return to the prestimulus system state despite persistent attractant concentrations. Here, CheC point mutants were examined in Bacillus subtilis for in vivo complementation and in vitro activity. The mutants were identified separating the three known abilities of CheC: CheD binding, CheY-P binding, and CheY-P phosphatase activity. Remarkably, the phosphatase ability was not as critical to the in vivo function of CheC as the ability to bind both CheY- P and CheD. Additionally, it was confirmed that CheY-P increases the affinity of CheC for CheD, the later of which is known to be necessary for receptor activation of CheA. These data suggest a model of CheC as a CheY-P-induced regulator of CheD. Here, CheY-P would cause CheC to sequester CheD from the chemoreceptors, inducing adaptation of the chemotaxis system. This model represents the first plausible means for feedback from the output of the system, CheY-P, to the receptors.	Univ Illinois, Coll Med, Dept Biochem, Urbana, IL 61801 USA; Univ Illinois, Coll Liberal Arts & Sci, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Ordal, GW (corresponding author), Univ Illinois, Coll Med, Dept Biochem, 506 S Matthews,190 MSB, Urbana, IL 61801 USA.	ordal@uiuc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054365] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM 54365] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADLER J, 1973, J GEN MICROBIOL, V74, P77, DOI 10.1099/00221287-74-1-77; Boesch KC, 2000, J BACTERIOL, V182, P3544, DOI 10.1128/JB.182.12.3544-3552.2000; BORKOVICH KA, 1989, P NATL ACAD SCI USA, V86, P1208, DOI 10.1073/pnas.86.4.1208; Chao XJ, 2006, CELL, V124, P561, DOI 10.1016/j.cell.2005.11.046; Djordjevic S, 1997, STRUCTURE, V5, P545, DOI 10.1016/S0969-2126(97)00210-4; Garrity LF, 1997, MICROBIOL-UK, V143, P2945, DOI 10.1099/00221287-143-9-2945; IRETON K, 1993, GENE DEV, V7, P283, DOI 10.1101/gad.7.2.283; Jasuja R, 1999, P NATL ACAD SCI USA, V96, P11346, DOI 10.1073/pnas.96.20.11346; Karatan E, 2001, J BIOL CHEM, V276, P43618, DOI 10.1074/jbc.M104955200; Kirby JR, 1999, J BIOL CHEM, V274, P11092, DOI 10.1074/jbc.274.16.11092; Kirby JR, 2001, MOL MICROBIOL, V42, P573, DOI 10.1046/j.1365-2958.2001.02581.x; KIRSCH ML, 1993, J BIOL CHEM, V268, P18610; KIRSCH ML, 1993, J BIOL CHEM, V268, P25350; Kristich CJ, 2004, J BACTERIOL, V186, P5950, DOI 10.1128/JB.186.17.5950-5955.2004; Kristich CJ, 2002, J BIOL CHEM, V277, P25356, DOI 10.1074/jbc.M201334200; Muff TJ, 2007, J BACTERIOL, V189, P7007, DOI 10.1128/JB.00896-07; Muff TJ, 2007, METHOD ENZYMOL, V423, P336, DOI 10.1016/S0076-6879(07)23015-0; Ordal Geroge W., 1993, P765; Park SY, 2004, MOL CELL, V16, P563, DOI 10.1016/j.molcel.2004.10.018; PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443; Rosario MML, 1996, MOL MICROBIOL, V21, P511, DOI 10.1111/j.1365-2958.1996.tb02560.x; ROSARIO MML, 1995, BIOCHEMISTRY-US, V34, P3823, DOI 10.1021/bi00011a040; Scharf BE, 1998, P NATL ACAD SCI USA, V95, P201, DOI 10.1073/pnas.95.1.201; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Szurmant H, 2004, J BIOL CHEM, V279, P21787, DOI 10.1074/jbc.M311497200; Szurmant H, 2003, J BIOL CHEM, V278, P48611, DOI 10.1074/jbc.M306180200; Szurmant L, 2004, MICROBIOL MOL BIOL R, V68, P301, DOI 10.1128/MMBR.68.2.301-319.2004; Terry K, 2006, MOL MICROBIOL, V61, P871, DOI 10.1111/j.1365-2958.2006.05283.x; Toker AS, 1997, J MOL BIOL, V273, P623, DOI 10.1006/jmbi.1997.1335; ULLAH AHJ, 1981, J BACTERIOL, V145, P958, DOI 10.1128/JB.145.2.958-965.1981; Varughese KI, 2006, J BACTERIOL, V188, P4970, DOI 10.1128/JB.00160-06; WEST AH, 1995, J MOL BIOL, V250, P276, DOI 10.1006/jmbi.1995.0376; Zhao R, 2002, NAT STRUCT BIOL, V9, P570; Zimmer MA, 2002, MOL MICROBIOL, V45, P555, DOI 10.1046/j.1365-2958.2002.03035.x; Zimmer MA, 2000, J BIOL CHEM, V275, P24264, DOI 10.1074/jbc.M004001200	35	32	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34120	34128		10.1074/jbc.M706432200	http://dx.doi.org/10.1074/jbc.M706432200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17908686	hybrid			2022-12-25	WOS:000251145700026
J	Shimura, K; Okada, A; Okada, K; Jikumaru, Y; Ko, KW; Toyomasu, T; Sassa, T; Hasegawa, M; Kodama, O; Shibuya, N; Koga, J; Nojiri, H; Yamane, H				Shimura, Kazuhiro; Okada, Atsushi; Okada, Kazunori; Jikumaru, Yusuke; Ko, Kwang-Wook; Toyomasu, Tomonobu; Sassa, Takeshi; Hasegawa, Morifumi; Kodama, Osamu; Shibuya, Naoto; Koga, Jinichiro; Nojiri, Hideaki; Yamane, Hisakazu			Identification of a biosynthetic gene cluster in rice for momilactones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COPALYL DIPHOSPHATE SYNTHASES; DITERPENE PHYTOALEXIN; PLASMA-MEMBRANE; ORYZALEXINS-A; ENT-COPALYL; CLONING; CELLS; GIBBERELLIN; EXPRESSION; ELICITOR	Rice diterpenoid phytoalexins such as momilactones and phytocassanes are produced in suspension-cultured rice cells treated with a chitin oligosaccharide elicitor and in rice leaves irradiated with UV light. The common substrate geranylgeranyl diphosphate is converted into diterpene hydrocarbon precursors via a two-step sequential cyclization and then into the bioactive phytoalexins via several oxidation steps. It has been suggested that microsomal cytochrome P-450 monooxygenases (P-450s) are involved in the downstream oxidation of the diterpene hydrocarbons leading to the phytoalexins and that a dehydrogenase is involved in momilactone biosynthesis. However, none of the enzymes involved in the downstream oxidation of the diterpene hydrocarbons have been identified. In this study, we found that a putative dehydrogenase gene (AK103462) and two functionally unknown P-450 genes (CYP99A2 and CYP99A3) form a chitin oligosaccharide elicitor- and UV-inducible gene cluster, together with OsKS4 and OsCyc1, the diterpene cyclase genes involved in momilactone biosynthesis. Functional analysis by heterologous expression in Escherichia coli followed by enzyme assays demonstrated that the AK103462 protein catalyzes the conversion of 3 beta-hydroxy- 9 beta H-pimara-7,15-dien-19,6 beta-olide into momilactone A. The double knockdown of CYP99A2 and CYP99A3 specifically suppressed the elicitor-inducible production of momilactones, strongly suggesting that CYP99A2, CYP99A3, or both are involved in momilactone biosynthesis. These results provide strong evidence for the presence on chromosome 4 of a gene cluster involved in momilactone biosynthesis.	Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, Tokyo 1138657, Japan; Yamagata Univ, Dept Bioresource Engn, Yamagata 9978555, Japan; Ibaraki Univ, Coll Agr, Ami, Ibaraki 3000393, Japan; Meiji Univ, Dept Life Sci, Kanagawa 2148571, Japan; Meiji Seika Kaisha Ltd, Food & Hlth Res & Dev Labs, Sakado, Saitama 3500289, Japan	University of Tokyo; Yamagata University; Ibaraki University; Meiji University; Meiji Holdings Co., Ltd.	Yamane, H (corresponding author), Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	ayamane@mail.ecc.u-tokyo.ac.jp	Hasegawa, Morifumi/G-6053-2011	Hasegawa, Morifumi/0000-0001-9829-2811; Koga, Jinichiro/0000-0003-2106-9894; Nojiri, Hideaki/0000-0003-3091-8691				AKATSUKA T, 1985, AGR BIOL CHEM TOKYO, V49, P1689, DOI 10.1080/00021369.1985.10866951; Atawong A, 2002, BIOSCI BIOTECH BIOCH, V66, P566, DOI 10.1271/bbb.66.566; Bak S, 1998, PLANT MOL BIOL, V36, P393, DOI 10.1023/A:1005915507497; CARTWRIGHT DW, 1981, PHYTOCHEMISTRY, V20, P535, DOI 10.1016/S0031-9422(00)84189-8; Cho EM, 2004, PLANT J, V37, P1, DOI 10.1046/j.1365-313X.2003.01926.x; Chuio T, 2007, BBA-GENE STRUCT EXPR, V1769, P497, DOI 10.1016/j.bbaexp.2007.04.006; Frey M, 1997, SCIENCE, V277, P696, DOI 10.1126/science.277.5326.696; Ito Y, 1997, PLANT J, V12, P347, DOI 10.1046/j.1365-313X.1997.12020347.x; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; KATO H, 1995, ARCH BIOCHEM BIOPHYS, V316, P707, DOI 10.1006/abbi.1995.1094; KATO H, 1993, PHYTOCHEMISTRY, V33, P79, DOI 10.1016/0031-9422(93)85399-C; KATO H, 1994, PHYTOCHEMISTRY, V36, P299, DOI 10.1016/S0031-9422(00)97064-X; KATO T, 1977, J CHEM SOC PERK T 1, P250, DOI 10.1039/p19770000250; KATO T, 1977, PHYTOCHEMISTRY, V16, P45, DOI 10.1016/0031-9422(77)83010-0; KODAMA O, 1992, PHYTOCHEMISTRY, V31, P3807, DOI 10.1016/S0031-9422(00)97532-0; Koga J, 1997, PHYTOCHEMISTRY, V44, P249, DOI 10.1016/S0031-9422(96)00534-1; KOGA J, 1995, TETRAHEDRON, V51, P7907, DOI 10.1016/0040-4020(95)00423-6; Miki D, 2004, PLANT CELL PHYSIOL, V45, P490, DOI 10.1093/pcp/pch048; Nemoto T, 2004, FEBS LETT, V571, P182, DOI 10.1016/j.febslet.2004.07.002; Okada A, 2007, PLANT MOL BIOL, V65, P177, DOI 10.1007/s11103-007-9207-2; Otomo K, 2004, BIOSCI BIOTECH BIOCH, V68, P2001, DOI 10.1271/bbb.68.2001; Otomo K, 2004, PLANT J, V39, P886, DOI 10.1111/j.1365-313X.2004.02175.x; Peters RJ, 2006, PHYTOCHEMISTRY, V67, P2307, DOI 10.1016/j.phytochem.2006.08.009; Prisic S, 2004, PLANT PHYSIOL, V136, P4228, DOI 10.1104/pp.104.050567; Sakamoto T, 2004, PLANT PHYSIOL, V134, P1642, DOI 10.1104/pp.103.033696; Siewers V, 2006, APPL ENVIRON MICROB, V72, P4619, DOI 10.1128/AEM.02919-05; TAMOGAMI S, 1993, TETRAHEDRON, V49, P2025, DOI 10.1016/S0040-4020(01)86302-X; Toyomasu T, 2004, BIOSCI BIOTECH BIOCH, V68, P146, DOI 10.1271/bbb.68.146; Tudzynski B, 2001, APPL ENVIRON MICROB, V67, P3514, DOI 10.1128/AEM.67.8.3514-3522.2001; Umemura K, 2002, PLANT CELL PHYSIOL, V43, P778, DOI 10.1093/pcp/pcf090; Wilderman PR, 2004, PLANT PHYSIOL, V135, P2098, DOI 10.1104/pp.104.045971; Xia ZQ, 2001, J BIOL CHEM, V276, P12614, DOI 10.1074/jbc.M008622200; Xiang CB, 1997, PLANT MOL BIOL, V34, P403, DOI 10.1023/A:1005873500238; Xu MM, 2004, PLANT J, V39, P309, DOI 10.1111/j.1365-313X.2004.02137.x; YAMADA A, 1993, BIOSCI BIOTECH BIOCH, V57, P405, DOI 10.1271/bbb.57.405	35	202	212	7	45	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34013	34018		10.1074/jbc.M703344200	http://dx.doi.org/10.1074/jbc.M703344200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17872948	hybrid			2022-12-25	WOS:000251145700015
J	Trosky, JE; Li, Y; Mukherjee, S; Keitany, G; Ball, H; Orth, K				Trosky, Jennifer E.; Li, Yan; Mukherjee, Sohini; Keitany, Gladys; Ball, Haydn; Orth, Kim			VopA inhibits ATP binding by acetylating the catalytic loop of MAPK kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YERSINIA EFFECTOR; VIBRIO-PARAHAEMOLYTICUS; YOPJ; ACTIVATION; RESPONSES; PROTEINS; RESIDUES; TARGET; MEK2	The bacterial pathogen Vibrio parahemeolyticus manipulates host signaling pathways during infections by injecting type III effectors. One of these effectors, Vibrio outer protein A (VopA), inhibits MAPK signaling via a novel mechanism, distinct from those described for other bacterial toxins, that disrupts this signaling pathway. VopA is an acetyltransferase that potently inhibits MAPK signaling pathways not only by preventing the activation of MAPK kinases (MKKs) but also by inhibiting the activity of activated MKKs. VopA acetylates a conserved lysine found in the catalytic loop of all kinases and blocks the binding of ATP, but not ADP, on the MKKs, resulting in an inactive phosphorylated kinase. Acetylation of this conserved lysine inhibits kinase activity by a new mechanism of regulation that has not been observed previously. Identifying the target of VopA reveals a way that the reversible post-translational modification of lysine acetylation can be used to regulate the activity of an enzyme.	Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; Univ Texas SW Med Ctr Dallas, Prot Chem Technol Ctr, Dallas, TX 75390 USA; Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; Univ Washington, Sch Publ Hlth, Seattle, WA 98195 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Washington; University of Washington Seattle	Orth, K (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Kim.Orth@utsouthwestern.edu	Dinalo, Jennifer/AAN-8708-2020; Orth, Kim/AAV-4421-2021	Orth, Kim/0000-0002-0678-7620; Dinalo, Jennifer/0000-0001-5174-5756	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK072134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008203] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 056404] Funding Source: Medline; NIDDK NIH HHS [1R21 DK 072134-01] Funding Source: Medline; NIGMS NIH HHS [5T32 GM 08203] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; Aubol BE, 2003, BIOCHEMISTRY-US, V42, P12813, DOI 10.1021/bi035200c; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; Mittal R, 2006, P NATL ACAD SCI USA, V103, P18574, DOI 10.1073/pnas.0608995103; Morris JG, 2003, CLIN INFECT DIS, V37, P272, DOI 10.1086/375600; Morrison DK, 2001, J CELL SCI, V114, P1609; Mukherjee S, 2007, TRENDS BIOCHEM SCI, V32, P210, DOI 10.1016/j.tibs.2007.03.007; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Navarro L, 2005, CURR OPIN MICROBIOL, V8, P21, DOI 10.1016/j.mib.2004.12.014; Navarro L, 2007, MOL CELL, V26, P465, DOI 10.1016/j.molcel.2007.04.025; Ohren JF, 2004, NAT STRUCT MOL BIOL, V11, P1192, DOI 10.1038/nsmb859; Orth K, 1999, SCIENCE, V285, P1920, DOI 10.1126/science.285.5435.1920; Orth K, 2002, CURR OPIN MICROBIOL, V5, P38, DOI 10.1016/S1369-5274(02)00283-7; ORTH K, 2007, MICROBE, V2, P183; Palmer LE, 1998, MOL MICROBIOL, V27, P953, DOI 10.1046/j.1365-2958.1998.00740.x; Staskawicz BJ, 2001, SCIENCE, V292, P2285, DOI 10.1126/science.1062013; Trosky JE, 2004, J BIOL CHEM, V279, P51953, DOI 10.1074/jbc.M407001200; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320	20	95	101	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34299	34305		10.1074/jbc.M706970200	http://dx.doi.org/10.1074/jbc.M706970200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17881352	hybrid			2022-12-25	WOS:000251145700045
J	Woods, WS; Boettcher, JM; Zhou, DH; Kloepper, KD; Hartman, KL; Ladror, DT; Qi, Z; Rienstra, CM; George, JM				Woods, Wendy S.; Boettcher, John M.; Zhou, Donghua H.; Kloepper, Kathryn D.; Hartman, Kevin L.; Ladror, Daniel T.; Qi, Zhi; Rienstra, Chad M.; George, Julia M.			Conformation-specific binding of alpha-synuclein to novel protein partners detected by phage display and NMR spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL PARKINSONS-DISEASE; K-ATP CHANNELS; SYNTHETIC MEMBRANES; INCLUSION FORMATION; SECONDARY STRUCTURE; MOLECULAR-CLONING; DOWN-SYNDROME; WILD-TYPE; ENDOSULFINE; EXPRESSION	alpha-Synuclein (AS) is an intrinsically unstructured protein in aqueous solution but is capable of forming beta-sheet-rich fibrils that accumulate as intracytoplasmic inclusions in Parkinson disease and certain other neurological disorders. However, AS binding to phospholipid membranes leads to a distinct change in protein conformation, stabilizing an extended amphipathic alpha-helical domain reminiscent of the exchangeable apolipoproteins. To better understand the significance of this conformational change, we devised a novel bacteriophage display screen to identify protein binding partners of helical AS and have identified 20 proteins with roles in diverse cellular processes related to membrane trafficking, ion channel modulation, redox metabolism, and gene regulation. To verify that the screen identifies proteins with specificity for helical AS, we further characterized one of these candidates, endosulfine alpha (ENSA), a small cAMP-regulated phosphoprotein implicated in the regulation of insulin secretion but also expressed abundantly in the brain. We used solution NMR to probe the interaction between ENSA and AS on the surface of SDS micelles. Chemical shift perturbation mapping experiments indicate that ENSA interacts specifically with residues in the N-terminal helical domain of AS in the presence of SDS but not in aqueous buffer lacking SDS. The ENSA-related protein ARPP-19 (cAMP-regulated phosphoprotein 19) also displays specific interactions with helical AS. These results confirm that the helical N terminus of AS can mediate specific interactions with other proteins and suggest that membrane binding may regulate the physiological activity of AS in vivo.	Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; Univ Illinois, Dept Chem, Urbana, IL 61801 USA; Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	George, JM (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, 524 Burrill Hall,407 S Goodwin Ave, Urbana, IL 61801 USA.	j-george@uiuc.edu	Woods, Wendy/B-6602-2008; George, Julia M/B-2169-2008	George, Julia M/0000-0001-6194-6914; Zhou, Donghua/0000-0002-6638-4014	NIA NIH HHS [R01 AG 13762] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG013762] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Ahn BH, 2002, J BIOL CHEM, V277, P12334, DOI 10.1074/jbc.M110414200; Alim MA, 2004, J ALZHEIMERS DIS, V6, P435; BARENHOLZ Y, 1977, BIOCHEMISTRY-US, V16, P2806, DOI 10.1021/bi00631a035; BOETTCHER JM, 2007, IN PRESS BIOMOL NMR; Bussell R, 2003, J MOL BIOL, V329, P763, DOI 10.1016/S0022-2836(03)00520-5; Bussell R, 2001, J BIOL CHEM, V276, P45996, DOI 10.1074/jbc.M106777200; Cabin DE, 2002, J NEUROSCI, V22, P8797; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Clayton DF, 1998, TRENDS NEUROSCI, V21, P249, DOI 10.1016/S0166-2236(97)01213-7; Dafforn TR, 2004, EMBO REP, V5, P1046, DOI 10.1038/sj.embor.7400276; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; de Beer T, 1998, SCIENCE, V281, P1357, DOI 10.1126/science.281.5381.1357; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dou JT, 2003, J NEUROCHEM, V87, P1086, DOI 10.1046/j.1471-4159.2003.02094.x; Dulubova I, 2001, J NEUROCHEM, V77, P229, DOI 10.1046/j.1471-4159.2001.00191.x; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Elkon H, 2002, J MOL NEUROSCI, V18, P229, DOI 10.1385/JMN:18:3:229; Engelender S, 1999, NAT GENET, V22, P110, DOI 10.1038/8820; Galvin JE, 2001, ARCH NEUROL-CHICAGO, V58, P186, DOI 10.1001/archneur.58.2.186; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Gerard M, 2006, FASEB J, V20, P524, DOI 10.1096/fj.05-5126fje; GODDARD TD, 2005, SPARKY3 VESION 3 112; Goers J, 2003, BIOCHEMISTRY-US, V42, P8465, DOI 10.1021/bi0341152; Gros L, 2002, DIABETOLOGIA, V45, P703, DOI 10.1007/s00125-002-0794-9; Heron L, 1998, P NATL ACAD SCI USA, V95, P8387, DOI 10.1073/pnas.95.14.8387; Hilfiker S, 2005, J NEUROSCI, V25, P2658, DOI 10.1523/JNEUROSCI.4278-04.2005; Hilfiker S, 1998, NAT NEUROSCI, V1, P29, DOI 10.1038/229; Huang HB, 2001, J BIOMOL NMR, V19, P383, DOI 10.1023/A:1011214512601; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Ihara M, 2003, J BIOL CHEM, V278, P24095, DOI 10.1074/jbc.M301352200; Jao CC, 2004, P NATL ACAD SCI USA, V101, P8331, DOI 10.1073/pnas.0400553101; Jensen PH, 1997, BIOCHEM J, V323, P539, DOI 10.1042/bj3230539; Jiang YF, 2004, CANCER RES, V64, P4539, DOI 10.1158/0008-5472.CAN-03-3650; Johnson PE, 1996, BIOCHEMISTRY-US, V35, P13895, DOI 10.1021/bi961186a; Kim SH, 2001, J NEURAL TRANSM-SUPP, P263; Kim SH, 2001, NEUROSCI LETT, V310, P77, DOI 10.1016/S0304-3940(01)02025-0; Kim SH, 2001, J NEURAL TRANSM-SUPP, P1; Kloepper KD, 2006, PROTEIN EXPRES PURIF, V48, P112, DOI 10.1016/j.pep.2006.02.009; Kontopoulos E, 2006, HUM MOL GENET, V15, P3012, DOI 10.1093/hmg/ddl243; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kweon GR, 2004, J BIOL CHEM, V279, P51783, DOI 10.1074/jbc.M407336200; Labeikovsky W, 2007, J MOL BIOL, V367, P1370, DOI 10.1016/j.jmb.2007.01.049; Lee D, 2002, J NEUROCHEM, V82, P1007, DOI 10.1046/j.1471-4159.2002.01024.x; Lee FJS, 2001, FASEB J, V15, P916, DOI 10.1096/fj.00-0334com; Liss B, 2005, NAT NEUROSCI, V8, P1742, DOI 10.1038/nn1570; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Menegon A, 2006, J NEUROSCI, V26, P11670, DOI 10.1523/JNEUROSCI.3321-06.2006; Meyers MB, 1998, J BIOL CHEM, V273, P18930, DOI 10.1074/jbc.273.30.18930; Miele AE, 2004, NAT STRUCT MOL BIOL, V11, P242, DOI 10.1038/nsmb736; Naciff JM, 1996, AM J PHYSIOL-CELL PH, V271, pC2004; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Palmer AG, 1996, J PHYS CHEM-US, V100, P13293, DOI 10.1021/jp9606117; Payton JE, 2001, MOL BRAIN RES, V95, P138, DOI 10.1016/S0169-328X(01)00257-1; Perrin RJ, 2000, J BIOL CHEM, V275, P34393, DOI 10.1074/jbc.M004851200; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Pontius J., 2003, NCBI HDB, P1; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; SEGREST JP, 1992, J LIPID RES, V33, P141; Smith WW, 2005, J NEUROSCI, V25, P5544, DOI 10.1523/JNEUROSCI.0482-05.2005; Spiliotis ET, 2006, J CELL SCI, V119, P4, DOI 10.1242/jcs.02746; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Thameem F, 2004, MOL GENET METAB, V81, P16, DOI 10.1016/j.ymgme.2003.09.013; Tieu K, 2003, J CLIN INVEST, V112, P892, DOI 10.1172/JCI200318797; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Ulmer TS, 2005, J BIOL CHEM, V280, P43179, DOI 10.1074/jbc.M507624200; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Utton MA, 2005, J CELL SCI, V118, P4645, DOI 10.1242/jcs.02558; Ved R, 2005, J BIOL CHEM, V280, P42655, DOI 10.1074/jbc.M505910200; Virsolvy A, 2002, BRIT J PHARMACOL, V135, P1810, DOI 10.1038/sj.bjp.0704635; VIRSOLVYVERGINE A, 1992, P NATL ACAD SCI USA, V89, P6629, DOI 10.1073/pnas.89.14.6629; WALAAS SI, 1983, J NEUROSCI, V3, P302; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b	76	60	67	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34555	34567		10.1074/jbc.M705283200	http://dx.doi.org/10.1074/jbc.M705283200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17893145	hybrid			2022-12-25	WOS:000251145700070
J	Chen, M; Guerrero, AD; Huang, L; Shabier, Z; Pan, M; Tan, TH; Wang, J				Chen, Min; Guerrero, Alan D.; Huang, Li; Shabier, Zainuer; Pan, Michael; Tan, Tse-Hua; Wang, Jin			Caspase-9-induced mitochondrial disruption through cleavage of anti-apoptotic BCL-2 family members	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASPASE-MEDIATED CLEAVAGE; CYTOCHROME-C RELEASE; CELL-DEATH; IMMUNE-SYSTEM; ACTIVATION; PROTEIN; MCL-1; REQUIREMENT; EXECUTIONER; APOPTOSOME	Mitochondrial disruption during apoptosis results in the release of cytochrome c that forms apoptosomes with Apaf-1 and caspase-9. Activation of caspase-9 by dimerization in apoptosomes then triggers a caspase signaling cascade. In addition, other apoptosis signaling molecules released from the mitochondrion, such as apoptosis-inducing factor and endonuclease G, may induce caspase-9-independent apoptosis. To determine the signaling events induced by caspase-9, we used chemically induced dimerization for specific activation of caspase-9. We observed that caspase-9 dimerization resulted in the loss of mitochondrial membrane potential and the cleavage of anti-apoptotic Bcl-2, Bcl-xL, and Mcl-1. Moreover, cleavage-resistant Bcl-2, Bcl-xL, or Mcl-1 potently inhibited caspase-9-dependent loss of mitochondrial membrane potential and the release of cytochrome c. Our data suggest that a caspase-9 signaling cascade induces feedback disruption of the mitochondrion through cleavage of anti-apoptotic Bcl-2, Bcl-xL, and Mcl-1.	Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA	Baylor College of Medicine	Wang, J (corresponding author), Baylor Coll Med, Dept Immunol, 1 Baylor Plaza,N920, Houston, TX 77030 USA.	jinwang@bcm.edu	Tan, Tse-Hua/ABD-7080-2021; Tan, Tse-Hua/E-3983-2010	Tan, Tse-Hua/0000-0003-4969-3170; Tan, Tse-Hua/0000-0003-4969-3170; Chen, Min/0000-0002-0093-9056; Wang, Jin/0000-0002-3116-0838				Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Cepero E, 2005, ONCOGENE, V24, P6354, DOI 10.1038/sj.onc.1208793; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Chao Y, 2005, PLOS BIOL, V3, P1079, DOI 10.1371/journal.pbio.0030183; Chen M, 2002, J BIOL CHEM, V277, P50761, DOI 10.1074/jbc.M210356200; Cheng EHY, 1997, SCIENCE, V278, P1966, DOI 10.1126/science.278.5345.1966; Clem RJ, 1998, P NATL ACAD SCI USA, V95, P554, DOI 10.1073/pnas.95.2.554; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Engels IH, 2000, ONCOGENE, V19, P4563, DOI 10.1038/sj.onc.1203824; Fan LF, 1999, HUM GENE THER, V10, P2273, DOI 10.1089/10430349950016924; Fujita N, 1998, ONCOGENE, V17, P1295, DOI 10.1038/sj.onc.1202065; Gottlieb RA, 2002, METHODS, V26, P341, DOI 10.1016/S1046-2023(02)00040-3; Grandgirard D, 1998, EMBO J, V17, P1268, DOI 10.1093/emboj/17.5.1268; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Herrant M, 2004, ONCOGENE, V23, P7863, DOI 10.1038/sj.onc.1208069; Jonas EA, 2004, P NATL ACAD SCI USA, V101, P13590, DOI 10.1073/pnas.0401372101; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; LI P, 2004, CELL, V116, P57; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Michels J, 2004, ONCOGENE, V23, P4818, DOI 10.1038/sj.onc.1207648; Opferman JT, 2003, NAT IMMUNOL, V4, P410, DOI 10.1038/ni0503-410; Pop C, 2006, MOL CELL, V22, P269, DOI 10.1016/j.molcel.2006.03.009; Rathore N, 2004, J BIOL CHEM, V279, P39358, DOI 10.1074/jbc.M406712200; Ravagnan L, 2002, J CELL PHYSIOL, V192, P131, DOI 10.1002/jcp.10111; Renatus M, 2001, P NATL ACAD SCI USA, V98, P14250, DOI 10.1073/pnas.231465798; Ricci JE, 2003, J CELL BIOL, V160, P65, DOI 10.1083/jcb.200208089; Slee EA, 2000, CELL DEATH DIFFER, V7, P556, DOI 10.1038/sj.cdd.4400689; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Susin SA, 1997, J EXP MED, V186, P25, DOI 10.1084/jem.186.1.25; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Weng CJ, 2005, J BIOL CHEM, V280, P10491, DOI 10.1074/jbc.M412819200; YANG J, 1997, SCIENCE, V275, P1132; Yu XC, 2005, STRUCTURE, V13, P1725, DOI 10.1016/j.str.2005.09.006	44	81	89	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33888	33895		10.1074/jbc.M702969200	http://dx.doi.org/10.1074/jbc.M702969200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17893147	hybrid			2022-12-25	WOS:000250840200070
J	Lecuyer, E; Lariviere, S; Sincennes, MC; Haman, A; Lahlil, R; Todorova, M; Tremblay, M; Wilkes, BC; Hoang, T				Lecuyer, Eric; Lariviere, Simon; Sincennes, Marie-Claude; Haman, Andre; Lahlil, Rachid; Todorova, Margarita; Tremblay, Mathieu; Wilkes, Brian C.; Hoang, Trang			Protein stability and transcription factor complex assembly determined by the SCL-LMO2 interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC STEM-CELLS; C-KIT EXPRESSION; SCL GENE-PRODUCT; LIM-DOMAIN; ERYTHROID-DIFFERENTIATION; APTEROUS ACTIVITY; BINDING PROTEINS; LINEAGE CHOICE; ADULT-MOUSE; LMO2 ACT	Gene expression programs are established by networks of interacting transcription factors. The basic helix-loop-helix factor SCL and the LIM-only protein LMO2 are components of transcription factor complexes that are essential for hematopoiesis. Here we show that LMO2 and SCL are predominant interaction partners in hematopoietic cells and that this interaction occurs through a conserved interface residing in the loop and helix 2 of SCL. This interaction nucleates the assembly of SCL complexes on DNA and is required for target gene induction and for the stimulation of erythroid and megakaryocytic differentiation. We also demonstrate that SCL determines LMO2 protein levels in hematopoietic cells and reveal that interaction with SCL prevents LMO2 degradation by the proteasome. We propose that the SCL-LMO2 interaction couples protein stabilization with higher order protein complex assembly, thus providing a powerful means of modulating the stoichiometry and spatiotemporal activity of SCL complexes. This interaction likely provides a rate-limiting step in the transcriptional control of hematopoiesis and leukemia, and similar mechanisms may operate to control the assembly of diverse protein modules.	Univ Montreal, Inst Rech Immunol & Cancerol, Montreal, PQ H3C 2J7, Canada; Univ Montreal, Dept Mol Biol, Montreal, PQ H3C 2J7, Canada; Univ Montreal, Dept Pharmacol, Montreal, PQ H3C 2J7, Canada; Univ Montreal, Dept Biochem, Montreal, PQ H3C 2J7, Canada; Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Hoang, T (corresponding author), Univ Montreal, Inst Rech Immunol & Cancerol, POB 6128,Downtown Branch, Montreal, PQ H3C 2J7, Canada.	Trang.hoang@umontreal.ca	Lahlil, Rachid/AAK-1654-2020	Lahlil, Rachid/0000-0003-2966-6386; Sincennes, Marie-Claude/0000-0002-1961-426X				APLAN PD, 1992, EMBO J, V11, P4073, DOI 10.1002/j.1460-2075.1992.tb05500.x; Bao JX, 2000, DEVELOPMENT, V127, P425; Begley CG, 1999, BLOOD, V93, P2760; Calkhoven CF, 2003, GENE DEV, V17, P959, DOI 10.1101/gad.251903; Chang DF, 2003, DEV CELL, V4, P107, DOI 10.1016/S1534-5807(02)00396-9; CHOWDARY DR, 1994, MOL CELL BIOL, V14, P1997, DOI 10.1128/MCB.14.3.1997; Coulombe P, 2004, MOL CELL BIOL, V24, P6140, DOI 10.1128/MCB.24.14.6140-6150.2004; Deane JE, 2003, EMBO J, V22, P2224, DOI 10.1093/emboj/cdg196; Elefanty AG, 1998, P NATL ACAD SCI USA, V95, P11897, DOI 10.1073/pnas.95.20.11897; ELLENBERGER T, 1994, GENE DEV, V8, P970, DOI 10.1101/gad.8.8.970; GIESE K, 1995, GENE DEV, V9, P995, DOI 10.1101/gad.9.8.995; Goardon N, 2006, EMBO J, V25, P357, DOI 10.1038/sj.emboj.7600934; GROSSCHEDL R, 1995, CURR OPIN CELL BIOL, V7, P362, DOI 10.1016/0955-0674(95)80091-3; Grutz GG, 1998, EMBO J, V17, P4594, DOI 10.1093/emboj/17.16.4594; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hall MA, 2003, P NATL ACAD SCI USA, V100, P992, DOI 10.1073/pnas.0237324100; Hiratani I, 2003, DEVELOPMENT, V130, P4161, DOI 10.1242/dev.00621; Hoang T, 1996, BLOOD, V87, P102; Huang SM, 2000, EMBO J, V19, P6792, DOI 10.1093/emboj/19.24.6792; Kim TK, 1997, MOL CELL, V1, P119, DOI 10.1016/S1097-2765(00)80013-1; Kong YF, 1997, MOL CELL BIOL, V17, P4750, DOI 10.1128/MCB.17.8.4750; Krosl G, 1998, J EXP MED, V188, P439, DOI 10.1084/jem.188.3.439; Lahlil R, 2004, MOL CELL BIOL, V24, P1439, DOI 10.1128/MCB.24.4.1439-1452.2004; Lecuyer E, 2004, EXP HEMATOL, V32, P11, DOI 10.1016/j.exphem.2003.10.010; Lecuyer E, 2002, BLOOD, V100, P2430, DOI 10.1182/blood-2002-02-0568; Lipford JR, 2003, NAT CELL BIOL, V5, P845, DOI 10.1038/ncb1003-845; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Mead PE, 2001, DEVELOPMENT, V128, P2301; Meier N, 2006, DEVELOPMENT, V133, P4913, DOI 10.1242/dev.02656; Merika M, 2001, CURR OPIN GENET DEV, V11, P205, DOI 10.1016/S0959-437X(00)00180-5; Mikkola HKA, 2003, NATURE, V421, P547, DOI 10.1038/nature01345; Milan M, 1999, MOL CELL, V4, P267, DOI 10.1016/S1097-2765(00)80374-3; Milan M, 2000, DEVELOPMENT, V127, P3069; Molinari E, 1999, EMBO J, V18, P6439, DOI 10.1093/emboj/18.22.6439; Ostendorff HP, 2002, NATURE, V416, P99, DOI 10.1038/416099a; Patterson LJ, 2007, BLOOD, V109, P2389, DOI 10.1182/blood-2006-02-003087; Porcher C, 1996, CELL, V86, P47, DOI 10.1016/S0092-8674(00)80076-8; Rabbitts TH, 1998, GENE DEV, V12, P2651, DOI 10.1101/gad.12.17.2651; ROBB L, 1995, P NATL ACAD SCI USA, V92, P7075, DOI 10.1073/pnas.92.15.7075; Robb L, 1996, EMBO J, V15, P4123, DOI 10.1002/j.1460-2075.1996.tb00787.x; Salghetti SE, 2000, P NATL ACAD SCI USA, V97, P3118, DOI 10.1073/pnas.050007597; Schlaeger TM, 2004, MOL CELL BIOL, V24, P7491, DOI 10.1128/MCB.24.17.7491-7502.2004; Schuh AH, 2005, MOL CELL BIOL, V25, P10235, DOI 10.1128/MCB.25.23.10235-10250.2005; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; Shivdasani RA, 1996, BLOOD, V87, P4025, DOI 10.1182/blood.V87.10.4025.bloodjournal87104025; Sieweke MH, 1998, CURR OPIN GENET DEV, V8, P545, DOI 10.1016/S0959-437X(98)80009-9; Silver L, 1997, BLOOD, V89, P1154, DOI 10.1182/blood.V89.4.1154; Swiers G, 2006, DEV BIOL, V294, P525, DOI 10.1016/j.ydbio.2006.02.051; Teranoa T, 2005, EXP HEMATOL, V33, P641, DOI 10.1016/j.exphem.2005.01.018; Thomas D, 2000, CURR BIOL, V10, pR341, DOI 10.1016/S0960-9822(00)00462-0; TJIAN R, 1994, CELL, V77, P5, DOI 10.1016/0092-8674(94)90227-5; Tremblay M, 2003, J BIOL CHEM, V278, P12680, DOI 10.1074/jbc.M209870200; Visvader JE, 1997, P NATL ACAD SCI USA, V94, P13707, DOI 10.1073/pnas.94.25.13707; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; WARREN AJ, 1994, CELL, V78, P45, DOI 10.1016/0092-8674(94)90571-1; Weihe U, 2001, DEVELOPMENT, V128, P4615; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Xu ZX, 2007, GENE DEV, V21, P942, DOI 10.1101/gad.1528507; Xu ZX, 2006, BIOCHEM J, V399, P297, DOI 10.1042/BJ20060873; Xu ZX, 2003, MOL CELL BIOL, V23, P7585, DOI 10.1128/MCB.23.21.7585-7599.2003; Yamada Y, 1998, P NATL ACAD SCI USA, V95, P3890, DOI 10.1073/pnas.95.7.3890	61	34	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46							33649	10.1074/jbc.M703939200	http://dx.doi.org/10.1074/jbc.M703939200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17878155	hybrid			2022-12-25	WOS:000250840200046
J	Abraham, JM; Sato, F; Cheng, YL; Paun, B; Kan, T; Olaru, A; Jin, Z; Yang, J; Agarwal, R; David, S; Hamilton, JP; Ito, T; Mori, Y; Meltzer, SJ				Abraham, John M.; Sato, Fumiaki; Cheng, Yulan; Paun, Bogdan; Kan, Takatsugu; Olaru, Alexandru; Jin, Zhe; Yang, Jian; Agarwal, Rachana; David, Stefan; Hamilton, James P.; Ito, Tetsuo; Mori, Yuriko; Meltzer, Stephen J.			Novel Decapeptides that Bind Avidly and Deliver Radioisotope to Colon Cancer Cells	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; BREAST-CANCER; LOW-GRADE; THERAPY; CHEMOTHERAPY; TRASTUZUMAB; TRIAL; PLUS; RADIOIMMUNOTHERAPY; PEPTIDES	Background. The rapidly growing field of targeted tumor therapy often utilizes an antibody, sometimes tagged with a tumor-ablating material such as radioisotope, directed against a specific molecule. Methodology/Principal Findings. This report describes the discovery of nine novel decapeptides which can be radioactively labeled, bind to, and deliver P-32 to colon cancer cells. The decapeptides vary from one another by one to three amino acids and demonstrate vastly different binding abilities. The most avidly binding decapeptide can permanently deliver very high levels of radioisotope to the adenocarcinoma cancer cell lines at an efficiency 35 to 150 times greater than to a variety of other cell types, including cell lines derived from other types of cancer or from normal tissue. Conclusions/Significance. This experimental approach represents a new example of a strategy, termed peptide binding therapy, for the potential treatment of colorectal and other adenocarcinomas.	[Abraham, John M.; Sato, Fumiaki; Cheng, Yulan; Paun, Bogdan; Kan, Takatsugu; Olaru, Alexandru; Jin, Zhe; Yang, Jian; Agarwal, Rachana; David, Stefan; Hamilton, James P.; Ito, Tetsuo; Mori, Yuriko; Meltzer, Stephen J.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Meltzer, Stephen J.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Abraham, JM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	jabrah14@jhmi.edu			National Cancer Institute [2RO1CA095323-14, 2RO1CA07705709, 1R01CA001808-05, 7R21/R33CA106763]; NATIONAL CANCER INSTITUTE [R01CA077057, R01CA001808, R01CA095323, R21CA106763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK067872] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants 2RO1CA095323-14, 2RO1CA07705709, 1R01CA001808-05 and 7R21/ R33CA106763 from the National Cancer Institute.	Aina OH, 2005, MOL CANCER THER, V4, P806, DOI 10.1158/1535-7163.MCT-05-0029; Aina OH, 2002, BIOPOLYMERS, V66, P184, DOI 10.1002/bip.10257; Boerman OC, 2007, ANTI-CANCER AGENT ME, V7, P335, DOI 10.2174/187152007780618126; Cilley JC, 2007, EXPERT OPIN BIOL TH, V7, P739, DOI 10.1517/14712598.7.5.739; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Davis TA, 2000, J CLIN ONCOL, V18, P3135, DOI 10.1200/JCO.2000.18.17.3135; Edwards BK, 2005, JNCI-J NATL CANCER I, V97, P1407, DOI 10.1093/jnci/dji289; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kreitman RJ, 2003, CURR OPIN MOL THER, V5, P44; Kreitman RJ, 2006, AAPS J, V8, pE532, DOI 10.1208/aapsj080363; Kreitman RJ, 2006, CURR DRUG TARGETS, V7, P1301, DOI 10.2174/138945006778559139; Nahta R, 2007, ONCOGENE, V26, P3637, DOI 10.1038/sj.onc.1210379; Okarvi SM, 2004, MED RES REV, V24, P357, DOI 10.1002/med.20002; Presta LG, 1997, CANCER RES, V57, P4593; Rini BI, 2007, CLIN CANCER RES, V13, p741S, DOI 10.1158/1078-0432.CCR-06-2110; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Siberil S, 2007, CRIT REV ONCOL HEMAT, V62, P26, DOI 10.1016/j.critrevonc.2006.12.003; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Tan-Chiu E, 2005, J CLIN ONCOL, V23, P7811, DOI 10.1200/JCO.2005.02.4091; Van Cutsem E, 2007, J CLIN ONCOL, V25, P1658, DOI 10.1200/JCO.2006.08.1620; Vose JM, 2004, ONCOLOGIST, V9, P160, DOI 10.1634/theoncologist.9-2-160; Wangler C, 2007, PROTEIN PEPTIDE LETT, V14, P273, DOI 10.2174/092986607780090874; Wiseman GA, 2001, CRIT REV ONCOL HEMAT, V39, P181, DOI 10.1016/S1040-8428(01)00107-X; Wu AM, 2005, NAT BIOTECHNOL, V23, P1137, DOI 10.1038/nbt1141; Zafir-Lavie I, 2007, ONCOGENE, V26, P3714, DOI 10.1038/sj.onc.1210372	25	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e964	10.1371/journal.pone.0000964	http://dx.doi.org/10.1371/journal.pone.0000964			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912343	gold, Green Published, Green Submitted			2022-12-25	WOS:000207455900002
J	Linksvayer, TA				Linksvayer, Timothy A.			Ant Species Differences Determined by Epistasis between Brood and Worker Genomes	PLOS ONE			English	Article							GENUS LEPTOTHORAX HYMENOPTERA; APIS-MELLIFERA; INTERACTING PHENOTYPES; MULTILEVEL SELECTION; GENETIC ARCHITECTURE; EVOLUTIONARY PROCESS; SOCIAL EVOLUTION; BEHAVIOR; CONFLICT; ENVIRONMENT	Epistasis arising from physiological interactions between gene products often contributes to species differences, particularly those involved in reproductive isolation. In social organisms, phenotypes are influenced by the genotypes of multiple interacting individuals. In theory, social interactions can give rise to an additional type of epistasis between the genomes of social partners that can contribute to species differences. Using a full-factorial cross-fostering design with three species of closely related Temnothorax ants, I found that adult worker size was determined by an interaction between the genotypes of developing brood and care-giving workers, i.e. intergenomic epistasis. Such intergenomic social epistasis provides a strong signature of coevolution between social partners. These results demonstrate that just as physiologically interacting genes coevolve, diverge, and contribute to species differences, so do socially interacting genes. Coevolution and conflict between social partners, especially relatives such as parents and offspring, has long been recognized as having widespread evolutionary effects. This coevolutionary process may often result in coevolved socially-interacting gene complexes that contribute to species differences.	[Linksvayer, Timothy A.] Indiana Univ, Dept Biol, Bloomington, IN USA	Indiana University System; Indiana University Bloomington	Linksvayer, TA (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	tlinksvayer@gmail.com		Linksvayer, Timothy/0000-0001-7034-1546	NSF; Indiana Academy of Sciences	NSF(National Science Foundation (NSF)); Indiana Academy of Sciences	This research was supported by an NSF Graduate Research Fellowship and a grant from the Indiana Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AF, 2001, AM NAT, V158, P308, DOI 10.1086/321324; Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; Alloway T.M., 1982, Psyche (Cambridge), V89, P249, DOI 10.1155/1982/64124; Bijma P, 2007, GENETICS, V175, P277, DOI 10.1534/genetics.106.062711; Blows MW, 2003, AM NAT, V161, P240, DOI 10.1086/345783; Bourke AFG, 1999, BEHAV ECOL SOCIOBIOL, V46, P287, DOI 10.1007/s002650050622; Brillet C, 2002, ETHOLOGY, V108, P115, DOI 10.1046/j.1439-0310.2002.00760.x; Burke JM, 2001, ANNU REV GENET, V35, P31, DOI 10.1146/annurev.genet.35.102401.085719; Buschinger A., 1973, EFFECTS TEMPERATURE, P229; CALDERONE NW, 1992, BEHAV ECOL SOCIOBIOL, V30, P219, DOI 10.1007/BF00166706; Calis JNM, 2002, APIDOLOGIE, V33, P193, DOI 10.1051/apido:2002009; Cheverud James M., 1994, P67; Chippindale AK, 2001, P NATL ACAD SCI USA, V98, P1671, DOI 10.1073/pnas.041378098; DASILVA DLN, 1977, BOLM ZOOL U S PAULO, V2, P7; Dobzhansky T, 1936, GENETICS, V21, P113; Foitzik S, 1999, ENTOMOL GEN, V24, P065; Gardner A, 2007, AM NAT, V169, P207, DOI 10.1086/510602; Goodnight CJ, 2005, POPUL ECOL, V47, P3, DOI 10.1007/s10144-005-0207-2; Goodnight CJ, 1997, AM NAT, V150, pS59, DOI 10.1086/286050; Griffing B., 1977, Proceedings of the International Conference on Quantitative Genetics, August 16-21, 1976., P413; HAMILTON WD, 1970, NATURE, V228, P1218, DOI 10.1038/2281218a0; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Herbers J.M., 1983, Psyche (Cambridge), V90, P361, DOI 10.1155/1983/52489; Holldobler B., 1990, pi; Hunt J, 2002, P NATL ACAD SCI USA, V99, P6828, DOI 10.1073/pnas.092676199; Kang MS, 2004, GENETIC ANAL COMPLEX; Kaptein N, 2005, ANIM BEHAV, V69, P293, DOI 10.1016/j.anbehav.2004.04.012; KELLER L, 1995, FUNCT ECOL, V9, P667, DOI 10.2307/2390159; Kolliker M, 2005, AM NAT, V166, P506, DOI 10.1086/491687; LE CONTE Y, 1995, J ECON ENTOMOL, V88, P798, DOI 10.1093/jee/88.4.798; Linksvayer TA, 2005, Q REV BIOL, V80, P317, DOI 10.1086/432266; LINKSVAYER TA, 2007, BEHAV ECOL IN PRESS; Linksvayer TA, 2006, EVOLUTION, V60, P2552, DOI 10.1111/j.0014-3820.2006.tb01889.x; LUMSDEN CJ, 1982, J THEOR BIOL, V95, P749, DOI 10.1016/0022-5193(82)90352-6; LYNCH M, 1987, P NATL ACAD SCI USA, V84, P8507, DOI 10.1073/pnas.84.23.8507; Lynch M., 1998, GENETICS ANAL QUANTI; Mackay WP, 2000, SOCIOBIOLOGY, V36, P265; MCCAULEY DE, 1980, EVOLUTION, V34, P813, DOI [10.2307/2408035, 10.1111/j.1558-5646.1980.tb04020.x]; Moore AJ, 1997, EVOLUTION, V51, P1352, DOI 10.1111/j.1558-5646.1997.tb01458.x; Moore AJ, 2005, AM NAT, V165, pS88, DOI 10.1086/429354; Moore AJ, 2002, AM NAT, V160, pS186, DOI 10.1086/342899; MORITZ RFA, 1987, BEHAV ECOL SOCIOBIOL, V21, P53, DOI 10.1007/BF00324435; Muller HJ, 1942, BIOL S, V6, P71; NONACS P, 1992, EVOLUTION, V46, P1605, DOI 10.1111/j.1558-5646.1992.tb01157.x; Oldroyd BP, 2001, BEHAV ECOL SOCIOBIOL, V50, P366, DOI 10.1007/s002650100376; Orr HA, 2001, TRENDS ECOL EVOL, V16, P343; Pankiw T, 2002, ANIM BEHAV, V64, P663, DOI 10.1006/anbe.2002.3096; Plateaux L., 1985, Actes des Colloques Insectes Sociaux, V2, P203; QUELLER DC, 1985, NATURE, V318, P366, DOI 10.1038/318366a0; Rice WR, 1997, BEHAV ECOL SOCIOBIOL, V41, P1, DOI 10.1007/s002650050357; Ross KG, 2002, BEHAV ECOL SOCIOBIOL, V51, P287, DOI [10.1007/s00265-001-0431-5, 10.1007/S00265-001-0431-5]; Ruppell O, 2001, HEREDITY, V87, P33, DOI 10.1046/j.1365-2540.2001.00904.x; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; TRIVERS RL, 1976, SCIENCE, V191, P249, DOI 10.1126/science.1108197; WADE MJ, 1980, SCIENCE, V210, P665, DOI 10.1126/science.210.4470.665; WADE MJ, 1979, AM NAT, V113, P399, DOI 10.1086/283398; Wade MJ, 1998, MATERNAL EFFECTS AS ADAPTATIONS, P5; Wenseleers T, 2006, J EVOLUTION BIOL, V19, P1419, DOI 10.1111/j.1420-9101.2006.01144.x; WESTEBERHARD MJ, 1983, Q REV BIOL, V58, P155, DOI 10.1086/413215; WHITE JM, 1968, GENETICS, V60, P395; WHITLOCK MC, 1995, ANNU REV ECOL SYST, V26, P601, DOI 10.1146/annurev.es.26.110195.003125; WILLHAM RL, 1963, BIOMETRICS, V19, P18, DOI 10.2307/2527570; WILSON EO, 1985, FORTS ZOOL, V31, P307; Wolf JB, 2003, P NATL ACAD SCI USA, V100, P4655, DOI 10.1073/pnas.0635741100; Wolf JB, 2000, EVOLUTION, V54, P1882, DOI 10.1111/j.0014-3820.2000.tb01235.x; Wolf JB, 1998, EVOLUTION, V52, P299, DOI [10.1111/j.1558-5646.1998.tb01632.x, 10.2307/2411068]; Wolf JB, 1999, AM NAT, V153, P254, DOI 10.1086/303168; Wolf JB, 2002, HEREDITY, V89, P300, DOI 10.1038/sj.hdy.6800140; Wolf JB., 2000, EPISTASIS EVOLUTIONA, P158; WOLF JB, EPISTASIS EVOLUTIONA; Wright S, 1931, GENETICS, V16, P0097	71	47	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e994	10.1371/journal.pone.0000994	http://dx.doi.org/10.1371/journal.pone.0000994			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912371	gold, Green Submitted, Green Published			2022-12-25	WOS:000207455900030
J	Lesueur, F; Oudot, T; Heath, S; Foglio, M; Lathrop, M; Prud'homme, JF; Fischer, J				Lesueur, Fabienne; Oudot, Tiphaine; Heath, Simon; Foglio, Mario; Lathrop, Mark; Prud'homme, Jean-Francois; Fischer, Judith			ADAM33, a New Candidate for Psoriasis Susceptibility	PLOS ONE			English	Article							GENOME-WIDE SEARCH; LINKAGE DISEQUILIBRIUM; ATOPIC-DERMATITIS; CHROMOSOME 6P; HLA-C; GENE; IDENTIFICATION; ASTHMA; PSORS1; POLYMORPHISMS	Psoriasis is a chronic skin disorder with multifactorial etiology. In a recent study, we reported results of a genome-wide scan on 46 French extended families presenting with plaque psoriasis. In addition to unambiguous linkage to the major susceptibility locus PSORS1 on Chromosome 6p21, we provided evidence for a susceptibility locus on Chromosome 20p13. To follow up this novel psoriasis susceptibility locus we used a family-based association test (FBAT) for an association scan over the 17 Mb candidate region. A total of 85 uncorrelated SNP markers located in 65 genes of the region were initially investigated in the same set of large families used for the genome wide search, which consisted of 295 nuclear families. When positive association was obtained for a SNP, candidate genes nearby were explored more in detail using a denser set of SNPs. Thus, the gene ADAM33 was found to be significantly associated with psoriasis in this family set (The best association was on a 3-SNP haplotype P = 0.00004, based on 1,000,000 permutations). This association was independent of PSORS1. ADAM33 has been previously associated with asthma, which demonstrates that immune system diseases may be controlled by common susceptibility genes with general effects on dermal inflammation and immunity. The identification of ADAM33 as a psoriasis susceptibility gene identified by positional cloning in an outbred population should provide insights into the pathogenesis and natural history of this common disease.	[Lesueur, Fabienne; Oudot, Tiphaine; Heath, Simon; Foglio, Mario; Lathrop, Mark; Fischer, Judith] Ctr Natl Genotypage, Evry, France; [Prud'homme, Jean-Francois] Genethon, Evry, France	CEA; UDICE-French Research Universities; Universite Paris Saclay	Lesueur, F (corresponding author), Ctr Natl Genotypage, Evry, France.	lesueurf@iarc.fr; fischer@cng.fr	Foglio, mary A./B-9149-2012; Fischer, Judith/E-6327-2016; Heath, Simon C/J-4138-2012; Lesueur, Fabienne/R-2178-2017	Foglio, mary A./0000-0001-7715-4452; Fischer, Judith/0000-0002-8580-8118; Heath, Simon C/0000-0002-9550-0897; Lesueur, Fabienne/0000-0001-7404-4549	Centre National de GeNotypage (CNG); Association Francaise contre les Myopathies (AFM); Genethon; GenopA'le	Centre National de GeNotypage (CNG); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Genethon; GenopA'le	This study was supported by the Centre National de GeNotypage (CNG), the Association Francaise contre les Myopathies (AFM), and Genethon. FL was recipient of a fellowship from GenopA'le.	Allen M, 2003, AM J HUM GENET, V73, P430; Asumalahti K, 2002, HUM MOL GENET, V11, P589, DOI 10.1093/hmg/11.5.589; Becker KG, 1998, P NATL ACAD SCI USA, V95, P9979, DOI 10.1073/pnas.95.17.9979; Bowcock AM, 2004, HUM MOL GENET, V13, pR43, DOI 10.1093/hmg/ddh094; Capon F, 2004, HUM MOL GENET, V13, P2361, DOI 10.1093/hmg/ddh273; Cebrian A, 2005, J CLIN ENDOCR METAB, V90, P6268, DOI 10.1210/jc.2004-2449; Chae SC, 2003, J HUM GENET, V48, P278, DOI 10.1007/s10038-003-0019-1; Cheng L, 2004, CLIN EXP ALLERGY, V34, P1192, DOI 10.1111/j.1365-2222.2004.02008.x; Cookson W, 1999, NATURE, V402, pB5, DOI 10.1038/35037002; Cookson WOCM, 2001, NAT GENET, V27, P372, DOI 10.1038/86867; Cox NJ, 2004, DIABETES, V53, pS19, DOI 10.2337/diabetes.53.2007.S19; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Drysdale CM, 2000, P NATL ACAD SCI USA, V97, P10483, DOI 10.1073/pnas.97.19.10483; Elder JT, 2006, J INVEST DERMATOL, V126, P1205, DOI 10.1038/sj.jid.5700357; Enlund F, 1999, HUM HERED, V49, P2, DOI 10.1159/000022832; Giardina E, 2006, HUM HERED, V61, P229, DOI 10.1159/000095059; Helms C, 2005, HUM GENET, V118, P466, DOI 10.1007/s00439-005-0048-2; Hewett D, 2002, GENOMICS, V79, P305, DOI 10.1006/geno.2002.6720; Holgate ST, 2003, THORAX, V58, P466, DOI 10.1136/thorax.58.6.466; Howard TD, 2003, J ALLERGY CLIN IMMUN, V112, P717, DOI 10.1016/S0091-6749(03)01939-0; Jannot AS, 2003, GENET EPIDEMIOL, V25, P158, DOI 10.1002/gepi.10256; Lange C, 2002, AM J HUM GENET, V71, P575, DOI 10.1086/342406; Lench N, 2005, J INVEST DERMATOL, V124, P545, DOI 10.1111/j.0022-202X.2005.23604.x; LESUEUR F, 2007, J INVESTIGATIVE 0308; Mahe E, 2002, EUR J DERMATOL, V12, P66; Nair RP, 2006, AM J HUM GENET, V78, P827, DOI 10.1086/503821; Nair RP, 1997, HUM MOL GENET, V6, P1349, DOI 10.1093/hmg/6.8.1349; Nevitt GJ, 1996, BRIT J DERMATOL, V135, P533, DOI 10.1046/j.1365-2133.1996.d01-1035.x; Powell RM, 2004, AM J RESP CELL MOL, V31, P13, DOI 10.1165/rcmb.2003-0330OC; Sagoo GS, 2004, J INVEST DERMATOL, V122, P1401, DOI 10.1111/j.0022-202X.2004.22607.x; Samuelsson L, 1999, HUM GENET, V105, P523, DOI 10.1007/s004390051141; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Stram DO, 2004, GENET EPIDEMIOL, V27, P365, DOI 10.1002/gepi.20028; Tagami H, 1997, CLIN DERMATOL, V15, P677, DOI 10.1016/S0738-081X(97)00024-2; Trembath RC, 1997, HUM MOL GENET, V6, P813, DOI 10.1093/hmg/6.5.813; Umland SP, 2003, AM J RESP CELL MOL, V29, P571, DOI 10.1165/rcmb.2003-0028OC; Van Eerdewegh P, 2002, NATURE, V418, P426, DOI 10.1038/nature00878; Veal CD, 2002, AM J HUM GENET, V71, P554, DOI 10.1086/342289; Veal CD, 2001, J MED GENET, V38, P7, DOI 10.1136/jmg.38.1.7; Vyse TJ, 1996, CELL, V85, P311, DOI 10.1016/S0092-8674(00)81110-1; Werner M, 2004, CLIN EXP ALLERGY, V34, P26, DOI 10.1111/j.1365-2222.2004.01846.x; Wigginton JE, 2005, BIOINFORMATICS, V21, P3445, DOI 10.1093/bioinformatics/bti529; Wjst M, 2007, ALLERGY, V62, P444, DOI 10.1111/j.1398-9995.2006.01298.x; Yoshinaka T, 2002, GENE, V282, P227, DOI 10.1016/S0378-1119(01)00818-6; Zhang XJ, 2002, J INVEST DERMATOL, V119, P1361, DOI 10.1046/j.1523-1747.2002.19612.x	45	35	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2007	2	9							e906	10.1371/journal.pone.0000906	http://dx.doi.org/10.1371/journal.pone.0000906			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HS	17878941	Green Submitted, gold, Green Published			2022-12-25	WOS:000207455700014
J	Camacho-Leal, P; Stanners, CP				Camacho-Leal, P.; Stanners, C. P.			The human carcinoembryonic antigen (CEA) GPI anchor mediates anoikis inhibition by inactivation of the intrinsic death pathway	ONCOGENE			English	Article						CEA; anoikis; molecular mechanism; caspases	HUMAN-TUMOR-MARKER; INTERCELLULAR-ADHESION MOLECULE; CYTOCHROME-C RELEASE; SIGNALING PATHWAY; CASPASE ACTIVATION; CELL-SURVIVAL; GENE FAMILY; INTEGRIN; DIFFERENTIATION; EXPRESSION	Human carcinoembryonic antigen (CEA) is a cell surface adhesion molecule member of the Immunoglobulin Superfamily (IgSF). Aberrant upregulation of CEA is a common feature found in a wide variety of human cancers such as colon, breast and lung. Previous in vitro and in vivo results have demonstrated that CEA can have tumorigenic effects including the inhibition of cell differentiation and anoikis, a specific type of apoptosis triggered by the absence of extracellular matrix-cell contacts. In the present work, we investigate the involvement of the caspase cascade in CEA-mediated inhibition of anoikis and the structural requirements for this signal. Expression of CEA and/or a chimeric protein consisting of the NCAM extracellular domain attached to the CEA-GPI anchor correlates with an early inactivation of caspase-9 and activation of the PI3-K/Akt survival pathway, and at later times, inactivation of caspase-8. The CEA-mediated caspase inactivation as well as activation of Akt was not observed by expression of a CEA molecule incapable of self-binding (DNCEA). These results suggest that the intrinsic caspase pathway is involved in the inhibitory effects of anoikis by CEA and this signal is dependent on the presence of self-adhesive extracellular domains and a CEA-GPI anchor.	[Camacho-Leal, P.] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; McGill Univ, McGill Canc Ctr, Montreal, PQ H3G 1Y6, Canada	McGill University; McGill University	Stanners, CP (corresponding author), McGill Univ, Dept Biochem, 3655 Promenade Sir William Osler, Montreal, PQ H3G 1Y6, Canada.	cliff.stanners@mcgill.ca						BENCHIMOL S, 1989, CELL, V57, P327, DOI 10.1016/0092-8674(89)90970-7; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Camacho-Leal P, 2007, J CELL PHYSIOL, V211, P791, DOI 10.1002/jcp.20989; CHA YJ, 2001, EXP MOL MED, V33, P28492; Deng YB, 2002, GENE DEV, V16, P33, DOI 10.1101/gad.949602; Duxbury MS, 2004, ONCOGENE, V23, P465, DOI 10.1038/sj.onc.1207036; EIDELMAN FJ, 1993, J CELL BIOL, V123, P467, DOI 10.1083/jcb.123.2.467; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; Frisch SM, 1999, CURR BIOL, V9, P1047, DOI 10.1016/S0960-9822(99)80455-2; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723; Grossmann J, 2002, APOPTOSIS, V7, P247, DOI 10.1023/A:1015312119693; Hammarstrom S, 1999, SEMIN CANCER BIOL, V9, P67, DOI 10.1006/scbi.1998.0119; Ilantzis C, 2002, NEOPLASIA, V4, P151, DOI 10.1038/sj.neo.7900201; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Marconi A, 2004, J CELL SCI, V117, P5815, DOI 10.1242/jcs.01490; Nho RS, 2005, J BIOL CHEM, V280, P26630, DOI 10.1074/jbc.M411798200; Nollau P, 1997, CANCER RES, V57, P2354; OIKAWA S, 1989, BIOCHEM BIOPH RES CO, V164, P39, DOI 10.1016/0006-291X(89)91679-3; Ordonez C, 2000, CANCER RES, V60, P3419; Ordonez C, 2007, J CELL PHYSIOL, V210, P757, DOI 10.1002/jcp.20887; Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3; Rennebeck G, 2005, CANCER RES, V65, P11230, DOI 10.1158/0008-5472.CAN-05-2763; Rojas M, 1996, CELL GROWTH DIFFER, V7, P655; ROSENBERG M, 1993, CANCER RES, V53, P4938; Rytomaa M, 2000, ONCOGENE, V19, P4461, DOI 10.1038/sj.onc.1203805; Screaton RA, 1997, J CELL BIOL, V137, P939, DOI 10.1083/jcb.137.4.939; Screaton RA, 2000, J CELL BIOL, V150, P613, DOI 10.1083/jcb.150.3.613; Soeth E, 2001, CLIN CANCER RES, V7, P2022; Stanners CP, 1998, CELL ADHES COMMUN S, V5, P57; Stupack DG, 2002, J CELL SCI, V115, P3729, DOI 10.1242/jcs.00071; Taheri M, 2003, J BIOL CHEM, V278, P14632, DOI 10.1074/jbc.M212500200; Tian B, 2002, J BIOL CHEM, V277, P24667, DOI 10.1074/jbc.M203565200; Tiberio R, 2002, FEBS LETT, V524, P139, DOI 10.1016/S0014-5793(02)03040-5; Viswanath V, 2001, J NEUROSCI, V21, P9519, DOI 10.1523/JNEUROSCI.21-24-09519.2001; Wang PB, 2003, J BIOL CHEM, V278, P19917, DOI 10.1074/jbc.M210337200; YAFFE D, 1968, P NATL ACAD SCI USA, V61, P477, DOI 10.1073/pnas.61.2.477	39	29	33	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 6	2008	27	11					1545	1553		10.1038/sj.onc.1210789	http://dx.doi.org/10.1038/sj.onc.1210789			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	271VC	17891182				2022-12-25	WOS:000253815800006
J	Fanning, AS; Lye, MF; Anderson, JM; Lavie, A				Fanning, Alan S.; Lye, Ming F.; Anderson, James M.; Lavie, Arnon			Domain swapping within PDZ2 is responsible for dimerization of ZO proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIGHT-JUNCTION; ZONULA OCCLUDENS-1; CRYSTAL-STRUCTURE; COMPLEX REVEALS; BINDING; RECOGNITION; MEMBRANE; ADHESION; MOTIFS; LOCALIZATION	ZO-1 is a multidomain protein involved in cell- cell junctions and contains three PDZ domains, which are necessary for its function in vivo. PDZ domains play a central role in assembling diverse protein complexes through their ability to recognize short peptide motifs on other proteins. We determined the structure of the second of the three PDZ domains of ZO-1, which is known to promote dimerization as well as bind to C-terminal sequences on connexins. The dimer is stabilized by extensive symmetrical domain swapping of beta-strands, which is unlike any other known mechanism of PDZ dimerization. The canonical peptide-binding groove remains intact in both subunits of the PDZ2 dimer and is created by elements contributed from both monomers. This unique structure reveals an additional example of how PDZ domains dimerize and has multiple implications for both peptide binding and oligomerization in vivo.	[Lye, Ming F.; Lavie, Arnon] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Fanning, Alan S.; Anderson, James M.] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of North Carolina; University of North Carolina Chapel Hill	Lavie, A (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, 900 S Ashland Ave,Mol Biol Res Bldg,Rm 1108, Chicago, IL 60607 USA.	Lavie@uic.edu	Lavie, Arnon/H-4927-2012	Lavie, Arnon/0000-0001-5591-8722; Anderson, James/0000-0003-2765-7996	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK061397, T32DK007739, R01DK061397] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK061397, R56 DK061397, R01 DK061397-05, T32 DK007739, DK61397] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anderson JM, 2004, CURR OPIN CELL BIOL, V16, P140, DOI 10.1016/j.ceb.2004.01.005; Appleton BA, 2006, J BIOL CHEM, V281, P22312, DOI 10.1074/jbc.M602901200; Bazzoni G, 2000, J BIOL CHEM, V275, P20520, DOI 10.1074/jbc.M905251199; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cuppen E, 1998, MOL BIOL CELL, V9, P671, DOI 10.1091/mbc.9.3.671; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Fanning AS, 2007, MOL BIOL CELL, V18, P721, DOI 10.1091/mbc.E06-08-0764; Fanning AS, 1998, CURR TOP MICROBIOL, V228, P209; Fanning AS, 1999, J CLIN INVEST, V103, P767, DOI 10.1172/JCI6509; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Giepmans BNG, 2004, CARDIOVASC RES, V62, P233, DOI 10.1016/j.cardiores.2003.12.009; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Hunter AW, 2005, MOL BIOL CELL, V16, P5686, DOI 10.1091/mbc.E05-08-0737; Im YJ, 2003, J BIOL CHEM, V278, P48099, DOI 10.1074/jbc.M306919200; Im YJ, 2003, J BIOL CHEM, V278, P8501, DOI 10.1074/jbc.M212263200; Itoh M, 1999, J CELL BIOL, V147, P1351, DOI 10.1083/jcb.147.6.1351; Itoh M, 1999, J BIOL CHEM, V274, P5981, DOI 10.1074/jbc.274.9.5981; Jemth P, 2007, BIOCHEMISTRY-US, V46, P8701, DOI 10.1021/bi7008618; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kang BS, 2003, STRUCTURE, V11, P845, DOI 10.1016/S0969-2126(03)00125-4; Kausalya PJ, 2004, MOL BIOL CELL, V15, P5503, DOI 10.1091/mbc.E04-04-0350; Kausalya PJ, 2001, FEBS LETT, V505, P92, DOI 10.1016/S0014-5793(01)02786-7; Lamzin V. S., 2001, INT TABLES CRYSTALLO, VF, P720; Li X, 2004, NEUROSCIENCE, V126, P611, DOI 10.1016/j.neuroscience.2004.03.063; Long JF, 2005, NAT STRUCT MOL BIOL, V12, P722, DOI 10.1038/nsmb958; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Polette M, 2005, CANCER RES, V65, P7691, DOI 10.1158/0008-5472.CAN-04-4230; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Reichert M, 2000, J BIOL CHEM, V275, P9492, DOI 10.1074/jbc.275.13.9492; Shieh BH, 1996, NEURON, V16, P991, DOI 10.1016/S0896-6273(00)80122-1; Singh D, 2005, J BIOL CHEM, V280, P30416, DOI 10.1074/jbc.M506799200; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Sorgen PL, 2004, J BIOL CHEM, V279, P54695, DOI 10.1074/jbc.M409552200; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; Utepbergenov DI, 2006, J BIOL CHEM, V281, P24671, DOI 10.1074/jbc.M512820200; van Zeijl L, 2007, J CELL BIOL, V177, P881, DOI 10.1083/jcb.200610144; Wittchen ES, 1999, J BIOL CHEM, V274, P35179, DOI 10.1074/jbc.274.49.35179; Zimmermann P, 2005, DEV CELL, V9, P377, DOI 10.1016/j.devcel.2005.07.011	41	43	45	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37710	37716		10.1074/jbc.M707255200	http://dx.doi.org/10.1074/jbc.M707255200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17928286	Green Submitted, Green Accepted, hybrid			2022-12-25	WOS:000251833600047
J	Funasaka, T; Hu, H; Hogan, V; Raz, A				Funasaka, Tatsuyoshi; Hu, Huankai; Hogan, Victor; Raz, Avraham			Down-regulation of phosphoglucose isomerase/autocrine motility factor expression sensitizes human fibrosarcoma cells to oxidative stress leading to cellular senescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR SUPPRESSION; CANCER; RECEPTOR; OVEREXPRESSION; NEUROLEUKIN; DEFICIENCY; LOCOMOTION; MECHANISM; EVOLUTION; ENZYMES	Phosphoglucose isomerase/autocrine motility factor (PGI/AMF) is a housekeeping gene product present in all cells, is an essential enzyme of catabolic glycolysis and anabolic gluconeogenesis, and regulates tumor cell growth and metastasis. Because glycolytic enzyme up-regulation of expression contributes to glycolytic flux, leading to increased of cell growth and a resistance to cellular stress of normal fibroblasts whereas down-regulation of PGI/AMF leads to mesenchymal-to-epithelial transition in tumor cells, we examined the involvement of PGI/AMF in overcoming cellular senescence in cancer cells. PGI/AMF cellular expression in HT1080 human fibrosarcoma was down-regulated by small interfering RNA methodology, which resulted in an increased sensitivity to oxidative stress and oxidative stress-induced cellular senescence. Signaling analysis revealed that the senescence pathway involving p21 cyclin-dependent kinase inhibitor was up-regulated in PGI/AMF knockdown cells and that superoxide dismutase is the upstream regulator protein of p21-mediated cellular senescence. A specific inhibitor of PGI/AMF induced cellular senescence and p21 expression in tumor cells exposed to an oxidative stress environment. Taken together, the results presented here suggest that PGI/AMF is involved in oxidative stress-induced cellular senescence and should bring novel insights into the control of cellular growth leading to a new methodology for cancer treatment.	Wayne State Univ, Sch Med, Karmanos Canc Inst, Tumor Progress & Metastasis Program, Detroit, MI 48201 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University	Raz, A (corresponding author), 110 E Warren Ave, Detroit, MI 48201 USA.	raza@karmanos.org			NATIONAL CANCER INSTITUTE [R01CA051714] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA51714] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAUMANN M, 1990, CANCER INVEST, V8, P351, DOI 10.3109/07357909009012053; Behrend L, 2003, BIOCHEM SOC T, V31, P1441; Benhar M, 2002, EMBO REP, V3, P420, DOI 10.1093/embo-reports/kvf094; Beutler E, 1997, BLOOD CELL MOL DIS, V23, P402, DOI 10.1006/bcmd.1997.0157; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Campisi J, 2003, NAT REV CANCER, V3, P339, DOI 10.1038/nrc1073; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Cao MJ, 2000, BIOCHEM BIOPH RES CO, V272, P485, DOI 10.1006/bbrc.2000.2803; CHEN Q, 1994, P NATL ACAD SCI USA, V91, P4130, DOI 10.1073/pnas.91.10.4130; Dawson PJ, 1996, AM J PATHOL, V148, P313; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; FILELLA X, 1991, TUMOR BIOL, V12, P360, DOI 10.1159/000217737; Funasaka T, 2007, CANCER RES, V67, P4236, DOI 10.1158/0008-5472.CAN-06-3935; GOMM SA, 1988, BRIT J CANCER, V58, P797, DOI 10.1038/bjc.1988.312; Gottlieb TM, 2002, ONCOGENE, V21, P1299, DOI 10.1038/sj.onc.1205181; GURNEY ME, 1986, SCIENCE, V234, P574, DOI 10.1126/science.3020690; Haga A, 2003, INT J CANCER, V107, P707, DOI 10.1002/ijc.11449; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Kim JW, 2005, TRENDS BIOCHEM SCI, V30, P142, DOI 10.1016/j.tibs.2005.01.005; Kondoh H, 2005, CANCER RES, V65, P177; Landis GN, 2005, MECH AGEING DEV, V126, P365, DOI 10.1016/j.mad.2004.08.012; Leonard SS, 2004, FREE RADICAL BIO MED, V37, P1921, DOI 10.1016/j.freeradbiomed.2004.09.010; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Matsumoto I, 1999, SCIENCE, V286, P1732, DOI 10.1126/science.286.5445.1732; Miller FR, 2000, J NATL CANCER I, V92, P1185, DOI 10.1093/jnci/92.14.1185A; NABI IR, 1992, CANCER METAST REV, V11, P5, DOI 10.1007/BF00047599; Niinaka Y, 1998, CANCER RES, V58, P2667; OBERLEY LW, 1988, MOL CELL BIOCHEM, V84, P147, DOI 10.1007/BF00421049; Oberley LW, 2001, ANTIOXID REDOX SIGN, V3, P461, DOI 10.1089/15230860152409095; Plymate SR, 2003, ONCOGENE, V22, P1024, DOI 10.1038/sj.onc.1206210; RAVINDRANATH Y, 1987, NEW ENGL J MED, V316, P258, DOI 10.1056/NEJM198701293160506; Roninson IB, 2003, CANCER RES, V63, P2705; SAFFORD SE, 1994, CANCER RES, V54, P4261; Serrano M, 2001, CURR OPIN CELL BIOL, V13, P748, DOI 10.1016/S0955-0674(00)00278-7; Shay JW, 2004, ONCOGENE, V23, P2919, DOI 10.1038/sj.onc.1207518; Shimizu K, 1999, FEBS LETT, V456, P295, DOI 10.1016/S0014-5793(99)00966-7; Silletti S, 1996, CURR TOP MICROBIOL, V213, P137; SOULE HD, 1990, CANCER RES, V50, P6075; Tanaka N, 2002, J MOL BIOL, V318, P985, DOI 10.1016/S0022-2836(02)00186-9; TARUNINA M, 1993, ONCOGENE, V8, P3165; Tsutsumi S, 2003, CANCER RES, V63, P242; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Watanabe H, 1996, CANCER RES, V56, P2960; Xu W, 1996, BLOOD, V87, P4502, DOI 10.1182/blood.V87.11.4502.bloodjournal87114502; Yakirevich E, 2000, BIOL REPROD, V62, P1016, DOI 10.1095/biolreprod62.4.1016; Zhou BHP, 2002, SEMIN ONCOL, V29, P62, DOI 10.1053/sonc.2002.34057	46	27	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36362	36369		10.1074/jbc.M706301200	http://dx.doi.org/10.1074/jbc.M706301200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17925402	hybrid			2022-12-25	WOS:000251458300027
J	Ravindranath, RMH; Devarajan, A; Uchida, T				Ravindranath, Rajeswari M. H.; Devarajan, Asokan; Uchida, Takashi			Spatiotemporal expression of ameloblastin isoforms during murine tooth development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-D-GLUCOSAMINE; ENAMEL PROTEIN; GENE-EXPRESSION; SIALIC ACIDS; AMELOGENIN; ANTIBODIES; MATRIX; BINDS; IMMUNOCYTOCHEMISTRY; LOCALIZATION	Ameloblasts synthesize and secrete the enamel matrix proteins (amelogenin, ameloblastin, and enamelin). This investigation examined the profiles of ameloblastin in the ameloblasts and in the enamel matrix during different postnatal (PN) days (days 0-9) of development of mouse molar, using an antibody specific for C-terminal sequence of ameloblastin (Ct; GNKVHQPQVHNAWRF). Ameloblastin is found in three different molecular sizes (37, 55, and 66 kDa) in both ameloblasts and enamel matrix during PN development. In the ameloblasts, the sequence of expression of these fractions varied. The 37-kDa fraction was observed (even before the appearances of mRNA of the proteases, enamelysin and kallikrein-4) on days 0 and 1, persisted until day 3, and was not found thereafter. Other isoforms (55 and 66 kDa) distinctly appeared in ameloblasts after day 1, reached a peak on day 5, and remained thereafter. The Ct-positive granules appeared beaded in the ameloblasts on day 3. In the extracellular matrix, a 37-kDa (but not 66- or 55-kDa) fraction was detected on days 0 and 1 and remained in the matrix throughout the PN days. The larger isoforms (55 and 66 kDa) appeared in the enamel matrix from day 3 onward. On days 0-3, but not later, the 37-kDa isoform co-localizes with amelogenin in Tomes' process and formative enamel, as revealed by laser scan confocal microscopy. Autoradiography confirmed accumulation of H-3-labeled amelogenin trityrosyl motif peptide in the region of Tomes' process and formative enamel from day 0 to 3. These observations suggest that the 37-kDa isoform interacts with amelogenin during early tooth development.	Univ So Calif, Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA 90033 USA; Hiroshima Univ, Grad Sch Biomed Sci, Dept Oral Biol, Div Mol Med Sci, Hiroshima 734, Japan	University of Southern California; Hiroshima University	Ravindranath, RMH (corresponding author), Univ So Calif, Sch Dent, Ctr Craniofacial Mol Biol, 2250 Alcazar St, Los Angeles, CA 90033 USA.	rravindr@usc.edu			NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013204] Funding Source: NIH RePORTER; NIDCR NIH HHS [R01-DE-13204-05] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		CARL SAL, 1993, J HISTOCHEM CYTOCHEM, V41, P1273; DEUTSCH D, 1991, J BIOL CHEM, V266, P16021; Fincham AG, 1999, J STRUCT BIOL, V126, P270, DOI 10.1006/jsbi.1999.4130; FINCHAM AG, 1994, CALCIFIED TISSUE INT, V55, P398, DOI 10.1007/BF00299322; Fong C D, 1996, Adv Dent Res, V10, P195; Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077; Gibson CW, 2001, J BIOL CHEM, V276, P31871, DOI 10.1074/jbc.M104624200; Hu JCC, 2002, EUR J ORAL SCI, V110, P307, DOI 10.1034/j.1600-0722.2002.21301.x; Iacob S, 2006, EUR J ORAL SCI, V114, P194, DOI 10.1111/j.1600-0722.2006.00287.x; Krebsbach PH, 1996, J BIOL CHEM, V271, P4431; Lee SK, 2003, MOL CELLS, V15, P216; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Nagano T, 2003, J DENT RES, V82, P982, DOI 10.1177/154405910308201209; NANCI A, 1985, J HISTOCHEM CYTOCHEM, V33, P1153, DOI 10.1177/33.11.4056379; NEGOESCU A, 1994, J HISTOCHEM CYTOCHEM, V42, P433, DOI 10.1177/42.3.7508473; Oida S, 2002, J DENT RES, V81, P103, DOI 10.1177/154405910208100204; RAVIDRANATH RMH, 2003, J BIOL CHEM, V276, P20293; RAVIDRANATH RMH, 2005, J GLYCOCONJ J, V22, P129; Ravindranath HH, 2004, BIOCHEM BIOPH RES CO, V323, P1075, DOI 10.1016/j.bbrc.2004.08.207; Ravindranath RMH, 2005, ACTA HISTOCHEM, V107, P43, DOI 10.1016/j.acthis.2004.11.004; Ravindranath RMH, 1999, J BIOL CHEM, V274, P2464, DOI 10.1074/jbc.274.4.2464; Ravindranath RMH, 2000, J BIOL CHEM, V275, P39654, DOI 10.1074/jbc.M006471200; RAVINDRANATH RMH, 1990, J VIROL, V64, P5430, DOI 10.1128/JVI.64.11.5430-5440.1990; Ravindranath RMH, 2001, J BIOL CHEM, V276, P36586, DOI 10.1074/jbc.M104656200; Uchida T, 1997, J HISTOCHEM CYTOCHEM, V45, P1329, DOI 10.1177/002215549704501002; Xiao GZ, 1998, J BIOL CHEM, V273, P32988, DOI 10.1074/jbc.273.49.32988; Yamakoshi Y, 2001, ARCH ORAL BIOL, V46, P1005, DOI 10.1016/S0003-9969(01)00070-X	27	10	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36370	36376		10.1074/jbc.M704731200	http://dx.doi.org/10.1074/jbc.M704731200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17921454	hybrid			2022-12-25	WOS:000251458300028
J	Young, KA; Chen, XJS; Holers, VM; Hannan, JP				Young, Kendra A.; Chen, Xiaojiang S.; Holers, V. Michael; Hannan, Jonathan P.			Isolating the Epstein-Barr virus gp350/220 binding site on complement receptor type 2 (CR2/CD21)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN LYMPHOCYTES-B; SYSTEMIC-LUPUS-ERYTHEMATOSUS; COMPLEMENT RECEPTOR TYPE-2; CD21 LIGAND-BINDING; C3D RECEPTOR; MONOCLONAL-ANTIBODY; IFN-ALPHA; CR-2; GLYCOPROTEIN; EBV	Complement receptor type 2 (CR2/CD21) is essential for the attachment of Epstein-Barr virus (EBV) to the surface of B-lymphocytes in an interaction mediated by the viral envelope glycoprotein gp350. The heavily glycosylated structure of EBV gp350 has recently been elucidated by x-ray crystallography, and the CR2 binding site on this protein has been characterized. To identify the corresponding gp350 binding site on CR2, we have undertaken a site-directed mutagenesis study targeting regions of CR2 that have previously been implicated in the binding of CR2 to the C3d/C3dg fragments of complement component C3. Wild-type or mutant forms of CR2 were expressed on K562 cells, and the ability of these CR2-expressing cells to bind gp350 was measured using flow cytometry. Mutations directed toward the two N-terminal extracellular domains of CR2 (SCR1-2) reveal that a large contiguous surface of CR2 SCR1-2 is involved in gp350 binding, including a number of positively charged residues (Arg-13, (Arg-28, (Arg-36, Lys-41, Lys-57, Lys-67, and Arg-83). These data appear to complement the CR2 binding site on gp350, which is characterized by a preponderance of negative charge. In addition to identifying the importance of charge in the formation of a CR2-gp350 complex, we also provide evidence that both SCR1 and SCR2 make contact with gp350. Specifically, two anti-CR2 monoclonal antibodies, designated as monoclonal antibodies 171 and 1048 whose primary epitopes are located within SCR2, inhibit binding of wild-type CR2 to EBV gp350; with regard to SCR1, both K562 cells expressing an S15P mutation and recombinant S15P CR2 proteins exhibit diminished gp350 binding.	Hlth Sci Ctr, Aurora, CO 80045 USA; Univ So Calif, Dept Mol & Computat Biol, Los Angeles, CA 90089 USA	University of Southern California	Hannan, JP (corresponding author), Univ Colorado Denver, Dept Med & Immunol, Div Rheumatol, Barbara Davis Ctr Childhood Diabet, POB 6511,Mail Stop B-115,1775 N Ursula St, Aurora, CO 80045 USA.	Jonathan.Hannan@UCHSC.edu		Hannan, Jonathan/0000-0003-3318-2341	NATIONAL CANCER INSTITUTE [R01CA053615] Funding Source: NIH RePORTER; NCI NIH HHS [R0-1 R01CA053615] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AHEARN JM, 1989, ADV IMMUNOL, V46, P183, DOI 10.1016/S0065-2776(08)60654-9; Ascherio A, 2000, EPIDEMIOLOGY, V11, P220, DOI 10.1097/00001648-200003000-00023; Asokan R, 2006, J IMMUNOL, V177, P383, DOI 10.4049/jimmunol.177.1.383; AUBRY JP, 1994, J IMMUNOL, V152, P5806; AUBRY JP, 1992, NATURE, V358, P505, DOI 10.1038/358505a0; BEISEL C, 1985, J VIROL, V54, P665, DOI 10.1128/JVI.54.3.665-674.1985; CAREL JC, 1990, J BIOL CHEM, V265, P12293; Carroll MC, 1997, CURR OPIN IMMUNOL, V9, P64, DOI 10.1016/S0952-7915(97)80160-4; Costenbader KH, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1893; DELCAYRE AX, 1991, EMBO J, V10, P919, DOI 10.1002/j.1460-2075.1991.tb08025.x; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; Fearon DT, 1998, SEMIN IMMUNOL, V10, P355, DOI 10.1006/smim.1998.0137; FINGEROTH JD, 1988, J VIROL, V62, P1442, DOI 10.1128/JVI.62.4.1442-1447.1988; FINGEROTH JD, 1984, P NATL ACAD SCI-BIOL, V81, P4510, DOI 10.1073/pnas.81.14.4510; FRADE R, 1985, P NATL ACAD SCI USA, V82, P1490, DOI 10.1073/pnas.82.5.1490; Griffin BE, 2005, EPSTEIN-BARR VIRUS, P113; Gross AJ, 2005, J IMMUNOL, V174, P6599, DOI 10.4049/jimmunol.174.11.6599; Guthridge JM, 2001, J IMMUNOL, V167, P5758, DOI 10.4049/jimmunol.167.10.5758; Guthridge JM, 2001, BIOCHEMISTRY-US, V40, P5931, DOI 10.1021/bi0101749; Haan KM, 2001, VIROLOGY, V290, P106, DOI 10.1006/viro.2001.1141; HADDAD RS, 1989, J VIROL, V63, P4998, DOI 10.1128/JVI.63.12.4998-5005.1989; Hannan JP, 2005, J MOL BIOL, V346, P845, DOI 10.1016/j.jmb.2004.12.007; HEDRICK JA, 1994, J IMMUNOL, V153, P4418; HOFFMAN GJ, 1980, P NATL ACAD SCI-BIOL, V77, P2979, DOI 10.1073/pnas.77.5.2979; Iwakiri D, 2005, EPSTEIN-BARR VIRUS, P157; Jackman WT, 1999, VACCINE, V17, P660, DOI 10.1016/S0264-410X(98)00248-5; Janz A, 2000, J VIROL, V74, P10142, DOI 10.1128/JVI.74.21.10142-10152.2000; Johannsen E, 2004, P NATL ACAD SCI USA, V101, P16286, DOI 10.1073/pnas.0407320101; KALLI KR, 1991, J IMMUNOL, V147, P590; LOWELL CA, 1989, J EXP MED, V170, P1931, DOI 10.1084/jem.170.6.1931; Mackett M, 1996, J MED VIROL, V50, P263, DOI 10.1002/(SICI)1096-9071(199611)50:3<263::AID-JMV9>3.0.CO;2-7; MARTIN DR, 1991, J EXP MED, V174, P1299, DOI 10.1084/jem.174.6.1299; Molesworth SJ, 2000, J VIROL, V74, P6324, DOI 10.1128/JVI.74.14.6324-6332.2000; MOLINA H, 1995, J IMMUNOL, V154, P5426; MOLINA H, 1991, J BIOL CHEM, V266, P12173; MOORE MD, 1989, J BIOL CHEM, V264, P20576; Morikis D, 2004, J IMMUNOL, V172, P7537, DOI 10.4049/jimmunol.172.12.7537; Mullen MM, 2002, MOL CELL, V9, P375, DOI 10.1016/S1097-2765(02)00465-3; Murray PG, 2005, EPSTEIN-BARR VIRUS, P93; NEMEROW GR, 1987, J VIROL, V61, P1416, DOI 10.1128/JVI.61.5.1416-1420.1987; NEMEROW GR, 1985, J VIROL, V55, P347, DOI 10.1128/JVI.55.2.347-351.1985; PEPYS MB, 1974, J EXP MED, V140, P126, DOI 10.1084/jem.140.1.126; Prota AE, 2002, P NATL ACAD SCI USA, V99, P10641, DOI 10.1073/pnas.162360499; Raab-Traub N, 2005, EPSTEIN-BARR VIRUS, P71; Roberge CJ, 1996, J IMMUNOL, V156, P4884; Salek-Ardakani S, 2004, J IMMUNOL, V173, P321, DOI 10.4049/jimmunol.173.1.321; Sarrias MR, 2001, J IMMUNOL, V167, P1490, DOI 10.4049/jimmunol.167.3.1490; Spriggs MK, 1996, J VIROL, V70, P5557, DOI 10.1128/JVI.70.8.5557-5563.1996; Szakonyi G, 2001, SCIENCE, V292, P1725, DOI 10.1126/science.1059118; Szakonyi G, 2006, NAT STRUCT MOL BIOL, V13, P996, DOI 10.1038/nsmb1161; TANNER J, 1988, J VIROL, V62, P4452, DOI 10.1128/JVI.62.12.4452-4464.1988; TANNER J, 1987, CELL, V50, P203, DOI 10.1016/0092-8674(87)90216-9; THORLEYLAWSON DA, 1980, P NATL ACAD SCI-BIOL, V77, P5307, DOI 10.1073/pnas.77.9.5307; Urquiza M, 2005, J BIOL CHEM, V280, P35598, DOI 10.1074/jbc.M504544200; WEIS JJ, 1984, P NATL ACAD SCI-BIOL, V81, P881, DOI 10.1073/pnas.81.3.881	55	25	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36614	36625		10.1074/jbc.M706324200	http://dx.doi.org/10.1074/jbc.M706324200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17925391	hybrid			2022-12-25	WOS:000251458300054
J	Millard, CJ; Ellis, IR; Pickford, AR; Schor, AM; Schor, SL; Campbell, ID				Millard, Christopher J.; Ellis, Ian R.; Pickford, Andrew R.; Schor, Ana M.; Schor, Seth L.; Campbell, Iain D.			The role of the fibronectin IGD motif in stimulating fibroblast migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-SITE; MODULE PAIR; PLASMA FIBRONECTIN; GELATIN-BINDING; CELL-ADHESION; MATRIX; RGD; IDENTIFICATION; FIBRILLOGENESIS; SEQUENCE	The motogenic activity of migration-stimulating factor, a truncated isoform of fibronectin (FN), has been attributed to the IGD motifs present in its FN type 1 modules. The structure-function relationship of various recombinant IGD-containing FN fragments is now investigated. Their structure is assessed by solution state NMR and their motogenic ability tested on fibroblasts. Even conservative mutations in the IGD motif are inactive or have severely reduced potency, while the structure remains essentially the same. A fragment with two IGD motifs is 100 times more active than a fragment with one and up to 106 times more than synthetic tetrapeptides. The wide range of potency in different contexts is discussed in terms of cryptic FN sites and cooperativity. These results give new insight into the stimulation of fibroblast migration by IGD motifs in FN.	Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; Univ Dundee, Unit Cell & Mol Biol, Dundee DD1 4HR, Scotland; Univ Portsmouth, Sch Biol Sci, Portsmouth PO1 2DY, Hants, England	University of Oxford; University of Dundee; University of Portsmouth	Campbell, ID (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	iain.campbell@bioch.ox.ac.uk	Ellis, Ian/AAM-9833-2021; Pickford, Andy/AGB-6901-2022	Ellis, Ian/0000-0001-8035-6012; Pickford, Andy/0000-0002-7237-0030; Millard, Chris/0000-0002-1012-0829	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bright Jr, 2000, METH MOL B, V139, P59; Curnis F, 2006, J BIOL CHEM, V281, P36466, DOI 10.1074/jbc.M604812200; Ellis IR, 2007, EXP CELL RES, V313, P732, DOI 10.1016/j.yexcr.2006.11.016; FUKAI F, 1991, J BIOL CHEM, V266, P8807; Homandberg Gene A., 1999, Frontiers in Bioscience, V4, pd713, DOI 10.2741/Homandberg; Houard X, 2005, INT J CANCER, V116, P378, DOI 10.1002/ijc.21053; HUMPHRIES MJ, 1986, J CELL BIOL, V103, P2637, DOI 10.1083/jcb.103.6.2637; HYNES RO, 1990, FIBRONECTINS, P1; Ingham KC, 2004, J BIOL CHEM, V279, P28132, DOI 10.1074/jbc.M312785200; KUMAGAI H, 1991, BIOCHEM BIOPH RES CO, V177, P74, DOI 10.1016/0006-291X(91)91950-H; MAIN AL, 1992, CELL, V71, P671, DOI 10.1016/0092-8674(92)90600-H; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; Millard CJ, 2005, FEBS LETT, V579, P4529, DOI 10.1016/j.febslet.2005.05.082; MOULD AP, 1991, EMBO J, V10, P4089, DOI 10.1002/j.1460-2075.1991.tb04985.x; Oberhauser AF, 2002, J MOL BIOL, V319, P433, DOI 10.1016/S0022-2836(02)00306-6; Potts JR, 1996, MATRIX BIOL, V15, P313, DOI 10.1016/S0945-053X(96)90133-X; POTTS JR, 1994, CURR OPIN CELL BIOL, V6, P648, DOI 10.1016/0955-0674(94)90090-6; Potts JR, 1999, BIOCHEMISTRY-US, V38, P8304, DOI 10.1021/bi990202b; Rudino-Pinera E, 2007, J MOL BIOL, V368, P833, DOI 10.1016/j.jmb.2007.02.061; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; Schor SL, 2003, CANCER RES, V63, P8827; Schor SL, 1999, J CELL SCI, V112, P3879; SCHOR SL, 1988, J CELL SCI, V90, P391; SCHOR SL, 1980, J CELL SCI, V41, P159; Schor SL, 1996, J CELL SCI, V109, P2581; SCHWARZBAUER JE, 1991, J CELL BIOL, V113, P1463, DOI 10.1083/jcb.113.6.1463; Sechler JL, 2001, J CELL BIOL, V154, P1081, DOI 10.1083/jcb.200102034; Takahashi S, 2007, J CELL BIOL, V178, P167, DOI 10.1083/jcb.200703021; Tomasini-Johansson BR, 2006, MATRIX BIOL, V25, P282, DOI 10.1016/j.matbio.2006.02.002; Vakonakis I, 2007, EMBO J, V26, P2575, DOI 10.1038/sj.emboj.7601694; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; YAMADA T, 1994, BIOCHEMISTRY-US, V33, P11678, DOI 10.1021/bi00205a002	32	30	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35530	35535		10.1074/jbc.M707532200	http://dx.doi.org/10.1074/jbc.M707532200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17921136	hybrid			2022-12-25	WOS:000251458100012
J	Chaptal, V; Vincent, F; Gueguen-Chaignon, V; Monedero, V; Poncet, S; Deutscher, J; Nessler, S; Morera, S				Chaptal, Vincent; Vincent, Fanny; Gueguen-Chaignon, Virginie; Monedero, Vicente; Poncet, Sandrine; Deutscher, Josef; Nessler, Sylvie; Morera, Solange			Structural analysis of the bacterial HPr kinase/phosphorylase V267F mutant gives insights into the allosteric regulation mechanism of this bifunctional enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; X-RAY STRUCTURE; PHOSPHOTRANSFERASE SYSTEM; CATABOLITE REPRESSION; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; PHOSPHORYLATION; COMPLEX; BINDING; ATP	The HPr kinase/phosphorylase (HPrK/P) is a bifunctional enzyme that controls the phosphorylation state of the phosphocarrier protein HPr, which regulates the utilization of carbon sources in Gram-positive bacteria. It uses ATP or pyrophosphate for the phosphorylation of serine 46 of HPr and inorganic phosphate for the dephosphorylation of Ser(P)-46-HPr via a phosphorolysis reaction. HPrK/P is a hexameric protein kinase of a new type with a catalytic core belonging to the family of nucleotide-binding protein with Walker A motif. It exhibits no structural similarity to eukaryotic protein kinases. So far, HPrK/P structures have shown the enzyme in its phosphorylase conformation. They permitted a detailed characterization of the phosphorolysis mechanism. In the absence of a structure with bound nucleotide, we used the V267F mutant enzyme to assess the kinase conformation. Indeed, the V267F replacement was found to cause an almost entire loss of the phosphorylase activity of Lactobacillus casei HPrK/P. In contrast, the kinase activity remained conserved. To elucidate the structural alterations leading to this drastic change of activity, the x-ray structure of the catalytic domain of L. casei HPrK/P-V267F was determined at 2.6 angstrom resolution. A comparison with the structure of the wild type enzyme showed that the mutation induces conformation changes compatible with the switch from phosphorylase to kinase function. Together with nucleotide binding fluorescence measurements, these results allowed us to decipher the cooperative behavior of the protein and to gain new insights into the allosteric regulation mechanism of HPrK/P.	CNRS, Lab Enzymol & Biochim Struct, 1 Ave Terrasse, F-91198 Gif Sur Yvette, France; CNRS INRA AgroParis Tech, Microbiol & Genet Mol, F-78850 Thiverval Grignon, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE	Nessler, S (corresponding author), CNRS, Lab Enzymol & Biochim Struct, 1 Ave Terrasse, F-91198 Gif Sur Yvette, France.	nessler@lebs.cnrs-gif.fr; morera@lebs.cnrs-gif.fr	Nessler, Sylvie/R-4296-2016; Monedero, Vicente/H-3876-2012	Nessler, Sylvie/0000-0003-4973-9941; Monedero, Vicente/0000-0001-7461-8047; chaptal, vincent/0000-0003-2603-0294; PONCET, Sandrine/0000-0002-2813-0793; morera, solange/0000-0001-7781-0448				Allen GS, 2003, J MOL BIOL, V326, P1203, DOI 10.1016/S0022-2836(02)01378-5; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boel G, 2003, J MOL MICROB BIOTECH, V5, P206, DOI 10.1159/000071072; Choi ID, 2006, BIOSCI BIOTECH BIOCH, V70, P1089, DOI 10.1271/bbb.70.1089; DEUTSCHER J, 1983, P NATL ACAD SCI-BIOL, V80, P6790, DOI 10.1073/pnas.80.22.6790; DEUTSCHER J, 1984, FEMS MICROBIOL LETT, V23, P157; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Dossonnet V, 2000, J BACTERIOL, V182, P2582, DOI 10.1128/JB.182.9.2582-2590.2000; Dyer CM, 2006, J BACTERIOL, V188, P7354, DOI 10.1128/JB.00637-06; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fieulaine S, 2002, P NATL ACAD SCI USA, V99, P13437, DOI 10.1073/pnas.192368699; Fieulaine S, 2001, EMBO J, V20, P3917, DOI 10.1093/emboj/20.15.3917; Formaneck MS, 2006, PROTEINS, V63, P846, DOI 10.1002/prot.20893; FUJITA Y, 1995, MOL MICROBIOL, V17, P953, DOI 10.1111/j.1365-2958.1995.mmi_17050953.x; Galinier A, 2002, J BIOL CHEM, V277, P11362, DOI 10.1074/jbc.M109527200; Herro R, 2005, J MOL MICROB BIOTECH, V9, P224, DOI 10.1159/000089650; Hill A.V, 1910, J PHYSL, V40, piv, DOI DOI 10.1113/JPHYSIOL.1910.SP001386; Jault JM, 2000, J BIOL CHEM, V275, P1773, DOI 10.1074/jbc.275.3.1773; Jones BE, 1997, J BIOL CHEM, V272, P26530, DOI 10.1074/jbc.272.42.26530; JULLIEN M, 1988, BIOCHIMIE, V70, P1807, DOI 10.1016/0300-9084(88)90042-9; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Marquez JA, 2002, P NATL ACAD SCI USA, V99, P3458, DOI 10.1073/pnas.052461499; Matyus L, 2006, J PHOTOCH PHOTOBIO B, V83, P223, DOI 10.1016/j.jphotobiol.2005.12.017; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Mijakovic I, 2002, P NATL ACAD SCI USA, V99, P13442, DOI 10.1073/pnas.212410399; Monedero V, 2001, EMBO J, V20, P3928, DOI 10.1093/emboj/20.15.3928; Monedero V, 2001, J BACTERIOL, V183, P3391, DOI 10.1128/JB.183.11.3391-3398.2001; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nessler S, 2003, J BACTERIOL, V185, P4003, DOI 10.1128/JB.185.14.4003-4010.2003; Pompeo F, 2003, BIOCHEMISTRY-US, V42, P6762, DOI 10.1021/bi034405i; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; RODIER FJL, 1982, EUR J BIOCHEM, V128, P451; Russell RB, 2002, FEBS LETT, V517, P1, DOI 10.1016/S0014-5793(02)02518-8; Tari LW, 1996, NAT STRUCT BIOL, V3, P355, DOI 10.1038/nsb0496-355; VERSTAETE IM, 1999, J BACTERIOL, V181, P2966; Yang QH, 2001, J BIOL CHEM, V276, P24608, DOI 10.1074/jbc.M102366200; Yu ZH, 2007, J MOL BIOL, V365, P732, DOI 10.1016/j.jmb.2006.10.035	38	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34952	34957		10.1074/jbc.M705979200	http://dx.doi.org/10.1074/jbc.M705979200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17878158	Green Published, hybrid			2022-12-25	WOS:000251155200039
J	Wu, SW; Chen, HR; Alexeyev, MF; King, JAC; Moore, TM; Stevens, T; Balczon, RD				Wu, Songwei; Chen, Hairu; Alexeyev, Mikhail F.; King, Judy A. C.; Moore, Timothy M.; Stevens, Troy; Balczon, Ronald D.			Microtubule motors regulate I-SOC activation necessary to increase endothelial cell permeability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAMSTER OVARY CELLS; OPERATED CA2+ ENTRY; ENDOPLASMIC-RETICULUM; CYTOPLASMIC DYNEIN; CALCIUM-CHANNELS; BARRIER FUNCTION; MEMBRANE; OVEREXPRESSION; DYNACTIN; PIGMENTATION	Calcium store depletion activates multiple ion channels, including calcium-selective and nonselective channels. Endothelial cells express TRPC1 and TRPC4 proteins that contribute to a calcium-selective store-operated current, I-SOC. Whereas thapsigargin activates the I-SOC in pulmonary artery endothelial cells (PAECs), it does not activate I-SOC in pulmonary microvascular endothelial cells (PMVECs), despite inducing a significant rise in global cytosolic calcium. Endoplasmic reticulum exhibits retrograde distribution in PMVECs when compared with PAECs. We therefore sought to determine whether endoplasmic reticulum-to-plasma membrane coupling represents an important determinant of I-SOC activation in PAECs and PMVECs. Endoplasmic reticulum organization is controlled by microtubules, because nocodozole induced microtubule disassembly and caused retrograde endoplasmic reticulum collapse in PMVECs. In PMVECs, rolipram treatment produced anterograde endoplasmic reticulum distribution and revealed a thapsigarin-activated I-SOC that was abolished by nocodozole and taxol. Microtubule motors control organelle distribution along microtubule tracks, with the dynein motor causing retrograde movement and the kinesin motor causing anterograde movement. Dynamitin expression reduces dynein motor function inducing anterograde endoplasmic reticulum transport, which allows for direct activation of I-SOC by thapsigargin in PMVECs. In contrast, expression of dominant negative kinesin light chain reduces kinesin motor function and induces retrograde endoplasmic reticulum transport; dominant negative kinesin light chain expression prevented the direct activation of I-SOC by thapsigargin in PAECs. I-SOC activation is an important step leading to disruption of cell-cell adhesion and increased macromolecular permeability. Thus, microtubule motor function plays an essential role in activating cytosolic calcium transitions through the membrane I-SOC channel leading to endothelial barrier disruption.	Univ S Alabama, Coll Med, Ctr Lung Biol, Dept Mol & Cellular Pharmacol, Mobile, AL 36688 USA; Univ S Alabama, Coll Med, Ctr Lung Biol, Dept Cell Biol & Neurosci, Mobile, AL 36688 USA; Univ S Alabama, Coll Med, Ctr Lung Biol, Dept Pathol, Mobile, AL 36688 USA; Univ S Alabama, Coll Med, Ctr Lung Biol, Dept Med, Mobile, AL 36688 USA	University of South Alabama; University of South Alabama; University of South Alabama; University of South Alabama	Wu, SW (corresponding author), Univ S Alabama, Coll Med, Ctr Lung Biol, Dept Mol & Cellular Pharmacol, Mobile, AL 36688 USA.	swu@jaguar1.usouthal.edu; rbalczon@usouthal.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060024, P01HL066299, R37HL060024] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-60024, HL-66299] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Balczon R, 2001, CHROMOSOMA, V110, P381, DOI 10.1007/s004120100157; BALCZON R, 1995, J CELL BIOL, V130, P105, DOI 10.1083/jcb.130.1.105; Barral DC, 2004, PIGM CELL RES, V17, P111, DOI 10.1111/j.1600-0749.2004.00138.x; Brough GH, 2001, FASEB J, V15, P1727, DOI 10.1096/fj.01-0108com; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Byers HR, 2003, J INVEST DERMATOL, V121, P813; Chetham PM, 1997, AM J PHYSIOL-LUNG C, V273, pL22, DOI 10.1152/ajplung.1997.273.1.L22; Chetham PM, 1999, AM J PHYSIOL-LUNG C, V276, pL41, DOI 10.1152/ajplung.1999.276.1.L41; Cioffi DL, 2005, CIRC RES, V97, P1164, DOI 10.1161/01.RES.0000193597.65217.00; Cioffi DL, 2003, CELL CALCIUM, V33, P323, DOI 10.1016/S0143-4160(03)00046-0; Creighton JR, 2003, AM J PHYSIOL-LUNG C, V284, pL100, DOI 10.1152/ajplung.00083.2002; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; Hirose H, 2004, EMBO J, V23, P1267, DOI 10.1038/sj.emboj.7600135; Kelly JJ, 1998, AM J PHYSIOL-LUNG C, V274, pL810, DOI 10.1152/ajplung.1998.274.5.L810; King J, 2004, MICROVASC RES, V67, P139, DOI 10.1016/j.mvr.2003.11.006; Lambert J, 1999, CELL MOL BIOL, V45, P905; Liu QQ, 2001, J CELL SCI, V114, P797; Logan DW, 2006, PIGM CELL RES, V19, P206, DOI 10.1111/j.1600-0749.2006.00307.x; Marklund U, 1996, EMBO J, V15, P5290, DOI 10.1002/j.1460-2075.1996.tb00914.x; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Metge B, 2004, J BIOL CHEM, V279, P41801, DOI 10.1074/jbc.M407094200; MINOTTI AM, 1991, J BIOL CHEM, V266, P3987; Moore TM, 1998, AM J PHYSIOL-LUNG C, V275, pL203, DOI 10.1152/ajplung.1998.275.2.L203; Nilius B, 2003, ENDOTHELIUM-J ENDOTH, V10, P5, DOI 10.1080/10623320303356; Oka T, 2005, J IMMUNOL, V174, P4584, DOI 10.4049/jimmunol.174.8.4584; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Quintana A, 2006, J BIOL CHEM, V281, P40302, DOI 10.1074/jbc.M607896200; Skold HN, 2002, PIGM CELL RES, V15, P357, DOI 10.1034/j.1600-0749.2002.02048.x; Stevens T, 2000, AM J PHYSIOL-LUNG C, V279, pL419, DOI 10.1152/ajplung.2000.279.3.L419; Stevens T, 1999, AM J PHYSIOL-LUNG C, V277, pL119, DOI 10.1152/ajplung.1999.277.1.L119; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Upadhyaya A, 2004, BIOPHYS J, V86, P2923, DOI 10.1016/S0006-3495(04)74343-X; Valetti C, 1999, MOL BIOL CELL, V10, P4107, DOI 10.1091/mbc.10.12.4107; Varadi A, 2004, J CELL SCI, V117, P4389, DOI 10.1242/jcs.01299; Vedrenne C, 2006, TRAFFIC, V7, P639, DOI 10.1111/j.1600-0854.2006.00419.x; Vedrenne C, 2005, MOL BIOL CELL, V16, P1928, DOI 10.1091/mbc.e04-07-0554; Verhey KJ, 1998, J CELL BIOL, V143, P1053, DOI 10.1083/jcb.143.4.1053; Watson P, 2005, NAT CELL BIOL, V7, P48, DOI 10.1038/ncb1206; Wedlich-Soldner R, 2002, MOL BIOL CELL, V13, P965, DOI 10.1091/mbc.01-10-0475; Wu SW, 2005, CIRC RES, V96, P856, DOI 10.1161/01.RES.0000163632.67282.1f	40	26	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34801	34808		10.1074/jbc.M704522200	http://dx.doi.org/10.1074/jbc.M704522200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17921144	hybrid			2022-12-25	WOS:000251155200022
J	Conz, C; OttoO, H; PeiskerO, K; Gautschi, M; Wolfle, T; Mayer, MP; Rospert, S				Conz, Charlotte; OttoO, Hendrik; PeiskerO, Kristin; Gautschi, Matthias; Woelfle, Tina; Mayer, Matthias P.; Rospert, Sabine			Functional characterization of the atypical Hsp70 subunit of yeast ribosome-associated complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; MOLECULAR CHAPERONES; DNAK CHAPERONE; PROTEINS; HSP110; TRANSLATION; SPECIFICITY; BINDING; LACKING; FAMILY	Eukaryotic ribosomes carry a stable chaperone complex termed ribosome-associated complex consisting of the J-domain protein Zuo1 and the Hsp70 Ssz1. Zuo1 and Ssz1 together with the Hsp70 homolog Ssb1/2 form a functional triad involved in translation and early polypeptide folding processes. Strains lacking one of these components display slow growth, cold sensitivity, and defects in translational fidelity. Ssz1 diverges from canonical Hsp70s insofar that neither the ability to hydrolyze ATP nor binding to peptide substrates is essential in vivo. The exact role within the chaperone triad and whether or not Ssz1 can hydrolyze ATP has remained unclear. We now find that Ssz1 is not an ATPase in vitro, and even its ability to bind ATP is dispensable in vivo. Furthermore, Ssz1 function was independent of ribosome-associated complex formation, indicating that Ssz1 is not merely a structural scaffold for Zuo1. Finally, Ssz1 function in vivo was inactivated when both nucleotide binding and Zuo1 interaction via the C-terminal domain were disrupted in the same mutant. The two domains of this protein thus cooperate in a way that allows for severe interference in either but not in both of them.	ZBMZ, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; Univ Freiburg, Fak Biol, D-79104 Freiburg, Germany; ETH Honggerberg, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; Heidelberg Univ, ZMBH, Zentrum Mol Biol, D-69120 Heidelberg, Germany	University of Freiburg; Swiss Federal Institutes of Technology Domain; ETH Zurich; Ruprecht Karls University Heidelberg	Rospert, S (corresponding author), ZBMZ, Inst Biochem & Mol Biol, Herrmann Herder Str 7, D-79104 Freiburg, Germany.	sabine.rospert@biochemie.uni-freiburg.de	Mayer, Matthias P./B-9340-2013	Mayer, Matthias P./0000-0002-7859-3112; Rospert, Sabine/0000-0002-3089-9614				Amor-Mahjoub M, 2006, J CHROMATOGR B, V844, P328, DOI 10.1016/j.jchromb.2006.07.031; Braun EL, 2001, MOL BIOL EVOL, V18, P1401, DOI 10.1093/oxfordjournals.molbev.a003924; BUCHBERGER A, 1994, NAT STRUCT BIOL, V1, P95, DOI 10.1038/nsb0294-95; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; CRAIG EA, 1985, MOL CELL BIOL, V5, P3517, DOI 10.1128/MCB.5.12.3517; Dragovic Z, 2006, BIOL CHEM, V387, P1593, DOI 10.1515/BC.2006.198; Dragovic Z, 2006, EMBO J, V25, P2519, DOI 10.1038/sj.emboj.7601138; Dresios J, 2006, MOL MICROBIOL, V59, P1651, DOI 10.1111/j.1365-2958.2006.05054.x; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; Gautschi M, 2001, P NATL ACAD SCI USA, V98, P3762, DOI 10.1073/pnas.071057198; Gautschi M, 2002, P NATL ACAD SCI USA, V99, P4209, DOI 10.1073/pnas.062048599; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; HAID A, 1983, METHOD ENZYMOL, V96, P192; Hatin I, 2007, GENETICS, V177, P1527, DOI 10.1534/genetics.107.070771; HEITMAN J, 1991, P NATL ACAD SCI USA, V88, P1948, DOI 10.1073/pnas.88.5.1948; Hennessy F, 2005, PROTEIN SCI, V14, P1697, DOI 10.1110/ps.051406805; Huang P, 2005, NAT STRUCT MOL BIOL, V12, P497, DOI 10.1038/nsmb942; Hundley H, 2002, P NATL ACAD SCI USA, V99, P4203, DOI 10.1073/pnas.062048399; James P, 1997, SCIENCE, V275, P387, DOI 10.1126/science.275.5298.387; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Mayer MP, 1999, J MOL BIOL, V289, P1131, DOI 10.1006/jmbi.1999.2844; MCCARTY JS, 1995, J MOL BIOL, V249, P126, DOI 10.1006/jmbi.1995.0284; Muldoon-Jacobs KL, 2006, EUKARYOT CELL, V5, P762, DOI 10.1128/EC.5.4.762-770.2006; NELSON RJ, 1992, CELL, V71, P97, DOI 10.1016/0092-8674(92)90269-I; OBrien MC, 1996, J BIOL CHEM, V271, P15874, DOI 10.1074/jbc.271.27.15874; Otto H, 2005, P NATL ACAD SCI USA, V102, P10064, DOI 10.1073/pnas.0504400102; Pfund C, 1998, EMBO J, V17, P3981, DOI 10.1093/emboj/17.14.3981; Rakwalska M, 2004, MOL CELL BIOL, V24, P9186, DOI 10.1128/MCB.24.20.9186-9197.2004; Rauch T, 2005, MOL MICROBIOL, V57, P357, DOI 10.1111/j.1365-2958.2005.04690.x; Raue U, 2007, J BIOL CHEM, V282, P7809, DOI 10.1074/jbc.M611436200; Raviol H, 2006, FEBS LETT, V580, P168, DOI 10.1016/j.febslet.2005.11.069; Raviol H, 2006, EMBO J, V25, P2510, DOI 10.1038/sj.emboj.7601139; Rospert S, 2005, REV PHYSIOL BIOCH P, V155, P1, DOI 10.1007/s10254-005-0039-7; Rospert S, 2004, CURR BIOL, V14, pR386, DOI 10.1016/j.cub.2004.05.013; Rospert S, 1995, METHOD ENZYMOL, V260, P287, DOI 10.1016/0076-6879(95)60145-7; Schonfeld HJ, 1995, PROG COLL POL SCI S, V99, P7; Shaner L, 2004, J BIOL CHEM, V279, P21992, DOI 10.1074/jbc.M313739200; Sherman F., 1986, METHODS YEAST GENETI; Walsh P, 2004, EMBO REP, V5, P567, DOI 10.1038/sj.embor.7400172; YAFFE MP, 1984, P NATL ACAD SCI-BIOL, V81, P4819, DOI 10.1073/pnas.81.15.4819; Yan W, 1998, EMBO J, V17, P4809, DOI 10.1093/emboj/17.16.4809	41	33	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					33977	33984		10.1074/jbc.M706737200	http://dx.doi.org/10.1074/jbc.M706737200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17901048	hybrid			2022-12-25	WOS:000251145700011
J	Izaguirre, G; Swanson, R; Raja, SM; Rezaie, AR; Olson, ST				Izaguirre, Gonzalo; Swanson, Richard; Raja, Srikumar M.; Rezaie, Alireza R.; Olson, Steven T.			Mechanism by which exosites promote the inhibition of blood coagulation proteases by heparin-activated antithrombin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REACTIVE CENTER LOOP; TARGET PROTEINASE SPECIFICITY; FACTOR-XA REACTION; CONFORMATIONAL-CHANGE; BINDING EXOSITE; FACTOR-IXA; PLASMINOGEN-ACTIVATOR; RAPID INHIBITION; TERNARY COMPLEX; BASIC RESIDUES	Heparin activates the serpin, antithrombin, to inhibit its target blood-clotting proteases by generating new protease interaction exosites. To resolve the effects of these exosites on the initial Michaelis docking step and the subsequent acylation and conformational change steps of antithrombin-protease reactions, we compared the reactions of catalytically inactive S195A and active proteases with site-specific fluorophore-labeled antithrombins that allow monitoring of these reaction steps. Heparin bound to N,N'-dimethyl-N-(acetyl)-N'-(7-nitrobenz-3-oxa-1,3diazol- 4-yl)ethylenediamine (NBD)-fluorophore-labeled antithrombins and accelerated the reactions of the labeled inhibitor with thrombin and factor Xa similar to wild type. Equilibrium binding of NBD- labeled antithrombins to S195A proteases showed that exosites generated by conformationally activating antithrombin with a heparin pentasaccharide enhanced the affinity of the serpin for S195A factor Xa minimally 100-fold. Moreover, additional bridging exosites provided by a hexadecasaccharide heparin activator enhanced antithrombin affinity for both S195A factor Xa and thrombin at least 1000-fold. Rapid kinetic studies showed that these exosite-mediated enhancements in Michaelis complex affinity resulted from increases in k(on) and decreases in k(off) and caused antithrombin-protease reactions to become diffusion-controlled. Competitive binding and kinetic studies with exosite mutant antithrombins showed that Tyr-253 was a critical mediator of exosite interactions with S195A factor Xa; that Glu-255, Glu-237, and Arg-399 made more modest contributions to these interactions; and that exosite interactions reduced koff for the Michaelis complex interaction. Together these results show that exosites generated by heparin activation of antithrombin function both to promote the formation of an initial antithrombin-protease Michaelis complex and to favor the subsequent acylation of this complex.	Univ Illinois, Ctr Mol Biol & Oral Dis, Chicago, IL 60612 USA; St Louis Univ, Dept Biochem & Mol Biol, St Louis, MO 63104 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Saint Louis University	Olson, ST (corresponding author), Univ Illinois, Ctr Mol Biol & Oral Dis, Rm 530C Dent M-C 860,801 S Paulina St, Chicago, IL 60612 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062565, R01HL039888, R37HL039888, R29HL039888] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-62565, HL-39888] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Backovic M, 2002, J PROTEOME RES, V1, P367, DOI 10.1021/pr025515z; Bedsted T, 2003, BIOCHEMISTRY-US, V42, P8143, DOI 10.1021/bi034363y; Bjork I, 1997, ADV EXP MED BIOL, V425, P17; CHOAY J, 1983, BIOCHEM BIOPH RES CO, V116, P492, DOI 10.1016/0006-291X(83)90550-8; Chuang YJ, 2001, J BIOL CHEM, V276, P14961, DOI 10.1074/jbc.M011550200; Chuang YJ, 1999, J BIOL CHEM, V274, P28142, DOI 10.1074/jbc.274.40.28142; Chuang YJ, 2001, BIOCHEMISTRY-US, V40, P6670, DOI 10.1021/bi002933d; CRAIG PA, 1989, J BIOL CHEM, V264, P5452; DANIELSSON A, 1986, J BIOL CHEM, V261, P5467; Dementiev A, 2006, J BIOL CHEM, V281, P3452, DOI 10.1074/jbc.M510564200; Dementiev A, 2004, NAT STRUCT MOL BIOL, V11, P863, DOI 10.1038/nsmb810; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Izaguirre G, 2006, J BIOL CHEM, V281, P13424, DOI 10.1074/jbc.M600415200; Izaguirre G, 2003, J BIOL CHEM, V278, P51433, DOI 10.1074/jbc.M309266200; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; Johnson DJD, 2006, EMBO J, V25, P2029, DOI 10.1038/sj.emboj.7601089; JORDAN RE, 1987, SCIENCE, V237, P777, DOI 10.1126/science.3649921; Li W, 2004, NAT STRUCT MOL BIOL, V11, P857, DOI 10.1038/nsmb811; LINDAHL P, 1991, BIOCHEM J, V276, P387, DOI 10.1042/bj2760387; Manithody C, 2002, BIOCHEMISTRY-US, V41, P6780, DOI 10.1021/bi0255367; MILETICH JP, 1981, METHOD ENZYMOL, V80, P221; MILLER DM, 1980, J BIOL CHEM, V255, P2465; NORDENMAN B, 1977, EUR J BIOCHEM, V78, P195, DOI 10.1111/j.1432-1033.1977.tb11730.x; OLSON ST, 1995, J BIOL CHEM, V270, P30007; OLSON ST, 1992, J BIOL CHEM, V267, P12528; Olson ST, 2004, THROMB HAEMOSTASIS, V92, P929, DOI 10.1160/TH04-06-0384; OLSON ST, 1981, J BIOL CHEM, V256, P1073; OLSON ST, 1991, J BIOL CHEM, V266, P6353; OLSON ST, 1985, J BIOL CHEM, V260, P153; OLSON ST, 1993, METHOD ENZYMOL, V222, P525; Olson ST, 2001, BIOCHEMISTRY-US, V40, P11742, DOI 10.1021/bi0107290; OWEN W G, 1973, Thrombosis Research, V3, P705, DOI 10.1016/0049-3848(73)90017-0; Petitou M, 1999, NATURE, V398, P417, DOI 10.1038/18877; Pike RN, 1997, J BIOL CHEM, V272, P19652, DOI 10.1074/jbc.272.32.19652; Rezaie AR, 1998, J BIOL CHEM, V273, P16824, DOI 10.1074/jbc.273.27.16824; Rezaie AR, 2000, BIOCHEMISTRY-US, V39, P12083, DOI 10.1021/bi0011126; Rezaie AR, 2000, J BIOL CHEM, V275, P3320, DOI 10.1074/jbc.275.5.3320; Rezaie AR, 2006, BIOCHEMISTRY-US, V45, P5324, DOI 10.1021/bi060056r; Rezaie AR, 2004, BIOCHEMISTRY-US, V43, P2898, DOI 10.1021/bi036145a; Rezaie AR, 1996, BIOCHEMISTRY-US, V35, P1918, DOI 10.1021/bi952065y; SHEEHAN JP, 1994, P NATL ACAD SCI USA, V91, P5518, DOI 10.1073/pnas.91.12.5518; SHORE JD, 1995, J BIOL CHEM, V270, P5395, DOI 10.1074/jbc.270.10.5395; Skinner R, 1997, J MOL BIOL, V266, P601, DOI 10.1006/jmbi.1996.0798; Stone SR, 1997, J MOL BIOL, V265, P344, DOI 10.1006/jmbi.1996.0727; Stratikos E, 1999, P NATL ACAD SCI USA, V96, P4808, DOI 10.1073/pnas.96.9.4808; SUN XJ, 1989, J BIOL CHEM, V264, P11288; Swanson R, 2007, J BIOL CHEM, V282, P2305, DOI 10.1074/jbc.M609546200; Turk B, 1997, BIOCHEMISTRY-US, V36, P6682, DOI 10.1021/bi9702492; Yang LK, 2002, J BIOL CHEM, V277, P50756, DOI 10.1074/jbc.M208485200	50	25	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46							33609	10.1074/jbc.M702462200	http://dx.doi.org/10.1074/jbc.M702462200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17875649	hybrid			2022-12-25	WOS:000250840200042
J	Filler, AG				Filler, Aaron G.			Homeotic Evolution in the Mammalia: Diversification of Therian Axial Seriation and the Morphogenetic Basis of Human Origins	PLOS ONE			English	Article							MIDDLE MIOCENE; HOX GENES; SKELETON; HOMINID; BODY; APE; SAHELANTHROPUS; MORPHOLOGY; OREOPITHECUS; SEGMENTATION	Background. Despite the rising interest in homeotic genes, little has been known about the course and pattern of evolution of homeotic traits across the mammalian radiation. An array of emerging and diversifying homeotic gradients revealed by this study appear to generate new body plans and drive evolution at a large scale. Methodology/Principal Findings. This study identifies and evaluates a set of homeotic gradients across 250 extant and fossil mammalian species and their antecedents over a period of 220 million years. These traits are generally expressed as co-linear gradients along the body axis rather than as distinct segmental identities. Relative position or occurrence sequence vary independently and are subject to polarity reversal and mirroring. Five major gradient modification sets are identified: (1)-quantitative changes of primary segmental identity pattern that appeared at the origin of the tetrapods; (2)-frame shift relation of costal and vertebral identity which diversifies from the time of amniote origins; (3)-duplication, mirroring, splitting and diversification of the neomorphic laminar process first commencing at the dawn of mammals; (4)-emergence of homologically variable lumbar lateral processes upon commencement of the radiation of therian mammals and; (5)-inflexions and transpositions of the relative position of the horizontal septum of the body and the neuraxis at the emergence of various orders of therian mammals. Convergent functional changes under homeotic control include laminar articular engagement with septo-neural transposition and ventrally arrayed lumbar transverse process support systems. Conclusion/Significance. Clusters of homeotic transformations mark the emergence point of mammals in the Triassic and the radiation of therians in the Cretaceous. A cluster of homeotic changes in the Miocene hominoid Morotopithecus that are still seen in humans supports establishment of a new "hominiform'' clade and suggests a homeotic origin for the human upright body plan.	[Filler, Aaron G.] Harvard Univ, Museum Comparat Zool, Dept Anthropol, Cambridge, MA 02138 USA; [Filler, Aaron G.] Cedars Sinai Med Ctr, Inst Spinal Disorders, Dept Neurosurg, Los Angeles, CA 90048 USA	Harvard University; Cedars Sinai Medical Center	Filler, AG (corresponding author), Harvard Univ, Museum Comparat Zool, Dept Anthropol, Cambridge, MA 02138 USA.	afiller@earthlink.net			NIH PHS Musculoskeletal Biology Training [5 T32 GM07117-09 0011]	NIH PHS Musculoskeletal Biology Training	Funding: Portions of this work were supported by NIH PHS Musculoskeletal Biology Training Grant # 5 T32 GM07117-09 0011.	Ahlberg PE, 2005, NATURE, V437, P137, DOI 10.1038/nature03893; Appel Toby A., 1987, CUVIER GEOFFROY DEBA; Argot C, 2003, J MORPHOL, V255, P279, DOI 10.1002/jmor.10062; Bateson W., 1894, MAT STUDY VARIATION; Bezuidenhout AJ, 1996, ONDERSTEPOORT J VET, V63, P131; Boszczyk BM, 2001, ANAT RECORD, V264, P157, DOI 10.1002/ar.1156; Brunet M, 2002, NATURE, V418, P145, DOI 10.1038/nature00879; Buchholtz EA, 2007, EVOL DEV, V9, P278, DOI 10.1111/j.1525-142X.2007.00160.x; Budd GE, 2006, BIOL REV, V81, P609, DOI 10.1017/S1464793106007135; BURKE AC, 1995, DEVELOPMENT, V121, P333; Burke AC, 2000, CURR TOP DEV BIOL, V47, P155; CARROLL SB, 1995, NATURE, V376, P479, DOI 10.1038/376479a0; Carroll SB, 2003, NATURE, V422, P849, DOI 10.1038/nature01495; Cheng Z, 2005, NATURE, V437, P88, DOI 10.1038/nature04000; Daeschler EB, 2006, NATURE, V440, P757, DOI 10.1038/nature04639; Dahn RD, 2007, NATURE, V445, P311, DOI 10.1038/nature05436; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; DeRobertis EM, 1996, NATURE, V380, P37, DOI 10.1038/380037a0; Douady CJ, 2003, P NATL ACAD SCI USA, V100, P8325, DOI 10.1073/pnas.0832467100; Filler Aaron G., 1993, P13; FILLER AG, 1979, THESIS U CHICAGO CHI; Filler AG, 2007, NEUROSURG FOCUS, V23, P1, DOI [10.3171/FOC-07/07/E4, DOI 10.3171/FOC-07/07/E4]; FILLER AG, 2007, UPRIGHT APE NEW ORIG; FILLER AG, 2007, THESIS HARVARD U CAM; Fischer MS, 2002, J EXP BIOL, V205, P1315; Flower WH, 1885, INTRO OSTEOLOGY MAMM, pxi; Flynn JJ, 2005, SYST BIOL, V54, P317, DOI 10.1080/10635150590923326; Galik K, 2004, SCIENCE, V305, P1450, DOI 10.1126/science.1098807; Geisler R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-11; Geoffroy Saint-Hilaire E., 1830, TRADUCTIONS IMITATIO; Geoffroy Saint-Hilaire E., 1822, MEMOIRES DU MUSEUM D, V9, P89; GOULD SJ, 2002, STRUCTURE EVOLUTIONA, pR21; Gregory William K., 1947, BULL AMER MUS NAT HIST, V88, P1; Guy F, 2005, P NATL ACAD SCI USA, V102, P18836, DOI 10.1073/pnas.0509564102; Haeusler M, 2002, J HUM EVOL, V43, P621, DOI 10.1006/jhev.2002.0595; Harcourt-Smith WEH, 2004, J ANAT, V204, P403, DOI 10.1111/j.0021-8782.2004.00296.x; Hoffstetter R., 1969, P201; Ishida H, 2004, J HUM EVOL, V46, P69, DOI 10.1016/j.jhevol.2003.10.001; Jacobs DK, 2005, EVOL DEV, V7, P498, DOI 10.1111/j.1525-142X.2005.05055.x; JENKINS FA, 1971, POSTCRANIAL SKELETON, pR10; Keith A, 1923, BMJ-BRIT MED J, V1923, P669, DOI 10.1136/bmj.1.3251.669; Keith A, 1923, BRIT MED J, V1923, P624; Keith A, 1923, BRIT MED J, V1923, P587; Keith A, 1923, BRIT MED J, V1923, P545; Keith A, 1923, BRIT MED J, V1923, P499; Keith A, 1923, BMJ-BRIT MED J, V1923, P451, DOI 10.1136/bmj.1.3246.451; Keith A, 1902, J ANAT PHYSIOL, V37, P18; KEMP TS, 2005, ORIGIN EVOLUTION MAM, pR10; Kielan-Jaworowska Zofia, 1994, Fossils and Strata, V36, P1; KIELANJAWOROWSK.Z, 2004, MAMMALS AGE DINOSAUR, pR15; Kohler M, 1997, P NATL ACAD SCI USA, V94, P11747, DOI 10.1073/pnas.94.21.11747; Kuratani S, 2005, ZOOL SCI, V22, P1, DOI 10.2108/zsj.22.1; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Li G, 2006, NATURE, V439, P195, DOI 10.1038/nature04168; Lovejoy CO, 2003, ANNU REV ANTHROPOL, V32, P85, DOI 10.1146/annurev.anthro.32.061002.093223; MACLATCHY I, 2004, EVOL ANTHROPOL, P90; MacLatchy L, 2000, J HUM EVOL, V39, P159, DOI 10.1006/jhev.2000.0407; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Minelli A, 2005, J EXP ZOOL PART B, V304B, P520, DOI 10.1002/jez.b.21044; Minelli A, 2004, TRENDS ECOL EVOL, V19, P423, DOI 10.1016/j.tree.2004.06.007; Moya-Sola S, 2004, SCIENCE, V306, P1339, DOI 10.1126/science.1103094; Nakatsukasa M, 2004, J HUM EVOL, V46, P777, DOI 10.1016/j.jhevol.2004.04.005; Narita Y, 2005, J EXP ZOOL PART B, V304B, P91, DOI 10.1002/jez.b.21029; Nilsson MA, 2004, GENE, V340, P189, DOI 10.1016/j.gene.2004.07.040; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; NUSSLEINVOLHARD C, 1994, SCIENCE, V266, P572, DOI 10.1126/science.7939708; NussleinVolhard C, 1996, SCI AM, V275, P54; NUSSLEINVOLHARD C, 1979, S SOC DEV BIOL, V37, P185; Ohman JC, 2005, SCIENCE, V307, P845; Owen R., 1848, ARCHETYPE HOMOLOGIES, DOI [10.5962/bhl.title.118611, DOI 10.5962/BHL.TITLE.118611]; OWEN R, 1862, T ZOOL SOC LONDON, V4, P89; Pilbeam D, 2004, J EXP ZOOL PART B, V302B, P241, DOI 10.1002/jez.b.22; Raaum RL, 2005, J HUM EVOL, V48, P237, DOI 10.1016/j.jhevol.2004.11.007; RICHARDS RJ, 2002, ROMANTIC CONCEPTION, pR19; ROBERTSON JT, 1972, EARLY HOMINID POSTUR; Rokas A, 2005, SCIENCE, V310, P1933, DOI 10.1126/science.1116759; Rook L, 1999, P NATL ACAD SCI USA, V96, P8795, DOI 10.1073/pnas.96.15.8795; Schilling N, 2006, J EXP BIOL, V209, P3925, DOI 10.1242/jeb.02400; SCHLOSSER G, 2004, MODULARITY DEV EVOLU, pR10; Slijper E. J., 1946, Verh K nod Akad Wet Amsterdam (2), V42, P1; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; Stollewerk A, 2003, NATURE, V423, P863, DOI 10.1038/nature01682; Stoltzfus A, 2006, EVOL DEV, V8, P304, DOI 10.1111/j.1525-142X.2006.00101.x; Theissen G, 2006, THEOR BIOSCI, V124, P349, DOI 10.1016/j.thbio.2005.11.002; Theissen G, 2004, NATURE, V428, P813, DOI 10.1038/428813b; Thorpe SKS, 2007, SCIENCE, V316, P1328, DOI 10.1126/science.1140799; TUTTLE R, 1974, CURR ANTHROPOL, V15, P389, DOI 10.1086/201494; Tuttle RH, 2006, DEV PRIMATOL-PROG PR, P249, DOI 10.1007/0-387-29798-7_19; vanEeden FJM, 1996, DEVELOPMENT, V123, P153; VONGOETHE JW, 1817, NATURWISSENSCHAFT UB; WALKER A, 1968, NATURE, V217, P980, DOI 10.1038/217980a0; WARD CV, 1993, AM J PHYS ANTHROPOL, V90, P77, DOI 10.1002/ajpa.1330900106; WARD CV, 1993, AM J PHYS ANTHROPOL, V92, P291, DOI 10.1002/ajpa.1330920306; WILLISTON SW, 1925, OSTEOLOGY REPTILES, pR13; Wolpoff MH, 2002, NATURE, V419, P581, DOI 10.1038/419581a; Young NM, 2004, J HUM EVOL, V46, P163, DOI 10.1016/j.jhevol.2003.11.002; YU JK, 2007, NATURE; Zollikofer CPE, 2005, NATURE, V434, P755, DOI 10.1038/nature03397	98	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1019	10.1371/journal.pone.0001019	http://dx.doi.org/10.1371/journal.pone.0001019			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925867	Green Submitted, gold, Green Published			2022-12-25	WOS:000207456000018
J	Ding, C; Liu, Y; Wang, Y; Park, BK; Wang, CY; Zheng, P; Liu, Y				Ding, Cheng; Liu, Yan; Wang, Yin; Park, Bae Keun; Wang, Cun-Yu; Zheng, Pan; Liu, Yang			Siglecg Limits the Size of B1a B Cell Lineage by Down-Regulating NF kappa B Activation	PLOS ONE			English	Article								Background. B1 B cells are believed to be a unique lineage with a distinct developmental pathway, function and activation requirement. How this lineage is genetically determined remained largely obscure. Methods and Principal Findings. Using the Siglecg-deficient mice with a knockin of green-fluorescent protein encoding sequence, we show here that, although the Siglecg gene is broadly expressed at high levels in all stages and/or lineages of B cells tested and at lower levels in other lineages, its deletion selectively expanded the B1a B cell lineages, including the frequency of the B1 cell progenitor in the bone marrow and the number of B1a cells in the peritoneal cavity, by postnatal expansion. The expansion of B1a B cells in the peritoneal correlated with enhanced activation of NF kappa B and was ablated by an IKK inhibitor. Conclusion and Significance. Our data revealed a critical role for Siglec G-NF kappa B pathway in regulating B1a B cell lineage. These data lead to a novel model of B1a lineage development that explains a large array of genetic data in this field.	[Ding, Cheng; Liu, Yan; Wang, Yin; Zheng, Pan; Liu, Yang] Univ Michigan, Sch Med, Dept Surg, Div Immunotherapy,Sect Gen Surg, Ann Arbor, MI 48109 USA; [Liu, Yang] Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI USA; [Zheng, Pan; Liu, Yang] Univ Michigan, Sch Med, Program Mol Mech Dis, Ann Arbor, MI USA; [Zheng, Pan; Liu, Yang] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI USA; [Zheng, Pan] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA; [Park, Bae Keun; Wang, Cun-Yu] Univ Calif Los Angeles, Sch Dent, Lab Mol Signaling & Apoptosis, Los Angeles, CA 90024 USA; [Ding, Cheng] Ohio State Univ, Integrated Biomed Grad Program, Columbus, OH 43210 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California Los Angeles; University System of Ohio; Ohio State University	Zheng, P (corresponding author), Univ Michigan, Sch Med, Dept Surg, Div Immunotherapy,Sect Gen Surg, Ann Arbor, MI 48109 USA.	panz@umich.edu; yangl@umich.edu	Zheng, Pan/E-8691-2011	Zheng, Pan/0000-0003-2598-3544; Liu, Yang/0000-0002-9442-700X	National Institutes of Health, USA; State of Ohio	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Ohio	This work is supported by National Institutes of Health, USA and Biomedical Research Technology Transfer fund of the State of Ohio. Neither has any role of any sponsors or funders in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Hardy RR, 2007, IMMUNITY, V26, P703, DOI 10.1016/j.immuni.2007.05.013; HARDY RR, 1984, J EXP MED, V159, P1169, DOI 10.1084/jem.159.4.1169; HARDY RR, 1991, P NATL ACAD SCI USA, V88, P11550, DOI 10.1073/pnas.88.24.11550; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Hayakawa K, 2003, J EXP MED, V197, P87, DOI 10.1084/jem.20021459; Hayakawa K, 1999, SCIENCE, V285, P113, DOI 10.1126/science.285.5424.113; Hoffmann A, 2007, NAT IMMUNOL, V8, P694, DOI 10.1038/ni1480; KANTOR AB, 1993, ANNU REV IMMUNOL, V11, P501, DOI 10.1146/annurev.immunol.11.1.501; Kitzig F, 2002, BIOCHEM BIOPH RES CO, V296, P355, DOI 10.1016/S0006-291X(02)00885-9; Li N, 2001, J BIOL CHEM, V276, P28106, DOI 10.1074/jbc.M100467200; Montecino-Rodriguez E, 2006, NAT IMMUNOL, V7, P293, DOI 10.1038/ni1301; Munday J, 2001, BIOCHEM J, V355, P489, DOI 10.1042/0264-6021:3550489; Oetke C, 2006, MOL CELL BIOL, V26, P1549, DOI 10.1128/MCB.26.4.1549-1557.2006; OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; Otipoby KL, 1996, NATURE, V384, P634, DOI 10.1038/384634a0; Pan C, 1999, IMMUNITY, V11, P495, DOI 10.1016/S1074-7613(00)80124-7; PAO LI, 2007, IMMUNITY IN PRESS; Park BK, 2007, NAT MED, V13, P62, DOI 10.1038/nm1519; PAUL WE, 2006, FUNDAMENTAL IMMUNOLO; Pohl T, 2002, P NATL ACAD SCI USA, V99, P4514, DOI 10.1073/pnas.072071599; Sato S, 1996, IMMUNITY, V5, P551, DOI 10.1016/S1074-7613(00)80270-8; SIDMAN CL, 1986, SCIENCE, V232, P1423, DOI 10.1126/science.3487115; Tung JW, 2006, P NATL ACAD SCI USA, V103, P6293, DOI 10.1073/pnas.0511305103; Wang CY, 1999, NAT MED, V5, P412, DOI 10.1038/7410; Whitney G, 2001, EUR J BIOCHEM, V268, P6083, DOI 10.1046/j.0014-2956.2001.02543.x	27	47	48	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e997	10.1371/journal.pone.0000997	http://dx.doi.org/10.1371/journal.pone.0000997			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912374	Green Published, gold, Green Submitted			2022-12-25	WOS:000207455900033
J	Paul, C; Povey, JE; Lawrence, NJ; Selfridge, J; Melton, DW; Saunders, PTK				Paul, Catriona; Povey, Joanne E.; Lawrence, Nicola J.; Selfridge, Jim; Melton, David W.; Saunders, Philippa T. K.			Deletion of Genes Implicated in Protecting the Integrity of Male Germ Cells Has Differential Effects on the Incidence of DNA Breaks and Germ Cell Loss	PLOS ONE			English	Article								Background. Infertility affects similar to 20% of couples in Europe and in 50% of cases the problem lies with the male partner. The impact of damaged DNA originating in the male germ line on infertility is poorly understood but may increase miscarriage. Mouse models allow us to investigate how deficiencies in DNA repair/damage response pathways impact on formation and function of male germ cells. We have investigated mice with deletions of ERCC1 (excision repair cross-complementing gene 1), MSH2 (MutS homolog 2, involved in mismatch repair pathway), and p53 (tumour suppressor gene implicated in elimination of germ cells with DNA damage). Principal Findings. We demonstrate for the first time that depletion of ERCC1 or p53 from germ cells results in an increased incidence of unrepaired DNA breaks in pachytene spermatocytes and increased numbers of caspase-3 positive (apoptotic) germ cells. Sertoli cell-only tubules were detected in testes from mice lacking expression of ERCC1 or MSH2 but not p53. The number of sperm recovered from epididymes was significantly reduced in mice lacking testicular ERCC1 and 40% of sperm contained DNA breaks whereas the numbers of sperm were not different to controls in adult Msh2 -/- or p53 -/- mice nor did they have significantly compromised DNA. Conclusions. These data have demonstrated that deletion of Ercc1, Msh2 and p53 can have differential but overlapping affects on germ cell function and sperm production. These findings increase our understanding of the ways in which gene mutations can have an impact on male fertility.	[Paul, Catriona; Saunders, Philippa T. K.] Queens Med Res Inst, MRC, Human Reprod Sci Unit, Edinburgh, Midlothian, Scotland; [Povey, Joanne E.; Lawrence, Nicola J.; Selfridge, Jim; Melton, David W.] Univ Edinburgh, Western Gen Hosp, Sir Alastair Currie Canc Res United Kingdom Labs, Mol Med Ctr, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Saunders, PTK (corresponding author), Queens Med Res Inst, MRC, Human Reprod Sci Unit, Edinburgh, Midlothian, Scotland.	p.saunders@ed.ac.uk	Saunders, Philippa TK/C-7489-2013	Saunders, Philippa TK/0000-0001-9051-9380; SELFRIDGE, JIM/0000-0003-2473-4386	MRC; Cancer Research UK [C376/A1570]; MRC [MC_U127685841, MC_U127685844] Funding Source: UKRI; Medical Research Council [MC_U127685841, MC_U127685844] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	CP was funded by an MRC studentship. This work was also supported by programme grant C376/A1570 from Cancer Research UK to DM and core MRC Unit funding to PTKS.	Baarends WM, 2001, REPRODUCTION, V121, P31, DOI 10.1530/rep.0.1210031; BAKALKIN GY, 1993, MOL BRAIN RES, V20, P137, DOI 10.1016/0169-328X(93)90119-A; Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; Barlow AL, 1997, EMBO J, V16, P5207, DOI 10.1093/emboj/16.17.5207; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8; Biggers J. D., 1971, CULTURE MOUSE EMBRYO, P86; Campbell AJ, 2000, BRIT MED BULL, V56, P616, DOI 10.1258/0007142001903427; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Chohan KR, 2004, ANDROLOGIA, V36, P321, DOI 10.1111/j.1439-0272.2004.00626.x; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; CLERMONT Y, 1963, AM J ANAT, V112, P35, DOI 10.1002/aja.1001120103; Cohen PE, 2001, BIOESSAYS, V23, P996, DOI 10.1002/bies.1145; Cooke HJ, 2002, NAT REV GENET, V3, P790, DOI 10.1038/nrg911; DAVIES AA, 1995, J BIOL CHEM, V270, P24638, DOI 10.1074/jbc.270.42.24638; DEVRIES A, 1995, NATURE, V377, P169, DOI 10.1038/377169a0; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Dunson DB, 2004, OBSTET GYNECOL, V103, P51, DOI 10.1097/01.AOG.0000100153.24061.45; Edelmann W, 1999, NAT GENET, V21, P123, DOI 10.1038/5075; Edelmann W, 1996, CELL, V85, P1125, DOI 10.1016/S0092-8674(00)81312-4; Embree-Ku M, 2002, EXP BIOL MED, V227, P545, DOI 10.1177/153537020222700720; Erster S, 2004, MOL CELL BIOL, V24, P6728, DOI 10.1128/MCB.24.15.6728-6741.2004; GORCZYCA W, 1993, EXP CELL RES, V207, P202, DOI 10.1006/excr.1993.1182; GRISWOLD MD, 1995, BIOL REPROD, V52, P211, DOI 10.1095/biolreprod52.2.211; Hamer G, 2003, BIOL REPROD, V68, P628, DOI 10.1095/biolreprod.102.008672; Hsia KT, 2003, DEVELOPMENT, V130, P369, DOI 10.1242/dev.00221; Jansen HT, 2001, BIOL REPROD, V65, P866, DOI 10.1095/biolreprod65.3.866; Jaroudi S, 2007, MUTAT RES-REV MUTAT, V635, P53, DOI 10.1016/j.mrrev.2006.09.002; Kirkpatrick DT, 1999, CELL MOL LIFE SCI, V55, P437, DOI 10.1007/s000180050300; Kneitz B, 2000, GENE DEV, V14, P1085; Kolas NK, 2005, J CELL BIOL, V171, P447, DOI 10.1083/jcb.200506170; Kolodner R, 1996, GENE DEV, V10, P1433, DOI 10.1101/gad.10.12.1433; KRZANOWSKA H, 1989, GAMETE RES, V23, P357, DOI 10.1002/mrd.1120230312; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; LAMMERS JHM, 1994, MOL CELL BIOL, V14, P1137, DOI 10.1128/MCB.14.2.1137; Li L, 1996, NUCLEIC ACIDS RES, V24, P1026, DOI 10.1093/nar/24.6.1026; Linke SP, 2003, CANCER RES, V63, P2596; Marcon E, 2005, BIOESSAYS, V27, P795, DOI 10.1002/bies.20264; Marty MS, 1999, MUTAT RES-FUND MOL M, V427, P39, DOI 10.1016/S0027-5107(99)00083-4; MATZUK MM, 1995, NATURE, V374, P356, DOI 10.1038/374356a0; MCWHIR J, 1993, NAT GENET, V5, P217, DOI 10.1038/ng1193-217; Meira LB, 2002, DNA REPAIR, V1, P929, DOI 10.1016/S1568-7864(02)00143-X; Modrich P, 1997, J BIOL CHEM, V272, P24727, DOI 10.1074/jbc.272.40.24727; Moens PB, 2002, J CELL SCI, V115, P1611; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; NAKANE H, 1995, NATURE, V377, P165, DOI 10.1038/377165a0; Ng JMY, 2002, MOL CELL BIOL, V22, P1233, DOI 10.1128/MCB.22.4.1233-1245.2002; Odorisio T, 1998, NAT GENET, V18, P257, DOI 10.1038/ng0398-257; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Polanski Z, 2000, J REPROD FERTIL, V119, P165, DOI 10.1530/reprod/119.1.165; Richardson LL, 2000, BIOL REPROD, V62, P789, DOI 10.1095/biolreprod62.3.789; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; ROTTER V, 1993, P NATL ACAD SCI USA, V90, P9075, DOI 10.1073/pnas.90.19.9075; Saunders PTK, 2001, MOL HUM REPROD, V7, P227, DOI 10.1093/molehr/7.3.227; SCHIESTL RH, 1990, MOL CELL BIOL, V10, P2485, DOI 10.1128/MCB.10.6.2485; SCHWARTZ D, 1993, ONCOGENE, V8, P1487; Schwartz D, 1999, CELL GROWTH DIFFER, V10, P665; Sedelnikova OA, 2002, RADIAT RES, V158, P486, DOI 10.1667/0033-7587(2002)158[0486:QDOIID]2.0.CO;2; Selfridge J, 2001, NUCLEIC ACIDS RES, V29, P4541, DOI 10.1093/nar/29.22.4541; Seo YR, 2004, EXP MOL MED, V36, P505, DOI 10.1038/emm.2004.64; Shannon M, 1999, GENOMICS, V62, P427, DOI 10.1006/geno.1999.6016; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Sjoblom T, 1996, ONCOGENE, V12, P2499; Sorahan T, 1997, BRIT J CANCER, V76, P1525, DOI 10.1038/bjc.1997.589; Stojic L, 2004, DNA REPAIR, V3, P1091, DOI 10.1016/j.dnarep.2004.06.006; Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X; Svetlanov A, 2004, EXP CELL RES, V296, P71, DOI 10.1016/j.yexcr.2004.03.020; Tang W, 1999, CANCER RES, V59, P2562; Twigg JP, 1998, HUM REPROD, V13, P1864, DOI 10.1093/humrep/13.7.1864; VanZelst SJ, 1995, REPROD FERT DEVELOP, V7, P1117, DOI 10.1071/RD9951117; WALDBIESER GC, 1986, GAMETE RES, V15, P153, DOI 10.1002/mrd.1120150206; WEEDA G, 1991, CARCINOGENESIS, V12, P2361, DOI 10.1093/carcin/12.12.2361; WIND N, 1995, CELL, V82, P321; Wood RD, 1996, ANNU REV BIOCHEM, V65, P135, DOI 10.1146/annurev.bi.65.070196.001031; Xu GG, 2005, BIOL REPROD, V73, P123, DOI 10.1095/biolreprod.104.039123; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411; Yin YZ, 1998, DEV BIOL, V204, P165, DOI 10.1006/dbio.1998.9074; Yin YZ, 2002, J ANDROL, V23, P64, DOI 10.1002/jand.2002.23.1.64; Yoshino M, 2002, DNA REPAIR, V1, P935, DOI 10.1016/S1568-7864(02)00144-1; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9; Zenzes MT, 2000, HUM REPROD UPDATE, V6, P122, DOI 10.1093/humupd/6.2.122; Zenzes MT, 1999, MOL HUM REPROD, V5, P125, DOI 10.1093/molehr/5.2.125; Zimmermann KC, 2001, PHARMACOL THERAPEUT, V92, P57, DOI 10.1016/S0163-7258(01)00159-0	86	46	46	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e989	10.1371/journal.pone.0000989	http://dx.doi.org/10.1371/journal.pone.0000989			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912366	Green Published, Green Submitted, gold			2022-12-25	WOS:000207455900025
J	Iwai, A; Hijikata, M; Hishiki, T; Isono, O; Chiba, T; Shimotohno, K				Iwai, A.; Hijikata, M.; Hishiki, T.; Isono, O.; Chiba, T.; Shimotohno, K.			Coiled-coil domain containing 85B suppresses the beta-catenin activityin a p53-dependent manner	ONCOGENE			English	Article						oncogenesis; Siah-1L; Wnt signal; tumor suppressor	P53; PATHWAY; TRANSCRIPTION; LOCALIZATION; ACCUMULATION; EXPRESSION; CANCER; TARGET; CELLS	Aberrant accumulation of beta-catenin is closely related to carcinogenesis. Mutations in the p53 gene are reported to induce the aberrant accumulation of beta-catenin in the absence of dysfunction in the glycogen synthase kinase 3 beta (GSK3 beta)-mediated degradation pathway, but the mechanism remains incompletely understood. Here, we show that human coiled-coil domain containing 85B (CCDC85B) is induced by p53 and regulates beta-catenin activity via interaction with the T-cell factor 4 in the nucleus. Moreover, CCDC85B enhances the degradation of beta-catenin and suppresses tumor cell growth. In conclusion, we revealed that CCDC85B-induced degradation of beta-catenin is independent of GSK3b and other p53-inducible products, Siah-1L, suggesting that CCDC85B constitutes the one of the frameworks of p53-induced multiple regulatory pathways for beta-catenin activity.	[Iwai, A.; Hijikata, M.; Hishiki, T.; Isono, O.; Shimotohno, K.] Kyoto Univ, Inst Virus Res, Dept Viral Oncol, Lab Human Tumor Viruses,Sakyoku, Kyoto 6068507, Japan; [Iwai, A.; Chiba, T.] Kyoto Univ, Dept Med, Div Gastroenterol & Hepatol, Kyoto 6068507, Japan	Kyoto University; Kyoto University	Shimotohno, K (corresponding author), Kyoto Univ, Inst Virus Res, Dept Viral Oncol, Lab Human Tumor Viruses,Sakyoku, Shogoin Kawara Cho 54, Kyoto 6068507, Japan.	kshimoto@virus.kyoto-u.ac.jp						Brazas R, 1996, SCIENCE, V274, P90, DOI 10.1126/science.274.5284.90; Cagatay T, 2002, ONCOGENE, V21, P7971, DOI 10.1038/sj.onc.1205919; Chung DC, 2000, GASTROENTEROLOGY, V119, P854, DOI 10.1053/gast.2000.16507; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Harte D, 1998, J NONLINEAR SCI, V8, P581, DOI 10.1007/s003329900060; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Henderson BR, 2000, NAT CELL BIOL, V2, P653, DOI 10.1038/35023605; Hurlstone A, 2002, EMBO J, V21, P2303, DOI 10.1093/emboj/21.10.2303; Iwai A, 2004, ONCOGENE, V23, P7593, DOI 10.1038/sj.onc.1208016; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Lee E, 2001, J CELL BIOL, V154, P983, DOI 10.1083/jcb.200102074; Lee TKW, 2002, CANCER CHEMOTH PHARM, V49, P78, DOI 10.1007/s00280-001-0376-4; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Park WS, 2001, J PATHOL, V193, P483; Prange W, 2003, J PATHOL, V201, P250, DOI 10.1002/path.1448; Roose J, 1999, BBA-REV CANCER, V1424, pM23, DOI 10.1016/S0304-419X(99)00026-8; Sadot E, 2001, MOL CELL BIOL, V21, P6768, DOI 10.1128/MCB.21.20.6768-6781.2001; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tolwinski NS, 2001, DEVELOPMENT, V128, P2107; Watashi K, 2003, MOL CELL BIOL, V23, P7498, DOI 10.1128/MCB.23.21.7498-7509.2003; Willert K, 1998, CURR OPIN GENET DEV, V8, P95, DOI 10.1016/S0959-437X(98)80068-3	22	14	16	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 6	2008	27	11					1520	1526		10.1038/sj.onc.1210801	http://dx.doi.org/10.1038/sj.onc.1210801			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	271VC	17873903				2022-12-25	WOS:000253815800003
J	Ananthanarayanan, B; Fosbrink, M; Rahdar, M; Zhang, J				Ananthanarayanan, Bharath; Fosbrink, Matthew; Rahdar, Meghdad; Zhang, Jin			Live-cell molecular analysis of Akt activation reveals roles for activation loop phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-B; PLECKSTRIN HOMOLOGY DOMAIN; CONFORMATIONAL-CHANGES; DYNAMICS; REPORTERS; PATHWAY; COMPLEX; BINDING; SYSTEM; FAMILY	Activation of the serine/threonine protein kinase Akt/PKB is a multi-step process involving membrane recruitment, phosphorylation, and membrane detachment. To investigate this process in the cellular context, we employed a live-cell fluorescence imaging approach to examine conformational changes of Akt and its membrane association. A fluorescence resonance energy transfer-based reporter of Akt action (ReAktion) reveals a conformational change that is critically dependent on the existence of a phosphorylatable threonine 308 in the activation loop, because mutations to either aspartate or alanine abolished the change. Furthermore, a mutant carrying a phosphorylation mimic at this position showed diminished membrane association, suggesting that this phosphorylation plays an important role of promoting the dissociation of activated Akt from the membrane. In addition, the membrane-associating pleckstrin homology domain was found to associate with the catalytic domain when Thr(308) is phosphorylated, suggesting such an interdomain interaction as a mechanism by which phosphorylation within the catalytic domain can affect membrane association. These studies uncover new regulatory roles of this critical phosphorylation event of Akt for ensuring its proper activation and function.	Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Solomon H Synder Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Zhang, J (corresponding author), 725 N Wolfe St,Hunterian 307, Baltimore, MD 21205 USA.	jzhang32@jhmi.edu			NCI NIH HHS [CA122673] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R21CA122673] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Allen MD, 2006, BIOCHEM BIOPH RES CO, V348, P716, DOI 10.1016/j.bbrc.2006.07.136; Ananthanarayanan B, 2005, P NATL ACAD SCI USA, V102, P15081, DOI 10.1073/pnas.0502889102; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Aoki M, 1998, P NATL ACAD SCI USA, V95, P14950, DOI 10.1073/pnas.95.25.14950; Astoul E, 1999, J CELL BIOL, V145, P1511, DOI 10.1083/jcb.145.7.1511; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Bellacosa A, 2005, ADV CANCER RES, V94, P29, DOI 10.1016/S0065-230X(05)94002-5; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Calleja V, 2003, BIOCHEM J, V372, P33, DOI 10.1042/BJ20030358; Calleja V, 2007, PLOS BIOL, V5, P780, DOI 10.1371/journal.pbio.0050095; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Frech M, 1997, J BIOL CHEM, V272, P8474, DOI 10.1074/jbc.272.13.8474; Hajduch E, 1998, DIABETES, V47, P1006, DOI 10.2337/diabetes.47.7.1006; Huang BX, 2006, MOL CELL PROTEOMICS, V5, P1045, DOI 10.1074/mcp.M600026-MCP200; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kunkel MT, 2005, J BIOL CHEM, V280, P5581, DOI 10.1074/jbc.M411534200; Kunstle G, 2002, MOL CELL BIOL, V22, P1513, DOI 10.1128/MCB.22.5.1513-1525.2002; Miyawaki A, 2003, DEV CELL, V4, P295, DOI 10.1016/S1534-5807(03)00060-1; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Neri LM, 2002, BBA-MOL CELL BIOL L, V1584, P73, DOI 10.1016/S1388-1981(02)00300-1; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Peterson RT, 1999, CURR BIOL, V9, pR521, DOI 10.1016/S0960-9822(99)80326-1; Scheid MP, 2002, MOL CELL BIOL, V22, P6247, DOI 10.1128/MCB.22.17.6247-6260.2002; Teitell MA, 2005, NAT REV CANCER, V5, P640, DOI 10.1038/nrc1672; Thomas CC, 2002, CURR BIOL, V12, P1256, DOI 10.1016/S0960-9822(02)00972-7; Varnai P, 2005, J CELL SCI, V118, P4879, DOI 10.1242/jcs.02606; Woodgett JR, 2005, CURR OPIN CELL BIOL, V17, P150, DOI 10.1016/j.ceb.2005.02.010; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976	31	43	46	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36634	36641		10.1074/jbc.M706227200	http://dx.doi.org/10.1074/jbc.M706227200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17928291	hybrid			2022-12-25	WOS:000251458300056
J	Garlatti, V; Martin, L; Gout, E; Reiser, JB; Fujita, T; Arlaud, GJ; Thielens, NM; Gaboriaud, C				Garlatti, Virginie; Martin, Lydie; Gout, Evelyne; Reiser, Jean-Baptiste; Fujita, Teizo; Arlaud, Gerard J.; Thielens, Nicole M.; Gaboriaud, Christine			Structural basis for innate immune sensing by M-ficolin and its control by a pH-dependent conformational switch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNAN-BINDING LECTIN; CRYSTAL-STRUCTURE; LDL RECEPTOR; RECOGNITION; PROTEIN; PATHWAY; ACID; BACTERIA; PROVIDES; SYSTEM	Ficolins are soluble oligomeric proteins with lectin-like activity, assembled from collagen fibers prolonged by fibrinogen-like recognition domains. They act as innate immune sensors by recognizing conserved molecular markers exposed on microbial surfaces and thereby triggering effector mechanisms such as enhanced phagocytosis and inflammation. In humans, L-and H-ficolins have been characterized in plasma, whereas a third species, M-ficolin, is secreted by monocytes and macrophages. To decipher the molecular mechanisms underlying their recognition properties, we previously solved the structures of the recognition domains of L-and H-ficolins, in complex with various model ligands (Garlatti, V., Belloy, N., Martin, L., Lacroix, M., Matsushita, M., Endo, Y., Fujita, T., Fontecilla-Camps, J. C., Arlaud, G. J., Thielens, N. M., and Gaboriaud, C. (2007) EMBO J. 24, 623-633). We now report the ligand-bound crystal structures of the recognition domain of M-ficolin, determined at high resolution (1.75-1.8 angstrom), which provides the first structural insights into its binding properties. Interaction with acetylated carbohydrates differs from the one previously described for L-ficolin. This study also reveals the structural determinants for binding to sialylated compounds, a property restricted to human M-ficolin and its mouse counterpart, ficolin B. Finally, comparison between the ligand-bound structures obtained at neutral pH and nonbinding conformations observed at pH 5.6 reveals how the ligand binding site is dislocated at acidic pH. This means that the binding function of M-ficolin is subject to a pH-sensitive conformational switch. Considering that the homologous ficolin B is found in the lysosomes of activated macrophages (Runza, V. L., Hehlgans, T., Echtenacher, B., Zahringer, U., Schwaeble, W. J., and Mannel, D. N. (2006) J. Endotoxin Res. 12, 120-126), we propose that this switch could play a physiological role in such acidic compartments.	Univ Grenoble 1, Commissariat Energie Atom, Cristallog & Cristallogenese Prot Lab, CNRS,Inst Biol Struct Jean Pierre Ebel, F-38027 Grenoble, France; Univ Grenoble 1, Commissariat Energie Atom, Lab Enzymol Mol, CNRS,Inst Biol Struct Jean Pierre Ebel, F-38027 Grenoble, France; Fukushima Med Univ, Dept Biochem, Fukushima, Japan	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Fukushima Medical University	Gaboriaud, C (corresponding author), Univ Grenoble 1, Commissariat Energie Atom, Cristallog & Cristallogenese Prot Lab, CNRS,Inst Biol Struct Jean Pierre Ebel, 41 Rue Jules Horowitz, F-38027 Grenoble, France.	christine.gaboriaud@ibs.fr	Reiser, Jean-Baptiste/W-7683-2019; Thielens, Nicole M/F-2512-2013	Reiser, Jean-Baptiste/0000-0001-6926-9137; Thielens, Nicole M/0000-0002-7354-0302				Aoyagi Y, 2005, J IMMUNOL, V174, P418, DOI 10.4049/jimmunol.174.1.418; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beglova N, 2005, TRENDS BIOCHEM SCI, V30, P309, DOI 10.1016/j.tibs.2005.03.007; Carlin AF, 2007, J BACTERIOL, V189, P1231, DOI 10.1128/JB.01155-06; Collins BE, 2004, P NATL ACAD SCI USA, V101, P6104, DOI 10.1073/pnas.0400851101; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Endo Y, 2005, IMMUNOGENETICS, V57, P837, DOI 10.1007/s00251-005-0058-1; Endo Y, 2007, IMMUNOBIOLOGY, V212, P371, DOI 10.1016/j.imbio.2006.11.014; Endo Y, 2006, ADV EXP MED BIOL, V586, P265; Frederiksen PD, 2005, SCAND J IMMUNOL, V62, P462, DOI 10.1111/j.1365-3083.2005.01685.x; Fujita T, 2004, IMMUNOL REV, V198, P185, DOI 10.1111/j.0105-2896.2004.0123.x; Gaboriaud C, 2003, J BIOL CHEM, V278, P46974, DOI 10.1074/jbc.M307764200; Garlatti V, 2007, EMBO J, V26, P623, DOI 10.1038/sj.emboj.7601500; Geijtenbeek TBH, 2000, NAT IMMUNOL, V1, P353, DOI 10.1038/79815; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Honore C, 2007, ARTHRITIS RHEUM, V56, P1598, DOI 10.1002/art.22564; JANEWAY CA, 1992, IMMUNOL TODAY, V13, P11, DOI 10.1016/0167-5699(92)90198-G; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kairies N, 2001, P NATL ACAD SCI USA, V98, P13519, DOI 10.1073/pnas.201523798; Krarup A, 2005, INFECT IMMUN, V73, P1052, DOI 10.1128/IAI.73.2.1052-1060.2005; Kuraya M, 2005, IMMUNOBIOLOGY, V209, P689, DOI 10.1016/j.imbio.2004.11.001; Liu Y, 2005, J IMMUNOL, V175, P3150, DOI 10.4049/jimmunol.175.5.3150; Lynch NJ, 2004, J IMMUNOL, V172, P1198, DOI 10.4049/jimmunol.172.2.1198; Ma YG, 2004, J BIOL CHEM, V279, P25307, DOI 10.1074/jbc.M400701200; Matsushita M, 2001, IMMUNOL REV, V180, P78, DOI 10.1034/j.1600-065X.2001.1800107.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Rossi V, 1998, J BIOL CHEM, V273, P1232, DOI 10.1074/jbc.273.2.1232; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; Runza VL, 2006, J ENDOTOXIN RES, V12, P120, DOI 10.1179/096805106X102147; SHERIFF S, 1994, NAT STRUCT BIOL, V1, P789, DOI 10.1038/nsb1194-789; Tanio M, 2007, J BIOL CHEM, V282, P3889, DOI 10.1074/jbc.M608627200; Tanio M, 2006, ACTA CRYSTALLOGR F, V62, P652, DOI 10.1107/S1744309106019786; Teh C, 2000, IMMUNOLOGY, V101, P225, DOI 10.1046/j.1365-2567.2000.00099.x; Teillet F, 2005, J IMMUNOL, V174, P2870, DOI 10.4049/jimmunol.174.5.2870; Thielens NM, 2001, J IMMUNOL, V166, P5068, DOI 10.4049/jimmunol.166.8.5068; van Vliet SJ, 2006, NAT IMMUNOL, V7, P1200, DOI 10.1038/ni1390; Wragg S, 1999, J BIOL CHEM, V274, P35400, DOI 10.1074/jbc.274.50.35400	37	55	57	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35814	35820		10.1074/jbc.M705741200	http://dx.doi.org/10.1074/jbc.M705741200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17897951	hybrid			2022-12-25	WOS:000251458100043
J	Partridge, JJ; Madsen, MA; Ardi, VC; Papagiannakopoulos, T; Kupriyanova, TA; Quigley, JP; Deryugina, EI				Partridge, Juneth J.; Madsen, Mark A.; Ardi, Veronica C.; Papagiannakopoulos, Thales; Kupriyanova, Tatyana A.; Quigley, James P.; Deryugina, Elena I.			Functional analysis of matrix metalloproteinases and tissue inhibitors of metalloproteinases differentially expressed by variants of human HT-1080 fibrosarcoma exhibiting high and low levels of intravasation and metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLIOMA-CELL INVASION; GENE-EXPRESSION; DOWN-REGULATION; CANCER-CELLS; TUMOR-GROWTH; IN-VIVO; CHORIOALLANTOIC MEMBRANE; ANGIOGENIC SWITCH; MATRIX-METALLOPROTEINASE-9; MMP-9	The role of tumor-derived matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinase (TIMPs) in cancer cell dissemination was analyzed by employing two variants of human HT-1080 fibrosarcoma, HT-hi/diss and HT-lo/diss, which differ by 50 - 100-fold in their ability to intravasate and metastasize in the chick embryo. HT-hi/diss and HT-lo/diss were compared by quantitative reverse transcription-PCR and Western blot analyses for mRNA and protein expression of nine MMPs (MMP-1, - 2, - 3, - 7, - 8, - 9, - 10, - 13, and - 14) and three TIMPs (TIMP-1, - 2, and - 3) in cultured cells in vitro and in primary tumors in vivo. MMP-1 and MMP-9 were more abundant in the HT-hi/diss variant, both in cultures and in tumors, whereas the HT-lo/diss variant consistently expressed higher levels of MMP-2, TIMP-1, and TIMP-2. Small interfering RNA-mediated down-regulation of MMP-2 and TIMP-2 increased intravasation of HT-lo/diss cells. Coordinately, treatment of the developing HT-hi/diss tumors with recombinant TIMP-1 and TIMP-2 significantly reduced HT-hi/diss cell intravasation. However, a substantial increase of HT-hi/diss dissemination was observed upon small interfering RNA-mediated down-regulation of three secreted MMPs, including the interstitial collagenase MMP-1 and the two gelatinases, MMP-2 and MMP-9, but not the membrane-tethered MMP-14. The addition of recombinant pro-MMP-9 protein to the HT-hi/diss tumors reversed the increased intravasation of HT-hi/diss cells, in which MMP-9 was stably down-regulated by short hairpin RNA interference. This rescue did not occur if the pro-MMP-9 was stoichiometrically complexed with TIMP-1, pointing to a direct role of the MMP-9 enzyme in regulation of HT-hi/diss intravasation. Collectively, these findings demonstrate that tumor-derived MMPs may have protective functions in cancer cell intravasation, i.e. not promoting but rather catalytically interfering with the early stages of cancer dissemination.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Quigley, JP (corresponding author), 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jquigley@scripps.edu; deryugin@scripps.edu			NCI NIH HHS [CA55852, CA105412, 5F31CA117058] Funding Source: Medline; NHLBI NIH HHS [T32HL07195] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA105412, F31CA117058, R01CA055852] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007195] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aalinkeel R, 2004, CANCER RES, V64, P5311, DOI 10.1158/0008-5472.CAN-2506-2; Agarwal D, 2003, DIFFERENTIATION, V71, P114, DOI 10.1046/j.1432-0436.2003.710202.x; Andarawewa KL, 2003, CANCER RES, V63, P5844; Balbin M, 2003, NAT GENET, V35, P252, DOI 10.1038/ng1249; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chantrain CF, 2006, EUR J CANCER, V42, P310, DOI 10.1016/j.ejca.2005.11.010; Chen JJW, 2001, CANCER RES, V61, P5223; Chirco R, 2006, CANCER METAST REV, V25, P99, DOI 10.1007/s10555-006-7893-x; Chun TH, 2004, J CELL BIOL, V167, P757, DOI 10.1083/jcb.200405001; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; Condeelis J, 2005, ANNU REV CELL DEV BI, V21, P695, DOI 10.1146/annurev.cellbio.21.122303.120306; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Deryugina EI, 2005, CANCER RES, V65, P10959, DOI 10.1158/0008-5472.CAN-05-2228; Ferreras M, 2000, FEBS LETT, V486, P247, DOI 10.1016/S0014-5793(00)02249-3; Filippov S, 2005, J EXP MED, V202, P663, DOI 10.1084/jem.20050607; Fingleton B, 2006, FRONT BIOSCI-LANDMRK, V11, P479, DOI 10.2741/1811; Giraudo E, 2004, J CLIN INVEST, V114, P623, DOI 10.1172/JCI200422087; Gomez DE, 1997, EUR J CELL BIOL, V74, P111; Gondi CS, 2004, NEURON GLIA BIOL, V1, P165, DOI 10.1017/S1740925X04000237; GORDON JR, 1986, INT J CANCER, V38, P437, DOI 10.1002/ijc.2910380321; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Hagedorn M, 2005, P NATL ACAD SCI USA, V102, P1643, DOI 10.1073/pnas.0408622102; Hamano Y, 2003, CANCER CELL, V3, P589, DOI 10.1016/S1535-6108(03)00133-8; Heljasvaara R, 2005, EXP CELL RES, V307, P292, DOI 10.1016/j.yexcr.2005.03.021; Hofmann UB, 2003, CANCER RES, V63, P8221; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Houghton AM, 2006, CANCER RES, V66, P6149, DOI 10.1158/0008-5472.CAN-04-0297; Hua J, 1996, CANCER RES, V56, P5279; Jodele S, 2006, CANCER METAST REV, V25, P35, DOI 10.1007/s10555-006-7887-8; Kim J, 1998, CELL, V94, P353, DOI 10.1016/S0092-8674(00)81478-6; Kridel SJ, 2001, J BIOL CHEM, V276, P20572, DOI 10.1074/jbc.M100900200; Lakka SS, 2003, CANCER RES, V63, P2454; Lakka SS, 2004, ONCOGENE, V23, P4681, DOI 10.1038/sj.onc.1207616; Lau A, 2004, EMBO J, V23, P3421, DOI 10.1038/sj.emboj.7600348; Lewis JD, 2006, NAT MED, V12, P354, DOI 10.1038/nm1368; London CA, 2003, CANCER GENE THER, V10, P823, DOI 10.1038/sj.cgt.7700642; Lugassy C, 2006, AM J DERMATOPATH, V28, P187, DOI 10.1097/00000372-200606000-00001; Madsen MA, 2006, J BIOL CHEM, V281, P15997, DOI 10.1074/jbc.M601223200; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Mira E, 2002, CLIN EXP METASTAS, V19, P313, DOI 10.1023/A:1015563031769; Montel V, 2004, CANCER RES, V64, P1687, DOI 10.1158/0008-5472.CAN-03-2047; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; Nuttall RK, 2003, MOL CANCER RES, V1, P333; Nyberg P, 2005, CANCER RES, V65, P3967, DOI 10.1158/0008-5472.CAN-04-2427; OGATA Y, 1995, J BIOL CHEM, V270, P18506, DOI 10.1074/jbc.270.31.18506; Olson MW, 1997, J BIOL CHEM, V272, P29975, DOI 10.1074/jbc.272.47.29975; OSSOWSKI L, 1980, CANCER RES, V40, P2300; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Pozzi A, 2000, P NATL ACAD SCI USA, V97, P2202, DOI 10.1073/pnas.040378497; Pozzi A, 2002, ONCOGENE, V21, P272, DOI 10.1038/sj.onc.1205045; RAMOSDESIMONE N, 1993, HYBRIDOMA, V12, P349, DOI 10.1089/hyb.1993.12.349; Rao JS, 2005, MOL CANCER THER, V4, P1399, DOI 10.1158/1535-7163.MCT-05-0082; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Saghatelian A, 2004, P NATL ACAD SCI USA, V101, P10000, DOI 10.1073/pnas.0402784101; Sanceau J, 2003, J BIOL CHEM, V278, P36537, DOI 10.1074/jbc.M304300200; SCHER CD, 1976, CELL, V8, P373, DOI 10.1016/0092-8674(76)90149-5; Seftor REB, 2001, CANCER RES, V61, P6322; Stupack DG, 2006, NATURE, V439, P95, DOI 10.1038/nature04323; TSUCHIYA Y, 1994, INT J CANCER, V56, P46; van Hinsbergh VWM, 2006, ARTERIOSCL THROM VAS, V26, P716, DOI 10.1161/01.ATV.0000209518.58252.17; Wang WG, 2004, CANCER RES, V64, P8585, DOI 10.1158/0008-5472.CAN-04-1136; Wang WG, 2002, CANCER RES, V62, P6278; WATANABE H, 1993, J CELL SCI, V104, P991; Wilson CL, 1997, P NATL ACAD SCI USA, V94, P1402, DOI 10.1073/pnas.94.4.1402; Wyatt CA, 2005, CANCER RES, V65, P11101, DOI 10.1158/0008-5472.CAN-05-2446; Xue CS, 2006, CANCER RES, V66, P192, DOI 10.1158/0008-5472.CAN-05-1242; Yu Q, 2000, GENE DEV, V14, P163; Zijlstra A, 2006, BLOOD, V107, P317, DOI 10.1182/blood-2005-04-1458; Zijlstra A, 2002, CANCER RES, V62, P7083	73	24	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35964	35977		10.1074/jbc.M705993200	http://dx.doi.org/10.1074/jbc.M705993200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17895241	hybrid			2022-12-25	WOS:000251458100057
J	Chen, Y; Hu, Y; Lu, K; Flannery, JG; Ma, JX				Chen, Ying; Hu, Yang; Lu, Kangmo; Flannery, John G.; Ma, Jian-xing			Very low density lipoprotein receptor, a negative regulator of the wnt signaling pathway and choroidal neovascularization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; RETINAL-PIGMENT EPITHELIUM; FAMILIAL EXUDATIVE VITREORETINOPATHY; SUBRETINAL NEOVASCULARIZATION; VASCULAR DEVELOPMENT; CELL PROLIFERATION; FACTOR EXPRESSION; MOUSE MODEL; GENE; ANGIOGENESIS	Choroidal neovascularization (CNV) in age-related macular degeneration is a leading cause of blindness. Very low density lipoprotein receptor gene knock-out (Vldlr(-/-)) mice have been shown to develop subretinal neovascularization (NV) with an unknown mechanism. The present study showed that in Vldlr(-/-) mice, NV initiated in the choroid and progressed to penetrate the retinal pigment epithelium layer, proliferating in the subretinal space. This phenotype recapitulated what is seen in wet age-related macular degeneration, suggesting that this is a CNV model. The CNV correlated with overexpression of vascular endothelial growth factor in Vldlr(-/-) eyecups and was blocked by a neutralizing antibody against vascular endothelial growth factor receptor-2. The wnt co-receptor LRP5/6 expression was significantly up-regulated in Vldlr(-/-) eyecups compared with that in wild-type mice. Significantly, Vldlr(-/-) mice showed impaired phosphorylation of downstream effectors of the wnt signaling pathway, glycogen synthase kinase-3 beta (GSK-3 beta), and beta-catenin, concomitant with increased levels of free GSK-3 beta and beta-catenin, suggesting an increased activity of the wnt pathway. Down-regulation of VLDLR by small interference RNA resulted in up-regulation of LRP5/6 expression and activation of beta-catenin in cultured endothelial cells. Furthermore, Dickkopf-1, a specific inhibitor of the wnt pathway, effectively decreased vascular endothelial growth factor and beta-catenin levels in the retinal pigment epithelium of Vldlr(-/-) mice and in cells transfected with the VLDLR small interference RNA. These results suggest that VLDLR functions as a negative regulator of CNV, and this function is mediated through the wnt pathway.	Univ Oklahoma, Hlth Sci Ctr, Dept Med, Dept Cell Biol, Oklahoma City, OK 73104 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Dept Mol & Cell Biol, Vis Sci & Neurosci Div, Berkeley, CA 94720 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of California System; University of California Berkeley	Ma, JX (corresponding author), 941 Stanton L Young Blvd,BSEB 328B, Oklahoma City, OK 73104 USA.	jian-xing-ma@ouhsc.edu		Flannery, John/0000-0002-0720-8897	NATIONAL EYE INSTITUTE [R01EY012231, R21EY015650, R33EY015650] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BATTEY FD, 1994, J BIOL CHEM, V269, P23268; Blaauwgeers HGT, 1999, AM J PATHOL, V155, P421, DOI 10.1016/S0002-9440(10)65138-3; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Chen Y, 2006, INVEST OPHTH VIS SCI, V47, P1177, DOI 10.1167/iovs.05-0965; COGAN D G, 1963, Trans Ophthalmol Soc U K, V83, P465; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; CONNOLLY SE, 1988, MICROVASC RES, V36, P275, DOI 10.1016/0026-2862(88)90028-3; Cursiefen C, 1997, KLIN MONATSBL AUGENH, V210, P341, DOI 10.1055/s-2008-1035072; Dale TC, 1998, BIOCHEM J, V329, P209; Easwaran V, 2003, CANCER RES, V63, P3145; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fruttiger M, 2002, INVEST OPHTH VIS SCI, V43, P522; FRYKMAN PK, 1995, P NATL ACAD SCI USA, V92, P8453, DOI 10.1073/pnas.92.18.8453; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Goodwin A. M., 2002, Angiogenesis, V5, P1, DOI 10.1023/A:1021563510866; Haines JL, 2006, INVEST OPHTH VIS SCI, V47, P329, DOI 10.1167/iovs.05-0116; Heckenlively JR, 2003, RETINA-J RET VIT DIS, V23, P518, DOI 10.1097/00006982-200308000-00012; Hembrough TA, 2001, J BIOL CHEM, V276, P12241, DOI 10.1074/jbc.M010395200; Ida H, 2003, INVEST OPHTH VIS SCI, V44, P5430, DOI 10.1167/iovs.03-0609; JOKINEN EV, 1994, J BIOL CHEM, V269, P26411; KAPUSTINA E. V., 1960, ARKH ANAT GISTOL I EMBRIOL, V39, P16; Kaykas A, 2004, NAT CELL BIOL, V6, P52, DOI 10.1038/ncb1081; Kim KI, 2006, ARTERIOSCL THROM VAS, V26, P91, DOI 10.1161/01.ATV.0000193569.12490.4b; Kondo H, 2003, BRIT J OPHTHALMOL, V87, P1291, DOI 10.1136/bjo.87.10.1291; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Marneros AG, 2005, AM J PATHOL, V167, P1451, DOI 10.1016/S0002-9440(10)61231-X; Masckauchan THN, 2006, PHYSIOLOGY, V21, P181, DOI 10.1152/physiol.00058.2005; Masckauchan TNH, 2006, MOL BIOL CELL, V17, P5163, DOI 10.1091/mbc.E06-04-0320; Millar JBA, 2002, GENOME BIOL, V3; Miller JW, 1997, AM J PATHOL, V151, P13; Nagineni CN, 2003, J CELL PHYSIOL, V197, P453, DOI 10.1002/jcp.10378; Nilsson L, 1999, J LIPID RES, V40, P913; Nozaki M, 2006, P NATL ACAD SCI USA, V103, P2328, DOI 10.1073/pnas.0408835103; Ojesina AI, 2004, J PEDIATR SURG, V39, P1446, DOI 10.1016/j.jpedsurg.2004.06.003; Orlandini M, 2003, J BIOL CHEM, V278, P44650, DOI 10.1074/jbc.M304255200; Orsulic S, 1996, CURR BIOL, V6, P1363, DOI 10.1016/S0960-9822(96)00731-2; Rehm HL, 2002, J NEUROSCI, V22, P4286, DOI 10.1523/JNEUROSCI.22-11-04286.2002; Richter M, 1998, INVEST OPHTH VIS SCI, V39, P2450; Robitaille J, 2002, NAT GENET, V32, P326, DOI 10.1038/ng957; SAKAI J, 1994, J BIOL CHEM, V269, P2173; Spilsbury K, 2000, AM J PATHOL, V157, P135, DOI 10.1016/S0002-9440(10)64525-7; Tachikawa K, 2004, P NATL ACAD SCI USA, V101, P15225, DOI 10.1073/pnas.0406473101; TAKAHASHI S, 1992, P NATL ACAD SCI USA, V89, P9252, DOI 10.1073/pnas.89.19.9252; Takahashi Sadao, 2004, J Atheroscler Thromb, V11, P200; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tiebel O, 1999, ATHEROSCLEROSIS, V145, P239, DOI 10.1016/S0021-9150(99)00068-4; Toomes C, 2004, AM J HUM GENET, V74, P721, DOI 10.1086/383202; Wang J, 2000, ONCOGENE, V19, P1843, DOI 10.1038/sj.onc.1203503; Wu BX, 2004, INVEST OPHTH VIS SCI, V45, P3857, DOI 10.1167/iovs.03-1302; Wyne KL, 1996, ARTERIOSCL THROM VAS, V16, P407, DOI 10.1161/01.ATV.16.3.407; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Zhang XB, 2001, CANCER RES, V61, P6050; 2004, MORB MORTAL WKLY REP, V53, P1069	54	89	91	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34420	34428		10.1074/jbc.M611289200	http://dx.doi.org/10.1074/jbc.M611289200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17890782	hybrid			2022-12-25	WOS:000251145700058
J	Moreland, JG; Davis, AP; Matsuda, JJ; Hook, JS; Bailey, G; Nauseef, WM; Lamb, FS				Moreland, Jessica G.; Davis, A. Paige; Matsuda, James J.; Hook, Jessica S.; Bailey, Gail; Nauseef, William M.; Lamb, Fred S.			Endotoxin priming of neutrophils requires NADPH oxidase-generated oxidants and is regulated by the anion transporter ClC-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOPOLYSACCHARIDE-BINDING-PROTEIN; RESPIRATORY BURST; CYTOSOLIC COMPONENTS; REDOX REGULATION; PLASMA-MEMBRANE; KAPPA-B; ACTIVATION; SUPEROXIDE; P38; PHOSPHORYLATION	Several soluble mediators, including endotoxin, prime neutrophils for an enhanced respiratory burst in response to subsequent stimulation. Priming of neutrophils occurs in vitro, and primed neutrophils are found in vivo. We previously localized the anion transporter ClC-3 to polymorphonuclear leukocytes (PMN) secretory vesicles and demonstrated that it is required for normal NADPH oxidase activation in response to both particulate and soluble stimuli. We now explore the contribution of the NADPH oxidase and ClC-3 to endotoxin-mediated priming. Lipooligosaccharide (LOS) from Neisseria meningitidis enhances the respiratory burst in response to formyl-Met-Leu-Phe, an effect that was impaired in PMNs lacking functional ClC-3 and under anaerobic conditions. Mobilization of receptors to the cell surface and phosphorylation of p38 MAPK by LOS were both impaired in PMN with the NADPH oxidase chemically inhibited or genetically absent and in cells lacking functional ClC-3. Furthermore, inhibition of the NADPH oxidase or ClC-3 in otherwise unstimulated cells elicited a phenotype similar to that seen after endotoxin priming, suggesting that basal oxidant production helps to maintain cellular quiescence. In summary, NADPH oxidase activation was required for LOS-mediated priming, but basal oxidants kept unstimulated cells from becoming primed. ClC-3 contributes to both of these processes.	Univ Iowa, Dept Pediat, Div Crit Care, Iowa City, IA 52242 USA; Univ Iowa, Inflammat Program, Iowa City, IA 52242 USA; Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; Vet Affairs Med Ctr, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Moreland, JG (corresponding author), Univ Iowa, Dept Pediat, Div Pediat Crit Care, 200 Hawkins Dr, Iowa City, IA 52242 USA.	jessica-moreland@uiowa.edu		Nauseef, William/0000-0003-4032-757X; Lamb, Fred/0000-0003-2955-5133	NHLBI NIH HHS [HL 62483-06] Funding Source: Medline; NIAID NIH HHS [AI 067533, AI 34879-19, P01 AI 4462] Funding Source: Medline; NICHD NIH HHS [5K12 HD 047349] Funding Source: Medline; NIDDK NIH HHS [DK 07690-15] Funding Source: Medline; BLRD VA [I01 BX000513] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD047349] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062483, R56HL062483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034879, R56AI034879, R21AI067533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007690] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000513] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); BLRD VA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)		AIDA Y, 1990, J IMMUNOL, V145, P3017; Ambruso DR, 2004, MOL GENET METAB, V81, P313, DOI 10.1016/j.ymgme.2004.01.009; [Anonymous], 2000, SCI STKE, V2000, P2000, DOI [10.1126/stke.2000.62.tw8, DOI 10.1126/STKE.2000.62.TW8]; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; BASS DA, 1986, J IMMUNOL, V136, P860; Blouin E, 1999, EUR J IMMUNOL, V29, P3419, DOI 10.1002/(SICI)1521-4141(199911)29:11<3419::AID-IMMU3419>3.3.CO;2-T; Bouaouina M, 2004, J IMMUNOL, V173, P1313, DOI 10.4049/jimmunol.173.2.1313; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; Brown GE, 2003, MOL CELL, V11, P35, DOI 10.1016/S1097-2765(03)00005-4; Chamseddine AH, 2003, AM J PHYSIOL-HEART C, V285, pH2284, DOI 10.1152/ajpheart.00459.2003; CHOLLETMARTIN S, 1992, AM REV RESPIR DIS, V146, P990, DOI 10.1164/ajrccm/146.4.990; CLARK RA, 1990, J CLIN INVEST, V85, P714, DOI 10.1172/JCI114496; Condliffe AM, 1996, IMMUNOLOGY, V89, P105, DOI 10.1046/j.1365-2567.1996.d01-711.x; Condliffe AM, 1998, CLIN SCI, V94, P461, DOI 10.1042/cs0940461; CROSS AR, 1986, BIOCHEM J, V237, P111, DOI 10.1042/bj2370111; Dang PMC, 2006, J CLIN INVEST, V116, P2033, DOI 10.1172/JCI27544; Dang PMC, 2003, BIOCHEMISTRY-US, V42, P4520, DOI 10.1021/bi0205754; DeLeo FR, 1998, J CLIN INVEST, V101, P455, DOI 10.1172/JCI949; Dickerson LW, 2002, BRAIN RES, V958, P227, DOI 10.1016/S0006-8993(02)03519-9; Duan D, 1997, NATURE, V390, P417, DOI 10.1038/37151; ElBenna J, 1996, ARCH BIOCHEM BIOPHYS, V334, P395; Filali M, 2006, FASEB J, V20, pA1163; FITTSCHEN C, 1988, J LEUKOCYTE BIOL, V43, P547, DOI 10.1002/jlb.43.6.547; FOLLIN P, 1992, INFLAMMATION, V16, P83, DOI 10.1007/BF00918949; FOREHAND JR, 1991, ADV EXP MED BIOL, V297, P65; Friedrich T, 1999, J BIOL CHEM, V274, P896, DOI 10.1074/jbc.274.2.896; GABIG TG, 1979, BLOOD, V53, P1133; Geiszt M, 1997, J BIOL CHEM, V272, P26471, DOI 10.1074/jbc.272.42.26471; Giardina PC, 2001, J BIOL CHEM, V276, P5883, DOI 10.1074/jbc.M009273200; Harfouche R, 2005, FASEB J, V19, P1728, DOI 10.1096/fj.04-3621fje; Huang P, 2001, J BIOL CHEM, V276, P20093, DOI 10.1074/jbc.M009376200; Jankowski A, 1999, J BIOL CHEM, V274, P26098, DOI 10.1074/jbc.274.37.26098; Kobayashi T, 1998, J CELL SCI, V111, P81; Li JM, 2004, CIRCULATION, V109, P1307, DOI 10.1161/01.CIR.0000118463.23388.B9; Li JM, 2002, J BIOL CHEM, V277, P19952, DOI 10.1074/jbc.M110073200; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Miller FJ, 2007, CIRC RES, V101, P663, DOI 10.1161/CIRCRESAHA.107.151076; Moreland JG, 2006, J BIOL CHEM, V281, P12277, DOI 10.1074/jbc.M511030200; Nauseef WM, 2001, J CLIN INVEST, V107, P401, DOI 10.1172/JCI11713; Ogura H, 1999, J TRAUMA, V46, P774, DOI 10.1097/00005373-199905000-00004; Ogura T, 2002, FASEB J, V16, P863, DOI 10.1096/fj.01-0845fje; PARK JW, 1992, J BIOL CHEM, V267, P17327; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; Segal BH, 2000, MEDICINE, V79, P170, DOI 10.1097/00005792-200005000-00004; Venet C, 2000, INTENS CARE MED, V26, P538, DOI 10.1007/s001340051201; VOSBECK K, 1990, J LEUKOCYTE BIOL, V47, P97, DOI 10.1002/jlb.47.2.97; Watson RWG, 2002, ANTIOXID REDOX SIGN, V4, P97, DOI 10.1089/152308602753625898; Yaffe MB, 1999, SURGERY, V126, P248, DOI 10.1016/S0039-6060(99)70162-5; Yamamoto A, 2002, CLIN EXP IMMUNOL, V129, P479, DOI 10.1046/j.1365-2249.2002.01930.x; Yan SR, 2002, INFECT IMMUN, V70, P4068, DOI 10.1128/IAI.70.8.4068-4074.2002	51	43	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					33958	33967		10.1074/jbc.M705289200	http://dx.doi.org/10.1074/jbc.M705289200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17908687	hybrid			2022-12-25	WOS:000251145700009
J	Naderi, S; Rezaei, HR; Taberlet, P; Zundel, S; Rafat, SA; Naghash, HR; El-Barody, MAA; Ertugrul, O; Pompanon, F				Naderi, Saeid; Rezaei, Hamid-Reza; Taberlet, Pierre; Zundel, Stephanie; Rafat, Seyed-Abbas; Naghash, Hamid-Reza; El-Barody, Mohamed A. A.; Ertugrul, Okan; Pompanon, Francois		Econogene Consortium	Large-Scale Mitochondrial DNA Analysis of the Domestic Goat Reveals Six Haplogroups with High Diversity	PLOS ONE			English	Article							CAPRA-HIRCUS; PHYLOGEOGRAPHIC STRUCTURE; INITIAL DOMESTICATION; PHYLOGENETIC ANALYSIS; INTEGRATED SOFTWARE; SEQUENCE; BREEDS; LINEAGES; GENETICS; ORIGINS	Background. From the beginning of domestication, the transportation of domestic animals resulted in genetic and demographic processes that explain their present distribution and genetic structure. Thus studying the present genetic diversity helps to better understand the history of domestic species. Methodology/Principal Findings. The genetic diversity of domestic goats has been characterized with 2430 individuals from all over the old world, including 946 new individuals from regions poorly studied until now (mainly the Fertile Crescent). These individuals represented 1540 haplotypes for the HVI segment of the mitochondrial DNA (mtDNA) control region. This large-scale study allowed the establishment of a clear nomenclature of the goat maternal haplogroups. Only five of the six previously defined groups of haplotypes were divergent enough to be considered as different haplogroups. Moreover a new mitochondrial group has been localized around the Fertile Crescent. All groups showed very high haplotype diversity. Most of this diversity was distributed among groups and within geographic regions. The weak geographic structure may result from the worldwide distribution of the dominant A haplogroup (more than 90% of the individuals). The large-scale distribution of other haplogroups (except one), may be related to human migration. The recent fragmentation of local goat populations into discrete breeds is not detectable with mitochondrial markers. The estimation of demographic parameters from mismatch analyses showed that all groups had a recent demographic expansion corresponding roughly to the period when domestication took place. But even with a large data set it remains difficult to give relative dates of expansion for different haplogroups because of large confidence intervals. Conclusions/Significance. We propose standard criteria for the definition of the different haplogroups based on the result of mismatch analysis and on the use of sequences of reference. Such a method could be also applied for clarifying the nomenclature of mitochondrial haplogroups in other domestic species.	[Naderi, Saeid; Rezaei, Hamid-Reza; Taberlet, Pierre; Zundel, Stephanie; Naghash, Hamid-Reza; Pompanon, Francois] Univ Grenoble 1, CNRS, Lab Ecol Alpine, UMR 5553, Grenoble, France; [Naderi, Saeid] Univ Guilan, Nat Resources Fac, Guilan, Iran; [Rezaei, Hamid-Reza] Gorgan Univ Agr & Nat Resources, Dept Environm Sci, Gorgan, Iran; [Rafat, Seyed-Abbas] Univ Tabriz, Fac Agr, Dept Anim Sci, Tabriz, Iran; [El-Barody, Mohamed A. A.] Minia Univ, Fac Agr, Dept Anim Prod, Al Minya, Egypt; [Ertugrul, Okan] Ankara Univ, Fac Vet Med, Dept Genet, TR-06100 Ankara, Turkey	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie; University of Guilan; University of Tabriz; Egyptian Knowledge Bank (EKB); Minia University; Ankara University	Pompanon, F (corresponding author), Univ Grenoble 1, CNRS, Lab Ecol Alpine, UMR 5553, Grenoble, France.	francois.pompanon@ujf-grenoble.fr	Crepaldi, Paola/L-4681-2017; Pérez, Trinidad/AAC-6729-2019; rafat, seyed abbas/GRX-3016-2022; Naderi, Saeid/ABG-3450-2021; Joost, Stéphane/B-4152-2010; Angiolillo, Antonella/F-4941-2012; Pompanon, François/D-3459-2009; rafat, seyed abbas/AAU-2025-2020; Bruford, Michael/Y-7463-2019; Hoda, Anila/GRY-7191-2022; Beja-Pereira, Albano/B-3681-2008; AJMONE MARSAN, Paolo/M-2466-2018; valentini, alessio/L-3970-2013; Canon Ferreras, Francisco Javier/M-5704-2018	Crepaldi, Paola/0000-0002-6526-2162; Pérez, Trinidad/0000-0003-1216-5593; rafat, seyed abbas/0000-0003-0231-1331; Naderi, Saeid/0000-0003-4918-208X; Joost, Stéphane/0000-0002-1184-7501; Angiolillo, Antonella/0000-0002-0158-3039; Pompanon, François/0000-0003-4600-0172; rafat, seyed abbas/0000-0003-0231-1331; Bruford, Michael/0000-0001-6357-6080; Hoda, Anila/0000-0003-0906-2550; Beja-Pereira, Albano/0000-0002-1607-7382; Roosen, Jutta/0000-0002-3032-399X; Ibeagha-Awemu, Eveline/0000-0001-8810-9294; Luikart, Gordon/0000-0001-8697-0582; Nijman, Isaac/0000-0002-1840-1158; Carta, Antonello/0000-0003-0534-4876; Lenstra, Johannes A./0000-0003-1745-7739; PILLA, Fabio/0000-0002-1781-994X; LIGDA, CHRISTINA/0000-0003-4980-3026; Rezaei, HamidReza/0000-0002-9422-5600; AJMONE MARSAN, Paolo/0000-0003-3165-4579; Niznikowski, Roman/0000-0002-8401-106X; CANALI, Gabriele/0000-0001-9244-8184; Marletta, Donata/0000-0002-8408-7443; valentini, alessio/0000-0003-4733-7519; Canon Ferreras, Francisco Javier/0000-0003-1137-0958; Dobi, Petrit/0000-0002-6101-0101; Baret, Philippe/0000-0002-6189-666X	Ministry of Science, Research, and Technology [800125, 791135]; Institut National de la Recherche Agronomique; Chronobos project [ANR 05-GANI-004-02]; EU [QLK5-CT-2001-02461]	Ministry of Science, Research, and Technology; Institut National de la Recherche Agronomique; Chronobos project; EU(European Commission)	Funding: S. Naderi and HR. Rezaei were supported by PhD scholarships from the Iranian Ministry of Science, Research, and Technology (number 800125 and, 791135 respectively). F. Pompanon was supported by the Institut National de la Recherche Agronomique. This work has been partially supported by the Chronobos project (ANR 05-GANI-004-02) and by the EU ECONOGENE contract QLK5-CT-2001-02461. The content of the publication does not represent necessarily the views of the European Commission or its services.	Amills M, 2004, J DAIRY RES, V71, P257, DOI 10.1017/S0022029904000342; Azor PJ, 2005, ANIM GENET, V36, P423, DOI 10.1111/j.1365-2052.2005.01327.x; Bradley DG, 1996, P NATL ACAD SCI USA, V93, P5131, DOI 10.1073/pnas.93.10.5131; Bruford MW, 2003, NAT REV GENET, V4, P900, DOI 10.1038/nrg1203; Canon J, 2006, ANIM GENET, V37, P327, DOI 10.1111/j.1365-2052.2006.01461.x; Chen SY, 2005, MOL PHYLOGENET EVOL, V37, P804, DOI 10.1016/j.ympev.2005.06.014; CLUTTONBROCK J, 1999, DOMESTICATED ANIMALS; Denver DR, 2000, SCIENCE, V289, P2342, DOI 10.1126/science.289.5488.2342; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fernandez H, 2006, P NATL ACAD SCI USA, V103, P15375, DOI 10.1073/pnas.0602753103; Freeman AR, 2004, MOL ECOL, V13, P3477, DOI 10.1111/j.1365-294X.2004.02311.x; Fumagalli L, 1996, MOL BIOL EVOL, V13, P31, DOI 10.1093/oxfordjournals.molbev.a025568; Hiendleder S, 1998, J MOL EVOL, V47, P441, DOI 10.1007/PL00006401; Howell N, 2003, AM J HUM GENET, V72, P659, DOI 10.1086/368264; Joshi MB, 2004, MOL BIOL EVOL, V21, P454, DOI 10.1093/molbev/msh038; Kuhner MK, 2006, BIOINFORMATICS, V22, P768, DOI 10.1093/bioinformatics/btk051; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lambert DM, 2002, SCIENCE, V295, P2270, DOI 10.1126/science.1068105; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Luikart G, 2001, P NATL ACAD SCI USA, V98, P5927, DOI 10.1073/pnas.091591198; MacHugh DE, 2001, P NATL ACAD SCI USA, V98, P5382, DOI 10.1073/pnas.111163198; Manceau V, 1999, MOL PHYLOGENET EVOL, V13, P504, DOI 10.1006/mpev.1999.0688; Mannen H, 2004, MOL PHYLOGENET EVOL, V32, P539, DOI 10.1016/j.ympev.2004.01.010; Meadow R. H., 1996, ORIGINS SPREAD AGR P, P390; Meadows JRS, 2007, GENETICS, V175, P1371, DOI 10.1534/genetics.106.068353; Meadows JRS, 2005, J HERED, V96, P494, DOI 10.1093/jhered/esi100; NADERI S, GENETIC EVIDEN UNPUB; Odahara S, 2006, ASIAN AUSTRAL J ANIM, V19, P482, DOI 10.5713/ajas.2006.482; PARISET L, 2006, J CHROMATOGRAPHY B; Pereira F, 2005, MOL ECOL, V14, P2313, DOI 10.1111/j.1365-294X.2005.02594.x; Pidancier N, 2006, MOL PHYLOGENET EVOL, V40, P739, DOI 10.1016/j.ympev.2006.04.002; Pietro P, 2003, DNA SEQUENCE, V14, P199, DOI 10.1080/1042517031000089487; PORTER V, 1996, GOATS WORLD; Pringle H, 1998, SCIENCE, V282, P1448, DOI 10.1126/science.282.5393.1448; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Sardina MT, 2006, ANIM GENET, V37, P376, DOI 10.1111/j.1365-2052.2006.01451.x; Schneider S, 1999, GENETICS, V152, P1079; Shackleton DM, 1997, WILD SHEEP GOATS THE; Sultana S, 2003, ANIM GENET, V34, P417, DOI 10.1046/j.0268-9146.2003.01040.x; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; TABERLET P, MOL ECOL; Takada T, 1997, BIOCHEM GENET, V35, P315, DOI 10.1023/A:1021869704889; TUNON MJ, 1989, ANIM GENET, V20, P205; VIGNE JD, 2000, ARCHAEOZOOLOGY NEAR, V4, P52; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zeder MA, 2006, TRENDS GENET, V22, P139, DOI 10.1016/j.tig.2006.01.007; Zeder MA, 2000, SCIENCE, V287, P2254, DOI 10.1126/science.287.5461.2254; Zeder Melinda A., 2005, P125	48	156	165	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1012	10.1371/journal.pone.0001012	http://dx.doi.org/10.1371/journal.pone.0001012			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925860	gold, Green Submitted, Green Published			2022-12-25	WOS:000207456000011
J	Miranda, I; Rocha, R; Santos, MC; Mateus, DD; Moura, GR; Carreto, L; Santos, MAS				Miranda, Isabel; Rocha, Rita; Santos, Maria C.; Mateus, Denisa D.; Moura, Gabriela R.; Carreto, Laura; Santos, Manuel A. S.			A Genetic Code Alteration Is a Phenotype Diversity Generator in the Human Pathogen Candida albicans	PLOS ONE			English	Article								Background. The discovery of genetic code alterations and expansions in both prokaryotes and eukaryotes abolished the hypothesis of a frozen and universal genetic code and exposed unanticipated flexibility in codon and amino acid assignments. It is now clear that codon identity alterations involve sense and non-sense codons and can occur in organisms with complex genomes and proteomes. However, the biological functions, the molecular mechanisms of evolution and the diversity of genetic code alterations remain largely unknown. In various species of the genus Candida, the leucine CUG codon is decoded as serine by a unique serine tRNA that contains a leucine 5'-CAG-3' anticodon (tRNA(CAG)(Ser)). We are using this codon identity redefinition as a model system to elucidate the evolution of genetic code alterations. Methodology/Principal Findings. We have reconstructed the early stages of the Candida genetic code alteration by engineering tRNAs that partially reverted the identity of serine CUG codons back to their standard leucine meaning. Such genetic code manipulation had profound cellular consequences as it exposed important morphological variation, altered gene expression, re-arranged the karyotype, increased cell-cell adhesion and secretion of hydrolytic enzymes. Conclusion/Significance. Our study provides the first experimental evidence for an important role of genetic code alterations as generators of phenotypic diversity of high selective potential and supports the hypothesis that they speed up evolution of new phenotypes.	[Miranda, Isabel; Rocha, Rita; Santos, Maria C.; Mateus, Denisa D.; Moura, Gabriela R.; Carreto, Laura; Santos, Manuel A. S.] Univ Aveiro, Dept Biol, CESAM, P-3800 Aveiro, Portugal	Universidade de Aveiro	Santos, MAS (corresponding author), Univ Aveiro, Dept Biol, CESAM, P-3800 Aveiro, Portugal.	msantos@bio.ua.pt	Mateus, Denisa D/J-8827-2014; Santos, Conceição/ABE-6172-2020; Moura, Gabriela R/E-6717-2010; Moura, Gabriela/GPF-9079-2022; Miranda, Isabel M./B-2017-2009; Rocha, Rita/M-9564-2013; dos Santos, Maria/B-7426-2012; Santos, Manuel/E-6704-2010	Mateus, Denisa D/0000-0002-8665-5176; Santos, Conceição/0000-0003-4129-6381; Moura, Gabriela R/0000-0003-2243-6123; Moura, Gabriela/0000-0003-2243-6123; Miranda, Isabel M./0000-0003-4839-1613; Rocha, Rita/0000-0003-1193-8320; Santos, Manuel/0000-0002-0437-1146	FCT/FEDER [POCI/BIA-MIC/55466/04, POCI/BIA-PRO/55472/2004, POCI/SAU-MMO/55476/2004, BD/19807/99, BD/8296/2002]; EMBO [RGP45/2005]; Fundação para a Ciência e a Tecnologia [POCI/SAU-MMO/55476/2004, POCI/BIA-PRO/55472/2004] Funding Source: FCT	FCT/FEDER(Portuguese Foundation for Science and TechnologyEuropean Commission); EMBO(European Molecular Biology Organization (EMBO)); Fundação para a Ciência e a Tecnologia	This study was supported by FCT/FEDER projects POCI/BIA-MIC/55466/04, POCI/BIA-PRO/55472/2004 and POCI/SAU-MMO/55476/2004. IM, RR are supported by FCT/FEDER, BD/19807/99 and BD/8296/2002 PhD grants, respectively. MASS was supported by an EMBO YIP and a Human Frontier Science Programme Grant (REF: RGP45/2005).	Bacher JM, 2005, P NATL ACAD SCI USA, V102, P1697, DOI 10.1073/pnas.0409064102; Bacher JM, 2001, J BACTERIOL, V183, P5414, DOI 10.1128/JB.183.18.5414-5425.2001; Bennett RJ, 2003, EMBO J, V22, P2505, DOI 10.1093/emboj/cdg235; BREITSCHOPF K, 1994, EMBO J, V13, P3166, DOI 10.1002/j.1460-2075.1994.tb06615.x; CARON F, 1985, NATURE, V314, P185, DOI 10.1038/314185a0; Castresana J, 1998, P NATL ACAD SCI USA, V95, P3703, DOI 10.1073/pnas.95.7.3703; Chin JW, 2003, SCIENCE, V301, P964, DOI 10.1126/science.1084772; CHU WS, 1993, J BACTERIOL, V175, P6637, DOI 10.1128/jb.175.20.6637-6651.1993; Dorazi R, 2002, MOL MICROBIOL, V44, P131, DOI 10.1046/j.1365-2958.2002.02847.x; FORTUNA M, 2000, CURRENT PROTOCOLS CY; Fu Y, 1998, INFECT IMMUN, V66, P1783, DOI 10.1128/IAI.66.4.1783-1786.1998; Gaur NK, 2002, CELL COMMUN ADHES, V9, P45, DOI 10.1080/15419060212187; Gaur NK, 1997, INFECT IMMUN, V65, P5289, DOI 10.1128/IAI.65.12.5289-5294.1997; Gaur NK, 1999, INFECT IMMUN, V67, P6040, DOI 10.1128/IAI.67.11.6040-6047.1999; Ghannoum MA, 2000, CLIN MICROBIOL REV, V13, P122, DOI 10.1128/CMR.13.1.122-143.2000; HANYU N, 1986, EMBO J, V5, P1307, DOI 10.1002/j.1460-2075.1986.tb04360.x; Hao B, 2002, SCIENCE, V296, P1462, DOI 10.1126/science.1069556; HARPER DS, 1989, P NATL ACAD SCI USA, V86, P3252, DOI 10.1073/pnas.86.9.3252; HEITZLER J, 1992, BIOCHIM BIOPHYS ACTA, V1129, P273, DOI 10.1016/0167-4781(92)90503-R; Hendrickson TL, 2004, ANNU REV BIOCHEM, V73, P147, DOI 10.1146/annurev.biochem.73.012803.092429; Hoyer LL, 2001, TRENDS MICROBIOL, V9, P176, DOI 10.1016/S0966-842X(01)01984-9; Huang GH, 2006, P NATL ACAD SCI USA, V103, P12813, DOI 10.1073/pnas.0605270103; Hull CM, 2000, SCIENCE, V289, P307, DOI 10.1126/science.289.5477.307; Hull CM, 1999, SCIENCE, V285, P1271, DOI 10.1126/science.285.5431.1271; IBRAHIM AS, 1995, INFECT IMMUN, V63, P1993, DOI 10.1128/IAI.63.5.1993-1998.1995; Innis MA, 1990, PCR PROTOCOLS GUIDE; Iwaguchi S, 2000, YEAST, V16, P411, DOI 10.1002/(SICI)1097-0061(20000330)16:5&lt;411::AID-YEA532&gt;3.0.CO;2-N; Janbon G, 1998, P NATL ACAD SCI USA, V95, P5150, DOI 10.1073/pnas.95.9.5150; Jones T, 2004, P NATL ACAD SCI USA, V101, P7329, DOI 10.1073/pnas.0401648101; Jukes TH, 1996, J MOL EVOL, V42, P321, DOI 10.1007/BF02198859; Knight RD, 2001, NAT REV GENET, V2, P49, DOI 10.1038/35047500; Knight RD, 2001, J MOL EVOL, V53, P299, DOI 10.1007/s002390010220; KOHRER K, 1991, METHOD ENZYMOL, V194, P398; LASKER BA, 1989, NUCLEIC ACIDS RES, V17, P3783, DOI 10.1093/nar/17.10.3783; Le Mouel A, 2003, EUKARYOT CELL, V2, P1076, DOI 10.1128/EC.2.5.1076-1090.2003; LEE BJ, 1989, J BIOL CHEM, V264, P9724; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Legrand M, 2004, MOL MICROBIOL, V52, P1451, DOI 10.1111/j.1365-2958.2004.04068.x; Li F, 2003, EUKARYOT CELL, V2, P1266, DOI 10.1128/EC.2.6.1266-1273.2003; LOVETT PS, 1991, J BACTERIOL, V173, P1810, DOI 10.1128/jb.173.5.1810-1812.1991; Magee BB, 2000, SCIENCE, V289, P310, DOI 10.1126/science.289.5477.310; MAGEE BB, 1987, J GEN MICROBIOL, V133, P425; Massey SE, 2003, GENOME RES, V13, P544, DOI 10.1101/gr.811003; Miller MG, 2002, CELL, V110, P293, DOI 10.1016/S0092-8674(02)00837-1; Miranda I, 2006, YEAST, V23, P203, DOI 10.1002/yea.1350; Naglik JR, 2003, MICROBIOL MOL BIOL R, V67, P400, DOI 10.1128/MMBR.67.3.400-428.2003; Nangle LA, 2006, CHEM BIOL, V13, P1091, DOI 10.1016/j.chembiol.2006.08.011; O'Sullivan JM, 2001, TRENDS GENET, V17, P20, DOI 10.1016/S0168-9525(00)02144-2; O'Sullivan JM, 2001, YEAST, V18, P313, DOI 10.1002/1097-0061(20010315)18:4&lt;313::AID-YEA673&gt;3.0.CO;2-7; OHAMA T, 1993, NUCLEIC ACIDS RES, V21, P4039, DOI 10.1093/nar/21.17.4039; OSULLIVAN JM, 2002, STANDARD NONSTANDARD, P279; Perepnikhatka V, 1999, J BACTERIOL, V181, P4041, DOI 10.1128/JB.181.13.4041-4049.1999; Perreau VM, 1999, J MOL BIOL, V293, P1039, DOI 10.1006/jmbi.1999.3209; Pla J, 1996, YEAST, V12, P1677; Rauceo JM, 2004, INFECT IMMUN, V72, P4948, DOI 10.1128/IAI.72.9.4948-4955.2004; RORABACHER DB, 1991, ANAL CHEM, V63, P139, DOI 10.1021/ac00002a010; Rottmann M, 2003, MOL MICROBIOL, V47, P943, DOI 10.1046/j.1365-2958.2003.03358.x; Rustchenko EP, 1997, MICROBIOL-UK, V143, P1765, DOI 10.1099/00221287-143-5-1765; RUSTCHENKOBULGAC EP, 1990, J BACTERIOL, V172, P1276, DOI 10.1128/jb.172.3.1276-1283.1990; RUSTCHENKOBULGAC EP, 1993, J GEN MICROBIOL, V139, P1195, DOI 10.1099/00221287-139-6-1195; SAMARANAYAKE LP, 1984, SABOURAUDIA, V22, P201; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sanchez-Silva R, 2003, CURR BIOL, V13, P442, DOI 10.1016/S0960-9822(03)00126-X; Santos MAS, 2004, TRENDS GENET, V20, P95, DOI 10.1016/j.tig.2003.12.009; Santos MAS, 1996, EMBO J, V15, P5060, DOI 10.1002/j.1460-2075.1996.tb00886.x; SANTOS MAS, 1993, EMBO J, V12, P607, DOI 10.1002/j.1460-2075.1993.tb05693.x; Santos MAS, 1999, MOL MICROBIOL, V31, P937, DOI 10.1046/j.1365-2958.1999.01233.x; SANTOS MAS, 1995, NUCLEIC ACIDS RES, V23, P1481, DOI 10.1093/nar/23.9.1481; Santos MAS, 1997, MOL MICROBIOL, V26, P423, DOI 10.1046/j.1365-2958.1997.5891961.x; Schultz DW, 1996, J MOL EVOL, V42, P597, DOI 10.1007/BF02352290; SCHULTZ DW, 1994, J MOL BIOL, V235, P1377, DOI 10.1006/jmbi.1994.1094; Selmecki A, 2005, MOL MICROBIOL, V55, P1553, DOI 10.1111/j.1365-2958.2005.04492.x; SOLL DR, 2002, PHENOTYPIC SWITCHING, P123; Staab JF, 1999, SCIENCE, V283, P1535, DOI 10.1126/science.283.5407.1535; Sugita T, 1999, SYST APPL MICROBIOL, V22, P79, DOI 10.1016/S0723-2020(99)80030-7; Sundstrom P, 2002, CELL MICROBIOL, V4, P461, DOI 10.1046/j.1462-5822.2002.00206.x; SUZUKI T, 1994, J BACTERIOL, V176, P3345, DOI 10.1128/jb.176.11.3345-3353.1994; SUZUKI T, 1989, J GEN MICROBIOL, V135, P425; Suzuki T, 1997, EMBO J, V16, P1122, DOI 10.1093/emboj/16.5.1122; Tuite MF, 1996, BIOCHIMIE, V78, P993, DOI 10.1016/S0300-9084(97)86722-3; VARSHNEY U, 1991, J BIOL CHEM, V266, P24712; WEYGANDDURASEVIC I, 1994, J BACTERIOL, V176, P232; Zheng XD, 2004, EMBO J, V23, P1845, DOI 10.1038/sj.emboj.7600195; Zordan RE, 2006, P NATL ACAD SCI USA, V103, P12807, DOI 10.1073/pnas.0605138103	84	40	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e996	10.1371/journal.pone.0000996	http://dx.doi.org/10.1371/journal.pone.0000996			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912373	Green Published, gold			2022-12-25	WOS:000207455900032
J	Dirnberger, D; Seuwen, K				Dirnberger, Dietmar; Seuwen, Klaus			Signaling of Human Frizzled Receptors to the Mating Pathway in Yeast	PLOS ONE			English	Article								Frizzled receptors have seven membrane-spanning helices and are considered as atypical G protein-coupled receptors (GPCRs). The mating response of the yeast Saccharomyces cerevisiae is mediated by a GPCR signaling system and this model organism has been used extensively in the past to study mammalian GPCR function. We show here that human Frizzled receptors (Fz1 and Fz2) can be properly targeted to the yeast plasma membrane, and that they stimulate the yeast mating pathway in the absence of added Wnt ligands, as evidenced by cell cycle arrest in G1 and reporter gene expression dependent on the mating pathway-activated FUS1 gene. Introducing intracellular portions of Frizzled receptors into the Ste2p backbone resulted in the generation of constitutively active receptor chimeras that retained mating factor responsiveness. Introducing intracellular portions of Ste2p into the Frizzled receptor backbone was found to strongly enhance mating pathway activation as compared to the native Frizzleds, likely by facilitating interaction with the yeast Ga protein Gpa1p. Furthermore, we show reversibility of the highly penetrant G1-phase arrests exerted by the receptor chimeras by deletion of the mating pathway effector FAR1. Our data demonstrate that Frizzled receptors can functionally replace mating factor receptors in yeast and offer an experimental system to study modulators of Frizzled receptors.	[Dirnberger, Dietmar; Seuwen, Klaus] Novartis Inst Biomed Res, Basel, Switzerland	Novartis	Dirnberger, D (corresponding author), Novartis Inst Biomed Res, Basel, Switzerland.	Dietmar.Dirnberger@Novartis.com			NIBR	NIBR	This work was sponsored by a "NIBR-Presidential Postdoctoral Fellowship'' granted to D. D.	Ahumada A, 2002, SCIENCE, V298, P2006, DOI 10.1126/science.1073776; [Anonymous], 1991, Methods Enzymol, V194, P1; Baranski TJ, 1999, J BIOL CHEM, V274, P15757, DOI 10.1074/jbc.274.22.15757; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Bickle M, 1998, EMBO J, V17, P2235, DOI 10.1093/emboj/17.8.2235; Brown AJ, 2000, YEAST, V16, P11, DOI 10.1002/(SICI)1097-0061(20000115)16:1<11::AID-YEA502>3.0.CO;2-K; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; CHANG F, 1990, CELL, V63, P999, DOI 10.1016/0092-8674(90)90503-7; Chen W, 2003, SCIENCE, V301, P1391, DOI 10.1126/science.1082808; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Crowe ML, 2000, J RECEPT SIGNAL TR R, V20, P61, DOI 10.3109/10799890009150037; DENOBEL JG, 1991, YEAST, V7, P313, DOI 10.1002/yea.320070402; Dirnberger D, 2006, CHEMBIOCHEM, V7, P936, DOI 10.1002/cbic.200500544; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; Dohlman HG, 1996, MOL CELL BIOL, V16, P5194; DOHMEN RJ, 1995, J BIOL CHEM, V270, P18099, DOI 10.1074/jbc.270.30.18099; Dowell SJ, 2002, RECEPTOR CHANNEL, V8, P343, DOI 10.1080/10606820214647; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Erickson JP, 1998, J BIOL CHEM, V273, P1506, DOI 10.1074/jbc.273.3.1506; Gazit A, 1999, ONCOGENE, V18, P5959, DOI 10.1038/sj.onc.1202985; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Goo JH, 1999, DNA CELL BIOL, V18, P429, DOI 10.1089/104454999315312; Katanaev VL, 2005, CELL, V120, P111, DOI 10.1016/j.cell.2004.11.014; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; KING K, 1990, SCIENCE, V250, P121, DOI 10.1126/science.2171146; Konopka JB, 1996, P NATL ACAD SCI USA, V93, P6764, DOI 10.1073/pnas.93.13.6764; KONOPKA JB, 1993, MOL CELL BIOL, V13, P6876, DOI 10.1128/MCB.13.11.6876; KONOPKA JB, 1995, MOL CELL BIOL, V15, P723; Ladds G, 2005, TRENDS BIOTECHNOL, V23, P367, DOI 10.1016/j.tibtech.2005.05.007; Liu T, 2001, SCIENCE, V292, P1718, DOI 10.1126/science.1060100; Liu XX, 2005, CURR BIOL, V15, P1989, DOI 10.1016/j.cub.2005.10.050; Liu XX, 1999, P NATL ACAD SCI USA, V96, P14383, DOI 10.1073/pnas.96.25.14383; Martin NP, 1999, BIOCHEMISTRY-US, V38, P682, DOI 10.1021/bi982062w; Minic J, 2005, FEBS J, V272, P524, DOI 10.1111/j.1742-4658.2004.04494.x; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Overton MC, 2005, EUKARYOT CELL, V4, P1963, DOI 10.1128/EC.4.12.1963-1970.2005; Pajot-Augy E, 2003, J RECEPT SIG TRANSD, V23, P155, DOI 10.1081/RRS-120025196; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; SIKORSKI RS, 1989, GENETICS, V122, P19; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; Sommers CM, 2000, BIOCHEMISTRY-US, V39, P6898, DOI 10.1021/bi992616a; Stefan CJ, 1999, J BIOL CHEM, V274, P1835, DOI 10.1074/jbc.274.3.1835; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wang HY, 2004, CELL MOL LIFE SCI, V61, P69, DOI 10.1007/s00018-003-3165-x; Wittke S, 1999, MOL BIOL CELL, V10, P2519, DOI 10.1091/mbc.10.8.2519; Zilberberg A, 2004, J BIOL CHEM, V279, P17535, DOI 10.1074/jbc.M311292200	48	10	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e954	10.1371/journal.pone.0000954	http://dx.doi.org/10.1371/journal.pone.0000954			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895994	Green Submitted, Green Published, gold			2022-12-25	WOS:000207455800032
J	Read, MA; Grigg, GC; Irwin, SR; Shanahan, D; Franklin, CE				Read, Mark A.; Grigg, Gordon C.; Irwin, Steve R.; Shanahan, Danielle; Franklin, Craig E.			Satellite Tracking Reveals Long Distance Coastal Travel and Homing by Translocated Estuarine Crocodiles, Crocodylus porosus	PLOS ONE			English	Article								Crocodilians have a wide distribution, often in remote areas, are cryptic, secretive and are easily disturbed by human presence. Their capacity for large scale movements is poorly known. Here, we report the first study of post-release movement patterns in translocated adult crocodiles, and the first application of satellite telemetry to a crocodilian. Three large male Crocodylus porosus (3.1-4.5 m) were captured in northern Australia and translocated by helicopter for 56, 99 and 411 km of coastline, the last across Cape York Peninsula from the west coast to the east coast. All crocodiles spent time around their release site before returning rapidly and apparently purposefully to their capture locations. The animal that circumnavigated Cape York Peninsula to return to its capture site, travelled more than 400 km in 20 days, which is the longest homeward travel yet reported for a crocodilian. Such impressive homing ability is significant because translocation has sometimes been used to manage potentially dangerous C. porosus close to human settlement. It is clear that large male estuarine crocodiles can exhibit strong site fidelity, have remarkable navigational skills, and may move long distances following a coastline. These long journeys included impressive daily movements of 10-30 km, often consecutively.	[Grigg, Gordon C.; Shanahan, Danielle; Franklin, Craig E.] Univ Queensland, Sch Integrat Biol, St Lucia, Qld, Australia; [Read, Mark A.] Queensland Pk & Wildlife Serv, Cairns, Qld, Australia; [Irwin, Steve R.] Australia Zoo, Beerwah, Qld, Australia	University of Queensland	Franklin, CE (corresponding author), Univ Queensland, Sch Integrat Biol, St Lucia, Qld, Australia.	c.franklin@uq.edu.au	Franklin, Craig/G-7343-2012; Shanahan, Danielle/F-8437-2013	Franklin, Craig/0000-0003-1315-3797; 	Charles Tanner Bequest; Wildlife Warriors Worldwide; Australian Research Council	Charles Tanner Bequest; Wildlife Warriors Worldwide; Australian Research Council(Australian Research Council)	This work was supported by the Charles Tanner Bequest, Wildlife Warriors Worldwide and an Australian Research Council Grant to CEF, MAR and SRI.	Beyer HL, 2004, HAWTHS ANAL TOOLS AR; Boustany AM, 2002, NATURE, V415, P35, DOI 10.1038/415035b; Chabreck RH, 1965, P SE ASS GAME FISH C, V19, P102; Ferraroli S, 2004, NATURE, V429, P521, DOI 10.1038/429521a; GORZULA SJ, 1978, OECOLOGIA, V35, P21, DOI 10.1007/BF00345539; Hays GC, 2004, NATURE, V429, P522, DOI 10.1038/429522a; JOUVENTIN P, 1990, NATURE, V343, P746, DOI 10.1038/343746a0; Kay WR, 2004, WILDLIFE RES, V31, P495, DOI 10.1071/WR04037; Lang J.W., 1987, P273; Read MA, 2004, WILDLIFE RES, V31, P527, DOI 10.1071/WR02025; RODDA GH, 1984, BEHAV ECOL SOCIOBIOL, V14, P241, DOI 10.1007/BF00299494; Ross JP., 1998, CROCODILES STATUS SU; Seymour R.S., 1987, P253; TAPLIN LE, 1981, SCIENCE, V212, P1045, DOI 10.1126/science.212.4498.1045; Walsh B., 1987, P249; WALSH B, 1993, WILDLIFE RES, V20, P127, DOI 10.1071/WR9930127; WEBB GJW, 1983, AUST WILDLIFE RES, V10, P403; WEBB GJW, 1978, AUST WILDLIFE RES, V5, P263, DOI 10.1071/WR9780263; 2000, ARGOS USERS MANUAL	19	59	66	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e949	10.1371/journal.pone.0000949	http://dx.doi.org/10.1371/journal.pone.0000949			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895990	Green Published, gold, Green Submitted			2022-12-25	WOS:000207455800028
J	Roizen, J; Luedke, CE; Herzog, ED; Muglia, LJ				Roizen, Jeffrey; Luedke, Christina E.; Herzog, Erik D.; Muglia, Louis J.			Oxytocin in the Circadian Timing of Birth	PLOS ONE			English	Article								Background. The molecular components determining the timing for birth remain an incompletely characterized aspect of reproduction, with important conceptual and therapeutic ramifications for management of preterm, post-term and arrested labor. Methodology/Principal Findings. To test the hypothesis that oxytocin mediates circadian regulation of birth, we evaluated parturition timing following shifts in light cycles in oxytocin (OT)-deficient mice. We find that, in contrast to wild type mice that do not shift the timing of birth following a 6-h advance or delay in the light cycle, OT-deficient mice delivered at random times of day. Moreover, shifts in the light-dark cycle of gravid wild type mice have little impact on the pattern of circadian oxytocin release. Conclusions/Significance. Our results demonstrate oxytocin plays a critical role in minimizing labor disruption due to circadian clock resetting.	[Roizen, Jeffrey; Muglia, Louis J.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Roizen, Jeffrey; Muglia, Louis J.] Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; [Roizen, Jeffrey; Muglia, Louis J.] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA; [Luedke, Christina E.] Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Herzog, Erik D.] Washington Univ, Dept Biol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Harvard University; Boston Children's Hospital; Washington University (WUSTL)	Muglia, LJ (corresponding author), Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.	Muglia_L@kids.wustl.edu	Roizen, Jeffrey D/J-5050-2012	Roizen, Jeffrey D/0000-0002-3384-6200; Herzog, Erik/0000-0001-7209-5174	March of Dimes	March of Dimes(March of Dimes)	March of Dimes	Caba M, 1996, BRAIN RES, V720, P7, DOI 10.1016/0006-8993(96)00036-4; Ceriani MF, 2002, J NEUROSCI, V22, P9305, DOI 10.1523/jneurosci.22-21-09305.2002; Egli M, 2004, ENDOCRINOLOGY, V145, P3386, DOI 10.1210/en.2003-1710; Forsling ML, 2000, EXP PHYSIOL, V85, p179S, DOI 10.1111/j.1469-445X.2000.tb00022.x; Forsling ML, 1995, ADV EXP MED BIOL, V395, P92; GOTO M, 1994, MOL BRAIN RES, V21, P349, DOI 10.1016/0169-328X(94)90266-6; Imamura T, 2000, AM J PHYSIOL-REG I, V279, pR1061, DOI 10.1152/ajpregu.2000.279.3.R1061; LINCOLN DW, 1976, NATURE, V260, P780, DOI 10.1038/260780a0; Miller BH, 2004, CURR BIOL, V14, P1367, DOI 10.1016/j.cub.2004.07.055; Nishimori K, 1996, P NATL ACAD SCI USA, V93, P11699, DOI 10.1073/pnas.93.21.11699; REFINETTI R, 1992, BEHAV NEURAL BIOL, V58, P27, DOI 10.1016/0163-1047(92)90862-X; REPPERT SM, 1987, BRAIN RES, V403, P398, DOI 10.1016/0006-8993(87)90084-9; Saeb-Parsy K, 2000, J NEUROENDOCRINOL, V12, P635; VISWANATHAN N, 1992, BIOL REPROD, V47, P6, DOI 10.1095/biolreprod47.1.6; Young WS, 1996, J NEUROENDOCRINOL, V8, P847, DOI 10.1046/j.1365-2826.1996.05266.x	15	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e922	10.1371/journal.pone.0000922	http://dx.doi.org/10.1371/journal.pone.0000922			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895964	Green Published, gold			2022-12-25	WOS:000207455800002
J	Kim, MS; Chang, X; Nagpal, JK; Yamashita, K; Baek, JH; Dasgupta, S; Wu, G; Osada, M; Woo, JH; Westra, WH; Trink, B; Ratovitski, EA; Moon, C; Sidransky, D				Kim, M. S.; Chang, X.; Nagpal, J. K.; Yamashita, K.; Baek, J. H.; Dasgupta, S.; Wu, G.; Osada, M.; Woo, J-H; Westra, W. H.; Trink, B.; Ratovitski, E. A.; Moon, C.; Sidransky, D.			The N-methyl-D-aspartate receptor type 2A is frequently methylated in human colorectal carcinoma and suppresses cell growth	ONCOGENE			English	Article						NMDAR2A; promoter hypermethylation; colon cancer; 5-aza-2'-deoxycytidine; tumor suppressor; biomarker	DISCS LARGE; PROMOTER METHYLATION; GENE-EXPRESSION; HUMAN HOMOLOG; LUNG-CANCER; HUMAN BRAIN; NMDA; HYPERMETHYLATION; BIOMARKER; PATTERNS	N-methyl-D-aspartate receptors (NMDARs) are the predominant excitatory neurotransmitter receptors in the mammalian brain. We found that among the three NMDARs examined (NMDAR1, NMDAR2A, NMDAR2B), only NMDAR2A was silenced in colorectal carcinoma (CRC) cell lines at basal line and reactivated by the demethylating agent, 5-aza-2'-deoxycytidine. NMDAR2A was expressed in normal colon epithelium, while expression was hardly detectable in colon cancer tissues. Promoter methylation of NMDAR2A was confirmed by bisulfite sequencing and combined bisulfite restriction analysis in the CRC cell lines and primary tumors. Quantitative methylation-specific PCR demonstrated NMDAR2A promoter hypermethylation in 82 of 100 primary human CRC, 15 of 100 normal corresponding epithelial tissues and 1 of 11 (9%) normal colon mucosa samples obtained from patients without cancer. Moreover, forced expression of full-length NMDAR2A in CRC cell lines induced apoptosis and almost abolished the ability of the cells to form colonies in culture, while NMDAR2A knockdown increased cell growth. Thus, NMDAR2A is commonly hypermethylated in primary human CRC and possesses tumor-suppressive activity.	[Kim, M. S.; Chang, X.; Nagpal, J. K.; Yamashita, K.; Dasgupta, S.; Wu, G.; Osada, M.; Woo, J-H; Trink, B.; Ratovitski, E. A.; Moon, C.; Sidransky, D.] Johns Hopkins Univ, Dept Otolaryngol, Head & Neck Canc Res Div, Baltimore, MD 21231 USA; [Baek, J. H.] Johns Hopkins Univ, Inst Cell Engn, Dept Med Genet, Baltimore, MD 21231 USA; [Westra, W. H.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Sidransky, D (corresponding author), Johns Hopkins Univ, Dept Otolaryngol, Head & Neck Canc Res Div, 1550 Orleans St, Baltimore, MD 21231 USA.	dsidrans@jhmi.edu						Anegawa NJ, 2000, MOL BRAIN RES, V77, P163, DOI 10.1016/S0169-328X(00)00050-4; Azim AC, 1995, GENOMICS, V30, P613, DOI 10.1006/geno.1995.1286; BACON KB, 1995, SCIENCE, V269, P1727, DOI 10.1126/science.7569902; Belinsky SA, 1998, P NATL ACAD SCI USA, V95, P11891, DOI 10.1073/pnas.95.20.11891; Choi SW, 2004, J ORAL PATHOL MED, V33, P533, DOI 10.1111/j.1600-0714.2004.00226.x; Ebert MPA, 2005, NEOPLASIA, V7, P771, DOI 10.1593/neo.05235; Esteller M, 2001, HUM MOL GENET, V10, P3001, DOI 10.1093/hmg/10.26.3001; Fang JY, 2004, CELL RES, V14, P217, DOI 10.1038/sj.cr.7290222; Gardiol D, 2006, INT J CANCER, V119, P1285, DOI 10.1002/ijc.21982; Gonzalez-Cadavid NF, 2000, J ANDROL, V21, P566; Gruber AD, 1999, CANCER RES, V59, P5488; Haraguchi K, 2000, GENES CELLS, V5, P905, DOI 10.1046/j.1365-2443.2000.00374.x; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; INAGAKI N, 1995, FASEB J, V9, P686, DOI 10.1096/fasebj.9.8.7768362; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Jeronimo C, 2001, J NATL CANCER I, V93, P1747, DOI 10.1093/jnci/93.22.1747; Kim MS, 2006, CANCER RES, V66, P3409, DOI 10.1158/0008-5472.CAN-05-1608; KIM MS, 2007, IN PRESS CLIN CANC R; Kunzelmann K, 2005, J MEMBRANE BIOL, V205, P159, DOI 10.1007/s00232-005-0781-4; Ludford-Menting MJ, 2002, J BIOL CHEM, V277, P4477, DOI 10.1074/jbc.M108479200; Mandelker DL, 2005, CANCER RES, V65, P4963, DOI 10.1158/0008-5472.CAN-04-3923; Markert JM, 2001, PHYSIOL GENOMICS, V5, P21, DOI 10.1152/physiolgenomics.2001.5.1.21; Matsumine A, 1996, SCIENCE, V272, P1020, DOI 10.1126/science.272.5264.1020; Palmisano WA, 2000, CANCER RES, V60, P5954; Pillozzi S, 2002, LEUKEMIA, V16, P1791, DOI 10.1038/sj.leu.2402572; Rootwelt T, 1998, J NEUROCHEM, V71, P1544; Said SI, 1996, P NATL ACAD SCI USA, V93, P4688, DOI 10.1073/pnas.93.10.4688; Sanchez-Cespedes M, 2000, CANCER RES, V60, P892; Saur D, 2002, AM J PHYSIOL-GASTR L, V282, pG349, DOI 10.1152/ajpgi.00226.2001; Schito AM, 1997, NEUROSCI LETT, V239, P49, DOI 10.1016/S0304-3940(97)00853-7; Sidransky D, 2002, NAT REV CANCER, V2, P210, DOI 10.1038/nrc755; Stepulak A, 2005, P NATL ACAD SCI USA, V102, P15605, DOI 10.1073/pnas.0507679102; Weaver KD, 2006, CANCER INVEST, V24, P35, DOI 10.1080/07357900500449546; Yamashita K, 2002, CANCER CELL, V2, P485, DOI 10.1016/S1535-6108(02)00215-5; Yanai H, 2000, GENES CELLS, V5, P815, DOI 10.1046/j.1365-2443.2000.00368.x	36	28	31	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 27	2008	27	14					2045	2054		10.1038/sj.onc.1210842	http://dx.doi.org/10.1038/sj.onc.1210842			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	279MK	17922030				2022-12-25	WOS:000254359100009
J	Choi, D; Lee, SJ; Hong, S; Kim, IH; Kang, S				Choi, D.; Lee, S-J; Hong, S.; Kim, I-H; Kang, S.			Prohibitin interacts with RNF2 and regulates E2F1 function via dual pathways	ONCOGENE			English	Article						prohibitin; RNF2; E2F1; p16; cell cycle	RB; REPRESSION; SUPPRESSOR; P53	Prohibitin, a tumor suppresser protein, plays an important role in the transcriptional regulation of various genes involved in cell-cycle control and proliferation. Recent studies have reported that the growth-suppressive property of the prohibitin protein is exhibited in its physical interaction with E2F family proteins and its subsequent repression of their transcriptional activity. Herein, we report that prohibitin interacts with RING finger protein 2 (RNF2), a member of the PcG (polycomb-group) family of proteins, and that the two proteins regulate the activity of E2F1 via dual pathways: the direct, prohibitin-mediated pathway and the indirect, p16-mediated pathway of E2F1 transcriptional regulation. Co-immunoprecipitation experiments showed that endogenous prohibitin interacts with endogenous RNF2. Interestingly, the expressed amounts of RNF2 and prohibitin were interdependently affected at the post-translational level. Furthermore, the depletion of either endogenous RNF2 or prohibitin using the RNA interference technique increased the level of p16 protein expression, resulting in a decrease in the transcriptional activity of E2F1 via the p16-CDK4-Rb pathway. In addition, chromatin immunoprecipitation assays showed that RNF2 was recruited to E2F1-response promoters along with prohibitin to inhibit the transcriptional activity of E2F1. Cell proliferation was also regulated by the prohibitin-RNF2 interaction. These results suggest that the RNF2-prohibitin complex regulates the activity of E2F1 via dual pathways.	[Choi, D.; Lee, S-J; Hong, S.; Kim, I-H; Kang, S.] Korea Univ, Grad Sch Life Sci & Biotechnol, Seoul 136701, South Korea	Korea University	Kang, S (corresponding author), Korea Univ, Grad Sch Life Sci & Biotechnol, Seoul 136701, South Korea.	skang@korea.ac.kr						Bell LA, 2004, CELL DEATH DIFFER, V11, P137, DOI 10.1038/sj.cdd.4401324; Fusaro G, 2003, J BIOL CHEM, V278, P47853, DOI 10.1074/jbc.M305171200; Harbour JW, 2000, CURR OPIN CELL BIOL, V12, P685, DOI 10.1016/S0955-0674(00)00152-6; Kim H, 2004, J AM SOC NEPHROL, V15, P2042, DOI 10.1097/01.ASN.0000133490.00348.59; Lee SJ, 2005, BIOCHEM J, V389, P457, DOI 10.1042/BJ20041982; Lee SJ, 2001, FEBS LETT, V503, P61, DOI 10.1016/S0014-5793(01)02689-8; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Magnaghi-Jaulin L, 1998, NATURE, V391, P601, DOI 10.1038/35410; SATO T, 1993, GENOMICS, V17, P762, DOI 10.1006/geno.1993.1402; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Sherr CJ, 2000, CANCER RES, V60, P3689; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang S, 2002, EMBO J, V21, P3019, DOI 10.1093/emboj/cdf302; Wang S, 1999, MOL CELL BIOL, V19, P7447; Wang S, 1999, ONCOGENE, V18, P3501, DOI 10.1038/sj.onc.1202684; Yoo YA, 2005, MOL CELL BIOL, V25, P6603, DOI 10.1128/MCB.25.15.6603-6616.2005; Zhu LA, 2005, EUR J CANCER, V41, P2415, DOI 10.1016/j.ejca.2005.08.009	18	44	47	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 13	2008	27	12					1716	1725		10.1038/sj.onc.1210806	http://dx.doi.org/10.1038/sj.onc.1210806			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	273WF	17873902				2022-12-25	WOS:000253962100007
J	Fainaru, O; Adini, A; Benny, O; Adini, I; Short, S; Bazinet, L; Nakai, K; Pravda, E; Hornstein, MD; D'Amato, RJ; Folkman, J				Fainaru, Ofer; Adini, Avner; Benny, Ofra; Adini, Irit; Short, Sarah; Bazinet, Lauren; Nakai, Kei; Pravda, Elke; Hornstein, Mark D.; D'Amato, Robert J.; Folkman, Judah			Dendritic cells support angiogenesis and promote lesion growth in a murine model of endometriosis	FASEB JOURNAL			English	Article						Lewis lung carcinoma; melanoma	PERITONEAL-FLUID; MIGRATION; IMMUNITY; ABSENCE; WOMEN; VEGF	Endometriosis affects 10-15% of women and is associated with pelvic pain and infertility. Angiogenesis plays an essential role in its pathogenesis. Dendritic cells (DCs) were recently implicated in supporting tumor angiogenesis. As both tumors and endometriosis lesions depend on angiogenesis, we investigated the possibility that DCs may also play a role in endometriosis. We induced endometriosis in 8-wk-old female C57BL/6 mice by implantation of autologous endometrium into the peritoneal cavity. We observed an abundance of CD11c(+) DCs infiltrating sites of angiogenesis in endometriosis lesions. We noticed a similar pattern of infiltrating DCs at sites of angiogenesis in the peritoneal Lewis lung carcinoma tumor model. These DCs were immature ( major histocompatability complex class IIlow) and expressed vascular endothelial growth factor receptor 2. Peritoneal implanted bone marrow-derived DCs (BMDCs) incorporated into both endometriosis lesions and into B16 melanoma tumors and enhanced their growth at 8 days compared with controls (5.1 +/- 2.5 vs. 1.5 +/- 0.5mm(2), n = 4 and 4, P<0.0001 for endometriosis; 67.6 +/- 15.1 vs. 22.7 +/- 14.6 mm(2), n = 5 and 7, P = 0.0004 for mouse melanoma). Finally, immature BMDCs but not mature BMDCs enhanced microvascular endothelial cell migration in vitro ( 219 +/- 51 vs. 93 +/- 32 cells, P = 0.02). Based on these findings, we suggest a novel role for DCs in supporting angiogenesis and promoting lesion growth both in endometriosis and in tumors.	[Fainaru, Ofer; Adini, Avner; Benny, Ofra; Adini, Irit; Short, Sarah; Bazinet, Lauren; Nakai, Kei; Pravda, Elke; D'Amato, Robert J.; Folkman, Judah] Harvard Univ, Sch Med, Childrens Hosp Boston, Vasc Biol Program,Dept Surg, Boston, MA 02115 USA; [Fainaru, Ofer; Hornstein, Mark D.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Obstet & Gynecol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Fainaru, O (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Boston, Vasc Biol Program,Dept Surg, 300 Longwood Ave, Boston, MA 02115 USA.	ofer.fainaru@childrens.harvard.edu	Benny, Ofra/AAB-3294-2021					Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Becker CM, 2006, AM J PATHOL, V168, P2074, DOI 10.2353/ajpath.2006.051133; Becker CM, 2006, FERTIL STERIL, V85, P71, DOI 10.1016/j.fertnstert.2005.07.1290; Becker CM, 2005, FERTIL STERIL, V84, P1144, DOI 10.1016/j.fertnstert.2005.04.040; Conejo-Garcia JR, 2004, NAT MED, V10, P950, DOI 10.1038/nm1097; Coukos G, 2005, BRIT J CANCER, V92, P1182, DOI 10.1038/sj.bjc.6602476; Cramer DW, 2002, ANN NY ACAD SCI, V955, P11, DOI 10.1111/j.1749-6632.2002.tb02761.x; CRAMER DW, 2002, ANN NY ACAD SCI, V955, P396; Dabrosin C, 2002, AM J PATHOL, V161, P909, DOI 10.1016/S0002-9440(10)64251-4; De Palma M, 2006, BBA-REV CANCER, V1766, P159, DOI 10.1016/j.bbcan.2006.06.003; DMOWSKI WP, 1981, AM J OBSTET GYNECOL, V141, P377, DOI 10.1016/0002-9378(81)90598-6; Donnez J, 1998, HUM REPROD, V13, P1686, DOI 10.1093/humrep/13.6.1686; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Efstathiou JA, 2005, FERTIL STERIL, V83, P171, DOI 10.1016/j.fertnstert.2004.06.058; Fainaru O, 2004, EMBO J, V23, P969, DOI 10.1038/sj.emboj.7600085; Folkman J, 2002, CANCER CELL, V1, P113, DOI 10.1016/S1535-6108(02)00038-7; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Giudice LC, 2004, LANCET, V364, P1789, DOI 10.1016/S0140-6736(04)17403-5; Hull ML, 2003, J CLIN ENDOCR METAB, V88, P2889, DOI 10.1210/jc.2002-021912; Iwasaki A, 2001, J IMMUNOL, V166, P4884, DOI 10.4049/jimmunol.166.8.4884; Labeur MS, 1999, J IMMUNOL, V162, P168; Lutz MB, 2000, EUR J IMMUNOL, V30, P1813, DOI 10.1002/1521-4141(200007)30:7<1813::AID-IMMU1813>3.0.CO;2-8; McLaren J, 1996, J CLIN INVEST, V98, P482, DOI 10.1172/JCI118815; Muller SM, 2005, P NATL ACAD SCI USA, V102, P10587, DOI 10.1073/pnas.0502752102; Nap AW, 2004, J CLIN ENDOCR METAB, V89, P1089, DOI 10.1210/jc.2003-031406; OOSTERLYNCK DJ, 1991, FERTIL STERIL, V56, P45; Pujol BF, 2001, EUR J CELL BIOL, V80, P99, DOI 10.1078/0171-9335-00136; SHOLLEY MM, 1984, LAB INVEST, V51, P624; Short SM, 2005, J CELL BIOL, V168, P643, DOI 10.1083/jcb.200407060; Suzumori N, 2004, FERTIL STERIL, V82, P93, DOI 10.1016/j.fertnstert.2003.11.043; Taylor RN, 2002, ANN NY ACAD SCI, V955, P89, DOI 10.1111/j.1749-6632.2002.tb02769.x; Webster B, 2006, J EXP MED, V203, P1903, DOI 10.1084/jem.20052272	32	83	90	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2008	22	2					522	529		10.1096/fj.07-9034com	http://dx.doi.org/10.1096/fj.07-9034com			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	257TY	17873101				2022-12-25	WOS:000252822600022
J	Gabet, AS; Accardi, R; Bellopede, A; Popp, S; Boukamp, P; Sylla, BS; Londono-Vallejo, JA; Tommasino, M				Gabet, Anne-Sophie; Accardi, Rosita; Bellopede, Angelica; Popp, Susanne; Boukamp, Petra; Sylla, Bakary S.; Londono-Vallejo, J. Arturo; Tommasino, Massimo			Impairment of the telomere/telomerase system and genomic instability are associated with keratinocyte immortalization induced by the skin human papillomavirus type 38	FASEB JOURNAL			English	Article						HPV38 E6 and E7; telomere dysfunctions; chromosomal abnormalities	REVERSE-TRANSCRIPTASE HTERT; SQUAMOUS-CELL CARCINOMAS; TELOMERE DYSFUNCTION; CHROMOSOMAL INSTABILITY; CANCER; E6; MICE; E7; CLASSIFICATION; ACTIVATION	The skin human papillomavirus (HPV) types belonging to the genus beta of the HPV phylogenetic tree appear to be associated with nonmelanoma skin cancer. We previously showed that the beta HPV type 38 E6 and E7 oncoproteins are able to inactivate the tumor suppressors p53 and retinoblastoma. Here, both viral proteins were expressed in primary human skin keratinocytes in order to study their effects on the telomere/telomerase system. We show that immortalization of skin keratinocytes induced by HPV38 E6/E7 is associated with hTERT gene overexpression. This event is, in part, explained by the accumulation of the p53-related protein, Delta Np73. Despite elevated levels of hTERT mRNA, the telomerase activity detected in HPV38 E6/E7 keratinocytes was lower than that observed in HPV16 E6/E7 keratinocytes. The low telomerase activation in highly proliferative HPV38 E6/E7 keratinocytes resulted in the presence of extremely short and unstable telomeres. In addition, we observed anaphase bridges, mitotic multipolarity, and dramatic genomic aberrations. Interestingly, the ectopic expression of hTERT prevents both telomere erosion and genomic instability. Thus, we showed that in HPV38 E6/E7 keratinocytes characterized by unscheduled proliferation, suboptimal activation of telomerase and subsequent extensive telomere shortening result in genomic instability facilitating cellular immortalization.	[Gabet, Anne-Sophie; Accardi, Rosita; Bellopede, Angelica; Sylla, Bakary S.; Tommasino, Massimo] Int Agcy Res Canc, WHO, Infect & Canc Biol Grp, F-69372 Lyon, France; [Popp, Susanne; Boukamp, Petra] Deutsch Krebsforschungszentrum, D-6900 Heidelberg, Germany; [Londono-Vallejo, J. Arturo] UPMC, CNRS, Inst Curie, UMR7147, Paris, France	World Health Organization; International Agency for Research on Cancer (IARC); Helmholtz Association; German Cancer Research Center (DKFZ); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite	Tommasino, M (corresponding author), Int Agcy Res Canc, WHO, Infect & Canc Biol Grp, 150 Cours Albert Thomas, F-69372 Lyon, France.	tommasino@iarc.fr	Londono-Vallejo, Arturo/ABH-5555-2020	Londono-Vallejo, Arturo/0000-0003-3535-7563				Accardi R, 2006, EMBO REP, V7, P334, DOI 10.1038/sj.embor.7400615; Aisner DL, 2002, CURR OPIN GENET DEV, V12, P80, DOI 10.1016/S0959-437X(01)00268-4; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Beitzinger M, 2006, ONCOGENE, V25, P813, DOI 10.1038/sj.onc.1209125; Bickenbach JR, 1998, J INVEST DERMATOL, V111, P1045, DOI 10.1046/j.1523-1747.1998.00420.x; Boldrini L, 2003, INT J MOL MED, V11, P607; BOUKAMP P, 1982, JNCI-J NATL CANCER I, V68, P415; Boukamp P, 2005, CARCINOGENESIS, V26, P1657, DOI 10.1093/carcin/bgi123; Caldeira S, 2003, J VIROL, V77, P2195, DOI 10.1128/JVI.77.3.2195-2206.2003; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; der-Sarkissian H, 2004, ONCOGENE, V23, P1221, DOI 10.1038/sj.onc.1207152; Dong W, 2005, J VIROL, V79, P14899, DOI 10.1128/JVI.79.23.14899-14908.2005; Filatov L, 1998, ONCOGENE, V16, P1825, DOI 10.1038/sj.onc.1201711; Gewin L, 2004, GENE DEV, V18, P2269, DOI 10.1101/gad.1214704; Gisselsson D, 2002, BRIT J CANCER, V87, P202, DOI 10.1038/sj.bjc.6600438; Gomez D, 2003, J BIOL CHEM, V278, P50554, DOI 10.1074/jbc.M308440200; Jackson S, 2000, ONCOGENE, V19, P592, DOI 10.1038/sj.onc.1203339; James MA, 2006, INT J CANCER, V119, P1878, DOI 10.1002/ijc.22064; Jin YS, 1999, GENE CHROMOSOME CANC, V26, P295, DOI 10.1002/(SICI)1098-2264(199912)26:4<295::AID-GCC3>3.0.CO;2-W; Klingelhutz AJ, 1996, NATURE, V380, P79, DOI 10.1038/380079a0; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Munger K, 2004, J VIROL, V78, P11451, DOI 10.1128/JVI.78.21.11451-11460.2004; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Murnane JP, 2004, BIOESSAYS, V26, P1164, DOI 10.1002/bies.20125; Pantic M, 2006, ONCOGENE, V25, P4413, DOI 10.1038/sj.onc.1209486; Parris CN, 1999, BRIT J CANCER, V79, P47, DOI 10.1038/sj.bjc.6690010; Pfister Herbert, 2003, J Natl Cancer Inst Monogr, P52; Plug-DeMaggio AW, 2004, ONCOGENE, V23, P3561, DOI 10.1038/sj.onc.1207388; Popp S, 2002, INT J CANCER, V99, P352, DOI 10.1002/ijc.10321; Racek T, 2005, J BIOL CHEM, V280, P40402, DOI 10.1074/jbc.C500193200; Rudolph KL, 2001, NAT GENET, V28, P155, DOI 10.1038/88871; Schaper ID, 2005, CANCER RES, V65, P1394, DOI 10.1158/0008-5472.CAN-04-3263; Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296; Steenbergen RDM, 2005, J CLIN VIROL, V32, pS25, DOI 10.1016/j.jcv.2004.11.019; Stewenius Y, 2005, P NATL ACAD SCI USA, V102, P5541, DOI 10.1073/pnas.0408454102; Stoppler H, 1997, J BIOL CHEM, V272, P13332, DOI 10.1074/jbc.272.20.13332; Ulaner GA, 2000, INT J CANCER, V85, P330, DOI 10.1002/(SICI)1097-0215(20000201)85:3<330::AID-IJC6>3.0.CO;2-U; Wu KJ, 1999, NAT GENET, V21, P220, DOI 10.1038/6010; Yi XM, 2000, NEOPLASIA, V2, P433, DOI 10.1038/sj.neo.7900113; Zhang AJ, 2004, ONCOGENE, V23, P7441, DOI 10.1038/sj.onc.1207527	40	50	50	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	FEB	2008	22	2					622	632		10.1096/fj.07-8389com	http://dx.doi.org/10.1096/fj.07-8389com			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	257TY	17898088				2022-12-25	WOS:000252822600032
J	Kalsotra, A; Du, LP; Wang, Y; Ladd, PA; Kikuta, Y; Duvic, M; Boyd, AS; Keeney, DS; Strobel, HW				Kalsotra, Auinash; Du, Liping; Wang, Ying; Ladd, Patricia A.; Kikuta, Yasushi; Duvic, Madeleine; Boyd, Alan S.; Keeney, Diane S.; Strobel, Henry W.			Inflammation resolved by retinoid X receptor-mediated inactivation of leukotriene signaling pathways	FASEB JOURNAL			English	Article						cytochromes P4504F; epidermal inflammation; resolution signals	CYTOCHROME-P450 CYP GENES; CHAIN FATTY-ACIDS; HUMAN SKIN CELLS; OMEGA-HYDROXYLASES; PSORIATIC LESIONS; ARACHIDONIC-ACID; B-4 RECEPTOR; EXPRESSION; METABOLISM; KERATINOCYTES	Leukotrienes are implicated in the pathogenesis of diverse, inflammation-driven diseases. Metabolic inactivation of leukotriene signaling is an innate response to resolve inflammation, yet little is known of mechanisms regulating disposition of leukotrienes in peripheral tissues afflicted in common inflammatory diseases. We studied leukotriene hydroxylases (CYP4F gene products) in human skin, a common target of inflammation and adverse drug reactions. Epidermal keratinocytes express at least six CYP4F enzymes; the most highly expressed and highly regulated is CYP4F3A-the main neutrophil leukotriene hydroxylase. Differentiation-specific factors and retinoids are positive CYP4F regulators in vitro, effecting increased leukotriene B4 hydroxylation (inactivation). CYP4F expression is up-regulated in situ in hyperproliferative dermatoses-an innate mechanism to repair and restore epidermal barrier competency-and after retinoid therapy. Enhanced CYP4F-mediated inactivation of leukotriene signaling is a previously unrecognized antiinflammatory property of therapeutic retinoids mediated by preferential interactions between retinoid X receptors and CYP4F promoter elements in epidermal cells.	[Kalsotra, Auinash; Wang, Ying; Strobel, Henry W.] Univ Texas Houston, Hlth Sci Ctr, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Du, Liping; Keeney, Diane S.] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA; [Ladd, Patricia A.; Boyd, Alan S.; Keeney, Diane S.] Vanderbilt Univ, Sch Med, Dept Med Dermatol, Nashville, TN 37212 USA; [Kikuta, Yasushi] Fukuyama Univ, Dept Appl Biol Sci, Fukuyama, Hiroshima, Japan; [Duvic, Madeleine] Univ Texas MD Anderson Canc Ctr, Dept Dermatol, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; Vanderbilt University; Vanderbilt University; Fukuyama University; University of Texas System; UTMD Anderson Cancer Center	Strobel, HW (corresponding author), Univ Texas Houston, Hlth Sci Ctr, Sch Med, Dept Biochem & Mol Biol, 6431 Fannin St,Med Sch Bldg 6,Room 200, Houston, TX 77030 USA.	henry.w.strobel@uth.tmc.edu		Kalsotra, Auinash/0000-0002-1011-0006	NATIONAL CANCER INSTITUTE [K24CA086815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045603, R01AR047357] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044174] Funding Source: NIH RePORTER; NCI NIH HHS [K24-CA86815] Funding Source: Medline; NIAMS NIH HHS [AR47357, R01 AR45603] Funding Source: Medline; NIMH NIH HHS [R01 MH070054] Funding Source: Medline; NINDS NIH HHS [R01 NS044174] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahmad N, 2004, J INVEST DERMATOL, V123, P417, DOI 10.1111/j.0022-202X.2004.23307.x; Arita M, 2005, BIOCHEM BIOPH RES CO, V338, P149, DOI 10.1016/j.bbrc.2005.07.181; Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; BARKER JNWN, 1991, LANCET, V337, P211, DOI 10.1016/0140-6736(91)92168-2; Baron JM, 2005, J INVEST DERMATOL, V125, P143, DOI 10.1111/j.0022-202X.2005.23791.x; Berry KAZ, 2003, J BIOL CHEM, V278, P24449, DOI 10.1074/jbc.M300856200; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Christmas P, 2001, J BIOL CHEM, V276, P38166; Cui X, 2003, BBA-GEN SUBJECTS, V1619, P325, DOI 10.1016/S0304-4165(02)00491-9; Curley CR, 2006, EUR J HUM GENET, V14, P1215, DOI 10.1038/sj.ejhg.5201687; Du LP, 2006, J PHARMACOL EXP THER, V319, P1162, DOI 10.1124/jpet.106.111724; Du LP, 2006, TOXICOL APPL PHARM, V213, P135, DOI 10.1016/j.taap.2005.10.003; Du LP, 2006, J PHARMACOL EXP THER, V316, P371, DOI 10.1124/jpet.105.093922; DUVIC M, 1997, J AM ACAD DERMATOL, V37, P18; Fisher GJ, 1996, FASEB J, V10, P1002, DOI 10.1096/fasebj.10.9.8801161; Fogh K, 2000, PROSTAG OTH LIPID M, V63, P43, DOI 10.1016/S0090-6980(00)00096-4; Gilroy DW, 2004, NAT REV DRUG DISCOV, V3, P401, DOI 10.1038/nrd1383; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Heise R, 2006, J INVEST DERMATOL, V126, P2473, DOI 10.1038/sj.jid.5700432; Honkakoski P, 2000, BIOCHEM J, V347, P321, DOI 10.1042/0264-6021:3470321; Kalsotra A, 2004, TOXICOL APPL PHARM, V199, P295, DOI 10.1016/j.taap.2003.12.033; Kalsotra A, 2003, FEBS LETT, V555, P236, DOI 10.1016/S0014-5793(03)01240-7; Kalsotra A, 2007, ARCH BIOCHEM BIOPHYS, V461, P104, DOI 10.1016/j.abb.2007.02.027; Kalsotra A, 2007, J CEREBR BLOOD F MET, V27, P963, DOI 10.1038/sj.jcbfm.9600396; Kalsotra A, 2006, PHARMACOL THERAPEUT, V112, P589, DOI 10.1016/j.pharmthera.2006.03.008; Kikuta Y, 2004, BBA-MOL CELL BIOL L, V1683, P7, DOI 10.1016/j.bbalip.2004.03.007; Kikuta Y, 2002, PROSTAG OTH LIPID M, V68-9, P345, DOI 10.1016/S0090-6980(02)00039-4; Kupper TS, 2004, NAT REV IMMUNOL, V4, P211, DOI 10.1038/nri1310; KUPPER TS, 1990, J CLIN INVEST, V86, P1783, DOI 10.1172/JCI114907; Ladd PA, 2003, J BIOL CHEM, V278, P35184, DOI 10.1074/jbc.M301666200; Le Quere V, 2004, J LIPID RES, V45, P1446, DOI 10.1194/jlr.M300463-JLR200; Lefevre C, 2006, HUM MOL GENET, V15, P767, DOI 10.1093/hmg/ddi491; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Merk HF, 2004, TOXICOL APPL PHARM, V195, P267, DOI 10.1016/j.taap.2003.09.023; MUKHTAR H, 1989, J INVEST DERMATOL, V93, P231, DOI 10.1111/1523-1747.ep12277578; Murphy RC, 2007, BIOCHEM J, V405, P379, DOI 10.1042/BJ20070289; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Nelson DR, 2004, PHARMACOGENETICS, V14, P1, DOI 10.1097/00008571-200401000-00001; Nigam S, 2005, BIOCHEM BIOPH RES CO, V338, P161, DOI 10.1016/j.bbrc.2005.09.065; Peters-Golden M, 2005, J IMMUNOL, V174, P589, DOI 10.4049/jimmunol.174.2.589; Quack M, 2002, J CELL BIOCHEM, V86, P601, DOI 10.1002/jcb.10247; Rizzo WB, 2005, HUM MUTAT, V26, P1, DOI 10.1002/humu.20181; SALMON JK, 1994, WESTERN J MED, V160, P146; Sanders RJ, 2006, J BIOL CHEM, V281, P13180, DOI 10.1074/jbc.M513481200; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Smith KJ, 2002, J CUTAN MED SURG, V6, P241, DOI 10.1007/s10227-001-0047-4; SOBERMAN RJ, 1988, J BIOL CHEM, V263, P7996; Sontag TJ, 2002, J BIOL CHEM, V277, P25290, DOI 10.1074/jbc.M201466200; Stark K, 2006, PROSTAG OTH LIPID M, V79, P114, DOI 10.1016/j.prostaglandins.2005.12.003; Stark K, 2005, ARCH BIOCHEM BIOPHYS, V441, P174, DOI 10.1016/j.abb.2005.07.003; Stark K, 2004, BASIC CLIN PHARMACOL, V94, P177; Stark K, 2003, ARCH BIOCHEM BIOPHYS, V409, P188, DOI 10.1016/S0003-9861(02)00511-8; Steinhoff M, 2001, CURR OPIN ALLERGY CL, V1, P469, DOI 10.1097/00130832-200110000-00014; Talas U, 2000, J INVEST DERMATOL, V114, P165, DOI 10.1046/j.1523-1747.2000.00825.x; Thacher SM, 2000, CURR PHARM DESIGN, V6, P25, DOI 10.2174/1381612003401415; Wang SK, 2000, J BIOL CHEM, V275, P40686, DOI 10.1074/jbc.M004512200; WHEELAN P, 1993, J BIOL CHEM, V268, P25439; Wheelan P, 1999, J PHARMACOL EXP THER, V288, P326; Winterfield L, 2003, CLIN DERMATOL, V21, P447, DOI 10.1016/j.clindermatol.2003.08.011; Xu FY, 2006, J PHARMACOL EXP THER, V318, P835, DOI 10.1124/jpet.106.104976; Yokomizo T, 2001, ARCH BIOCHEM BIOPHYS, V385, P231, DOI 10.1006/abbi.2000.2168; Yokomizo T, 2001, J BIOL CHEM, V276, P12454, DOI 10.1074/jbc.M011361200; Zhang XL, 2000, BIOCHEM BIOPH RES CO, V279, P864, DOI 10.1006/bbrc.2000.4020; Zouboulis CC, 2001, SKIN PHARMACOL APPL, V14, P303, DOI 10.1159/000056361	64	8	9	2	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	FEB	2008	22	2					538	547		10.1096/fj.07-9244com	http://dx.doi.org/10.1096/fj.07-9244com			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	257TY	17884973				2022-12-25	WOS:000252822600024
J	Harrigan, JA; Piotrowski, J; Di Noto, L; Levine, RL; Bohr, VA				Harrigan, Jeanine A.; Piotrowski, Jason; Di Noto, Luca; Levine, Rodney L.; Bohr, Vilhelm A.			Metal-catalyzed oxidation of the Werner syndrome protein causes loss of catalytic activities and impaired protein-protein interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIXED-FUNCTION OXIDATION; DNA-DAMAGE; BINDING-SITE; WRN PROTEIN; MECHANISM; HELICASE; COMPLEX; IRON; AGE; KU	Metal-catalyzed oxidation reactions target amino acids in the metal binding pocket of proteins. Such oxidation reactions generally result in either preferential degradation of the protein or accumulation of a catalytically inactive pool of protein with age. Consistently, levels of oxidized proteins have been shown to increase with age. The segmental, progeroid disorder Werner syndrome results from loss of the Werner syndrome protein (WRN). WRN is a member of the RecQ family of DNA helicases and possesses exonuclease and ATP-dependent helicase activities. Furthermore, each of the helicase and exonuclease domains of WRN contains a metal binding pocket. In this report we examined for metal-catalyzed oxidation of WRN in the presence of iron or copper. We found that WRN was oxidized in vitro by iron but not by copper. Iron-mediated oxidation resulted in the inhibition of both WRN helicase and exonuclease activities. Oxidation of WRN also inhibited binding to several known protein partners. In addition, we did not observe degradation of oxidized WRN by the 20 S proteasome in vitro. Finally, exposure of cells to hydrogen peroxide resulted in oxidation of WRN in vivo. Therefore, our results demonstrate that WRN undergoes metal-catalyzed oxidation in the presence of iron, and iron-mediated oxidation of WRN likely results in the accumulation of a catalytically inactive form of the protein, which may contribute to age-related phenotypes.	NIH, NIA, Lab Mol Gerontol, Baltimore, MD 21224 USA; NIH, NHLBI, Biochem Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Bohr, VA (corresponding author), NIH, NIA, Lab Mol Gerontol, 5600 Nathan Shock Dr, Baltimore, MD 21224 USA.	vbohr@nih.gov	Bohr, Vilhelm/AAP-5931-2020; Levine, Rodney L/D-9885-2011		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000225, Z01HL000225] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000726, ZIAAG000726] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Barlow C, 1999, P NATL ACAD SCI USA, V96, P9915, DOI 10.1073/pnas.96.17.9915; Bernstein DA, 2003, EMBO J, V22, P4910, DOI 10.1093/emboj/cdg500; Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1; Choudhary S, 2004, J BIOL CHEM, V279, P34603, DOI 10.1074/jbc.M401901200; Cooper MP, 2000, GENE DEV, V14, P907; Di Noto L, 2005, J BIOL CHEM, V280, P39907, DOI 10.1074/jbc.M506247200; EPSTEIN CJ, 1966, MEDICINE, V45, P177, DOI 10.1097/00005792-196605000-00001; FARBER JM, 1986, J BIOL CHEM, V261, P4574; Featherstone C, 1999, MUTAT RES-DNA REPAIR, V434, P3, DOI 10.1016/S0921-8777(99)00006-3; FRY DC, 1986, P NATL ACAD SCI USA, V83, P907, DOI 10.1073/pnas.83.4.907; FUCCI L, 1983, P NATL ACAD SCI-BIOL, V80, P1521, DOI 10.1073/pnas.80.6.1521; Gray MD, 1997, NAT GENET, V17, P100, DOI 10.1038/ng0997-100; Graziewicz MA, 2002, NUCLEIC ACIDS RES, V30, P2817, DOI 10.1093/nar/gkf392; Grune T, 2003, BIOCHEM BIOPH RES CO, V305, P709, DOI 10.1016/S0006-291X(03)00809-X; Karmakar P, 2002, NUCLEIC ACIDS RES, V30, P3583, DOI 10.1093/nar/gkf482; Levine RL, 2001, EXP GERONTOL, V36, P1495, DOI 10.1016/S0531-5565(01)00135-8; Li BM, 2001, J BIOL CHEM, V276, P9896, DOI 10.1074/jbc.M008575200; Luo S, 2006, ANAL BIOCHEM, V350, P233, DOI 10.1016/j.ab.2005.10.048; Machwe A, 2000, NUCLEIC ACIDS RES, V28, P2762, DOI 10.1093/nar/28.14.2762; McMurray MA, 2003, SCIENCE, V301, P1908, DOI 10.1126/science.1087706; MELLO AC, 1991, MUTAT RES, V251, P109, DOI 10.1016/0027-5107(91)90220-I; Meneghini R, 1997, FREE RADICAL BIO MED, V23, P783, DOI 10.1016/S0891-5849(97)00016-6; Mian IS, 1997, NUCLEIC ACIDS RES, V25, P3187, DOI 10.1093/nar/25.16.3187; Mushegian AR, 1997, P NATL ACAD SCI USA, V94, P5831, DOI 10.1073/pnas.94.11.5831; OLIVER CN, 1987, J BIOL CHEM, V262, P5488; Opresko PL, 2002, J BIOL CHEM, V277, P41110, DOI 10.1074/jbc.M205396200; Orren DK, 1999, NUCLEIC ACIDS RES, V27, P3557, DOI 10.1093/nar/27.17.3557; Pagano G, 2005, FREE RADICAL RES, V39, P529, DOI 10.1080/10715760500092683; Perry JJP, 2006, NAT STRUCT MOL BIOL, V13, P414, DOI 10.1038/nsmb1088; SANDSTROM BE, 1994, FREE RADICAL BIO MED, V16, P177, DOI 10.1016/0891-5849(94)90141-4; SHACTER E, 1995, FREE RADICAL BIO MED, V18, P815, DOI 10.1016/0891-5849(95)93872-4; Shen JC, 1998, J BIOL CHEM, V273, P34139, DOI 10.1074/jbc.273.51.34139; Sinclair DA, 2003, SCIENCE, V301, P1859, DOI 10.1126/science.1090465; Stadtman ER, 2000, ANN NY ACAD SCI, V899, P191; Stadtman ER, 1998, DRUG METAB REV, V30, P225, DOI 10.3109/03602539808996310; STADTMAN ER, 1990, FREE RADICAL BIO MED, V9, P315, DOI 10.1016/0891-5849(90)90006-5; Tuteja N, 2004, EUR J BIOCHEM, V271, P1849, DOI 10.1111/j.1432-1033.2004.04094.x; von Kobbe C, 2003, MOL CELL BIOL, V23, P8601, DOI 10.1128/MCB.23.23.8601-8613.2003; Williams AB, 1999, FASEB J, V13, P1435, DOI 10.1096/fasebj.13.11.1435	40	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36403	36411		10.1074/jbc.M706107200	http://dx.doi.org/10.1074/jbc.M706107200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17911100	hybrid			2022-12-25	WOS:000251458300032
J	Bagai, I; Liu, W; Rensing, C; Blackburn, NJ; McEvoy, MM				Bagai, Ireena; Liu, Wenbo; Rensing, Christopher; Blackburn, Ninian J.; McEvoy, Megan M.			Substrate-linked conformational change in the periplasmic component of a Cu(I)/Ag(I) efflux system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-FUSION PROTEIN; RAY-ABSORPTION SPECTROSCOPY; GRAM-NEGATIVE BACTERIA; CURVED-WAVE THEORY; ESCHERICHIA-COLI; DRUG EFFLUX; MULTIDRUG TRANSPORTER; COPPER HOMEOSTASIS; EXAFS CALCULATIONS; RESISTANCE	Gram-negative bacteria utilize dual membrane resistance nodulation division-type efflux systems to export a variety of substrates. These systems contain an essential periplasmic component that is important for assembly of the protein complex. We show here that the periplasmic protein CusB from the Cus copper/silver efflux system has a critical role in Cu(I) and Ag(I) binding. Isothermal titration calorimetry experiments demonstrate that one Ag(I) ion is bound per CusB molecule with high affinity. X-ray absorption spectroscopy data indicate that the metal environment is an all-sulfur 3-coordinate environment. Candidates for the metal-coordinating residues were identified from sequence analysis, which showed four conserved methionine residues. Mutations of three of these methionine residues to isoleucine resulted in significant effects on CusB metal binding in vitro. Cells containing these CusB variants also show a decrease in their ability to grow on copper-containing plates, indicating an important functional role for metal binding by CusB. Gel filtration chromatography demonstrates that upon binding metal, CusB undergoes a conformational change to a more compact structure. Based on these structural and functional effects of metal binding, we propose that the periplasmic component of resistance nodulation division-type efflux systems plays an active role in export through substrate-linked conformational changes.	Univ Arizona, Dept Biochem & Mol Biophys, Tucson, AZ 85721 USA; Univ Arizona, Dept Soil Water & Environm Sci, Tucson, AZ 85721 USA; Oregon Hlth & Sci Univ, Oregon Grad Inst Sci & Engn, Dept Environm & Biomol Syst, Beaverton, OR 97006 USA	University of Arizona; University of Arizona; Oregon Health & Science University	McEvoy, MM (corresponding author), Univ Arizona, Dept Biochem & Mol Biophys, 1041 E Lowell St, Tucson, AZ 85721 USA.	mcevoy@email.arizona.edu	Rensing, Christopher/D-3947-2011	Rensing, Christopher/0000-0002-5012-7953	NIGMS NIH HHS [GM079192, R01 GM079192, GM54803] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054803, R01GM079192] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aires JR, 2005, J BACTERIOL, V187, P1923, DOI 10.1128/JB.187.6.1923-1929.2005; Akama H, 2004, J BIOL CHEM, V279, P25939, DOI 10.1074/jbc.C400164200; Augustus AM, 2004, J BACTERIOL, V186, P1851, DOI 10.1128/JB.186.6.1851-1860.2004; Binsted N, 1996, J SYNCHROTRON RADIAT, V3, P185, DOI 10.1107/S0909049596005651; BINSTED N, 1998, EXCURVE 9 2; Blackburn NJ, 2000, BIOCHEMISTRY-US, V39, P2316, DOI 10.1021/bi992334a; Borges-Walmsley MI, 2003, J BIOL CHEM, V278, P12903, DOI 10.1074/jbc.M209457200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DINH T, 1994, J BACTERIOL, V176, P3825, DOI 10.1128/JB.176.13.3825-3831.1994; Eswaran J, 2004, CURR OPIN STRUC BIOL, V14, P741, DOI 10.1016/j.sbi.2004.10.003; Franke S, 2003, J BACTERIOL, V185, P3804, DOI 10.1128/JB.185.13.3804-3812.2003; Franke S, 2001, MICROBIOL-SGM, V147, P965, DOI 10.1099/00221287-147-4-965; George G. N., 1990, STANFORD SYNCHROTRON; Grass G, 2001, J BACTERIOL, V183, P2145, DOI 10.1128/JB.183.6.2145-2147.2001; GURMAN SJ, 1984, J PHYS C SOLID STATE, V17, P143, DOI 10.1088/0022-3719/17/1/019; GURMAN SJ, 1986, J PHYS C SOLID STATE, V19, P1845, DOI 10.1088/0022-3719/19/11/021; Higgins MK, 2004, P NATL ACAD SCI USA, V101, P9994, DOI 10.1073/pnas.0400375101; Ip H, 2003, J BIOL CHEM, V278, P50474, DOI 10.1074/jbc.M305152200; Jelesarov I, 1999, J MOL RECOGNIT, V12, P3, DOI 10.1002/(SICI)1099-1352(199901/02)12:1<3::AID-JMR441>3.0.CO;2-6; Kittleson JT, 2006, BIOCHEMISTRY-US, V45, P11096, DOI 10.1021/bi0612622; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lobedanz S, 2007, P NATL ACAD SCI USA, V104, P4612, DOI 10.1073/pnas.0610160104; MCROIE DK, 1993, SELF ASS SYSTEMS ANA, P1; Mikolosko J, 2006, STRUCTURE, V14, P577, DOI 10.1016/j.str.2005.11.015; Munkelt D, 2004, J BACTERIOL, V186, P8036, DOI 10.1128/JB.186.23.8036-8043.2004; Munson GP, 2000, J BACTERIOL, V182, P5864, DOI 10.1128/JB.182.20.5864-5871.2000; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Nikaido H, 1998, J BACTERIOL, V180, P4686, DOI 10.1128/JB.180.17.4686-4692.1998; Outten FW, 2001, J BIOL CHEM, V276, P30670, DOI 10.1074/jbc.M104122200; PICKERING IJ, 1993, J AM CHEM SOC, V115, P9498, DOI 10.1021/ja00074a014; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Poole K, 2004, CLIN MICROBIOL INFEC, V10, P12, DOI 10.1111/j.1469-0691.2004.00763.x; Poole Keith, 2001, Current Topics in Medicinal Chemistry, V1, P59, DOI 10.2174/1568026013395605; Ralle M, 2003, J BIOL CHEM, V278, P23163, DOI 10.1074/jbc.M303474200; Solioz M, 2002, BIOCHEM SOC T, V30, P688, DOI 10.1042/bst0300688; Thanabalu T, 1998, EMBO J, V17, P6487, DOI 10.1093/emboj/17.22.6487; Touze T, 2004, MOL MICROBIOL, V53, P697, DOI 10.1111/j.1365-2958.2004.04158.x; Tseng Tsai-Tien, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P107; Vaccaro L, 2006, BIOPHYS J, V91, P558, DOI 10.1529/biophysj.105.080010; Yang S, 2006, P NATL ACAD SCI USA, V103, P2386, DOI 10.1073/pnas.0502890102; Zgurskaya HI, 1999, J MOL BIOL, V285, P409, DOI 10.1006/jmbi.1998.2313; Zgurskaya HI, 2000, MOL MICROBIOL, V37, P219, DOI 10.1046/j.1365-2958.2000.01926.x	42	79	79	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35695	35702		10.1074/jbc.M703937200	http://dx.doi.org/10.1074/jbc.M703937200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17893146	hybrid			2022-12-25	WOS:000251458100030
J	Corradi, GR; Adamo, HP				Corradi, Gerardo R.; Adamo, Hugo P.			Intramolecular fluorescence resonance energy transfer between fused autofluorescent proteins reveals rearrangements of the N- and C-terminal segments of the plasma membrane Ca2+ pump involved in the activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALMODULIN-BINDING DOMAIN; CALCIUM-PUMP; ERYTHROCYTE CA-2+-ATPASE; MONOCLONAL-ANTIBODIES; CATALYTIC CORE; ISOFORM 4B; SITE; INTERACTS; REGION; OLIGOMERIZATION	The blue and green fluorescent proteins (BFP and GFP) have been fused at the N- and C-terminal ends, respectively, of the plasma membrane Ca2+ pump (PMCA) isoform 4xb (hPMCA4xb). The fusion protein was successfully expressed in yeast and purified by calmodulin affinity chromatography. Despite the presence of the fused autofluorescent proteins BFP-PMCA-GFP performed similarly to the wild-type enzyme with respect to Ca2+-ATPase activity and sensitivity to calmodulin activation. In the autoinhibited state BFP-PMCA-GFP exhibited a significant intramolecular fluorescence resonance energy transfer (FRET) consistent with the location of the fluorophores at an average distance of 45 angstrom. The FRET intensity in BFP-PMCA-GFP decreased when the enzyme was activated either by Ca2+-calmodulin, partial proteolysis, or acidic lipids. Moreover, FRET decreased and became insensitive to calmodulin when hPMCA4xb was activated by mutation D170N in BFP-PMCA(D170N)-GFP. The results suggest that the ends of the PMCA are in close proximity in the autoinhibited conformation, and they separate or reorient when the PMCA achieves its final activated conformation.	Univ Buenos Aires, Fac Farm & Bioquim, IQUIFIB, RA-1113 Buenos Aires, DF, Argentina	University of Buenos Aires	Adamo, HP (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, IQUIFIB, Junin 956, RA-1113 Buenos Aires, DF, Argentina.	hpadamo@qb.ffyb.uba.ar	Adamo, Hugo Pedro/ABB-8338-2021	Adamo, Hugo Pedro/0000-0002-1712-8049; Corradi, Gerardo Raul/0000-0003-0354-7709				Adamo HP, 1998, BIOCHEM J, V331, P763, DOI 10.1042/bj3310763; Adamo HP, 2000, BIOCHEMISTRY-US, V39, P14893, DOI 10.1021/bi001222c; ADAMO HP, 1992, J BIOL CHEM, V267, P14244; Adamo HP, 2000, BBA-BIOMEMBRANES, V1464, P127, DOI 10.1016/S0005-2736(99)00253-9; AXELSEN KB, 1998, BIOCHIM BIOPHYS ACTA, V1365, P37; Bauer A, 1996, YEAST, V12, P965, DOI 10.1002/(SICI)1097-0061(199608)12:10<965::AID-YEA999>3.0.CO;2-Q; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bredeston LM, 2004, J BIOL CHEM, V279, P41619, DOI 10.1074/jbc.M403116200; Brini M, 2003, J BIOL CHEM, V278, P24500, DOI 10.1074/jbc.M300784200; BRODIN P, 1992, EUR J BIOCHEM, V204, P939, DOI 10.1111/j.1432-1033.1992.tb16715.x; Buch-Pedersen MJ, 2000, J BIOL CHEM, V275, P39167, DOI 10.1074/jbc.M007537200; Caride AJ, 1996, BIOCHEM J, V316, P353, DOI 10.1042/bj3160353; COELHOSAMPAIO T, 1991, J BIOL CHEM, V266, P22266; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; ENYEDI A, 1989, J BIOL CHEM, V264, P12313; Enyedi A, 1996, J BIOL CHEM, V271, P32461, DOI 10.1074/jbc.271.50.32461; ENYEDI A, 1994, J BIOL CHEM, V269, P41; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; FALCHETTO R, 1992, PROTEIN SCI, V1, P1613, DOI 10.1002/pro.5560011209; FALCHETTO R, 1991, BIOL CHEM, V266, P2930; FILOTEO AG, 1992, J BIOL CHEM, V267, P11800; GLYNN IM, 1964, BIOCHEM J, V90, P147, DOI 10.1042/bj0900147; HAO LN, 1994, J BIOL CHEM, V269, P14268; Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135; Kobe B, 1999, NATURE, V402, P373, DOI 10.1038/46478; KOSKKOSICKA D, 1988, J BIOL CHEM, V263, P18184; KOSKKOSICKA D, 1989, J BIOL CHEM, V264, P19495; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lakowicz J.R., 2010, PRINCIPLE FLUORESCEN, DOI 10.1007/978-0-387-46312-4/COVER; Levi V, 2002, BIOPHYS J, V82, P437, DOI 10.1016/S0006-3495(02)75408-8; MAGOCSI M, 1991, BIOCHIM BIOPHYS ACTA, V1063, P7, DOI 10.1016/0005-2736(91)90346-A; Mitra RD, 1996, GENE, V173, P13, DOI 10.1016/0378-1119(95)00768-7; Padanyi R, 2003, J BIOL CHEM, V278, P35798, DOI 10.1074/jbc.M305794200; Paszty K, 2002, J BIOL CHEM, V277, P36146, DOI 10.1074/jbc.M205457200; Penheiter AR, 2003, BIOCHEMISTRY-US, V42, P12115, DOI 10.1021/bi027098+; Penniston JT, 1998, J MEMBRANE BIOL, V165, P101, DOI 10.1007/s002329900424; Pinto FD, 2006, FEBS LETT, V580, P1576, DOI 10.1016/j.febslet.2006.01.088; REMEDIOS D, 1995, J STRUCT BIOL, V115, P175; RICHARDS DE, 1978, BIOCHIM BIOPHYS ACTA, V511, P194, DOI 10.1016/0005-2736(78)90313-9; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Strehler EE, 2004, CURR MOL MED, V4, P323, DOI 10.2174/1566524043360735; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Verma AK, 1996, J BIOL CHEM, V271, P3714	44	37	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35440	35448		10.1074/jbc.M703377200	http://dx.doi.org/10.1074/jbc.M703377200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17901055	hybrid			2022-12-25	WOS:000251458100003
J	Li, Y; Wang, Y; Kim, EJ; Beemiller, P; Wang, CY; Swanson, J; You, M; Guan, KL				Li, Yong; Wang, Yian; Kim, Eunjung; Beemiller, Peter; Wang, Cun-Yu; Swanson, Joel; You, Ming; Guan, Kun-Liang			Bnip3 mediates the hypoxia-induced inhibition on mammalian target of rapamycin by interacting with rheb	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; TUMOR-SUPPRESSOR COMPLEX; S6 KINASE ACTIVATION; RICTOR-MTOR COMPLEX; CELL-GROWTH CONTROL; SMALL GTPASE RHEB; TSC2 GAP ACTIVITY; TUBEROUS-SCLEROSIS; PANCREATIC-CANCER; TRANSMEMBRANE DOMAIN	The mammalian target of rapamycin (mTOR) is a central controller of cell growth, and it regulates translation, cell size, cell viability, and cell morphology. mTOR integrates a wide range of extracellular and intracellular signals, including growth factors, nutrients, energy levels, and stress conditions. Rheb, a Ras-related small GTPase, is a key upstream activator of mTOR. In this study, we found that Bnip3, a hypoxia-inducible Bcl-2 homology 3 domain-containing protein, directly binds Rheb and inhibits the mTOR pathway. Bnip3 decreases Rheb GTP levels in a manner depending on the binding to Rheb and the presence of the N-terminal domain. Both knockdown and overexpression experiments show that Bnip3 plays an important role in mTOR inactivation in response to hypoxia. Moreover, Bnip3 inhibits cell growth in vivo by suppressing the mTOR pathway. These observations demonstrate that Bnip3 mediates the inhibition of the mTOR pathway in response to hypoxia.	Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Inst Gerontol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; Washington Univ, Sch Med, Alvin J Siteman Canc Ctr, St Louis, MO 63110 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL)	Guan, KL (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	kunliang@umich.edu	Swanson, Joel A/P-4362-2014; Guan, Kun-Liang/ADK-7088-2022	Swanson, Joel A/0000-0003-0900-8212; Beemiller, Peter/0000-0002-2736-3405	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035950, R01AI064668] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI035950, R01 AI035950-14, R01 AI064668-03, R01 AI064668] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abe T, 2005, J GASTROENTEROL, V40, P504, DOI 10.1007/s00535-005-1576-1; Arsham AM, 2003, J BIOL CHEM, V278, P29655, DOI 10.1074/jbc.M212770200; Aspuria PJ, 2004, CELL SIGNAL, V16, P1105, DOI 10.1016/j.cellsig.2004.03.019; Beemiller P, 2006, PLOS BIOL, V4, P987, DOI 10.1371/journal.pbio.0040162; BOYD JM, 1994, CELL, V79, P341, DOI 10.1016/0092-8674(94)90202-X; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Bruick RK, 2000, P NATL ACAD SCI USA, V97, P9082, DOI 10.1073/pnas.97.16.9082; Castro AF, 2003, J BIOL CHEM, V278, P32493, DOI 10.1074/jbc.C300226200; Chen G, 1997, J EXP MED, V186, P1975, DOI 10.1084/jem.186.12.1975; Chen G, 1999, J BIOL CHEM, V274, P7, DOI 10.1074/jbc.274.1.7; Clark GJ, 1997, J BIOL CHEM, V272, P10608; Corradetti MN, 2005, J BIOL CHEM, V280, P9769, DOI 10.1074/jbc.C400557200; Daido S, 2004, CANCER RES, V64, P4286, DOI 10.1158/0008-5472.CAN-03-3084; Dan HC, 2002, J BIOL CHEM, V277, P35364, DOI 10.1074/jbc.M205838200; Erkan M, 2005, ONCOGENE, V24, P4421, DOI 10.1038/sj.onc.1208642; Eshleman JS, 2002, CANCER RES, V62, P7291; Figueroa C, 2001, J BIOL CHEM, V276, P28219, DOI 10.1074/jbc.M101763200; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Giatromanolaki A, 2004, CLIN CANCER RES, V10, P5566, DOI 10.1158/1078-0432.CCR-04-0076; Goncharova EA, 2002, J BIOL CHEM, V277, P30958, DOI 10.1074/jbc.M202678200; Guo K, 2001, CELL DEATH DIFFER, V8, P367, DOI 10.1038/sj.cdd.4400810; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hoppe A, 2002, BIOPHYS J, V83, P3652, DOI 10.1016/S0006-3495(02)75365-4; Inoki K, 2006, TRENDS CELL BIOL, V16, P206, DOI 10.1016/j.tcb.2006.02.002; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2005, MICROBIOL MOL BIOL R, V69, P79, DOI 10.1128/MMBR.69.1.79-100.2005; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim JY, 2002, ARCH BIOCHEM BIOPHYS, V398, P147, DOI 10.1006/abbi.2001.2673; Kwiatkowski DJ, 2003, ANN HUM GENET, V67, P87, DOI 10.1046/j.1469-1809.2003.00012.x; Lee H, 2006, MOL CELLS, V21, P1; Li Y, 2004, MOL CELL BIOL, V24, P7965, DOI 10.1128/MCB.24.18.7965-7975.2004; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Long XM, 2005, J BIOL CHEM, V280, P23433, DOI 10.1074/jbc.C500169200; Manka D, 2005, CANCER RES, V65, P11689, DOI 10.1158/0008-5472.CAN-05-3091; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Manning BD, 2003, TRENDS BIOCHEM SCI, V28, P573, DOI 10.1016/j.tibs.2003.09.003; Matsushima M, 1998, GENE CHROMOSOME CANC, V21, P230, DOI 10.1002/(SICI)1098-2264(199803)21:3<230::AID-GCC7>3.0.CO;2-0; Murai M, 2005, BRIT J CANCER, V92, P1165, DOI 10.1038/sj.bjc.6602422; Murai M, 2005, CLIN CANCER RES, V11, P1021; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Okami J, 2004, CANCER RES, V64, P5338, DOI 10.1158/0008-5472.CAN-04-0089; Ray R, 2000, J BIOL CHEM, V275, P1439, DOI 10.1074/jbc.275.2.1439; Reiling JH, 2004, GENE DEV, V18, P2879, DOI 10.1101/gad.322704; Roccio M, 2006, ONCOGENE, V25, P657, DOI 10.1038/sj.onc.1209106; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Sowter HM, 2001, CANCER RES, V61, P6669; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Sulistijo ES, 2006, J MOL BIOL, V364, P974, DOI 10.1016/j.jmb.2006.09.065; Sulistijo ES, 2003, J BIOL CHEM, V278, P51950, DOI 10.1074/jbc.M308429200; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Urano J, 2005, MOL MICROBIOL, V58, P1074, DOI 10.1111/j.1365-2958.2005.04877.x; Vande Velde C, 2000, MOL CELL BIOL, V20, P5454, DOI 10.1128/MCB.20.15.5454-5468.2000; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Webster KA, 2005, J MOL CELL CARDIOL, V38, P35, DOI 10.1016/j.yjmcc.2004.11.007; WENG QP, 1995, MOL CELL BIOL, V15, P2333; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang Q, 2006, P NATL ACAD SCI USA, V103, P6811, DOI 10.1073/pnas.0602282103; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Yasuda M, 1998, ONCOGENE, V17, P2525, DOI 10.1038/sj.onc.1202467; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	71	201	207	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35803	35813		10.1074/jbc.M705231200	http://dx.doi.org/10.1074/jbc.M705231200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17928295	hybrid			2022-12-25	WOS:000251458100042
J	Martin, KA; Merenick, BL; Ding, M; Fetalvero, KM; Rzucidlo, EM; Kozul, CD; Brown, DJ; Chiu, HY; Shyu, M; Drapeau, BL; Wagner, RJ; Powell, RJ				Martin, Kathleen A.; Merenick, Bethany L.; Ding, Min; Fetalvero, Kristina M.; Rzucidlo, Eva M.; Kozul, Courtney D.; Brown, David J.; Chiu, Helen Y.; Shyu, Maureen; Drapeau, Bethany L.; Wagner, Robert J.; Powell, Richard J.			Rapamycin promotes vascular smooth muscle cell differentiation through insulin receptor substrate-1/phosphatidylinositol 3-kinase/Akt2 feedback signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELUTING STENTS; AMINO-ACID; RESISTANCE; PHENOTYPE; PATHWAY; GROWTH; SIROLIMUS; ROLES; AKT2; PROLIFERATION	The phenotypic plasticity of mature vascular smooth muscle cells (VSMCs) facilitates angiogenesis and wound healing, but VSCM dedifferentiation also contributes to vascular pathologies such as intimal hyperplasia. Insulin/insulin-like growth factor I(IGF-I) is unique among growth factors in promoting VSMC differentiation via preferential activation of phosphatidylinositol 3-kinase (PI3K) and Akt. We have previously reported that rapamycin promotes VSMC differentiation by inhibiting the mammalian target of rapamycin (mTOR) target S6K1. Here, we show that rapamycin activates Akt and induces contractile protein expression in human VSMC in an insulin-like growth factor I-dependent manner, by relieving S6K1-dependent negative regulation of insulin receptor substrate-1 (IRS-1). In skeletal muscle and adipocytes, rapamycin relieves mTOR/S6K1-dependent inhibitory phosphorylation of IRS-1, thus preventing IRS-1 degradation and enhancing PI3K activation. We report that this mechanism is functional in VSMCs and crucial for rapamycin-induced differentiation. Rapamycin inhibits S6K1-dependent IRS-1 serine phosphorylation, increases IRS-1 protein levels, and promotes association of tyrosine-phosphorylated IRS-1 with PI3K. A rapamycin-resistant S6K1 mutant prevents rapamycin-induced Akt activation and VSMC differentiation. Notably, we find that rapamycin selectively activates only the Akt2 isoform and that Akt2, but not Akt1, is sufficient to induce contractile protein expression. Akt2 is required for rapamycin-induced VSMC differentiation, whereas Akt1 appears to oppose contractile protein expression. The anti-restenotic effect of rapamycin in patients may be attributable to this unique pattern of PI3K effector regulation wherein anti-differentiation signals from S6K1 are inhibited, but pro-differentiation Akt2 activity is promoted through an IRS-1 feedback signaling mechanism.	Dartmouth Med Sch, Div Vasc Surg, Lebanon, NH 03756 USA; Dartmouth Med Sch, Dept Pharmacol & Toxicol, Lebanon, NH 03756 USA	Dartmouth College; Dartmouth College	Martin, KA (corresponding author), Dartmouth Hitchcock Med Ctr, Div Vasc Surg, 1 Med Ctr Dr, Lebanon, NH 03756 USA.	Kathleen.A.Martin@Dartmouth.edu		Martin, Kathleen/0000-0002-1748-0034	NATIONAL CANCER INSTITUTE [T32CA009658] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL071905, R01HL076612] Funding Source: NIH RePORTER; NCI NIH HHS [CA09658] Funding Source: Medline; NHLBI NIH HHS [5K08HL71905-3, R01 HL76612] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bae SS, 2003, J BIOL CHEM, V278, P49530, DOI 10.1074/jbc.M306782200; Brown DJ, 2005, J VASC SURG, V41, P509, DOI 10.1016/j.jvs.2004.12.024; Calera MR, 1998, J BIOL CHEM, V273, P7201, DOI 10.1074/jbc.273.13.7201; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Dibra A, 2005, NEW ENGL J MED, V353, P663, DOI 10.1056/NEJMoa044372; Duan C, 2000, CIRC RES, V86, P15, DOI 10.1161/01.RES.86.1.15; Eisenberg MJ, 2006, AM J CARDIOL, V98, P375, DOI 10.1016/j.amjcard.2006.02.042; Fetalvero KM, 2006, AM J PHYSIOL-HEART C, V290, pH1337, DOI 10.1152/ajpheart.00936.2005; Greene MW, 2002, BIOCHEMISTRY-US, V41, P7082, DOI 10.1021/bi015992f; Harrington LS, 2005, TRENDS BIOCHEM SCI, V30, P35, DOI 10.1016/j.tibs.2004.11.003; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hayashi K, 2004, J BIOL CHEM, V279, P40807, DOI 10.1074/jbc.M405100200; Hayashi K, 1998, J BIOL CHEM, V273, P28860, DOI 10.1074/jbc.273.44.28860; Hayashi K, 1999, J CELL BIOL, V145, P727, DOI 10.1083/jcb.145.4.727; Hixon ML, 2000, J CLIN INVEST, V106, P1011, DOI 10.1172/JCI8252; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Liu L, 2006, ONCOGENE, V25, P7029, DOI 10.1038/sj.onc.1209691; Liu ZP, 2005, DEV CELL, V9, P261, DOI 10.1016/j.devcel.2005.05.017; Martin KA, 2004, AM J PHYSIOL-CELL PH, V286, pC507, DOI 10.1152/ajpcell.00201.2003; Martin KA, 2002, ADV CANCER RES, V86, P1, DOI 10.1016/S0065-230X(02)86001-8; MARX SO, 1995, CIRC RES, V76, P412, DOI 10.1161/01.RES.76.3.412; Moliterno DJ, 2005, NEW ENGL J MED, V353, P724, DOI 10.1056/NEJMe058140; Ohkawa Y, 2003, BIOCHEM BIOPH RES CO, V301, P78, DOI 10.1016/S0006-291X(02)02965-0; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Ozes ON, 2001, P NATL ACAD SCI USA, V98, P4640, DOI 10.1073/pnas.051042298; Poon M, 1996, J CLIN INVEST, V98, P2277, DOI 10.1172/JCI119038; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193; Tremblay F, 2005, DIABETES, V54, P2674, DOI 10.2337/diabetes.54.9.2674; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; Yang ZZ, 2003, J BIOL CHEM, V278, P32124, DOI 10.1074/jbc.M302847200; Zhang HB, 2007, J CLIN INVEST, V117, P730, DOI 10.1172/JCI28984; Zhou GL, 2006, J BIOL CHEM, V281, P36443, DOI 10.1074/jbc.M600788200	39	109	117	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					36112	36120		10.1074/jbc.M703914200	http://dx.doi.org/10.1074/jbc.M703914200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17908691	hybrid			2022-12-25	WOS:000251458100070
J	Woloszynek, JC; Coleman, T; Semenkovich, CF; Sands, MS				Woloszynek, Josh C.; Coleman, Trey; Semenkovich, Clay F.; Sands, Mark S.			Lysosomal dysfunction results in altered energy balance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUCOPOLYSACCHARIDOSIS TYPE-VII; NEURONAL CEROID-LIPOFUSCINOSIS; MOUSE MODEL; MICE; FAT; DEFICIENCY; AUTOPHAGY; STORAGE; GENE	The mucopolysaccharidosis (MPS) type VII mouse was originally described as the adipose storage deficiency mouse because of its extreme lean phenotype of unknown etiology. Here, we show that adipose storage deficiency and lower leptin levels are common to five different lysosomal storage diseases (LSDs): MPSI, MPSIIIB, MPSVII, Niemann-Pick type A/B, and infantile neuronal ceroid lipofuscinosis. Elevated circulating pro-inflammatory proteins (VCAM1 and MCP1) were found in multiple LSDs. Multiple anti-inflammatory strategies (dexamethasone, MCP1 deficiency, M3 expression) failed to alter adiposity in LSD animals. All of the models had normal or greater caloric intake and lower to normal metabolic rate, fasting plasma glucose, non-esterified fatty acids, cholesterol, and triglycerides. Triglycerides were lower in the livers of MPSI mice, and the trend was lower in the muscle. Lipid absorption and processing in MPSI mice were indistinguishable from those in normal mice following oral gavage of olive oil. The increased lean mass of MPSI and MPSIIIB mice suggests a shift in adipose triglycerides to lysosomal storage. In agreement, MPSI livers had a similar total caloric content but reduced caloric density, indicating a shift in energy from lipids to proteins/carbohydrates (lysosomal storage). Enzyme replacement therapy normalized the caloric density within 48 h without reducing total caloric content. This was due to an increase in lipids. Recycling of stored material is likely reduced or nonexistent. Therefore, to maintain homeostasis, energy is likely diverted to synthesis at the expense of typical energy storage depots. Thus, these diseases will serve as important tools in studying the role of lysosome function in metabolism and obesity.	Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Sands, MS (corresponding author), Washington Univ, Sch Med, Dept Med, 660 S Euclid Ave, St Louis, MO 63110 USA.	msands@im.wustl.edu		Sands, Mark/0000-0002-5559-0832; Semenkovich, Clay/0000-0003-1163-1871	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL083762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057586, P30DK056341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043205, R56NS043205] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL083762] Funding Source: Medline; NIDDK NIH HHS [DK56341, P30 DK056341, DK57586, P30 DK056341-06, P30 DK056341-07] Funding Source: Medline; NINDS NIH HHS [NS043205] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BEAMER WG, 1982, MOUSE NEWSLETT, V67, P21; Bernal-Mizrachi C, 2002, ARTERIOSCL THROM VAS, V22, P961, DOI 10.1161/01.ATV.0000019404.65403.71; Bijvelds MJC, 2005, AM J PHYSIOL-GASTR L, V288, pG646, DOI 10.1152/ajpgi.00295.2004; BIRKENMEIER EH, 1989, J CLIN INVEST, V83, P1258, DOI 10.1172/JCI114010; Cao Y, 2006, J BIOL CHEM, V281, P20483, DOI 10.1074/jbc.M602180200; Cuervo AM, 2004, MOL CELL BIOCHEM, V263, P55, DOI 10.1023/B:MCBI.0000041848.57020.57; Du H, 1998, HUM MOL GENET, V7, P1347, DOI 10.1093/hmg/7.9.1347; Du H, 2005, AM J ROENTGENOL, V184, P658, DOI 10.2214/ajr.184.2.01840658; Du H, 2001, J LIPID RES, V42, P489; Frisella WA, 2001, MOL THER, V3, P351, DOI 10.1006/mthe.2001.0274; Gerhardt CC, 2001, MOL CELL ENDOCRINOL, V175, P81, DOI 10.1016/S0303-7207(01)00394-X; Hofmann SL, 1997, NEUROPEDIATRICS, V28, P27, DOI 10.1055/s-2007-973661; Reitman ML, 2002, ANNU REV NUTR, V22, P459, DOI 10.1146/annurev.nutr.22.010402.102849; SANDS MS, 1993, P NATL ACAD SCI USA, V90, P6567, DOI 10.1073/pnas.90.14.6567; SANDS MS, 1994, J CLIN INVEST, V93, P2324, DOI 10.1172/JCI117237; Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100; Scriver CR, 2001, METABOLIC MOL BASES, V8, P3371; Vellodi A, 2005, BRIT J HAEMATOL, V128, P413, DOI 10.1111/j.1365-2141.2004.05293.x; [No title captured]	19	57	58	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35765	35771		10.1074/jbc.M705124200	http://dx.doi.org/10.1074/jbc.M705124200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17911106	hybrid			2022-12-25	WOS:000251458100038
J	Fan, X; Liu, YH; Smith, D; Konermann, L; Siu, KWM; Golemi-Kotra, D				Fan, Xin; Liu, Yuhong; Smith, Daryl; Konermann, Lars; Siu, K. W. Michael; Golemi-Kotra, Dasantila			Diversity of penicillin-binding proteins - Resistance factor FmtA of Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-LACTAM ANTIBIOTICS; LEVEL METHICILLIN RESISTANCE; BACTERIAL-CELL WALL; DRUG-RESISTANCE; SIGNALING PATHWAY; DD-PEPTIDASES; SWISS-MODEL; GENE; MECHANISM; CLONING	Antibiotic-resistant Staphylococcus aureus is a major concern to public health. Methicillin-resistant S. aureus strains are completely resistant to all beta-lactams antibiotics. One of the main factors involved in methicillin resistance in S. aureus is the penicillin-binding protein, PBP2a. This protein is insensitive to inactivation by beta-lactam antibiotics such as methicillin. Although other proteins are implicated in high and homogeneous levels of methicillin resistance, the functions of these other proteins remain elusive. Herein, we report for the first time on the putative function of one of these proteins, FmtA. This protein specifically interacts with beta-lactam antibiotics forming covalently bound complexes. The serine residue present in the sequence motif Ser-X-X-Lys (which is conserved among penicillin-binding proteins and beta-lactamases) is the active-site nucleophile during the formation of acyl-enzyme species. FmtA has a low binding affinity for beta-lactams, and it experiences a slow acylation rate, suggesting that this protein is intrinsically resistant to beta-lactam inactivation. We found that FmtA undergoes conformational changes in presence of beta-lactams that may be essential to the beta-lactam resistance mechanism. FmtA binds to peptidoglycan in vitro. Our findings suggest that FmtA is a penicillin-binding protein, and as such, it may compensate for suppressed peptidoglycan biosynthesis under beta-lactam induced cell wall stress conditions.	York Univ, Dept Chem, Toronto, ON M3J 1P3, Canada; York Univ, Ctr Res Mass Spectrometry, Toronto, ON M3J 1P3, Canada; Univ Western Ontario, Dept Chem, London, ON N6A 5B7, Canada	York University - Canada; York University - Canada; Western University (University of Western Ontario)	Golemi-Kotra, D (corresponding author), York Univ, Dept Chem, Toronto, ON M3J 1P3, Canada.	dgkotra@yorku.ca	/N-6611-2013	/0000-0003-1299-6987				ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; Amyes SGB, 2005, BRIT MED J, V330, P976, DOI 10.1136/bmj.330.7498.976; Barrett D, 2005, J BACTERIOL, V187, P2215, DOI 10.1128/JB.187.6.2215-2217.2005; Berger-Bachi B, 1999, CELL MOL LIFE SCI, V56, P764, DOI 10.1007/s000180050023; Berger-Bachi B, 1998, DRUG RESIST UPDATE, V1, P325, DOI 10.1016/S1368-7646(98)80048-4; Berger-Bachi B, 2002, ARCH MICROBIOL, V178, P165, DOI 10.1007/s00203-002-0436-0; BERGERBACHI B, 1992, ANTIMICROB AGENTS CH, V36, P1367, DOI 10.1128/AAC.36.7.1367; Chambers HF, 2001, EMERG INFECT DIS, V7, P178, DOI 10.3201/eid0702.010204; Chambers HF, 1997, CLIN MICROBIOL REV, V10, P781, DOI 10.1128/CMR.10.4.781; COX RA, 1995, J HOSP INFECT, V29, P107, DOI 10.1016/0195-6701(95)90192-2; CROSSLEY K, 1979, J INFECT DIS, V139, P280, DOI 10.1093/infdis/139.3.280; DEJONGE BLM, 1992, J BIOL CHEM, V267, P11248; DELENCASTRE H, 1994, J ANTIMICROB CHEMOTH, V33, P7, DOI 10.1093/jac/33.1.7; DELENCASTRE H, 1994, ANTIMICROB AGENTS CH, V38, P2590, DOI 10.1128/AAC.38.11.2590; DUBUS A, 1994, BIOCHEM J, V301, P485, DOI 10.1042/bj3010485; EFTINK MR, 1976, BIOCHEMISTRY-US, V15, P672, DOI 10.1021/bi00648a035; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fitzgerald JR, 2001, P NATL ACAD SCI USA, V98, P8821, DOI 10.1073/pnas.161098098; Fuda C, 2004, J BIOL CHEM, V279, P40802, DOI 10.1074/jbc.M403589200; Fuda CCS, 2005, CELL MOL LIFE SCI, V62, P2617, DOI 10.1007/s00018-005-5148-6; Gee KR, 2001, ELECTROPHORESIS, V22, P960, DOI 10.1002/1522-2683()22:5<960::AID-ELPS960>3.0.CO;2-9; GEORGOPAPADAKOU NH, 1980, ANTIMICROB AGENTS CH, V18, P834, DOI 10.1128/AAC.18.5.834; Goffin C, 2002, MICROBIOL MOL BIOL R, V66, P702, DOI 10.1128/MMBR.66.4.702-738.2002; Goffin C, 1998, MICROBIOL MOL BIOL R, V62, P1079, DOI 10.1128/MMBR.62.4.1079-1093.1998; Golemi-Kotra D, 2003, J BIOL CHEM, V278, P18419, DOI 10.1074/jbc.M300611200; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Howe RA, 2004, LANCET, V364, P500, DOI 10.1016/S0140-6736(04)16803-7; Howe RA, 2004, EMERG INFECT DIS, V10, P855, DOI 10.3201/eid1005.030556; Hujer AM, 2005, ANTIMICROB AGENTS CH, V49, P612, DOI 10.1128/AAC.49.2.612-618.2005; JACOB F, 1990, PROTEIN ENG, V4, P79, DOI 10.1093/protein/4.1.79; JACOB F, 1990, BIOCHEM J, V271, P399, DOI 10.1042/bj2710399; Komatsuzawa H, 1999, ANTIMICROB AGENTS CH, V43, P2121, DOI 10.1128/AAC.43.9.2121; Komatsuzawa H, 2000, FEMS MICROBIOL LETT, V188, P35, DOI 10.1016/S0378-1097(00)00194-4; Komatsuzawa H, 2000, J ANTIMICROB CHEMOTH, V45, P421, DOI 10.1093/jac/45.4.421; Komatsuzawa H, 1997, ANTIMICROB AGENTS CH, V41, P2355, DOI 10.1128/AAC.41.11.2355; Komatsuzawa H, 2001, FEMS MICROBIOL LETT, V203, P49, DOI 10.1111/j.1574-6968.2001.tb10819.x; KRAULIS PJ, 1991, SCIENCE, V254, P581, DOI 10.1126/science.1658931; Kuroda M, 2003, MOL MICROBIOL, V49, P807, DOI 10.1046/j.1365-2958.2003.03599.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lakowicz J. R., 1991, TOPICS FLUORESCENCE; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lamotte-Brasseur J, 2000, PROTEINS, V40, P23, DOI 10.1002/(SICI)1097-0134(20000701)40:1<23::AID-PROT40>3.0.CO;2-7; Lee M, 2003, J AM CHEM SOC, V125, P16322, DOI 10.1021/ja038445l; Leski TA, 2005, J BACTERIOL, V187, P1815, DOI 10.1128/JB.187.5.1815-1824.2005; Lim D, 2002, NAT STRUCT BIOL, V9, P870, DOI 10.1038/nsb858; Lim SM, 2005, ANAESTHESIA, V60, P887, DOI 10.1111/j.1365-2044.2005.04220.x; Lowy FD, 2003, J CLIN INVEST, V111, P1265, DOI 10.1172/JC1200318535; Macheboeuf P, 2006, FEMS MICROBIOL REV, V30, P673, DOI 10.1111/j.1574-6976.2006.00024.x; MAKI H, 1994, J BACTERIOL, V176, P4993, DOI 10.1128/jb.176.16.4993-5000.1994; McAleese F, 2006, J BACTERIOL, V188, P1120, DOI 10.1128/JB.188.3.1120-1133.2006; McCallum N, 2006, BBA-GEN SUBJECTS, V1760, P1475, DOI 10.1016/j.bbagen.2006.06.008; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; MONNAIE D, 1994, BIOCHEMISTRY-US, V33, P5193, DOI 10.1021/bi00183a024; MORENO F, 1995, CLIN INFECT DIS, V21, P1308, DOI 10.1093/clinids/21.5.1308; MURAKAMI K, 1989, J BACTERIOL, V171, P874, DOI 10.1128/jb.171.2.874-879.1989; Mwangi MM, 2007, P NATL ACAD SCI USA, V104, P9451, DOI 10.1073/pnas.0609839104; *NOV, 2006, PET SYST MAN, P63; Pagliero E, 2004, ANTIMICROB AGENTS CH, V48, P1848, DOI 10.1128/AAC.48.5.1848-1855.2004; Pinho MG, 2001, P NATL ACAD SCI USA, V98, P10886, DOI 10.1073/pnas.191260798; Pinho MG, 2001, J BACTERIOL, V183, P6525, DOI 10.1128/JB.183.22.6525-6531.2001; REYNOLDS P, 1988, ANTIBIOTICS INHIBITI; Said-Salim B, 2003, INFECT CONT HOSP EP, V24, P451, DOI 10.1086/502231; SARAVOLATZ LD, 1982, ANN INTERN MED, V97, P325, DOI 10.7326/0003-4819-97-3-325; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Scheffers DJ, 2005, MICROBIOL MOL BIOL R, V69, P585, DOI 10.1128/MMBR.69.4.585-607.2005; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shin I, 2002, PROTEIN SCI, V11, P2022, DOI 10.1110/ps.0205102; Silvaggi NR, 2003, BIOCHEMISTRY-US, V42, P1199, DOI 10.1021/bi0268955; Ursinus A, 2004, J BACTERIOL, V186, P6728, DOI 10.1128/JB.186.20.6728-6737.2004; Utaida S, 2003, MICROBIOL-SGM, V149, P2719, DOI 10.1099/mic.0.26426-0; Wada A, 1998, J BACTERIOL, V180, P2759, DOI 10.1128/JB.180.10.2759-2765.1998; WILKIN JM, 1994, BIOCHEM J, V301, P477, DOI 10.1042/bj3010477; WILKIN JM, 1993, BIOCHEM J, V293, P195, DOI 10.1042/bj2930195; Wu SW, 1996, MICROB DRUG RESIST, V2, P277, DOI 10.1089/mdr.1996.2.277; Zhang HZ, 2001, SCIENCE, V291, P1962, DOI 10.1126/science.1055144; Zhao GS, 1999, ANTIMICROB AGENTS CH, V43, P1124, DOI 10.1128/AAC.43.5.1124	78	30	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35143	35152		10.1074/jbc.M706296200	http://dx.doi.org/10.1074/jbc.M706296200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17925392	hybrid			2022-12-25	WOS:000251155200059
J	Golubovic, A; Kuhn, A; Williamson, M; Kalbacher, H; Holstein, TW; Grimmelikhuijzen, CJP; Grunder, S				Golubovic, Andjelko; Kuhn, Anne; Williamson, Michael; Kalbacher, Hubert; Holstein, Thomas W.; Grimmelikhuijzen, Cornelis J. P.; Gruender, Stefan			A peptide-gated ion channel from the freshwater polyp Hydra	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL SODIUM-CHANNEL; NA+ CHANNEL; NERVOUS SYSTEMS; FMRFAMIDE; NEUROPEPTIDES; MAGNIPAPILLATA; LOCALIZATION; SELECTIVITY; EXPRESSION; MUTATION	Chemical transmitters are either low molecular weight molecules or neuropeptides. As a general rule, neuropeptides activate only slow metabotropic receptors. To date, only one exception to this rule is known, the FMRFamide-activated Na+ channel (FaNaC) from snails. Until now FaNaC has been regarded as a curiosity, and it was not known whether peptide-gated ionotropic receptors are also present in other animal groups. Nervous systems first evolved in cnidarians, which extensively use neuropeptides. Here we report cloning from the freshwater cnidarian Hydra of a novel ion channel (Hydra sodium channel, HyNaC) that is directly gated by the neuropeptides Hydra-RFamides I and II and is related to FaNaC. The cells expressing HyNaC localize to the base of the tentacles, adjacent to the neurons producing the Hydra-RFamides, suggesting that the peptides are the natural ligands for this channel. Our results suggest that neuropeptides were already used for fast transmission in ancient nervous systems.	Univ Wurzburg, Dept Physiol 2, D-97070 Wurzburg, Germany; Heidelberg Inst Zool, D-69120 Heidelberg, Germany; Univ Copenhagen, Inst Biol, Dept Cell Biol & Comparat Zool, DK-2100 Copenhagen, Denmark; Univ Tubingen, Interfak Inst Biochem, D-72074 Tubingen, Germany	University of Wurzburg; University of Copenhagen; Eberhard Karls University of Tubingen	Grunder, S (corresponding author), Univ Wurzburg, Dept Physiol 2, Rontgenring 9, D-97070 Wurzburg, Germany.	stefan.gruender@uni-wuerzburg.de	Gründer, Stefan/I-2495-2019	Gründer, Stefan/0000-0002-7635-9883; Holstein, Thomas/0000-0003-0480-4674; Grimmelikhuijzen, Cornelis Johannes Pieter/0000-0001-6486-2046				Askwith CC, 2000, NEURON, V26, P133, DOI 10.1016/S0896-6273(00)81144-7; Chen XM, 2007, J PHYSIOL-LONDON, V579, P657, DOI 10.1113/jphysiol.2006.120733; Coscoy S, 1998, J BIOL CHEM, V273, P8317, DOI 10.1074/jbc.273.14.8317; COTTRELL GA, 1990, PFLUG ARCH EUR J PHY, V416, P612, DOI 10.1007/BF00382698; Cottrell GA, 2001, FEBS LETT, V489, P71, DOI 10.1016/S0014-5793(01)02081-6; Darmer D, 1998, BIOCHEM J, V332, P403, DOI 10.1042/bj3320403; Grimmelikhuijzen CJP, 1996, INT REV CYTOL, V167, P37, DOI 10.1016/S0074-7696(08)61345-5; GRIMMELIKHUIJZEN CJP, 1985, CELL TISSUE RES, V241, P171, DOI 10.1007/BF00214639; GRIMMELIKHUIJZEN CJP, 1983, NEUROSCIENCE, V9, P837, DOI 10.1016/0306-4522(83)90272-5; Grunder S, 2000, NEUROREPORT, V11, P1607; Grunder S, 1997, EMBO J, V16, P899, DOI 10.1093/emboj/16.5.899; Guder C, 2006, DEVELOPMENT, V133, P901, DOI 10.1242/dev.02265; Hansen GN, 2000, CELL TISSUE RES, V301, P245; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kellenberger S, 1999, P NATL ACAD SCI USA, V96, P4170, DOI 10.1073/pnas.96.7.4170; Kellenberger S, 1999, J GEN PHYSIOL, V114, P13, DOI 10.1085/jgp.114.1.13; KOIZUMI O, 1989, J EXP ZOOL, V249, P17, DOI 10.1002/jez.1402490105; LINGUEGLIA E, 1995, NATURE, V378, P730, DOI 10.1038/378730a0; Mano I, 1999, BIOESSAYS, V21, P568, DOI 10.1002/(SICI)1521-1878(199907)21:7&lt;568::AID-BIES5&gt;3.0.CO;2-L; Moosler A, 1996, BIOCHEM BIOPH RES CO, V229, P596, DOI 10.1006/bbrc.1996.1849; Paukert M, 2004, J BIOL CHEM, V279, P18783, DOI 10.1074/jbc.M401477200; Raible F, 2004, CURR BIOL, V14, pR106, DOI 10.1016/j.cub.2004.01.015; Schaefer L, 2000, FEBS LETT, V471, P205, DOI 10.1016/S0014-5793(00)01403-4; Schultheiss M, 1997, CELL MOL LIFE SCI, V53, P842, DOI 10.1007/s000180050104; Sheng SH, 2000, J BIOL CHEM, V275, P8572, DOI 10.1074/jbc.275.12.8572; Snyder PM, 1999, J BIOL CHEM, V274, P28484, DOI 10.1074/jbc.274.40.28484; Westfall JA, 1996, J NEUROCYTOL, V25, P735, DOI 10.1007/BF02284838	27	69	70	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35098	35103		10.1074/jbc.M706849200	http://dx.doi.org/10.1074/jbc.M706849200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17911098	hybrid			2022-12-25	WOS:000251155200054
J	Gosmain, Y; Avril, I; Mamin, A; Philippe, J				Gosmain, Yvan; Avril, Isabelle; Mamin, Aline; Philippe, Jacques			Pax-6 and c-Maf functionally interact with the alpha-cell-specific DNA element G1 in vivo to promote glucagon gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMEODOMAIN PROTEIN CDX-2/3; PANCREATIC ENDOCRINE-CELLS; BETA-CELL; PROGLUCAGON GENE; TRANSCRIPTION FACTORS; RESPONSIVE ELEMENT; ACTIVATE GLUCAGON; BINDING-PROTEIN; ISLET CELLS; INSULIN	Specific expression of the glucagon gene in the rat pancreas requires the presence of the G1 element localized at -100/-49 base pairs on the promoter. Although it is known that multiple transcription factors such as Pax-6, Cdx-2/3, c-Maf, Maf-B, and Brain-4 can activate the glucagon gene promoter through G1, their relative importance in vivo is unknown. We first studied the expression of Maf-B, c-Maf, and Cdx-2/3 in the developing and adult mouse pancreas. Although Maf-B was detectable in a progressively increasing number of alpha-cells throughout development and in adulthood, c-Maf and Cdx-2/3 were expressed at low and very low levels, respectively. However, c-Maf but not Cdx-2/3 was detectable in adult islets by Western blot analyses. We then demonstrated the in vivo interactions of Pax-6, Cdx2/3, Maf-B, and c-Maf but not Brain-4 with the glucagon gene promoter in glucagon-producing cells. Although Pax-6, Cdx2/3, Maf-B, and c-Maf were all able to bind G1 by themselves, we showed that Pax-6 could interact with Maf-B, c-Maf, and Cdx2/3 and activate transcription of the glucagon gene promoter. Overexpression of dominant negative forms of Cdx-2/3 and Mafs in alpha-cell lines indicated that Cdx-2/3 and the Maf proteins interact on an overlapping site within G1 and that this binding site is critical in the activation of the glucagon gene promoter. Finally, we show that specific inhibition of Pax-6 and c-Maf but not Cdx-2/3 or Maf-B led to decreases in endogenous glucagon gene expression and that c-Maf binds the glucagon gene promoter in mouse islets. We conclude that Pax-6 and c-Maf interact with G1 to activate basal expression of the glucagon gene.	Univ Geneva, Sch Med, Diabet Unit, Div Endocrinol Diabet & Nutr,Univ Hosp, CH-1211 Geneva 14, Switzerland	University of Geneva	Gosmain, Y (corresponding author), Univ Geneva, Sch Med, Diabet Unit, Div Endocrinol Diabet & Nutr,Univ Hosp, CH-1211 Geneva 14, Switzerland.	Yvan.Gosmain@hcuge.ch						Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Andersen FG, 1999, FEBS LETT, V445, P306, DOI 10.1016/S0014-5793(99)00145-3; Artner I, 2006, DIABETES, V55, P297, DOI 10.2337/diabetes.55.02.06.db05-0946; Artner I, 2007, P NATL ACAD SCI USA, V104, P3853, DOI 10.1073/pnas.0700013104; CORDIERBUSSAT M, 1995, MOL CELL BIOL, V15, P3904; DRUCKER DJ, 1987, J BIOL CHEM, V262, P15659; Duong DT, 2002, J BIOL CHEM, V277, P32234, DOI 10.1074/jbc.M204873200; Gauthier BR, 2007, BIOCHEM J, V403, P593, DOI 10.1042/BJ20070053; Gauthier BR, 2002, MOL ENDOCRINOL, V16, P170, DOI 10.1210/me.16.1.170; GIORDANO E, 1993, AM J PHYSIOL, V265, pC358, DOI 10.1152/ajpcell.1993.265.2.C358; Heller RS, 2004, DEV BIOL, V268, P123, DOI 10.1016/j.ydbio.2003.12.008; Hill ME, 1999, MOL ENDOCRINOL, V13, P1474, DOI 10.1210/me.13.9.1474; Hussain MA, 1997, MOL CELL BIOL, V17, P7186, DOI 10.1128/MCB.17.12.7186; Hussain MA, 1999, J BIOL CHEM, V274, P28950, DOI 10.1074/jbc.274.41.28950; Jin TR, 1996, MOL CELL BIOL, V16, P19; Kataoka K, 2004, J MOL ENDOCRINOL, V32, P9, DOI 10.1677/jme.0.0320009; KATAOKA K, 1994, MOL CELL BIOL, V14, P7581, DOI 10.1128/MCB.14.11.7581; KUMAR V, 1988, CELL, V55, P145, DOI 10.1016/0092-8674(88)90017-7; La Rosa S, 2004, VIRCHOWS ARCH, V445, P248, DOI 10.1007/s00428-004-1080-7; Laser B, 1996, J BIOL CHEM, V271, P28984, DOI 10.1074/jbc.271.46.28984; Matsuoka T, 2003, MOL CELL BIOL, V23, P6049, DOI 10.1128/MCB.23.17.6049-6062.2003; MOREL C, 1995, J BIOL CHEM, V270, P3046, DOI 10.1074/jbc.270.7.3039; Nishimura W, 2006, DIABETES, V55, pA362; Nishimura W, 2006, DEV BIOL, V293, P526, DOI 10.1016/j.ydbio.2006.02.028; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; PHILIPPE J, 1988, MOL CELL BIOL, V8, P4877, DOI 10.1128/MCB.8.11.4877; PHILIPPE J, 1990, J BIOL CHEM, V265, P1465; PHILIPPE J, 1994, DIABETES, V43, P523, DOI 10.2337/diabetes.43.4.523; PHILIPPE J, 1991, ENDOCR REV, V12, P252, DOI 10.1210/edrv-12-3-252; PHILIPPE J, 1991, P NATL ACAD SCI USA, V88, P7224, DOI 10.1073/pnas.88.16.7224; PHILIPPE J, 1995, J BIOL CHEM, V270, P3039, DOI 10.1074/jbc.270.7.3039; Planque N, 2001, J BIOL CHEM, V276, P35751, DOI 10.1074/jbc.M104523200; POWERS AC, 1990, DIABETES, V39, P406, DOI 10.2337/diabetes.39.4.406; Ritz-Laser B, 1999, J BIOL CHEM, V274, P4124, DOI 10.1074/jbc.274.7.4124; Ritz-Laser B, 2002, DIABETOLOGIA, V45, P97, DOI 10.1007/s125-002-8249-9; Ritz-Laser B, 2003, DIABETOLOGIA, V46, P810, DOI 10.1007/s00125-003-1115-7; Rosanas-Urgell A, 2005, MOL CELL ENDOCRINOL, V237, P59, DOI 10.1016/j.mce.2005.03.008; Sander M, 1997, GENE DEV, V11, P1662, DOI 10.1101/gad.11.13.1662; SCHISLER JC, 2005, P NATL ACAD SCI USA, V102, P7927; SCHREIBER E, 1988, EMBO J, V7, P4221, DOI 10.1002/j.1460-2075.1988.tb03319.x; SosaPineda B, 1997, NATURE, V386, P399, DOI 10.1038/386399a0; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; TAKAKI R, 1984, DIABETES, V33, P879, DOI 10.2337/diabetes.33.9.879; Tsuchiya M, 2007, DIABETES, V56, pA430; Tsuchiya M, 2006, PANCREAS, V32, P408, DOI 10.1097/01.mpa.0000220867.64787.99; TURQUE N, 1994, MOL ENDOCRINOL, V8, P929, DOI 10.1210/me.8.7.929; Wang HY, 2001, J BIOL CHEM, V276, P25279, DOI 10.1074/jbc.M101233200; Wang PX, 2006, ENDOCRINOLOGY, V147, P1950, DOI 10.1210/en.2005-0910; Yang Y, 2005, J MOL BIOL, V351, P453, DOI 10.1016/j.jmb.2005.05.072	49	41	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35024	35034		10.1074/jbc.M702795200	http://dx.doi.org/10.1074/jbc.M702795200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17901057	hybrid			2022-12-25	WOS:000251155200047
J	Sawasdikosol, S; Pyarajan, S; Alzabin, S; Matejovic, G; Burakoff, SJ				Sawasdikosol, Sansana; Pyarajan, Saiju; Alzabin, Saba; Matejovic, Gabriel; Burakoff, Steven J.			Prostaglandin E-2 activates HPK1 kinase activity via a PKA-dependent pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC PROGENITOR KINASE-1; N-TERMINAL KINASE; ADAPTER PROTEINS; GENE-EXPRESSION; T-LYMPHOCYTES; EP4 RECEPTOR; CELLS; TRANSCRIPTION; GROWTH; AP-1	Hematopoietic progenitor kinase 1 (HPK1) is a hematopoietic cell-restricted member of the Ste20 serine/threonine kinase super family. We recently reported that the immunosuppressive eicosanoid, prostaglandin E-2 (PGE(2)), is capable of activating HPK1 in T cells. In this report, we demonstrate that unlike the TCR-induced activation of HPK1 kinase activity, the induction of HPK1 catalytic activity by PGE(2) does not require the presence of phosphotyrosine-based signaling molecules such as Lck, ZAP-70, SLP-76, and Lat. Nor does the PGE(2)-induced HPK1 activation require the intermolecular interaction between its proline-rich regions and the SH3 domain-containing adaptor proteins, as required by the signaling from the TCR to HPK1. Instead, our study reveals that PGE(2) signal to HPK1 via a 3'-5'-cyclic adenosine monophosphate-regulated, PKA-dependent pathway. Consistent with this observation, changing the serine 171 residue that forms the optimal PKA phosphorylation site within the "activation loop" of HPK1 to alanine completely prevents this mutant from responding to PGE(2)-generated stimulation signals. Moreover, the inability of HPK1 to respond to PGE(2) stimulation in PKA-deficient S49 cells further supports the importance of PKA in this signaling pathway. We speculate that this unique signaling pathway enables PGE(2) signals to engage a proven negative regulator of TCR signal transduction pathway and uses it to inhibit T cell activation.	NYU, Sch Med, Inst Canc, New York, NY 10016 USA	New York University	Sawasdikosol, S (corresponding author), NYU, Sch Med, Inst Canc, New York, NY 10016 USA.	sawasdik@saturn.med.nyu.edu		Alzabin, Saba/0000-0003-3474-1846				Anafi M, 1997, J BIOL CHEM, V272, P27804, DOI 10.1074/jbc.272.44.27804; ANASTASSIOU ED, 1992, J IMMUNOL, V148, P2845; Arakawa T, 1996, J BIOL CHEM, V271, P29569, DOI 10.1074/jbc.271.47.29569; Arnold R, 2005, MOL CELL BIOL, V25, P2364, DOI 10.1128/MCB.25.6.2364-2383.2005; BETZ M, 1991, J IMMUNOL, V146, P108; Blaschke V, 1996, FEBS LETT, V394, P39, DOI 10.1016/0014-5793(96)00928-3; Boomer JS, 2005, J CELL BIOCHEM, V95, P34, DOI 10.1002/jcb.20401; BOSSEMEYER D, 1995, FEBS LETT, V369, P57, DOI 10.1016/0014-5793(95)00580-3; Brenner D, 2005, EMBO J, V24, P4279, DOI 10.1038/sj.emboj.7600894; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Chang JH, 1998, MOL CELL BIOL, V18, P4986, DOI 10.1128/MCB.18.9.4986; Chen YR, 1999, ONCOGENE, V18, P7370, DOI 10.1038/sj.onc.1203116; CHOUAIB S, 1985, J IMMUNOL, V135, P1172; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Ensenat D, 1999, J BIOL CHEM, V274, P33945, DOI 10.1074/jbc.274.48.33945; Giannouli CC, 2006, CELL SIGNAL, V18, P1417, DOI 10.1016/j.cellsig.2005.11.002; Gu CH, 2000, J BIOL CHEM, V275, P20726, DOI 10.1074/jbc.M000152200; Hu MCT, 1996, GENE DEV, V10, P2251, DOI 10.1101/gad.10.18.2251; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kiefer F, 1996, EMBO J, V15, P7013, DOI 10.1002/j.1460-2075.1996.tb01093.x; Ling P, 1999, MOL CELL BIOL, V19, P1359; Ling P, 2001, J BIOL CHEM, V276, P18908, DOI 10.1074/jbc.M101485200; Liou J, 2000, IMMUNITY, V12, P399, DOI 10.1016/S1074-7613(00)80192-2; Liu SK, 2000, J IMMUNOL, V165, P1417, DOI 10.4049/jimmunol.165.3.1417; Ma WB, 2001, ONCOGENE, V20, P1703, DOI 10.1038/sj.onc.1204224; Mori K, 1996, J MOL MED-JMM, V74, P333, DOI 10.1007/BF00207510; Nagata Y, 1999, BLOOD, V93, P3347, DOI 10.1182/blood.V93.10.3347.410k06_3347_3354; Oehrl W, 1998, ONCOGENE, V17, P1893, DOI 10.1038/sj.onc.1202108; Paliogianni F, 1996, CELL IMMUNOL, V171, P95, DOI 10.1006/cimm.1996.0178; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; Sauer K, 2001, J BIOL CHEM, V276, P45207, DOI 10.1074/jbc.M106811200; Sawasdikosol S, 2003, BLOOD, V101, P3687, DOI 10.1182/blood-2002-07-2316; Schulze-Luehrmann J, 2002, BLOOD, V100, P954, DOI 10.1182/blood-2002-01-0089; Shui JW, 2007, NAT IMMUNOL, V8, P84, DOI 10.1038/ni1416; Takayama K, 2002, J BIOL CHEM, V277, P44147, DOI 10.1074/jbc.M204810200; Tsuji S, 2001, J EXP MED, V194, P529, DOI 10.1084/jem.194.4.529; Wang WF, 1997, J BIOL CHEM, V272, P22771, DOI 10.1074/jbc.272.36.22771; Yu J, 2001, MOL CELL BIOL, V21, P6102, DOI 10.1128/MCB.21.18.6102-6112.2001; Zhou GS, 1999, J BIOL CHEM, V274, P13133, DOI 10.1074/jbc.274.19.13133; Zhou TH, 2000, J BIOL CHEM, V275, P2513, DOI 10.1074/jbc.275.4.2513	40	25	30	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34693	34699		10.1074/jbc.M707425200	http://dx.doi.org/10.1074/jbc.M707425200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17895239	hybrid			2022-12-25	WOS:000251155200011
J	Jacobs, AT; Marnett, LJ				Jacobs, Aaron T.; Marnett, Lawrence J.			Heat shock factor 1 attenuates 4-hydroxynonenal-mediated apoptosis - Critical role for heat shock protein 70 induction and stabilization of Bcl-X-L	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; TRANSCRIPTION FACTOR HSF1; DNA-BINDING ACTIVITY; OXIDATIVE STRESS; LIPID-PEROXIDATION; GENE-EXPRESSION; CELL-DEATH; MOLECULAR CHAPERONES; NEGATIVE REGULATION; MAMMALIAN-CELLS	Lipid peroxidation is a consequence of both normal physiology and oxidative stress that generates various reactive metabolites, a principal end product being 4-hydroxynonenal (HNE). As a diffusible electrophile, HNE reacts extensively with cellular nucleophiles. Consequently, HNE alters cellular signaling and activates the intrinsic apoptotic cascade. We have previously demonstrated that in addition to promoting apoptosis, HNE activates stress response pathways, including the antioxidant, endoplasmic reticulum stress, DNA damage, and heat shock responses. Here we demonstrate that activation of the heat shock response by HNE is dependent on the expression and nuclear translocation of heat shock factor 1 (HSF1), which promotes the expression of heat shock protein 40 (Hsp40) and Hsp70-1. Ectopic expression and immunoprecipitation of c-Myc-tagged Hsp70-1 indicates that HNE disrupts the inhibitory interaction between Hsp70-1 and HSF1, leading to the activation heat shock gene expression. Using siRNA to silence HSF1 expression, we observe that HSF1 is necessary for the induction of Hsp40 and Hsp70-1 by HNE, and the lack of Hsp expression is correlated with an increase in apoptosis. Nrf2, the transcription factor that mediates the antioxidant response, was also silenced using siRNA. Silencing Nrf2 also enhanced the cytotoxicity of HNE, but not as effectively as HSF1. Silencing HSF1 expression facilitates the activation of JNK pro-apoptotic signaling and selectively decreases expression of the anti-apoptotic Bcl-2 family member Bcl-XL. Overexpression of Bcl-XL attenuates HNE-mediated apoptosis in HSF1-silenced cells. Overall, activation of HSF1 and stabilization of Bcl-XL mediate a protective response that may contribute significantly to the cellular biology of lipid peroxidation.	Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Vanderbit Inst Chem Biol,Dept Biochem, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Vanderbit Ingram Comprehens Cancer Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Marnett, LJ (corresponding author), Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Vanderbit Inst Chem Biol,Dept Biochem, 221 Kirkland Hall, Nashville, TN 37232 USA.	larry.marnett@vanderbilt.edu			NIEHS NIH HHS [P01ES013125] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES013125] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ABRAVAYA K, 1992, GENE DEV, V6, P1153, DOI 10.1101/gad.6.7.1153; Ali A, 1998, MOL CELL BIOL, V18, P4949, DOI 10.1128/MCB.18.9.4949; Bai JR, 2005, CANCER RES, V65, P2344, DOI 10.1158/0008-5472.CAN-04-3502; Baler R, 1996, CELL STRESS CHAPERON, V1, P33, DOI 10.1379/1466-1268(1996)001<0033:EFAROH>2.3.CO;2; BALER R, 1993, MOL CELL BIOL, V13, P2486, DOI 10.1128/MCB.13.4.2486; Bartsch H, 2005, MUTAT RES-FUND MOL M, V591, P34, DOI 10.1016/j.mrfmmm.2005.04.013; Bharadwaj S, 1999, MOL CELL BIOL, V19, P8033; Biasi F, 2006, FREE RADICAL BIO MED, V41, P443, DOI 10.1016/j.freeradbiomed.2006.04.005; CAJELLI E, 1987, MUTAT RES, V190, P169, DOI 10.1016/0165-7992(87)90050-9; CAJONE F, 1989, BIOCHEM J, V262, P977, DOI 10.1042/bj2620977; CAJONE F, 1989, FREE RADICAL RES COM, V7, P189, DOI 10.3109/10715768909087941; Carbone DL, 2005, J PHARMACOL EXP THER, V315, P8, DOI 10.1124/jpet.105.088088; Carbone DL, 2004, CHEM RES TOXICOL, V17, P1459, DOI 10.1021/tx049838g; CHEN HJC, 1994, CHEM RES TOXICOL, V7, P857, DOI 10.1021/tx00042a021; Chen HQ, 2006, FEBS LETT, V580, P3145, DOI 10.1016/j.febslet.2006.04.066; Chen SR, 2003, FREE RADICAL BIO MED, V34, P1315, DOI 10.1016/S0891-5849(03)00146-1; Chen ZH, 2005, J BIOL CHEM, V280, P41921, DOI 10.1074/jbc.M508556200; Cheng JZ, 1999, ARCH BIOCHEM BIOPHYS, V372, P29, DOI 10.1006/abbi.1999.1479; Cheng JZ, 2001, ARCH BIOCHEM BIOPHYS, V392, P197, DOI 10.1006/abbi.2001.2452; Cho HY, 2006, ANTIOXID REDOX SIGN, V8, P76, DOI 10.1089/ars.2006.8.76; Douki T, 2004, FREE RADICAL BIO MED, V37, P62, DOI 10.1016/j.freeradbiomed.2004.04.013; Fujimura Satoshi, 2003, Hematol J, V4, P328, DOI 10.1038/sj.thj.6200321; Gabai VL, 2002, MOL CELL BIOL, V22, P3415, DOI 10.1128/MCB.22.10.3415-3424.2002; Gibbons NB, 2000, PROSTATE, V45, P58; GRUNE T, 1993, INT J TISSUE REACT, V15, P145; HAHN GM, 1982, RADIAT RES, V92, P452, DOI 10.2307/3575917; Herbst U, 1999, J CELL PHYSIOL, V181, P295, DOI 10.1002/(SICI)1097-4652(199911)181:2<295::AID-JCP11>3.0.CO;2-I; HOWARD MK, 1993, J NEUROCHEM, V60, P1783, DOI 10.1111/j.1471-4159.1993.tb13404.x; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Ishii T, 2004, CIRC RES, V94, P609, DOI 10.1161/01.RES.0000119171.44657.45; Ji C, 2001, CHEM RES TOXICOL, V14, P1090, DOI 10.1021/tx000186f; Jiang M, 2006, ONCOGENE, V25, P4056, DOI 10.1038/sj.onc.1209440; Kalinich JF, 2000, FREE RADICAL RES, V33, P349, DOI 10.1080/10715760000300891; Kruman I, 1997, J NEUROSCI, V17, P5089; Kuo CC, 2006, J BIOL CHEM, V281, P38200, DOI 10.1074/jbc.M605439200; Kutuk O, 2007, REDOX REP, V12, P30, DOI 10.1179/135100007X162329; Lau SS, 2000, AM J PHYSIOL-HEART C, V278, pH1439, DOI 10.1152/ajpheart.2000.278.5.H1439; Lee JM, 2003, J BIOL CHEM, V278, P12029, DOI 10.1074/jbc.M211558200; Li J, 2005, TOXICOL SCI, V83, P313, DOI 10.1093/toxsci/kfi027; Lytle RA, 2004, J NEURO-ONCOL, V68, P233, DOI 10.1023/B:NEON.0000033382.40601.5a; MARINARI UM, 1984, CELL BIOCHEM FUNCT, V2, P243, DOI 10.1002/cbf.290020411; Montine TJ, 1996, J NEUROPATH EXP NEUR, V55, P202, DOI 10.1097/00005072-199602000-00009; Moseley PL, 1997, J APPL PHYSIOL, V83, P1413, DOI 10.1152/jappl.1997.83.5.1413; MOSSER DD, 1993, MOL CELL BIOL, V13, P5427, DOI 10.1128/MCB.13.9.5427; Nakagawa Y, 2002, J BIOCHEM MOL BIOL, V35, P452; Nollen EAA, 2002, J CELL SCI, V115, P2809; Pandey P, 2000, EMBO J, V19, P4310, DOI 10.1093/emboj/19.16.4310; Park HS, 2001, EMBO J, V20, P446, DOI 10.1093/emboj/20.3.446; Ran RQ, 2004, GENE DEV, V18, P1466, DOI 10.1101/gad.1188204; Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839; Ribeil JA, 2007, NATURE, V445, P102, DOI 10.1038/nature05378; Saleh A, 2000, NAT CELL BIOL, V2, P476, DOI 10.1038/35019510; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; Sayre LM, 1997, J NEUROCHEM, V68, P2092; Selley ML, 1998, FREE RADICAL BIO MED, V25, P169, DOI 10.1016/S0891-5849(98)00021-5; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; Shi YZ, 2006, SHOCK, V26, P277, DOI 10.1097/01.shk.0000223134.17877.ad; Shih AY, 2003, J NEUROSCI, V23, P3394, DOI 10.1523/jneurosci.23-08-03394.2003; Singleton KD, 2006, AM J PHYSIOL-LUNG C, V290, pL956, DOI 10.1152/ajplung.00466.2005; Soh YJ, 2000, MOL PHARMACOL, V58, P535, DOI 10.1124/mol.58.3.535; Sowell J, 2004, P NATL ACAD SCI USA, V101, P17964, DOI 10.1073/pnas.0408433102; Sowell J, 2005, J CHROMATOGR B, V827, P139, DOI 10.1016/j.jchromb.2005.05.046; Stankiewicz AR, 2005, J BIOL CHEM, V280, P38729, DOI 10.1074/jbc.M509497200; UCHIDA K, 1994, BIOCHEMISTRY-US, V33, P12487, DOI 10.1021/bi00207a016; West JD, 2005, CHEM RES TOXICOL, V18, P1642, DOI 10.1021/tx050211n; WINKLER P, 1984, BIOCHIM BIOPHYS ACTA, V796, P232, DOI 10.1016/0005-2760(84)90122-X; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3; ZUO JR, 1994, MOL CELL BIOL, V14, P7557, DOI 10.1128/MCB.14.11.7557	68	85	91	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33412	33420		10.1074/jbc.M706799200	http://dx.doi.org/10.1074/jbc.M706799200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17873279	hybrid			2022-12-25	WOS:000250840200021
J	Meier, R; Muhlethaler-Mottet, A; Flahaut, M; Coulon, A; Fusco, C; Louache, F; Auderset, K; Bourloud, KB; Daudigeos, E; Ruegg, C; Vassal, G; Gross, N; Joseph, JM				Meier, Roland; Muehlethaler-Mottet, Annick; Flahaut, Marjorie; Coulon, Aurelie; Fusco, Carlo; Louache, Fawzia; Auderset, Katya; Bourloud, Katia Balmas; Daudigeos, Estelle; Ruegg, Curzio; Vassal, Gilles; Gross, Nicole; Joseph, Jean-Marc			The Chemokine Receptor CXCR4 Strongly Promotes Neuroblastoma Primary Tumour and Metastatic Growth, but not Invasion	PLOS ONE			English	Article								Neuroblastoma (NB) is a heterogeneous, and particularly malignant childhood neoplasm in its higher stages, with a propensity to form metastasis in selected organs, in particular liver and bone marrow, and for which there is still no efficient treatment available beyond surgery. Recent evidence indicates that the CXCR4/CXCL12 chemokine/receptor axis may be involved in promoting NB invasion and metastasis. In this study, we explored the potential role of CXCR4 in the malignant behaviour of NB, using a combination of in vitro functional analyses and in vivo growth and metastasis assessment in an orthotopic NB mouse model. We show here that CXCR4 overexpression in non-metastatic CXCR4-negative NB cells IGR-NB8 and in moderately metastatic, CXCR4 expressing NB cells IGR-N91, strongly increased tumour growth of primary tumours and liver metastases, without altering the frequency or the pattern of metastasis. Moreover shRNA-mediated knock-down experiments confirmed our observations by showing that silencing CXCR4 in NB cells impairs in vitro and almost abrogates in vivo growth. High levels of CXCL12 were detected in the mouse adrenal gland (the primary tumour site), and in the liver suggesting a paracrine effect of host-derived CXCL12 on NB growth. In conclusion, this study reveals a yet unreported NB-specific predominant growth and survival-promoting role of CXCR4, which warrants a critical reconsideration of the role of CXCR4 in the malignant behaviour of NB and other cancers.	[Gross, Nicole; Joseph, Jean-Marc] Univ Lausanne Hosp, CHUV, Dept Paediat, Surg Unit, Lausanne, Switzerland; [Fusco, Carlo] Univ Inst Pathol, Div Expt Pathol, Lausanne, Switzerland; [Louache, Fawzia] Inst Gustave Roussy, INSERM, U362, F-94805 Villejuif, France; [Daudigeos, Estelle; Vassal, Gilles] Inst Gustave Roussy, Unite Propre Rech Enseignement Super EA3535, F-94805 Villejuif, France; [Ruegg, Curzio] Lausanne Canc Ctr, Multidisciplinary Oncol Ctr CePO, Div Expt Oncol, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy	Gross, N (corresponding author), Univ Lausanne Hosp, CHUV, Dept Paediat, Surg Unit, Lausanne, Switzerland.	nicole.gross@chuv.ch	Fusco, Carlo/AAC-7332-2022; Mühlethaler-Mottet, Annick/H-2848-2019; Meier, Roland/ABI-4322-2020; Louache, Fawzia/M-4901-2017	Mühlethaler-Mottet, Annick/0000-0001-8274-0907; Louache, Fawzia/0000-0002-4247-5421	Swiss National Scientific Foundation; FORCE foundation; UICC; Yamagiwa- Yoshida Memorial International Cancer Study; Oncosuisse	Swiss National Scientific Foundation(Swiss National Science Foundation (SNSF)); FORCE foundation; UICC; Yamagiwa- Yoshida Memorial International Cancer Study; Oncosuisse	Funding: This work has been supported by grants from the Swiss National Scientific Foundation (JMJ and NG), FORCE foundation, (NG, RM and JMJ), a UICC (Union Internationale Contre le Cancer) Yamagiwa- Yoshida Memorial International Cancer Study Grant (RM), and an Oncosuisse grant (to RM).	Airoldi I, 2006, CLIN CANCER RES, V12, P77, DOI 10.1158/1078-0432.CCR-05-1376; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Balkwill F, 2003, SEMIN IMMUNOL, V15, P49, DOI 10.1016/S1044-5323(02)00127-6; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Calvet L, 2006, ONCOGENE, V25, P3150, DOI 10.1038/sj.onc.1209348; Campbell JJ, 2000, CURR OPIN IMMUNOL, V12, P336, DOI 10.1016/S0952-7915(00)00096-0; Cui NH, 2005, CLIN CANCER RES, V11, P2713, DOI 10.1158/1078-0432.CCR-04-1767; Ehtesham M, 2006, ONCOGENE; FERRANDIS E, 1994, CANCER RES, V54, P2256; Flahaut M, 2006, APOPTOSIS, V11, P255, DOI 10.1007/s10495-006-3435-9; Geminder H, 2001, J IMMUNOL, V167, P4747, DOI 10.4049/jimmunol.167.8.4747; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hasmim M, 2005, THROMB HAEMOSTASIS, V94, P1060, DOI 10.1160/TH05-02-0108; Hatse S, 2003, Cell Mol Biol (Noisy-le-grand), V49 Online Pub, pOL443; Joseph JM, 2005, INT J CANCER, V113, P881, DOI 10.1002/ijc.20681; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Khanna C, 2002, IN VIVO, V16, P77; Killion JJ, 1998, CANCER METAST REV, V17, P279, DOI 10.1023/A:1006140513233; Kim J, 2006, ANN SURG, V244, P113, DOI 10.1097/01.sla.0000217690.65909.9c; Kubetzko FBB, 2004, CARCINOGENESIS, V25, P1839, DOI 10.1093/carcin/bgh190; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; MANZOTTI C, 1993, CLIN EXP METASTAS, V11, P5, DOI 10.1007/BF00880061; Marchesi F, 2004, CANCER RES, V64, P8420, DOI 10.1158/0008-5472.CAN-04-1343; Mashino K, 2002, CANCER RES, V62, P2937; Mori T, 2004, MOL CANCER THER, V3, P29; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nevo I, 2004, IMMUNOL LETT, V92, P163, DOI 10.1016/j.imlet.2003.10.019; RASHYAHANA M, 2004, FASEB J, V18, P1240; Sabri S, 2006, BLOOD, V108, P134, DOI 10.1182/blood-2005-03-1219; Scotton CJ, 2002, CANCER RES, V62, P5930; Taichman RS, 2002, CANCER RES, V62, P1832; Tamamura H, 2004, FEBS LETT, V569, P99, DOI 10.1016/j.febslet.2004.05.056; Uhm JH, 1996, CLIN EXP METASTAS, V14, P421, DOI 10.1007/BF00128958; Valteau D, 1996, CANCER RES, V56, P362; Wang JH, 2005, CELL SIGNAL, V17, P1578, DOI 10.1016/j.cellsig.2005.03.022; Zeelenberg IS, 2003, CANCER RES, V63, P3833; Zhang LB, 2007, NEOPLASIA, V9, P36, DOI 10.1593/neo.06670; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	44	49	57	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1016	10.1371/journal.pone.0001016	http://dx.doi.org/10.1371/journal.pone.0001016			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925864	Green Submitted, Green Published, gold			2022-12-25	WOS:000207456000015
J	Decker, EH; Kerkhoff, AJ; Moses, ME				Decker, Ethan H.; Kerkhoff, Andrew J.; Moses, Melanie E.			Global Patterns of City Size Distributions and Their Fundamental Drivers	PLOS ONE			English	Article							BODY-SIZE; ZIPFS LAW; POPULATION-DENSITY; MODEL; INTERMITTENCY; ENERGETICS; SYSTEMS; GROWTH; ENERGY	Urban areas and their voracious appetites are increasingly dominating the flows of energy and materials around the globe. Understanding the size distribution and dynamics of urban areas is vital if we are to manage their growth and mitigate their negative impacts on global ecosystems. For over 50 years, city size distributions have been assumed to universally follow a power function, and many theories have been put forth to explain what has become known as Zipf's law (the instance where the exponent of the power function equals unity). Most previous studies, however, only include the largest cities that comprise the tail of the distribution. Here we show that national, regional and continental city size distributions, whether based on census data or inferred from cluster areas of remotely-sensed nighttime lights, are in fact lognormally distributed through the majority of cities and only approach power functions for the largest cities in the distribution tails. To explore generating processes, we use a simple model incorporating only two basic human dynamics, migration and reproduction, that nonetheless generates distributions very similar to those found empirically. Our results suggest that macroscopic patterns of human settlements may be far more constrained by fundamental ecological principles than more fine-scale socioeconomic factors.	[Decker, Ethan H.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Kerkhoff, Andrew J.] Kenyon Coll, Dept Biol, Gambier, OH 43022 USA; [Kerkhoff, Andrew J.] Kenyon Coll, Dept Math, Gambier, OH 43022 USA; [Moses, Melanie E.] Univ New Mexico, Dept Comp Sci, Albuquerque, NM 87131 USA	University of New Mexico; Kenyon College; Kenyon College; University of New Mexico	Decker, EH (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	ehd@ehdecker.com		Kerkhoff, Andrew/0000-0001-9617-8687	NASA; National Science Foundation	NASA(National Aeronautics & Space Administration (NASA)); National Science Foundation(National Science Foundation (NSF))	This research was supported in part by NASA and a National Science Foundation Doctoral Research Fellowship. Both groups funded the research but were not involved in conducting or analyzing the research.	Andersson C, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.026204; Banavar JR, 1999, NATURE, V399, P130, DOI 10.1038/20144; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Brown J. H., 1995, MACROECOLOGY; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; CARROLL GR, 1982, PROG HUM GEOG, V6, P1; Collins JP, 2000, AM SCI, V88, P416; DAMUTH J, 1981, NATURE, V290, P699, DOI 10.1038/290699a0; Decker EH, 2000, ANNU REV ENERG ENV, V25, P685, DOI 10.1146/annurev.energy.25.1.685; Decker Ethan H, 2002, ScientificWorldJournal, V2, P374; Eeckhout J, 2004, AM ECON REV, V94, P1429, DOI 10.1257/0002828043052303; Elvidge CD, 1997, PHOTOGRAMM ENG REM S, V63, P727; Enquist BJ, 1998, NATURE, V395, P163, DOI 10.1038/25977; Gabaix X, 1999, AM ECON REV, V89, P129, DOI 10.1257/aer.89.2.129; GABAIX X, 2003, HDB URBAN REGIONAL E, V4; Gibrat R, 1931, INEGALITIES EC; HILL BM, 1970, J AM STAT ASSOC, V65, P1220, DOI 10.2307/2284288; LEWIN R, 1985, SCIENCE, V229, P151, DOI 10.1126/science.229.4709.151; Loehle C, 2006, ECOLOGY, V87, P2221, DOI 10.1890/0012-9658(2006)87[2221:SADRFB]2.0.CO;2; Mandelbrot B. B., 1977, FRACTAL GEOMETRY NAT; Manrubia SC, 1998, PHYS REV E, V58, P295, DOI 10.1103/PhysRevE.58.295; MAURER BA, 1992, EVOLUTION, V46, P939, DOI 10.1111/j.1558-5646.1992.tb00611.x; Maurer BA, 1998, SCIENCE, V279, P502, DOI 10.1126/science.279.5350.502; MONTROLL EW, 1982, P NATL ACAD SCI USA, V79, P3380, DOI 10.1073/pnas.79.10.3380; Moses ME, 2003, ECOL LETT, V6, P295, DOI 10.1046/j.1461-0248.2003.00446.x; Nekola JC, 2007, ECOL LETT, V10, P188, DOI 10.1111/j.1461-0248.2006.01003.x; Odum Eugene, 1997, ECOLOGY BRIDGE SCI S; Perline R, 1996, PHYS REV E, V54, P220, DOI 10.1103/PhysRevE.54.220; Pickett STA, 2001, ANNU REV ECOL SYST, V32, P127, DOI 10.1146/annurev.ecolsys.32.081501.114012; Pumain D., 1982, DYNAMIQUE VILLES; Robson B.T., 1973, URBAN GROWTH APPROAC; Rodriguez-Iturbe I., 1997, FRACTAL RIVER BASINS; SIMON HA, 1955, BIOMETRIKA, V42, P425; Stanley HE, 1996, PHYSICA A, V231, P20, DOI 10.1016/0378-4371(96)00086-6; Stauffer D., 1992, INTRO PERCOLATION TH; Sutton P, 1997, PHOTOGRAMM ENG REM S, V63, P1303; *SWISS FED STAT OF, 1997, ANN POP STAT; Tobler W., 1995, GLOBAL DEMOGRAPHY PR; Turco R.P., 1997, EARTH SIEGE AIR POLL; *UN POP DIV, 2001, WORLD POP PROSP 2000; *UN POP DIV, 1996, WORLD URB PROSP 1996; *US BUR CENS, 1999, EST POP METR AR; *US GEOL SURV, 1995, GEOGR NAM INF SYST; WATT AS, 1947, J ECOL, V35, P1, DOI 10.2307/2256497; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; WHO/UNEP, 1994, ANN REPORT; *WORLD RES I, 1998, WORLD RES 1998 99; WYLLYS RE, 1981, LIBR TRENDS, V30, P53; Zanette DH, 1997, PHYS REV LETT, V79, P523, DOI 10.1103/PhysRevLett.79.523; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	50	50	50	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e934	10.1371/journal.pone.0000934	http://dx.doi.org/10.1371/journal.pone.0000934			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895975	Green Published, Green Submitted, gold			2022-12-25	WOS:000207455800013
J	Grzmil, M; Whiting, D; Maule, J; Anastasaki, C; Amatruda, JF; Kelsh, RN; Norbury, CJ; Patton, EE				Grzmil, Michal; Whiting, Danny; Maule, John; Anastasaki, Corina; Amatruda, James F.; Kelsh, Robert N.; Norbury, Chris J.; Patton, E. Elizabeth			The INT6 Cancer Gene and MEK Signaling Pathways Converge during Zebrafish Development	PLOS ONE			English	Article							CELL-CYCLE; EXPRESSION; PROGRESSION; PATTERNS; P53	Background. Int-6 (integration site 6) was identified as an oncogene in a screen of tumorigenic mouse mammary tumor virus (MMTV) insertions. INT6 expression is altered in human cancers, but the precise role of disrupted INT6 in tumorigenesis remains unclear, and an animal model to study Int-6 physiological function has been lacking. Principal Findings. Here, we create an in vivo model of Int6 function in zebrafish, and through genetic and chemical-genetic approaches implicate Int6 as a tissue-specific modulator of MEK-ERK signaling. We find that Int6 is required for normal expression of MEK1 protein in human cells, and for Erk signaling in zebrafish embryos. Loss of either Int6 or Mek signaling causes defects in craniofacial development, and Int6 and Erk-signaling have overlapping domains of tissue expression. Significance. Our results provide new insight into the physiological role of vertebrate Int6, and have implications for the treatment of human tumors displaying altered INT6 expression.	[Grzmil, Michal; Whiting, Danny; Norbury, Chris J.; Patton, E. Elizabeth] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Maule, John; Anastasaki, Corina; Patton, E. Elizabeth] Univ Edinburgh, Western Gen Hosp, Canc Res Ctr, Edinburgh, Midlothian, Scotland; [Maule, John; Anastasaki, Corina; Patton, E. Elizabeth] MRC, Human Genet Unit, Edinburgh, Midlothian, Scotland; [Amatruda, James F.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Amatruda, James F.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Amatruda, James F.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Kelsh, Robert N.] Univ Bath, Ctr Regenerat Med, Dev Biol Programme, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	University of Oxford; University of Edinburgh; University of Edinburgh; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Bath	Patton, EE (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	epatton@staffmail.ed.ac.uk	Kelsh, Robert/B-6445-2008	Kelsh, Robert/0000-0002-9381-0066; Grzmil, Michal/0000-0002-7866-8145	MRC; CRUK; AICR; Medical Research Council [G120/875, MC_U127585840] Funding Source: researchfish; MRC [MC_U127585840, G120/875] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CRUK(Cancer Research UK); AICR; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by a MRC grant to EEP, and by grants from CRUK and the AICR to CJN. Funders had no role in the design or conduct of the study, in the collection, analysis, or interpretation of the data, or in the preparation, review, or approval of the manuscript.	Asano K, 1997, J BIOL CHEM, V272, P23477, DOI 10.1074/jbc.272.38.23477; Bentires-Alj M, 2006, NAT MED, V12, P283, DOI 10.1038/nm0306-283; BUCHSBAUM S, 2007, HUMAN INT6 INTERACTS, P1; Buttitta F, 2005, CLIN CANCER RES, V11, P3198, DOI 10.1158/1078-0432.CCR-04-2308; Callahan R, 2000, ONCOGENE, V19, P992, DOI 10.1038/sj.onc.1203276; Chen L, 2007, J BIOL CHEM, V282, P12707, DOI 10.1074/jbc.M700423200; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Corson LB, 2003, DEVELOPMENT, V130, P4527, DOI 10.1242/dev.00669; Crane R, 2000, MOL BIOL CELL, V11, P3993, DOI 10.1091/mbc.11.11.3993; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Graham A, 2005, J ANAT, V207, P479, DOI 10.1111/j.1469-7580.2005.00472.x; Javidan Y, 2004, METHOD CELL BIOL, V76, P415; Jenkins CCL, 2005, EUKARYOT CELL, V4, P1840, DOI 10.1128/EC.4.11.1840-1850.2005; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Krens SFG, 2006, GENE EXPR PATTERNS, V6, P1019, DOI 10.1016/j.modgep.2006.04.008; MACK DL, 2007, BR CAN RES, V4, P42; Marchetti A, 2001, INT J ONCOL, V18, P175; Mayeur GL, 2002, FEBS LETT, V514, P49, DOI 10.1016/S0014-5793(02)02307-4; Morris C, 2005, ONCOGENE, V24, P1203, DOI 10.1038/sj.onc.1208268; Morris C, 2007, EMBO REP, V8, P596, DOI 10.1038/sj.embor.7400955; MURAKAMI S, 2000, PNAS, V97, P113; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; Patton EE, 2005, CURR BIOL, V15, P249, DOI 10.1016/j.cub.2005.01.031; Rasmussen SB, 2001, ONCOGENE, V20, P5291, DOI 10.1038/sj.onc.1204624; RIJSEWIJK F, 1987, CELL, V50, P649, DOI 10.1016/0092-8674(87)90038-9; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Shepard JL, 2004, METHOD CELL BIOL, V76, P109; TEKMAL RR, 1997, FRONT BIOSCI, V379, P519; Traicoff JL, 2007, J BIOMED SCI, V14, P395, DOI 10.1007/s11373-007-9149-3; Watkins SJ, 2004, CELL PROLIFERAT, V37, P149, DOI 10.1111/j.1365-2184.2004.00305.x; WESTERFIELD M, 1995, ZEBRAFISH BOOK; Wilkie AOM, 2005, CYTOKINE GROWTH F R, V16, P187, DOI 10.1016/j.cytogfr.2005.03.001; Yen HCS, 2003, CELL CYCLE, V2, P81, DOI 10.4161/cc.2.2.340; Zebrafish Nusslein-Volhard C., 2002, PRACTICAL APPROACH; Zhou CS, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-14	37	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e959	10.1371/journal.pone.0000959	http://dx.doi.org/10.1371/journal.pone.0000959			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895999	Green Published, Green Submitted, gold			2022-12-25	WOS:000207455800037
J	Beadell, JS; Atkins, C; Cashion, E; Jonker, M; Fleischer, RC				Beadell, Jon S.; Atkins, Colm; Cashion, Erin; Jonker, Michelle; Fleischer, Robert C.			Immunological Change in a Parasite-Impoverished Environment: Divergent Signals from Four Island Taxa	PLOS ONE			English	Article							GENETIC-VARIATION; AVIAN MALARIA; MICROSATELLITE LOCI; REPRODUCTIVE EFFORT; IMMUNE-RESPONSE; INFECTIOUS-DISEASES; NATURAL ANTIBODIES; FOUNDER EVENTS; HOUSE SPARROWS; TRADE-OFFS	Dramatic declines of native Hawaiian avifauna due to the human-mediated emergence of avian malaria and pox prompted an examination of whether island taxa share a common altered immunological signature, potentially driven by reduced genetic diversity and reduced exposure to parasites. We tested this hypothesis by characterizing parasite prevalence, genetic diversity and three measures of immune response in two recently-introduced species (Neochmia temporalis and Zosterops lateralis) and two island endemics (Acrocephalus aequinoctialis and A. rimitarae) and then comparing the results to those observed in closely-related mainland counterparts. The prevalence of blood parasites was significantly lower in 3 of 4 island taxa, due in part to the absence of certain parasite lineages represented in mainland populations. Indices of genetic diversity were unchanged in the island population of N. temporalis; however, allelic richness was significantly lower in the island population of Z. lateralis while both allelic richness and heterozygosity were significantly reduced in the two island-endemic species examined. Although parasite prevalence and genetic diversity generally conformed to expectations for an island system, we did not find evidence for a pattern of uniformly altered immune responses in island taxa, even amongst endemic taxa with the longest residence times. The island population of Z. lateralis exhibited a significantly reduced inflammatory cell-mediated response while levels of natural antibodies remained unchanged for this and the other recently introduced island taxon. In contrast, the island endemic A. rimitarae exhibited a significantly increased inflammatory response as well as higher levels of natural antibodies and complement. These measures were unchanged or lower in A. aequinoctialis. We suggest that small differences in the pathogenic landscape and the stochastic history of mutation and genetic drift are likely to be important in shaping the unique immunological profiles of small isolated populations. Consequently, predicting the impact of introduced disease on the many other endemic faunas of the remote Pacific will remain a challenge.	[Beadell, Jon S.; Atkins, Colm; Cashion, Erin; Fleischer, Robert C.] Smithsonian Inst, Natl Zool Pk, Genet Program, Washington, DC 20008 USA; [Beadell, Jon S.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Jonker, Michelle] Australian Inst Marine Sci, Townsville, Qld 4810, Australia	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; University System of Maryland; University of Maryland College Park; Australian Institute of Marine Science	Beadell, JS (corresponding author), Smithsonian Inst, Natl Zool Pk, Genet Program, Washington, DC 20008 USA.	beadellj@si.edu	Jonker, Michelle/P-8910-2019; Jonker, Michelle/A-4563-2016	Jonker, Michelle/0000-0002-0876-6081; Jonker, Michelle/0000-0002-0876-6081; Atkins, Colm/0000-0003-4110-161X	National Science Foundation [0508754]; Smithsonian Institution (Abbott Fund); Cosmos Club; American Ornithologists' Union	National Science Foundation(National Science Foundation (NSF)); Smithsonian Institution (Abbott Fund)(Smithsonian InstitutionSmithsonian National Museum of Natural History); Cosmos Club; American Ornithologists' Union	This project was supported by the National Science Foundation ( Grant No. 0508754), Smithsonian Institution (Abbott Fund grant and graduate fellowship), Cosmos Club, and the American Ornithologists' Union.	Acevedo-Whitehouse K, 2003, NATURE, V422, P35, DOI 10.1038/422035a; Adamo SA, 2004, ANIM BEHAV, V68, P1443, DOI 10.1016/j.anbehav.2004.05.005; Aguilar A, 2004, P NATL ACAD SCI USA, V101, P3490, DOI 10.1073/pnas.0306582101; Amos W, 2001, P ROY SOC B-BIOL SCI, V268, P2021, DOI 10.1098/rspb.2001.1751; Aparicio JM, 2006, MOL ECOL, V15, P4659, DOI 10.1111/j.1365-294X.2006.03111.x; Atkinson Carter T., 2006, Pacific Conservation Biology, V12, P229; Atkinson CT, 1995, PARASITOLOGY, V111, pS59, DOI 10.1017/S003118200007582X; Atkinson CT, 2000, J WILDLIFE DIS, V36, P197, DOI 10.7589/0090-3558-36.2.197; Atkinson CT, 2001, CONDOR, V103, P209, DOI 10.1650/0010-5422(2001)103[0209:PSRADO]2.0.CO;2; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P1707, DOI 10.1098/rspb.1998.0492; BAKER AJ, 1987, EVOLUTION, V41, P525, DOI 10.1111/j.1558-5646.1987.tb05823.x; Beadell JS, 2006, P ROY SOC B-BIOL SCI, V273, P2935, DOI 10.1098/rspb.2006.3671; Beadell JS, 2004, MOL ECOL, V13, P3829, DOI 10.1111/j.1365-294X.2004.02363.x; Beadell JS, 2005, J PARASITOL, V91, P683, DOI 10.1645/GE-3412RN; BENNETT GF, 1993, J NAT HIST, V27, P993, DOI 10.1080/00222939300770621; BLAKERS M, 1985, ATLAS AUSTR BIRDS, P738; Blondel J, 2000, VIE MILIEU, V50, P205; Boots M, 2004, P ROY SOC B-BIOL SCI, V271, P715, DOI 10.1098/rspb.2003.2655; Clegg SM, 2002, P NATL ACAD SCI USA, V99, P8127, DOI 10.1073/pnas.102583399; Clifford DL, 2006, BIOL CONSERV, V131, P230, DOI 10.1016/j.biocon.2006.04.029; Colautti RI, 2004, ECOL LETT, V7, P721, DOI 10.1111/j.1461-0248.2004.00616.x; COOPER JE, 1993, J ZOO WILDLIFE MED, V24, P256; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Deerenberg C, 1997, P ROY SOC B-BIOL SCI, V264, P1021, DOI 10.1098/rspb.1997.0141; Degnan SM, 1999, MOL ECOL, V8, P159; DOBSON A P, 1988, Conservation Biology, V2, P31, DOI 10.1111/j.1523-1739.1988.tb00333.x; Fleischer RC, 1998, MOL ECOL, V7, P533, DOI 10.1046/j.1365-294x.1998.00364.x; Frankham R, 1997, HEREDITY, V78, P311, DOI 10.1038/hdy.1997.46; Frentiu FD, 2003, MOL ECOL NOTES, V3, P462, DOI 10.1046/j.1471-8286.2003.00484.x; Friend M, 2001, AUK, V118, P290, DOI 10.1642/0004-8038(2001)118[0290:DEIBCF]2.0.CO;2; Fromont E, 2001, PARASITOLOGY, V123, P143, DOI 10.1017/S0031182001008277; Goltsman M, 2005, J ZOOL, V267, P405, DOI 10.1017/S0952836905007557; Goltsman M., 1996, Oryx, V30, P251; Gonzalez G, 1999, J ANIM ECOL, V68, P1225, DOI 10.1046/j.1365-2656.1999.00364.x; Gottdenker NL, 2005, BIOL CONSERV, V126, P429, DOI 10.1016/j.biocon.2005.06.025; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; GUSTAFSSON L, 1994, PHILOS T R SOC B, V346, P323, DOI 10.1098/rstb.1994.0149; Hale KA, 2007, ANIM CONSERV, V10, P2, DOI 10.1111/j.1469-1795.2006.00059.x; Hansson B, 2000, MOL ECOL, V9, P1529, DOI 10.1046/j.1365-294x.2000.01028.x; Hansson B, 2005, ANIM CONSERV, V8, P83, DOI 10.1017/S1367943004001878; Hawley DM, 2005, BIOL LETTERS, V1, P326, DOI 10.1098/rsbl.2005.0303; Hillgarth Nigella, 1997, P78; Hochberg ME, 2001, J EVOLUTION BIOL, V14, P539, DOI 10.1046/j.1420-9101.2001.00312.x; Humphrey B. D., 2002, Nutritional biotechnology in the feed and food industries. Proceedings of Alltech's 18th Annual Symposium: from niche markets to mainstream, Lexington, Kentucky, USA, 13-15 May 2002, P69; Janeway CA, 2005, IMMUNOBIOLOGY; Jarvi SI, 2003, CONSERV GENET, V4, P629, DOI 10.1023/A:1025626529806; Jarvi SI, 2001, STUD AVIAN BIOL-SER, P254; KLASING KC, 1988, J NUTR, V118, P1158, DOI 10.1093/jn/118.9.1158; Lindstrom KM, 2004, P ROY SOC B-BIOL SCI, V271, P1513, DOI 10.1098/rspb.2004.2752; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Long JL, 1981, INTRO BIRDS WORLD; LYLES AM, 1993, J ZOO WILDLIFE MED, V24, P315; Martin LB, 2003, P ROY SOC B-BIOL SCI, V270, P153, DOI 10.1098/rspb.2002.2185; Martin TE, 2001, P NATL ACAD SCI USA, V98, P2071, DOI 10.1073/pnas.98.4.2071; Martinez MC, 2006, EDUC POLICY, V20, P299, DOI 10.1177/0895904805285017; Matson KD, 2005, DEV COMP IMMUNOL, V29, P275, DOI 10.1016/j.dci.2004.07.006; Matson KD, 2006, P ROY SOC B-BIOL SCI, V273, P2267, DOI 10.1098/rspb.2006.3590; Merino S, 2000, P ROY SOC B-BIOL SCI, V267, P2507, DOI 10.1098/rspb.2000.1312; MILDER S L, 1982, Bulletin of the British Ornithologists' Club, V102, P20; Millien V, 2006, PLOS BIOL, V4, P1863, DOI 10.1371/journal.pbio.0040321; Moller AP, 2004, OIKOS, V104, P299, DOI 10.1111/j.0030-1299.2004.12844.x; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Nordling D, 1998, P ROY SOC B-BIOL SCI, V265, P1291, DOI 10.1098/rspb.1998.0432; OBRIEN SJ, 1985, SCIENCE, V227, P1428, DOI 10.1126/science.2983425; Ochsenbein AF, 2000, IMMUNOL TODAY, V21, P624, DOI 10.1016/S0167-5699(00)01754-0; Parker Patricia G, 2006, Auk, V123, P625, DOI 10.1093/auk/123.3.625; Parmentier HK, 2004, DEV COMP IMMUNOL, V28, P39, DOI 10.1016/S0145-305X(03)00087-9; Pearman PB, 2005, ECOL LETT, V8, P401, DOI 10.1111/j.1461-0248.2005.00735.x; Peters A, 2004, AM NAT, V164, P51, DOI 10.1086/421302; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reid JM, 2003, P ROY SOC B-BIOL SCI, V270, P2151, DOI 10.1098/rspb.2003.2480; Richard FA, 2002, J PARASITOL, V88, P819, DOI 10.1645/0022-3395(2002)088[0819:ACAOPB]2.0.CO;2; Richardson DS, 2000, MOL ECOL, V9, P2226; ROELKE ME, 1993, CURR BIOL, V3, P340, DOI 10.1016/0960-9822(93)90197-V; Schmid-Hempel P, 2003, TRENDS ECOL EVOL, V18, P27, DOI 10.1016/S0169-5347(02)00013-7; SCRIMSHAW NS, 1991, JPEN-PARENTER ENTER, V15, P589, DOI 10.1177/0148607191015006589; Sefc KM, 2001, MOL ECOL NOTES, V1, P252, DOI 10.1046/j.1471-8278.2001.00095.x; Smits JE, 2005, VET PATHOL, V42, P59, DOI 10.1354/vp.42-1-59; Smits JE, 1999, FUNCT ECOL, V13, P567, DOI 10.1046/j.1365-2435.1999.00338.x; Spielman D, 2004, CONSERV GENET, V5, P439, DOI 10.1023/B:COGE.0000041030.76598.cd; Steadman DW, 1997, J BIOGEOGR, V24, P737, DOI 10.1046/j.1365-2699.1997.00157.x; Tarr CL, 1998, MOL ECOL, V7, P719, DOI 10.1046/j.1365-294x.1998.00385.x; Tompkins DM, 2006, J ROY SOC NEW ZEAL, V36, P51, DOI 10.1080/03014223.2006.9517799; Valkiunas, 2005, AVIAN MALARIA PARASI, P932; Viney ME, 2005, TRENDS ECOL EVOL, V20, P665, DOI 10.1016/j.tree.2005.10.003; WARNER RE, 1968, CONDOR, V70, P101, DOI 10.2307/1365954; Whiteman NK, 2006, P ROY SOC B-BIOL SCI, V273, P797, DOI 10.1098/rspb.2005.3396; Wiggins DA, 1998, OECOLOGIA, V115, P478, DOI 10.1007/s004420050544; Wikelski M, 2004, ECOL SOC, V9; Wright S, 1931, GENETICS, V16, P0097; Yorinks N, 2000, AUK, V117, P731, DOI 10.1642/0004-8038(2000)117[0731:EOMOAB]2.0.CO;2; Zuk M, 2002, AM NAT, V160, pS9, DOI 10.1086/342131	93	24	24	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2007	2	9							e896	10.1371/journal.pone.0000896	http://dx.doi.org/10.1371/journal.pone.0000896			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HS	17878931	Green Published, gold, Green Submitted			2022-12-25	WOS:000207455700004
J	Burmeister, C; Luersen, K; Heinick, A; Hussein, A; Domagalski, M; Walter, RD; Liebau, E				Burmeister, Cora; Lueersen, Kai; Heinick, Alexander; Hussein, Ayman; Domagalski, Marzena; Walter, Rolf D.; Liebau, Eva			Oxidative stress in Caenorhabditis elegans: protective effects of the Omega class glutathione transferase (GSTO-1)	FASEB JOURNAL			English	Article						antioxidant; RNA interference; GST	UBIQUITIN-CONJUGATING ENZYMES; AGE-AT-ONSET; S-TRANSFERASE; C-ELEGANS; FUNCTIONAL-ANALYSIS; CONFERS RESISTANCE; REDOX REGULATION; GENE-TRANSFER; GATA-FACTOR; IDENTIFICATION	To elucidate the function of Omega class glutathione transferases (GSTs) (EC 2.5.1.18) in multicellular organisms, the GSTO-1 from Caenorhabditis elegans (GSTO-1; C29E4.7) was investigated. Disc diffusion assays using Escherichia coli overexpressing GSTO-1 provided a test of resistance to long-term exposure under oxidative stress. After affinity purification, the recombinant GSTO-1 had minimal catalytic activity toward classic GST substrates but displayed significant thiol oxidoreductase and dehydroascorbate reductase activity. Microinjection of the GSTO-1-promoter green fluorescent protein construct and immunolocalization by electron microscopy localized the protein exclusively in the intestine of all postembryonic stages of C. elegans. Deletion analysis identified an similar to 300-nucleotide sequence upstream of the ATG start site necessary for GSTO-1 expression. Site-specific mutagenesis of a GATA transcription factor binding motif in the minimal promoter led to the loss of reporter expression. Similarly, RNA interference (RNAi) of Elt-2 indicated the involvement of this gut-specific transcription factor in GSTO-1 expression. Transcriptional upregulation under stress conditions of GSTO-1 was confirmed by analyzing promoter-reporter constructs in transgenic C. elegans strains. To investigate the function of GSTO-1 in vivo, transgenic animals overexpressing GSTO-1 were generated exhibiting an increased resistance to juglone-, paraquat-, and cumene hydroperoxide-induced oxidative stress. Specific silencing of the GSTO-1 by RNAi created worms with an increased sensitivity to several prooxidants, arsenite, and heat shock. We conclude that the stress-responsive GSTO-1 plays a key role in counteracting environmental stress.	[Burmeister, Cora; Lueersen, Kai; Heinick, Alexander; Liebau, Eva] Univ Munster, Inst Anim Physiol, D-48143 Munster, Germany; [Hussein, Ayman] An Najah Natl Univ, Fac Sci, Nablus, Israel; [Domagalski, Marzena; Walter, Rolf D.] Bernhard Nocht Inst Trop Med, Hamburg, Germany	University of Munster; An Najah National University; Bernhard Nocht Institut fur Tropenmedizin	Liebau, E (corresponding author), Univ Munster, Inst Anim Physiol, Hindenburgpl 55, D-48143 Munster, Germany.	liebaue@uni-muenster.de		Heinick, Alexander/0000-0002-3770-105X				Ayyadevara S, 2005, AGING CELL, V4, P257, DOI 10.1111/j.1474-9726.2005.00168.x; Board PG, 2000, J BIOL CHEM, V275, P24798, DOI 10.1074/jbc.M001706200; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caccuri AM, 2002, J BIOL CHEM, V277, P18777, DOI 10.1074/jbc.M201137200; CLOS J, 1994, PROTEIN EXPRES PURIF, V5, P133, DOI 10.1006/prep.1994.1020; Denton H, 2004, BIOCHEM J, V381, P405, DOI 10.1042/BJ20040283; Dixon DP, 2002, J BIOL CHEM, V277, P30859, DOI 10.1074/jbc.M202919200; Dulhunty A, 2001, J BIOL CHEM, V276, P3319, DOI 10.1074/jbc.M007874200; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fukushige T, 1998, DEV BIOL, V198, P286, DOI 10.1016/S0012-1606(98)80006-7; Fukushige T, 2003, GENETICS, V165, P575; Fukushige T, 2005, DEV BIOL, V279, P446, DOI 10.1016/j.ydbio.2004.12.012; Garcera A, 2006, BIOCHEM J, V398, P187, DOI 10.1042/BJ20060034; Ghezzi P, 2005, FREE RADICAL RES, V39, P573, DOI 10.1080/10715760500072172; Giustarini D, 2004, J CELL MOL MED, V8, P201, DOI 10.1111/j.1582-4934.2004.tb00275.x; GRANATO M, 1994, NUCLEIC ACIDS RES, V22, P1762, DOI 10.1093/nar/22.9.1762; JahngenHodge J, 1997, J BIOL CHEM, V272, P28218, DOI 10.1074/jbc.272.45.28218; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kampkotter A, 2003, J MOL BIOL, V325, P25, DOI 10.1016/S0022-2836(02)01174-9; Kim J, 2006, BIOCHEM J, V398, P451, DOI 10.1042/BJ20060424; Kodym R, 1999, J BIOL CHEM, V274, P5131, DOI 10.1074/jbc.274.8.5131; Komatsu M, 2004, EMBO J, V23, P1977, DOI 10.1038/sj.emboj.7600205; Laliberte RE, 2003, J BIOL CHEM, V278, P16567, DOI 10.1074/jbc.M211596200; Leiers BR, 2003, FREE RADICAL BIO MED, V34, P1405, DOI 10.1016/S0891-5849(03)00102-3; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Li YJ, 2003, HUM MOL GENET, V12, P3259, DOI 10.1093/hmg/ddg357; Liao VHC, 2005, BIOMETALS, V18, P519, DOI 10.1007/s10534-005-2996-3; Liebau E, 1997, BIOCHEM J, V324, P659, DOI 10.1042/bj3240659; Liebau E, 2000, MOL BIOCHEM PARASIT, V109, P101, DOI 10.1016/S0166-6851(00)00232-2; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Murakami R, 2005, DEV GROWTH DIFFER, V47, P581; Obin M, 1998, FASEB J, V12, P561, DOI 10.1096/fasebj.12.7.561; Oskouian B, 2005, J BIOL CHEM, V280, P18403, DOI 10.1074/jbc.M410928200; Schmuck EM, 2005, PHARMACOGENET GENOM, V15, P493, DOI 10.1097/01.fpc.0000165725.81559.e3; Shi HL, 2004, MOL CELL BIOCHEM, V255, P67, DOI 10.1023/B:MCBI.0000007262.26044.e8; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Townsend DM, 2003, ONCOGENE, V22, P7369, DOI 10.1038/sj.onc.1206940; WHITBREAD AK, 1940, METHOD ENZYMOL, V401, P78; Yin SP, 2005, J BIOL CHEM, V280, P34985, DOI 10.1074/jbc.M503522200; Yin ZL, 2001, J HISTOCHEM CYTOCHEM, V49, P983, DOI 10.1177/002215540104900806; Zakharyan RA, 2001, CHEM RES TOXICOL, V14, P1051, DOI 10.1021/tx010052h	42	94	101	1	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2008	22	2					343	354		10.1096/fj.06-7426com	http://dx.doi.org/10.1096/fj.06-7426com			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	257TY	17901115				2022-12-25	WOS:000252822600004
J	Lee, KS; Raymond, LD; Schoen, B; Raymond, GJ; Kett, L; Moore, RA; Johnson, LM; Taubner, L; Speare, JO; Onwubiko, HA; Baron, GS; Caughey, WS; Caughey, B				Lee, Kil S.; Raymond, Lynne D.; Schoen, Brianna; Raymond, Gregory J.; Kett, Lauren; Moore, Roger A.; Johnson, Lisa M.; Taubner, Lara; Speare, Jonathan O.; Onwubiko, Henry A.; Baron, Gerald S.; Caughey, Winslow S.; Caughey, Byron			Hemin interactions and alterations of the subcellular localization of prion protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLULAR PRION; CASPASE-3 ACTIVATION; NEUROBLASTOMA-CELLS; OCTAREPEAT REGION; SULFATED GLYCANS; OXIDATIVE STRESS; PLASMA-MEMBRANE; CULTURED-CELLS; ENDOCYTOSIS; DISEASE	Hemin (iron protoporphyrin IX) is a crucial component of many physiological processes acting either as a prosthetic group or as an intracellular messenger. Some unnatural, synthetic porphyrins have potent anti-scrapie activity and can interact with normal prion protein (PrPC). These observations raised the possibility that hemin, as a natural porphyrin, is a physiological ligand for PrPC. Accordingly, we evaluated PrPC interactions with hemin. When hemin (3-10 mu M) was added to the medium of cultured cells, clusters of PrPC formed on the cell surface, and the detergent solubility of PrPC decreased. The addition of hemin also induced PrPC internalization and turnover. The ability of hemin to bind directly to PrPC was demonstrated by hemin-agarose affinity chromatography and UV-visible spectroscopy. Multiple hemin molecules bound primarily to the N-terminal third of PrPC, with reduced binding to PrPC lacking residues 34-94. These hemin-PrPC interactions suggest that PrPC may participate in hemin homeostasis, sensing, and/or uptake and that hemin might affect PrPC functions.	NIAID, NIH, Rocky Mt Labs, Persistent Viral Dis Lab, Hamilton, MT 59840 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Caughey, B (corresponding author), Rocky Mt Labs, 903 S 4th St, Hamilton, MT 59840 USA.	bcaughey@nih.gov	Lee, Kil S/D-3678-2012; Lee, Kil Sun/AAL-8564-2020	Lee, Kil S/0000-0002-2390-2774; 	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000580, Z01AI000580] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Atamna H, 2006, P NATL ACAD SCI USA, V103, P3381, DOI 10.1073/pnas.0600134103; Basu S, 2007, MOL BIOL CELL, V18, P3302, DOI 10.1091/mbc.E07-04-0317; BORCHELT DR, 1990, J CELL BIOL, V110, P743, DOI 10.1083/jcb.110.3.743; Brazier MW, 2006, BRAIN RES BULL, V68, P346, DOI 10.1016/j.brainresbull.2005.09.010; Brown LR, 2003, J NEUROCHEM, V87, P353, DOI 10.1046/j.1471-4159.2003.01996.x; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; Caughey B, 2006, ACCOUNTS CHEM RES, V39, P646, DOI 10.1021/ar050068p; CAUGHEY B, 1989, J VIROL, V63, P175, DOI 10.1128/JVI.63.1.175-181.1989; Caughey WS, 1998, P NATL ACAD SCI USA, V95, P12117, DOI 10.1073/pnas.95.21.12117; Cheng F, 2006, J NEUROCHEM, V98, P1445, DOI 10.1111/j.1471-4159.2006.03981.x; Choi KH, 2005, GLYCOCONJUGATE J, V22, P63, DOI 10.1007/s10719-005-0326-1; Everse J, 2005, FREE RADICAL BIO MED, V38, P1296, DOI 10.1016/j.freeradbiomed.2005.01.018; Faller M, 2007, NAT STRUCT MOL BIOL, V14, P23, DOI 10.1038/nsmb1182; Galzigna L, 2000, CLIN CHIM ACTA, V300, P131, DOI 10.1016/S0009-8981(00)00313-2; Graner E, 2000, MOL BRAIN RES, V76, P85, DOI 10.1016/S0169-328X(99)00334-4; Hou SW, 2006, ACCOUNTS CHEM RES, V39, P918, DOI 10.1021/ar040020w; Hvidberg V, 2005, BLOOD, V106, P2572, DOI 10.1182/blood-2005-03-1185; Kiachopoulos S, 2004, TRAFFIC, V5, P426, DOI 10.1111/j.1398-9219.2004.00185.x; Klamt F, 2001, FREE RADICAL BIO MED, V30, P1137; Kocisko DA, 2006, ANTIMICROB AGENTS CH, V50, P1034, DOI 10.1128/AAC.50.3.1034-1044.2006; Kocisko DA, 2006, ANTIMICROB AGENTS CH, V50, P759, DOI 10.1128/AAC.50.2.759-761.2006; Kocisko DA, 2007, ANAL BIOCHEM, V363, P154, DOI 10.1016/j.ab.2006.11.007; Krishnamurthy P, 2007, PHARMACOL THERAPEUT, V114, P345, DOI 10.1016/j.pharmthera.2007.02.001; Kuczius T, 2004, BIOL CHEM, V385, P739, DOI 10.1515/BC.2004.090; Kumar S, 2005, TOXICOL LETT, V157, P175, DOI 10.1016/j.toxlet.2005.03.004; Lawson VA, 2001, J BIOL CHEM, V276, P35265, DOI 10.1074/jbc.M103799200; LIN H, 1987, ANAL BIOCHEM, V161, P323, DOI 10.1016/0003-2697(87)90458-1; Lopes MH, 2005, J NEUROSCI, V25, P11330, DOI 10.1523/JNEUROSCI.2313-05.2005; Maxson L, 2003, ANAL BIOCHEM, V323, P54, DOI 10.1016/j.ab.2003.07.028; Millhauser GL, 2007, ANNU REV PHYS CHEM, V58, P299, DOI 10.1146/annurev.physchem.58.032806.104657; Minana R, 2001, EUR J NEUROSCI, V13, P749, DOI 10.1046/j.0953-816x.2000.01439.x; Mitteregger G, 2007, BRAIN PATHOL, V17, P174, DOI 10.1111/j.1750-3639.2007.00061.x; Monzani E, 2001, BBA-PROTEIN STRUCT M, V1547, P302, DOI 10.1016/S0167-4838(01)00192-3; Morris RJ, 2006, FEBS LETT, V580, P5565, DOI 10.1016/j.febslet.2006.07.053; Nadal RC, 2007, FREE RADICAL BIO MED, V42, P79, DOI 10.1016/j.freeradbiomed.2006.09.019; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Nunziante M, 2005, J CELL SCI, V118, P4959, DOI 10.1242/jcs.02609; Pauly PC, 1998, J BIOL CHEM, V273, P33107, DOI 10.1074/jbc.273.50.33107; Petersen RB, 2005, ACTA NEUROPATHOL, V110, P232, DOI 10.1007/s00401-005-1034-4; Priola SA, 2003, J INFECT DIS, V188, P699, DOI 10.1086/377310; Priola SA, 2000, SCIENCE, V287, P1503, DOI 10.1126/science.287.5457.1503; Quaglio E, 2001, J BIOL CHEM, V276, P11432, DOI 10.1074/jbc.M009666200; Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127; SCHMITT TH, 1993, ARCH BIOCHEM BIOPHYS, V307, P96, DOI 10.1006/abbi.1993.1566; Schmitt-Ulms G, 2001, J MOL BIOL, V314, P1209, DOI 10.1006/jmbi.2000.5183; Scibior Dorota, 2006, Postepy Hig Med Dosw (Online), V60, P170; SHYNG SL, 1993, J BIOL CHEM, V268, P15922; SHYNG SL, 1995, J BIOL CHEM, V270, P30221; STAHL N, 1991, FASEB J, V5, P2799, DOI 10.1096/fasebj.5.13.1916104; Sumudhu W, 2001, CURR BIOL, V11, P519, DOI 10.1016/S0960-9822(01)00147-6; Sun JY, 2004, P NATL ACAD SCI USA, V101, P1461, DOI 10.1073/pnas.0308083100; Sunyach C, 2003, EMBO J, V22, P3591, DOI 10.1093/emboj/cdg344; Sunyach C, 2005, J NEUROCHEM, V92, P1399, DOI 10.1111/j.1471-4159.2004.02989.x; Sunyach C, 2007, J BIOL CHEM, V282, P1956, DOI 10.1074/jbc.M609663200; Takemura K, 2006, EXP BIOL MED, V231, P204; Taylor DR, 2007, BIOCHEM J, V402, P17, DOI 10.1042/BJ20061736; Warner RG, 2002, J BIOL CHEM, V277, P18421, DOI 10.1074/jbc.M110406200; Watt NT, 2005, J BIOL CHEM, V280, P35914, DOI 10.1074/jbc.M507327200; White AR, 1999, AM J PATHOL, V155, P1723, DOI 10.1016/S0002-9440(10)65487-9; Wong C, 2001, EMBO J, V20, P377, DOI 10.1093/emboj/20.3.377; Zahn R, 1997, FEBS LETT, V417, P400, DOI 10.1016/S0014-5793(97)01330-6; Zeng FN, 2003, J NEUROCHEM, V84, P480, DOI 10.1046/j.1471-4159.2003.01529.x; Zhu YH, 2002, DNA CELL BIOL, V21, P333, DOI 10.1089/104454902753759744	63	40	43	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36525	36533		10.1074/jbc.M705620200	http://dx.doi.org/10.1074/jbc.M705620200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17925394	hybrid			2022-12-25	WOS:000251458300045
J	Mans, BJ; Calvo, E; Ribeiro, JMC; Andersen, JF				Mans, Ben J.; Calvo, Eric; Ribeiro, Jose M. C.; Andersen, John F.			The crystal structure of D7r4, a salivary biogenic amine-binding protein from the malaria mosquito anopheles gambiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADULT FEMALE MOSQUITO; HISTAMINE-BINDING; PHEROMONE-BINDING; AEDES-AEGYPTI; DENSITY MODIFICATION; RHODNIUS-PROLIXUS; NMR STRUCTURE; GLAND; SIALOME; CLONING	The D7-related (D7r) proteins of the malaria vector Anopheles gambiae have been shown to bind the biogenic amines serotonin, norepinephrine, and histamine with high affinity. One member of the group (D7r1 or hamadarin) has also been shown to have an anticoagulant/antikinin activity. To understand the mechanistic details of its antihemostatic/anti-inflammatory effects, we have determined the crystal structure of one member of this group, D7r4, along with the structures of ligand complexes with serotonin, tryptamine, histamine, and norepinephrine. The D7 fold consists of an arrangement of eight alpha-helices stabilized by three disulfide bonds. The structure is similar to those of the arthropod odorant-binding proteins, a relationship that had been predicted based on sequence comparisons. Although odorant-binding proteins commonly have six alpha-helices, D7r4 has eight, resulting in significantly different positioning and structure of the ligand binding pocket. The pocket itself is lined by hydrophobic side chains along with polar and charged groups oriented to form hydrogen bonds with the aliphatic amino group and with groups on the aromatic portions of the ligands. These structures, along with accompanying mutagenesis studies, have allowed us to identify critical residues for biogenic amine binding and to predict which members of the large D7 protein family found in blood-feeding nematocerous Diptera will function as biogenic amine-binding proteins.	NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Andersen, JF (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Rm 2E32B,Twinbrook 3 Bldg,12735 Twinbrook Pkwy, Rockville, MD 20852 USA.	jandersen@niaid.nih.gov	Calvo, Eric/ABB-4935-2021; Mans, Ben J./M-2427-2017	Calvo, Eric/0000-0001-7880-2730; Mans, Ben J./0000-0002-0177-0029; Ribeiro, Jose/0000-0002-9107-0818	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI001012, ZIAAI001012, ZIAAI000810, Z01AI000810] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andersen JF, 2003, J BIOL CHEM, V278, P4611, DOI 10.1074/jbc.M211438200; Anderson JM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-52; Arca B, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P483; Calvo E, 2006, J BIOL CHEM, V281, P1935, DOI 10.1074/jbc.M510359200; Calvo E, 2004, INSECT MOL BIOL, V13, P73, DOI 10.1111/j.1365-2583.2004.00463.x; Calvo E, 2002, INSECT BIOCHEM MOLEC, V32, P1419, DOI 10.1016/S0965-1748(02)00062-0; Calvo E, 2007, INSECT BIOCHEM MOLEC, V37, P164, DOI 10.1016/j.ibmb.2006.11.005; Campbell CL, 2005, INSECT MOL BIOL, V14, P121, DOI 10.1111/j.1365-2583.2004.00537.x; *CCPA, 1994, ACTA CRYSTALLOGR D, V50, P760; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Francischetti IMB, 2002, J EXP BIOL, V205, P2429; Hekmat-Scafe DS, 2000, GENETICS, V155, P117; Horst R, 2001, P NATL ACAD SCI USA, V98, P14374, DOI 10.1073/pnas.251532998; Isawa H, 2007, INSECT BIOCHEM MOLEC, V37, P466, DOI 10.1016/j.ibmb.2007.02.002; JAMES AA, 1991, MOL BIOCHEM PARASIT, V44, P245, DOI 10.1016/0166-6851(91)90010-4; KLEYWEGT GJ, 1995, STRUCTURE, V3, P535, DOI 10.1016/S0969-2126(01)00187-3; Lee D, 2002, FEBS LETT, V531, P314, DOI 10.1016/S0014-5793(02)03548-2; Looger LL, 2003, NATURE, V423, P185, DOI 10.1038/nature01556; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Montfort WR, 2000, BBA-PROTEIN STRUCT M, V1482, P110, DOI 10.1016/S0167-4838(00)00165-5; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OTWINOWSKI Z, 1991, P CCP4 STUD WEEK 25, P60; Paesen GC, 1999, MOL CELL, V3, P661, DOI 10.1016/S1097-2765(00)80359-7; RIBEIRO JMC, 1994, J EXP MED, V180, P2251, DOI 10.1084/jem.180.6.2251; RIBEIRO JMC, 1994, J MED ENTOMOL, V31, P747, DOI 10.1093/jmedent/31.5.747; Ribeiro JMC, 1999, J EXP BIOL, V202, P809; Ribeiro JMC, 2004, INSECT BIOCHEM MOLEC, V34, P543, DOI 10.1016/j.ibmb.2004.02.008; RIBEIRO JMC, 1995, INFECT AGENT DIS, V4, P143; Ribeiro JMC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-6; Rothemund S, 1999, STRUCT FOLD DES, V7, P1325, DOI 10.1016/S0969-2126(00)80022-2; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; Sangamnatdej S, 2002, INSECT MOL BIOL, V11, P79, DOI 10.1046/j.0962-1075.2001.00311.x; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Tegoni M, 2000, BBA-PROTEIN STRUCT M, V1482, P229, DOI 10.1016/S0167-4838(00)00167-9; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Valenzuela JG, 1999, BIOCHEMISTRY-US, V38, P11209, DOI 10.1021/bi990761i; Valenzuela JG, 2002, INSECT BIOCHEM MOLEC, V32, P1101, DOI 10.1016/S0965-1748(02)00047-4; Weston-Davies W, 2002, LANCET, V359, P1067, DOI 10.1016/S0140-6736(02)08075-3	42	63	64	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36626	36633		10.1074/jbc.M706410200	http://dx.doi.org/10.1074/jbc.M706410200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17928288	hybrid			2022-12-25	WOS:000251458300055
J	Beran, RKF; Serebrov, V; Pyle, AM				Beran, Rudolf K. F.; Serebrov, Victor; Pyle, Anna Marie			The serine protease domain of hepatitis C viral NS3 activates RNA helicase activity by promoting the binding of RNA substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTATIONAL ANALYSIS; VIRUS; REQUIRES; NS4A; TRANSLOCATION; INHIBITORS; SEPARATION; MECHANISM; MOTOR	Nonstructural (NS) protein 3 is a DEXH/D-box motor protein that is an essential component of the hepatitis C viral (HCV) replicative complex. The full-length NS3 protein contains two functional modules, both of which are essential in the life cycle of HCV: a serine protease domain at the N terminus and an ATPase/helicase domain (NS3hel) at the C terminus. Truncated NS3hel constructs have been studied extensively; the ATPase, nucleic acid binding, and helicase activities have been examined and NS3hel has been used as a target in the development of antivirals. However, a comprehensive comparison of NS3 and NS3hel activities has not been performed, so it remains unclear whether the protease domain plays a vital role in NS3 helicase function. Given that many DEXH/D-box proteins are activated upon interaction with cofactor proteins, it is important to establish if the protease domain acts as the cofactor for stimulating NS3 helicase function. Here we show that the protease domain greatly enhances both the direct and functional binding of RNA to NS3. Whereas electrostatics plays an important role in this process, there is a specific allosteric contribution from the interaction interface between NS3hel and the protease domain. Most importantly, we establish that the protease domain is required for RNA unwinding by NS3. Our results suggest that, in addition to its role in cleavage of host and viral proteins, the NS3 protease domain is essential for the process of viral RNA replication and, given its electrostatic contribution to RNA binding, it may also assist in packaging of the viral RNA.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Yale University; Howard Hughes Medical Institute	Pyle, AM (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 266 Whitney Ave,Bass Bldg,Rm 334, New Haven, CT 06520 USA.	anna.pyle@yale.edu		Serebrov, Victor/0000-0002-5800-3103	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM071120, R01GM060620] Funding Source: NIH RePORTER; NIGMS NIH HHS [F32 GM071120-01A1, GM60620] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beran RKF, 2006, J MOL BIOL, V358, P974, DOI 10.1016/j.jmb.2006.02.078; Binder M, 2007, J VIROL, V81, P5270, DOI 10.1128/JVI.00032-07; Borowski P, 2003, EUR J BIOCHEM, V270, P1645, DOI 10.1046/j.1432-1033.2003.03540.x; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; Coburn GA, 1999, GENE DEV, V13, P2594, DOI 10.1101/gad.13.19.2594; Diges CM, 2001, EMBO J, V20, P5503, DOI 10.1093/emboj/20.19.5503; FAILLA C, 1994, J VIROL, V68, P3753, DOI 10.1128/JVI.68.6.3753-3760.1994; Foy E, 2003, SCIENCE, V300, P1145, DOI 10.1126/science.1082604; Frick DN, 2007, CURR ISSUES MOL BIOL, V9, P1; Frick DN, 2007, J MOL BIOL, V365, P1017, DOI 10.1016/j.jmb.2006.10.023; Frick DN, 2004, J BIOL CHEM, V279, P1269, DOI 10.1074/jbc.M310630200; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Granneman S, 2006, NUCLEIC ACIDS RES, V34, P3189, DOI 10.1093/nar/gkl419; Hwang B, 2004, RNA, V10, P1277, DOI 10.1261/rna.7100904; Ishido S, 1998, BIOCHEM BIOPH RES CO, V244, P35, DOI 10.1006/bbrc.1998.8202; Jankowsky E, 2000, NATURE, V403, P447, DOI 10.1038/35000239; Kawaoka J, 2004, NAT STRUCT MOL BIOL, V11, P526, DOI 10.1038/nsmb771; Lam AMI, 2006, J VIROL, V80, P404, DOI 10.1128/JVI.80.1.404-411.2006; Lam AMI, 2003, J VIROL, V77, P3950, DOI 10.1128/JVI.77.7.3950-3961.2003; Levin MK, 2005, NAT STRUCT MOL BIOL, V12, P429, DOI 10.1038/nsmb920; Lin C, 2005, J BIOL CHEM, V280, P36784, DOI 10.1074/jbc.M506462200; Lindenbach BD, 2007, J VIROL, V81, P8905, DOI 10.1128/JVI.00937-07; Merrick WC, 1997, METHODS, V11, P333, DOI 10.1006/meth.1996.0431; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Myong S, 2007, SCIENCE, V317, P513, DOI 10.1126/science.1144130; Pang PS, 2002, EMBO J, V21, P1168, DOI 10.1093/emboj/21.5.1168; PAOLETTI E, 1974, J BIOL CHEM, V249, P3281; Piccininni S, 2002, J BIOL CHEM, V277, P45670, DOI 10.1074/jbc.M204124200; Py B, 1996, NATURE, V381, P169, DOI 10.1038/381169a0; Serebrov V, 2004, NATURE, V430, P476, DOI 10.1038/nature02704; SUZICH JA, 1993, J VIROL, V67, P6152, DOI 10.1128/JVI.67.10.6152-6158.1993; Tackett AJ, 2005, J BIOL CHEM, V280, P10797, DOI 10.1074/jbc.M407971200; Tai CL, 2001, J VIROL, V75, P8289, DOI 10.1128/JVI.75.17.8289-8297.2001; Tanaka N, 2007, GENE DEV, V21, P2312, DOI 10.1101/gad.1580507; Turner AMW, 2007, J BACTERIOL, V189, P2769, DOI 10.1128/JB.01509-06; Vanzo NF, 1998, GENE DEV, V12, P2770, DOI 10.1101/gad.12.17.2770; Voet D., 1995, BIOCHEMISTRY; Weirich CS, 2006, NAT CELL BIOL, V8, P668, DOI 10.1038/ncb1424; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; Yao NH, 1999, STRUCTURE, V7, P1353, DOI 10.1016/S0969-2126(00)80025-8; Yao NH, 1997, NAT STRUCT BIOL, V4, P463, DOI 10.1038/nsb0697-463; Yi MK, 2007, J VIROL, V81, P629, DOI 10.1128/JVI.01890-06; Zhang C, 2005, J VIROL, V79, P8687, DOI 10.1128/JVI.79.14.8687-8697.2005	43	89	92	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34913	34920		10.1074/jbc.M707165200	http://dx.doi.org/10.1074/jbc.M707165200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17921146	hybrid			2022-12-25	WOS:000251155200034
J	Dunn-Siegrist, I; Leger, O; Daubeuf, B; Poitevin, Y; Depis, F; Herren, S; Kosco-Vilbois, M; Dean, Y; Pugin, J; Elson, G				Dunn-Siegrist, Irene; Leger, Olivier; Daubeuf, Bruno; Poitevin, Yves; Depis, Fabien; Herren, Suzanne; Kosco-Vilbois, Marie; Dean, Yann; Pugin, Jerome; Elson, Greg			Pivotal involvement of Fc gamma receptor IIA in the neutralization of lipopolysaccharide signaling via a potent novel anti-TLR4 monoclonal antibody 15C1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA TOLL; HUMAN MONOCYTES; CUTTING EDGE; IN-VIVO; TLR4; BINDING; ACTIVATION; CELLS; MD-2; LPS	The mammalian Toll-like receptor (TLR) family has evolved to sense pathogens in the environment and protect the host against infection. TLR4 recognizes lipopolysaccharide (LPS) from Gram-negative bacteria and induces a signaling cascade that, when exaggerated, has been associated with severe sepsis. Wehave generated a TLR4-specific monoclonal antibody, 15C1, which neutralizes LPS-induced TLR4 activation in a dose-dependent manner. 15C1 potently blocks the effects of LPS on a panel of primary cells and cell lines in vitro. The binding of 15C1 was mapped to an epitope in the second portion of the extracellular region of TLR4, which has been shown previously to be functionally important in the recognition of LPS. Furthermore, we demonstrate a novel mechanism of inhibition, as the effects of 15C1 are partially Fc-dependent, involving the regulatory Fc gamma receptor IIA (CD32A). In addition to introducing 15C1 as a potent clinical candidate for use in the treatment of LPS-mediated indications, our work demonstrates a newly discovered pathway whose manipulation is pivotal in achieving optimal neutralizing benefit.	NovImmune SA, CH-1228 Geneva, Switzerland; Univ Med Ctr, CH-1211 Geneva, Switzerland	NovImmune SA; University of Geneva	Elson, G (corresponding author), NovImmune SA, Plan-les-Ouates, CH-1228 Geneva, Switzerland.	gelson@novimmune.com						Akashi S, 2000, J IMMUNOL, V164, P3471, DOI 10.4049/jimmunol.164.7.3471; Akashi-Takamura S, 2006, J IMMUNOL, V176, P4244, DOI 10.4049/jimmunol.176.7.4244; Annane D, 2005, LANCET, V365, P63, DOI 10.1016/S0140-6736(04)17667-8; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; BAUMGARTNER JD, 1985, LANCET, V2, P59; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Carlsson LE, 1998, BLOOD, V92, P1526, DOI 10.1182/blood.V92.5.1526.417k26_1526_1531; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Cohen SB, 2005, HYBRIDOMA, V24, P27, DOI 10.1089/hyb.2005.24.27; Correia JD, 2001, J BIOL CHEM, V276, P21129, DOI 10.1074/jbc.M009164200; Dijstelbloem HM, 2001, TRENDS IMMUNOL, V22, P510, DOI 10.1016/S1471-4906(01)02014-2; Elson G, 2007, BLOOD, V109, P1574, DOI 10.1182/blood-2006-06-032961; Flo TH, 2002, J BIOL CHEM, V277, P35489, DOI 10.1074/jbc.M201366200; Gamberale R, 2003, BLOOD, V102, P2698, DOI 10.1182/blood-2003-05-1416; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; GAY NJ, 1991, NATURE, V351, P355, DOI 10.1038/351355b0; GOLDIE AS, 1995, JAMA-J AM MED ASSOC, V274, P172, DOI 10.1001/jama.274.2.172; Groger M, 1996, J IMMUNOL, V156, P1549; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Hamerman JA, 2005, NAT IMMUNOL, V6, P579, DOI 10.1038/ni1204; HAMERMAN JA, 2006, SCI STKE, pRE1, DOI DOI 10.1126/STKE.3202006RE1; Hamerman JA, 2006, J IMMUNOL, V177, P2051, DOI 10.4049/jimmunol.177.4.2051; Hawkins LD, 2004, CURR TOP MED CHEM, V4, P1147, DOI 10.2174/1568026043388123; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; JONES ST, 1991, BIO-TECHNOL, V9, P88, DOI 10.1038/nbt0191-88; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Lanier LL, 2000, IMMUNOL TODAY, V21, P611, DOI 10.1016/S0167-5699(00)01745-X; Maresco DL, 1999, J IMMUNOL, V162, P6458; Marshall JC, 2003, NAT REV DRUG DISCOV, V2, P391, DOI 10.1038/nrd1084; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Meng GX, 2004, J CLIN INVEST, V113, P1473, DOI 10.1172/JCI200420762; Merck E, 2006, J IMMUNOL, V176, P3149, DOI 10.4049/jimmunol.176.5.3149; Merck E, 2005, BLOOD, V105, P3623, DOI 10.1182/blood-2004-07-2809; MOST J, 1992, IMMUNOL LETT, V32, P159, DOI 10.1016/0165-2478(92)90109-2; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Nattermann J, 2000, J ENDOTOXIN RES, V6, P257, DOI 10.1179/096805100101532126; Nimmerjahn F, 2005, IMMUNITY, V23, P41, DOI 10.1016/j.immuni.2005.05.010; Ohta S, 2006, CLIN VACCINE IMMUNOL, V13, P1131, DOI 10.1128/CVI.00173-06; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; PARREN PWHI, 1992, J CLIN INVEST, V90, P1537, DOI 10.1172/JCI116022; Pfeiffer A, 2001, EUR J IMMUNOL, V31, P3153, DOI 10.1002/1521-4141(200111)31:11<3153::AID-IMMU3153>3.0.CO;2-0; POLLACK M, 1983, J CLIN INVEST, V72, P1874, DOI 10.1172/JCI111150; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Pugin J, 2004, BLOOD, V104, P4071, DOI 10.1182/blood-2003-04-1290; PUGIN J, 1993, P NATL ACAD SCI USA, V90, P2744, DOI 10.1073/pnas.90.7.2744; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Rallabhandi P, 2006, J IMMUNOL, V177, P322, DOI 10.4049/jimmunol.177.1.322; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Siberil S, 2007, CRIT REV ONCOL HEMAT, V62, P26, DOI 10.1016/j.critrevonc.2006.12.003; VANDEWINKEL JGJ, 1991, J LEUKOCYTE BIOL, V49, P511, DOI 10.1002/jlb.49.5.511; Visintin A, 2003, J BIOL CHEM, V278, P48313, DOI 10.1074/jbc.M306802200; WEINGARTEN R, 1993, J LEUKOCYTE BIOL, V53, P518, DOI 10.1002/jlb.53.5.518; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311	57	45	48	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34817	34827		10.1074/jbc.M706440200	http://dx.doi.org/10.1074/jbc.M706440200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17921137	hybrid			2022-12-25	WOS:000251155200024
J	Yi, HQ; Friedman, JL; Ferreira, PA				Yi, Haiqing; Friedman, Julie L.; Ferreira, Paulo A.			The cyclophilin-like domain of Ran-binding protein-2 modulates selectively the activity of the ubiquitin-proteasome system and protein biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-PORE COMPLEX; MULTIUBIQUITIN-CHAIN-BINDING; LINKED MENTAL-RETARDATION; 26S PROTEASOME; SUMO-1 MODIFICATION; REGULATORY SUBUNIT; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL-ANALYSIS; HUMAN-DISEASES; CDNA CLONING	The ubiquitin-proteasome system (UPS) plays a critical role in protein degradation. The 19S regulatory particle (RP) of the 26S proteasome mediates the recognition, deubiquitylation, unfolding, and channeling of ubiquitylated substrates to the 20S proteasome. Several subunits of the 19S RP interact with a growing number of factors. The cyclophilin-like domain (CLD) of Ran-binding protein-2 (RanBP2/Nup358) associates specifically with at least one subunit, S1, of the base subcomplex of the 19S RP, but the functional implications of this interaction on the UPS activity are elusive. This study shows the CLD of RanBP2 promotes selectively the accumulation of a subset of reporter substrates of the UPS, such as the ubiquitin (Ub)-fusion yellow fluorescent protein (YFP) degradation substrate, UbG76V-YFP, and the N-end rule substrate, Ub-R-YFP. Conversely, the degradation of endoplasmic reticulum and misfolded proteins, and of those linked to UPS-independent degradation, is not affected by CLD. The selective effect of CLD on the UPS in vivo is independent of, and synergistic with, proteasome inhibitors, and CLD does not affect the intrinsic proteolytic activity of the 20S proteasome. The inhibitory activity of CLD on the UPS resides in a purported SUMO binding motif. We also found two RanBP2 substrates, RanGTPase-activating protein and retinitis pigmentosa GTPase regulator interacting protein-1 alpha 1, whose steady-state levels are selectively modulated by CLD. Hence, the CLD of RanBP2 acts as a novel auxiliary modulator of the UPS activity; it may contribute to the molecular and subcellular compartmentation of the turnover of properly folded proteins and modulation of the expressivity of several neurological diseases.	Duke Univ, Ctr Med, Dept Ophthalmol, Durham, NC 27710 USA; Duke Univ, Ctr Med, Dept Mol Genet & Microbiol, Durham, NC 27710 USA	Duke University; Duke University	Ferreira, PA (corresponding author), Duke Univ, Ctr Med, Dept Ophthalmol, Durham, NC 27710 USA.	ferre044@mc.duke.edu	Ferreira, Paulo/A-3893-2008; Ferreira, Paulo A/S-4209-2016	Ferreira, Paulo A/0000-0003-4585-1717; Yi, Haiqing/0000-0003-2254-6226	NATIONAL EYE INSTITUTE [R01EY011993, P30EY005722] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY011993, 2P30-EY005722-21, EY011993] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aslanukov A, 2006, PLOS GENET, V2, P1653, DOI 10.1371/journal.pgen.0020177; Baumer M, 2000, J BIOL CHEM, V275, P38929, DOI 10.1074/jbc.M007925200; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Braslavsky CIV, 2000, BIOCHEMISTRY-US, V39, P11629, DOI 10.1021/bi001010f; Buschmann T, 2000, CELL, V101, P753, DOI 10.1016/S0092-8674(00)80887-9; Cai YF, 2001, J BIOL CHEM, V276, P41594, DOI 10.1074/jbc.M104514200; Castagnet P, 2003, HUM MOL GENET, V12, P1847, DOI 10.1093/hmg/ddg202; Cho KI, 2007, TRAFFIC, V8, P1722, DOI 10.1111/j.1600-0854.2007.00647.x; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Ciechanover A, 2005, CELL DEATH DIFFER, V12, P1178, DOI 10.1038/sj.cdd.4401692; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Delphin C, 1997, MOL BIOL CELL, V8, P2379, DOI 10.1091/mbc.8.12.2379; DEMARINI DJ, 1995, MOL CELL BIOL, V15, P6311; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; Ethen CM, 2007, FEBS LETT, V581, P885, DOI 10.1016/j.febslet.2007.01.061; Fauser S, 2001, MAMM GENOME, V12, P406, DOI 10.1007/s003350010291; FERREIRA PA, 1995, J BIOL CHEM, V270, P23179, DOI 10.1074/jbc.270.39.23179; Ferreira PA, 1996, NATURE, V383, P637, DOI 10.1038/383637a0; Ferreira PA, 1998, J BIOL CHEM, V273, P24676, DOI 10.1074/jbc.273.38.24676; Ferreira PA, 1997, P NATL ACAD SCI USA, V94, P1556, DOI 10.1073/pnas.94.4.1556; Ferreira PA, 2000, METHOD ENZYMOL, V315, P455; Ferrell K, 2000, TRENDS BIOCHEM SCI, V25, P83, DOI 10.1016/S0968-0004(99)01529-7; Fu HY, 1998, J BIOL CHEM, V273, P1970, DOI 10.1074/jbc.273.4.1970; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; GOUW LG, 1994, NEUROLOGY, V44, P1441, DOI 10.1212/WNL.44.8.1441; Hirsch C, 2000, TRENDS CELL BIOL, V10, P268, DOI 10.1016/S0962-8924(00)01768-2; Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7; Jiang YH, 2004, CURR OPIN PEDIATR, V16, P419, DOI 10.1097/01.mop.0000133634.79661.cd; Kapphahn RJ, 2007, EXP EYE RES, V84, P646, DOI 10.1016/j.exer.2006.12.002; Kisselev AF, 2005, METHOD ENZYMOL, V398, P364, DOI 10.1016/S0076-6879(05)98030-0; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kleijnen MF, 2000, MOL CELL, V6, P409, DOI 10.1016/S1097-2765(00)00040-X; Kristiansen M, 2007, MOL CELL, V26, P175, DOI 10.1016/j.molcel.2007.04.001; Kurtzman AL, 2001, P NATL ACAD SCI USA, V98, P5602, DOI 10.1073/pnas.101129698; LARRIVEE DC, 1981, J GEN PHYSIOL, V78, P521, DOI 10.1085/jgp.78.5.521; Lee GW, 1998, J BIOL CHEM, V273, P6503, DOI 10.1074/jbc.273.11.6503; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Lin L, 1998, CELL, V92, P819, DOI 10.1016/S0092-8674(00)81409-9; Lindsten K, 2003, NAT BIOTECHNOL, V21, P897, DOI 10.1038/nbt851; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Mahajan R, 1998, J CELL BIOL, V140, P259, DOI 10.1083/jcb.140.2.259; MARTIN JJ, 1994, ACTA NEUROPATHOL, V88, P277; Matilla A, 2001, HUM MOL GENET, V10, P2821, DOI 10.1093/hmg/10.24.2821; McNaught KS, 2003, EXP NEUROL, V179, P38, DOI 10.1006/exnr.2002.8050; Menendez-Benito V, 2005, HUM MOL GENET, V14, P2787, DOI 10.1093/hmg/ddi312; Ortolan TG, 2000, NAT CELL BIOL, V2, P601, DOI 10.1038/35023547; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Roepman R, 2000, HUM MOL GENET, V9, P2095, DOI 10.1093/hmg/9.14.2095; Saeki Y, 2002, BIOCHEM BIOPH RES CO, V293, P986, DOI 10.1016/S0006-291X(02)00340-6; Saitoh H, 2002, J BIOL CHEM, V277, P4755, DOI 10.1074/jbc.M104453200; Sakata E, 2003, EMBO REP, V4, P301, DOI 10.1038/sj.embor.embor764; Schmidt M, 2005, BIOL CHEM, V386, P725, DOI 10.1515/BC.2005.085; SCHNEUWLY S, 1989, P NATL ACAD SCI USA, V86, P5390, DOI 10.1073/pnas.86.14.5390; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Schwartz AL, 1999, ANNU REV MED, V50, P57; Sheaff RJ, 2000, MOL CELL, V5, P403, DOI 10.1016/S1097-2765(00)80435-9; SHIEH BH, 1989, NATURE, V338, P67, DOI 10.1038/338067a0; Singh BB, 1999, J BIOL CHEM, V274, P37370, DOI 10.1074/jbc.274.52.37370; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; STAMNES MA, 1991, CELL, V65, P219, DOI 10.1016/0092-8674(91)90156-S; Tarpey PS, 2007, AM J HUM GENET, V80, P345, DOI 10.1086/511134; Tsurumi C, 1996, EUR J BIOCHEM, V239, P912, DOI 10.1111/j.1432-1033.1996.0912u.x; vanNocker S, 1996, MOL CELL BIOL, V16, P6020; WILKEN N, 1995, EUR J CELL BIOL, V68, P211; Witkovsky P, 2004, DOC OPHTHALMOL, V108, P17, DOI 10.1023/B:DOOP.0000019487.88486.0a; WU J, 1995, J BIOL CHEM, V270, P14209, DOI 10.1074/jbc.270.23.14209; Yeh ETH, 2000, GENE, V248, P1, DOI 10.1016/S0378-1119(00)00139-6; Yokota K, 1996, MOL BIOL CELL, V7, P853, DOI 10.1091/mbc.7.6.853; YOKOYAMA N, 1995, NATURE, V376, P184, DOI 10.1038/376184a0; Young P, 1998, J BIOL CHEM, V273, P5461, DOI 10.1074/jbc.273.10.5461; Zou YX, 2007, AM J HUM GENET, V80, P561, DOI 10.1086/512489	77	14	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34770	34778		10.1074/jbc.M706903200	http://dx.doi.org/10.1074/jbc.M706903200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17911097	hybrid			2022-12-25	WOS:000251155200019
J	Kerr, ID; Sivakolundu, S; Li, Z; Buchsbaum, JC; Knox, LA; Kriwacki, R; White, SW				Kerr, Iain D.; Sivakolundu, Sivashankar; Li, Zhenmei; Buchsbaum, Jeffrey C.; Knox, Luke A.; Kriwacki, Richard; White, Stephen W.			Crystallographic and NMR analyses of UvsW and UvsW.1 from bacteriophage T4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; DNA-REPLICATION; GENOME INSTABILITY; FORK REVERSAL; RNA HELICASE; PROTEIN; DOMAIN; RECOMBINATION; REPAIR; RESTRAINTS	The uvsWXY system is implicated in the replication and repair of the bacteriophage T4 genome. Whereas the roles of the recombinase (UvsX) and the recombination mediator protein (UvsY) are known, the precise role of UvsW is unclear. Sequence analysis identifies UvsW as a member of the monomeric SF2 helicase superfamily that translocates nucleic acid substrates via the action of two RecA-like motor domains. Functional homologies to Escherichia coli RecG and biochemical analyses have shown that UvsW interacts with branched nucleic acid substrates, suggesting roles in recombination and the rescue of stalled replication forks. A sequencing error at the 3'-end of the uvsW gene has revealed a second, short open reading frame that encodes a protein of unknown function called UvsW.1. We have determined the crystal structure of UvsW to 2.7 angstrom and the NMR solution structure of UvsW.1. UvsW has a four-domain architecture with structural homology to the eukaryotic SF2 helicase, Rad54. A model of the UvsW-ssDNA complex identifies structural elements and conserved residues that may interact with nucleic acid substrates. The NMR solution structure of UvsW.1 reveals a dynamic four-helix bundle with homology to the structure-specific nucleic acid binding module of RecQ helicases.	St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; Penn State Univ, Milton S Hershey Med Ctr, Dept Radiat Oncol, Hershey, PA 17033 USA; Univ Tennessee, Ctr Hlth Sci, Dept Mol Sci, Memphis, TN 38163 USA	St Jude Children's Research Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Tennessee System; University of Tennessee Health Science Center	Kriwacki, R (corresponding author), St Jude Childrens Res Hosp, Dept Biol Struct, 332 N Lauderdale St, Memphis, TN 38105 USA.	Richard.Kriwacki@stjude.org; Stephen.White@stjude.org	White, Stephen W/N-8164-2018; Kriwacki, Richard/N-8154-2018	Kriwacki, Richard/0000-0002-9798-6018	NCI NIH HHS [CA 21765] Funding Source: Medline; NIGMS NIH HHS [GM 66934] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066934] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beernink HTH, 1999, TRENDS BIOCHEM SCI, V24, P385, DOI 10.1016/S0968-0004(99)01451-6; Bernstein DA, 2003, EMBO J, V22, P4910, DOI 10.1093/emboj/cdg500; Bernstein DA, 2005, STRUCTURE, V13, P1173, DOI 10.1016/j.str.2005.04.018; BERNSTEIN H, 1989, J BACTERIOL, V171, P2265, DOI 10.1128/jb.171.5.2265-2270.1989; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CarlesKinch K, 1997, EMBO J, V16, P4142, DOI 10.1093/emboj/16.13.4142; Caruthers JM, 2000, P NATL ACAD SCI USA, V97, P13080, DOI 10.1073/pnas.97.24.13080; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DERR LK, 1990, MOL GEN GENET, V222, P257, DOI 10.1007/BF00633826; DERR LK, 1990, J MOL BIOL, V214, P643, DOI 10.1016/0022-2836(90)90283-R; Dudas KC, 2001, MOL CELL BIOL, V21, P2706, DOI 10.1128/MCB.21.8.2706-2715.2001; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Hall MC, 1999, MOL MICROBIOL, V34, P867, DOI 10.1046/j.1365-2958.1999.01659.x; Heyer WD, 2006, NUCLEIC ACIDS RES, V34, P4115, DOI 10.1093/nar/gkl481; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; Kitano K, 2007, J BIOL CHEM, V282, P2717, DOI 10.1074/jbc.M610142200; Klein HL, 2002, MOL CELL, V9, P471, DOI 10.1016/S1097-2765(02)00493-8; Korber P, 2004, CELL, V117, P5, DOI 10.1016/S0092-8674(04)00296-X; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kreuzer KN, 2005, ANNU REV MICROBIOL, V59, P43, DOI 10.1146/annurev.micro.59.030804.121255; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Li N, 2002, MOL MICROBIOL, V43, P1079, DOI 10.1046/j.1365-2958.2002.02809.x; Liu Z, 1999, STRUCTURE, V7, P1557, DOI 10.1016/S0969-2126(00)88346-X; McGlynn P, 2002, NAT REV MOL CELL BIO, V3, P859, DOI 10.1038/nrm951; McGlynn P, 2001, P NATL ACAD SCI USA, V98, P8227, DOI 10.1073/pnas.111008698; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Miller ES, 2003, MICROBIOL MOL BIOL R, V67, P86, DOI 10.1128/MMBR.67.1.86-156.2003; Myung K, 2001, NAT GENET, V27, P113, DOI 10.1038/83673; Nelson SW, 2007, J BIOL CHEM, V282, P407, DOI 10.1074/jbc.M608153200; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nilges M, 1997, J MOL BIOL, V269, P408, DOI 10.1006/jmbi.1997.1044; Nossal NG, 2001, MOL CELL, V7, P31, DOI 10.1016/S1097-2765(01)00152-6; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAUSE A, 1992, EMBO J, V11, P2643, DOI 10.1002/j.1460-2075.1992.tb05330.x; Pazin MJ, 1997, CELL, V88, P737, DOI 10.1016/S0092-8674(00)81918-2; Schmuckli-Maurer J, 2003, NUCLEIC ACIDS RES, V31, P1013, DOI 10.1093/nar/gkg190; Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; Sickmier EA, 2004, STRUCTURE, V12, P583, DOI 10.1016/j.str.2004.02.016; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2001, CELL, V107, P79, DOI 10.1016/S0092-8674(01)00501-3; SNOW R, 1967, J BACTERIOL, V94, P571, DOI 10.1128/JB.94.3.571-575.1967; Tanner NK, 2003, MOL CELL, V11, P127, DOI 10.1016/S1097-2765(03)00006-6; Theis K, 1999, EMBO J, V18, P6899, DOI 10.1093/emboj/18.24.6899; Thoma NH, 2005, NAT STRUCT MOL BIOL, V12, P350, DOI 10.1038/nsmb919; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Webb MR, 2007, J BIOL CHEM, V282, P34401, DOI 10.1074/jbc.M705913200; Whitby MC, 1998, J BIOL CHEM, V273, P19729, DOI 10.1074/jbc.273.31.19729	60	17	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34392	34400		10.1074/jbc.M705900200	http://dx.doi.org/10.1074/jbc.M705900200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17878153	hybrid			2022-12-25	WOS:000251145700055
J	Acquisti, C; Poste, G; Curtiss, D; Kumar, S				Acquisti, Claudia; Poste, George; Curtiss, David; Kumar, Sudhir			Nullomers: Really a Matter of Natural Selection?	PLOS ONE			English	Article								Background. Nullomers are short DNA sequences that are absent from the genomes of humans and other species. Assuming that nullomers are the signatures of natural selection against deleterious sequences in humans, the use of nullomers in drug target identification, pesticide development, environmental monitoring, and forensic applications has been envisioned. Results. Here, we show that the hypermutability of CpG dinucleotides, rather than the natural selection against the nullomer sequences, is likely the reason for the phenomenal event of short sequence motifs becoming nullomers. Furthermore, many reported human nullomers differ by only one nucleotide, which reinforces the role of mutation in the evolution of the constellation of nullomers in populations and species. The known nullomers in chimpanzee, cow, dog, and mouse genomes show patterns that are consistent with those seen in humans. Conclusions. The role of mutations, instead of selection, in generating nullomers cast doubt on the utility of nullomers in many envisioned applications, because of their dependence on the role of lethal selection on the origin of nullomers.	[Acquisti, Claudia; Curtiss, David; Kumar, Sudhir] Arizona State Univ, Ctr Evolutionary Funct Gen, Tempe, AZ 85287 USA; [Acquisti, Claudia; Poste, George; Kumar, Sudhir] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Acquisti, Claudia; Poste, George; Kumar, Sudhir] Arizona State Univ, Biodesign Inst, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Kumar, S (corresponding author), Arizona State Univ, Ctr Evolutionary Funct Gen, Tempe, AZ 85287 USA.	s.kumar@asu.edu	Kumar, Sudhir/F-1411-2011	Kumar, Sudhir/0000-0002-9918-8212	National Institutes of Health and National Science Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002096] Funding Source: NIH RePORTER	National Institutes of Health and National Science Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Funding: This work was supported in part by research grants from National Institutes of Health and National Science Foundation (SK).	Fofanov Y, 2004, BIOINFORMATICS, V20, P2421, DOI 10.1093/bioinformatics/bth266; GEDDES L, 2007, NEW SCI, V2585, P12; Gentles AJ, 2001, GENOME RES, V11, P540, DOI 10.1101/gr.163101; Hampikian G, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P355; Haubold B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-123; JOSSE J, 1961, J BIOL CHEM, V236, P864; Kidwell MG, 2002, GENETICA, V115, P49, DOI 10.1023/A:1016072014259; Subramanian S, 2003, GENOME RES, V13, P838, DOI 10.1101/gr.1152803; SVED J, 1990, P NATL ACAD SCI USA, V87, P4692, DOI 10.1073/pnas.87.12.4692	9	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1022	10.1371/journal.pone.0001022	http://dx.doi.org/10.1371/journal.pone.0001022			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925870	Green Published, gold			2022-12-25	WOS:000207456000021
J	Bielaszewska, M; Kock, R; Friedrich, AW; von Eiff, C; Zimmerhackl, LB; Karch, H; Mellmann, A				Bielaszewska, Martina; Koeck, Robin; Friedrich, Alexander W.; von Eiff, Christof; Zimmerhackl, Lothar B.; Karch, Helge; Mellmann, Alexander			Shiga Toxin-Mediated Hemolytic Uremic Syndrome: Time to Change the Diagnostic Paradigm?	PLOS ONE			English	Article							ENTEROHEMORRHAGIC ESCHERICHIA-COLI; ENCODING BACTERIOPHAGES; BACTERIAL GENOTYPES; UNITED-STATES; IN-VITRO; O157-H7; GENE; INFECTION; STRAINS; SEROPATHOTYPES	Background. Hemolytic uremic syndrome (HUS) is caused by enterohemorrhagic Escherichia coli (EHEC) which possess genes encoding Shiga toxin (stx), the major virulence factor, and adhesin intimin (eae). However, the frequency of stx-negative/eae-positive E. coli in stools of HUS patients and the clinical significance of such strains are unknown. Methodology/Principal Findings. Between 1996 and 2006, we sought stx-negative/eae-positive E. coli in stools of HUS patients using colony blot hybridization with the eae probe and compared the isolates to EHEC causing HUS. stx-negative/eae-positive E. coli were isolated as the only pathogens from stools of 43 (5.5%) of 787 HUS patients; additional 440 (55.9%) patients excreted EHEC. The majority (90.7%) of the stx-negative/eae-positive isolates belonged to serotypes O26: H11/NM (nonmotile), O103:H2/NM, O145:H28/NM, and O157:H7/NM, which were also the most frequent serotypes identified among EHEC. The stx-negative isolates shared non-stx virulence and fitness genes with EHEC of the corresponding serotypes and clustered with them into the same clonal complexes in multilocus sequence typing, demonstrating their close relatedness to EHEC. Conclusions/Significance. At the time of microbiological analysis, similar to 5% of HUS patients shed no longer the causative EHEC, but do excrete stx-negative derivatives of EHEC that lost stx during infection. In such patients, the EHEC etiology of HUS is missed using current methods detecting solely stx or Shiga toxin; this can hamper epidemiological investigations and lead to inappropriate clinical management. While maintaining the paradigm that HUS is triggered by Shiga toxin, our data demonstrate the necessity of considering genetic changes of the pathogen during infection to adapt appropriately diagnostic strategies.	[Bielaszewska, Martina; Koeck, Robin; Friedrich, Alexander W.; Karch, Helge; Mellmann, Alexander] Univ Munster, Inst Hyg, Munster, Germany; [Bielaszewska, Martina; Koeck, Robin; Friedrich, Alexander W.; Karch, Helge; Mellmann, Alexander] Univ Munster, Natl Consulting Lab Hemolyt Urem Syndrome, Munster, Germany; [von Eiff, Christof] Univ Munster, Inst Med Microbiol, Munster, Germany; [Zimmerhackl, Lothar B.] Univ Innsbruck Hosp, Dept Pediat, A-6020 Innsbruck, Austria	University of Munster; University of Munster; University of Munster; Medical University of Innsbruck	Bielaszewska, M (corresponding author), Univ Munster, Inst Hyg, Munster, Germany.	mbiela@uni-muenster.de	Friedrich, Alex/ABG-9823-2020; Köck, Robin/AAC-1552-2019; Bielaszewska, Martina/AAC-9812-2022	Mellmann, Alexander/0000-0002-0649-5185	Interdisciplinary Center of Clinical Research (IZKF) Munster [Ka2/061/04]; EU [LSHB-CT-2005-512061, 0313937C]	Interdisciplinary Center of Clinical Research (IZKF) Munster; EU(European Commission)	Funding: This study was supported by a grant from the Interdisciplinary Center of Clinical Research (IZKF) Munster (project no. Ka2/061/04), by a grant from the EU Network of Excellence EuroPathoGenomic (number LSHB-CT-2005-512061), and by a grant from the EU Network ERA-NET PathoGenoMics (project number 0313937C). The funders had no role in study design, data collection, analysis, and interpretation, decision to publish, or preparation, review or approval of the manuscript.	Ake JA, 2005, PEDIATRICS, V115, pE673, DOI 10.1542/peds.2004-2236; Banatvala N, 2001, J INFECT DIS, V183, P1063, DOI 10.1086/319269; Beutin L, 2003, INFECT IMMUN, V71, P3995, DOI 10.1128/IAI.71.7.3995-4002.2003; Bielaszewska M, 2006, APPL ENVIRON MICROB, V72, P1900, DOI 10.1128/AEM.72.3.1900-1909.2006; Bielaszewska M, 2005, J CLIN MICROBIOL, V43, P4225, DOI 10.1128/JCM.43.8.4225-4228.2005; Bielaszewska M, 2005, J CLIN MICROBIOL, V43, P452, DOI 10.1128/JCM.43.1.452-454.2005; Bielaszewska M, 2007, APPL ENVIRON MICROB, V73, P3144, DOI 10.1128/AEM.02937-06; Bielaszewska M, 2006, CLIN INFECT DIS, V43, P1160, DOI 10.1086/508195; Bockemuhl J., 2003, MANUAL CLIN MICROBIO, P672; Bokete TN, 1997, J INFECT DIS, V175, P1382, DOI 10.1086/516470; Bopp CA, 2003, MANUAL CLIN MICROBIO, P654; Brooks JT, 2005, J INFECT DIS, V192, P1422, DOI 10.1086/466536; CIMOLAI N, 1994, CLIN NEPHROL, V42, P85; Creuzburg K, 2005, MICROBIOL-SGM, V151, P941, DOI 10.1099/mic.0.27632-0; DONNENBERG MS, 1993, J CLIN INVEST, V92, P1418, DOI 10.1172/JCI116718; Elliott EJ, 2001, ARCH DIS CHILD, V85, P125, DOI 10.1136/adc.85.2.125; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Friedrich AW, 2007, CLIN INFECT DIS, V45, P39, DOI 10.1086/518573; Friedrich AW, 2004, J CLIN MICROBIOL, V42, P4697, DOI 10.1128/JCM.42.10.4697-4701.2004; Gerber A, 2002, J INFECT DIS, V186, P493, DOI 10.1086/341940; Janka A, 2003, INFECT IMMUN, V71, P3634, DOI 10.1128/IAI.71.6.3634-3638.2003; Janka A, 2002, INT J MED MICROBIOL, V292, P207, DOI 10.1078/1438-4221-00206; Jelacic JK, 2003, J INFECT DIS, V188, P719, DOI 10.1086/376999; Karch H, 2005, INT J MED MICROBIOL, V295, P405, DOI 10.1016/j.ijmm.2005.06.009; Karch H, 1999, INFECT IMMUN, V67, P5994, DOI 10.1128/IAI.67.11.5994-6001.1999; Karmali MA, 2003, J CLIN MICROBIOL, V41, P4930, DOI 10.1128/JCM.41.11.4930-4940.2003; Klein EJ, 2002, J PEDIATR-US, V141, P172, DOI 10.1067/mpd.2002.125908; Lynn RM, 2005, EMERG INFECT DIS, V11, P590, DOI 10.3201/eid1104.040833; Mellmann A, 2005, CLIN INFECT DIS, V41, P785, DOI 10.1086/432722; Nachamkin I., 2003, MANUAL CLIN MICROBIO, P902; Park CH, 2002, J CLIN MICROBIOL, V40, P3542, DOI 10.1128/JCM.40.9.3542-3543.2002; Paton AW, 2001, INFECT IMMUN, V69, P6999, DOI 10.1128/IAI.69.11.6999-7009.2001; Prager R, 2003, INT J MED MICROBIOL, V292, P477, DOI 10.1078/1438-4221-00226; RICHARDSON SE, 1988, HUM PATHOL, V19, P1102, DOI 10.1016/S0046-8177(88)80093-5; Sandvig K, 2001, TOXICON, V39, P1629, DOI 10.1016/S0041-0101(01)00150-7; Shaikh N, 2003, J BACTERIOL, V185, P3596, DOI 10.1128/JB.185.12.3596-3605.2003; Siegler RL, 2003, JAMA-J AM MED ASSOC, V290, P1379, DOI 10.1001/jama.290.10.1379; Sonntag AK, 2004, J CLIN MICROBIOL, V42, P954, DOI 10.1128/JCM.42.3.954-962.2004; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; TARR PI, 1990, J INFECT DIS, V162, P553, DOI 10.1093/infdis/162.2.553; Toma C, 2004, J CLIN MICROBIOL, V42, P4937, DOI 10.1128/JCM.42.11.4937-4946.2004; Tozzi AE, 2003, EMERG INFECT DIS, V9, P106, DOI 10.3201/eid0901.020266; Wagner PL, 2002, INFECT IMMUN, V70, P3985, DOI 10.1128/IAI.70.8.3985-3993.2002; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Wong CS, 2000, NEW ENGL J MED, V342, P1930, DOI 10.1056/NEJM200006293422601; Zhang WL, 2007, INT J MED MICROBIOL, V297, P17, DOI 10.1016/j.ijmm.2006.10.004; Zhang WL, 2002, J CLIN MICROBIOL, V40, P4486, DOI 10.1128/JCM.40.12.4486-4492.2002; Zhang XP, 2000, J INFECT DIS, V181, P664, DOI 10.1086/315239; Zimmerhackl LB, 2000, NEW ENGL J MED, V342, P1990, DOI 10.1056/NEJM200006293422611	49	112	118	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1024	10.1371/journal.pone.0001024	http://dx.doi.org/10.1371/journal.pone.0001024			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925872	Green Submitted, Green Published, gold			2022-12-25	WOS:000207456000023
J	Little, TJ; Nelson, L; Hupp, T				Little, Tom J.; Nelson, Lenny; Hupp, Ted			Adaptive Evolution of a Stress Response Protein	PLOS ONE			English	Article								Background. Some cancers are mediated by an interplay between tissue damage, pathogens and localised innate immune responses, but the mechanisms that underlie these linkages are only beginning to be unravelled. Methods and Principal Findings. Here we identify a strong signature of adaptive evolution on the DNA sequence of the mammalian stress response gene SEP53, a member of the epidermal differentiation complex fused-gene family known for its role in suppressing cancers. The SEP53 gene appears to have been subject to adaptive evolution of a type that is commonly (though not exclusively) associated with coevolutionary arms races. A similar pattern of molecular evolution was not evident in the p53 cancer-suppressing gene. Conclusions. Our data thus raises the possibility that SEP53 is a component of the mucosal/epithelial innate immune response engaged in an ongoing interaction with a pathogen. Although the pathogenic stress mediating adaptive evolution of SEP53 is not known, there are a number of well-known candidates, in particular viruses with established links to carcinoma.	[Little, Tom J.] Univ Edinburgh, Sch Biol, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland; [Nelson, Lenny; Hupp, Ted] Univ Edinburgh, CRUK Signal Transduct Grp P53, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Little, TJ (corresponding author), Univ Edinburgh, Sch Biol, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland.	tlittle1@staffmail.ed.ac.uk	Little, Tom J/B-7890-2009	Little, Tom J/0000-0002-8945-0416	Cancer Research UK; International Association for Cancer Research; Wellcome Trust; MRC Human Genetics Unit, Edinburgh	Cancer Research UK(Cancer Research UK); International Association for Cancer Research; Wellcome Trust(Wellcome TrustEuropean Commission); MRC Human Genetics Unit, Edinburgh(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank John Maule of the MRC Human Genetics Unit, Edinburgh for technical advice and support. Andrew Rambaut, Phillipe Lemey, Darren Obbard and Brian Charlesworth provided advice on analysis and discussion.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BLAKE MJ, 1990, J BIOL CHEM, V265, P15275; BLAKE MJ, 1991, AM J PHYSIOL, V260, pR663, DOI 10.1152/ajpregu.1991.260.4.R663; Brandtzaeg P, 1999, IMMUNOL TODAY, V20, P141, DOI 10.1016/S0167-5699(98)01413-3; Chae SW, 2004, GASTROENTEROLOGY, V126, pA33; CLARK NL, 2005, PLOS BIOL, V1; Contzler R, 2005, J INVEST DERMATOL, V124, P990, DOI 10.1111/j.0022-202X.2005.23694.x; Cox JT, 2006, CURR OPIN OBSTET GYN, V18, pS5, DOI 10.1097/01.gco.0000216315.72572.fb; Darragh J, 2006, FEBS J, V273, P1930, DOI 10.1111/j.1742-4658.2006.05206.x; Eckmann L, 2005, SPRINGER SEMIN IMMUN, V27, P181, DOI 10.1007/s00281-005-0207-5; Ford MJ, 2002, MOL ECOL, V11, P1245, DOI 10.1046/j.1365-294X.2002.01536.x; Hopwood D, 1997, GUT, V41, P156, DOI 10.1136/gut.41.2.156; Hurst LD, 2002, TRENDS GENET, V18, P486, DOI 10.1016/S0168-9525(02)02722-1; Iimura M, 2005, J IMMUNOL, V174, P4901, DOI 10.4049/jimmunol.174.8.4901; Imai FL, 2005, INT J BIOCHEM CELL B, V37, P1641, DOI 10.1016/j.biocel.2005.02.005; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; KOSAKOVSKYPOND SL, 2005, BIOINFORMATICS, V21, P675; Kuper H, 2000, J INTERN MED, V248, P171, DOI 10.1046/j.1365-2796.2000.00742.x; Lakhotia SC, 1996, EXPERIENTIA, V52, P751, DOI 10.1007/BF01923984; Li WH, 2005, NATURE, V437, P50, DOI 10.1038/437050a; Little TJ, 2005, INSECT MOL BIOL, V14, P599, DOI 10.1111/j.1365-2583.2005.00588.x; Little TJ, 2004, J MOL EVOL, V59, P498, DOI 10.1007/s00239-004-2641-8; MACDONALD JH, 1991, NATURE, V351, P652; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Mosser DD, 2004, ONCOGENE, V23, P2907, DOI 10.1038/sj.onc.1207529; Obbard DJ, 2007, MOL ECOL, V16, P3497, DOI 10.1111/j.1365-294X.2007.03395.x; Obbard DJ, 2006, CURR BIOL, V16, P580, DOI 10.1016/j.cub.2006.01.065; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Pond SK, 2005, MOL BIOL EVOL, V22, P2375, DOI 10.1093/molbev/msi232; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Schlenke TA, 2003, GENETICS, V164, P1471; Snijders PJF, 2006, J PATHOL, V208, P152, DOI 10.1002/path.1866; Wyckoff GJ, 2005, TRENDS GENET, V21, P381, DOI 10.1016/j.tig.2005.05.005; Yagui-Beltran A, 2001, EUR J BIOCHEM, V268, P5343, DOI 10.1046/j.0014-2956.2001.02468.x; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7	39	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1003	10.1371/journal.pone.0001003	http://dx.doi.org/10.1371/journal.pone.0001003			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925851	Green Published, gold			2022-12-25	WOS:000207456000002
J	Lee, I; Li, ZH; Marcotte, EM				Lee, Insuk; Li, Zhihua; Marcotte, Edward M.			An Improved, Bias-Reduced Probabilistic Functional Gene Network of Baker's Yeast, Saccharomyces cerevisiae	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; GENOME-WIDE PREDICTION; 60S RIBOSOMAL-SUBUNITS; GLOBAL ANALYSIS; DATABASE; EXPRESSION; COMPLEXES; RNA; TRANSLATION; DISCOVERY	Background. Probabilistic functional gene networks are powerful theoretical frameworks for integrating heterogeneous functional genomics and proteomics data into objective models of cellular systems. Such networks provide syntheses of millions of discrete experimental observations, spanning DNA microarray experiments, physical protein interactions, genetic interactions, and comparative genomics; the resulting networks can then be easily applied to generate testable hypotheses regarding specific gene functions and associations. Methodology/Principal Findings. We report a significantly improved version (v. 2) of a probabilistic functional gene network [1] of the baker's yeast, Saccharomyces cerevisiae. We describe our optimization methods and illustrate their effects in three major areas: the reduction of functional bias in network training reference sets, the application of a probabilistic model for calculating confidences in pair-wise protein physical or genetic interactions, and the introduction of simple thresholds that eliminate many false positive mRNA co-expression relationships. Using the network, we predict and experimentally verify the function of the yeast RNA binding protein Puf6 in 60S ribosomal subunit biogenesis. Conclusions/Significance. YeastNet v. 2, constructed using these optimizations together with additional data, shows significant reduction in bias and improvements in precision and recall, in total covering 102,803 linkages among 5,483 yeast proteins (95% of the validated proteome). YeastNet is available from http://www.yeastnet.org.	[Lee, Insuk; Li, Zhihua; Marcotte, Edward M.] Univ Texas Austin, Ctr Syst & Synthet Biol, Inst Mol & Cellular Biol, Austin, TX 78712 USA; [Marcotte, Edward M.] Univ Texas Austin, Dept Chem & Biochem, Inst Mol & Cellular Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Marcotte, EM (corresponding author), Univ Texas Austin, Ctr Syst & Synthet Biol, Inst Mol & Cellular Biol, Austin, TX 78712 USA.	marcotte@icmb.utexas.edu	Li, ZhiHua/GYU-9914-2022; Lee, Insuk/F-7722-2010; li, zh/HII-5698-2022	Marcotte, Edward/0000-0001-8808-180X	N.S.F [IIS-0325116, EIA0219061]; N.I.H. [GM06779-01, GM076536-01]; Welch [F-1515]; Packard Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076536] Funding Source: NIH RePORTER	N.S.F(National Science Foundation (NSF)); N.I.H.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch(The Welch Foundation); Packard Fellowship(The David & Lucile Packard Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the N.S.F. (IIS-0325116, EIA0219061), N.I.H. (GM06779-01, GM076536-01), Welch (F-1515), and a Packard Fellowship (EMM). These agencies were not involved in the design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript.	Adams CC, 2002, RNA, V8, P150, DOI 10.1017/S1355838202010026; Aloy P, 2003, BIOINFORMATICS, V19, P161, DOI 10.1093/bioinformatics/19.1.161; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bader GD, 2002, NAT BIOTECHNOL, V20, P991, DOI 10.1038/nbt1002-991; Bader GD, 2001, NUCLEIC ACIDS RES, V29, P242, DOI 10.1093/nar/29.1.242; BAIM SB, 1985, MOL CELL BIOL, V5, P1839, DOI 10.1128/MCB.5.8.1839; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Bowers PM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r35; Braga-Neto UM, 2004, BIOINFORMATICS, V20, P374, DOI 10.1093/bioinformatics/btg419; Brauer MJ, 2005, MOL BIOL CELL, V16, P2503, DOI 10.1091/mbc.E04-11-0968; CARLSON MW, 2002, THESIS U TEXAS; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; Dandekar T, 1998, TRENDS BIOCHEM SCI, V23, P324, DOI 10.1016/S0968-0004(98)01274-2; Date SV, 2003, NAT BIOTECHNOL, V21, P1055, DOI 10.1038/nbt861; Dwight SS, 2002, NUCLEIC ACIDS RES, V30, P69, DOI 10.1093/nar/30.1.69; EFRON B, 1983, J AM STAT ASSOC, V78, P316, DOI 10.2307/2288636; Efron B., 1994, INTRO BOOTSTRAP; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Fraser AG, 2004, NAT GENET, V36, P559, DOI 10.1038/ng1370; Fromont-Racine M, 2000, YEAST, V17, P95, DOI 10.1002/1097-0061(20000630)17:2<95::AID-YEA16>3.0.CO;2-H; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gollub J, 2003, NUCLEIC ACIDS RES, V31, P94, DOI 10.1093/nar/gkg078; Gu W, 2004, GENE DEV, V18, P1452, DOI 10.1101/gad.1189004; Gunsalus KC, 2005, NATURE, V436, P861, DOI 10.1038/nature03876; Hart GT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-236; Ho JHN, 1999, MOL CELL BIOL, V19, P2389; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hoang T, 2005, MOL CELL BIOL, V25, P5523, DOI 10.1128/MCB.25.13.5523-5534.2005; Horsey EW, 2004, RNA, V10, P813, DOI 10.1261/rna.5255804; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Huttenhower C, 2006, BIOINFORMATICS, V22, P2890, DOI 10.1093/bioinformatics/btl492; Huynen M, 2000, GENOME RES, V10, P1204, DOI 10.1101/gr.10.8.1204; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Jenssen TK, 2001, NAT GENET, V28, P21, DOI 10.1038/88213; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; LEE I, 2007, METHODS MOL BIOL COM; Lee I, 2007, METHOD MICROBIOL, V36, P597, DOI 10.1016/S0580-9517(06)36024-2; Marcotte Cynthia J Verjovsky, 2002, Appl Bioinformatics, V1, P93; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Mellor JC, 2002, NUCLEIC ACIDS RES, V30, P306, DOI 10.1093/nar/30.1.306; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; Myers CL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-187; Myers CL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r114; Nariai N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000337; Newman JRS, 2000, P NATL ACAD SCI USA, V97, P13203, DOI 10.1073/pnas.97.24.13203; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Reguly Teresa, 2006, J Biol, V5, P11, DOI 10.1186/jbiol36; Rhodes DR, 2005, NAT BIOTECHNOL, V23, P951, DOI 10.1038/nbt1103; ROTENBERG MO, 1988, GENE DEV, V2, P160, DOI 10.1101/gad.2.2.160; Sangster TA, 2004, BIOESSAYS, V26, P348, DOI 10.1002/bies.20020; Shapira M, 2004, MOL BIOL CELL, V15, P5659, DOI 10.1091/mbc.E04-04-0340; Sima C, 2005, BIOINFORMATICS, V21, P1046, DOI 10.1093/bioinformatics/bti081; Stapley B J, 2000, Pac Symp Biocomput, P529; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Wade CH, 2006, YEAST, V23, P293, DOI 10.1002/yea.1353; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Witten I. H., 2005, DATA MINING PRACTICA; Wolf YI, 2001, GENOME RES, V11, P356, DOI 10.1101/gr.GR-1619R; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303; Yanai I, 2001, P NATL ACAD SCI USA, V98, P7940, DOI 10.1073/pnas.141236298; Zhong WW, 2006, SCIENCE, V311, P1481, DOI 10.1126/science.1123287	77	146	149	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e988	10.1371/journal.pone.0000988	http://dx.doi.org/10.1371/journal.pone.0000988			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912365	Green Published, gold			2022-12-25	WOS:000207455900024
J	Molli, PR; Singh, RR; Lee, SW; Kumar, R				Molli, P. R.; Singh, R. R.; Lee, S. W.; Kumar, R.			MTA1-mediated transcriptional repression of BRCA1 tumor suppressor gene	ONCOGENE			English	Article						NURD complex; chromatin remodeling centrosome; aneuploidy	SPORADIC BREAST-CANCER; CENTROSOME AMPLIFICATION; CELL-CYCLE; ESTROGEN-RECEPTOR; DOWN-REGULATION; MTA1 GENE; PROTEIN; INSTABILITY; EXPRESSION; COMPLEX	Metastasis-associated tumor antigen 1 (MTA1), a component of the nucleosome remodeling and deacetylating (NuRD) complex is routinely upregulated in several cancers. In the present study, we investigated the potential role of MTA1 in BRCA1 transcriptional repression and subsequent chromosomal instability. MTA1-NuRD complex was found to negatively regulate BRCA1 transcription by physically associating with an atypical estrogen-responsive element (ERE) on the BRCA1 promoter. Moreover, MTA1 and HDAC complex recruited to the ERE of BRCA1 promoter in an ER a-dependent manner. Accordingly, BRCA1 protein levels were enhanced by silencing of either MTA1 expression or by treatment with the specific histone deacetylase inhibitor trichostatin A. MTA1's strong repressive effects on BRCA1 expression was supported by our observation that cells stably overexpressing MTA1 showed centrosome amplification which has been long implicated as a phenotype for BRCA1 repression. Accordingly, overexpression of BRCA1 in cells stably over expressing MTA1 resulted in restoration of normal centrosome numbers. Together, these findings strongly implicate MTA1 in the transcriptional repression of BRCA1 leading to abnormal centrosome number and chromosomal instability.	[Molli, P. R.; Singh, R. R.; Kumar, R.] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Lee, S. W.] Massachusetts Gen Hosp, Harvard Cutaneous Biol Res Ctr, Charlestown, MA USA; [Kumar, R.] Baylor Coll Med, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; Harvard University; Massachusetts General Hospital; Baylor College of Medicine	Kumar, R (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	rkumar@mdanderson.org			NATIONAL CANCER INSTITUTE [R01CA065746, U01CA065746, R01CA098823] Funding Source: NIH RePORTER; NCI NIH HHS [CA 098823, R01 CA098823, U01 CA065746, R01 CA065746, CA65746, R01 CA098823-04, R01 CA065746-05] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bagheri-Yarmand R, 2004, DEVELOPMENT, V131, P3469, DOI 10.1242/dev.01213; Baker KM, 2003, J BIOL CHEM, V278, P17876, DOI 10.1074/jbc.M209480200; Balasenthil S, 2006, HUM PATHOL, V37, P656, DOI 10.1016/j.humpath.2006.01.024; Birgisdottir V, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1522; Chabalier C, 2006, CELL CYCLE, V5, P1001, DOI 10.4161/cc.5.9.2726; Chen XW, 2006, EXPERT REV ANTICANC, V6, P187, DOI 10.1586/14737140.6.2.187; D'Assoro AB, 2002, ONCOGENE, V21, P6146, DOI 10.1038/sj.onc.1205772; Deng CX, 2006, NUCLEIC ACIDS RES, V34, P1416, DOI 10.1093/nar/gkl010; Fukasawa K, 2005, CANCER LETT, V230, P6, DOI 10.1016/j.canlet.2004.12.028; Fukasawa K, 1996, SCIENCE, V271, P1744, DOI 10.1126/science.271.5256.1744; Hamatsu T, 2003, ONCOL REP, V10, P599; Indraccolo S, 2006, EUR J CANCER, V42, P1475, DOI 10.1016/j.ejca.2006.01.057; Jang KS, 2006, CANCER SCI, V97, P374, DOI 10.1111/j.1349-7006.2006.00186.x; Kanai M, 2003, MOL CELL BIOL, V23, P2451, DOI 10.1128/MCB.23.7.2451-2462.2003; Ko MJ, 2006, ONCOGENE, V25, P298, DOI 10.1038/sj.onc.1209028; Kumar R, 2003, SEMIN ONCOL, V30, P30, DOI 10.1053/j.seminoncol.2003.08.005; Magdinier F, 1998, ONCOGENE, V17, P3169, DOI 10.1038/sj.onc.1202248; Martin MD, 2006, BREAST CANCER RES TR, V95, P7, DOI 10.1007/s10549-005-9016-8; Mazumdar A, 2001, NAT CELL BIOL, V3, P30, DOI 10.1038/35050532; Mullan PB, 2006, ONCOGENE, V25, P5854, DOI 10.1038/sj.onc.1209872; Nawa A, 2000, J CELL BIOCHEM, V79, P202, DOI 10.1002/1097-4644(20001101)79:2<202::AID-JCB40>3.0.CO;2-L; Ouchi T, 2006, CANCER BIOL THER, V5, P470, DOI 10.4161/cbt.5.5.2845; Rio PG, 1999, INT J CANCER, V80, P823, DOI 10.1002/(SICI)1097-0215(19990315)80:6<823::AID-IJC5>3.0.CO;2-3; Rosen EM, 2006, CANCER LETT, V236, P175, DOI 10.1016/j.canlet.2005.04.037; Simbulan-Rosenthal CM, 2001, NUCLEIC ACIDS RES, V29, P841, DOI 10.1093/nar/29.3.841; Starita LM, 2004, MOL CELL BIOL, V24, P8457, DOI 10.1128/MCB.24.19.8457-8466.2004; Starita LM, 2003, CURR OPIN CELL BIOL, V15, P345, DOI 10.1016/S0955-0674(03)00042-5; Talukder AH, 2003, J BIOL CHEM, V278, P11676, DOI 10.1074/jbc.M209570200; Toh Y, 1999, BRIT J CANCER, V79, P1723, DOI 10.1038/sj.bjc.6690274; TOH Y, 1994, J BIOL CHEM, V269, P22958; Turner NC, 2007, ONCOGENE, V26, P2126, DOI 10.1038/sj.onc.1210014; Weaver Z, 2002, ONCOGENE, V21, P5097, DOI 10.1038/sj.onc.1205636; Xu CF, 1997, J BIOL CHEM, V272, P20994, DOI 10.1074/jbc.272.34.20994; Yarden RI, 2006, MOL CANCER THER, V5, P1396, DOI 10.1158/1535-7163.MCT-05-0471	34	60	69	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 27	2008	27	14					1971	1980		10.1038/sj.onc.1210839	http://dx.doi.org/10.1038/sj.onc.1210839			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	279MK	17922032	Green Accepted			2022-12-25	WOS:000254359100002
J	Ma, S; Lee, TK; Zheng, BJ; Chan, K; Guan, XY				Ma, S.; Lee, T. K.; Zheng, B-J; Chan, K. W.; Guan, X-Y			CD133(+) HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway	ONCOGENE			English	Article						HCC; CD133; survival; cancer stem cells; chemoresistance	ACUTE MYELOID-LEUKEMIA; PROSPECTIVE IDENTIFICATION; APOPTOSIS	The recent discovery of cancer stem cells (CSCs) has played a pivotal role in changing our view of carcinogenesis and chemotherapy. Based on this concept, CSCs are responsible for the formation and growth of neoplastic tissue and are naturally resistant to chemotherapy, explaining why traditional chemotherapies can initially shrinka tumor but fails to eradicate it in full, allowing eventual recurrence. Recently, we identified a CSC population in hepatocellular carcinoma (HCC) characterized by their CD133 phenotype. However, the molecular mechanism by which it escapes conventional therapies remains unknown. Here, we examined the sensitivity of these cells to chemotherapeutic agents (doxorubicin and fluorouracil) and the possible mechanistic pathway by which resistance may be regulated. Purified CD133(+) HCC cells isolated from human HCC cell line and xenograft mouse models survived chemotherapy in increased proportions relative to most tumor cells which lack the CD133 phenotype; the underlying mechanism of which required the preferential expression of survival proteins involved in the Akt/PKB and Bcl-2 pathway. Treatment of CD133(+) HCC cells with an AKT1 inhibitor, specific to the Akt/PKB pathway, significantly reduced the expression of the survival proteins that was normally expressed endogenously. In addition, treatment of unsorted HCC cells with both anticancer drugs in vitro significantly enriched the CD133(+) subpopulation. In conclusion, our results show that CD133(+) HCC cells contribute to chemoresistance through preferential activation of Akt/PKB and Bcl-2 cell survival response. Targeting of this specific survival signaling pathway in CD133(+) HCC CSCs may provide a novel therapeutic model for the disease.	[Ma, S.; Guan, X-Y] Univ Hong Kong, Li Ka Shing Fac Med, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China; [Ma, S.; Chan, K. W.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Lee, T. K.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Zheng, B-J] Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Guan, XY (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Clin Oncol, Room L10-56,10-F Lab Block,21 Sassoon Rd, Hong Kong, Hong Kong, Peoples R China.	xyguan@hkucc.hku.hk	Guan, Xin-Yuan/A-3639-2009; Ma, Stephanie Kwai Yee/C-4766-2009; /A-3639-2009	Guan, Xin-Yuan/0000-0002-4485-6017; Lee, Kin Wah/0000-0003-0682-322X; Ma, Stephanie Kwai Yee/0000-0002-2029-7943; /0000-0003-1874-9805				Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Fabregat I, 2007, LIVER INT, V27, P155, DOI 10.1111/j.1478-3231.2006.01409.x; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Haraguchi N, 2006, STEM CELLS, V24, P506, DOI 10.1634/stemcells.2005-0282; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Suetsugi A, 2006, BIOCHEM BIOPH RES CO, V351, P820, DOI 10.1016/j.bbrc.2006.10.128; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Yin SY, 2007, INT J CANCER, V120, P1444, DOI 10.1002/ijc.22476	29	611	657	2	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 13	2008	27	12					1749	1758		10.1038/sj.onc.1210811	http://dx.doi.org/10.1038/sj.onc.1210811			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	273WF	17891174				2022-12-25	WOS:000253962100010
J	Holbert, MA; Sikorski, T; Carten, J; Snowflack, D; Hodawadekar, S; Marmorstein, R				Holbert, Marc A.; Sikorski, Timothy; Carten, Juliana; Snowflack, Danielle; Hodawadekar, Santosh; Marmorstein, Ronen			The human monocytic leukemia zinc finger histone acetyltransferase domain contains DNA-binding activity implicated in chromatin targeting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; NUCLEOSOME RECOGNITION; IN-VITRO; PROTEIN; ACETYLATION; GCN5; TRANSCRIPTION; MECHANISM	The human monocytic leukemia zinc finger (MOZ) protein is an essential transcriptional coactivator and histone acetyltransferase ( HAT) that plays a primary role in the differentiation of erythroid and myeloid cells and is required to maintain hematopoietic stem cells. Chromosomal translocations involving the HAT-encoded region are also associated with acute myeloid leukemia. Here we present the x-ray crystal structure of the MOZ HAT domain and related biochemical studies. We find that the HAT domain contains a central region that is structurally and functionally conserved with the yeast MYST HAT protein Esa1, but contains more divergent N- and C-terminal regions harboring a TFIIIA-type zinc finger and helix-turn-helix DNA-binding motifs. Solution DNA-binding and acetyltransferase activity assays, in concert with mutagenesis, confirm that the MOZ HAT domain binds strongly to DNA through the zinc finger and helix-turn-helix motifs and that DNA binding and catalysis are not mutually exclusive. Consistent with the DNA-binding properties of MOZ, we also show that MOZ is able to acetylate nucleosomes and free histones equally well, whereas other HATs prefer free histones. Our results reveal, for the first time, that enzymatic and DNA-targeting activities can be contained within the same chromatin regulatory domain.	Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; Univ Penn, Dept Chem, Philadelphia, PA 19104 USA	The Wistar Institute; University of Pennsylvania	Marmorstein, R (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	marmor@wistar.org			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060293] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM60293, R01 GM060293] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahn SH, 2005, CELL, V120, P25, DOI 10.1016/j.cell.2004.11.016; Akhtar A, 2000, NATURE, V407, P405, DOI 10.1038/35030169; Akhtar A, 2001, EMBO REP, V2, P113, DOI 10.1093/embo-reports/kve022; Alekshun MN, 2001, NAT STRUCT BIOL, V8, P710, DOI 10.1038/90429; ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Berndsen CE, 2007, BIOCHEMISTRY-US, V46, P2091, DOI 10.1021/bi602366n; BIANCHI ME, 1989, SCIENCE, V243, P1056, DOI 10.1126/science.2922595; Borrow J, 1996, NAT GENET, V14, P33, DOI 10.1038/ng0996-33; BRADBURY EM, 1992, BIOESSAYS, V14, P9; BRIDGES D, 2005, SCI STKE, pRE10, DOI DOI 10.1126/STKE.2962005RE10; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Clements A, 2003, MOL CELL, V12, P461, DOI 10.1016/S1097-2765(03)00288-0; Clements A, 1999, EMBO J, V18, P3521, DOI 10.1093/emboj/18.13.3521; Da GP, 2006, P NATL ACAD SCI USA, V103, P2057, DOI 10.1073/pnas.0510949103; de la Cruz X, 2005, BIOESSAYS, V27, P164, DOI 10.1002/bies.20176; Deguchi K, 2003, CANCER CELL, V3, P259, DOI 10.1016/S1535-6108(03)00051-5; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; Grant PA, 1999, J BIOL CHEM, V274, P5895, DOI 10.1074/jbc.274.9.5895; Grune T, 2003, MOL CELL, V12, P449, DOI 10.1016/S1097-2765(03)00273-9; HARRISON SC, 1990, ANNU REV BIOCHEM, V59, P933, DOI 10.1146/annurev.bi.59.070190.004441; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; Kamine J, 1996, VIROLOGY, V216, P357, DOI 10.1006/viro.1996.0071; Katsumoto T, 2006, GENE DEV, V20, P1321, DOI 10.1101/gad.1393106; Kitabayashi I, 2001, EMBO J, V20, P7184, DOI 10.1093/emboj/20.24.7184; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LILLEY DMJ, 1992, NATURE, V357, P282, DOI 10.1038/357282a0; Lo WS, 2000, MOL CELL, V5, P917, DOI 10.1016/S1097-2765(00)80257-9; Luger K, 1999, METHOD ENZYMOL, V304, P3; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Neuwald AF, 1997, TRENDS BIOCHEM SCI, V22, P154, DOI 10.1016/S0968-0004(97)01034-7; Nolte RT, 1998, P NATL ACAD SCI USA, V95, P2938, DOI 10.1073/pnas.95.6.2938; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Owen DJ, 2000, EMBO J, V19, P6141, DOI 10.1093/emboj/19.22.6141; Pardo PS, 2002, J BIOL CHEM, V277, P50860, DOI 10.1074/jbc.M203839200; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Poux AN, 2003, BIOCHEMISTRY-US, V42, P14366, DOI 10.1021/bi035632n; Poux AN, 2002, P NATL ACAD SCI USA, V99, P14065, DOI 10.1073/pnas.222373899; Qian CM, 2005, NAT STRUCT MOL BIOL, V12, P1078, DOI 10.1038/nsmb1022; Reifsnyder C, 1996, NAT GENET, V14, P42, DOI 10.1038/ng0996-42; Rojas JR, 1999, NATURE, V401, P93, DOI 10.1038/43487; Rozman M, 2004, GENE CHROMOSOME CANC, V40, P140, DOI 10.1002/gcc.20022; SCHULTZ SC, 1991, SCIENCE, V253, P1001, DOI 10.1126/science.1653449; Schwartz T, 1999, SCIENCE, V284, P1841, DOI 10.1126/science.284.5421.1841; Sharma M, 2000, J BIOL CHEM, V275, P35200, DOI 10.1074/jbc.M004838200; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Smith ER, 1998, P NATL ACAD SCI USA, V95, P3561, DOI 10.1073/pnas.95.7.3561; Steiner T, 2002, EMBO J, V21, P4641, DOI 10.1093/emboj/cdf455; Takechi S, 1999, BIOCHEM BIOPH RES CO, V266, P405, DOI 10.1006/bbrc.1999.1836; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P1863, DOI 10.1107/S0907444999010033; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Thomas T, 2006, GENE DEV, V20, P1175, DOI 10.1101/gad.1382606; Trievel RC, 1999, P NATL ACAD SCI USA, V96, P8931, DOI 10.1073/pnas.96.16.8931; Utley RT, 1996, METHOD ENZYMOL, V274, P276; VIPOND IB, 1993, MOL MICROBIOL, V9, P225, DOI 10.1111/j.1365-2958.1993.tb01685.x; Wang WD, 1998, P NATL ACAD SCI USA, V95, P492, DOI 10.1073/pnas.95.2.492; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yan Y, 2000, MOL CELL, V6, P1195, DOI 10.1016/S1097-2765(00)00116-7; Yan Y, 2002, NAT STRUCT BIOL, V9, P862, DOI 10.1038/nsb849	62	39	41	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36603	36613		10.1074/jbc.M705812200	http://dx.doi.org/10.1074/jbc.M705812200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17925393	hybrid			2022-12-25	WOS:000251458300053
J	Fiaschi, M; Rozell, B; Bergstrom, A; Toftgard, R; Kleman, MI				Fiaschi, Marie; Rozell, Bjorn; Bergstrom, Asa; Toftgard, Rune; Kleman, Marika I.			Targeted expression of GLI1 in the mammary gland disrupts pregnancy-induced maturation and causes lactation failure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR SNAIL; E-CADHERIN; INDIAN HEDGEHOG; GENE-EXPRESSION; SONIC HEDGEHOG; HAIR FOLLICLE; KNOCKOUT MICE; MOUSE UTERUS; ACTIVATION; TISSUE	The Hedgehog signaling pathway regulates the development and function of numerous tissues and when mis-regulated causes tumorigenesis. To assess the role of a deregulated Hedgehog signaling pathway in the mammary gland we targeted the expression of the Hedgehog effector protein, GLI1, to mammary epithelial cells using a bigenic inducible system. A constitutively active Hedgehog signaling pathway resulted with 100% penetrance in an undifferentiated mammary lobuloalveolar network during pregnancy. GLI1-expressing transgenic females were unable to lactate and milk protein gene expression was essentially absent. The inability to lactate was permanent and independent of continued GLI1 transgene expression. An increased expression of the GLI1 response gene Snail coupled to reduced expression of E-cadherin and STAT5 in the transgenic mammary gland provides a likely molecular explanation, underlying the observed phenotypic changes. In addition, remodeling of the mammary gland after parturition was impaired and expression of GLI1 was associated with accumulation of cellular debris in the mammary ducts during involution, indicating a defect in the clearance of dead cells. Areas with highly proliferative epithelial cells were observed in mammary glands with induced expression of GLI1. Within such areas an increased frequency of cells expressing nuclear Cyclin D1 was observed. Taken together the data support the notion that correct regulation of Hedgehog signaling within the epithelial cell compartment is critical for pregnancy-induced mammary gland development and remodeling.	Karolinska Inst, Dept Biosci & Nutr, SE-14157 Huddinge, Sweden; Karolinska Inst, Unit Morphol Phenotype Anal, Clin Res Ctr, SE-14157 Huddinge, Sweden; Karolinska Inst, Dept Lab Med, Div Pathol, SE-14157 Huddinge, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Toftgard, R (corresponding author), Karolinska Inst, Dept Biosci & Nutr, SE-14157 Huddinge, Sweden.	rune.toftgard@biosci.ki.se			NATIONAL CANCER INSTITUTE [U01CA105491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR047898] Funding Source: NIH RePORTER; NCI NIH HHS [U01 CA105491] Funding Source: Medline; NIAMS NIH HHS [AR47898] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abrahams VM, 2004, AM J REPROD IMMUNOL, V51, P275, DOI 10.1111/j.1600-0897.2004.00156.x; Agren M, 2004, GENE, V330, P101, DOI 10.1016/j.gene.2004.01.010; Altaba ARI, 1998, DEVELOPMENT, V125, P2203; Aza-Blanc P, 2000, DEVELOPMENT, V127, P4293; Bai CB, 2004, DEV CELL, V6, P103, DOI 10.1016/S1534-5807(03)00394-0; Bai CB, 2002, DEVELOPMENT, V129, P4753; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bitgood MJ, 1996, CURR BIOL, V6, P298, DOI 10.1016/S0960-9822(02)00480-3; Boussadia O, 2002, MECH DEVELOP, V115, P53, DOI 10.1016/S0925-4773(02)00090-4; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cohen MM, 2003, AM J MED GENET A, V123A, P5, DOI 10.1002/ajmg.a.20495; Come C, 2004, J MAMMARY GLAND BIOL, V9, P183, DOI 10.1023/B:JOMG.0000037161.91969.de; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; DANIEL CW, 1995, DEV BIOL, V169, P511, DOI 10.1006/dbio.1995.1165; Duman-Scheel M, 2002, NATURE, V417, P299, DOI 10.1038/417299a; Gallego MI, 2002, DEV BIOL, V249, P131, DOI 10.1006/dbio.2002.0761; Gunther EJ, 2002, FASEB J, V16, DOI 10.1096/fj.01-0551com; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Hanayama R, 2005, P NATL ACAD SCI USA, V102, P16886, DOI 10.1073/pnas.0508599102; Hatsell SJ, 2006, DEVELOPMENT, V133, P3661, DOI 10.1242/dev.02542; Hennighausen L, 2001, DEV CELL, V1, P467, DOI 10.1016/S1534-5807(01)00064-8; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Kouros-Mehr H, 2006, DEV DYNAM, V235, P3404, DOI 10.1002/dvdy.20978; Lee J, 1997, DEVELOPMENT, V124, P2537; Lee K, 2006, NAT GENET, V38, P1204, DOI 10.1038/ng1874; Lewis MT, 1999, DEVELOPMENT, V126, P5181; Lewis MT, 2001, DEV BIOL, V238, P133, DOI 10.1006/dbio.2001.0410; Li N, 2005, EMBO J, V24, P1942, DOI 10.1038/sj.emboj.7600674; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Liu XW, 1998, CELL GROWTH DIFFER, V9, P795; Louro ID, 2002, CANCER RES, V62, P5867; Matsumoto H, 2002, DEV BIOL, V245, P280, DOI 10.1006/dbio.2002.0645; Michno K, 2003, DEV BIOL, V264, P153, DOI 10.1016/S0012-1606(03)00401-9; Monks J, 2002, J MAMMARY GLAND BIOL, V7, P163, DOI 10.1023/A:1020351919634; Moraes RC, 2007, DEVELOPMENT, V134, P1231, DOI 10.1242/dev.02797; Ormandy CJ, 1997, GENE DEV, V11, P167, DOI 10.1101/gad.11.2.167; Park HL, 2000, DEVELOPMENT, V127, P1593; RAMIREZ A, 1994, DIFFERENTIATION, V58, P53, DOI 10.1007/s002580050065; Shillingford JM, 2003, J HISTOCHEM CYTOCHEM, V51, P555, DOI 10.1177/002215540305100501; Takamoto N, 2002, MOL ENDOCRINOL, V16, P2338, DOI 10.1210/me.2001-0154; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Veltmaat JM, 2006, DEVELOPMENT, V133, P2325, DOI 10.1242/dev.02394; Wagner KU, 2002, DEVELOPMENT, V129, P1377; Wagner KU, 2004, MOL CELL BIOL, V24, P5510, DOI 10.1128/MCB.24.12.5510-5520.2004; Wang QT, 2000, DEVELOPMENT, V127, P3131	46	38	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					36090	36101		10.1074/jbc.M704280200	http://dx.doi.org/10.1074/jbc.M704280200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17928300	hybrid			2022-12-25	WOS:000251458100068
J	Nichols, RA; Dengler, AF; Nakagawa, EM; Bashkin, M; Paul, BT; Wu, JL; Khan, GM				Nichols, Robert A.; Dengler, Andrew F.; Nakagawa, Emily M.; Bashkin, Marisa; Paul, Brian T.; Wu, Jianlin; Khan, Ghous M.			A constitutive, transient receptor potential-like Ca2+ influx pathway in presynaptic nerve endings independent of voltage-gated Ca2+ channels and Na+/Ca2+ exchange	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							GLIOMA HYBRID-CELLS; SODIUM-CALCIUM EXCHANGE; RAT-BRAIN SYNAPTOSOMES; ENDOPLASMIC-RETICULUM; EXTRACELLULAR CALCIUM; TRANSMITTER RELEASE; SYNAPTIC-TRANSMISSION; NEUROBLASTOMA-CELLS; INTACT SYNAPTOSOMES; RYANODINE RECEPTORS	Calcium levels in the presynaptic nerve terminal are altered by several pathways, including voltage-gated Ca2+ channels, the Na+/Ca2+ exchanger, Ca2+-ATPase, and the mitochondria. The influx pathway for homeostatic control of [Ca2+](i) in the nerve terminal has been unclear. One approach to detecting the pathway that maintains internal Ca2+ is to test for activation of Ca2+ influx following Ca2+ depletion. Here, we demonstrate that a constitutive influx pathway for Ca2+ exists in presynaptic terminals to maintain internal Ca2+ independent of voltage-gated Ca2+ channels and Na+/Ca2+ exchange, as measured in intact isolated nerve endings from mouse cortex and in intact varicosities in a neuronal cell line using fluorescence spectroscopy and confocal imaging. The Mg2+ and lanthanide sensitivity of the influx pathway, in addition to its pharmacological and short hairpin RNA sensitivity, and the results of immunostaining for transient receptor potential (TRP) channels indicate the involvement of TRPC channels, possibly TRPC5 and TRPC1. This constitutive Ca2+ influx pathway likely serves to maintain synaptic function under widely varying levels of synaptic activity.	Drexel Univ, Dept Physiol & Pharmacol, Coll Med, Philadelphia, PA 19102 USA	Drexel University	Nichols, RA (corresponding author), 245 N 15th St, Philadelphia, PA 19102 USA.	robert.nichols@drexel.edu			NATIONAL INSTITUTE ON AGING [R01AG021586] Funding Source: NIH RePORTER; NIA NIH HHS [AG21586] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ahmmed GU, 2004, J BIOL CHEM, V279, P20941, DOI 10.1074/jbc.M313975200; AKERMAN KEO, 1981, EUR J BIOCHEM, V117, P491; Arnaudeau S, 2001, J BIOL CHEM, V276, P29430, DOI 10.1074/jbc.M103274200; Bardo S, 2006, TRENDS PHARMACOL SCI, V27, P78, DOI 10.1016/j.tips.2005.12.008; BENNINGER C, 1980, BRAIN RES, V187, P165, DOI 10.1016/0006-8993(80)90502-8; Bergsman JB, 2000, J NEUROSCI, V20, P4368, DOI 10.1523/JNEUROSCI.20-12-04368.2000; Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; BLAUSTEIN MP, 1975, J PHYSIOL-LONDON, V247, P657, DOI 10.1113/jphysiol.1975.sp010951; Borst JGG, 1999, J PHYSIOL-LONDON, V521, P123, DOI 10.1111/j.1469-7793.1999.00123.x; Bouchard R, 2003, PROG NEUROBIOL, V69, P391, DOI 10.1016/S0301-0082(03)00053-4; Brain KL, 2001, NEUROSCIENCE, V106, P395, DOI 10.1016/S0306-4522(01)00280-9; Budd SL, 1996, J NEUROCHEM, V66, P403, DOI 10.1046/j.1471-4159.1996.66010403.x; Carter AG, 2002, J NEUROSCI, V22, P21, DOI 10.1523/JNEUROSCI.22-01-00021.2002; Castelli L, 2003, J MEMBRANE BIOL, V195, P121, DOI 10.1007/s00232-003-0614-2; Chang DTW, 2006, J NEUROSCI, V26, P7035, DOI 10.1523/JNEUROSCI.1012-06.2006; Chernaya G, 1996, J BIOL CHEM, V271, P5378, DOI 10.1074/jbc.271.10.5378; Cohen JE, 2004, NEUROSCIENTIST, V10, P12, DOI 10.1177/1073858403259440; Collin T, 2005, CURR OPIN NEUROBIOL, V15, P275, DOI 10.1016/j.conb.2005.05.003; Demeuse P, 2006, J GEN PHYSIOL, V127, P421, DOI 10.1085/jgp.200509410; DRAPEAU P, 1984, J PHYSIOL-LONDON, V348, P493, DOI 10.1113/jphysiol.1984.sp015121; DUNKLEY PR, 1986, BRAIN RES, V372, P115, DOI 10.1016/0006-8993(86)91464-2; EBERHARD M, 1989, BIOCHEM BIOPH RES CO, V163, P309, DOI 10.1016/0006-291X(89)92136-0; Egelman DM, 1999, BIOPHYS J, V76, P1856, DOI 10.1016/S0006-3495(99)77345-5; Emptage NJ, 2001, NEURON, V29, P197, DOI 10.1016/S0896-6273(01)00190-8; Flemming PK, 2006, J BIOL CHEM, V281, P4977, DOI 10.1074/jbc.M510301200; FONTANA G, 1993, J NEUROCHEM, V60, P843, DOI 10.1111/j.1471-4159.1993.tb03228.x; Goel M, 2002, J BIOL CHEM, V277, P48303, DOI 10.1074/jbc.M207882200; Greka A, 2003, NAT NEUROSCI, V6, P837, DOI 10.1038/nn1092; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; Halaszovich CR, 2000, J BIOL CHEM, V275, P37423, DOI 10.1074/jbc.M007010200; HAN HQ, 1991, NATURE, V349, P697, DOI 10.1038/349697a0; He LP, 2005, J BIOL CHEM, V280, P10997, DOI 10.1074/jbc.M411797200; HEINEMANN U, 1990, PROG BRAIN RES, V83, P197; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Hui H, 2006, J PHYSIOL-LONDON, V572, P165, DOI 10.1113/jphysiol.2005.102889; Jiang XP, 2003, J BIOL CHEM, V278, P42867, DOI 10.1074/jbc.M304487200; Jinno S, 2002, NEUROSCIENCE, V113, P449, DOI 10.1016/S0306-4522(02)00172-0; Juhaszova M, 2000, EUR J NEUROSCI, V12, P839, DOI 10.1046/j.1460-9568.2000.00974.x; KOMULAINEN H, 1987, NEUROCHEM INT, V10, P55, DOI 10.1016/0197-0186(87)90172-0; Korge P, 1999, EUR J BIOCHEM, V265, P273, DOI 10.1046/j.1432-1327.1999.00724.x; Kozak JA, 2003, BIOPHYS J, V84, P922, DOI 10.1016/S0006-3495(03)74909-1; Kozak JA, 2002, J GEN PHYSIOL, V120, P221, DOI 10.1085/jgp.20028601; Langeslag M, 2007, J BIOL CHEM, V282, P232, DOI 10.1074/jbc.M605300200; Li NZ, 2003, J NEUROSCI, V23, P10302; Liang Y, 2002, J NEUROPHYSIOL, V87, P1132, DOI 10.1152/jn.00661.2001; Lievremont JP, 2005, MOL PHARMACOL, V68, P758, DOI 10.1124/mol.105.012856; Lukyanetz EA, 1998, J PHYSIOL-LONDON, V510, P371, DOI 10.1111/j.1469-7793.1998.371bk.x; Ma HT, 2000, SCIENCE, V287, P1647, DOI 10.1126/science.287.5458.1647; MARTINEZSERRANO A, 1992, MOL BIOL CELL, V3, P235, DOI 10.1091/mbc.3.2.235; Martone ME, 1999, CELL TISSUE RES, V295, P395, DOI 10.1007/s004410051246; MCGEE R, 1978, P NATL ACAD SCI USA, V75, P1314, DOI 10.1073/pnas.75.3.1314; MCGRAW CF, 1980, J CELL BIOL, V85, P228, DOI 10.1083/jcb.85.2.228; MEIRI U, 1972, SCIENCE, V176, P308, DOI 10.1126/science.176.4032.308; Millan C, 2002, J BIOL CHEM, V277, P14092, DOI 10.1074/jbc.M109044200; Mori Y, 1998, NEUROREPORT, V9, P507; Muschol M, 1999, BIOPHYS J, V77, P577, DOI 10.1016/S0006-3495(99)76914-6; NACHSHEN DA, 1985, J PHYSIOL-LONDON, V363, P87, DOI 10.1113/jphysiol.1985.sp015697; Narita K, 2000, J GEN PHYSIOL, V115, P519, DOI 10.1085/jgp.115.4.519; NAVONE F, 1986, J CELL BIOL, V103, P2511, DOI 10.1083/jcb.103.6.2511; Nayak SV, 1999, NEUROSCIENCE, V91, P107, DOI 10.1016/S0306-4522(98)00520-X; Nayak SV, 2001, J NEUROCHEM, V76, P1860, DOI 10.1046/j.1471-4159.2001.00197.x; NELSON P, 1976, P NATL ACAD SCI USA, V73, P123, DOI 10.1073/pnas.73.1.123; Nicholls DG, 2003, NEUROCHEM RES, V28, P1433, DOI 10.1023/A:1025653805029; NICHOLLS DG, 1981, PHILOS T ROY SOC B, V296, P115, DOI 10.1098/rstb.1981.0176; Nichols RA, 1996, J NEUROCHEM, V67, P581; NICHOLSON C, 1980, FED PROC, V39, P1519; NICHOLSON C, 1977, P NATL ACAD SCI USA, V74, P1287, DOI 10.1073/pnas.74.3.1287; Obukhov AG, 2005, J NEUROSCI, V25, P1234, DOI 10.1523/JNEUROSCI.4451-04.2005; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Partridge LD, 2000, BRAIN RES, V867, P143, DOI 10.1016/S0006-8993(00)02275-7; Raiteri L, 2002, J NEUROCHEM, V80, P706, DOI 10.1046/j.0022-3042.2001.00750.x; Reid CA, 2003, TRENDS NEUROSCI, V26, P683, DOI 10.1016/j.tins.2003.10.003; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Ronde P, 1998, J NEUROCHEM, V70, P1094; Ronde P, 2001, NEUROSCIENCE, V102, P979, DOI 10.1016/S0306-4522(00)00512-1; Ronde P, 2000, J PHYSIOL-LONDON, V529, P307, DOI 10.1111/j.1469-7793.2000.00307.x; RUAT M, 1995, P NATL ACAD SCI USA, V92, P3161, DOI 10.1073/pnas.92.8.3161; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Rusakov DA, 2003, NEURON, V37, P287, DOI 10.1016/S0896-6273(03)00025-4; Rusakov DA, 2006, NEUROSCIENTIST, V12, P317, DOI 10.1177/1073858405284672; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; SCOTT ID, 1980, BIOCHEM J, V192, P873, DOI 10.1042/bj1920873; Scotti AL, 1999, PHILOS T ROY SOC B, V354, P357, DOI 10.1098/rstb.1999.0387; Sharma G, 2003, NEURON, V38, P929, DOI 10.1016/S0896-6273(03)00322-2; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Smith RM, 1974, CRITICAL STABILITY C, V1-6; Smith SM, 2004, NEURON, V41, P243, DOI 10.1016/S0896-6273(03)00837-7; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; TAREILUS E, 1993, NEUROCHEM INT, V23, P331, DOI 10.1016/0197-0186(93)90077-I; Tozzi A, 2003, EUR J NEUROSCI, V18, P2133, DOI 10.1046/j.1460-9568.2003.02936.x; Trebak M, 2002, J BIOL CHEM, V277, P21617, DOI 10.1074/jbc.M202549200; Unni VK, 2004, J NEUROSCI, V24, P9612, DOI 10.1523/JNEUROSCI.5583-03.2004; Vassilev PM, 1997, BIOPHYS J, V72, P2103, DOI 10.1016/S0006-3495(97)78853-2; Venkatachalam K, 2002, NAT CELL BIOL, V4, pE263, DOI 10.1038/ncb1102-e263; von Bohlen und Halbach O, 2005, CELL TISSUE RES, V322, P201, DOI 10.1007/s00441-005-0004-4; Wu JL, 2006, J NEUROCHEM, V98, P481, DOI 10.1111/j.1471-4159.2006.03901.x; Xu F, 1998, ANESTH ANALG, V87, P701, DOI 10.1097/00000539-199809000-00040; YEAGER RE, 1987, J NEUROSCI, V7, P2390; Zeng FN, 2004, J PHYSIOL-LONDON, V559, P739, DOI 10.1113/jphysiol.2004.065391	103	17	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					36102	36111		10.1074/jbc.M706002200	http://dx.doi.org/10.1074/jbc.M706002200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17928293	hybrid			2022-12-25	WOS:000251458100069
J	Watanabe, K; Hamada, S; Bianco, C; Mancino, M; Nagaoka, T; Gonzales, M; Bailly, V; Strizzi, L; Salomon, DS				Watanabe, Kazuhide; Hamada, Shin; Bianco, Caterina; Mancino, Mario; Nagaoka, Tadahiro; Gonzales, Monica; Bailly, Veronique; Strizzi, Luigi; Salomon, David S.			Requirement of Glycosylphosphatidylinositol anchor of cripto-1 for trans activity as a nodal co-receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIGHT ASYMMETRIC EXPRESSION; ONE-EYED-PINHEAD; EGF-CFC FAMILY; INTERCELLULAR TRANSFER; SIGNALING PATHWAY; PRION PROTEIN; MOUSE; CELLS; IDENTIFICATION; CANCER	Cripto-1 (CR-1) has an indispensable role as a Nodal coreceptor for patterning of body axis in embryonic development. CR-1 is reported to have a paracrine activity as a Nodal co-receptor, although CR-1 is primarily produced as a glycosylphosphatidylinositol (GPI)-anchored membrane protein. Regulation of cis and trans function of CR-1 should be important to establish the precise body patterning. However, the mechanism by which GPI-anchored CR-1 can act in trans is not well known. Here we confirmed the paracrine activity of CR-1 by fluorescent cell-labeling and immunofluorescent staining. We generated COOH-terminal-truncated soluble forms of CR-1 based on the attachment site for the GPI moiety (omega-site), which we identified in the present study. GPI-anchored CR-1 has a significantly higher activity than COOH-terminal-truncated soluble forms to induce Nodal signal in trans as well as in cis. Moreover, transmembrane forms of CR-1 partially retained their ability to induce Nodal signaling only when type I receptor Activin-like kinase 4 was overexpressed. NTERA2/D1 cells, which express endogenous CR-1, lost the cell-surface expression of CR-1 after phosphatidylinositol-phospholipase C treatment and became refractory to stimulation of Nodal. These observations suggest that GPI attachment of CR-1 is required for the paracrine activity as a Nodal co-receptor.	NCI, Tumor Growth Factor Sect, Mammary Biol & Tumorigenesis Lab, Ctr Canc Res,NIH, Bethesda, MD 20892 USA; Biogen Idec Inc, Cambridge, MA 02142 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Biogen	Salomon, DS (corresponding author), Bldg 37,Rm 1118B,37 Convent Dr, Bethesda, MD 20892 USA.	salomond@mail.nih.gov	Nagaoka, Tadahiro/ABI-3842-2022; Hamada, Shin/Z-3023-2019; Watanabe, Kazuhide/C-9667-2017	Nagaoka, Tadahiro/0000-0002-9391-0243; Watanabe, Kazuhide/0000-0002-5331-0593; Mancino, Mario/0000-0003-1957-3119	Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Adachi H, 1999, GENE DEV, V13, P1589, DOI 10.1101/gad.13.12.1589; Adkins HB, 2003, J CLIN INVEST, V112, P575, DOI 10.1172/JCI200317788; Anderson SM, 1996, P NATL ACAD SCI USA, V93, P5894, DOI 10.1073/pnas.93.12.5894; Bamford RN, 2000, NAT GENET, V26, P365, DOI 10.1038/81695; Bianco C, 2002, MOL CELL BIOL, V22, P2586, DOI 10.1128/MCB.22.8.2586-2597.2002; Bianco C, 2006, CLIN CANCER RES, V12, P5158, DOI 10.1158/1078-0432.CCR-06-0274; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; Chea HK, 2005, DEV DYNAM, V234, P269, DOI 10.1002/dvdy.20549; Chen CH, 2004, CURR BIOL, V14, P618, DOI 10.1016/j.cub.2004.02.042; Chu GC, 2004, DEVELOPMENT, V131, P3501, DOI 10.1242/dev.01248; Chu JH, 2005, DEVELOPMENT, V132, P5539, DOI 10.1242/dev.02157; Davis DM, 2007, NAT REV IMMUNOL, V7, P238, DOI 10.1038/nri2020; FURUKAWA Y, 1994, BBA-BIOMEMBRANES, V1190, P273, DOI 10.1016/0005-2736(94)90084-1; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Hirokawa N, 2006, CELL, V125, P33, DOI 10.1016/j.cell.2006.03.002; Lauc G, 2006, BBA-GEN SUBJECTS, V1760, P584, DOI 10.1016/j.bbagen.2005.11.014; Le Good JA, 2005, CURR BIOL, V15, P31, DOI 10.1016/j.cub.2004.12.062; Liu T, 2002, J BIOL CHEM, V277, P47671, DOI 10.1074/jbc.M207458200; Marikawa Y, 2006, SEMIN CELL DEV BIOL, V17, P175, DOI 10.1016/j.semcdb.2006.04.003; Minchiotti G, 2000, MECH DEVELOP, V90, P133, DOI 10.1016/S0925-4773(99)00235-X; Minchiotti G, 2001, DEVELOPMENT, V128, P4501; MORAN P, 1992, J CELL BIOL, V119, P763, DOI 10.1083/jcb.119.4.763; Nicholson TB, 2007, J CELL BIOL, V177, P211, DOI 10.1083/jcb.200701158; Nicholson TB, 2006, J CELL BIOL, V175, P647, DOI 10.1083/jcb.200605001; Norris DP, 1999, GENE DEV, V13, P1575, DOI 10.1101/gad.13.12.1575; Okada Y, 2005, CELL, V121, P633, DOI 10.1016/j.cell.2005.04.008; Parisi S, 2003, J CELL BIOL, V163, P303, DOI 10.1083/jcb.200303010; Saijoh Y, 2000, MOL CELL, V5, P35, DOI 10.1016/S1097-2765(00)80401-3; Sakuma R, 2002, GENES CELLS, V7, P401, DOI 10.1046/j.1365-2443.2002.00528.x; Salomon DS, 2000, ENDOCR-RELAT CANCER, V7, P199, DOI 10.1677/erc.0.0070199; Schiffer SG, 2001, J BIOL CHEM, V276, P37769; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Shi SL, 2007, J BIOL CHEM, V282, P20133, DOI 10.1074/jbc.M702593200; Tabata T, 2004, DEVELOPMENT, V131, P703, DOI 10.1242/dev.01043; Walmsley AR, 2001, EMBO J, V20, P703, DOI 10.1093/emboj/20.4.703; Watanabe K, 2007, J BIOL CHEM, V282, P31643, DOI 10.1074/jbc.M702713200; Wheeler SF, 2002, GLYCOBIOLOGY, V12, P261, DOI 10.1093/glycob/12.4.261; Xing PX, 2004, CANCER RES, V64, P4018, DOI 10.1158/0008-5472.CAN-03-3888; Xu CH, 1999, DEVELOPMENT, V126, P483; Yamamoto M, 2001, GENE DEV, V15, P1242, DOI 10.1101/gad.883901; Yan YT, 2002, MOL CELL BIOL, V22, P4439, DOI 10.1128/MCB.22.13.4439-4449.2002; Yeo CY, 2001, MOL CELL, V7, P949, DOI 10.1016/S1097-2765(01)00249-0; Zhang JJ, 1998, CELL, V92, P241, DOI 10.1016/S0092-8674(00)80918-6	43	45	45	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35772	35786		10.1074/jbc.M707351200	http://dx.doi.org/10.1074/jbc.M707351200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17925387	hybrid			2022-12-25	WOS:000251458100039
J	Garscha, U; Jerneren, F; Chung, D; Keller, NP; Hamberg, M; Oliw, EH				Garscha, Ulrike; Jerneren, Fredrik; Chung, DaWoon; Keller, Nancy P.; Hamberg, Mats; Oliw, Ernst H.			Identification of dioxygenases required for aspergillus development - Studies of products, stereochemistry, and the reaction mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNGUS GAEUMANNOMYCES-GRAMINIS; LINOLEATE DIOL SYNTHASE; HYDROPEROXIDE ISOMERASE; ACID 8R-DIOXYGENASE; MASS-SPECTROMETRY; NIDULANS; BIOSYNTHESIS; OXYGENATION; METABOLITES; OXYLIPINS	Aspergillus sp. contain ppoA, ppoB, and ppoC genes, which code for fatty acid oxygenases with homology to fungal linoleate 7,8-diol synthases (7,8-LDS) and cyclooxygenases. Our objective was to identify these enzymes, as ppo gene replacements show critical developmental aberrancies in sporulation and pathogenicity in the human pathogen Aspergillus fumigatus and the genetic model Aspergillus nidulans. The PpoAs of A. fumigatus and A. nidulans were identified as (8R)-dioxygenases with hydroperoxide isomerase activity, designated 5,8-LDS. 5,8-LDS transformed 18:2n-6 to (8R)-hydroperoxyoctadecadienoic acid ((8R)- HPODE) and (5S,8R)-dihydroxy-9Z,12Z-octadecadienoic acid ((5S,8R)-DiHODE). We also detected 8,11-LDS in A. fumigatus and (10R)-dioxygenases in both Aspergilli. The diol synthases oxidized [(8R)-2H] 18: 2n-6 to (8R)-HPODE with retention of the deuterium label, suggesting antarafacial hydrogen abstraction and insertion of molecular oxygen. Experiments with stereospecifically deuterated 18: 2n-6 showed that (8R)HPODE was isomerized by 5,8- and 8,11-LDS to (5S, 8R)DiHODE and to (8R,11S)-dihydroxy-9Z, 12Z-octadecadienoic acid, respectively, by suprafacial hydrogen abstraction and oxygen insertion at C-5 and C-11. PpoCs were identified as (10R)-dioxygenases, which catalyzed abstraction of the pro-S hydrogen at C-8 of 18: 2n-6, double bond migration, and antafacial insertion of molecular oxygen with formation of (10R)-hydroxy8E, 12Z-hydroperoxyoctadecadienoic acid ((10R)-HPODE). Deletion of ppoA led to prominent reduction of (8R)- H(P) ODE and complete loss of (5S,8R)-DiHODE biosynthesis, whereas biosynthesis of (10R)-HPODE was unaffected. Deletion of ppoC caused biosynthesis of traces of racemic 10-HODE but did not affect the biosynthesis of other oxylipins. We conclude that ppoA of Aspergillus sp. may code for 5,8-LDS with catalytic similarities to 7,8-LDS and ppoC for linoleate (10R)-dioxygenases. Identification of these oxygenases and their products will provide tools for analyzing the biological impact of oxylipin biosynthesis in Aspergilli.	Uppsala Biomed Ctr, Dept Pharmaceut Biosci, SE-75124 Uppsala, Sweden; Univ Wisconsin, Dept Med & Microbiol Immunobiol, Madison, WI 53706 USA; Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA; Karolinska Inst, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Karolinska Institutet	Oliw, EH (corresponding author), Uppsala Biomed Ctr, Dept Pharmaceut Biosci, SE-75124 Uppsala, Sweden.	Ernst.Oliw@farmbio.uu.se	Keller, Nancy P./ABC-5911-2021; Garscha, Ulrike/G-3559-2018	Oliw, Ernst/0000-0002-7986-8130; Hamberg, Mats/0000-0002-8910-7810; Garscha, Ulrike/0000-0002-3645-7833; Jerneren, Fredrik/0000-0003-0897-7177				Akakabe Y, 2005, BIOSCI BIOTECH BIOCH, V69, P1539, DOI 10.1271/bbb.69.1539; BOWERS WS, 1986, SCIENCE, V232, P105, DOI 10.1126/science.232.4746.105; BRODOWSKY ID, 1994, ANN NY ACAD SCI, V744, P314, DOI 10.1111/j.1749-6632.1994.tb52750.x; BRODOWSKY ID, 1992, BIOCHIM BIOPHYS ACTA, V1124, P59, DOI 10.1016/0005-2760(92)90126-G; BRODOWSKY ID, 1992, J BIOL CHEM, V267, P14738; BRODOWSKY ID, 1993, BIOCHIM BIOPHYS ACTA, V1168, P68, DOI 10.1016/0005-2760(93)90267-D; BRODOWSKY ID, 1994, EUR J PHARMACOL, V254, P43, DOI 10.1016/0014-2999(94)90368-9; CHAMPE SP, 1989, J BACTERIOL, V171, P3982, DOI 10.1128/jb.171.7.3982-3988.1989; Coffa G, 2005, BIOCHEM BIOPH RES CO, V338, P87, DOI 10.1016/j.bbrc.2005.07.185; Cristea M, 2003, LIPIDS, V38, P1275, DOI 10.1007/s11745-003-1189-3; Daiyasu H, 2000, J MOL EVOL, V51, P433, DOI 10.1007/s002390010106; de Boer HJ, 2005, J ETHNOPHARMACOL, V96, P461, DOI 10.1016/j.jep.2004.09.035; DOONAN JH, 1992, J CELL SCI, V103, P599; Fox SR, 2000, LIPIDS, V35, P23, DOI 10.1007/s11745-000-0490-5; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Garscha U, 2007, ANAL BIOCHEM, V367, P238, DOI 10.1016/j.ab.2007.04.045; Hamberg M, 2005, BIOCHEM BIOPH RES CO, V338, P169, DOI 10.1016/j.bbrc.2005.08.117; Hamberg M, 1998, J BIOL CHEM, V273, P13080, DOI 10.1074/jbc.273.21.13080; HAMBERG M, 1994, ARCH BIOCHEM BIOPHYS, V309, P77, DOI 10.1006/abbi.1994.1087; HAMBERG M, 1992, LIPIDS, V27, P487, DOI 10.1007/BF02536128; Hornsten L, 1999, J BIOL CHEM, V274, P28219, DOI 10.1074/jbc.274.40.28219; Jones MG, 2007, MICROBIOL-SGM, V153, P1, DOI 10.1099/mic.0.2006/001479-0; KOSHINO H, 1987, TETRAHEDRON LETT, V28, P73, DOI 10.1016/S0040-4039(00)95652-1; LABEQUE R, 1987, J AM CHEM SOC, V109, P2828, DOI 10.1021/ja00243a048; MAZUR P, 1990, TETRAHEDRON LETT, V31, P3837, DOI 10.1016/S0040-4039(00)97482-3; Murphy RC, 2005, ANAL BIOCHEM, V346, P1, DOI 10.1016/j.ab.2005.04.042; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Oliw EH, 1998, LIPIDS, V33, P843, DOI 10.1007/s11745-998-0280-0; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Su C, 1998, J BIOL CHEM, V273, P20744, DOI 10.1074/jbc.273.33.20744; Su C, 1996, J BIOL CHEM, V271, P14112, DOI 10.1074/jbc.271.24.14112; Thuresson ED, 2001, J BIOL CHEM, V276, P10347, DOI 10.1074/jbc.M009377200; Tsitsigiannis D, 2004, EUKARYOT CELL, V3, P1398, DOI 10.1128/EC.3.6.1398-1411.2004; Tsitsigiannis DI, 2006, MOL MICROBIOL, V59, P882, DOI 10.1111/j.1365-2958.2005.05000.x; Tsitsigiannis DI, 2005, INFECT IMMUN, V73, P4548, DOI 10.1128/IAI.73.8.4548-4559.2005; Tsitsigiannis DI, 2005, MICROBIOL-SGM, V151, P1809, DOI 10.1099/mic.0.27880-0; Tsitsigiannis DI, 2004, J BIOL CHEM, V279, P11344, DOI 10.1074/jbc.M310840200; Wadman MW, 2005, LIPIDS, V40, P1163, DOI 10.1007/s11745-005-1481-2; Wilson DM, 2002, ADV EXP MED BIOL, V504, P3; WURZENBERGER M, 1984, BIOCHIM BIOPHYS ACTA, V794, P25, DOI 10.1016/0005-2760(84)90293-5; Xue T, 2004, ARCH MICROBIOL, V182, P346, DOI 10.1007/s00203-004-0707-z	41	77	84	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34707	34718		10.1074/jbc.M705366200	http://dx.doi.org/10.1074/jbc.M705366200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17906293	hybrid			2022-12-25	WOS:000251155200013
J	Hervas-Aguilar, A; Rodriguez, JM; Tilburn, J; Arst, HN; Penalva, MA				Hervas-Aguilar, America; Rodriguez, Jose M.; Tilburn, Joan; Arst, Herbert N., Jr.; Penalva, Miguel A.			Evidence for the direct involvement of the proteasome in the proteolytic processing of the Aspergillus nidulans zinc finger transcription factor PacC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B P105; GLYCINE-RICH REGION; CUBITUS-INTERRUPTUS; AMBIENT PH; 20S PROTEASOME; REQUIRES PHOSPHORYLATION; NUCLEAR-LOCALIZATION; BETA-TRCP; HEDGEHOG; PROTEIN	The 72-kDa zinc finger transcription factor PacC, distantly related to Ci/Gli developmental regulators, undergoes two-step proteolytic processing in response to alkaline ambient pH. "Signaling protease" cleavage of PacC(72) removes a processing-inhibitory C-terminal domain, making its truncated PacC(53) product accessible to a second "processing" protease, yielding PacC(27). Features of the processing proteolysis suggested the proteasome as a candidate protease. We constructed, using gene replacements, two missense active site mutations in preB, the Aspergillus nidulans orthologue of Saccharomyces cerevisiae PRE2 encoding the proteasome beta 5 subunit. preB1(K101A) is lethal. Viable preB2(K101R) impairs growth and, like its equivalent pre2(K108R) in yeast, impairs chymotryptic activity. pre2(K108R) and preB2(K101R) active site mutations consistently shift position of the scissile bonds when PacC is processed in S. cerevisiae and A. nidulans, respectively, indicating that PacC must be a direct substrate of the proteasome. preB2K101R leads to a 2-3-fold elevation in NimE mitotic cyclin levels but appears to result in PacC instability, suggesting an altered balance between processing and degradation. preB2(K101R) compensates the marked impairment in PacC(27) formation resulting from deletion of the processing efficiency determinant in PacC, further indicating direct proteasomal involvement in the formation of PacC(27). Deletion of a Gly-Pro- Ala-rich region within this processing efficiency determinant markedly destabilizes PacC. Arg substitutions of Lys residues within this efficiency determinant and nearby show that they cooperate to promote PacC processing. A quadruple Lys-to-Arg substitution (4K -> R) impairs formation of PacC(27) and leads to persistence of PacC(53). Wild-type PacC(53) becomes multiply phosphorylated upon alkaline pH exposure. Processing-impaired 4K -> R PacC(53) becomes excessively phosphorylated.	CSIC, Ctr Invest Biol, Dept Mol Microbiol, E-28040 Madrid, Spain; Imperial Coll London, Dept Microbiol, London SW7 2AZ, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Imperial College London	Penalva, MA (corresponding author), CSIC, Ctr Invest Biol, Dept Mol Microbiol, E-28040 Madrid, Spain.	penalva@cib.csic.es	Penalva, Miguel A/G-2295-2015	Penalva, Miguel A/0000-0002-3102-2806	Wellcome Trust [067878] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALVARO J, 2003, THESIS U AUTONOMA MA; ARST HN, 1994, MOL GEN GENET, V245, P787, DOI 10.1007/BF00297286; Arst HN, 2003, TRENDS GENET, V19, P224, DOI 10.1016/S0168-9525(03)00052-0; AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; Chen P, 1996, CELL, V86, P961, DOI 10.1016/S0092-8674(00)80171-3; Chen Y, 1998, P NATL ACAD SCI USA, V95, P2349, DOI 10.1073/pnas.95.5.2349; Chen Y, 1999, DEVELOPMENT, V126, P3607; COVE DJ, 1966, BIOCHIM BIOPHYS ACTA, V113, P51, DOI 10.1016/S0926-6593(66)80120-0; DENISON SH, 1995, J BIOL CHEM, V270, P28519, DOI 10.1074/jbc.270.48.28519; Diez E, 2002, EMBO J, V21, P1350, DOI 10.1093/emboj/21.6.1350; Espeso EA, 2000, EMBO J, V19, P719, DOI 10.1093/emboj/19.4.719; Espeso EA, 1997, J MOL BIOL, V274, P466, DOI 10.1006/jmbi.1997.1428; Fernandez-Martinez J, 2003, J MOL BIOL, V334, P667, DOI 10.1016/j.jmb.2003.09.072; Groll M, 1999, P NATL ACAD SCI USA, V96, P10976, DOI 10.1073/pnas.96.20.10976; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Heinemeyer W, 1997, J BIOL CHEM, V272, P25200, DOI 10.1074/jbc.272.40.25200; Heissmeyer V, 1999, EMBO J, V18, P4766, DOI 10.1093/emboj/18.17.4766; Hoyt MA, 2006, EMBO J, V25, P1720, DOI 10.1038/sj.emboj.7601058; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; Kisselev AF, 2000, J BIOL CHEM, V275, P14831, DOI 10.1074/jbc.275.20.14831; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; Lee SC, 2007, MOL MICROBIOL, V63, P1039, DOI 10.1111/j.1365-2958.2006.05575.x; Li WS, 1997, GENETICS, V145, P63; Lin L, 1996, MOL CELL BIOL, V16, P2248; Lin L, 1998, CELL, V92, P819, DOI 10.1016/S0092-8674(00)81409-9; Methot N, 1999, CELL, V96, P819, DOI 10.1016/S0092-8674(00)80592-9; MIMS CW, 1988, PROTOPLASMA, V144, P132, DOI 10.1007/BF01637246; Mingot JM, 1999, MOL CELL BIOL, V19, P1390; Moorthy AK, 2006, EMBO J, V25, P1945, DOI 10.1038/sj.emboj.7601081; Nayak T, 2006, GENETICS, V172, P1557, DOI 10.1534/genetics.105.052563; Ohlmeyer JT, 1998, NATURE, V396, P749, DOI 10.1038/25533; OREJAS M, 1995, GENE DEV, V9, P1622, DOI 10.1101/gad.9.13.1622; Orian A, 2000, EMBO J, V19, P2580, DOI 10.1093/emboj/19.11.2580; Orian A, 1999, MOL CELL BIOL, V19, P3664; Osmani AH, 2006, NAT PROTOC, V1, P2517, DOI 10.1038/nprot.2006.406; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Penalva MA, 2004, ANNU REV MICROBIOL, V58, P425, DOI 10.1146/annurev.micro.58.030603.123715; PERIAS MM, 2007, EUKARYOT CELL, V6, P960; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Price MA, 2002, CELL, V108, P823, DOI 10.1016/S0092-8674(02)00664-5; Rodgers KJ, 2003, INT J BIOCHEM CELL B, V35, P716, DOI 10.1016/S1357-2725(02)00391-6; Sears C, 1998, J BIOL CHEM, V273, P1409, DOI 10.1074/jbc.273.3.1409; Smelkinson MG, 2006, CURR BIOL, V16, P110, DOI 10.1016/j.cub.2005.12.012; Staszczak M, 2005, BIOCHIMIE, V87, P755, DOI 10.1016/j.biochi.2005.03.002; Stimpson HEM, 2006, EMBO J, V25, P662, DOI 10.1038/sj.emboj.7600984; Takeuchi J, 2007, EMBO J, V26, P123, DOI 10.1038/sj.emboj.7601476; Tempe D, 2006, MOL CELL BIOL, V26, P4316, DOI 10.1128/MCB.02183-05; Tian L, 2005, NAT STRUCT MOL BIOL, V12, P1045, DOI 10.1038/nsmb1018; Tilburn J, 2005, GENETICS, V171, P393, DOI 10.1534/genetics.105.044644; TILBURN J, 1983, GENE, V26, P205, DOI 10.1016/0378-1119(83)90191-9; TILBURN J, 1995, EMBO J, V14, P779, DOI 10.1002/j.1460-2075.1995.tb07056.x; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang BW, 2006, P NATL ACAD SCI USA, V103, P33, DOI 10.1073/pnas.0509927103; Wu L, 1998, J CELL BIOL, V141, P1575, DOI 10.1083/jcb.141.7.1575; Xu WJ, 2001, J BACTERIOL, V183, P6917, DOI 10.1128/JB.183.23.6917-6923.2001; Zhang MS, 2003, EMBO J, V22, P1488, DOI 10.1093/emboj/cdg158; Zhang MS, 2004, J BIOL CHEM, V279, P8635, DOI 10.1074/jbc.M310449200	60	64	71	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34735	34747		10.1074/jbc.M706723200	http://dx.doi.org/10.1074/jbc.M706723200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17911112	Green Published, hybrid			2022-12-25	WOS:000251155200016
J	Ju, ZL; Volpi, SA; Hassan, R; Martinez, N; Giannini, SL; Gold, T; Birshtein, BK				Ju, Zhongliang; Volpi, Sabrina A.; Hassan, Rabih; Martinez, Nancy; Giannini, Sandra L.; Gold, Tamar; Birshtein, Barbara K.			Evidence for physical interaction between the immunoglobulin heavy chain variable region and the 3 ' regulatory region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GLOBIN LOCUS; B-CELLS; DNA REARRANGEMENTS; GENE-EXPRESSION; IGH LOCUS; IN-VIVO; 3' END; TRANSCRIPTION; ENHANCER; VARIANTS	B cell-specific expression of immunoglobulin heavy chain (IgH) genes utilizes two cis regulatory regions, the intronic enhancer (E mu), located in the J(H)-C mu intron, and a complex regulatory region that lies 3 ' to the IgH gene cluster, 3 ' RR. We hypothesized that the 3 ' RR is involved in IgH gene transcription in plasma cells via physical interaction between distal 3 ' RR enhancers and target V-H sequences, with loop formation by intervening DNA. In support of this hypothesis we report sequence data at DNA recombination breakpoints as evidence for loop formation preceding DNA inversion in a plasma cell line. In addition, using the chromosome conformation capture technique, physical interactions between VH and 3 ' RR were analyzed directly and detected in MPC11 plasma cells and variants and normal splenic B cells but not detected in splenic T cells or in non-B cells. V-H-3 ' RR interactions were present in the absence of E mu, but when the hs1,2 enhancer was replaced by a Neo(R) gene in a variant cell line lacking E mu, H chain expression was lost, and interactions between VH and 3 ' RR and among the 3 ' RR regulators themselves were severely disrupted. In addition, the chromosome conformation capture technique detected interactions between the myc promoter and 3 ' RR elements in MPC11, which like other plasmacytomas contains a reciprocal translocation between the c-myc and the IgH locus. In sum, our data support a hypothesis that cis V-H-3 ' RR and myc-3 ' RR interactions involve physical interactions between these DNA elements.	Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Birshtein, BK (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	birshtei@aecom.yu.edu			NCI NIH HHS [P30 CA13330, 5T32 CA09173] Funding Source: Medline; NIAID NIH HHS [AI13509, R01 AI013509] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA013330, T32CA009173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI013509, R37AI013509] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arulampalam V, 1997, IMMUNOL TODAY, V18, P549, DOI 10.1016/S0167-5699(97)01154-7; CALVO CF, 1991, J IMMUNOL, V146, P1353; Dekker J, 2006, NAT METHODS, V3, P17, DOI 10.1038/NMETH823; Dunnick WA, 2005, J EXP MED, V201, P1459, DOI 10.1084/jem.20041988; ECKHARDT LA, 1982, P NATL ACAD SCI-BIOL, V79, P3006, DOI 10.1073/pnas.79.9.3006; ECKHARDT LA, 1985, MOL CELL BIOL, V5, P856, DOI 10.1128/MCB.5.4.856; Garrett FE, 2005, MOL CELL BIOL, V25, P1511, DOI 10.1128/MCB.25.4.1511-1525.2005; GILMORE GL, 1988, J IMMUNOL, V141, P1754; GILMORE GL, 1987, J IMMUNOL, V139, P619; GREGOR PD, 1986, MOL CELL BIOL, V6, P1903, DOI 10.1128/MCB.6.6.1903; KOSKIMIES S, 1976, NATURE, V264, P480, DOI 10.1038/264480a0; Lieberson R, 1995, EMBO J, V14, P6229, DOI 10.1002/j.1460-2075.1995.tb00313.x; Liu Z, 2005, MOL CELL BIOL, V25, P3220, DOI 10.1128/MCB.25.8.3220-3231.2005; Madisen L, 1998, MOL CELL BIOL, V18, P6281, DOI 10.1128/MCB.18.11.6281; Majumder P, 2006, J BIOL CHEM, V281, P18435, DOI 10.1074/jbc.M601298200; Manis JP, 1998, J EXP MED, V188, P1421, DOI 10.1084/jem.188.8.1421; Max E E., 2003, FUNDAMENTAL IMMUNOLO, P107; MICHAELSON JS, 1995, NUCLEIC ACIDS RES, V23, P975, DOI 10.1093/nar/23.6.975; Pinaud E, 2001, IMMUNITY, V15, P187, DOI 10.1016/S1074-7613(01)00181-9; Ragoczy T, 2006, GENE DEV, V20, P1447, DOI 10.1101/gad.1419506; Rogozin IB, 2004, J IMMUNOL, V172, P3382, DOI 10.4049/jimmunol.172.6.3382; Roldan E, 2005, NAT IMMUNOL, V6, P31, DOI 10.1038/ni1150; Saleque S, 1997, J IMMUNOL, V158, P4780; Saleque S, 1999, J IMMUNOL, V162, P2791; Sayegh C, 2005, GENE DEV, V19, P322, DOI 10.1101/gad.1254305; SCHLISSEL MS, 1991, J EXP MED, V173, P711, DOI 10.1084/jem.173.3.711; Sepulveda MA, 2005, MOL IMMUNOL, V42, P605, DOI 10.1016/j.molimm.2004.09.006; Shi XR, 2001, INT IMMUNOL, V13, P1003, DOI 10.1093/intimm/13.8.1003; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Splinter E, 2004, METHOD ENZYMOL, V375, P493; STANTON LW, 1984, P NATL ACAD SCI-BIOL, V81, P829, DOI 10.1073/pnas.81.3.829; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; Yang QX, 2005, MOL CELL BIOL, V25, P6021, DOI 10.1128/MCB.25.14.6021-6030.2005; ZALLER DM, 1985, P NATL ACAD SCI USA, V82, P5088, DOI 10.1073/pnas.82.15.5088; Zhang BY, 2007, J IMMUNOL, V178, P6297, DOI 10.4049/jimmunol.178.10.6297; Zhou J, 2002, P NATL ACAD SCI USA, V99, P13693, DOI 10.1073/pnas.212392399	37	40	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35169	35178		10.1074/jbc.M705719200	http://dx.doi.org/10.1074/jbc.M705719200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17921139	hybrid			2022-12-25	WOS:000251155200062
J	Marques, AJ; Glanemann, C; Ramos, PC; Dohmen, J				Marques, Antonio J.; Glanemann, Christoph; Ramos, Paula C.; Dohmen, Juergen			The C-terminal extension of the beta 7 subunit and activator complexes stabilize nascent 20 S proteasomes and promote their maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							26S PROTEASOME; SITE FORMATION; YEAST; UBIQUITIN; DEGRADATION; COMPLETION; BIOGENESIS; CHAPERONES; EXPRESSION; RESOLUTION	The eukaryotic 20 S proteasome is formed by dimerization of two precursor complexes containing the maturation factor Ump1. beta 7/Pre4 is the only one of the 14 subunits forming the 20 S proteasome that is absent from these precursor complexes in Saccharomyces cerevisiae. Increased expression of Pre4 leads to a reduction in the level of precursor complex, indicating that Pre4 incorporation into these complexes is rate-limiting for their dimerization. When we purified these precursor complexes, we observed co-purification of Blm10, a large protein known to attach to the alpha ring surface of proteasomes. In contrast to single mutants lacking either Blm10 or the C-terminal extension of Pre4, a mutant lacking both grew extremely poorly, accumulated very high levels of precursor complexes, and was impaired in beta subunit maturation. The effect of blm10 Delta on proteasome biogenesis is modest, apparently because the 19 S regulatory particle is capable of substituting for Blm10, as long as precursor complex dimers are stabilized by the Pre4Cterminus. We found that a mutation (sen3/rpn2) affecting the Rpn2 subunit inhibits attachment of the 19 S activator to the 20 S particle or its precursors. Although the sen3 mutation alone had no apparent effect on precursor complex dimerization and active site maturation, the sen3 blm10 double mutant was impaired in these processes. Together these data demonstrate that Blm10 and the 19 S activator have a partially redundant function in stabilizing nascent 20 S proteasomes and in promoting their activation.	Univ Cologne, Inst Genet, D-50674 Cologne, Germany; Univ Algarve, Fac Ciencias & Tecnol, Dept Quim Bioquim & Farm, P-8000117 Faro, Portugal	University of Cologne; Universidade do Algarve	Dohmen, J (corresponding author), Univ Cologne, Inst Genet, Zulpicher Str 47, D-50674 Cologne, Germany.	j.dohmen@uni-koeln.de		Dohmen, R. Jurgen/0000-0002-5756-6780				Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; Arendt CS, 1997, P NATL ACAD SCI USA, V94, P7156, DOI 10.1073/pnas.94.14.7156; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Chen P, 1996, CELL, V86, P961, DOI 10.1016/S0092-8674(00)80171-3; DEMARINI DJ, 1995, MOL CELL BIOL, V15, P6311; DeMartino GN, 2007, CELL, V129, P659, DOI 10.1016/j.cell.2007.05.007; Dohmen RJ, 2007, BBA-MOL CELL RES, V1773, P1599, DOI 10.1016/j.bbamcr.2007.05.015; Dohmen R. Jurgen, 2005, V301, P243; Fehlker M, 2003, EMBO REP, V4, P959, DOI 10.1038/sj.embor.embor938; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hanna J, 2007, FEBS LETT, V581, P2854, DOI 10.1016/j.febslet.2007.03.053; Heinemeyer W, 2004, CELL MOL LIFE SCI, V61, P1562, DOI 10.1007/s00018-004-4130-z; Heinemeyer W, 1997, J BIOL CHEM, V272, P25200, DOI 10.1074/jbc.272.40.25200; Hirano Y, 2006, MOL CELL, V24, P977, DOI 10.1016/j.molcel.2006.11.015; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; Iwanczyk J, 2006, J MOL BIOL, V363, P648, DOI 10.1016/j.jmb.2006.08.010; Kruger E, 2001, BIOCHIMIE, V83, P289, DOI 10.1016/S0300-9084(01)01241-X; Le Tallec B, 2007, MOL CELL, V27, P660, DOI 10.1016/j.molcel.2007.06.025; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Lehmann A, 2002, J MOL BIOL, V317, P401, DOI 10.1006/jmbi.2002.5443; Li X, 2007, EMBO J, V26, P2339, DOI 10.1038/sj.emboj.7601681; London MK, 2004, FEBS LETT, V567, P259, DOI 10.1016/j.febslet.2004.04.078; Mannhaupt G, 1999, FEBS LETT, V450, P27, DOI 10.1016/S0014-5793(99)00467-6; Mullapudi S, 2004, BIOPHYS J, V87, P4098, DOI 10.1529/biophysj.104.051144; Nandi D, 1997, EMBO J, V16, P5363, DOI 10.1093/emboj/16.17.5363; NEUHOFF V, 1990, ELECTROPHORESIS, V11, P101, DOI 10.1002/elps.1150110202; Palanimurugan R, 2004, EMBO J, V23, P4857, DOI 10.1038/sj.emboj.7600473; Ramos PC, 2004, J BIOL CHEM, V279, P14323, DOI 10.1074/jbc.M308757200; Ramos PC, 1998, CELL, V92, P489, DOI 10.1016/S0092-8674(00)80942-3; Realini C, 1997, J BIOL CHEM, V272, P25483, DOI 10.1074/jbc.272.41.25483; Reed SH, 2007, DNA REPAIR, V6, P149, DOI 10.1016/j.dnarep.2006.10.026; Schmidt M, 2005, NAT STRUCT MOL BIOL, V12, P294, DOI 10.1038/nsmb914; Unno M, 2002, STRUCTURE, V10, P609, DOI 10.1016/S0969-2126(02)00748-7; Ustrell V, 2002, EMBO J, V21, P3516, DOI 10.1093/emboj/cdf333; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; Witt S, 2006, STRUCTURE, V14, P1179, DOI 10.1016/j.str.2006.05.019; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298	38	71	77	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34869	34876		10.1074/jbc.M705836200	http://dx.doi.org/10.1074/jbc.M705836200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17911101	Green Published, hybrid			2022-12-25	WOS:000251155200029
J	Merino, E; Sanjuan, MA; Moraga, I; Cipres, A; Merida, I				Merino, Ernesto; Sanjuan, Miguel A.; Moraga, Ignacio; Cipres, Angel; Merida, Isabel			Role of the diacylglycerol kinase alpha-conserved domains in membrane targeting in intact T cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; INDUCED TRANSLOCATION; BINDING DOMAIN; C-DELTA; ACTIVATION; PROTEIN; SPHINGOSINE; HOMOLOGY; CALCIUM; ENZYME	Diacylglycerol kinase (DGK) phosphorylates diacylglycerol to phosphatidic acid, modifying the cellular levels of these two lipid mediators. Ten DGK isoforms, grouped into five subtypes, are found in higher organisms. All contain a conserved C-terminal domain and at least two cysteine-rich motifs of unknown function. DGK alpha is a type I enzyme that acts as a negative modulator of diacylglycerol-based signals during T cell activation. Here we studied the functional role of the DGK alpha domains using mutation alanalysis to investigate membrane binding in intact cells. We show that the two atypical C1domains are essential for plasma membrane targeting of the protein in intact cells but unnecessary for catalytic activity. We also identify the C-terminal sequence of the protein as essential for membrane binding in a phosphatidic acid-dependent manner. Finally we demonstrate that, in the absence of the calcium binding domain, receptor-dependent translocation of the truncated protein is regulated by phosphorylation of Tyr(335). This functional study provides new insight into the role of the so-called conserved domains of this lipid kinase family and demonstrates the existence of additional domains that confer specific plasma membrane localization to this particular isoform.	Ctr Nacl Biotecnol, Dept Immunol & Oncol, Consejo Super Invest Cient, E-28049 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Merida, I (corresponding author), Ctr Nacl Biotecnol, Dept Immunol & Oncol, Consejo Super Invest Cient, E-28049 Madrid, Spain.	imerida@cnb.uam.es	Sanjuán, Miguel Ángel/I-6896-2019; Ciprés, Ángel/ABH-6863-2020; Merida, Isabel/A-9713-2014	Sanjuán, Miguel Ángel/0000-0001-6694-0634; Merida, Isabel/0000-0003-2762-6241; Cipres, Angel/0000-0001-7086-2704; Moraga, Ignacio/0000-0001-9909-0701				Abe T, 2003, BIOCHEM J, V375, P673, DOI 10.1042/BJ20031052; BESTERMAN JM, 1986, P NATL ACAD SCI USA, V83, P9378, DOI 10.1073/pnas.83.24.9378; Caricasole A, 2002, J BIOL CHEM, V277, P4790, DOI 10.1074/jbc.M110249200; Cipres A, 2003, J BIOL CHEM, V278, P35629, DOI 10.1074/jbc.M305635200; Delon C, 2004, J BIOL CHEM, V279, P44763, DOI 10.1074/jbc.M405771200; DESAI DM, 1990, NATURE, V348, P66, DOI 10.1038/348066a0; Drugan JK, 1996, J BIOL CHEM, V271, P233, DOI 10.1074/jbc.271.1.233; Flores I, 1996, J BIOL CHEM, V271, P10334, DOI 10.1074/jbc.271.17.10334; Fukunaga-Takenaka R, 2005, GENES CELLS, V10, P311, DOI 10.1111/j.1365-2443.2005.00842.x; Ghosh S, 2003, J BIOL CHEM, V278, P45690, DOI 10.1074/jbc.M302933200; Goto K, 1996, P NATL ACAD SCI USA, V93, P11196, DOI 10.1073/pnas.93.20.11196; Houssa B, 1999, J BIOL CHEM, V274, P6820, DOI 10.1074/jbc.274.11.6820; Houssa B, 1997, J BIOL CHEM, V272, P10422; Hurley JH, 2000, ANNU REV BIOPH BIOM, V29, P49, DOI 10.1146/annurev.biophys.29.1.49; Hurley JH, 1997, PROTEIN SCI, V6, P477; Jiang Y, 2000, J BIOL CHEM, V275, P34092, DOI 10.1074/jbc.M004914200; Jones DR, 2002, FASEB J, V16, P595, DOI 10.1096/fj.01-0762fje; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Los AP, 2007, BBA-MOL CELL RES, V1773, P352, DOI 10.1016/j.bbamcr.2006.12.004; MARONEY AC, 1989, J BIOL CHEM, V264, P2537; Nelson CD, 2007, SCIENCE, V315, P663, DOI 10.1126/science.1134562; Olenchock BA, 2006, NAT IMMUNOL, V7, P1174, DOI 10.1038/ni1400; Pitson SM, 2000, J BIOL CHEM, V275, P33945, DOI 10.1074/jbc.M006176200; SAKANE F, 1991, J BIOL CHEM, V266, P7096; Sakane F, 1996, BIOCHEM J, V318, P583, DOI 10.1042/bj3180583; Sanders CR, 1996, BIOCHEMISTRY-US, V35, P8610, DOI 10.1021/bi9604892; Sanjuan MA, 2003, J IMMUNOL, V170, P2877, DOI 10.4049/jimmunol.170.6.2877; Sanjuan MA, 2001, J CELL BIOL, V153, P207, DOI 10.1083/jcb.153.1.207; Santos T, 2002, J BIOL CHEM, V277, P30300, DOI 10.1074/jbc.M200999200; Shirai Y, 2000, J BIOL CHEM, V275, P24760, DOI 10.1074/jbc.M003151200; Stahelin RV, 2005, J BIOL CHEM, V280, P43030, DOI 10.1074/jbc.M507574200; Stahelin RV, 2005, J BIOL CHEM, V280, P19784, DOI 10.1074/jbc.M411285200; Sugiura M, 2002, J BIOL CHEM, V277, P23294, DOI 10.1074/jbc.M201535200; Topham MK, 2006, J CELL BIOCHEM, V97, P474, DOI 10.1002/jcb.20704; Topham MK, 1998, NATURE, V394, P697, DOI 10.1038/29337; van Baal J, 2005, J BIOL CHEM, V280, P9870, DOI 10.1074/jbc.M409301200; Wattenberg BW, 2006, J LIPID RES, V47, P1128, DOI 10.1194/jlr.R600003-JLR200; Yakubchyk Y, 2005, MOL CELL BIOL, V25, P7289, DOI 10.1128/MCB.25.16.7289-7302.2005; Yasuda S, 2007, FEBS LETT, V581, P551, DOI 10.1016/j.febslet.2007.01.022; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X	40	33	36	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35396	35404		10.1074/jbc.M702085200	http://dx.doi.org/10.1074/jbc.M702085200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17911109	hybrid			2022-12-25	WOS:000251155200082
J	Ryoo, SR; Jeong, HK; Radnaabazar, C; Yoo, JJ; Cho, HJ; Lee, HW; Kim, IS; Cheon, YH; Ahn, YS; Chung, SH; Song, WJ				Ryoo, Soo-Ryoon; Jeong, Hey Kyeong; Radnaabazar, Chinzorig; Yoo, Jin-Ju; Cho, Hyun-Jeong; Lee, Hye-Won; Kim, In-Sook; Cheon, Young-Hee; Ahn, Young Soo; Chung, Sul-Hee; Song, Woo-Joo			DYRK1A-mediated hyperphosphorylation of Tau - A functional link between Down syndrome and Alzheimer disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNDROME CRITICAL REGION; PROTEIN-TAU; HUMAN HOMOLOG; MOUSE MODEL; ABNORMAL PHOSPHORYLATION; KINASE; MINIBRAIN; DYRK1A; EXPRESSION; MICE	Most individuals with Down syndrome show early onset of Alzheimer disease (AD), resulting from the extra copy of chromosome 21. Located on this chromosome is a gene that encodes the dual specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A). One of the pathological hallmarks in AD is the presence of neurofibrillary tangles (NFTs), which are insoluble deposits that consist of abnormally hyperphosphorylated Tau. Previously it was reported that Tau at the Thr-212 residue was phosphorylated by Dyrk1A in vitro. To determine the physiological significance of this phosphorylation, an analysis was made of the amount of phospho-Thr-212- Tau (pT212) in the brains of transgenic mice that over-express the human DYRK1A protein ( DYRK1A TG mice) that we recently generated. A significant increase in the amount of pT212 was found in the brains of DYRK1A transgenic mice when compared with age-matched littermate controls. We further examined whether Dyrk1A phosphorylates other Tau residues that are implicated in NFTs. We found that Dyrk1A also phosphorylates Tau at Ser-202 and Ser-404 in vitro. Phosphorylation by Dyrk1A strongly inhibited the ability of Tau to promote microtubule assembly. Following this, using mammalian cells and DYRK1A TG mouse brains, it was demonstrated that the amounts of phospho-Ser-202-Tau and phospho-Ser-404-Tau are enhanced when DYRK1A amounts are high. These results provide the first in vivo evidence for a physiological role of DYRK1A in the hyperphosphorylation of Tau and suggest that the extra copy of the DYRK1A gene contributes to the early onset of AD.	Inje Univ, Grad Program Neurosci, Inst Brain Sci & Technol, Pusan 614735, South Korea; Yonsei Univ, Coll Med, Brain Korea 21 Project Med Sci, Brain Res Inst, Seoul 120749, South Korea; Yonsei Univ, Coll Med, Dept Pharmacol, Seoul 120749, South Korea; Eulji Univ, Sch Med, Dept Anat & Neurosci, Taejon 301832, South Korea	Inje University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Eulji University	Chung, SH (corresponding author), Inje Univ, Grad Program Neurosci, Inst Brain Sci & Technol, 633-146 Gaegeum 2 Dong, Pusan 614735, South Korea.	sulchung@inje.ac.kr; wjsong@inje.ac.kr		Ryoo, Soo-Ryoon/0000-0003-2798-0443				Abraha A, 2000, J CELL SCI, V113, P3737; Ahn KJ, 2006, NEUROBIOL DIS, V22, P463, DOI 10.1016/j.nbd.2005.12.006; Alonso AD, 2006, P NATL ACAD SCI USA, V103, P8864, DOI 10.1073/pnas.0603214103; Altafaj X, 2001, HUM MOL GENET, V10, P1915, DOI 10.1093/hmg/10.18.1915; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Bielska AA, 2006, BIOCHEMISTRY-US, V45, P5527, DOI 10.1021/bi052662c; BRAAK E, 1994, ACTA NEUROPATHOL, V87, P554, DOI 10.1007/s004010050124; BURGER PC, 1973, AM J PATHOL, V73, P457; CAMPBELL S K, 1987, Society for Neuroscience Abstracts, V13, P678; Cataldo AM, 2003, J NEUROSCI, V23, P6788; Ding HP, 2006, J BIOL CHEM, V281, P19107, DOI 10.1074/jbc.M511697200; Duff K, 2005, NAT MED, V11, P826, DOI 10.1038/nm0805-826; Ferrer I, 2005, NEUROBIOL DIS, V20, P392, DOI 10.1016/j.nbd.2005.03.020; Fotaki V, 2002, MOL CELL BIOL, V22, P6636, DOI 10.1128/MCB.22.18.6636-6647.2002; Galceran J, 2003, J NEURAL TRANSM-SUPP, P139; GALLYAS F, 1971, ACTA MORPHOL HUNG, V19, P1; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Guimera J, 1999, GENOMICS, V57, P407, DOI 10.1006/geno.1999.5775; Guimera J, 1996, HUM MOL GENET, V5, P1305, DOI 10.1093/hmg/5.9.1305; Hammerle B, 2003, EUR J NEUROSCI, V17, P2277, DOI 10.1046/j.1460-9568.2003.02665.x; Himpel S, 2000, J BIOL CHEM, V275, P2431, DOI 10.1074/jbc.275.4.2431; JACOBS PA, 1959, LANCET, V1, P710; Johnson GVW, 2004, J CELL SCI, V117, P5721, DOI 10.1242/jcs.01558; Kentrup H, 1996, J BIOL CHEM, V271, P3488; KOPKE E, 1993, J BIOL CHEM, V268, P24374; KORENBERG JR, 1994, P NATL ACAD SCI USA, V91, P4997, DOI 10.1073/pnas.91.11.4997; KSIEZAKREDING H, 1992, BRAIN RES, V597, P209, DOI 10.1016/0006-8993(92)91476-U; LEJEUNE J, 1959, CR HEBD ACAD SCI, V248, P1721; Lochhead PA, 2005, CELL, V121, P925, DOI 10.1016/j.cell.2005.03.034; Marti E, 2003, BRAIN RES, V964, P250, DOI 10.1016/S0006-8993(02)04069-6; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Necula M, 2005, FEBS LETT, V579, P1453, DOI 10.1016/j.febslet.2005.01.047; Rahmani Z, 1998, BIOCHEM BIOPH RES CO, V253, P514, DOI 10.1006/bbrc.1998.9803; Rankin CA, 2005, MOL BRAIN RES, V138, P84, DOI 10.1016/j.molbrainres.2005.04.012; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Shindoh N, 1996, BIOCHEM BIOPH RES CO, V225, P92, DOI 10.1006/bbrc.1996.1135; Smith DJ, 1997, NAT GENET, V16, P28, DOI 10.1038/ng0597-28; Song WJ, 1996, GENOMICS, V38, P331, DOI 10.1006/geno.1996.0636; Spires TL, 2006, AM J PATHOL, V168, P1598, DOI 10.2353/ajpath.2006.050840; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Woods YL, 2001, BIOCHEM J, V355, P609, DOI 10.1042/bj3550609; Yoshida H, 2004, J NEUROCHEM, V90, P352, DOI 10.1111/j.1471-4159.2004.02479.x	43	172	178	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34850	34857		10.1074/jbc.M707358200	http://dx.doi.org/10.1074/jbc.M707358200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17906291	hybrid			2022-12-25	WOS:000251155200027
J	Shibolet, O; Giallourakis, C; Rosenberg, I; Mueller, T; Xavier, RJ; Podolsky, DK				Shibolet, Oren; Giallourakis, Cosmas; Rosenberg, Ian; Mueller, Tobias; Xavier, Ramnik J.; Podolsky, Daniel K.			AKAP13, a RhoA GTPase-specific guanine exchange factor, is a novel regulator of TLR2 signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B ACTIVATION; PROTEIN-KINASE-A; VAV PROTEINS; INVOLVEMENT; RECEPTOR-3; PATHOGENS; RESPONSES	Members of the guanine exchange factor (GEF) family of scaffold proteins are involved in the integration of signal flow downstream of many receptors in adaptive immunity. However, the full complement of GEFs that function downstream of Toll-like receptors (TLRs) requires further identification and functional understanding. By systematically integrating expression profiles from immune and epithelial cells with functional studies, we demonstrate that protein kinase A anchoring protein 13 (AKAP13), a scaffold protein with GEF activity, is an activator of NF-kappa B downstream of TLR2 signaling. Stimulation of the human macrophage cell line THP-1 and epithelial cells with a TLR2 ligand caused a significant up-regulation in AKAP13 mRNA, corresponding to an increase in protein expression. Analysis of TLR2 reporter cell lines deficient in AKAP 13 expression revealed significantly reduced NF-kappa B activation and reduced secretion of interleukin-8 and MCP-1 in response to specific ligand stimulation. Furthermore, NF-kappa B activation was partially inhibited by a GEF-deficient AKAP13 mutant. AKAP13 was also involved in phosphorylation of JNK but not of extracellular signal-regulated kinase ERK1 and -2 following ligand stimulation. Together, our results suggest that AKAP13 plays a role in TLR2-mediated NF-kappa B activation and suggest that GEF-containing scaffold proteins may confer specificity to innate immune responses downstream of TLRs.	Massachusetts Gen Hosp, Gastroenterol Unit, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA; Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Podolsky, DK (corresponding author), Massachusetts Gen Hosp, Gastroenterol Unit, Ctr Study Inflammatory Bowel Dis, Jackson Bldg,Rm 719,55 Fruit St, Boston, MA 02114 USA.	dpodolsky@partners.org		Mueller, Tobias/0000-0003-3426-5421	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, P30DK040561, R01DK060049] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK060049, P30 DK040561, DK043351, DK060049, P30 DK040561-12] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Appert-Collin A, 2007, P NATL ACAD SCI USA, V104, P10140, DOI 10.1073/pnas.0701099104; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Asehnoune K, 2005, CELL SIGNAL, V17, P385, DOI 10.1016/j.cellsig.2004.08.005; Carnegie GK, 2004, MOL CELL, V15, P889, DOI 10.1016/j.molcel.2004.09.015; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Chen LY, 2004, J BIOL CHEM, V279, P7208, DOI 10.1074/jbc.M309542200; Diviani D, 2001, J BIOL CHEM, V276, P44247, DOI 10.1074/jbc.M106629200; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Driggers PH, 2001, J BIOL CHEM, V276, P46792, DOI 10.1074/jbc.M106927200; Dutt P, 2004, CELL SIGNAL, V16, P201, DOI 10.1016/S0898-6568(03)00132-3; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Furuta GT, 2001, J EXP MED, V193, P1027, DOI 10.1084/jem.193.9.1027; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Hebeis B, 2005, BLOOD, V106, P635, DOI 10.1182/blood-2004-10-3919; Jaffe AB, 2005, CURR BIOL, V15, P405, DOI 10.1016/j.cub.2004.12.082; Jenner RG, 2005, NAT REV MICROBIOL, V3, P281, DOI 10.1038/nrmicro1126; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Majumdar M, 1999, J BIOL CHEM, V274, P26815, DOI 10.1074/jbc.274.38.26815; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; Meller N, 2005, J CELL SCI, V118, P4937, DOI 10.1242/jcs.02671; Miletic AV, 2007, BLOOD, V109, P3360, DOI 10.1182/blood-2006-07-033662; Nishiya T, 2005, J BIOL CHEM, V280, P37107, DOI 10.1074/jbc.M504951200; Oda K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100057; Olson MF, 1997, ONCOGENE, V15, P2827, DOI 10.1038/sj.onc.1201594; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Renshaw MW, 1996, J BIOL CHEM, V271, P21691, DOI 10.1074/jbc.271.36.21691; Ruse M, 2006, IMMUNOL RES, V34, P33, DOI 10.1385/IR:34:1:33; Sendide K, 2005, J IMMUNOL, V174, P4210, DOI 10.4049/jimmunol.174.7.4210; Shyamsundar R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r22; Sterpetti P, 1999, MOL CELL BIOL, V19, P1334; Stovall SH, 2004, J BIOL CHEM, V279, P13809, DOI 10.1074/jbc.M311434200; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Teusch N, 2004, J IMMUNOL, V173, P507, DOI 10.4049/jimmunol.173.1.507	36	44	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35308	35317		10.1074/jbc.M704426200	http://dx.doi.org/10.1074/jbc.M704426200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17878165	hybrid			2022-12-25	WOS:000251155200074
J	Youn, MY; Yoo, HS; Kim, MJ; Hwang, SY; Choi, Y; Desiderio, SV; Yoo, JY				Youn, Min-Young; Yoo, Hyun-Seok; Kim, Min-Jung; Hwang, Sun-Young; Choi, Yongwook; Desiderio, Stephen V.; Yoo, Joo-Yeon			hCTR9, a component of Paf1 complex, participates in the transcription of interleukin 6-responsive genes through regulation of STAT3-DNA interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; ACUTE-PHASE RESPONSE; HISTONE METHYLATION; IN-VIVO; SACCHAROMYCES-CEREVISIAE; ELONGATION COMPLEX; EXPRESSION; YEAST; PROTEIN; PROMOTER	PAF, which is composed of Paf1, Cdc73, Ctr9, Leo1, and Rtf1, is a novel complex with multiple functions in transcription-related activities. The PAF complex interacts with histone-modifying enzymes and RNA polymerase II to regulate transcription. With general transcription regulatory potential in yeast, Hyrax/ Cdc73 has been reported to associate with beta-catenin to control Wnt/Wg signal-specific transcription in Drosophila. Here, we present the first evidence of IL-6 signal-specific transcriptional regulation by SH2BP1/CTR9 in mammals. Upon LPS injection of mice, we observed transient induction of the mammalian PAF complex in the liver. Inhibition of CTR9 specifically abrogated expression of IL-6-responsive genes, but had no effect on genes constitutively expressed or induced by interferon-beta, TNF alpha, or IL-1 beta. The PAF complex was found in the promoter regions of IL-6-responsive HP and FGG gamma, but not in the promoter region of constitutively active GAPDH. Transcriptional activation by STAT3 was inhibited when CTR9 siRNA was introduced, whereas transcriptional activation was enhanced by mCtr9 overexpression. IL-6-activated Stat3 was found to co-localize and interact with CTR9. In CTR9-depleted cells, decreased STAT3 association with the promoter regions, as well as impaired K4-trimethylation of histone H3 in the coding regions, of target genes was observed. These data suggest that CTR9 participates in the transcription of IL-6-responsive genes through the regulation of DNA association of STAT3 and modification of histone methylation.	Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, South Korea; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Pohang University of Science & Technology (POSTECH); Johns Hopkins University	Yoo, JY (corresponding author), Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, South Korea.	jyoo@postech.ac.kr			NHLBI NIH HHS [R01HL07391] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adelman K, 2006, MOL CELL BIOL, V26, P250, DOI 10.1128/MCB.26.1.250-260.2006; AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; Betz JL, 2002, MOL GENET GENOMICS, V268, P272, DOI 10.1007/s00438-002-0752-8; He YH, 2004, GENE DEV, V18, P2774, DOI 10.1101/gad.1244504; Kamimura D, 2004, REV PHYSIOL BIOCH P, V149, P1, DOI 10.1007/s10254-003-0012-2; Koch C, 1999, NUCLEIC ACIDS RES, V27, P2126, DOI 10.1093/nar/27.10.2126; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Laribee RN, 2005, CURR BIOL, V15, P1487, DOI 10.1016/j.cub.2005.07.028; MACKIEWICZ A, 1992, J IMMUNOL, V149, P2021; Malek SN, 1996, J BIOL CHEM, V271, P6952, DOI 10.1074/jbc.271.12.6952; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Mosimann C, 2006, CELL, V125, P327, DOI 10.1016/j.cell.2006.01.053; Mueller CL, 2004, MOL CELL, V14, P447, DOI 10.1016/S1097-2765(04)00257-6; Mueller CL, 2002, MOL CELL BIOL, V22, P1971, DOI 10.1128/MCB.22.7.1971-1980.2002; Ng HH, 2003, J BIOL CHEM, V278, P33625, DOI 10.1074/jbc.C300270200; Penheiter KL, 2005, MOL CELL, V20, P213, DOI 10.1016/j.molcel.2005.08.023; Pokholok DK, 2002, MOL CELL, V9, P799, DOI 10.1016/S1097-2765(02)00502-6; Porter SE, 2002, EUKARYOT CELL, V1, P830, DOI 10.1128/EC.1.5.830-842.2002; Ramadori G, 1999, SEMIN LIVER DIS, V19, P141, DOI 10.1055/s-2007-1007106; Rozenblatt-Rosen O, 2005, MOL CELL BIOL, V25, P612, DOI 10.1128/MCB.25.2.612-620.2005; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Sheldon KE, 2005, MOL CELL, V20, P225, DOI 10.1016/j.molcel.2005.08.026; Shi XM, 1996, MOL CELL BIOL, V16, P669; Shi XM, 1997, MOL CELL BIOL, V17, P1160, DOI 10.1128/MCB.17.3.1160; Squazzo SL, 2002, EMBO J, V21, P1764, DOI 10.1093/emboj/21.7.1764; Szak ST, 2001, MOL CELL BIOL, V21, P3375, DOI 10.1128/MCB.21.10.3375-3386.2001; Wade PA, 1996, PROTEIN EXPRES PURIF, V8, P85, DOI 10.1006/prep.1996.0077; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Yart A, 2005, MOL CELL BIOL, V25, P5052, DOI 10.1128/MCB.25.12.5052-5060.2005; Yoo JY, 2003, P NATL ACAD SCI USA, V100, P1157, DOI 10.1073/pnas.0336385100; Zauberman A, 2001, J BIOL CHEM, V276, P24719, DOI 10.1074/jbc.M005813200; Zhang ZX, 2000, BLOOD, V96, P3466, DOI 10.1182/blood.V96.10.3466.h8003466_3466_3472; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422; Zhu B, 2005, GENE DEV, V19, P1668, DOI 10.1101/gad.1292105	35	25	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34727	34734		10.1074/jbc.M705411200	http://dx.doi.org/10.1074/jbc.M705411200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17911113	hybrid			2022-12-25	WOS:000251155200015
J	Daiho, T; Yamasaki, K; Danko, S; Suzuki, H				Daiho, Takashi; Yamasaki, Kazuo; Danko, Stefania; Suzuki, Hiroshi			Critical role of glu(40)-ser(48) loop linking actuator domain and first transmembrane helix of Ca2+-ATPase in Ca2+ deocclusion and release from ADP-insensitive phosphoenzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; CALCIUM-PUMP; PHOSPHORYLATED INTERMEDIATE; ADENOSINE-TRIPHOSPHATASE; SKELETAL-MUSCLE; A-DOMAIN; CONFORMATIONAL TRANSITION; TRANSPORT ACTIVITY; KINETIC-PROPERTIES; REACTION-MECHANISM	The functional importance of the length of the A/M1 linker (Glu(40)-Ser(48)) connecting the actuator domain and the first transmembrane helix of sarcoplasmic reticulum Ca2+-ATPase was explored by its elongation with glycine insertion at Pro(42)/Ala(43) and Gly(46)/Lys(47). Two or more glycine insertions at each site completely abolished ATPase activity. The isomerization of phosphoenzyme (EP) intermediate from the ADP-sensitive form (E1P) to the ADP-insensitive form (E2P) was markedly accelerated, but the decay of EP was completely blocked in these mutants. The E2P accumulated was therefore demonstrated to be E2PCa(2) possessing two occluded Ca2+ ions at the transport sites, and the Ca2+ deocclusion and release into lumen were blocked in the mutants. By contrast, the hydrolysis of the Ca2+-free form of E2P produced from Pi without Ca2+ was as rapid in the mutants as in the wild type. Analysis of resistance against trypsin and proteinase K revealed that the structure of E2PCa(2) accumulated is an intermediate state between E1PCa(2) and the Ca2+-released E2P state. Namely in E2PCa(2), the actuator domain is already largely rotated from its position in E1PCa(2) and associated with the phosphorylation domain as in the Ca2+-released E2P state; however, in E2PCa(2), the hydrophobic interactions among these domains and Leu(119)/Tyr(122) on the top of second transmembrane helix are not yet formed properly. This is consistent with our previous finding that these interactions at Tyr(122) are critical for formation of the Ca2+-released E2P structure. Results showed that the EP isomerization/Ca2+-release process consists of the following two steps: E1PCa(2) -> E2PCa(2) -> E2P + 2Ca(2+); and the intermediate state E2PCa(2) was identified for the first time. Results further indicated that the A/M1 linker with its appropriately short length, probably because of the strain imposed in E2PCa(2), is critical for the correct positioning and interactions of the actuator and phosphorylation domains to cause structural changes for the Ca2+ deocclusion and release.	Asahikawa Med Coll, Dept Biochem, Asahikawa, Hokkaido 0788510, Japan	Asahikawa Medical College	Daiho, T (corresponding author), Asahikawa Med Coll, Dept Biochem, Asahikawa, Hokkaido 0788510, Japan.	daiho@asahikawa-med.ac.jp						Anthonisen AN, 2006, J BIOL CHEM, V281, P31572, DOI 10.1074/jbc.M605194200; CLARKE DM, 1990, J BIOL CHEM, V265, P14088; Clausen JD, 2004, P NATL ACAD SCI USA, V101, P2776, DOI 10.1073/pnas.0400122101; Daiho T, 1999, J BIOL CHEM, V274, P23910, DOI 10.1074/jbc.274.34.23910; Daiho T, 2003, J BIOL CHEM, V278, P39197, DOI 10.1074/jbc.M305200200; Daiho T, 1999, FEBS LETT, V444, P54, DOI 10.1016/S0014-5793(99)00027-7; Danko S, 2004, J BIOL CHEM, V279, P14991, DOI 10.1074/jbc.M313363200; Danko S, 2001, FEBS LETT, V505, P129, DOI 10.1016/S0014-5793(01)02801-0; Danko S, 2001, FEBS LETT, V489, P277, DOI 10.1016/S0014-5793(01)02111-1; DEMEIS L, 1980, BIOCHEMISTRY-US, V19, P4252, DOI 10.1021/bi00559a017; DEMEIS L, 1982, J BIOL CHEM, V257, P1289; EBASHI S, 1962, J CELL BIOL, V14, P389, DOI 10.1083/jcb.14.3.389; Einholm AP, 2004, J BIOL CHEM, V279, P15888, DOI 10.1074/jbc.M400158200; FROEHLICH JP, 1985, BIOCHEMISTRY-US, V24, P126, DOI 10.1021/bi00322a018; HANEL AM, 1991, BIOCHEMISTRY-US, V30, P11320, DOI 10.1021/bi00111a019; HASSELBACH W, 1961, BIOCHEM Z, V333, P518; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; INAO S, 1986, BIOCHIM BIOPHYS ACTA, V857, P28, DOI 10.1016/0005-2736(86)90095-7; INESI G, 1990, PHYSIOL REV, V70, P749, DOI 10.1152/physrev.1990.70.3.749; INESI G, 1988, METHOD ENZYMOL, V157, P154; JUUL B, 1995, J BIOL CHEM, V270, P20123, DOI 10.1074/jbc.270.34.20123; KANAZAWA T, 1970, J BIOCHEM-TOKYO, V67, P693, DOI 10.1093/oxfordjournals.jbchem.a129297; Kato S, 2003, J BIOL CHEM, V278, P9624, DOI 10.1074/jbc.M208861200; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P946, DOI 10.1128/MCB.9.3.946; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lenoir G, 2004, J BIOL CHEM, V279, P9156, DOI 10.1074/jbc.M311411200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MacLennan DH, 1997, J BIOL CHEM, V272, P28815, DOI 10.1074/jbc.272.46.28815; Mahaney JE, 2004, BIOCHEMISTRY-US, V43, P4400, DOI 10.1021/bi035068g; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; McIntosh D.B., 1998, ADV MOL CEL A&B, V23A, P33; Moller JV, 2002, J BIOL CHEM, V277, P38647, DOI 10.1074/jbc.M204603200; MOLLER M, 1986, ADV PINEAL RES, V1, P51; MYUNG J, 1995, BIOCHEMISTRY-US, V34, P3077, DOI 10.1021/bi00009a039; NAKAMURA Y, 1984, J BIOL CHEM, V259, P8183; NAKAMURA Y, 1986, J BIOL CHEM, V261, P3090; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Picard M, 2005, J BIOL CHEM, V280, P18745, DOI 10.1074/jbc.M501596200; Picard M, 2007, J MOL BIOL, V368, P1, DOI 10.1016/j.jmb.2007.01.082; PICK U, 1982, J BIOL CHEM, V257, P6120; PRAGER R, 1979, EUR J BIOCHEM, V97, P239, DOI 10.1111/j.1432-1033.1979.tb13108.x; SAGARA Y, 1992, J BIOL CHEM, V267, P1286; SAGARA Y, 1992, J BIOL CHEM, V267, P12606; Sato K, 2004, J BIOL CHEM, V279, P35595, DOI 10.1074/jbc.M404887200; Seekoe T, 2001, J BIOL CHEM, V276, P46737, DOI 10.1074/jbc.M106320200; SHIGEKAWA M, 1983, J BIOL CHEM, V258, P8698; SHIGEKAWA M, 1978, J BIOL CHEM, V253, P1451; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Takahashi M, 2007, P NATL ACAD SCI USA, V104, P5800, DOI 10.1073/pnas.0700979104; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; WAKABAYASHI S, 1987, J BIOL CHEM, V262, P11524; Wang GL, 2005, J BIOL CHEM, V280, P26508, DOI 10.1074/jbc.M503789200; WEBER K, 1969, J BIOL CHEM, V244, P4406; Xu C, 2004, J BIOL CHEM, V279, P17973, DOI 10.1074/jbc.M313263200; Yamasaki K, 2004, J BIOL CHEM, V279, P2202, DOI 10.1074/jbc.M309398200	59	48	50	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34429	34447		10.1074/jbc.M707665200	http://dx.doi.org/10.1074/jbc.M707665200			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17881350	Green Submitted, hybrid			2022-12-25	WOS:000251145700059
J	Evans, PM; Zhang, W; Chen, X; Yang, J; Bhakat, KK; Liu, CM				Evans, Paul M.; Zhang, Wen; Chen, Xi; Yang, Jun; Bhakat, Kishor K.; Liu, Chunming			Krurppel-like factor 4 is acetylated by p300 and regulates gene transcription via modulation of histone acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KRUPPEL-LIKE FACTOR; TUMOR-SUPPRESSOR GENE; CHAIN FATTY-ACIDS; CANCER CELL-LINE; BETA-CATENIN; COLON-CANCER; DNA-BINDING; ENTEROCYTE DIFFERENTIATION; COACTIVATORS P300; EPITHELIAL-CELLS	Colon cancer is the second leading cause of cancer death in the United States. Kruppel-like factor 4 (KLF4) is a transcription factor involved in both proliferation and differentiation in the colon. It is down-regulated in both mouse and human colonic adenomas and has been implicated as a tumor suppressor in the gut, whereas in breast cancer, KLF4 is an oncogene. KLF4 is also involved in reprogramming differentiated cells into pluripotent stem cells. KLF4 can act as a transcriptional activator or repressor, but the underlying mechanisms are poorly understood. We found that p300, a CREB-binding protein-related protein, interacts with KLF4 both in vitro and in vivo and activates transcription. We further made the novel observation that endogenous KLF4 is acetylated by p300/CBP in vivo and that mutations of the acetylated lysines resulted in a decreased ability of KLF4 to activate target genes, suggesting that acetylation is important for KLF4-mediated transactivation. Furthermore, we found that KLF4 differentially modulates histone H4 acetylation at the promoters of target genes. Co-transfection of KLF4 and HDAC3 resulted in a synergistic repression of a cyclin B-1 reporter construct. Our results suggest that KLF4 might function as an activator or repressor of transcription depending on whether it interacts with co-activators such as p300 and CREB-binding protein or co-repressors such as HDAC3.	Univ Texas Galveston, Med Branch, Dept Biochem & Mol Biol, Sealy Ctr Canc Cell Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Liu, CM (corresponding author), Univ Texas Galveston, Med Branch, Dept Biochem & Mol Biol, Sealy Ctr Canc Cell Biol, Galveston, TX 77555 USA.	chliu@utmb.edu	Bhakat, Kishor/C-8072-2012	Evans, Paul/0000-0002-5981-7117	NATIONAL CANCER INSTITUTE [R21CA112007, T32CA117834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071976] Funding Source: NIH RePORTER; NCI NIH HHS [R21 CA 112007, T32 CA 117834] Funding Source: Medline; NIDDK NIH HHS [R01 DK071976, R01 DK 071976, R01 DK071976-01A2] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Basson MD, 1998, P SOC EXP BIOL MED, V217, P476, DOI 10.3181/00379727-217-44261; Bhakat KK, 2004, NUCLEIC ACIDS RES, V32, P3033, DOI 10.1093/nar/gkh632; Chan HM, 2001, J CELL SCI, V114, P2363; Daly K, 2006, DNA CELL BIOL, V25, P49, DOI 10.1089/dna.2006.25.49; Dang DT, 2000, FEBS LETT, V476, P203, DOI 10.1016/S0014-5793(00)01727-0; Daniels DL, 2002, MOL CELL, V10, P573, DOI 10.1016/S1097-2765(02)00631-7; Dormeyer W, 2005, METHODS, V36, P376, DOI 10.1016/j.ymeth.2005.03.006; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Evans PM, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-22; Foster KW, 1999, CELL GROWTH DIFFER, V10, P423; Foster KW, 2000, CANCER RES, V60, P6488; GarrettSinha LA, 1996, J BIOL CHEM, V271, P31384, DOI 10.1074/jbc.271.49.31384; Geiman DE, 2000, NUCLEIC ACIDS RES, V28, P1106, DOI 10.1093/nar/28.5.1106; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; HEERDT BG, 1994, CANCER RES, V54, P3288; Hinnebusch BF, 2004, AM J PHYSIOL-GASTR L, V286, pG23, DOI 10.1152/ajpgi.00203.2003; Katz JP, 2005, GASTROENTEROLOGY, V128, P935, DOI 10.1053/j.gastro.2005.02.022; Katz JP, 2002, DEVELOPMENT, V129, P2619; Lee CH, 1999, P NATL ACAD SCI USA, V96, P12311, DOI 10.1073/pnas.96.22.12311; Levy L, 2004, MOL CELL BIOL, V24, P3404, DOI 10.1128/MCB.24.8.3404-3414.2004; Li D, 2005, CANCER RES, V65, P9216, DOI 10.1158/0008-5472.CAN-05-1040; LUNDBLAD JR, 1995, NATURE, V374, P85, DOI 10.1038/374085a0; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nakano K, 1997, J BIOL CHEM, V272, P22199, DOI 10.1074/jbc.272.35.22199; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Pandya AY, 2004, CLIN CANCER RES, V10, P2709, DOI 10.1158/1078-0432.CCR-03-0484; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; Siddique A, 2003, J GASTROINTEST SURG, V7, P1053, DOI 10.1016/j.gassur.2003.09.006; Sowa Y, 1997, BIOCHEM BIOPH RES CO, V241, P142, DOI 10.1006/bbrc.1997.7786; Sui GC, 2004, CELL, V117, P859, DOI 10.1016/j.cell.2004.06.004; Swamynathan SK, 2007, MOL CELL BIOL, V27, P182, DOI 10.1128/MCB.00846-06; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; VAN LC, 1996, GENE EXPRESSION, V5, P245; Wang QD, 2001, GASTROENTEROLOGY, V120, P1381, DOI 10.1053/gast.2001.24044; Wang R, 2005, J BIOL CHEM, V280, P11528, DOI 10.1074/jbc.M413930200; Wei DY, 2006, CARCINOGENESIS, V27, P23, DOI 10.1093/carcin/bgi243; Wei XL, 2007, CANCER RES, V67, P1853, DOI 10.1158/0008-5472.CAN-06-3063; Yoon HS, 2004, J BIOL CHEM, V279, P5035, DOI 10.1074/jbc.M307631200; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166; Zhang W, 2006, MOL CELL BIOL, V26, P2055, DOI 10.1128/MCB.26.6.2055-2064.2006; Zhang WJ, 1998, P NATL ACAD SCI USA, V95, P9855, DOI 10.1073/pnas.95.17.9855; Zhang WJ, 2001, MOL CELL BIOL, V21, P2413, DOI 10.1128/MCB.21.7.2413-2422.2001; Zhang WQ, 2000, J BIOL CHEM, V275, P18391, DOI 10.1074/jbc.C000062200; Zhao WD, 2004, ONCOGENE, V23, P395, DOI 10.1038/sj.onc.1207067	53	159	173	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					33994	34002		10.1074/jbc.M701847200	http://dx.doi.org/10.1074/jbc.M701847200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17908689	hybrid			2022-12-25	WOS:000251145700013
J	Sonoda, H; Okada, T; Jahangeer, S; Nakamura, SI				Sonoda, Hirofumi; Okada, Taro; Jahangeer, Saleem; Nakamura, Shun-Ichi			Requirement of phospholipase D for ilimaquinone-induced golgi membrane fragmentation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTOR; PROTEIN-KINASE-C; LYSOPHOSPHATIDIC ACID; PHOSPHATIDIC-ACID; PLASMA-MEMBRANE; CELL-SURFACE; ACTIVATION; TRANSPORT; ALPHA; NETWORK	Although organelles such as the endoplasmic reticulum and Golgi apparatus are highly compartmentalized, these organelles are interconnected through a network of vesicular trafficking. The marine sponge metabolite ilimaquinone (IQ) is known to induce Golgi membrane fragmentation and is widely used to study the mechanism of vesicular trafficking. Although IQ treatment causes protein kinase D (PKD) activation, the detailed mechanism of IQ-induced Golgi membrane fragmentation remains unclear. In this work, we found that IQ treatment of cells caused a robust activation of phospholipase D (PLD). In the presence of 1-butanol but not 2-butanol, IQ-induced Golgi membrane fragmentation was completely blocked. In addition, IQ failed to induce Golgi membrane fragmentation in PLD knock-out DT40 cells. Furthermore, IQ-induced PKD activation was completely blocked by treatment with either 1-butanol or propranolol. Notably, IQ-induced Golgi membrane fragmentation was also blocked by propranolol treatment. These results indicate that PLD-catalyzed formation of phosphatidic acid is a prerequisite for IQ-induced Golgi membrane fragmentation and that enzymatic conversion of phosphatidic acid to diacylglycerol is necessary for subsequent activation of PKD and IQ-induced Golgi membrane fragmentation.	Kobe Univ, Grad Sch Med, Dept Mol & Cellular Biol, Div Biochem, Kobe, Hyogo 6500017, Japan	Kobe University	Nakamura, SI (corresponding author), Kobe Univ, Grad Sch Med, Dept Mol & Cellular Biol, Div Biochem, Kobe, Hyogo 6500017, Japan.	snakamur@kobe-u.ac.jp	Nakamura, Shun/GVN-8593-2022	Sonoda, Hirofumi/0000-0003-3353-1783				Anel AMD, 2005, J CELL BIOL, V169, P83, DOI 10.1083/jcb.200412089; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; Bi K, 1997, CURR BIOL, V7, P301, DOI 10.1016/S0960-9822(06)00153-9; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; CONRICODE KM, 1992, J BIOL CHEM, V267, P7199; Cremona O, 2001, J CELL SCI, V114, P1041; Cross MJ, 1996, CURR BIOL, V6, P588, DOI 10.1016/S0960-9822(02)00545-6; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Hornia A, 1999, MOL CELL BIOL, V19, P7672; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Jamora C, 1997, CELL, V91, P617, DOI 10.1016/S0092-8674(00)80449-3; Jones D, 1999, BBA-MOL CELL BIOL L, V1439, P229, DOI 10.1016/S1388-1981(99)00097-9; Kam Y, 2004, BIOCHEM BIOPH RES CO, V315, P139, DOI 10.1016/j.bbrc.2004.01.034; Kooijman EE, 2003, TRAFFIC, V4, P162, DOI 10.1034/j.1600-0854.2003.00086.x; Ktistakis NT, 1996, J CELL BIOL, V134, P295, DOI 10.1083/jcb.134.2.295; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; Liscovitch M, 2000, BIOCHEM J, V345, P401, DOI 10.1042/0264-6021:3450401; Nakamura S, 1995, P NATL ACAD SCI USA, V92, P12319, DOI 10.1073/pnas.92.26.12319; Oka M, 2002, BIOCHEM BIOPH RES CO, V294, P1109, DOI 10.1016/S0006-291X(02)00614-9; Oka M, 2003, FEBS LETT, V554, P179, DOI 10.1016/S0014-5793(03)01158-X; Ponnambalam S, 2003, MOL MEMBR BIOL, V20, P129, DOI 10.1080/0968768031000084172; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Roth MG, 1999, CHEM PHYS LIPIDS, V98, P141, DOI 10.1016/S0009-3084(99)00026-2; Siddhanta A, 1998, J BIOL CHEM, V273, P17995, DOI 10.1074/jbc.273.29.17995; Singer WD, 1996, J BIOL CHEM, V271, P4504; TAKEDA S, 1992, P NATL ACAD SCI USA, V89, P4023, DOI 10.1073/pnas.89.9.4023; TAKIZAWA PA, 1993, CELL, V73, P1079, DOI 10.1016/0092-8674(93)90638-7; Weigert R, 1999, NATURE, V402, P429, DOI 10.1038/46587	29	30	30	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34085	34092		10.1074/jbc.M705593200	http://dx.doi.org/10.1074/jbc.M705593200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17897952	hybrid			2022-12-25	WOS:000251145700023
J	Johnson, LA; Prevo, R; Clasper, S; Jackson, DG				Johnson, Louise A.; Prevo, Remko; Clasper, Steven; Jackson, David G.			Inflammation-induced uptake and degradation of the lymphatic endothelial hyaluronan receptor LYVE-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; L-SELECTIN LIGAND; MAJOR E-SELECTIN; BINDING PROTEINS; GENE-EXPRESSION; DENDRITIC CELLS; TNF-ALPHA; CD44; LYMPHANGIOGENESIS; CANCER	The hyaluronan receptor LYVE-1 is selectively expressed in the endothelium of lymphatic capillaries, where it has been proposed to function in hyaluronan clearance and hyaluronan-mediated leukocyte adhesion. However, recent studies suggest that hyaluronan homeostasis is unperturbed in LYVE-1(-/-) mice and that lymphatic adhesion/transmigration may be largely mediated by ICAM-1 and VCAM-1 rather than LYVE-1. Here we have explored the possibility that LYVE-1 functions during inflammation and report that the receptor is down-regulated by pro-inflammatory cytokines. Using cultured primary lymphatic endothelial cells, we show that surface expression of LYVE-1 is rapidly and reversibly lost after exposure to tumor necrosis factor-alpha( TNF alpha) and TNF beta via internalization and degradation of the receptor in lysosomes, coupled with a shutdown in gene expression. Curiously, internalization does not result in significant uptake of hyaluronan, a process that is largely insensitive to the novel LYVE-1 adhesion blocking monoclonal antibody 3A, and proceeds almost equally in resting and inflammation-activated lymphatic endothelial cells. Finally, we show that TNF can induce down-modulation of LYVE-1 in ex vivo murine dermal tissue explants and present evidence that the process occurs in vivo, in the context of murine allergen-induced skin inflammation. These findings suggest that LYVE-1 can function independently of hyaluronan and have implications for the use of LYVE-1 as a histological marker for lymphangiogenesis in human pathology.	John Radcliffe Hosp, Weatherall Inst Mol Med, MRC, Human Immunol Unit, Oxford OX3 9DS, England	University of Oxford	Jackson, DG (corresponding author), John Radcliffe Hosp, Weatherall Inst Mol Med, MRC, Human Immunol Unit, Oxford OX3 9DS, England.	djackson@hammer.imm.ox.ac.uk		, david/0000-0002-4133-9364; Johnson, Louise/0000-0001-6667-8912	MRC [MC_U137884182] Funding Source: UKRI; Medical Research Council [MC_U137884182, G0801186] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ANSTEE DJ, 1991, IMMUNOLOGY, V74, P197; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Baluk P, 2005, J CLIN INVEST, V115, P247, DOI 10.1172/JCI200522037; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Breiteneder-Geleff S, 1999, AM J PATHOL, V154, P385, DOI 10.1016/S0002-9440(10)65285-6; Burdick MM, 2006, J BIOL CHEM, V281, P13899, DOI 10.1074/jbc.M513617200; CUMBERBATCH M, 1995, IMMUNOLOGY, V84, P31; Day AJ, 2002, J BIOL CHEM, V277, P4585, DOI 10.1074/jbc.R100036200; Dimitroff CJ, 2000, P NATL ACAD SCI USA, V97, P13841, DOI 10.1073/pnas.250484797; Dimitroff CJ, 2001, J CELL BIOL, V153, P1277, DOI 10.1083/jcb.153.6.1277; FAULKNER CB, 1995, INFECT IMMUN, V63, P4084, DOI 10.1128/IAI.63.10.4084-4090.1995; FRASER JRE, 1988, BIOCHEM J, V256, P153, DOI 10.1042/bj2560153; FRASER JRE, 1989, CIBA F SYMP, V143, P41; Gale NW, 2007, MOL CELL BIOL, V27, P595, DOI 10.1128/MCB.01503-06; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; Gee K, 2003, J BIOL CHEM, V278, P37275, DOI 10.1074/jbc.M302309200; Grabbe S, 1998, IMMUNOL TODAY, V19, P37, DOI 10.1016/S0167-5699(97)01186-9; HARDINGHAM TE, 1992, FASEB J, V6, P861, DOI 10.1096/fasebj.6.3.1740236; Harris EN, 2007, J BIOL CHEM, V282, P2785, DOI 10.1074/jbc.M607787200; HARRISONLAVOIE KJ, 1993, EMBO J, V12, P2847, DOI 10.1002/j.1460-2075.1993.tb05946.x; Jackson DG, 2001, TRENDS IMMUNOL, V22, P317, DOI 10.1016/S1471-4906(01)01936-6; Jackson DG, 2003, TRENDS CARDIOVAS MED, V13, P1, DOI 10.1016/S1050-1738(02)00189-5; Jackson DG, 2004, APMIS, V112, P526, DOI 10.1111/j.1600-0463.2004.apm11207-0811.x; JACKSON DG, 2004, GLYCOFORUM; Jeltsch M, 1997, SCIENCE, V276, P1423, DOI 10.1126/science.276.5317.1423; Johnson LA, 2006, J EXP MED, V203, P2763, DOI 10.1084/jem.20051759; KNUDSON CB, 1993, FASEB J, V7, P1233, DOI 10.1096/fasebj.7.13.7691670; Kriehuber E, 2001, J EXP MED, V194, P797, DOI 10.1084/jem.194.6.797; Levesque MC, 1999, CELL IMMUNOL, V193, P209, DOI 10.1006/cimm.1999.1456; Maiti A, 1998, SCIENCE, V282, P941, DOI 10.1126/science.282.5390.941; Meyer K, 1934, J BIOL CHEM, V107, P629; Millan J, 2006, NAT CELL BIOL, V8, P113, DOI 10.1038/ncb1356; Mishra JP, 2005, J BIOL CHEM, V280, P26825, DOI 10.1074/jbc.M500244200; Mummert DI, 2004, J INVEST DERMATOL, V122, P846, DOI 10.1046/j.0022-202X.2004.22127.x; Mummert ME, 2002, J IMMUNOL, V169, P4322, DOI 10.4049/jimmunol.169.8.4322; NIGHTINGALE T, 2005, HYALURONAN STRUCTURE, V2, P615; Nisato RE, 2004, AM J PATHOL, V165, P11, DOI 10.1016/S0002-9440(10)63271-3; Noble PW, 2002, MATRIX BIOL, V21, P25, DOI 10.1016/S0945-053X(01)00184-6; Pepper MS, 2001, CLIN CANCER RES, V7, P462; Prevo R, 2004, J BIOL CHEM, V279, P52580, DOI 10.1074/jbc.M406897200; Prevo R, 2001, J BIOL CHEM, V276, P19420, DOI 10.1074/jbc.M011004200; Pullinger BD, 1937, J PATHOL BACTERIOL, V45, P157, DOI 10.1002/path.1700450115; Rubbia-Brandt L, 2004, CLIN CANCER RES, V10, P6919, DOI 10.1158/1078-0432.CCR-04-0397; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Stessels F, 2004, BRIT J CANCER, V90, P1429, DOI 10.1038/sj.bjc.6601727; TAMMI R, 1991, J INVEST DERMATOL, V97, P126, DOI 10.1111/1523-1747.ep12478553; TAMMI R, 1994, PROG HISTOCHEM CYTOC, V29, P1; Tamura Y, 2003, J BIOL CHEM, V278, P12613, DOI 10.1074/jbc.M210211200; Termeer CC, 2000, J IMMUNOL, V165, P1863, DOI 10.4049/jimmunol.165.4.1863; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Van der Auwera I, 2004, CLIN CANCER RES, V10, P7965, DOI 10.1158/1078-0432.CCR-04-0063; Van Trappen PO, 2001, GYNECOL ONCOL, V82, P1, DOI 10.1006/gyno.2001.6292; VANDERAUWERA I, 2006, BE J CANC, P1; Weigel JA, 2003, J BIOL CHEM, V278, P9808, DOI 10.1074/jbc.M211462200; West D. C., 1989, CIBA F SYMP, V143, P201; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Witte MH, 2006, CANCER METAST REV, V25, P159, DOI 10.1007/s10555-006-8496-2; Zhou B, 2000, J BIOL CHEM, V275, P37733, DOI 10.1074/jbc.M003030200	59	112	116	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46							33671	10.1074/jbc.M702889200	http://dx.doi.org/10.1074/jbc.M702889200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17884820	hybrid			2022-12-25	WOS:000250840200048
J	Nikolic, DM; Gong, MC; Turk, J; Post, SR				Nikolic, Dejan M.; Gong, Ming C.; Turk, John; Post, Steven R.			Class a scavenger receptor-mediated macrophage adhesion requires coupling of calcium-independent phospholipase A(2) and 12/15-lipoxygenase to rac and Cdc42 activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARACHIDONIC-ACID LIBERATION; PROTEIN-KINASE; ACTIN POLYMERIZATION; LIPID-PEROXIDATION; PROSTAGLANDIN E-2; MONOCYTE ADHESION; PANCREATIC-ISLETS; MESSENGER-RNA; EXPRESS GROUP; NITRIC-OXIDE	Class A scavenger receptors (SR-A) participate in multiple macrophage functions including adhesion to modified extracellular matrix proteins present in various inflammatory disorders such as atherosclerosis and diabetes. By mediating macrophage adhesion to modified proteins and increasing macrophage retention, SR-A may contribute to the inflammatory process. Eicosanoids produced after phospholipase A(2) (PLA2)-catalyzed release of arachidonic acid (AA) are important regulators of macrophage function and inflammatory responses. The potential roles of AA release and metabolism in SR-A-mediated macrophage adhesion were determined using macrophages adherent to modified protein. SR-A-dependent macrophage adhesion was abolished by selectively inhibiting calcium-independent PLA2 (iPLA(2)) activity and absent in macrophages isolated from iPLA(2)beta(-/-) mice. Our results further demonstrate that 12/15lipoxygenase (12/15-LOX)-derived, but not cyclooxygenase- or cytochrome P450-dependent epoxygenase-derived AA metabolites, are specifically required for SR-A-dependent adhesion. Because of their role in regulating actin polymerization and cell adhesion, Rac and Cdc42 activation were also examined and shown to be increased via an iPLA(2)- and LOX-dependent pathway. Together, our results identify a novel role for iPLA(2)-catalyzed AA release and its metabolism by 12/15-LOX in coupling SR-A-mediated macrophage adhesion to Rac and Cdc42 activation.	Univ Kentucky, Dept Mol & Biomed Pharmacol, UK Med Ctr, Lexington, KY 40536 USA; Univ Kentucky, Dept Physiol, Lexington, KY 40536 USA; Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	University of Kentucky; University of Kentucky; Washington University (WUSTL)	Post, SR (corresponding author), Univ Kentucky, Dept Mol & Biomed Pharmacol, UK Med Ctr, MS305, Lexington, KY 40536 USA.	spost@uky.edu		Post, Steven/0000-0002-4711-1723	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK034388, P30DK056341, P60DK020579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103422] Funding Source: NIH RePORTER; NCRR NIH HHS [P41-RR00954, P41 RR000954-30, P41 RR000954] Funding Source: Medline; NHLBI NIH HHS [HL075241, R01 HL075241] Funding Source: Medline; NIDDK NIH HHS [P60 DK020579, P60 DK020579-269005, P30 DK056341-06, R37-DK34388, R37 DK034388-23, R37 DK034388, P60-DK20579, P30-DK56341, P30 DK056341-069003, P30 DK056341, P30 DK056341-07] Funding Source: Medline; NIGMS NIH HHS [P41 GM103422] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akiba S, 2002, BIOCHEM PHARMACOL, V63, P1969, DOI 10.1016/S0006-2952(02)00988-7; Akiba S, 1999, J BIOL CHEM, V274, P19906, DOI 10.1074/jbc.274.28.19906; Bagrodia S, 1998, J BIOL CHEM, V273, P23633, DOI 10.1074/jbc.273.37.23633; Balboa MA, 1997, J BIOL CHEM, V272, P8576, DOI 10.1074/jbc.272.13.8576; Bao SZ, 2006, J BIOL CHEM, V281, P20958, DOI 10.1074/jbc.M600075200; Bao SZ, 2004, J BIOL CHEM, V279, P38194, DOI 10.1074/jbc.M406489200; Berton G, 1999, CELL SIGNAL, V11, P621, DOI 10.1016/S0898-6568(99)00003-0; Bleich D, 1999, J CLIN INVEST, V103, P1431, DOI 10.1172/JCI5241; Bolick DT, 2005, ARTERIOSCL THROM VAS, V25, P2301, DOI 10.1161/01.ATV.0000186181.19909.a6; Chinnici CM, 2005, AM J PATHOL, V167, P1371, DOI 10.1016/S0002-9440(10)61224-2; CHUANG TH, 1993, J BIOL CHEM, V268, P26206; Coller SP, 2001, J LEUKOCYTE BIOL, V70, P142; Cyrus T, 1999, J CLIN INVEST, V103, P1597, DOI 10.1172/JCI5897; Cyrus T, 2001, CIRCULATION, V103, P2277; D'Souza-Schorey C, 1998, MOL CELL BIOL, V18, P3936, DOI 10.1128/MCB.18.7.3936; Daugherty A, 2001, J LIPID RES, V42, P1049; DeMali KA, 2003, J CELL SCI, V116, P2389, DOI 10.1242/jcs.00605; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Dormond O, 2001, NAT MED, V7, P1041, DOI 10.1038/nm0901-1041; Dransart E, 2005, TRAFFIC, V6, P957, DOI 10.1111/j.1600-0854.2005.00335.x; ELKHOURY J, 1994, J BIOL CHEM, V269, P10197; ElKhoury J, 1996, NATURE, V382, P716; Fleming I, 2007, PROSTAG OTH LIPID M, V82, P60, DOI 10.1016/j.prostaglandins.2006.05.003; Fong LG, 1999, J BIOL CHEM, V274, P36808, DOI 10.1074/jbc.274.51.36808; Fukuhara-Takaki K, 2005, J BIOL CHEM, V280, P3355, DOI 10.1074/jbc.M408715200; Gowen BB, 2000, MATRIX BIOL, V19, P61, DOI 10.1016/S0945-053X(99)00052-9; HABERLAND ME, 1985, P NATL ACAD SCI USA, V82, P2693, DOI 10.1073/pnas.82.9.2693; HABERLAND ME, 1982, P NATL ACAD SCI-BIOL, V79, P1712, DOI 10.1073/pnas.79.6.1712; Hatley ME, 2003, J BIOL CHEM, V278, P25369, DOI 10.1074/jbc.M301175200; Haworth R, 1997, J EXP MED, V186, P1431, DOI 10.1084/jem.186.9.1431; HAZEN SL, 1991, J BIOL CHEM, V266, P7227; HILTUNEN T, 1995, CIRCULATION, V92, P3297, DOI 10.1161/01.CIR.92.11.3297; Hiltunen TP, 1998, CIRCULATION, V97, P1079, DOI 10.1161/01.CIR.97.11.1079; Horiuchi S, 2005, ANN NY ACAD SCI, V1043, P671, DOI 10.1196/annals.1333.076; Hsu HY, 1998, J BIOL CHEM, V273, P1240, DOI 10.1074/jbc.273.2.1240; Huber J, 2006, J LIPID RES, V47, P1054, DOI 10.1194/jlr.M500555-JLR200; Jacobson DA, 2007, J BIOL CHEM, V282, P7442, DOI 10.1074/jbc.M607858200; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Kirkham PA, 2003, FREE RADICAL BIO MED, V35, P697, DOI 10.1016/S0891-5849(03)00390-3; LEFKOWITH JB, 1992, J IMMUNOL, V149, P1729; Li SL, 2006, DIABETES, V55, P2611, DOI 10.2337/db06-0164; Ma ZM, 1997, J BIOL CHEM, V272, P11118; Mancuso DJ, 2000, J BIOL CHEM, V275, P9937, DOI 10.1074/jbc.275.14.9937; Miki S, 1996, FEBS LETT, V399, P241, DOI 10.1016/S0014-5793(96)01332-4; Miller YI, 2003, MOL BIOL CELL, V14, P4196, DOI 10.1091/mbc.E03-02-0063; Miller YI, 2001, J BIOL CHEM, V276, P19431, DOI 10.1074/jbc.M011276200; Moran JM, 2005, J BIOL CHEM, V280, P28162, DOI 10.1074/jbc.M500013200; Natarajan R, 2004, ARTERIOSCL THROM VAS, V24, P1542, DOI 10.1161/01.ATV.0000133606.69732.4c; NEEDLEMAN P, 1986, ANNU REV BIOCHEM, V55, P69, DOI 10.1146/annurev.biochem.55.1.69; Nikolic DM, 2007, AM J PHYSIOL-CELL PH, V292, pC1450, DOI 10.1152/ajpcell.00401.2006; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; PEPPELENBOSCH MP, 1995, CELL, V81, P849, DOI 10.1016/0092-8674(95)90005-5; PETERSGOLDEN M, 1993, AM J PHYSIOL-LUNG C, V264, P438; Phillis JW, 2006, BRAIN RES REV, V52, P201, DOI 10.1016/j.brainresrev.2006.02.002; Pollaud-Cherion C, 1998, EUR J BIOCHEM, V253, P345, DOI 10.1046/j.1432-1327.1998.2530345.x; Post SR, 2002, J LIPID RES, V43, P1829, DOI 10.1194/jlr.M200231-JLR200; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; ROSOLOWSKY M, 1993, AM J PHYSIOL, V264, pH327, DOI 10.1152/ajpheart.1993.264.2.H327; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Santiago-Garcia J, 2003, J BIOL CHEM, V278, P6942, DOI 10.1074/jbc.M208358200; Santiago-Garcia J, 2001, J BIOL CHEM, V276, P30655, DOI 10.1074/jbc.M102879200; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Seno K, 2000, J MED CHEM, V43, P1041, DOI 10.1021/jm9905155; Shin EA, 1999, FEBS LETT, V452, P355, DOI 10.1016/S0014-5793(99)00657-2; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Sun DX, 1996, J BIOL CHEM, V271, P24055, DOI 10.1074/jbc.271.39.24055; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tang J, 1997, J BIOL CHEM, V272, P8567, DOI 10.1074/jbc.272.13.8567; Teslenko V, 1997, BBA-LIPID LIPID MET, V1344, P189, DOI 10.1016/S0005-2760(96)00137-3; Usui HK, 2007, DIABETES, V56, P363, DOI 10.2337/db06-0359; van Velzen AG, 1999, EXP CELL RES, V250, P264, DOI 10.1006/excr.1999.4530; Whitman SC, 2000, J LIPID RES, V41, P807; Woo CH, 2000, BIOCHEM BIOPH RES CO, V268, P231, DOI 10.1006/bbrc.2000.2102; Worthylake RA, 2001, J CELL BIOL, V154, P147, DOI 10.1083/jcb.200103048; Worthylake RA, 2003, J BIOL CHEM, V278, P13578, DOI 10.1074/jbc.M211584200; Yamada M, 1997, J PHARMACOL EXP THER, V281, P1005; Zamir E, 2001, J CELL SCI, V114, P3583; Zamora R, 1998, EUR J PHARMACOL, V349, P307, DOI 10.1016/S0014-2999(98)00211-8	81	36	36	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33405	33411		10.1074/jbc.M704133200	http://dx.doi.org/10.1074/jbc.M704133200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17873277	hybrid, Green Accepted			2022-12-25	WOS:000250840200020
J	Rich, T; Varadaraj, A				Rich, Tina; Varadaraj, Archana			Ataxin-1 Fusion Partners Alter PolyQ Lethality and Aggregation	PLOS ONE			English	Article								Intranuclear inclusion bodies (IBs) are the histopathologic markers of multiple protein folding diseases. IB formation has been extensively studied using fluorescent fusion products of pathogenic polyglutamine (polyQ) expressing proteins. These studies have been informative in determining the cellular targets of expanded polyQ protein as well as the methods by which cells rid themselves of IBs. The experimental thrust has been to intervene in the process of polyQ aggregation in an attempt to alleviate cytotoxicity. However new data argues against the notion that polyQ aggregation and cytotoxicity are inextricably linked processes. We reasoned that changing the protein context of a disease causing polyQ protein could accelerate its precipitation as an IB, potentially reducing its cytotoxicity. Our experimental strategy simply exploited the fact that conjoined proteins influence each others folding and aggregation properties. We fused a full-length pathogenic ataxin-1 construct to fluorescent tags (GFP and DsRed1-E5) that exist at different oligomeric states. The spectral properties of the DsRed1-E5-ataxin-1 transfectants had the additional advantage of allowing us to correlate fluorochrome maturation with cytotoxicity. Each fusion protein expressed a distinct cytotoxicity and IB morphology. Flow cytometric analyses of transfectants expressing the greatest fluorescent signals revealed that the DsRed1-E5-ataxin-1 fusion was more toxic than GFP fused ataxin-1 (31.8+/-4.5% cell death versus 12.85+/-3%), although co-transfection with the GFP fusion inhibited maturation of the DsRed1-E5 fluorochrome and diminished the toxicity of the DsRed1-E5-ataxin-1 fusion. These data show that polyQ driven aggregation can be influenced by fusion partners to generate species with different toxic properties and provide new opportunities to study IB aggregation, maturation and lethality.	[Rich, Tina; Varadaraj, Archana] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England	University of Cambridge	Rich, T (corresponding author), Univ Glasgow, Fac Vet Sci, Inst Comparat Med, Glasgow, Lanark, Scotland.	T.Rich@vet.gla.ac.uk		Varadaraj, Archana/0000-0002-1868-1268				Borden KLB, 2002, MOL CELL BIOL, V22, P5259, DOI 10.1128/MCB.22.15.5259-5269.2002; BULONE D, 2007, PLOS ONE E, V111, P1; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Cowan KJ, 2003, HUM MOL GENET, V12, P1377, DOI 10.1093/hmg/ddg151; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; Dovey CL, 2004, J PATHOL, V203, P877, DOI 10.1002/path.1604; Everett RD, 2006, J VIROL, V80, P7995, DOI 10.1128/JVI.00734-06; Fu LW, 2005, NEUROBIOL DIS, V20, P656, DOI 10.1016/j.nbd.2005.05.015; Fu LW, 2005, MOL BIOL CELL, V16, P4905, DOI 10.1091/mbc.E05-01-0019; Hoshino M, 2006, J CELL BIOL, V172, P589, DOI 10.1083/jcb.200509132; Janer A, 2006, J CELL BIOL, V174, P65, DOI 10.1083/jcb.200511045; Kumada S, 2002, J NEUROPATH EXP NEUR, V61, P984, DOI 10.1093/jnen/61.11.984; Menon RP, 2006, CELL MOL LIFE SCI, V63, P1677, DOI 10.1007/s00018-006-6097-4; Michalik A, 2003, HUM MOL GENET, V12, pR173, DOI 10.1093/hmg/ddg295; Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215; Nozaki K, 2001, NEUROREPORT, V12, P3357, DOI 10.1097/00001756-200110290-00042; Nye AC, 2002, MOL CELL BIOL, V22, P3437, DOI 10.1128/MCB.22.10.3437-3449.2002; Poirier MA, 2005, HUM MOL GENET, V14, P765, DOI 10.1093/hmg/ddi071; Rich T, 1999, HUM MOL GENET, V8, P2451, DOI 10.1093/hmg/8.13.2451; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Schwarz-Romond T, 2005, J CELL SCI, V118, P5269, DOI 10.1242/jcs.02646; Sebastian Sarah, 2007, Curr Infect Dis Rep, V9, P167, DOI 10.1007/s11908-007-0013-4; Sheffield LG, 2006, J NEUROPATH EXP NEUR, V65, P45, DOI 10.1097/01.jnen.0000195939.40410.08; Skinner PJ, 1997, NATURE, V389, P971, DOI 10.1038/40153; Takahashi J, 2003, NEUROBIOL DIS, V13, P230, DOI 10.1016/S0969-9961(03)00080-9; Terskikh A, 2000, SCIENCE, V290, P1585, DOI 10.1126/science.290.5496.1585; Terskikh AV, 2002, J BIOL CHEM, V277, P7633, DOI 10.1074/jbc.C100694200; Varadaraj A, 2007, J PATHOL, V211, P471, DOI 10.1002/path.2126; Villagra NT, 2006, NEUROBIOL DIS, V21, P181, DOI 10.1016/j.nbd.2005.07.003; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Wall MA, 2000, NAT STRUCT BIOL, V7, P1133; Zoghbi HY, 2000, CURR OPIN NEUROBIOL, V10, P655, DOI 10.1016/S0959-4388(00)00135-5	33	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1014	10.1371/journal.pone.0001014	http://dx.doi.org/10.1371/journal.pone.0001014			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925862	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000207456000013
J	Oganesyan, G; Saha, SK; Pietras, EM; Guo, B; Miyahira, AK; Zarnegar, B; Cheng, G				Oganesyan, Gagik; Saha, Supriya K.; Pietras, Eric M.; Guo, Beichu; Miyahira, Andrea K.; Zarnegar, Brian; Cheng, Genhong			IRF3-dependent type I interferon response in B cells regulates CpG-mediated antibody production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; TOLL-LIKE RECEPTORS; INDEPENDENT ANTIVIRAL RESPONSE; BACTERIAL-DNA; T-BET; IMMUNE-RESPONSES; GENE-EXPRESSION; ACTIVATION; MICE; LYMPHOCYTES	Hypomethylated CpG oligonucleotides (CpG) are not only potent adjuvants for enhancing adaptive immune responses but may also play a critical role in the development of autoimmune diseases such as Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE). Here we provide evidence that, in addition to dendritic cells, murine B lymphocytes also exhibit a type I IFN response to CpG-B. Unlike dendritic cells, B cell-mediated type I IFN induction depended on the transcription factor IRF3, but similar to dendritic cells this pathway was independent of the IRF3 kinase TBK1. Utilizing type I IFN receptor-deficient mice, we were able to demonstrate that this IFN pathway enhanced Syndecan-1 expression and IgM production and was required for IgG2a production following CpG-B stimulation. Overall, our findings identify a unique IFN pathway in B cells that may play a central role in mediating B cell biology in response to CpG, potentially implicating this pathway in autoantibody production and the pathogenesis of certain autoimmune diseases.	[Oganesyan, Gagik; Saha, Supriya K.; Pietras, Eric M.; Guo, Beichu; Miyahira, Andrea K.; Zarnegar, Brian; Cheng, Genhong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Oganesyan, Gagik; Saha, Supriya K.] Univ Calif Los Angeles, Med Scientist Training Program, Los Angeles, CA 90095 USA; [Cheng, Genhong] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Cheng, Genhong] Univ Calif Los Angeles, Johnsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Cheng, G (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, 8-240 Factor Bldg,10833 Conte Ave, Los Angeles, CA 90095 USA.	gcheng@mednet.ucla.edu	Saha, Supriya/AAC-5365-2019	Miyahira, Andrea/0000-0003-4976-002X	NCI NIH HHS [R01 CA87924] Funding Source: Medline; NIAID NIH HHS [R01 AI056154] Funding Source: Medline; NIGMS NIH HHS [R01 GM57559, GM08042] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA087924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057559, T32GM008042] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARNOLD LW, 1988, J IMMUNOL, V140, P4355; ARNOLD LW, 1983, J IMMUNOL, V131, P2064; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Bas A, 2004, SCAND J IMMUNOL, V59, P566, DOI 10.1111/j.0300-9475.2004.01440.x; Behar S M, 1989, Int Rev Immunol, V5, P23, DOI 10.3109/08830188909086988; Braun D, 2003, J AUTOIMMUN, V20, P15, DOI 10.1016/S0896-8411(02)00109-9; Chu RS, 1997, J EXP MED, V186, P1623, DOI 10.1084/jem.186.10.1623; Coro ES, 2006, J IMMUNOL, V176, P4343, DOI 10.4049/jimmunol.176.7.4343; Dalpke A, 2002, BIODRUGS, V16, P419, DOI 10.2165/00063030-200216060-00003; Decker T, 2002, J CLIN INVEST, V109, P1271, DOI 10.1172/JCI200215770; Doyle SE, 2003, J IMMUNOL, V170, P3565, DOI 10.4049/jimmunol.170.7.3565; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; EHLERS M, 2006, J EXP MED; EMLEN W, 1994, J IMMUNOL, V152, P3685; Fields ML, 2003, IMMUNOL RES, V27, P219, DOI 10.1385/IR:27:2-3:219; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gongora R, 2001, IMMUNITY, V14, P727, DOI 10.1016/S1074-7613(01)00152-2; Hacker H, 2000, J EXP MED, V192, P595, DOI 10.1084/jem.192.4.595; Hemmi H, 2003, J IMMUNOL, V170, P3059, DOI 10.4049/jimmunol.170.6.3059; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Jung J, 2002, J IMMUNOL, V169, P2368, DOI 10.4049/jimmunol.169.5.2368; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; KRIEG AM, 1995, J CLIN IMMUNOL, V15, P284, DOI 10.1007/BF01541318; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Krieg AM, 2002, NAT IMMUNOL, V3, P423, DOI 10.1038/ni0502-423; Le Bon A, 2006, J IMMUNOL, V176, P2074, DOI 10.4049/jimmunol.176.4.2074; Le Page C, 2000, Rev Immunogenet, V2, P374; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Liu NS, 2003, NAT IMMUNOL, V4, P687, DOI 10.1038/ni941; Millan CLB, 1998, P NATL ACAD SCI USA, V95, P15553, DOI 10.1073/pnas.95.26.15553; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Peng SL, 2003, NAT IMMUNOL, V4, P1041, DOI 10.1038/ni1103-1041a; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Ronnblom L, 2002, HUM IMMUNOL, V63, P1181, DOI 10.1016/S0198-8859(02)00757-7; Ronnblom L, 2001, TRENDS IMMUNOL, V22, P427, DOI 10.1016/S1471-4906(01)01955-X; RONNBLOM LE, 1991, ANN INTERN MED, V115, P178, DOI 10.7326/0003-4819-115-3-178; Rui LX, 2003, NAT IMMUNOL, V4, P594, DOI 10.1038/ni924; STEWARD MW, 1976, CLIN EXP IMMUNOL, V26, P363; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Tran TT, 2003, CLIN IMMUNOL, V109, P278, DOI 10.1016/j.clim.2003.08.012; Viglianti GA, 2003, IMMUNITY, V19, P837, DOI 10.1016/S1074-7613(03)00323-6; Wang ZH, 1997, CELL IMMUNOL, V180, P162, DOI 10.1006/cimm.1997.1156; Weiner GJ, 2000, J LEUKOCYTE BIOL, V68, P455; Xu WF, 2005, J IMMUNOL, V175, P7419, DOI 10.4049/jimmunol.175.11.7419	53	28	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					802	808		10.1074/jbc.M704755200	http://dx.doi.org/10.1074/jbc.M704755200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17925397	hybrid			2022-12-25	WOS:000252128100019
J	Hisatsune, C; Yasumatsu, K; Takahashi-Iwanaga, H; Ogawa, N; Kuroda, Y; Yoshida, R; Ninomiya, Y; Mikoshiba, K				Hisatsune, Chihiro; Yasumatsu, Keiko; Takahashi-Iwanaga, Hiromi; Ogawa, Naoko; Kuroda, Yukiko; Yoshida, Ryusuke; Ninomiya, Yuzo; Mikoshiba, Katsuhiko			Abnormal taste perception in mice lacking the type 3 inositol 1,4,5-trisphosphate receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UMAMI TASTE; SWEET TASTE; MAMMALIAN SWEET; CATION CHANNEL; CELLS; BITTER; TRPM5; TRANSDUCTION; EXPRESSION; RESPONSES	Inositol 1,4,5-trisphosphate receptor (IP3R) is one of the important calcium channels expressed in the endoplasmic reticulum and has been shown to play crucial roles in various physiological phenomena. Type 3 IP3R is expressed in taste cells, but the physiological relevance of this receptor in taste perception in vivo is still unknown. Here, we show that mice lacking IP(3)R3 show abnormal behavioral and electrophysiological responses to sweet, umami, and bitter substances that trigger G-protein-coupled receptor activation. In contrast, responses to salty and acid tastes are largely normal in the mutant mice. We conclude that IP3R3 is a principal mediator of sweet, bitter, and umami taste perception and would be a missing molecule linking phospholipase C beta 2 to TRPM5 activation.	[Hisatsune, Chihiro; Ogawa, Naoko; Kuroda, Yukiko; Mikoshiba, Katsuhiko] RIKEN, Dev Neurobiol Lab, Brain Res Inst, Wako, Saitama 3510198, Japan; [Hisatsune, Chihiro; Mikoshiba, Katsuhiko] Univ Tokyo, Div Mol Neurobiol, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan; [Yasumatsu, Keiko; Yoshida, Ryusuke; Ninomiya, Yuzo] Kyushu Univ, Grad Sch Dent Sci, Sect Oral Neurosci, Higashi Ku, Fukuoka 8128582, Japan; [Takahashi-Iwanaga, Hiromi] Hokkaido Univ, Sch Med, Dept Anat, Sapporo, Hokkaido 0608638, Japan; [Mikoshiba, Katsuhiko] Japan Sci & Technol Agcy, ICORP, Calcium Oscillat Project, Chiyoda Ku, Tokyo 1020084, Japan	RIKEN; University of Tokyo; Kyushu University; Hokkaido University; Japan Science & Technology Agency (JST)	Hisatsune, C (corresponding author), RIKEN, Dev Neurobiol Lab, Brain Res Inst, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	chihiro@brain.riken.go.jp; mikosiba@brain.riken.go.jp	Takahashi-Iwanaga, Hiromi/A-4294-2012; Hisatsune, Chihiro/C-6661-2017; Mikoshiba, Katsuhiko/N-7943-2015; Kuroda, Yukiko/L-6332-2013; Kuroda, Yukiko/L-6332-2013	Hisatsune, Chihiro/0000-0001-7811-7784; Kuroda, Yukiko/0000-0002-5335-4238; Kuroda, Yukiko/0000-0001-7713-9471				Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Asano-Miyoshi M, 2001, CHEM SENSES, V26, P259, DOI 10.1093/chemse/26.3.259; AVENET P, 1988, NATURE, V331, P351, DOI 10.1038/331351a0; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Clapp TR, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-6; CUMMINGS TA, 1992, J GEN PHYSIOL, V99, P591, DOI 10.1085/jgp.99.4.591; Damak S, 2006, CHEM SENSES, V31, P253, DOI 10.1093/chemse/bjj027; Damak S, 2003, SCIENCE, V301, P850, DOI 10.1126/science.1087155; Dotson CD, 2005, CHEM SENSES, V30, P593, DOI 10.1093/chemse/bji053; Futatsugi A, 2005, SCIENCE, V309, P2232, DOI 10.1126/science.1114110; Hattori M, 2004, J BIOL CHEM, V279, P11967, DOI 10.1074/jbc.M311456200; He W, 2004, J NEUROSCI, V24, P7674, DOI 10.1523/JNEUROSCI.2441-04.2004; Hofmann T, 2003, CURR BIOL, V13, P1153, DOI 10.1016/S0960-9822(03)00431-7; Kawai K, 2000, P NATL ACAD SCI USA, V97, P11044, DOI 10.1073/pnas.190066697; KOLESNIKOV SS, 1995, NATURE, V376, P85, DOI 10.1038/376085a0; Matsumoto M, 1996, NATURE, V379, P168, DOI 10.1038/379168a0; Misaka T, 1998, ANN NY ACAD SCI, V855, P150, DOI 10.1111/j.1749-6632.1998.tb10558.x; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Ninomiya Y, 2000, J NUTR, V130, p950S, DOI 10.1093/jn/130.4.950S; Perez CA, 2003, CELL CALCIUM, V33, P541, DOI 10.1016/S0143-4160(03)00059-9; Perez CA, 2002, NAT NEUROSCI, V5, P1169, DOI 10.1038/nn952; Prawitt D, 2003, P NATL ACAD SCI USA, V100, P15166, DOI 10.1073/pnas.2334624100; ROYER SM, 1988, J COMP NEUROL, V270, P11, DOI 10.1002/cne.902700103; Scott K, 2005, NEURON, V48, P455, DOI 10.1016/j.neuron.2005.10.015; Scott K, 2004, CURR OPIN NEUROBIOL, V14, P423, DOI 10.1016/j.conb.2004.06.003; SUGIYAMA T, 1994, FEBS LETT, V349, P191, DOI 10.1016/0014-5793(94)00662-8; TAKEDA M, 1976, ARCH HISTOL JAPON, V39, P257, DOI 10.1679/aohc1950.39.257; Ullrich ND, 2005, CELL CALCIUM, V37, P267, DOI 10.1016/j.ceca.2004.11.001; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhang Z, 2007, J NEUROSCI, V27, P5777, DOI 10.1523/JNEUROSCI.4973-06.2007; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	33	113	117	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37225	37231		10.1074/jbc.M705641200	http://dx.doi.org/10.1074/jbc.M705641200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17925404	hybrid			2022-12-25	WOS:000251646000048
J	Sayegh, J; Webb, K; Cheng, DH; Bedford, MT; Clarke, SG				Sayegh, Joyce; Webb, Kristofor; Cheng, Donghang; Bedford, Mark T.; Clarke, Steven G.			Regulation of protein arginine methyltransferase 8 (PRMT8) activity by its N-terminal domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN ARGININE METHYLTRANSFERASE; SUBSTRATE-SPECIFICITY; S-ADENOSYLMETHIONINE; METHYLATION; BINDING; TRANSCRIPTION; RESIDUES; RNA; IDENTIFICATION; FAMILY	Human protein arginine methyltransferase PRMT8 has been recently described as a type I enzyme in brain that is localized to the plasma membrane by N-terminal myristoylation. The amino acid sequence of human PRMT8 is almost 80% identical to human PRMT1, the major protein arginine methyltransferase activity in mammalian cells. However, the activity of a recombinant PRMT8 GST fusion protein toward methyl-accepting substrates is much lower than that of a GST fusion of PRMT1. We show here that both His-tagged and GST fusion species lacking the initial 60 amino acid residues of PRMT8 have enhanced enzymatic activity, suggesting that the N-terminal domain may regulate PRMT8 activity. This conclusion is supported by limited proteolysis experiments showing an increase in the activity of the digested full-length protein, consistent with the loss of the N-terminal domain. In contrast, the activity of the N-terminal truncated protein was slightly diminished by limited proteolysis. Significantly, we detect automethylation at two sites in the N-terminal domain, as well as binding sites for SH3 domain-containing proteins. We suggest that the N-terminal domain may function as an autoregulator that may be displaced by interaction with one or more physiological inducers.	Univ Calif Los Angeles, Inst Mol Biol, Dept Chem & Biochem, Los Angeles, CA 90095 USA; Univ Texas MD Anderson Canc Ctr, Sci Pk Res Div, Smithville, TX 78957 USA	University of California System; University of California Los Angeles; University of Texas System; UTMD Anderson Cancer Center	Clarke, SG (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Dept Chem & Biochem, 607 Charles E Young Dr E, Los Angeles, CA 90095 USA.	clarke@mbi.ucla.edu	Bedford, Mark T/E-7856-2011	Webb, Kristofor/0000-0001-8111-9756	NIGMS NIH HHS [GM026020] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026020, R37GM026020] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Araya N, 2005, BIOCHEM BIOPH RES CO, V329, P653, DOI 10.1016/j.bbrc.2005.02.018; Bachand F, 2004, EMBO J, V23, P2641, DOI 10.1038/sj.emboj.7600265; Bachand F, 2007, EUKARYOT CELL, V6, P889, DOI 10.1128/EC.00099-07; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Bedford MT, 2000, J BIOL CHEM, V275, P16030, DOI 10.1074/jbc.M909368199; Branscombe TL, 2001, J BIOL CHEM, V276, P32971, DOI 10.1074/jbc.M105412200; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Cheng DH, 2007, MOL CELL, V25, P71, DOI 10.1016/j.molcel.2006.11.019; Cook JR, 2006, BIOCHEM BIOPH RES CO, V342, P472, DOI 10.1016/j.bbrc.2006.01.167; Covic M, 2005, EMBO J, V24, P85, DOI 10.1038/sj.emboj.7600500; El Messaoudi S, 2006, P NATL ACAD SCI USA, V103, P13351, DOI 10.1073/pnas.0605692103; Espejo A, 2002, BIOCHEM J, V367, P697, DOI 10.1042/BJ20020860; Fabbrizio E, 2002, EMBO REP, V3, P641, DOI 10.1093/embo-reports/kvf136; Fackelmayer FO, 2005, TRENDS BIOCHEM SCI, V30, P666, DOI 10.1016/j.tibs.2005.10.002; Farrar C, 2002, J BIOL CHEM, V277, P27856, DOI 10.1074/jbc.M203911200; Frankel A, 2002, J BIOL CHEM, V277, P3537, DOI 10.1074/jbc.M108786200; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; Gehrig PM, 2004, J AM SOC MASS SPECTR, V15, P142, DOI 10.1016/j.jasms.2003.10.002; Goulet I, 2007, J BIOL CHEM, V282, P33009, DOI 10.1074/jbc.M704349200; Herrmann F, 2005, J BIOL CHEM, V280, P38005, DOI 10.1074/jbc.M502458200; Hung CM, 2004, GENE, V340, P179, DOI 10.1016/j.gene.2004.07.039; INARNITSU M, 2006, FEBS LETT, V580, P6603; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Krause CD, 2007, PHARMACOL THERAPEUT, V113, P50, DOI 10.1016/j.pharmthera.2006.06.007; Krones-Herzig A, 2006, J BIOL CHEM, V281, P3025, DOI 10.1074/jbc.M509770200; Lee J, 2005, J BIOL CHEM, V280, P32890, DOI 10.1074/jbc.M506944200; Lee JH, 2005, J BIOL CHEM, V280, P3656, DOI 10.1074/jbc.M405295200; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; LIU Q, 1995, MOL CELL BIOL, V15, P2800; Miranda TB, 2004, J BIOL CHEM, V279, P22902, DOI 10.1074/jbc.M312904200; Naeem H, 2007, MOL CELL BIOL, V27, P120, DOI 10.1128/MCB.00815-06; Nagar B, 2006, MOL CELL, V21, P787, DOI 10.1016/j.molcel.2006.01.035; Niewmierzycka A, 1999, J BIOL CHEM, V274, P814, DOI 10.1074/jbc.274.2.814; Pahlich S, 2006, BBA-PROTEINS PROTEOM, V1764, P1890, DOI 10.1016/j.bbapap.2006.08.008; Rowe DC, 2006, P NATL ACAD SCI USA, V103, P6299, DOI 10.1073/pnas.0510041103; Swiercz R, 2005, BIOCHEM J, V386, P85, DOI 10.1042/BJ20041466; Taneda T, 2007, BRAIN RES, V1155, P1, DOI 10.1016/j.brainres.2007.03.086; Tang J, 1998, J BIOL CHEM, V273, P16935, DOI 10.1074/jbc.273.27.16935; Tang J, 2000, J BIOL CHEM, V275, P7723, DOI 10.1074/jbc.275.11.7723; Tanner S, 2005, ANAL CHEM, V77, P4626, DOI 10.1021/ac050102d; Yadav N, 2003, P NATL ACAD SCI USA, V100, P6464, DOI 10.1073/pnas.1232272100; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Yun CY, 2000, J CELL BIOL, V150, P707, DOI 10.1083/jcb.150.4.707; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zobel-Thropp P, 1998, J BIOL CHEM, V273, P29283, DOI 10.1074/jbc.273.45.29283	45	80	85	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36444	36453		10.1074/jbc.M704650200	http://dx.doi.org/10.1074/jbc.M704650200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17925405	hybrid			2022-12-25	WOS:000251458300036
J	McNevin, DB; Badger, MR; Whitney, SM; von Caemmerer, S; Tcherkez, GGB; Farquhar, GD				McNevin, Dennis B.; Badger, Murray R.; Whitney, Spencer M.; von Caemmerer, Susanne; Tcherkez, Guillaume G. B.; Farquhar, Graham D.			Differences in carbon isotope discrimination of three variants of d-ribulose-1,5-bisphosphate carboxylase/oxygenase reflect differences in their catalytic mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBULOSE-BISPHOSPHATE CARBOXYLASE; WATER-USE EFFICIENCY; RIBULOSEBISPHOSPHATE CARBOXYLASE; RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE; PHOSPHOENOLPYRUVATE CARBOXYLASE; LARGE SUBUNITS; SIDE REACTIONS; FRACTIONATION; RUBISCO; OXYGEN	The carboxylation kinetic (stable carbon) isotope effect was measured for purified D-ribulose-1,5-bisphosphate carboxylases/oxygenases (Rubiscos) with aqueous CO2 as substrate by monitoring Rayleigh fractionation using membrane inlet mass spectrometry. This resulted in discriminations (Delta) of 27.4 +/- 0.9 parts per thousand for wild-type tobacco Rubisco, 22.2 +/- 2.1 parts per thousand for Rhodospirillum rubrum Rubisco, and 11.2 +/- 1.6 parts per thousand for a large subunit mutant of tobacco Rubisco in which Leu(335) is mutated to valine (L335V). These Delta values are consistent with the photosynthetic discrimination determined for wild-type tobacco and transplastomic tobacco lines that exclusively produce R. rubrum or L335V Rubisco. The Delta values are indicative of the potential evolutionary variability of Delta values for a range of Rubiscos from different species: Form I Rubisco from higher plants; prokaryotic Rubiscos, including Form II; and the L335V mutant. We explore the implications of these Delta values for the Rubisco catalytic mechanism and suggest that Rubiscos that are associated with a lower Delta value have a less product-like carboxylation transition state and/or allow a decarboxylation step that evolution has excluded in higher plants.	Australian Natl Univ, Res Sch Biol Sci, Canberra, ACT 2601, Australia; Univ Canberra, Sch Hlth Sci, Bruce, ACT 2601, Australia; Univ Paris 11, Lab Ecophysiol Vegetale, F-91405 Orsay, France	Australian National University; University of Canberra; UDICE-French Research Universities; Universite Paris Saclay	Farquhar, GD (corresponding author), Australian Natl Univ, Res Sch Biol Sci, GPO Box 475, Canberra, ACT 2601, Australia.	graham.farquhar@anu.edu.au	von Caemmerer, Susanne/C-9317-2009; Tcherkez, Guillaume/L-1300-2015; Whitney, Spencer M/C-9266-2009; McNevin, Dennis/H-3351-2019; FARQUHAR, GRAHAM D/A-3722-2008	Whitney, Spencer M/0000-0003-2954-2359; McNevin, Dennis/0000-0003-1665-3367; Badger, Murray/0000-0001-9428-2579; Farquhar, Graham/0000-0002-7065-1971				Andersson I, 2003, ARCH BIOCHEM BIOPHYS, V414, P130, DOI 10.1016/S0003-9861(03)00164-4; Andrews T.J., 1987, BIOCH PLANTS, P131, DOI 10.1016/B978-0-12-675410-0.50009-9; ANDREWS TJ, 1991, J BIOL CHEM, V266, P9447; ANDREWS TJ, 1985, J BIOL CHEM, V260, P4632; ANDREWS TJ, 1988, J BIOL CHEM, V263, P12213; Badger MR, 1998, CAN J BOT, V76, P1052, DOI 10.1139/b98-074; BADGER MR, 2008, IN PRESS J EXP BOT; Badger MR, 1978, CARNEGIE I WASHINGTO, P355; Berti PJ, 1999, METHOD ENZYMOL, V308, P355; BIGELEISEN J, 1949, J CHEM PHYS, V17, P675, DOI 10.1063/1.1747368; Brugnoli Enrico, 2000, VVolume 9, P399; BUNCEL E, 1977, CARBON 13 ORGANIC CH; BUTZ ND, 1989, PLANT PHYSIOL, V89, P735, DOI 10.1104/pp.89.3.735; CHRISTELLER JT, 1976, PLANT PHYSIOL, V57, P580, DOI 10.1104/pp.57.4.580; Cooper A, 1999, CURR OPIN CHEM BIOL, V3, P557, DOI 10.1016/S1367-5931(99)00008-3; CRAIG H, 1957, GEOCHIM COSMOCHIM AC, V12, P133, DOI 10.1016/0016-7037(57)90024-8; EDMONDSON DL, 1990, PLANT PHYSIOL, V93, P1376, DOI 10.1104/pp.93.4.1376; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; FARQUHAR GD, 1982, AUST J PLANT PHYSIOL, V9, P121, DOI 10.1071/PP9820121; FARQUHAR GD, 1983, AUST J PLANT PHYSIOL, V10, P205, DOI 10.1071/PP9830205; FARQUHAR GD, 1984, AUST J PLANT PHYSIOL, V11, P539, DOI 10.1071/PP9840539; FARQUHAR GD, 1979, ARCH BIOCHEM BIOPHYS, V193, P456, DOI 10.1016/0003-9861(79)90052-3; GRIFFITHS H, 1990, PLANTA, V181, P604, DOI 10.1007/BF00193017; GRIFFITHS H, 1992, PLANT CELL ENVIRON, V15, P1051, DOI 10.1111/j.1365-3040.1992.tb01655.x; Griffiths H, 2007, PLANT PHYSIOL, V143, P1055, DOI 10.1104/pp.106.088302; GUTTERIDGE S, 1995, PLANT CELL, V7, P809, DOI 10.1105/tpc.7.7.809; GUY RD, 1993, PLANT PHYSIOL, V101, P37, DOI 10.1104/pp.101.1.37; JAWOROWSKI A, 1985, J BIOL CHEM, V260, P944; Kane HJ, 1998, PLANT PHYSIOL, V117, P1059, DOI 10.1104/pp.117.3.1059; KROOPNICK P, 1976, EARTH PLANET SC LETT, V32, P375, DOI 10.1016/0012-821X(76)90078-9; LAING WA, 1976, BIOCHEM J, V159, P563, DOI 10.1042/bj1590563; LANE GA, 1956, SCIENCE, V123, P574, DOI 10.1126/science.123.3197.574; LORIMER GH, 1986, PHILOS T ROY SOC B, V313, P397, DOI 10.1098/rstb.1986.0046; McNevin DB, 2006, FUNCT PLANT BIOL, V33, P1115, DOI 10.1071/FP06201; Melander L.C.S., 1960, ISOTOPE EFFECTS REAC; MOOK WG, 1974, EARTH PLANET SC LETT, V22, P169, DOI 10.1016/0012-821X(74)90078-8; Moore W.J., 1983, BASIC PHYS CHEM; MORELL MK, 1994, J BIOL CHEM, V269, P8091; MORELL MK, 1990, FEBS LETT, V265, P41, DOI 10.1016/0014-5793(90)80879-N; OLEARY MH, 1992, PLANT CELL ENVIRON, V15, P1099, DOI 10.1111/j.1365-3040.1992.tb01660.x; OLEARY MH, 1981, BIOCHEMISTRY-US, V20, P7308, DOI 10.1021/bi00528a040; OLEARY MH, 1981, PHYTOCHEMISTRY, V20, P553, DOI 10.1016/0031-9422(81)85134-5; OLEARY MH, 1988, ACCOUNTS CHEM RES, V21, P450, DOI 10.1021/ar00156a003; PANETH P, 1985, BIOCHEMISTRY-US, V24, P5143, DOI 10.1021/bi00340a028; Pearce FG, 2003, J BIOL CHEM, V278, P32526, DOI 10.1074/jbc.M305493200; PIERCE J, 1980, BIOCHEMISTRY-US, V19, P934, DOI 10.1021/bi00546a018; PIERCE J, 1986, J BIOL CHEM, V261, P248; REIBACH PH, 1977, PLANT PHYSIOL, V59, P564, DOI 10.1104/pp.59.4.564; Robinson JJ, 2003, LIMNOL OCEANOGR, V48, P48, DOI 10.4319/lo.2003.48.1.0048; ROESKE CA, 1984, BIOCHEMISTRY-US, V23, P6275, DOI 10.1021/bi00320a058; ROESKE CA, 1985, BIOCHEMISTRY-US, V24, P1603, DOI 10.1021/bi00328a005; Ruuska S, 1998, AUST J PLANT PHYSIOL, V25, P859, DOI 10.1071/PP98079; SCHLOSS JV, 1982, J BIOL CHEM, V257, P4691; Scott KM, 2004, ENVIRON MICROBIOL, V6, P1210, DOI 10.1111/j.1462-2920.2004.00642.x; SERVAITES JC, 1985, ARCH BIOCHEM BIOPHYS, V238, P154, DOI 10.1016/0003-9861(85)90151-1; Spreitzer RJ, 1999, PHOTOSYNTH RES, V60, P29, DOI 10.1023/A:1006240202051; Taylor TC, 1996, NAT STRUCT BIOL, V3, P95, DOI 10.1038/nsb0196-95; Tcherkez G, 2005, FUNCT PLANT BIOL, V32, P277, DOI 10.1071/FP04211; Tcherkez GGB, 2006, P NATL ACAD SCI USA, V103, P7246, DOI 10.1073/pnas.0600605103; von Caemmerer S., 2000, BIOCH MODELS LEAF PH; VONCAEMMERER S, 1989, PLANTA, V178, P463, DOI 10.1007/BF00963816; Whitney SM, 1999, PLANT PHYSIOL, V121, P579, DOI 10.1104/pp.121.2.579; Whitney SM, 2001, P NATL ACAD SCI USA, V98, P14738, DOI 10.1073/pnas.261417298; WONG WW, 1979, PLANT PHYSIOL, V63, P852, DOI 10.1104/pp.63.5.852; WRIGHT GC, 1988, AUST J PLANT PHYSIOL, V15, P815, DOI 10.1071/PP9880815	65	70	73	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					36068	36076		10.1074/jbc.M706274200	http://dx.doi.org/10.1074/jbc.M706274200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17925403	Green Published, hybrid			2022-12-25	WOS:000251458100066
J	Huang, K; Chan, SJ; Hua, QX; Chu, YC; Wang, RY; Klaproth, B; Jia, WH; Whittaker, J; De Meyts, P; Nakagawa, SH; Steiner, DF; Katsoyannis, PG; Weiss, MA				Huang, Kun; Chan, Shu Jin; Hua, Qing-xin; Chu, Ying-Chi; Wang, Run-ying; Klaproth, Birgit; Jia, Wenhua; Whittaker, Jonathan; De Meyts, Pierre; Nakagawa, Satoe H.; Steiner, Donald F.; Katsoyannis, Panayotis G.; Weiss, Michael A.			The A-chain of insulin contacts the insert domain of the insulin receptor: Photo-cross-linking and mutagenesis of a diabetes-related crevice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALANINE-SCANNING MUTAGENESIS; LIGAND-BINDING DOMAIN; NEGATIVE COOPERATIVITY; SIDE-CHAIN; GROWTH-FACTOR; ALPHA-HELIX; AMINO-ACIDS; B-CHAIN; STRUCTURAL SWITCH; CRYSTAL-STRUCTURE	The contribution of the insulin A-chain to receptor binding is investigated by photo-cross-linking and nonstandard mutagenesis. Studies focus on the role of Val(A3), which projects within a crevice between the A- and B-chains. Engineered receptor alpha-subunits containing specific protease sites ("midi- receptors") are employed to map the site of photo-cross-linking by an analog containing a photoactivable A3 side chain (para-azido-Phe ( Pap)). The probe cross-links to a C-terminal peptide (residues 703-719 of the receptor A isoform, KT (FE) under barD (YLHN) under bar VV (FV) under bar PRPS) containing side chains critical for hormone binding ( underlined); the corresponding segment of the holoreceptor was shown previously to cross-link to a Pap(B25)- insulin analog. Because Pap is larger than Val and so may protrude beyond the A3-associated crevice, we investigated analogs containing A3 substitutions comparable in size to Val as follows: Thr, allo-Thr, and alpha-aminobutyric acid (Aba). Substitutions were introduced within an engineered monomer. Whereas previous studies of smaller substitutions (Gly(A3) and Ser(A3)) encountered nonlocal conformational perturbations, NMR structures of the present analogs are similar to wild-type insulin; the variant side chains are accommodated within a native-like crevice with minimal distortion. Receptor binding activities of Aba(A3) and allo-Thr(A3) analogs are reduced at least 10-fold; the activity of Thr(A3)-DKP-insulin is reduced 5-fold. The hormone-receptor interface is presumably destabilized either by a packing defect (Aba(A3)) or by altered polarity (allo-Thr(A3) and Thr(A3)). Our results provide evidence that Val(A3), a site of mutation causing diabetes mellitus, contacts the insert domain-derived tail of the alpha-subunit in a hormone-receptor complex.	Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Nutr, Cleveland, OH 44106 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA; NYU, Mt Sinai Sch Med, Dept Pharmacol & Biol Chem, New York, NY 10029 USA; Hagedorn Res Inst, Receptor Syst Biol Lab, DK-2820 Gentofte, Denmark	Case Western Reserve University; Case Western Reserve University; University of Chicago; Icahn School of Medicine at Mount Sinai; New York University; Novo Nordisk; Hagedorn Research Institute	Weiss, MA (corresponding author), Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA.	michael.weiss@case.edu	Huang, Kun/H-4427-2012	De Meyts, Pierre/0000-0001-6214-0824	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020595, R01DK013914, R01DK056673, R37DK013914, R01DK040949, R01DK065890, P30DK020595] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK20595, DK13914, DK065890, DK40949, DK56673, R01 DK040949] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Bass J, 1996, J BIOL CHEM, V271, P19367, DOI 10.1074/jbc.271.32.19367; Bayley H., 1984, AZIDES NITRENES REAC, P433; Brandt J, 2001, J BIOL CHEM, V276, P12378, DOI 10.1074/jbc.M009402200; Brunger A. T, 1993, XPLOR MANUAL VERSION; BURLEY SK, 1988, ADV PROTEIN CHEM, V39, P125; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; CARA JF, 1990, J BIOL CHEM, V265, P17820; CHAKRABARTTY A, 1995, ADV PROTEIN CHEM, V46, P141, DOI 10.1016/S0065-3233(08)60334-4; CHAKRABARTTY A, 1994, PROTEIN SCI, V3, P843; Chan SJ, 2007, J BIOL CHEM, V282, P13754, DOI 10.1074/jbc.M700724200; Chen H, 1998, BBA-PROTEIN STRUCT M, V1429, P69, DOI 10.1016/S0167-4838(98)00219-2; CHOWDHRY V, 1979, ANNU REV BIOCHEM, V48, P293, DOI 10.1146/annurev.bi.48.070179.001453; CHU YC, 1994, BIOCHEMISTRY-US, V33, P11278, DOI 10.1021/bi00203a025; CISZAK E, 1995, STRUCTURE, V3, P615, DOI 10.1016/S0969-2126(01)00195-2; Cosgrove L, 1995, PROTEIN EXPRES PURIF, V6, P789, DOI 10.1006/prep.1995.0010; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; DEMEYTS P, 1978, NATURE, V273, P504; DEMEYTS P, 1976, J BIOL CHEM, V251, P1877; DEMEYTS P, 1994, DIABETOLOGIA, V37, pS135, DOI 10.1007/BF00400837; DEMEYTS P, 1973, BIOCHEM BIOPH RES CO, V55, P154, DOI 10.1016/S0006-291X(73)80072-5; Denley A, 2004, MOL ENDOCRINOL, V18, P2502, DOI 10.1210/me.2004-0183; DEREWENDA U, 1991, J MOL BIOL, V220, P425, DOI 10.1016/0022-2836(91)90022-X; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; DOIG AJ, 1995, PROTEIN SCI, V4, P1325, DOI 10.1002/pro.5560040708; Guo ZY, 2001, IUBMB LIFE, V52, P309, DOI 10.1080/152165401317291165; Henrichs T, 2005, P NATL ACAD SCI USA, V102, P4246, DOI 10.1073/pnas.0408520102; HU SQ, 1993, BIOCHEMISTRY-US, V32, P2631, DOI 10.1021/bi00061a022; Hua QX, 2006, J BIOL CHEM, V281, P24900, DOI 10.1074/jbc.M602691200; Hua QX, 2006, J BIOL CHEM, V281, P24889, DOI 10.1074/jbc.M602617200; Hua QX, 1996, J MOL BIOL, V259, P297, DOI 10.1006/jmbi.1996.0320; HUA QX, 1991, BIOCHEMISTRY-US, V30, P5505, DOI 10.1021/bi00236a025; Hua QX, 1998, J MOL BIOL, V277, P103, DOI 10.1006/jmbi.1997.1574; Hua QX, 1996, J MOL BIOL, V264, P390, DOI 10.1006/jmbi.1996.0648; HUA QX, 1991, NATURE, V354, P238, DOI 10.1038/354238a0; HUA QX, 1993, J MOL BIOL, V230, P387, DOI 10.1006/jmbi.1993.1156; Huang K, 2004, J MOL BIOL, V341, P529, DOI 10.1016/j.jmb.2004.05.023; Jacoby E, 1996, J MOL BIOL, V258, P136, DOI 10.1006/jmbi.1996.0239; Karplus PA, 1997, PROTEIN SCI, V6, P1302; KEEFER LM, 1981, BIOCHEM BIOPH RES CO, V100, P1229, DOI 10.1016/0006-291X(81)91955-0; KOBAYASHI M, 1982, BIOCHEM BIOPH RES CO, V107, P329, DOI 10.1016/0006-291X(82)91708-9; KOBAYASHI M, 1986, BIOCHEM BIOPH RES CO, V137, P250, DOI 10.1016/0006-291X(86)91203-9; Kristensen C, 1997, J BIOL CHEM, V272, P12978, DOI 10.1074/jbc.272.20.12978; Kristensen C, 1998, J BIOL CHEM, V273, P17780, DOI 10.1074/jbc.273.28.17780; KUROSE T, 1994, J BIOL CHEM, V269, P29190; LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li MY, 2002, IUBMB LIFE, V53, P57, DOI 10.1080/15216540210808; Liu M, 2005, J BIOL CHEM, V280, P13209, DOI 10.1074/jbc.C400475200; Lou MZ, 2006, P NATL ACAD SCI USA, V103, P12429, DOI 10.1073/pnas.0605395103; Ludvigsen S, 1998, J MOL BIOL, V279, P1, DOI 10.1006/jmbi.1998.1801; LYU PC, 1991, P NATL ACAD SCI USA, V88, P5317, DOI 10.1073/pnas.88.12.5317; LYU PC, 1990, SCIENCE, V250, P669, DOI 10.1126/science.2237416; MARSHALL RN, 1974, J CLIN ENDOCR METAB, V39, P283, DOI 10.1210/jcem-39-2-283; McKern NM, 2006, NATURE, V443, P218, DOI 10.1038/nature05106; MERRIFIELD RB, 1982, BIOCHEMISTRY-US, V21, P5020, DOI 10.1021/bi00263a028; MIRMIRA RG, 1991, J BIOL CHEM, V266, P1428; MIRMIRA RG, 1989, J BIOL CHEM, V264, P6349; MIRMIRA RG, 1991, BIOCHEMISTRY-US, V30, P8222, DOI 10.1021/bi00247a019; Mynarcik DC, 1996, J BIOL CHEM, V271, P2439, DOI 10.1074/jbc.271.5.2439; Mynarcik DC, 1997, J BIOL CHEM, V272, P18650, DOI 10.1074/jbc.272.30.18650; Nakagawa SH, 2006, J BIOL CHEM, V281, P22386, DOI 10.1074/jbc.M603547200; NAKAGAWA SH, 1992, BIOCHEMISTRY-US, V31, P3204, DOI 10.1021/bi00127a023; Nakagawa SH, 2000, BIOCHEMISTRY-US, V39, P15826, DOI 10.1021/bi001802+; Nanjo K, 1986, Trans Assoc Am Physicians, V99, P132; NANJO K, 1986, J CLIN INVEST, V77, P514, DOI 10.1172/JCI112331; Olsen HB, 1998, J MOL BIOL, V284, P477, DOI 10.1006/jmbi.1998.2175; ONEIL KT, 1990, SCIENCE, V250, P646, DOI 10.1126/science.2237415; Pace CN, 2000, PROTEINS, P1; PAUL JI, 1990, J BIOL CHEM, V265, P13074; Qiao ZS, 2003, J BIOL CHEM, V278, P17800, DOI 10.1074/jbc.M300906200; SHOELSON S, 1983, NATURE, V302, P540, DOI 10.1038/302540a0; SHOELSON SE, 1992, BIOCHEMISTRY-US, V31, P1757, DOI 10.1021/bi00121a025; SHOELSON SE, 1984, J CLIN INVEST, V73, P1351, DOI 10.1172/JCI111338; SHOELSON SE, 1993, J BIOL CHEM, V268, P4085; Sosnick TR, 2000, METHOD ENZYMOL, V317, P393; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; Toth G, 2001, PROTEIN ENG, V14, P543, DOI 10.1093/protein/14.8.543; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; Wan ZL, 2005, BIOCHEMISTRY-US, V44, P5000, DOI 10.1021/bi047585k; Wan ZL, 2004, BIOCHEMISTRY-US, V43, P16119, DOI 10.1021/bi048223f; Wan ZL, 2003, BIOCHEMISTRY-US, V42, P12770, DOI 10.1021/bi034430o; Weiss MA, 2002, J MOL BIOL, V315, P103, DOI 10.1006/jmbi.2001.5224; Weiss MA, 2000, BIOCHEMISTRY-US, V39, P15429, DOI 10.1021/bi001905s; Weiss MA, 2001, J BIOL CHEM, V276, P40018, DOI 10.1074/jbc.M104634200; Whittaker J, 2005, J BIOL CHEM, V280, P20932, DOI 10.1074/jbc.M411320200; WILLIAMS PF, 1995, J BIOL CHEM, V270, P3012, DOI 10.1074/jbc.270.7.3012; Xu B, 2004, BIOCHEMISTRY-US, V43, P8356, DOI 10.1021/bi0497796; Xu B, 2004, DIABETES, V53, P1599, DOI 10.2337/diabetes.53.6.1599; Xu B, 2002, J MOL BIOL, V316, P435, DOI 10.1006/jmbi.2001.5377; Xu B, 2002, PROTEIN SCI, V11, P104, DOI 10.1110/ps.ps.32102; Xu JA, 1998, PROTEIN SCI, V7, P158, DOI 10.1002/pro.5560070117; Zamyatnin A A, 1972, Prog Biophys Mol Biol, V24, P107, DOI 10.1016/0079-6107(72)90005-3	93	37	39	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35337	35349		10.1074/jbc.M705996200	http://dx.doi.org/10.1074/jbc.M705996200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17884811	hybrid			2022-12-25	WOS:000251155200077
J	Hayashi, A; Kasahara, T; Iwamoto, K; Ishiwata, M; Kametani, M; Kakiuchi, C; Furuichi, T; Kato, T				Hayashi, Akiko; Kasahara, Takaoki; Iwamoto, Kazuya; Ishiwata, Mizuho; Kametani, Mizue; Kakiuchi, Chihiro; Furuichi, Teiichi; Kato, Tadafumi			The role of brain-derived neurotrophic factor (BDNF)- induced XBP1 splicing during brain development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; TRANSCRIPTION FACTOR XBP-1; PLASMA-CELL DIFFERENTIATION; TRANSGENIC MOUSE MODEL; MESSENGER-RNA; GROWTH CONES; ER STRESS; IN-VIVO; NEURONS	Accumulation of unfolded proteins in the endoplasmic reticulum initiates intracellular signaling termed the unfolded protein response (UPR). Although Xbp1 serves as a pivotal transcription factor for the UPR, the physiological role of UPR signaling and Xbp1 in the central nervous system remains to be elucidated. Here, we show that Xbp1 mRNA was highly expressed during neurodevelopment and activated Xbp1 protein was distributed throughout developing neurons, including neurites. The isolated neurite culture system and time-lapse imaging demonstrated that Xbp1 was activated in neurites in response to brain-derived neurotrophic factor (BDNF), followed by subsequent translocation of the active Xbp1 into the nucleus. BDNF-dependent neurite outgrowth was significantly attenuated in Xbp1(-/-) neurons. These findings suggest that BDNF initiates UPR signaling in neurites and that Xbp1, which is activated as part of the UPR, conveys the local information from neurites to the nucleus, contributing the neurite outgrowth.	RIKEN, Lab Mol Dynam Mental Disorders, Wako, Saitama 3510198, Japan; RIKEN, Brain Sci Inst, Lab Mol Neurogenesis, Wako, Saitama 3510198, Japan	RIKEN; RIKEN	Kato, T (corresponding author), Hirosawa 2-1, Wako, Saitama 3510198, Japan.	kato@brain.riken.jp	Kato, Tadafumi/J-3583-2014; Kakiuchi, Chihiro/AAO-1103-2020; Furuichi, Teiichi/B-5086-2014; Kasahara, Takaoki/AAJ-5367-2020	Kato, Tadafumi/0000-0001-7856-3952; Furuichi, Teiichi/0000-0002-9676-1888; Kasahara, Takaoki/0000-0002-0953-5146				Bao JX, 2004, NAT NEUROSCI, V7, P1250, DOI 10.1038/nn1342; Barrett LE, 2006, NAT METHODS, V3, P455, DOI 10.1038/NMETH885; Bassell GJ, 1998, J NEUROSCI, V18, P251; BUNGE MB, 1973, J CELL BIOL, V56, P713, DOI 10.1083/jcb.56.3.713; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; CLAUSS IM, 1993, DEV DYNAM, V197, P146, DOI 10.1002/aja.1001970207; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Crino PB, 1996, NEURON, V17, P1173, DOI 10.1016/S0896-6273(00)80248-2; DAILEY ME, 1989, J NEUROSCI, V9, P1897; Di Nardo AA, 2007, MOL CELL NEUROSCI, V35, P230, DOI 10.1016/j.mcn.2007.02.015; Glanzer J, 2005, P NATL ACAD SCI USA, V102, P16859, DOI 10.1073/pnas.0503783102; Goffinet A., 2000, MOUSE BRAIN DEV; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Inoue A, 1997, SCIENCE, V276, P1428, DOI 10.1126/science.276.5317.1428; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Kakiuchi C, 2006, J NEUROCHEM, V97, P545, DOI 10.1111/j.1471-4159.2006.03772.x; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; Mao CH, 2004, NAT MED, V10, P1013, DOI 10.1038/nm1004-1013; Martin KC, 2004, CURR OPIN NEUROBIOL, V14, P305, DOI 10.1016/j.conb.2004.05.009; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Murakami T, 2007, NEUROSCIENCE, V146, P1, DOI 10.1016/j.neuroscience.2007.01.069; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; OBATA K, 1987, BRAIN RES, V404, P169, DOI 10.1016/0006-8993(87)91368-0; Ohnishi H, 2005, J NEUROSCI, V25, P2702, DOI 10.1523/JNEUROSCI.5173-04.2005; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Paschen W, 2004, J NEUROCHEM, V88, P983, DOI 10.1046/j.1471-4159.2003.02218.x; Patrick GN, 2006, CURR OPIN NEUROBIOL, V16, P90, DOI 10.1016/j.conb.2006.01.007; Reimold AM, 2000, GENE DEV, V14, P152; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Schratt GM, 2004, J NEUROSCI, V24, P7366, DOI 10.1523/JNEUROSCI.1739-04.2004; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Takei N, 2001, J BIOL CHEM, V276, P42818, DOI 10.1074/jbc.M103237200; TORRE ER, 1992, J NEUROSCI, V12, P762; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; Wellmann H, 2001, J BIOL CHEM, V276, P11821, DOI 10.1074/jbc.M009253200; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2006, J CELL BIOL, V172, P565, DOI 10.1083/jcb.200508145; Zheng JQ, 2001, J NEUROSCI, V21, P9291, DOI 10.1523/JNEUROSCI.21-23-09291.2001	42	88	90	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34525	34534		10.1074/jbc.M704300200	http://dx.doi.org/10.1074/jbc.M704300200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17890727	hybrid			2022-12-25	WOS:000251145700067
J	Martin, MJ; Tanos, T; Garcia, AB; Martin, D; Gutkind, JS; Coso, OA; Marinissen, MJ				Martin, Maria Jose; Tanos, Tamara; Garcia, Ana Belen; Martin, Daniel; Gutkind, J. Silvio; Coso, Omar A.; Marinissen, Maria Julia			The G alpha(12/13) family of heterotrimeric G proteins and the small GTPase RhoA link the Kaposi Sarcoma-associated herpes virus G protein-coupled receptor to heme oxygenase-1 expression and tumorigenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; LEUKEMIA-ASSOCIATED RHO; FACTOR-KAPPA-B; GENE-EXPRESSION; UP-REGULATION; TRANSFORMING ACTIVITY; TRANSCRIPTION FACTOR; CHEMOKINE RECEPTOR; MULTIPLE PATHWAYS; VEGF SYNTHESIS	Heme oxygenase-1 (HO-1), an inducible enzyme that metabolizes the heme group, is highly expressed in human Kaposi sarcoma lesions. Its expression is up-regulated by the G protein-coupled receptor from the Kaposi sarcoma-associated herpes virus (vGPCR). Although recent evidence shows that HO-1 contributes to vGPCR-induced tumorigenesis and vascular endothelial growth factor (VEGF) expression, the molecular steps that link vGPCR to HO-1 remain unknown. Here we show that vGPCR induces HO-1 expression and transformation through the G alpha(12/13) family of heterotrimeric G proteins and the small GTPase RhoA. Targeted small hairpin RNA knockdown expression of G alpha(12), G alpha(13), or RhoA and inhibition of RhoA activity impair vGPCR- induced transformation and ho-1 promoter activity. Knockdown expression of RhoA also reduces vGPCR-induced VEFG-A secretion and blocks tumor growth in a murine allograft tumor model. NIH-3T3 cells expressing constitutively activated G alpha(13) or RhoA implanted in nude mice develop tumors displaying spindle-shaped cells that express HO-1 and VEGF-A, similarly to vGPCR-derived tumors. RhoAQL-induced tumor growth is reduced 80% by small hairpin RNA-mediated knockdown expression of HO-1 in the implanted cells. Likewise, inhibition of HO-1 activity by chronic administration of the HO-1 inhibitor tin protoporphyrin IX to mice reduces RhoAQL-induced tumor growth by 70%. Our study shows that vGPCR induces HO-1 expression through the G alpha(12/13)/RhoA axes and shows for the first time a potential role for HO-1 as a therapeutic target in tumors where RhoA has oncogenic activity.	Univ Autonoma Madrid, Fac Med, Dept Bioquim, Inst Invest Biomed A Sols, E-28029 Madrid, Spain; Univ Buenos Aires, IFYBYNE CONICET, Fac Ciencias Exactas & Nat, Dept Fisiol & Biol Mol, RA-1428 Buenos Aires, DF, Argentina; NIDCR, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA	Autonomous University of Madrid; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Marinissen, MJ (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Bioquim, Inst Invest Biomed A Sols, Arzobispo Morcillo 4, E-28029 Madrid, Spain.	mjmarinissen@iib.uam.es	Gutkind, J. Silvio/A-1053-2009; Martin, Maria Jose/E-5105-2011; Gutkind, J. Silvio/J-1201-2016; soler, martha maricel m gomez/L-6025-2014	Martin, Maria Jose/0000-0002-0202-7309; Gutkind, J. Silvio/0000-0002-5150-4482; soler, martha maricel m gomez/0000-0002-4412-8108; Martin Izquierdo, Daniel/0000-0002-8880-9087; Tanos, Tamara/0000-0002-3217-3104; Martin, Maria Jose/0000-0001-6988-0761	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000551] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Alam J, 2004, ANTIOXID REDOX SIGN, V6, P924, DOI 10.1089/1523086041798114; Amerongen GPV, 2003, ARTERIOSCL THROM VAS, V23, P211, DOI 10.1161/01.ATV.0000054198.68894.88; ANDERSON KE, 1984, J PHARMACOL EXP THER, V228, P327; Arvanitakis L, 1997, NATURE, V385, P347, DOI 10.1038/385347a0; Bais C, 2003, CANCER CELL, V3, P131, DOI 10.1016/S1535-6108(03)00024-2; Bais C, 1998, NATURE, V391, P86, DOI 10.1038/34193; Benitah SA, 2004, BBA-REV CANCER, V1705, P121, DOI 10.1016/j.bbcan.2004.10.002; Berberat PO, 2005, CLIN CANCER RES, V11, P3790, DOI 10.1158/1078-0432.CCR-04-2159; Booden MA, 2002, MOL CELL BIOL, V22, P4053, DOI 10.1128/MCB.22.12.4053-4061.2002; Brouard S, 2000, J EXP MED, V192, P1015, DOI 10.1084/jem.192.7.1015; Bussolati B, 2006, ANTIOXID REDOX SIGN, V8, P1153, DOI 10.1089/ars.2006.8.1153; Caballero F, 2004, INT J EXP PATHOL, V85, P213, DOI 10.1111/j.0959-9673.2004.00391.x; Cannon ML, 2004, ONCOGENE, V23, P514, DOI 10.1038/sj.onc.1207021; Chen GG, 2004, J CELL BIOCHEM, V92, P1246, DOI 10.1002/jcb.20157; Chikumi H, 2002, J BIOL CHEM, V277, P27130, DOI 10.1074/jbc.M204715200; Cisowski J, 2005, BIOCHEM BIOPH RES CO, V326, P670, DOI 10.1016/j.bbrc.2004.11.083; CORNELIUS CE, 1984, PEDIATR RES, V18, P728, DOI 10.1203/00006450-198408000-00010; Couty JP, 2001, J BIOL CHEM, V276, P33805, DOI 10.1074/jbc.M104631200; Dadke D, 2003, CANCER RES, V63, P8837; del Pulgar TG, 2005, BIOESSAYS, V27, P602, DOI 10.1002/bies.20238; Devesa I, 2005, ARTHRITIS RHEUM-US, V52, P3230, DOI 10.1002/art.21356; DEVIVO M, 1992, J BIOL CHEM, V267, P18263; Doi K, 1999, BRIT J CANCER, V80, P1945, DOI 10.1038/sj.bjc.6690624; Drummond GS, 2004, SEMIN PERINATOL, V28, P365, DOI 10.1053/j.semperi.2004.09.004; Dulak J, 2004, ANTIOXID REDOX SIGN, V6, P858, DOI 10.1089/1523086041797980; Dulak J, 2002, ANTIOXID REDOX SIGN, V4, P229, DOI 10.1089/152308602753666280; Fang J, 2004, APOPTOSIS, V9, P27, DOI 10.1023/B:APPT.0000012119.83734.4e; Flore O, 1998, NATURE, V394, P588, DOI 10.1038/29093; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; Fromm C, 1997, P NATL ACAD SCI USA, V94, P10098, DOI 10.1073/pnas.94.19.10098; Fukuhara S, 2000, J BIOL CHEM, V275, P21730, DOI 10.1074/jbc.M002410200; Fukuhara S, 2001, ONCOGENE, V20, P1661, DOI 10.1038/sj.onc.1204182; Fukuhara S, 2000, FEBS LETT, V485, P183, DOI 10.1016/S0014-5793(00)02224-9; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; Goldhar AS, 2005, MOL CELL ENDOCRINOL, V232, P9, DOI 10.1016/j.mce.2005.01.005; Goodman AI, 1997, P SOC EXP BIOL MED, V214, P54; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Hamden KE, 2005, LEUKEMIA, V19, P18, DOI 10.1038/sj.leu.2403532; Hoang MV, 2004, P NATL ACAD SCI USA, V101, P1874, DOI 10.1073/pnas.0308525100; Ishizaka N, 1997, HYPERTENSION, V29, P790, DOI 10.1161/01.HYP.29.3.790; Jazwa A, 2006, FREE RADICAL BIO MED, V40, P1250, DOI 10.1016/j.freeradbiomed.2005.11.016; Jensen KK, 2005, J IMMUNOL, V174, P3686, DOI 10.4049/jimmunol.174.6.3686; Jozkowicz A, 2002, ANTIOXID REDOX SIGN, V4, P577, DOI 10.1089/15230860260220076; Kappas A, 2001, PEDIATRICS, V108, P25, DOI 10.1542/peds.108.1.25; Kiemer AK, 2003, ENDOCRINOLOGY, V144, P802, DOI 10.1210/en.2002-220610; Kruger AL, 2006, J PHARMACOL EXP THER, V319, P1144, DOI 10.1124/jpet.106.107482; Lam CW, 2005, J IMMUNOL, V174, P2297, DOI 10.4049/jimmunol.174.4.2297; Liu ZM, 2004, ONCOGENE, V23, P503, DOI 10.1038/sj.onc.1207173; Maines MD, 2005, BIOCHEM BIOPH RES CO, V338, P568, DOI 10.1016/j.bbrc.2005.08.121; Malaguarnera L, 2004, J CELL BIOCHEM, V93, P197, DOI 10.1002/jcb.20167; Marinissen MJ, 2006, J BIOL CHEM, V281, P11332, DOI 10.1074/jbc.M512199200; Marinissen MJ, 2003, J BIOL CHEM, V278, P46814, DOI 10.1074/jbc.M305709200; Marinissen MJ, 2004, MOL CELL, V14, P29, DOI 10.1016/S1097-2765(04)00153-4; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; Marinissen MT, 2001, GENE DEV, V15, P535, DOI 10.1101/gad.855801; Martin D, 2004, J BIOL CHEM, V279, P8919, DOI 10.1074/jbc.M309660200; Matsuoka Y, 1999, NEUROPHARMACOLOGY, V38, P825, DOI 10.1016/S0028-3908(99)00020-9; Mayerhofer M, 2004, CANCER RES, V64, P3148, DOI 10.1158/0008-5472.CAN-03-1200; McAllister SC, 2004, BLOOD, V103, P3465, DOI 10.1182/blood-2003-08-2781; Montaner S, 2006, CANCER RES, V66, P168, DOI 10.1158/0008-5472.CAN-05-1026; Montaner S, 2003, CANCER CELL, V3, P23, DOI 10.1016/S1535-6108(02)00237-4; Montaner S, 2004, BLOOD, V104, P2903, DOI 10.1182/blood-2003-12-4436; Mutlu AD, 2007, CANCER CELL, V11, P245, DOI 10.1016/j.ccr.2007.01.015; Nishie A, 1999, CLIN CANCER RES, V5, P1107; Okamoto I, 2006, INT J CANCER, V119, P1312, DOI 10.1002/ijc.21937; Pan YL, 2004, BIOCHEM BIOPH RES CO, V315, P686, DOI 10.1016/j.bbrc.2004.01.108; Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463; Pille JY, 2005, MOL THER, V11, P267, DOI 10.1016/j.ymthe.2004.08.029; Polson AG, 2002, CANCER RES, V62, P4525; Rojo AI, 2006, FREE RADICAL BIO MED, V41, P247, DOI 10.1016/j.freeradbiomed.2006.04.002; SARDANA MK, 1987, P NATL ACAD SCI USA, V84, P2464, DOI 10.1073/pnas.84.8.2464; Shepard LW, 2001, J BIOL CHEM, V276, P45979, DOI 10.1074/jbc.M104783200; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; Sodhi A, 2000, CANCER RES, V60, P4873; Sodhi A, 2004, FASEB J, V18, P422, DOI 10.1096/fj.03-1035hyp; Sodhi A, 2004, P NATL ACAD SCI USA, V101, P4821, DOI 10.1073/pnas.0400835101; Sodhi A, 2006, CANCER CELL, V10, P133, DOI 10.1016/j.ccr.2006.05.026; Sun J, 2005, FEBS LETT, V579, P5494, DOI 10.1016/j.febslet.2005.08.080; Sunamura Makoto, 2003, Angiogenesis, V6, P15, DOI 10.1023/A:1025803600840; Turcotte S, 2003, J CELL SCI, V116, P2247, DOI 10.1242/jcs.00427; Vazquez-Prado J, 2004, METHOD ENZYMOL, V390, P259; Was H, 2006, AM J PATHOL, V169, P2181, DOI 10.2353/ajpath.2006.051365; Wojciak-Stothard B, 2006, AM J PHYSIOL-LUNG C, V290, pL1173, DOI 10.1152/ajplung.00309.2005; Xu HS, 2006, AM J PHYSIOL-RENAL, V291, pF995, DOI 10.1152/ajprenal.00092.2006; XU NZ, 1994, BIOCHEM BIOPH RES CO, V201, P603, DOI 10.1006/bbrc.1994.1744; Yanagawa T, 2004, ORAL ONCOL, V40, P21, DOI 10.1016/S1368-8375(03)00128-3; Yang TY, 2000, J EXP MED, V191, P445, DOI 10.1084/jem.191.3.445; YOSHINAGA T, 1982, J BIOL CHEM, V257, P7778; Zeng LX, 2005, FASEB J, V19, P1845, DOI 10.1096/fj.05-4240fje	89	20	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34510	34524		10.1074/jbc.M703043200	http://dx.doi.org/10.1074/jbc.M703043200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17881360	Green Published, hybrid			2022-12-25	WOS:000251145700066
J	Charbonneau, M; Harper, K; Grondin, F; Pelmus, M; McDonald, PP; Dubois, CM				Charbonneau, Martine; Harper, Kelly; Grondin, Francine; Pelmus, Manuela; McDonald, Patrick P.; Dubois, Claire M.			Hypoxia-inducible factor mediates hypoxic and tumor necrosis factor alpha-induced increases in tumor necrosis factor-alpha converting enzyme/ADAM17 expression by synovial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ENDOTHELIAL GROWTH-FACTOR; TNF-ALPHA; RHEUMATOID-ARTHRITIS; GENE-EXPRESSION; FACTOR-I; TRANSCRIPTION FACTORS; BREAST-CANCER; NITRIC-OXIDE; DNA-BINDING	Chronic hypoxia and inflammatory cytokines are hallmarks of inflammatory joint diseases like rheumatoid arthritis ( RA), suggesting a link between this microenvironment and central pathological events. Because TACE/ADAM17 is the predominant protease catalyzing the release of tumor necrosis factor alpha (TNF alpha), a cytokine that triggers a cascade of events leading to RA, we examined the regulation of this metalloprotease in response to hypoxia and TNF alpha itself. We report that low oxygen concentrations and TNF alpha enhance TACE mRNA levels in synovial cells through direct binding of hypoxia-inducible factor-1 (HIF-1) to the 5' promoter region. This is associated with elevated TACE activity as shown by the increase in TNF alpha shedding rate. By the use of HIF-1-deficient cells and by obliterating NF-kappa B activation, it was determined that the hypoxic TACE response is mediated by HIF-1 signaling, whereas the regulation by TNF alpha also requires NF-kappa B activation. As a support for the in vivo relevance of the HIF-1 axis for TACE regulation, immunohistological analysis of TACE and HIF-1 expression in RA synovium indicates that TACE is up-regulated in both fibroblast- and macrophage-like synovial cells where it localizes with elevated expression of both HIF-1 and TNF alpha. These findings suggest a mechanism by which TACE is increased in RA-affected joints. They also provide novel mechanistic clues on the influence of the hypoxic and inflammatory microenvironment on joint diseases.	Univ Sherbrooke, Fac Med, Div Immunol, Dept Pediat, Sherbrooke, PQ J1H 5N4, Canada; Univ Sherbrooke, Fac Med, Dept Pathol, Sherbrooke, PQ J1H 5N4, Canada; Univ Sherbrooke, Fac Med, Dept Med, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke; University of Sherbrooke; University of Sherbrooke	Dubois, CM (corresponding author), Univ Sherbrooke, Fac Med, Div Immunol, Dept Pediat, Sherbrooke, PQ J1H 5N4, Canada.	Claire.M.Dubois@usherbrooke.ca						Althoff K, 2000, EUR J BIOCHEM, V267, P2624, DOI 10.1046/j.1432-1327.2000.01278.x; Amin AR, 1999, OSTEOARTHR CARTILAGE, V7, P392, DOI 10.1053/joca.1998.0221; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Berra E, 2006, EMBO REP, V7, P41, DOI 10.1038/sj.embor.7400598; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Blanchette F, 2001, J BIOL CHEM, V276, P33986, DOI 10.1074/jbc.M100093200; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Bzowska M, 2004, EUR J BIOCHEM, V271, P2808, DOI 10.1111/j.1432-1033.2004.04215.x; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; DiDonato J, 1996, MOL CELL BIOL, V16, P1295; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DINGLE JTM, 1956, BRIT J EXP PATHOL, V37, P318; Fabre-Lafay S, 2005, J BIOL CHEM, V280, P19543, DOI 10.1074/jbc.M410943200; FIRESTEIN GS, 1987, ARTHRITIS RHEUM, V30, P864, DOI 10.1002/art.1780300804; Garton KJ, 2001, J BIOL CHEM, V276, P37993; Granet C, 2004, ARTHRITIS RES THER, V6, pR190, DOI 10.1186/ar1159; Haddad JJ, 2001, FEBS LETT, V505, P269, DOI 10.1016/S0014-5793(01)02833-2; Han ZN, 1998, AUTOIMMUNITY, V28, P197, DOI 10.3109/08916939808995367; Handel ML, 1995, ARTHRITIS RHEUM, V38, P1762, DOI 10.1002/art.1780381209; Hashimoto A, 2007, ARTHRITIS RHEUM, V56, P1094, DOI 10.1002/art.22450; Hellwig-Burgel T, 1999, BLOOD, V94, P1561, DOI 10.1182/blood.V94.5.1561.417a06_1561_1567; Hollander AP, 2001, ARTHRITIS RHEUM-US, V44, P1540, DOI 10.1002/1529-0131(200107)44:7<1540::AID-ART277>3.0.CO;2-7; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Kimura H, 2001, J BIOL CHEM, V276, P2292, DOI 10.1074/jbc.M008398200; Kishore N, 2003, J BIOL CHEM, V278, P32861, DOI 10.1074/jbc.M211439200; KOONG AC, 1994, CANCER RES, V54, P5273; Langlois MF, 1997, J BIOL CHEM, V272, P24927, DOI 10.1074/jbc.272.40.24927; Lendeckel U, 2005, J CANCER RES CLIN, V131, P41, DOI 10.1007/s00432-004-0619-y; Majka S, 2002, INVEST OPHTH VIS SCI, V43, P260; MAPP PI, 1995, BRIT MED BULL, V51, P419, DOI 10.1093/oxfordjournals.bmb.a072970; McDonald PP, 1999, J IMMUNOL, V163, P6164; Miyazawa K, 1998, AM J PATHOL, V152, P793; Mizui Y, 1999, GENE, V233, P67, DOI 10.1016/S0378-1119(99)00155-9; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Moss ML, 2001, DRUG DISCOV TODAY, V6, P417, DOI 10.1016/S1359-6446(01)01738-X; NAGASHIMA M, 1995, J RHEUMATOL, V22, P1624; Ohta S, 2001, J RHEUMATOL, V28, P1756; Oikawa M, 2001, BIOCHEM BIOPH RES CO, V289, P39, DOI 10.1006/bbrc.2001.5927; Patel IR, 1998, J IMMUNOL, V160, P4570; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Peters CL, 2004, ARTHRITIS RHEUM-US, V50, P291, DOI 10.1002/art.11473; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Rovida E, 2001, J IMMUNOL, V166, P1583, DOI 10.4049/jimmunol.166.3.1583; Ryan S, 2005, CIRCULATION, V112, P2660, DOI 10.1161/CIRCULATIONAHA.105.556746; Sandau KB, 2001, J BIOL CHEM, V276, P39805, DOI 10.1074/jbc.M107689200; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; Schlondorff J, 1999, J CELL SCI, V112, P3603; SILVER IA, 1975, PHILOS T ROY SOC B, V271, P261, DOI 10.1098/rstb.1975.0050; Vincenti MP, 1998, ARTHRITIS RHEUM, V41, P1987, DOI 10.1002/1529-0131(199811)41:11<1987::AID-ART14>3.3.CO;2-#; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Weir EC, 1996, P NATL ACAD SCI USA, V93, P10240, DOI 10.1073/pnas.93.19.10240; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; Xu HS, 2006, ARTHRITIS RHEUM-US, V54, P3441, DOI 10.1002/art.22169; Zhou J, 2003, AM J PHYSIOL-CELL PH, V284, pC439, DOI 10.1152/ajpcell.00294.2002	59	84	85	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33714	33724		10.1074/jbc.M704041200	http://dx.doi.org/10.1074/jbc.M704041200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17884817	hybrid			2022-12-25	WOS:000250840200053
J	Haugstetter, J; Maurer, MA; Blicher, T; Pagac, M; Wider, G; Ellgaard, L				Haugstetter, Johannes; Maurer, Michael Andreas; Blicher, Thomas; Pagac, Martin; Wider, Gerhard; Ellgaard, Lars			Structure-function analysis of the endoplasmic reticulum oxidoreductase TMX3 reveals interdomain stabilization of the n-terminal redox-active domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-DISULFIDE-ISOMERASE; THIOREDOXIN-LIKE DOMAINS; CRYSTAL-STRUCTURE; BOND FORMATION; TRANSMEMBRANE PROTEIN; PH-DEPENDENCE; BINDING SITE; B' DOMAIN; PEPTIDE; ERP57	Disulfide bond formation in the endoplasmic reticulum is catalyzed by enzymes of the protein disulfide-isomerase family that harbor one or more thioredoxin-like domains. We recently discovered the transmembrane protein TMX3, a thiol-disulfide oxidoreductase of the protein disulfide-isomerase family. Here, we show that the endoplasmic reticulum-luminal region of TMX3 contains three thioredoxin-like domains, an N-terminal redox-active domain ( named a) followed by two enzymatically inactive domains (b and b'). Using the recombinantly expressed TMX3 domain constructs a, ab, and abb', we compared structural stability and enzymatic properties. By structural and biophysical methods, we demonstrate that the reduced a domain has features typical of a globular folded domain that is, however, greatly destabilized upon oxidization. Importantly, interdomain stabilization by the b domain renders the a domain more resistant toward chemical denaturation and proteolysis in both the oxidized and reduced form. In combination with molecular modeling studies of TMX3 abb', the experimental results provide a new understanding of the relationship between the multidomain structure of TMX3 and its function as a redox enzyme. Overall, the data indicate that in addition to their role as substrate and co-factor binding domains, redox-inactive thioredoxin-like domains also function in stabilizing neighboring redox-active domains.	ETH, Inst Biochem, CH-8093 Zurich, Switzerland; Tech Univ Denmark, Bioctr DTU, DK-2800 Lyngby, Denmark; ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Technical University of Denmark; Swiss Federal Institutes of Technology Domain; ETH Zurich	Ellgaard, L (corresponding author), Univ Copenhagen, Dept Mol Biol, August Krogh Bldg, DK-2100 Copenhagen, Denmark.	lellgaard@aki.ku.dk	Ellgaard, Lars/I-9034-2014	Ellgaard, Lars/0000-0002-7018-0137; Wider, Gerhard/0000-0001-9366-7645; Maurer, Michael/0000-0003-1504-7285				Alanen HI, 2006, ANTIOXID REDOX SIGN, V8, P283, DOI 10.1089/ars.2006.8.283; Alanen HI, 2003, ANTIOXID REDOX SIGN, V5, P367, DOI 10.1089/152308603768295096; APPENZELLERHERZ.C, 2007, ANTIOX REDOX SIGNAL, V10; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; CREIGHTON TE, 1980, J MOL BIOL, V142, P43, DOI 10.1016/0022-2836(80)90205-3; DARBY NJ, 1995, BIOCHEMISTRY-US, V34, P11725, DOI 10.1021/bi00037a009; Darby NJ, 1998, J MOL BIOL, V276, P239, DOI 10.1006/jmbi.1997.1504; DARBY NJ, 1994, BIOCHEMISTRY-US, V33, P7937, DOI 10.1021/bi00191a022; Darby NJ, 1995, BIOCHEMISTRY-US, V34, P16770, DOI 10.1021/bi00051a027; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Frickel EM, 2004, J BIOL CHEM, V279, P18277, DOI 10.1074/jbc.M314089200; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GIVOL D, 1964, J BIOL CHEM, V239, pC3116; Hansen RE, 2005, BIOCHEMISTRY-US, V44, P5899, DOI 10.1021/bi0500372; Haugstetter J, 2005, J BIOL CHEM, V280, P8371, DOI 10.1074/jbc.M413924200; Jessop CE, 2007, EMBO J, V26, P28, DOI 10.1038/sj.emboj.7601505; Kemmink J, 1996, BIOCHEMISTRY-US, V35, P7684, DOI 10.1021/bi960335m; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; Kozlov G, 2006, STRUCTURE, V14, P1331, DOI 10.1016/j.str.2006.06.019; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6; Lappi AK, 2004, J MOL BIOL, V335, P283, DOI 10.1016/j.jmb.2003.10.051; Maeda K, 2006, STRUCTURE, V14, P1701, DOI 10.1016/j.str.2006.09.012; MARTIN JL, 1993, NATURE, V365, P464, DOI 10.1038/365464a0; Matsuo Y, 2004, ARCH BIOCHEM BIOPHYS, V423, P81, DOI 10.1016/j.abb.2003.11.003; Matsuo Y, 2001, J BIOL CHEM, V276, P10032, DOI 10.1074/jbc.M011037200; Meng XF, 2003, BIOCHEM GENET, V41, P99, DOI 10.1023/A:1022073917044; Mezghrani A, 2001, EMBO J, V20, P6288, DOI 10.1093/emboj/20.22.6288; Monsellier E, 2005, PROTEIN ENG DES SEL, V18, P445, DOI 10.1093/protein/gzi046; QIN J, 1995, STRUCTURE, V3, P289, DOI 10.1016/S0969-2126(01)00159-9; Raturi A, 2007, FREE RADICAL BIO MED, V43, P62, DOI 10.1016/j.freeradbiomed.2007.03.025; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Ruddock LW, 1996, BIOCHEM J, V315, P1001, DOI 10.1042/bj3151001; Russell SJ, 2004, J BIOL CHEM, V279, P18861, DOI 10.1074/jbc.M400575200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sevier CS, 2006, ANTIOXID REDOX SIGN, V8, P797, DOI 10.1089/ars.2006.8.797; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Wallner B, 2003, PROTEIN SCI, V12, P1073, DOI 10.1110/ps.0236803; Wang SR, 1998, NAT STRUCT BIOL, V5, P476, DOI 10.1038/nsb0698-476; WEISSMAN JS, 1993, NATURE, V365, P185, DOI 10.1038/365185a0; Zahn R, 1996, P NATL ACAD SCI USA, V93, P15024, DOI 10.1073/pnas.93.26.15024; ZAPUN A, 1993, BIOCHEMISTRY-US, V32, P5083, DOI 10.1021/bi00070a016	43	21	21	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33859	33867		10.1074/jbc.M706442200	http://dx.doi.org/10.1074/jbc.M706442200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17881353	hybrid			2022-12-25	WOS:000250840200067
J	Kimura, M; Yamamoto, T; Zhang, J; Itoh, K; Kyo, M; Kamiya, T; Aburatani, H; Katsuoka, F; Kurokawa, H; Tanaka, T; Motohashi, H; Yamamoto, M				Kimura, Momoko; Yamamoto, Tae; Zhang, Jianyong; Itoh, Ken; Kyo, Motoki; Kamiya, Terue; Aburatani, Hiroyuki; Katsuoka, Fumiki; Kurokawa, Hirofumi; Tanaka, Toshiyuki; Motohashi, Hozumi; Yamamoto, Masayuki			Molecular basis distinguishing the DNA binding profile of Nrf2-Maf heterodimer from that of maf homodimer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; TRANSCRIPTION FACTORS; CRYSTAL-STRUCTURE; GROWTH-FACTOR; PROTEINS; DOMAIN; DIFFERENTIATION; RECOGNITION; ACTIVATION; ELEMENT	Nrf2-small Maf heterodimer activates the transcription of many cytoprotective genes through the antioxidant response element and serves as a key factor in xenobiotic and oxidative stress responses. Our surface plasmon resonance-microarray binding analysis revealed that both Nrf2-MafG heterodimer and MafG homodimer bind to the consensus Maf recognition element with high affinity but bind differentially to the suboptimal binding sequences degenerated from the consensus. We examined the molecular basis distinguishing the binding profile of Nrf2- MafG heterodimer from that of MafG homodimer and found that the Ala-502 residue in the basic region of Nrf2 is a critical determinant of its binding specificity. In Maf proteins, a tyrosine resides in the position corresponding to Ala-502 in Nrf2. We prepared a mutant Nrf2 molecule in which Ala- 502 was replaced with tyrosine. In surface plasmon resonance-microarray analysis, heterodimer of Nrf2(A502Y) and MafG displayed a binding specificity similar to that of MafG homodimer. The target genes activated by mutant Nrf2( A502Y)- small Maf heterodimer were largely different, albeit with some overlap, from those activated by wild-type Nrf2-small Maf, indicating that the array of target genes regulated by Nrf2- small Maf heterodimer differs substantially from that regulated by Maf homodimer in vivo. These results suggest that the distinct DNA binding profile of Nrf2- Maf heterodimer is biologically significant for Nrf2 to function as a key regulator of cytoprotective genes. Our contention is supported that the differential DNA binding specificity between Maf homodimers and Nrf2-Maf heterodimers establishes the differential gene regulation by these dimer-forming transcription factors.	Tohoku Univ, Grad Sch Med, Dept Med Biochem, Aoba Ku, Sendai, Miyagi 9808575, Japan; Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058572, Japan; Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058572, Japan; Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; Hirosaki Univ, Sch Med, Dept Stress Response Sci, Hirosaki, Aomori 0368562, Japan; TOYOBO Co Ltd, Biotechnol Frontier Project, Tsuruga 9140047, Japan; Univ Tokyo, Adv Sci & Technol Res Ctr, Tokyo 1538904, Japan; Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 9808577, Japan; Tohoku Univ, Grad Sch Med, Environm Response Project, ERATO JST, Sendai, Miyagi 9808575, Japan	Tohoku University; University of Tsukuba; University of Tsukuba; University of Tsukuba; Hirosaki University; Toyobo Co., Ltd; University of Tokyo; Tohoku University; Japan Science & Technology Agency (JST); Tohoku University	Motohashi, H (corresponding author), Tohoku Univ, Grad Sch Med, Dept Med Biochem, Aoba Ku, 2-1 Seiryo Cho, Sendai, Miyagi 9808575, Japan.	hozumim@mail.tains.tohoku.ac.jp	Yamamoto, Masayuki/A-4873-2010; ZHANG, Jianyong/L-5934-2015; Kurokawa, Hirofumi/A-7231-2010; Itoh, Ken/B-9506-2013; Motohashi, Hozumi/AAZ-2628-2020	Yamamoto, Masayuki/0000-0002-9073-9436; Itoh, Ken/0000-0002-5518-0729; Katsuoka, Fumiki/0000-0003-0939-7887				Blank V, 1997, TRENDS BIOCHEM SCI, V22, P437, DOI 10.1016/S0968-0004(97)01105-5; Brand M, 2004, NAT STRUCT MOL BIOL, V11, P73, DOI 10.1038/nsmb713; Dlakic M, 2001, EMBO J, V20, P828, DOI 10.1093/emboj/20.4.828; ELLENBERGER TE, 1992, CELL, V71, P1223, DOI 10.1016/S0092-8674(05)80070-4; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; IGARASHI K, 1994, NATURE, V367, P568, DOI 10.1038/367568a0; Itoh K, 1999, FREE RADICAL RES, V31, P319, DOI 10.1080/10715769900300881; ITOH K, 1997, BIOCHEM BIOPH RES CO, V236, P4184; KATAOKA K, 1994, MOL CELL BIOL, V14, P700, DOI 10.1128/MCB.14.1.700; KATAOKA K, 1993, J VIROL, V67, P2133, DOI 10.1128/JVI.67.4.2133-2141.1993; Kataoka K, 2001, J BIOL CHEM, V276, P36849, DOI 10.1074/jbc.M102234200; Katsuoka F, 2005, MOL CELL BIOL, V25, P8044, DOI 10.1128/MCB.25.18.8044-8051.2005; Katsuoka F, 2003, MOL CELL BIOL, V23, P1163, DOI 10.1128/MCB.23.4.1163-1174.2003; KERPPOLA TK, 1994, ONCOGENE, V9, P3149; Kusunoki H, 2002, NAT STRUCT BIOL, V9, P252, DOI 10.1038/nsb771; Kyo M, 2004, GENES CELLS, V9, P153, DOI 10.1111/j.1356-9597.2004.00711.x; Liu L, 2004, CANCER RES, V64, P3491, DOI 10.1158/0008-5472.CAN-03-2106; Motohashi H, 2000, CELL, V103, P865, DOI 10.1016/S0092-8674(00)00190-2; Motohashi H, 2004, P NATL ACAD SCI USA, V101, P6379, DOI 10.1073/pnas.0305902101; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Motohashi H, 2002, GENE, V294, P1, DOI 10.1016/S0378-1119(02)00788-6; Motohashi H, 2006, MOL CELL BIOL, V26, P4652, DOI 10.1128/MCB.02193-05; NEY PA, 1990, NUCLEIC ACIDS RES, V18, P6011, DOI 10.1093/nar/18.20.6011; Nioi P, 2005, MOL CELL BIOL, V25, P10895, DOI 10.1128/MCB.25.24.10895-10906.2005; Rosenzweig T, 2006, CANCER RES, V66, P4139, DOI 10.1158/0008-5472.CAN-05-2851; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; Shamji AF, 2003, MOL CELL, V12, P271, DOI 10.1016/j.molcel.2003.08.016; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; Yamamoto T, 2006, GENES CELLS, V11, P575, DOI 10.1111/j.1365-2443.2006.00965.x; Zhang J, 2007, BIOCHEM J, V404, P459, DOI 10.1042/BJ20061611; Zhang JY, 2006, MOL CELL BIOL, V26, P7942, DOI 10.1128/MCB.00700-06	31	79	81	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46							33681	10.1074/jbc.M706863200	http://dx.doi.org/10.1074/jbc.M706863200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17875642	hybrid			2022-12-25	WOS:000250840200049
J	Weiner, BE; Huang, H; Dattilo, BM; Nilges, MJ; Fanning, E; Chazin, WJ				Weiner, Brian E.; Huang, Hao; Dattilo, Brian M.; Nilges, Mark J.; Fanning, Ellen; Chazin, Walter J.			An iron-sulfur cluster in the C-terminal domain of the p58 subunit of human DNA primase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-ALPHA-PRIMASE; REPLICATION IN-VITRO; HUMAN GINS COMPLEX; ENDONUCLEASE-III; B-SUBUNIT; ESCHERICHIA-COLI; PRIMER SYNTHESIS; REPAIR; INITIATION; PROTEIN	DNA primase synthesizes short RNA primers that are required to initiate DNA synthesis on the parental template strands during DNA replication. Eukaryotic primase contains two subunits, p48 and p58, and is normally tightly associated with DNA polymerase alpha. Despite the fundamental importance of primase in DNA replication, structural data on eukaryotic DNA primase are lacking. The p48/p58 dimer was subjected to limited proteolysis, which produced two stable structural domains: one containing the bulk of p48 and the other corresponding to the C-terminal fragment of p58. These domains were identified by mass spectrometry and N-terminal sequencing. The C-terminal p58 domain (p58C) was expressed, purified, and characterized. CD and NMR spectroscopy experiments demonstrated that p58C forms a well folded structure. The protein has a distinctive brownish color, and evidence from inductively coupled plasma mass spectrometry, UV-visible spectrophotometry, and EPR spectroscopy revealed characteristics consistent with the presence of a [4Fe-4S] high potential iron protein cluster. Four putative cysteine ligands were identified using a multiple sequence alignment, and substitution of just one was sufficient to cause loss of the iron-sulfur cluster and a reduction in primase enzymatic activity relative to the wildtype protein. The discovery of an iron-sulfur cluster in DNA primase that contributes to enzymatic activity provides the first suggestion that the DNA replication machinery may have redox-sensitive activities. Our results offer new horizons in which to investigate the function of high potential [4Fe-4S] clusters in DNA-processing machinery.	Vanderbilt Univ, Ctr Struct Biol, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA; Univ Illinois, Illinois EPR Res Ctr, Urbana, IL 61801 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Illinois System; University of Illinois Urbana-Champaign	Chazin, WJ (corresponding author), Vanderbilt Univ, Ctr Struct Biol, 465 21st Ave S,Ste 5140, Nashville, TN 37232 USA.	walter.chazin@vanderbilt.edu			NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052948, T32GM008320, R01GM065484] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA68485] Funding Source: Medline; NIEHS NIH HHS [P50 ES00267] Funding Source: Medline; NIGMS NIH HHS [R01 GM065484, GM65484, GM52948, T32 GM008320] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Arezi B, 1999, BIOCHEMISTRY-US, V38, P12899, DOI 10.1021/bi9908991; Arezi B, 2000, TRENDS BIOCHEM SCI, V25, P572, DOI 10.1016/S0968-0004(00)01680-7; Arunkumar AI, 2005, NAT STRUCT MOL BIOL, V12, P332, DOI 10.1038/nsmb916; Boal AK, 2005, BIOCHEMISTRY-US, V44, P8397, DOI 10.1021/bi047494n; Boon EM, 2003, P NATL ACAD SCI USA, V100, P12543, DOI 10.1073/pnas.2035257100; Brown NM, 2002, J BIOL CHEM, V277, P7246, DOI 10.1074/jbc.M110282200; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Chepanoske CL, 2000, ARCH BIOCHEM BIOPHYS, V380, P11, DOI 10.1006/abbi.2000.1890; Coldren CD, 1997, P NATL ACAD SCI USA, V94, P6635, DOI 10.1073/pnas.94.13.6635; Copeland WC, 1997, PROTEIN EXPRES PURIF, V9, P1, DOI 10.1006/prep.1996.0665; COPELAND WC, 1993, J BIOL CHEM, V268, P26179; Cortez D, 2005, GENE DEV, V19, P1007, DOI 10.1101/gad.1316905; CUNNINGHAM RP, 1989, BIOCHEMISTRY-US, V28, P4450, DOI 10.1021/bi00436a049; De Falco M, 2007, EMBO REP, V8, P99, DOI 10.1038/sj.embor.7400870; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dilg AWE, 1999, J BIOL INORG CHEM, V4, P727, DOI 10.1007/s007750050345; DORNREITER I, 1992, EMBO J, V11, P769, DOI 10.1002/j.1460-2075.1992.tb05110.x; FOIANI M, 1995, MOL CELL BIOL, V15, P883; Foiani M, 1997, TRENDS BIOCHEM SCI, V22, P424; FOIANI M, 1994, MOL CELL BIOL, V14, P923, DOI 10.1128/MCB.14.2.923; FRANCESCONI S, 1991, P NATL ACAD SCI USA, V88, P3877, DOI 10.1073/pnas.88.9.3877; Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; Guan Y, 1998, NAT STRUCT BIOL, V5, P1058, DOI 10.1038/4168; HEMMINGA MA, 2007, ESR SPECTROSCOPY MEM, P261; Hinks JA, 2002, J BIOL CHEM, V277, P16936, DOI 10.1074/jbc.M200668200; Hubscher U, 2002, ANNU REV BIOCHEM, V71, P133, DOI 10.1146/annurev.biochem.71.090501.150041; Jiang XH, 2006, EMBO J, V25, P5516, DOI 10.1038/sj.emboj.7601432; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kamada K, 2007, NAT STRUCT MOL BIOL, V14, P388, DOI 10.1038/nsmb1231; Klinge S, 2007, NAT STRUCT MOL BIOL, V14, P875, DOI 10.1038/nsmb1288; Labib K, 2007, TRENDS CELL BIOL, V17, P271, DOI 10.1016/j.tcb.2007.04.002; Lambert S, 2007, DNA REPAIR, V6, P1042, DOI 10.1016/j.dnarep.2007.02.024; Lao-Sirieix SH, 2005, NAT STRUCT MOL BIOL, V12, P1137, DOI 10.1038/nsmb1013; Lao-Sirieix SH, 2005, TRENDS GENET, V21, P568, DOI 10.1016/j.tig.2005.07.010; LePape L, 1997, J AM CHEM SOC, V119, P9757, DOI 10.1021/ja963349o; Lill R, 2006, ANNU REV CELL DEV BI, V22, P457, DOI 10.1146/annurev.cellbio.22.010305.104538; LONGHESE MP, 1993, GENETICS, V133, P183; Lukianova OA, 2005, CURR OPIN CHEM BIOL, V9, P145, DOI 10.1016/j.cbpa.2005.02.006; Michael WM, 2000, SCIENCE, V289, P2133, DOI 10.1126/science.289.5487.2133; MICHAELS ML, 1990, NUCLEIC ACIDS RES, V18, P3841, DOI 10.1093/nar/18.13.3841; Ott RD, 2002, MOL CELL BIOL, V22, P5669, DOI 10.1128/MCB.22.16.5669-5678.2002; Paulsen RD, 2007, DNA REPAIR, V6, P953, DOI 10.1016/j.dnarep.2007.02.015; Porello SL, 1998, BIOCHEMISTRY-US, V37, P6465, DOI 10.1021/bi972433t; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Schneider A, 1998, J BIOL CHEM, V273, P21608, DOI 10.1074/jbc.273.34.21608; Schub O, 2001, J BIOL CHEM, V276, P38076; SHEAFF RJ, 1993, BIOCHEMISTRY-US, V32, P3027, DOI 10.1021/bi00063a014; Staples CR, 1996, BIOCHEMISTRY-US, V35, P11425, DOI 10.1021/bi961007p; Stauffer ME, 2004, J BIOL CHEM, V279, P30915, DOI 10.1074/jbc.R400015200; THAYER MM, 1995, EMBO J, V14, P4108, DOI 10.1002/j.1460-2075.1995.tb00083.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Uchiyama M, 2004, MOL CELL BIOL, V24, P7419, DOI 10.1128/MCB.24.17.7419-7434.2004; Voitenleitner C, 1997, ONCOGENE, V14, P1611, DOI 10.1038/sj.onc.1200975; Voitenleitner C, 1999, MOL CELL BIOL, V19, P646; Weisshart K, 2000, J BIOL CHEM, V275, P17328, DOI 10.1074/jbc.M000717200; Zerbe LK, 2002, BIOCHEMISTRY-US, V41, P4891, DOI 10.1021/bi016030b	59	93	94	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33444	33451		10.1074/jbc.M705826200	http://dx.doi.org/10.1074/jbc.M705826200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17893144	hybrid			2022-12-25	WOS:000250840200024
J	Morris, SA; Almeida, AD; Tanaka, H; Ohta, K; Ohnuma, S				Morris, Samantha A.; Almeida, Alexandra D.; Tanaka, Hideaki; Ohta, Kunimasa; Ohnuma, Shin-ichi			Tsukushi Modulates Xnr2, FGF and BMP Signaling: Regulation of Xenopus Germ Layer Formation	PLOS ONE			English	Article								Background. Cell-cell communication is essential in tissue patterning. In early amphibian development, mesoderm is formed in the blastula-stage embryo through inductive interactions in which vegetal cells act on overlying equatorial cells. Members of the TGF-beta family such as activin B, Vg1, derriere and Xenopus nodal-related proteins (Xnrs) are candidate mesoderm inducing factors, with further activity to induce endoderm of the vegetal region. TGF-beta-like ligands, including BMP, are also responsible for patterning of germ layers. In addition, FGF signaling is essential for mesoderm formation whereas FGF signal inhibition has been implicated in endoderm induction. Clearly, several signaling pathways are coordinated to produce an appropriate developmental output; although intracellular crosstalk is known to integrate multiple pathways, relatively little is known about extracellular coordination. Methodology/Principal Findings. Here, we show that Xenopus Tsukushi (X-TSK), a member of the secreted small leucine rich repeat proteoglycan (SLRP) family, is expressed in ectoderm, endoderm, and the organizer during early development. We have previously reported that X-TSK binds to and inhibits BMP signaling in cooperation with chordin. We now demonstrate two novel interactions: X-TSK binds to and inhibits signaling by FGF8b, in addition to binding to and enhancement of Xnr2 signaling. This signal integration by X-TSK at the extracellular level has an important role in germ layer formation and patterning. Vegetally localized X-TSK potentiates endoderm formation through coordination of BMP, FGF and Xnr2 signaling. In contrast, X-TSK inhibition of FGF-MAPK signaling blocks ventrolateral mesoderm formation, while BMP inhibition enhances organizer formation. These actions of X-TSK are reliant upon its expression in endoderm and dorsal mesoderm, with relative exclusion from ventrolateral mesoderm, in a pattern shaped by FGF signals. Conclusions/Significance. Based on our observations, we propose a novel mechanism by which X-TSK refines the field of positional information by integration of multiple pathways in the extracellular space.	[Morris, Samantha A.; Almeida, Alexandra D.; Ohnuma, Shin-ichi] Univ Cambridge, Res Ctr, Hutchison Med Res Council, Dept Oncol, Cambridge, England; [Tanaka, Hideaki; Ohta, Kunimasa] Kumamoto Univ, Grad Sch Med Sci, Dept Dev Neurobiol, Kumamoto, Japan	University of Cambridge; Kumamoto University	Morris, SA (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Henry Wellcome Bldg Canc & Dev Biol, Cambridge, England.	s.morris@gurdon.cam.ac.uk; so218@cam.ac.uk	Ohta, Kunimasa/AAW-6993-2020	Ohta, Kunimasa/0000-0002-4564-9757; D. ALMEIDA, ALEXANDRA/0000-0002-2708-2072; Ohnuma, Shin-ichi/0000-0002-3305-5126	Cancer Research UK; Medical Research Council; FCT Portugal; PRESTO Japan	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); FCT Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission); PRESTO Japan	Funding: Cancer Research UK, Medical Research Council, FCT Portugal, PRESTO Japan	Abe T, 2005, MECH DEVELOP, V122, P671, DOI 10.1016/j.mod.2004.12.006; Afouda BA, 2005, DEVELOPMENT, V132, P763, DOI 10.1242/dev.01647; Agius E, 2000, DEVELOPMENT, V127, P1173; AMAYA E, 1993, DEVELOPMENT, V118, P477; AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; Baker JC, 1996, GENE DEV, V10, P1880, DOI 10.1101/gad.10.15.1880; Bell E, 2003, DEVELOPMENT, V130, P1381, DOI 10.1242/dev.00344; Birsoy B, 2005, DEVELOPMENT, V132, P591, DOI 10.1242/dev.01599; Butler K, 2001, METHODS, V23, P303, DOI 10.1006/meth.2000.1142; Cha SW, 2004, BIOCHEM BIOPH RES CO, V315, P100, DOI 10.1016/j.bbrc.2004.01.019; CHO KWY, 1991, CELL, V67, P1111, DOI 10.1016/0092-8674(91)90288-A; Clements D, 2003, DEV BIOL, V258, P454, DOI 10.1016/S0012-1606(03)00124-6; Clements D, 1999, DEVELOPMENT, V126, P4903; Contakos SP, 2005, DEV BIOL, V288, P294, DOI 10.1016/j.ydbio.2005.09.015; Darras S, 1997, DEVELOPMENT, V124, P4275; Dorey K, 2006, DEV BIOL, V292, P303, DOI 10.1016/j.ydbio.2006.01.006; Dyson S, 1998, CELL, V93, P557, DOI 10.1016/S0092-8674(00)81185-X; Ecochard V, 1995, DEV BIOL, V172, P699, DOI 10.1006/dbio.1995.8052; Engleka MJ, 2001, DEV BIOL, V237, P159, DOI 10.1006/dbio.2001.0366; Fainsod A, 1997, MECH DEVELOP, V63, P39, DOI 10.1016/S0925-4773(97)00673-4; Fletcher RB, 2006, DEVELOPMENT, V133, P1703, DOI 10.1242/dev.02342; GRAFF JM, 1994, CELL, V79, P169, DOI 10.1016/0092-8674(94)90409-X; Green J, 2002, DEV DYNAM, V225, P392, DOI 10.1002/dvdy.10170; GREEN JBA, 1990, NATURE, V347, P391, DOI 10.1038/347391a0; GREEN JBA, 1992, CELL, V71, P731, DOI 10.1016/0092-8674(92)90550-V; GURDON JB, 1995, NATURE, V376, P520, DOI 10.1038/376520a0; GURDON JB, 1994, NATURE, V371, P487, DOI 10.1038/371487a0; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Harrington AE, 2006, EMBO J, V25, P1035, DOI 10.1038/sj.emboj.7601000; Heasman J, 1997, DEVELOPMENT, V124, P4179; Henry GL, 1998, SCIENCE, V281, P91, DOI 10.1126/science.281.5373.91; Hocking AM, 1998, MATRIX BIOL, V17, P1; Hogan BLM, 1996, CURR OPIN GENET DEV, V6, P432, DOI 10.1016/S0959-437X(96)80064-5; Hudson C, 1997, CELL, V91, P397, DOI 10.1016/S0092-8674(00)80423-7; JONES CM, 1995, DEVELOPMENT, V121, P3651; Joseph EM, 1997, DEV BIOL, V184, P367, DOI 10.1006/dbio.1997.8510; Kofron M, 1999, DEVELOPMENT, V126, P5759; Kuriyama S, 2006, DEVELOPMENT, V133, P75, DOI 10.1242/dev.02178; LABONNE C, 1995, DEVELOPMENT, V121, P1475; Larrain J, 2000, DEVELOPMENT, V127, P821; Lemaire P, 1998, DEVELOPMENT, V125, P2371; Lin XH, 2000, MATRIX BIOL, V19, P303, DOI 10.1016/S0945-053X(00)00073-1; Loose M, 2004, DEV BIOL, V271, P467, DOI 10.1016/j.ydbio.2004.04.014; Moreno M, 2005, EMBO J, V24, P1397, DOI 10.1038/sj.emboj.7600615; Nieuwkoop P D, 1967, Acta Biotheor, V17, P151, DOI 10.1007/BF01601986; Ohta K, 2004, DEV CELL, V7, P347, DOI 10.1016/j.devcel.2004.08.014; OHTA K, 2006, DEVELOPMENT; Onichtchouk D, 1999, NATURE, V401, P480, DOI 10.1038/46794; Pera EM, 2003, GENE DEV, V17, P3023, DOI 10.1101/gad.1153603; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Poulain M, 2006, DEVELOPMENT, V133, P2189, DOI 10.1242/dev.02387; Pownall ME, 2003, DEV BIOL, V256, P89, DOI 10.1016/S0012-1606(02)00120-3; Sasai Y, 1996, EMBO J, V15, P4547, DOI 10.1002/j.1460-2075.1996.tb00832.x; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Schohl A, 2002, DEVELOPMENT, V129, P37; SMITH JC, 1990, NATURE, V345, P729, DOI 10.1038/345729a0; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; Steinbach OC, 1998, DEV BIOL, V202, P280, DOI 10.1006/dbio.1998.8993; STERN CD, 2004, GASTRULATION CELLS E, P219; Sun BI, 1999, DEVELOPMENT, V126, P1467; Takahashi S, 2000, DEVELOPMENT, V127, P5319; Weber H, 2000, DEVELOPMENT, V127, P4345; WEEKS DL, 1987, CELL, V51, P861, DOI 10.1016/0092-8674(87)90109-7; WHITMAN M, 1992, NATURE, V357, P252, DOI 10.1038/357252a0; Williams PH, 2004, CURR BIOL, V14, P1916, DOI 10.1016/j.cub.2004.10.020; Xanthos JB, 2002, DEVELOPMENT, V129, P4027; Xanthos JB, 2001, DEVELOPMENT, V128, P167; Zetser A, 2001, DEV BIOL, V240, P168, DOI 10.1006/dbio.2001.0465; Zhang C, 2005, DEV BIOL, V278, P526, DOI 10.1016/j.ydbio.2004.11.008; Zhang Y, 1999, TRENDS CELL BIOL, V9, P274, DOI 10.1016/S0962-8924(99)01579-2	71	34	36	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1004	10.1371/journal.pone.0001004	http://dx.doi.org/10.1371/journal.pone.0001004			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925852	Green Submitted, Green Published, gold			2022-12-25	WOS:000207456000003
J	Gioia, J; Yerrapragada, S; Qin, X; Jiang, HY; Igboeli, OC; Muzny, D; Dugan-Rocha, S; Ding, Y; Hawes, A; Liu, W; Perez, L; Kovar, C; Dinh, H; Lee, S; Nazareth, L; Blyth, P; Holder, M; Buhay, C; Tirumalai, MR; Liu, YM; Dasgupta, I; Bokhetache, L; Fujita, M; Karouia, F; Moorthy, PE; Siefert, J; Uzman, A; Buzumbo, P; Verma, A; Zwiya, H; McWilliams, BD; Olowu, A; Clinkenbeard, KD; Newcombe, D; Golebiewski, L; Petrosino, JF; Nicholson, WL; Fox, GE; Venkateswaran, K; Highlander, SK; Weinstock, GM				Gioia, Jason; Yerrapragada, Shailaja; Qin, Xiang; Jiang, Huaiyang; Igboeli, Okezie C.; Muzny, Donna; Dugan-Rocha, Shannon; Ding, Yan; Hawes, Alicia; Liu, Wen; Perez, Lesette; Kovar, Christie; Dinh, Huyen; Lee, Sandra; Nazareth, Lynne; Blyth, Peter; Holder, Michael; Buhay, Christian; Tirumalai, Madhan R.; Liu, Yamei; Dasgupta, Indrani; Bokhetache, Lina; Fujita, Masaya; Karouia, Fathi; Moorthy, Prahathees Eswara; Siefert, Johnathan; Uzman, Akif; Buzumbo, Prince; Verma, Avani; Zwiya, Hiba; McWilliams, Brian D.; Olowu, Adeola; Clinkenbeard, Kenneth D.; Newcombe, David; Golebiewski, Lisa; Petrosino, Joseph F.; Nicholson, Wayne L.; Fox, George E.; Venkateswaran, Kasthuri; Highlander, Sarah K.; Weinstock, George M.			Paradoxical DNA Repair and Peroxide Resistance Gene Conservation in Bacillus pumilus SAFR-032	PLOS ONE			English	Article							SOLUBLE SPORE PROTEINS; ESCHERICHIA-COLI; OXIDATIVE STRESS; SUBTILIS SPORES; SIGMA-FACTOR; GENOME; IDENTIFICATION; HELICASE; EXPRESSION; SEQUENCE	Background. Bacillus spores are notoriously resistant to unfavorable conditions such as UV radiation, gamma-radiation, H2O2, desiccation, chemical disinfection, or starvation. Bacillus pumilus SAFR-032 survives standard decontamination procedures of the Jet Propulsion Lab spacecraft assembly facility, and both spores and vegetative cells of this strain exhibit elevated resistance to UV radiation and H2O2 compared to other Bacillus species. Principal Findings. The genome of B. pumilus SAFR-032 was sequenced and annotated. Lists of genes relevant to DNA repair and the oxidative stress response were generated and compared to B. subtilis and B. licheniformis. Differences in conservation of genes, gene order, and protein sequences are highlighted because they potentially explain the extreme resistance phenotype of B. pumilus. The B. pumilus genome includes genes not found in B. subtilis or B. licheniformis and conserved genes with sequence divergence, but paradoxically lacks several genes that function in UV or H2O2 resistance in other Bacillus species. Significance. This study identifies several candidate genes for further research into UV and H2O2 resistance. These findings will help explain the resistance of B. pumilus and are applicable to understanding sterilization survival strategies of microbes.	[Gioia, Jason; Yerrapragada, Shailaja; Qin, Xiang; Jiang, Huaiyang; Igboeli, Okezie C.; Muzny, Donna; Dugan-Rocha, Shannon; Ding, Yan; Hawes, Alicia; Liu, Wen; Perez, Lesette; Kovar, Christie; Dinh, Huyen; Lee, Sandra; Nazareth, Lynne; Blyth, Peter; Holder, Michael; Buhay, Christian; Highlander, Sarah K.; Weinstock, George M.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Weinstock, George M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [McWilliams, Brian D.; Golebiewski, Lisa; Petrosino, Joseph F.; Highlander, Sarah K.; Weinstock, George M.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Tirumalai, Madhan R.; Liu, Yamei; Dasgupta, Indrani; Bokhetache, Lina; Fujita, Masaya; Karouia, Fathi; Moorthy, Prahathees Eswara; Siefert, Johnathan; Fox, George E.] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Uzman, Akif; Buzumbo, Prince; Verma, Avani; Zwiya, Hiba] Univ Houston Downtown, Dept Nat Sci, Houston, TX USA; [Olowu, Adeola] St Thomas Univ, Houston, TX USA; [Clinkenbeard, Kenneth D.] Oklahoma State Univ, Dept Vet Pathobiol, Ctr Vet Hlth Sci, Stillwater, OK 74078 USA; [Newcombe, David] Univ Idaho Coeur dAlene, Coeur Dalene, ID USA; [Newcombe, David; Venkateswaran, Kasthuri] CALTECH, Jet Prop Lab, Pasadena, CA USA; [Nicholson, Wayne L.] Univ Florida, Space Life Sci Lab, Dept Microbiol & Cell Sci, Kennedy Space Ctr, FL USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Houston System; University of Houston; University of Houston System; University of Houston; University of Houston Downtown; University of Saint Thomas; Oklahoma State University System; Oklahoma State University - Stillwater; Idaho; Idaho State University; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); State University System of Florida; University of Florida	Weinstock, GM (corresponding author), Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA.	gwstock@bcm.tmc.edu	Eswara, Prahathees/J-2353-2019; Weinstock, George M/C-6314-2013; Tirumalai, Madhan R/J-4988-2017; Petrosino, Joseph F./AAF-1621-2019; Willson, richard/AAD-4832-2019	Eswara, Prahathees/0000-0003-4430-261X; Weinstock, George M/0000-0002-2997-4592; Tirumalai, Madhan R/0000-0002-5999-333X; Fujita, Masaya/0000-0003-0060-5328; Karouia, Fathi/0000-0002-1142-9684	NSF [414410]; NASA [NNG05GN75G]; NRA ROSS	NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); NRA ROSS	This research was supported in part by grants to GMW (NSF-414410), GEF (NASA-Exobiology #NNG05GN75G) and KV (contract to JPL/Caltech from NASA and funded by NRA ROSS 2005). The sponsors had no role in the conduct of this study.	Aamodt RM, 2004, J BIOL CHEM, V279, P13601, DOI 10.1074/jbc.M314277200; Andersson B, 1996, ANAL BIOCHEM, V236, P107, DOI 10.1006/abio.1996.0138; Au N, 2005, J BACTERIOL, V187, P7655, DOI 10.1128/JB.187.22.7655-7666.2005; Bagyan I, 1998, J BACTERIOL, V180, P6704, DOI 10.1128/JB.180.24.6704-6712.1998; Bagyan I, 1998, J BACTERIOL, V180, P2057, DOI 10.1128/JB.180.8.2057-2062.1998; Benardini JN, 2003, ASTROBIOLOGY, V3, P709, DOI 10.1089/153110703322736033; Brosh RM, 1997, J BIOL CHEM, V272, P572; Cabrera-Hernandez A, 1999, GENE, V232, P1, DOI 10.1016/S0378-1119(99)00124-9; Cao M, 2005, J BACTERIOL, V187, P2948, DOI 10.1128/JB.187.9.2948-2956.2005; CARRILLOMARTINEZ Y, 1994, J BACTERIOL, V176, P5357, DOI 10.1128/JB.176.17.5357-5363.1994; Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1; CasillasMartinez L, 1997, J BACTERIOL, V179, P7420, DOI 10.1128/jb.179.23.7420-7425.1997; Cortezzo DE, 2005, J APPL MICROBIOL, V98, P606, DOI 10.1111/j.1365-2672.2004.02495.x; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; DODD IB, 1988, PROTEIN ENG, V2, P174, DOI 10.1093/protein/2.3.174; Duigou S, 2004, MOL MICROBIOL, V54, P439, DOI 10.1111/j.1365-2958.2004.04259.x; Eisen JA, 1999, MUTAT RES-DNA REPAIR, V435, P171, DOI 10.1016/S0921-8777(99)00050-6; Essen LO, 2006, CELL MOL LIFE SCI, V63, P1266, DOI 10.1007/s00018-005-5447-y; FARR SB, 1991, MICROBIOL REV, V55, P561, DOI 10.1128/MMBR.55.4.561-585.1991; Fuangthong M, 2001, J BACTERIOL, V183, P4134, DOI 10.1128/JB.183.14.4134-4141.2001; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Groban ES, 2005, NUCLEIC ACIDS RES, V33, P6287, DOI 10.1093/nar/gki939; Havlak P, 2004, GENOME RES, V14, P721, DOI 10.1101/gr.2264004; Hawkins T, 2006, PROTEIN SCI, V15, P1550, DOI 10.1110/ps.062153506; Jedrzejas MJ, 2003, CRIT REV BIOCHEM MOL, V38, P173, DOI 10.1080/713609234; Kanno S, 1999, NUCLEIC ACIDS RES, V27, P3096, DOI 10.1093/nar/27.15.3096; Keijser BJF, 2007, J BACTERIOL, V189, P3624, DOI 10.1128/JB.01736-06; Kempf MJ, 2005, ASTROBIOLOGY, V5, P391, DOI 10.1089/ast.2005.5.391; KOOISTRA J, 1993, MOL MICROBIOL, V7, P915, DOI 10.1111/j.1365-2958.1993.tb01182.x; Lin J, 2007, GENE, V387, P15, DOI 10.1016/j.gene.2006.07.031; Liu XF, 2006, J BIOL CHEM, V281, P27827, DOI 10.1074/jbc.M601398200; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martins-Pinheiro M, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-17; Matsumoto T, 2005, GENES GENET SYST, V80, P385, DOI 10.1266/ggs.80.385; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; McLeod MP, 2004, J BACTERIOL, V186, P5842, DOI 10.1128/JB.186.17.5842-5855.2004; MOELLER R, 2007, ARCH MICROBIOLOGY; MOELLER R, 2007, J BACTERIOLOGY; Moore JK, 1996, MOL CELL BIOL, V16, P2164, DOI 10.1128/mcb.16.5.2164; MOROHOSHI F, 1990, NUCLEIC ACIDS RES, V18, P5473, DOI 10.1093/nar/18.18.5473; Mostertz J, 2004, MICROBIOL-SGM, V150, P497, DOI 10.1099/mic.0.26665-0; Newcombe DA, 2005, APPL ENVIRON MICROB, V71, P8147, DOI 10.1128/AEM.71.12.8147-8156.2005; Nicholson WL, 2000, MICROBIOL MOL BIOL R, V64, P548, DOI 10.1128/MMBR.64.3.548-572.2000; Pedraza-Reyes M, 2004, J BACTERIOL, V186, P6485, DOI 10.1128/JB.186.19.6485-6491.2004; Petit MA, 1998, MOL MICROBIOL, V29, P261, DOI 10.1046/j.1365-2958.1998.00927.x; Priest Fergus G., 1993, P3; Rawlings ND, 2006, NUCLEIC ACIDS RES, V34, pD270, DOI 10.1093/nar/gkj089; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rohankhedkar MS, 2006, J BACTERIOL, V188, P223, DOI 10.1128/JB.188.1.223-230.2006; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Salas-Pacheco JA, 2005, J BACTERIOL, V187, P7374, DOI 10.1128/JB.187.21.7374-7381.2005; Sambrook J, 2001, MOL CLONING LAB MANU; SASSANFAR M, 1991, J BIOL CHEM, V266, P2767; Setlow P, 2006, J APPL MICROBIOL, V101, P514, DOI 10.1111/j.1365-2672.2005.02736.x; Setlow P, 2001, ENVIRON MOL MUTAGEN, V38, P97, DOI 10.1002/em.1058; SETLOW P, 1995, ANNU REV MICROBIOL, V49, P29, DOI 10.1146/annurev.mi.49.100195.000333; Smith BT, 2001, MOL CELL, V8, P1197, DOI 10.1016/S1097-2765(01)00402-6; Smits WK, 2005, J BACTERIOL, V187, P3921, DOI 10.1128/JB.187.12.3921-3930.2005; TOVARROJO F, 1991, J BACTERIOL, V173, P4827, DOI 10.1128/jb.173.15.4827-4835.1991; Truglio JJ, 2006, CHEM REV, V106, P233, DOI 10.1021/cr040471u; Voloshin ON, 2003, J BIOL CHEM, V278, P28284, DOI 10.1074/jbc.M301188200; Wang ST, 2006, J MOL BIOL, V358, P16, DOI 10.1016/j.jmb.2006.01.059; Weller GR, 2002, SCIENCE, V297, P1686, DOI 10.1126/science.1074584; Wheeler DL, 2005, NUCLEIC ACIDS RES, V33, pD39, DOI 10.1093/nar/gki062; YASBIN RE, 1992, MOL MICROBIOL, V6, P1263, DOI 10.1111/j.1365-2958.1992.tb00847.x; Yasuda T, 1998, EMBO J, V17, P3207, DOI 10.1093/emboj/17.11.3207; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zeller T, 2006, NATURWISSENSCHAFTEN, V93, P259, DOI 10.1007/s00114-006-0106-1	70	98	530	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e928	10.1371/journal.pone.0000928	http://dx.doi.org/10.1371/journal.pone.0000928			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895969	Green Published, Green Submitted, gold			2022-12-25	WOS:000207455800007
J	Kelley, DJ; Davidson, RJ; Elliott, JL; Lahvis, GP; Yin, JCP; Bhattacharyya, A				Kelley, Daniel J.; Davidson, Richard J.; Elliott, Jamie L.; Lahvis, Garet P.; Yin, Jerry C. P.; Bhattacharyya, Anita			The Cyclic AMP Cascade Is Altered in the Fragile X Nervous System	PLOS ONE			English	Article								Fragile X syndrome (FX), the most common heritable cause of mental retardation and autism, is a developmental disorder characterized by physical, cognitive, and behavioral deficits. FX results from a trinucleotide expansion mutation in the fmr1 gene that reduces levels of fragile X mental retardation protein (FMRP). Although research efforts have focused on FMRP's impact on mGluR signaling, how the loss of FMRP leads to the individual symptoms of FX is not known. Previous studies on human FX blood cells revealed alterations in the cyclic adenosine 3', 5'-monophosphate (cAMP) cascade. We tested the hypothesis that cAMP signaling is altered in the FX nervous system using three different model systems. Induced levels of cAMP in platelets and in brains of fmr1 knockout mice are substantially reduced. Cyclic AMP induction is also significantly reduced in human FX neural cells. Furthermore, cAMP production is decreased in the heads of FX Drosophila and this defect can be rescued by reintroduction of the dfmr gene. Our results indicate that a robust defect in cAMP production in FX is conserved across species and suggest that cAMP metabolism may serve as a useful biomarker in the human disease population. Reduced cAMP induction has implications for the underlying causes of FX and autism spectrum disorders. Pharmacological agents known to modulate the cAMP cascade may be therapeutic in FX patients and can be tested in these models, thus supplementing current efforts centered on mGluR signaling.	[Bhattacharyya, Anita] Univ Wisconsin, Waisman Ctr, Stem Cells & Dev Disorders Lab, Madison, WI 53705 USA; [Kelley, Daniel J.; Davidson, Richard J.] Univ Wisconsin, Waisman Ctr, Waisman Lab Brain Imaging & Behav, Madison, WI 53705 USA; [Kelley, Daniel J.] Univ Wisconsin, Sch Med & Publ Hlth, Neurosci Training Program, Madison, WI 53705 USA; [Kelley, Daniel J.; Elliott, Jamie L.] Univ Wisconsin, Sch Med & Publ Hlth, Med Scientist Training Program, Madison, WI 53705 USA; [Lahvis, Garet P.] Univ Wisconsin, Dept Surg, Madison, WI 53705 USA; [Elliott, Jamie L.; Yin, Jerry C. P.] Univ Wisconsin, Dept Genet, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Bhattacharyya, A (corresponding author), Univ Wisconsin, Waisman Ctr, Stem Cells & Dev Disorders Lab, Madison, WI 53705 USA.	bhattacharyy@waisman.wisc.edu		Lahvis, Garet/0000-0002-1986-8251; Davidson, Richard/0000-0002-8506-4964; Bhattacharyya, Anita/0000-0002-0360-7145	FRAXA Foundation Research; National Institute of Child Health and Human Development [P30 HD03352]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008692] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067774] Funding Source: NIH RePORTER	FRAXA Foundation Research; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a FRAXA Foundation Research Grant (AB) and in part by a core grant from the National Institute of Child Health and Human Development (P30 HD03352).	Azad SC, 2004, J NEUROSCI, V24, P9953, DOI 10.1523/JNEUROSCI.2134-04.2004; Bacchelli E, 2003, MOL PSYCHIATR, V8, P916, DOI 10.1038/sj.mp.4001340; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; Balazs R, 1998, J NEUROCHEM, V70, P2446; Barad M, 1998, P NATL ACAD SCI USA, V95, P15020, DOI 10.1073/pnas.95.25.15020; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; Berry-Kravis E, 1998, J NEUROSCI RES, V51, P41, DOI 10.1002/(SICI)1097-4547(19980101)51:1<41::AID-JNR4>3.0.CO;2-L; BERRYKRAVIS E, 1992, ANN NEUROL, V31, P22, DOI 10.1002/ana.410310105; BERRYKRAVIS E, 1995, PEDIATR RES, V38, P638, DOI 10.1203/00006450-199511000-00002; BERRYKRAVIS E, 1993, AM J MED GENET, V45, P81, DOI 10.1002/ajmg.1320450120; BHATTACHARYYA A, STEM CELLS IN PRESS; Bourtchouladze R, 2003, P NATL ACAD SCI USA, V100, P10518, DOI 10.1073/pnas.1834280100; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Caldwell MA, 2001, NAT BIOTECHNOL, V19, P475, DOI 10.1038/88158; Cartmell J, 1997, BRIT J PHARMACOL, V121, P1263, DOI 10.1038/sj.bjp.0701266; DEER JLR, 1995, J BIOL CHEM, V270, P12623, DOI 10.1074/jbc.270.21.12623; GILMAN AG, 1995, BIOSCIENCE REP, V15, P65, DOI 10.1007/BF01200143; Hagerman RJ, 2002, FRAGILE X SYNDROME D, P3; Heyduk E, 2003, COMB CHEM HIGH T SCR, V6, P347; Hines LM, 2005, BIOL PSYCHIAT, V58, P955, DOI 10.1016/j.biopsych.2005.05.040; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Kaytor MD, 2001, CELL, V107, P555, DOI 10.1016/S0092-8674(01)00590-6; Kooy RF, 2003, TRENDS GENET, V19, P148; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; McBride SMJ, 2005, NEURON, V45, P753, DOI 10.1016/j.neuron.2005.01.038; Miyashiro KY, 2003, NEURON, V37, P417, DOI 10.1016/S0896-6273(03)00034-5; MOOS M, 1988, SEC MESS PHOSPHOPROT, V12, P163; Musumeci SA, 2000, EPILEPSIA, V41, P19, DOI 10.1111/j.1528-1157.2000.tb01499.x; Ortinau S, 2005, ANN NY ACAD SCI, V1041, P211, DOI 10.1196/annals.1282.032; OTTE AP, 1989, CELL, V58, P641, DOI 10.1016/0092-8674(89)90099-8; Pacheco R, 2004, J BIOL CHEM, V279, P33352, DOI 10.1074/jbc.M401761200; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; Pilc A, 1996, PROG NEURO-PSYCHOPH, V20, P673, DOI 10.1016/0278-5846(96)00040-1; Serajee FJ, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.4.e42; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Warwick HK, 2005, J NEUROCHEM, V93, P232, DOI 10.1111/j.1471-4159.2005.03012.x; Yan QJ, 2005, NEUROPHARMACOLOGY, V49, P1053, DOI 10.1016/j.neuropharm.2005.06.004; Zhang YQ, 2005, MOL CELL PROTEOMICS, V4, P278, DOI 10.1074/mcp.M400174-MCP200; Zhang YQ, 2005, TRENDS GENET, V21, P37, DOI 10.1016/j.tig.2004.11.003	40	62	63	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e931	10.1371/journal.pone.0000931	http://dx.doi.org/10.1371/journal.pone.0000931			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895972	Green Submitted, Green Published, gold			2022-12-25	WOS:000207455800010
J	Okvist, A; Johansson, S; Kuzmin, A; Bazov, I; Merino-Martinez, R; Ponomarev, I; Mayfield, RD; Harris, RA; Sheedy, D; Garrick, T; Harper, C; Hurd, YL; Terenius, L; Ekstrom, TJ; Bakalkin, G; Yakovleva, T				Okvist, Anna; Johansson, Sofia; Kuzmin, Alexander; Bazov, Igor; Merino-Martinez, Roxana; Ponomarev, Igor; Mayfield, R. Dayne; Harris, R. Adron; Sheedy, Donna; Garrick, Therese; Harper, Clive; Hurd, Yasmin L.; Terenius, Lars; Ekstrom, Tomas J.; Bakalkin, Georgy; Yakovleva, Tatjana			Neuroadaptations in Human Chronic Alcoholics: Dysregulation of the NF-kappa B System	PLOS ONE			English	Article							DNA-BINDING ACTIVITY; GENE-EXPRESSION; FRONTAL-CORTEX; RAT-BRAIN; LONG-TERM; TRANSCRIPTION; ETHANOL; PROTEIN; ACTIVATION; PHOSPHORYLATION	Background. Alcohol dependence and associated cognitive impairments apparently result from neuroadaptations to chronic alcohol consumption involving changes in expression of multiple genes. Here we investigated whether transcription factors of Nuclear Factor-kappaB (NF-kappa B) family, controlling neuronal plasticity and neurodegeneration, are involved in these adaptations in human chronic alcoholics. Methods and Findings. Analysis of DNA-binding of NF-kappa B (p65/p50 heterodimer) and the p50 homodimer as well as NF-kappa B proteins and mRNAs was performed in postmortem human brain samples from 15 chronic alcoholics and 15 control subjects. The prefrontal cortex involved in alcohol dependence and cognition was analyzed and the motor cortex was studied for comparison. The p50 homodimer was identified as dominant kappa B binding factor in analyzed tissues. NF-kappa B and p50 homodimer DNA-binding was downregulated, levels of p65 (RELA) mRNA were attenuated, and the stoichiometry of p65/p50 proteins and respective mRNAs was altered in the prefrontal cortex of alcoholics. Comparison of a number of p50 homodimer/NF-kappa B target DNA sites, kappa B elements in 479 genes, down-or upregulated in alcoholics demonstrated that genes with kappa B elements were generally upregulated in alcoholics. No significant differences between alcoholics and controls were observed in the motor cortex. Conclusions. We suggest that cycles of alcohol intoxication/withdrawal, which may initially activate NF-kappa B, when repeated over years downregulate RELA expression and NF-kappa B and p50 homodimer DNA-binding. Downregulation of the dominant p50 homodimer, a potent inhibitor of gene transcription apparently resulted in derepression of kappa B regulated genes. Alterations in expression of p50 homodimer/NF-kappa B regulated genes may contribute to neuroplastic adaptation underlying alcoholism.	[Okvist, Anna; Johansson, Sofia; Kuzmin, Alexander; Bazov, Igor; Terenius, Lars; Ekstrom, Tomas J.; Bakalkin, Georgy; Yakovleva, Tatjana] Karolinska Inst, Dept Clin Neurosci, Sect Alcohol & Drug Dependence Res, Stockholm, Sweden; [Merino-Martinez, Roxana] Karolinska Inst, Dept Mol Med, Stockholm, Sweden; [Ponomarev, Igor; Mayfield, R. Dayne; Harris, R. Adron] Univ Texas Austin, Waggoner Ctr Alcohol & Addict Res, Austin, TX 78712 USA; [Sheedy, Donna; Garrick, Therese; Harper, Clive] Univ Sydney, Discipline Pathol, Sydney, NSW 2006, Australia; [Hurd, Yasmin L.] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Hurd, Yasmin L.] Mt Sinai Sch Med, Dept Pharmacol & Biol Chem, New York, NY USA; [Bakalkin, Georgy; Yakovleva, Tatjana] Uppsala Univ, Dept Pharmaceut Biosci, Div Biol Res Drug Dependence, Uppsala, Sweden	Karolinska Institutet; Karolinska Institutet; University of Texas System; University of Texas Austin; University of Sydney; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Uppsala University	Bakalkin, G (corresponding author), Karolinska Inst, Dept Clin Neurosci, Sect Alcohol & Drug Dependence Res, Stockholm, Sweden.	Georgy.Bakalkin@ki.se	Ekström, Tomas/B-7764-2013	Merino Martinez, Roxana/0000-0002-8939-0003; Bakalkin, Georgy/0000-0002-8074-9833; Bazov, Igor/0000-0003-4388-1656	AFA Forsakring; Research Foundation of the Swedish Alcohol Retail Monopoly (SRA); Karolinska Institutet; Swedish Science Research Council; Swedish National Drug Policy Coordinator; University of Sydney; National Health and Medical Research Council of Australia; Neuroscience Institute of Schizophrenia and Allied Disorders; National Institute of Alcohol Abuse and Alcoholism; NSW Department of Health; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R24AA012725, R28AA012725] Funding Source: NIH RePORTER	AFA Forsakring; Research Foundation of the Swedish Alcohol Retail Monopoly (SRA); Karolinska Institutet(Karolinska Institutet); Swedish Science Research Council; Swedish National Drug Policy Coordinator; University of Sydney(University of Sydney); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Neuroscience Institute of Schizophrenia and Allied Disorders; National Institute of Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NSW Department of Health; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by grants from the AFA Forsakring to AK, YLH, TJE and GB, the Research Foundation of the Swedish Alcohol Retail Monopoly (SRA) and Karolinska Institutet to AK, TJE and GB, and the Swedish Science Research Council and the Swedish National Drug Policy Coordinator to GB. The Australian Brain Donor Programs NSW Tissue Resource Centre was supported by The University of Sydney, National Health and Medical Research Council of Australia, Neuroscience Institute of Schizophrenia and Allied Disorders, National Institute of Alcohol Abuse and Alcoholism and NSW Department of Health.	Agartz I, 1999, ARCH GEN PSYCHIAT, V56, P356, DOI 10.1001/archpsyc.56.4.356; Alexander-Kaufman K, 2006, MOL PSYCHIATR, V11, P56, DOI 10.1038/sj.mp.4001741; Altura BM, 2002, EUR J PHARMACOL, V448, P89, DOI 10.1016/S0014-2999(02)01899-X; Association AP, 1994, DIAGN STAT MAN MENT, V4th; BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0; BAKALKIN G, 1994, MOL BRAIN RES, V24, P301, DOI 10.1016/0169-328X(94)90143-0; Bakalkin G, 1997, NEUROREPORT, V8, P2143; Bakalkin G, 1998, NEUROREPORT, V9, P2147, DOI 10.1097/00001756-199806220-00044; BAKALKIN GY, 1993, MOL BRAIN RES, V20, P137, DOI 10.1016/0169-328X(93)90119-A; Blanco AM, 2005, J IMMUNOL, V175, P6893, DOI 10.4049/jimmunol.175.10.6893; Boffelli D, 2003, SCIENCE, V299, P1391, DOI 10.1126/science.1081331; BOURS V, 1990, NATURE, V348, P76, DOI 10.1038/348076a0; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chen-Park FE, 2002, J BIOL CHEM, V277, P24701, DOI 10.1074/jbc.M200007200; Crews FT, 2006, ALCOHOL CLIN EXP RES, V30, P720, DOI 10.1111/j.1530-0277.2006.00084.x; Crews FT, 2005, ALCOHOL CLIN EXP RES, V29, P1504, DOI 10.1097/01.alc.0000175013.50644.61; Davis RL, 2004, NEUROSCI LETT, V371, P128, DOI 10.1016/j.neulet.2004.08.051; Ehrlich ME, 2002, J NEUROSCI, V22, P9155; Fadda F, 1998, PROG NEUROBIOL, V56, P385, DOI 10.1016/S0301-0082(98)00032-X; Flatscher-Bader T, 2005, J NEUROCHEM, V93, P359, DOI 10.1111/j.1471-4159.2004.03021.x; GEIGER A, 2004, PARALLEL COMPUTING L, V14, P301; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; GRANT KA, 1995, CLIN NEUROSCI, V3, P155; GRANT KA, 1990, EUR J PHARMACOL, V176, P289, DOI 10.1016/0014-2999(90)90022-X; Grundstrom S, 2004, J BIOL CHEM, V279, P8460, DOI 10.1074/jbc.M312398200; Guan HC, 2005, J BIOL CHEM, V280, P9957, DOI 10.1074/jbc.M412180200; GUERRINI L, 1995, P NATL ACAD SCI USA, V92, P9077, DOI 10.1073/pnas.92.20.9077; Hajishengallis G, 2004, INFECT IMMUN, V72, P1188, DOI 10.1128/IAI.72.2.1188-1191.2004; HARPER CG, 1985, LANCET, V2, P327; Hoberg JE, 2006, MOL CELL BIOL, V26, P457, DOI 10.1128/MCB.26.2.457-471.2006; HOPE BT, 1994, NEURON, V13, P1235, DOI 10.1016/0896-6273(94)90061-2; Huang CJ, 2002, INT J DEV NEUROSCI, V20, P289, DOI 10.1016/S0736-5748(02)00022-9; Huang R, 2006, GENOMICS, V87, P315, DOI 10.1016/j.ygeno.2005.11.011; JENSEN GB, 1993, LANCET, V342, P1201; Johansson S, 2007, BRAIN RES, V1132, P20, DOI 10.1016/j.brainres.2006.11.026; Kaltschmidt B, 1997, P NATL ACAD SCI USA, V94, P2642, DOI 10.1073/pnas.94.6.2642; Kaltschmidt B, 2006, MOL CELL BIOL, V26, P2936, DOI 10.1128/MCB.26.8.2936-2946.2006; Kaltschmidt B, 2005, BBA-MOL CELL RES, V1745, P287, DOI 10.1016/j.bbamcr.2005.05.009; KALTSCHMIDT C, 1993, MECH DEVELOP, V43, P135, DOI 10.1016/0925-4773(93)90031-R; Kearns JD, 2006, J CELL BIOL, V173, P659, DOI 10.1083/jcb.200510155; Koob GF, 2003, ALCOHOL CLIN EXP RES, V27, P232, DOI 10.1097/01.ALC.0000057122.36127.C2; KORNER M, 1989, NEURON, V3, P563, DOI 10.1016/0896-6273(89)90266-3; Kril JJ, 1997, NEUROSCIENCE, V79, P983, DOI 10.1016/S0306-4522(97)00083-3; KRIL JJ, 1989, ACTA NEUROPATHOL, V79, P200, DOI 10.1007/BF00294379; LI CCH, 1994, J BIOL CHEM, V269, P30089; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liu JW, 2006, NEUROPSYCHOPHARMACOL, V31, P1574, DOI 10.1038/sj.npp.1300947; Martone R, 2003, P NATL ACAD SCI USA, V100, P12247, DOI 10.1073/pnas.2135255100; Mattson MP, 2005, NEUROCHEM RES, V30, P883, DOI 10.1007/s11064-005-6961-x; Mazzeo A, 2004, ARCH NEUROL-CHICAGO, V61, P1097, DOI 10.1001/archneur.61.7.1097; Meffert MK, 2005, TRENDS NEUROSCI, V28, P37, DOI 10.1016/j.tins.2004.11.002; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; MERINOMARTINEZ R, PROMETHEUS SYS UNPUB; Michaelson JS, 2003, J CELL SCI, V116, P345, DOI 10.1242/jcs.00234; Moynagh Paul N, 2005, J Cell Sci, V118, P4589, DOI 10.1242/jcs.02579; Muller MM, 2006, P NATL ACAD SCI USA, V103, P14250, DOI 10.1073/pnas.0606668103; Nickols JC, 2003, NAT NEUROSCI, V6, P161, DOI 10.1038/nn995; Niehrs C, 1999, NATURE, V402, P483, DOI 10.1038/990025; O'Mahony A, 2006, MOL CELL BIOL, V26, P7283, DOI 10.1128/MCB.00510-06; O'Riordan KJ, 2006, J NEUROSCI, V26, P4870, DOI 10.1523/JNEUROSCI.4527-05.2006; PARSONS OA, 1993, NEUROL CLIN, V11, P205, DOI 10.1016/S0733-8619(18)30178-6; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Rulten SL, 2006, GENES BRAIN BEHAV, V5, P257, DOI 10.1111/j.1601-183X.2005.00157.x; Salomoni P, 2006, TRENDS CELL BIOL, V16, P97, DOI 10.1016/j.tcb.2005.12.002; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Schmidt KS, 2005, DEMENT GERIATR COGN, V20, P286, DOI 10.1159/000088306; Sullivan EV, 2005, PSYCHOPHARMACOLOGY, V180, P583, DOI 10.1007/s00213-005-2267-6; Teferedegne B, 2006, MOL CELL BIOL, V26, P5759, DOI 10.1128/MCB.00271-06; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Ward RJ, 1996, FEBS LETT, V389, P119, DOI 10.1016/0014-5793(96)00545-5; Wasserman WW, 2000, NAT GENET, V26, P225, DOI 10.1038/79965; YAKOVLEVA T, 2006, NEUROBIOLOGY AGING; Yamamoto Y, 2004, TRENDS BIOCHEM SCI, V29, P72, DOI 10.1016/j.tibs.2003.12.003; Yeh SH, 2004, MOL PHARMACOL, V65, P1286, DOI 10.1124/mol.65.5.1286; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X; JASPAR DATABASE	77	57	58	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e930	10.1371/journal.pone.0000930	http://dx.doi.org/10.1371/journal.pone.0000930			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895971	Green Published, Green Submitted, gold			2022-12-25	WOS:000207455800009
J	Poulsen, M; Erhardt, DP; Molinaro, DJ; Lin, TL; Currie, CR				Poulsen, Michael; Erhardt, Daniel P.; Molinaro, Daniel J.; Lin, Ting-Li; Currie, Cameron R.			Antagonistic Bacterial Interactions Help Shape Host-Symbiont Dynamics within the Fungus-Growing Ant-Microbe Mutualism	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; EVOLUTION; CONFLICT; HYMENOPTERA; PLANT; AGRICULTURE; RECOGNITION; COEVOLUTION; SPECIFICITY; PERSPECTIVE	Conflict within mutually beneficial associations is predicted to destabilize relationships, and theoretical and empirical work exploring this has provided significant insight into the dynamics of cooperative interactions. Within mutualistic associations, the expression and regulation of conflict is likely more complex than in intraspecific cooperative relationship, because of the potential presence of: i) multiple genotypes of microbial species associated with individual hosts, ii) multiple species of symbiotic lineages forming cooperative partner pairings, and iii) additional symbiont lineages. Here we explore complexity of conflict expression within the ancient and coevolved mutualistic association between attine ants, their fungal cultivar, and actinomycetous bacteria (Pseudonocardia). Specifically, we examine conflict between the ants and their Pseudonocardia symbionts maintained to derive antibiotics against parasitic microfungi (Escovopsis) infecting the ants' fungus garden. Symbiont assays pairing isolates of Pseudonocardia spp. associated with fungus-growing ants spanning the phylogenetic diversity of the mutualism revealed that antagonism between strains is common. In contrast, antagonism was substantially less common between more closely related bacteria associated with Acromyrmex leaf-cutting ants. In both experiments, the observed variation in antagonism across pairings was primarily due to the inhibitory capabilities and susceptibility of individual strains, but also the phylogenetic relationships between the ant host of the symbionts, as well as the pair-wise genetic distances between strains. The presence of antagonism throughout the phylogenetic diversity of Pseudonocardia symbionts indicates that these reactions likely have shaped the symbiosis from its origin. Antagonism is expected to prevent novel strains from invading colonies, enforcing single-strain rearing within individual ant colonies. While this may align ant-actinomycete interests in the bipartite association, the presence of single strains of Pseudonocardia within colonies may not be in the best interest of the ants, because increasing the diversity of bacteria, and thereby antibiotic diversity, would help the ant-fungus mutualism deal with the specialized parasites.	[Poulsen, Michael; Erhardt, Daniel P.; Molinaro, Daniel J.; Currie, Cameron R.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Lin, Ting-Li] Univ Wisconsin, Dept Stat, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Poulsen, M (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	poulsen@wisc.edu	Poulsen, Michael/C-6276-2012	Poulsen, Michael/0000-0002-2839-1715	Lundbeckfonden; National Science Foundation [DEB-0110073]	Lundbeckfonden(Lundbeckfonden); National Science Foundation(National Science Foundation (NSF))	Funded by Lundbeckfonden to MP and National Science Foundation (Integrative Research Challenges in Environmental Biology DEB-0110073) to CRC.	Aanen DK, 2002, P NATL ACAD SCI USA, V99, P14887, DOI 10.1073/pnas.222313099; AUTUORI M, 1956, INSTINCT COMPORTEMEN; BASS M, 1994, ECOL ENTOMOL, V19, P215, DOI 10.1111/j.1365-2311.1994.tb00412.x; Bot ANM, 2001, EVOLUTION, V55, P1980, DOI 10.1111/j.0014-3820.2001.tb01315.x; Bronstein JL, 2003, AM NAT, V162, pS24, DOI 10.1086/378645; BROOK I, 2004, CRITIC REV MICR, V25, P155; Cafaro MJ, 2005, CAN J MICROBIOL, V51, P441, DOI 10.1139/W05-023; CHAPELA IH, 1994, SCIENCE, V266, P1691, DOI 10.1126/science.266.5191.1691; Clark MA, 2000, EVOLUTION, V54, P517, DOI 10.1111/j.0014-3820.2000.tb00054.x; Clay K, 2005, P NATL ACAD SCI USA, V102, P12465, DOI 10.1073/pnas.0503059102; Currie CR, 2006, SCIENCE, V311, P81, DOI 10.1126/science.1119744; Currie CR, 1999, NATURE, V398, P701, DOI 10.1038/19519; Currie CR, 2003, SCIENCE, V299, P386, DOI 10.1126/science.1078155; Currie CR, 2003, NATURE, V423, P461, DOI 10.1038/nature01563; Currie CR, 2003, OIKOS, V101, P91, DOI 10.1034/j.1600-0706.2003.12036.x; Currie CR, 1999, P NATL ACAD SCI USA, V96, P7998, DOI 10.1073/pnas.96.14.7998; Currie CR, 2001, OECOLOGIA, V128, P99, DOI 10.1007/s004420100630; Currie CR, 2001, P ROY SOC B-BIOL SCI, V268, P1033, DOI 10.1098/rspb.2001.1605; Davelos AL, 2004, APPL ENVIRON MICROB, V70, P1051, DOI 10.1128/AEM.70.2.1051-1058.2004; Davelos AL, 2004, CAN J MICROBIOL, V50, P79, DOI 10.1139/W03-107; Denison RF, 2000, AM NAT, V156, P567, DOI 10.1086/316994; Frank SA, 1996, P ROY SOC B-BIOL SCI, V263, P339, DOI 10.1098/rspb.1996.0052; Frank SA, 2003, EVOLUTION, V57, P693; Gerardo NM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-88; Gerardo NM, 2006, PLOS BIOL, V4, P1358, DOI 10.1371/journal.pbio.0040235; Gerardo NM, 2004, P ROY SOC B-BIOL SCI, V271, P1791, DOI 10.1098/rspb.2004.2792; Green AM, 2002, MOL ECOL, V11, P191, DOI 10.1046/j.1365-294X.2002.01433.x; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Herre EA, 1999, TRENDS ECOL EVOL, V14, P49, DOI 10.1016/S0169-5347(98)01529-8; Huth CJ, 2000, ECOLOGY, V81, P1100, DOI 10.2307/177181; IKEDA H, 1992, SEARCH BIOACTIVE COM, P327; Kiers ET, 2003, NATURE, V425, P78, DOI 10.1038/nature01931; LAW R, 1992, P ROY SOC B-BIOL SCI, V248, P69, DOI 10.1098/rspb.1992.0044; Leigh EG, 1999, MG BEH ECOL, P15; Maddison D.R., 2005, MACCLADE 4 07 OS X; Marquez LM, 2007, SCIENCE, V315, P513, DOI 10.1126/science.1136237; Mehdiabadi NJ, 2006, NATURE, V442, P881, DOI 10.1038/442881a; Mikheyev AS, 2007, MOL ECOL, V16, P209, DOI 10.1111/j.1365-294X.2006.03134.x; Mueller UG, 2001, Q REV BIOL, V76, P169, DOI 10.1086/393867; Mueller UG, 1998, SCIENCE, V281, P2034, DOI 10.1126/science.281.5385.2034; Mueller UG, 2002, AM NAT, V160, pS67, DOI 10.1086/342084; Mueller UG, 2004, BEHAV ECOL, V15, P357, DOI 10.1093/beheco/arh020; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Poulsen M, 2005, SCIENCE, V307, P741, DOI 10.1126/science.1106688; Poulsen M, 2005, MOL ECOL, V14, P3597, DOI 10.1111/j.1365-294X.2005.02695.x; Poulsen M, 2002, INSECT SOC, V49, P15, DOI 10.1007/s00040-002-8271-5; POULSEN M, 2006, INSECT SYMBIOSIS, V2, P57; Ratnieks FLW, 2006, ANNU REV ENTOMOL, V51, P581, DOI 10.1146/annurev.ento.51.110104.151003; Riley MA, 1996, J IND MICROBIOL, V17, P151, DOI 10.1007/BF01574688; Riley MA, 2003, J EVOLUTION BIOL, V16, P690, DOI 10.1046/j.1420-9101.2003.00575.x; Rudgers JA, 2004, P ROY SOC B-BIOL SCI, V271, P2481, DOI 10.1098/rspb.2004.2900; Sachs JL, 2004, Q REV BIOL, V79, P135, DOI 10.1086/383541; Schneider S., 2000, ARLEQUIN VER 2 000 S; Schultz TR, 1995, SYST ENTOMOL, V20, P337, DOI 10.1111/j.1365-3113.1995.tb00100.x; Stahl DA, 2006, NATURE, V443, P925, DOI 10.1038/nature05208; Stanton ML, 2003, AM NAT, V162, pS10, DOI 10.1086/378646; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tintjer T, 2006, NEW PHYTOL, V170, P513, DOI 10.1111/j.1469-8137.2006.01720.x; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Viana AMM, 2001, CHEMOECOLOGY, V11, P29, DOI 10.1007/PL00001829; Visick KL, 2000, J BACTERIOL, V182, P4578, DOI 10.1128/JB.182.16.4578-4586.2000; von Ihering H., 1898, ZOOL ANZ, V21, P238; West SA, 2002, SCIENCE, V296, P72, DOI 10.1126/science.1065507; Wu D, 2006, PLOS BIOL, V4, P1079, DOI 10.1371/journal.pbio.0040188; Yahr R, 2004, MOL ECOL, V13, P3367, DOI 10.1111/j.1365-294X.2004.02350.x; Zhang MM, 2007, ISME J, V1, P313, DOI 10.1038/ismej.2007.41	68	41	41	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e960	10.1371/journal.pone.0000960	http://dx.doi.org/10.1371/journal.pone.0000960			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17896000	Green Published, Green Submitted, gold			2022-12-25	WOS:000207455800038
J	Trombone, APF; Silva, CL; Lima, KM; Oliver, C; Jamur, MC; Prescott, AR; Coelho-Castelo, AAM				Trombone, Ana Paula F.; Silva, Celio L.; Lima, Karla M.; Oliver, Constance; Jamur, Maria Celia; Prescott, Alan R.; Coelho-Castelo, Arlete A. M.			Endocytosis of DNA-Hsp65 Alters the pH of the Late Endosome/Lysosome and Interferes with Antigen Presentation	PLOS ONE			English	Article							DIRECT GENE-TRANSFER; BACTERIAL CPG-DNA; PLASMID DNA; NUCLEAR IMPORT; IN-VIVO; EXPRESSION; CELLS; TUBERCULOSIS; MECHANISM; DELIVERY	Background. Experimental models using DNA vaccine has shown that this vaccine is efficient in generating humoral and cellular immune responses to a wide variety of DNA-derived antigens. Despite the progress in DNA vaccine development, the intracellular transport and fate of naked plasmid DNA in eukaryotic cells is poorly understood, and need to be clarified in order to facilitate the development of novel vectors and vaccine strategies. Methodology and Principal Findings. Using confocal microscopy, we have demonstrated for the first time that after plasmid DNA uptake an inhibition of the acidification of the lysosomal compartment occurs. This lack of acidification impaired antigen presentation to CD4 T cells, but did not alter the recruitment of MyD88. The recruitment of Rab 5 and Lamp I were also altered since we were not able to co-localize plasmid DNA with Rab 5 and Lamp I in early endosomes and late endosomes/lysosomes, respectively. Furthermore, we observed that the DNA capture process in macrophages was by clathrin-mediated endocytosis. In addition, we observed that plasmid DNA remains in vesicles until it is in a juxtanuclear location, suggesting that the plasmid does not escape into the cytoplasmic compartment. Conclusions and Significance. Taken together our data suggests a novel mechanism involved in the intracellular trafficking of plasmid DNA, and opens new possibilities for the use of lower doses of plasmid DNA to regulate the immune response.	[Trombone, Ana Paula F.; Silva, Celio L.; Lima, Karla M.; Coelho-Castelo, Arlete A. M.] Univ Sao Paulo, Dept Biochem & Immunol, Sch Med Ribeirao Preto, Sao Paulo, Brazil; [Trombone, Ana Paula F.; Silva, Celio L.; Coelho-Castelo, Arlete A. M.] Univ Sao Paulo, Brazilian TB Res Network, Sch Med Ribeirao Preto, Sao Paulo, Brazil; [Oliver, Constance; Jamur, Maria Celia] Univ Sao Paulo, Dept Cellular & Mol Biol, Sch Med Ribeirao Preto, Sao Paulo, Brazil; [Prescott, Alan R.] Univ Dundee, Sch Life Sci, Div Cell Biol & Immunol, Dundee, Scotland	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; University of Dundee	Coelho-Castelo, AAM (corresponding author), Univ Sao Paulo, Dept Biochem & Immunol, Sch Med Ribeirao Preto, Sao Paulo, Brazil.	arlete@fmrp.usp.br	Castelo, Arlete AM Coelho/C-8530-2012; Prescott, Alan/Y-5956-2018; Silva, Celio/C-4639-2012; Garlet, Ana Paula Trombone/N-9346-2013	Prescott, Alan/0000-0002-0747-7317; Silva, Celio/0000-0002-0043-4568; Garlet, Ana Paula Trombone/0000-0002-8102-6098; Coelho-Castelo, Arlete A. M./0000-0001-5737-2671	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Pesquisa (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and Conselho Nacional de Pesquisa (CNPq).	ABBAS AK, 2003, CELLULAR MOL IMMUNOL, P81; Accapezzato D, 2005, J EXP MED, V202, P817, DOI 10.1084/jem.20051106; ACSADI G, 1991, NEW BIOL, V3, P71; Ahmad-Nejad P, 2002, EUR J IMMUNOL, V32, P1958, DOI 10.1002/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO;2-U; Basner-Tschakarjan E, 2004, GENE THER, V11, P765, DOI 10.1038/sj.gt.3302221; BENVENISTY N, 1986, P NATL ACAD SCI USA, V83, P9551, DOI 10.1073/pnas.83.24.9551; Budker V, 2000, J GENE MED, V2, P76, DOI 10.1002/(SICI)1521-2254(200003/04)2:2<76::AID-JGM97>3.0.CO;2-4; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Ciftci K, 2001, INT J PHARM, V218, P81, DOI 10.1016/S0378-5173(01)00623-8; Clark PR, 1999, CURR OPIN MOL THER, V1, P158; Coelho-Castelo AAM, 2003, HUM GENE THER, V14, P1279, DOI 10.1089/104303403767740812; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Foster KA, 2001, J PHARM PHARMACOL, V53, P57, DOI 10.1211/0022357011775190; Gurunathan S, 2000, ANNU REV IMMUNOL, V18, P927, DOI 10.1146/annurev.immunol.18.1.927; Hacker H, 2000, J EXP MED, V192, P595, DOI 10.1084/jem.192.4.595; Hagstrom JE, 1997, J CELL SCI, V110, P2323; Hengge UR, 1996, J CLIN INVEST, V97, P2911, DOI 10.1172/JCI118750; Jilek S, 2005, ADV DRUG DELIVER REV, V57, P377, DOI 10.1016/j.addr.2004.09.010; Klemm AR, 1998, BIOCHEM PHARMACOL, V56, P41, DOI 10.1016/S0006-2952(98)00098-7; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Lechardeur D, 2005, ADV DRUG DELIVER REV, V57, P755, DOI 10.1016/j.addr.2004.12.008; Li K, 1997, J MOL CELL CARDIOL, V29, P1499, DOI 10.1006/jmcc.1997.0389; LOWRIE DB, 1994, VACCINE, V12, P1537, DOI 10.1016/0264-410X(94)90080-9; Lowrie DB, 1999, NATURE, V400, P269, DOI 10.1038/22326; Lowrie DB, 2000, VACCINE, V18, P1712, DOI 10.1016/S0264-410X(99)00512-5; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; Lukacs GL, 2000, J BIOL CHEM, V275, P1625, DOI 10.1074/jbc.275.3.1625; Mui B, 2000, BBA-BIOMEMBRANES, V1467, P281, DOI 10.1016/S0005-2736(00)00226-1; Newman SL, 2006, J IMMUNOL, V176, P1806, DOI 10.4049/jimmunol.176.3.1806; Panyam J, 2003, ADV DRUG DELIVER REV, V55, P329, DOI 10.1016/S0169-409X(02)00228-4; Panyam J, 2002, FASEB J, V16, DOI 10.1096/fj.02-0088com; Pillay CS, 2002, BIOCHEM J, V363, P417, DOI 10.1042/0264-6021:3630417; Schnare M, 2000, CURR BIOL, V10, P1139, DOI 10.1016/S0960-9822(00)00700-4; SIKES ML, 1994, HUM GENE THER, V5, P837, DOI 10.1089/hum.1994.5.7-837; Simoes S, 1999, CURR OPIN MOL THER, V1, P147; Sonawane ND, 2003, J BIOL CHEM, V278, P44826, DOI 10.1074/jbc.M308643200; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; STENMARK H, 1994, EMBO J, V13, P575, DOI 10.1002/j.1460-2075.1994.tb06295.x; Suh HR, 1998, J BIOMED MATER RES, V42, P331, DOI 10.1002/(SICI)1097-4636(199811)42:2<331::AID-JBM19>3.0.CO;2-L; Tascon RE, 1996, NAT MED, V2, P888, DOI 10.1038/nm0896-888; Underhill DM, 1999, P NATL ACAD SCI USA, V96, P14459, DOI 10.1073/pnas.96.25.14459; Wattiaux R, 2000, ADV DRUG DELIVER REV, V41, P201, DOI 10.1016/S0169-409X(99)00066-6; West MA, 1999, EUR J IMMUNOL, V29, P3450, DOI 10.1002/(SICI)1521-4141(199911)29:11<3450::AID-IMMU3450>3.0.CO;2-A; Wiethoff CM, 2003, J PHARM SCI-US, V92, P203, DOI 10.1002/jps.10286; Wilson GL, 1999, J BIOL CHEM, V274, P22025, DOI 10.1074/jbc.274.31.22025; WOLFF JA, 1992, J CELL SCI, V103, P1249; WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918; Zelphati O, 1996, PHARMACEUT RES, V13, P1367, DOI 10.1023/A:1016026101195; Zelphati O, 1996, P NATL ACAD SCI USA, V93, P11493, DOI 10.1073/pnas.93.21.11493; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	50	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e923	10.1371/journal.pone.0000923	http://dx.doi.org/10.1371/journal.pone.0000923			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895965	Green Published, Green Submitted, gold			2022-12-25	WOS:000207455800003
J	Wani, AA; Ahanger, SH; Bapat, SA; Rangrez, AY; Hingankar, N; Suresh, CG; Barnabas, S; Patole, MS; Shouche, YS				Wani, Aijaz A.; Ahanger, Sajad H.; Bapat, Sharmila A.; Rangrez, Ashraf Y.; Hingankar, Nitin; Suresh, C. G.; Barnabas, Shama; Patole, Milind S.; Shouche, Yogesh S.			Analysis of Mitochondrial DNA Sequences in Childhood Encephalomyopathies Reveals New Disease-Associated Variants	PLOS ONE			English	Article								Background. Mitochondrial encephalomyopathies are a heterogeneous group of clinical disorders generally caused due to mutations in either mitochondrial DNA (mtDNA) or nuclear genes encoding oxidative phosphorylation (OXPHOS). We analyzed the mtDNA sequences from a group of 23 pediatric patients with clinical and morphological features of mitochondrial encephalopathies and tried to establish a relationship of identified variants with the disease. Methodology/Principle Findings. Complete mitochondrial genomes were amplified by PCR and sequenced by automated DNA sequencing. Sequencing data was analyzed by SeqScape software and also confirmed by BLASTn program. Nucleotide sequences were compared with the revised Cambridge reference sequence (CRS) and sequences present in mitochondrial databases. The data obtained shows that a number of known and novel mtDNA variants were associated with the disease. Most of the non-synonymous variants were heteroplasmic (A4136G, A9194G and T11916A) suggesting their possibility of being pathogenic in nature. Some of the missense variants although homoplasmic were showing changes in highly conserved amino acids (T3394C, T3866C, and G9804A) and were previously identified with diseased conditions. Similarly, two other variants found in tRNA genes (G5783A and C8309T) could alter the secondary structure of Cys-tRNA and Lys-tRNA. Most of the variants occurred in single cases; however, a few occurred in more than one case (e. g. G5783A and A10149T). Conclusions and Significance. The mtDNA variants identified in this study could be the possible cause of mitochondrial encephalomyopathies with childhood onset in the patient group. Our study further strengthens the pathogenic score of known variants previously reported as provisionally pathogenic in mitochondrial diseases. The novel variants found in the present study can be potential candidates for further investigations to establish the relationship between their incidence and role in expressing the disease phenotype. This study will be useful in genetic diagnosis and counseling of mitochondrial diseases in India as well as worldwide.	[Wani, Aijaz A.; Ahanger, Sajad H.; Bapat, Sharmila A.; Rangrez, Ashraf Y.; Patole, Milind S.; Shouche, Yogesh S.] Natl Ctr Cell Sci, Pune, Maharashtra, India; [Hingankar, Nitin; Suresh, C. G.; Barnabas, Shama] Natl Chem Lab, Div Biochem Sci, Pune, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL)	Shouche, YS (corresponding author), Natl Ctr Cell Sci, Pune, Maharashtra, India.	yogesh@nccs.res.in	Rangrez, Ashraf/H-4988-2016; Bapat, Sharmila/AGU-4130-2022	Rangrez, Ashraf/0000-0003-2630-9754; Bapat, Sharmila/0000-0002-9557-2233	Department of Biotechnology, India; Council of Scientific and Industrial Research (CSIR), India	Department of Biotechnology, India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	This study was supported by a grant from Department of Biotechnology, India. Wani A. A. is Senior Research fellow of Council of Scientific and Industrial Research (CSIR), India.	Abu-Amero KK, 2006, INVEST OPHTH VIS SCI, V47, P4211, DOI 10.1167/iovs.06-0295; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00; BROWN MD, 1992, GENETICS, V130, P163; BROWN MD, 1995, HUM MUTAT, V6, P311, DOI 10.1002/humu.1380060405; Carelli V, 2003, TRENDS GENET, V19, P257, DOI 10.1016/S0168-9525(03)00072-6; Da Pozzo P, 2004, BIOCHEM BIOPH RES CO, V324, P360, DOI 10.1016/j.bbrc.2004.09.058; DiMauro S, 2000, BRAIN PATHOL, V10, P431; DIMAURO S, 1993, ARCH NEUROL-CHICAGO, V50, P1197, DOI 10.1001/archneur.1993.00540110075008; Fauser S, 2002, BIOCHEM BIOPH RES CO, V295, P342, DOI 10.1016/S0006-291X(02)00672-1; Feigenbaum A, 2006, AM J MED GENET A, V140A, P2216, DOI 10.1002/ajmg.a.31436; HOWELL N, 1991, AM J HUM GENET, V48, P935; Hutchin TP, 2000, CELL MOL LIFE SCI, V57, P1927, DOI 10.1007/PL00000673; Janssen RJRJ, 2004, EXPERT REV MOL DIAGN, V4, P143, DOI 10.1586/14737159.4.2.143; Kovalenko SA, 1996, BIOCHEM BIOPH RES CO, V222, P201, DOI 10.1006/bbrc.1996.0722; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Liang MH, 1998, AM J MED GENET, V77, P395, DOI 10.1002/(SICI)1096-8628(19980605)77:5<395::AID-AJMG8>3.0.CO;2-M; Marchington DR, 1996, HUM MOL GENET, V5, P473, DOI 10.1093/hmg/5.4.473; Martorell L, 2006, EUR J HUM GENET, V14, P520, DOI 10.1038/sj.ejhg.5201606; Matsumoto M, 1999, Ophthalmic Genet, V20, P153, DOI 10.1076/opge.20.3.153.2281; McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819; Palanichamy MG, 2004, AM J HUM GENET, V75, P966, DOI 10.1086/425871; Parfait B, 1998, BIOCHEM BIOPH RES CO, V247, P57, DOI 10.1006/bbrc.1998.8666; Pereira C, 2007, BIOCHEM BIOPH RES CO, V354, P937, DOI 10.1016/j.bbrc.2007.01.068; Rajkumar R, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-26; Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967; Sarzi E, 2007, AM J MED GENET A, V143A, P33, DOI 10.1002/ajmg.a.31565; SHOFFNER JM, 1995, NEUROLOGY, V45, P286, DOI 10.1212/WNL.45.2.286; Simon DK, 1999, ANNU REV MED, V50, P111; Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063; Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Uusimaa J, 2004, PEDIATRICS, V114, P443, DOI 10.1542/peds.114.2.443; Zhadanov SI, 2005, BIOCHEM BIOPH RES CO, V332, P1115, DOI 10.1016/j.bbrc.2005.05.059	34	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e942	10.1371/journal.pone.0000942	http://dx.doi.org/10.1371/journal.pone.0000942			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895983	Green Published, gold, Green Submitted			2022-12-25	WOS:000207455800021
J	Mantovani, G; Bondioni, S; Lania, AG; Rodolfo, M; Peverelli, E; Polentarutti, N; Rodriguez, TV; Ferrero, S; Bosari, S; Beck-Peccoz, P; Spada, A				Mantovani, G.; Bondioni, S.; Lania, A. G.; Rodolfo, M.; Peverelli, E.; Polentarutti, N.; Rodriguez, T. Veliz; Ferrero, S.; Bosari, S.; Beck-Peccoz, P.; Spada, A.			High expression of PKA regulatory subunit 1A protein is related to proliferation of human melanoma cells	ONCOGENE			English	Article						melanomas; PKA; cAMP; R1/R2 ratio; proliferation	HL-60 LEUKEMIA-CELLS; RII-BETA-SUBUNIT; KINASE-A; MALIGNANT-MELANOMA; ADENYLYL CYCLASE; MUTATIONS; GROWTH; ALPHA; CAMP; DIFFERENTIATION	The cAMP-protein kinase A (PKA) pathway is the major signal transduction pathway involved in melanocyte-stimulating hormone receptor-mediated signaling and melanin production, whereas its role in the control of melanocyte proliferation is still controversial. In this study, we evaluated the effects of selective activation of the different PKA regulatory subunits type 1A (R1A) and type 2B (R2B) on melanocyte proliferation. Immunohistochemistry demonstrated that normal melanocytes lacked R1A protein whereas this subunit was highly expressed in all human melanomas studied (N = 20) and in six human melanoma cell lines. Pharmacological activation of the R2 subunits by the cAMP analogue 8-Cl-cAMP inhibited proliferation and increased caspase-3 activity by 68.77 +/- 10.5 and 72 +/- 9% respectively, in all cell lines with the exception of the only p53-mutated one. Similar effects were obtained by activating R2 subunits with other analogues and by silencing R1A expression. The antiproliferative and proapoptotic effects of 8-Cl-cAMP were comparable to those observed with commonly used antitumoral drugs. Moreover, 8-Cl-cAMP potentiated the effects of these drugs on both cell proliferation and caspase-3 activity. In conclusion, this study first reports that human melanomas are characterized by a high R1/R2 ratio and that pharmacological and genetic manipulations able to revert this unbalanced expression cause significant antiproliferative and proapoptotic effects in melanoma cells.	[Mantovani, G.; Bondioni, S.; Lania, A. G.; Peverelli, E.; Beck-Peccoz, P.; Spada, A.] Univ Milan, Dept Med Sci, Endocrine Unit, Fdn Policlin Osped Maggiore IRCCS, I-20122 Milan, Italy; [Rodolfo, M.] Ist Nazl Studio & Cura Tumori, IRCCS, Unit Melanoma Genet, I-20133 Milan, Italy; [Polentarutti, N.; Rodriguez, T. Veliz] IRCCS, Ist Clin Humanitas, Dept Immunol & Inflammat, Milan, Italy; [Ferrero, S.; Bosari, S.] AO San Paolo, Dept Med Surg & Dent, Pathol Unit, Milan, Italy; [Ferrero, S.; Bosari, S.] Fdn Osped Maggiore, IRCCS, Milan, Italy	University of Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Humanitas Research Hospital; IRCCS Ca Granda Ospedale Maggiore Policlinico	Spada, A (corresponding author), Univ Milan, Dept Med Sci, Endocrine Unit, Fdn Policlin Osped Maggiore IRCCS, Via F Sforza 35, I-20122 Milan, Italy.	anna.spada@unimi.it	rodolfo, monica/H-2671-2012; lania, andrea/AAA-9020-2019; Bosari, Silvano/K-7744-2016; Mantovani, Giovanna/A-2378-2014	rodolfo, monica/0000-0002-9196-0298; Bosari, Silvano/0000-0002-9744-6951; Mantovani, Giovanna/0000-0002-9065-3886; Peverelli, Erika/0000-0002-4424-7895; Lania, Andrea Gerardo Antonio/0000-0002-5380-2141	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Cho YS, 2000, P NATL ACAD SCI USA, V97, P835, DOI 10.1073/pnas.97.2.835; Cho-Chung YS, 2005, ANN NY ACAD SCI, V1058, P76, DOI 10.1196/annals.1359.014; CHOCHUNG YS, 1990, CANCER RES, V50, P7093; CHOCHUNG YS, 1995, CRIT REV ONCOL HEMAT, V21, P2133; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Daniotti M, 2004, ONCOGENE, V23, P5968, DOI 10.1038/sj.onc.1207780; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; DELUCA M, 1993, J CELL SCI, V105, P1079; Di Stasi D, 2005, INT J CANCER, V115, P224, DOI 10.1002/ijc.20885; Dumaz N, 2005, FEBS J, V272, P3491, DOI 10.1111/j.1742-4658.2005.04763.x; HANDSCHIN JC, 1979, FEBS LETT, V106, P301, DOI 10.1016/0014-5793(79)80519-0; HUNT G, 1994, PIGM CELL RES, V7, P217, DOI 10.1111/j.1600-0749.1994.tb00052.x; Kirschner LS, 2000, NAT GENET, V26, P89, DOI 10.1038/79238; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; Lania A, 2001, EUR J ENDOCRINOL, V145, P543, DOI 10.1530/eje.0.1450543; Lania AG, 2004, CANCER RES, V64, P9193, DOI 10.1158/0008-5472.CAN-04-1847; LEVINE N, 1991, JAMA-J AM MED ASSOC, V266, P2730, DOI 10.1001/jama.266.19.2730; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Nesterova M, 1996, EUR J BIOCHEM, V235, P486, DOI 10.1111/j.1432-1033.1996.00486.x; ROHLFF C, 1993, J BIOL CHEM, V268, P5774; Schwede F, 2000, BIOCHEMISTRY-US, V39, P8803, DOI 10.1021/bi000304y; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Tanami H, 2004, ONCOGENE, V23, P8796, DOI 10.1038/sj.onc.1208152; TORTORA G, 1990, P NATL ACAD SCI USA, V87, P705, DOI 10.1073/pnas.87.2.705; WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403	25	40	41	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR	2008	27	13					1834	1843		10.1038/sj.onc.1210831	http://dx.doi.org/10.1038/sj.onc.1210831			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	276NZ	17906691				2022-12-25	WOS:000254150600003
J	Rashmi, R; Pillai, SG; Vijayalingam, S; Ryerse, J; Chinnadurai, G				Rashmi, R.; Pillai, S. G.; Vijayalingam, S.; Ryerse, J.; Chinnadurai, G.			BH3-only protein BIK induces caspase-independent cell death with autophagic features in Bcl-2 null cells	ONCOGENE			English	Article						BIK; Bcl-2; autophagy; Beclin-1; LC3	MALIGNANT GLIOMA-CELLS; FAMILY PROTEINS; DOWN-REGULATION; CANCER-CELLS; APOPTOSIS; BAX; EXPRESSION; SURVIVAL; REQUIREMENT; INDUCTION	The BH3-only protein BIK normally induces apoptotic cell death. Here, we have investigated the role of BCL-2 in BIK-induced cell death using Bcl-2(+/+) and Bcl-2(-/-) mouse embryo fibroblasts. Ectopic expression of BIK in Bcl-2(-/-) cells resulted in enhanced cell death compared to Bcl-2(-/-) cells. In these cells, while caspase-8 was activated, there was no significant activation of caspase-9 and 3. There was no detectable mitochondrial to cytosolic release of cytochrome-c. However, there was significant redistribution of AIF from mitochondria to the nucleus. The extent of BIK-induced cell death was augmented by treatment with the pancaspase inhibitor, zVAD-fmk. The Bcl- 2 null cells expressingB IK exhibited autophagic features such as cytosolic vacuoles, punctate distribution of LC3 and enhanced expression of Beclin-1. The survival of BIK-expressing Bcl-2(-/-) cells was enhanced in the presence of PI3 kinase inhibitors 3-methyladenine and Wortmannin and also by depletion of Atg5 and Beclin-1. Death of BIK-expressing Bcl-2(-/-) cells treated with zVAD-fmk was increased under caspase-8 depletion. Our results suggest enhanced expression of BIK in the Bcl- 2 deficient cells leads to cell death with autophagic features and the extent of such cell death could be increased by inhibition of caspases.	[Rashmi, R.; Pillai, S. G.; Vijayalingam, S.; Chinnadurai, G.] St Louis Univ, Hlth Sci Ctr, Inst Mol Virol, St Louis, MO 63110 USA; [Ryerse, J.] St Louis Univ, Hlth Sci Ctr, Dept Pathol, St Louis, MO 63110 USA	Saint Louis University; Saint Louis University	Chinnadurai, G (corresponding author), St Louis Univ, Hlth Sci Ctr, Inst Mol Virol, 3681 Pk Ave, St Louis, MO 63110 USA.	chinnag@slu.edu	Pillai, Sreeraj G/M-2369-2013; Pillai, Rashmi Ramachandran/B-8130-2012	Pillai, Sreeraj G/0000-0002-0285-0813; Pillai, Rashmi Ramachandran/0000-0002-1619-7763	NATIONAL CANCER INSTITUTE [R01CA033616, R01CA073803, R21CA116262] Funding Source: NIH RePORTER; NCI NIH HHS [CA-73803, CA-116262, R01 CA033616-27, R21 CA116262-01, R21 CA116262, R01 CA033616, R01 CA073803, R01 CA073803-08, CA-33616] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bassik MC, 2004, EMBO J, V23, P1207, DOI 10.1038/sj.emboj.7600104; BOYD JM, 1995, ONCOGENE, V11, P1921; Dai ZY, 2006, BIOCHEM BIOPH RES CO, V351, P455, DOI 10.1016/j.bbrc.2006.10.055; Daido S, 2004, CANCER RES, V64, P4286, DOI 10.1158/0008-5472.CAN-03-3084; Elangovan B, 1997, J BIOL CHEM, V272, P24494, DOI 10.1074/jbc.272.39.24494; Garcia N, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-93; Golstein P, 2007, TRENDS BIOCHEM SCI, V32, P37, DOI 10.1016/j.tibs.2006.11.001; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kanzawa T, 2005, ONCOGENE, V24, P980, DOI 10.1038/sj.onc.1208095; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Lu Y, 2006, PLOS MED, V3, P2229, DOI 10.1371/journal.pmed.0030467; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Mathai JP, 2005, J BIOL CHEM, V280, P23829, DOI 10.1074/jbc.M500800200; Naumann U, 2003, HUM GENE THER, V14, P1235, DOI 10.1089/104303403767740777; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Oppermann M, 2005, ONCOGENE, V24, P7369, DOI 10.1038/sj.onc.1208890; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Rashmi R, 2005, CARCINOGENESIS, V26, P713, DOI 10.1093/carcin/bgi025; Saeki K, 2000, CELL DEATH DIFFER, V7, P1263, DOI 10.1038/sj.cdd.4400759; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Sturm I, 2006, CELL DEATH DIFFER, V13, P619, DOI 10.1038/sj.cdd.4401782; Theodorakis P, 2002, CANCER RES, V62, P3373; Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Xu Y, 2006, J BIOL CHEM, V281, P19179, DOI 10.1074/jbc.M513377200; Yanagisawa H, 2003, CELL DEATH DIFFER, V10, P798, DOI 10.1038/sj.cdd.4401246; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yu L, 2006, P NATL ACAD SCI USA, V103, P4952, DOI 10.1073/pnas.0511288103; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	31	54	56	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 28	2008	27	10					1366	1375		10.1038/sj.onc.1210783	http://dx.doi.org/10.1038/sj.onc.1210783			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	267ZR	17873911	Green Accepted			2022-12-25	WOS:000253548200003
J	Pang, PC; Tissot, B; Drobnis, EZ; Sutovsky, P; Morris, HR; Clark, GF; Dell, A				Pang, Poh-Choo; Tissot, Berangere; Drobnis, Erma Z.; Sutovsky, Peter; Morris, Howard R.; Clark, Gary F.; Dell, Anne			Expression of bisecting type and Lewis(x)/Lewis(y) terminated N-Glycans on human sperm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN SEMINAL PLASMA; NATURAL-KILLER-CELLS; TESTICULAR GERM-CELLS; HUMAN UTERINE CERVIX; TUMOR-MARKER CA125; CLASS-I MOLECULES; DC-SIGN; SEMINIFEROUS TUBULES; LOTUS-TETRAGONOLOBUS; FUCOSYL TRANSFERASE	Human sperm lack major histocompatibility class I molecules, making them susceptible to lysis by natural killer (NK) cells. Major histocompatibility class I negative tumor cells block NK cellysis by expressing sufficient amounts of bisecting type N-glycans on their surfaces. Therefore, sperm could employ the same strategy to evade NK cell lysis. The total N-glycans derived from sperm were sequenced using ultrasensitive mass spectrometric and conventional approaches. Three major classes of N-glycans were detected, (i) high mannose, (ii) biantennary bisecting type, and (iii) biantennary, triantennary, and tetraantennary oligosaccharides terminated with Lewis(x) and Lewis(y) sequences. Immunostaining of normal sperm showed that glycoproteins bearing Lewis(y) sequences are localized to the acrosome and not the plasma membrane. In contrast, defective sperm showed distinct surface labeling with anti-Lewis(y) antibody. The substantial expression of high mannose and complex type N-glycans terminated with Lewis(x) and Lewis(y) sequences suggests that sperm glycoproteins are highly decorated with ligands for DC-SIGN. Based on previous studies, the addition of such carbohydrate signals should inhibit antigen-specific responses directed against sperm glycoproteins in both the male and female reproductive systems. Thus, the major N-glycans of human sperm are associated with the inhibition of both innate and adaptive immune responses. These results provide more support for the eutherian fetoembryonic defense system hypothesis that links the expression of carbohydrate functional groups to the protection of gametes and the developing human in utero. This study also highlights the usefulness of glycomic profiling for revealing potential physiological functions of glycans expressed in specific cell types.	Univ Missouri, Sch Med, Dept Obstet Gynecol & Womens Hlth, Div Reprod & Perinatal Res, Columbia, MO 65212 USA; Univ Missouri, Sch Med, Dept Obstet Gynecol & Womens Hlth, Div Reprod Endocrinol & Infertil, Columbia, MO 65212 USA; Univ Missouri, Div Anim Sci, Columbia, MO 65202 USA; M SCAN Ltd, Wokingham RG41 2TZ, Berks, England; Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Div Mol Biosci, London SW7 2AZ, England	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Imperial College London	Clark, GF (corresponding author), Univ Missouri, Sch Med, Dept Obstet Gynecol & Womens Hlth, Div Reprod & Perinatal Res, Columbia, MO 65212 USA.	clarkgf@health.missouri.edu; a.dell@imperial.ac.uk	Drobnis, Erna Z./M-2706-2016	Drobnis, Erna Z./0000-0001-5495-3489; Sutovsky, Peter/0000-0002-9231-2823	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI060397] Funding Source: NIH RePORTER; NIAID NIH HHS [AI060397-03] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome TrustEuropean Commission)		ADACHI M, 1988, J EXP MED, V167, P323, DOI 10.1084/jem.167.2.323; Algarra I, 2004, CANCER IMMUNOL IMMUN, V53, P904, DOI 10.1007/s00262-004-0517-9; Avril T, 2006, J LEUKOCYTE BIOL, V80, P787, DOI 10.1189/jlb.1005559; Baldus SE, 2006, HISTOL HISTOPATHOL, V21, P503, DOI 10.14670/HH-21.503; Barber LD, 1996, J IMMUNOL, V156, P3275; Bergman M, 2006, NAT REV MICROBIOL, V4, P151, DOI 10.1038/nrmicro1344; Bergman MP, 2004, J EXP MED, V200, P979, DOI 10.1084/jem.20041061; BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; Chalabi S, 2002, J BIOL CHEM, V277, P32562, DOI 10.1074/jbc.M205152200; Clark GF, 1997, MOL HUM REPROD, V3, P5, DOI 10.1093/molehr/3.1.5; Clarke K, 2000, CANCER RES, V60, P4804; CROSS NL, 1987, GAMETE RES, V16, P23, DOI 10.1002/mrd.1120160104; DCruz OJ, 1996, FERTIL STERIL, V65, P843, DOI 10.1016/S0015-0282(16)58224-7; DCruz OJ, 1997, AM J REPROD IMMUNOL, V37, P172; DIXON FJ, 1955, J EXP MED, V101, P245, DOI 10.1084/jem.101.3.245; Drobnis E Z, 1992, Oxf Rev Reprod Biol, V14, P1; Dym M, 1970, Biology Reprod., V3, P308; ELOUAGARI K, 1995, J BIOL CHEM, V270, P26970; Falco M, 1999, J EXP MED, V190, P793, DOI 10.1084/jem.190.6.793; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Fijak M, 2006, IMMUNOL REV, V213, P66, DOI 10.1111/j.1600-065X.2006.00438.x; HANISCH FG, 1986, EUR J BIOCHEM, V155, P239, DOI 10.1111/j.1432-1033.1986.tb09482.x; Haslam SM, 2000, GLYCOBIOLOGY, V10, P223, DOI 10.1093/glycob/10.2.223; HEAD JR, 1985, PERSPECT BIOL MED, V29, P115; Hutter H, 1998, J REPROD IMMUNOL, V38, P101, DOI 10.1016/S0165-0378(98)00032-1; ITOH M, 1995, ARCH ANDROLOGY, V35, P93, DOI 10.3109/01485019508987859; Itoh M, 2005, J REPROD IMMUNOL, V67, P57, DOI 10.1016/j.jri.2005.06.007; Itoh M, 1995, J ANAT, V187, P671; Jang-Lee J, 2006, METHOD ENZYMOL, V415, P59, DOI 10.1016/S0076-6879(06)15005-3; Karre K, 2002, SCAND J IMMUNOL, V55, P221, DOI 10.1046/j.1365-3083.2002.01053.x; KASHIWAGI N, 1994, TOHOKU J EXP MED, V173, P115, DOI 10.1620/tjem.173.115; LEE MC, 1985, ANAT REC, V212, P282, DOI 10.1002/ar.1092120310; Lombardo F, 2001, HUM REPROD UPDATE, V7, P450, DOI 10.1093/humupd/7.5.450; MEDAWAR PB, 1953, SYM SOC EXP BIOL, V7, P320; Meyer S, 2005, J BIOL CHEM, V280, P37349, DOI 10.1074/jbc.M507100200; Morris HR, 1996, J BIOL CHEM, V271, P32159, DOI 10.1074/jbc.271.50.32159; MYERS RB, 1995, J UROLOGY, V153, P1572, DOI 10.1016/S0022-5347(01)67464-0; NARASIMHAN S, 1985, BIOCHEMISTRY-US, V24, P1694, DOI 10.1021/bi00328a019; Nicoll G, 1999, J BIOL CHEM, V274, P34089, DOI 10.1074/jbc.274.48.34089; Ozanon C, 2005, HUM REPROD, V20, P2271, DOI 10.1093/humrep/dei013; PANDYA IJ, 1985, FERTIL STERIL, V43, P417; Patankar MS, 1997, MOL HUM REPROD, V3, P501, DOI 10.1093/molehr/3.6.501; Patankar MS, 2005, GYNECOL ONCOL, V99, P704, DOI 10.1016/j.ygyno.2005.07.030; PEREIRA MEA, 1974, BIOCHEMISTRY-US, V13, P3184, DOI 10.1021/bi00712a029; PIKE BL, 1980, J EXP MED, V152, P1407, DOI 10.1084/jem.152.5.1407; Pilch B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r40; Poland DCW, 2002, PROSTATE, V52, P34, DOI 10.1002/pros.10085; RONQUIST G, 1984, UROL RES, V12, P243; RONQUIST G, 1983, INT J FERTIL, V28, P239; RUMKE P, 1959, AM J CLIN PATHOL, V32, P357; Saari T, 1996, J REPROD IMMUNOL, V31, P65, DOI 10.1016/0165-0378(96)00962-X; Schroter S, 1999, J BIOL CHEM, V274, P29862, DOI 10.1074/jbc.274.42.29862; SETCHELL BP, 1967, J PHYSIOL-LONDON, V189, P63; Sutovsky Peter, 2004, Methods Mol Biol, V253, P59; Sutton-Smith M, 2007, GLYCOBIOLOGY, V17, P553, DOI 10.1093/glycob/cwm025; THOMPSON LA, 1992, AM J REPROD IMMUNOL, V28, P85, DOI 10.1111/j.1600-0897.1992.tb00765.x; TSUJI Y, 1988, J EXP MED, V168, P343, DOI 10.1084/jem.168.1.343; TUNG KSK, 1981, IMMUNOL REV, V55, P217, DOI 10.1111/j.1600-065X.1981.tb00344.x; van Die I, 2003, GLYCOBIOLOGY, V13, P471, DOI 10.1093/glycob/cwg052; van Liempt E, 2006, FEBS LETT, V580, P6123, DOI 10.1016/j.febslet.2006.10.009; VANHALBEEK H, 1985, BIOCHEM BIOPH RES CO, V131, P507, DOI 10.1016/0006-291X(85)91831-5; Wong NK, 2003, J BIOL CHEM, V278, P28619, DOI 10.1074/jbc.M302741200; World Health Organization (WHO), 1999, WHO LAB MANUAL EXAMI, V4th; Yan LY, 1997, GLYCOCONJUGATE J, V14, P45, DOI 10.1023/A:1018508914551; Yoshimura M, 1996, CANCER RES, V56, P412; YULE TD, 1988, J IMMUNOL, V141, P1161; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0	67	49	53	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36593	36602		10.1074/jbc.M705134200	http://dx.doi.org/10.1074/jbc.M705134200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17913713	hybrid			2022-12-25	WOS:000251458300052
J	Morimoto, H; Kondoh, K; Nishimoto, S; Terasawa, K; Nishida, E				Morimoto, Hiroko; Kondoh, Kunio; Nishimoto, Satoko; Terasawa, Kazuya; Nishida, Eisuke			Activation of a C-terminal transcriptional activation domain of ERK5 by autophosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAYS; PROTEIN-KINASE PATHWAYS; MAMMALIAN MAP KINASE; REGULATED KINASE-5; MEK5-ERK5 PATHWAY; TARGETED DELETION; GROWTH-FACTOR; BMK1/ERK5; ERK5/BMK1; CASCADES	ERK5 plays a crucial role in many biological processes by regulating transcription. ERK5 has a large C-terminal-half that contains a transcriptional activation domain. However, it has remained unclear how its transcriptional activation activity is regulated. Here, we show that the activated kinase activity of ERK5 is required for the C-terminal-half to enhance the AP-1 activity, and that the activated ERK5 undergoes autophosphorylation on its most C-terminal region. Changing these phosphorylatable threonine and serine residues to unphosphorylatable alanines significantly reduces the transcriptional activation activity of ERK5. Moreover, phosphomimetic mutants of the C-terminal-half of ERK5 without an N-terminal kinase domain are shown to be able to enhance the AP-1 activity in fibroblastic cells. These results reveal the role of the stimulus-induced ERK5 autophosphorylation in regulation of gene expression.	Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan	Kyoto University	Nishida, E (corresponding author), Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan.	L50174@sakura.kudpc.kyoto-u.ac.jp		Kondoh, Kunio/0000-0002-1139-328X				Abe J, 1996, J BIOL CHEM, V271, P16586, DOI 10.1074/jbc.271.28.16586; Ahn Natalie G., 1992, Current Opinion in Cell Biology, V4, P992, DOI 10.1016/0955-0674(92)90131-U; Akaike M, 2004, MOL CELL BIOL, V24, P8691, DOI 10.1128/MCB.24.19.8691-8704.2004; Buschbeck M, 2005, J BIOL CHEM, V280, P2659, DOI 10.1074/jbc.M412599200; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; English JM, 1998, J BIOL CHEM, V273, P3854, DOI 10.1074/jbc.273.7.3854; Fukuhara S, 2000, J BIOL CHEM, V275, P21730, DOI 10.1074/jbc.M002410200; Hayashi M, 2004, J CLIN INVEST, V113, P1138, DOI 10.1172/JCI200419890; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kamakura S, 1999, J BIOL CHEM, V274, P26563, DOI 10.1074/jbc.274.37.26563; Kasler HG, 2000, MOL CELL BIOL, V20, P8382, DOI 10.1128/MCB.20.22.8382-8389.2000; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Kato Y, 1998, NATURE, V395, P713, DOI 10.1038/27234; Kondoh K, 2006, MOL CELL BIOL, V26, P1679, DOI 10.1128/MCB.26.5.1679-1690.2006; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; LEE JD, 1995, BIOCHEM BIOPH RES CO, V213, P715, DOI 10.1006/bbrc.1995.2189; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mody N, 2003, BIOCHEM J, V372, P567, DOI 10.1042/BJ20030193; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; Nishimoto S, 2005, EMBO REP, V6, P1064, DOI 10.1038/sj.embor.7400515; Pouyssegur J, 2002, BIOCHEM PHARMACOL, V64, P755, DOI 10.1016/S0006-2952(02)01135-8; Regan CP, 2002, P NATL ACAD SCI USA, V99, P9248, DOI 10.1073/pnas.142293999; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Sohn SJ, 2002, J BIOL CHEM, V277, P43344, DOI 10.1074/jbc.M207573200; STURGILL TW, 1991, BIOCHIM BIOPHYS ACTA, V1092, P350, DOI 10.1016/S0167-4889(97)90012-4; Terasawa K, 2003, GENES CELLS, V8, P263, DOI 10.1046/j.1365-2443.2003.00631.x; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; Wang X, 2005, MOL CELL BIOL, V25, P336, DOI 10.1128/MCB.25.1.336-345.2005; WORONICZ JD, 1995, MOL CELL BIOL, V15, P6364; Yan C, 2001, J BIOL CHEM, V276, P10870, DOI 10.1074/jbc.M009286200; Yan Lijun, 2003, BMC Dev Biol, V3, P11, DOI 10.1186/1471-213X-3-11; Yang CC, 1998, NUCLEIC ACIDS RES, V26, P4771, DOI 10.1093/nar/26.20.4771; ZHOU GC, 1995, J BIOL CHEM, V270, P12665, DOI 10.1074/jbc.270.21.12665	36	73	79	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35449	35456		10.1074/jbc.M704079200	http://dx.doi.org/10.1074/jbc.M704079200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17928297	hybrid			2022-12-25	WOS:000251458100004
J	Moss, ML; Bomar, M; Liu, Q; Sage, H; Dempsey, P; Lenhart, PM; Gillispie, PA; Stoeck, A; Wildeboer, D; Bartsch, JW; Palmisano, R; Zhou, P				Moss, Marcia L.; Bomar, Martha; Liu, Qian; Sage, Harvey; Dempsey, Peter; Lenhart, Patricia M.; Gillispie, Patricia A.; Stoeck, Alexander; Wildeboer, Dirk; Bartsch, Joerg W.; Palmisano, Ralf; Zhou, Pei			The ADAM10 prodomain is a specific inhibitor of ADAM10 proteolytic activity and inhibits cellular shedding events	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-CONVERTING ENZYME; CLEAVAGE; METALLOPROTEINASES; RECEPTOR; ADAM-10; PROTEIN; DOMAIN	ADAM10 is a disintegrin metalloproteinase that processes amyloid precursor protein and ErbB ligands and is involved in the shedding of many type I and type II single membrane-spanning proteins. Like tumor necrosis factor-alpha-converting enzyme (TACE or ADAM17), ADAM10 is expressed as a zymogen, and removal of the prodomain results in its activation. Here we report that the recombinant mouse ADAM10 prodomain, purified from Escherichia coli, is a potent competitive inhibitor of the human ADAM10 catalytic/disintegrin domain, with a K-i of 48 nM. Moreover, the mouse ADAM10 prodomain is a selective inhibitor as it only weakly inhibits other ADAM family proteinases in the micromolar range and does not inhibit members of the matrix metalloproteinase family under similar conditions. Mouse prodomains of TACE and ADAM8 do not inhibit their respective enzymes, indicating that ADAM10 inhibition by its prodomain is unique. In cell-based assays we show that the ADAM10 prodomain inhibits betacellulin shedding, demonstrating that it could be of potential use as a therapeutic agent to treat cancer.	Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; BioZyme Inc, Apex, NC 27523 USA; Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; Kings Coll London, Dept Biochem, London SE1 9NH, England; Univ Bielefeld, Fac Biol, D-33615 Bielefeld, Germany	Duke University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of London; King's College London; University of Bielefeld	Zhou, P (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Rm 242,Nanaline Bldg,Res Dr, Durham, NC 27710 USA.	peizhou@biochem.duke.edu	Zhou, Pei/O-6704-2019; Bartsch, Joerg Walter/AAB-2951-2020	Zhou, Pei/0000-0002-7823-3416; Bartsch, Prof. Joerg Walter/0000-0002-2773-3357; Palmisano, Ralf/0000-0003-4283-2115	NIDDK NIH HHS [DK63363, DK59778] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059778, R01DK063363] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anders A, 2001, FASEB J, V15, P1837, DOI 10.1096/fj.01-0007fje; Black RA, 2003, BIOCHEM SOC SYMP, V70, P39, DOI 10.1042/bss0700039; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; BLOBEL CP, 1992, NATURE, V356, P248, DOI 10.1038/356248a0; Budagian V, 2004, J BIOL CHEM, V279, P40368, DOI 10.1074/jbc.M404125200; Fahrenholz F, 2000, ANN NY ACAD SCI, V920, P215; Gonzales PE, 2004, J BIOL CHEM, V279, P31638, DOI 10.1074/jbc.M401311200; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Hougaard S, 2000, BIOCHEM BIOPH RES CO, V275, P261, DOI 10.1006/bbrc.2000.3295; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Koizumi M, 2002, GASTROENTEROLOGY, V122, pA245; Kojro E, 2005, SUB CELL BIOCHEM, V38, P105; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Loechel F, 1999, J BIOL CHEM, V274, P13427, DOI 10.1074/jbc.274.19.13427; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Milla ME, 1999, J BIOL CHEM, V274, P30563, DOI 10.1074/jbc.274.43.30563; Moss ML, 2007, ANAL BIOCHEM, V366, P144, DOI 10.1016/j.ab.2007.04.043; Moss ML, 2004, BIOCHEMISTRY-US, V43, P7227, DOI 10.1021/bi049677f; Moss ML, 2002, ESSAYS BIOCHEM, V38, P141, DOI 10.1042/bse0380141; Naus S, 2006, BIOL CHEM, V387, P337, DOI 10.1515/BC.2006.045; Pan DJ, 1997, CELL, V90, P271, DOI 10.1016/S0092-8674(00)80335-9; Peduto L, 2005, CANCER RES, V65, P9312, DOI 10.1158/0008-5472.CAN-05-1063; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Rasmussen FH, 2004, BIOCHEMISTRY-US, V43, P2987, DOI 10.1021/bi036063m; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sanderson MP, 2005, J BIOL CHEM, V280, P1826, DOI 10.1074/jbc.M408804200; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; Wei S, 2005, J BIOL CHEM, V280, P32877, DOI 10.1074/jbc.C500220200; Zhou BBS, 2005, EXPERT OPIN INV DRUG, V14, P591, DOI 10.1517/13543784.14.6.591	31	112	112	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35712	35721		10.1074/jbc.M703231200	http://dx.doi.org/10.1074/jbc.M703231200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17895248	hybrid			2022-12-25	WOS:000251458100032
J	Ohoka, N; Hattori, T; Kitagawa, M; Onozaki, K; Hayashi, H				Ohoka, Nobumichi; Hattori, Takayuki; Kitagawa, Masatoshi; Onozaki, Kikuo; Hayashi, Hidetoshi			Critical and functional regulation of CHOP (c/EBP homologous protein) through the N-terminal portion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; TRANSCRIPTION FACTORS; INITIATION FACTOR-2-ALPHA; MAMMALIAN-CELLS; GENE-EXPRESSION; STRESS; DEGRADATION; UBIQUITIN; KINASE; P53	C/EBP homologous protein (CHOP) is an endoplasmic reticulum stress-inducible protein that plays a critical role in the regulation of programmed cell death; however, the regulation of its function has not been well characterized. We have previously demonstrated that CHOP is regulated by the ubiquitin-proteasome system. In this study, during the process of clarifying the mechanism of the degradation of CHOP, we identified a novel regulation domain of CHOP in its N-terminal portion that is involved in various regulations and functions. The CHOP N-terminal domain is necessary not only for protein degradation but also for its transactivity and interaction with p300. In addition, trichostatin A, a histone deacetylase inhibitor, repressed the degradation of CHOP protein via the N-terminal domain. TRB3, a mammalian tribbles homolog that functions as a repressor of CHOP, also interacted with CHOP via the N-terminal portion and significantly blocked the association of p300 with CHOP. These results suggest that the N-terminal portion of CHOP plays a crucial role in its functional regulation and enable us to identify a novel function of TRB3 as an intracellular antagonist of the p300-binding domain of CHOP.	Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Mol Hlth Sci, Nagoya, Aichi 4678603, Japan; Hamamatsu Univ Sch Med, Dept Biochem 1, Hamamatsu, Shizuoka 4313192, Japan	Nagoya City University; Hamamatsu University School of Medicine	Hayashi, H (corresponding author), 3-1 Tanabe Dori,Mizuho Ku, Nagoya, Aichi 4678603, Japan.	hhayashi@phar.nagoya-cu.ac.jp						Bowers AJ, 2003, ONCOGENE, V22, P2823, DOI 10.1038/sj.onc.1206367; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHEN JJ, 1991, P NATL ACAD SCI USA, V88, P7729, DOI 10.1073/pnas.88.17.7729; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; FORNACE AJ, 1989, MOL CELL BIOL, V9, P4196, DOI 10.1128/MCB.9.10.4196; Freiman RN, 2003, CELL, V112, P11, DOI 10.1016/S0092-8674(02)01278-3; Grossman SR, 2003, SCIENCE, V300, P342, DOI 10.1126/science.1080386; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hatakeyama S, 1999, P NATL ACAD SCI USA, V96, P3859, DOI 10.1073/pnas.96.7.3859; Hattori T, 2003, FEBS LETT, V541, P33, DOI 10.1016/S0014-5793(03)00283-7; Hattori T, 2003, ONCOGENE, V22, P1273, DOI 10.1038/sj.onc.1206204; HOCHSTRASSER M, 1995, CURR OPIN CELL BIOL, V7, P215, DOI 10.1016/0955-0674(95)80031-X; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; KOSTURA M, 1989, MOL CELL BIOL, V9, P1576, DOI 10.1128/MCB.9.4.1576; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Pahl HL, 1996, CURR OPIN CELL BIOL, V8, P340, DOI 10.1016/S0955-0674(96)80007-X; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Rorth P, 2000, MOL CELL, V6, P23; Ubeda M, 1996, MOL CELL BIOL, V16, P1479; Ubeda M, 2003, J BIOL CHEM, V278, P40514, DOI 10.1074/jbc.M306404200; Wang XJ, 2004, FEBS LETT, V561, P195, DOI 10.1016/S0014-5793(04)00168-1; Wang XZ, 1998, EMBO J, V17, P3619, DOI 10.1093/emboj/17.13.3619; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	31	61	70	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35687	35694		10.1074/jbc.M703735200	http://dx.doi.org/10.1074/jbc.M703735200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17872950	hybrid			2022-12-25	WOS:000251458100029
J	Villagra, A; Ulloa, N; Zhang, XH; Yuan, ZG; Sotomayor, E; Seto, E				Villagra, Alejandro; Ulloa, Natalia; Zhang, Xiaohong; Yuan, Zhigang; Sotomayor, Eduardo; Seto, Edward			Histone deacetylase 3 down-regulates cholesterol synthesis through repression of lanosterol synthase gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR YY1; ELEMENT-BINDING PROTEIN; LOW-DENSITY-LIPOPROTEIN; HISTONE DEACETYLASE; REDUCTASE-ACTIVITY; IN-VIVO; INHIBITORS; PROMOTER; CYCLASE; 2,3-OXIDOSQUALENE	In vertebrates, a key step in the biosynthesis of cholesterol and steroid hormones is the conversion of (S)-2,3-oxidosqualene to lanosterol. The enzyme that catalyzes this complex cyclization/rearrangement step via the protosteryl cation intermediate is lanosterol synthase ((S)-2,3-epoxysqualene mutase ( cyclizing, lanosterol forming), EC 5.4.99.7). Because of the crucial role that lanosterol synthase plays in cholesterol biosynthesis, there is great interest in the identification of drugs that target this enzyme for anticholesteremic purposes. Although most studies on lanosterol synthase in the past have focused on the structural and biochemical functions of this enzyme, almost nothing is known concerning how the synthesis of lanosterol synthase is regulated. Here, we report that histone deacetylase 3 (HDAC3) represses transcription from the lanosterol synthase promoter. Overexpression of HDAC3 decreases, whereas knockdown of HDAC3 by small interfering RNA increases, endogenous lanosterol synthase mRNA in cells. Similarly, in transient transfection assays, overexpression of HDAC3 decreases, whereas depletion of HDAC3 increases, expression of a reporter gene under the control of the lanosterol synthase promoter. Stable cell lines that overexpress HDAC3 show a decrease in lanosterol synthase mRNA and have lower cholesterol concentrations compared with parental cells. Extensive promoter analyses coupled with chromatin immunoprecipitation assays reveal that the transcription factor YY1 binds to and recruits HDAC3 to the lanosterol synthase promoter. Together, our results demonstrate that HDAC3 represses the synthesis of a key regulatory enzyme and reveal a novel mechanism by which the cholesterol biosynthetic pathway can be regulated.	H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; Univ Concepcion, Sch Pharm, Dept Clin Biochem & Immunol, Concepcion, Chile	H Lee Moffitt Cancer Center & Research Institute; Universidad de Concepcion	Seto, E (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, SRB 23011,12902 Magnolia Dr, Tampa, FL 33612 USA.	ed.seto@moffitt.org		Villagra, Alejandro/0000-0001-9346-8355	NCI NIH HHS [CA109699] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA109699] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Atchison L, 2003, EMBO J, V22, P1347, DOI 10.1093/emboj/cdg124; BAKER CH, 1995, BIOCHEM BIOPH RES CO, V213, P154, DOI 10.1006/bbrc.1995.2110; Bennett MK, 1999, J BIOL CHEM, V274, P13025, DOI 10.1074/jbc.274.19.13025; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; Brown AJ, 1996, J LIPID RES, V37, P320; Brown JL, 2003, DEVELOPMENT, V130, P285, DOI 10.1242/dev.00204; BROWN MS, 1978, J BIOL CHEM, V253, P1121; Chouinard RA, 1998, J BIOL CHEM, V273, P22409, DOI 10.1074/jbc.273.35.22409; Christenson LK, 2001, ENDOCRINOLOGY, V142, P28, DOI 10.1210/endo.142.1.7867; Duncan RE, 2005, CANCER EPIDEM BIOMAR, V14, P1897, DOI 10.1158/1055-9965.EPI-05-0027; Duncan RE, 2004, J BIOL CHEM, V279, P33079, DOI 10.1074/jbc.M400732200; Ericsson J, 1999, J BIOL CHEM, V274, P14508, DOI 10.1074/jbc.274.20.14508; Evert BO, 2006, J NEUROSCI, V26, P11474, DOI 10.1523/JNEUROSCI.2053-06.2006; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Hampton RY, 2000, CURR BIOL, V10, pR298, DOI 10.1016/S0960-9822(00)00434-6; HARIHARAN N, 1991, P NATL ACAD SCI USA, V88, P9799, DOI 10.1073/pnas.88.21.9799; Herman GE, 2003, HUM MOL GENET, V12, pR75, DOI 10.1093/hmg/ddg072; Ishizuka T, 2003, MOL CELL BIOL, V23, P5122, DOI 10.1128/MCB.23.15.5122-5131.2003; Kelley RI, 2001, ANNU REV GENOM HUM G, V2, P299, DOI 10.1146/annurev.genom.2.1.299; Klampfer L, 2004, J BIOL CHEM, V279, P30358, DOI 10.1074/jbc.M401359200; Li D, 2005, J BIOL CHEM, V280, P26941, DOI 10.1074/jbc.M500463200; Mahlknecht U, 2004, J IMMUNOL, V173, P3979, DOI 10.4049/jimmunol.173.6.3979; Maron DJ, 2000, CIRCULATION, V101, P207, DOI 10.1161/01.CIR.101.2.207; Miida Takashi, 2004, J Atheroscler Thromb, V11, P253; Morand OH, 1997, J LIPID RES, V38, P373; Mori M, 2006, J CLIN INVEST, V116, P395, DOI 10.1172/JCI20797; NESS GC, 1991, J BIOL CHEM, V266, P14854; Osborne TF, 1997, CURR BIOL, V7, pR172, DOI 10.1016/S0960-9822(97)70081-2; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PISANESCHI G, 1994, BIOCHEM BIOPH RES CO, V205, P1236, DOI 10.1006/bbrc.1994.2797; Rawson RB, 1999, J BIOL CHEM, V274, P28549, DOI 10.1074/jbc.274.40.28549; Rowe AH, 2003, CIRC RES, V93, P717, DOI 10.1161/01.RES.0000097606.43659.F4; Sakano Y, 2004, J ANTIBIOT, V57, P564, DOI 10.7164/antibiotics.57.564; Schroeder TM, 2004, J BIOL CHEM, V279, P41998, DOI 10.1074/jbc.M403702200; SETO E, 2006, BIOL HDAC3, P61; Sever N, 2003, MOL CELL, V11, P25, DOI 10.1016/S1097-2765(02)00822-5; Shenoy SD, 2004, MOL PHARMACOL, V65, P1302, DOI 10.1124/mol.65.5.1302; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; Simons K, 2002, J CLIN INVEST, V110, P597, DOI 10.1172/JCI200216390; Tabas I, 2002, J CLIN INVEST, V110, P583, DOI 10.1172/JCI200216381; Thoma R, 2004, NATURE, V432, P118, DOI 10.1038/nature02993; Thomas MJ, 1999, GENE, V236, P197, DOI 10.1016/S0378-1119(99)00261-9; Villagra A, 2006, J BIOL CHEM, V281, P22695, DOI 10.1074/jbc.M511640200; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Yang WM, 1996, P NATL ACAD SCI USA, V93, P12845, DOI 10.1073/pnas.93.23.12845; Yang WM, 1997, J BIOL CHEM, V272, P28001, DOI 10.1074/jbc.272.44.28001; Yang WM, 2002, J BIOL CHEM, V277, P9447, DOI 10.1074/jbc.M105993200; Yang Y, 2003, NOVON, V13, P153, DOI 10.2307/3393581; Yao YL, 2001, MOL CELL BIOL, V21, P5979, DOI 10.1128/MCB.21.17.5979-5991.2001; Yin L, 2005, MOL ENDOCRINOL, V19, P1452, DOI 10.1210/me.2005-0057; Young M, 1996, HUM GENET, V97, P620, DOI 10.1007/s004390050105; Zhang XH, 2004, MOL CELL BIOL, V24, P5106, DOI 10.1128/MCB.24.12.5106-5118.2004	54	26	26	4	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35457	35470		10.1074/jbc.M701719200	http://dx.doi.org/10.1074/jbc.M701719200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17925399	hybrid			2022-12-25	WOS:000251458100005
J	Bunka, DHJ; Mantle, BJ; Morten, IJ; Tennent, GA; Radford, SE; Stockley, PG				Bunka, David H. J.; Mantle, Benjamin J.; Morten, Isobel J.; Tennent, Glenys A.; Radford, Sheena E.; Stockley, Peter G.			Production and characterization of RNA aptamers specific for amyloid fibril epitopes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIALYSIS-RELATED AMYLOIDOSIS; FORMATION IN-VITRO; PRION-PROTEIN; SYSTEMIC AMYLOIDOSIS; MOLECULAR-MECHANISM; SECONDARY STRUCTURE; ALZHEIMER-DISEASE; CRYSTAL-STRUCTURE; OPERATOR COMPLEX; NEUTRAL PH	One of the most fascinating features of amyloid fibrils is their generic cross-beta architecture that can be formed from many different and completely unrelated proteins. Nonetheless, amyloid fibrils with diverse structural and phenotypic properties can form, both in vivo and in vitro, from the same protein sequence. Here, we have exploited the power of RNA selection techniques to isolate small, structured, single-stranded RNA molecules known as aptamers that were targeted specifically to amyloid-like fibrils formed in vitro from beta(2)-microglobulin (beta(2)m), the amyloid fibril protein associated with dialysis-related amyloidosis. The aptamers bind with high affinity (apparent K-D similar to nM) to beta(2)m fibrils with diverse morphologies generated under different conditions in vitro, as well as to amyloid fibrils isolated from tissues of dialysis-related amyloidosis patients, demonstrating that they can detect conserved epitopes between different fibrillar species of beta(2)m. Interestingly, the aptamers also recognize some other, but not all, amyloid fibrils generated in vitro or isolated from ex vivo sources. Based on these observations, we have shown that although amyloid fibrils share many common structural properties, they also have features that are unique to individual fibril types.	Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; UCL, Ctr Amyloidosis & Acute Phase Prot, London NW3 2PF, England	University of Leeds; University of London; University College London	Radford, SE (corresponding author), Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England.	s.e.radford@leeds.ac.uk; stockley@bmb.leeds.ac.uk		Stockley, Peter/0000-0002-1360-2751; Radford, Sheena/0000-0002-3079-8039	Biotechnology and Biological Sciences Research Council [G19036] Funding Source: Medline; Medical Research Council [G0200529] Funding Source: Medline; Wellcome Trust [075099] Funding Source: Medline; MRC [G0200529] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alexandrescu AT, 2005, PROTEIN SCI, V14, P1; Bunka DHJ, 2006, NAT REV MICROBIOL, V4, P588, DOI 10.1038/nrmicro1458; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Check E, 2002, NATURE, V415, P462, DOI 10.1038/415462a; Chiti F, 2001, PROTEIN SCI, V10, P879, DOI 10.1110/ps.42401; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cox JC, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf107; Cribbs DH, 1997, J BIOL CHEM, V272, P7431, DOI 10.1074/jbc.272.11.7431; Danesh F, 2001, SEMIN DIALYSIS, V14, P80, DOI 10.1046/j.1525-139x.2001.00035.x; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Ellingham M, 2006, RNA, V12, P1970, DOI 10.1261/rna.161006; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Famulok M, 2000, ACCOUNTS CHEM RES, V33, P591, DOI 10.1021/ar960167q; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; Floege J, 1996, NEPHRON, V72, P9, DOI 10.1159/000188801; GEJYO F, 1985, BIOCHEM BIOPH RES CO, V129, P701, DOI 10.1016/0006-291X(85)91948-5; GEJYO F, 1986, NEW ENGL J MED, V314, P585; GILLMORE JP, 2005, NAT CLIN PRACT, V263, P263; Giorgetti S, 2007, PROTEIN SCI, V16, P343, DOI 10.1110/ps.062563507; Gosal WS, 2005, J MOL BIOL, V351, P850, DOI 10.1016/j.jmb.2005.06.040; Jahn TR, 2005, AMYLOID PROTEINS: THE BETA SHEET CONFORMATION AND DISEASE, VOLS 1 AND 2, P667, DOI 10.1002/9783527619344.ch26; Jahn TR, 2006, NAT STRUCT MOL BIOL, V13, P195, DOI 10.1038/nsmb1058; Jahn TR, 2005, FEBS J, V272, P5962, DOI 10.1111/j.1742-4658.2005.05021.x; JAHN TR, 2007, IN PRESS ARCH BIOCH; Johansson AS, 2007, FEBS J, V274, P990, DOI 10.1111/j.1742-4658.2007.05647.x; Kad NM, 2003, J MOL BIOL, V330, P785, DOI 10.1016/S0022-2836(03)00583-7; Kad NM, 2001, J MOL BIOL, V313, P559, DOI 10.1006/jmbi.2001.5071; KLUNK WE, 1989, J HISTOCHEM CYTOCHEM, V37, P1273, DOI 10.1177/37.8.2666510; Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007; Krebs MRH, 2000, J MOL BIOL, V300, P541, DOI 10.1006/jmbi.2000.3862; Kreplak L, 2006, ADV PROTEIN CHEM, V73, P217, DOI 10.1016/S0065-3233(06)73007-8; LeVine III H., 1995, INT J EXP CLIN INVES, V2, P1, DOI DOI 10.3109/13506129509031881; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; McGregor A, 1999, J BIOL CHEM, V274, P2255, DOI 10.1074/jbc.274.4.2255; McParland VJ, 2002, NAT STRUCT BIOL, V9, P326, DOI 10.1038/nsb791; McParland VJ, 2000, BIOCHEMISTRY-US, V39, P8735, DOI 10.1021/bi000276j; Meier JJ, 2006, AM J PHYSIOL-ENDOC M, V291, pE1317, DOI 10.1152/ajpendo.00082.2006; Myers SL, 2006, BIOCHEMISTRY-US, V45, P2311, DOI 10.1021/bi052434i; NAGAI K, 1990, NATURE, V348, P515, DOI 10.1038/348515a0; Ng EWM, 2006, NAT REV DRUG DISCOV, V5, P123, DOI 10.1038/nrd1955; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; PARSONS ID, 1995, NUCLEIC ACIDS RES, V23, P211, DOI 10.1093/nar/23.2.211; Pepys MB, 2006, ANNU REV MED, V57, P223, DOI 10.1146/annurev.med.57.121304.131243; PEPYS MB, 1979, CLIN EXP IMMUNOL, V38, P284; PEPYS MB, 1993, NATURE, V362, P553, DOI 10.1038/362553a0; Plattt GW, 2005, J MOL BIOL, V346, P279, DOI 10.1016/j.jmb.2004.11.035; Proske D, 2002, CHEMBIOCHEM, V3, P717, DOI 10.1002/1439-7633(20020802)3:8<717::AID-CBIC717>3.0.CO;2-C; Radford SE, 2005, BBA-PROTEINS PROTEOM, V1753, P51, DOI 10.1016/j.bbapap.2005.07.006; Relini A, 2006, J BIOL CHEM, V281, P16521, DOI 10.1074/jbc.M513827200; Rhie A, 2003, J BIOL CHEM, V278, P39697, DOI 10.1074/jbc.M305297200; ROBERTSON DL, 1990, NATURE, V344, P467, DOI 10.1038/344467a0; SAMBROOK I, 2001, MOL CLONING LAB MANU, V2; Sayer NM, 2004, J BIOL CHEM, V279, P13102, DOI 10.1074/jbc.M310928200; Schaffer J, 2000, KIDNEY INT, V58, P873, DOI 10.1046/j.1523-1755.2000.00237.x; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Sekijima Y, 2006, AMYLOID, V13, P236, DOI 10.1080/13506120600960882; Smith DP, 2003, J MOL BIOL, V330, P943, DOI 10.1016/S0022-2836(03)00687-9; Sunde M, 1998, Q REV BIOPHYS, V31, P1, DOI 10.1017/S0033583598003400; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; TENNENT GA, 1995, P NATL ACAD SCI USA, V92, P4299, DOI 10.1073/pnas.92.10.4299; Tennent GA, 1999, METHOD ENZYMOL, V309, P26; Tojo K, 2006, NEUROSCI RES, V56, P441, DOI 10.1016/j.neures.2006.08.014; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; VALEGARD K, 1994, NATURE, V371, P623, DOI 10.1038/371623a0; VANYPERSELE C, 1996, DIALYSIS AMYLOID, P34; Weiss S, 1997, J VIROL, V71, P8790, DOI 10.1128/JVI.71.11.8790-8797.1997; Westermark GT, 1999, METHOD ENZYMOL, V309, P3; Westermark P, 2005, AMYLOID, V12, P1, DOI 10.1080/13506120500032196; Wetzel R, 2007, BIOCHEMISTRY-US, V46, P1, DOI 10.1021/bi0620959; White JT, 2001, P NATL ACAD SCI USA, V98, P13019, DOI 10.1073/pnas.241406698; White RR, 2000, J CLIN INVEST, V106, P929, DOI 10.1172/JCI11325; Wlotzka B, 2002, P NATL ACAD SCI USA, V99, P8898, DOI 10.1073/pnas.132067399; Yamaguchi I, 2001, BIOCHEMISTRY-US, V40, P8499, DOI 10.1021/bi0027128; Yamamoto S, 2005, BBA-PROTEINS PROTEOM, V1753, P4, DOI 10.1016/j.bbapap.2005.09.006; Ylera F, 2002, BIOCHEM BIOPH RES CO, V290, P1583, DOI 10.1006/bbrc.2002.6354; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	76	36	39	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34500	34509		10.1074/jbc.M703679200	http://dx.doi.org/10.1074/jbc.M703679200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17878167	Green Published, hybrid			2022-12-25	WOS:000251145700065
J	Qin, J; Fu, HL; Ye, J; Bencze, KZ; Stemmler, TL; Rawlings, DE; Rosen, BP				Qin, Jie; Fu, Hsueh-Liang; Ye, Jun; Bencze, Krisztina Z.; Stemmler, Timothy L.; Rawlings, Douglas E.; Rosen, Barry P.			Convergent evolution of a new arsenic binding site in the ArsR/SmtB family of metalloregulators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUREUS PI258 CADC; ARS OPERON; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; REPRESSOR; PROTEINS; FERROOXIDANS; SELECTIVITY; RESISTANCE; SMTB	Acidithiobacillus ferrooxidans has an arsenic resistance operon that is controlled by an As(III)-responsive transcriptional repressor, AfArsR, a member of the ArsR/SmtB family of metalloregulators. AfArsR lacks the As(III) binding site of the ArsRs from plasmid R773 and Escherichia coli, which have a Cys(32)-Val-Cys(34)-Asp-Leu-Cys(37) sequence in the DNA binding site. In contrast, it has three cysteine residues, Cys(95), Cys(96), and Cys(102), that are not present in the R773 and E. coli ArsRs. The results of direct As(III) binding measurements and x-ray absorption spectroscopy show that these three cysteine residues form a 3-coordinate As(III) binding site. DNA binding studies indicate that binding of As(III) to these cysteine residues produces derepression. Homology modeling indicates that As(III) binding sites in AfArsR are located at the ends of antiparallel C-terminal helices in each monomer that form a dimerization domain. These results suggest that the As(III)-S-3 binding sites in AfArsR and R773 ArsR arose independently at spatially distinct locations in their three-dimensional structures.	Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA; Univ Stellenbosch, Dept Microbiol, ZA-7602 Matieland, South Africa	Wayne State University; Stellenbosch University	Rosen, BP (corresponding author), Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA.	brosen@med.wayne.edu	Ye, Jun/J-8823-2012	Rosen, Barry P./0000-0002-5230-4271	NIAID NIH HHS [R01 AI043428, R01 AI 043428] Funding Source: Medline; NIDDK NIH HHS [R01 DK068139, R01 DK 068139, R01 DK068139-03] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068139] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Banci L, 2007, J BIOL CHEM, V282, P30181, DOI 10.1074/jbc.M701119200; BHATTACHARJEE H, 1995, J BIOL CHEM, V270, P11245, DOI 10.1074/jbc.270.19.11245; Bhattacharjee H, 2007, MOL MICROBIOLOGY HEA, P371, DOI [10.1007/7171_2006_086, DOI 10.1007/7171_2006_086]; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Busenlehner LS, 2002, J MOL BIOL, V319, P685, DOI 10.1016/S0022-2836(02)00299-1; Butcher BG, 2000, APPL ENVIRON MICROB, V66, P1826, DOI 10.1128/AEM.66.5.1826-1833.2000; Butcher BG, 2002, MICROBIOL-SGM, V148, P3983, DOI 10.1099/00221287-148-12-3983; CARLIN A, 1995, J BACTERIOL, V177, P981, DOI 10.1128/jb.177.4.981-986.1995; Cavet JS, 2003, J BIOL CHEM, V278, P44560, DOI 10.1074/jbc.M307877200; Cook WJ, 1998, J MOL BIOL, V275, P337, DOI 10.1006/jmbi.1997.1443; DeLano W. L., 2001, PYMOL USERS MANUAL; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x; Pennella MA, 2005, BIOMETALS, V18, P413, DOI 10.1007/s10534-005-3716-8; Ramirez-Solis A, 2004, INORG CHEM, V43, P2954, DOI 10.1021/ic0351592; Sambrook J, 1998, MOL CLONING LAB MANU, V2nd; Shi WP, 1996, J BIOL CHEM, V271, P9291, DOI 10.1074/jbc.271.16.9291; SHI WP, 1994, J BIOL CHEM, V269, P19826; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Xu C, 1999, METALS AND GENETICS, P5; Ye J, 2005, J BACTERIOL, V187, P4214, DOI 10.1128/JB.187.12.4214-4221.2005	23	65	68	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34346	34355		10.1074/jbc.M706565200	http://dx.doi.org/10.1074/jbc.M706565200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17897948	Green Accepted, hybrid			2022-12-25	WOS:000251145700050
J	Yamaguchi, T; Kimura, J; Miki, Y; Yoshida, K				Yamaguchi, Tomoko; Kimura, Junko; Miki, Yoshio; Yoshida, Kiyotsugu			The deubiquitinating enzyme USP11 controls an I kappa B kinase alpha(IKK alpha)-p53 signaling pathway in response to tumor necrosis factor alpha(TNF alpha)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; P53 TUMOR-SUPPRESSOR; LYN TYROSINE KINASE; APOPTOTIC RESPONSE; IKK-ALPHA; C-DELTA; CELL-DEATH; PROTEIN; PHOSPHORYLATION; TRANSCRIPTION	Post-translational modification and degradation of proteins by the ubiquitin-proteasome system are key regulatory events in cellular responses to various stimuli. The NF-kappa B B signaling pathway is controlled by the ubiquitin-mediated proteolysis. Although mechanisms of ubiquitination in the NF-kappa B pathway have been extensively studied, deubiquitination-mediated regulation of the NF-kappa B signaling remains poorly understood. The present studies show that a deubiquitinating enzyme, USP11, specifically regulates I kappa B kinase alpha (IKK alpha) among the NF-kappa B signaling molecules. Knocking down USP11 attenuates expression of IKK alpha in the transcriptional, but not the post- translational, level. However, down-regulation of USP11 dramatically enhances NF-kappa B activity in response to tumor necrosis factor-alpha, indicating that IKK alpha does not require activation of NF-kappa B. Instead, knock down of USP11 or IKK alpha is associated with abrogation of p53 expression upon exposure to tumor necrosis factor-alpha. In concert with these results, silencing of USP11 is associated with transcriptional attenuation of the p53- responsive genes, such as p21 or Bax. Importantly, the ectopic expression of IKK alpha into cells silenced for USP11 restores p53 expression, demonstrating that USP11 functions as an upstream regulator of an IKK alpha-p53 signaling pathway.	Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Genet, Bunkyo Ku, Tokyo 1138510, Japan	Tokyo Medical & Dental University (TMDU)	Yoshida, K (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Genet, Bunkyo Ku, Yushima 1-5-45, Tokyo 1138510, Japan.	yos.mgen@mri.tmd.ac.jp						Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Donato NJ, 1998, J BIOL CHEM, V273, P5067, DOI 10.1074/jbc.273.9.5067; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; GOTLIEB WH, 1994, AM J OBSTET GYNECOL, V170, P1121, DOI 10.1016/S0002-9378(94)70106-7; Gu LB, 2004, J BIOL CHEM, V279, P52141, DOI 10.1074/jbc.M407915200; Hoberg JE, 2006, MOL CELL BIOL, V26, P457, DOI 10.1128/MCB.26.2.457-471.2006; Hoberg JE, 2004, MOL CELL, V16, P245, DOI 10.1016/j.molcel.2004.10.010; Huang WC, 2007, MOL CELL, V26, P75, DOI 10.1016/j.molcel.2007.02.019; Ideguchi H, 2002, BIOCHEM J, V367, P87, DOI 10.1042/BJ20011851; JEOUNG DI, 1995, J BIOL CHEM, V270, P18367, DOI 10.1074/jbc.270.31.18367; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kawabata M, 1998, EMBO J, V17, P4056, DOI 10.1093/emboj/17.14.4056; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Ladiwala U, 1999, J NEUROCHEM, V73, P605, DOI 10.1046/j.1471-4159.1999.0730605.x; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Nakano H, 1998, P NATL ACAD SCI USA, V95, P3537, DOI 10.1073/pnas.95.7.3537; Park KJ, 2005, MOL CELL, V18, P71, DOI 10.1016/j.molcel.2005.03.006; Taira N, 2007, MOL CELL, V25, P725, DOI 10.1016/j.molcel.2007.02.007; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Yamaguchi T, 2007, CELL SIGNAL, V19, P2088, DOI 10.1016/j.cellsig.2007.06.002; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Yoshida K, 2006, MOL CELL BIOL, V26, P3414, DOI 10.1128/MCB.26.9.3414-3431.2006; Yoshida K, 1999, J BIOL CHEM, V274, P34663, DOI 10.1074/jbc.274.49.34663; Yoshida K, 2000, MOL CELL BIOL, V20, P5370, DOI 10.1128/MCB.20.15.5370-5380.2000; Yoshida K, 2006, J BIOL CHEM, V281, P5734, DOI 10.1074/jbc.M512074200; Yoshida K, 2005, NAT CELL BIOL, V7, P278, DOI 10.1038/ncb1228; Yoshida K, 2003, EMBO J, V22, P1431, DOI 10.1093/emboj/cdg134; Yoshida K, 2002, MOL CELL BIOL, V22, P3292, DOI 10.1128/MCB.22.10.3292-3300.2002	35	61	63	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					33943	33948		10.1074/jbc.M706282200	http://dx.doi.org/10.1074/jbc.M706282200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17897950	hybrid			2022-12-25	WOS:000251145700007
J	Zhao, KH; Zhang, J; Tu, JM; Boehm, S; Ploescher, M; Eichacker, L; Bubenzer, C; Scheer, H; Wang, X; Zhou, M				Zhao, Kai-Hong; Zhang, Juan; Tu, Jun-Ming; Boehm, Stephan; Ploescher, Matthias; Eichacker, Lutz; Bubenzer, Claudia; Scheer, Hugo; Wang, Xing; Zhou, Ming			Lyase activities of CpcS- and CpcT-like proteins from Nostoc PCC7120 and sequential reconstitution of binding sites of phycoerythrocyanin and phycocyanin beta-subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO ATTACHMENT; ANABAENA SP PCC-7120; HOLO-ALPHA SUBUNIT; C-PHYCOCYANIN; CHROMOPHORE ATTACHMENT; CRYSTAL-STRUCTURE; PHYCOBILIPROTEIN LYASE; BILIN LYASE; PHYCOVIOLOBILIN; PHYCOBILISOME	Genes all5292 (cpcS2) and alr0617 (cpcS1) in the cyanobacterium Nostoc PCC7120 are homologous to the biliprotein lyase cpcS, and genes all5339 (cpcT1) and alr0647 (cpcT2) are homologous to the lyase cpcT. The functions of the encoded proteins were screened in vitro and in a heterologous Escherichia coli system with plasmids conferring biosynthesis of the phycocyanobilin chromophore and of the acceptor proteins beta-phycoerythrocyanin (PecB) or beta-phycocyanin (CpcB). CpcT1 is a regioselective biliprotein lyase attaching phycocyanobilin exclusively to cysteine beta 155 but does not discriminate between CpcB and PecB. The in vitro reconstitutions required no cofactors, and kinetic constants were determined for CpcT1 under in vitro conditions. No lyase activity was found for the lyase homologues CpcS2 and CpcT2, but complexes are formed in vitro between CpcT1 and CpcS1, CpcT2, or PecE (subunit of phycoviolobilin: alpha-phycoerythrocyanin isomerase lyase). The genes coding the inactive homologues, cpcS2 and cpcT2, are transcribed in N-starved Nostoc. In sequential binding experiments with CpcT1 and CpcS1, a chromophore at cysteine 84 inhibited the subsequent attachment to cysteine 155, whereas the inverse sequence generates subunits carrying both chromophores.	Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China; Huazhong Univ Sci & Technol, Coll Environm Sci & Engn, Wuhan 430074, Hubei, Peoples R China; Univ Munich, Dept Biol 1, D-80638 Munich, Germany	Huazhong University of Science & Technology; Huazhong University of Science & Technology; University of Munich	Zhao, KH (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China.	khzhao@163.com						Adir N, 2002, BBA-BIOENERGETICS, V1556, P168, DOI 10.1016/S0005-2728(02)00359-6; Anderson LK, 1998, MOL MICROBIOL, V30, P467, DOI 10.1046/j.1365-2958.1998.01081.x; ARCIERO DM, 1988, J BIOL CHEM, V263, P18343; ARCIERO DM, 1988, J BIOL CHEM, V263, P18358; ARCIERO DM, 1988, J BIOL CHEM, V263, P18350; BERKELMAN TR, 1986, ANAL BIOCHEM, V156, P194, DOI 10.1016/0003-2697(86)90173-9; Bienert R, 2006, J BIOL CHEM, V281, P5216, DOI 10.1074/jbc.M507243200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cai YA, 2001, ANAL BIOCHEM, V290, P186, DOI 10.1006/abio.2000.4979; Cobley JG, 2002, MOL MICROBIOL, V44, P1517, DOI 10.1046/j.1365-2958.2002.02966.x; COLE WJ, 1968, BIOCHEMISTRY-US, V7, P2929, DOI 10.1021/bi00848a033; DEBRECZENY MP, 1995, J PHYS CHEM-US, V99, P8412, DOI 10.1021/j100020a080; Dolganov N, 1999, J BACTERIOL, V181, P610, DOI 10.1128/JB.181.2.610-617.1999; DUERRING M, 1990, J MOL BIOL, V211, P633, DOI 10.1016/0022-2836(90)90270-V; EBERLEIN M, ISOLIERUNG SEQUENZIE; FAIRCHILD CD, 1994, J BIOL CHEM, V269, P8686; FAIRCHILD CD, 1992, P NATL ACAD SCI USA, V89, P7017, DOI 10.1073/pnas.89.15.7017; FAIRCHILD CD, 1994, J BIOL CHEM, V269, P28988; Gambetta GA, 2001, P NATL ACAD SCI USA, V98, P10566, DOI 10.1073/pnas.191375198; Gantt E., 2003, LIGHT HARVESTING ANT, P307, DOI DOI 10.1007/978-94-017-2087-8_10; Glazer A. N, 1994, ADV MOL CELL BIOL, V10, P119; GLAZER AN, 1973, J BIOL CHEM, V248, P659; GROSSMAN AR, 1993, MICROBIOL REV, V57, P725, DOI 10.1128/MMBR.57.3.725-749.1993; Kahn K, 1997, J BACTERIOL, V179, P998, DOI 10.1128/jb.179.4.998-1006.1997; Kaneko T, 2001, DNA RES, V8, P205, DOI 10.1093/dnares/8.5.205; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAGARIAS JC, 1988, J BIOL CHEM, V263, P12977; Landgraf FT, 2001, FEBS LETT, V508, P459, DOI 10.1016/S0014-5793(01)02988-X; MOHAMED A, 1989, PLANT MOL BIOL, V13, P693, DOI 10.1007/BF00016024; NAGY JO, 1985, J BIOL CHEM, V260, P4864; Nakamura Y, 2003, DNA RES, V10, P137, DOI 10.1093/dnares/10.4.137; Palenik B, 2003, NATURE, V424, P1037, DOI 10.1038/nature01943; Parbel A, 1997, PHOTOSYNTH RES, V54, P25, DOI 10.1023/A:1005877531271; Ritter S, 1999, J STRUCT BIOL, V126, P86, DOI 10.1006/jsbi.1999.4106; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SAUER K, 1988, BIOCHIM BIOPHYS ACTA, V936, P157, DOI 10.1016/0005-2728(88)90232-0; SCHIRMER T, 1987, J MOL BIOL, V196, P677, DOI 10.1016/0022-2836(87)90040-4; Schluchter W. M., 1999, PHOTOTROPHIC PROKARY, P83; Shen G., 2004, PS 2004 LIGHT HARV S, P14; Shen G, 2006, J BIOL CHEM, V281, P17768, DOI 10.1074/jbc.M602563200; Sidler W. A., 1994, MOL BIOL CYANOBACTER, P139, DOI [10.1007/978-94-011-0227-8_7, DOI 10.1007/978-94-011-0227-8_7]; Stanne TM, 2007, J BIOL CHEM, V282, P14394, DOI 10.1074/jbc.M700275200; Storf M, 2001, BIOCHEMISTRY-US, V40, P12444, DOI 10.1021/bi010776s; SWANSON RV, 1992, J BIOL CHEM, V267, P16146; Toole CM, 1998, MOL MICROBIOL, V30, P475, DOI 10.1046/j.1365-2958.1998.01082.x; Tooley AJ, 2002, J BACTERIOL, V184, P4666, DOI 10.1128/JB.184.17.4666-4671.2002; Tooley AJ, 2001, P NATL ACAD SCI USA, V98, P10560, DOI 10.1073/pnas.181340998; Wang XQ, 2001, ACTA CRYSTALLOGR D, V57, P784, DOI 10.1107/S0907444901004528; Wu SH, 2000, BIOCHEMISTRY-US, V39, P13487, DOI 10.1021/bi001123z; Zhao KH, 2007, P NATL ACAD SCI USA, V104, P14300, DOI 10.1073/pnas.0706209104; Zhao KH, 2006, J BIOL CHEM, V281, P8573, DOI 10.1074/jbc.M513796200; Zhao KH, 2006, FEBS J, V273, P1262, DOI 10.1111/j.1742-4658.2006.05149.x; Zhao KH, 2005, BIOCHEMISTRY-US, V44, P8126, DOI 10.1021/bi0500168; Zhao KH, 2005, BBA-BIOENERGETICS, V1706, P81, DOI 10.1016/j.bbabio.2004.09.008; Zhao KH, 2004, BIOCHEMISTRY-US, V43, P11576, DOI 10.1021/bi0491548; Zhao KH, 2004, BBA-BIOENERGETICS, V1657, P131, DOI 10.1016/j.bbabio.2004.04.010; Zhao KH, 2002, EUR J BIOCHEM, V269, P4542, DOI 10.1046/j.1432-1033.2002.03148.x; ZHAO KH, 1995, BBA-BIOENERGETICS, V1228, P235, DOI 10.1016/0005-2728(94)00181-4; Zhao KH, 2000, FEBS LETT, V469, P9, DOI 10.1016/S0014-5793(00)01245-X; ZHOU JH, 1992, J BIOL CHEM, V267, P16138	60	51	60	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34093	34103		10.1074/jbc.M703038200	http://dx.doi.org/10.1074/jbc.M703038200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17895251	hybrid			2022-12-25	WOS:000251145700024
J	Semtner, M; Schaefer, M; Pinkenburg, O; Plant, TD				Semtner, Marcus; Schaefer, Michael; Pinkenburg, Olaf; Plant, Tim D.			Potentiation of TRPC5 by protons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSELECTIVE CATION CHANNELS; CAPSAICIN RECEPTOR; HEK293 CELLS; MICE LACKING; ACTIVATION; CURRENTS; TRPV1; NOMENCLATURE; SENSATION; BINDING	Mammalian members of the classical transient receptor potential channel subfamily ( TRPC) are Ca2+-permeable cation channels involved in receptor-mediated increases in intracellular Ca2+. TRPC4 and TRPC5 form a group within the TRPC subfamily and are activated in a phospholipase C-dependent manner by an unidentified messenger. Unlike most other Ca2+-permeable channels, TRPC4 and -5 are potentiated by micromolar concentrations of La3+ and Gd3+. This effect results from an action of the cations at two glutamate residues accessible from the extracellular solution. Here, we show that TRPC4 and -5 respond to changes in extracellular pH. Lowering the pH increased both G protein-activated and spontaneous TRPC5 currents. Both effects were already observed with small reductions in pH ( from 7.4 to 7.0) and increased up to pH 6.5. TRPC4 was also potentiated by decreases in pH, whereas TRPC6 was only inhibited, with a pIC(50) of 5.7. Mutation of the glutamate residues responsible for lanthanoid sensitivity of TRPC5 (E543Q and E595Q) modified the potentiation of TRPC5 by acid. Further evidence for a similarity in the actions of lanthanoids and H+ on TRPC5 is the reduction in single channel conductance and dramatic increase in channel open probability in the presence of either H+ or Gd3+ that leads to larger integral currents. In conclusion, the high sensitivity of TRPC5 to H+ indicates that, in addition to regulation by phospholipase C and other factors, the channel may act as a sensor of pH that links decreases in extracellular pH to Ca2+ entry and depolarization.	Univ Marburg, Inst Pharmakol & Toxikol, Fachbereich Med, D-35032 Marburg, Germany; Charite Campus Benjamin Franklin, Inst Pharmakol, D-14195 Berlin, Germany	Philipps University Marburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Plant, TD (corresponding author), Univ Marburg, Inst Pharmakol & Toxikol, Fachbereich Med, Karl Von Frisch Str 1, D-35032 Marburg, Germany.	plant@staff.uni-marburg.de						Ahern GP, 2005, J NEUROSCI, V25, P5109, DOI 10.1523/JNEUROSCI.0237-05.2005; Baumann TK, 2000, J NEUROSCI, V20; Beech D. J., 2007, V179, P109; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Clapham DE, 2005, PHARMACOL REV, V57, P427, DOI 10.1124/pr.57.4.6; FENWICK EM, 1982, J PHYSIOL-LONDON, V331, P599, DOI 10.1113/jphysiol.1982.sp014394; Flemming PK, 2006, J BIOL CHEM, V281, P4977, DOI 10.1074/jbc.M510301200; Gavva NR, 2005, MOL PHARMACOL, V68, P1524, DOI 10.1124/mol.105.015727; Gunthorpe NJ, 2001, PFLUG ARCH EUR J PHY, V442, P668; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Immke DC, 2003, NEURON, V37, P75, DOI 10.1016/S0896-6273(02)01130-3; Jiang JM, 2005, J GEN PHYSIOL, V126, P137, DOI 10.1085/jgp.200409185; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Jung S, 2003, J BIOL CHEM, V278, P3562, DOI 10.1074/jbc.M211484200; Montell C, 2002, MOL CELL, V9, P229, DOI 10.1016/S1097-2765(02)00448-3; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Okada T, 1998, J BIOL CHEM, V273, P10279, DOI 10.1074/jbc.273.17.10279; Pedersen SF, 2005, CELL CALCIUM, V38, P233, DOI 10.1016/j.ceca.2005.06.028; Philipp S, 1996, EMBO J, V15, P6166, DOI 10.1002/j.1460-2075.1996.tb01004.x; Philipp S, 1998, EMBO J, V17, P4274, DOI 10.1093/emboj/17.15.4274; Plant TD, 2005, N-S ARCH PHARMACOL, V371, P266, DOI 10.1007/s00210-005-1055-5; Plant TD, 2003, CELL CALCIUM, V33, P441, DOI 10.1016/S0143-4160(03)00055-1; RAMANAN SV, 1992, J NEUROSCI METH, V42, P91, DOI 10.1016/0165-0270(92)90139-5; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; REICHLING DB, 1991, J PHYSIOL-LONDON, V441, P199, DOI 10.1113/jphysiol.1991.sp018746; Riccio A, 2002, MOL BRAIN RES, V109, P95, DOI 10.1016/S0169-328X(02)00527-2; Ryu SJ, 2003, J GEN PHYSIOL, V122, P45, DOI 10.1085/jgp.200308847; Schaefer M, 2000, J BIOL CHEM, V275, P17517, DOI 10.1074/jbc.275.23.17517; Schaefer M, 2002, J BIOL CHEM, V277, P3752, DOI 10.1074/jbc.M109850200; Schaefer M, 2001, FASEB J, V15, P1634, DOI 10.1096/fj.00-0824fje; Shimizu S, 2006, J PHYSIOL-LONDON, V570, P219, DOI 10.1113/jphysiol.2005.097998; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Suzuki M, 2003, J BIOL CHEM, V278, P22664, DOI 10.1074/jbc.M302561200; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Tousova K, 2005, MOL CELL NEUROSCI, V30, P207, DOI 10.1016/j.mcn.2005.07.004; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Walker RL, 2001, AM J PHYSIOL-CELL PH, V280, pC1184, DOI 10.1152/ajpcell.2001.280.5.C1184; Yamada H, 2000, NEUROSCI LETT, V285, P111, DOI 10.1016/S0304-3940(00)01033-8; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821; Zeng FN, 2004, J PHYSIOL-LONDON, V559, P739, DOI 10.1113/jphysiol.2004.065391; Zholos AV, 1997, AM J PHYSIOL-GASTR L, V272, pG215, DOI 10.1152/ajpgi.1997.272.2.G215	45	69	72	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33868	33878		10.1074/jbc.M702577200	http://dx.doi.org/10.1074/jbc.M702577200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17884814	hybrid			2022-12-25	WOS:000250840200068
J	Tsutsumi, S; Sugiura, R; Ma, Y; Tokuoka, H; Ohta, K; Ohte, R; Noma, A; Suzuki, T; Kuno, T				Tsutsumi, Satoshi; Sugiura, Reiko; Ma, Yan; Tokuoka, Hideki; Ohta, Kazuki; Ohte, Rieko; Noma, Akiko; Suzuki, Tsutomu; Kuno, Takayoshi			Wobble inosine tRNA modification is essential to cell cycle progression in G(1)/S and G(2)/M transitions in fission yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOSINE-DEAMINASE; CYTIDINE DEAMINASE; SEQUENCES; PATHWAY; COMPLEX	Inosine (I) at position 34 (wobble position) of tRNA is formed by the hydrolytic deamination of a genomically encoded adenosine (A). The enzyme catalyzing this reaction, termed tRNA A: 34 deaminase, is the heterodimeric Tad2p/ADAT2 center dot Tad3p/ADAT3 complex in eukaryotes. In budding yeast, deletion of each subunitis lethal, indicating that the wobble inosine tRNA modification is essential for viability; however, most of its physiological roles remain unknown. To identify novel cell cycle mutants in fission yeast, we isolated the tad3-1 mutant that is allelic to the tad3(+) gene encoding a homolog of budding yeast Tad3p. Interestingly, the tad3-1 mutant cells principally exhibited cell cycle-specific phenotype, namely temperature-sensitive and irreversible cell cycle arrest both in G(1) and G(2). Further analyses revealed that in the tad3-1 mutant cells, the S257N mutation that occurred in the catalytically inactive Tad3 subunit affected its association with catalytically active Tad2 subunit, leading to an impairment in the A to I conversion at position 34 of tRNA. In tad3-1 mutant cells, the over expression of the tad3(+) gene completely suppressed the decreased tRNA inosine content. Notably, the overexpression of the tad2(+) gene partially suppressed the temperature-sensitive phenotype and the decreased tRNA inosine content, indicating that the tad3-1 mutant phenotype is because of the insufficient I-34 formation of tRNA. These results suggest that the wobble inosine tRNA modification is essential for cell cycle progression in the G1/S and G2/M transitions in fission yeast.	Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Pharmacol & Pharmacogenom,Chuo Ku, Kobe, Hyogo 6500017, Japan; Kinki Univ, Sch Pharmaceut Sci, Lab Mol Pharmacogenom, Higashiosaka, Osaka 5778502, Japan; Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan	Kobe University; Kindai University (Kinki University); University of Tokyo	Kuno, T (corresponding author), Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Pharmacol & Pharmacogenom,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	tkuno@med.kobe-u.ac.jp	Suzuki, Tsutomu/J-1776-2015	Suzuki, Tsutomu/0000-0002-9731-1731				BETTS L, 1994, J MOL BIOL, V235, P635, DOI 10.1006/jmbi.1994.1018; Bjork Glenn R., 1995, P165; Cheng H, 2002, MOL BIOL CELL, V13, P2963, DOI 10.1091/mbc.01-09-0463; Chung SJ, 2005, J MED CHEM, V48, P658, DOI 10.1021/jm0496279; CRICK FHC, 1966, J MOL BIOL, V19, P548, DOI 10.1016/S0022-2836(66)80022-0; Curran J. F., 1998, MODIFICATION EDITING, P493; Gerber A, 1998, EMBO J, V17, P4780, DOI 10.1093/emboj/17.16.4780; Gerber AP, 1999, SCIENCE, V286, P1146, DOI 10.1126/science.286.5442.1146; HOLLEY RW, 1965, J BIOL CHEM, V240, P2122; Kaneko T, 2003, EMBO J, V22, P657, DOI 10.1093/emboj/cdg066; Kita A, 2004, MOL BIOL CELL, V15, P2920, DOI 10.1091/mbc.E03-09-0659; KOHLI J, 1977, GENETICS, V87, P471; KOHRER K, 1991, METHOD ENZYMOL, V194, P398; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Noma A, 2006, EMBO J, V25, P2142, DOI 10.1038/sj.emboj.7601105; OLEINICK NL, 1977, ARCH BIOCHEM BIOPHYS, V182, P171, DOI 10.1016/0003-9861(77)90296-X; Rocha EPC, 2004, GENOME RES, V14, P2279, DOI 10.1101/gr.2896904; SAKA Y, 1993, CELL, V74, P383, DOI 10.1016/0092-8674(93)90428-S; Senger B, 1997, BIOCHEMISTRY-US, V36, P8269, DOI 10.1021/bi970206l; Sprinzl M, 1998, NUCLEIC ACIDS RES, V26, P148, DOI 10.1093/nar/26.1.148; Toda T, 1996, MOL CELL BIOL, V16, P6752; Xie KF, 2004, P NATL ACAD SCI USA, V101, P8114, DOI 10.1073/pnas.0400493101	23	35	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46							33459	10.1074/jbc.M706869200	http://dx.doi.org/10.1074/jbc.M706869200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17875641	hybrid			2022-12-25	WOS:000250840200026
J	Frank, SA				Frank, Steven A.			Maladaptation and the Paradox of Robustness in Evolution	PLOS ONE			English	Article								Background. Organisms use a variety of mechanisms to protect themselves against perturbations. For example, repair mechanisms fix damage, feedback loops keep homeostatic systems at their setpoints, and biochemical filters distinguish signal from noise. Such buffering mechanisms are often discussed in terms of robustness, which may be measured by reduced sensitivity of performance to perturbations. Methodology/Principal Findings. I use a mathematical model to analyze the evolutionary dynamics of robustness in order to understand aspects of organismal design by natural selection. I focus on two characters: one character performs an adaptive task; the other character buffers the performance of the first character against perturbations. Increased perturbations favor enhanced buffering and robustness, which in turn decreases sensitivity and reduces the intensity of natural selection on the adaptive character. Reduced selective pressure on the adaptive character often leads to a less costly, lower performance trait. Conclusions/Significance. The paradox of robustness arises from evolutionary dynamics: enhanced robustness causes an evolutionary reduction in the adaptive performance of the target character, leading to a degree of maladaptation compared to what could be achieved by natural selection in the absence of robustness mechanisms. Over evolutionary time, buffering traits may become layered on top of each other, while the underlying adaptive traits become replaced by cheaper, lower performance components. The paradox of robustness has widespread implications for understanding organismal design.	Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA	University of California System; University of California Irvine	Frank, SA (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA.	safrank@uci.edu		Frank, Steven/0000-0001-7348-7794	National Science Foundation [DEB-0089741]; National Institute of General Medical Sciences [U01-GM-76499]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM076499] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: National Science Foundation grant DEB-0089741 and National Institute of General Medical Sciences MIDAS Program grant support the research of this author.	ALEXANDER RM, 1981, SCI PROGRESS-UK, V67, P109; Alon U, 2007, INTRO SYSTEMS BIOL D; de Visser JAGM, 2003, EVOLUTION, V57, P1959, DOI 10.1554/02-750R; Diamond J, 2002, J PHYSIOL-LONDON, V542, P337, DOI 10.1113/jphysiol.2002.018366; Frank SA, 2004, P NATL ACAD SCI USA, V101, P8061, DOI 10.1073/pnas.0400561101; Goldstein B, 2004, NAT REV IMMUNOL, V4, P445, DOI 10.1038/nri1374; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Rice SH, 1998, EVOLUTION, V52, P647, DOI 10.1111/j.1558-5646.1998.tb03690.x; Wagner A., 2005, ROBUSTNESS EVOLVABIL; WEIBEL ER, 1998, PRINCIPLES ANIMAL DE	12	27	28	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1021	10.1371/journal.pone.0001021	http://dx.doi.org/10.1371/journal.pone.0001021			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925869	Green Published, Green Submitted, gold			2022-12-25	WOS:000207456000020
J	Edwards, RJ; Davey, NE; Shields, DC				Edwards, Richard J.; Davey, Norman E.; Shields, Denis C.			SLiMFinder: A Probabilistic Method for Identifying Over-Represented, Convergently Evolved, Short Linear Motifs in Proteins	PLOS ONE			English	Article								Background. Short linear motifs (SLiMs) in proteins are functional microdomains of fundamental importance in many biological systems. SLiMs typically consist of a 3 to 10 amino acid stretch of the primary protein sequence, of which as few as two sites may be important for activity, making identification of novel SLiMs extremely difficult. In particular, it can be very difficult to distinguish a randomly recurring "motif'' from a truly over-represented one. Incorporating ambiguous amino acid positions and/or variable-length wildcard spacers between defined residues further complicates the matter. Methodology/Principal Findings. In this paper we present two algorithms. SLiMBuild identifies convergently evolved, short motifs in a dataset of proteins. Motifs are built by combining dimers into longer patterns, retaining only those motifs occurring in a sufficient number of unrelated proteins. Motifs with fixed amino acid positions are identified and then combined to incorporate amino acid ambiguity and variable-length wildcard spacers. The algorithm is computationally efficient compared to alternatives, particularly when datasets include homologous proteins, and provides great flexibility in the nature of motifs returned. The SLiMChance algorithm estimates the probability of returned motifs arising by chance, correcting for the size and composition of the dataset, and assigns a significance value to each motif. These algorithms are implemented in a software package, SLiMFinder. SLiMFinder default settings identify known SLiMs with 100% specificity, and have a low false discovery rate on random test data. Conclusions/Significance. The efficiency of SLiMBuild and low false discovery rate of SLiMChance make SLiMFinder highly suited to high throughput motif discovery and individual high quality analyses alike. Examples of such analyses on real biological data, and how SLiMFinder results can help direct future discoveries, are provided. SLiMFinder is freely available for download under a GNU license from http://bioinformatics.ucd.ie/shields/software/slimfinder/.	[Edwards, Richard J.; Davey, Norman E.; Shields, Denis C.] Univ Coll Dublin, Univ Coll Dublin Complex & Adapt Syst Lab, Univ Coll Dublin Conway Inst Biomol & Biomed Sci, Dublin 2, Ireland; [Edwards, Richard J.] Univ Southampton, Sch Biol Sci, Southampton, Hants, England	University College Dublin; University of Southampton	Edwards, RJ (corresponding author), Univ Coll Dublin, Univ Coll Dublin Complex & Adapt Syst Lab, Univ Coll Dublin Conway Inst Biomol & Biomed Sci, Dublin 2, Ireland.	r.edwards@soton.ac.uk	Edwards, Richard/C-8755-2011; Davey, Norman/D-5362-2013	Edwards, Richard/0000-0002-3645-5539; Shields, Denis/0000-0003-4015-2474; Davey, Norman/0000-0002-4151-3510; Davey, Norman/0000-0001-6988-4850	Science Foundation Ireland	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was funded by Science Foundation Ireland. The funders had no role in the manuscript or the work presented therein.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Balla S, 2006, NAT METHODS, V3, P175, DOI 10.1038/nmeth856; Birney E, 2006, NUCLEIC ACIDS RES, V34, pD556, DOI 10.1093/nar/gkj133; CEOL A, 2006, NUCLEIC ACIDS RES, V29, P29; Davey NE, 2006, NUCLEIC ACIDS RES, V34, P3546, DOI 10.1093/nar/gkl486; De Falco S, 2001, J BIOL CHEM, V276, P36613, DOI 10.1074/jbc.M102377200; Deng Q, 2007, J VIROL, V81, P4244, DOI 10.1128/JVI.01270-06; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Neduva V, 2005, PLOS BIOL, V3, P2090, DOI 10.1371/journal.pbio.0030405; Neduva V, 2005, FEBS LETT, V579, P3342, DOI 10.1016/j.febslet.2005.04.005; Neduva V, 2006, CURR OPIN BIOTECH, V17, P465, DOI 10.1016/j.copbio.2006.08.002; Neduva V, 2006, NUCLEIC ACIDS RES, V34, pW350, DOI 10.1093/nar/gkl159; NEURATH AR, 1992, J EXP MED, V175, P461, DOI 10.1084/jem.175.2.461; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Rigoutsos I, 1998, BIOINFORMATICS, V14, P55, DOI 10.1093/bioinformatics/14.1.55; ZHOU SY, 1995, METHOD ENZYMOL, V254, P523	18	114	116	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e967	10.1371/journal.pone.0000967	http://dx.doi.org/10.1371/journal.pone.0000967			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912346	Green Submitted, gold, Green Published			2022-12-25	WOS:000207455900005
J	Sheng, Y; Engstrom, PG; Lenhard, B				Sheng, Ying; Engstrom, Par G.; Lenhard, Boris			Mammalian MicroRNA Prediction through a Support Vector Machine Model of Sequence and Structure	PLOS ONE			English	Article							NONCODING RNAS; IDENTIFICATION; MOUSE; EXPRESSION; GENES; PRECURSORS; VERTEBRATE; TRANSCRIPTS; THOUSANDS; ELEMENTS	Background. MicroRNAs (miRNAs) are endogenous small noncoding RNA gene products, on average 22 nt long, found in a wide variety of organisms. They play important regulatory roles by targeting mRNAs for degradation or translational repression. There are 377 known mouse miRNAs and 475 known human miRNAs in the May 2007 release of the miRBase database, the majority of which are conserved between the two species. A number of recent reports imply that it is likely that many mammalian miRNAs remain to be discovered. The possibility that there are more of them expressed at lower levels or in more specialized expression contexts calls for the exploitation of genome sequence information to accelerate their discovery. Methodology/Principal Findings. In this article, we describe a computational method-mirCoS-that uses three support vector machine models sequentially to discover new miRNA candidates in mammalian genomes based on sequence, secondary structure, and conservation. mirCoS can efficiently detect the majority of known miRNAs and predicts an extensive set of hairpin structures based on human-mouse comparisons. In total, 3476 mouse candidates and 3441 human candidates were found. These hairpins are more similar to known miRNAs than to negative controls in several aspects not considered by the prediction algorithm. A significant fraction of predictions is supported by existing expression evidence. Conclusions/Significance. Using a novel approach, mirCoS performs comparably to or better than existing miRNA prediction methods, and contributes a significant number of new candidate miRNAs for experimental verification.	[Sheng, Ying; Engstrom, Par G.; Lenhard, Boris] Univ Bergen, Bergen Ctr Computat Sci, Computat Biol Unit, Bergen, Norway; [Sheng, Ying; Engstrom, Par G.; Lenhard, Boris] Univ Bergen, Sars Int Ctr Marine Mol Biol, Bergen, Norway; [Sheng, Ying; Engstrom, Par G.] Karolinska Inst, Dept Cell & Mol Biol, Programme Genom & Bioinformat, Stockholm, Sweden	University of Bergen; University of Bergen; Karolinska Institutet	Lenhard, B (corresponding author), Univ Bergen, Bergen Ctr Computat Sci, Computat Biol Unit, Bergen, Norway.	Boris.Lenhard@bccs.uib.no		Lenhard, Boris/0000-0002-1114-1509; Engstrom, Par/0000-0001-5265-2121	Functional Genomics Programme (FUGE) of the Research Council of Norway; Sars Centre for Marine Molecular Biology	Functional Genomics Programme (FUGE) of the Research Council of Norway(Research Council of Norway); Sars Centre for Marine Molecular Biology	This work was supported by the Functional Genomics Programme (FUGE) of the Research Council of Norway and a core grant from the Sars Centre for Marine Molecular Biology.	Ashurst JL, 2005, NUCLEIC ACIDS RES, V33, pD459, DOI 10.1093/nar/gki135; Bailey PJ, 2006, EXP CELL RES, V312, P3108, DOI 10.1016/j.yexcr.2006.06.017; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Barutcuoglu Z, 2006, BIOINFORMATICS, V22, P830, DOI 10.1093/bioinformatics/btk048; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Berezikov E, 2006, GENOME RES, V16, P1289, DOI 10.1101/gr.5159906; Berezikov E, 2006, NAT GENET, V38, pS2, DOI 10.1038/ng1794; Bhardwaj N, 2005, NUCLEIC ACIDS RES, V33, P6486, DOI 10.1093/nar/gki949; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chen Y-W, 2003, COMBINING SVMS VARIO; Davis E, 2005, CURR BIOL, V15, P743, DOI 10.1016/j.cub.2005.02.060; Dostie J, 2003, RNA, V9, P180, DOI 10.1261/rna.2141503; Duan Ranhui, 2006, V342, P267, DOI 10.1385/1-59745-123-1:267; Engstrom PG, 2006, PLOS GENET, V2, P564, DOI 10.1371/journal.pgen.0020047; Gomez-Skarmeta JL, 2006, DEV DYNAM, V235, P870, DOI 10.1002/dvdy.20659; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Gu J, 2006, MAMM GENOME, V17, P1033, DOI 10.1007/s00335-006-0007-9; Helvik SA, 2007, BIOINFORMATICS, V23, P142, DOI 10.1093/bioinformatics/btl570; Hertel J, 2006, BIOINFORMATICS, V22, pE197, DOI 10.1093/bioinformatics/btl257; Hoglund A, 2006, BIOINFORMATICS, V22, P1158, DOI 10.1093/bioinformatics/btl002; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; Kodzius R, 2006, NAT METHODS, V3, P211, DOI 10.1038/nmeth0306-211; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Lee Chung-Tien, 2006, Birth Defects Research, V78, P129, DOI 10.1002/bdrc.20072; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lenhard B, 2002, BIOINFORMATICS, V18, P1135, DOI 10.1093/bioinformatics/18.8.1135; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; LOONG SNK, 2007, NOVO SVM CLASSIFICAT; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lunter G, 2006, PLOS COMPUT BIOL, V2, P2, DOI 10.1371/journal.pcbi.0020005; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Michael MZ, 2003, MOL CANCER RES, V1, P882; Mineno J, 2006, NUCLEIC ACIDS RES, V34, P1765, DOI 10.1093/nar/gkl096; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; O'Rourke Jason R., 2006, Birth Defects Research, V78, P172, DOI 10.1002/bdrc.20071; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Sandelin A, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-99; SCHUSTER P, 1994, P ROY SOC B-BIOL SCI, V255, P279, DOI 10.1098/rspb.1994.0040; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Sewer A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-267; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Takada S, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl653; Vlieghe D, 2006, NUCLEIC ACIDS RES, V34, pD95, DOI 10.1093/nar/gkj115; Washietl S, 2005, NAT BIOTECHNOL, V23, P1383, DOI 10.1038/nbt1144; Watanabe T, 2005, FEBS LETT, V579, P318, DOI 10.1016/j.febslet.2004.11.067; Watanabe T, 2006, GENE DEV, V20, P1732, DOI 10.1101/gad.1425706; Wheeler G, 2006, FEBS LETT, V580, P2195, DOI 10.1016/j.febslet.2006.03.019; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Xue CH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-310; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yousef M, 2006, BIOINFORMATICS, V22, P1325, DOI 10.1093/bioinformatics/btl094; Yu ZR, 2005, BIOL REPROD, V73, P427, DOI 10.1095/biolreprod.105.040998	72	40	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e946	10.1371/journal.pone.0000946	http://dx.doi.org/10.1371/journal.pone.0000946			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895987	Green Submitted, gold, Green Published			2022-12-25	WOS:000207455800025
J	Gallego, MA; Ballot, C; Kluza, J; Hajji, N; Martoriati, A; Castera, L; Cuevas, C; Formstecher, P; Joseph, B; Kroemer, G; Bailly, C; Marchetti, P				Gallego, M-A; Ballot, C.; Kluza, J.; Hajji, N.; Martoriati, A.; Castera, L.; Cuevas, C.; Formstecher, P.; Joseph, B.; Kroemer, G.; Bailly, C.; Marchetti, P.			Overcoming chemoresistance of non-small cell lung carcinoma through restoration of an AIF-dependent apoptotic pathway	ONCOGENE			English	Article						apoptosis; mitochondria; chemotherapy	CANCER-CELLS; MITOCHONDRIAL-DNA; LAMELLARIN-D; DEATH; INHIBITOR; CHEMOTHERAPY; TRANSLOCATION; COMBINATION; EXPRESSION; REDUCTION	Non-small cell lung carcinomas (NSCLCs) are typically resistant against apoptosis induced by standard chemotherapy. We evaluated the effects of the two potential antitumor agents of the lamellarin class on a highly apoptosis-resistant NSCLC cell line. Both the marine alkaloid lamellarin-D and its synthetic amino derivative PM031379 induced the activation of Bax, the mitochondrial release of cytochrome c and apoptosis-inducing factor (AIF), as well as the activation of caspase-3. However, only PM031379 triggered cell death and sign of nuclear apoptosis coupled to the nuclear translocation of AIF. Depletion of AIF with small interfering RNA or microinjection of a neutralizing anti-AIF antibody largely prevented PM031379-induced cytotoxicity, underscoring the essential contribution of AIF to NSCLC killing. Using NSCLC cells lacking mitochondrial DNA, we showed that the generation of mitochondrial reactive oxygen species (ROS) was crucial for the PM031379-induced translocation of AIF to the nucleus and subsequently cell death. Pretreatment of NSCLC cells with menadione, a mitochondrial ROS generator, was able to restore the deficient chemotherapy-induced apoptosis of NSCLC cells. Altogether, these data suggest that mitochondrial ROS generation is crucial for overriding the chemoresistance of NSCLC cells. Moreover, this study delineates the unique mechanism of action of lamellarins as potential anticancer agents.	[Gallego, M-A; Ballot, C.; Kluza, J.; Martoriati, A.; Castera, L.; Formstecher, P.; Bailly, C.; Marchetti, P.] Univ Lille 2, Fac Med, INSERM, Jean Pierre Aubert Res Ctr,U837, F-59045 Lille, France; [Hajji, N.; Joseph, B.] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Cuevas, C.] PharmaMar, E-28770 Madrid, Spain; [Kroemer, G.] Inst Gustave Roussy, INSERM, U848, F-94805 Villejuif, France	Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Karolinska Institutet; PharmaMar; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy	Marchetti, P (corresponding author), Univ Lille 2, Fac Med, INSERM, Jean Pierre Aubert Res Ctr,U837, 1 Pl Verdun, F-59045 Lille, France.	philippe.marchetti@lille.inserm.fr	hajji, nabil/AAV-1435-2020; Kroemer, Guido/AAY-9859-2020; BAILLY, Christian/AAK-2799-2021; KROEMER, Guido/B-4263-2013; Kluza, Jérome/B-6312-2012	BAILLY, Christian/0000-0002-2973-9357; KROEMER, Guido/0000-0002-9334-4405; Kluza, Jérome/0000-0002-7346-1305; MARCHETTI, Philippe/0000-0002-4663-6800; Castera, Laurent/0000-0002-0459-3400; Joseph, Bertrand/0000-0001-5655-9979; Martoriati, Alain/0000-0002-5684-1728				Anderson CP, 1997, EUR J CANCER, V33, P2016, DOI 10.1016/S0959-8049(97)00203-7; Armand R, 2004, TOXICOL APPL PHARM, V196, P68, DOI 10.1016/j.taap.2003.12.001; Bailly Christian, 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P363, DOI 10.2174/1568011043352939; Bartling B, 2004, EXP CELL RES, V298, P83, DOI 10.1016/j.yexcr.2004.04.007; BERGH J, 1985, ACTA PATH MICRO IM A, V93, P133; Broker LE, 2004, CANCER RES, V64, P27, DOI 10.1158/0008-5472.CAN-03-3060; Cande C, 2004, J CELL SCI, V117, P4461, DOI 10.1242/jcs.01356; Ekedahl J, 2003, CANCER BIOL THER, V2, P663; Engel RH, 2006, FRONT BIOSCI-LANDMRK, V11, P300, DOI 10.2741/1798; Facompre M, 2003, CANCER RES, V63, P7392; Fennell DA, 2005, CLIN CANCER RES, V11, P2097, DOI 10.1158/1078-0432.CCR-04-1482; Ferreira CG, 2001, ANN ONCOL, V12, P799, DOI 10.1023/A:1011167113067; Ferreira CG, 2001, CLIN CANCER RES, V7, P2468; Furre IE, 2005, CANCER RES, V65, P11051, DOI 10.1158/0008-5472.CAN-05-0510; Gabellini N, 2006, J CELL PHYSIOL, V207, P711, DOI 10.1002/jcp.20627; Gallego MA, 2004, ONCOGENE, V23, P6282, DOI 10.1038/sj.onc.1207835; Galluzzi L, 2006, ONCOGENE, V25, P4812, DOI 10.1038/sj.onc.1209598; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Joseph B, 2001, ONCOGENE, V20, P2877, DOI 10.1038/sj.onc.1204402; Kang YH, 2004, CANCER RES, V64, P8960, DOI 10.1158/0008-5472.CAN-04-1830; Kang YH, 2004, INT J CANCER, V112, P385, DOI 10.1002/ijc.20424; KAWABE Y, 1991, NATURE, V349, P245, DOI 10.1038/349245a0; Kluza J, 2006, CANCER RES, V66, P3177, DOI 10.1158/0008-5472.CAN-05-1929; Krishnaiah P, 2004, J NAT PROD, V67, P1168, DOI 10.1021/np030503t; Marchetti P, 1996, CANCER RES, V56, P2033; Marchetti P., 1996, APOPTOSIS, V1, P119; Murahashi H, 2003, J LEUKOCYTE BIOL, V73, P399, DOI 10.1189/jlb.0702335; Nyman U, 2005, J BIOL CHEM, V280, P34159, DOI 10.1074/jbc.M500394200; O'Connor K, 2006, APOPTOSIS, V11, P1205, DOI 10.1007/s10495-006-6796-1; Okouoyo S, 2004, INT J CANCER, V108, P580, DOI 10.1002/ijc.11585; Park MT, 2005, BLOOD, V105, P1724, DOI 10.1182/blood-2004-07-2938; Park YC, 2005, LIFE SCI, V77, P2059, DOI 10.1016/j.lfs.2005.04.021; Susin SA, 2000, J EXP MED, V192, P571, DOI 10.1084/jem.192.4.571; Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461; Yang LL, 2003, CANCER RES, V63, P831; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367; Zhivotovsky B, 2003, SEMIN CANCER BIOL, V13, P125, DOI 10.1016/S1044-579X(02)00130-X	37	62	63	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 27	2008	27	14					1981	1992		10.1038/sj.onc.1210833	http://dx.doi.org/10.1038/sj.onc.1210833			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	279MK	17906690				2022-12-25	WOS:000254359100003
J	Julian, LM; Palander, O; Seifried, LA; Foster, JEG; Dick, FA				Julian, L. M.; Palander, O.; Seifried, L. A.; Foster, J. E. G.; Dick, F. A.			Characterization of an E2F1-specific binding domain in pRB and its implications for apoptotic regulation	ONCOGENE			English	Article						cell cycle; retinoblastoma; E2F; apoptosis; transcription	CELL-CYCLE ARREST; E2F; PROTEINS; FAMILY; PROLIFERATION	The retinoblastoma protein (pRB) has the dual capability to negatively regulate both E2F-induced cell cycle entry and E2F1-induced apoptosis. In this report, we characterize a unique pRB-E2F1 interaction. Using mutagenesis to disrupt E2F1 binding, we find that the ability of pRB to regulate E2F1-induced apoptosis is diminished when this interaction is lost. Strikingly, this mutant form of pRB retains the ability to control E2F responsive cell cycle genes and blocks cell proliferation. These functional properties are the reciprocal of a previously described E2F binding mutant of pRB that interacts with E2F1, but lacks the ability to interact with other E2Fs. Our work shows that these distinct interactions allow pRB to separately regulate E2F-induced cell proliferation and apoptosis. This suggests a novel form of regulation whereby separate types of binding contacts between the same types of molecules can confer distinct functional outcomes.	[Julian, L. M.; Palander, O.; Seifried, L. A.; Foster, J. E. G.; Dick, F. A.] Univ Western Ontario, Dept Biochem, Childrens Hlth Res Inst, London, ON N6A 4L6, Canada	Western University (University of Western Ontario)	Dick, FA (corresponding author), Univ Western Ontario, Dept Biochem, Childrens Hlth Res Inst, 790 Commiss Rd E, London, ON N6A 4L6, Canada.	fdick@uwo.ca		Foster, Julia/0000-0002-6971-5683				Dick FA, 2000, MOL CELL BIOL, V20, P3715, DOI 10.1128/MCB.20.10.3715-3727.2000; Dick FA, 2003, MOL CELL, V12, P639, DOI 10.1016/S1097-2765(03)00344-7; Dick FA, 2002, J VIROL, V76, P6224, DOI 10.1128/JVI.76.12.6224-6234.2002; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Ginsberg D, 2002, FEBS LETT, V529, P122, DOI 10.1016/S0014-5793(02)03270-2; Johnson DG, 2006, CURR MOL MED, V6, P731; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Rubin SM, 2005, CELL, V123, P1093, DOI 10.1016/j.cell.2005.09.044; Stevens C, 2003, CELL CYCLE, V2, P435, DOI 10.4161/cc.2.5.462; Strobeck MW, 2000, ONCOGENE, V19, P1857, DOI 10.1038/sj.onc.1203510; Takahashi Y, 2000, GENE DEV, V14, P804; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Urist M, 2004, GENE DEV, V18, P3041, DOI 10.1101/gad.1221004; Wells J, 2000, MOL CELL BIOL, V20, P5797, DOI 10.1128/MCB.20.16.5797-5807.2000	16	33	34	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 6	2008	27	11					1572	1579		10.1038/sj.onc.1210803	http://dx.doi.org/10.1038/sj.onc.1210803			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	271VC	17891180				2022-12-25	WOS:000253815800009
J	Benny, O; Kim, SK; Gvili, K; Radzishevsky, IS; Mor, A; Verduzco, L; Menon, LG; Black, PM; Machluf, M; Carroll, RS				Benny, Ofra; Kim, Seung-Ki; Gvili, Koby; Radzishevsky, Inna S.; Mor, Amram; Verduzco, Luis; Menon, Lata G.; Black, Peter M.; Machluf, Marcelle; Carroll, Rona S.			In vivo fate and therapeutic efficacy of PF-4/CTF microspheres in an orthotopic human glioblastoma model	FASEB JOURNAL			English	Article						angiogenesis; brain tumor; PLGA; local delivery	BIODEGRADABLE MICROSPHERES; ENDOGENOUS INHIBITORS; LOADED MICROSPHERES; DRUG-DELIVERY; GROWTH-FACTOR; BRAIN-TUMORS; ANGIOGENESIS; RELEASE; PLATELET-FACTOR-4; BIOCOMPATIBILITY	The correlation between glioma grade and angiogenesis suggests that antiangiogenic therapies are potentially therapeutically effective for these tumors. However, to achieve tumor suppression, antiangiogenic therapies need to be administered daily using high systemic quantities. We designed a biodegradable polymeric device that overcomes those barriers by providing sustained local delivery of a C-terminal fragment of platelet factor 4 (PF-4/CTF), an antiangiogenic agent. Fluorescent-labeled microspheres composed of poly lactic-coglycolic acid (PLGA) were loaded with rhodamine-labeled PF-4/CTF and formulated to release their contents over time. Fluorescent labeling enabled the correlation between the in vitro to the in vivo kinetic and release studies. PF-4/CTF microspheres were injected into established intracranial human glioma tumors in nude mice. Noninvasive magnetic resonance imaging (MRI) was used to assess the therapeutic response. Tumor size, microvessel density, proliferation, and apoptosis rate were measured by histological analysis. Intracranially, the microspheres were located throughout the tumor bed and continuously released PF-4/CTF during the entire experimental period. MRI and histological studies showed that a single injection of microspheres containing PF-4/CTF caused a 65.2% and 72% reduction in tumor volume, respectively, with a significant decrease in angiogenesis and an increase in apoptosis. Our data demonstrate that polymeric microspheres are an effective therapeutic approach for delivering antiangiogenic agents that result in the inhibition of glioma tumor growth.	[Benny, Ofra; Gvili, Koby; Radzishevsky, Inna S.; Mor, Amram; Machluf, Marcelle; Carroll, Rona S.] Technion Israel Inst Technol, Dept Food Engn & Biotechnol, Fac Biotechnol & Food Engn, IL-32000 Haifa, Israel; [Kim, Seung-Ki; Verduzco, Luis; Menon, Lata G.; Black, Peter M.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Neurosurg, Boston, MA 02115 USA; [Kim, Seung-Ki; Verduzco, Luis; Menon, Lata G.; Black, Peter M.] Harvard Univ, Childrens Hosp, Sch Med, Boston, MA 02115 USA; [Kim, Seung-Ki] Seoul Natl Univ Hosp, Dept Neurosurg, Seoul 110744, South Korea	Technion Israel Institute of Technology; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Seoul National University (SNU); Seoul National University Hospital	Carroll, RS (corresponding author), Technion Israel Inst Technol, Dept Food Engn & Biotechnol, Fac Biotechnol & Food Engn, IL-32000 Haifa, Israel.	machlufm@tx.technion.ac.il; rcarroll@rics.bwh.harvard.edu	Benny, Ofra/AAB-3294-2021; Kim, Seung-Ki/J-2742-2012	Radzishevsky, Inna/0000-0001-7748-7599				ARSHADY R, 1991, J CONTROL RELEASE, V17, P1, DOI 10.1016/0168-3659(91)90126-X; Behin A, 2003, LANCET, V361, P323, DOI 10.1016/S0140-6736(03)12328-8; Bello L, 2002, CLIN CANCER RES, V8, P3539; Benny O, 2005, CLIN CANCER RES, V11, P768; Bikfalvi A, 2004, SEMIN THROMB HEMOST, V30, P379, DOI 10.1055/s-2004-831051; Cadee JA, 2001, J BIOMED MATER RES, V56, P600, DOI 10.1002/1097-4636(20010915)56:4<600::AID-JBM1133>3.0.CO;2-I; Edlund U, 2002, ADV POLYM SCI, V157, P67; ELDRIDGE JH, 1991, MOL IMMUNOL, V28, P287, DOI 10.1016/0161-5890(91)90076-V; Etzler FM, 1997, PART PART SYST CHAR, V14, P278, DOI 10.1002/ppsc.19970140604; FRIESS W, J PHARM SCI, V91, P845; Gao P, 2006, CHEM PHARM BULL, V54, P89, DOI 10.1248/cpb.54.89; Gavini E, 2005, AAPS PHARMSCITECH, V6, DOI 10.1208/pt060117; Giussani C, 2003, CANCER RES, V63, P2499; Hagedorn M, 2002, CANCER RES, V62, P6884; Hagedorn M, 2001, FASEB J, V15, P550; Hyon SH, 2000, YONSEI MED J, V41, P720, DOI 10.3349/ymj.2000.41.6.720; Joki T, 2001, NAT BIOTECHNOL, V19, P35, DOI 10.1038/83481; Jouan V, 1999, BLOOD, V94, P984, DOI 10.1182/blood.V94.3.984.415k31_984_993; Lesniak MS, 2005, TECHNOL CANCER RES T, V4, P417, DOI 10.1177/153303460500400409; Li YH, 2003, CANCER BIOTHER RADIO, V18, P829, DOI 10.1089/108497803770418373; MAIONE TE, 1990, SCIENCE, V247, P77, DOI 10.1126/science.1688470; MENEI P, 1993, BIOMATERIALS, V14, P470, DOI 10.1016/0142-9612(93)90151-Q; Menei P, 1996, NEUROSURGERY, V39, P117, DOI 10.1097/00006123-199607000-00023; NEUFELD G, 1988, J CELL PHYSIOL, V136, P537, DOI 10.1002/jcp.1041360321; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Patil Siddhesh D, 2004, Diabetes Technol Ther, V6, P887, DOI 10.1089/dia.2004.6.887; Prior S, 2004, J ANTIMICROB CHEMOTH, V53, P981, DOI 10.1093/jac/dkh227; Rege TA, 2005, NEURO-ONCOLOGY, V7, P106, DOI 10.1215/S115285170400119X; Rojas J, 1999, INT J PHARM, V183, P67, DOI 10.1016/S0378-5173(99)00046-0; RUCINSKI B, 1986, AM J PHYSIOL, V251, pH800, DOI 10.1152/ajpheart.1986.251.4.H800; RUIZ JM, 1990, PHARMACEUT RES, V7, P928, DOI 10.1023/A:1015945806917; Saini P, 1997, DRUG DELIV, V4, P129, DOI 10.3109/10717549709051884; Sales-Junior PA, 2005, VET IMMUNOL IMMUNOP, V107, P281, DOI 10.1016/j.vetimm.2005.05.004; Saltzman WM, 1999, PHARMACEUT RES, V16, P232, DOI 10.1023/A:1018824324275; Schmidt KF, 2004, J NEURO-ONCOL, V68, P207, DOI 10.1023/B:NEON.0000033364.43142.bf; Schmidt NO, 2004, CLIN CANCER RES, V10, P1255, DOI 10.1158/1078-0432.CCR-03-0052; Sun YP, 2004, MAGN RESON MED, V51, P893, DOI 10.1002/mrm.20029; Tanaka T, 1997, NAT MED, V3, P437, DOI 10.1038/nm0497-437; Tracy MA, 1999, BIOMATERIALS, V20, P1057, DOI 10.1016/S0142-9612(99)00002-2; Veziers J, 2001, J NEUROSURG, V95, P489, DOI 10.3171/jns.2001.95.3.0489	40	31	32	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2008	22	2					488	499		10.1096/fj.07-8801com	http://dx.doi.org/10.1096/fj.07-8801com			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	257TY	17873103				2022-12-25	WOS:000252822600019
J	Farmer, JL; Burghardt, RC; Jousan, FD; Hansen, PJ; Bazer, FW; Spencer, TE				Farmer, Jennifer L.; Burghardt, Robert C.; Jousan, F. Dean; Hansen, Peter J.; Bazer, Fuller W.; Spencer, Thomas E.			Galectin 15 (LGALS15) functions in trophectoderm migration and attachment	FASEB JOURNAL			English	Article						trophoblast; apoptosis	LEYDEN CRYSTAL PROTEIN; EXTRACELLULAR-MATRIX PROTEINS; OVINE UTERUS; ENDOGENOUS RETROVIRUSES; OSTEOPONTIN EXPRESSION; DOMESTIC-ANIMALS; EARLY-PREGNANCY; BOVINE EMBRYOS; CONCEPTUS; PROGESTERONE	Galectin 15 (LGALS15) is expressed specifically by the endometrial luminal epithelium ( LE) of the ovine uterus in concert with blastocyst growth, elongation, and implantation. LGALS15 contains a predicted carbohydrate recognition domain (CRD) as well as LDV and RGD recognition sequences for integrin binding. Studies tested the hypothesis that LGALS15 is a secreted regulator of blastocyst development, as well as growth, migration, adhesion, and apoptosis of trophoblast. Bovine embryos were produced in vitro by standard conditions, and putative zygotes were cultured in the presence of recombinant ovine LGALS15. Rates of embryo cleavage and blastocyst formation were not affected by LGALS15. LGALS15 moderately increased proliferation of ovine trophectoderm (oTr) cells. Staurosporine elicited apoptosis of oTr cells, which could be partially inhibited by LGALS15. Migration of oTr cells was stimulated by LGALS15 that was dependent on Jun N-terminal kinase (JNK). A dose-dependent increase in oTr cell attachment to LGALS15 was found that could be inhibited by cyclic GRGDS, but not GRADS, peptides. Mutation of the LDVRGD integrin binding sequence of LGALS15 to LADRAD decreased its ability to promote oTr cell attachment, whereas mutation of the CRD had little effect. LGALS15 induced formation of robust focal adhesions in oTr cells that was abolished by mutation of the LDVRGD sequence. Collectively, these results support the hypothesis that LGALS15 stimulates trophectoderm cell migration and attachment via integrin binding and activation which are critical to blastocyst elongation and implantation.	[Farmer, Jennifer L.; Bazer, Fuller W.; Spencer, Thomas E.] Texas A&M Univ, Ctr Anim Biotechnol & Genom, College Stn, TX 77843 USA; [Farmer, Jennifer L.; Bazer, Fuller W.; Spencer, Thomas E.] Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA; [Burghardt, Robert C.] Texas A&M Univ, Image Anal Lab, College Stn, TX 77843 USA; [Burghardt, Robert C.] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX 77843 USA; [Jousan, F. Dean; Hansen, Peter J.] Univ Florida, Dept Anim Sci, Gainesville, FL 32611 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; State University System of Florida; University of Florida	Spencer, TE (corresponding author), Texas A&M Univ, Ctr Anim Biotechnol & Genom, 442 Kleberg Ctr,2471 TAMU, College Stn, TX 77843 USA.	tspencer@tamu.edu	Spencer, Thomas/AAD-6434-2020; Burghardt, Robert C./AAF-4847-2021; Bazer, Fuller/AAF-4317-2021; Hansen, Peter/AAI-4693-2021	Burghardt, Robert C./0000-0003-1021-8444; Bazer, Fuller/0000-0002-5823-5086; Hansen, Peter/0000-0003-3061-9333; Spencer, Thomas/0000-0003-2815-766X; Jousan, Frank Dean/0000-0002-2006-0612	NIEHS NIH HHS [P30 ES0910607] Funding Source: Medline	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Aplin J D, 1997, Rev Reprod, V2, P84, DOI 10.1530/ror.0.0020084; Armant DR, 2005, DEV BIOL, V280, P260, DOI 10.1016/j.ydbio.2005.02.009; Arroyo J, 2004, PLACENTA, V25, P379, DOI 10.1016/j.placenta.2003.11.001; ASHWORTH CJ, 1989, BIOL REPROD, V40, P425, DOI 10.1095/biolreprod40.2.425; BAZER FW, 1975, J ANIM SCI, V41, P1376, DOI 10.2527/jas1975.4151376x; BAZER FW, 1992, P SOC EXP BIOL MED, V199, P373, DOI 10.3181/00379727-199-43371A; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; BOHN H, 1983, ONCODEV BIOL MED, V4, P343; Burghardt RC, 2002, CELLS TISSUES ORGANS, V172, P202, DOI 10.1159/000066969; CARNEGIE JA, 1985, AM J ANAT, V174, P471, DOI 10.1002/aja.1001740409; Cooper DNW, 2002, BBA-GEN SUBJECTS, V1572, P209, DOI 10.1016/S0304-4165(02)00310-0; Dunlap KA, 2006, P NATL ACAD SCI USA, V103, P14390, DOI 10.1073/pnas.0603836103; Dunphy JL, 2000, J BIOL CHEM, V275, P32106, DOI 10.1074/jbc.M003739200; Dvorak AM, 1996, HISTOL HISTOPATHOL, V11, P711; Dyer KD, 1996, LIFE SCI, V58, P2073, DOI 10.1016/0024-3205(96)00201-9; FLECHON JE, 1986, REPROD NUTR DEV, V26, P1017, DOI 10.1051/rnd:19860609; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Gray CA, 2006, BIOL REPROD, V74, P383, DOI 10.1095/biolreprod.105.046656; Gray CA, 2005, REPRODUCTION, V130, P231, DOI 10.1530/rep.1.00637; Gray CA, 2004, P NATL ACAD SCI USA, V101, P7982, DOI 10.1073/pnas.0402669101; Gray CA, 2002, REPRODUCTION, V124, P289, DOI 10.1530/rep.0.1240289; Gray CA, 2000, BIOL REPROD, V62, P448, DOI 10.1095/biolreprod62.2.448; Gray CA, 2001, BIOL REPROD, V64, P1608, DOI 10.1095/biolreprod64.6.1608; GUILLOMOT M, 1995, J REPROD FERTIL, P39; GUILLOMOT M, 1990, BIOL CELL, V68, P205, DOI 10.1016/0248-4900(90)90309-Q; GUILLOMOT M, 1981, PLACENTA, V2, P169, DOI 10.1016/S0143-4004(81)80021-5; Guillomot M, 1993, REPROD MAMMALS MAN, P387; Hayashi K, 2007, ENDOCRINOLOGY, V148, P3496, DOI 10.1210/en.2007-0283; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; HIRABAYASHI J, 1994, GLYCOCONJUGATE J, V11, P437, DOI 10.1007/BF00731280; Hughes RC, 2001, BIOCHIMIE, V83, P667; Johnson GA, 2003, BIOL REPROD, V69, P1458, DOI 10.1095/biolreprod.103.020651; Johnson GA, 2001, BIOL REPROD, V65, P820, DOI 10.1095/biolreprod65.3.820; Joyce MM, 2005, PLACENTA, V26, P160, DOI 10.1016/j.placenta.2004.05.009; Kabir J, 2002, BIOCHEM J, V367, P145, DOI 10.1042/BJ20020665; Karin M, 2005, IUBMB LIFE, V57, P283, DOI 10.1080/15216540500097111; Lee VH, 1998, BIOL REPROD, V58, P1277, DOI 10.1095/biolreprod58.5.1277; LEWIS SK, IN PRESS BIOL REPROD; LIAW L, 1994, CIRC RES, V74, P214, DOI 10.1161/01.RES.74.2.214; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Maddox-Hyttel P, 2003, REPRODUCTION, P103; MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791; Nayal A, 2004, CURR OPIN CELL BIOL, V16, P94, DOI 10.1016/j.ceb.2003.11.007; Ochieng J, 1998, BIOCHEM BIOPH RES CO, V246, P788, DOI 10.1006/bbrc.1998.8708; ODA Y, 1993, J BIOL CHEM, V268, P5929; PARRISH JJ, 1986, THERIOGENOLOGY, V25, P591, DOI 10.1016/0093-691X(86)90143-3; Paula-Lopes FF, 1998, BIOL REPROD, V59, P1406, DOI 10.1095/biolreprod59.6.1406; Popovici RM, 2005, J CLIN ENDOCR METAB, V90, P6170, DOI 10.1210/jc.2004-2529; Raspotnig G, 1999, ANAL BIOCHEM, V275, P74, DOI 10.1006/abio.1999.4309; Rivera RM, 2001, REPRODUCTION, V121, P107, DOI 10.1530/rep.0.1210107; Roberts R M, 1987, Adv Exp Med Biol, V230, P137; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Satterfield MC, 2006, BIOL REPROD, V75, P289, DOI 10.1095/biolreprod.106.052944; Soto P, 2003, AM J REPROD IMMUNOL, V50, P380, DOI 10.1034/j.1600-0897.2003.00101.x; Spencer T E, 2004, J Anim Sci, V82 E-Suppl, pE4; Spencer TE, 2004, REPRODUCTION, V128, P657, DOI 10.1530/rep.1.00398; Spencer TE, 2004, ANIM REPROD SCI, V82-3, P537, DOI 10.1016/j.anireprosci.2004.04.014; Spencer TE, 2004, BIOL REPROD, V71, P2, DOI 10.1095/biolreprod.103.024133; Spencer TE, 2007, REPROD FERT DEVELOP, V19, P65, DOI 10.1071/RD06102; Swaminathan GJ, 1999, BIOCHEMISTRY-US, V38, P13837, DOI 10.1021/bi990756e; THATCHER WW, 1995, J REPROD FERTIL, P15; Vogel V, 2006, ANNU REV BIOPH BIOM, V35, P459, DOI 10.1146/annurev.biophys.35.040405.102013; von Wolff M, 2005, MOL HUM REPROD, V11, P189, DOI 10.1093/molehr/gah144; Wang JL, 2004, BBA-GEN SUBJECTS, V1673, P75, DOI 10.1016/j.bbagen.2004.03.013; WELLER PF, 1984, J BIOL CHEM, V259, P5100; Wolf E, 2003, REPROD DOMEST ANIM, V38, P276, DOI 10.1046/j.1439-0531.2003.00435.x; Yang RY, 2003, CELL MOL LIFE SCI, V60, P267, DOI 10.1007/s000180300022	68	58	60	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2008	22	2					548	560		10.1096/fj.07-9308com	http://dx.doi.org/10.1096/fj.07-9308com			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	257TY	17890287				2022-12-25	WOS:000252822600025
J	Nika, K; Tautz, L; Arimura, Y; Vang, T; Williams, S; Mustelin, T				Nika, Konstantina; Tautz, Lutz; Arimura, Yutaka; Vang, Torkel; Williams, Scott; Mustelin, Tomas			A weak Lck tail bite is necessary for Lck function in T cell antigen receptor signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PROTEIN-KINASE; TERMINAL SRC KINASE; LEUKOCYTE-COMMON ANTIGEN; SH2 DOMAIN; ZETA-CHAIN; PHOSPHOTYROSINE PHOSPHATASE; NEGATIVE REGULATION; HOMOLOGY-2 DOMAIN; ADAPTER PROTEIN; ZAP-70 KINASE	Src family kinases are suppressed by a "tail bite" mechanism, in which the binding of a phosphorylated tyrosine in the C terminus of the protein to the Src homology (SH)2 domain in the N-terminal half of the protein forces the catalytic domain into an inactive conformation stabilized by an additional SH3 interaction. In addition to this intramolecular suppressive function, the SH2 domain also mediates intermolecular interactions, which are crucial for T cell antigen receptor (TCR) signaling. To better understand the relative importance of these two opposite functions of the SH2 domain of the Src family kinase Lck in TCR signaling, we created three mutants of Lck in which the intramolecular binding of the C terminus to the SH2 domain was strengthened. The mutants differed from wild-type Lck only in one to three amino acid residues following the negative regulatory tyrosine 505, which was normally phosphorylated by Csk and dephosphorylated by CD45 in the mutants. In the Lck-negative JCaM1 cell line, the Lck mutants had a much reduced ability to transduce signals from the TCR in a manner that directly correlated with SH2-Tyr(P)(505) affinity. The mutant with the strongest tail bite was completely unable to support any ZAP-70 phosphorylation, mitogen-activated protein kinase activation, or downstream gene activation in response to TCR ligation, whereas other mutants had intermediate abilities. Lipid raft targeting was not affected. We conclude that Lck is regulated by a weak tail bite to allow for its activation and service in TCR signaling, perhaps through a competitive SH2 engagement mechanism.	Burnham Inst Med Res, Program Inflammatory Dis Res, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA; Burnham Inst Med Res, Program Signal Transduct, Ctr Canc, La Jolla, CA 92037 USA; Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute; University of Oxford	Nika, K (corresponding author), Burnham Inst Med Res, Program Inflammatory Dis Res, Infect & Inflammatory Dis Ctr, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	konstantina.nika@path.ox.ac.uk; tomasm@amgen.com	Tautz, Lutz/M-9989-2014	Tautz, Lutz/0000-0002-4075-6238; Nika, Konstantina/0000-0002-9620-0263; Mustelin, Tomas/0000-0001-5912-8840	NIAID NIH HHS [AI35603, AI53585] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053585, R01AI035603] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alonso A, 2003, NAT IMMUNOL, V4, P44, DOI 10.1038/ni856; AMREIN KE, 1988, P NATL ACAD SCI USA, V85, P4247, DOI 10.1073/pnas.85.12.4247; Ayrapetov MK, 2006, J BIOL CHEM, V281, P23776, DOI 10.1074/jbc.M604219200; BANIYASH M, 1988, J BIOL CHEM, V263, P18225; BERGMAN M, 1992, EMBO J, V11, P2919, DOI 10.1002/j.1460-2075.1992.tb05361.x; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; CARON L, 1992, MOL CELL BIOL, V12, P2720, DOI 10.1128/MCB.12.6.2720; CHAN AC, 1995, EMBO J, V14, P2499, DOI 10.1002/j.1460-2075.1995.tb07247.x; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; Choi YB, 1999, J IMMUNOL, V163, P5242; CHOW LML, 1993, NATURE, V365, P156, DOI 10.1038/365156a0; Couture C, 1996, J BIOL CHEM, V271, P24294, DOI 10.1074/jbc.271.39.24294; Couture C, 1996, J BIOL CHEM, V271, P24880, DOI 10.1074/jbc.271.40.24880; Denny MF, 2000, MOL CELL BIOL, V20, P1426, DOI 10.1128/MCB.20.4.1426-1435.2000; DESAI DM, 1993, CELL, V73, P541, DOI 10.1016/0092-8674(93)90141-C; DUPLAY P, 1994, J EXP MED, V179, P1163, DOI 10.1084/jem.179.4.1163; FURUKAWA T, 1994, P NATL ACAD SCI USA, V91, P10928, DOI 10.1073/pnas.91.23.10928; Gibson S, 1996, J BIOL CHEM, V271, P7079, DOI 10.1074/jbc.271.12.7079; Gorska MM, 2004, J EXP MED, V199, P369, DOI 10.1084/jem.20030589; Hardwick JS, 1997, J BIOL CHEM, V272, P25429, DOI 10.1074/jbc.272.41.25429; HAUGHN L, 1992, NATURE, V358, P328, DOI 10.1038/358328a0; Heyeck SD, 1997, J BIOL CHEM, V272, P25401, DOI 10.1074/jbc.272.40.25401; Holdorf AD, 2002, NAT IMMUNOL, V3, P259, DOI 10.1038/ni761; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; KORETZKY GA, 1990, NATURE, V346, P66, DOI 10.1038/346066a0; Lerner EC, 2002, NAT STRUCT BIOL, V9, P365, DOI 10.1038/nsb782; Liu KQ, 1998, J EXP MED, V187, P1721, DOI 10.1084/jem.187.10.1721; LUO K, 1990, ONCOGENE, V5, P921; LUO KX, 1990, MOL CELL BIOL, V10, P5305, DOI 10.1128/MCB.10.10.5305; MARTH JD, 1988, NATURE, V332, P171, DOI 10.1038/332171a0; MARTH JD, 1988, MOL CELL BIOL, V8, P540, DOI 10.1128/MCB.8.2.540; Marti F, 2001, J EXP MED, V193, P1425, DOI 10.1084/jem.193.12.1425; MCFARLAND EDC, 1993, P NATL ACAD SCI USA, V90, P1402, DOI 10.1073/pnas.90.4.1402; MUSTELIN T, 1989, P NATL ACAD SCI USA, V86, P6302, DOI 10.1073/pnas.86.16.6302; MUSTELIN T, 1989, IMMUNOL TODAY, V10, P189, DOI 10.1016/0167-5699(89)90322-8; Mustelin T, 2002, FRONT BIOSCI-LANDMRK, V7, pD918, DOI 10.2741/musteli1; MUSTELIN T, 1990, ONCOGENE, V5, P809; MUSTELIN T, 1993, TRENDS BIOCHEM SCI, V18, P215, DOI 10.1016/0968-0004(93)90192-P; MUSTELIN T, 1994, SRC FAMILY TYROSINE, P1; Nam HJ, 2005, J EXP MED, V201, P441, DOI 10.1084/jem.20041890; NEUMEISTER EN, 1995, MOL CELL BIOL, V15, P3171; Nika K, 2006, MOL CELL BIOL, V26, P1806, DOI 10.1128/MCB.26.5.1806-1816.2006; OETKEN C, 1994, MOL IMMUNOL, V31, P1295, DOI 10.1016/0161-5890(94)90047-7; OSTERGAARD HL, 1990, J EXP MED, V172, P347, DOI 10.1084/jem.172.1.347; OSTERGAARD HL, 1989, P NATL ACAD SCI USA, V86, P8959, DOI 10.1073/pnas.86.22.8959; Pelosi M, 1999, J BIOL CHEM, V274, P14229, DOI 10.1074/jbc.274.20.14229; Perez-Villar JJ, 1999, J IMMUNOL, V163, P6435; PINGEL JT, 1989, CELL, V58, P1055, DOI 10.1016/0092-8674(89)90504-7; Porter M, 2000, J BIOL CHEM, V275, P2721, DOI 10.1074/jbc.275.4.2721; Rahmouni S, 2006, NAT CELL BIOL, V8, P524, DOI 10.1038/ncb1398; SAKSELA K, 1995, EMBO J, V14, P484, DOI 10.1002/j.1460-2075.1995.tb07024.x; SAMELSON LE, 1986, CELL, V46, P1083, DOI 10.1016/0092-8674(86)90708-7; SANDERS ME, 1988, IMMUNOL TODAY, V9, P195, DOI 10.1016/0167-5699(88)91212-1; SEFTON BM, 1991, ONCOGENE, V6, P683; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; TAKEMOTO Y, 1995, EMBO J, V14, P3403, DOI 10.1002/j.1460-2075.1995.tb07346.x; Torgersen KM, 2001, J BIOL CHEM, V276, P29313, DOI 10.1074/jbc.C100014200; Vang T, 2004, EUR J IMMUNOL, V34, P2191, DOI 10.1002/eji.200425036; Vang T, 2001, J EXP MED, V193, P497, DOI 10.1084/jem.193.4.497; Wardenburg JB, 1996, J BIOL CHEM, V271, P19641, DOI 10.1074/jbc.271.33.19641; WEBER JR, 1992, J EXP MED, V176, P373, DOI 10.1084/jem.176.2.373; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yang YM, 2003, MOL CELL BIOL, V23, P7667, DOI 10.1128/MCB.23.21.7667-7677.2003; Yaqub S, 2003, BIOCHEM J, V372, P271, DOI 10.1042/BJ20030021; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; Zhou J, 1998, EUR J IMMUNOL, V28, P1645, DOI 10.1002/(SICI)1521-4141(199805)28:05<1645::AID-IMMU1645>3.0.CO;2-D; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	68	26	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					36000	36009		10.1074/jbc.M702779200	http://dx.doi.org/10.1074/jbc.M702779200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17897955	hybrid			2022-12-25	WOS:000251458100060
J	Brooks, NL; Trent, CM; Raetzsch, CF; Flurkey, K; Boysen, G; Perfetti, MT; Jeong, YC; Klebanov, S; Patel, KB; Khodush, VR; Kupper, LL; Carling, D; Swenberg, JA; Harrison, DE; Combs, TP				Brooks, Natasha L.; Trent, Chad M.; Raetzsch, Carl F.; Flurkey, Kevin; Boysen, Gunnar; Perfetti, Michael T.; Jeong, Yo-Chan; Klebanov, Simon; Patel, Kajal B.; Khodush, Valerie R.; Kupper, Lawrence L.; Carling, David; Swenberg, James A.; Harrison, David E.; Combs, Terry P.			Low utilization of circulating glucose after food withdrawal in Snell dwarf mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATIC INSULIN-RESISTANCE; ACTIVATED PROTEIN-KINASE; ACETYL-COA CARBOXYLASE; LIFE-SPAN; PLASMA-GLUCOSE; CALORIC RESTRICTION; OXIDATIVE STRESS; GENE-EXPRESSION; AGING RATS; COMPLEX I	Glucose metabolism is altered in long-lived people and mice. Although it is clear that there is an association between altered glucose metabolism and longevity, it is not known whether this link is causal or not. Our current hypothesis is that decreased fasting glucose utilization may increase longevity by reducing oxygen radical production, a potential cause of aging. We observed that whole body fasting glucose utilization was lower in the Snell dwarf, a long-lived mutant mouse. Whole body fasting glucose utilization may be reduced by a decrease in the production of circulating glucose. Our isotope labeling analysis indicated both gluconeogenesis and glycogenolysis were suppressed in Snell dwarfs. Elevated circulating adiponectin may contribute to the reduction of glucose production in Snell dwarfs. Adiponectin lowered the appearance of glucose in the media over hepatoma cells by suppressing gluconeogenesis and glycogenolysis. The suppression of glucose production by adiponectin in vitro depended on AMP-activated protein kinase, a cell mediator of fatty acid oxidation. Elevated fatty acid oxidation was indicated in Snell dwarfs by increased utilization of circulating oleic acid, reduced intracellular triglyceride content, and increased phosphorylation of acetyl-CoA carboxylase. Finally, protein carbonyl content, a marker of oxygen radical damage, was decreased in Snell dwarfs. The correlation between high glucose utilization and elevated oxygen radical production was also observed in vitro by altering the concentrations of glucose and fatty acids in the media or pharmacologic inhibition of glucose and fatty acid oxidation with 4-hydroxycyanocinnamic acid and etomoxir, respectively.	Univ N Carolina, Sch Publ Hlth, Dept Nutr, Sch Med, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Environm Sci & Engn, Chapel Hill, NC USA; Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; Jackson Lab, Bar Harbor, ME 04609 USA; Columbia Univ, Coll Phys & Surg, New York, NY 10025 USA; Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, London W12 0NN, England	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Jackson Laboratory; Columbia University; Imperial College London	Combs, TP (corresponding author), Univ N Carolina, Sch Publ Hlth, Dept Nutr, Sch Med, Chapel Hill, NC 27599 USA.	terrycombs@unc.edu	Carling, David/F-1943-2014; Boysen, Gunnar/U-3272-2019	Carling, David/0000-0002-2316-1830; Boysen, Gunnar/0000-0001-8364-9881	Medical Research Council [MC_U120027537] Funding Source: Medline; NIA NIH HHS [AG18003, AG025007] Funding Source: Medline; NIDDK NIH HHS [DK075573, DK056350] Funding Source: Medline; NIEHS NIH HHS [ES10126] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK075573, P30DK056350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018003, R01AG025007] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Al-Regaiey KA, 2007, J GERONTOL A-BIOL, V62, P18, DOI 10.1093/gerona/62.1.18; Andreelli F, 2006, ENDOCRINOLOGY, V147, P2432, DOI 10.1210/en.2005-0898; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Barja G, 1998, J BIOENERG BIOMEMBR, V30, P235, DOI 10.1023/A:1020592719405; Barja G, 2004, TRENDS NEUROSCI, V27, P595, DOI 10.1016/j.tins.2004.07.005; BARON AD, 1985, J CLIN INVEST, V76, P1782, DOI 10.1172/JCI112169; Bartke A, 2001, NATURE, V414, P412, DOI 10.1038/35106646; Barzilai N, 1998, J CLIN INVEST, V101, P1353, DOI 10.1172/JCI485; Basu R, 2004, AM J PHYSIOL-ENDOC M, V287, pE55, DOI 10.1152/ajpendo.00549.2003; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Berryman DE, 2004, GROWTH HORM IGF RES, V14, P309, DOI 10.1016/j.ghir.2004.02.005; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; BORG KE, 1995, P SOC EXP BIOL MED, V210, P126; Boss O, 1998, EUR J ENDOCRINOL, V139, P1, DOI 10.1530/eje.0.1390001; CHERRINGTON AD, 1978, METABOLISM, V27, P787, DOI 10.1016/0026-0495(78)90213-5; Civitarese AE, 2006, CELL METAB, V4, P75, DOI 10.1016/j.cmet.2006.05.002; Combs TP, 2001, J CLIN INVEST, V108, P1875, DOI 10.1172/JCI200114120; Combs TP, 2004, ENDOCRINOLOGY, V145, P367, DOI 10.1210/en.2003-1068; Combs TP, 2002, ENDOCRINOLOGY, V143, P998, DOI 10.1210/endo.143.3.8662; Combs TP, 2003, DIABETES, V52, P268, DOI 10.2337/diabetes.52.2.268; DACOSTA KA, 1993, J BIOL CHEM, V268, P2100; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; Elahi D, 2000, EUR J CLIN NUTR, V54, pS112, DOI 10.1038/sj.ejcn.1601032; Fisher SJ, 2003, J CLIN INVEST, V111, P463, DOI 10.1172/JCI16426; Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898; Gastaldelli A, 2004, J CLIN ENDOCR METAB, V89, P3914, DOI 10.1210/jc.2003-031941; Grivennikova VG, 2006, BBA-BIOENERGETICS, V1757, P553, DOI 10.1016/j.bbabio.2006.03.013; Gupta G, 2000, AM J PHYSIOL-ENDOC M, V278, pE985, DOI 10.1152/ajpendo.2000.278.6.E985; HARRIS SB, 1994, MECH AGEING DEV, V73, P209, DOI 10.1016/0047-6374(94)90053-1; Hauck SJ, 2001, EXP BIOL MED, V226, P552; Hill AG, 1998, BRIT J SURG, V85, P884; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Hsieh CC, 2006, FASEB J, V20, P259, DOI 10.1096/fj.05-4376com; Itoh Y, 2001, P NATL ACAD SCI USA, V98, P9913, DOI 10.1073/pnas.171319498; Knutson VP, 2000, ENDOCRINOLOGY, V141, P693, DOI 10.1210/en.141.2.693; KRUSZYNSKA YT, 1987, BIOCHEM PHARMACOL, V36, P3917, DOI 10.1016/0006-2952(87)90458-8; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Kushnareva Y, 2002, BIOCHEM J, V368, P545, DOI 10.1042/BJ20021121; Landau BR, 1996, J CLIN INVEST, V98, P378, DOI 10.1172/JCI118803; LANG CH, 1987, METABOLISM, V36, P180, DOI 10.1016/0026-0495(87)90015-1; Leiser SF, 2006, MECH AGEING DEV, V127, P821, DOI 10.1016/j.mad.2006.08.003; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Li LO, 2006, J BIOL CHEM, V281, P37246, DOI 10.1074/jbc.M604427200; Liochev SI, 2007, FREE RADICAL BIO MED, V42, P1465, DOI 10.1016/j.freeradbiomed.2007.02.015; MASORO EJ, 1989, J GERONTOL, V44, pB20, DOI 10.1093/geronj/44.1.B20; MASORO EJ, 1992, J GERONTOL, V47, pB202, DOI 10.1093/geronj/47.6.B202; Mattison JA, 2000, J AM AGING ASSOC, V23, P9, DOI 10.1007/s11357-000-0002-0; MCCARTER R, 1985, AM J PHYSIOL, V248, pE488; Merrill CL, 2002, TOXICOL SCI, V68, P93, DOI 10.1093/toxsci/68.1.93; Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x; MIRAND EA, 1953, P SOC EXP BIOL MED, V82, P746; Natali A, 2006, DIABETOLOGIA, V49, P434, DOI 10.1007/s00125-006-0141-7; Nawrocki AR, 2006, J BIOL CHEM, V281, P2654, DOI 10.1074/jbc.M505311200; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Paolisso G, 1996, AM J PHYSIOL-ENDOC M, V270, pE890, DOI 10.1152/ajpendo.1996.270.5.E890; PINKERTON W, 1964, P SOC EXP BIOL MED, V116, P959, DOI 10.3181/00379727-116-29420; Previs SF, 1996, J MASS SPECTROM, V31, P639, DOI 10.1002/(SICI)1096-9888(199606)31:6<639::AID-JMS336>3.0.CO;2-S; ROSSETTI L, 1991, DIABETES, V40, P444, DOI 10.2337/diabetes.40.4.444; Rossetti L, 1997, J CLIN INVEST, V100, P1831, DOI 10.1172/JCI119711; ROYLE GT, 1983, J SURG RES, V34, P187, DOI 10.1016/0022-4804(83)90059-8; SHIPLEY RA, 1972, TRACER METHODS IN VI, P1; Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142; Stauber AJ, 2005, MOL PHARMACOL, V67, P681, DOI 10.1124/mol.104.007278; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; VERDONK CA, 1981, DIABETES, V30, P535, DOI 10.2337/diabetes.30.6.535; WITTERS LA, 1991, BIOCHEM BIOPH RES CO, V181, P1486, DOI 10.1016/0006-291X(91)92107-U; Woods A, 2000, MOL CELL BIOL, V20, P6704, DOI 10.1128/MCB.20.18.6704-6711.2000; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788	70	37	37	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35069	35077		10.1074/jbc.M700484200	http://dx.doi.org/10.1074/jbc.M700484200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17905742	Green Published, hybrid			2022-12-25	WOS:000251155200051
J	Jung, HY; Seong, HA; Ha, HJ				Jung, Haiyoung; Seong, Hyun-A.; Ha, Hyunjung			NM23-H1 tumor suppressor and its interacting partner STRAP activate p53 function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-ASSOCIATED PROTEIN; GROWTH-FACTOR; PHYSICAL INTERACTION; DIPHOSPHATE KINASE; CANCER-CELLS; DNA-BINDING; WILD-TYPE; MDM2; STABILITY; ONCOPROTEIN	p53 plays a critical role in a variety of growth inhibitory responses, including cell cycle arrest, differentiation, and apoptosis, and contributes to tumor suppression. Here we show that NM23-H1 and its binding partner STRAP (serine-threonine kinase receptor-associated protein) interact with p53 and potentiate p53 activity. Both NM23-H1 and STRAP directly interact with the central DNA binding domain within residues 113-290. The use of NM23-H1 and STRAP mutants revealed that Cys(145) of NM23-H1 and Cys(152) (or Cys(270)) of STRAP were responsible for p53 binding. Furthermore, Cys(176) and Cys(135) of p53 were required to bind NM23-H1 and STRAP, respectively. Ectopic expression of wild-type NM23-H1 and STRAP, but not NM23-H1(C145S) and STRAP(C152S/C270S), positively regulated p53-mediated transcription in a dose-dependent manner. Knockdown of endogenous NM23-H1 or STRAP produced an opposite trend and inhibited the p53-mediated transcription. Similarly, NM23-H1 and STRAP stimulated p53-induced apoptosis and growth inhibition, whereas the NM23-H1(C145S) and STRAP(C152S/C270S) mutants had no effect. We also demonstrated that p53 activation by NM23-H1 and STRAP was mediated by removing Mdm2, a negative regulator of p53, from the p53-Mdm2 complex. These results suggest that NM23-H1 and its interacting partner STRAP physically interact with p53 and positively regulate its functions, including p53-induced apoptosis and cell cycle arrest.	Chungbuk Natl Univ, Dept Biochem, Sch Life Sci, Biotechnol Res Inst, Cheongju 361763, South Korea	Chungbuk National University	Ha, HJ (corresponding author), Chungbuk Natl Univ, Dept Biochem, Sch Life Sci, Biotechnol Res Inst, Cheongju 361763, South Korea.	hyunha@chungbuk.ac.kr						ANDERSON CW, 2003, HDB CELL SIGNALING, V3, P237; Anumanthan G, 2006, CANCER RES, V66, P10824, DOI 10.1158/0008-5472.CAN-06-1599; Asher G, 2002, P NATL ACAD SCI USA, V99, P3099, DOI 10.1073/pnas.052706799; Asher G, 2001, P NATL ACAD SCI USA, V98, P1188, DOI 10.1073/pnas.021558898; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Buschmann T, 2001, MOL CELL BIOL, V21, P2743, DOI 10.1128/MCB.21.8.2743-2754.2001; Buzek J, 2002, NUCLEIC ACIDS RES, V30, P2340, DOI 10.1093/nar/30.11.2340; Caspari T, 2000, CURR BIOL, V10, pR315, DOI 10.1016/S0960-9822(00)00439-5; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; Damalas A, 2001, EMBO J, V20, P4912, DOI 10.1093/emboj/20.17.4912; Gervasi F, 1996, CELL GROWTH DIFFER, V7, P1689; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Gorina S, 1996, SCIENCE, V274, P1001, DOI 10.1126/science.274.5289.1001; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Haider SK, 2006, CANCER RES, V66, P6156, DOI 10.1158/0008-5472.CAN-05-3261; Hofseth LJ, 2004, TRENDS PHARMACOL SCI, V25, P177, DOI 10.1016/j.tips.2004.02.009; Hollstein M, 1996, NUCLEIC ACIDS RES, V24, P141, DOI 10.1093/nar/24.1.141; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; Hsieh JK, 1999, MOL CELL, V3, P181, DOI 10.1016/S1097-2765(00)80309-3; Ishikawa N, 2003, J BIOENERG BIOMEMBR, V35, P7, DOI 10.1023/A:1023433504713; IWABUCHI K, 1994, P NATL ACAD SCI USA, V91, P6098, DOI 10.1073/pnas.91.13.6098; JENKINS JR, 1988, J VIROL, V62, P3903, DOI 10.1128/JVI.62.10.3903-3906.1988; Jung H, 2001, J BIOL CHEM, V276, P15504, DOI 10.1074/jbc.M009620200; Kaeser MD, 2004, J BIOL CHEM, V279, P7598, DOI 10.1074/jbc.M311732200; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; KANTOR JD, 1993, CANCER RES, V53, P1971; Kimura N, 2000, J BIOENERG BIOMEMBR, V32, P309, DOI 10.1023/A:1005549315846; Koivusalo R, 2006, CANCER RES, V66, P11817, DOI 10.1158/0008-5472.CAN-06-2185; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Leung KM, 2002, CANCER RES, V62, P4890; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; May P, 1999, ONCOGENE, V18, P7621, DOI 10.1038/sj.onc.1203285; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Oh W, 2006, J BIOL CHEM, V281, P17457, DOI 10.1074/jbc.M601857200; Otero AD, 2000, J BIOENERG BIOMEMBR, V32, P269, DOI 10.1023/A:1005589029959; Park K, 2005, CANCER RES, V65, P749; Prives C, 1999, J PATHOL, V187, P112; RAINWATER R, 1995, MOL CELL BIOL, V15, P3892; RUPPERT JM, 1993, MOL CELL BIOL, V13, P3811, DOI 10.1128/MCB.13.6.3811; Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7; SCHEFFNER M, 1992, J VIROL, V66, P5100, DOI 10.1128/JVI.66.8.5100-5105.1992; Seong HA, 2005, J BIOL CHEM, V280, P42897, DOI 10.1074/jbc.M507539200; Seong HA, 2007, J BIOL CHEM, V282, P12272, DOI 10.1074/jbc.M609279200; Seong HA, 2007, J BIOL CHEM, V282, P12075, DOI 10.1074/jbc.M609832200; Sharp DA, 1999, J BIOL CHEM, V274, P38189, DOI 10.1074/jbc.274.53.38189; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wise-Draper TM, 2006, MOL CELL BIOL, V26, P7506, DOI 10.1128/MCB.00430-06; Zilfou JT, 2001, MOL CELL BIOL, V21, P3974, DOI 10.1128/MCB.21.12.3974-3985.2001	50	79	82	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35293	35307		10.1074/jbc.M705181200	http://dx.doi.org/10.1074/jbc.M705181200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17916563	hybrid			2022-12-25	WOS:000251155200073
J	Kim, JS; Diebold, BA; Babior, BM; Knaus, UG; Bokoch, GM				Kim, Jun-Sub; Diebold, Becky A.; Babior, Bernard M.; Knaus, Ulla G.; Bokoch, Gary M.			Regulation of Nox1 activity via protein kinase A-mediated phosphorylation of NoxA1 and 14-3-3 binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTROPHIL NADPH OXIDASE; SMOOTH-MUSCLE-CELLS; EPITHELIAL-CELLS; INDUCED ACTIVATION; RESPIRATORY BURST; ENDOTHELIAL-CELLS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; SH3 DOMAIN; CYCLIC-AMP	Nox activator 1 (NoxA1) is a homologue of p67(phox) that acts in conjunction with Nox organizer 1 (NoxO1) to regulate reactive oxygen species (ROS) production by the NADPH oxidase Nox1. The phosphorylation of cytosolic regulatory components by multiple kinases plays important roles in assembly and activity of the phagocyte NADPH oxidase (Nox2) system, but little is known about regulation by phosphorylation in the Nox1 system. Here we identify Ser(172) and Ser(461) of NoxA1 as phosphorylation sites for protein kinase A (PKA). A consequence of this phosphorylation was the enhancement of NoxA1 complex formation with 14-3-3 proteins. Using both a transfected human embryonic kidney 293 cell Nox1 model system and endogenous Nox1 in colon cell lines, we showed that the elevation of cAMP inhibits, whereas the inhibition of PKA enhances, Nox1-dependent ROS production through effects on NoxA1. Inhibition of Nox1 activity was intensified by the availability of 14-3-3 zeta protein, and this regulatory interaction was dependent on PKA-phosphorylatable sites at Ser172 and Ser461 in NoxA1. We showed that phosphorylation and 14-3-3 binding induce the dissociation of NoxA1 from the Nox1 complex at the plasma membrane, suggesting a mechanism for the inhibitory effect on Nox1 activity. Our data establish that PKA-phosphorylated NoxA1 is a new binding partner of 14-3-3 protein (s) and that this forms the basis of a novel mechanism regulating the formation of ROS by Nox1 and, potentially, other NoxA1-regulated Nox family members.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; Emory Univ, Dept Pathol, Atlanta, GA 30322 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Emory University	Diebold, BA (corresponding author), Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA.	bdiebol@emory.edu; bokoch@scripps.edu			NATIONAL CANCER INSTITUTE [R01CA068376] Funding Source: NIH RePORTER; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [P01CI000095] Funding Source: NIH RePORTER; NCI NIH HHS [CA068376] Funding Source: Medline; NCPDCID CDC HHS [CI000095] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCPDCID CDC HHS		Ago T, 1999, J BIOL CHEM, V274, P33644, DOI 10.1074/jbc.274.47.33644; Ago T, 2003, P NATL ACAD SCI USA, V100, P4474, DOI 10.1073/pnas.0735712100; Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; Banfi B, 2003, J BIOL CHEM, V278, P3510, DOI 10.1074/jbc.C200613200; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; BengisGarber C, 1996, CELL SIGNAL, V8, P291, DOI 10.1016/0898-6568(96)00052-6; Bokoch GM, 2003, TRENDS BIOCHEM SCI, V28, P502, DOI 10.1016/S0968-0004(03)00194-4; BRIDGES D, 2005, SCI STKE, pRE10, DOI DOI 10.1126/STKE.2962005RE10; Brown GE, 2004, J BIOL CHEM, V279, P27059, DOI 10.1074/jbc.M314258200; Cheng GJ, 2004, J BIOL CHEM, V279, P4737, DOI 10.1074/jbc.M305968200; Cheng G, 2006, J BIOL CHEM, V281, P17718, DOI 10.1074/jbc.M512751200; CLARK RA, 1990, J CLIN INVEST, V85, P714, DOI 10.1172/JCI114496; Crawford MA, 2006, J IMMUNOL, V176, P7557, DOI 10.4049/jimmunol.176.12.7557; Dikalova A, 2005, CIRCULATION, V112, P2668, DOI 10.1161/CIRCULATIONAHA.105.538934; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Geiszt M, 2003, J BIOL CHEM, V278, P20006, DOI 10.1074/jbc.M301289200; Groemping Y, 2005, BIOCHEM J, V386, P401, DOI 10.1042/BJ20041835; Groemping Y, 2003, CELL, V113, P343, DOI 10.1016/S0092-8674(03)00314-3; Hanna IR, 2004, FREE RADICAL BIO MED, V37, P1542, DOI 10.1016/j.freeradbiomed.2004.08.011; Humphries KM, 2007, J BIOL CHEM, V282, P22072, DOI 10.1074/jbc.M702582200; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; Kawahara T, 2005, AM J PHYSIOL-CELL PH, V288, pC450, DOI 10.1152/ajpcell.00319.2004; KNAUS UG, 1995, SCIENCE, V269, P221, DOI 10.1126/science.7618083; Kuwano Y, 2006, AM J PHYSIOL-CELL PH, V290, pC433, DOI 10.1152/ajpcell.00135.2005; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P319, DOI 10.1016/j.freeradbiomed.2007.03.028; Lassegue B, 2001, CIRC RES, V88, P888, DOI 10.1161/hh0901.090299; Lin P, 2005, J IMMUNOL, V174, P2981, DOI 10.4049/jimmunol.174.5.2981; LIU D, 1995, NATURE, V376, P191, DOI 10.1038/376191a0; LUBRAN MM, 1988, ANN CLIN LAB SCI, V18, P58; Matsuno K, 2005, CIRCULATION, V112, P2677, DOI 10.1161/CIRCULATIONAHA.105.573709; Miyano K, 2006, J BIOL CHEM, V281, P21857, DOI 10.1074/jbc.M513665200; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Ouedraogo R, 2006, DIABETES, V55, P1840, DOI 10.2337/db05-1174; Porter GW, 2006, SEMIN CANCER BIOL, V16, P193, DOI 10.1016/j.semcancer.2006.03.003; Ranjan P, 2006, ANTIOXID REDOX SIGN, V8, P1447, DOI 10.1089/ars.2006.8.1447; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Rokutan K, 2006, ANTIOXID REDOX SIGN, V8, P1573, DOI 10.1089/ars.2006.8.1573; Sheppard FR, 2005, J LEUKOCYTE BIOL, V78, P1025, DOI 10.1189/jlb.0804442; SIMCHOWITZ L, 1980, J IMMUNOL, V124, P1482; Sorescu GP, 2004, CIRC RES, V95, P773, DOI 10.1161/01.RES.0000145728.22878.45; Spisani S, 1996, CELL SIGNAL, V8, P269, DOI 10.1016/0898-6568(96)00049-6; Suh YA, 1999, NATURE, V401, P79, DOI 10.1038/43459; Sumimoto H, 2005, BIOCHEM BIOPH RES CO, V338, P677, DOI 10.1016/j.bbrc.2005.08.210; Szanto I, 2005, J PATHOL, V207, P164, DOI 10.1002/path.1824; Takeya R, 2003, J BIOL CHEM, V278, P25234, DOI 10.1074/jbc.M212856200; Ueyama T, 2006, MOL CELL BIOL, V26, P2160, DOI 10.1128/MCB.26.6.2160-2174.2006; Vojtova J, 2006, CURR OPIN MICROBIOL, V9, P69, DOI 10.1016/j.mib.2005.12.011; Wilker EW, 2005, J BIOL CHEM, V280, P18891, DOI 10.1074/jbc.M500982200; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yasunari K, 2000, CIRCULATION, V101, P2302, DOI 10.1161/01.CIR.101.19.2302; Zhang LX, 1997, J BIOL CHEM, V272, P13717, DOI 10.1074/jbc.272.21.13717; ZHANG SJ, 1995, J BIOL CHEM, V270, P23934, DOI 10.1074/jbc.270.41.23934	55	78	81	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34787	34800		10.1074/jbc.M704754200	http://dx.doi.org/10.1074/jbc.M704754200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17913709	hybrid			2022-12-25	WOS:000251155200021
J	Le, GT; Abbenante, G; Fairlie, DP				Le, Giang Thanh; Abbenante, Giovanni; Fairlie, David P.			Profiling the enzymatic properties and inhibition of human complement factor B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLOMERULONEPHRITIS TYPE-II; VIRUS NS3 PROTEASE; ALTERNATIVE PATHWAY; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; RENAL-DISEASE; MRL/LPR MICE; ANTIPHOSPHOLIPID SYNDROME; C3 ACTIVATION; FACTOR-H; INFLAMMATION	Human complement factor B is the crucial catalytic component of the C3 convertase enzyme that activates the alternative pathway of complement-mediated immunity. Although a serine protease in its own right, factor B circulates in human serum as an inactive zymogen and there is a crystal structure only for the inactive state of factor B and various fragments. To provide greater insight to the catalytic function and properties of factor B, we have used short para-nitroanilide derivatives of 4-to 15-residue peptides as substrates to profile the catalytic properties of factor B. Among factors found to influence catalytic activity of factor B was an unusual dependence on pH. Non-physiological alkaline conditions strongly promoted substrate cleavage by factor B, consistent with a pH-accessible conformation of the enzyme that may be critical for catalytic function. Small N-terminal extensions to conventional hexapeptide para-nitroanilide substrates significantly increased catalytic activity of factor B, which was more selective for its cleavage site than trypsin. The new chromogenic assay enabled optimization of catalysis conditions, the profiling of different substrate sequences, and the development of the first reversible and competitive substrate-based inhibitor of factor B. The inhibitor was also shown to prevent in vitro formation of C3a from C3 by factor B, by synthetic and by natural C3 convertase of the alternative complement activation pathway, and to block formation of membrane attack complex. The availability of a reversible substrate-based inhibitor that could stabilize the active conformation of factor B, in conjunction with a pH-promoted higher processing activity, may offer a new avenue to obtain crystal structures of factor B and C3 convertase in an active conformation.	Univ Queensland, Ctr Drug Design & Dev, Inst Mol Biosci, Brisbane, Qld 4072, Australia	University of Queensland	Fairlie, DP (corresponding author), Univ Queensland, Ctr Drug Design & Dev, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	d.fairlie@imb.uq.edu.au	Le, Giang/I-3178-2016; Fairlie, David P/F-8865-2014	Le, Giang/0000-0002-2591-9190; Fairlie, David P/0000-0002-7856-8566				Abbenante G, 2000, LETT PEPT SCI, V7, P347, DOI 10.1023/A:1013016323676; Abbenante Giovanni, 2005, Med Chem, V1, P71, DOI 10.2174/1573406053402569; Angelo PF, 2006, J BIOL CHEM, V281, P3116, DOI 10.1074/jbc.M510096200; Appel GB, 2005, J AM SOC NEPHROL, V16, P1392, DOI 10.1681/ASN.2005010078; Arumugam TV, 2007, P NATL ACAD SCI USA, V104, P14104, DOI 10.1073/pnas.0700506104; Bao LH, 2002, J IMMUNOL, V168, P3601, DOI 10.4049/jimmunol.168.7.3601; Bessaud M, 2005, VIRUS RES, V107, P57, DOI 10.1016/j.virusres.2004.06.015; Bessaud M, 2006, VIRUS RES, V120, P79, DOI 10.1016/j.virusres.2006.01.021; Bhattacharya AA, 2004, STRUCTURE, V12, P371, DOI 10.1016/j.str.2004.02.012; Elliott MK, 2004, KIDNEY INT, V65, P129, DOI 10.1111/j.1523-1755.2004.00371.x; Fairlie DP, 2000, J MED CHEM, V43, P1271, DOI 10.1021/jm990315t; FISHELSON Z, 1984, J IMMUNOL, V132, P1425; Furlong ST, 2000, IMMUNOPHARMACOLOGY, V48, P199, DOI 10.1016/S0162-3109(00)00205-8; Hinshelwood J, 2000, J MOL BIOL, V301, P1267, DOI 10.1006/jmbi.2000.4044; HOGASEN K, 1995, J CLIN INVEST, V95, P1054, DOI 10.1172/JCI117751; INAGI R, 1991, IMMUNOL LETT, V27, P49, DOI 10.1016/0165-2478(91)90243-4; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Jing H, 2000, EMBO J, V19, P164, DOI 10.1093/emboj/19.2.164; KAM CM, 1987, J BIOL CHEM, V262, P3444; Katschke KJ, 2007, J EXP MED, V204, P1319, DOI 10.1084/jem.20070432; Lenderink AM, 2007, AM J PHYSIOL-RENAL, V293, pF555, DOI 10.1152/ajprenal.00403.2006; Leung D, 2000, J MED CHEM, V43, P305, DOI 10.1021/jm990412m; Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200; Li J, 2005, J BIOL CHEM, V280, P28766, DOI 10.1074/jbc.M500588200; MERI S, 1992, J EXP MED, V175, P939, DOI 10.1084/jem.175.4.939; Milder FJ, 2007, NAT STRUCT MOL BIOL, V14, P224, DOI 10.1038/nsmb1210; Milder FJ, 2006, STRUCTURE, V14, P1587, DOI 10.1016/j.str.2006.08.008; Mollnes TE, 2006, MOL IMMUNOL, V43, P107, DOI 10.1016/j.molimm.2005.06.014; Nall TA, 2004, J BIOL CHEM, V279, P48535, DOI 10.1074/jbc.M406810200; PANGBURN MK, 1986, BIOCHEM J, V235, P723, DOI 10.1042/bj2350723; Park P, 2002, AM J PHYSIOL-RENAL, V282, pF352, DOI 10.1152/ajprenal.00160.2001; Peyrefitte CN, 2007, VIRUS GENES, V34, P185, DOI 10.1007/s11262-006-0052-1; Pickering MC, 2002, NAT GENET, V31, P424, DOI 10.1038/ng912; Ponnuraj K, 2004, MOL CELL, V14, P17, DOI 10.1016/S1097-2765(04)00160-1; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Sahu A, 1996, J IMMUNOL, V157, P884; Salmon JE, 2007, NAT CLIN PRACT RHEUM, V3, P140, DOI 10.1038/ncprheum0432; Sim RB, 2004, BIOCHEM SOC T, V32, P21, DOI 10.1042/BST0320021; Taube C, 2006, P NATL ACAD SCI USA, V103, P8084, DOI 10.1073/pnas.0602357103; Thurman JM, 2006, J IMMUNOL, V176, P1305, DOI 10.4049/jimmunol.176.3.1305; Thurman JM, 2004, MOL IMMUNOL, V41, P318; Thurman JM, 2003, J IMMUNOL, V170, P1517, DOI 10.4049/jimmunol.170.3.1517; Tyndall JDA, 2005, CHEM REV, V105, P973, DOI 10.1021/cr040669e; Wang Y, 1996, P NATL ACAD SCI USA, V93, P8563, DOI 10.1073/pnas.93.16.8563; Watanabe H, 2000, J IMMUNOL, V164, P786, DOI 10.4049/jimmunol.164.2.786; Xu YY, 2001, IMMUNOL REV, V180, P123, DOI 10.1034/j.1600-065X.2001.1800111.x; Zhou WD, 2000, J CLIN INVEST, V105, P1363, DOI 10.1172/JCI8621	47	20	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34809	34816		10.1074/jbc.M705646200	http://dx.doi.org/10.1074/jbc.M705646200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17921140	hybrid			2022-12-25	WOS:000251155200023
J	Pothacharoen, P; Kalayanamitra, K; Deepa, SS; Fukui, S; Hattori, T; Fukushima, N; Hardingham, T; Kongtawelert, P; Sugahara, K				Pothacharoen, Peraphan; Kalayanamitra, Kittiwan; Deepa, Sarama S.; Fukui, Shigeyuki; Hattori, Tomohide; Fukushima, Nobuhiro; Hardingham, Timothy; Kongtawelert, Prachya; Sugahara, Kazuyuki			Two related but distinct chondroitin sulfate mimetope octasaccharide sequences recognized by monoclonal antibody WF6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHARK CARTILAGE; NEURITE OUTGROWTH; DERMATAN SULFATE; SYNOVIAL-FLUID; D-ORBITALS; TESTICULAR HYALURONIDASE; PROTEOGLYCAN METABOLISM; FORCE-FIELD; OSTEOARTHRITIS; EPITOPE	Chondroitin sulfate (CS) proteoglycans are major components of cartilage and other connective tissues. The monoclonal antibody WF6, developed against embryonic shark cartilage CS, recognizes an epitope in CS chains, which is expressed in ovarian cancer and variably in joint diseases. To elucidate the structure of the epitope, we isolated oligosaccharide fractions from a partial chondroitinase ABC digest of shark cartilage CS-C and established their chain length, disaccharide composition, sulfate content, and sulfation pattern. These structurally defined oligosaccharide fractions were characterized for binding to WF6 by enzyme-linked immunosorbent assay using an oligosaccharide microarray prepared with CS oligosaccharides derivatized with a fluorescent aminolipid. The lowest molecular weight fraction recognized by WF6 contained octasaccharides, which were split into five subfractions. The most reactive subfraction contained several distinct octasaccharide sequences. Two octasaccharides, Delta D-C-C-C and Delta C-C-A-D ( where A represents GlcUA beta 1-3GalNAc(4-O-sulfate), C is GlcUA beta 1-3GalNAc(6-O-sulfate), D is GlcUA(2-O-sulfate)beta 1-3GalNAc(6-Osulfate), Delta C is Delta(4,5)HexUA alpha 1-3GalNAc(6-O-sulfate), and Delta D is Delta(4,5)HexUA(2-O-sulfate)alpha 1-3GalNAc(6-O-sulfate)), were recognized by WF6, but other related octasaccharides, Delta C-A- D-C and Delta C-C-C-C, were not. The structure and sequences of both the binding and nonbinding octasaccharides were compared by computer modeling, which revealed a remarkable similarity between the shape and distribution of the electrostatic potential in the two different octasaccharide sequences that bound to WF6 and that differed from the nonbinding octasaccharides. The strong similarity in structure predicted for the two binding CS octasaccharides (Delta D-C-C-C and Delta C-C-A-D) provided a possible explanation for their similar affinity for WF6, although they differed in sequence and thus form two specific mimetopes for the antibody.	Hokkaido Univ, Grad Sch Life Sci, Lab Proteoglycan Signaling & Therapeut, Frontier Res Ctr Post Genom Sci & Technol,Kita Ku, Sapporo, Hokkaido 0010021, Japan; Chiang Mai Univ, Thailand Excellence Ctr Tissue Engn, Dept Biochem, Fac Med, Chiang Mai 50200, Thailand; Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 6588558, Japan; Kyoto Sangyo Univ, Dept Biotechnol, Fac Engn, Kyoto 6038558, Japan; Sci & Technol Syst Inc, Shibuya Ku, Tokyo 1500002, Japan; Univ Manchester, United Kingdom Ctr Tissue Engn, Fac Life Sci, Manchester M13 9PT, Lancs, England; Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Fac Life Sci, Manchester M13 9PT, Lancs, England	Hokkaido University; Chiang Mai University; Kobe Pharmaceutical University; Kyoto Sangyo University; University of Manchester; University of Manchester	Sugahara, K (corresponding author), Hokkaido Univ, Grad Sch Life Sci, Lab Proteoglycan Signaling & Therapeut, Frontier Res Ctr Post Genom Sci & Technol,Kita Ku, Nishi 11 Choume,Kita 21 Jo, Sapporo, Hokkaido 0010021, Japan.	k-sugar@sci.hokudai.ac.jp	Pothacharoen, Peraphan/GZG-6521-2022	Pothacharoen, Peraphan/0000-0002-8560-553X; kongtawelert, prachya/0000-0002-5963-2796; Hardingham, Timothy/0000-0001-8271-6763; Deepa, Sathyaseelan/0000-0002-3669-4820	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AVNUR Z, 1984, CELL, V38, P811, DOI 10.1016/0092-8674(84)90276-9; BAKER J, 1986, J COMPUT CHEM, V7, P385, DOI 10.1002/jcc.540070402; Bao XF, 2005, J BIOL CHEM, V280, P35318, DOI 10.1074/jbc.M507304200; Bao XF, 2005, J BIOL CHEM, V280, P23184, DOI 10.1074/jbc.M503036200; BIGGE JC, 1995, ANAL BIOCHEM, V230, P229, DOI 10.1006/abio.1995.1468; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; Blanchard V, 2007, BIOCHEMISTRY-US, V46, P1167, DOI 10.1021/bi061971f; Brown MP, 1998, AM J VET RES, V59, P786; CATERSON B, 1990, J CELL SCI, V97, P411; CATERSON B, 1990, BIOCHEM SOC T, V18, P820, DOI 10.1042/bst0180820; Caterson B, 1995, ACTA ORTHOP SCAND, V66, P121, DOI 10.3109/17453679509157666; Clark T, 1995, J MOL MODEL, V1, P22, DOI 10.1007/s008940050004; Clement AM, 1999, NEUROSCI LETT, V269, P125, DOI 10.1016/S0304-3940(99)00432-2; Clement AM, 1998, J BIOL CHEM, V273, P28444, DOI 10.1074/jbc.273.43.28444; Deepa SS, 2007, GLYCOBIOLOGY, V17, P631, DOI 10.1093/glycob/cwm021; Deepa SS, 2007, BIOCHEMISTRY-US, V46, P2453, DOI 10.1021/bi602374m; DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024; FernaudEspinosa I, 1996, J NEUROBIOL, V30, P410, DOI 10.1002/(SICI)1097-4695(199607)30:3<410::AID-NEU9>3.0.CO;2-7; HARDINGHAM TE, 1992, FASEB J, V6, P861, DOI 10.1096/fasebj.6.3.1740236; HARDINGHAM TE, 1994, CARBOHYD RES, V255, P241, DOI 10.1016/S0008-6215(00)90982-0; HAZELL PK, 1995, ARTHRITIS RHEUM, V38, P953, DOI 10.1002/art.1780380711; HEINEGARD D, 1977, J BIOL CHEM, V252, P1980; Ito Y, 2005, GLYCOBIOLOGY, V15, P593, DOI 10.1093/glycob/cwi036; Johnson KA, 2002, AM J VET RES, V63, P775, DOI 10.2460/ajvr.2002.63.775; JUHASZ P, 1995, CARBOHYD RES, V270, P131, DOI 10.1016/0008-6215(94)00012-5; Kawashima H, 2002, J BIOL CHEM, V277, P12921, DOI 10.1074/jbc.M200396200; Kinoshita A, 1999, ANAL BIOCHEM, V269, P367, DOI 10.1006/abio.1999.4027; Kitagawa H, 1997, GLYCOBIOLOGY, V7, P905, DOI 10.1093/glycob/7.7.905; Klamt A., 1993, J CHEM SOC P2, V2, P799, DOI DOI 10.1039/P29930000799; KONGTAWELERT P, 2005, Patent No. 2005118645; Letourneau PC, 1992, CURR OPIN GENET DEV, V2, P625, DOI 10.1016/S0959-437X(05)80183-2; Lewis S, 1999, ANN RHEUM DIS, V58, P441, DOI 10.1136/ard.58.7.441; Li H, 1995, J MOL EVOL, V41, P878; LOHMANDER LS, 1991, ACTA ORTHOP SCAND, V62, P623, DOI 10.3109/17453679108994513; Lohmander LS, 1997, J RHEUMATOL, V24, P782; MARK MP, 1989, DEV BIOL, V133, P475, DOI 10.1016/0012-1606(89)90051-1; MARK MP, 1990, DIFFERENTIATION, V43, P37, DOI 10.1111/j.1432-0436.1990.tb00428.x; MULLIKEN RS, 1955, J CHEM PHYS, V23, P1833, DOI 10.1063/1.1740588; Nadanaka S, 1997, GLYCOBIOLOGY, V7, P253, DOI 10.1093/glycob/7.2.253; Nadanaka S, 1998, J BIOL CHEM, V273, P3296, DOI 10.1074/jbc.273.6.3296; Nandini CD, 2006, ADV PHARMACOL, V53, P253, DOI 10.1016/S1054-3589(05)53012-6; Politzer P, 1991, REV COMPUTATIONAL CH, V2, P273, DOI [10.1002/wcms.1326, DOI 10.1002/9780470125793.CH7]; Pothacharoen P, 2006, OSTEOARTHR CARTILAGE, V14, P299, DOI 10.1016/j.joca.2005.10.005; Pothacharoen P, 2006, J BIOCHEM, V140, P517, DOI 10.1093/jb/mvj181; Purushothaman A, 2007, J BIOL CHEM, V282, P19442, DOI 10.1074/jbc.M700630200; RAPPE AK, 1992, J AM CHEM SOC, V114, P10024, DOI 10.1021/ja00051a040; RAPPE AK, 1993, INORG CHEM, V32, P3438, DOI 10.1021/ic00068a012; RAUHUT G, 1993, J COMPUT CHEM, V14, P503, DOI 10.1002/jcc.540140502; RAUHUT G, 1993, J AM CHEM SOC, V115, P9174, DOI 10.1021/ja00073a036; RAUHUT G, 1993, J AM CHEM SOC, V115, P9127, DOI 10.1021/ja00073a031; REICHARDT LF, 1991, ANNU REV NEUROSCI, V14, P531, DOI 10.1146/annurev.neuro.14.1.531; SORRELL JM, 1990, J HISTOCHEM CYTOCHEM, V38, P393, DOI 10.1177/38.3.1689338; SORRELL JM, 1993, MATRIX, V13, P351, DOI 10.1016/S0934-8832(11)80040-5; Stoll MS, 2000, EUR J BIOCHEM, V267, P1795, DOI 10.1046/j.1432-1327.2000.01178.x; SUGAHARA K, 1994, CARBOHYD RES, V255, P145, DOI 10.1016/S0008-6215(00)90976-5; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Sugahara K, 1996, GLYCOCONJUGATE J, V13, P609, DOI 10.1007/BF00731449; Sugahara K, 1996, EUR J BIOCHEM, V239, P871, DOI 10.1111/j.1432-1033.1996.0871u.x; THIEL W, 1992, THEOR CHIM ACTA, V81, P391, DOI 10.1007/BF01134863; THIEL W, 1994, J MOL STRUC-THEOCHEM, V119, P141, DOI 10.1016/0166-1280(94)85037-2; Thiel W, 1996, J PHYS CHEM-US, V100, P616, DOI 10.1021/jp952148o; TOMASI J, 1994, CHEM REV, V94, P2027, DOI 10.1021/cr00031a013; Voityuk AA, 2000, J PHYS CHEM A, V104, P4089, DOI 10.1021/jp994394w; YAMAGATA T, 1968, J BIOL CHEM, V243, P1523; Yamaguchi K, 2006, GLYCOCONJUGATE J, V23, P513, DOI 10.1007/s10719-006-7151-z	65	32	36	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35232	35246		10.1074/jbc.M702255200	http://dx.doi.org/10.1074/jbc.M702255200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17884822	Green Submitted, hybrid			2022-12-25	WOS:000251155200068
J	Wei, L; Laurence, A; Elias, KM; O'Shea, JJ				Wei, Lai; Laurence, Arian; Elias, Kevin M.; O'Shea, John J.			IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELLS; GENE-EXPRESSION; RECEPTOR; DIFFERENTIATION; CYTOKINE; INTERLEUKIN-21; INFLAMMATION; INTERFERON; ACTIVATION; MECHANISMS	CD4(+) helper T cells can differentiate into several possible fates including: Th1, Th2, T regulatory, and Th17 cells. Although, cytokine production by non-T cells is an important factor in helper T cell differentiation, a characteristic feature of both Th1 and Th2 lineages is their ability to secrete cytokines that promote their respective differentiation. However, cytokines produced by T cells that help to sustain Th17 cells have not yet been identified. Here we show that IL-21 is a product of Th17 cells, which is induced in a Stat3-dependent manner. Additionally, Stat3 can directly bind the Il21 promoter. IL-21 also induces IL-17 production and expression of the transcription factor, ROR gamma t. Furthermore, generation of Th17 cells in the conventional manner is attenuated by blocking IL-21. IL-21 is known to activate Stat3 and its ability to induce Th17 differentiation is abrogated in the absence of Stat3. These data argue that IL-21 serves as an autocrine factor secreted by Th17 cells that promotes or sustains Th17 lineage commitment.	NIH, NIAMSD, Mol Immunol & Inflammat Branch, Bethesda, MD 20892 USA; NIH, Howard Hughes Med Inst, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA	Wei, L (corresponding author), NIH, NIAMSD, Mol Immunol & Inflammat Branch, Bethesda, MD 20892 USA.	weil2@mail.nih.gov	Laurence, Arian/A-8770-2009; Wei, Lai/D-1088-2014	Laurence, Arian/0000-0003-0942-8292; Elias, Kevin/0000-0003-1502-5553	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041106, Z01AR041159] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 AR041106-13] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; Ettinger R, 2005, J IMMUNOL, V175, P7867, DOI 10.4049/jimmunol.175.12.7867; Fedele G, 2005, INFECT IMMUN, V73, P1590, DOI 10.1128/IAI.73.3.1590-1597.2005; Frohlich A, 2007, BLOOD, V109, P2023, DOI 10.1182/blood-2006-05-021600; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; Herber D, 2007, J IMMUNOL, V178, P3822, DOI 10.4049/jimmunol.178.6.3822; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kim HP, 2005, J BIOL CHEM, V280, P25291, DOI 10.1074/jbc.M501459200; Kovanen PE, 2004, IMMUNOL REV, V202, P67, DOI 10.1111/j.0105-2896.2004.00203.x; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; O'Garra A, 2004, NAT MED, V10, P801, DOI 10.1038/nm0804-801; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Pesce J, 2006, J CLIN INVEST, V116, P2044, DOI 10.1172/JCI27727; Pfeffer LM, 2004, J BIOL CHEM, V279, P31304, DOI 10.1074/jbc.M308975200; Suto A, 2006, J IMMUNOL, V177, P3721, DOI 10.4049/jimmunol.177.6.3721; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Wurster AL, 2002, J EXP MED, V196, P969, DOI 10.1084/jem.20020620; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Yao ZB, 1995, IMMUNITY, V3, P811, DOI 10.1016/1074-7613(95)90070-5; Young DA, 2007, ARTHRITIS RHEUM, V56, P1152, DOI 10.1002/art.22452; Zeng R, 2005, J EXP MED, V201, P139, DOI 10.1084/jem.20041057; Zeng R, 2007, BLOOD, V109, P4135, DOI 10.1182/blood-2006-10-054973; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	28	487	522	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34605	34610		10.1074/jbc.M705100200	http://dx.doi.org/10.1074/jbc.M705100200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17884812	Green Accepted, hybrid			2022-12-25	WOS:000251155200002
J	Ye, JQ; Cho, SH; Fuselier, J; Li, WK; Beckwith, J; Rapoport, TA				Ye, Jiqing; Cho, Seung-Hyun; Fuselier, Jessica; Li, Weikai; Beckwith, Jon; Rapoport, Tom A.			Crystal structure of an unusual thioredoxin protein with a zinc finger domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ESCRT-II; EXPRESSION; COMPLEX; MODEL; MECHANISM; FORMS	Many Gram- negative bacteria have two cytoplasmic thioredoxins, thioredoxin-1 and -2, encoded by the trxA and trxC genes, respectively. Both thioredoxins have the highly conserved WCGPC motif and function as disulfide-bond reductases. However, thioredoxin-2 has unique features: it has an N-terminal motif that binds a zinc ion, and its transcription is under the control of OxyR, which allows it to be up-regulated under oxidative stress. Here, we report the crystal structure of thioredoxin-2 from Rhodobacter capsulatus. The C-terminal region of thioredoxin-2 forms a canonical thioredoxin fold with a central beta-sheet consisting of five strands and four flanking alpha-helices on either side. The N-terminal zinc finger is composed of four short beta-strands (S1-S4) connected by three short loops (L1-L3). The four cysteines are at loops L1 and L3 and form a tetragonal binding site for a zinc ion. The zinc finger is close to the first beta-strand and first alpha-helix of the thioredoxin fold. Nevertheless, the zinc finger may not directly affect the oxidoreductase activity of thioredoxin-2 because the zinc finger is not near the active site of a protomer and because thioredoxin-2 is a monomer in solution. On the basis of structural similarity to the zinc fingers in Npl4 and Vps36, we propose that the N-terminal zinc finger of thioredoxin-2 mediates protein-protein interactions, possibly with its substrates or chaperones.	Harvard Univ, Howard Hughes Med Inst, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Dept Microbiol & Mol Genet, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Rapoport, TA (corresponding author), Harvard Univ, Howard Hughes Med Inst, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	tom_rapoport@hms.harvard.edu		cho, seung-hyun/0000-0002-5548-4239	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL097083, K99HL097083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052586] Funding Source: NIH RePORTER; NHLBI NIH HHS [K99 HL097083, R00 HL097083] Funding Source: Medline; NIGMS NIH HHS [GM052586] Funding Source: Medline; PHS HHS [GMO41883] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Amorim GC, 2007, J BIOMOL NMR, V38, P99, DOI 10.1007/s10858-007-9144-z; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bao R, 2007, PROTEINS, V66, P246, DOI 10.1002/prot.21194; BOYD D, 1987, P NATL ACAD SCI USA, V84, P8525, DOI 10.1073/pnas.84.23.8525; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Capitani G, 2000, J MOL BIOL, V302, P135, DOI 10.1006/jmbi.2000.4006; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Collet JF, 2003, J BIOL CHEM, V278, P45325, DOI 10.1074/jbc.M307818200; Donaldson LW, 2003, J BIOL CHEM, V278, P48991, DOI 10.1074/jbc.M307826200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GAN ZR, 1991, J BIOL CHEM, V266, P1692; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; HOLMGREN A, 1995, STRUCTURE, V3, P239, DOI 10.1016/S0969-2126(01)00153-8; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; JENG MF, 1994, STRUCTURE, V2, P853, DOI 10.1016/S0969-2126(94)00086-7; KATTI SK, 1990, J MOL BIOL, V212, P167, DOI 10.1016/0022-2836(90)90313-B; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Li K, 2003, MICROBIOL-SGM, V149, P419, DOI 10.1099/mic.0.25978-0; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Miranda-Vizuete A, 1997, J BIOL CHEM, V272, P30841, DOI 10.1074/jbc.272.49.30841; Oktyabrsky ON, 2007, BIOCHEMISTRY-MOSCOW+, V72, P132, DOI 10.1134/S0006297907020022; Perederina A, 2004, CELL, V118, P297, DOI 10.1016/j.cell.2004.06.030; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; QIN J, 1995, STRUCTURE, V3, P289, DOI 10.1016/S0969-2126(01)00159-9; Ritz D, 2000, J BIOL CHEM, V275, P2505, DOI 10.1074/jbc.275.4.2505; Ritz D, 2001, ANNU REV MICROBIOL, V55, P21, DOI 10.1146/annurev.micro.55.1.21; Rozhkova A, 2004, EMBO J, V23, P1709, DOI 10.1038/sj.emboj.7600178; RUSSEL M, 1985, P NATL ACAD SCI USA, V82, P29, DOI 10.1073/pnas.82.1.29; Smeets A, 2005, PROTEIN SCI, V14, P2610, DOI 10.1110/ps.051632905; Takahashi N, 1996, BIOCHEMISTRY-US, V35, P8342, DOI 10.1021/bi960465v; Teo H, 2004, DEV CELL, V7, P559, DOI 10.1016/j.devcel.2004.09.003; Teo HL, 2006, CELL, V125, P99, DOI 10.1016/j.cell.2006.01.047; Uson I, 1999, CURR OPIN STRUC BIOL, V9, P643, DOI 10.1016/S0959-440X(99)00020-2; Wang B, 2003, J BIOL CHEM, V278, P20225, DOI 10.1074/jbc.M300459200; Zeller T, 2006, J BACTERIOL, V188, P7689, DOI 10.1128/JB.00660-06; Zhu WL, 1996, NAT STRUCT BIOL, V3, P122, DOI 10.1038/nsb0296-122	39	13	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34945	34951		10.1074/jbc.M704044200	http://dx.doi.org/10.1074/jbc.M704044200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17913712	hybrid			2022-12-25	WOS:000251155200038
J	Zhou, YB; Yang, W; Lurtz, MM; Ye, YM; Huang, Y; Lee, HW; Chen, YY; Louis, CF; Yang, JJ				Zhou, Yubin; Yang, Wei; Lurtz, Monica M.; Ye, Yiming; Huang, Yun; Lee, Hsiau-Wei; Chen, Yanyi; Louis, Charles F.; Yang, Jenny J.			Identification of the calmodulin binding domain of connexin 43	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN KINASE; GAP-JUNCTION CHANNELS; SPECTROSCOPIC CHARACTERIZATION; SECONDARY STRUCTURE; TARGET RECOGNITION; PEPTIDE; CALCIUM; COMPLEX; CA2+; AFFINITY	Calmodulin (CaM) has been implicated in mediating the Ca2+-dependent regulation of gap junctions. This report identifies a CaM-binding motif comprising residues 136-158 in the intracellular loop of Cx43. A 23-mer peptide encompassing this CaM-binding motif was shown to bind Ca2+-CaM with 1: 1 stoichiometry by using various biophysical approaches, including surface plasmon resonance, circular dichroism, fluorescence spectroscopy, and NMR. Far UV circular dichroism studies indicated that the Cx43-derived peptide increased its alpha-helical contents on CaM binding. Fluorescence and NMR studies revealed conformational changes of both the peptide and CaM following formation of the CaM-peptide complex. The apparent dissociation constant of the peptide binding to CaM in physiologic K+ is in the range of 0.7-1 mu M. Upon binding of the peptide to CaM, the apparent K-d of Ca2+ for CaM decreased from 2.9 +/- 0.1 to 1.6 +/- 0.1 mu M, and the Hill coefficient n(H) increased from 2.1 +/- 0.1 to 3.3 +/- 0.5. Transient expression in HeLa cells of two different mutant Cx43-EYFP constructs without the putative Cx43 CaM-binding site eliminated the Ca2+- dependent inhibition of Cx43 gap junction permeability, confirming that residues 136-158 in the intracellular loop of Cx43 contain the CaM-binding site that mediates the Ca2+-dependent regulation of Cx43 gap junctions. Our results provide the first direct evidence that CaM binds to a specific region of the ubiquitous gap junction protein Cx43 in a Ca2+-dependent manner, providing a molecular basis for the well characterized Ca2+-dependent inhibition of Cx43-containing gap junctions.	Georgia State Univ, Dept Chem, Atlanta, GA 30302 USA; Ctr Dis Control & Prevent, Proteom Lab, Biotechnol Core Facil Branch, Atlanta, GA 30333 USA; Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA	University System of Georgia; Georgia State University; Centers for Disease Control & Prevention - USA; University of California System; University of California Riverside	Yang, JJ (corresponding author), Georgia State Univ, Dept Chem, Univ Plaza, Atlanta, GA 30302 USA.	chejjy@langate.gsu.edu	Chen, Yanyi/H-7096-2013; Zhou, Yubin/D-4748-2011; LEE, HSIAU-WEI/A-1415-2012	Chen, Yanyi/0000-0002-7755-0882; Zhou, Yubin/0000-0001-7962-0517; Lee, Hsiau-Wei/0000-0002-6060-6341; Huang, Yun/0000-0001-5950-9168	NATIONAL EYE INSTITUTE [R01EY005684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062999] Funding Source: NIH RePORTER; NEI NIH HHS [EY-05684] Funding Source: Medline; NIGMS NIH HHS [GM62999, R01 GM062999] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmad S, 2001, EUR J BIOCHEM, V268, P4544, DOI 10.1046/j.1432-1327.2001.02380.x; Balog EM, 2003, J BIOL CHEM, V278, P15615, DOI 10.1074/jbc.M209180200; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Bhattacharya S, 2004, BBA-MOL CELL RES, V1742, P69, DOI 10.1016/j.bbamcr.2004.09.002; Black DJ, 2004, CELL CALCIUM, V35, P415, DOI 10.1016/j.ceca.2003.10.005; Brokx RD, 2004, J STRUCT BIOL, V146, P272, DOI 10.1016/j.jsb.2003.12.007; Brown SE, 1997, J BIOL CHEM, V272, P3389, DOI 10.1074/jbc.272.6.3389; Burr GS, 2005, BIOCHEM BIOPH RES CO, V335, P1191, DOI 10.1016/j.bbrc.2005.08.007; Chou JJ, 2001, NAT STRUCT BIOL, V8, P990, DOI 10.1038/nsb1101-990; Churchill GC, 2001, AM J PHYSIOL-CELL PH, V281, pC972, DOI 10.1152/ajpcell.2001.281.3.C972; Clapperton JA, 2002, BIOCHEMISTRY-US, V41, P14669, DOI 10.1021/bi026660t; Duffy HS, 2002, J BIOL CHEM, V277, P36706, DOI 10.1074/jbc.M207016200; Elshorst B, 1999, BIOCHEMISTRY-US, V38, P12320, DOI 10.1021/bi9908235; Fruen BR, 2003, BIOCHEMISTRY-US, V42, P2740, DOI 10.1021/bi0267689; GANDOLFI SA, 1990, CURR EYE RES, V9, P533, DOI 10.3109/02713689008999593; Gomes AV, 2000, ARCH BIOCHEM BIOPHYS, V379, P28, DOI 10.1006/abbi.2000.1827; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; IKURA M, 1991, BIOCHEMISTRY-US, V30, P9216, DOI 10.1021/bi00102a013; Ikura M, 2006, P NATL ACAD SCI USA, V103, P1159, DOI 10.1073/pnas.0508640103; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; Ishida H, 2006, PROTEIN PEPTIDE LETT, V13, P455, DOI 10.2174/092986606776819600; JOHNSON JD, 1983, BIOCHEM J, V211, P473, DOI 10.1042/bj2110473; Johnson JD, 1996, J BIOL CHEM, V271, P761, DOI 10.1074/jbc.271.2.761; Jones DT, 1998, FEBS LETT, V423, P281, DOI 10.1016/S0014-5793(98)00095-7; KASTURI R, 1993, J BIOL CHEM, V268, P7958; Kranz JK, 2002, J BIOL CHEM, V277, P16351, DOI 10.1074/jbc.C200139200; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lai A, 2006, J CELL SCI, V119, P532, DOI 10.1242/jcs.02770; LAPORTE DC, 1981, BIOCHEMISTRY-US, V20, P3965, DOI 10.1021/bi00517a004; LEHRMAN SR, 1990, BIOCHEMISTRY-US, V29, P5590, DOI 10.1021/bi00475a025; Lurtz MM, 2003, AM J PHYSIOL-CELL PH, V285, pC1475, DOI 10.1152/ajpcell.00361.2002; Mal TK, 2002, BIOCHEMISTRY-US, V41, P12899, DOI 10.1021/bi0264162; Martin SR, 1996, BIOCHEMISTRY-US, V35, P3508, DOI 10.1021/bi952522a; MARTIN SR, 1986, BIOCHEM J, V238, P485, DOI 10.1042/bj2380485; Mathias RT, 1997, PHYSIOL REV, V77, P21, DOI 10.1152/physrev.1997.77.1.21; Mayer BJ, 2001, J CELL SCI, V114, P1253; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; Mitaku S, 2002, BIOINFORMATICS, V18, P608, DOI 10.1093/bioinformatics/18.4.608; MUSIL LS, 1990, J MEMBRANE BIOL, V116, P163, DOI 10.1007/BF01868674; Nicol S, 1997, BIOCHEMISTRY-US, V36, P11487, DOI 10.1021/bi970709r; NOMA A, 1987, J PHYSIOL-LONDON, V382, P193, DOI 10.1113/jphysiol.1987.sp016363; OLWIN BB, 1984, J BIOL CHEM, V259, P949; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; Peracchia C, 2004, BBA-BIOMEMBRANES, V1662, P61, DOI 10.1016/j.bbamem.2003.10.020; Peracchia C, 2000, J BIOL CHEM, V275, P26220, DOI 10.1074/jbc.M004007200; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Rosenberg OS, 2005, CELL, V123, P849, DOI 10.1016/j.cell.2005.10.029; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Sorgen PL, 2004, BIOPHYS J, V87, P574, DOI 10.1529/biophysj.103.039230; Torok K, 1997, BIOCHEM J, V326, P479; Trost C, 2001, BIOCHEM J, V355, P663, DOI 10.1042/bj3550663; Turner JH, 2004, J BIOL CHEM, V279, P17027, DOI 10.1074/jbc.M313919200; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; URBAUER JL, 1995, BIOCHEMISTRY-US, V34, P8099, DOI 10.1021/bi00025a016; WALLACE RW, 1983, METHOD ENZYMOL, V102, P39; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Xiong LW, 2002, J BIOL CHEM, V277, P40862, DOI 10.1074/jbc.M206763200; Yamauchi E, 2003, NAT STRUCT BIOL, V10, P226, DOI 10.1038/nsb900; Yamniuk AP, 2004, J BIOL CHEM, V279, P7698, DOI 10.1074/jbc.M310763200; YANG JJ, 1995, J MOL BIOL, V252, P483, DOI 10.1006/jmbi.1995.0513; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; ZHAN Q, 1991, J BIOL CHEM, V266, P21810; ZHANG MJ, 1994, BIOCHEMISTRY-US, V33, P1163, DOI 10.1021/bi00171a016; ZHANG MJ, 1993, PROTEIN SCI, V2, P1931, DOI 10.1002/pro.5560021114; Zhang XR, 2005, ARCH BIOCHEM BIOPHYS, V440, P111, DOI 10.1016/j.abb.2005.06.004	65	70	71	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35005	35017		10.1074/jbc.M707728200	http://dx.doi.org/10.1074/jbc.M707728200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17901047	hybrid			2022-12-25	WOS:000251155200045
J	Herbert, SP; Odell, AF; Ponnambalam, S; Walker, JH				Herbert, Shane P.; Odell, Adam F.; Ponnambalam, Sreenivasan; Walker, John H.			The confluence-dependent interaction of cytosolic phospholipase A(2)-alpha with annexin A1 regulates endothelial cell prostaglandin E-2 generation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GOLGI-APPARATUS; ENDOPLASMIC-RETICULUM; CONTACT INHIBITION; INTERACTION-MODEL; CATALYTIC DOMAIN; PROTEIN; A(2); LOCALIZATION; MEMBRANES; PROLIFERATION	The regulated generation of prostaglandins from endothelial cells is critical to vascular function. Here we identify a novel mechanism for the regulation of endothelial cell prostaglandin generation. Cytosolic phospholipase A(2)-alpha (cPLA(2)alpha) cleaves phospholipids in a Ca2+-dependent manner to yield free arachidonic acid and lysophospholipid. Arachidonic acid is then converted into prostaglandins by the action of cyclooxygenase enzymes and downstream synthases. By previously undefined mechanisms, nonconfluent endothelial cells generate greater levels of prostaglandins than confluent cells. Here we demonstrate that Ca2+-independent association of cPLA(2)alpha with the Golgi apparatus of confluent endothelial cells correlates with decreased prostaglandin synthesis. Golgi association blocks arachidonic acid release and prevents functional coupling between cPLA(2)alpha and COX-mediated prostaglandin synthesis. When inactivated at the Golgi apparatus of confluent endothelial cells, cPLA(2)alpha is associated with the phospholipid-binding protein annexin A1. Furthermore, the siRNA-mediated knockdown of endogenous annexin A1 significantly reverses the inhibitory effect of confluence on endothelial cell prostaglandin generation. Thus the confluence-dependent interaction of cPLA(2)alpha and annexin A1 at the Golgi acts as a novel molecular switch controlling cPLA(2)alpha activity and endothelial cell prostaglandin generation.	Univ Leeds, Fac Biol Sci, Inst Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Walker, JH (corresponding author), Univ Leeds, Fac Biol Sci, Inst Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England.	j.h.walker@leeds.ac.uk	Odell, Adam/J-1386-2012	Herbert, Shane/0000-0003-2517-1845; Ponnambalam, Sreenivasan/0000-0002-4452-7619	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ACKERMANN EJ, 1995, J BIOL CHEM, V270, P445, DOI 10.1074/jbc.270.1.445; Akiba S, 2004, BIOL PHARM BULL, V27, P1174, DOI 10.1248/bpb.27.1174; Bunt G, 1997, J CELL SCI, V110, P2449; Chandrasekharan NV, 2002, P NATL ACAD SCI USA, V99, P13926, DOI 10.1073/pnas.162468699; CHANNON JY, 1990, J BIOL CHEM, V265, P5409; CLARK JD, 1995, J LIPID MEDIAT CELL, V12, P83, DOI 10.1016/0929-7855(95)00012-F; Dennis EA, 1997, TRENDS BIOCHEM SCI, V22, P1, DOI 10.1016/S0968-0004(96)20031-3; Dominguez M, 1999, J CELL BIOL, V145, P673, DOI 10.1083/jcb.145.4.673; EVANS CE, 1984, PROSTA LEUKOTR MED, V14, P255, DOI 10.1016/0262-1746(84)90209-9; Evans JH, 2004, J BIOL CHEM, V279, P6005, DOI 10.1074/jbc.M311246200; Evans JH, 2001, J BIOL CHEM, V276, P30150, DOI 10.1074/jbc.M100943200; FLOWER RJ, 1994, TRENDS PHARMACOL SCI, V15, P71, DOI 10.1016/0165-6147(94)90281-X; Gao YS, 2002, EUR J CELL BIOL, V81, P391, DOI 10.1078/0171-9335-00260; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Grewal S, 2005, FEBS J, V272, P1278, DOI 10.1111/j.1742-4658.2005.04565.x; Grewal S, 2004, EUR J BIOCHEM, V271, P69, DOI 10.1046/j.1432-1033.2003.03903.x; Grewal S, 2003, J CELL SCI, V116, P2303, DOI 10.1242/jcs.00446; Grewal S, 2002, J CELL SCI, V115, P4533, DOI 10.1242/jcs.00146; Grimmer S, 2005, TRAFFIC, V6, P144, DOI 10.1111/j.1600-0854.2005.00258.x; Herbert SP, 2005, MOL BIOL CELL, V16, P3800, DOI 10.1091/mbc.E05-02-0164; Hirabayashi T, 2004, BIOL PHARM BULL, V27, P1168, DOI 10.1248/bpb.27.1168; Howell GJ, 2004, MOL MEMBR BIOL, V21, P413, DOI 10.1080/09687860400011571; Jaffe EA, 1984, BIOL ENDOTHELIAL CEL, P1; Jiang HM, 2004, J BIOL CHEM, V279, P55905, DOI 10.1074/jbc.M406094200; Kamiyama M, 2006, ONCOGENE, V25, P7019, DOI 10.1038/sj.onc.1209694; Kim SW, 2001, FEBS LETT, V489, P243, DOI 10.1016/S0014-5793(00)02326-7; Kim SW, 2001, J BIOL CHEM, V276, P15712, DOI 10.1074/jbc.M009905200; Kramer RM, 1997, FEBS LETT, V410, P49, DOI 10.1016/S0014-5793(97)00322-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamour NF, 2007, J LIPID RES, V48, P1293, DOI 10.1194/jlr.M700083-JLR200; Lampugnani MG, 2003, J CELL BIOL, V161, P793, DOI 10.1083/jcb.200209019; Lim LHK, 2007, FASEB J, V21, P968, DOI 10.1096/fj.06-7464rev; Lukowski S, 1996, J BIOL CHEM, V271, P24164, DOI 10.1074/jbc.271.39.24164; MORITA I, 1995, J BIOL CHEM, V273, P9886; Murakami M, 2003, FEBS LETT, V546, P251, DOI 10.1016/S0014-5793(03)00596-9; Nakatani Y, 2000, J BIOL CHEM, V275, P1161, DOI 10.1074/jbc.275.2.1161; NALEFSKI EA, 1994, J BIOL CHEM, V269, P18239; NOVIKOFF PM, 1983, P NATL ACAD SCI-BIOL, V80, P4364, DOI 10.1073/pnas.80.14.4364; Okada T, 2005, J CELL BIOL, V171, P361, DOI 10.1083/jcb.200503165; OPAS M, 1991, J CELL PHYSIOL, V149, P160, DOI 10.1002/jcp.1041490120; Parente L, 2004, INFLAMM RES, V53, P125, DOI 10.1007/s00011-003-1235-z; Pettus BJ, 2004, J BIOL CHEM, V279, P11320, DOI 10.1074/jbc.M309262200; SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643; SCHWEIZER A, 1990, EUR J CELL BIOL, V53, P185; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; Smith WL, 1996, J BIOL CHEM, V271, P33157, DOI 10.1074/jbc.271.52.33157; Sorby M, 1996, J BIOL CHEM, V271, P10963; STREET IP, 1993, BIOCHEMISTRY-US, V32, P5935, DOI 10.1021/bi00074a003; Suzuki E, 2000, J BIOL CHEM, V275, P3637, DOI 10.1074/jbc.275.5.3637; Tang LL, 2000, CIRC RES, V86, P663, DOI 10.1161/01.RES.86.6.663; Torii S, 2004, DEV CELL, V7, P33, DOI 10.1016/j.devcel.2004.05.019; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANE JR, 1990, NEW ENGL J MED, V323, P27; WHATLEY RE, 1994, J CLIN INVEST, V94, P1889, DOI 10.1172/JCI117539; Wu T, 1997, J BIOL CHEM, V272, P17145, DOI 10.1074/jbc.272.27.17145; Yang M, 1997, J BIOL CHEM, V272, P1970, DOI 10.1074/jbc.272.3.1970	56	38	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34468	34478		10.1074/jbc.M701541200	http://dx.doi.org/10.1074/jbc.M701541200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17873281	hybrid			2022-12-25	WOS:000251145700062
J	Rothenberg, E; Trakselis, MA; Bell, SD; Ha, T				Rothenberg, Eli; Trakselis, Michael A.; Bell, Stephen D.; Ha, Taekjip			MCM forked substrate specificity involves dynamic interaction with the 5 '-tail	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARCHAEAL DNA-REPLICATION; HEPATITIS-C VIRUS; COLI REP HELICASE; SINGLE-MOLECULE; SULFOLOBUS-SOLFATARICUS; ANOMALOUS DIFFUSION; UNWINDING MECHANISM; HEXAMERIC HELICASE; BACTERIOPHAGE T7; TRANSLOCATION	The archaeal minichromosome maintenance protein MCM forms a homohexameric complex that functions as the DNA replicative helicase and serves as a model system for its eukaryotic counterpart. Here, we applied single molecule fluorescence resonance energy transfer methods to probe the substrate specificity and binding mechanism of MCM from the hyperthermophilic Archaea Sulfolobus solfataricus on various DNA substrates. S. solfataricus MCM displays a binding preference for forked substrates relative to partial or full duplex substrates. Moreover, the nature of MCM binding to Y-shaped substrates is distinct in that MCM loads on the 3'-tail while interacting with the 5'-tail likely via the MCM surface. These results provide the first elucidation of a dynamic nature of interaction between a ring-shaped helicase interacting with an opposing single-stranded DNA tail. This interaction contributes to substrate selectivity and increases the stability of the forked DNA-MCM complex, with possible implications for the MCM unwinding mechanism.	Univ Illinois, Dept Phys, Howard Hughes Med Inst, Urbana, IL 61801 USA; Hutchison Med Res Council Res Ctr, Med Res Council Canc Cell Unit, Cambridge CB2 2XZ, England	Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign	Ha, T (corresponding author), Univ Illinois, Dept Phys, Howard Hughes Med Inst, 1110 W Green St, Urbana, IL 61801 USA.	tjha@uiuc.edu	Rothenberg, Eli/A-6879-2009; Ha, Taekjip/B-9506-2009; Trakselis, Michael/V-3806-2019	Ha, Taekjip/0000-0003-2195-6258; Bell, Stephen/0000-0002-8474-6592; Trakselis, Michael/0000-0001-7054-8475; Rothenberg, Eli/0000-0002-1382-1380	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065367] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 065367, R01 GM065367] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barry ER, 2006, MICROBIOL MOL BIOL R, V70, P876, DOI 10.1128/MMBR.00029-06; Barry ER, 2007, NUCLEIC ACIDS RES, V35, P988, DOI 10.1093/nar/gkl1117; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Carpentieri F, 2002, J BIOL CHEM, V277, P12118, DOI 10.1074/jbc.M200091200; Chen YJ, 2005, J MOL BIOL, V346, P389, DOI 10.1016/j.jmb.2004.11.076; Delagoutte E, 2002, Q REV BIOPHYS, V35, P431, DOI 10.1017/S0033583502003852; Dessinges MN, 2004, P NATL ACAD SCI USA, V101, P6439, DOI 10.1073/pnas.0306713101; Dohoney KM, 2001, NATURE, V409, P370, DOI 10.1038/35053124; Donmez I, 2007, J BIOL CHEM, V282, P21116, DOI 10.1074/jbc.M702136200; Donmez I, 2006, NUCLEIC ACIDS RES, V34, P4216, DOI 10.1093/nar/gkl508; Duggin IG, 2006, J BIOL CHEM, V281, P15029, DOI 10.1074/jbc.R500029200; Dumont S, 2006, NATURE, V439, P105, DOI 10.1038/nature04331; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Fletcher RJ, 2003, NAT STRUCT BIOL, V10, P160, DOI 10.1038/nsb893; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Galletto R, 2004, J MOL BIOL, V343, P101, DOI 10.1016/j.jmb.2004.07.056; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Ha T, 2002, NATURE, V419, P638, DOI 10.1038/nature01083; Ha T, 2001, METHODS, V25, P78, DOI 10.1006/meth.2001.1217; Ha T, 2007, CELL, V129, P1249, DOI 10.1016/j.cell.2007.06.007; Haugland GT, 2006, NUCLEIC ACIDS RES, V34, P6337, DOI 10.1093/nar/gkl864; Jeong YJ, 2004, P NATL ACAD SCI USA, V101, P7264, DOI 10.1073/pnas.0400372101; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Johnson DS, 2007, CELL, V129, P1299, DOI 10.1016/j.cell.2007.04.038; Kelman LM, 2003, MOL MICROBIOL, V48, P605, DOI 10.1046/j.1365-2958.2003.03369.x; Kelman Z, 2005, CURR OPIN MICROBIOL, V8, P669, DOI 10.1016/j.mib.2005.10.001; Lee JB, 2006, NATURE, V439, P621, DOI 10.1038/nature04317; Lee JK, 2001, P NATL ACAD SCI USA, V98, P54, DOI 10.1073/pnas.98.1.54; Lindner K, 2002, MOL BIOL CELL, V13, P435, DOI 10.1091/mbc.01-11-0537; Maiorano D, 2006, CURR OPIN CELL BIOL, V18, P130, DOI 10.1016/j.ceb.2006.02.006; Marinsek N, 2006, EMBO REP, V7, P539, DOI 10.1038/sj.embor.7400649; McGeoch AT, 2005, NAT STRUCT MOL BIOL, V12, P756, DOI 10.1038/nsmb974; Metzler R, 2000, PHYS REP, V339, P1, DOI 10.1016/S0370-1573(00)00070-3; Metzler R, 1999, PHYS REV LETT, V82, P3563, DOI 10.1103/PhysRevLett.82.3563; Myong S, 2005, NATURE, V437, P1321, DOI 10.1038/nature04049; Myong S, 2007, SCIENCE, V317, P513, DOI 10.1126/science.1144130; Patel SS, 2006, J BIOL CHEM, V281, P18265, DOI 10.1074/jbc.R600008200; Rasnik I, 2004, J MOL BIOL, V336, P395, DOI 10.1016/j.jmb.2003.12.031; Shin JH, 2003, J BIOL CHEM, V278, P49053, DOI 10.1074/jbc.M308599200; Spies M, 2003, CELL, V114, P647, DOI 10.1016/S0092-8674(03)00681-0; Stano NM, 2005, NATURE, V435, P370, DOI 10.1038/nature03615; Takahashi TS, 2005, TRENDS BIOCHEM SCI, V30, P437, DOI 10.1016/j.tibs.2005.06.007; von Hippel PH, 2003, BIOESSAYS, V25, P1168, DOI 10.1002/bies.10369; Yang H, 2003, SCIENCE, V302, P262, DOI 10.1126/science.1086911; Yang H, 2002, J CHEM PHYS, V117, P10965, DOI 10.1063/1.1521154; Yu ZL, 2004, J MOL BIOL, V340, P1197, DOI 10.1016/j.jmb.2004.05.024; Zhuang XW, 2000, SCIENCE, V288, P2048, DOI 10.1126/science.288.5473.2048	47	74	74	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34229	34234		10.1074/jbc.M706300200	http://dx.doi.org/10.1074/jbc.M706300200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17884823	hybrid			2022-12-25	WOS:000251145700038
J	Dharmasena, MN; Jewell, DA; Taylor, RK				Dharmasena, Madushini N.; Jewell, David A.; Taylor, Ronald K.			Development of peptide mimics of a protective epitope of Vibrio cholerae ogawa o-antigen and investigation of the structural basis of peptide mimicry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE; ANTICARBOHYDRATE ANTIBODIES; MONOCLONAL-ANTIBODY; ADULT VOLUNTEERS; SEROTYPE INABA; VACCINE; MIMOTOPE; LIPOPOLYSACCHARIDE; MICE; INDUCTION	As an alternative approach toward the development of a cholera vaccine, the potential of peptide mimics of Vibrio cholerae lipopolysaccharide (LPS) to elicit cross-reactive immune responses against LPS was investigated. Two closely related protective monoclonal antibodies, S-20-4 and A-20-6, which are specific for Ogawa O-antigen (O-specific polysaccharide; O-SP) of V. cholerae O1, were used as the target antibodies (Abs) to pan phage display libraries under different elution conditions. Six phage clones identified from S-20-4 panning showed significant binding to both S-20-4 and A-20-6. Thus, it is likely that these phage-displayed peptides mimic an important conformational epitope of Ogawa antigens and are not simply functionally recognized by S-20-4. Each of the six phage clones that could bind to both monoclonal antibodies also competed with LPS for binding to S-20-4, suggesting that the peptides bind close to the paratope of the Ab. In order to predict how these peptide mimics interact with S-20-4 compared with its carbohydrate counterpart, one peptide mimic, 4P-8, which is one of the highest affinity binders and shares motifs with several other peptide mimics, was selected for further studies using computer modeling methods and site-directed mutagenesis. These studies suggest that 4P-8 is recognized as a hairpin structure that mimics some O-SP interactions with S-20-4 and also makes unique ligand interactions with S-20-4. In addition, 4P-8-KLH was able to elicit anti-LPS Abs in mice, but the immune response was not vibriocidal or protective. However, boosting with 4P-8-KLH after immunizing with LPS prolonged the LPS-reactive IgG and IgM Ab responses as well as vibriocidal titers and provided a much greater degree of protection than priming with LPS alone.	Dartmouth Med Sch, Dept Microbiol & Immunol, Hanover, NH 03755 USA; Dartmouth Med Sch, Dept Genet, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College	Taylor, RK (corresponding author), Dartmouth Med Sch, Dept Microbiol & Immunol, Hanover, NH 03755 USA.	Ronald.K.Taylor@dartmouth.edu		Jewell, David/0000-0001-5931-7588	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI025096, F32AI125096, R22AI025096, R37AI025096] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 25096, R37 AI025096] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 2001, Wkly Epidemiol Rec, V76, P117; Beenhouwer DO, 2002, J IMMUNOL, V169, P6992, DOI 10.4049/jimmunol.169.12.6992; BompardGilles C, 1996, STRUCTURE, V4, P1441, DOI 10.1016/S0969-2126(96)00151-7; Boutonnier A, 2003, J MICROBIOL METH, V55, P745, DOI 10.1016/j.mimet.2003.08.010; Buchwald UK, 2005, INFECT IMMUN, V73, P325, DOI 10.1128/IAI.73.1.325-333.2005; Chattejee SN, 2003, BBA-MOL BASIS DIS, V1639, P65, DOI 10.1016/j.bbadis.2003.08.004; Chatterjee SN, 2006, BBA-MOL BASIS DIS, V1762, P1, DOI 10.1016/j.bbadis.2005.08.005; Chernyak A, 2002, J INFECT DIS, V185, P950, DOI 10.1086/339583; De Bolle X, 1999, J MOL BIOL, V294, P181, DOI 10.1006/jmbi.1999.3248; DeLano WL, 2005, PYMOL; DEVLIN JJ, 1990, SCIENCE, V249, P404, DOI 10.1126/science.2143033; Fleuridor R, 2001, J IMMUNOL, V166, P1087, DOI 10.4049/jimmunol.166.2.1087; Gupta RK, 1998, INFECT IMMUN, V66, P3095, DOI 10.1128/IAI.66.7.3095-3099.1998; GUPTA RK, 1992, INFECT IMMUN, V60, P3201, DOI 10.1128/IAI.60.8.3201-3208.1992; Hafner C, 2005, J INVEST DERMATOL, V124, P125, DOI 10.1111/j.0022-202X.2004.23515.x; Hardy B, 2005, VACCINE, V23, P4283, DOI 10.1016/j.vaccine.2005.04.009; Harris SL, 1997, P NATL ACAD SCI USA, V94, P2454, DOI 10.1073/pnas.94.6.2454; Hill DR, 2006, LANCET INFECT DIS, V6, P361, DOI 10.1016/S1473-3099(06)70494-7; Hou YC, 2003, J IMMUNOL, V170, P4373, DOI 10.4049/jimmunol.170.8.4373; Hutchins WA, 1996, MOL IMMUNOL, V33, P503, DOI 10.1016/0161-5890(96)00012-0; Kieber-Emmons T, 1999, NAT BIOTECHNOL, V17, P660, DOI 10.1038/10870; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lesinski GB, 2001, J MICROBIOL METH, V47, P135, DOI 10.1016/S0167-7012(01)00290-1; Lesinski GB, 2001, VACCINE, V19, P1717, DOI 10.1016/S0264-410X(00)00397-2; Maitta RW, 2004, INFECT IMMUN, V72, P196, DOI 10.1128/IAI.72.1.196-208.2004; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; MCDONALD IK, 1995, PROTEIN ENG, V8, P217, DOI 10.1093/protein/8.3.217; Monzavi-Karbassi B, 2003, VACCINE, V21, P753, DOI 10.1016/S0264-410X(02)00703-X; Monzavi-Karbassi B, 2002, TRENDS BIOTECHNOL, V20, P207, DOI 10.1016/S0167-7799(02)01940-6; Monzavi-Karbassi B, 2007, VACCINE, V25, P3022, DOI 10.1016/j.vaccine.2007.01.072; Neuberger MS, 2000, PHILOS T ROY SOC B, V355, P357, DOI 10.1098/rstb.2000.0573; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Phalipon A, 1997, EUR J IMMUNOL, V27, P2620, DOI 10.1002/eji.1830271022; Pincus SH, 1998, J IMMUNOL, V160, P293; Prinz DM, 2003, IMMUNOLOGY, V110, P242, DOI 10.1046/j.1365-2567.2003.01732.x; Provenzano D, 2006, MICROBIOL IMMUNOL, V50, P899, DOI 10.1111/j.1348-0421.2006.tb03866.x; Qadri F, 2005, J INFECT DIS, V192, P573, DOI 10.1086/432074; Ryan ET, 2006, EXPERT REV VACCINES, V5, P483, DOI 10.1586/14760584.5.4.483; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; Shin JS, 2002, J IMMUNOL, V168, P6273, DOI 10.4049/jimmunol.168.12.6273; Stanfield RL, 2003, VIROLOGY, V315, P159, DOI 10.1016/S0042-6822(03)00525-7; SUN D, 1990, J INFECT DIS, V161, P1231, DOI 10.1093/infdis/161.6.1231; Transue TR, 1998, PROTEINS, V32, P515, DOI 10.1002/(SICI)1097-0134(19980901)32:4<515::AID-PROT9>3.0.CO;2-E; Villeneuve S, 2000, P NATL ACAD SCI USA, V97, P8433, DOI 10.1073/pnas.060022997; Vyas NK, 2003, P NATL ACAD SCI USA, V100, P15023, DOI 10.1073/pnas.2431286100; Vyas NK, 2002, BIOCHEMISTRY-US, V41, P13575, DOI 10.1021/bi0261387; Wang J, 1998, J BIOL CHEM, V273, P2777, DOI 10.1074/jbc.273.5.2777	47	21	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33805	33816		10.1074/jbc.M707314200	http://dx.doi.org/10.1074/jbc.M707314200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17881351	hybrid			2022-12-25	WOS:000250840200063
J	Hou, XW; Liu, RJ; Ross, S; Smart, EJ; Zhu, HN; Gong, WM				Hou, Xiaowei; Liu, Rujuan; Ross, Stuart; Smart, Eric J.; Zhu, Haining; Gong, Weimin			Crystallographic studies of human MitoNEET	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL-MEMBRANE PROTEIN; IRON-SULFUR PROTEIN; PIOGLITAZONE TREATMENT; THIAZOLIDINEDIONE; MODEL; SEQUENCE; ROSIGLITAZONE; PURIFICATION; EXPRESSION; AGONISTS	MitoNEET was identified as an outer mitochondrial membrane protein that can potentially bind the anti-diabetes drug pioglitazone. The crystal structure of the cytoplasmic mitoNEET (residues 33-108) is determined in this study. The structure presents a novel protein fold and contains a [2Fe-2S] cluster-binding domain. The [2Fe-2S] cluster is coordinated to the protein by Cys-72, Cys-74, Cys-83, and His-87 residues. This coordination is also novel compared with the traditional [2Fe-2S] cluster coordinated by four cysteines or two cysteines and two histidines. The cytoplasmic mitoNEET forms homodimers in solution and in crystal. The dimerization is mainly mediated by hydrophobic interactions as well as hydrogen bonds coordinated by two water molecules binding at the interface. His-87 residue, which plays an important role in the coordination of the [2Fe-2S] cluster, is exposed to the solvent on the dimer surface. It is proposed that mitoNEET dimer may interact with other proteins via the surface residues in close proximity to the [2Fe-2S] cluster.	Chinese Acad Sci, Inst Biophys, Ctr Struct & Mol Biol, Natl Key Lab Macrobiomol, Beijing 100101, Peoples R China; Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; Univ Kentucky, Dept Pediat, Coll Med, Kentucky Pediat Res Inst, Lexington, KY 40536 USA	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Kentucky; University of Kentucky	Zhu, HN (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, 741 S Limestone, Lexington, KY 40536 USA.	haining@uky.edu; wgong@ibp.ac.cn	Zhu, Haining/A-6076-2008	Zhu, Haining/0000-0001-5498-6694; Liu, Ru-Juan/0000-0001-7459-3126; Hou, Xiaowei/0000-0002-6668-1115	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049126] Funding Source: NIH RePORTER; NCRR NIH HHS [P20RR015592] Funding Source: Medline; NIDDK NIH HHS [R01 DK077632] Funding Source: Medline; NINDS NIH HHS [R01NS049126] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aronoff S, 2000, DIABETES CARE, V23, P1605, DOI 10.2337/diacare.23.11.1605; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunmair B, 2004, DIABETES, V53, P1052, DOI 10.2337/diabetes.53.4.1052; Colca JR, 2004, AM J PHYSIOL-ENDOC M, V286, pE252, DOI 10.1152/ajpendo.00424.2003; Donnelly MI, 2006, PROTEIN EXPRES PURIF, V47, P446, DOI 10.1016/j.pep.2005.12.011; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FEE JA, 1984, J BIOL CHEM, V259, P124; Feinstein DL, 2005, BIOCHEM PHARMACOL, V70, P177, DOI 10.1016/j.bcp.2005.03.033; Feinstein DL, 2002, ANN NEUROL, V51, P694, DOI 10.1002/ana.10206; Ghosh S, 2007, MOL PHARMACOL, V71, P1695, DOI 10.1124/mol.106.033845; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Heneka MT, 2005, BRAIN, V128, P1442, DOI 10.1093/brain/awh452; Home PD, 2007, NEW ENGL J MED, V357, P28, DOI 10.1056/NEJMoa073394; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kiaei M, 2005, EXP NEUROL, V191, P331, DOI 10.1016/j.expneurol.2004.10.007; Klotz L, 2005, J IMMUNOL, V175, P4948, DOI 10.4049/jimmunol.175.8.4948; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Levy Y, 2006, ANNU REV BIOPH BIOM, V35, P389, DOI 10.1146/annurev.biophys.35.040405.102134; Lill R, 2006, BBA-MOL CELL RES, V1763, P652, DOI 10.1016/j.bbamcr.2006.05.011; Lin JZ, 2007, P NATL ACAD SCI USA, V104, P14640, DOI 10.1073/pnas.0702426104; Lin JP, 2005, SCIENCE, V310, P1311, DOI 10.1126/science.1118316; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paddock ML, 2007, P NATL ACAD SCI USA, V104, P14342, DOI 10.1073/pnas.0707189104; Perez-Ortiz JM, 2007, MOL PHARMACOL, V72, P407, DOI 10.1124/mol.106.032458; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pershadsingh HA, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-3; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schutz B, 2005, J NEUROSCI, V25, P7805, DOI 10.1523/JNEUROSCI.2038-05.2005; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsoi TV, 1999, APPL ENVIRON MICROB, V65, P2151; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wiley SE, 2007, J BIOL CHEM, V282, P23745, DOI 10.1074/jbc.C700107200; Wiley SE, 2007, P NATL ACAD SCI USA, V104, P5318, DOI 10.1073/pnas.0701078104	38	70	72	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33242	33246		10.1074/jbc.C700172200	http://dx.doi.org/10.1074/jbc.C700172200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17905743	hybrid			2022-12-25	WOS:000250840200002
J	Goedhart, J; Vermeer, JEM; Adjobo-Hermans, MJW; van Weeren, L; Gadella, TWJ				Goedhart, Joachim; Vermeer, Joop E. M.; Adjobo-Hermans, Merel J. W.; van Weeren, Laura; Gadella, Theodorus W. J., Jr.			Sensitive Detection of p65 Homodimers Using Red-Shifted and Fluorescent Protein-Based FRET Couples	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; LIVING CELLS; MONOMERIC RED; RHODAMINE 6G; CYAN; DYNAMICS; CA2+; INDICATORS; MICROSCOPY; STANDARDS	Background. Fluorescence Resonance Energy Transfer (FRET) between the green fluorescent protein (GFP) variants CFP and YFP is widely used for the detection of protein-protein interactions. Nowadays, several monomeric red-shifted fluorescent proteins are available that potentially improve the efficiency of FRET. Methodology/Principal Findings. To allow side-by-side comparison of several fluorescent protein combinations for detection of FRET, yellow or orange fluorescent proteins were directly fused to red fluorescent proteins. FRET from yellow fluorescent proteins to red fluorescent proteins was detected by both FLIM and donor dequenching upon acceptor photobleaching, showing that mCherry and mStrawberry were more efficient acceptors than mRFP1. Circular permutated yellow fluorescent protein variants revealed that in the tandem constructs the orientation of the transition dipole moment influences the FRET efficiency. In addition, it was demonstrated that the orange fluorescent proteins mKO and mOrange are both suitable as donor for FRET studies. The most favorable orange-red FRET pair was mKO-mCherry, which was used to detect homodimerization of the NF-kappa B subunit p65 in single living cells, with a threefold higher lifetime contrast and a twofold higher FRET efficiency than for CFP-YFP. Conclusions/Significance. The observed high FRET efficiency of red-shifted couples is in accordance with increased Forster radii of up to 64 angstrom, being significantly higher than the Forster radius of the commonly used CFP-YFP pair. Thus, red-shifted FRET pairs are preferable for detecting protein-protein interactions by donor-based FRET methods in single living cells.	[Goedhart, Joachim; Vermeer, Joop E. M.; Adjobo-Hermans, Merel J. W.; van Weeren, Laura; Gadella, Theodorus W. J., Jr.] Univ Amsterdam, Swammerdam Inst Life Sci, Ctr Adv Microscopy, Sect Mol Cytol, Amsterdam, Netherlands	University of Amsterdam	Goedhart, J (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Ctr Adv Microscopy, Sect Mol Cytol, Amsterdam, Netherlands.	j.goedhart@science.uva.nl	Adjobo-Hermans, Merel/AAN-5989-2020; Adjobo-Hermans, M.J.W./L-4170-2015; Vermeer, Joop E.M./J-2232-2014	Adjobo-Hermans, Merel/0000-0002-5947-2876; Adjobo-Hermans, M.J.W./0000-0002-5947-2876; Vermeer, Joop E.M./0000-0001-8876-5873; Goedhart, Joachim/0000-0002-0630-3825; Gadella, Theodorus/0000-0002-7639-219X	EU [LSHG-CT-2003-503259]	EU(European Commission)	Funding: Part of this work is supported by the EU integrated project on "Molecular Imaging'' LSHG-CT-2003-503259. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjobo-Hermans MJW, 2006, J CELL SCI, V119, P5087, DOI 10.1242/jcs.03284; Bastiaens PIH, 1996, EMBO J, V15, P4246, DOI 10.1002/j.1460-2075.1996.tb00799.x; BASTIAENS PIH, 1992, BIOCHEMISTRY-US, V31, P7050, DOI 10.1021/bi00146a005; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chudakov DM, 2005, TRENDS BIOTECHNOL, V23, P605, DOI 10.1016/j.tibtech.2005.10.005; DOMINGO B, 2007, MICROSC RES TECH; Fischer M, 1996, CHEM PHYS LETT, V260, P115, DOI 10.1016/0009-2614(96)00838-X; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Galperin E, 2004, NAT METHODS, V1, P209, DOI 10.1038/NMETH720; Ganesan S, 2006, P NATL ACAD SCI USA, V103, P4089, DOI 10.1073/pnas.0509922103; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Harpur AG, 2001, NAT BIOTECHNOL, V19, P167, DOI 10.1038/84443; He LS, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni057; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Immink RGH, 2002, P NATL ACAD SCI USA, V99, P2416, DOI 10.1073/pnas.042677699; Jares-Erijman EA, 2003, NAT BIOTECHNOL, V21, P1387, DOI 10.1038/nbt896; Jares-Erijman EA, 2006, CURR OPIN CHEM BIOL, V10, P409, DOI 10.1016/j.cbpa.2006.08.021; Karasawa S, 2004, BIOCHEM J, V381, P307, DOI 10.1042/BJ20040321; Koushik SV, 2006, BIOPHYS J, V91, pL99, DOI 10.1529/biophysj.106.096206; Kremers GJ, 2006, BIOCHEMISTRY-US, V45, P6570, DOI 10.1021/bi0516273; Magde D, 2002, PHOTOCHEM PHOTOBIOL, V75, P327, DOI 10.1562/0031-8655(2002)075<0327:FQYATR>2.0.CO;2; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Miyawaki A, 2003, DEV CELL, V4, P295, DOI 10.1016/S1534-5807(03)00060-1; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Nguyen AW, 2005, NAT BIOTECHNOL, V23, P355, DOI 10.1038/nbt1066; Ohashi T, 2007, PROTEIN SCI, V16, P1429, DOI 10.1110/ps.072845607; Peyker A, 2005, CHEMBIOCHEM, V6, P78, DOI 10.1002/cbic.200400280; Pfeifer D, 2006, J FLUORESC, V16, P581, DOI 10.1007/s10895-006-0086-8; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Schultz C, 2005, CHEMBIOCHEM, V6, P1323, DOI 10.1002/cbic.200500012; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shimozono S, 2006, BIOCHEMISTRY-US, V45, P6267, DOI 10.1021/bi060093i; Sinnecker D, 2005, BIOCHEMISTRY-US, V44, P7085, DOI 10.1021/bi047881x; Sorkin A, 2000, CURR BIOL, V10, P1395, DOI 10.1016/S0960-9822(00)00785-5; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; van Munster EB, 2005, ADV BIOCHEM ENG BIOT, V95, P143; Van Munster EB, 2005, J MICROSC-OXFORD, V218, P253, DOI 10.1111/j.1365-2818.2005.01483.x; Van Munster EB, 2004, J MICROSC-OXFORD, V213, P29, DOI 10.1111/j.1365-2818.2004.01249.x; van Munster EB, 2004, CYTOM PART A, V58A, P185, DOI 10.1002/cyto.a.20013; Vermeer JEM, 2004, J MICROSC-OXFORD, V214, P190, DOI 10.1111/j.0022-2720.2004.01318.x; Wu XL, 2006, CYTOM PART A, V69A, P477, DOI 10.1002/cyto.a.20300; Yasuda R, 2006, CURR OPIN NEUROBIOL, V16, P551, DOI 10.1016/j.conb.2006.08.012; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976	50	69	71	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1011	10.1371/journal.pone.0001011	http://dx.doi.org/10.1371/journal.pone.0001011			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925859	Green Published, gold, Green Submitted			2022-12-25	WOS:000207456000010
J	Laurance, WF; Nascimento, HEM; Laurance, SG; Andrade, A; Ewers, RM; Harms, KE; Luizao, RCC; Ribeiro, JE				Laurance, William F.; Nascimento, Henrique E. M.; Laurance, Susan G.; Andrade, Ana; Ewers, Robert M.; Harms, Kyle E.; Luizao, Regina C. C.; Ribeiro, Jose E.			Habitat Fragmentation, Variable Edge Effects, and the Landscape-Divergence Hypothesis	PLOS ONE			English	Article							RAIN-FOREST FRAGMENTATION; POSITIVE FEEDBACKS; SPECIES RESPONSES; TREE MORTALITY; VEGETATION; MATRIX; ENVIRONMENT; MICROCLIMATE; COMMUNITIES; RECRUITMENT	Edge effects are major drivers of change in many fragmented landscapes, but are often highly variable in space and time. Here we assess variability in edge effects altering Amazon forest dynamics, plant community composition, invading species, and carbon storage, in the world's largest and longest-running experimental study of habitat fragmentation. Despite detailed knowledge of local landscape conditions, spatial variability in edge effects was only partially foreseeable: relatively predictable effects were caused by the differing proximity of plots to forest edge and varying matrix vegetation, but windstorms generated much random variability. Temporal variability in edge phenomena was also only partially predictable: forest dynamics varied somewhat with fragment age, but also fluctuated markedly over time, evidently because of sporadic droughts and windstorms. Given the acute sensitivity of habitat fragments to local landscape and weather dynamics, we predict that fragments within the same landscape will tend to converge in species composition, whereas those in different landscapes will diverge in composition. This 'landscape-divergence hypothesis', if generally valid, will have key implications for biodiversity-conservation strategies and for understanding the dynamics of fragmented ecosystems.	[Laurance, William F.; Laurance, Susan G.] Smithsonian Trop Res Inst, Balboa, Panama; [Nascimento, Henrique E. M.; Andrade, Ana; Luizao, Regina C. C.] Smithsonian Trop Res Inst, Natl Inst Amazonian Res INPA, Biol Dynam Forest Fragments Project, Manaus, Amazonas, Brazil; [Ewers, Robert M.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Harms, Kyle E.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Ribeiro, Jose E.] Natl Inst Amazonian Res INPA, Dept Bot, Manaus, Amazonas, Brazil	Smithsonian Institution; Smithsonian Tropical Research Institute; Institute Nacional de Pesquisas da Amazonia; Smithsonian Institution; Smithsonian Tropical Research Institute; Zoological Society of London; Louisiana State University System; Louisiana State University; Institute Nacional de Pesquisas da Amazonia	Laurance, WF (corresponding author), Smithsonian Trop Res Inst, Balboa, Panama.	laurancew@si.edu	Nascimento, Henrique E/F-8612-2012; Laurance, Susan/G-6021-2011; Ribeiro, Jose Eduardo L. S./A-8574-2013; Laurance, William F/B-2709-2012	Laurance, Susan/0000-0002-2831-2933; Ribeiro, Jose Eduardo L. S./0000-0002-2389-5631; Laurance, William F/0000-0003-4430-9408	U. S. National Science Foundation; NASA-LBA Program; A. W. Mellon Foundation; Conservation, Food and Health Foundation; World Wildlife Fund-U.S.; MacArthur Foundation; National Institute for Amazonian Research; Smithsonian Institution	U. S. National Science Foundation(National Science Foundation (NSF)); NASA-LBA Program(National Aeronautics & Space Administration (NASA)); A. W. Mellon Foundation; Conservation, Food and Health Foundation; World Wildlife Fund-U.S.; MacArthur Foundation; National Institute for Amazonian Research; Smithsonian Institution(Smithsonian Institution)	Funding: Support was provided by the U. S. National Science Foundation, NASA-LBA Program, A. W. Mellon Foundation, Conservation, Food and Health Foundation, World Wildlife Fund-U.S., MacArthur Foundation, National Institute for Amazonian Research, and Smithsonian Institution.	ASIER GP, 2005, SCIENCE, V310, P480; Benedick S, 2006, J APPL ECOL, V43, P967, DOI 10.1111/j.1365-2664.2006.01209.x; Benitez-Malvido J, 1998, CONSERV BIOL, V12, P380, DOI 10.1046/j.1523-1739.1998.96295.x; Bierregaard Richard O. Jr., 1997, P138; BOOSE ER, 1994, ECOL MONOGR, V64, P369, DOI 10.2307/2937142; BROADBENT EN, CONSERV BIO IN PRESS; Bruna EM, 1999, NATURE, V402, P139, DOI 10.1038/45963; Cadenasso ML, 2003, BIOSCIENCE, V53, P750, DOI 10.1641/0006-3568(2003)053[0750:AFFATO]2.0.CO;2; CHEN JQ, 1992, ECOL APPL, V2, P387, DOI 10.2307/1941873; CHEN JQ, 1995, ECOL APPL, V5, P74, DOI 10.2307/1942053; Cochrane MA, 2002, J TROP ECOL, V18, P311, DOI 10.1017/S0266467402002237; Cochrane MA, 1999, SCIENCE, V284, P1832, DOI 10.1126/science.284.5421.1832; Crist TO, 2003, AM NAT, V162, P734, DOI 10.1086/378901; Cronin JT, 2003, ECOLOGY, V84, P1506, DOI 10.1890/0012-9658(2003)084[1506:MHAHII]2.0.CO;2; D'Angelo SA, 2004, J TROP ECOL, V20, P243, DOI 10.1017/S0266467403001032; Didham Raphael K., 1997, P55; Didham RK, 1998, ECOL MONOGR, V68, P295, DOI 10.1890/0012-9615(1998)068[0295:BSRTTF]2.0.CO;2; Didham RK, 1999, BIOTROPICA, V31, P17, DOI 10.1111/j.1744-7429.1999.tb00113.x; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Ewers RM, 2007, ECOLOGY, V88, P96, DOI 10.1890/0012-9658(2007)88[96:SIBEAA]2.0.CO;2; Fearnside PM, 2001, ENVIRON CONSERV, V28, P23, DOI 10.1017/S0376892901000030; Ferreira LV, 1997, CONSERV BIOL, V11, P797, DOI 10.1046/j.1523-1739.1997.96167.x; Foster MS, 1998, BIOTROPICA, V30, P470, DOI 10.1111/j.1744-7429.1998.tb00081.x; Gascon C, 2000, SCIENCE, V288, P1356, DOI 10.1126/science.288.5470.1356; Gascon C, 1999, BIOL CONSERV, V91, P223, DOI 10.1016/S0006-3207(99)00080-4; GATES JE, 1978, ECOLOGY, V59, P871, DOI 10.2307/1938540; Gilbert B, 2006, AM NAT, V168, P304, DOI 10.1086/506969; Grau HR, 2004, BIOTROPICA, V36, P52, DOI 10.1111/j.1744-7429.2004.tb00295.x; Harper KA, 2005, CONSERV BIOL, V19, P768, DOI 10.1111/j.1523-1739.2005.00045.x; JANZEN DH, 1983, OIKOS, V41, P402, DOI 10.2307/3544100; KAPOS V, 1993, J ECOL, V81, P425, DOI 10.2307/2261521; KAPOS V, 1989, J TROP ECOL, V5, P173, DOI 10.1017/S0266467400003448; Kapos Valerie, 1997, P33; Kupfer JA, 2006, GLOBAL ECOL BIOGEOGR, V15, P8, DOI 10.1111/j.1466-822x.2006.00204.x; Laurance W. F., 1997, P71; Laurance W.F., 1997, TROPICAL FOREST REMN, P616; LAURANCE WF, 1991, BIOL CONSERV, V57, P205, DOI 10.1016/0006-3207(91)90139-Z; Laurance WF, 2001, ECOLOGY, V82, P105, DOI 10.1890/0012-9658(2001)082[0105:RFFATS]2.0.CO;2; Laurance WF, 1998, ECOLOGY, V79, P2032, DOI 10.1890/0012-9658(1998)079[2032:RFFATD]2.0.CO;2; Laurance WF, 1997, SCIENCE, V278, P1117, DOI 10.1126/science.278.5340.1117; Laurance WF, 2004, SCIENCE, V304, P1109, DOI 10.1126/science.304.5674.1109b; Laurance WF, 1998, CONSERV BIOL, V12, P460, DOI 10.1046/j.1523-1739.1998.97175.x; Laurance WF, 1998, FOREST ECOL MANAG, V110, P173, DOI 10.1016/S0378-1127(98)00291-6; Laurance WF, 2002, J VEG SCI, V13, P595, DOI 10.1111/j.1654-1103.2002.tb02086.x; Laurance WF, 2001, CONSERV BIOL, V15, P1488, DOI 10.1046/j.1523-1739.2001.01088.x; Laurance WF, 2002, CONSERV BIOL, V16, P605, DOI 10.1046/j.1523-1739.2002.01025.x; Laurance WF, 2004, PHILOS T R SOC B, V359, P345, DOI 10.1098/rstb.2003.1430; Laurance WF, 2000, NATURE, V404, P836, DOI 10.1038/35009032; Laurance WF, 2001, J TROP ECOL, V17, P771, DOI 10.1017/S0266467401001596; Laurance WF, 2001, CONSERV BIOL, V15, P1529, DOI 10.1046/j.1523-1739.2001.01093.x; Laurance WF, 2001, SCIENCE, V291, P438, DOI 10.1126/science.291.5503.438; LAURANCE WF, 2006, EMERGING THREATS TRO, P534; Laurance WF, 2006, P NATL ACAD SCI USA, V103, P19010, DOI 10.1073/pnas.0609048103; Laurance William F, 2006, Ecology, V87, P469, DOI 10.1890/05-0064; Lovejoy T.E., 1986, P257; MALCOLM JR, 1994, ECOLOGY, V75, P2438, DOI 10.2307/1940897; MATLACK GR, 1993, BIOL CONSERV, V66, P185, DOI 10.1016/0006-3207(93)90004-K; Mesquita RCG, 2001, J ECOL, V89, P528, DOI 10.1046/j.1365-2745.2001.00583.x; Mesquita RCG, 1999, BIOL CONSERV, V91, P129, DOI 10.1016/S0006-3207(99)00086-5; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Nascimento HEM, 2004, ECOL APPL, V14, pS127; Nascimento HEM, 2006, CONSERV BIOL, V20, P853, DOI 10.1111/j.1523-1739.2006.00344.x; NELSON BW, 1994, ECOLOGY, V75, P853, DOI 10.2307/1941742; PATTERSON B D, 1987, Conservation Biology, V1, P323, DOI 10.1111/j.1523-1739.1987.tb00052.x; Pohlman CL, 2007, BIOTROPICA, V39, P62, DOI 10.1111/j.1744-7429.2006.00238.x; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Savill P. S., 1983, Forestry Abstracts Review Article, V44, P473; Sizer N, 1999, BIOL CONSERV, V91, P135, DOI 10.1016/S0006-3207(99)00076-2; SOMERVILLE A, 1980, NEW ZEAL J FOR SCI, V10, P476; Suarez AV, 1998, ECOLOGY, V79, P2041, DOI 10.1890/0012-9658(1998)079[2041:EOFAIO]2.0.CO;2; Turton Stephen M., 1997, P45; Vasconcelos HL, 2005, OECOLOGIA, V144, P456, DOI 10.1007/s00442-005-0117-1; Vasconcelos HL, 2004, ECOL APPL, V14, P884, DOI 10.1890/03-5093; Wright DH, 1998, OECOLOGIA, V113, P1, DOI 10.1007/s004420050348; YOUNG A, 1994, BIOL CONSERV, V67, P63, DOI 10.1016/0006-3207(94)90010-8	76	271	280	2	156	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1017	10.1371/journal.pone.0001017	http://dx.doi.org/10.1371/journal.pone.0001017			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925865	Green Submitted, gold, Green Published			2022-12-25	WOS:000207456000016
J	Audhya, A; McLeod, IX; Yates, JR; Oegema, K				Audhya, Anjon; McLeod, Ian X.; Yates, John R., III; Oegema, Karen			MVB-12, a Fourth Subunit of Metazoan ESCRT-I, Functions in Receptor Downregulation	PLOS ONE			English	Article								After ligand binding and endocytosis, cell surface receptors can continue to signal from endosomal compartments until sequestered from the cytoplasm. An important mechanism for receptor downregulation in vivo is via the inward budding of receptors into intralumenal vesicles to form specialized endosomes called multivesicular bodies (MVBs) that subsequently fuse with lysosomes, degrading their cargo. This process requires four heterooligomeric protein complexes collectively termed the ESCRT machinery. In yeast, ESCRT-I is a heterotetrameric complex comprised of three conserved subunits and a fourth subunit for which identifiable metazoan homologs were lacking. Using C. elegans, we identify MVB-12, a fourth metazoan ESCRT-I subunit. Depletion of MVB-12 slows the kinetics of receptor downregulation in vivo, but to a lesser extent than inhibition of other ESCRT-I subunits. Consistent with these findings, targeting of MVB-12 to membranes requires the other ESCRT-I subunits, but MVB-12 is not required to target the remaining ESCRT-I components. Both endogenous and recombinant ESCRT-I are stable complexes with a 1:1:1:1 subunit stoichiometry. MVB-12 has two human homologs that co-localize and co-immunoprecipitate with the ESCRT-I component TSG101. Thus, MVB-12 is a conserved core component of metazoan ESCRT-I that regulates its activity during MVB biogenesis.	[Audhya, Anjon; Oegema, Karen] Univ Calif San Diego, Ludwig Inst Canc Res, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [McLeod, Ian X.; Yates, John R., III] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; Scripps Research Institute	Audhya, A (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	aaudhya@ucsd.edu; koegema@ucsd.edu			NIH [RR11823]; Ludwig Institute for Cancer Research; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Institute for Cancer Research; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	AA is a Fellow of the Helen Hay Whitney Foundation; JY receives support from grant NIH RR11823 that funds the YRC; KO is a Pew Scholar in the Biomedical Sciences and receives salary and additional support from the Ludwig Institute for Cancer Research.	Audhya A, 2005, J CELL BIOL, V171, P267, DOI 10.1083/jcb.200506124; Audhya A, 2007, J CELL BIOL, V178, P43, DOI 10.1083/jcb.200701139; Bache KG, 2004, MOL BIOL CELL, V15, P4337, DOI 10.1091/mbc.E04-03-0250; Bache KG, 2004, EMBO J, V23, P2707, DOI 10.1038/sj.emboj.7600292; Bishop N, 2001, J BIOL CHEM, V276, P11735, DOI 10.1074/jbc.M009863200; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Chu T, 2006, J CELL BIOL, V175, P815, DOI 10.1083/jcb.200608053; Curtiss M, 2007, MOL BIOL CELL, V18, P636, DOI 10.1091/mbc.E06-07-0588; Demirov DG, 2004, VIRUS RES, V106, P87, DOI 10.1016/j.virusres.2004.08.007; Desai A, 2003, GENE DEV, V17, P2421, DOI 10.1101/gad.1126303; Eastman SW, 2005, J BIOL CHEM, V280, P628, DOI 10.1074/jbc.M410384200; Gonzalez-Gaitan Marcos, 2003, Cell, V115, P513, DOI 10.1016/S0092-8674(03)00932-2; Grant B, 1999, MOL BIOL CELL, V10, P4311, DOI 10.1091/mbc.10.12.4311; GREENSTEIN D, 2005, C ELEGANS; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Kadandale P, 2005, CURR BIOL, V15, P2222, DOI 10.1016/j.cub.2005.10.043; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Konishi H, 2006, J BIOL CHEM, V281, P28919, DOI 10.1074/jbc.M605693200; Kostelansky MS, 2007, CELL, V129, P485, DOI 10.1016/j.cell.2007.03.016; Lin Y, 2005, J BIOL CHEM, V280, P12799, DOI 10.1074/jbc.M413968200; McCarter J, 1999, DEV BIOL, V205, P111, DOI 10.1006/dbio.1998.9109; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Oegema K, 1999, J CELL BIOL, V144, P721, DOI 10.1083/jcb.144.4.721; Oegema K, 2001, J CELL BIOL, V153, P1209, DOI 10.1083/jcb.153.6.1209; Oestreich AJ, 2007, MOL BIOL CELL, V18, P646, DOI 10.1091/mbc.E06-07-0601; Porter AC, 1998, ONCOGENE, V17, P1343, DOI 10.1038/sj.onc.1202171; Praitis V, 2001, GENETICS, V157, P1217; Sato K, 2006, MOL BIOL CELL, V17, P3085, DOI 10.1091/mbc.E06-03-0211; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Tan S, 2001, PROTEIN EXPRES PURIF, V21, P224, DOI 10.1006/prep.2000.1363; Vivekanand P, 2006, ANNU REV GENET, V40, P139, DOI 10.1146/annurev.genet.40.110405.090555; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Zhong Q, 1997, CANCER RES, V57, P4225	37	39	46	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e956	10.1371/journal.pone.0000956	http://dx.doi.org/10.1371/journal.pone.0000956			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895996	gold, Green Submitted, Green Published			2022-12-25	WOS:000207455800034
J	Kitajima, S; Kudo, Y; Ogawa, I; Tatsuka, M; Kawai, H; Pagano, M; Takata, T				Kitajima, Shojiro; Kudo, Yasusei; Ogawa, Ikuko; Tatsuka, Masaaki; Kawai, Hidehiko; Pagano, Michele; Takata, Takashi			Constitutive Phosphorylation of Aurora-A on Ser51 Induces Its Stabilization and Consequent Overexpression in Cancer	PLOS ONE			English	Article							ANAPHASE-PROMOTING COMPLEX/CYCLOSOME; CENTROSOME AMPLIFICATION; DESTRUCTION BOX; PROTEIN-KINASE; CELL-CYCLE; DEGRADATION; IDENTIFICATION; RECOGNITION; TRANSFORMATION; PROTEOLYSIS	Background. The serine/threonine kinase Aurora-A (Aur-A) is a proto-oncoprotein overexpressed in a wide range of human cancers. Overexpression of Aur-A is thought to be caused by gene amplification or mRNA overexpression. However, recent evidence revealed that the discrepancies between amplification of Aur-A and overexpression rates of Aur-A mRNA were observed in breast cancer, gastric cancer, hepatocellular carcinoma, and ovarian cancer. We found that aggressive head and neck cancers exhibited overexpression and stabilization of Aur-A protein without gene amplification or mRNA overexpression. Here we tested the hypothesis that aberration of the protein destruction system induces accumulation and consequently overexpression of Aur-A in cancer. Principal Findings. Aur-A protein was ubiquitinylated by APC(Cdh1) and consequently degraded when cells exited mitosis, and phosphorylation of Aur-A on Ser51 was observed during mitosis. Phosphorylation of Aur-A on Ser51 inhibited its APC(Cdh1)-mediated ubiquitylation and consequent degradation. Interestingly, constitutive phosphorylation on Ser51 was observed in head and neck cancer cells with protein overexpression and stabilization. Indeed, phosphorylation on Ser51 was observed in head and neck cancer tissues with Aur-A protein overexpression. Moreover, an Aur-A Ser51 phospho-mimetic mutant displayed stabilization of protein during cell cycle progression and enhanced ability to cell transformation. Conclusions/Significance. Broadly, this study identifies a new mode of Aur-A overexpression in cancer through phosphorylation-dependent inhibition of its proteolysis in addition to gene amplification and mRNA overexpression. We suggest that the inhibition of Aur-A phosphorylation can represent a novel way to decrease Aur-A levels in cancer therapy.	[Kitajima, Shojiro; Kudo, Yasusei; Takata, Takashi] Hiroshima Univ, Grad Sch Biomed Sci, Div Frontier Med Sci, Dept Oral & Maxillofacial Pathobiol, Hiroshima, Japan; [Ogawa, Ikuko] Hiroshima Univ Hosp, Ctr Oral Clin Examinat, Hiroshima, Japan; [Tatsuka, Masaaki; Kawai, Hidehiko] Hiroshima Univ, Dept Regulatory Radiobiol, Res Inst Radiat Biol & Med, Hiroshima, Japan; [Pagano, Michele] NYU, Sch Med, Dept Pathol, Inst Canc, New York, NY USA	Hiroshima University; Hiroshima University; Hiroshima University; New York University	Kudo, Y (corresponding author), Hiroshima Univ, Grad Sch Biomed Sci, Div Frontier Med Sci, Dept Oral & Maxillofacial Pathobiol, Hiroshima, Japan.	ykudo@hiroshima-u.ac.jp; ttakata@hiroshima-u.ac.jp		Kawai, Hidehiko/0000-0003-2213-7166; Kitajima, Shojiro/0000-0002-4000-0473; pagano, michele/0000-0003-3210-2442; Kudo, Yasusei/0000-0002-0392-7720	Ministry of Education, Science and Culture of Japan; Uehara memorial foundation; National Institutes of Health [R37-CA76584, R01-GM57587, R21-CA125173]; NATIONAL CANCER INSTITUTE [R21CA125173, R37CA076584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057587] Funding Source: NIH RePORTER	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara memorial foundation(Uehara Memorial Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research was supported by grants-in-aid from the Ministry of Education, Science and Culture of Japan (YK and TT); grants from Uehara memorial foundation (YK) and grants from the National Institutes of Health (R37-CA76584, R01-GM57587 and R21-CA125173) (MP).	Anand S, 2003, CANCER CELL, V3, P51, DOI 10.1016/S1535-6108(02)00235-0; Arlot-Bonnemains Y, 2001, FEBS LETT, V508, P149, DOI 10.1016/S0014-5793(01)03048-4; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Carrano AC, 2001, J CELL BIOL, V153, P1381, DOI 10.1083/jcb.153.7.1381; Carroll CW, 2005, CURR BIOL, V15, P11, DOI 10.1016/j.cub.2004.12.066; Castro A, 2002, EMBO REP, V3, P457, DOI 10.1093/embo-reports/kvf095; Castro A, 2002, EMBO REP, V3, P1209, DOI 10.1093/embo-reports/kvf241; Crane R, 2004, J CELL SCI, V117, P5975, DOI 10.1242/jcs.01418; Eytan E, 2006, P NATL ACAD SCI USA, V103, P2081, DOI 10.1073/pnas.0510695103; Fukuda T, 2005, MOL CELL BIOL, V25, P5270, DOI 10.1128/MCB.25.12.5270-5281.2005; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Goepfert TM, 2000, CURR TOP DEV BIOL, V49, P331; Gritsko TM, 2003, CLIN CANCER RES, V9, P1420; Guardavaccaro D, 2003, DEV CELL, V4, P799, DOI 10.1016/S1534-5807(03)00154-0; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Honda K, 2000, ONCOGENE, V19, P2812, DOI 10.1038/sj.onc.1203609; Horn V, 2007, MOL BIOL CELL, V18, P1233, DOI 10.1091/mbc.E06-12-1152; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Jeng YM, 2004, CLIN CANCER RES, V10, P2065, DOI 10.1158/1078-0432.CCR-1057-03; Kitajima S, 2004, AM J PATHOL, V165, P2147, DOI 10.1016/S0002-9440(10)63264-6; Li DH, 2003, CLIN CANCER RES, V9, P991; Lindon C, 2004, J CELL BIOL, V164, P233, DOI 10.1083/jcb.200309035; Littlepage LE, 2002, GENE DEV, V16, P2274, DOI 10.1101/gad.1007302; Littlepage LE, 2002, P NATL ACAD SCI USA, V99, P15440, DOI 10.1073/pnas.202606599; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; Marumoto T, 2005, NAT REV CANCER, V5, P42, DOI 10.1038/nrc1526; Meraldi P, 2002, EMBO J, V21, P483, DOI 10.1093/emboj/21.4.483; Miyoshi Y, 2001, INT J CANCER, V92, P370, DOI 10.1002/ijc.1200; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Nguyen HG, 2005, MOL CELL BIOL, V25, P4977, DOI 10.1128/MCB.25.12.4977-4992.2005; Ota T, 2002, CANCER RES, V62, P5168; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pfleger CM, 2000, GENE DEV, V14, P655; Reiter R, 2006, CLIN CANCER RES, V12, P5136, DOI 10.1158/1078-0432.CCR-05-1650; Rojanala S, 2004, MOL CANCER THER, V3, P451; Sakakura C, 2001, BRIT J CANCER, V84, P824, DOI 10.1054/bjoc.2000.1684; Stewart S, 2005, CANCER RES, V65, P8730, DOI 10.1158/0008-5472.CAN-05-1500; Taguchi S, 2002, FEBS LETT, V519, P59, DOI 10.1016/S0014-5793(02)02711-4; Takahashi T, 2000, JPN J CANCER RES, V91, P1007, DOI 10.1111/j.1349-7006.2000.tb00878.x; Tanaka T, 1999, CANCER RES, V59, P2041; Tanner MM, 2000, CLIN CANCER RES, V6, P1833; Tatsuka M, 2005, ONCOGENE, V24, P1122, DOI 10.1038/sj.onc.1208293; Wang SS, 1998, SCIENCE, V282, P284, DOI 10.1126/science.282.5387.284; Watanabe T, 2002, JPN J CANCER RES, V93, P1114, DOI 10.1111/j.1349-7006.2002.tb01213.x; YAGI T, 1989, MOL CARCINOGEN, V1, P222, DOI 10.1002/mc.2940010404; Yamano H, 2004, MOL CELL, V13, P137, DOI 10.1016/S1097-2765(03)00480-5; Zhang DW, 2004, ONCOGENE, V23, P8720, DOI 10.1038/sj.onc.1208153; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	49	42	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e944	10.1371/journal.pone.0000944	http://dx.doi.org/10.1371/journal.pone.0000944			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895985	Green Published, gold, Green Submitted			2022-12-25	WOS:000207455800023
J	Li, G; Wang, JH; Rossiter, SJ; Jones, G; Zhang, SY				Li, Gang; Wang, Jinhong; Rossiter, Stephen J.; Jones, Gareth; Zhang, Shuyi			Accelerated FoxP2 Evolution in Echolocating Bats	PLOS ONE			English	Article							COMBINATION-SENSITIVE NEURONS; DETECTING POSITIVE SELECTION; MEDIAL GENICULATE-BODY; LIKELIHOOD METHOD; MOUSTACHED BAT; SEVERE SPEECH; TARGET RANGE; NOSED BAT; PROTEIN; GENE	FOXP2 is a transcription factor implicated in the development and neural control of orofacial coordination, particularly with respect to vocalisation. Observations that orthologues show almost no variation across vertebrates yet differ by two amino acids between humans and chimpanzees have led to speculation that recent evolutionary changes might relate to the emergence of language. Echolocating bats face especially challenging sensorimotor demands, using vocal signals for orientation and often for prey capture. To determine whether mutations in the FoxP2 gene could be associated with echolocation, we sequenced FoxP2 from echolocating and non-echolocating bats as well as a range of other mammal species. We found that contrary to previous reports, FoxP2 is not highly conserved across all nonhuman mammals but is extremely diverse in echolocating bats. We detected divergent selection (a change in selective pressure) at FoxP2 between bats with contrasting sonar systems, suggesting the intriguing possibility of a role for FoxP2 in the evolution and development of echolocation. We speculate that observed accelerated evolution of FoxP2 in bats supports a previously proposed function in sensorimotor coordination.	[Rossiter, Stephen J.] Univ London, Sch Biol & Chem Sci, London, England; [Li, Gang; Wang, Jinhong; Zhang, Shuyi] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China; [Li, Gang] Chinese Acad Sci, Inst Zool, Beijing, Peoples R China; [Li, Gang] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Jones, Gareth] Univ Bristol, Sch Biol Sci, Bristol, Avon, England	University of London; East China Normal University; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Bristol	Rossiter, SJ (corresponding author), Univ London, Sch Biol & Chem Sci, London, England.	s.j.rossiter@qmul.ac.uk; syzhang@bio.ecnu.edu.cn	Rossiter, Stephen J/E-2111-2011; Zhang, Shuyi/B-5117-2011; li, gang/E-5640-2014	li, gang/0000-0001-7400-5486; Rossiter, Stephen/0000-0002-3881-4515; Jones, Gareth/0000-0002-1904-3735	East China Normal University [14-008]	East China Normal University	This work was funded by a special grant from East China Normal University to SZ and a Darwin Initiative grant (14-008) to GJ.	ALDRIDGE HDJN, 1990, J MAMMAL, V71, P242, DOI 10.2307/1382175; Anisimova M, 2002, MOL BIOL EVOL, V19, P950, DOI 10.1093/oxfordjournals.molbev.a004152; Bielawski Joseph P., 2003, Journal of Structural and Functional Genomics, V3, P201, DOI 10.1023/A:1022642807731; Bielawski JP, 2004, J MOL EVOL, V59, P121, DOI 10.1007/s00239-004-2597-8; BIRKY CW, 1988, P NATL ACAD SCI USA, V85, P6414, DOI 10.1073/pnas.85.17.6414; Boughman JW, 1998, P ROY SOC B-BIOL SCI, V265, P227, DOI 10.1098/rspb.1998.0286; Brenowitz EA, 1997, J NEUROBIOL, V33, P517, DOI 10.1002/(SICI)1097-4695(19971105)33:5<517::AID-NEU3>3.0.CO;2-7; Choi JH, 2000, BIOINFORMATICS, V16, P1056, DOI 10.1093/bioinformatics/16.11.1056; COVEY E, 1995, LOWER BRAINSTEM AUDI, P235; Eick GN, 2005, MOL BIOL EVOL, V22, P1869, DOI 10.1093/molbev/msi180; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; ESSER KH, 1994, NEUROREPORT, V5, P1718, DOI 10.1097/00001756-199409080-00007; Ferland RJ, 2003, J COMP NEUROL, V460, P266, DOI 10.1002/cne.10654; Fisher SE, 2006, NAT REV GENET, V7, P9, DOI 10.1038/nrg1747; Fitzgerald EMG, 2006, P ROY SOC B-BIOL SCI, V273, P2955, DOI 10.1098/rspb.2006.3664; Foote AD, 2006, BIOL LETT-UK, V2, P509, DOI 10.1098/rsbl.2006.0525; Griffin DR, 1958, LISTENING DARK; Grothe B, 2000, MICROSC RES TECHNIQ, V51, P382, DOI 10.1002/1097-0029(20001115)51:4<382::AID-JEMT7>3.0.CO;2-7; Haesler S, 2004, J NEUROSCI, V24, P3164, DOI 10.1523/JNEUROSCI.4369-03.2004; HERZING DL, 2004, ECHOLOCATION BATS DO; Hiryu S, 2006, J COMP PHYSIOL A, V192, P807, DOI 10.1007/s00359-006-0118-5; Hu KL, 2006, NEUROREPORT, V17, P1743, DOI 10.1097/01.wnr.0000239959.91190.c8; Hughes M, 1998, BEHAV ECOL SOCIOBIOL, V42, P437, DOI 10.1007/s002650050458; Hutcheon JM, 1998, PHILOS T R SOC B, V353, P607, DOI 10.1098/rstb.1998.0229; Janik VM, 1997, ADV STUD BEHAV, V26, P59, DOI 10.1016/S0065-3454(08)60377-0; Janik VM, 2000, SCIENCE, V289, P1355, DOI 10.1126/science.289.5483.1355; Jarvis ED, 2004, ANN NY ACAD SCI, V1016, P749, DOI 10.1196/annals.1298.038; JOHNSON F, 1995, J COMP NEUROL, V358, P260, DOI 10.1002/cne.903580208; JONES G, 1993, P ROY SOC B-BIOL SCI, V252, P125, DOI 10.1098/rspb.1993.0055; Jones G, 2006, TRENDS ECOL EVOL, V21, P149, DOI 10.1016/j.tree.2006.01.001; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lai CSL, 2003, BRAIN, V126, P2455, DOI 10.1093/brain/awg247; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Li SR, 2004, MOL CELL BIOL, V24, P809, DOI 10.1128/MCB.24.2.809-822.2004; Liegeois F, 2003, NAT NEUROSCI, V6, P1230, DOI 10.1038/nn1138; MacDermot KD, 2005, AM J HUM GENET, V76, P1074, DOI 10.1086/430841; Marczyk G. R., 2003, INT J FORENSIC MENT, V2, P7, DOI DOI 10.1080/14999013.2003.10471175; Mercado E, 2005, ANIM COGN, V8, P93, DOI 10.1007/s10071-004-0238-7; Moss C. F., 1995, BEHAV STUDIES AUDITO, P87; Moss CF, 2003, CURR OPIN NEUROBIOL, V13, P751, DOI 10.1016/j.conb.2003.10.016; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nelson DA, 2000, P NATL ACAD SCI USA, V97, P13348, DOI 10.1073/pnas.240457797; Nummela S, 2004, NATURE, V430, P776, DOI 10.1038/nature02720; OLSEN JF, 1991, J NEUROPHYSIOL, V65, P1254, DOI 10.1152/jn.1991.65.6.1254; OLSEN JF, 1991, J NEUROPHYSIOL, V65, P1275, DOI 10.1152/jn.1991.65.6.1275; PAULIN MG, 1993, BRAIN BEHAV EVOLUT, V41, P39, DOI 10.1159/000113822; POLLAK G, 1977, SCIENCE, V196, P675, DOI 10.1126/science.857318; Pollak G.D., 1989, NEURAL BASIS ECHOLOC; Poole JH, 2005, NATURE, V434, P455, DOI 10.1038/434455a; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Scharff C, 2005, CURR OPIN NEUROBIOL, V15, P694, DOI 10.1016/j.conb.2005.10.004; Schuddekopf K, 1996, P NATL ACAD SCI USA, V93, P9661, DOI 10.1073/pnas.93.18.9661; Shriberg LD, 2006, J SPEECH LANG HEAR R, V49, P500, DOI 10.1044/1092-4388(2006/038); Shu WG, 2005, P NATL ACAD SCI USA, V102, P9643, DOI 10.1073/pnas.0503739102; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; Springer MS, 2001, P NATL ACAD SCI USA, V98, P6241, DOI 10.1073/pnas.111551998; Stone EA, 2005, GENOME RES, V15, P978, DOI 10.1101/gr.3804205; SUGA N, 1979, SCIENCE, V206, P351, DOI 10.1126/science.482944; Teeling EC, 2000, NATURE, V403, P188, DOI 10.1038/35003188; Teeling EC, 2002, P NATL ACAD SCI USA, V99, P1431, DOI 10.1073/pnas.022477199; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Teramitsu I, 2004, J NEUROSCI, V24, P3152, DOI 10.1523/JNEUROSCI.5589-03.2004; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Van den Bussche RA, 2004, J MAMMAL, V85, P321, DOI 10.1644/1545-1542(2004)085<0321:PRARCF>2.0.CO;2; Vargha-Khadem F, 2005, NAT REV NEUROSCI, V6, P131, DOI 10.1038/nrn1605; Wang XM, 2007, J COMP PHYSIOL A, V193, P13, DOI 10.1007/s00359-006-0167-9; Webb DM, 2005, J HERED, V96, P212, DOI 10.1093/jhered/esi025; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Zeesman S, 2006, AM J MED GENET A, V140A, P509, DOI 10.1002/ajmg.a.31110; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhang JZ, 2002, GENETICS, V162, P1825	74	107	111	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2007	2	9							e900	10.1371/journal.pone.0000900	http://dx.doi.org/10.1371/journal.pone.0000900			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HS	17878935	Green Published, gold, Green Submitted			2022-12-25	WOS:000207455700008
J	Li, Y; Lu, J; Cohen, D; Prochownik, EV				Li, Y.; Lu, J.; Cohen, D.; Prochownik, E. V.			Transformation, genomic instability and senescence mediated by platelet/megakaryocyte glycoprotein Ib alpha	ONCOGENE			English	Article						c-Myc; tetraploidy; aneuploidy; von Willebrand's factor	C-MYC TARGET; ONCOGENE-INDUCED SENESCENCE; HUMAN-CELLS; CANCER; GENES; OVEREXPRESSION; TUMORIGENESIS; ANEUPLOIDY; DEFECTS; GROWTH	GpIb alpha, a subunit of the von Willebrand factor receptor, functions during blood clotting to promote platelet adhesion and activation. GpIb alpha is widely expressed, is positively regulated by c-Myc and is essential for the promotion of c-Myc-mediated chromosomal instability. We now show that GpIba is also a classical oncoprotein in which its deregulated expression leads to transformation, reduced growth factor requirements, increased resistance to apoptosis, and, in primary cells, p53-dependent senescence. Finally, GpIb alpha also promotes double-stranded DNA breaks, and induces profound nuclear dysmorphology, indicating that, in addition to its direct transforming function, it displays genotoxicity at several distinct levels. These findings identify novel functions for GpIb alpha and pathways through which c-Myc mediates transformation and global genomic destabilization.	[Li, Y.; Lu, J.; Cohen, D.; Prochownik, E. V.] Childrens Hosp Pittsburgh, Rangos Res Ctr, Hematol Oncol Sect, Pittsburgh, PA 15213 USA; [Prochownik, E. V.] Univ Pittsburgh, Med Ctr, Dept Mol Genet & Biochem, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Prochownik, EV (corresponding author), Childrens Hosp Pittsburgh, Rangos Res Ctr, Hematol Oncol Sect, Room 8125,3460 5th Ave, Pittsburgh, PA 15213 USA.	procev@chp.edu			NATIONAL CANCER INSTITUTE [R01CA105033, R01CA078259] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA105033, R01CA078259] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Andalis AA, 2004, GENETICS, V167, P1109, DOI 10.1534/genetics.104.029256; Andreassen PR, 2001, MOL BIOL CELL, V12, P1315, DOI 10.1091/mbc.12.5.1315; Andreassen PR, 2003, MUTAT RES-FUND MOL M, V532, P245, DOI 10.1016/j.mrfmmm.2003.08.020; Asazuma N, 1997, BLOOD, V90, P4789, DOI 10.1182/blood.V90.12.4789.4789_4789_4798; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Canobbio H, 2004, CELL SIGNAL, V16, P1329, DOI 10.1016/j.cellsig.2004.05.008; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Dai KS, 2005, BLOOD, V106, P1975, DOI 10.1182/blood-2005-01-0440; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Ekwall K, 1999, GENETICS, V153, P1153; Feng S, 1999, BLOOD, V93, P4256, DOI 10.1182/blood.V93.12.4256.412k33_4256_4263; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; HARLEY CB, 1995, CURR OPIN GENET DEV, V5, P249, DOI 10.1016/0959-437X(95)80016-6; Iarmarcovai G, 2006, TOXICOL LETT, V166, P1, DOI 10.1016/j.toxlet.2006.05.015; Kanaji T, 2004, BLOOD, V104, P3161, DOI 10.1182/blood-2004-03-0893; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Korkola JE, 2006, CANCER RES, V66, P820, DOI 10.1158/0008-5472.CAN-05-2445; Li Q, 1999, MOL CELL BIOL, V19, P5339; Li YJ, 2007, P NATL ACAD SCI USA, V104, P3490, DOI 10.1073/pnas.0610163104; Lopez J A, 1997, Curr Opin Hematol, V4, P323; Maines JZ, 2004, DEVELOPMENT, V131, P775, DOI 10.1242/dev.00932; Meek DW, 2000, PATHOL BIOL, V48, P246; Menssen A, 2007, CELL CYCLE, V6, P339, DOI 10.4161/cc.6.3.3808; Neiman PE, 2006, ONCOGENE, V25, P6325, DOI 10.1038/sj.onc.1209646; Nesbit CE, 2000, ONCOGENE, V19, P3200, DOI 10.1038/sj.onc.1203636; Ozaki Y, 2005, J THROMB HAEMOST, V3, P1745, DOI 10.1111/j.1538-7836.2005.01379.x; Pierce SB, 2004, DEVELOPMENT, V131, P2317, DOI 10.1242/dev.01108; Prochownik EV, 2007, CELL CYCLE, V6, P1024, DOI 10.4161/cc.6.9.4161; Radich JP, 2006, P NATL ACAD SCI USA, V103, P2794, DOI 10.1073/pnas.0510423103; Ravid K, 2002, J CELL PHYSIOL, V190, P7, DOI 10.1002/jcp.10035; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Rogulski K, 2005, ONCOGENE, V24, P7524, DOI 10.1038/sj.onc.1208897; Rogulski KR, 2005, P NATL ACAD SCI USA, V102, P18968, DOI 10.1073/pnas.0507902102; Rothermund K, 2005, CANCER RES, V65, P2097, DOI 10.1158/0008-5472.CAN-04-2928; Saunders W, 2003, CANCER BIOL THER, V2, P253, DOI 10.4161/cbt.2.3.379; Saunders WS, 2000, P NATL ACAD SCI USA, V97, P303, DOI 10.1073/pnas.97.1.303; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Sedivy JM, 2007, CANCER CELL, V11, P389, DOI 10.1016/j.ccr.2007.04.014; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Storchova Z, 2006, NATURE, V443, P541, DOI 10.1038/nature05178; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Thorpe PH, 2007, TRENDS GENET, V23, P263, DOI 10.1016/j.tig.2007.03.016; Weaver BAA, 2006, CURR OPIN CELL BIOL, V18, P658, DOI 10.1016/j.ceb.2006.10.002; Weinstock DM, 2006, DNA REPAIR, V5, P1065, DOI 10.1016/j.dnarep.2006.05.028; Yin XY, 1999, ONCOGENE, V18, P1177, DOI 10.1038/sj.onc.1202410; Yin XY, 2002, J BIOL CHEM, V277, P19998, DOI 10.1074/jbc.M200860200; Zhou ZQ, 2001, TRENDS CELL BIOL, V11, pS10, DOI 10.1016/S0962-8924(01)02121-3	54	11	12	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 6	2008	27	11					1599	1609		10.1038/sj.onc.1210794	http://dx.doi.org/10.1038/sj.onc.1210794			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	271VC	17873907				2022-12-25	WOS:000253815800012
J	Head, BP; Patel, HH; Tsutsumi, YM; Hu, Y; Mejia, T; Mora, RC; Insel, PA; Roth, DM; Drummond, JC; Patel, PM				Head, Brian P.; Patel, Hemal H.; Tsutsumi, Yasuo M.; Hu, Yue; Mejia, Trisha; Mora, Rosalia C.; Insel, Paul A.; Roth, David M.; Drummond, John C.; Patel, Piyush M.			Caveolin-1 expression is essential for N-methyl-D-aspartate receptor-mediated Src and extracellular signal-regulated kinase 1/2 activation and protection of primary neurons from ischemic cell death	FASEB JOURNAL			English	Article						preconditioning; neuroprotection; neuronal apoptosis; membrane rafts; ionotropic glutamate receptors; colocalization	LONG-TERM POTENTIATION; PROTEIN-COUPLED RECEPTOR; TYROSINE PHOSPHORYLATION; NMDA RECEPTORS; HIPPOCAMPAL-NEURONS; LIPID RAFTS; SCAFFOLDING DOMAIN; PC12 CELLS; IN-VITRO; RAT	N-Methyl-D-aspartate (NMDA) receptor (NMDAR) activation and downstream signaling are important for neuronal function. Activation of prosurvival Src family kinases and extracellular signal-regulated kinase (ERK) 1/2 is initiated by NMDAR activation, but the cellular organization of these kinases in relation to NMDARs is not entirely clear. We hypothesized that caveolin-1 scaffolds and coordinates protein complexes involved in NMDAR signaling and that this organization is necessary for neuronal preconditioning, whereby NMDAR activation protects neurons from subsequent ischemic cell death. We found that sublethal ischemia (SLI) or preconditioning via NMDA treatment of primary cortical neurons from neonatal rats or mice increases expression of phosphorylated (P) caveofin-1, P-Src, and P-ERK1/2. The NMDAR antagonist, MK801, or the Src inhibitor, PP2, attenuated SLI-induced preconditioning. NMDAR2B distributed to buoyant fractions and heavy fractions, partially colocalized with caveolin-1 and the membrane raft marker, cholera toxin B. Cultures of primary neurons treated with caveolin-1 small interfering RNA or from caveolin-1(-/-) mice lacked the NMDA-mediated increase in P-Src and P-ERK, as well as SLI- and NMDA-induced preconditioning. Adenovirally mediated expression of caveolin-1 in neurons from caveolin-1(-/-) mice restored NMDA-mediated enhancement of P-Src and P-ERK1/2, redistributed NMDAR2B to buoyant fractions, and enhanced NMDAR2B localization to membrane rafts. We conclude that caveolin-1, perhaps via its ability to scaffold key signaling components, is essential for NMDAR localization to neuronal membrane rafts, NMDAR/Src tyrosine kinase family/ERK signaling, and protection of neurons from ischemic injury and cell death.	[Tsutsumi, Yasuo M.; Insel, Paul A.; Roth, David M.; Drummond, John C.; Patel, Piyush M.] Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA; [Head, Brian P.; Patel, Hemal H.; Tsutsumi, Yasuo M.; Hu, Yue; Mejia, Trisha; Roth, David M.; Drummond, John C.; Patel, Piyush M.] Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92093 USA; [Insel, Paul A.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Mora, Rosalia C.] Cornell Univ, Weill Med Coll, Dept Ophthalmol, Margaret Dyson Vis Res Inst, Ithaca, NY USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; University of California System; University of California San Diego; Cornell University	Patel, PM (corresponding author), Vet Affairs San Diego Healthcare Syst, 3350 La Jolla Village Dr, San Diego, CA 92161 USA.	ppatel@ucsd.edu	Tsutsumi, Yasuo M/G-1972-2012; Patel, Hemal/C-7325-2019	Patel, Hemal/0000-0001-6722-9625	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066232, R01GM034107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047570] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 66232, GM 34107] Funding Source: Medline; NINDS NIH HHS [NS 047570] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Augustine GJ, 2003, NEURON, V40, P331, DOI 10.1016/S0896-6273(03)00639-1; BEHNISCH T, 1995, NEUROSCI LETT, V192, P185, DOI 10.1016/0304-3940(95)11641-9; Besshoh S, 2005, J NEUROCHEM, V93, P186, DOI 10.1111/j.1471-4159.2004.03009.x; Bu J, 2003, J NEUROSCI RES, V72, P185, DOI 10.1002/jnr.10556; Cao HM, 2004, EXP CELL RES, V294, P159, DOI 10.1016/j.yexcr.2003.11.010; Cao HM, 2002, J BIOL CHEM, V277, P8771, DOI 10.1074/jbc.C100661200; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; CHRISTIE BR, 1995, J NEUROPHYSIOL, V73, P2553, DOI 10.1152/jn.1995.73.6.2553; CHUN MY, 1994, P NATL ACAD SCI USA, V91, P11728, DOI 10.1073/pnas.91.24.11728; Cohen AW, 2003, AM J PHYSIOL-CELL PH, V284, pC457, DOI 10.1152/ajpcell.00380.2002; COLLINGRIDGE GL, 1995, TRENDS NEUROSCI, V18, P54, DOI 10.1016/0166-2236(95)93868-X; Couet J, 1997, J BIOL CHEM, V272, P30429, DOI 10.1074/jbc.272.48.30429; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; Craig AM, 2006, TRENDS NEUROSCI, V29, P8, DOI 10.1016/j.tins.2005.11.002; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; Dingledine R, 1999, PHARMACOL REV, V51, P7; Galbiati F, 1998, P NATL ACAD SCI USA, V95, P10257, DOI 10.1073/pnas.95.17.10257; Gaudreault SB, 2005, J NEUROCHEM, V92, P831, DOI 10.1111/j.1471-4159.2004.02917.x; Gaudreault SB, 2004, J BIOL CHEM, V279, P356, DOI 10.1074/jbc.M304777200; Gidday JM, 1999, J CEREBR BLOOD F MET, V19, P331, DOI 10.1097/00004647-199903000-00011; GLENNEY JR, 1989, J BIOL CHEM, V264, P20163; Grabb MC, 1999, J NEUROSCI, V19, P1657; Head BP, 2005, J BIOL CHEM, V280, P31036, DOI 10.1074/jbc.M502540200; Head BP, 2007, TRENDS CELL BIOL, V17, P51, DOI 10.1016/j.tcb.2006.11.008; Head BP, 2006, J BIOL CHEM, V281, P26391, DOI 10.1074/jbc.M602577200; Hell JW, 1996, P NATL ACAD SCI USA, V93, P3362, DOI 10.1073/pnas.93.8.3362; HEURTEAUX C, 1995, P NATL ACAD SCI USA, V92, P4666, DOI 10.1073/pnas.92.10.4666; Hibbert AP, 2006, MOL CELL NEUROSCI, V32, P387, DOI 10.1016/j.mcn.2006.06.001; HUETTNER JE, 1986, J NEUROSCI, V6, P3044; Jasmin JF, 2007, CIRC RES, V100, P721, DOI 10.1161/01.RES.0000260180.42709.29; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kamiguchi H, 2006, J NEUROCHEM, V98, P330, DOI 10.1111/j.1471-4159.2006.03888.x; Kang MJ, 2006, EXP MOL MED, V38, P126, DOI 10.1038/emm.2006.16; Li JH, 1998, EUR J NEUROSCI, V10, P1704, DOI 10.1046/j.1460-9568.1998.00169.x; Lisanti Michael P., 1994, Trends in Cell Biology, V4, P231, DOI 10.1016/0962-8924(94)90114-7; Lu YM, 1998, SCIENCE, V279, P1363, DOI 10.1126/science.279.5355.1363; MCDONALD JW, 1990, BRAIN RES REV, V15, P41, DOI 10.1016/0165-0173(90)90011-C; MOON IS, 1994, P NATL ACAD SCI USA, V91, P3954, DOI 10.1073/pnas.91.9.3954; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Nakazawa T, 2001, J BIOL CHEM, V276, P693, DOI 10.1074/jbc.M008085200; Ostrom RS, 2002, MOL PHARMACOL, V62, P983, DOI 10.1124/mol.62.5.983; Papadia S, 2005, J NEUROSCI, V25, P4279, DOI 10.1523/JNEUROSCI.5019-04.2005; Patel HH, 2007, FASEB J, V21, P1565, DOI 10.1096/fj.06-7719com; Peiro S, 2000, J BIOL CHEM, V275, P37846, DOI 10.1074/jbc.M000487200; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Raymond CR, 2007, TRENDS NEUROSCI, V30, P167, DOI 10.1016/j.tins.2007.01.007; Raymond CR, 2006, J PHYSIOL-LONDON, V570, P97, DOI 10.1113/jphysiol.2005.098947; Rostas JAP, 1996, P NATL ACAD SCI USA, V93, P10452, DOI 10.1073/pnas.93.19.10452; Rubino A, 2000, TRENDS PHARMACOL SCI, V21, P225, DOI 10.1016/S0165-6147(00)01483-8; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Sedding DG, 2005, CIRC RES, V96, P635, DOI 10.1161/01.RES.0000160610.61306.0f; Shack S, 2003, MOL CELL BIOL, V23, P2407, DOI 10.1128/MCB.23.7.2407-2414.2003; Soriano FX, 2006, J NEUROSCI, V26, P4509, DOI 10.1523/JNEUROSCI.0455-06.2006; Sutton MA, 2005, J NEUROBIOL, V64, P116, DOI 10.1002/neu.20152; Tovar KR, 1999, J NEUROSCI, V19, P4180; Trushina E, 2006, BEHAV BRAIN RES, V172, P24, DOI 10.1016/j.bbr.2006.04.024; Volonte D, 2001, J BIOL CHEM, V276, P8094, DOI 10.1074/jbc.M009245200; Washbourne P, 2002, NAT NEUROSCI, V5, P751, DOI 10.1038/nn883; Yang M, 2001, J NEUROCHEM, V77, P580, DOI 10.1046/j.1471-4159.2001.00255.x; Yu XM, 1997, SCIENCE, V275, P674, DOI 10.1126/science.275.5300.674; Yuen EY, 2005, J BIOL CHEM, V280, P29420, DOI 10.1074/jbc.M504499200; Zinchuk O, 2004, CELL TISSUE RES, V317, P265, DOI 10.1007/s00441-004-0919-1	63	94	96	3	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2008	22	3					828	840		10.1096/fj.07-9299com	http://dx.doi.org/10.1096/fj.07-9299com			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	276LQ	17905724				2022-12-25	WOS:000254143700021
J	Sklan, EH; Serrano, RL; Einav, S; Pfeffer, SR; Lambright, DG; Glenn, JS				Sklan, Ella H.; Serrano, Ramon L.; Einav, Shirit; Pfeffer, Suzanne R.; Lambright, David G.; Glenn, Jeffrey S.			TBC1D20 is a Rab1 GTPase-activating protein that mediates hepatitis C virus replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA REPLICATION; ENDOPLASMIC-RETICULUM; LEGIONELLA-PNEUMOPHILA; MEMBRANE ASSOCIATION; VESICULAR TRANSPORT; GOLGI COMPARTMENTS; VIRAL REPLICATION; NS5A PROTEIN; DOMAIN; IDENTIFICATION	Like other viruses, productive hepatitis C virus (HCV) infection depends on certain critical host factors. We have recently shown that an interaction between HCV nonstructural protein NS5A and a host protein, TBC1D20, is necessary for efficient HCV replication. TBC1D20 contains a TBC (Tre-2, Bub2, and Cdc16) domain present in most known Rab GTPase-activating proteins ( GAPs). The latter are master regulators of vesicular membrane transport, as they control the activity of membrane-associated Rab proteins. To better understand the role of the NS5A-TBC1D20 interaction in the HCV life cycle, we used a biochemical screen to identify the TBC1D20 Rab substrate. TBC1D20 was found to be the first known GAP for Rab1, which is implicated in the regulation of anterograde traffic between the endoplasmic reticulum and the Golgi complex. Mutation of amino acids implicated in Rab GTPase activation by other TBC domain-containing GAPs abrogated the ability of TBC1D20 to activate Rab1 GTPase. Overexpression of TBC1D20 blocked the transport of exogenous vesicular stomatitis virus G protein from the endoplasmic reticulum, validating the involvement of TBC1D20 in this pathway. Rab1 depletion significantly decreased HCV RNA levels, suggesting a role for Rab1 in HCV replication. These results highlight a novel mechanism by which viruses can hijack host cell machinery and suggest an attractive model whereby the NS5A-TBC1D20 interaction may promote viral membrane-associated RNA replication.	Stanford Univ, Sch Med, Div Gastroenterol & Hepatol, Palo Alto, CA 94304 USA; Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; Vet Affairs Med Ctr, Palo Alto, CA 94304 USA; Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Program Mol Med, Worcester, MA 01605 USA	Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Massachusetts System; University of Massachusetts Worcester	Glenn, JS (corresponding author), Stanford Univ, Sch Med, Div Gastroenterol & Hepatol, CCSR Bldg,Rm 3115,269 Campus Dr, Palo Alto, CA 94304 USA.	jeffrey.glenn@stanford.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK037332, R01DK064223] Funding Source: NIH RePORTER; NIDDK NIH HHS [R37-DK37332, R01-DK064223] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Albert S, 1999, EMBO J, V18, P5216, DOI 10.1093/emboj/18.19.5216; Allan BB, 2000, SCIENCE, V289, P444, DOI 10.1126/science.289.5478.444; Alvarez C, 2003, MOL BIOL CELL, V14, P2116, DOI 10.1091/mbc.E02-09-0625; Appel N, 2005, J VIROL, V79, P3187, DOI 10.1128/JVI.79.5.3187-3194.2005; Bernards A, 2004, TRENDS CELL BIOL, V14, P377, DOI 10.1016/j.tcb.2004.05.003; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Brass V, 2002, J BIOL CHEM, V277, P8130, DOI 10.1074/jbc.M111289200; Cho NJ, 2007, J VIROL, V81, P6682, DOI 10.1128/JVI.02783-06; Cuif MH, 1999, EMBO J, V18, P1772, DOI 10.1093/emboj/18.7.1772; Dabbeekeh JTS, 2007, ONCOGENE, V26, P2804, DOI 10.1038/sj.onc.1210081; De Antoni A, 2002, J BIOL CHEM, V277, P41023, DOI 10.1074/jbc.M205783200; Du LL, 1998, J BIOL CHEM, V273, P3253, DOI 10.1074/jbc.273.6.3253; Du LL, 2001, MOL BIOL CELL, V12, P1215, DOI 10.1091/mbc.12.5.1215; Einav S, 2004, J VIROL, V78, P11288, DOI 10.1128/JVI.78.20.11288-11295.2004; Elazar M, 2003, J VIROL, V77, P6055, DOI 10.1128/JVI.77.10.6055-6061.2003; Evans MJ, 2004, P NATL ACAD SCI USA, V101, P13038, DOI 10.1073/pnas.0405152101; Fuchs E, 2007, J CELL BIOL, V177, P1133, DOI 10.1083/jcb.200612068; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Fukui K, 1997, J BIOL CHEM, V272, P4655, DOI 10.1074/jbc.272.8.4655; Haas AK, 2005, NAT CELL BIOL, V7, P887, DOI 10.1038/ncb1290; Haas AK, 2007, J CELL SCI, V120, P2997, DOI 10.1242/jcs.014225; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Itoh T, 2006, J BIOL CHEM, V281, P31823, DOI 10.1074/jbc.M603808200; Konan KV, 2003, J VIROL, V77, P7843, DOI 10.1128/JVI.77.14.7843-7855.2003; Krishnan MN, 2007, J VIROL, V81, P4881, DOI 10.1128/JVI.02210-06; Lanzetti L, 2000, NATURE, V408, P374, DOI 10.1038/35042605; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Machner MP, 2006, DEV CELL, V11, P47, DOI 10.1016/j.devcel.2006.05.013; Miinea CP, 2005, BIOCHEM J, V391, P87, DOI 10.1042/BJ20050887; Monetta P, 2007, MOL BIOL CELL, V18, P2400, DOI 10.1091/mbc.E06-11-1005; Moradpour D, 2003, ANTIVIR RES, V60, P103, DOI 10.1016/j.antiviral.2003.08.017; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Murata T, 2006, NAT CELL BIOL, V8, P971, DOI 10.1038/ncb1463; Neddermann P, 1999, J VIROL, V73, P9984, DOI 10.1128/JVI.73.12.9984-9991.1999; NUOFFER C, 1994, J CELL BIOL, V125, P225, DOI 10.1083/jcb.125.2.225; Pan XJ, 2006, NATURE, V442, P303, DOI 10.1038/nature04847; Pei L, 2002, CANCER RES, V62, P5420; Penin F, 2004, J BIOL CHEM, V279, P40835, DOI 10.1074/jbc.M404761200; Pfeffer S, 2005, NAT CELL BIOL, V7, P856, DOI 10.1038/ncb0905-856; Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500; PLUTNER H, 1991, J CELL BIOL, V115, P31, DOI 10.1083/jcb.115.1.31; REED L. J., 1938, AMER JOUR HYG, V27, P493; Shi ST, 2002, VIROLOGY, V292, P198, DOI 10.1006/viro.2001.1225; Sklan EH, 2007, J VIROL, V81, P11096, DOI 10.1128/JVI.01249-07; Stone M, 2007, J VIROL, V81, P4551, DOI 10.1128/JVI.01366-06; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; TANJI Y, 1995, J VIROL, V69, P3980, DOI 10.1128/JVI.69.7.3980-3986.1995; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; Tu H, 1999, VIROLOGY, V263, P30, DOI 10.1006/viro.1999.9893; Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233; Williams R, 2006, HEPATOLOGY, V44, P521, DOI 10.1002/hep.21347; WILSON BS, 1994, J CELL BIOL, V125, P557, DOI 10.1083/jcb.125.3.557; Xue Q, 2007, ARCH VIROL, V152, P955, DOI 10.1007/s00705-006-0905-x; Zech B, 2003, J GEN VIROL, V84, P555, DOI 10.1099/vir.0.18801-0; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang XM, 2005, BIOCHEM BIOPH RES CO, V335, P154, DOI 10.1016/j.bbrc.2005.07.070	56	89	95	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36354	36361		10.1074/jbc.M705221200	http://dx.doi.org/10.1074/jbc.M705221200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17901050	hybrid			2022-12-25	WOS:000251458300026
J	Zapata, A; Kivell, B; Han, Y; Javitch, JA; Bolan, EA; Kuraguntla, D; Jaligam, V; Oz, M; Jayanthi, LD; Samuvel, DJ; Ramamoorthy, S; Shippenberg, TS				Zapata, Agustin; Kivell, Bronwyn; Han, Yang; Javitch, Jonathan A.; Bolan, Elizabeth A.; Kuraguntla, David; Jaligam, Vanaja; Oz, Murat; Jayanthi, Lankupalle D.; Samuvel, Devadoss J.; Ramamoorthy, Sammanda; Shippenberg, Toni S.			Regulation of dopamine transporter function and cell surface expression by D3 dopamine receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; ELEMENT-BINDING PROTEIN; WILD-TYPE MICE; D-3 RECEPTOR; IN-VIVO; PHOSPHATIDYLINOSITOL 3-KINASE; DEPENDENT MECHANISM; PHORBOL ESTERS; NEUROTRANSMITTER TRANSPORTERS; NOREPINEPHRINE TRANSPORTER	D-3 dopamine receptors are expressed by dopamine neurons and are implicated in the modulation of presynaptic dopamine neurotransmission. The mechanisms underlying this modulation remain ill defined. The dopamine transporter, which terminates dopamine transmission via reuptake of released neurotransmitter, is regulated by receptor- and second messenger-linked signaling pathways. Whether D3 receptors regulate dopamine transporter function is unknown. We addressed this issue using a fluorescent imaging technique that permits real time quantification of dopamine transporter function in living single cells. Accumulation of the fluorescent dopamine transporter substrate trans-4-[4-(dimethylamino) styryl]-1-methylpyridinium (ASP(+)) in human embryonic kidney cells expressing human dopamine transporter was saturable and temperature-dependent. In cells co-expressing dopamine transporter and D3 receptors, the D2/D3 agonist quinpirole produced a rapid, concentration-dependent, and pertussis toxin-sensitive increase of ASP(+) uptake. Similar agonist effects were observed in Neuro2A cells and replicated in human embryonic kidney cells using a radioligand uptake assay in which binding to and activation of D3 receptors by [H-3] dopamine was prevented. D3 receptor stimulation activated phosphoinositide 3-kinase and MAPK. Inhibition of either kinase prevented the quinpirole-induced increase in uptake. D3 receptor activation differentially affected dopamine transporter function and subcellular distribution depending on the duration of agonist exposure. Biotinylation experiments revealed that the rapid increase of uptake was associated with increased cell surface and decreased intracellular expression and increased dopamine transporter exocytosis. In contrast, prolonged agonist exposure reduced uptake and transporter cell surface expression. These results demonstrate that D3 receptors regulate dopamine transporter function and identify a novel mechanism by which D3 receptors regulate extracellular dopamine concentrations.	NIDA, Integrat Neurosci Sect, NIH, Intramural Res Program,Dept Hlth & Human Serv, Baltimore, MD 21224 USA; Columbia Univ, Coll Phys & Surg, Ctr Mol Recognit, Dept Psychiat, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Ctr Mol Recognit, Dept Pharmacol, New York, NY 10032 USA; Med Univ S Carolina, Dept Neurosci, Div Neurosci Res, Charleston, SC 29425 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); Columbia University; Columbia University; Medical University of South Carolina	Shippenberg, TS (corresponding author), NIDA, Integrat Neurosci Sect, NIH, Intramural Res Program,Dept Hlth & Human Serv, 5500 Nathan Shock Dr, Baltimore, MD 21224 USA.	tshippen@intra.nida.nih.gov	Oz, Murat/E-2148-2012; Kivell, Bronwyn M/P-3140-2014	Kivell, Bronwyn M/0000-0001-9699-553X; Javitch, Jonathan/0000-0001-7395-2967	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054137, R01MH062612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA022413, Z01DA000538, R01DA011495, P50DA015369] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIDA NIH HHS [P50DA015369, DA11495, K05 DA022413] Funding Source: Medline; NIGMS NIH HHS [GM081054] Funding Source: Medline; NIMH NIH HHS [MH54137, MH062612, MH57324] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; Apparsundaram S, 2001, J PHARMACOL EXP THER, V299, P666; Batchelor M, 1998, J NEUROSCI, V18, P10304; Beom SR, 2004, J BIOL CHEM, V279, P28304, DOI 10.1074/jbc.M403899200; Bolan EA, 2007, MOL PHARMACOL, V71, P1222, DOI 10.1124/mol.106.027763; Boulay D, 1999, NEUROPHARMACOLOGY, V38, P555, DOI 10.1016/S0028-3908(98)00213-5; Brami-Cherrier K, 2002, J NEUROSCI, V22, P8911; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Carvelli L, 2002, J NEUROCHEM, V81, P859, DOI 10.1046/j.1471-4159.2002.00892.x; CASS WA, 1994, NEUROSCI LETT, V176, P259, DOI 10.1016/0304-3940(94)90096-5; Cervinski MA, 2005, J BIOL CHEM, V280, P40442, DOI 10.1074/jbc.M501969200; Copeland BJ, 1996, J PHARMACOL EXP THER, V277, P1527; Cussac D, 1999, MOL PHARMACOL, V56, P1025, DOI 10.1124/mol.56.5.1025; Depoortere R, 1999, PSYCHOPHARMACOLOGY, V147, P20, DOI 10.1007/s002130051133; Dickinson SD, 1999, J NEUROCHEM, V72, P148, DOI 10.1046/j.1471-4159.1999.0720148.x; Ekman A, 1998, N-S ARCH PHARMACOL, V358, P342, DOI 10.1007/PL00005263; Elmhurst JL, 2000, MOL BRAIN RES, V80, P63, DOI 10.1016/S0169-328X(00)00120-0; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Foster JD, 2002, J BIOL CHEM, V277, P25178, DOI 10.1074/jbc.M200294200; Fournier KM, 2004, J BIOL CHEM, V279, P34505, DOI 10.1074/jbc.M404032200; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Granas C, 2003, J BIOL CHEM, V278, P4990, DOI 10.1074/jbc.M205058200; Gulley JM, 2003, EUR J PHARMACOL, V479, P139, DOI 10.1016/j.ejphar.2003.08.064; Huff RA, 1997, J NEUROCHEM, V68, P225; Jayanthi LD, 2006, J BIOL CHEM, V281, P23326, DOI 10.1074/jbc.M601156200; Jayanthi LD, 2004, J BIOL CHEM, V279, P19315, DOI 10.1074/jbc.M311172200; Johnson LA, 2005, NEUROPHARMACOLOGY, V49, P750, DOI 10.1016/j.neuropharm.2005.08.018; Joseph JD, 2002, NEUROSCIENCE, V112, P39, DOI 10.1016/S0306-4522(02)00067-2; Joyce JN, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-22; Joyce JN, 2005, DRUG DISCOV TODAY, V10, P917, DOI 10.1016/S1359-6446(05)03491-4; Joyce JN, 2001, PHARMACOL THERAPEUT, V90, P231, DOI 10.1016/S0163-7258(01)00139-5; Kahlig KM, 2004, J BIOL CHEM, V279, P8966, DOI 10.1074/jbc.M303976200; Kelkar DA, 2007, BBA-BIOMEMBRANES, V1768, P2011, DOI 10.1016/j.bbamem.2007.05.011; Khoshbouei H, 2003, J BIOL CHEM, V278, P12070, DOI 10.1074/jbc.M212815200; Kim KM, 2001, J BIOL CHEM, V276, P37409, DOI 10.1074/jbc.M106728200; KITAYAMA S, 1994, EUR J PHARM-MOLEC PH, V268, P115, DOI 10.1016/0922-4106(94)90180-5; KIVELL BM, 2004, SOC NEUROSCI ABSTR V; Koeltzow TE, 1998, J NEUROSCI, V18, P2231; Le Foll B, 2000, EUR PSYCHIAT, V15, P140, DOI 10.1016/S0924-9338(00)00219-4; Lee-Kwon W, 2003, J BIOL CHEM, V278, P16494, DOI 10.1074/jbc.M300580200; Li LB, 2004, J BIOL CHEM, V279, P21012, DOI 10.1074/jbc.M311972200; Lin ZC, 2003, J BIOL CHEM, V278, P20162, DOI 10.1074/jbc.M209584200; Loder MK, 2003, J BIOL CHEM, V278, P22168, DOI 10.1074/jbc.M301845200; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Mason JN, 2005, J NEUROSCI METH, V143, P3, DOI 10.1016/j.jneumeth.2004.09.028; Mayfield RD, 2001, MOL PHARMACOL, V59, P113, DOI 10.1124/mol.59.1.113; MEIERGERD SM, 1993, J NEUROCHEM, V61, P764; Melikian HE, 2004, PHARMACOL THERAPEUT, V104, P17, DOI 10.1016/j.pharmthera.2004.07.006; Melikian HE, 1999, J NEUROSCI, V19, P7699; Moron JA, 2003, J NEUROSCI, V23, P8480; NEUMEYER JL, 1992, J MED CHEM, V35, P1466, DOI 10.1021/jm00086a016; Neve KA, 2004, J RECEPT SIG TRANSD, V24, P165, DOI 10.1081/LRST-200029981; Prasad BM, 2001, J NEUROSCI, V21, P7561, DOI 10.1523/JNEUROSCI.21-19-07561.2001; Robbins AK, 1998, BIOTECHNIQUES, V25, P240, DOI 10.2144/98252st04; Samuvel DJ, 2005, J NEUROSCI, V25, P29, DOI 10.1523/JNEUROSCI.3754-04.2005; Saunders C, 2000, P NATL ACAD SCI USA, V97, P6850, DOI 10.1073/pnas.110035297; Schwartz JC, 2000, BRAIN RES REV, V31, P277, DOI 10.1016/S0165-0173(99)00043-0; Schwartz JW, 2003, J BIOL CHEM, V278, P9768, DOI 10.1074/jbc.M209824200; SOKOLOFF P, 1990, NATURE, V347, P146, DOI 10.1038/347146a0; STRYER L, 1986, ANNU REV CELL BIOL, V2, P391, DOI 10.1146/annurev.cb.02.110186.002135; Tepper JM, 1997, J NEUROSCI, V17, P2519; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Versteeg HH, 2000, BIOCHEM J, V350, P717, DOI 10.1042/0264-6021:3500717; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wang D, 2005, J BIOL CHEM, V280, P18703, DOI 10.1074/jbc.M500381200; Witkin JM, 2004, J PHARMACOL EXP THER, V308, P957, DOI 10.1124/jpet.103.059980; Xu M, 1999, SYNAPSE, V31, P210, DOI 10.1002/(SICI)1098-2396(19990301)31:3<210::AID-SYN6>3.3.CO;2-S; Zahniser NR, 2001, PHARMACOL THERAPEUT, V92, P21, DOI 10.1016/S0163-7258(01)00158-9; Zapata A, 2002, J NEUROCHEM, V81, P1035, DOI 10.1046/j.1471-4159.2002.00893.x; Zapata A, 2001, NEUROPHARMACOLOGY, V41, P351, DOI 10.1016/S0028-3908(01)00069-7	71	81	81	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35842	35854		10.1074/jbc.M611758200	http://dx.doi.org/10.1074/jbc.M611758200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17923483	hybrid			2022-12-25	WOS:000251458100046
J	Mancuso, DJ; Sims, HF; Han, XL; Jenkins, CM; Guan, SP; Yang, K; Moon, SH; Pietka, T; Abumrad, NA; Schlesinger, PH; Gross, RW				Mancuso, David J.; Sims, Harold F.; Han, Xianlin; Jenkins, Christopher M.; Guan, Shao Ping; Yang, Kui; Moon, Sung Ho; Pietka, Terri; Abumrad, Nada A.; Schlesinger, Paul H.; Gross, Richard W.			Genetic ablation of calcium-independent phospholipase A(2)gamma leads to alterations in mitochondrial lipid metabolism and function resulting in a deficient mitochondrial bioenergetic phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C; SHOTGUN LIPIDOMICS; CALORIC RESTRICTION; SIGNALING PATHWAYS; BARTH-SYNDROME; A(2) IPLA(2); CARDIOLIPIN; BRAIN; IDENTIFICATION; ACCUMULATION	Previously, we identified a novel calcium-independent phospholipase, designated calcium-independent phospholipase A(2) gamma (iPLA(2)gamma),which possesses dual mitochondrial and peroxisomal subcellular localization signals. To identify the roles of iPLA(2)gamma in cellular bioenergetics, we generated mice null for the iPLA(2)gamma gene by eliminating the active site of the enzyme through homologous recombination. Mice null for iPLA(2)gamma display multiple bioenergetic dysfunctional phenotypes, including 1) growth retardation, 2) cold intolerance, 3) reduced exercise endurance, 4) greatly increased mortality from cardiac stress after transverse aortic constriction, 5) abnormal mitochondrial function with a 65% decrease in ascorbate-induced Complex IV-mediated oxygen consumption, and 6) a reduction in myocardial cardiolipin content accompanied by an altered cardiolipin molecular species composition. We conclude that iPLA(2)gamma is essential for maintaining efficient bioenergetic mitochondrial function through tailoring mitochondrial membrane lipid metabolism and composition.	Washington Univ, Sch Med, Dept Med, Div Bioorgan Chem & Mol Pharmacol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, Div Nutr Sci, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Washington Univ, Dept Chem, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Gross, RW (corresponding author), Washington Univ, Sch Med, Dept Med, Div Bioorgan Chem & Mol Pharmacol, St Louis, MO 63110 USA.	rgross@wustl.edu	Schlesinger, Paul H/C-6049-2012		NHLBI NIH HHS [5P01HL57278-10, R01 HL041250, P01 HL057278-10, P01 HL057278] Funding Source: Medline; NIDDK NIH HHS [R01 DK033301, P30 DK056341-06, P30 DK056341-07, P30 DK056341, DK56351] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057278, R01HL041250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033301, P30DK056341] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bao SZ, 2004, J BIOL CHEM, V279, P38194, DOI 10.1074/jbc.M406489200; BOLHUIS PA, 1991, AM J HUM GENET, V48, P481; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Breen EP, 2006, J BIOL CHEM, V281, P2114, DOI 10.1074/jbc.M511575200; Brustovetsky T, 2005, J NEUROCHEM, V94, P980, DOI 10.1111/j.1471-4159.2005.03248.x; Budnik LT, 2002, BIOL REPROD, V67, P935, DOI 10.1095/biolreprod.101.003087; Budnik Lygia T, 2003, Reprod Biol Endocrinol, V1, P37, DOI 10.1186/1477-7827-1-37; Chen JL, 2005, J BIOL CHEM, V280, P25396, DOI 10.1074/jbc.M413948200; Dahlberg M, 2007, J PHYS CHEM B, V111, P7194, DOI 10.1021/jp071954f; DiMarzo V, 1996, BIOCHEM BIOPH RES CO, V227, P281, DOI 10.1006/bbrc.1996.1501; Duchen MR, 2004, DIABETES, V53, pS96, DOI 10.2337/diabetes.53.2007.S96; Filosto M, 2007, ACTA NEUROL SCAND, V115, P211, DOI 10.1111/j.1600-0404.2006.00777.x; Fujishima H, 1999, P NATL ACAD SCI USA, V96, P4803, DOI 10.1073/pnas.96.9.4803; Gadd ME, 2006, J BIOL CHEM, V281, P6931, DOI 10.1074/jbc.M510845200; Garlid KD, 1996, J BIOL CHEM, V271, P2615, DOI 10.1074/jbc.271.5.2615; Garrido C, 2006, CELL DEATH DIFFER, V13, P1423, DOI 10.1038/sj.cdd.4401950; Goldenthal MJ, 2004, MOL CELL BIOCHEM, V262, P1, DOI 10.1023/B:MCBI.0000038228.85494.3b; Gomez B, 1999, BIOCHEMISTRY-US, V38, P9031, DOI 10.1021/bi990603r; Haber EP, 2003, J CELL PHYSIOL, V194, P1, DOI 10.1002/jcp.10187; Han XL, 2007, BIOCHEMISTRY-US, V46, P6417, DOI 10.1021/bi7004015; Han XL, 2000, BIOCHEM J, V352, P79, DOI 10.1042/0264-6021:3520079; Han XL, 2006, J LIPID RES, V47, P864, DOI 10.1194/jlr.D500044-JLR200; Han XL, 2005, EXPERT REV PROTEOMIC, V2, P253, DOI 10.1586/14789450.2.2.253; Han XL, 2004, BIOCHEMISTRY-US, V43, P15584, DOI 10.1021/bi048307o; Han XL, 2005, MASS SPECTROM REV, V24, P367, DOI 10.1002/mas.20023; Heath-Engel HM, 2006, BBA-MOL CELL RES, V1763, P549, DOI 10.1016/j.bbamcr.2006.02.006; Huss JM, 2005, J CLIN INVEST, V115, P547, DOI 10.1172/JCI200524405; Kinsey GR, 2007, AM J PHYSIOL-RENAL, V292, pF853, DOI 10.1152/ajprenal.00318.2006; Klingenspor M, 2003, EXP PHYSIOL, V88, P141, DOI 10.1113/eph8802508; Lelliott CJ, 2006, PLOS BIOL, V4, P2042, DOI 10.1371/journal.pbio.0040369; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; Mancuso DJ, 2007, J BIOL CHEM, V282, P9216, DOI 10.1074/jbc.M607307200; Mancuso DJ, 2004, EUR J BIOCHEM, V271, P4709, DOI 10.1111/j.1432-1033.2004.04435.x; Mancuso DJ, 2000, J BIOL CHEM, V275, P9937, DOI 10.1074/jbc.275.14.9937; Marin-Garcia J, 2004, J MOL MED, V82, P565, DOI 10.1007/s00109-004-0567-7; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; McFarland R, 2007, CURR TOP DEV BIOL, V77, P113, DOI 10.1016/S0070-2153(06)77005-3; Mingrone G, 2004, ANN NY ACAD SCI, V1033, P99, DOI 10.1196/annals.1320.009; Monemdjou S, 2000, AM J PHYSIOL-ENDOC M, V279, pE941, DOI 10.1152/ajpendo.2000.279.4.E941; Mozo J, 2005, BIOSCIENCE REP, V25, P227, DOI 10.1007/s10540-005-2887-4; Nedergaard J, 2001, BIOCHEM SOC T, V29, P756; Nicholls D.G., 2001, BIOENERGETICS, V3; Pete MJ, 1996, J BIOL CHEM, V271, P18114, DOI 10.1074/jbc.271.30.18114; PINHEIRO TJT, 1994, BIOCHEMISTRY-US, V33, P2459, DOI 10.1021/bi00175a014; Porter RK, 2006, BBA-BIOENERGETICS, V1757, P446, DOI 10.1016/j.bbabio.2006.04.012; Ramanadham S, 2004, BIOCHEMISTRY-US, V43, P918, DOI 10.1021/bi035536m; Ricci JE, 2003, J CELL BIOL, V160, P65, DOI 10.1083/jcb.200208089; Ricquier D, 2005, P NUTR SOC, V64, P47, DOI 10.1079/PNS2004408; Ritz P, 2005, CURR OPIN CLIN NUTR, V8, P415, DOI 10.1097/01.mco.0000172582.86890.19; ROBINSON NC, 1993, J BIOENERG BIOMEMBR, V25, P153, DOI 10.1007/BF00762857; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Rosenberger TA, 2003, J LIPID RES, V44, P109, DOI 10.1194/jlr.M200298-JLR200; Schlame M, 2005, CHEM PHYS LIPIDS, V138, P38, DOI 10.1016/j.chemphyslip.2005.08.002; Schlame M, 2002, ANN NEUROL, V51, P634, DOI 10.1002/ana.10176; Schlame M, 2006, FEBS LETT, V580, P5450, DOI 10.1016/j.febslet.2006.07.022; Seleznev K, 2006, J BIOL CHEM, V281, P22275, DOI 10.1074/jbc.M604330200; Shinzawa-Itoh K, 2007, EMBO J, V26, P1713, DOI 10.1038/sj.emboj.7601618; Siciliano G, 2007, BIOSCIENCE REP, V27, P53, DOI 10.1007/s10540-007-9037-0; SIEGEL DP, 1984, BIOPHYS J, V45, P399, DOI 10.1016/S0006-3495(84)84164-8; SIL VAJE, 2006, PHYS REV, V86, P435; SKULACHEV VP, 1991, FEBS LETT, V294, P158, DOI 10.1016/0014-5793(91)80658-P; Sonoda J, 2007, P NATL ACAD SCI USA, V104, P5223, DOI 10.1073/pnas.0611623104; Spencer CT, 2006, PEDIATRICS, V118, pE337, DOI 10.1542/peds.2005-2667; Stewart A, 2002, J BIOL CHEM, V277, P29526, DOI 10.1074/jbc.M204856200; Su X, 2005, BIOCHEMISTRY-US, V44, P5234, DOI 10.1021/bi047773a; Tolwani RJ, 2005, PLOS GENET, V1, P205, DOI 10.1371/journal.pgen.0010023; Tsukihara T, 2003, P NATL ACAD SCI USA, V100, P15304, DOI 10.1073/pnas.2635097100; Turk J, 2004, CAN J PHYSIOL PHARM, V82, P824, DOI 10.1139/Y04-064; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Vercesi AE, 2006, FRONT BIOSCI-LANDMRK, V11, P2554, DOI 10.2741/1990; Villena JA, 2007, P NATL ACAD SCI USA, V104, P1418, DOI 10.1073/pnas.0607696104; Vreken P, 2000, BIOCHEM BIOPH RES CO, V279, P378, DOI 10.1006/bbrc.2000.3952; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wallace DC, 2001, AM J MED GENET, V106, P71, DOI 10.1002/ajmg.1393; Wallace DC, 2001, MENT RETARD DEV D R, V7, P158, DOI 10.1002/mrdd.1023; Wallace Douglas C, 2002, Methods Mol Biol, V197, P3, DOI 10.1385/1-59259-284-8:003; Wang ZP, 2005, J BIOL CHEM, V280, P6840, DOI 10.1074/jbc.M405287200; Williams SD, 2002, BIOCHEM J, V362, P23, DOI 10.1042/bj3620023; Wilson PA, 2006, J LIPID RES, V47, P1940, DOI 10.1194/jlr.M600185-JLR200; Xing HM, 2000, EMBO J, V19, P349, DOI 10.1093/emboj/19.3.349; Xu Y, 2003, J BIOL CHEM, V278, P51380, DOI 10.1074/jbc.M307382200; Xu Y, 2006, J BIOL CHEM, V281, P39217, DOI 10.1074/jbc.M606100200; Yan W, 2005, J BIOL CHEM, V280, P26669, DOI 10.1074/jbc.M502358200; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200	85	117	118	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34611	34622		10.1074/jbc.M707795200	http://dx.doi.org/10.1074/jbc.M707795200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17923475	Green Accepted, hybrid			2022-12-25	WOS:000251155200003
J	Torres-Salazar, D; Fahlke, C				Torres-Salazar, Delany; Fahlke, Christoph			Neuronal glutamate transporters vary in substrate transport rate but not in unitary anion channel conductance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID TRANSPORTERS; CEREBELLAR PURKINJE-CELLS; GATED CHLORIDE CHANNEL; INDIVIDUAL SUBUNITS; ION-CHANNEL; CURRENTS; EAAT4; NEURODEGENERATION; TRANSLOCATION; ACTIVATION	Excitatory amino acid transporters (EAATs) not only sustain a secondary active glutamate transport but also function as anion-selective ion channels. The relative proportion of currents generated by glutamate transport or by the chloride conductance varies for each cloned EAAT subtype. For EAAT1, EAAT2, and EAAT3, the anion current is only a small component of the total transporter-associated current amplitude, whereas EAAT4 and EAAT5 transporters mediate predominantly anion currents. We here demonstrate that the distinct current proportions are entirely due to differences in glutamate transport rates. EAAT3 and EAAT4 differ in unitary glutamate transport rates as well as in the voltage and substrate dependence of anion channel opening, but ion conduction properties are very similar. Noise analysis revealed identical unitary current amplitudes and similar absolute open probabilities for the two anion channels. The low glutamate transport rate of EAAT4 allows regulation of cellular excitability without interfering with extracellular glutamate homeostasis and makes this EAAT isoform ideally suited to regulate excitability in dendritic spines of Purkinje neurons.	Inst Neurophysiol, Med Hochschule, D-30625 Hannover, Germany; Zentrum Systemische Neurowissenschaften, D-30625 Hannover, Germany		Fahlke, C (corresponding author), Inst Neurophysiol, Med Hochschule, D-30625 Hannover, Germany.	fahlke.christoph@mh-hannover.de	Fahlke, Christoph/G-3635-2013	Fahlke, Christoph/0000-0001-8602-9952; Torres-Salazar, Delany/0000-0002-6789-9810				Alvarez O, 2002, ADV PHYSIOL EDUC, V26, P327, DOI 10.1152/advan.00006.2002; Aoyama K, 2006, NAT NEUROSCI, V9, P119, DOI 10.1038/nn1609; Callaway JC, 1997, J NEUROPHYSIOL, V77, P145, DOI 10.1152/jn.1997.77.1.145; Dehnes Y, 1998, J NEUROSCI, V18, P3606; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Fairman WA, 1999, AM J PHYSIOL-RENAL, V277, pF481, DOI 10.1152/ajprenal.1999.277.4.F481; Gendreau S, 2004, J BIOL CHEM, V279, P39505, DOI 10.1074/jbc.M408038200; Grewer C, 2000, P NATL ACAD SCI USA, V97, P9706, DOI 10.1073/pnas.160170397; Grewer C, 2005, BIOCHEMISTRY-US, V44, P11913, DOI 10.1021/bi050987n; Grewer C, 2001, BIOCHEMISTRY-US, V40, P232, DOI 10.1021/bi0015919; HARVEY RJ, 1991, PROG NEUROBIOL, V36, P437, DOI 10.1016/0301-0082(91)90012-P; HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310; Huang YHH, 2004, J NEUROSCI, V24, P103, DOI 10.1523/JNEUROSCI.4473-03.2004; Koch HP, 2007, J NEUROSCI, V27, P2943, DOI 10.1523/JNEUROSCI.0118-07.2007; Larsson HP, 1996, BIOPHYS J, V70, P733, DOI 10.1016/S0006-3495(96)79613-3; Leary GP, 2007, J NEUROSCI, V27, P2938, DOI 10.1523/JNEUROSCI.4851-06.2007; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; Melzer N, 2005, P NATL ACAD SCI USA, V102, P19214, DOI 10.1073/pnas.0508837103; Melzer N, 2003, J BIOL CHEM, V278, P50112, DOI 10.1074/jbc.M307990200; Mim C, 2005, J GEN PHYSIOL, V126, P571, DOI 10.1085/jgp.200509365; Otis TS, 1998, J NEUROSCI, V18, P7099; Palmer MJ, 2003, J NEUROSCI, V23, P4831; Peghini P, 1997, EMBO J, V16, P3822, DOI 10.1093/emboj/16.13.3822; Sesti F, 1998, J GEN PHYSIOL, V112, P651, DOI 10.1085/jgp.112.6.651; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; SIGWORTH FJ, 1992, METHOD ENZYMOL, V207, P746; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; Torres-Salazar D, 2006, J NEUROSCI, V26, P7513, DOI 10.1523/JNEUROSCI.4545-05.2006; Trotti D, 2001, BRAIN RES, V914, P196, DOI 10.1016/S0006-8993(01)02802-5; Wadiche JI, 1998, J NEUROSCI, V18, P7650; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Watzke N, 2001, FEBS LETT, V503, P121, DOI 10.1016/S0014-5793(01)02715-6; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0	33	35	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34719	34726		10.1074/jbc.M704118200	http://dx.doi.org/10.1074/jbc.M704118200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17908688	hybrid			2022-12-25	WOS:000251155200014
J	Wood, JL; Singh, N; Mer, G; Chen, JJ				Wood, Jamie L.; Singh, Namit; Mer, Georges; Chen, Junjie			MCPH1 functions in an H2AX-dependent but MDC1-independent pathway in response to DNA damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHECKPOINT CONTROL; PROTEIN; MDC1; BRCA1; CHK1; MICROCEPHALIN; ACTIVATION; 53BP1; P53	Microcephalin (MCPH1) is one of the causative genes for the autosomal recessive disorder, primary microcephaly, characterized by dramatic reduction in brain size and mental retardation. MCPH1 also functions in the DNA damage response, participating in cell cycle checkpoint control. However, how MCPH1 is regulated in the DNA damage response still remains unknown. Here we report that the ability of MCPH1 to localize to the sites of DNA double-strand breaks depends on its C-terminal tandem BRCT domains. Although MCPH1 foci formation depends on H2AX phosphorylation after DNA damage, it can occur independently of MDC1. We also show that MCPH1 binds to a phospho-H2AX peptide in vitro with an affinity similar to that of MDC1, and overexpression of wild type, but not C-BRCT mutants of MCPH1, can interfere with the foci formation of MDC1 and 53BP1. Collectively, our data suggest MCPH1 is recruited to double-strand breaks via its interaction with gamma H2AX, which is mediated by MCPH1 C-terminal BRCT domains. These observations support that MCPH1 acts early in DNA damage responsive pathways.	Mayo Clin, Coll Med, Dept Mol Pharmacol, Dept Expt Therapeut, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA	Mayo Clinic; Mayo Clinic; Yale University	Chen, JJ (corresponding author), Mayo Clin, Coll Med, Dept Mol Pharmacol, Dept Expt Therapeut, Rochester, MN 55905 USA.	junjie.chen@yale.edu	Mer, Georges/AAT-4946-2021	Mer, Georges/0000-0002-1900-1578	NATIONAL CANCER INSTITUTE [R01CA092312, R01CA100109, R01CA109449] Funding Source: NIH RePORTER; NCI NIH HHS [CA109449, CA100109, R01 CA100109, R01 CA109449, R01 CA109449-04, R01 CA092312, CA092312] Funding Source: Medline; NIGMS NIH HHS [F31 GM770802] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alderton GK, 2006, NAT CELL BIOL, V8, P725, DOI 10.1038/ncb1431; Au WWY, 2005, J BIOL CHEM, V280, P6993, DOI 10.1074/jbc.M408879200; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Brown EJ, 2000, GENE DEV, V14, P397; Chini C, 2006, ONCOGENE, V25, P4165, DOI 10.1038/sj.onc.1209447; DiTullio RA, 2002, NAT CELL BIOL, V4, P998, DOI 10.1038/ncb892; Garshasbi M, 2006, HUM GENET, V118, P708, DOI 10.1007/s00439-005-0104-y; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Jowsey PA, 2004, J BIOL CHEM, V279, P55562, DOI 10.1074/jbc.M411021200; Lin SY, 2005, P NATL ACAD SCI USA, V102, P15105, DOI 10.1073/pnas.0507722102; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Maser RS, 2001, NAT GENET, V27, P417, DOI 10.1038/86920; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Rai R, 2006, CANCER CELL, V10, P145, DOI 10.1016/j.ccr.2006.07.002; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Trimborn Marc, 2005, Hum Mutat, V26, P496, DOI 10.1002/humu.9382; Xu XZ, 2004, J BIOL CHEM, V279, P34091, DOI 10.1074/jbc.C400139200; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004; Yu XC, 2006, GENE DEV, V20, P1721, DOI 10.1101/gad.1431006	26	81	90	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35416	35423		10.1074/jbc.M705245200	http://dx.doi.org/10.1074/jbc.M705245200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17925396	Green Accepted, hybrid			2022-12-25	WOS:000251155200084
J	Amaral, JD; Castro, RE; Sola, S; Steer, CJ; Rodrigues, CMP				Amaral, Joana D.; Castro, Rui E.; Sola, Susana; Steer, Clifford J.; Rodrigues, Cecilia M. P.			p53 is a key molecular target of ursodeoxycholic acid in regulating apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RING-FINGER DOMAIN; RAT HEPATOCYTES; GLUCOCORTICOID-RECEPTOR; TUMOR-SUPPRESSOR; BILE-ACIDS; TRANSCRIPTIONAL ACTIVATION; TAUROURSODEOXYCHOLIC ACID; PERMEABILITY TRANSITION; NUCLEAR EXPORT; CYTOCHROME-C	p53 plays an important role in regulating expression of genes that mediate cell cycle progression and/or apoptosis. In addition, we have previously shown that the hydrophilic bile acid ursodeoxycholic acid (UDCA) prevents transforming growth factor beta 1-induced p53 stabilization and apoptosis in primary rat hepatocytes. Therefore, we hypothesized that p53 may represent an important target in bile acid-induced modulation of apoptosis and cell survival. In this study we demonstrated that UDCA reduces p53 transcriptional activity, thereby preventing its ability to induce Bax expression, mitochondrial translocation, cytochrome c release, and apoptosis in primary rat hepatocytes. More importantly, bile acid inhibition of p53-induced apoptosis was associated with decreased p53 DNA binding activity. Subcellular localization of p53 was also altered by UDCA. Both events appear to be related with increased association between p53 and its direct repressor, Mdm-2. In conclusion, these results further clarify the antiapoptotic mechanism of UDCA and suggest that modulation of Mdm-2/p53 interaction is a prime target for this bile acid.	Univ Lisbon, Fac Pharm, P-1649003 Lisbon, Portugal; Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	Universidade de Lisboa; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Rodrigues, CMP (corresponding author), Univ Lisbon, Fac Pharm, Av Prof Gama Pinto, P-1649003 Lisbon, Portugal.	cmprodrigues@ff.ul.pt	Amaral, Joana/M-4660-2013; Rodrigues, Cecilia MP/M-3572-2013; Amaral, Joana São José Dias/M-7809-2019; Solá, Susana/AAI-4580-2021; Castro, Rui E/AAG-4179-2021; Castro, Rui E/I-2975-2013; Solá, Susana/M-5251-2013; iMed.ULisboa, CellFun/A-4244-2014	Amaral, Joana/0000-0001-9504-5102; Rodrigues, Cecilia MP/0000-0002-4829-754X; Amaral, Joana São José Dias/0000-0001-9504-5102; Solá, Susana/0000-0003-2036-797X; Castro, Rui E/0000-0002-7417-0091; Castro, Rui E/0000-0002-7417-0091; Solá, Susana/0000-0003-2036-797X; 				Amaral Joana D, 2007, Expert Rev Endocrinol Metab, V2, P487, DOI 10.1586/17446651.2.4.487; Balint E, 2001, BRIT J CANCER, V85, P1813, DOI 10.1054/bjoc.2001.2128; Bossy-Wetzel E, 1999, MUTAT RES-DNA REPAIR, V434, P243, DOI 10.1016/S0921-8777(99)00032-4; BOTLA R, 1995, J PHARMACOL EXP THER, V272, P930; Boyd SD, 2000, NAT CELL BIOL, V2, P563, DOI 10.1038/35023500; Castro RE, 2005, J HEPATOL, V42, P897, DOI 10.1016/j.jhep.2005.01.026; Chao C, 2000, EMBO J, V19, P4967, DOI 10.1093/emboj/19.18.4967; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Chipuk JE, 2003, J CLIN IMMUNOL, V23, P355, DOI 10.1023/A:1025365432325; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Espinoza-Fonseca LM, 2006, BIOPOLYMERS, V83, P365, DOI 10.1002/bip.20566; Freedman DA, 1999, CELL MOL LIFE SCI, V55, P96, DOI 10.1007/s000180050273; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; Grasberger BL, 2005, J MED CHEM, V48, P909, DOI 10.1021/jm049137g; Green DR, 2000, CELL, V102, P1, DOI 10.1016/S0092-8674(00)00003-9; HAMADA K, 1994, CARCINOGENESIS, V15, P1911, DOI 10.1093/carcin/15.9.1911; HARPER JW, 1993, CELL, V75, P805; Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Im E, 2005, NUTR CANCER, V51, P110, DOI 10.1207/s15327914nc5101_15; Im E, 2004, J NUTR, V134, P483, DOI 10.1093/jn/134.2.483; Jimenez GS, 2000, NAT GENET, V26, P37, DOI 10.1038/79152; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Kren BT, 2001, LIVER TRANSPLANT, V7, P321, DOI 10.1053/jlts.2001.23062; Kritzer JA, 2004, J AM CHEM SOC, V126, P9468, DOI 10.1021/ja031625a; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; MARIASH CN, 1986, J BIOL CHEM, V261, P9583; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Miura T, 2001, J BIOL CHEM, V276, P47371, DOI 10.1074/jbc.M107098200; MIYASHITA T, 1995, CELL, V80, P293; Monte MJ, 2002, J HEPATOL, V36, P534, DOI 10.1016/S0168-8278(01)00296-3; Moroni MC, 2001, NAT CELL BIOL, V3, P552, DOI 10.1038/35078527; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200; Pastorino JG, 1998, J BIOL CHEM, V273, P7770, DOI 10.1074/jbc.273.13.7770; Paumgartner G, 2002, HEPATOLOGY, V36, P525, DOI 10.1053/jhep.2002.36088; POUPON RE, 1991, NEW ENGL J MED, V324, P1548, DOI 10.1056/NEJM199105303242204; Rajesh KG, 2005, J MOL CELL CARDIOL, V39, P766, DOI 10.1016/j.yjmcc.2005.07.014; Ramalho RM, 2004, J NEUROCHEM, V90, P567, DOI 10.1111/j.1471-4159.2004.02517.x; Rodrigues CMP, 1998, J CLIN INVEST, V101, P2790, DOI 10.1172/JCI1325; Rodrigues CMP, 1999, CELL DEATH DIFFER, V6, P842, DOI 10.1038/sj.cdd.4400560; SCATES DK, 1995, CARCINOGENESIS, V16, P1489, DOI 10.1093/carcin/16.7.1489; Schon O, 2002, J MOL BIOL, V323, P491, DOI 10.1016/S0022-2836(02)00852-5; Sengupta S, 2004, ANN NY ACAD SCI, V1024, P54, DOI 10.1196/annals.1321.005; Setchell KDR, 1997, GASTROENTEROLOGY, V112, P226, DOI 10.1016/S0016-5085(97)70239-7; Sola S, 2005, HEPATOLOGY, V42, P925, DOI 10.1002/hep.20870; Sola S, 2004, BIOCHEMISTRY-US, V43, P8429, DOI 10.1021/bi049781x; Sola S, 2003, MOL MED, V9, P226, DOI 10.2119/2003-00042.Rodrigues; Sola S, 2003, J BIOL CHEM, V278, P48831, DOI 10.1074/jbc.M300468200; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; TANAKA H, 1992, BIOCHEM BIOPH RES CO, V188, P942, DOI 10.1016/0006-291X(92)91146-H; Thompson T, 2004, J BIOL CHEM, V279, P53015, DOI 10.1074/jbc.M410233200; Thornborrow EC, 2002, ONCOGENE, V21, P990, DOI 10.1038/sj.onc.1205069; Unger T, 1999, ONCOGENE, V18, P3205, DOI 10.1038/sj.onc.1202656; UNGER T, 1992, EMBO J, V11, P1383, DOI 10.1002/j.1460-2075.1992.tb05183.x; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Yu J, 2005, BIOCHEM BIOPH RES CO, V331, P851, DOI 10.1016/j.bbrc.2005.03.189	64	65	69	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34250	34259		10.1074/jbc.M704075200	http://dx.doi.org/10.1074/jbc.M704075200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17881359	hybrid			2022-12-25	WOS:000251145700040
J	Amat, R; Solanes, G; Giralt, M; Villarroya, F				Amat, Ramon; Solanes, Gemma; Giralt, Marta; Villarroya, Francesc			SIRT1 is involved in glucocorticoid-mediated control of uncoupling protein-3 gene transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RECEPTOR COACTIVATOR; FATTY-ACID OXIDATION; SKELETAL-MUSCLE; HISTONE DEACETYLASE; THYROID-HORMONE; RETINOIC ACID; EXPRESSION; CELLS; MYOD; DIFFERENTIATION	UCP3 (uncoupling protein-3) is a mitochondrial membrane transporter expressed preferentially in skeletal muscle. UCP3 lowers mitochondrial membrane potential and protects muscle cells against an overload of fatty acids, and it probably reduces excessive production of reactive oxygen species. Accordingly, ucp3 gene transcription is highly sensitive to fatty acid-dependent stimulation and also to other unrelated stress signals. In this study, glucocorticoids are identified as major inducers of ucp3 gene transcription in muscle. Glucocorticoids activate the transcription of the ucp3 gene through a glucocorticoid receptor-binding site in the promoter region. Glucocorticoids are capable of inducing ucp3 gene transcription independently from the myogenic regulatory factor MyoD, in contrast with the transcriptional activation of the ucp3 gene through other nuclear hormone receptors. An interplay of regulatory factors modulates positively (p300) or negatively (histone deacetylases) the action of glucocorticoids on ucp3 gene transcription via histone acetylation or deacetylation processes, respectively. Among them, SIRT1 acts as a major repressor of ucp3 gene expression in response to glucocorticoids. The action of SIRT1 requires its deacetylase activity and results in histone deacetylation in the ucp3 promoter. Moreover, it involves a specific impairment of association of p300 with the glucocorticoid receptor. Agents activating SIRT1, such as resveratrol, repress ucp3 gene expression. The control of SIRT1 activity via the metabolic redox status of the cell points to a novel regulatory pathway of ucp3 gene transcription in response to metabolic and stress signaling in muscle cells.	Univ Barcelona, Fac Biol, Dept Bioquim & Biol Mol, E-08028 Barcelona, Spain; Univ Barcelona, Inst Biomed, E-08028 Barcelona, Spain; Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr, Barcelona 08028, Spain	University of Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III	Villarroya, F (corresponding author), Univ Barcelona, Fac Biol, Dept Bioquim & Biol Mol, Avda Diagonal 645, E-08028 Barcelona, Spain.	fvillarroya@ub.edu	Amat, Ramon/F-2681-2010; Giralt, Marta/A-4756-2013; Villarroya, Francesc/K-4357-2014	Amat, Ramon/0000-0001-8284-2540; Giralt, Marta/0000-0001-7968-4190; Villarroya, Francesc/0000-0003-1266-9142				AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; Bakhtiarova A, 2006, BIOCHEM BIOPH RES CO, V351, P481, DOI 10.1016/j.bbrc.2006.10.057; Blanco JCG, 1998, GENE DEV, V12, P1638, DOI 10.1101/gad.12.11.1638; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Bouras T, 2005, J BIOL CHEM, V280, P10264, DOI 10.1074/jbc.M408748200; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; BRAUN T, 1992, GENE DEV, V6, P888, DOI 10.1101/gad.6.5.888; Brun S, 1999, FEBS LETT, V453, P205, DOI 10.1016/S0014-5793(99)00722-X; Brun S, 1999, DIABETES, V48, P1217, DOI 10.2337/diabetes.48.6.1217; Busquets S, 2005, FEBS LETT, V579, P717, DOI 10.1016/j.febslet.2004.12.050; Carballo-Jane E, 2004, J STEROID BIOCHEM, V88, P191, DOI 10.1016/j.jsbmb.2003.11.012; Chakravarti D, 1996, NATURE, V383, P99, DOI 10.1038/383099a0; CRESCENZI M, 1990, P NATL ACAD SCI USA, V87, P8442, DOI 10.1073/pnas.87.21.8442; Fu MF, 2006, MOL CELL BIOL, V26, P8122, DOI 10.1128/MCB.00289-06; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Garcia-Martinez C, 2001, FASEB J, V15, P2033, DOI 10.1096/fj.00-0828fje; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; GLASS CK, 1989, CELL, V59, P697, DOI 10.1016/0092-8674(89)90016-0; Gong DW, 1997, J BIOL CHEM, V272, P24129, DOI 10.1074/jbc.272.39.24129; Hasselgren P O, 1999, Curr Opin Clin Nutr Metab Care, V2, P201, DOI 10.1097/00075197-199905000-00002; HELMBERG A, 1995, EMBO J, V14, P452, DOI 10.1002/j.1460-2075.1995.tb07021.x; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; MacLellan JD, 2005, DIABETES, V54, P2343, DOI 10.2337/diabetes.54.8.2343; Mal A, 2001, EMBO J, V20, P1739, DOI 10.1093/emboj/20.7.1739; Mills EM, 2002, J BIOL CHEM, V277, P27385, DOI 10.1074/jbc.M111860200; Pedraza N, 2006, ENDOCRINOLOGY, V147, P4695, DOI 10.1210/en.2006-0226; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Qiu Y, 2006, MOL CELL, V22, P669, DOI 10.1016/j.molcel.2006.04.019; Ricquier D, 2000, BIOCHEM J, V345, P161, DOI 10.1042/0264-6021:3450161; Sinclair DA, 2005, MECH AGEING DEV, V126, P987, DOI 10.1016/j.mad.2005.03.019; Solanes G, 2000, FASEB J, V14, P2141; Solanes G, 2005, BIOCHEM J, V386, P505, DOI 10.1042/BJ20041073; Solanes G, 2003, MOL ENDOCRINOL, V17, P1944, DOI 10.1210/me.2002-0395; Sun XY, 2003, AM J PHYSIOL-ENDOC M, V285, pE512, DOI 10.1152/ajpendo.00446.2002; Tai H, 2000, BIOCHEM BIOPH RES CO, V267, P311, DOI 10.1006/bbrc.1999.1954; Weigle DS, 1998, DIABETES, V47, P298, DOI 10.2337/diabetes.47.2.298; Yamamoto T, 1997, J BIOL CHEM, V272, P30595, DOI 10.1074/jbc.272.49.30595; YANG H, 2006, AM J PHYSIOL, V292, pR337; Yu XX, 2000, AM J PHYSIOL-ENDOC M, V279, pE433, DOI 10.1152/ajpendo.2000.279.2.E433; Zhang QH, 2006, INT J MOL MED, V18, P1223	41	70	73	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34066	34076		10.1074/jbc.M707114200	http://dx.doi.org/10.1074/jbc.M707114200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17884810	hybrid			2022-12-25	WOS:000251145700021
J	Simon, S; Fontaine, JM; Martin, JL; Sun, X; Hoppe, AD; Welsh, MJ; Benndorf, R; Vicart, P				Simon, Stephanie; Fontaine, Jean-Marc; Martin, Jody L.; Sun, Xiankui; Hoppe, Adam D.; Welsh, Michael J.; Benndorf, Rainer; Vicart, Patrick			Myopathy-associated alpha B-crystallin mutants - Abnormal phosphorylation, intracellular location, and interactions with other small heat shock proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTERIOR POLAR CATARACT; MARIE-TOOTH-DISEASE; BETA-CRYSTALLIN; HSP22 HSPB8; MUTATION; DESMIN; R120G; APOPTOSIS; GENE; R120G-ALPHA-B-CRYSTALLIN	Three mutations (R120G, Q151X, and 464delCT) in the small heat shock protein alpha B-crystallin cause inherited myofibrillar myopathy. In an effort to elucidate the molecular basis for the associated myopathy, we have determined the following for these mutant alpha B-crystallin proteins: (i) the formation of aggregates in transfected cells; (ii) the partition into different subcellular fractions; (iii) the phosphorylation status; and (iv) the ability to interact with themselves, with wild-type alpha B-crystallin, and with other small heat shock proteins that are abundant in muscles. We found that all three alpha B-crystallin mutants have an increased tendency to form cytoplasmic aggregates in transfected cells and significantly increased levels of phosphorylation when compared with the wildtype protein. Although wild-type alpha B-crystallin partitioned essentially into the cytosol and membranes/organelles fractions, mutant alpha B-crystallin proteins partitioned additionally into the nuclear and cytoskeletal fractions. By using various protein interaction assays, including quantitative fluorescence resonance energy transfer measurements in live cells, we found abnormal interactions of the various alpha B-crystallin mutants with wild-type alpha B-crystallin, with themselves, and with the other small heat shock proteins Hsp20, Hsp22, and possibly with Hsp27. The collected data suggest that each alpha B-crystallin mutant has a unique pattern of abnormal interaction properties. These distinct properties of the alpha B-crystallin mutants identified are likely to contribute to a better understanding of the gradual manifestation and clinical heterogeneity of the associated myopathy in patients.	Univ Paris 07, UFR Biochim, EA 300 Stress & Pathol Cytosquelette, F-75005 Paris, France; Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; Loyola Univ, Dept Med, Cardiovasc Inst, Maywood, IL 60153 USA	UDICE-French Research Universities; Universite Paris Cite; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Loyola University Chicago	Simon, S (corresponding author), Univ Paris 07, UFR Biochim, EA 300 Stress & Pathol Cytosquelette, F-75005 Paris, France.	stef.labo@gmail.com	Welsh, Michael/B-1968-2008; Stephanie, Simon/A-3845-2013; Hoppe, Adam/U-8563-2019	Hoppe, Adam/0000-0003-4180-0840	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011188] Funding Source: NIH RePORTER; NIEHS NIH HHS [P01 ES 11188] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Arrigo AP, 2005, ANTIOXID REDOX SIGN, V7, P414, DOI 10.1089/ars.2005.7.414; Berry V, 2001, AM J HUM GENET, V69, P1141, DOI 10.1086/324158; Boelens WC, 1998, J BIOL CHEM, V273, P28085, DOI 10.1074/jbc.273.43.28085; Bova MP, 1999, P NATL ACAD SCI USA, V96, P6137, DOI 10.1073/pnas.96.11.6137; CARVER JA, 1995, BBA-PROTEIN STRUCT M, V1252, P251, DOI 10.1016/0167-4838(95)00146-L; Chen QH, 2005, CIRC RES, V97, P1018, DOI 10.1161/01.RES.0000189262.92896.0b; Clemen CS, 2005, FEBS LETT, V579, P3777, DOI 10.1016/j.febslet.2005.05.051; den Engelsman J, 2004, EUR J BIOCHEM, V271, P4195, DOI 10.1111/j.1432-1033.2004.04359.x; den Engelsman J, 2003, J BIOL CHEM, V278, P4699, DOI 10.1074/jbc.M211403200; den Englesman J, 2005, J BIOL CHEM, V280, P37139, DOI 10.1074/jbc.M504106200; Der Perng M, 1999, J BIOL CHEM, V274, P33235, DOI 10.1074/jbc.274.47.33235; Ehrnsperger M, 1999, J BIOL CHEM, V274, P14867, DOI 10.1074/jbc.274.21.14867; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; Fan GC, 2005, TRENDS CARDIOVAS MED, V15, P138, DOI 10.1016/j.tcm.2005.05.004; Fontaine JM, 2006, FASEB J, V20, P2168, DOI 10.1096/fj.06-5911fje; Fontaine JM, 2005, BIOCHEM BIOPH RES CO, V337, P1006, DOI 10.1016/j.bbrc.2005.09.148; Fu L, 2002, J BIOL CHEM, V277, P4255, DOI 10.1074/jbc.M110027200; Gaestel M, 2002, Prog Mol Subcell Biol, V28, P151; Ganea E, 2001, CURR PROTEIN PEPT SC, V2, P205, DOI 10.2174/1389203013381107; Giese KC, 2002, J BIOL CHEM, V277, P46310, DOI 10.1074/jbc.M208926200; Golenhofen N, 2004, HISTOCHEM CELL BIOL, V122, P415, DOI 10.1007/s00418-004-0711-z; Hoppe A, 2002, BIOPHYS J, V83, P3652, DOI 10.1016/S0006-3495(02)75365-4; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Inagaki N, 2006, BIOCHEM BIOPH RES CO, V342, P379, DOI 10.1016/j.bbrc.2006.01.154; Inaguma Y, 2001, EUR J CELL BIOL, V80, P741, DOI 10.1078/0171-9335-00203; Irobi J, 2004, NAT GENET, V36, P597, DOI 10.1038/ng1328; Ito H, 2003, CELL MOL LIFE SCI, V60, P1217, DOI 10.1007/s00018-003-3024-9; Ito H, 1997, J BIOL CHEM, V272, P29934, DOI 10.1074/jbc.272.47.29934; Ito H, 2002, J BIOCHEM, V131, P593, DOI 10.1093/oxfordjournals.jbchem.a003139; Ito K, 2001, J BIOL CHEM, V276, P5346, DOI 10.1074/jbc.M009004200; IWAKI T, 1990, J HISTOCHEM CYTOCHEM, V38, P31, DOI 10.1177/38.1.2294148; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Kamradt MC, 2005, J BIOL CHEM, V280, P11059, DOI 10.1074/jbc.M413382200; Kamradt MC, 2002, J BIOL CHEM, V277, P38731, DOI 10.1074/jbc.M201770200; Kamradt MC, 2001, J BIOL CHEM, V276, P16059, DOI 10.1074/jbc.C100107200; Kato K, 1998, J BIOL CHEM, V273, P28346, DOI 10.1074/jbc.273.43.28346; Kato K, 2001, J NEUROCHEM, V76, P730, DOI 10.1046/j.1471-4159.2001.00038.x; KATO K, 1994, J BIOL CHEM, V269, P15302; Kijima K, 2005, J HUM GENET, V50, P473, DOI 10.1007/s10038-005-0280-6; Kumar LVS, 1999, J BIOL CHEM, V274, P24137, DOI 10.1074/jbc.274.34.24137; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; Liu MG, 2006, INVEST OPHTH VIS SCI, V47, P3461, DOI 10.1167/iovs.05-1438; Liu S, 2007, BIOCHEM BIOPH RES CO, V354, P109, DOI 10.1016/j.bbrc.2006.12.152; Liu Xiao-min, 2005, Zhonghua Yixue Yichuanxue Zazhi, V22, P510; Liu YZ, 2006, INVEST OPHTH VIS SCI, V47, P1069, DOI 10.1167/iovs.05-1004; Lutsch G, 1997, CIRCULATION, V96, P3466; Maloyan A, 2005, CIRCULATION, V112, P3451, DOI 10.1161/CIRCULATIONAHA.105.572552; Martin JL, 2002, AM J PHYSIOL-HEART C, V283, pH85, DOI 10.1152/ajpheart.00512.2001; Pasta SY, 2004, MOL VIS, V10, P655; Perng MD, 2004, MOL BIOL CELL, V15, P2335, DOI 10.1091/mbc.E03-12-0893; Pilotto A, 2006, BIOCHEM BIOPH RES CO, V346, P1115, DOI 10.1016/j.bbrc.2006.05.203; Sanbe A, 2005, P NATL ACAD SCI USA, V102, P13592, DOI 10.1073/pnas.0503324102; Sanbe A, 2007, J BIOL CHEM, V282, P555, DOI 10.1074/jbc.M605481200; Selcen D, 2003, ANN NEUROL, V54, P804, DOI 10.1002/ana.10767; Stamler R, 2005, J MOL BIOL, V353, P68, DOI 10.1016/j.jmb.2005.08.025; Sugiyama Y, 2000, J BIOL CHEM, V275, P1095, DOI 10.1074/jbc.275.2.1095; Sun XK, 2004, J BIOL CHEM, V279, P2394, DOI 10.1074/jbc.M311324200; Sun Y, 2005, FEBS J, V272, P2613, DOI 10.1111/j.1742-4658.2005.04708.x; Tang BS, 2005, HUM GENET, V116, P222, DOI 10.1007/s00439-004-1218-3; Tang BS, 2005, ARCH NEUROL-CHICAGO, V62, P1201, DOI 10.1001/archneur.62.8.1201; Treweek TM, 2005, FEBS J, V272, P711, DOI 10.1111/j.1742-4658.2004.04507.x; van de Klundert FAJM, 1998, EUR J BIOCHEM, V258, P1014, DOI 10.1046/j.1432-1327.1998.2581014.x; van den IJssel P, 2003, EXP CELL RES, V287, P249, DOI 10.1016/S0014-4827(03)00092-2; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Wang KY, 2000, EUR J BIOCHEM, V267, P4705, DOI 10.1046/j.1432-1327.2000.01521.x; Wang XJ, 2001, CIRC RES, V89, P84, DOI 10.1161/hh1301.092688; Zhang Fu-feng, 2005, Zhonghua Yixue Yichuanxue Zazhi, V22, P361; Zobel ATC, 2003, HUM MOL GENET, V12, P1609, DOI 10.1093/hmg/ddg173	69	57	59	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34276	34287		10.1074/jbc.M703267200	http://dx.doi.org/10.1074/jbc.M703267200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17897943	hybrid			2022-12-25	WOS:000251145700043
J	Tamaki, H; Shimada, A; Ito, Y; Ohya, M; Takase, J; Miyashita, M; Miyagawa, H; Nozaki, H; Nakayama, R; Kumagai, H				Tamaki, Hisanori; Shimada, Atsushi; Ito, Yoshihiro; Ohya, Mihoko; Takase, Juri; Miyashita, Masahiro; Miyagawa, Hisashi; Nozaki, Hiroyuki; Nakayama, Reiko; Kumagai, Hidehiko			LPT1 encodes a membrane-bound O-acyltransferase involved in the acylation of lysophospholipids in the yeast Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOPHOSPHATIDIC ACID ACYLTRANSFERASE; PLATELET-ACTIVATING-FACTOR; MAJOR HISTOCOMPATIBILITY COMPLEX; LYSO-PAF ACETYLTRANSFERASE; ESCHERICHIA-COLI; 1-ACYL-SN-GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE; GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE; ENDOPLASMIC-RETICULUM; ACETYL-COA; BARTH-SYNDROME	Phospholipids are major components of cellular membranes that participate in a range of cellular processes. Phosphatidic acid (PA) is a key molecule in the phospholipid biosynthetic pathway. In Saccharomyces cerevisiae, SLC1 has been identified as the gene encoding lysophosphatidic acid acyltransferase, which catalyzes PA synthesis. However, despite the importance of PA, disruption of SLC1 does not affect cell viability (Nagiec, M. M., Wells, G. B., Lester, R. L., and Dickson, R. C. (1993) J. Biol. Chem. 268, 22156-22163). We originally aimed to identify the acetyl-CoA: lyso platelet-activating factor acetyltransferase (lysoPAF AT) gene in yeast. Screening of a complete set of yeast deletion clones (4741 homozygous diploid clones) revealed a single mutant strain, YOR175c, with a defect in lysoPAF AT activity. YOR175c has been predicted to be a member of the membrane-bound O-acyltransferase superfamily, and we designated the gene LPT1. An Lpt1-green fluorescent protein fusion protein localized at the endoplasmic reticulum. Other than lysoPAF AT activity, Lpt1 catalyzed acyltransferase activity with a wide variety of lysophospholipids as acceptors, including lysophosphatidic acid, lysophosphatidylcholine, lysophosphatidylethanolamine, lysophosphatidylglycerol, lysophosphatidylinositol, and lysophosphatidylserine. A liquid chromatography-mass spectrometry analysis indicated that lysophosphatidylcholine and lysophosphatidylethanolamine accumulated in the Delta lpt1 mutant strain. Although the Delta lpt1 mutant strain did not show other detectable defects, the Delta lpt1 Delta slc1 double mutant strain had a synthetic lethal phenotype. These results indicate that, in concert with Slc1, Lpt1 plays a central role in PA biosynthesis, which is essential for cell viability.	Kagoshima Univ, Fac Agr, Dept Biochem Sci & Technol, Kagoshima 8900065, Japan; Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Kyoto 6068502, Japan; Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Kyoto 6068502, Japan; Kyoto Womens Univ, Dept Food Sci, Kyoto 606, Japan; Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Ishikawa 9218836, Japan	Kagoshima University; Kyoto University; Kyoto University; Kyoto Womens University; Ishikawa Prefecture University	Tamaki, H (corresponding author), Kagoshima Univ, Fac Agr, Dept Biochem Sci & Technol, 1-21-24 Korimoto, Kagoshima 8900065, Japan.	noritama@ms.kagoshima-u.ac.jp	Ito, Yoshihiro/T-1095-2019	Ito, Yoshihiro/0000-0002-1154-253X; Ito, Yoshihiro/0000-0001-7693-3593				Aguado B, 1997, BIOCHEM SOC T, V25, pS597, DOI 10.1042/bst025s597; Aguado B, 1998, J BIOL CHEM, V273, P4096, DOI 10.1074/jbc.273.7.4096; Athenstaedt K, 1997, J BACTERIOL, V179, P7611, DOI 10.1128/jb.179.24.7611-7616.1997; Barth PG, 1999, J INHERIT METAB DIS, V22, P555, DOI 10.1023/A:1005568609936; BENGHEZAL M, 2007, J BIOL CHEM     0803; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bosson R, 2006, MOL BIOL CELL, V17, P2636, DOI 10.1091/mbc.E06-02-0104; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cao JS, 2004, J BIOL CHEM, V279, P31727, DOI 10.1074/jbc.M402930200; Carman GM, 1996, J BIOL CHEM, V271, P13293, DOI 10.1074/jbc.271.23.13293; Chen XN, 2006, P NATL ACAD SCI USA, V103, P11724, DOI 10.1073/pnas.0604946103; COLEMAN J, 1990, J BIOL CHEM, V265, P17215; COLEMAN J, 1992, MOL GEN GENET, V232, P295, DOI 10.1007/BF00280009; Dircks L, 1999, PROG LIPID RES, V38, P461, DOI 10.1016/S0163-7827(99)00012-0; Eberhardt C, 1997, J BIOL CHEM, V272, P20299, DOI 10.1074/jbc.272.32.20299; Fernandez JP, 2005, J BIOL CHEM, V280, P8544, DOI 10.1074/jbc.M413999200; Fragopoulou E, 2005, MEDIAT INFLAMM, P263, DOI 10.1155/MI.2005.263; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; GOMEZCAMBRONERO J, 1986, BIOCHEM J, V237, P439, DOI 10.1042/bj2370439; GREEN PR, 1983, J BIOL CHEM, V258, P862; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Holst B, 2000, MOL MICROBIOL, V37, P108, DOI 10.1046/j.1365-2958.2000.01968.x; Hong J, 2001, J BIOSCI BIOENG, V92, P434, DOI 10.1016/S1389-1723(01)80292-9; Ishii S, 2000, PROG LIPID RES, V39, P41, DOI 10.1016/S0163-7827(99)00016-8; JAIN S, 2007, J BIOL CHEM     0828; KENNEDY EP, 1961, FED PROC, V20, P934; Kume K, 1997, BIOCHEM BIOPH RES CO, V237, P663, DOI 10.1006/bbrc.1997.7214; LANDS WEM, 1960, J BIOL CHEM, V235, P2233; LANDS WEM, 1963, J BIOL CHEM, V238, P898; LEE KS, 1994, J BIOL CHEM, V269, P19725; Lewin TM, 2004, J BIOL CHEM, V279, P13488, DOI 10.1074/jbc.M314032200; Li D, 2003, J HUM GENET, V48, P438, DOI 10.1007/s10038-003-0045-z; Li GL, 2007, BBA-MOL CELL BIOL L, V1771, P432, DOI 10.1016/j.bbalip.2006.06.007; LIGHTNER VA, 1983, J BIOL CHEM, V258, P856; Lorenz MC, 1997, EMBO J, V16, P7008, DOI 10.1093/emboj/16.23.7008; Lu B, 2005, BIOCHEM J, V385, P469, DOI 10.1042/BJ20041348; MATSUSHITA M, 1995, J BIOCHEM-TOKYO, V117, P447, DOI 10.1093/jb/117.2.447; MERKL I, 1963, J BIOL CHEM, V238, P905; NAGIEC MM, 1993, J BIOL CHEM, V268, P22156; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; NAKAYAMA R, 1994, BBA-GEN SUBJECTS, V1199, P137, DOI 10.1016/0304-4165(94)90108-2; PINCKARD RN, 1979, J IMMUNOL, V123, P1847; PRESCOTT SM, 1990, J BIOL CHEM, V265, P17381; Riekhof WR, 2007, J BIOL CHEM, V282, P28344, DOI 10.1074/jbc.M705256200; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SHIN DH, 1991, J BIOL CHEM, V266, P23834; Shindou H, 2007, J BIOL CHEM, V282, P6532, DOI 10.1074/jbc.M609641200; Sorger D, 2003, APPL MICROBIOL BIOT, V61, P289, DOI 10.1007/s00253-002-1212-4; Stamps AC, 1997, BIOCHEM J, V326, P455, DOI 10.1042/bj3260455; Taguchi R, 2000, J MASS SPECTROM, V35, P953, DOI 10.1002/1096-9888(200008)35:8<953::AID-JMS23>3.0.CO;2-4; Testet E, 2005, BIOCHEM J, V387, P617, DOI 10.1042/BJ20041491; WALLIS JW, 1989, CELL, V58, P409, DOI 10.1016/0092-8674(89)90855-6; West J, 1997, DNA CELL BIOL, V16, P691, DOI 10.1089/dna.1997.16.691; WYKLE RL, 1980, J BIOL CHEM, V255, P256; Yamashita A, 2001, J BIOL CHEM, V276, P26745, DOI 10.1074/jbc.M101795200; Yamashita A, 1997, J BIOCHEM-TOKYO, V122, P1; Yang HY, 1996, SCIENCE, V272, P1353, DOI 10.1126/science.272.5266.1353; Yang YZ, 2004, J BIOL CHEM, V279, P55866, DOI 10.1074/jbc.M406710200; Ye GM, 2005, DNA SEQUENCE, V16, P386, DOI 10.1080/10425170500213712; YET SF, 1993, BIOCHEMISTRY-US, V32, P9486, DOI 10.1021/bi00087a029; Zheng ZF, 2001, J BIOL CHEM, V276, P41710, DOI 10.1074/jbc.M104749200	62	67	83	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34288	34298		10.1074/jbc.M704509200	http://dx.doi.org/10.1074/jbc.M704509200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17890783	hybrid			2022-12-25	WOS:000251145700044
J	Weng, Z; Signore, AP; Gao, Y; Wang, S; Zhang, F; Hastings, T; Yin, XM; Chen, J				Weng, Zhongfang; Signore, Armando P.; Gao, Yanqin; Wang, Suping; Zhang, Feng; Hastings, Teresa; Yin, Xiao-Ming; Chen, Jun			Leptin protects against 6-hydroxydopamine-induced dopaminergic cell death via mitogen-activated protein kinase signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR MESSENGER-RNA; JAK-STAT PATHWAY; NEUROTROPHIC FACTOR; PARKINSONS-DISEASE; SUBSTANTIA-NIGRA; RAT-BRAIN; CEREBRAL-ISCHEMIA; NEURONAL SURVIVAL; INDUCED APOPTOSIS; GENE DELIVERY	The death of midbrain dopaminergic neurons in sporadic Parkinson disease is of unknown etiology but may involve altered growth factor signaling. The present study showed that leptin, a centrally acting hormone secreted by adipocytes, rescued dopaminergic neurons, reversed behavioral asymmetry, and restored striatal catecholamine levels in the unilateral 6-hydroxydopamine (6-OHDA) mouse model of dopaminergic cell death. In vitro studies using the murine dopaminergic cell line MN9D showed that leptin attenuated 6-OHDA-induced apoptotic markers, including caspase-9 and caspase-3 activation, internucleosomal DNA fragmentation, and cytochrome c release. ERK1/2 phosphorylation (pERK1/2) was found to be critical for mediating leptin-induced neuroprotection, because inhibition of the MEK pathway blocked both the pERK1/2 response and the pro-survival effect of leptin in cultures. Knockdown of the downstream messengers JAK2 or GRB2 precluded leptin-induced pERK1/2 activation and neuroprotection. Leptin/pERK1/2 signaling involved phosphorylation and nuclear localization of CREB (pCREB), a well known survival factor for dopaminergic neurons. Leptin induced a marked MEK-dependent increase in pCREB that was essential for neuroprotection following 6-OHDA toxicity. Transfection of a dominant negative MEK protein abolished leptin-enhanced pCREB formation, whereas a dominant negative CREB or decoy oligonucleotide diminished both pCREB binding to its target DNA sequence and MN9D survival against 6-OHDA toxicity. Moreover, in the substantia nigra of mice, leptin treatment increased the levels of pERK1/2, pCREB, and the downstream gene product BDNF, which were reversed by the MEK inhibitor PD98059. Collectively, these data provide evidence that leptin prevents the degeneration of dopaminergic neurons by 6-OHDA and may prove useful in the treatment of Parkinson disease.	Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA 15261 USA; Fudan Univ, Sch Med, State Key Lab Med Neurobiol, Shanghai 200032, Peoples R China; Vet Affairs Pittsburgh Hlth Care Syst, Ctr Geriatr Res Educ & Clin, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Fudan University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Chen, J (corresponding author), Univ Pittsburgh, Dept Neurol, Sch Med, S-507,Biomed Sci tower, Pittsburgh, PA 15213 USA.	chenj2@upmc.edu	Gao, Yanqin/I-6790-2016; Zhang, Feng/X-2287-2019	Gao, Yanqin/0000-0002-4915-9819; Zhang, Feng/0000-0001-7275-9989; Chen, Jun/0000-0002-8077-3403	NINDS NIH HHS [NS 44178, NS 45048, NS 43802] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043802, R01NS045048, R01NS044178] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Banks AS, 2000, J BIOL CHEM, V275, P14563, DOI 10.1074/jbc.275.19.14563; Banks WA, 1996, PEPTIDES, V17, P305, DOI 10.1016/0196-9781(96)00025-3; Bensadoun JC, 2000, EXP NEUROL, V164, P15, DOI 10.1006/exnr.2000.7409; Berhow MT, 1996, J NEUROSCI, V16, P8019; Bjorbaek C, 2001, J BIOL CHEM, V276, P4747, DOI 10.1074/jbc.M007439200; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Brennan AM, 2006, NAT CLIN PRACT ENDOC, V2, P318, DOI 10.1038/ncpendmet0196; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Cavanaugh JE, 2006, J NEUROSCI RES, V84, P1367, DOI 10.1002/jnr.21024; Chalovich EM, 2006, J BIOL CHEM, V281, P17870, DOI 10.1074/jbc.M602632200; Chen J, 1998, J NEUROSCI, V18, P4914; Chu CT, 2005, J NEUROCHEM, V94, P1685, DOI 10.1111/j.1471-4159.2005.03329.x; Cowen T, 2002, AUTON NEUROSCI-BASIC, V96, P20, DOI 10.1016/S1566-0702(01)00376-9; Dicou E, 2001, NEUROREPORT, V12, P3947, DOI 10.1097/00001756-200112210-00019; DIGICAYLIOGLU M, 1995, P NATL ACAD SCI USA, V92, P3717, DOI 10.1073/pnas.92.9.3717; Ding YM, 2004, J NEUROCHEM, V89, P776, DOI 10.1111/j.1471-4159.2004.02415.x; Ditlevsen DK, 2007, EUR J NEUROSCI, V25, P1678, DOI 10.1111/j.1460-9568.2007.05436.x; Elmquist JK, 1998, J COMP NEUROL, V395, P535; Enwere E, 2004, J NEUROSCI, V24, P8354, DOI 10.1523/JNEUROSCI.2751-04.2004; Figlewicz DP, 2003, BRAIN RES, V964, P107, DOI 10.1016/S0006-8993(02)04087-8; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Fujita Y, 2002, CLIN EXP IMMUNOL, V128, P21, DOI 10.1046/j.1365-2249.2002.01797.x; Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006; Gertler A, 2006, TRENDS ENDOCRIN MET, V17, P372, DOI 10.1016/j.tem.2006.09.006; GUNDERSEN HJG, 1986, J MICROSC-OXFORD, V143, P3, DOI 10.1111/j.1365-2818.1986.tb02764.x; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Hegyi K, 2004, CELL BIOL INT, V28, P159, DOI 10.1016/j.cellbi.2003.12.003; Hetman M, 2004, EUR J BIOCHEM, V271, P2050, DOI 10.1111/j.1432-1033.2004.04133.x; Hoda MR, 2007, BRIT J SURG, V94, P346, DOI 10.1002/bjs.5530; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Imada K, 2000, MOL IMMUNOL, V37, P1, DOI 10.1016/S0161-5890(00)00018-3; Komori T, 2006, NEUROSCIENCE, V139, P1107, DOI 10.1016/j.neuroscience.2005.12.066; Kurrimbux D, 2004, NEUROSCIENCE, V123, P527, DOI 10.1016/j.neuroscience.2003.08.061; Larsen KE, 2002, J NEUROSCI, V22, P8951; Leclere PG, 2005, J NEUROSCI METH, V142, P137, DOI 10.1016/j.jneumeth.2004.08.012; Liang QH, 2004, J NEUROSCI RES, V77, P747, DOI 10.1002/jnr.20198; Lu JN, 2006, NEUROSCI LETT, V407, P240, DOI 10.1016/j.neulet.2006.08.053; Luo YM, 2006, J NEUROCHEM, V97, P435, DOI 10.1111/j.1471-4159.2006.03758.x; Masutani H, 2004, MOL NEUROBIOL, V29, P229, DOI 10.1385/MN:29:3:229; Mercer JG, 1996, FEBS LETT, V387, P113, DOI 10.1016/0014-5793(96)00473-5; Mogi M, 1999, NEUROSCI LETT, V270, P45, DOI 10.1016/S0304-3940(99)00463-2; Mutze J, 2006, NEUROSCI LETT, V394, P105, DOI 10.1016/j.neulet.2005.10.031; Parain K, 1999, NEUROREPORT, V10, P557, DOI 10.1097/00001756-199902250-00021; Park J, 2006, DIABETES, V55, pA18; Ries V, 2006, P NATL ACAD SCI USA, V103, P18757, DOI 10.1073/pnas.0606401103; Rouet-Benzineb R, 2004, J BIOL CHEM, V279, P16495, DOI 10.1074/jbc.M312999200; Saxena NK, 2004, FASEB J, V18, P1612, DOI 10.1096/fj.04-1847fje; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Signore AP, 2006, J NEUROCHEM, V96, P428, DOI 10.1111/j.1471-4159.2005.03587.x; Simic G, 1997, J COMP NEUROL, V379, P482, DOI 10.1002/(SICI)1096-9861(19970324)379:4<482::AID-CNE2>3.0.CO;2-Z; Solaroglu I, 2006, STROKE, V37, P1123, DOI 10.1161/01.STR.0000208205.26253.96; Son JH, 1999, J NEUROSCI, V19, P10, DOI 10.1523/JNEUROSCI.19-01-00010.1999; SPINA MB, 1992, J NEUROCHEM, V59, P99, DOI 10.1111/j.1471-4159.1992.tb08880.x; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Tardito D, 2006, PHARMACOL REV, V58, P115, DOI 10.1124/pr.58.1.7; TOMAC A, 1995, NATURE, V373, P335, DOI 10.1038/373335a0; Troadec JD, 2002, MOL PHARMACOL, V62, P1043, DOI 10.1124/mol.62.5.1043; Walton MR, 2000, TRENDS NEUROSCI, V23, P48, DOI 10.1016/S0166-2236(99)01500-3; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Zhang L, 2002, J NEUROSCI METH, V117, P207, DOI 10.1016/S0165-0270(02)00114-0	62	126	131	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34479	34491		10.1074/jbc.M705426200	http://dx.doi.org/10.1074/jbc.M705426200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17895242	hybrid			2022-12-25	WOS:000251145700063
J	Keating, SE; Maloney, GM; Moran, EM; Bowie, AG				Keating, Sinead E.; Maloney, Geraldine M.; Moran, Ellen M.; Bowie, Andrew G.			IRAK-2 participates in multiple toll-like receptor signaling pathways to NF kappa B via activation of TRAF6 ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOPOLYSACCHARIDE-INDUCED INTERLEUKIN-10; INTERFERON-ALPHA INDUCTION; VACCINIA-VIRUS; ADAPTER MOLECULE; PROTEIN-KINASE; MICE LACKING; IL-1; FAMILY; MYD88; REGULATOR	Toll-like receptor (TLR) signaling is known to involve interleukin-1 receptor-associated kinases (IRAKs), however the particular role of IRAK-2 has remained unclear. Further, although IRAK-1 was originally thought to be central for the TLR-NF kappa B signaling axis, recent data have shown that it is dispensable for NF kappa B activation for some TLRs and demonstrated an alternative role for it in interferon regulatory factor activation. Here we show that IRAK-2 is critical for the TLR-mediated NF kappa B activation pathway. The poxviral TLR antagonist A52 inhibited NF kappa B activation by TLR2, -3, -4, -5, -7, and -9 ligands, via its interaction with IRAK-2, while not affecting interferon regulatory factor activation. Knockdown of IRAK-2 expression by small interfering RNA suppressed TLR3, TLR4, and TLR8 signaling to NF kappa B in human cell lines, and importantly, TLR4-mediated chemokine production in primary human cells. IRAK-2 usage by different TLRs was distinct, because it acted downstream of the TLR adaptors MyD88 and Mal but upstream of TRIF. Expression of IRAK-2, but not IRAK-1, led to TRAF6 ubiquitination, an event critical for NF kappa B activation. Further, IRAK-2 loss-of-function mutants, which could not activate NF kappa B, were incapable of promoting TRAF6 ubiquitination. Thus we propose that IRAK-2 plays a more central role than IRAK-1 in TLR signaling to NF kappa B.	Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland	Trinity College Dublin	Bowie, AG (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland.	agbowie@tcd.ie	Moran, Ellen/H-7722-2019	Moran, Ellen/0000-0002-0743-0770; Bowie, Andrew/0000-0001-5316-4373				Akira S, 2006, CURR TOP MICROBIOL, V311, P1; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bowie A, 2000, P NATL ACAD SCI USA, V97, P10162, DOI 10.1073/pnas.160027697; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Carty M, 2006, NAT IMMUNOL, V7, P1074, DOI 10.1038/ni1382; Chen HQ, 2006, FEBS LETT, V580, P3145, DOI 10.1016/j.febslet.2006.04.066; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Harte MT, 2003, J EXP MED, V197, P343, DOI 10.1084/jem.20021652; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; Huang YS, 2004, J BIOL CHEM, V279, P51697, DOI 10.1074/jbc.M410369200; Jiang ZF, 2003, J BIOL CHEM, V278, P16713, DOI 10.1074/jbc.M300562200; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kanakaraj P, 1998, J EXP MED, V187, P2073, DOI 10.1084/jem.187.12.2073; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Maloney G, 2005, J BIOL CHEM, V280, P30838, DOI 10.1074/jbc.M501917200; Martin MU, 2002, BBA-MOL CELL RES, V1592, P265, DOI 10.1016/S0167-4889(02)00320-8; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Oshiumi H, 2003, J BIOL CHEM, V278, P49751, DOI 10.1074/jbc.M305820200; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Schmidt A, 2001, MOL CELL BIOL, V21, P438, DOI 10.1128/MCB.21.2.438-448.2001; Schoenemeyer A, 2005, J BIOL CHEM, V280, P17005, DOI 10.1074/jbc.M412584200; Song YJ, 2006, P NATL ACAD SCI USA, V103, P2689, DOI 10.1073/pnas.0511096103; Stack J, 2005, J EXP MED, V201, P1007, DOI 10.1084/jem.20041442; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Swantek JL, 2000, J IMMUNOL, V164, P4301, DOI 10.4049/jimmunol.164.8.4301; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Thomas JA, 1999, J IMMUNOL, V163, P978; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	38	163	172	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33435	33443		10.1074/jbc.M705266200	http://dx.doi.org/10.1074/jbc.M705266200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17878161	hybrid			2022-12-25	WOS:000250840200023
J	Zhang, T; Zhuang, SH; Casteel, DE; Looney, DJ; Boss, GR; Pilz, RB				Zhang, Tong; Zhuang, Shunhui; Casteel, Darren E.; Looney, David J.; Boss, Gerry R.; Pilz, Renate B.			A cysteine-rich LIM-only protein mediates regulation of smooth muscle-specific gene expression by cGMP-dependent protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; REDUCES NEOINTIMA FORMATION; SOLUBLE GUANYLATE-CYCLASE; CYCLIC-GMP; CELL PHENOTYPE; NITRIC-OXIDE; VASCULAR INJURY; BALLOON INJURY; MARKER GENES; I-ALPHA	Vascular smooth muscle cells (VSMCs) undergo phenotypic modulation, changing from a differentiated, contractile to a dedifferentiated, synthetic phenotype; the change is associated with decreased expression of smooth muscle (SM)-specific genes and loss of cGMP-dependent protein kinase (PKG), but transfection of PKG into de-differentiated VSMCs restores SM-specific gene expression. Weshow that small interference RNA-mediated down-regulation or pharmacologic inhibition of PKG reduced SM-specific gene expression in differentiated VSMCs and provide a mechanism for cGMP/PKG regulation of SM-specific genes involving the cysteine-rich LIM-only protein CRP4. PKG associated with CRP4 and phosphorylated the protein in intact cells. CRP4 had no intrinsic transcriptional activity, but exhibited adaptor function, because it acted synergistically with serum response factor (SRF) and GATA6 to activate the SM-alpha-actin promoter. cGMP stimulation of the promoter required PKG and CRP4 co-expression with SRF and GATA6. A phosphorylation-deficient mutant CRP4 and a CRP4 deletion mutant deficient in PKG binding did not support cGMP/PKG stimulation of the SM-alpha-actin promoter. In the presence of wild-type but not mutant CRP4, cGMP/PKG enhanced SRF binding to a probe encoding the distal SM-alpha-actin promoter CArG (CC(AT)(6)GG) element. CRP4 and SRF associated with CArG elements of endogenous SM-specific genes in intact chromatin. Small interference RNA-mediated down-regulation of CRP4 prevented the positive effects of cGMP/PKG on SM-specific gene expression. In the presence of CRP4, cGMP/PKG increased SRF- and GATA6-dependent expression of endogenous SM-specific genes in pluripotent 10T1/2 cells. Thus, CRP4 mediates cGMP/PKG stimulation of SM-specific gene expression, and PKG plays an important role in regulating the phenotype of VSMCs.	Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Canc, La Jolla, CA 92093 USA; Vet Adm Med Ctr, La Jolla, CA 92161 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Pilz, RB (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	rpilz@ucsd.edu		Boss, Gerry/0000-0002-9758-8714	NIAID NIH HHS [P30-AI36214, T32-AI007469] Funding Source: Medline; NIAMS NIH HHS [R01-AR051300] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007469, P30AI036214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051300] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Anderson PG, 2000, ARTERIOSCL THROM VAS, V20, P2192, DOI 10.1161/01.ATV.20.10.2192; ARBER S, 1994, CELL, V79, P221, DOI 10.1016/0092-8674(94)90192-9; Belaguli NS, 2000, MOL CELL BIOL, V20, P7550, DOI 10.1128/MCB.20.20.7550-7558.2000; Boerth NJ, 1997, J VASC RES, V34, P245, DOI 10.1159/000159231; Bois PRJ, 2005, MOL CELL BIOL, V25, P7645, DOI 10.1128/MCB.25.17.7645-7656.2005; Brophy CM, 2002, J VASC RES, V39, P95, DOI 10.1159/000057758; Browner NC, 2004, J BIOL CHEM, V279, P46631, DOI 10.1074/jbc.M408518200; Casteel DE, 2002, J BIOL CHEM, V277, P32003, DOI 10.1074/jbc.M112332200; Chang DF, 2003, DEV CELL, V4, P107, DOI 10.1016/S1534-5807(02)00396-9; Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086; Chen YC, 2003, MOL CELL BIOL, V23, P4066, DOI 10.1128/MCB.23.12.4066-4082.2003; CORNWELL TL, 1994, J VASC RES, V31, P330, DOI 10.1159/000159061; CORNWELL TL, 1994, AM J PHYSIOL-CELL PH, V267, pC1405, DOI 10.1152/ajpcell.1994.267.5.C1405; Dey NB, 1998, CIRC RES, V82, P139; Doi K, 2001, ARTERIOSCL THROM VAS, V21, P930, DOI 10.1161/01.ATV.21.6.930; Gudi T, 2002, J BIOL CHEM, V277, P37382, DOI 10.1074/jbc.M204491200; Hanlon M, 1999, J BIOL CHEM, V274, P14224, DOI 10.1074/jbc.274.20.14224; Hayashi T, 2004, CARDIOVASC RES, V61, P339, DOI 10.1016/j.cardiores.2003.09.027; Hoofnagle MH, 2006, ARTERIOSCL THROM VAS, V26, P2579, DOI 10.1161/01.ATV.0000249623.79871.bc; Huber A, 2000, J BIOL CHEM, V275, P5504, DOI 10.1074/jbc.275.8.5504; Idriss SD, 1999, J BIOL CHEM, V274, P9489, DOI 10.1074/jbc.274.14.9489; Jain MK, 1996, J BIOL CHEM, V271, P10194, DOI 10.1074/jbc.271.17.10194; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Karim MA, 1996, GENOMICS, V31, P167, DOI 10.1006/geno.1996.0028; Kawai-Kowase K, 2005, MOL CELL BIOL, V25, P8009, DOI 10.1128/MCB.25.18.8009-8023.2005; Kawai-Kowase K, 2007, AM J PHYSIOL-CELL PH, V292, pC59, DOI 10.1152/ajpcell.00394.2006; KIMES BW, 1976, EXP CELL RES, V98, P349, DOI 10.1016/0014-4827(76)90446-8; Kloiber K, 1999, J MOL BIOL, V292, P893, DOI 10.1006/jmbi.1999.3118; Kong YF, 1997, MOL CELL BIOL, V17, P4750, DOI 10.1128/MCB.17.8.4750; Lincoln TM, 2006, FRONT BIOSCI-LANDMRK, V11, P356, DOI 10.2741/1803; Liu N, 2006, CURR OPIN CELL BIOL, V18, P715, DOI 10.1016/j.ceb.2006.10.003; Lohmann SM, 2005, FRONT BIOSCI, V10, P1313, DOI 10.2741/1621; Mack CP, 2001, J BIOL CHEM, V276, P341, DOI 10.1074/jbc.M005505200; McDonald OG, 2006, J CLIN INVEST, V116, P36, DOI 10.1172/JCI26505; Melichar VO, 2004, P NATL ACAD SCI USA, V101, P16671, DOI 10.1073/pnas.0405509101; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Morris KV, 2004, MOL THER, V10, P181, DOI 10.1016/j.ymthe.2004.03.019; Munzel T, 2003, CIRCULATION, V108, P2172, DOI 10.1161/01.CIR.0000094403.78467.C3; Oelze M, 2000, CIRC RES, V87, P999, DOI 10.1161/01.RES.87.11.999; OKANO I, 1993, FEBS LETT, V333, P51, DOI 10.1016/0014-5793(93)80373-3; Orstavik S, 1997, GENOMICS, V42, P311, DOI 10.1006/geno.1997.4743; Otterbein LE, 2003, NAT MED, V9, P183, DOI 10.1038/nm817; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pfeifer A, 1998, EMBO J, V17, P3045, DOI 10.1093/emboj/17.11.3045; Regan CP, 2000, J CLIN INVEST, V106, P1139, DOI 10.1172/JCI10522; ROTHMAN A, 1992, CIRCULATION, V86, P1977, DOI 10.1161/01.CIR.86.6.1977; Sauzeau V, 2003, J BIOL CHEM, V278, P9472, DOI 10.1074/jbc.M212776200; Sinnaeve P, 2002, CIRCULATION, V105, P2911, DOI 10.1161/01.CIR.0000018169.59205.CA; Sinnaeve P, 2001, CIRC RES, V88, P103, DOI 10.1161/01.RES.88.1.103; Smith PJ, 2002, SIGHT SOUND, V12, P32; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Tzeng E, 1996, MOL MED, V2, P211, DOI 10.1007/BF03401618; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wei J, 2005, CIRC RES, V97, P1323, DOI 10.1161/01.RES.0000194331.76925.5c; Weiskirchen R, 2003, BIOESSAYS, V25, P152, DOI 10.1002/bies.10226; Weiskirchen R, 2001, BIOCHEM J, V359, P485, DOI 10.1042/0264-6021:3590485; Wolfsgruber W, 2003, P NATL ACAD SCI USA, V100, P13519, DOI 10.1073/pnas.1936024100; Yamahara K, 2003, P NATL ACAD SCI USA, V100, P3404, DOI 10.1073/pnas.0538059100; Yao X, 1999, BIOCHEMISTRY-US, V38, P5701, DOI 10.1021/bi982036y; Yoshida T, 2003, CIRC RES, V92, P856, DOI 10.1161/01.RES.0000068405.49081.09; Yuasa K, 1999, J BIOL CHEM, V274, P37429, DOI 10.1074/jbc.274.52.37429; Zeng Y, 2006, J BIOL CHEM, V281, P16951, DOI 10.1074/jbc.M602099200; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000; Zhou WL, 2007, AM J PHYSIOL-LUNG C, V292, pL1459, DOI 10.1152/ajplung.00143.2006	64	25	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33367	33380		10.1074/jbc.M707186200	http://dx.doi.org/10.1074/jbc.M707186200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17878170	hybrid			2022-12-25	WOS:000250840200016
J	Knight, JDR; Qian, B; Baker, D; Kothary, R				Knight, James D. R.; Qian, Bin; Baker, David; Kothary, Rashmi			Conservation, Variability and the Modeling of Active Protein Kinases	PLOS ONE			English	Article								The human proteome is rich with protein kinases, and this richness has made the kinase of crucial importance in initiating and maintaining cell behavior. Elucidating cell signaling networks and manipulating their components to understand and alter behavior require well designed inhibitors. These inhibitors are needed in culture to cause and study network perturbations, and the same compounds can be used as drugs to treat disease. Understanding the structural biology of protein kinases in detail, including their commonalities, differences and modes of substrate interaction, is necessary for designing high quality inhibitors that will be of true use for cell biology and disease therapy. To this end, we here report on a structural analysis of all available active-conformation protein kinases, discussing residue conservation, the novel features of such conservation, unique properties of atypical kinases and variability in the context of substrate binding. We also demonstrate how this information can be used for structure prediction. Our findings will be of use not only in understanding protein kinase function and evolution, but they highlight the flaws inherent in kinase drug design as commonly practiced and dictate an appropriate strategy for the sophisticated design of specific inhibitors for use in the laboratory and disease therapy.	[Knight, James D. R.; Kothary, Rashmi] Ottawa Hlth Res Inst, Program Mol Med, Ottawa, ON, Canada; [Knight, James D. R.; Kothary, Rashmi] Univ Ottawa, Ctr Neuromuscular Dis, Ottawa, ON, Canada; [Knight, James D. R.; Kothary, Rashmi] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Qian, Bin; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Kothary, Rashmi] Univ Ottawa, Dept Med, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Washington; University of Washington Seattle; University of Ottawa	Kothary, R (corresponding author), Ottawa Hlth Res Inst, Program Mol Med, Ottawa, ON, Canada.	rkothary@ohri.ca	Baker, David/K-8941-2012	Baker, David/0000-0001-7896-6217; Kothary, Rashmi/0000-0002-9239-7310	Canadian Institutes of Health Research Canadian Graduate Scholarship; Multiple Sclerosis Society of Canada (MSSC); American Leukemia and Lymphoma Society Fellowship; Howard Hughes Medical Institute	Canadian Institutes of Health Research Canadian Graduate Scholarship(Canadian Institutes of Health Research (CIHR)); Multiple Sclerosis Society of Canada (MSSC); American Leukemia and Lymphoma Society Fellowship; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by a Canadian Institutes of Health Research Canadian Graduate Scholarship and a Multiple Sclerosis Society of Canada (MSSC) Studentship (JDRK), by an American Leukemia and Lymphoma Society Fellowship (BQ), the Howard Hughes Medical Institute (DB) and an MSSC grant (RK).	Bellon S, 1999, STRUCTURE, V7, P1057, DOI 10.1016/S0969-2126(99)80173-7; Biondi RM, 2002, EMBO J, V21, P4219, DOI 10.1093/emboj/cdf437; Biondi RM, 2003, BIOCHEM J, V372, P1, DOI 10.1042/BJ20021641; Blencke S, 2004, CHEM BIOL, V11, P691, DOI 10.1016/j.chembiol.2004.02.029; Bogoyevitch MA, 2005, BBA-PROTEINS PROTEOM, V1754, P79, DOI 10.1016/j.bbapap.2005.07.025; CARRERA AC, 1993, P NATL ACAD SCI USA, V90, P442, DOI 10.1073/pnas.90.2.442; Claude J, 2004, SYST BIOL, V53, P933, DOI 10.1080/10635150490889498; DAS R, PROTEINS IN PRESS; Dedhar S, 1999, TRENDS CELL BIOL, V9, P319, DOI 10.1016/S0962-8924(99)01612-8; Drennan D, 2004, PROG BIOPHYS MOL BIO, V85, P1, DOI 10.1016/S0079-6107(03)00060-9; Dryden I., 1998, STAT ANAL SHAPE; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Felberg J, 2004, J BIOL CHEM, V279, P3455, DOI 10.1074/jbc.M309537200; GOODALL C, 1991, J ROY STAT SOC B MET, V53, P285, DOI 10.1111/j.2517-6161.1991.tb01825.x; Grishin NV, 2001, J STRUCT BIOL, V134, P167, DOI 10.1006/jsbi.2001.4335; Gutteridge A, 2005, TRENDS BIOCHEM SCI, V30, P622, DOI 10.1016/j.tibs.2005.09.006; Hawkins J, 2000, ARCH BIOCHEM BIOPHYS, V382, P310, DOI 10.1006/abbi.2000.2005; Hommes D, 2002, GASTROENTEROLOGY, V122, P7, DOI 10.1053/gast.2002.30770; Huang JH, 2003, BIOCHEM BIOPH RES CO, V303, P532, DOI 10.1016/S0006-291X(03)00387-5; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; Iyer GH, 2005, J MOL BIOL, V351, P1110, DOI 10.1016/j.jmb.2005.06.011; Kent J.T., 1992, ART STAT SCI, P115; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; LaRonde-LeBlanc N, 2005, J BIOL CHEM, V280, P37297, DOI 10.1074/jbc.R500013200; LaRonde-LeBlanc N, 2005, FEBS J, V272, P2800, DOI 10.1111/j.1742-4658.2005.04702.x; LaRonde-LeBlanc N, 2004, STRUCTURE, V12, P1585, DOI 10.1016/j.str.2004.06.016; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Liu Y, 1999, CHEM BIOL, V6, P671, DOI 10.1016/S1074-5521(99)80118-5; Lougheed JC, 2004, J BIOL CHEM, V279, P44039, DOI 10.1074/jbc.M406703200; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Min XS, 2004, STRUCTURE, V12, P1303, DOI 10.1016/j.str.2004.04.014; Nolen B, 2003, BIOCHEMISTRY-US, V42, P9575, DOI 10.1021/bi0344331; Nolen B, 2001, NAT STRUCT BIOL, V8, P176, DOI 10.1038/84178; Ono-Saito N, 1999, PHARMACOL THERAPEUT, V82, P123, DOI 10.1016/S0163-7258(98)00070-9; OWEN DJ, 1995, STRUCTURE, V3, P467, DOI 10.1016/S0969-2126(01)00180-0; Perea SE, 2004, CANCER RES, V64, P7127, DOI 10.1158/0008-5472.CAN-04-2086; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Qian KC, 2005, J BIOL CHEM, V280, P6130, DOI 10.1074/jbc.M409123200; Robinson MJ, 1996, BIOCHEMISTRY-US, V35, P5641, DOI 10.1021/bi952723e; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Russo AA, 1996, NAT STRUCT BIOL, V3, P696, DOI 10.1038/nsb0896-696; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Sebolt-Leopold JS, 2006, NATURE, V441, P457, DOI 10.1038/nature04874; Shah Kavita, 2003, Methods Mol Biol, V233, P253; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Tereshko V, 2001, NAT STRUCT BIOL, V8, P899, DOI 10.1038/nsb1001-899; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Todd AE, 2002, TRENDS BIOCHEM SCI, V27, P419, DOI 10.1016/S0968-0004(02)02158-8; Tu Z, 2003, CELL SIGNAL, V15, P65, DOI 10.1016/S0898-6568(02)00056-6; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Xu BE, 2000, J BIOL CHEM, V275, P16795, DOI 10.1074/jbc.275.22.16795; XU RM, 1995, EMBO J, V14, P1015, DOI 10.1002/j.1460-2075.1995.tb07082.x; Yamaguchi H, 2001, MOL CELL, V7, P1047, DOI 10.1016/S1097-2765(01)00256-8; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Yde CW, 2005, J MOL BIOL, V347, P399, DOI 10.1016/j.jmb.2005.01.003; Young TA, 2003, NAT STRUCT BIOL, V10, P168, DOI 10.1038/nsb897; ZHENG JH, 1993, ACTA CRYSTALLOGR D, V49, P362, DOI 10.1107/S0907444993000423; Zhou TJ, 2004, STRUCTURE, V12, P1891, DOI 10.1016/j.str.2004.07.021	59	43	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e982	10.1371/journal.pone.0000982	http://dx.doi.org/10.1371/journal.pone.0000982			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912359	gold, Green Published			2022-12-25	WOS:000207455900018
J	Martyniuk, CJ; Aris-Brosou, S; Drouin, G; Cahn, J; Trudeau, VL				Martyniuk, Christopher J.; Aris-Brosou, Stephane; Drouin, Guy; Cahn, Joel; Trudeau, Vance L.			Early Evolution of Ionotropic GABA Receptors and Selective Regimes Acting on the Mammalian-Specific Theta and Epsilon Subunits	PLOS ONE			English	Article								Background. The amino acid neurotransmitter GABA is abundant in the central nervous system (CNS) of both invertebrates and vertebrates. Receptors of this neurotransmitter play a key role in important processes such as learning and memory. Yet, little is known about the mode and tempo of evolution of the receptors of this neurotransmitter. Here, we investigate the phylogenetic relationships of GABA receptor subunits across the chordates and detail their mode of evolution among mammals. Principal Findings. Our analyses support two major monophyletic clades: one clade containing GABA(A) receptor alpha, gamma, and epsilon subunits, and another one containing GABA(A) receptor rho, beta, delta, theta, and pi subunits. The presence of GABA receptor subunits from each of the major clades in the Ciona intestinalis genome suggests that these ancestral duplication events occurred before the divergence of urochordates. However, while gene divergence proceeded at similar rates on most receptor subunits, we show that the mammalian-specific subunits theta and epsilon experienced an episode of positive selection and of relaxed constraints, respectively, after the duplication event. Sites putatively under positive selection are placed on a three-dimensional model obtained by homology-modeling. Conclusions. Our results suggest an early divergence of the GABA receptor subunits, before the split from urochordates. We show that functional changes occurred in the lineages leading to the mammalian-specific subunit theta, and we identify the amino acid sites putatively responsible for the functional divergence. We discuss potential consequences for the evolution of mammals and of their CNS.	[Martyniuk, Christopher J.; Aris-Brosou, Stephane; Drouin, Guy; Cahn, Joel; Trudeau, Vance L.] Univ Ottawa, Dept Biol, Ottawa, ON, Canada; [Martyniuk, Christopher J.; Aris-Brosou, Stephane; Drouin, Guy; Cahn, Joel; Trudeau, Vance L.] Univ Ottawa, Ctr Adv Res Environm Gen, Ottawa, ON, Canada; [Aris-Brosou, Stephane] Univ Ottawa, Dept Math & Stat, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; University of Ottawa	Aris-Brosou, S (corresponding author), Univ Ottawa, Dept Biol, Ottawa, ON, Canada.	sarisbro@uottawa.ca	Trudeau, Vance L./P-5542-2019	Trudeau, Vance L./0000-0002-0845-9444; Aris-Brosou, Stephane/0000-0003-4987-0296; Martyniuk, Christopher J./0000-0003-0921-4796	Ontario Graduate Scholarship; Natural Sciences and Engineering Research Council	Ontario Graduate Scholarship(Ontario Graduate Scholarship); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by an Ontario Graduate Scholarship to CJM, and by Natural Sciences and Engineering Research Council Discovery Grants to VLT, SAB and GD.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anadon R, 1998, J COMP NEUROL, V401, P293; AnselmoFranci JA, 1997, BRAIN RES, V767, P289, DOI 10.1016/S0006-8993(97)00613-6; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Arvat E, 2002, J ENDOCRINOL INVEST, V25, P735, DOI 10.1007/BF03345110; Bates PA, 2001, PROTEINS, P39; Bielawski Joseph P., 2003, Journal of Structural and Functional Genomics, V3, P201, DOI 10.1023/A:1022642807731; Bormann J, 2000, TRENDS PHARMACOL SCI, V21, P16, DOI 10.1016/S0165-6147(99)01413-3; BORMANN J, 1995, TRENDS NEUROSCI, V18, P515, DOI 10.1016/0166-2236(95)98370-E; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Costa E, 2002, NEUROPHARMACOLOGY, V43, P925, DOI 10.1016/S0028-3908(02)00199-5; Couve A, 2000, MOL CELL NEUROSCI, V16, P296, DOI 10.1006/mcne.2000.0908; CUTTING GR, 1992, GENOMICS, V12, P801, DOI 10.1016/0888-7543(92)90312-G; Darlison MG, 2005, CELL MOL NEUROBIOL, V25, P607, DOI 10.1007/s10571-005-4004-4; DARLISON MG, 1992, TRENDS NEUROSCI, V15, P469, DOI 10.1016/0166-2236(92)90091-L; Dent JA, 2006, J MOL EVOL, V62, P523, DOI 10.1007/s00239-005-0018-2; Derry JMC, 2004, J NEUROCHEM, V88, P1431, DOI 10.1046/j.1471-4159.2003.02264.x; ERIKSSON KS, 1994, J COMP NEUROL, V345, P528, DOI 10.1002/cne.903450405; Galperin MY, 1999, GENETICA, V106, P159, DOI 10.1023/A:1003705601428; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HEBEBRAND J, 1987, J NEUROCHEM, V48, P1103, DOI 10.1111/j.1471-4159.1987.tb05633.x; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; Huelsenbeck JP, 2004, MOL BIOL EVOL, V21, P1123, DOI 10.1093/molbev/msh123; Irwin DM, 2005, J HERED, V96, P205, DOI 10.1093/jhered/esi024; Johnston Graham A. R., 2002, Current Topics in Medicinal Chemistry, V2, P903, DOI 10.2174/1568026023393453; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kass-Simon G, 2003, COMP BIOCHEM PHYS A, V136, P329, DOI 10.1016/S1095-6433(03)00168-5; Kellogg CK, 1998, PERSPECT DEV NEUROBI, V5, P219; Koulen P, 1997, J COMP NEUROL, V380, P520, DOI 10.1002/(SICI)1096-9861(19970421)380:4<520::AID-CNE8>3.0.CO;2-3; Moragues N, 2003, BRAIN RES, V967, P285, DOI 10.1016/S0006-8993(02)04270-1; Myhrer T, 2003, BRAIN RES REV, V41, P268, DOI 10.1016/S0165-0173(02)00268-0; Newell JG, 2004, J NEUROSCI, V24, P11226, DOI 10.1523/JNEUROSCI.3746-04.2004; NIELSEN M, 1978, BRAIN RES, V141, P342, DOI 10.1016/0006-8993(78)90203-2; Nielsen R, 1998, GENETICS, V148, P929; OHTA T, 1989, GENOME, V31, P304, DOI 10.1139/g89-048; Okamura Y, 2005, PHYSIOL GENOMICS, V22, P269, DOI 10.1152/physiolgenomics.00229.2004; ORONA E, 1990, J COMP NEUROL, V294, P633, DOI 10.1002/cne.902940410; ORTELLS MO, 1995, TRENDS NEUROSCI, V18, P121, DOI 10.1016/0166-2236(95)93887-4; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; RABOW LE, 1995, SYNAPSE, V21, P189, DOI 10.1002/syn.890210302; Ranna Martin, 2006, BMC Pharmacology, V6, P1, DOI 10.1186/1471-2210-6-1; Rocha AA, 2006, NEUROPEPTIDES, V40, P57, DOI 10.1016/j.npep.2005.10.005; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Russek SJ, 1999, GENE, V227, P213, DOI 10.1016/S0378-1119(98)00594-0; Shimeld SM, 2000, P NATL ACAD SCI USA, V97, P4449, DOI 10.1073/pnas.97.9.4449; Simon J, 2004, J BIOL CHEM, V279, P41422, DOI 10.1074/jbc.M401354200; Sinkkonen ST, 2000, J NEUROSCI, V20, P3588, DOI 10.1523/JNEUROSCI.20-10-03588.2000; Tsang SY, 2007, MOL BIOL EVOL, V24, P599, DOI 10.1093/molbev/msl188; Vandepoele K, 2004, P NATL ACAD SCI USA, V101, P1638, DOI 10.1073/pnas.0307968100; Venclovas C, 2005, PROTEINS, V61, P99, DOI 10.1002/prot.20725; Whiting PJ, 1999, NEUROCHEM INT, V34, P387, DOI 10.1016/S0197-0186(99)00048-0; Xue H, 1998, J MOL EVOL, V47, P323, DOI 10.1007/PL00006390; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2000, GENETICS, V155, P431; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZZ, 2005, MATHEMATICS OF EVOLUTION AND PHYLOGENY, P63; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	62	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2007	2	9							e894	10.1371/journal.pone.0000894	http://dx.doi.org/10.1371/journal.pone.0000894			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HS	17878929	Green Published, gold			2022-12-25	WOS:000207455700002
J	Chaigne-Delalande, B; Anies, G; Kramer, I; Genot, E				Chaigne-Delalande, B.; Anies, G.; Kramer, I.; Genot, E.			Nonadherent cells switch to a Rac-mediated, SHIP regulated, Akt activation mode for survival	ONCOGENE			English	Article						adhesion; anoikis; akt; rac; SHIP; survival	PROTEIN-KINASE B; INTEGRINS; PATHWAYS; MOTILITY; ADHESION; 3-KINASE; PHOSPHORYLATION; PI-3-KINASE; P130(CAS); ANOIKIS	Constitutively active Rac stimulates Akt activity in T lymphocytes cultured in suspension. This regulation contrasts with findings obtained in fibroblasts, endothelial or neuronal cells grown on substrate, where Akt stimulation occurs independently of Rac. We now show that V12Rac-mediated stimulation of Akt is not restricted to the hematopoietic lineage but is dependent on the adherence status of the cell. V12Rac-mediated stimulation of Akt as well as molecular association between Rac and Akt occurred exclusively in cells kept in suspension. Stimulation and complex formation are dependent on SHIP but in a manner that differs from its role in dephosphorylation of phosphoinositide lipids. Adherent cells lacking SHIP, but not those lacking PTEN, are able to activate Akt through the Rac pathway. Our data reveal the existence of a bona. de Rac to Akt signaling pathway, tightly regulated by SHIP and operational in suspended cells only. This pathway may point to an alternative survival signal that is called into action when cells lose contact with the substrate and/or with other cells.	[Chaigne-Delalande, B.; Anies, G.; Kramer, I.; Genot, E.] Univ Bordeaux 1, European Inst Chem & Biol, Pessac, France; [Chaigne-Delalande, B.; Anies, G.; Kramer, I.; Genot, E.] INSERM, U889, Bordeaux, France	UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm)	Chaigne-Delalande, B (corresponding author), IECB, INSERT U441, 2 Rue Robert Escapit, F-33600 Pessac, France.	e.genot@iecb.u-bordeaux.fr	Genot, Elisabeth/G-8031-2014					Astoul E, 2001, TRENDS IMMUNOL, V22, P490, DOI 10.1016/S1471-4906(01)01973-1; Coniglio SJ, 2001, J BIOL CHEM, V276, P28113, DOI 10.1074/jbc.M102299200; del Pozo MA, 2000, EMBO J, V19, P2008, DOI 10.1093/emboj/19.9.2008; Del Pozo MA, 2002, NAT CELL BIOL, V4, P232, DOI 10.1038/ncb759; Downward J, 2004, SEMIN CELL DEV BIOL, V15, P177, DOI 10.1016/j.semcdb.2004.01.002; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; Genot E, 1998, ONCOGENE, V17, P1731, DOI 10.1038/sj.onc.1202101; Genot EM, 2000, MOL CELL BIOL, V20, P5469, DOI 10.1128/MCB.20.15.5469-5478.2000; Grodzki ACG, 2003, BRAZ J MED BIOL RES, V36, P1101, DOI 10.1590/S0100-879X2003000800017; Higuchi M, 2001, CURR BIOL, V11, P1958, DOI 10.1016/S0960-9822(01)00599-1; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; Kim D, 2001, FASEB J, V15, P1953, DOI 10.1096/fj.01-0198com; Krystal G, 2000, SEMIN IMMUNOL, V12, P397, DOI 10.1006/smim.2000.0222; MARTE BM, 1997, CURR BIOL, V63, P3; Moreau V, 2003, MOL CELL BIOL, V23, P6809, DOI 10.1128/MCB.23.19.6809-6822.2003; NOJIMA Y, 1995, J BIOL CHEM, V270, P15398, DOI 10.1074/jbc.270.25.15398; Ono M, 1997, CELL, V90, P293, DOI 10.1016/S0092-8674(00)80337-2; Parekh DB, 2000, BIOCHEM J, V352, P425, DOI 10.1042/0264-6021:3520425; Prasad N, 2001, MOL CELL BIOL, V21, P1416, DOI 10.1128/MCB.21.4.1416-1428.2001; QIU RG, 1995, NATURE, V374, P457, DOI 10.1038/374457a0; Reif K, 1996, CURR BIOL, V6, P1445, DOI 10.1016/S0960-9822(96)00749-X; RUOSLAHTI E, 1994, CELL, V77, P477, DOI 10.1016/0092-8674(94)90209-7; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Snyder JT, 2003, J BIOL CHEM, V278, P21099, DOI 10.1074/jbc.M301418200; Soga N, 2001, EXP CELL RES, V269, P73, DOI 10.1006/excr.2001.5295; Song JX, 2004, NAT IMMUNOL, V5, P150, DOI 10.1038/ni1030; TSUJIMURA T, 1995, INT ARCH ALLERGY IMM, V106, P377, DOI 10.1159/000236870; van Weering DHJ, 1998, MOL CELL BIOL, V18, P1802, DOI 10.1128/MCB.18.4.1802; WARD SG, 1992, EUR J IMMUNOL, V22, P45, DOI 10.1002/eji.1830220108; Ward SG, 1996, IMMUNOL TODAY, V17, P187, DOI 10.1016/0167-5699(96)80618-9; Watton SJ, 1999, CURR BIOL, V9, P433, DOI 10.1016/S0960-9822(99)80192-4; Welch H, 1998, J BIOL CHEM, V273, P11248, DOI 10.1074/jbc.273.18.11248; WENNSTROM S, 1994, CURR BIOL, V4, P385, DOI 10.1016/S0960-9822(00)00087-7	33	8	8	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2008	27	13					1876	1885		10.1038/sj.onc.1210830	http://dx.doi.org/10.1038/sj.onc.1210830			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	276NZ	17906692				2022-12-25	WOS:000254150600007
J	Ha, KN; Traaseth, NJ; Verardi, R; Zamoon, J; Cembran, A; Karim, CB; Thomas, DD; Veglia, G				Ha, Kim N.; Traaseth, Nathaniel J.; Verardi, Raffaello; Zamoon, Jamillah; Cembran, Alessandro; Karim, Christine B.; Thomas, David D.; Veglia, Gianluigi			Controlling the inhibition of the sarcoplasmic Ca2+-ATPase by tuning phospholamban structural dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADVANCED HEART-FAILURE; SOLID-STATE NMR; DILATED CARDIOMYOPATHY; CONFORMATIONAL SWITCH; PROTEIN SECONDARY; CALCIUM-PUMP; PHOSPHORYLATION; CA2+; DOMAIN; SITE	Cardiac contraction and relaxation are regulated by conformational transitions of protein complexes that are responsible for calcium trafficking through cell membranes. Central to the muscle relaxation phase is a dynamic membrane protein complex formed by Ca2+-ATPase (SERCA) and phospholamban (PLN), which in humans is responsible for similar to 70% of the calcium re-uptake in the sarcoplasmic reticulum. Dysfunction in this regulatory mechanism causes severe pathophysiologies. In this report, we used a combination of nuclear magnetic resonance, electron paramagnetic resonance, and coupled enzyme assays to investigate how single mutations at position 21 of PLN affects its structural dynamics and, in turn, its interaction with SERCA. We found that it is possible to control the activity of SERCA by tuning PLN structural dynamics. Both increased rigidity and mobility of the PLN backbone cause a reduction of SERCA inhibition, affecting calcium transport. Although the more rigid, loss-of-function (LOF) mutants have lower binding affinities for SERCA, the more dynamic LOF mutants have binding affinities similar to that of PLN. Here, we demonstrate that it is possible to harness this knowledge to design new LOF mutants with activity similar to S16E (a mutant already used in gene therapy) for possible application in recombinant gene therapy. As proof of concept, we show a new mutant of PLN, P21G, with improved LOF characteristics in vitro.	[Verardi, Raffaello; Zamoon, Jamillah; Karim, Christine B.; Thomas, David D.; Veglia, Gianluigi] Univ Minnesota, Dept Biochem Biophys & Mol Biol, Minneapolis, MN 55455 USA; [Ha, Kim N.; Traaseth, Nathaniel J.; Cembran, Alessandro; Veglia, Gianluigi] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Veglia, G (corresponding author), Univ Minnesota, Dept Biochem Biophys & Mol Biol, 6-155 Jackson Hall, Minneapolis, MN 55455 USA.	veglia@chem.umn.edu	Traaseth, Nathaniel/B-4751-2010; Thomas, David D/B-4257-2012; Cembran, Alessandro/B-1561-2016	Cembran, Alessandro/0000-0002-9868-4994; Thomas, David D./0000-0002-8822-2040; Karim, Christine/0000-0002-7321-7695	NHLBI NIH HHS [K02HL080081, K02 HL080081-02, K02 HL080081] Funding Source: Medline; NIGMS NIH HHS [R01 GM027906-27, R01 GM027906, R01 GM064742, GM64742, R01 GM064742-06A1, GM27906] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL080081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027906, R01GM064742] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Afara MR, 2006, BIOCHEMISTRY-US, V45, P8617, DOI 10.1021/bi0523761; Asahi M, 1999, J BIOL CHEM, V274, P32855, DOI 10.1074/jbc.274.46.32855; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2006, ANN NY ACAD SCI, V1080, P165, DOI 10.1196/annals.1380.015; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; Buck B, 2003, PROTEIN EXPRES PURIF, V30, P253, DOI 10.1016/S1046-5928(03)00127-X; CASELLA G, 2001, STAT INFERENCE, P161; Chien K.R, 2006, NOVART FDN SYMP, V274, P272; Chien K.R, 2006, NOVART FDN SYMP, V274, P256; CHIEN KR, 1926, NOVART FDN SYMP, V274, P244; Cornea RL, 1997, BIOCHEMISTRY-US, V36, P2960, DOI 10.1021/bi961955q; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Hagemann D, 2002, TRENDS CARDIOVAS MED, V12, P51, DOI 10.1016/S1050-1738(01)00145-1; Haghighi K, 2006, P NATL ACAD SCI USA, V103, P1388, DOI 10.1073/pnas.0510519103; Haghighi K, 2003, J CLIN INVEST, V111, P869, DOI 10.1172/JCI200317892; Hoshijima M, 2002, NAT MED, V8, P864, DOI 10.1038/nm739; Hoshijima M, 2006, J AM COLL CARDIOL, V48, pA15, DOI 10.1016/j.jacc.2006.06.070; Inesi G, 2006, BIOCHEMISTRY-US, V45, P13769, DOI 10.1021/bi061255d; JAMES P, 1989, NATURE, V342, P90, DOI 10.1038/342090a0; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Karim CB, 1998, BIOCHEMISTRY-US, V37, P12074, DOI 10.1021/bi980642n; Karim CB, 2006, J MOL BIOL, V358, P1032, DOI 10.1016/j.jmb.2006.02.051; Karim CB, 2004, P NATL ACAD SCI USA, V101, P14437, DOI 10.1073/pnas.0402801101; Karim CB, 2007, NAT PROTOC, V2, P42, DOI 10.1038/nprot.2007.2; Kaye DM, 2007, J AM COLL CARDIOL, V50, P253, DOI 10.1016/j.jacc.2007.03.047; Kimura Y, 1997, J BIOL CHEM, V272, P15061, DOI 10.1074/jbc.272.24.15061; Kimura Y, 1998, J BIOL CHEM, V273, P14238, DOI 10.1074/jbc.273.23.14238; Li JH, 2005, BIOCHEMISTRY-US, V44, P16181, DOI 10.1021/bi051075o; MacLennan DH, 2000, EUR J BIOCHEM, V267, P5291, DOI 10.1046/j.1432-1327.2000.01566.x; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; MacLennan DH, 2002, J MOL CELL CARDIOL, V34, P897, DOI 10.1006/jmcc.2002.2031; MacLennan DH, 1998, ANN NY ACAD SCI, V853, P31, DOI 10.1111/j.1749-6632.1998.tb08254.x; MARION D, 1989, BIOCHEMISTRY-US, V28, P6150, DOI 10.1021/bi00441a004; Mascioni A, 2002, J AM CHEM SOC, V124, P9392, DOI 10.1021/ja026507m; Mattiazzi A, 2006, BRAZ J MED BIOL RES, V39, P563, DOI 10.1590/S0100-879X2006000500001; Meiler J, 2003, P NATL ACAD SCI USA, V100, P12105, DOI 10.1073/pnas.1831973100; Metcalfe EE, 2005, BIOCHEMISTRY-US, V44, P4386, DOI 10.1021/bi047571e; Metcalfe EE, 2004, BIOPHYS J, V87, P1205, DOI 10.1529/biophysj.103.038844; Minamisawa S, 2003, J BIOL CHEM, V278, P9570, DOI 10.1074/jbc.M213132200; Mueller B, 2004, BIOCHEMISTRY-US, V43, P8754, DOI 10.1021/bi049732k; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Reddy LG, 2003, BIOCHEMISTRY-US, V42, P4585, DOI 10.1021/bi026995a; Schmidt AG, 2001, CARDIOVASC DRUG THER, V15, P387, DOI 10.1023/A:1013381204658; Schmitt JP, 2003, SCIENCE, V299, P1410, DOI 10.1126/science.1081578; Simmerman HKB, 1996, J BIOL CHEM, V271, P5941, DOI 10.1074/jbc.271.10.5941; Simmerman HKB, 1998, PHYSIOL REV, V78, P921, DOI 10.1152/physrev.1998.78.4.921; SIMMERMAN HKB, 1986, J BIOL CHEM, V261, P3333; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2003, P NATL ACAD SCI USA, V100, P467, DOI 10.1073/pnas.0237326100; Traaseth NJ, 2006, J MOL BIOL, V358, P1041, DOI 10.1016/j.jmb.2006.02.047; Traaseth NJ, 2007, P NATL ACAD SCI USA, V104, P14676, DOI 10.1073/pnas.0701016104; WEGENER AD, 1989, J BIOL CHEM, V264, P11468; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; Zamoon J, 2005, P NATL ACAD SCI USA, V102, P4747, DOI 10.1073/pnas.0406039102; Zamoon J, 2003, BIOPHYS J, V85, P2589, DOI 10.1016/S0006-3495(03)74681-5; ZUIDERWEG ERP, 1989, BIOCHEMISTRY-US, V28, P2387, DOI 10.1021/bi00432a008	58	48	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37205	37214		10.1074/jbc.M704056200	http://dx.doi.org/10.1074/jbc.M704056200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17908690	hybrid			2022-12-25	WOS:000251646000046
J	Chen, IJ; Chen, HL; Demetriou, M				Chen, I-Ju; Chen, Hung-Lin; Demetriou, Michael			Lateral compartmentalization of T cell receptor versus CD45 by galectin-N-glycan binding and Microfilaments coordinate basal and activation signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE KINASE; LIPID RAFTS; IMMUNOLOGICAL SYNAPSE; ANTIGEN RECEPTOR; MEMBRANE MICRODOMAINS; PHYSICAL ASSOCIATION; PLASMA-MEMBRANE; LCK ACTIVITY; SURFACE; PHOSPHATASE	Lateral compartmentalization of membrane proteins into microdomains regulates signal transduction; however, structural determinants are incompletely understood. Membrane glycoproteins bind galectins in proportion to the number (i.e. NX( S/T) sites) and degree of GlcNAc branching within attached N-glycans, forming a molecular lattice that negatively regulates T cell function and autoimmunity. We find that in resting T cells, partition of CD45 inside and T cell receptor (TCR)/CD4-Lck/Zap-70 outside microdomains is positively and negatively regulated by the galectin lattice and actin cytoskeleton, respectively. In the absence of TCR ligands, the galectin lattice counteracts F-actin to retain CD45 in microdomains while concurrently blocking TCR/CD4-Lck/Zap-70 partition to microdomains by preventing a conformational change in the TCR that recruits Nck/Wiscott Aldrich Syndrome (WASp)/SLP76/F-actin/CD4 to TCR. The counterbalancing activities of the galectin lattice and actin cytoskeleton negatively and positively regulate Lck activity in resting cells and CD45 versus TCR clustering and signaling at the early immune synapse, respectively. Microdomain-localized CD45 inactivates Lck and inhibits TCR signaling at the early immune synapse. Thus, the galectin lattice and actin cytoskeleton interact on opposing sides of the plasma membrane to control microdomain structure and function, coupling basal growth signaling with thresholds to activation.	Univ Calif Irvine, Dept Neurol, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Demetriou, M (corresponding author), Univ Calif Irvine, Dept Neurol, Irvine, CA 92697 USA.	mdemetri@uci.edu		Chen, Hung-Lin/0000-0001-7900-3391; Demetriou, Michael/0000-0002-2224-7798				Alegre ML, 2001, NAT REV IMMUNOL, V1, P220, DOI 10.1038/35105024; Baker M, 2000, EMBO J, V19, P4644, DOI 10.1093/emboj/19.17.4644; Barda-Saad M, 2005, NAT IMMUNOL, V6, P80, DOI 10.1038/ni1143; Billadeau DD, 2006, TRAFFIC, V7, P1451, DOI 10.1111/j.1600-0854.2006.00491.x; Brewer CF, 2002, CURR OPIN STRUC BIOL, V12, P616, DOI 10.1016/S0959-440X(02)00364-0; Burack WR, 2002, J IMMUNOL, V169, P2837, DOI 10.4049/jimmunol.169.6.2837; BURNS CM, 1994, J BIOL CHEM, V269, P13594; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; CHUCK RS, 1990, P NATL ACAD SCI USA, V87, P5021, DOI 10.1073/pnas.87.13.5021; Collins BE, 2006, NAT IMMUNOL, V7, P199, DOI 10.1038/ni1283; D'Oro U, 1999, J IMMUNOL, V162, P1879; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; DERRY JMJ, 1994, CELL, V78, P635, DOI 10.1016/0092-8674(94)90528-2; Edidin M, 2003, ANNU REV BIOPH BIOM, V32, P257, DOI 10.1146/annurev.biophys.32.110601.142439; Edmonds SD, 2002, J IMMUNOL, V169, P5036, DOI 10.4049/jimmunol.169.9.5036; Fragoso R, 2003, J IMMUNOL, V170, P913, DOI 10.4049/jimmunol.170.2.913; Freiberg BA, 2002, NAT IMMUNOL, V3, P911, DOI 10.1038/ni836; Gallego MD, 1997, BLOOD, V90, P3089, DOI 10.1182/blood.V90.8.3089; Gaus K, 2005, J CELL BIOL, V171, P121, DOI 10.1083/jcb.200505047; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Granovsky M, 2000, NAT MED, V6, P306; Grewal PK, 2006, MOL CELL BIOL, V26, P4970, DOI 10.1128/MCB.00308-06; Grigorian A, 2007, J BIOL CHEM, V282, P20027, DOI 10.1074/jbc.M701890200; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Hawash IY, 2002, BBA-MOL CELL RES, V1589, P140, DOI 10.1016/S0167-4889(02)00165-9; He X, 2002, EUR J IMMUNOL, V32, P2578, DOI 10.1002/1521-4141(200209)32:9<2578::AID-IMMU2578>3.0.CO;2-3; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Irles C, 2003, NAT IMMUNOL, V4, P189, DOI 10.1038/ni877; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; Kabouridis PS, 1997, EMBO J, V16, P4983, DOI 10.1093/emboj/16.16.4983; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; LEE SU, 2007, J BIOL CHEM, V282; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Lichtenberg D, 2005, TRENDS BIOCHEM SCI, V30, P430, DOI 10.1016/j.tibs.2005.06.004; Mayor S, 2004, TRAFFIC, V5, P231, DOI 10.1111/j.1600-0854.2004.00172.x; Minguet S, 2007, IMMUNITY, V26, P43, DOI 10.1016/j.immuni.2006.10.019; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; Morgan R, 2004, J IMMUNOL, V173, P7200, DOI 10.4049/jimmunol.173.12.7200; Mustelin T, 2005, NAT REV IMMUNOL, V5, P43, DOI 10.1038/nri1530; Nieminen J, 2007, J BIOL CHEM, V282, P1374, DOI 10.1074/jbc.M604506200; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Pace KE, 1999, J IMMUNOL, V163, P3801; Parolini I, 1996, BLOOD, V87, P3783, DOI 10.1182/blood.V87.9.3783.bloodjournal8793783; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; PELCHENMATTHEWS A, 1992, J CELL BIOL, V117, P279, DOI 10.1083/jcb.117.2.279; Penninger JM, 2001, NAT IMMUNOL, V2, P389, DOI 10.1038/87687; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Pradhan D, 2002, IMMUNITY, V17, P303, DOI 10.1016/S1074-7613(02)00396-5; ROJO JM, 1989, P NATL ACAD SCI USA, V86, P3311, DOI 10.1073/pnas.86.9.3311; SAIZAWA K, 1987, NATURE, V328, P260, DOI 10.1038/328260a0; SATO T, 1993, BIOCHEMISTRY-US, V32, P12694, DOI 10.1021/bi00210a019; Shaw AS, 2006, NAT IMMUNOL, V7, P1139, DOI 10.1038/ni1405; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Sims TN, 2007, CELL, V129, P773, DOI 10.1016/j.cell.2007.03.037; Stillman BN, 2006, J IMMUNOL, V176, P778, DOI 10.4049/jimmunol.176.2.778; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; Szymczak AL, 2005, J IMMUNOL, V175, P270, DOI 10.4049/jimmunol.175.1.270; TULSIANI DRP, 1982, J BIOL CHEM, V257, P7936; Urbanek RA, 2001, J MED CHEM, V44, P1777, DOI 10.1021/jm000447i; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Viola A, 1996, SCIENCE, V273, P104, DOI 10.1126/science.273.5271.104; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; Zhang M, 2005, J IMMUNOL, V174, P1479, DOI 10.4049/jimmunol.174.3.1479	67	105	106	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35361	35372		10.1074/jbc.M706923200	http://dx.doi.org/10.1074/jbc.M706923200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17897956	Green Published, hybrid			2022-12-25	WOS:000251155200079
J	Yu, P; Kodadek, T				Yu, Peng; Kodadek, Thomas			Dynamics of the hypoxia-inducible factor-1-vascular endothelial growth factor promoter complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTROGEN-RECEPTOR-ALPHA; LIGAND-SPECIFIC DYNAMICS; TRANSCRIPTIONAL FUNCTION; REGULATORY PARTICLE; ACTIVATION DOMAIN; BINDING DOMAIN; 26S PROTEASOME; TURNOVER; PROTEINS; COACTIVATOR	Some transactivator-promoter complexes are highly dynamic due to active disruption of the complex by proteolytic or non-proteolytic mechanisms, and this appears to be an important mechanism by which their activity is governed tightly and eventually terminated. However, the generality of these mechanisms is unclear. In this report, we address the dynamics of hypoxia-inducible factor-1 (HIF-1) binding to the vascular endothelial growth factor promoter. HIF-1 is a heterodimeric transcription factor whose activity is triggered by an increase in HIF-1 alpha levels in hypoxic cells. A "competition ChIP" assay is employed to demonstrate that HIF-1 alpha forms a kinetically stable complex with the native vascular endothelial growth factor promoter that has a half-life in excess of 1 h. Thus, HIF-1 activity does not require rapid proteolytic turnover of the promoter-bound transactivator, nor is the activator-promoter complex constantly disassembled by chaperones. However, we do find that after cessation of the inducing signal, HIF-1 activity is slowly returned to basal levels by proteasome-mediated proteolysis of the promoter-bound HIF-1 alpha protein.	Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Translat Res, Dallas, TX 75390 USA; Univ Texas SW Med Ctr Dallas, Dept Biol Mol, Div Translat Res, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Kodadek, T (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Translat Res, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Thomas.kodadek@utsouthwestern.edu		Kodadek, Thomas/0000-0003-1930-4795	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066380] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM66380] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Auld KL, 2006, MOL CELL, V21, P861, DOI 10.1016/j.molcel.2006.02.020; Brady KL, 2005, J BIOL CHEM, V280, P26743, DOI 10.1074/jbc.M502677200; Bres V, 2003, NAT CELL BIOL, V5, P754, DOI 10.1038/ncb1023; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Chavez S, 1997, P NATL ACAD SCI USA, V94, P2885, DOI 10.1073/pnas.94.7.2885; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; Corton JC, 1998, J BIOL CHEM, V273, P13776, DOI 10.1074/jbc.273.22.13776; Elbi C, 2004, P NATL ACAD SCI USA, V101, P2876, DOI 10.1073/pnas.0400116101; Ezhkova E, 2004, MOL CELL, V13, P435, DOI 10.1016/S1097-2765(04)00026-7; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Ferdous A, 2002, BIOCHEMISTRY-US, V41, P12798, DOI 10.1021/bi020425t; Ferdous A, 2001, MOL CELL, V7, P981, DOI 10.1016/S1097-2765(01)00250-7; Ferdous A, 2007, GENE DEV, V21, P112, DOI 10.1101/gad.1493207; Freeman BC, 2002, SCIENCE, V296, P2232, DOI 10.1126/science.1073051; Freeman BC, 2001, TRENDS BIOCHEM SCI, V26, P285, DOI 10.1016/S0968-0004(01)01834-5; GOLDBERG MA, 1994, J BIOL CHEM, V269, P4355; Gonzalez F, 2002, SCIENCE, V296, P548, DOI 10.1126/science.1069490; Greer SF, 2003, NAT IMMUNOL, V4, P1074, DOI 10.1038/ni985; Hager GL, 2004, BBA-GENE STRUCT EXPR, V1677, P46, DOI 10.1016/j.bbaexp.2003.09.016; Hirota K, 2006, CRIT REV ONCOL HEMAT, V59, P15, DOI 10.1016/j.critrevonc.2005.12.003; JOHNSTON SA, 1987, CELL, V50, P143, DOI 10.1016/0092-8674(87)90671-4; Kaelin WG, 2005, BIOCHEM BIOPH RES CO, V338, P627, DOI 10.1016/j.bbrc.2005.08.165; Kaluz S, 2006, MOL CELL BIOL, V26, P5895, DOI 10.1128/MCB.00552-06; Klokk TI, 2007, MOL CELL BIOL, V27, P1823, DOI 10.1128/MCB.01297-06; Kodadek T, 2006, CELL, V127, P261, DOI 10.1016/j.cell.2006.10.002; Lassot I, 2007, MOL CELL, V25, P369, DOI 10.1016/j.molcel.2006.12.020; Lee DH, 1998, MOL CELL BIOL, V18, P30, DOI 10.1128/MCB.18.1.30; Lee DY, 2005, CELL, V123, P423, DOI 10.1016/j.cell.2005.08.015; Lipford JR, 2005, NATURE, V438, P113, DOI 10.1038/nature04098; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; LOUVION JF, 1993, GENE, V131, P129, DOI 10.1016/0378-1119(93)90681-R; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Muratani M, 2005, CELL, V120, P887, DOI 10.1016/j.cell.2004.12.025; Nalley K, 2006, NATURE, V442, P1054, DOI 10.1038/nature05067; Nawaz Z, 2004, MOL ENDOCRINOL, V18, P493, DOI 10.1210/me.2003-0388; Picard D, 2000, METHOD ENZYMOL, V327, P385, DOI 10.1016/S0076-6879(00)27291-1; Piotrowski J, 1997, J BIOL CHEM, V272, P23712, DOI 10.1074/jbc.272.38.23712; Pritts TA, 2002, AM J PHYSIOL-REG I, V282, pR1016, DOI 10.1152/ajpregu.00492.2001; Rayasam GV, 2005, MOL CELL BIOL, V25, P2406, DOI 10.1128/MCB.25.6.2406-2418.2005; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; Salghetti SE, 2001, SCIENCE, V293, P1651, DOI 10.1126/science.1062079; Salghetti SE, 2000, P NATL ACAD SCI USA, V97, P3118, DOI 10.1073/pnas.050007597; SCHERRER LC, 1993, BIOCHEMISTRY-US, V32, P5381, DOI 10.1021/bi00071a013; Semenza GL, 2002, BIOCHEM PHARMACOL, V64, P993, DOI 10.1016/S0006-2952(02)01168-1; Sikder D, 2006, J BIOL CHEM, V281, P27346, DOI 10.1074/jbc.M604706200; Stenoien DL, 2001, NAT CELL BIOL, V3, P15, DOI 10.1038/35050515; Sulahian R, 2006, NUCLEIC ACIDS RES, V34, P1351, DOI 10.1093/nar/gkl012; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Valley CC, 2005, MOL CELL BIOL, V25, P5417, DOI 10.1128/MCB.25.13.5417-5428.2005; VASHEE S, 1995, P NATL ACAD SCI USA, V92, P10683, DOI 10.1073/pnas.92.23.10683; Wu RC, 2007, CELL, V129, P1125, DOI 10.1016/j.cell.2007.04.039; Yang E, 2002, J BIOL CHEM, V277, P13455, DOI 10.1074/jbc.M112038200; Yao J, 2006, NATURE, V442, P1050, DOI 10.1038/nature05025	56	18	20	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35035	35045		10.1074/jbc.M707557200	http://dx.doi.org/10.1074/jbc.M707557200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17916562	hybrid			2022-12-25	WOS:000251155200048
J	Vila-Carriles, WH; Zhou, ZH; Bubien, JK; Fuller, CM; Benos, DJ				Vila-Carriles, Wanda H.; Zhou, Zhen-Hong; Bubien, James K.; Fuller, Catherine M.; Benos, Dale J.			Participation of the chaperone Hsc70 in the trafficking and functional expression of ASIC2 in glioma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL NA+ CHANNEL; CYSTIC-FIBROSIS; ION CHANNELS; SODIUM-CHANNELS; PROTEIN; CFTR; PROLIFERATION; DEGRADATION; FAMILY	High-grade glioma cells express subunits of the ENaC/Deg superfamily, including members of ASIC subfamily. Our previous work has shown that glioma cells exhibit a basally active cation current, which is not present in low-grade tumor cells or normal astrocytes, and that can be blocked by amiloride. When ASIC2 is present within the channel complex in the plasma membrane, the channel is rendered non-functional because of inherent negative effectors that require ASIC2. We have previously shown that high-grade glioma cells functionally express this current because of the lack of ASIC2 in the plasma membrane. We now hypothesize that ASIC2 trafficking in glioma cells is regulated by a specific chaperone protein, namely Hsc70. Our results demonstrated that Hsc70 co-immunoprecipitates with ASIC2 and that it is overexpressed in glioma cells as compared with normal astrocytes. In contrast, there was no difference in the expression of calnexin, which also co-immunoprecipitates with ASIC2. In addition, glycerol and sodium 4-phenylbutyrate reduced the amount of Hsc70 expressed in glioma cells to levels found in normal astrocytes. Transfection of Hsc70 siRNA inhibited the constitutively activated amiloride-sensitive current, decreased migration, and increased ASIC2 surface expression in glioma cells. These results support an association between Hsc70 and ASIC2 that may underlie the increased retention of ASIC2 in the endoplasmic reticulum of glioma cells. The data also suggest that decreasing Hsc70 expression promotes reversion of a high-grade glioma cell to a more normal astrocytic phenotype.	Univ Alabama Birmingham, Dept Physiol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Biophys, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Benos, DJ (corresponding author), 1918 Univ Blvd,MCLM 704, Birmingham, AL 35294 USA.	benos@physiology.uab.edu	Fuller, Cathy/B-4046-2011		NATIONAL CANCER INSTITUTE [R01CA101952, P50CA097247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK037206, R01DK037206] Funding Source: NIH RePORTER; NCI NIH HHS [P50 CA 97247, CA 101952] Funding Source: Medline; NIDDK NIH HHS [R01 DK037206, DK 37206] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bercovich B, 1997, J BIOL CHEM, V272, P9002; Berdiev BK, 2003, J BIOL CHEM, V278, P15023, DOI 10.1074/jbc.M300991200; Bertrand CA, 2003, AM J PHYSIOL-CELL PH, V285, pC1, DOI 10.1152/ajpcell.00554.2002; Bronk P, 2001, NEURON, V30, P475, DOI 10.1016/S0896-6273(01)00292-6; Clay JR, 2002, J NEUROSCI RES, V67, P745, DOI 10.1002/jnr.10182; GarciaAnoveros J, 1997, P NATL ACAD SCI USA, V94, P1459, DOI 10.1073/pnas.94.4.1459; Giese A, 2003, ACT NEUR S, V88, P153; KOPITO RR, 1999, PHYSIOL REV, V79, P167; Lang F, 2005, J MEMBRANE BIOL, V205, P147, DOI 10.1007/s00232-005-0780-5; Lang F, 2006, CONTRIB NEPHROL, V152, P142, DOI 10.1159/000096321; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; McFerrin MB, 2006, NEURON GLIA BIOL, V2, P39, DOI 10.1017/S1740925X06000044; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Rohde M, 2005, GENE DEV, V19, P570, DOI 10.1101/gad.305405; Rubenstein RC, 2000, AM J PHYSIOL-CELL PH, V278, pC259, DOI 10.1152/ajpcell.2000.278.2.C259; Rubenstein RC, 2001, AM J PHYSIOL-LUNG C, V281, pL43, DOI 10.1152/ajplung.2001.281.1.L43; Skach WR, 2000, KIDNEY INT, V57, P825, DOI 10.1046/j.1523-1755.2000.00921.x; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Staub O, 2000, KIDNEY INT, V57, P809, DOI 10.1046/j.1523-1755.2000.00919.x; STAUB O, 1992, J CELL BIOL, V119, P1497, DOI 10.1083/jcb.119.6.1497; Valentijn JA, 1998, J BIOL CHEM, V273, P30344, DOI 10.1074/jbc.273.46.30344; Vila-Carriles WH, 2006, J BIOL CHEM, V281, P19220, DOI 10.1074/jbc.M603100200; Welch WJ, 2004, SEMIN CELL DEV BIOL, V15, P31, DOI 10.1016/j.semcdb.2003.12.011; Xia JZ, 2003, GENE, V313, P91, DOI 10.1016/S0378-1119(03)00633-4; Zeitlin PL, 2002, MOL THER, V6, P119, DOI 10.1006/mthe.2002.0639; Zhang H, 2002, J BIOL CHEM, V277, P28948, DOI 10.1074/jbc.M111706200; Zhang YM, 2001, MOL BIOL CELL, V12, P1303, DOI 10.1091/mbc.12.5.1303	27	42	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34381	34391		10.1074/jbc.M705354200	http://dx.doi.org/10.1074/jbc.M705354200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17878160	hybrid			2022-12-25	WOS:000251145700054
J	Zhang, Y; Pu, H; Wang, QS; Cheng, S; Zhao, WX; Zhang, Y; Zhao, JD				Zhang, Ying; Pu, Hai; Wang, Qingsong; Cheng, Shu; Zhao, Weixing; Zhang, Yan; Zhao, Jindong			PII is important in regulation of nitrogen metabolism but not required for heterocyst formation in the cyanobacterium Anabaena sp PCC 7120	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PROTEIN; GLNB GENE-PRODUCT; P-II PROTEIN; SP STRAIN PCC-7942; SP PCC 7120; GLUTAMINE-SYNTHETASE; ESCHERICHIA-COLI; FILAMENTOUS CYANOBACTERIA; CELLULAR-DIFFERENTIATION; SUPEROXIDE-DISMUTASE	PII is an important signal protein for regulation of nitrogen metabolism in bacteria and plants. We constructed a mutant of glnB, encoding PII, in a heterocystous cyanobacterium, Anabaena sp. PCC 7120, with a cre-loxP system. The mutant (MP2 alpha) grew more slowly than the wild type under all nitrogen regimens. It excreted a large amount of ammonium when grown on nitrate due to altered activities of glutamine synthetase and nitrate reductase. MP2 alpha had a low nitrogenase activity but was able to form heterocysts under diazotrophic conditions, suggesting that PII is not required for heterocyst differentiation. Analysis of the PII with mass spectroscopy found tyrosine nitration at Tyr-51 under diazotrophic conditions while no phosphorylation at Ser-49 was detected. The strains 51F and 49A, which have PII with mutations of Y51F and S49A, respectively, were constructed to analyze the functions of the two key residues on the T-loop. Like MP2 alpha, they had low nitrogenase activity and grew slowly under diazotrophic conditions. 49A was also impaired in nitrate uptake and formed heterocysts in the presence of nitrate. The up-regulation of ntcA after nitrogen stepdown, which was present in the wild type, was not observed in 51F and 49A. While our results showed that the Ser-49 residue is important to the function of PII in Anabaena sp. PCC 7120, evidence from the PII pattern of the wild type and 49A in non-denaturing gel electrophoresis suggested that Ser-49 is not modified. The possible physiological roles of tyrosine nitration of PII are discussed.	Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Genet Engn, Beijing 100871, Peoples R China	Peking University	Zhao, JD (corresponding author), Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Genet Engn, Beijing 100871, Peoples R China.	jzhao@pku.edu.cn	zhao, weixing/H-3154-2013	zhao, weixing/0000-0001-5746-3696				Aldehni MF, 2003, J BACTERIOL, V185, P2582, DOI 10.1128/JB.185.8.2582-2591.2003; Arcondeguy T, 2001, MICROBIOL MOL BIOL R, V65, P80, DOI 10.1128/MMBR.65.1.80-105.2001; AUSTIN S, 1981, CELL, V25, P729, DOI 10.1016/0092-8674(81)90180-X; BLACK TA, 1993, MOL MICROBIOL, V9, P77, DOI 10.1111/j.1365-2958.1993.tb01670.x; BROWN MS, 1971, P NATL ACAD SCI USA, V68, P2949, DOI 10.1073/pnas.68.12.2949; Buikema WJ, 2001, P NATL ACAD SCI USA, V98, P2729, DOI 10.1073/pnas.051624898; BUIKEMA WJ, 1991, GENE DEV, V5, P321, DOI 10.1101/gad.5.2.321; Burillo S, 2004, J BACTERIOL, V186, P3346, DOI 10.1128/JB.186.11.3346-3354.2004; Cassina AM, 2000, J BIOL CHEM, V275, P21409, DOI 10.1074/jbc.M909978199; Espinosa J, 2006, MOL MICROBIOL, V61, P457, DOI 10.1111/j.1365-2958.2006.05231.x; Forchhammer K, 2004, FEMS MICROBIOL REV, V28, P319, DOI 10.1016/j.femsre.2003.11.001; Forchhammer K, 1997, EUR J BIOCHEM, V244, P869, DOI 10.1111/j.1432-1033.1997.00869.x; FORCHHAMMER K, 1995, J BACTERIOL, V177, P2033, DOI 10.1128/jb.177.8.2033-2040.1995; FORCHHAMMER K, 1994, J BACTERIOL, V176, P84, DOI 10.1128/JB.176.1.84-91.1994; FRIAS JE, 1994, MOL MICROBIOL, V14, P823, DOI 10.1111/j.1365-2958.1994.tb01318.x; GHASSEMIAN M, 1994, MICROBIOL-UK, V140, P1151, DOI 10.1099/13500872-140-5-1151; Ghosh K, 2002, METHODS, V28, P374, DOI 10.1016/S1046-2023(02)00244-X; Hanson TE, 1998, MICROBIOL-SGM, V144, P1537, DOI 10.1099/00221287-144-6-1537; Heinrich A, 2004, MOL MICROBIOL, V52, P1303, DOI 10.1111/j.1365-2958.2004.04058.x; Herrero A, 2004, FEMS MICROBIOL REV, V28, P469, DOI 10.1016/j.femsre.2004.04.003; HERRERO A, 1981, J BACTERIOL, V145, P175, DOI 10.1128/JB.145.1.175-180.1981; Huang X, 2004, P NATL ACAD SCI USA, V101, P4848, DOI 10.1073/pnas.0400429101; Hunsucker SW, 2004, BIOCHEM BIOPH RES CO, V317, P1121, DOI 10.1016/j.bbrc.2004.03.173; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Laurent S, 2005, P NATL ACAD SCI USA, V102, P9907, DOI 10.1073/pnas.0502337102; Laurent S, 2004, FEBS LETT, V576, P261, DOI 10.1016/j.febslet.2004.09.014; Leigh JA, 2007, ANNU REV MICROBIOL, V61, P349, DOI 10.1146/annurev.micro.61.080706.093409; Liotenberg S, 1996, FEMS MICROBIOL LETT, V144, P185, DOI 10.1016/0378-1097(96)00360-6; Liu YF, 2000, BBA-GENE STRUCT EXPR, V1491, P248, DOI 10.1016/S0167-4781(00)00022-1; MacMillanCrow LA, 1996, P NATL ACAD SCI USA, V93, P11853, DOI 10.1073/pnas.93.21.11853; Martin-Figueroa E, 2000, FEBS LETT, V476, P282, DOI 10.1016/S0014-5793(00)01722-1; Meeks JC, 2002, MICROBIOL MOL BIOL R, V66, P94, DOI 10.1128/MMBR.66.1.94-121.2002; Muro-Pastor AM, 2002, MOL MICROBIOL, V44, P1377, DOI 10.1046/j.1365-2958.2002.02970.x; NIFA AJ, 2005, CURR OPIN MICROBIOL, V8, P168; ORR J, 1981, J BIOL CHEM, V256, P3091; PANLNSKA KA, 2002, MICROBIOLOGY, V148, P2405; Paz-Yepes J, 2003, FEBS LETT, V543, P42, DOI 10.1016/S0014-5793(03)00384-3; Peluffo G, 2007, CARDIOVASC RES, V75, P291, DOI 10.1016/j.cardiores.2007.04.024; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; SOLORZANO L, 1969, LIMNOL OCEANOGR, V14, P799, DOI 10.4319/lo.1969.14.5.0799; SON HS, 1987, J BIOL CHEM, V262, P8690; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; THOMAS J, 1977, J BACTERIOL, V129, P1545, DOI 10.1128/JB.129.3.1545-1555.1977; TSINOREMAS NF, 1991, P NATL ACAD SCI USA, V88, P4565, DOI 10.1073/pnas.88.11.4565; vanHeeswijk WC, 1996, MOL MICROBIOL, V21, P133, DOI 10.1046/j.1365-2958.1996.6281349.x; WEI TF, 1994, J BACTERIOL, V176, P4473, DOI 10.1128/JB.176.15.4473-4482.1994; Wolk CP, 2000, PROKARYOTIC DEVELOPMENT, P83; Yoon HS, 1998, SCIENCE, V282, P935, DOI 10.1126/science.282.5390.935; Zhang CC, 2006, MOL MICROBIOL, V59, P367, DOI 10.1111/j.1365-2958.2005.04979.x; Zhao WX, 2007, PLANT CELL PHYSIOL, V48, P563, DOI 10.1093/pcp/pcm025; Zhao YH, 2005, P NATL ACAD SCI USA, V102, P5744, DOI 10.1073/pnas.0501782102; Zhou RB, 1998, P NATL ACAD SCI USA, V95, P4959, DOI 10.1073/pnas.95.9.4959	53	28	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46							33641	10.1074/jbc.M706500200	http://dx.doi.org/10.1074/jbc.M706500200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17875643	hybrid			2022-12-25	WOS:000250840200045
J	Fick, J; Lindberg, RH; Tysklind, M; Haemig, PD; Waldenstrom, J; Wallensten, A; Olsen, B				Fick, Jerker; Lindberg, Richard H.; Tysklind, Mats; Haemig, Paul D.; Waldenstrom, Jonas; Wallensten, Anders; Olsen, Bjorn			Antiviral Oseltamivir Is not Removed or Degraded in Normal Sewage Water Treatment: Implications for Development of Resistance by Influenza A Virus	PLOS ONE			English	Article								Oseltamivir is the main antiviral for treatment and prevention of pandemic influenza. The increase in oseltamivir resistance reported recently has therefore sparked a debate on how to use oseltamivir in non pandemic influenza and the risks associated with wide spread use during a pandemic. Several questions have been asked about the fate of oseltamivir in the sewage treatment plants and in the environment. We have assessed the fate of oseltamivir and discuss the implications of environmental residues of oseltamivir regarding the occurrence of resistance. A series of batch experiments that simulated normal sewage treatment with oseltamivir present was conducted and the UV-spectra of oseltamivir were recorded. Findings: Our experiments show that the active moiety of oseltamivir is not removed in normal sewage water treatments and is not degraded substantially by UV light radiation, and that the active substance is released in waste water leaving the plant. Our conclusion is that a ubiquitous use of oseltamivir may result in selection pressures in the environment that favor development of drug-resistance.	[Fick, Jerker; Lindberg, Richard H.; Tysklind, Mats] Umea Univ, Dept Chem, Umea, Sweden; [Haemig, Paul D.; Waldenstrom, Jonas; Olsen, Bjorn] Kalmar Univ, Sect Zoonot Ecol & Epidemiol, Kalmar, Sweden; [Waldenstrom, Jonas] Lund Univ, Dept Anim Ecol, S-22362 Lund, Sweden; [Wallensten, Anders] Kalmar Cty Council, Smedby Hlth Ctr, Kalmar, Sweden; [Wallensten, Anders] Linkoping Univ, Fac Hlth Sci, Div Virol, Dept Mol & Clin Med IMK, Linkoping, Sweden; [Olsen, Bjorn] Univ Uppsala Hosp, Infect Dis Sect, Dept Clin Sci, Uppsala, Sweden	Umea University; Linnaeus University; University of Kalmar; Lund University; Linkoping University; Uppsala University; Uppsala University Hospital	Fick, J (corresponding author), Umea Univ, Dept Chem, Umea, Sweden.	jerker.fick@chem.umu.se	Berglund Fick, Jerker/HDO-5788-2022; Waldenström, Jonas/E-4460-2013; Lindberg, Richard/C-8882-2013	Waldenström, Jonas/0000-0002-1152-4235; Fick, Jerker/0000-0002-3949-7371; Tysklind, Mats/0000-0001-8709-6970; Olsen, Bjorn/0000-0002-4646-691X	Umea University; The Swedish Research Council; The Swedish Research Council FORMAS	Umea University; The Swedish Research Council(Swedish Research Council); The Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas)	Umea University, The Swedish Research Council and The Swedish Research Council FORMAS which were the major funders, had no role in the experiments, the analysis of the data or the preparation of the publication. All authors had full access to all the data; the corresponding author had the final responsibility to submit to publication.	Boreen AL, 2003, AQUAT SCI, V65, P320, DOI 10.1007/s00027-003-0672-7; Carr J, 2002, ANTIVIR RES, V54, P79, DOI 10.1016/S0166-3542(01)00215-7; Chutinimitkul S, 2007, J VIROL METHODS, V139, P44, DOI 10.1016/j.jviromet.2006.09.007; *F HOFFM LTD, 2005, FURTH EXP TAM MAN CA; *FAO OIE WHO, 2005, CONS AV INFL HUM HLT; Gubareva LV, 2001, ANTIMICROB AGENTS CH, V45, P3403, DOI 10.1128/AAC.45.12.3403-3408.2001; Gubareva LV, 2000, LANCET, V355, P827, DOI 10.1016/S0140-6736(99)11433-8; Hatakeyama S, 2007, JAMA-J AM MED ASSOC, V297, P1435, DOI 10.1001/jama.297.13.1435; Herlocher ML, 2004, J INFECT DIS, V190, P1627, DOI 10.1086/424572; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; Lindberg RH, 2006, ENVIRON SCI TECHNOL, V40, P1042, DOI 10.1021/es0516211; Lindberg RH, 2005, ENVIRON SCI TECHNOL, V39, P3421, DOI 10.1021/es048143z; McKimm-Breschkin J, 2003, ANTIMICROB AGENTS CH, V47, P2264, DOI 10.1128/AAC.47.7.2264-2272.2003; Monto AS, 2006, ANTIMICROB AGENTS CH, V50, P2395, DOI 10.1128/AAC.01339-05; Moscona A, 2005, NEW ENGL J MED, V353, P2633, DOI 10.1056/NEJMp058291; Moscona A, 2007, JAMA-J AM MED ASSOC, V297, P1492, DOI 10.1001/jama.297.13.1492; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Oxford JS, 2000, REV MED VIROL, V10, P119, DOI 10.1002/(SICI)1099-1654(200003/04)10:2&lt;119::AID-RMV272&gt;3.0.CO;2-O; Singer AC, 2007, ENVIRON HEALTH PERSP, V115, P102, DOI 10.1289/ehp.9574; STALLKNECHT DE, 1988, VET RES COMMUN, V12, P125, DOI 10.1007/BF00362792; STALLKNECHT DE, 1990, AVIAN DIS, V34, P406, DOI 10.2307/1591428; STALLKNECHT DE, 1990, AVIAN DIS, V34, P412, DOI 10.2307/1591429; Sweetman S. C., 2007, MARTINDALE COMPLETE; Ternes TA, 2004, WATER RES, V38, P4075, DOI 10.1016/j.watres.2004.07.015; WEBSTER RG, 1978, VIROLOGY, V84, P268, DOI 10.1016/0042-6822(78)90247-7; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; *WHO, 2005, WHO DRUG INFORM, V19, P273; Wiltshire H, 2000, J CHROMATOGR B, V745, P373, DOI 10.1016/S0378-4347(00)00300-5	28	76	79	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e986	10.1371/journal.pone.0000986	http://dx.doi.org/10.1371/journal.pone.0000986			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912363	Green Published, Green Submitted, gold			2022-12-25	WOS:000207455900022
J	Forstmeier, W				Forstmeier, Wolfgang			Do Individual Females Differ Intrinsically in Their Propensity to Engage in Extra-Pair Copulations?	PLOS ONE			English	Article								Background. While many studies have investigated the occurrence of extra-pair paternity in wild populations of birds, we still know surprisingly little about whether individual females differ intrinsically in their principal readiness to copulate, and to what extent this readiness is affected by male attractiveness. Methodology/Findings. To address this question I used captive zebra finches (Taeniopygia guttata) as a model system. I first measured female readiness to copulate when courted by a male for the first time in life. Second, I conducted choice-chamber experiments to assess the mating preferences of individual females prior to pair formation. I then paired females socially with a non-desired mate and once they had formed a stable pair bond, I observed the inclination of these females to engage in extra-pair copulations with various males. Females showing a high readiness to copulate when courted by a male for the first time in life were much more likely to engage in extra-pair copulations later in life than others. Male attractiveness, as measured in choice tests, was a useful predictor of whether females engaged in extra-pair copulations with these males, but, surprisingly, the attractiveness of a female's social partner had no effect on her fidelity. However, it remained unclear what made some males more attractive than others. Contrary to a widespread but rarely tested hypothesis, females did not preferentially copulate with males having a redder beak or singing at a higher rate. Rather it seemed that song rate was a confounding factor in choice-chamber experiments: song attracted the female's attention but did not increase the male's attractiveness as a copulation partner. Conclusions/Significance. Intrinsic variation in female readiness to copulate as well as variation in the attractiveness of the extra-pair male but not the social partner decided the outcome of extra-pair encounters.	[Forstmeier, Wolfgang] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Forstmeier, Wolfgang] Max Planck Inst Ornithol, Dept Behav Ecol & Evolutionary Genet, Seewiesen, Germany	University of Sheffield; Max Planck Society	Forstmeier, W (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	forstmeier@orn.mpg.de			DFG [FO 340/1]; EU [HPMF-CT-2002-01871]	DFG(German Research Foundation (DFG)); EU(European Commission)	This project was funded by an Emmy-Noether Fellowship (DFG: FO 340/1) and a Marie-Curie Fellowship (EU: HPMF-CT-2002-01871).	BIRKHEAD TR, 1990, BEHAV ECOL SOCIOBIOL, V27, P315, DOI 10.1007/BF00164002; BIRKHEAD TR, 1988, ANIM BEHAV, V36, P1853, DOI 10.1016/S0003-3472(88)80133-7; Birkhead TR, 1992, SPERM COMPETITION BI; Blount JD, 2003, SCIENCE, V300, P125, DOI 10.1126/science.1082142; BURLEY N, 1987, ETHOLOGY, V76, P133; BURLEY NT, 1994, ANIM BEHAV, V48, P1031, DOI 10.1006/anbe.1994.1336; Burley NT, 1996, BEHAV ECOL, V7, P218, DOI 10.1093/beheco/7.2.218; COLLINS SA, 1994, BEHAV ECOL SOCIOBIOL, V35, P21, DOI 10.1007/s002650050065; Dall SRX, 2004, ECOL LETT, V7, P734, DOI 10.1111/j.1461-0248.2004.00618.x; Dietrich V, 2004, BEHAVIOUR, V141, P817, DOI 10.1163/1568539042265644; Forstmeier W, 2004, ANIM BEHAV, V68, P1017, DOI 10.1016/j.anbehav.2004.02.007; Forstmeier W, 2004, ANIM BEHAV, V68, P1005, DOI 10.1016/j.anbehav.2004.02.003; Gil D, 2002, TRENDS ECOL EVOL, V17, P133, DOI 10.1016/S0169-5347(02)02410-2; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; HOUTMAN AM, 1992, P ROY SOC B-BIOL SCI, V249, P3, DOI 10.1098/rspb.1992.0075; Immelmann K., 1959, Zool Jb (Abt Syst), V86, P437; JOHNSON K, 1998, ORNITHOLOGICAL MONOG, V49, P1; Ligon JD, 1999, EVOLUTION AVIAN BREE; Petrie M, 1998, TRENDS ECOL EVOL, V13, P52, DOI 10.1016/S0169-5347(97)01232-9; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; SILCOX AP, 1982, ANIM BEHAV, V30, P1237, DOI 10.1016/S0003-3472(82)80216-9; Weatherhead PJ, 1999, P ROY SOC B-BIOL SCI, V266, P1027, DOI 10.1098/rspb.1999.0739; Westneat DF, 2003, ANNU REV ECOL EVOL S, V34, P365, DOI 10.1146/annurev.ecolsys.34.011802.132439; Witte K, 2006, ETHOL ECOL EVOL, V18, P195, DOI 10.1080/08927014.2006.9522707; ZANN R, 1996, ZEBRA FINCH	26	49	50	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e952	10.1371/journal.pone.0000952	http://dx.doi.org/10.1371/journal.pone.0000952			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895992	gold, Green Published, Green Submitted			2022-12-25	WOS:000207455800030
J	Heyers, D; Manns, M; Luksch, H; Gunturkun, O; Mouritsen, H				Heyers, Dominik; Manns, Martina; Luksch, Harald; Guentuerkuen, Onur; Mouritsen, Henrik			A Visual Pathway Links Brain Structures Active during Magnetic Compass Orientation in Migratory Birds	PLOS ONE			English	Article								The magnetic compass of migratory birds has been suggested to be light-dependent. Retinal cryptochrome-expressing neurons and a forebrain region, "Cluster N", show high neuronal activity when night-migratory songbirds perform magnetic compass orientation. By combining neuronal tracing with behavioral experiments leading to sensory-driven gene expression of the neuronal activity marker ZENK during magnetic compass orientation, we demonstrate a functional neuronal connection between the retinal neurons and Cluster N via the visual thalamus. Thus, the two areas of the central nervous system being most active during magnetic compass orientation are part of an ascending visual processing stream, the thalamofugal pathway. Furthermore, Cluster N seems to be a specialized part of the visual wulst. These findings strongly support the hypothesis that migratory birds use their visual system to perceive the reference compass direction of the geomagnetic field and that migratory birds "see" the reference compass direction provided by the geomagnetic field.	[Heyers, Dominik; Mouritsen, Henrik] Carl von Ossietzky Univ Oldenburg, Inst Biol, AG Neurosensor, D-2900 Oldenburg, Germany; [Manns, Martina; Guentuerkuen, Onur] Ruhr Univ Bochum, Inst Cognit Neurosci, Dept Biophychol, Bochum, Germany; [Luksch, Harald] Tech Univ Munich, Dept Zool, D-8050 Freising Weihenstephan, Germany	Carl von Ossietzky Universitat Oldenburg; Ruhr University Bochum; Technical University of Munich	Heyers, D (corresponding author), Carl von Ossietzky Univ Oldenburg, Inst Biol, AG Neurosensor, D-2900 Oldenburg, Germany.	dominik.heyers@uni-oldenburg.de	Manns, Martina/AAX-1421-2021; Mouritsen, Henrik/A-5401-2010; Heyers, Dominik/D-3885-2015	Mouritsen, Henrik/0000-0001-7082-4839; Heyers, Dominik/0000-0002-2831-6985; Gunturkun, Onur/0000-0003-4173-5233; Luksch, Harald/0000-0002-9835-7715; Manns, Martina/0000-0001-8860-9504	VolkswagenStiftung; Deutsche Forschungsgemeinschaft [FOR 701, MO 1408/1-2, Lu 622/8, SFB 509]	VolkswagenStiftung(Volkswagen); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	VolkswagenStiftung ("Dynamics and adaptivity of neuronal systems" grant given to D. Heyers and "Nachwuchsgruppe/Lichtenberg" grant given to H. Mouritsen), Deutsche Forschungsgemeinschaft (FOR 701 and MO 1408/1-2 grants to H. Mouritsen; Lu 622/8 grant to H. Luksch; SFB 509 to M. Manns and O. Gunturkun).	Cochran WW, 2004, SCIENCE, V304, P405, DOI 10.1126/science.1095844; Fleissner G, 2003, J COMP NEUROL, V458, P350, DOI 10.1002/cne.10579; GUNTURKUN O, 1991, J COMP NEUROL, V314, P721, DOI 10.1002/cne.903140407; Gunturkun Onur, 2000, P1, DOI 10.1016/B978-012747605-6/50002-X; Gunturkun Onur, 1993, P115; Hellmann B, 2001, J COMP NEUROL, V429, P94, DOI 10.1002/1096-9861(20000101)429:1<94::AID-CNE8>3.0.CO;2-5; Hellmann B, 2004, J COMP NEUROL, V472, P395, DOI 10.1002/cne.20056; Jarvis ED, 1998, NEURON, V21, P775, DOI 10.1016/S0896-6273(00)80594-2; Jarvis ED, 2004, ANN NY ACAD SCI, V1016, P749, DOI 10.1196/annals.1298.038; Jarvis ED, 1997, P NATL ACAD SCI USA, V94, P4097, DOI 10.1073/pnas.94.8.4097; KARTEN H, 1968, ANAT REC, V160, P373; KARTEN HJ, 1973, STEREOTACTIC ATLAS B; Kirschvink JL, 2001, CURR OPIN NEUROBIOL, V11, P462, DOI 10.1016/S0959-4388(00)00235-X; Koshiba M, 2005, NEUROSCI RES, V52, P235, DOI 10.1016/j.neures.2005.03.017; Kuenzel W.J., 1988, STEREOTAXIC ATLAS BR; Liedvogel M, 2007, EUR J NEUROSCI, V25, P1166, DOI 10.1111/j.1460-9568.2007.05350.x; Marin G, 2003, J COMP NEUROL, V458, P361, DOI 10.1002/cne.10591; MICELI D, 1990, BRAIN RES, V518, P317, DOI 10.1016/0006-8993(90)90990-S; Moller A, 2004, NATURWISSENSCHAFTEN, V91, P585, DOI 10.1007/s00114-004-0578-9; Mouritsen H, 2005, CURR OPIN NEUROBIOL, V15, P406, DOI 10.1016/j.conb.2005.06.003; Mouritsen H, 2005, P NATL ACAD SCI USA, V102, P8339, DOI 10.1073/pnas.0409575102; Mouritsen H, 2004, CURR BIOL, V14, P1946, DOI 10.1016/j.cub.2004.10.025; Mouritsen H, 2004, P NATL ACAD SCI USA, V101, P14294, DOI 10.1073/pnas.0405968101; Mouritsen H, 2001, J EXP BIOL, V204, P3855; Muheim R, 2002, J EXP BIOL, V205, P3845; REMY M, 1991, J COMP NEUROL, V305, P57, DOI 10.1002/cne.903050107; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; SCHULTEN K, 1978, BIOPHYS J, V24, P295, DOI 10.1016/S0006-3495(78)85378-8; SHU SY, 1988, NEUROSCI LETT, V85, P169, DOI 10.1016/0304-3940(88)90346-1; STOKES TM, 1974, J COMP NEUROL, V156, P337, DOI 10.1002/cne.901560305; Walker MM, 1997, NATURE, V390, P371, DOI 10.1038/37057; WILTSCHK.W, 1972, SCIENCE, V176, P62, DOI 10.1126/science.176.4030.62; Wiltschko R., 1995, TIEROSYCHOL; WILTSCHKO W, 1993, NATURE, V364, P525, DOI 10.1038/364525a0; Wiltschko W, 2002, NATURWISSENSCHAFTEN, V89, P445, DOI 10.1007/s00114-002-0356-5	35	134	139	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e937	10.1371/journal.pone.0000937	http://dx.doi.org/10.1371/journal.pone.0000937			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895978	Green Published, Green Submitted, gold			2022-12-25	WOS:000207455800016
J	Klapholz-Brown, Z; Walmsley, GG; Nusse, YM; Nusse, R; Brown, PO				Klapholz-Brown, Zach; Walmsley, Graham G.; Nusse, Ysbrand M.; Nusse, Roel; Brown, Patrick O.			Transcriptional Program Induced by Wnt Protein in Human Fibroblasts Suggests Mechanisms for Cell Cooperativity in Defining Tissue Microenvironments	PLOS ONE			English	Article								Background. The Wnt signaling system plays key roles in development, regulation of stem cell self-renewal and differentiation, cell polarity, morphogenesis and cancer. Given the multifaceted roles of Wnt signaling in these processes, its transcriptional effects on the stromal cells that make up the scaffold and infrastructure of epithelial tissues are of great interest. Methods and Results. To begin to investigate these effects, we used DNA microarrays to identify transcriptional targets of the Wnt pathway in human lung fibroblasts. Cells were treated with active Wnt3a protein in culture, and RNA was harvested at 4 hours and 24 hours. Nuclear accumulation of beta-Catenin, as shown by immunofluorescence, and induction of AXIN2 demonstrate that fibroblasts are programmed to respond to extracellular Wnt signals. In addition to several known Wnt targets, we found many new Wnt induced genes, including many transcripts encoding regulatory proteins. Transcription factors with important developmental roles, including HOX genes, dominated the early transcriptional response. Furthermore, we found differential expression of several genes that play direct roles in the Wnt signaling pathway, as well as genes involved in other cell signaling pathways including fibroblast growth factor (FGF) and bone morphogenetic protein (BMP) signaling. The gene most highly induced by Wnt3a was GREMLIN2, which encodes a secreted BMP antagonist. Conclusions. Elevated expression of GREMLIN2 suggests a new role for Wnt signals in the maintenance of stem cell niches, whereby Wnt signals induce nearby fibroblasts to produce a BMP antagonist, inhibiting differentiation and promoting expansion of stem cells in their microenvironment. We suggest that Wnt-induced changes in the gene expression program of local stromal cells may play an important role in the establishment of specialized niches hospitable to the self-renewal of normal or malignant epithelial stem cells in vivo.	[Klapholz-Brown, Zach; Walmsley, Graham G.; Brown, Patrick O.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Nusse, Ysbrand M.; Nusse, Roel] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA; [Nusse, Roel; Brown, Patrick O.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Klapholz-Brown, Z (corresponding author), Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA.	zklapholzbrown@umail.ucsb.edu		Nusse, Ysbrand/0000-0001-6437-1490	Howard Hughes Medical Institute; NIH [CA77097]; NATIONAL CANCER INSTITUTE [R01CA077097] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Howard Hughes Medical Institute and NIH grant CA77097 funded the work. The funders had no role in the design or conduct of the study or preparation or approval of the manuscript.	Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; Chamorro MN, 2005, EMBO J, V24, P73, DOI 10.1038/sj.emboj.7600460; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Deimling J, 2007, AM J PHYSIOL-LUNG C, V292, pL725, DOI 10.1152/ajplung.00221.2006; Eblaghie MC, 2006, DEV BIOL, V291, P67, DOI 10.1016/j.ydbio.2005.12.006; Fukuda S, 2007, MOL CELL BIOL, V27, P4931, DOI 10.1128/MCB.02435-06; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Hendrix ND, 2006, CANCER RES, V66, P1354, DOI 10.1158/0008-5472.CAN-05-3694; Im J, 2007, BIOCHEM BIOPH RES CO, V354, P296, DOI 10.1016/j.bbrc.2006.12.205; Jamora C, 2003, NATURE, V422, P317, DOI 10.1038/nature01458; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Ogawa K, 2006, BIOCHEM BIOPH RES CO, V343, P159, DOI 10.1016/j.bbrc.2006.02.127; Olumi AF, 1999, CANCER RES, V59, P5002; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Roberts DJ, 1998, DEVELOPMENT, V125, P2791; Sakiyama J, 2000, DEV BIOL, V227, P12, DOI 10.1006/dbio.2000.9880; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Shats I, 2007, CELL CYCLE, V6, P1141, DOI 10.4161/cc.6.10.4251; Shimokawa T, 2003, CANCER RES, V63, P6116; Sneddon JB, 2006, P NATL ACAD SCI USA, V103, P14842, DOI 10.1073/pnas.0606857103; Thesleff I, 2003, J CELL SCI, V116, P1647, DOI 10.1242/jcs.00410; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; West RB, 2005, PLOS BIOL, V3, P1101, DOI 10.1371/journal.pbio.0030187; Willert Jennifer, 2002, BMC Dev Biol, V2, P8, DOI 10.1186/1471-213X-2-8	28	66	71	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e945	10.1371/journal.pone.0000945	http://dx.doi.org/10.1371/journal.pone.0000945			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895986	gold, Green Submitted, Green Published			2022-12-25	WOS:000207455800024
J	Guirouilh-Barbat, J; Huck, S; Lopez, BS				Guirouilh-Barbat, J.; Huck, S.; Lopez, B. S.			S-phase progression stimulates both the mutagenic KU-independent pathway and mutagenic processing of KU-dependent intermediates, for nonhomologous end joining	ONCOGENE			English	Article						double strand break repair; nonhomologous end joining; S phase; genetic instability; cell cycle; mammalian cells	DOUBLE-STRAND BREAKS; MAMMALIAN-CELL CYCLE; HOMOLOGOUS RECOMBINATION; V(D)J RECOMBINATION; DNA-REPAIR; NHEJ; TRANSLOCATIONS; REARRANGEMENTS; INVOLVEMENT; STABILITY	We used intrachromosomal substrates to directly monitor the effect of the cell cycle on the efficiency and the accuracy of nonhomologous end joining (NHEJ) in mammalian cells. We show that both KU and KU-independent (KU-alt) pathways are efficient when maintaining cells in G(1)/S, in G(2)/M or during dynamic progression through S phase. In addition, the accuracy of NHEJ is barely altered when the cells are blocked in G(1)/S or in G(2)/M. However, progression through S phase increases the frequency of deletions, which is a hallmark of the KU-alt pathway. Moreover, we show that the intermediates that are generated by the KU-dependent end joining of non-fully complementary ends, and which contain mismatches, nicks or gap intermediates, are less accurately processed when the cells progress through S phase. In conclusion, both KU and KU-alt processes are active throughout the cell cycle, but the repair is more error prone during S phase, both by increasing the mutagenic KU-alt pathway and decreasing the accuracy of the repair of the intermediates generated by the KU-dependent pathway.	[Guirouilh-Barbat, J.; Huck, S.; Lopez, B. S.] Inst Radiobiol Cellulaire & Mol, DSV, UMR CEA,UMR 217, CNRS, F-92265 Fontenay Aux Roses, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Lopez, BS (corresponding author), Inst Radiobiol Cellulaire & Mol, DSV, UMR CEA,UMR 217, CNRS, 18 Route Panorama,BAT 05, F-92265 Fontenay Aux Roses, France.	bernard.lopez@cea.fr	guirouilh-barbat, josée/AAX-7140-2020; Lopez, Bernard S/O-7308-2017; guirouilh-barbat, josee/O-7286-2017	Lopez, Bernard S/0000-0001-5088-0155; guirouilh-barbat, josee/0000-0002-8845-7333				Audebert M, 2004, J BIOL CHEM, V279, P55117, DOI 10.1074/jbc.M404524200; Ausubel F., 1999, CURRENT PROTOCOLS MO; Capp JP, 2007, NUCLEIC ACIDS RES, V35, P3551, DOI 10.1093/nar/gkm243; Capp JP, 2006, NUCLEIC ACIDS RES, V34, P2998, DOI 10.1093/nar/gkl380; Cohen PE, 2001, BIOESSAYS, V23, P996, DOI 10.1002/bies.1145; Couedel C, 2004, GENE DEV, V18, P1293, DOI 10.1101/gad.1209204; Feldmann E, 2000, NUCLEIC ACIDS RES, V28, P2585, DOI 10.1093/nar/28.13.2585; Ferguson DO, 2000, P NATL ACAD SCI USA, V97, P6630, DOI 10.1073/pnas.110152897; Gao YJ, 1998, IMMUNITY, V9, P367, DOI 10.1016/S1074-7613(00)80619-6; GILBERT DM, 1995, J BIOL CHEM, V270, P9597, DOI 10.1074/jbc.270.16.9597; Greaves MF, 2003, NAT REV CANCER, V3, P639, DOI 10.1038/nrc1164; Guirouilh-Barbat J, 2004, MOL CELL, V14, P611, DOI 10.1016/j.molcel.2004.05.008; Honma M, 2003, ENVIRON MOL MUTAGEN, V42, P288, DOI 10.1002/em.10201; Honma M, 2007, DNA REPAIR, V6, P781, DOI 10.1016/j.dnarep.2007.01.004; JEGGO PA, 1990, MUTAT RES, V239, P1, DOI 10.1016/0165-1110(90)90028-A; Jung D, 2004, CELL, V116, P299, DOI 10.1016/S0092-8674(04)00039-X; LALANDE M, 1990, EXP CELL RES, V186, P332, DOI 10.1016/0014-4827(90)90313-Y; Lee SM, 1997, J BIOL CHEM, V272, P7532, DOI 10.1074/jbc.272.11.7532; LEVENSON V, 1993, NUCLEIC ACIDS RES, V21, P3997, DOI 10.1093/nar/21.17.3997; Liang F, 1998, P NATL ACAD SCI USA, V95, P5172, DOI 10.1073/pnas.95.9.5172; Mills KD, 2004, GENE DEV, V18, P1283, DOI 10.1101/gad.1204304; Rodrigue A, 2006, EMBO J, V25, P222, DOI 10.1038/sj.emboj.7600914; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Saintigny Y, 2007, ONCOGENE, V26, P2769, DOI 10.1038/sj.onc.1210075; Saintigny Y, 2001, EMBO J, V20, P3861, DOI 10.1093/emboj/20.14.3861; STAMATO TD, 1988, RADIAT RES, V115, P325, DOI 10.2307/3577168; Wang HC, 2003, NUCLEIC ACIDS RES, V31, P5377, DOI 10.1093/nar/gkg728; Weinstock DM, 2006, BLOOD, V107, P777, DOI 10.1182/blood-2005-06-2437; Zucman-Rossi J, 1998, P NATL ACAD SCI USA, V95, P11786, DOI 10.1073/pnas.95.20.11786	29	21	21	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 13	2008	27	12					1726	1736		10.1038/sj.onc.1210807	http://dx.doi.org/10.1038/sj.onc.1210807			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	273WF	17891177				2022-12-25	WOS:000253962100008
J	Enomoto, A; Kido, N; Ito, M; Morita, A; Matsumoto, Y; Takamatsu, N; Hosoi, Y; Miyagawa, K				Enomoto, A.; Kido, N.; Ito, M.; Morita, A.; Matsumoto, Y.; Takamatsu, N.; Hosoi, Y.; Miyagawa, K.			Negative regulation of MEKK1/2 signaling by Serine-Threonine kinase 38 (STK38)	ONCOGENE			English	Article						STK38; MEKK1; MEKK2; MAPKKK; signal transduction	ACTIVATED PROTEIN-KINASE; KAPPA-B ACTIVATION; N-TERMINAL KINASE; CELL LINE MOLT-4; MEK KINASE; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; MAP KINASES; JUN KINASES; JNK	Mitogen-activated protein kinases (MAPKs) are activated through the kinase cascades of MAPK, MAPK kinase (MAPKK) and MAPKK kinase (MAPKKK). MAPKKKs phosphorylate and activate their downstream MAPKKs, which in turn phosphorylate and activate their downstream MAPKs. MAPKKK proteins relay upstream signals through the MAPK cascades to induce cellular responses. However, the molecular mechanisms by which given MAPKKKs are regulated remain largely unknown. Here, we found that serine-threonine protein kinase 38, STK38, physically interacts with the MAPKKKs MEKK1 and MEKK2 (MEKK1/2). The carboxy terminus, including the catalytic domain, but not the amino terminus of MEKK1/2 was necessary for the interaction with STK38. STK38 inhibited MEKK1/2 activation without preventing MEKK1/2 binding to its substrate, SEK1. Importantly, STK38 suppressed the autophosphorylation of MEKK2 without interfering with MEKK2 dimer formation, and converted MEKK2 from its phosphorylated to its nonphosphorylated form. The negative regulation of MEKK1/2 was not due to its phosphorylation by STK38. On the other hand, stk38 short hairpin RNA enhanced sorbitol-induced activation of MEKK2 and phosphorylation of the downstream MAPKKs, MKK3/6. Taken together, our results indicate that STK38 negatively regulates the activation of MEKK1/2 by direct interaction with the catalytic domain of MEKK1/2, suggesting a novel mechanism of MEKK1/2 regulation.	[Enomoto, A.; Kido, N.; Matsumoto, Y.; Hosoi, Y.; Miyagawa, K.] Univ Tokyo, Grad Sch Med, Sect Radiol Biol, Ctr Dis Biol & Integrat Med,Bunkyo Ku, Tokyo 1130033, Japan; [Kido, N.] Univ Tokyo, Sch Med, Tokyo 113, Japan; [Ito, M.; Takamatsu, N.] Kitasato Univ, Sch Sci, Dept Biosci, Kanagawa, Japan; [Morita, A.] Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, Chiba, Japan; [Matsumoto, Y.] Tokyo Inst Technol, Nucl Reactors Res Lab, Dept Nucl Engn, Tokyo 152, Japan	University of Tokyo; University of Tokyo; Kitasato University; Tokyo University of Science; Tokyo Institute of Technology	Enomoto, A (corresponding author), Univ Tokyo, Grad Sch Med, Sect Radiol Biol, Ctr Dis & Integrat Med,Bunkyo Ku, 3-7-2001 Hongo, Tokyo 1130033, Japan.	aenomoto@m.u-tokyo.ac.jp	Morita, Akinori/D-1418-2011					Bidlingmaier S, 2001, MOL CELL BIOL, V21, P2449, DOI 10.1128/MCB.21.7.2449-2462.2001; Blank JL, 1996, J BIOL CHEM, V271, P5361, DOI 10.1074/jbc.271.10.5361; CANO E, 1995, TRENDS BIOCHEM SCI, V20, P117, DOI 10.1016/S0968-0004(00)88978-1; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chayama K, 2001, P NATL ACAD SCI USA, V98, P4599, DOI 10.1073/pnas.081021898; Chen W, 2002, J BIOL CHEM, V277, P49105, DOI 10.1074/jbc.M204934200; Cheng J, 2005, MOL CELL BIOL, V25, P5955, DOI 10.1128/MCB.25.14.5955-5964.2005; Cheng JK, 2005, J BIOL CHEM, V280, P13477, DOI 10.1074/jbc.M414258200; Cheng JK, 2000, MOL CELL BIOL, V20, P2334, DOI 10.1128/MCB.20.7.2334-2342.2000; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Deak JC, 1997, BIOCHEM J, V322, P185, DOI 10.1042/bj3220185; Enomoto A, 2000, CANCER LETT, V155, P137, DOI 10.1016/S0304-3835(00)00422-5; Enomoto A, 2003, INT J RADIAT BIOL, V79, P589, DOI 10.1080/09553000310001597273; Enslen H, 1998, J BIOL CHEM, V273, P1741, DOI 10.1074/jbc.273.3.1741; Fanger GR, 1998, J BIOL CHEM, V273, P3476, DOI 10.1074/jbc.273.6.3476; Guo ZJ, 2002, MOL CELL BIOL, V22, P5761, DOI 10.1128/MCB.22.16.5761-5768.2002; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Hergovich A, 2006, NAT REV MOL CELL BIO, V7, P253, DOI 10.1038/nrm1891; HERSKOWITZ I, 1995, CELL, V80, P187, DOI 10.1016/0092-8674(95)90402-6; ITOM, 1999, MOL CELL BIOL, V19, P7539; JOHNSTON LH, 1990, MOL CELL BIOL, V10, P1358, DOI 10.1128/MCB.10.4.1358; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kesavan K, 2004, J CELL PHYSIOL, V199, P140, DOI 10.1002/jcp.10457; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; LANGECARTER CA, 1993, SCIENCE, V260, P315, DOI 10.1126/science.8385802; LIN AN, 1995, SCIENCE, V268, P286, DOI 10.1126/science.7716521; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Minamino T, 1999, P NATL ACAD SCI USA, V96, P15127, DOI 10.1073/pnas.96.26.15127; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; Ryoo K, 2004, J BIOL CHEM, V279, P43589, DOI 10.1074/jbc.M404359200; Su B, 2001, J BIOL CHEM, V276, P14784, DOI 10.1074/jbc.M010134200; Tamaskovic R, 2003, FEBS LETT, V546, P73, DOI 10.1016/S0014-5793(03)00474-5; Verde F, 1998, P NATL ACAD SCI USA, V95, P7526, DOI 10.1073/pnas.95.13.7526; WASKIEWICZ AJ, 1995, CURR OPIN CELL BIOL, V7, P798, DOI 10.1016/0955-0674(95)80063-8; Xia Y, 1998, GENE DEV, V12, P3369, DOI 10.1101/gad.12.21.3369; YAN MH, 1994, NATURE, V372, P798; Yang JH, 2001, NAT IMMUNOL, V2, P620, DOI 10.1038/89769; Yujiri T, 2000, P NATL ACAD SCI USA, V97, P7272, DOI 10.1073/pnas.130176697; Zhang DY, 2006, EMBO J, V25, P97, DOI 10.1038/sj.emboj.7600913	43	24	28	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2008	27	13					1930	1938		10.1038/sj.onc.1210828	http://dx.doi.org/10.1038/sj.onc.1210828			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	276NZ	17906693				2022-12-25	WOS:000254150600012
J	Barrett, CML; Freudl, R; Robinson, C				Barrett, Claire M. L.; Freudl, Roland; Robinson, Colin			Twin arginine translocation (Tat)-dependent export in the apparent absence of TatABC or TatA complexes using modified Escherichia coli TatA subunits that substitute for TatB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEC-INDEPENDENT PROTEIN; BLUE NATIVE ELECTROPHORESIS; SIGNAL PEPTIDE; TRANSPORT SYSTEM; BACTERIAL; COMPONENT; PATHWAY; FORM; SEQUENCE; BACILLUS	The twin arginine translocation pathway exports folded proteins across the cytoplasmic membrane of many bacteria. In Escherichia coli and other Gram-negative bacteria, TatA, TatB, and TatC are all essential for efficient translocation, and current models suggest that separate TatABC and TatA complexes coalesce at the point of translocation. However, other microbes appear only to possess tatA and tatC genes. In Escherichia coli, virtually no translocation is observed when only TatA and TatC are present, but several mutations at the extreme N terminus of TatA were shown to support translocation. Here we show that these apparently bifunctional mutant TatA variants can function as typical TatA components because translocation is observed when they are co-expressed with TatBC, and they assemble into large, heterogeneous complexes that resemble wild type TatA complexes. However, cells expressing TatC plus the mutant TatA variants do not contain complexes that resemble the expected 370-kDa TatABC complex, clearly indicating that the mutant TatA forms cannot assemble efficiently, or stably, into this complex. The simultaneous expression of wild type TatA furthermore blocks translocation activity, suggesting that the mutant TatA forms preferentially bind to other TatA molecules rather than TatC. Surprisingly, we observe translocation in the absence of detectable free TatA, when translational fusions of the mutant TatAs with TatC are expressed. Transport can thus proceed in the simultaneous absence of TatABC and TatA complexes at detectable levels, and we conclude that the active translocon may be formed from dynamic twin arginine translocation complexes, one or more of which may await characterization.	Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; Forschungszentrum Julich, Inst Biotechnol 1, D-52425 Julich, Germany	University of Warwick; Helmholtz Association; Research Center Julich	Robinson, C (corresponding author), Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England.	Colin.robinson@warwick.ac.uk	Freudl, Roland/N-4179-2017	Freudl, Roland/0000-0003-0743-1279				Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Alami M, 2002, J BIOL CHEM, V277, P20499, DOI 10.1074/jbc.M201711200; Barrett CML, 2005, FEBS J, V272, P2261, DOI 10.1111/j.1742-4658.2005.04654.x; Barrett CML, 2005, J MOL BIOL, V347, P453, DOI 10.1016/j.jmb.2005.01.026; Behrendt J, 2004, FEMS MICROBIOL LETT, V234, P303, DOI 10.1016/j.femsle.2004.03.048; Blaudeck N, 2005, J BIOL CHEM, V280, P3426, DOI 10.1074/jbc.M411210200; Bogsch EG, 1998, J BIOL CHEM, V273, P18003, DOI 10.1074/jbc.273.29.18003; Bolhuis A, 2001, J BIOL CHEM, V276, P20213, DOI 10.1074/jbc.M100682200; Bolhuis A, 2000, FEBS LETT, V472, P88, DOI 10.1016/S0014-5793(00)01428-9; CHADDOCK AM, 1995, EMBO J, V14, P2715, DOI 10.1002/j.1460-2075.1995.tb07272.x; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; Dabney-Smith C, 2006, J BIOL CHEM, V281, P5476, DOI 10.1074/jbc.M512453200; Dalbey RE, 2000, ANNU REV CELL DEV BI, V16, P51, DOI 10.1146/annurev.cellbio.16.1.51; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Ilbert M, 2003, J BIOL CHEM, V278, P28787, DOI 10.1074/jbc.M302730200; Jack RL, 2001, J BACTERIOL, V183, P1801, DOI 10.1128/JB.183.5.1801-1804.2001; Jongbloed JDH, 2004, MOL MICROBIOL, V54, P1319, DOI 10.1111/j.1365-2958.2004.04341.x; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; Oates J, 2005, J MOL BIOL, V346, P295, DOI 10.1016/j.jmb.2004.11.047; Oates J, 2003, J MOL BIOL, V330, P277, DOI 10.1016/S0022-2836(03)00621-1; Pop OI, 2003, J BIOL CHEM, V278, P38428, DOI 10.1074/jbc.M306516200; Porcelli I, 2002, BIOCHEMISTRY-US, V41, P13690, DOI 10.1021/bi026142i; Robinson C, 2004, BBA-MOL CELL RES, V1694, P135, DOI 10.1016/j.bbamcr.2004.03.010; Rodrigue A, 1999, J BIOL CHEM, V274, P13223, DOI 10.1074/jbc.274.19.13223; Santini CL, 1998, EMBO J, V17, P101, DOI 10.1093/emboj/17.1.101; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Sargent F, 1999, J BIOL CHEM, V274, P36073, DOI 10.1074/jbc.274.51.36073; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; SCHMIDT TGM, 1993, PROTEIN ENG, V6, P109, DOI 10.1093/protein/6.1.109; SILVESTRO A, 1989, BIOCHIM BIOPHYS ACTA, V999, P206; Stanley NR, 2000, J BIOL CHEM, V275, P11591, DOI 10.1074/jbc.275.16.11591; TAKESHITA S, 1987, GENE, V61, P63, DOI 10.1016/0378-1119(87)90365-9; Weiner JH, 1998, CELL, V93, P93, DOI 10.1016/S0092-8674(00)81149-6; Wexler M, 2000, J BIOL CHEM, V275, P16717, DOI 10.1074/jbc.M000800200; Yen MR, 2002, ARCH MICROBIOL, V177, P441, DOI 10.1007/s00203-002-0408-4	36	18	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36206	36213		10.1074/jbc.M704127200	http://dx.doi.org/10.1074/jbc.M704127200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17881358	hybrid			2022-12-25	WOS:000251458300010
J	Berdiev, BK; Cormet-Boyaka, E; Tousson, A; Qadri, YJ; Oosterveld-Hut, HMJ; Hong, JS; Gonzales, PA; Fuller, CM; Sorscher, EJ; Lukacs, GL; Benos, DJ				Berdiev, Bakhrom K.; Cormet-Boyaka, Estelle; Tousson, Albert; Qadri, Yawar J.; Oosterveld-Hut, Henderika M. J.; Hong, Jeong S.; Gonzales, Patricia A.; Fuller, Cathy M.; Sorscher, Eric J.; Lukacs, Gergely L.; Benos, Dale J.			Molecular proximity of cystic fibrosis transmembrane conductance regulator and epithelial sodium channel assessed by fluorescence resonance energy transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE NA+ CHANNELS; CHLORIDE CHANNEL; CFTR; PROTEIN; EXPRESSION; GENE; ENAC; IDENTIFICATION; INHIBITION; ACTIVATION	We present the evidence for a direct physical association of cystic fibrosis transmembrane conductance regulator (CFTR) and epithelial sodium channel (ENaC), two major ion channels implicated in the pathophysiology of cystic fibrosis, a devastating inherited disease. We employed fluorescence resonance energy transfer, a distance-dependent imaging technique with capability to detect molecular complexes with near angstrom resolution, to estimate the proximity of CFTR and ENaC, an essential variable for possible physical interaction to occur. Fluorescence resonance energy transfer studies were complemented with a classic biochemical approach: coimmunoprecipitation. Our results place CFTR and ENaC within reach of each other, suggestive of a direct interaction between these two proteins.	Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, High Resolut Imaging Facil, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA; Ohio State Univ, Davis Heart & Lung Res Inst, Div Pulm & Crit Care & Sleep Med, Columbus, OH 43210 USA; Lambert Instruments, NL-9313 TH Leutingewolde, Netherlands; NIH, NHLBI, Kidney & Electrolyte Metab Lab, Bethesda, MD 20892 USA; Univ Toronto, Hosp Sick Children, Res Inst, Dept Lab Med & Pathobiol Program Cell & Lung Biol, Toronto, ON M5G 1X8, Canada	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University System of Ohio; Ohio State University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Berdiev, BK (corresponding author), Univ Alabama Birmingham, Dept Cell Biol, 1918 Univ Blvd,MCLM 725, Birmingham, AL 35294 USA.	berdiev@uab.edu	Fuller, Cathy/B-4046-2011; Cormet-Boyaka, Estelle/H-5624-2011	Lukacs, Gergely/0000-0003-0900-0675; Sorscher, Eric J./0000-0001-9341-3354; Qadri, Yawar/0000-0003-2138-4018	NIDDK NIH HHS [R01-DK075302, P50 DK53090-05, 2R01-DK37206-15] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075302, R01DK037206, P50DK053090] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aleksandrov AA, 2007, PFLUG ARCH EUR J PHY, V453, P693, DOI 10.1007/s00424-006-0140-z; Bebok Z, 2002, J BIOL CHEM, V277, P43041, DOI 10.1074/jbc.M203154200; Berdiev BK, 2000, BIOPHYS J, V78, P1881, DOI 10.1016/S0006-3495(00)76737-3; Berdiev BK, 1999, CURR TOP MEMBR, V47, P351; Boucher RC, 2004, EUR RESPIR J, V23, P146, DOI 10.1183/09031936.03.00057003; Briel M, 1998, J PHYSIOL-LONDON, V508, P825, DOI 10.1111/j.1469-7793.1998.825bp.x; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; CANESSA CM, 1993, NATURE, V361, P467, DOI 10.1038/361467a0; CLEGG RM, 1992, METHOD ENZYMOL, V211, P353; Clegg RM, 2003, METHOD ENZYMOL, V360, P509; Cormet-Boyaka E, 2002, P NATL ACAD SCI USA, V99, P12477, DOI 10.1073/pnas.192203899; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Greeson JN, 2006, BRAIN RES, V1091, P140, DOI 10.1016/j.brainres.2006.02.084; Grunder S, 1997, EMBO J, V16, P899, DOI 10.1093/emboj/16.5.899; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Hebeisen S, 2004, J BIOL CHEM, V279, P13140, DOI 10.1074/jbc.M312649200; Helms MN, 2005, J BIOL CHEM, V280, P40885, DOI 10.1074/jbc.M509646200; Ismailov II, 1996, J BIOL CHEM, V271, P4725; Ismailov II, 1997, AM J PHYSIOL-CELL PH, V272, pC1077, DOI 10.1152/ajpcell.1997.272.4.C1077; Ji HL, 2000, J BIOL CHEM, V275, P27947; Karpova TS, 2003, J MICROSC-OXFORD, V209, P56, DOI 10.1046/j.1365-2818.2003.01100.x; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Knepper MA, 2001, ACTA PHYSIOL SCAND, V173, P11, DOI 10.1046/j.1365-201X.2001.00880.x; KNOWLES M, 1981, NEW ENGL J MED, V305, P1489, DOI 10.1056/NEJM198112173052502; KNOWLES MR, 1981, AM REV RESPIR DIS, V124, P484; Konstas AA, 2003, PFLUG ARCH EUR J PHY, V445, P513, DOI 10.1007/s00424-002-0957-z; Kremers GJ, 2006, BIOCHEMISTRY-US, V45, P6570, DOI 10.1021/bi0516273; Kunzelmann K, 1999, J MEMBRANE BIOL, V168, P1, DOI 10.1007/s002329900492; Kunzelmann K., 2003, CYSTIC FIBROSIS TRAN, P55; Lai MZ, 2005, NAT NEUROSCI, V8, P435, DOI 10.1038/nn1418; Letz B, 1997, AM J PHYSIOL-CELL PH, V272, pC657, DOI 10.1152/ajpcell.1997.272.2.C657; Ling BN, 1997, J BIOL CHEM, V272, P594; LINGUEGLIA E, 1993, FEBS LETT, V318, P95, DOI 10.1016/0014-5793(93)81336-X; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; Meltzer RH, 2007, J BIOL CHEM, V282, P25548, DOI 10.1074/jbc.M703825200; Moyer BD, 1998, J BIOL CHEM, V273, P21759, DOI 10.1074/jbc.273.34.21759; Moyer BD, 1999, J CLIN INVEST, V104, P1353, DOI 10.1172/JCI7453; Nagel G, 2005, J PHYSIOL-LONDON, V564, P671, DOI 10.1113/jphysiol.2004.079046; Nagel G, 2001, EMBO REP, V2, P249, DOI 10.1093/embo-reports/kve045; Nagel Georg, 2004, J Cyst Fibros, V3 Suppl 2, P109, DOI 10.1016/j.jcf.2004.05.043; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; SELVIN PR, 1995, METHOD ENZYMOL, V246, P300; Staruschenko A, 2004, J BIOL CHEM, V279, P27729, DOI 10.1074/jbc.M404169200; STUTTS MJ, 1995, SCIENCE, V269, P847, DOI 10.1126/science.7543698; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R	49	37	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36481	36488		10.1074/jbc.M708089200	http://dx.doi.org/10.1074/jbc.M708089200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17913705	hybrid			2022-12-25	WOS:000251458300040
J	Sugano, Y; Muramatsu, R; Ichiyanagi, A; Sato, T; Shoda, M				Sugano, Yasushi; Muramatsu, Riichi; Ichiyanagi, Atsushi; Sato, Takao; Shoda, Makoto			DyP, a unique dye-decolorizing peroxidase, represents a novel heme peroxidase family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WHITE-ROT BASIDIOMYCETE; CRYSTAL-STRUCTURE; MANGANESE PEROXIDASE; LIGNIN PEROXIDASE; PHANEROCHAETE-CHRYSOSPORIUM; SPECTRAL CHARACTERIZATION; HETEROLOGOUS EXPRESSION; ASPERGILLUS-ORYZAE; OXIDIZED STATES; CDNA CLONING	DyP, a unique dye-decolorizing enzyme from the fungus Thanatephorus cucumeris Dec 1, has been classified as a peroxidase but lacks homology to almost all other known plant peroxidases. The primary structure of DyP shows moderate sequence homology to only two known proteins: the peroxide-dependent phenol oxidase, TAP, and the hypothetical peroxidase, cpop21. Here, we show the first crystal structure of DyP and reveal that this protein has a unique tertiary structure with a distal heme region that differs from that of most other peroxidases. DyP lacks an important histidine residue known to assist in the formation of a Fe4(+) oxoferryl center and a porphyrin-based cation radical intermediate (compound I) during the action of ubiquitous peroxidases. Instead, our tertiary structural and spectrophotometric analyses of DyP suggest that an aspartic acid and an arginine are involved in the formation of compound I. Sequence analysis reveals that the important aspartic acid and arginine mentioned above and histidine of the heme ligand are conserved among DyP, TAP, and cpop21, and structural and phylogenetic analyses confirmed that these three enzymes do not belong to any other families of peroxidase. These findings, which strongly suggest that DyP is a representative heme peroxidase from a novel family, should facilitate the identification of additional new family members and accelerate the classification of this novel peroxidase family.	Tokyo Inst Technol, Chem Resources Lab R1 29, Midori Ku, Yokohama, Kanagawa 2268503, Japan; Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology	Sugano, Y (corresponding author), Tokyo Inst Technol, Chem Resources Lab R1 29, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268503, Japan.	ysugano@res.titech.ac.jp		Sugano, Yasushi/0000-0001-8463-5131				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banat IM, 1996, BIORESOURCE TECHNOL, V58, P217, DOI 10.1016/S0960-8524(96)00113-7; Bonagura CA, 1999, J BIOL CHEM, V274, P37827, DOI 10.1074/jbc.274.53.37827; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Camarero S, 1999, J BIOL CHEM, V274, P10324, DOI 10.1074/jbc.274.15.10324; Dunford HB, 1999, HEME PEROXIDASE; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FINZEL BC, 1984, J BIOL CHEM, V259, P3027; Gajhede M, 1997, NAT STRUCT BIOL, V4, P1032, DOI 10.1038/nsb1297-1032; GLENN JK, 1985, ARCH BIOCHEM BIOPHYS, V242, P329, DOI 10.1016/0003-9861(85)90217-6; GOLD MH, 1984, ARCH BIOCHEM BIOPHYS, V234, P353, DOI 10.1016/0003-9861(84)90280-7; GOODIN DB, 1993, BIOCHEMISTRY-US, V32, P3313, DOI 10.1021/bi00064a014; Henriksen A, 1998, J BIOL CHEM, V273, P2241, DOI 10.1074/jbc.273.4.2241; Johjima T, 2003, APPL MICROBIOL BIOT, V61, P220, DOI 10.1007/s00253-003-1236-4; Kim SJ, 1999, APPL ENVIRON MICROB, V65, P1029; McRee DE, 1992, J MOL GRAPHICS, V10, P44, DOI DOI 10.1016/0263-7855(92)80022-6; MITTLER R, 1991, FEBS LETT, V289, P257, DOI 10.1016/0014-5793(91)81083-K; POULOS TL, 1993, J BIOL CHEM, V268, P4429; RASMUSSEN CB, 1993, FEBS LETT, V321, P102, DOI 10.1016/0014-5793(93)80630-D; RENGANATHAN V, 1986, BIOCHEMISTRY-US, V25, P1626, DOI 10.1021/bi00355a027; Saijo S, 2005, ACTA CRYSTALLOGR F, V61, P729, DOI 10.1107/S1744309105019469; Sato T, 2004, ACTA CRYSTALLOGR D, V60, P149, DOI 10.1107/S0907444903025472; Shakeri M, 2007, J BIOSCI BIOENG, V103, P129, DOI 10.1263/jbb.103.129; SHANNON LM, 1966, J BIOL CHEM, V241, P2166; SHAW PD, 1961, J BIOL CHEM, V236, P1626; Sturm A, 2006, J BIOL CHEM, V281, P13972, DOI 10.1074/jbc.M511891200; Sugano Y, 2001, J BIOSCI BIOENG, V92, P594, DOI 10.1263/jbb.92.594; Sugano Y, 1999, J BIOSCI BIOENG, V87, P411, DOI 10.1016/S1389-1723(99)80087-5; Sugano Y, 2000, APPL ENVIRON MICROB, V66, P1754, DOI 10.1128/AEM.66.4.1754-1758.2000; Sugano Y, 2006, APPL MICROBIOL BIOT, V73, P862, DOI 10.1007/s00253-006-0545-9; Sundaramoorthy M, 1995, STRUCTURE, V3, P1367, DOI 10.1016/S0969-2126(01)00274-X; SUNDARAMOORTHY M, 1994, J BIOL CHEM, V269, P32759; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; WARIISHI H, 1988, BIOCHEMISTRY-US, V27, P5365, DOI 10.1021/bi00414a061; Welinder KG, 1992, CURR OPIN STRUC BIOL, V2, P388, DOI [DOI 10.1016/0959-440X(92)90230-5, 10.1016/0959-440x(92)90230-5]; Yamada Y, 2002, NAT STRUCT BIOL, V9, P691, DOI 10.1038/nsb834	36	159	163	5	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36652	36658		10.1074/jbc.M706996200	http://dx.doi.org/10.1074/jbc.M706996200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17928290	hybrid			2022-12-25	WOS:000251458300058
J	Dalal, S; Klemba, M				Dalal, Seema; Klemba, Michael			Roles for two aminopeptidases in vacuolar hemoglobin catabolism in Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIGESTIVE VACUOLE; CYSTEINE PROTEASE; LEUCYL AMINOPEPTIDASE; FLUORESCENT PROTEIN; MALARIA PARASITE; M1 FAMILY; IN-VIVO; LOCALIZATION; DISRUPTION; DEGRADATION	During the erythrocytic stage of its life cycle, the human malaria parasite Plasmodium falciparum catabolizes large quantities of host-cell hemoglobin in an acidic organelle, the food vacuole. A current model for the catabolism of globin-derived oligopeptides invokes peptide transport out of the food vacuole followed by hydrolysis to amino acids by cytosolic aminopeptidases. To test this model, we have examined the roles of four parasite aminopeptidases during the erythrocytic cycle. Localization of tagged aminopeptidases, coupled with biochemical analysis of enriched food vacuoles, revealed the presence of amino acid-generating pathways in the food vacuole as well as the cytosol. Based on the localization data and in vitro assays, we propose a specific role for one of the plasmodial enzymes, aminopeptidase P, in the catabolism of proline-containing peptides in both the vacuole and the cytosol. We establish an apparent requirement for three of the four aminopeptidases ( including the two food vacuole enzymes) for efficient parasite proliferation. To gain insight into the impact of aminopeptidase inhibition on parasite development, we examined the effect of the presence of amino acids in the culture medium of the parasite on the toxicity of the aminopeptidase inhibitor bestatin. The ability of bestatin to block parasite replication was only slightly affected when 19 of 20 amino acids were withdrawn from the medium, indicating that exogenous amino acids cannot compensate for the loss of aminopeptidase activity. Together, these results support the development of aminopeptidase inhibitors as novel chemotherapeutics directed against malaria.	Virginia Polytech Inst & State Univ, Dept Biochem, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Klemba, M (corresponding author), Virginia Tech, 306 Engel Hall, Blacksburg, VA 24061 USA.	klemba@vt.edu						Allary M, 2002, PARASITOLOGY, V125, P1, DOI 10.1017/S0031182002001828; Allen RJW, 2004, TRENDS PARASITOL, V20, P7, DOI 10.1016/j.pt.2003.10.015; BALL EG, 1948, J BIOL CHEM, V175, P547; Bennett TN, 2004, MOL BIOCHEM PARASIT, V133, P99, DOI 10.1016/j.molbiopara.2003.09.008; Bradshaw RA, 1998, TRENDS BIOCHEM SCI, V23, P263, DOI 10.1016/S0968-0004(98)01227-4; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; Cunningham DF, 1997, BBA-PROTEIN STRUCT M, V1343, P160, DOI 10.1016/S0167-4838(97)00134-9; DIVO AA, 1985, J PROTOZOOL, V32, P59, DOI 10.1111/j.1550-7408.1985.tb03013.x; Eksi S, 2004, MOL MICROBIOL, V53, P243, DOI 10.1111/j.1365-2958.2004.04108.x; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Florent I, 1998, MOL BIOCHEM PARASIT, V97, P149, DOI 10.1016/S0166-6851(98)00143-1; Gardiner DL, 2006, J BIOL CHEM, V281, P1741, DOI 10.1074/jbc.M508955200; Gavigan CS, 2001, MOL BIOCHEM PARASIT, V117, P37, DOI 10.1016/S0166-6851(01)00327-9; Goldberg DE, 2005, CURR TOP MICROBIOL, V295, P275; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Janse Chris J., 1994, V42, P295; Klemba M, 2004, J CELL BIOL, V164, P47, DOI 10.1083/jcb200307147; Klemba M, 2004, J BIOL CHEM, V279, P43000, DOI 10.1074/jbc.M408123200; Kolakovich KA, 1997, MOL BIOCHEM PARASIT, V87, P123, DOI 10.1016/S0166-6851(97)00062-5; KROGSTAD DJ, 1985, J CELL BIOL, V101, P2302, DOI 10.1083/jcb.101.6.2302; Krugliak M, 2002, MOL BIOCHEM PARASIT, V119, P249, DOI 10.1016/S0166-6851(01)00427-3; Kuhn Y, 2007, CELL MICROBIOL, V9, P1004, DOI 10.1111/j.1462-5822.2006.00847.x; KUMAR N, 1991, MOL BIOCHEM PARASIT, V48, P47, DOI 10.1016/0166-6851(91)90163-Z; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lew VL, 2003, BLOOD, V101, P4189, DOI 10.1182/blood-2002-08-2654; Liu J, 2006, P NATL ACAD SCI USA, V103, P8840, DOI 10.1073/pnas.0601876103; Loria P, 1999, BIOCHEM J, V339, P363, DOI 10.1042/0264-6021:3390363; MAKLER MT, 1993, AM J TROP MED HYG, V48, P205, DOI 10.4269/ajtmh.1993.48.205; Martin RE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r26; Martin RE, 2007, BLOOD, V109, P2217, DOI 10.1182/blood-2005-11-026963; Nankya-Kitaka MF, 1998, PARASITOL RES, V84, P552, DOI 10.1007/s004360050447; Omara-Opyene AL, 2004, J BIOL CHEM, V279, P54088, DOI 10.1074/jbc.M409605200; Ponpuak M, 2007, MOL MICROBIOL, V63, P314, DOI 10.1111/j.1365-2958.2006.05443.x; Rosenthal PJ, 2002, CURR OPIN HEMATOL, V9, P140, DOI 10.1097/00062752-200203000-00010; Saliba KJ, 1998, BIOCHEM PHARMACOL, V56, P313, DOI 10.1016/S0006-2952(98)00140-3; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SHERMAN IW, 1977, B WORLD HEALTH ORGAN, V55, P265; SHERMAN IW, 1970, INT J BIOCHEM, V1, P635, DOI 10.1016/0020-711X(70)90033-9; Sijwali PS, 2004, P NATL ACAD SCI USA, V101, P8721, DOI 10.1073/pnas.0402738101; Sijwali PS, 2004, P NATL ACAD SCI USA, V101, P4384, DOI 10.1073/pnas.0307720101; SLOMIANNY C, 1983, J PROTOZOOL, V30, P376, DOI 10.1111/j.1550-7408.1983.tb02934.x; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Stack CM, 2007, J BIOL CHEM, V282, P2069, DOI 10.1074/jbc.M609251200; Stockel-Maschek A, 2003, ANAL BIOCHEM, V322, P60, DOI 10.1016/S0003-2697(03)00464-0; Thompson NE, 2003, ANAL BIOCHEM, V323, P171, DOI 10.1016/j.ab.2003.08.003; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; TURNER AJ, 2004, HDB PROTEOLYTIC ENZY, P930; Wilk S, 1998, J BIOL CHEM, V273, P15961, DOI 10.1074/jbc.273.26.15961; Wu YM, 2003, GENOME RES, V13, P601, DOI 10.1101/gr.913403; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	51	114	116	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35978	35987		10.1074/jbc.M703643200	http://dx.doi.org/10.1074/jbc.M703643200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17895246	hybrid			2022-12-25	WOS:000251458100058
J	Wu, JW; Yang, YS; Zhang, JH; Ji, P; Du, WJ; Jiang, P; Xie, DH; Huang, HD; Wu, M; Zhang, GZ; Wu, JH; Shi, YY				Wu, Jiawen; Yang, Yinshan; Zhang, Jiahai; Ji, Peng; Du, Wenjing; Jiang, Peng; Xie, Dinghai; Huang, Hongda; Wu, Mian; Zhang, Guangzhao; Wu, Jihui; Shi, Yunyu			Domain-swapped dimerization of the second PDZ domain of ZO2 may provide a structural basis for the polymerization of claudins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIGHT JUNCTION PROTEIN; TUMOR-SUPPRESSOR PROTEIN; GUANYLATE KINASE DOMAINS; CRYSTAL-STRUCTURE; INTRAMOLECULAR INTERACTION; ZONULA OCCLUDENS; EPITHELIAL-CELLS; COMPLEX REVEALS; ZO-1; SEQUENCE	Zonula occludens proteins (ZOs), including ZO1/2/3, are tight junction-associated proteins. Each of them contains three PDZ domains. It has been demonstrated that ZO1 can form either homodimers or heterodimers with ZO2 or ZO3 through the second PDZ domain. However, the underlying structural basis is not well understood. In this study, the solution structure of the second PDZ domain of ZO2 (ZO2-PDZ2) was determined using NMR spectroscopy. The results revealed a novel dimerization mode for PDZ domains via three-dimensional domain swapping, which can be generalized to homodimers of ZO1-PDZ2 or ZO3-PDZ2 and heterodimers of ZO1-PDZ2/ZO2-PDZ2 or ZO1-PDZ2/ZO3-PDZ2 due to high conservation between PDZ2 domains in ZO proteins. Furthermore, GST pull-down experiments and immunoprecipitation studies demonstrated that interactions between ZO1-PDZ2 and ZO2-PDZ2 and their self-associations indeed exist both in vitro and in vivo. Chemical cross-linking and dynamic laser light scattering experiments revealed that both ZO1-PDZ2 and ZO2-PDZ2 can form oligomers in solution. This PDZ domain-mediated oligomerization of ZOs may provide a structural basis for the polymerization of claudins, namely the formation of tight junctions.	Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; Univ Sci & Technol China, Dept Chem Phys, Hefei 230026, Anhui, Peoples R China; Anhui Coll Tradit Chinese Med, Sch Ch Western Med, Hefei 230038, Anhui, Peoples R China; INSERM, Ctr Biochim Struct, U554, F-34090 Montpellier, France; CNRS, UMR5048, F-34090 Montpellier, France	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Anhui University of Chinese Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Wu, JH (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China.	wujihui@ustc.edu.cn; yyshi@ustc.edu.cn	Jiang, Peng/A-1946-2013; du, wenjing/A-2530-2013; Huang, Hongda/G-8962-2015; Shi, Yunyu/B-3240-2009	du, wenjing/0000-0002-3967-9984; Shi, Yunyu/0000-0002-1348-4759; Wu, Mian/0000-0002-2714-0500				Aijaz S, 2006, INT REV CYTOL, V248, P261, DOI 10.1016/S0074-7696(06)48005-0; Albright RA, 1996, BIOCHEMISTRY-US, V35, P735, DOI 10.1021/bi951958n; ANDERSON JM, 1995, BIOCHEM SOC T, V23, P470, DOI 10.1042/bst0230470; BALDA MS, 1993, J CELL BIOL, V123, P293, DOI 10.1083/jcb.123.2.293; BENNETT MJ, 1994, PROTEIN SCI, V3, P1464, DOI 10.1002/pro.5560030912; BERNE BJ, 1976, DYNAMIC LIGHT SCATTE, P11; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CEREIJIDO M, 1993, J CELL SCI, P127; CEREIJIDO M, 1989, J MEMBRANE BIOL, V110, P1, DOI 10.1007/BF01870987; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Furuse M, 2001, J CELL BIOL, V153, P263, DOI 10.1083/jcb.153.2.263; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Gonzalez-Mariscal L, 2000, SEMIN CELL DEV BIOL, V11, P315, DOI 10.1006/scdb.2000.0178; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; GREEN SM, 1995, NAT STRUCT BIOL, V2, P746, DOI 10.1038/nsb0995-746; GUMBINER B, 1991, P NATL ACAD SCI USA, V88, P3460, DOI 10.1073/pnas.88.8.3460; Haskins J, 1998, J CELL BIOL, V141, P199, DOI 10.1083/jcb.141.1.199; Huber JD, 2001, TRENDS NEUROSCI, V24, P719, DOI 10.1016/S0166-2236(00)02004-X; Im YJ, 2003, J BIOL CHEM, V278, P48099, DOI 10.1074/jbc.M306919200; Im YJ, 2003, J BIOL CHEM, V278, P8501, DOI 10.1074/jbc.M212263200; Itoh M, 1999, J CELL BIOL, V147, P1351, DOI 10.1083/jcb.147.6.1351; Itoh M, 1999, J BIOL CHEM, V274, P5981, DOI 10.1074/jbc.274.9.5981; ITOH M, 1993, J CELL BIOL, V121, P491, DOI 10.1083/jcb.121.3.491; Jeansonne B, 2003, CELL MOL BIOL, V49, P13; JESAITIS LA, 1994, J CELL BIOL, V124, P949, DOI 10.1083/jcb.124.6.949; KIM SK, 1995, CURR OPIN CELL BIOL, V7, P641, DOI 10.1016/0955-0674(95)80105-7; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KORTT AA, 1994, EUR J BIOCHEM, V221, P151, DOI 10.1111/j.1432-1033.1994.tb18724.x; Kuhlendahl S, 1998, EUR J BIOCHEM, V252, P305, DOI 10.1046/j.1432-1327.1998.2520305.x; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Martin-Padura I, 1998, J CELL BIOL, V142, P117, DOI 10.1083/jcb.142.1.117; Masuko N, 1999, J BIOL CHEM, V274, P5782, DOI 10.1074/jbc.274.9.5782; McGee AW, 2001, MOL CELL, V8, P1291, DOI 10.1016/S1097-2765(01)00411-7; McGee AW, 1999, J BIOL CHEM, V274, P17431, DOI 10.1074/jbc.274.25.17431; MURRAY AJ, 1995, P NATL ACAD SCI USA, V92, P7337, DOI 10.1073/pnas.92.16.7337; OTTING G, 1989, J MAGN RESON, V85, P586, DOI 10.1016/0022-2364(89)90249-7; PERISIC O, 1994, STRUCTURE, V2, P1217, DOI 10.1016/S0969-2126(94)00123-5; Poon IKH, 2005, TRAFFIC, V6, P173, DOI 10.1111/j.1600-0854.2005.00268.x; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shin HW, 2000, J NEUROSCI, V20, P3580, DOI 10.1523/JNEUROSCI.20-10-03580.2000; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Tavares GA, 2001, MOL CELL, V8, P1313, DOI 10.1016/S1097-2765(01)00416-6; Tsukita S, 1999, TRENDS CELL BIOL, V9, P268, DOI 10.1016/S0962-8924(99)01578-0; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; Utepbergenov DI, 2006, J BIOL CHEM, V281, P24671, DOI 10.1074/jbc.M512820200; Van Itallie CM, 2003, AM J PHYSIOL-RENAL, V285, pF1078, DOI 10.1152/ajprenal.00116.2003; WILLOTT E, 1993, P NATL ACAD SCI USA, V90, P7834, DOI 10.1073/pnas.90.16.7834; WOODS DF, 1993, MECH DEVELOP, V44, P85, DOI 10.1016/0925-4773(93)90059-7; Yu ASL, 2003, J BIOL CHEM, V278, P17350, DOI 10.1074/jbc.M213286200	56	27	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35988	35999		10.1074/jbc.M703826200	http://dx.doi.org/10.1074/jbc.M703826200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17897942	hybrid			2022-12-25	WOS:000251458100059
J	Bourhis, E; Hymowitz, SG; Cochran, AG				Bourhis, Eric; Hymowitz, Sarah G.; Cochran, Andrea G.			The mitotic regulator survivin binds as a monomer to its functional interactor borealin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOSOMAL PASSENGER COMPLEX; AURORA-B; CRYSTAL-STRUCTURE; REVEALS; CENTROMERE; INHIBITOR; INCENP	Survivin is a member of the IAP ( (i) under bar nhibitor of (a) under bar poptosis) protein family, defined in part by the presence of a zinc-binding baculoviral inhibitory repeat (BIR) domain. Most BIR domains bind short sequences beginning with alanine, and in this manner, they recognize and block the action of key targets in apoptotic pathways. However, Survivin binds only very weakly to typical IAP ligands. Unique features of Survivin are the long C-terminal helix following the BIR domain and a short segment ( linking the helix and BIR domains) that mediates Survivin homodimerization. Despite this detailed knowledge of the structure of Survivin itself, there is a current lack of understanding about how Survivin recognizes cellular binding partners, and consequently, many questions about Survivin function remain unanswered. We determined two co-crystal structures of Survivin and a minimal binding fragment from the chromosomal passenger protein Borealin, a well validated functional interactor. The interaction between Survivin and Borealin involves extensive packing between the long C-terminal helix of Survivin and a long Borealin helix. Surprisingly, an additional important interaction occurs between the Survivin homodimerization interface and a short segment of Borealin. This segment both structurally mimics and displaces one Survivin monomer. The relevance of this unexpected interaction was tested by mutagenesis of two key Borealin residues. Mutant Borealin introduced into HeLa cells failed to localize properly during mitosis and also caused mislocalization of other chromosomal passenger proteins. This suggests that the mutant is dominant-negative and confirms the functional importance of the interaction surface identified in the crystal structures.	Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA	Roche Holding; Genentech	Cochran, AG (corresponding author), Genentech Inc, Dept Prot Engn, 1 DNA Way,MS 27, San Francisco, CA 94080 USA.	andrea@gene.com		Cochran, Andrea/0000-0001-6469-795X				Altieri DC, 2006, CURR OPIN CELL BIOL, V18, P609, DOI 10.1016/j.ceb.2006.08.015; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Chantalat L, 2000, MOL CELL, V6, P183, DOI 10.1016/S1097-2765(00)00019-8; Colnaghi R, 2006, J BIOL CHEM, V281, P33450, DOI 10.1074/jbc.C600164200; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Faragher AJ, 2007, MOL BIOL CELL, V18, P1337, DOI 10.1091/mbc.E06-05-0409; Franklin MC, 2003, BIOCHEMISTRY-US, V42, P8223, DOI 10.1021/bi034227t; Gassmann R, 2004, J CELL BIOL, V166, P179, DOI 10.1083/jcb.200404001; Klein UR, 2006, MOL BIOL CELL, V17, P2547, DOI 10.1091/mbc.E05-12-1133; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lens SMA, 2006, MOL BIOL CELL, V17, P1897, DOI 10.1091/mbc.E05-08-0727; Lens SMA, 2006, CURR OPIN CELL BIOL, V18, P616, DOI 10.1016/j.ceb.2006.08.016; Muchmore SW, 2000, MOL CELL, V6, P173, DOI 10.1016/S1097-2765(00)00018-6; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Romano A, 2003, J CELL BIOL, V161, P229, DOI 10.1083/jcb.200207117; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Sampath SC, 2004, CELL, V118, P187, DOI 10.1016/j.cell.2004.06.026; Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031; Shi YG, 2000, NAT STRUCT BIOL, V7, P620, DOI 10.1038/77904; Sun CH, 2005, BIOCHEMISTRY-US, V44, P11, DOI 10.1021/bi0485171; Vader G, 2006, EMBO REP, V7, P85, DOI 10.1038/sj.embor.7400562; Vader G, 2006, J CELL BIOL, V173, P833, DOI 10.1083/jcb.200604032; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P602; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2	24	39	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35018	35023		10.1074/jbc.M706233200	http://dx.doi.org/10.1074/jbc.M706233200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17881355	hybrid			2022-12-25	WOS:000251155200046
J	Laursen, KB; Mielke, E; Iannaccone, P; Fuchtbauer, EM				Laursen, Kristian Bruun; Mielke, Esther; Iannaccone, Philip; Fuechtbauer, Ernst-Martin			Mechanism of transcriptional activation by the proto-oncogene Twist1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SAETHRE-CHOTZEN-SYNDROME; DNA-BINDING PROTEINS; LOOP-HELIX PROTEINS; BHLH PROTEIN; MAMMALIAN-CELLS; OSTEOBLAST DIFFERENTIATION; MUSCLE DIFFERENTIATION; DORSOVENTRAL PATTERN; REGULATORY ELEMENTS; DROSOPHILA EMBRYO	Mammalian Twist1, a master regulator in development and a key factor in tumorigenesis, is known to repress transcription by several mechanisms and is therefore considered to mediate its function mainly through inhibition. A role of Twist1 as transactivator has also been reported but, so far, without providing a mechanism for such an activity. Here we show that heterodimeric complexes of Twist1 and E12 mediate E-box-dependent transcriptional activation. We identify a novel Twist1 transactivation domain that coactivates together with the less potent E12 transactivation domain. We found three specific residues in the highly conserved WR domain to be essential for the transactivating function of murine Twist1 and suggest an alpha-helical structure of the transactivation domain.	Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus, Denmark; Northwestern Univ, Childrens Mem Res Ctr, Dev Biol Program, Chicago, IL 60614 USA	Aarhus University; Northwestern University	Fuchtbauer, EM (corresponding author), Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus, Denmark.	emf@mb.au.dk						Alexander NR, 2006, CANCER RES, V66, P3365, DOI 10.1158/0008-5472.CAN-05-3401; ARONHEIM A, 1993, P NATL ACAD SCI USA, V90, P8063, DOI 10.1073/pnas.90.17.8063; BAIN G, 1993, MOL CELL BIOL, V13, P3522, DOI 10.1128/MCB.13.6.3522; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9; BODMER R, 1990, DEVELOPMENT, V110, P661; Bourgeois P, 1998, HUM MOL GENET, V7, P945, DOI 10.1093/hmg/7.6.945; BRAUN T, 1990, NATURE, V346, P663, DOI 10.1038/346663a0; BRAUN T, 1989, EMBO J, V8, P701, DOI 10.1002/j.1460-2075.1989.tb03429.x; Castanon I, 2002, GENE, V287, P11, DOI 10.1016/S0378-1119(01)00893-9; Castanon I, 2001, DEVELOPMENT, V128, P3145; CHEN ZF, 1995, GENE DEV, V9, P686, DOI 10.1101/gad.9.6.686; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; Connerney J, 2006, DEV DYNAM, V235, P1345, DOI 10.1002/dvdy.20717; Corsi AK, 2002, DEVELOPMENT, V129, P2761; Cripps RM, 1998, GENE DEV, V12, P422, DOI 10.1101/gad.12.3.422; Demontis S, 2006, CELL DEATH DIFFER, V13, P335, DOI 10.1038/sj.cdd.4401744; El Ghouzzi V, 2001, FEBS LETT, V492, P112, DOI 10.1016/S0014-5793(01)02238-4; ElGhouzzi V, 1997, NAT GENET, V15, P42; Firulli BA, 2005, NAT GENET, V37, P373, DOI 10.1038/ng1525; FUCHTBAUER EM, 1995, DEV DYNAM, V204, P316; Funato N, 2001, MOL CELL BIOL, V21, P7416, DOI 10.1128/MCB.21.21.7416-7428.2001; Gong XQ, 2002, J BIOL CHEM, V277, P12310, DOI 10.1074/jbc.M110228200; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; Guenou H, 2005, HUM MOL GENET, V14, P1429, DOI 10.1093/hmg/ddi152; Gullaud M, 2003, CELL DEATH DIFFER, V10, P641, DOI 10.1038/sj.cdd.4401222; Hamamori Y, 1997, MOL CELL BIOL, V17, P6563, DOI 10.1128/MCB.17.11.6563; Hamamori Y, 1999, CELL, V96, P405, DOI 10.1016/S0092-8674(00)80553-X; Harfe BD, 1998, GENE DEV, V12, P2623, DOI 10.1101/gad.12.16.2623; HARLAND R, 1985, J CELL BIOL, V101, P1094, DOI 10.1083/jcb.101.3.1094; Hebrok M, 1997, EXP CELL RES, V232, P295, DOI 10.1006/excr.1997.3541; HEBROK M, 1994, DEV BIOL, V165, P537, DOI 10.1006/dbio.1994.1273; Howard TD, 1997, NAT GENET, V15, P36, DOI 10.1038/ng0197-36; IP YT, 1992, GENE DEV, V6, P1728, DOI 10.1101/gad.6.9.1728; IP YT, 1992, GENE DEV, V6, P1518, DOI 10.1101/gad.6.8.1518; Isaac A, 2000, MECH DEVELOP, V93, P41, DOI 10.1016/S0925-4773(00)00261-6; JAIN VK, 1991, ANAL BIOCHEM, V199, P119, DOI 10.1016/0003-2697(91)90278-2; Kophengnavong T, 2000, MOL CELL BIOL, V20, P261, DOI 10.1128/MCB.20.1.261-272.2000; Kwok WK, 2005, CANCER RES, V65, P5153, DOI 10.1158/0008-5472.CAN-04-3785; LASSAR AB, 1991, CELL, V66, P305, DOI 10.1016/0092-8674(91)90620-E; Lee MS, 2000, BONE, V27, P591, DOI 10.1016/S8756-3282(00)00380-X; Lee YM, 1997, J BIOL CHEM, V272, P17531, DOI 10.1074/jbc.272.28.17531; Maestro R, 1999, GENE DEV, V13, P2207, DOI 10.1101/gad.13.17.2207; Markus M, 2002, J BIOL CHEM, V277, P6469, DOI 10.1074/jbc.M110659200; Massari ME, 1996, MOL CELL BIOL, V16, P121; MIRONCHIK Y, 2005, CANCER RES, V65, P1081; MITSUI K, 1993, J BIOL CHEM, V268, P24415; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; NEUHOLD LA, 1993, CELL, V74, P1033, DOI 10.1016/0092-8674(93)90725-6; O'Rourke MP, 2002, INT J DEV BIOL, V46, P401; Ohuchida K, 2007, INT J CANCER, V120, P1634, DOI 10.1002/ijc.22295; Oshima A, 2002, J CELL BIOCHEM, V86, P792, DOI 10.1002/jcb.10272; Petropoulos H, 2000, J BIOL CHEM, V275, P25095, DOI 10.1074/jbc.M004251200; Puri PL, 1997, MOL CELL, V1, P35, DOI 10.1016/S1097-2765(00)80005-2; QUONG MW, 1993, MOL CELL BIOL, V13, P792, DOI 10.1128/MCB.13.2.792; RASHEED S, 1974, CANCER, V33, P1027, DOI 10.1002/1097-0142(197404)33:4<1027::AID-CNCR2820330419>3.0.CO;2-Z; Rice DPC, 2000, DEVELOPMENT, V127, P1845; SALMINEN A, 1991, J CELL BIOL, V115, P905, DOI 10.1083/jcb.115.4.905; Sartorelli V, 1999, MOL CELL, V4, P725, DOI 10.1016/S1097-2765(00)80383-4; Sartorelli V, 1997, MOL CELL BIOL, V17, P1010, DOI 10.1128/MCB.17.2.1010; SHISHIDO E, 1993, DEVELOPMENT, V117, P751; SIMPSON P, 1983, GENETICS, V105, P615; Skerjanc IS, 1996, J BIOL CHEM, V271, P3555, DOI 10.1074/jbc.271.7.3555; Sloan SR, 1996, MOL CELL BIOL, V16, P6900; Soo K, 2002, DEV BIOL, V247, P251, DOI 10.1006/dbio.2002.0699; Sosic D, 2003, CELL, V112, P169, DOI 10.1016/S0092-8674(03)00002-3; Spicer DB, 1996, SCIENCE, V272, P1476, DOI 10.1126/science.272.5267.1476; THISSE B, 1987, NUCLEIC ACIDS RES, V15, P3439, DOI 10.1093/nar/15.8.3439; Valsesia-Wittmann S, 2004, CANCER CELL, V6, P625, DOI 10.1016/j.ccr.2004.09.033; Villavicencio EH, 2002, GENESIS, V32, P247, DOI 10.1002/gene.10078; WEINTRAUB H, 1990, P NATL ACAD SCI USA, V87, P5623, DOI 10.1073/pnas.87.15.5623; WEINTRAUB H, 1991, GENE DEV, V5, P1377, DOI 10.1101/gad.5.8.1377; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yin ZZ, 1997, DEVELOPMENT, V124, P4971; Yousfi M, 2002, BIOCHEM BIOPH RES CO, V297, P641, DOI 10.1016/S0006-291X(02)02260-X; Zhang Z, 2007, HUM PATHOL, V38, P598, DOI 10.1016/j.humpath.2006.10.004; ZHOU JM, 1994, MOL CELL BIOL, V14, P6232, DOI 10.1128/MCB.14.9.6232; Zhuang YA, 1998, MOL CELL BIOL, V18, P3340, DOI 10.1128/MCB.18.6.3340	80	37	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34623	34633		10.1074/jbc.M707085200	http://dx.doi.org/10.1074/jbc.M707085200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17893140	hybrid			2022-12-25	WOS:000251155200004
J	Xu, AG; Haines, N; Dlugosz, M; Rana, NA; Takeuchi, H; Haltiwanger, RS; Irvine, KD				Xu, Aiguo; Haines, Nicola; Dlugosz, Malgosia; Rana, Nadia A.; Takeuchi, Hideyuki; Haltiwanger, Robert S.; Irvine, Kenneth D.			In vitro reconstitution of the modulation of Drosophila notch-ligand binding by fringe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH FACTOR-LIKE; O-LINKED FUCOSE; LUNATIC-FRINGE; DELTA INTERACTIONS; N-GLYCANS; CELLS; GLYCOSYLATION; GLYCOSYLTRANSFERASE; DORSAL; GENE	Notch signaling plays critical roles in animal development and physiology. The activation of Notch receptors by their ligands is modulated by Fringe-dependent glycosylation. Fringe catalyzes the addition of N-acetylglucosamine in a beta 1,3 linkage onto O-fucose on epidermal growth factor-like domains. This modification of Notch by Fringe influences the binding of Notch ligands to Notch receptors. However, prior studies have relied on in vivo glycosylation, leaving unresolved the question of whether addition of N-acetylglucosamine is sufficient to modulate Notch-ligand interactions on its own, or whether instead it serves as a precursor to subsequent post-translational modifications. Here, we describe the results of in vitro assays using purified components of the Drosophila Notch signaling pathway. In vitro glycosylation and ligand binding studies establish that the addition of N-acetylglucosamine onto O-fucose in vitro is sufficient both to enhance Notch binding to the Delta ligand and to inhibit Notch binding to the Serrate ligand. Further elongation by galactose does not detectably influence Notch-ligand binding in vitro. Consistent with these observations, carbohydrate compositional analysis and mass spectrometry on Notch isolated from cells identified only N-acetylglucosamine added onto Notch in the presence of Fringe. These observations argue against models in which Fringe-dependent glycosylation modulates Notch signaling by acting as a precursor to subsequent modifications and instead establish the simple addition of N-acetylglucosamine as a basis for the effects of Fringe on Drosophila Notch-ligand binding.	Rutgers State Univ, Waksman Inst, Howard Hughes Med Inst, Piscataway, NJ 08854 USA; Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; SUNY Stony Brook, Dept Biochem & Cell Biol, Inst Cell & Dev Biol, Stony Brook, NY 11794 USA	Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University New Brunswick; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Irvine, KD (corresponding author), Rutgers State Univ, Waksman Inst, Howard Hughes Med Inst, POB 759, Piscataway, NJ 08854 USA.	irvine@waksman.rutgers.edu	Takeuchi, Hideyuki/AAZ-9210-2020		NIGMS NIH HHS [R01-GM61126, R01 GM061126, R01-GM54594] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061126, R01GM054594] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amado M, 1999, BBA-GEN SUBJECTS, V1473, P35, DOI 10.1016/S0304-4165(99)00168-3; Asano M, 1997, EMBO J, V16, P1850, DOI 10.1093/emboj/16.8.1850; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Chen JH, 2001, P NATL ACAD SCI USA, V98, P13716, DOI 10.1073/pnas.241398098; Chen JH, 2006, GENE EXPR PATTERNS, V6, P376, DOI 10.1016/j.modgep.2005.09.009; Chen YW, 2007, DEV BIOL, V306, P736, DOI 10.1016/j.ydbio.2007.04.013; Correia T, 2003, P NATL ACAD SCI USA, V100, P6404, DOI 10.1073/pnas.1131007100; Evrard YA, 1998, NATURE, V394, P377, DOI 10.1038/28632; Fleming RJ, 1997, DEVELOPMENT, V124, P2973; Furukawa K, 1999, BBA-GEN SUBJECTS, V1473, P54, DOI 10.1016/S0304-4165(99)00169-5; Guo S, 2001, GLYCOBIOLOGY, V11, P813, DOI 10.1093/glycob/11.10.813; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Haines N, 2005, GLYCOBIOLOGY, V15, P335, DOI 10.1093/glycob/cwi017; Haltiwanger RS, 2002, BBA-GEN SUBJECTS, V1573, P328, DOI 10.1016/S0304-4165(02)00400-2; Haltiwanger RS, 1997, J BIOL CHEM, V272, P8752, DOI 10.1074/jbc.272.13.8752; HARDY MR, 1994, METHOD ENZYMOL, V230, P208; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Hofsteenge J, 2001, J BIOL CHEM, V276, P6485, DOI 10.1074/jbc.M008073200; IRVINE KD, 1994, CELL, V79, P595, DOI 10.1016/0092-8674(94)90545-2; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Li QX, 1997, DEV BIOL, V181, P257, DOI 10.1006/dbio.1996.8444; Moloney DJ, 1997, J BIOL CHEM, V272, P19046, DOI 10.1074/jbc.272.30.19046; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Nita-Lazar A, 2006, METHOD ENZYMOL, V417, P93, DOI 10.1016/S0076-6879(06)17008-1; Okajima T, 2003, J BIOL CHEM, V278, P42340, DOI 10.1074/jbc.M308687200; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Papayannopoulos V, 1998, SCIENCE, V281, P2031, DOI 10.1126/science.281.5385.2031; Perez L, 2005, MECH DEVELOP, V122, P479, DOI 10.1016/j.mod.2004.12.007; Sasaki N, 2007, BIOCHEM BIOPH RES CO, V354, P522, DOI 10.1016/j.bbrc.2007.01.015; Sasamura T, 2003, DEVELOPMENT, V130, P4785, DOI 10.1242/dev.00679; Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI 10.1016/j.cub.2004.01.023; Shao L, 2003, J BIOL CHEM, V278, P7775, DOI 10.1074/jbc.M212221200; Shimizu K, 2001, J BIOL CHEM, V276, P25753, DOI 10.1074/jbc.M103473200; Stolz A, 2008, GLYCOCONJUGATE J, V25, P167, DOI 10.1007/s10719-007-9069-5; Yang LT, 2005, MOL BIOL CELL, V16, P927, DOI 10.1091/mbc.e04-07-0614; Zhang NA, 1998, NATURE, V394, P374, DOI 10.1038/28625	38	79	81	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35153	35162		10.1074/jbc.M707040200	http://dx.doi.org/10.1074/jbc.M707040200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17923477	hybrid			2022-12-25	WOS:000251155200060
J	Khan, MT; Bhanumathy, CD; Schug, ZT; Joseph, SK				Khan, M. Tariq; Bhanumathy, Cunnigaiper D.; Schug, Zachary T.; Joseph, Suresh K.			Role of inositol 1,4,5-trisphosphate receptors in apoptosis in DT40 lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRISPHOSPHATE RECEPTOR; ENDOPLASMIC-RETICULUM; CELL-DEATH; IP3 RECEPTORS; MOLECULAR DETERMINANTS; GENETIC-EVIDENCE; CALCIUM-RELEASE; CA2+ RELEASE; MEMBRANE; TYPE-1	The role of inositol 1,4,5-trisphosphate receptors (IP3R) in caspase-3 activation and cell death was investigated in DT40 chicken B-lymphocytes stably expressing various IP3R constructs. Both full-length type-I IP3R and a truncated construct corresponding to the caspase-3 cleaved "channel-only" fragment were able to support staurosporine (STS)-induced caspase-3 activation and cell death even when the IP3R construct harbored a mutation that inactivates the pore of the Ca2+ channel (D2550A). However, a full-length wild-type IP3R did not promote caspase-3 activation when the 159-amino acid cytosol-exposed C-terminal tail was deleted. STS caused an increase in cytosolic free Ca2+ in DT40 cells expressing wildtype or pore-dead IP3R mutants. However, in the latter case all the Ca2+ increase originated from Ca2+ entry across the plasma membrane. Caspase-3 activation of pore-dead DT40 cells was also more sensitive to extracellular Ca2+ chelation when compared with wild-type cells. STS-mediated release of cytochrome c into the cytosol and mitochondrial membrane potential depolarization could also be observed in DT40 cells lacking IP(3)Rs or containing the pore-dead mutant. We conclude that nonfunctional IP(3)Rs can sustain apoptosis in DT40 lymphocytes, because they facilitate Ca2+ entry mechanisms across the plasma membrane. Although the intrinsic ion-channel function of IP(3)Rs is dispensable for apoptosis induced by STS, the C-terminal tail of IP(3)Rs appears to be essential, possibly reflecting key protein-protein interactions with this domain.	Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA	Jefferson University	Joseph, SK (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, 1020 Locust St,JAH 230A, Philadelphia, PA 19107 USA.	suresh.joseph@mail.tju.edu		Schug, Zachary/0000-0003-4197-8227	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA007463] Funding Source: NIH RePORTER; NIAAA NIH HHS [T32 AA 07463] Funding Source: Medline; NIDDK NIH HHS [R01 DK 34804] Funding Source: Medline; NINDS NIH HHS [R29 NS 051822] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alzayady KJ, 2005, BIOCHEM J, V392, P601, DOI 10.1042/BJ20050949; Assefa Z, 2004, J BIOL CHEM, V279, P43227, DOI 10.1074/jbc.M403872200; Boehning D, 2000, J BIOL CHEM, V275, P21492, DOI 10.1074/jbc.M001724200; Boehning D, 2003, NAT CELL BIOL, V5, P1051, DOI 10.1038/ncb1063; Boehning D, 2005, P NATL ACAD SCI USA, V102, P1466, DOI 10.1073/pnas.0409650102; Boehning D, 2001, J BIOL CHEM, V276, P13509, DOI 10.1074/jbc.C100094200; Bossy-Wetzel E, 1998, EMBO J, V17, P37, DOI 10.1093/emboj/17.1.37; Chen R, 2004, J CELL BIOL, V166, P193, DOI 10.1083/jcb.200309146; Dellis O, 2006, SCIENCE, V313, P229, DOI 10.1126/science.1125203; Diaz F, 2000, CELL CALCIUM, V27, P315, DOI 10.1054/ceca.2000.0126; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Fukatsu K, 2006, BIOCHEM BIOPH RES CO, V342, P573, DOI 10.1016/j.bbrc.2006.02.010; Futatsugi A, 2005, SCIENCE, V309, P2232, DOI 10.1126/science.1114110; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hajnoczky G, 2003, BIOCHEM BIOPH RES CO, V304, P445, DOI 10.1016/S0006-291X(03)00616-8; Hang LS, 2000, J NEUROCHEM, V75, P1852; Hauser HP, 1998, J CELL BIOL, V141, P1415, DOI 10.1083/jcb.141.6.1415; Hawkins TE, 2002, P NATL ACAD SCI USA, V99, P8054, DOI 10.1073/pnas.132598099; Hirota J, 1999, J BIOL CHEM, V274, P34433, DOI 10.1074/jbc.274.48.34433; Hurne AM, 2005, J BIOL CHEM, V280, P36994, DOI 10.1074/jbc.M506441200; Jayaraman T, 1997, MOL CELL BIOL, V17, P3005, DOI 10.1128/MCB.17.6.3005; Joseph SK, 1997, J BIOL CHEM, V272, P1579, DOI 10.1074/jbc.272.3.1579; JOSEPH SK, 1993, J BIOL CHEM, V268, P6477; Joseph SK, 2007, APOPTOSIS, V12, P951, DOI 10.1007/s10495-007-0719-7; Khan AA, 1996, SCIENCE, V273, P503, DOI 10.1126/science.273.5274.503; Khan MT, 2006, J BIOL CHEM, V281, P3731, DOI 10.1074/jbc.M509262200; Kiselyov K, 2001, BIOCHEM J, V360, P17, DOI 10.1042/0264-6021:3600017; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Lui HM, 2003, MOL CANCER RES, V1, P508; Mendes CCP, 2005, J BIOL CHEM, V280, P40892, DOI 10.1074/jbc.M506623200; Mikoshiba K, 2006, J NEUROCHEM, V97, P1627, DOI 10.1111/j.1471-4159.2006.03985.x; Nagata S, 2000, EXP CELL RES, V256, P12, DOI 10.1006/excr.2000.4834; Nakayama T, 2004, BIOCHEM J, V377, P299, DOI 10.1042/BJ20030599; Oakes SA, 2005, P NATL ACAD SCI USA, V102, P105, DOI 10.1073/pnas.0408352102; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; QUITANA A, 2006, J BIOL CHEM, V281, P40302; Rizzuto R, 2003, ONCOGENE, V22, P8619, DOI 10.1038/sj.onc.1207105; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Samraj AK, 2006, J BIOL CHEM, V281, P29652, DOI 10.1074/jbc.M603487200; Schug ZT, 2006, J BIOL CHEM, V281, P24431, DOI 10.1074/jbc.M604190200; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Szabadkai G, 2004, FEBS LETT, V567, P111, DOI 10.1016/j.febslet.2004.04.059; Taketo MM, 2002, BBA-MOL CELL BIOL L, V1585, P72, DOI 10.1016/S1388-1981(02)00326-8; van Rossum DB, 2004, P NATL ACAD SCI USA, V101, P2323, DOI 10.1073/pnas.0308565100; Vazquez G, 2002, EMBO J, V21, P4531, DOI 10.1093/emboj/cdf467; Wagner LE, 2003, J BIOL CHEM, V278, P45811, DOI 10.1074/jbc.M306270200; White C, 2005, NAT CELL BIOL, V7, P1021, DOI 10.1038/ncb1302	49	23	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32983	32990		10.1074/jbc.M705183200	http://dx.doi.org/10.1074/jbc.M705183200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17875645	hybrid			2022-12-25	WOS:000250625400047
J	Gopalan, S				Gopalan, Suresh			A Multidirectional Non-Cell Autonomous Control and a Genetic Interaction Restricting Tobacco Etch Virus Susceptibility in Arabidopsis	PLOS ONE			English	Article								Background. Viruses constitute a major class of pathogens that infect a variety of hosts. Understanding the intricacies of signaling during host-virus interactions should aid in designing disease prevention strategies and in understanding mechanistic aspects of host and pathogen signaling machinery. Methodology/Principal Findings. An Arabidopsis mutant, B149, impaired in susceptibility to Tobacco etch virus (TEV), a positive strand RNA virus of picoRNA family, was identified using a high-throughput genetic screen and a counterselection scheme. The defects include initiation of infection foci, rate of cell-to-cell movement and long distance movement. Conclusions/Significance. The defect in infectivity is conferred by a recessive locus. Molecular genetic analysis and complementation analysis with three alleles of a previously published mutant lsp1 (loss of susceptibility to potyviruses) indicate a genetic interaction conferring haploinsufficiency between the B149 locus and certain alleles of lsp1 resulting in impaired host susceptibility. The pattern of restriction of TEV foci on leaves at or near the boundaries of certain cell types and leaf boundaries suggest dysregulation of a multidirectional non-cell autonomous regulatory mechanism. Understanding the nature of this multidirectional signal and the molecular genetic mechanism conferring it should potentially reveal a novel arsenal in the cellular machinery.	[Gopalan, Suresh] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA	Washington State University	Gopalan, S (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Mol Biol, Boston, MA 02115 USA.	gopalans2@hotmail.com			National Institutes of Health [AI43288, AI27832]; United States Department of Agriculture [NRI 2002-3531911560]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI043288, R29AI027832, R01AI027832, R01AI043288, R21AI043288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by grants from National Institutes of Health (AI43288 and AI27832) and the United States Department of Agriculture (NRI 2002-3531911560) to James C. Carrington while at the Institute of Biological Chemistry, Washington State University, USA.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; ALLISON R, 1986, VIROLOGY, V154, P9, DOI 10.1016/0042-6822(86)90425-3; Ashe HL, 2006, DEVELOPMENT, V133, P385, DOI 10.1242/dev.02238; Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bendahmane A, 1999, PLANT CELL, V11, P781, DOI 10.1105/tpc.11.5.781; Browning KS, 1996, PLANT MOL BIOL, V32, P107, DOI 10.1007/BF00039380; CARRINGTON JC, 1988, P NATL ACAD SCI USA, V85, P3391, DOI 10.1073/pnas.85.10.3391; Carrington JC, 1996, PLANT CELL, V8, P1669, DOI 10.1105/tpc.8.10.1669; Chisholm ST, 2000, P NATL ACAD SCI USA, V97, P489, DOI 10.1073/pnas.97.1.489; COCKERHAM G, 1970, HEREDITY, V25, P309, DOI 10.1038/hdy.1970.35; CULVER JN, 1991, MOL PLANT MICROBE IN, V4, P458, DOI 10.1094/MPMI-4-458; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; DOLJA VV, 1992, P NATL ACAD SCI USA, V89, P10208, DOI 10.1073/pnas.89.21.10208; Duprat A, 2002, PLANT J, V32, P927, DOI 10.1046/j.1365-313X.2002.01481.x; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; ISHIKAWA M, 1991, MOL GEN GENET, V230, P33, DOI 10.1007/BF00290647; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Kasschau KD, 1998, CELL, V95, P461, DOI 10.1016/S0092-8674(00)81614-1; KLEMENT Z, 1964, PHYTOPATHOLOGY, V54, P474; Lander AD, 2007, CELL, V128, P245, DOI 10.1016/j.cell.2007.01.004; Lartey RT, 1998, MOL PLANT MICROBE IN, V11, P706, DOI 10.1094/MPMI.1998.11.7.706; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Lellis AD, 2002, CURR BIOL, V12, P1046, DOI 10.1016/S0960-9822(02)00898-9; Leonard S, 2000, J VIROL, V74, P7730, DOI 10.1128/JVI.74.17.7730-7737.2000; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Lu R, 2005, NATURE, V436, P1040, DOI 10.1038/nature03870; Lucas WJ, 2004, NAT REV MOL CELL BIO, V5, P712, DOI 10.1038/nrm1470; Mahajan SK, 1998, PLANT J, V14, P177, DOI 10.1046/j.1365-313X.1998.00105.x; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Ohshima K, 1998, VIROLOGY, V243, P472, DOI 10.1006/viro.1998.9078; OKEEFE DP, 1994, PLANT PHYSIOL, V105, P473, DOI 10.1104/pp.105.2.473; PADGETT HS, 1993, PLANT CELL, V5, P577, DOI 10.1105/tpc.5.5.577; Palauqui JC, 1998, P NATL ACAD SCI USA, V95, P9675, DOI 10.1073/pnas.95.16.9675; Ruud KA, 1998, J BIOL CHEM, V273, P10325, DOI 10.1074/jbc.273.17.10325; Schaad MC, 2000, VIROLOGY, V273, P300, DOI 10.1006/viro.2000.0416; Schott DH, 2005, P NATL ACAD SCI USA, V102, P18420, DOI 10.1073/pnas.0507123102; Sheng JS, 1998, VIROLOGY, V249, P119, DOI 10.1006/viro.1998.9238; Vance V, 2001, SCIENCE, V292, P2277, DOI 10.1126/science.1061334; Vernoux T, 2005, CURR OPIN GENET DEV, V15, P388, DOI 10.1016/j.gde.2005.06.008; Voinnet O, 1997, NATURE, V389, P553, DOI 10.1038/39215; Voinnet O, 2000, CELL, V103, P157, DOI 10.1016/S0092-8674(00)00095-7; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Waterhouse PM, 2001, NATURE, V411, P834, DOI 10.1038/35081168; WHITHAM S, 1994, CELL, V78, P1101, DOI 10.1016/0092-8674(94)90283-6; Whitham SA, 1999, P NATL ACAD SCI USA, V96, P772, DOI 10.1073/pnas.96.2.772; Whitham SA, 2000, PLANT CELL, V12, P569, DOI 10.1105/tpc.12.4.569; Wilkins C, 2005, NATURE, V436, P1044, DOI 10.1038/nature03957; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Wittmann S, 1997, VIROLOGY, V234, P84, DOI 10.1006/viro.1997.8634; Yoshii M, 1998, PLANT J, V13, P211, DOI 10.1046/j.1365-313X.1998.00024.x; Yoshii M, 1998, J VIROL, V72, P8731, DOI 10.1128/JVI.72.11.8731-8737.1998	57	2	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e985	10.1371/journal.pone.0000985	http://dx.doi.org/10.1371/journal.pone.0000985			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912362	Green Published, Green Submitted, gold			2022-12-25	WOS:000207455900021
J	Denning, L; Anderson, JA; Davis, R; Gregg, JP; Kuzdenyi, J; Maselli, RA				Denning, Lisa; Anderson, Jennifer A.; Davis, Ryan; Gregg, Jeffrey P.; Kuzdenyi, Jennifer; Maselli, Ricardo A.			High Throughput Genetic Analysis of Congenital Myasthenic Syndromes Using Resequencing Microarrays	PLOS ONE			English	Article								Background. The use of resequencing microarrays for screening multiple, candidate disease loci is a promising alternative to conventional capillary sequencing. We describe the performance of a custom resequencing microarray for mutational analysis of Congenital Myasthenic Syndromes (CMSs), a group of disorders in which the normal process of neuromuscular transmission is impaired. Methodology/Principal Findings. Our microarray was designed to assay the exons and flanking intronic regions of 8 genes linked to CMSs. A total of 31 microarrays were hybridized with genomic DNA from either individuals with known CMS mutations or from healthy controls. We estimated an overall microarray call rate of 93.61%, and we found the percentage agreement between the microarray and capillary sequencing techniques to be 99.95%. In addition, our microarray exhibited 100% specificity and 99.99% reproducibility. Finally, the microarray detected 22 out of the 23 known missense mutations, but it failed to detect all 7 known insertion and deletion (indels) mutations, indicating an overall sensitivity of 73.33% and a sensitivity with respect to missense mutations of 95.65%. Conclusions/Significance. Overall, our microarray prototype exhibited strong performance and proved highly efficient for screening genes associated with CMSs. Until indels can be efficiently assayed with this technology, however, we recommend using resequencing microarrays for screening CMS mutations after common indels have been first assayed by capillary sequencing.	[Denning, Lisa; Anderson, Jennifer A.; Kuzdenyi, Jennifer; Maselli, Ricardo A.] Univ Calif Davis, Dept Neurol, Davis, CA 95616 USA; [Davis, Ryan; Gregg, Jeffrey P.] Univ Calif Davis, Dept Pathol, Med Invest Neurodev Disorders Inst, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Maselli, RA (corresponding author), Univ Calif Davis, Dept Neurol, Davis, CA 95616 USA.	ramaselli@ucdavis.edu		Davis, Ryan/0000-0001-7439-6683	Muscular Dystrophy Association; Myasthenia Gravis Foundation of America; NIEHS [1 P01 ES11269-01]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011269] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); Myasthenia Gravis Foundation of America; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was funded by awards from the Muscular Dystrophy Association and the Myasthenia Gravis Foundation of America. In addition, the microarray core facility at the UC Davis M. I. N. D. Institute was supported by NIEHS 1 P01 ES11269-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beeson D, 2006, SCIENCE, V313, P1975, DOI 10.1126/science.1130837; Beeson David, 2005, Neuromuscul Disord, V15, P498, DOI 10.1016/j.nmd.2005.05.001; Chevessier F, 2004, HUM MOL GENET, V13, P3229, DOI 10.1093/hmg/ddh333; Cutler DJ, 2001, GENOME RES, V11, P1913, DOI 10.1101/gr.197201; Engel AG, 2005, CURR OPIN PHARMACOL, V5, P308, DOI 10.1016/j.coph.2004.12.007; Engel AG, 2003, MUSCLE NERVE, V27, P4, DOI 10.1002/mus.10269; Hacia JG, 1999, NAT GENET, V21, P42, DOI 10.1038/4469; Huentelman MJ, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-149; Karaman MW, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni034; Mandal MNA, 2005, INVEST OPHTH VIS SCI, V46, P3355, DOI 10.1167/iovs.05-0007; Muller JS, 2004, NEUROMUSCULAR DISORD, V14, P744, DOI 10.1016/j.nmd.2004.06.010; Nichols P, 1999, ANN NEUROL, V45, P439, DOI 10.1002/1531-8249(199904)45:4<439::AID-ANA4>3.0.CO;2-W; Ohno K, 2002, AM J HUM GENET, V70, P875, DOI 10.1086/339465; Ohno K, 1998, P NATL ACAD SCI USA, V95, P9654, DOI 10.1073/pnas.95.16.9654; Ohno K, 2001, P NATL ACAD SCI USA, V98, P2017, DOI 10.1073/pnas.98.4.2017; Ohno Kinji, 2005, Acta Myol, V24, P50; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; TENGS T, 2005, CANC LETT, V229, P227; Webster R, 2004, NEUROLOGY, V62, P1090, DOI 10.1212/01.WNL.0000118205.99701.41; Xu N, 2005, AM J OBSTET GYNECOL, V192, P1274, DOI 10.1016/j.ajog.2004.12.066	21	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2007	2	9							e918	10.1371/journal.pone.0000918	http://dx.doi.org/10.1371/journal.pone.0000918			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HS	17878953	Green Submitted, Green Published, gold			2022-12-25	WOS:000207455700026
J	Vadysirisack, DD; Chen, ESW; Zhang, Z; Tsai, MD; Chang, GD; Jhiang, SM				Vadysirisack, Douangsone D.; Chen, Eric S. -W.; Zhang, Zhaoxia; Tsai, Ming-Daw; Chang, Geen-Dong; Jhiang, Sissy M.			Identification of in Vivo phosphorylation sites and their functional significance in the sodium iodide symporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROID NA+/I-SYMPORTER; SODIUM/IODIDE SYMPORTER; POTASSIUM CHANNEL; TRANSPORT; ATP; NIS; DEGRADATION; EXPRESSION; MUTATION; SERINE	The Na+/I- symporter (NIS)-mediated iodide uptake activity is the basis for targeted radioiodide ablation of thyroid cancers. Although it has been shown that NIS protein is phosphorylated, neither the in vivo phosphorylation sites nor their functional significance has been reported. In this study, Ser-43, Thr-49, Ser-227, Thr-577, and Ser-581 were identified as in vivo NIS phosphorylation sites by mass spectrometry. Kinetic analysis of NIS mutants of the corresponding phosphorylated amino acid residue indicated that the velocity of iodide transport of NIS is modulated by the phosphorylation status of Ser-43 and Ser-581. We also found that the phosphorylation status of Thr-577 may be important for NIS protein stability and that the phosphorylation status of Ser-227 is functionally silent. Thr-49 appears to be critical for proper local structure/conformation of NIS because mutation of Thr-49 to alanine, aspartic acid, or serine results in reduced NIS activity without alterations in total or cell surface NIS protein levels. Taken together, we showed that NIS protein levels and functional activity could be modulated by phosphorylation through distinct mechanisms.	[Vadysirisack, Douangsone D.; Jhiang, Sissy M.] Ohio State Univ, Integrated Biomed Sci Grad Program, Columbus, OH 43210 USA; [Zhang, Zhaoxia; Jhiang, Sissy M.] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [Vadysirisack, Douangsone D.; Zhang, Zhaoxia; Jhiang, Sissy M.] Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Jhiang, Sissy M.] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Tsai, Ming-Daw] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Chang, Geen-Dong] Natl Taiwan Univ, Grad Inst Biochem Sci, Taipei 106, Taiwan	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Academia Sinica - Taiwan; National Taiwan University	Jhiang, SM (corresponding author), Ohio State Univ, Integrated Biomed Sci Grad Program, Columbus, OH 43210 USA.	jhiang.1@osu.edu	Tsai, Ming-Daw/G-4689-2019; Chen, Eric (Sheng-Wen)/G-8258-2014	Tsai, Ming-Daw/0000-0003-1374-0414; 	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001876] Funding Source: NIH RePORTER; NIBIB NIH HHS [1 R01 EB001876] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Apasov SG, 1996, J BIOL CHEM, V271, P25677, DOI 10.1074/jbc.271.41.25677; Breitschopf K, 2000, MOL CELL BIOL, V20, P1886, DOI 10.1128/MCB.20.5.1886-1896.2000; Castro MR, 2001, J CLIN ENDOCR METAB, V86, P5627, DOI 10.1210/jc.86.11.5627; De la Vieja A, 2007, J BIOL CHEM, V282, P25290, DOI 10.1074/jbc.M700147200; De la Vleja A, 2004, J CELL SCI, V117, P677, DOI 10.1242/jcs.00898; Dohan O, 2002, MOL ENDOCRINOL, V16, P1893, DOI 10.1210/me.2002-0071; Eskandari S, 1997, J BIOL CHEM, V272, P27230, DOI 10.1074/jbc.272.43.27230; Glavy JS, 2000, J BIOL CHEM, V275, P1479, DOI 10.1074/jbc.275.2.1479; Han XB, 1999, J AM SOC NEPHROL, V10, P1874; Hinsby AM, 2003, MOL CELL PROTEOMICS, V2, P29, DOI 10.1074/mcp.M200075-MCP200; HOU JZ, 1993, PROTEIN SCI, V2, P86; Huff RA, 1997, J NEUROCHEM, V68, P225; Jayanthi LD, 2006, J BIOL CHEM, V281, P23326, DOI 10.1074/jbc.M601156200; Law RM, 2000, J BIOL CHEM, V275, P23986, DOI 10.1074/jbc.M910283199; Lee TS, 2006, J BIOL CHEM, V281, P25560, DOI 10.1074/jbc.M508661200; Levy O, 1998, J BIOL CHEM, V273, P22657, DOI 10.1074/jbc.273.35.22657; Levy O, 1998, FEBS LETT, V429, P36, DOI 10.1016/S0014-5793(98)00522-5; Martinez LO, 2003, J BIOL CHEM, V278, P37368, DOI 10.1074/jbc.M307161200; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Park KS, 2006, SCIENCE, V313, P976, DOI 10.1126/science.1124254; Ren YJ, 2006, J BIOL CHEM, V281, P11769, DOI 10.1074/jbc.M513125200; Riedel C, 2001, J BIOL CHEM, V276, P21458, DOI 10.1074/jbc.M100561200; Rolli-Derkinderen M, 2005, CIRC RES, V96, P1152, DOI 10.1161/01.RES.0000170084.88780.ea; Roosbeek S, 2004, J BIOL CHEM, V279, P37779, DOI 10.1074/jbc.M401821200; Smanik PA, 1996, BIOCHEM BIOPH RES CO, V226, P339, DOI 10.1006/bbrc.1996.1358; Surti TS, 2005, P NATL ACAD SCI USA, V102, P17828, DOI 10.1073/pnas.0509122102; Tonacchera M, 2002, J CLIN ENDOCR METAB, V87, P352, DOI 10.1210/jc.87.1.352; Vadysirisack DD, 2007, ENDOCR-RELAT CANCER, V14, P421, DOI 10.1677/erc.1.01263; Wu SL, 2006, MOL CELL PROTEOMICS, V5, P1610, DOI 10.1074/mcp.M600105-MCP200; Xu ZC, 1996, J BIOL CHEM, V271, P9313, DOI 10.1074/jbc.271.16.9313; Zhang ZX, 2005, J CLIN ENDOCR METAB, V90, P6131, DOI 10.1210/jc.2005-0895	31	30	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					36820	36828		10.1074/jbc.M706817200	http://dx.doi.org/10.1074/jbc.M706817200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17913707	hybrid, Green Published			2022-12-25	WOS:000251646000006
J	Lee, OH; Jain, AK; Papusha, V; Jaiswal, AK				Lee, Ok-Hee; Jain, Abhinav K.; Papusha, Victor; Jaiswal, Anil K.			An auto-regulatory loop between stress sensors INrf2 and Nrf2 controls their cellular abundance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-MEDIATED EXPRESSION; PROTEIN-KINASE-C; GENE-EXPRESSION; OXIDOREDUCTASE-1 GENE; ANTIOXIDANT INDUCTION; INDUCIBLE EXPRESSION; RESPONSIVE ELEMENT; NUCLEAR EXPORT; KEAP1; ACTIVATION	INrf2:Nrf2 are sensors of chemical/radiation stress. Nrf2 dissociates from INrf2 in response to a stress and translocates in the nucleus. This leads to induction of a battery of antioxidant genes that protect cells. Nrf2 is then exported out and degraded. INrf2 functions as an adaptor of ubiquitin ligase for ubiquitination and degradation of Nrf2. Here we demonstrate the presence of a novel feedback autoregulatory loop between INrf2 and Nrf2 that controls cellular abundance of INrf2 and Nrf2. Nrf2 controls its own degradation by regulating expression and induction of the INrf2 gene. The antioxidant treatment of cells led to nuclear localization and stabilization of Nrf2 and induction of INrf2 gene expression. Mutagenesis, transfection, and chromatin immunoprecipitation assays identified an antioxidant-response element in the reverse strand of the proximal INrf2 promoter that binds to Nrf2 and regulates expression and antioxidant induction of the INrf2 gene. In addition, short interfering RNA inhibition or overexpression of Nrf2 led to a respective decrease and increase in INrf2 gene expression. These results implicated Nrf2 in the regulation of expression and induction of INrf2. The induction of INrf2 followed ubiquitination and degradation of Nrf2 and suppression of INrf2 gene expression. In conclusion, Nrf2 regulates INrf2 by controlling its transcription, and INrf2 controls Nrf2 by degrading it.	Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA	Baylor College of Medicine	Jaiswal, AK (corresponding author), Univ Maryland, Sch Med, Dept Pharmacol & Expt Therapeut, 655 W Baltimore St, Baltimore, MD 21201 USA.	ajaiswal@som.umaryland.edu	Jain, Abhinav K/A-2540-2013	Jain, Abhinav/0000-0003-3268-514X	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012265] Funding Source: NIH RePORTER; NIEHS NIH HHS [R01 ES012265] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Banning A, 2005, MOL CELL BIOL, V25, P4914, DOI 10.1128/MCB.25.12.4914-4923.2005; Bloom DA, 2003, J BIOL CHEM, V278, P44675, DOI 10.1074/jbc.M307633200; BREEN AP, 1995, FREE RADICAL BIO MED, V18, P1033, DOI 10.1016/0891-5849(94)00209-3; Dhakshinamoorthy S, 2001, ONCOGENE, V20, P3906, DOI 10.1038/sj.onc.1204506; Dhakshinamoorthy S, 2000, CURR TOP CELL REGUL, V36, P201; Hayes JD, 2001, CANCER LETT, V174, P103, DOI 10.1016/S0304-3835(01)00695-4; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Ikeda H, 2004, BIOCHEM J, V380, P515, DOI 10.1042/BJ20031948; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Jain AK, 2007, J BIOL CHEM, V282, P16502, DOI 10.1074/jbc.M611336200; Jain AK, 2006, J BIOL CHEM, V281, P12132, DOI 10.1074/jbc.M511198200; Jain AK, 2005, J BIOL CHEM, V280, P29158, DOI 10.1074/jbc.M502083200; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Kang MI, 2004, P NATL ACAD SCI USA, V101, P2046, DOI 10.1073/pnas.0308347100; Kim YJ, 2007, CANCER RES, V67, P546, DOI 10.1158/0008-5472.CAN-06-2401; Kobayashi M, 2006, ADV ENZYME REGUL, V46, P113, DOI 10.1016/j.advenzreg.2006.01.007; Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; Nguyen T, 2005, J BIOL CHEM, V280, P32485, DOI 10.1074/jbc.M503074200; Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; RUSHMORE TH, 1990, J BIOL CHEM, V265, P14648; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; THELEN M, 1993, PHYSIOL REV, V73, P797, DOI 10.1152/physrev.1993.73.4.797; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Wang W, 2006, FREE RADICAL BIO MED, V40, P1119, DOI 10.1016/j.freeradbiomed.2005.10.063; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004	31	147	155	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36412	36420		10.1074/jbc.M706517200	http://dx.doi.org/10.1074/jbc.M706517200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17925401	hybrid			2022-12-25	WOS:000251458300033
J	Fresquet, M; Jowitt, TA; Ylostalo, J; Coffey, P; Meadows, RS; Ala-Kokko, L; Thornton, DJ; Briggs, MD				Fresquet, Maryline; Jowitt, Thomas A.; Yloestalo, Joni; Coffey, Paul; Meadows, Roger S.; Ala-Kokko, Leena; Thornton, David J.; Briggs, Michael D.			Structural and functional characterization of recombinant matrilin-3 A-domain and implications for human genetic bone diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE EPIPHYSEAL DYSPLASIA; OLIGOMERIC MATRIX PROTEIN; DUAL-POLARIZATION INTERFEROMETRY; VON-WILLEBRAND-FACTOR; COLLAGEN-IX; EXTRACELLULAR-MATRIX; ANALYTICAL ULTRACENTRIFUGATION; CONFORMATIONAL-CHANGES; FACTOR-B; CARTILAGE	Mutations in matrilin-3 result in multiple epiphyseal dysplasia, which is characterized by delayed and irregular bone growth and early onset osteoarthritis. The majority of disease-causing mutations are located within the beta-sheet of the single A-domain of matrilin-3, suggesting that they disrupt the structure and/or function of this important domain. Indeed, the expression of mutant matrilin-3 results in its intracellular retention within the rough endoplasmic reticulum of cells, where it elicits an unfolded protein response. To understand the folding characteristics of the matrilin-3 A-domain we determined its structure using CD, analytical ultracentrifugation, and dual polarization interferometry. This study defined novel structural features of the matrilin-3 A-domain and identified a conformational change induced by the presence or the absence of Zn2+. In the presence of Zn2+ the A-domain adopts a more stable "tighter" conformation. However, after the removal of Zn2+ a potential structural rearrangement of the metal ion-dependent adhesion site motif occurs, which leads to a more "relaxed" conformation. Finally, to characterize the interactions of the matrilin-3 A-domain we performed binding studies on a BIAcore using type II and IX collagen and cartilage oligomeric matrix protein. We were able to demonstrate that it binds to type II and IX collagen and cartilage oligomeric matrix protein in a Zn2+ -dependent manner. Furthermore, we have also determined that the matrilin-3 A-domain appears to bind exclusively to the COL3 domain of type IX collagen and that this binding is abolished in the presence of a disease causing mutation in type IX collagen.	Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; Tulane Univ, Ctr Gene Therapy, New Orleans, LA 70118 USA; Univ Manchester, Sch Phys & Astron, Manchester M13 9PL, Lancs, England; Univ Oulu, Dept Med Biochem & Mol Biol, Collagen Res Unit, FIN-90014 Oulu, Finland; Connect Tissue Gene Tests, Allentown, PA 18103 USA	University of Manchester; Tulane University; University of Manchester; University of Oulu	Briggs, MD (corresponding author), Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Michael Smith Bldg, Oxford Rd, Manchester M13 9PT, Lancs, England.	mike.briggs@manchester.ac.uk	Ylostalo, Joni/AAH-9457-2019	Ylostalo, Joni/0000-0001-9746-1994; Thornton, David/0000-0001-7148-1970; Fresquet, Maryline/0000-0001-9530-6392; Jowitt, Thomas/0000-0002-4045-0933	Wellcome Trust [071161] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Belluoccio D, 1998, GENOMICS, V53, P391, DOI 10.1006/geno.1998.5519; Bhattacharya AA, 2004, STRUCTURE, V12, P371, DOI 10.1016/j.str.2004.02.012; BISHOP PN, 1994, BIOCHEM J, V299, P497, DOI 10.1042/bj2990497; Bonnemann CG, 2000, P NATL ACAD SCI USA, V97, P1212, DOI 10.1073/pnas.97.3.1212; Briggs MD, 2002, HUM MUTAT, V19, P465, DOI 10.1002/humu.10066; Budde B, 2005, MOL CELL BIOL, V25, P10465, DOI 10.1128/MCB.25.23.10465-10478.2005; Chapman KL, 2001, NAT GENET, V28, P393, DOI 10.1038/ng573; Chen Q, 1999, MOL BIOL CELL, V10, P2149, DOI 10.1091/mbc.10.7.2149; Cotterill SL, 2005, HUM MUTAT, V26, P557, DOI 10.1002/humu.20263; DICESARE P, 1994, FEBS LETT, V354, P237, DOI 10.1016/0014-5793(94)01134-6; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; HEDBOM E, 1992, J BIOL CHEM, V267, P6132; Hinshelwood J, 2000, J MOL BIOL, V298, P135, DOI 10.1006/jmbi.2000.3632; Holden P, 2001, J BIOL CHEM, V276, P6046, DOI 10.1074/jbc.M009507200; Jackson GC, 2004, J MED GENET, V41, P52, DOI 10.1136/jmg.2003.011429; Kapyla J, 2004, J BIOL CHEM, V279, P51677, DOI 10.1074/jbc.M409412200; Karim K, 2007, ANAL CHEM, V79, P3023, DOI 10.1021/ac051254b; Kennedy J, 2005, EUR J HUM GENET, V13, P547, DOI 10.1038/sj.ejhg.5201374; Kennedy Jason, 2005, Hum Mutat, V25, P593, DOI 10.1002/humu.9342; Klatt AR, 2000, J BIOL CHEM, V275, P3999, DOI 10.1074/jbc.275.6.3999; Ko YP, 2005, BIOCHEM J, V386, P367, DOI 10.1042/BJ20041486; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; LEIGHTON MP, 2007, HUM MOL GENET; Lohiniva J, 2000, AM J MED GENET, V90, P216, DOI 10.1002/(SICI)1096-8628(20000131)90:3<216::AID-AJMG6>3.0.CO;2-1; Mann HH, 2004, J BIOL CHEM, V279, P25294, DOI 10.1074/jbc.M403778200; NEWTON G, 1994, GENOMICS, V24, P435, DOI 10.1006/geno.1994.1649; Nicolae C, 2007, J BIOL CHEM, V282, P22163, DOI 10.1074/jbc.M610994200; NISHIMURA I, 1989, J BIOL CHEM, V264, P20033; Nokelainen M, 1998, MATRIX BIOL, V16, P329, DOI 10.1016/S0945-053X(98)90004-X; OLDBERG A, 1992, J BIOL CHEM, V267, P22346; Olsen BR, 1997, INT J BIOCHEM CELL B, V29, P555, DOI 10.1016/S1357-2725(96)00100-8; Otten C, 2005, J MED GENET, V42, P774, DOI 10.1136/jmg.2004.029462; Paassilta P, 1999, AM J HUM GENET, V64, P1036, DOI 10.1086/302328; Pihlajamaa T, 1999, J BIOL CHEM, V274, P22464, DOI 10.1074/jbc.274.32.22464; Ricard-Blum S, 2006, ANAL BIOCHEM, V352, P252, DOI 10.1016/j.ab.2006.02.011; Rosenberg K, 1998, J BIOL CHEM, V273, P20397, DOI 10.1074/jbc.273.32.20397; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Shen ZX, 1995, MATRIX BIOL, V14, P773, DOI 10.1016/S0945-053X(05)80020-4; Smith RKW, 1997, MATRIX BIOL, V16, P255, DOI 10.1016/S0945-053X(97)90014-7; Swann MJ, 2004, ANAL BIOCHEM, V329, P190, DOI 10.1016/j.ab.2004.02.019; Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x; Thompsett AR, 2007, BBA-PROTEINS PROTEOM, V1774, P920, DOI 10.1016/j.bbapap.2007.05.007; Thur J, 2001, J BIOL CHEM, V276, P6083, DOI 10.1074/jbc.M009512200; Wagener R, 1997, FEBS LETT, V413, P129, DOI 10.1016/S0014-5793(97)00895-8; Wagener R, 2005, FEBS LETT, V579, P3323, DOI 10.1016/j.febslet.2005.03.018; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; WU J, 2004, DEP ORTHOPAEDICS SPO, P35	48	36	37	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34634	34643		10.1074/jbc.M705301200	http://dx.doi.org/10.1074/jbc.M705301200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17881354	hybrid, Green Accepted			2022-12-25	WOS:000251155200005
J	Sajish, M; Tiwari, D; Rananaware, D; Nandicoori, VK; Prakash, B				Sajish, Mathew; Tiwari, Divya; Rananaware, Dimple; Nandicoori, Vinay Kumar; Prakash, Balaji			A charge reversal differentiates (p) ppGpp synthesis by monofunctional and bifunctional Rel proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; STATIONARY-PHASE; GLOBAL REGULATOR; (P)PPGPP; TRANSCRIPTION; REL(MTB); DNA	A major regulatory mechanism evolved by microorganisms to combat stress is the regulation mediated by ( p) ppGpp ( the stringent response molecule), synthesized and hydrolyzed by Rel proteins. These are divided into bifunctional and monofunctional proteins based on the presence or absence of the hydrolysis activity. Although these proteins require Mg2+ for ( p) ppGpp synthesis, high Mg2+ was shown to inhibit this reaction in bifunctional Rel proteins from Mycobacterium tuberculosis and Streptococcus equisimilis. This is not a characteristic feature in enzymes that use a dual metal ion mechanism, such as DNA polymerases that are known to carry out a similar pyrophosphate transfer reaction. Comparison of polymerase Pol beta and Rel(Seq) structures that share a common fold led to the proposal that the latter would follow a single metal ion mechanism. Surprisingly, in contrast to bifunctional Rel, we did not find inhibition of guanosine 5'-triphosphate, 3'-diphosphate ( pppGpp) synthesis at higher Mg2+ in the monofunctional RelA from Escherichia coli. We show that a charge reversal in a conserved motif in the synthesis domains explains this contrast; an RXKD motif in the bifunctional proteins is reversed to an EXDD motif. The differential response of these proteins to Mg2+ could also be noticed in fluorescent nucleotide binding and circular dichroism experiments. In mutants where the motifs were reversed, the differential effect could also be reversed. We infer that although a catalytic Mg2+ is common to both bifunctional and monofunctional proteins, the latter would utilize an additional metal binding site formed by EXDD. This work, for the first time, brings out differences in (p)ppGpp synthesis by the two classes of Rel proteins.	Natl Inst Immunol, New Delhi 110067, India; Indian Inst Technol, Dept Biol Sci & Engn, Kanpur 208016, Uttar Pradesh, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur	Nandicoori, VK (corresponding author), Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India.	vinaykn@nii.res.in; bprakash@iitk.ac.in		Tiwari, Divya/0000-0001-7631-2471; Mathew, Sajish/0000-0001-6715-5953; Nandicoori, Vinay/0000-0002-5682-4178	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; Artsimovitch I, 2004, CELL, V117, P299, DOI 10.1016/S0092-8674(04)00401-5; Avarbock A, 2005, BIOCHEMISTRY-US, V44, P9913, DOI 10.1021/bi0505316; Avarbock D, 2000, BIOCHEMISTRY-US, V39, P11640, DOI 10.1021/bi001256k; Black CB, 1998, J BIOL INORG CHEM, V3, P292, DOI 10.1007/s007750050234; Braeken K, 2006, TRENDS MICROBIOL, V14, P45, DOI 10.1016/j.tim.2005.11.006; Cashel M., 1996, ESCHERICHIA COLI SAL, P1458; Dahl JL, 2003, P NATL ACAD SCI USA, V100, P10026, DOI 10.1073/pnas.1631248100; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Gralla JD, 2005, MOL MICROBIOL, V55, P973, DOI 10.1111/j.1365-2958.2004.04455.x; Hammer BK, 2002, MOL MICROBIOL, V44, P107, DOI 10.1046/j.1365-2958.2002.02884.x; Hogg T, 2004, CELL, V117, P57, DOI 10.1016/S0092-8674(04)00260-0; Jain V, 2007, BIOPHYS CHEM, V127, P41, DOI 10.1016/j.bpc.2006.12.003; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kuhar I, 2001, MOL MICROBIOL, V41, P207, DOI 10.1046/j.1365-2958.2001.02508.x; Magnusson LU, 2005, TRENDS MICROBIOL, V13, P236, DOI 10.1016/j.tim.2005.03.008; Mechold U, 2002, J BACTERIOL, V184, P2878, DOI 10.1128/JB.184.11.2878-2888.2002; Primm TP, 2000, J BACTERIOL, V182, P4889, DOI 10.1128/JB.182.17.4889-4898.2000; REMMERS AE, 1994, J BIOL CHEM, V269, P13771; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; Sun JH, 2001, J BACTERIOL, V183, P3488, DOI 10.1128/JB.183.11.3488-3498.2001; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Van Delden C, 2001, J BACTERIOL, V183, P5376, DOI 10.1128/JB.183.18.5376-5384.2001; van der Biezen EA, 2000, P NATL ACAD SCI USA, V97, P3747, DOI 10.1073/pnas.060392397; Wagner R, 2002, J MOL MICROB BIOTECH, V4, P331	27	36	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34977	34983		10.1074/jbc.M704828200	http://dx.doi.org/10.1074/jbc.M704828200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17911108	hybrid			2022-12-25	WOS:000251155200042
J	Srivastava, AK; Qin, XZ; Wedhas, N; Arnush, M; Linkhart, TA; Chadwick, RB; Kumar, A				Srivastava, Apurva K.; Qin, Xuezhong; Wedhas, Nia; Arnush, Marc; Linkhart, Thomas A.; Chadwick, Robert B.; Kumar, Ashok			Tumor necrosis factor-alpha augments matrix metalloproteinase-9 production in skeletal muscle cells through the activation of transforming growth factor-beta-activated kinase 1(TAK1)-dependent signaling pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DUCHENNE MUSCULAR-DYSTROPHY; MATRIX METALLOPROTEINASES; INFLAMMATORY MYOPATHIES; TRANSCRIPTION FACTOR; TNF-ALPHA; MEDIATED ACTIVATION; MMP-9 EXPRESSION; GENE-EXPRESSION; HEART-FAILURE	We have investigated the effect of tumor necrosis factor-alpha (TNF-alpha) on the production of extracellular matrix-degrading proteases in skeletal muscles. Using microarray, quantitative PCR, Western blotting, and zymography, we found that TNF-alpha drastically increases the production of matrix metalloproteinase (MMP)-9 from C2C12 myotubes. In vivo administration of TNF-alpha in mice increased the transcript level of MMP-9 in skeletal muscle tissues. Although TNF-alpha activated all the three MAPKs (i.e. ERK1/2, JNK, and p38), inhibition of ERK1/2 or p38 but not JNK blunted the TNF-alpha-induced production of MMP-9 from myotubes. Inhibition of Akt also inhibited the TNF-alpha-induced production of MMP-9. TNF-alpha increased the activation of transcription factors NF-kappa B and AP-1 but not SP-1 in myotubes. Overexpression of a dominant negative inhibitor of NF-kappa B or AP-1 blocked the TNF-alpha-induced expression of MMP-9 in myotubes. Similarly, point mutations in AP-1- or NF-kappa B-binding sites in MMP-9 promoter inhibited the TNF-alpha-induced expression of a reporter gene. TNF-alpha increased the activity of transforming growth factor-beta-activating kinase-1 (TAK1). Furthermore, overexpression of a dominant negative mutant of TAK1 blocked the TNF-alpha-induced expression of MMP-9 and activation of NF-kappa B and AP-1. Our results also suggest that TNF-alpha induces MMP-9 expression in muscle cells through the recruitment of TRAF-2, Fas-associated protein with death domain, and TNF receptor-associated protein with death domain but not NIK or TRAF-6 proteins. We conclude that TAK1-mediated pathways are involved in TNF-alpha-induced MMP-9 production in skeletal muscle cells.	Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, Louisville, KY 40202 USA; Jerry L Pettis Mem Vet Adm Med Ctr, Loma Linda, CA 92357 USA; Loma Linda Univ, Sch Med, Loma Linda, CA 92350 USA	University of Louisville; Loma Linda University	Kumar, A (corresponding author), Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, 500 S Preston St, Louisville, KY 40202 USA.	ashok.kumar@louisville.edu		Kumar, Ashok/0000-0002-2444-9529; Kumar, Ashok/0000-0001-8571-2848	NATIONAL INSTITUTE ON AGING [R01AG029623] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG029623, R01 AG029623-01, R01 AG129623] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Acharyya S, 2007, J CLIN INVEST, V117, P889, DOI 10.1172/JCI30556; Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Behren A, 2005, CANCER RES, V65, P11613, DOI 10.1158/0008-5472.CAN-05-2672; Besse A, 2007, J BIOL CHEM, V282, P3918, DOI 10.1074/jbc.M608867200; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Carmeli E, 2004, MUSCLE NERVE, V29, P191, DOI 10.1002/mus.10529; Carvalho RF, 2006, INT J EXP PATHOL, V87, P437, DOI 10.1111/j.1365-2613.2006.00497.x; Chakrabarti S, 2006, J LEUKOCYTE BIOL, V79, P214, DOI 10.1189/jlb.0605353; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Chen ZJ, 2006, CELL DEATH DIFFER, V13, P687, DOI 10.1038/sj.cdd.4401869; Cho A, 2000, ARTERIOSCL THROM VAS, V20, P2527, DOI 10.1161/01.ATV.20.12.2527; Choi YC, 2000, NEUROLOGY, V54, P65, DOI 10.1212/WNL.54.1.65; Cohen M, 2006, MOL HUM REPROD, V12, P225, DOI 10.1093/molehr/gal023; Dogra C, 2006, J BIOL CHEM, V281, P10327, DOI 10.1074/jbc.M511131200; Dogra C, 2007, FASEB J, V21, P1857, DOI 10.1096/fj.06-7537com; Dogra C, 2007, J BIOL CHEM, V282, P15000, DOI 10.1074/jbc.M608668200; Fingleton B, 2007, CURR PHARM DESIGN, V13, P333, DOI 10.2174/138161207779313551; Giannelli G, 2005, HISTOL HISTOPATHOL, V20, P99, DOI 10.14670/HH-20.99; Goetzl EJ, 1996, J IMMUNOL, V156, P1; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Han SW, 2006, J BIOL CHEM, V281, P29614, DOI 10.1074/jbc.M604013200; HELBLINGLECLERC A, 1995, NAT GENET, V11, P216, DOI 10.1038/ng1095-216; Hu JL, 2007, NAT REV DRUG DISCOV, V6, P480, DOI 10.1038/nrd2308; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; Jobsis GJ, 1996, NAT GENET, V14, P113, DOI 10.1038/ng0996-113; Jorda M, 2005, J CELL SCI, V118, P3371, DOI 10.1242/jcs.02465; Kandarian SC, 2006, MUSCLE NERVE, V33, P155, DOI 10.1002/mus.20442; Kherif S, 1998, NEUROPATH APPL NEURO, V24, P309; Kherif S, 1999, DEV BIOL, V205, P158, DOI 10.1006/dbio.1998.9107; Kieseier BC, 2001, BRAIN, V124, P341, DOI 10.1093/brain/124.2.341; Kim KC, 2005, ARCH PHARM RES, V28, P1257, DOI 10.1007/BF02978209; Kumar A, 2004, J MOL MED, V82, P434, DOI 10.1007/s00109-004-0555-y; Kumar A, 1999, FEBS LETT, V462, P140, DOI 10.1016/S0014-5793(99)01487-8; Kumar A, 2004, FASEB J, V18, P1524, DOI 10.1096/fj.04-2414com; Kumar A, 2003, FASEB J, V17, P386, DOI 10.1096/fj.02-0542com; Kumar A, 2002, J BIOL CHEM, V277, P46493, DOI 10.1074/jbc.M203654200; Lee CW, 2007, AM J PHYSIOL-LUNG C, V292, pL799, DOI 10.1152/ajplung.00311.2006; Lewis MP, 2000, J MUSCLE RES CELL M, V21, P223, DOI 10.1023/A:1005670507906; Li YP, 2000, AM J PHYSIOL-REG I, V279, pR1165, DOI 10.1152/ajpregu.2000.279.4.R1165; Li YP, 2001, CURR OPIN RHEUMATOL, V13, P483, DOI 10.1097/00002281-200111000-00005; LIGHT N, 1984, BIOCHEM J, V219, P1017, DOI 10.1042/bj2191017; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Matthews CP, 2007, CANCER RES, V67, P2430, DOI 10.1158/0008-5472.CAN-06-0522; Mayer U, 2003, J BIOL CHEM, V278, P14587, DOI 10.1074/jbc.R200022200; Michele DE, 2003, J BIOL CHEM, V278, P15457, DOI 10.1074/jbc.R200031200; Mourkioti F, 2006, J CLIN INVEST, V116, P2945, DOI 10.1172/JCI28721; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Ray A, 2005, J IMMUNOL, V175, P4039, DOI 10.4049/jimmunol.175.6.4039; Reznick AZ, 2003, MUSCLE NERVE, V27, P51, DOI 10.1002/mus.10277; Roach DM, 2002, EUR J VASC ENDOVASC, V23, P260, DOI 10.1053/ejvs.2002.1598; Sakurai H, 2003, J BIOL CHEM, V278, P36916, DOI 10.1074/jbc.M301598200; Sanes JR, 2003, J BIOL CHEM, V278, P12601, DOI 10.1074/jbc.R200027200; SATO H, 1993, J BIOL CHEM, V268, P23460; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Schoser BGH, 2002, ACTA NEUROL SCAND, V105, P309, DOI 10.1034/j.1600-0404.2002.1o104.x; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Solan NJ, 2002, J BIOL CHEM, V277, P1405, DOI 10.1074/jbc.M109619200; Spate U, 2004, CURR OPIN CLIN NUTR, V7, P265, DOI 10.1097/01.mco.0000126344.88494.de; Thorud HMS, 2005, AM J PHYSIOL-REG I, V289, pR389, DOI 10.1152/ajpregu.00067.2005; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597	65	50	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35113	35124		10.1074/jbc.M705329200	http://dx.doi.org/10.1074/jbc.M705329200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17897957	hybrid, Green Accepted			2022-12-25	WOS:000251155200056
J	Yeo, HJ; Beck, LH; Thompson, SR; Farach-Carson, MC; McDonald, JM; Clemens, TL; Zayzafoon, M				Yeo, Hyeonju; Beck, Lauren H.; Thompson, Sunnie R.; Farach-Carson, Mary C.; McDonald, Jay M.; Clemens, Thomas L.; Zayzafoon, Majd			Conditional disruption of calcineurin B1 in osteoblasts increases bone formation and reduces bone resorption	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE; NUCLEAR FACTOR; NFAT; DIFFERENTIATION; CELLS; CALMODULIN; GROWTH; OSTEOCLASTOGENESIS; EXPRESSION; CALCIUM	We recently reported that the pharmacological inhibition of calcineurin (Cn) by low concentrations of cyclosporin A increases osteoblast differentiation in vitro and bone mass in vivo. To determine whether Cn exerts direct actions in osteoblasts, we generated mice lacking Cnb1 ( Cn regulatory subunit) in osteoblasts (Delta Cnb1(OB)) using Cre-mediated recombination methods. Transgenic mice expressing Cre recombinase, driven by the human osteocalcin promoter, were crossed with homozygous mice that express loxP-flanked Cnb1 (Cnb1(f/f)). Microcomputed tomography analysis of tibiae at 3 months showed that Delta Cnb1(OB) mice had dramatic increases in bone mass compared with controls. Histomorphometric analyses showed significant increases in mineral apposition rate (67%), bone volume (32%), trabecular thickness (29%), and osteoblast numbers (68%) as well as a 40% decrease in osteoclast numbers as compared with the values from control mice. To delete Cnb1 in vitro, primary calvarial osteoblasts, harvested from Cnb1(f/f) mice, were infected with adenovirus expressing the Cre recombinase. Cre-expressing osteoblasts had a complete inhibition of Cnb1 protein levels but differentiated and mineralized more rapidly than control, green fluorescent protein-expressing cells. Deletion of Cnb1 increased expression of osteoprotegerin and decreased expression of RANKL. Co-culturing Cnb1-deficient osteoblasts with wild type osteoclasts demonstrated that osteoblasts lacking Cnb1 failed to support osteoclast differentiation in vitro. Taken together, our findings demonstrate that the inhibition of Cnb1 in osteoblasts increases bone mass by directly increasing osteoblast differentiation and indirectly decreasing osteoclastogenesis.	Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Delaware	Zayzafoon, M (corresponding author), Univ Alabama Birmingham, Dept Pathol, 813 Shelby Biomed Res Bldg,1825 Univ Blvd, Birmingham, AL 35294 USA.	mzayzafo@uab.edu		Thompson, Sunnie/0000-0002-7338-8822; Farach-Carson, Mary/0000-0002-4526-3088	NCI NIH HHS [CA109119, P01-CA098912] Funding Source: Medline; NIAMS NIH HHS [R01-AR053898, AR050235] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA098912, R01CA109119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050235, R01AR053898] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Aubin JE, 1998, J CELL BIOCHEM, P73, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<73::AID-JCB11>3.0.CO;2-L; Chang CP, 2004, J CLIN INVEST, V113, P1051, DOI 10.1172/JCI200420049; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Feng X, 2001, J CLIN INVEST, V107, P1137, DOI 10.1172/JCI12040; Heit JJ, 2006, NATURE, V443, P345, DOI 10.1038/nature05097; Hirotani H, 2004, J BIOL CHEM, V279, P13984, DOI 10.1074/jbc.M213067200; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Horsley V, 2002, J CELL BIOL, V156, P771, DOI 10.1083/jcb.200111073; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kegley KM, 2001, DEV BIOL, V232, P115, DOI 10.1006/dbio.2001.0179; KLEE CB, 1979, P NATL ACAD SCI USA, V76, P6270, DOI 10.1073/pnas.76.12.6270; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Komarova SV, 2005, P NATL ACAD SCI USA, V102, P2643, DOI 10.1073/pnas.0406874102; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; Liu XM, 2007, P NATL ACAD SCI USA, V104, P2259, DOI 10.1073/pnas.0604153104; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; McCabe LR, 1996, ENDOCRINOLOGY, V137, P4398, DOI 10.1210/en.137.10.4398; Neal JW, 2003, J BIOL CHEM, V278, P17246, DOI 10.1074/jbc.M300528200; Neilson JR, 2004, IMMUNITY, V20, P255, DOI 10.1016/S1074-7613(04)00052-4; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Parsons SA, 2003, MOL CELL BIOL, V23, P4331, DOI 10.1128/MCB.23.12.4331-4343.2003; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ranger AM, 2000, J EXP MED, V191, P9, DOI 10.1084/jem.191.1.9; Shibasaki F, 2002, J BIOCHEM, V131, P1, DOI 10.1093/oxfordjournals.jbchem.a003063; Shin CS, 2005, J BONE MINER RES, V20, P2200, DOI 10.1359/JBMR.050809; Sullivan KMC, 2002, GENETICS, V161, P183; Sun L, 2005, P NATL ACAD SCI USA, V102, P17130, DOI 10.1073/pnas.0508480102; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Wagner EF, 2002, ANN RHEUM DIS, V61, P40, DOI 10.1136/ard.61.suppl_2.ii40; Winslow MM, 2006, DEV CELL, V10, P771, DOI 10.1016/j.devcel.2006.04.006; Yang TTC, 2006, MOL CELL BIOL, V26, P7372, DOI 10.1128/MCB.00580-06; Yeo H, 2007, BONE, V40, P1502, DOI 10.1016/j.bone.2007.02.017; Zayzafoon M, 2005, J BIOL CHEM, V280, P7049, DOI 10.1074/jbc.M412680200; Zayzafoon M, 2004, ENDOCRINOLOGY, V145, P2421, DOI 10.1210/en.2003-1156; Zayzafoon M, 2004, J BIOL CHEM, V279, P3662, DOI 10.1074/jbc.M308158200; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200; Zhang W, 1996, J EXP MED, V183, P413, DOI 10.1084/jem.183.2.413; Zhu LL, 2005, BIOCHEM BIOPH RES CO, V326, P131, DOI 10.1016/j.bbrc.2004.10.212	39	37	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35318	35327		10.1074/jbc.M702435200	http://dx.doi.org/10.1074/jbc.M702435200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17884821	hybrid			2022-12-25	WOS:000251155200075
J	Vincent, OD; Schwem, BE; Steed, PR; Jiang, W; Fillingame, RH				Vincent, Owen D.; Schwem, Brian E.; Steed, P. Ryan; Jiang, Warren; Fillingame, Robert H.			Fluidity of structure and swiveling of helices in the subunit c ring of Escherichia coli ATP synthase as revealed by cysteine-cysteine cross-linking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AQUEOUS ACCESS CHANNELS; COUPLING H+ TRANSPORT; POLAR LOOP; PROTON TRANSLOCATION; GAMMA-SUBUNIT; ROTARY MOTOR; F-0; F1; EPSILON; SECTOR	Subunit c in the membrane-traversing F-o sector of Escherichia coli ATP synthase is known to fold with two transmembrane helices and form an oligomeric ring of 10 or more subunits in the membrane. Models for the E. coli ring structure have been proposed based upon NMR solution structures and intersubunit cross-linking of Cys residues in the membrane. The E. coli models differ from the recent x-ray diffraction structure of the isolated Ilyobacter tartaricus c-ring. Furthermore, key cross-linking results supporting the E. coli model prove to be incompatible with the I. tartaricus structure. To test the applicability of the I. tartaricus model to the E. coli c-ring, we compared the cross-linking of a pair of doubly Cys substituted c-subunits, each of which was compatible with one model but not the other. The key finding of this study is that both A21C/M65C and A21C/I66C doubly substituted c-subunits form high yield oligomeric structures, c(2), c(3)... c(10), via intersubunit disulfide bond formation. The results indicate that helical swiveling, with resultant interconversion of the two conformers predicted by the E. coli and I. tartaricus models, must be occurring over the time course of the cross-linking experiment. In the additional experiments reported here, we tried to ascertain the preferred conformation in the membrane to help define the most likely structural model. We conclude that both structures must be able to form in the membrane, but that the helical swiveling that promotes their interconversion may not be necessary during rotary function.	Univ Wisconsin, Dept Biomol Chem, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Fillingame, RH (corresponding author), Univ Wisconsin, Dept Biomol Chem, Sch Med & Publ Hlth, 1300 Univ Ave, Madison, WI 53706 USA.	rhfillin@wisc.edu		Steed, Ryan/0000-0001-5445-0080	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023105, R37GM023105] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-23105] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aksimentiev A, 2004, BIOPHYS J, V86, P1332, DOI 10.1016/S0006-3495(04)74205-8; Angevine CM, 2007, J BIOL CHEM, V282, P9001, DOI 10.1074/jbc.M610848200; Angevine CM, 2003, P NATL ACAD SCI USA, V100, P13179, DOI 10.1073/pnas.2234364100; Angevine CM, 2003, J BIOL CHEM, V278, P6066, DOI 10.1074/jbc.M210199200; BARIK S, 1996, METHOD MOL BIOL, V68, P203; Cain BD, 2000, J BIOENERG BIOMEMBR, V32, P365, DOI 10.1023/A:1005575919638; Capaldi RA, 2002, TRENDS BIOCHEM SCI, V27, P154, DOI 10.1016/S0968-0004(01)02051-5; Dimroth P, 2006, EMBO REP, V7, P276, DOI 10.1038/sj.embor.7400646; Dmitriev OY, 1999, P NATL ACAD SCI USA, V96, P7785, DOI 10.1073/pnas.96.14.7785; Fillingame RH, 2002, BBA-BIOENERGETICS, V1555, P29, DOI 10.1016/S0005-2728(02)00250-5; Fillingame RH, 2000, J EXP BIOL, V203, P9; FRAGA D, 1989, J BIOL CHEM, V264, P6797; FRAGA D, 1994, J BIOL CHEM, V269, P7532; Girvin ME, 1998, BIOCHEMISTRY-US, V37, P8817, DOI 10.1021/bi980511m; HERMOLIN J, 1995, J BIOL CHEM, V270, P2815, DOI 10.1074/jbc.270.6.2815; Hermolin J, 1999, J BIOL CHEM, V274, P17011, DOI 10.1074/jbc.274.24.17011; Jiang WP, 1998, P NATL ACAD SCI USA, V95, P6607, DOI 10.1073/pnas.95.12.6607; Jiang WP, 2001, P NATL ACAD SCI USA, V98, P4966, DOI 10.1073/pnas.081424898; Jones PC, 1998, J BIOL CHEM, V273, P17178, DOI 10.1074/jbc.273.27.17178; Kuo PH, 1998, FEBS LETT, V426, P217, DOI 10.1016/S0014-5793(98)00337-8; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Meier T, 2002, EMBO REP, V3, P1094, DOI 10.1093/embo-reports/kvf216; MILLER MJ, 1989, J BIOL CHEM, V264, P305; MILLER MJ, 1990, P NATL ACAD SCI USA, V87, P4900, DOI 10.1073/pnas.87.13.4900; Mitome N, 2004, P NATL ACAD SCI USA, V101, P12159, DOI 10.1073/pnas.0403545101; MOSHER ME, 1985, J BIOL CHEM, V260, P4807; Nakano T, 2006, J MOL BIOL, V358, P132, DOI 10.1016/j.jmb.2006.01.011; Pogoryelov D, 2005, EMBO REP, V6, P1040, DOI 10.1038/sj.embor.7400517; Rastogi VK, 1999, NATURE, V402, P263, DOI 10.1038/46224; Richardson J. S., 1989, PREDICTION PROTEIN S, P1; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schulenberg B, 1999, J BIOL CHEM, V274, P34233, DOI 10.1074/jbc.274.48.34233; Schwem BE, 2006, J BIOL CHEM, V281, P37861, DOI 10.1074/jbc.M607453200; SENIOR AE, 1988, PHYSIOL REV, V68, P177, DOI 10.1152/physrev.1988.68.1.177; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Tsunoda SP, 2001, P NATL ACAD SCI USA, V98, P898, DOI 10.1073/pnas.031564198; Valiyaveetil FI, 1997, J BIOL CHEM, V272, P32635, DOI 10.1074/jbc.272.51.32635; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; WATTS SD, 1995, FEBS LETT, V368, P235, DOI 10.1016/0014-5793(95)00658-V; Watts SD, 1996, J BIOL CHEM, V271, P28341, DOI 10.1074/jbc.271.45.28341; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509; ZHANG Y, 1994, J BIOL CHEM, V269, P5473; ZHANG Y, 1995, J BIOL CHEM, V270, P24609, DOI 10.1074/jbc.270.41.24609; ZHANG Y, 1994, J BIOL CHEM, V269, P10221	44	11	11	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33788	33794		10.1074/jbc.M706904200	http://dx.doi.org/10.1074/jbc.M706904200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17893141	hybrid			2022-12-25	WOS:000250840200061
J	Voltz, JW; Brush, M; Sikes, S; Steplock, D; Weinman, EJ; Shenolikar, S				Voltz, James W.; Brush, Matthew; Sikes, Suzanne; Steplock, Deborah; Weinman, Edward J.; Shenolikar, Shirish			Phosphorylation of PDZ1 domain attenuates NHERF-1 binding to cellular targets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCHANGER REGULATORY FACTOR; TRANSMEMBRANE CONDUCTANCE REGULATOR; PARATHYROID-HORMONE REGULATION; CAMP-MEDIATED INHIBITION; PROXIMAL TUBULE CELLS; OPOSSUM KIDNEY-CELLS; NA+-H+ EXCHANGER; FACTOR-I; 3 NHE3; PROTEIN	NHERF-1 ((N) under bara(+)-H+ (e) under bar xchanger (r) under bar egulatory (f) under bar actor (1) under bar, also known as EBP50 (e) under bar zrin-(b) under bar inding (p) under bar rotein of (5) under bar0 kDa) is a phosphoprotein that assembles multiprotein complexes via two PDZ domains and a C-terminal ezrin-binding domain. Current work utilized metabolic labeling in cultured cells expressing wild type GFP-NHERF-1 to define the physiological importance of NHERF-1 phosphorylation. Treatment of cells with phosphatase inhibitors calyculin A and okadaic acid enhanced NHERF-1 phosphorylation and inhibited its dimerization. Eliminating C-terminal serines abolished the modulation of NHERF-1 dimerization by phosphatase inhibitors and identified the phosphorylation of the PDZ1 domain that attenuated its binding to physiological targets, including beta(2)-adrenergic receptor, platelet-derived growth factor receptor, cystic fibrosis transmembrane conductance regulator, and sodium-phosphate cotransporter type IIa. The major covalent modification of PDZ1 was mapped to serine 77. Confocal microscopy of cultured cells suggested key roles for PDZ1 and ERM-binding domain in localizing NHERF-1 at the cell surface. The substitution S77A eliminated PDZ1 phosphorylation and increased NHERF-1 localization at the cell periphery. In contrast, S77D reduced NHERF-1 colocalization with cortical actin cytoskeleton. These data suggested that serine 77 phosphorylation played key role in modulating NHERF-1 association with plasma membrane targets and identified a novel mechanism by which PDZ1 phosphorylation may transduce hormonal signals to regulate the function of membrane proteins in epithelial tissues.	Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Univ Maryland, Sch Med, Dept Vet Affairs, Dept Med, Baltimore, MD 21201 USA	Duke University; University System of Maryland; University of Maryland Baltimore	Shenolikar, S (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, LSRC C315,Res Dr, Durham, NC 27710 USA.	Sheno001@mc.duke.edu			NIDDK NIH HHS [DK55881] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055881] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahn W, 2001, J BIOL CHEM, V276, P17236, DOI 10.1074/jbc.M011763200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Capuano P, 2007, AM J PHYSIOL-CELL PH, V292, pC927, DOI 10.1152/ajpcell.00126.2006; Cunningham R, 2006, AM J PHYSIOL-RENAL, V291, pF896, DOI 10.1152/ajprenal.00036.2006; Cunninghan R, 2004, J BIOL CHEM, V279, P37815, DOI 10.1074/jbc.M405893200; Dransfield DT, 1997, EMBO J, V16, P35, DOI 10.1093/emboj/16.1.35; Fouassier L, 2005, EXP CELL RES, V306, P264, DOI 10.1016/j.yexcr.2005.02.011; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Hall RA, 1999, J BIOL CHEM, V274, P24328, DOI 10.1074/jbc.274.34.24328; He JQ, 2001, J BIOL CHEM, V276, P41559, DOI 10.1074/jbc.M106859200; Khundmiri SJ, 2005, J AM SOC NEPHROL, V16, P2598, DOI 10.1681/ASN.2004121049; Lamprecht G, 1998, J BIOL CHEM, V273, P29972, DOI 10.1074/jbc.273.45.29972; Lau AG, 2001, BIOCHEMISTRY-US, V40, P8572, DOI 10.1021/bi0103516; Li JQ, 2007, J BIOL CHEM, V282, P27086, DOI 10.1074/jbc.M702019200; Li JQ, 2005, J BIOL CHEM, V280, P37634, DOI 10.1074/jbc.M502305200; Mahon MJ, 2004, J BIOL CHEM, V279, P23550, DOI 10.1074/jbc.M313229200; Maudsley S, 2000, MOL CELL BIOL, V20, P8352, DOI 10.1128/MCB.20.22.8352-8363.2000; Morales FC, 2007, MOL CELL BIOL, V27, P2527, DOI 10.1128/MCB.01372-06; Moyer BD, 1999, J CLIN INVEST, V104, P1353, DOI 10.1172/JCI7453; Murtazina R, 2007, J BIOL CHEM, V282, P25141, DOI 10.1074/jbc.M701910200; Naren AP, 2003, P NATL ACAD SCI USA, V100, P342, DOI 10.1073/pnas.0135434100; Raghuram V, 2001, P NATL ACAD SCI USA, V98, P1300, DOI 10.1073/pnas.031538898; Raghuram V, 2003, P NATL ACAD SCI USA, V100, P9620, DOI 10.1073/pnas.1633250100; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Saotome I, 2004, DEV CELL, V6, P855, DOI 10.1016/j.devcel.2004.05.007; Shenolikar S, 2002, P NATL ACAD SCI USA, V99, P11470, DOI 10.1073/pnas.162232699; Shenolikar S, 2001, FEBS LETT, V489, P233, DOI 10.1016/S0014-5793(01)02109-3; Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797; Takahashi Y, 2006, EMBO J, V25, P910, DOI 10.1038/sj.emboj.7600979; Voltz JW, 2001, ONCOGENE, V20, P6309, DOI 10.1038/sj.onc.1204774; Weinman EJ, 2000, BIOCHEMISTRY-US, V39, P6123, DOI 10.1021/bi000064m; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050; Weinman EJ, 2003, BIOCHEMISTRY-US, V42, P12662, DOI 10.1021/bi035244l; WEINMAN EJ, 1995, J CLIN INVEST, V95, P2143, DOI 10.1172/JCI117903; WEINMAN EJ, 1993, J CLIN INVEST, V92, P1781, DOI 10.1172/JCI116767; WEINMAN EJ, 2007, IN PRESS J CLIN INVE; Yun CHC, 1997, P NATL ACAD SCI USA, V94, P3010, DOI 10.1073/pnas.94.7.3010; Yun CHC, 1998, J BIOL CHEM, V273, P25856, DOI 10.1074/jbc.273.40.25856; Zizak M, 1999, J BIOL CHEM, V274, P24753, DOI 10.1074/jbc.274.35.24753	40	59	61	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33879	33887		10.1074/jbc.M703481200	http://dx.doi.org/10.1074/jbc.M703481200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17895247	hybrid			2022-12-25	WOS:000250840200069
J	Junne, T; Schwede, T; Goder, V; Spiess, M				Junne, Tina; Schwede, Torsten; Goder, Veit; Spiess, Martin			Mutations in the Sec61p channel affecting signal sequence recognition and membrane protein topology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLOCATION CHANNEL; TRANSMEMBRANE ORIENTATION; ENDOPLASMIC-RETICULUM; CHARGED RESIDUES; ANCHOR PROTEINS; PLUG DOMAIN; EXPORT; DETERMINANTS; CONTRIBUTES; TRANSPORT	The orientation of most single-spanning membrane proteins obeys the "positive-insiderule", i.e. the flanking region of the transmembrane segment that is more positively charged remains in the cytosol. These membrane proteins are integrated by the Sec61/SecY translocon, but how their orientation is achieved is unknown. We have screened for mutations in yeast Sec61p that alter the orientation of single-spanning membrane proteins. We identified a class of mutants that are less efficient in retaining the positively charged flanking region in the cytosol. Surprisingly, these mutations are located at many different sites in the Sec61/SecY molecule, and they do not only involve charged amino acid residues. All these mutants have a prl phenotype that so far have only been seen in bacteria; they allow proteins with defective signal sequences to be translocated, likely because the Sec61p channel opens more easily. A similar correlation between topology defects and prl phenotype was also seen with previously identified yeast Sec61 mutants. Our results suggest a model in which the regulated opening of the translocon is required for the faithful orientation of membrane proteins.	Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	University of Basel	Spiess, M (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.	Martin.Spiess@unibas.ch	Goder, Veit/F-8092-2016; Schwede, Torsten/A-4650-2008	Schwede, Torsten/0000-0003-2715-335X; Spiess, Martin/0000-0001-7139-0550; Goder, Veit/0000-0003-0854-4873				Alder NN, 2004, J BIOL CHEM, V279, P22787, DOI 10.1074/jbc.R400002200; BELTZER JP, 1991, J BIOL CHEM, V266, P973; COLLIER DN, 1988, CELL, V53, P273, DOI 10.1016/0092-8674(88)90389-3; Denzer AJ, 1995, EMBO J, V14, P6311, DOI 10.1002/j.1460-2075.1995.tb00321.x; DERMAN AI, 1993, EMBO J, V12, P879, DOI 10.1002/j.1460-2075.1993.tb05728.x; EMR SD, 1981, CELL, V23, P79, DOI 10.1016/0092-8674(81)90272-5; Finke K, 1996, EMBO J, V15, P1482, DOI 10.1002/j.1460-2075.1996.tb00492.x; Goder V, 2004, MOL BIOL CELL, V15, P1470, DOI 10.1091/mbc.E03-08-0599; Goder V, 2003, EMBO J, V22, P3645, DOI 10.1093/emboj/cdg361; HARTMANN E, 1989, P NATL ACAD SCI USA, V86, P5786, DOI 10.1073/pnas.86.15.5786; Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799; Junne T, 2006, MOL BIOL CELL, V17, P4063, DOI 10.1091/mbc.E06-03-0200; Li WK, 2007, MOL CELL, V26, P511, DOI 10.1016/j.molcel.2007.05.002; Maillard AP, 2007, J BIOL CHEM, V282, P1281, DOI 10.1074/jbc.M610060200; Mitra K, 2005, NATURE, V438, P318, DOI 10.1038/nature04133; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; Osborne AR, 2007, CELL, V129, P97, DOI 10.1016/j.cell.2007.02.036; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; Pilon M, 1997, EMBO J, V16, P4540, DOI 10.1093/emboj/16.15.4540; Plath K, 2000, J CELL BIOL, V151, P167, DOI 10.1083/jcb.151.1.167; Prinz WA, 1998, J BIOL CHEM, V273, P8419, DOI 10.1074/jbc.273.14.8419; RANDALL LL, 1990, SCIENCE, V248, P860, DOI 10.1126/science.2188362; ROBZYK K, 1992, NUCLEIC ACIDS RES, V20, P3790, DOI 10.1093/nar/20.14.3790; Rosch K, 2000, J BIOL CHEM, V275, P14916, DOI 10.1074/jbc.M000456200; SAKAGUCHI M, 1992, P NATL ACAD SCI USA, V89, P16, DOI 10.1073/pnas.89.1.16; Saparov SM, 2007, MOL CELL, V26, P501, DOI 10.1016/j.molcel.2007.03.022; Shimohata N, 2007, J CELL BIOL, V176, P307, DOI 10.1083/jcb.200611121; Smith MA, 2005, J BACTERIOL, V187, P6454, DOI 10.1128/JB.187.18.6454-6465.2005; STIRLING CJ, 1992, MOL BIOL CELL, V3, P129, DOI 10.1091/mbc.3.2.129; Tam PCK, 2005, EMBO J, V24, P3380, DOI 10.1038/sj.emboj.7600804; UHLAND K, 1994, J BACTERIOL, V176, P4565, DOI 10.1128/JB.176.15.4565-4571.1994; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Veenendaal AKJ, 2004, BBA-MOL CELL RES, V1694, P81, DOI 10.1016/j.bbamcr.2004.02.009; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635; Wahlberg JM, 1997, J CELL BIOL, V137, P555, DOI 10.1083/jcb.137.3.555	36	56	56	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					33201	33209		10.1074/jbc.M707219200	http://dx.doi.org/10.1074/jbc.M707219200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17893139	hybrid			2022-12-25	WOS:000250625400067
J	Lam, JS; Huang, HB; Levitz, SM				Lam, Jennifer S.; Huang, Haibin; Levitz, Stuart M.			Effect of Differential N-linked and O-linked Mannosylation on Recognition of Fungal Antigens by Dendritic Cells	PLOS ONE			English	Article								Background. An experimental approach for improving vaccine efficacy involves targeting antigens to mannose receptors (MRs) on dendritic cells (DCs) and other professional antigen presenting cells. Previously, we demonstrated that mannosylated Pichia pastoris-derived recombinant proteins exhibited increased immunogenicity compared to proteins lacking mannosylation. In order to gain insight into the mechanisms responsible for this observation, the present study examined the cellular uptake of the mannosylated and deglycosylated recombinant proteins. Methodology/ Principal Findings. Utilizing transfected cell lines, roles for the macrophage mannose receptor (MMR, CD206) and DC-SIGN (CD209) in the recognition of the mannosylated, but not deglycosylated, antigens were demonstrated. The uptake of mannosylated antigens into murine bone marrow-derived DCs (BMDCs) was inhibited by yeast mannans (YMs), suggesting a mannose-specific C-type lectin receptor-dependent process, while the uptake of deglycosylated antigens remained unaffected. In particular, antigens with both N-linked and extensive O-linked mannosylation showed the highest binding and uptake by BMDCs. Finally, confocal microscopy studies revealed that both mannosylated and deglycosylated P. pastoris-derived recombinant proteins localized in MHC class II+ compartments within BMDCs. Conclusions/ Significance. Taken together with our previous results, these data suggest that increased uptake by mannose-specific C-type lectin receptors is the major mechanism responsible for the enhanced antigenicity seen with mannosylated proteins. These findings have important implications for vaccine design and contribute to our understanding of how glycosylation affects the immune response to eukaryotic pathogens.	[Huang, Haibin; Levitz, Stuart M.] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA; [Lam, Jennifer S.; Levitz, Stuart M.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Lam, Jennifer S.; Levitz, Stuart M.] Boston Univ, Sch Med, Immunol Training Program, Boston, MA 02118 USA; [Lam, Jennifer S.; Levitz, Stuart M.] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA	University of Massachusetts System; University of Massachusetts Worcester; Boston University; Boston University; Boston University	Levitz, SM (corresponding author), Univ Massachusetts, Med Ctr, Worcester, MA 01605 USA.	Stuart.Levitz@Umassmed.edu	Huang, Haibin/G-7364-2011		National Institutes of Health [RO1 AI25780, RO1 AI37532]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037532, R01AI066087, R01AI025780] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding: This work was supported by National Institutes of Health grants RO1 AI25780 and RO1 AI37532.	Apostolopoulos V, 1996, VACCINE, V14, P930, DOI 10.1016/0264-410X(95)00258-3; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Boes M, 2002, NATURE, V418, P983, DOI 10.1038/nature01004; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Cambi A, 2005, CELL MICROBIOL, V7, P481, DOI 10.1111/j.1462-5822.2005.00506.x; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Dzionek A, 2001, J EXP MED, V194, P1823, DOI 10.1084/jem.194.12.1823; East L, 2002, BBA-GEN SUBJECTS, V1572, P364, DOI 10.1016/S0304-4165(02)00319-7; Engering A, 2002, J IMMUNOL, V168, P2118, DOI 10.4049/jimmunol.168.5.2118; Engering AJ, 1997, EUR J IMMUNOL, V27, P2417, DOI 10.1002/eji.1830270941; Figdor CG, 2002, NAT REV IMMUNOL, V2, P77, DOI 10.1038/nri723; Frison N, 2003, J BIOL CHEM, V278, P23922, DOI 10.1074/jbc.M302483200; Keler T, 2004, EXPERT OPIN BIOL TH, V4, P1953, DOI 10.1517/14712598.4.12.1953; Lam JS, 2005, J IMMUNOL, V175, P7496, DOI 10.4049/jimmunol.175.11.7496; Levitz SM, 2001, P NATL ACAD SCI USA, V98, P10422, DOI 10.1073/pnas.181331398; Luong M, 2007, VACCINE, V25, P4340, DOI 10.1016/j.vaccine.2007.03.027; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Lutz MB, 1997, J IMMUNOL, V159, P3707; Mansour MK, 2006, J IMMUNOL, V176, P3053, DOI 10.4049/jimmunol.176.5.3053; Mansour MK, 2002, J IMMUNOL, V168, P2872, DOI 10.4049/jimmunol.168.6.2872; Mitchell DA, 2001, J BIOL CHEM, V276, P28939, DOI 10.1074/jbc.M104565200; Napper CE, 2001, J BIOL CHEM, V276, P14759, DOI 10.1074/jbc.M100425200; Ramakrishna V, 2004, J IMMUNOL, V172, P2845, DOI 10.4049/jimmunol.172.5.2845; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Specht CA, 2007, J INFECT DIS, V196, P796, DOI 10.1086/520536; Stahl PD, 1998, CURR OPIN IMMUNOL, V10, P50, DOI 10.1016/S0952-7915(98)80031-9; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; STEINMAN RM, 1995, J EXP MED, V182, P283, DOI 10.1084/jem.182.2.283; Strahl-Bolsinger S, 1999, BBA-GEN SUBJECTS, V1426, P297, DOI 10.1016/S0304-4165(98)00131-7; Tan MCAA, 1997, EUR J IMMUNOL, V27, P2426, DOI 10.1002/eji.1830270942; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182	32	48	49	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2007	2	10							e1009	10.1371/journal.pone.0001009	http://dx.doi.org/10.1371/journal.pone.0001009			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HV	17925857	Green Published, gold			2022-12-25	WOS:000207456000008
J	Hartman, MCT; Josephson, K; Lin, CW; Szostak, JW				Hartman, Matthew C. T.; Josephson, Kristopher; Lin, Chi-Wang; Szostak, Jack W.			An Expanded Set of Amino Acid Analogs for the Ribosomal Translation of Unnatural Peptides	PLOS ONE			English	Article								Background. The application of in vitro translation to the synthesis of unnatural peptides may allow the production of extremely large libraries of highly modified peptides, which are a potential source of lead compounds in the search for new pharmaceutical agents. The specificity of the translation apparatus, however, limits the diversity of unnatural amino acids that can be incorporated into peptides by ribosomal translation. We have previously shown that over 90 unnatural amino acids can be enzymatically loaded onto tRNA. Methodology/Principal Findings. We have now used a competition assay to assess the efficiency of tRNA-aminoacylation of these analogs. We have also used a series of peptide translation assays to measure the efficiency with which these analogs are incorporated into peptides. The translation apparatus tolerates most side chain derivatives, a few alpha,alpha disubstituted, N-methyl and alpha-hydroxy derivatives, but no beta-amino acids. We show that over 50 unnatural amino acids can be incorporated into peptides by ribosomal translation. Using a set of analogs that are efficiently charged and translated we were able to prepare individual peptides containing up to 13 different unnatural amino acids. Conclusions/Significance. Our results demonstrate that a diverse array of unnatural building blocks can be translationally incorporated into peptides. These building blocks provide new opportunities for in vitro selections with highly modified drug-like peptides.	[Hartman, Matthew C. T.; Josephson, Kristopher; Lin, Chi-Wang; Szostak, Jack W.] Massachusetts Gen Hosp, Dept Mol Biol, Howard Hughes Med Inst, Ctr Computat & Integrat Biol,Simches Res Ctr, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute	Szostak, JW (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Howard Hughes Med Inst, Ctr Computat & Integrat Biol,Simches Res Ctr, Boston, MA 02114 USA.	szostak@molbio.mgh.harvard.edu			Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by the Howard Hughes Medical Institute. Jack Szostak is an Investigator, and Matthew Hartman, Kris Josephson, and Chi-Wang Lin are/were HHMI Research Associates.	AHLUWALIA GS, 1990, PHARMACOL THERAPEUT, V46, P243, DOI 10.1016/0163-7258(90)90094-I; Asahara H, 2005, BIOCHEMISTRY-US, V44, P11254, DOI 10.1021/bi050204y; BAIN JD, 1991, TETRAHEDRON, V47, P2389, DOI 10.1016/S0040-4020(01)81776-2; BAIN JD, 1989, J AM CHEM SOC, V111, P8013, DOI 10.1021/ja00202a052; Beiboer SHW, 1996, PROTEIN ENG, V9, P345, DOI 10.1093/protein/9.4.345; Bemis GW, 1999, J MED CHEM, V42, P5095, DOI 10.1021/jm9903996; Blount KF, 2007, NAT CHEM BIOL, V3, P44, DOI 10.1038/nchembio842; Budisa N, 2001, PROTEIN SCI, V10, P1281, DOI 10.1110/ps.51601; BUSIELLO V, 1979, BIOCHIM BIOPHYS ACTA, V564, P311, DOI 10.1016/0005-2787(79)90228-4; CHRISTNE.PJ, 1971, J BIOL CHEM, V246, P7551; Cleland TA, 1996, MOL NEUROBIOL, V13, P97, DOI 10.1007/BF02740637; Deming TJ, 1996, MACROMOLECULES, V29, P1442, DOI 10.1021/ma9510698; ELLMAN JA, 1992, SCIENCE, V255, P197, DOI 10.1126/science.1553546; FAHNESTOCK S, 1971, SCIENCE, V173, P340, DOI 10.1126/science.173.3994.340; Fahnestock S, 1974, Methods Enzymol, V30, P489; Forster AC, 2003, P NATL ACAD SCI USA, V100, P6353, DOI 10.1073/pnas.1132122100; Forster AC, 2001, ANAL BIOCHEM, V297, P60, DOI 10.1006/abio.2001.5329; FOWDEN L, 1963, NATURE, V199, P35, DOI 10.1038/199035a0; HALL LE, 1974, RES COMMUN CHEM PATH, V9, P145; Hanes J, 1997, P NATL ACAD SCI USA, V94, P4937, DOI 10.1073/pnas.94.10.4937; Hartman MCT, 2006, P NATL ACAD SCI USA, V103, P4356, DOI 10.1073/pnas.0509219103; HECKLER TG, 1988, BIOCHEMISTRY-US, V27, P7254, DOI 10.1021/bi00419a012; HECKLER TG, 1984, BIOCHEMISTRY-US, V23, P1468, DOI 10.1021/bi00302a020; HOHSAKA T, 1993, FEBS LETT, V335, P47, DOI 10.1016/0014-5793(93)80436-X; Hohsaka T, 1999, J AM CHEM SOC, V121, P34, DOI 10.1021/ja9813109; HORTIN G, 1983, METHOD ENZYMOL, V96, P777; Ikeda Y, 2003, PROTEIN ENG, V16, P699, DOI 10.1093/protein/gzg084; Josephson K, 2005, J AM CHEM SOC, V127, P11727, DOI 10.1021/ja0515809; Kiick KL, 2002, P NATL ACAD SCI USA, V99, P19, DOI 10.1073/pnas.012583299; Kiick KL, 2001, FEBS LETT, V502, P25, DOI 10.1016/S0014-5793(01)02657-6; Kilz S, 1999, J MASS SPECTROM, V34, P281, DOI 10.1002/(SICI)1096-9888(199904)34:4<281::AID-JMS750>3.0.CO;2-M; Kirshenbaum K, 2002, CHEMBIOCHEM, V3, P235, DOI 10.1002/1439-7633(20020301)3:2/3<235::AID-CBIC235>3.0.CO;2-7; Koh JT, 1997, BIOCHEMISTRY-US, V36, P11314, DOI 10.1021/bi9707685; LEA PJ, 1973, PHYTOCHEMISTRY, V12, P1903, DOI 10.1016/S0031-9422(00)91509-7; LEMEIGNAN B, 1993, J MOL BIOL, V231, P161, DOI 10.1006/jmbi.1993.1269; Levengood J, 2004, J BIOL CHEM, V279, P17707, DOI 10.1074/jbc.M313665200; Lincecum TL, 2003, MOL CELL, V11, P951, DOI 10.1016/S1097-2765(03)00098-4; Martinez JS, 2000, SCIENCE, V287, P1245, DOI 10.1126/science.287.5456.1245; MATTHEAKIS LC, 1994, P NATL ACAD SCI USA, V91, P9022, DOI 10.1073/pnas.91.19.9022; Mayer C, 2003, BIOCHEMISTRY-US, V42, P4787, DOI 10.1021/bi034011r; MCLENNAN H, 1983, PROG NEUROBIOL, V20, P251, DOI 10.1016/0301-0082(83)90004-7; Merryman C, 2004, CHEM BIOL, V11, P575, DOI 10.1016/j.chembiol.2004.03.009; Millward SW, 2005, J AM CHEM SOC, V127, P14142, DOI 10.1021/ja054373h; Minks C, 2000, TETRAHEDRON, V56, P9431, DOI 10.1016/S0040-4020(00)00827-9; MORRIS H, 1972, Journal of Bacteriology, V111, P203; Murakami H, 2006, NAT METHODS, V3, P357, DOI 10.1038/NMETH877; Murakami M, 1997, PHYTOCHEMISTRY, V45, P1197, DOI 10.1016/S0031-9422(97)00131-3; Mursinna RS, 2004, BIOCHEMISTRY-US, V43, P155, DOI 10.1021/bi034919h; NEAL AL, 1968, ARCH BIOCHEM BIOPHYS, V127, P426, DOI 10.1016/0003-9861(68)90246-4; Ninomiya K, 2004, J AM CHEM SOC, V126, P15984, DOI 10.1021/ja048200o; NOREN CJ, 1989, SCIENCE, V244, P182, DOI 10.1126/science.2649980; OFARRELL PH, 1978, CELL, V14, P545, DOI 10.1016/0092-8674(78)90241-6; PAPAS TS, 1970, J BIOL CHEM, V245, P1588; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; ROESSER JR, 1989, BIOCHEMISTRY-US, V28, P5185, DOI 10.1021/bi00438a041; Sabina J, 2003, J BACTERIOL, V185, P6158, DOI 10.1128/JB.185.20.6158-6170.2003; Sando S, 2007, J AM CHEM SOC, V129, P6180, DOI 10.1021/ja068033n; SCHLESIN.S, 1967, J BIOL CHEM, V242, P3369; SCHWEIZER EE, 1968, J ORG CHEM, V34, P207; Sever S, 1996, BIOCHEMISTRY-US, V35, P32, DOI 10.1021/bi952103d; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Soutourina J, 2000, J BIOL CHEM, V275, P32535, DOI 10.1074/jbc.M005166200; SPIZEK J, 1969, BIOCHEM BIOPH RES CO, V34, P17; Suchanek M, 2005, NAT METHODS, V2, P261, DOI 10.1038/NMETH752; Tan ZP, 2004, J AM CHEM SOC, V126, P12752, DOI 10.1021/ja0472174; Tang Y, 2002, BIOCHEMISTRY-US, V41, P10635, DOI 10.1021/bi026130x; Tsao ML, 2006, J AM CHEM SOC, V128, P4572, DOI 10.1021/ja058262u; van Hest JCM, 2000, J AM CHEM SOC, V122, P1282, DOI 10.1021/ja992749j; Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n; Wang L, 2006, ANNU REV BIOPH BIOM, V35, P225, DOI 10.1146/annurev.biophys.35.101105.121507	70	122	141	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e972	10.1371/journal.pone.0000972	http://dx.doi.org/10.1371/journal.pone.0000972			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912351	Green Published, gold, Green Submitted			2022-12-25	WOS:000207455900010
J	Ferreira, RA; Lazzari, CR; Lorenzo, MG; Pereira, MH				Ferreira, Raquel A.; Lazzari, Claudio R.; Lorenzo, Marcelo G.; Pereira, Marcos H.			Do Haematophagous Bugs Assess Skin Surface Temperature to Detect Blood Vessels?	PLOS ONE			English	Article							RHODNIUS-PROLIXUS HEMIPTERA; DROSOPHILA; ORIENTATION; ANTENNAE; PAINLESS	Background. It is known that some blood-sucking insects have the ability to reach vessels under the host skin with their mouthparts to feed blood from inside them. However, the process by which they locate these vessels remains largely unknown. Less than 5% of the skin is occupied by blood vessels and thus, it is not likely that insects rely on a "random search strategy", since it would increase the probability of being killed by their hosts. Indeed, heterogeneities along the skin surface might offer exploitable information for guiding insect's bites. Methodology/Principal Findings. We tested whether the bug Rhodnius prolixus can evaluate temperature discontinuities along the body surface in order to locate vessels before piercing the host skin. When placed over a rabbit ear, the bug's first bites were mostly directed towards the main vessels. When insects were confronted to artificial linear heat sources presenting a temperature gradient against the background, most bites were directly addressed to the warmer linear source, notwithstanding the temperature of both, the source and the background. Finally, tests performed using uni- and bilaterally antennectomized insects revealed that the bilateral integration of thermal inputs from both antennae is necessary for precisely directing bites. Conclusions/Significance. R. prolixus may be able to exploit the temperature differences observed over the skin surface to locate blood vessles. Bugs bite the warmest targets regardless of the target/background temperatures, suggesting that they do not bite choosing a preferred temperature, but select temperature discontinuities along the skin. This strategy seems to be an efficient one for finding blood vessels within a wide temperature range, allowing finding them on different hosts, as well as on different areas of the host body. Our study also adds new insight about the use of antennal thermal inputs by blood sucking bugs.	[Ferreira, Raquel A.; Lorenzo, Marcelo G.] Fiocruz MS, Ctr Pesquisas Rene Rachou, Lab Triatomineos & Epidemiol Doenca Chagas, BR-30190 Belo Horizonte, MG, Brazil; [Lazzari, Claudio R.] Univ Tours, CNRS, UMR 6035, Inst Rech Biol Insecte, Tours, France; [Pereira, Marcos H.] Univ Fed Minas Gerais, Lab Fisiol Insetos Hematofagos, Belo Horizonte, MG, Brazil	Fundacao Oswaldo Cruz; Centre National de la Recherche Scientifique (CNRS); Universite de Tours; Universidade Federal de Minas Gerais	Lorenzo, MG (corresponding author), Fiocruz MS, Ctr Pesquisas Rene Rachou, Lab Triatomineos & Epidemiol Doenca Chagas, BR-30190 Belo Horizonte, MG, Brazil.	marcelo@cpqrr.fiocruz.br	Lazzari, Claudio R/D-2869-2009; Lorenzo, Marcelo Gustavo/R-1301-2018; Lazzari, Claudio/H-6286-2019; Lorenzo, Marcelo/B-7674-2008; Pereira, Marcos H/A-3774-2012; Ferreira, Raquel Conceição/J-5236-2015; Pereira, Marcos Horácio/AAE-7076-2021	Lazzari, Claudio R/0000-0003-3703-0302; Lorenzo, Marcelo Gustavo/0000-0002-4000-5514; Lazzari, Claudio/0000-0003-3703-0302; Pereira, Marcos H/0000-0003-4843-0088; Ferreira, Raquel Conceição/0000-0001-8897-9345; Pereira, Marcos Horácio/0000-0003-4843-0088	IRR/FIOCRUZ; FAPEMIG; CAPES; CNPq; FAPEBIO/UFMG; CNRS; Universite Francois Rabelais	IRR/FIOCRUZ; FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEBIO/UFMG; CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Francois Rabelais	Funding was provided by IRR/FIOCRUZ, FAPEMIG, CAPES, CNPq and FAPEBIO/UFMG, CNRS and Universite Francois Rabelais.	BERNARD J, 1974, THESIS U RENNES FRAN; Catala S, 1996, J MORPHOL, V228, P195, DOI 10.1002/(SICI)1097-4687(199605)228:2<195::AID-JMOR8>3.3.CO;2-O; CHAGAS C, 1909, MEM I OSWALDO CRUZ, V1, P159, DOI DOI 10.1590/S0074-02761909000200008; Flores GB, 1996, J INSECT PHYSIOL, V42, P433, DOI 10.1016/0022-1910(95)00137-9; FLORES GB, 2001, THESIS U BUENOS AIRE; Guarneri AA, 2003, ACTA TROP, V87, P361, DOI 10.1016/S0001-706X(03)00121-9; LAVOIPIERRE M. M. J., 1959, ANN TROP MED AND PARASITOL, V53, P235; LAZZARI CR, 1992, J INSECT PHYSIOL, V38, P895, DOI 10.1016/0022-1910(92)90101-I; LAZZARI CR, 1989, ENTOMOL GEN, V14, P183; LAZZARI CR, 1989, J INSECT PHYSIOL, V35, P525, DOI 10.1016/0022-1910(89)90060-7; Lehane M.J., 2005, BIOL BLOOD SUCKING I, V2nd; LENT H, 1979, Bulletin of the American Museum of Natural History, V163, P123; Reisenman CE, 2002, J EXP BIOL, V205, P201; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; Sayeed O, 1996, P NATL ACAD SCI USA, V93, P6079, DOI 10.1073/pnas.93.12.6079; Schmitz H, 2000, J INSECT PHYSIOL, V46, P745, DOI 10.1016/S0022-1910(99)00163-8; Schofield CJ, 1994, TRIATOMINAEBIOLOGY C; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Wigglesworth VB, 1934, J EXP BIOL, V11, P120; World Health Organization, 2005, REP SCI WORK GROUP C; Xu SY, 2006, GENES BRAIN BEHAV, V5, P602, DOI 10.1111/j.1601-183X.2006.00213.x; Zars T, 2001, J COMP PHYSIOL A, V187, P235, DOI 10.1007/s003590100194; ZELEDON R, 1981, ANNU REV ENTOMOL, V26, P101, DOI 10.1146/annurev.en.26.010181.000533	23	43	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e932	10.1371/journal.pone.0000932	http://dx.doi.org/10.1371/journal.pone.0000932			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895973	gold, Green Published, Green Submitted			2022-12-25	WOS:000207455800011
J	Garzia, L; D'Angelo, A; Amoresano, A; Knauer, SK; Cirulli, C; Campanella, C; Stauber, RH; Steegborn, C; Iolascon, A; Zollo, M				Garzia, L.; D'Angelo, A.; Amoresano, A.; Knauer, S. K.; Cirulli, C.; Campanella, C.; Stauber, R. H.; Steegborn, C.; Iolascon, A.; Zollo, M.			Phosphorylation of nm23-H1 by CKI induces its complex formation with h-prune and promotes cell motility	ONCOGENE			English	Article						h-prune; nm23; CKI; motility; IC261	NUCLEOSIDE DIPHOSPHATE KINASE; CASEIN KINASE-1; INHIBITORY-ACTIVITY; GLYCOGEN-SYNTHASE; GENE-EXPRESSION; BREAST-CANCER; BETA-CATENIN; PROTEIN; OVEREXPRESSION; BINDING	The combination of an increase in the cAMP-phosphodiesterase activity of h-prune and its interaction with nm23-H1 have been shown to be key steps in the induction of cellular motility in breast cancer cells. Here we present the molecular mechanisms of this interaction. The region of the nm23-h-prune interaction lies between S120 and S125 of nm23, where missense mutants show impaired binding; this region has been highly conserved throughout evolution, and can undergo serine phosphorylation by casein kinase I. Thus, the casein kinase I delta-epsilon specific inhibitor IC261 impairs the formation of the nm23-h-prune complex, which translates 'in vitro' into inhibition of cellular motility in a breast cancer cellular model. A competitive permeable peptide containing the region for phosphorylation by casein kinase I impairs cellular motility to the same extent as IC261. The identification of these two modes of inhibition of formation of the nm23-H1-h-prune protein complex pave the way toward new challenges, including translational studies using IC261 or this competitive peptide 'in vivo' to inhibit cellular motility induced by nm23-H1-h-prune complex formation during progression of breast cancer.	[Garzia, L.; D'Angelo, A.; Iolascon, A.; Zollo, M.] CEINGE, Ctr Ingn Genet & Biotecnol Avsnzate, I-80131 Naples, Italy; [Amoresano, A.; Cirulli, C.] Univ Naples Federico II, Complesso Univ Monte S Angelo, Dipartimento Chim Organ & Biochim, Naples, Italy; [Knauer, S. K.; Stauber, R. H.] Georg Speyer Haus, Frankfurt, Germany; [Campanella, C.] Univ Naples Federico II, Dipartimento Biol Struct & Funz, Naples, Italy; [Stauber, R. H.] Univ Hosp Mainz, Lab Mol Tumour Biol, Dept Otolaryngol, Mainz, Germany; [Steegborn, C.] Ruhr Univ Bochum, Dept Phys Chem, Bochum, Germany; [Zollo, M.] Univ Naples Federico II, Fac Sci Biotechnol, Dipartimento Biochim & Biotecnol Med, Naples, Italy	CEINGE Biotecnologie Avanzate; University of Naples Federico II; University of Naples Federico II; University Hospital Mainz; Ruhr University Bochum; University of Naples Federico II	Zollo, M (corresponding author), CEINGE, Ctr Ingn Genet & Biotecnol Avsnzate, Via Comunale Margherita 482, I-80131 Naples, Italy.	zollo@ceinge.unina.it	Knauer, Shirley K/E-7931-2012; Iolascon, Achille/A-4461-2014	Knauer, Shirley K/0000-0003-4321-0924; AMORESANO, Angela/0000-0002-8386-655X; Stauber, Roland/0000-0002-1341-4523	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P17, DOI 10.1016/S0968-0004(97)01162-6; Biondi RM, 1996, FEBS LETT, V399, P183, DOI 10.1016/S0014-5793(96)01299-9; BOMINAAR AA, 1994, FEBS LETT, V353, P5, DOI 10.1016/0014-5793(94)00997-X; Cong F, 2004, MOL CELL BIOL, V24, P2000, DOI 10.1128/MCB.24.5.2000-2011.2004; Cooper CD, 2002, J BIOL CHEM, V277, P44962, DOI 10.1074/jbc.M209427200; Crawford RM, 2005, BIOCHEM J, V392, P201, DOI 10.1042/BJ20050269; Crawford RM, 2006, MOL CELL BIOL, V26, P5921, DOI 10.1128/MCB.00315-06; D'Angelo A, 2004, CELL CYCLE, V3, P758; D'Angelo A, 2004, CANCER CELL, V5, P137, DOI 10.1016/S1535-6108(04)00021-2; ENGEL M, 1994, BIOCHEM BIOPH RES CO, V199, P1041, DOI 10.1006/bbrc.1994.1334; FIOL CJ, 1988, ARCH BIOCHEM BIOPHYS, V267, P797, DOI 10.1016/0003-9861(88)90089-6; Forus A, 2001, ONCOGENE, V20, P6881, DOI 10.1038/sj.onc.1204874; Gao ZH, 2002, P NATL ACAD SCI USA, V99, P1182, DOI 10.1073/pnas.032468199; GARZIA L, 2003, BIOTECHNIQUES, V384, P390; Garzia L, 2006, J BIOENERG BIOMEMBR, V38, P205, DOI 10.1007/s10863-006-9036-z; Heo YJ, 1997, J CHROMATOGR A, V781, P251; Hino S, 2003, J BIOL CHEM, V278, P14066, DOI 10.1074/jbc.M213265200; Izeradjene K, 2004, CANCER RES, V64, P8036, DOI 10.1158/0008-5472.CAN-04-0762; KANTOR JD, 1993, CANCER RES, V53, P1971; Kim MS, 2002, BIOCHEM BIOPH RES CO, V291, P663, DOI 10.1006/bbrc.2002.6503; Kim YI, 2003, BIOCHEM BIOPH RES CO, V307, P281, DOI 10.1016/S0006-291X(03)01195-1; Knauer SK, 2005, ANAL CHEM, V77, P4815, DOI 10.1021/ac050413o; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; Kobayashi T, 2006, MOL CELL BIOL, V26, P898, DOI 10.1128/MCB.26.3.898-911.2006; KURET J, 1985, EUR J BIOCHEM, V151, P39, DOI 10.1111/j.1432-1033.1985.tb09066.x; Lacombe ML, 2000, J BIOENERG BIOMEMBR, V32, P247, DOI 10.1023/A:1005584929050; Lascu I, 2000, J BIOENERG BIOMEMBR, V32, P213; Lee M, 2003, J BIOL CHEM, V278, P39653, DOI 10.1074/jbc.M306104200; Li GB, 2004, J BIOL CHEM, V279, P15938, DOI 10.1074/jbc.M314116200; MacDonald NJ, 1996, J BIOL CHEM, V271, P25107, DOI 10.1074/jbc.271.41.25107; MARIN O, 1994, EUR J BIOCHEM, V223, P647, DOI 10.1111/j.1432-1033.1994.tb19037.x; Marin O, 2003, P NATL ACAD SCI USA, V100, P10193, DOI 10.1073/pnas.1733909100; Mashhoon N, 2000, J BIOL CHEM, V275, P20052, DOI 10.1074/jbc.M001713200; MEGGIO F, 1993, BIOCHIM BIOPHYS ACTA, V1164, P223, DOI 10.1016/0167-4838(93)90252-M; Middelhaufe S, 2007, BIOCHEM J, V407, P199, DOI 10.1042/BJ20070408; Mocan I, 2007, BIOCHEM J, V403, P149, DOI 10.1042/BJ20061141; Otsuki Y, 2001, P NATL ACAD SCI USA, V98, P4385, DOI 10.1073/pnas.071411598; Pagano MA, 2004, BIOCHEM BIOPH RES CO, V321, P1040, DOI 10.1016/j.bbrc.2004.07.067; Palacios F, 2002, NAT CELL BIOL, V4, P929, DOI 10.1038/ncb881; Rena G, 2004, EMBO REP, V5, P60, DOI 10.1038/sj.embor.7400048; Reymond A, 1999, ONCOGENE, V18, P7244, DOI 10.1038/sj.onc.1203140; Steeg PS, 2005, AM J PATHOL, V166, P1291, DOI 10.1016/S0002-9440(10)62348-6; STEEG PS, 1988, CANCER RES, V48, P6550; Tseng YH, 2001, CANCER RES, V61, P2071; Wagner PD, 1997, P NATL ACAD SCI USA, V94, P9000, DOI 10.1073/pnas.94.17.9000; Zhang BL, 2004, MOL CELL BIOL, V24, P6205, DOI 10.1128/MCB.24.14.6205-6214.2004; Zollo M, 2005, CLIN CANCER RES, V11, P199	47	39	41	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2008	27	13					1853	1864		10.1038/sj.onc.1210822	http://dx.doi.org/10.1038/sj.onc.1210822			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	276NZ	17906697				2022-12-25	WOS:000254150600005
J	Berg, DT; Gupta, A; Richardson, MA; O'Brien, LA; Calnek, D; Grinnell, BW				Berg, David T.; Gupta, Akanksha; Richardson, Mark A.; O'Brien, Lee A.; Calnek, David; Grinnell, Brian W.			Negative regulation of inducible nitric-oxide synthase expression mediated through transforming growth factor-beta-dependent modulation of transcription factor TCF11	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-C; ENDOTOXIN-INDUCED HYPOTENSION; SMOOTH-MUSCLE-CELLS; KINASE; INHIBITION; DELTA; PKC; PHOSPHORYLATION; THROMBOMODULIN; FIBROBLASTS	Inducible nitric-oxide synthase ( iNOS) plays a central role in the regulation of vascular function and response to injury. A central mediator controlling iNOS expression is transforming growth factor-beta (TGF-beta), which represses its expression through a mechanism that is poorly understood. We have identified a binding site in the iNOS promoter that interacts with the nuclear heterodimer TCF11/MafG using chromatin immunoprecipitation and mutation analyses. We demonstrate that binding at this site acts to repress the induction of iNOS gene expression by cytokines. We show that this repressor is induced by TGF-beta 1 and by Smad6-short, which enhances TGF-beta signaling. In contrast, the up-regulation of TCF11/MafG binding could be suppressed by overexpression of the TGF-beta inhibitor Smad7, and a small interfering RNA to TCF11 blocked the suppression of iNOS by TGF-beta. The binding of TCF11/MafG to the iNOS promoter could be enhanced by phorbol 12-myristate 13-acetate and suppressed by the protein kinase C inhibitor staurosporine. Moreover, the induction of TCF11/MafG binding by TGF-beta and Smad6-short could be blocked by staurosporine, and the effect of TGF-beta was blocked by the selective protein kinase C inhibitor calphostin C. Consistent with the in vitro data, we found suppression of TCF11 coincident with iNOS upregulation in a rat model of endotoxemia, and we observed a highly significant negative correlation between TCF11 and nitric oxide production. Furthermore, treatment with activated protein C, a serine protease effective in septic shock, blocked the down-regulation of TCF11 and suppressed endotoxin-induced iNOS. Overall, our results demonstrate a novel mechanism by which iNOS expression is regulated in the context of inflammatory activation.	[Berg, David T.; Gupta, Akanksha; Richardson, Mark A.; O'Brien, Lee A.; Calnek, David; Grinnell, Brian W.] Lilly Corp Ctr, Lilly Res Labs, Div Biotechnol Discovery Res, Indianapolis, IN 46285 USA	Eli Lilly	Grinnell, BW (corresponding author), Lilly Corp Ctr, Lilly Res Labs, Div Biotechnol Discovery Res, Indianapolis, IN 46285 USA.	bgrinnell@lilly.com						Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Berg DT, 2005, J BIOL CHEM, V280, P14943, DOI 10.1074/jbc.C400579200; BERG DT, 1995, J BIOL CHEM, V270, P15447, DOI 10.1074/jbc.270.26.15447; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Calnek DS, 1998, EXP CELL RES, V238, P294, DOI 10.1006/excr.1997.3812; Chen CA, 2006, TRANSL RES, V148, P134, DOI 10.1016/j.trsl.2006.03.008; Farre AL, 1996, ARTERIOSCL THROM VAS, V16, P1263, DOI 10.1161/01.ATV.16.10.1263; Feinberg MW, 2004, J BIOL CHEM, V279, P16388, DOI 10.1074/jbc.M309664200; FINDER J, 1995, AM J PHYSIOL-LUNG C, V268, pL862, DOI 10.1152/ajplung.1995.268.5.L862; GENG YJ, 1994, BBA-MOL CELL RES, V1223, P125, DOI 10.1016/0167-4889(94)90081-7; GRINNELL BW, 1988, MOL CELL BIOL, V8, P3448, DOI 10.1128/MCB.8.8.3448; Gupta A, 2003, SHOCK, V20, P375, DOI 10.1097/01.shk.0000087202.34916.0c; Gupta AK, 2002, AM J PHYSIOL-CELL PH, V283, pC1065, DOI 10.1152/ajpcell.00100.2002; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Hoffmann JN, 2004, CRIT CARE MED, V32, P1011, DOI 10.1097/01.CCM.0000120058.88975.42; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Isobe H, 2001, CIRCULATION, V104, P1171, DOI 10.1161/hc3501.093799; Johnsen O, 1996, NUCLEIC ACIDS RES, V24, P4289, DOI 10.1093/nar/24.21.4289; Johnsen O, 1998, NUCLEIC ACIDS RES, V26, P512, DOI 10.1093/nar/26.2.512; Kalil AC, 2004, SHOCK, V21, P222, DOI 10.1097/01.shk.0000116778.27924.79; Lee MS, 2005, MOL CELL BIOL, V25, P6921, DOI 10.1128/MCB.25.16.6921-6936.2005; Li HG, 2000, J PATHOL, V190, P244, DOI 10.1002/(SICI)1096-9896(200002)190:3<244::AID-PATH575>3.0.CO;2-8; Lim JY, 2005, J MOL CELL CARDIOL, V39, P627, DOI 10.1016/j.yjmcc.2005.06.016; Lirk Philipp, 2002, Current Drug Targets - Inflammation and Allergy, V1, P89, DOI 10.2174/1568010023344913; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Matejovic M, 2004, SHOCK, V21, P458, DOI 10.1097/00024382-200405000-00010; Mizutani A, 2000, BLOOD, V95, P3781; MUHL H, 1994, BIOCHEM J, V303, P607; Mulsow JJW, 2005, ANN SURG, V242, P880, DOI 10.1097/01.sla.0000189606.58343.cd; Murphy P, 2000, MECH DEVELOP, V97, P141, DOI 10.1016/S0925-4773(00)00413-5; Perrella MA, 1996, P NATL ACAD SCI USA, V93, P2054, DOI 10.1073/pnas.93.5.2054; Pullamsetti SS, 2006, THROMB HAEMOSTASIS, V95, P720, DOI 10.1160/TH05-07-0518; REIFELMILLER AE, 1991, J BIOL CHEM, V266, P13873; Richardson MA, 2000, ENDOCRINOLOGY, V141, P3908, DOI 10.1210/en.141.10.3908; Runyan CE, 2003, AM J PHYSIOL-RENAL, V285, pF413, DOI 10.1152/ajprenal.00082.2003; Russo MT, 2004, DEV BIOL, V267, P517, DOI 10.1016/j.ydbio.2003.11.005; Sakaguchi M, 2004, J CELL BIOL, V164, P979, DOI 10.1083/jcb.200312041; SCHINI VB, 1992, EUR J PHARMACOL, V216, P379, DOI 10.1016/0014-2999(92)90434-6; Taylor BS, 1998, BIOCHEMISTRY-MOSCOW+, V63, P766; Tazi KA, 2002, LIVER, V22, P178, DOI 10.1034/j.1600-0676.2002.01616.x; Vila-del Sol V, 2007, J LEUKOCYTE BIOL, V81, P272, DOI DOI 10.1189/JLB.0905529; Vodovotz Yoram, 1994, Progress in Growth Factor Research, V5, P341, DOI 10.1016/0955-2235(94)00004-5; Wang HS, 2005, J CELL BIOCHEM, V95, P256, DOI 10.1002/jcb.20405; Zhang L, 2004, J BIOL CHEM, V279, P28315, DOI 10.1074/jbc.C400115200	44	48	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					36837	36844		10.1074/jbc.M706909200	http://dx.doi.org/10.1074/jbc.M706909200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17928287	hybrid			2022-12-25	WOS:000251646000008
J	Derbyshire, ER; Marletta, MA				Derbyshire, Emily R.; Marletta, Michael A.			Butyl isocyanide as a probe of the activation mechanism of soluble guanylate cyclase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITROSYL-HEME COMPLEX; NITRIC-OXIDE; CARBON-MONOXIDE; PARAMAGNETIC-RESONANCE; DISSOCIATION; MYOGLOBIN; BINDING; HEMOGLOBIN; EQUILIBRIA; DOMAINS	Nitric oxide (NO) is a physiologically relevant activator of the hemoprotein soluble guanylate cyclase (sGC). In the presence of NO, sGC is activated several hundredfold above the basal level by a mechanism that remains to be elucidated. The heme ligand n-butyl isocyanide (BIC) was used to probe the mechanism of NO activation of sGC. Electronic absorption spectroscopy was used to show that BIC binds to the sGC heme, forming a 6-coordinate complex with an absorbance maximum at 429 nm. BIC activates sGC 2-5-fold, and synergizes with the allosteric activator YC-1, to activate the enzyme 15-25-fold. YC-1 activates the sGC-BIC complex, and leads to an increase in both the V-max and K-m. BIC was also used to probe the mechanism of NO activation. The activity of the sGC-BIC complex increases 15-fold in the presence of NO, without displacing BIC at the heme, which is consistent with previous reports that proposed the involvement of a non-heme NO binding site in the activation process.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Phys Biosci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Marletta, MA (corresponding author), 570 Stanley Hall, Berkeley, CA 94720 USA.	marletta@berkeley.edu			NIGMS NIH HHS [R01 GM077365-02, GM077365, R01 GM077365] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077365] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Antonini E., 1971, HEMOGLOBIN MYOGLOBIN; BUECHLER WA, 1994, ANN NY ACAD SCI, V714, P151; Cary SPL, 2006, TRENDS BIOCHEM SCI, V31, P231, DOI 10.1016/j.tibs.2006.02.003; Cary SPL, 2005, P NATL ACAD SCI USA, V102, P13064, DOI 10.1073/pnas.0506289102; CRAVEN PA, 1978, J BIOL CHEM, V253, P8433; Denninger JW, 2000, BIOCHEMISTRY-US, V39, P4191, DOI 10.1021/bi992332q; Denninger JW, 1999, BBA-BIOENERGETICS, V1411, P334, DOI 10.1016/S0005-2728(99)00024-9; Derbyshire ER, 2005, BIOCHEMISTRY-US, V44, P16257, DOI 10.1021/bi0515671; Friebe A, 1996, EMBO J, V15, P6863, DOI 10.1002/j.1460-2075.1996.tb01078.x; Friebe A, 1997, BIOCHEMISTRY-US, V36, P1194, DOI 10.1021/bi962047w; GEORGE RCC, 1951, SCIENCE, V114, P629, DOI 10.1126/science.114.2972.629; Karow DS, 2005, BIOCHEMISTRY-US, V44, P16266, DOI 10.1021/bi051601b; Kharitonov VG, 1999, BIOCHEMISTRY-US, V38, P10699, DOI 10.1021/bi990277f; Kharitonov VG, 1997, BIOCHEM BIOPH RES CO, V239, P284, DOI 10.1006/bbrc.1997.7470; Lee DS, 2001, BIOCHEMISTRY-US, V40, P2669, DOI 10.1021/bi002225s; LEIN A, 1956, P NATL ACAD SCI USA, V42, P51, DOI 10.1073/pnas.42.2.51; MANSUY D, 1977, EUR J BIOCHEM, V76, P617, DOI 10.1111/j.1432-1033.1977.tb11632.x; Milani M, 2004, J BIOL CHEM, V279, P21520, DOI 10.1074/jbc.M401320200; MOORE EG, 1976, J BIOL CHEM, V251, P2788; Munzel T, 2003, CIRCULATION, V108, P2172, DOI 10.1161/01.CIR.0000094403.78467.C3; Poulos TL, 2006, CURR OPIN STRUC BIOL, V16, P736, DOI 10.1016/j.sbi.2006.09.006; ROMBERG RW, 1979, BIOCHEMISTRY-US, V18, P5387, DOI 10.1021/bi00591a020; Roy B, 2006, P NATL ACAD SCI USA, V103, P12185, DOI 10.1073/pnas.0602544103; Russwurm M, 2004, EMBO J, V23, P4443, DOI 10.1038/sj.emboj.7600422; Sayed N, 2007, P NATL ACAD SCI USA, V104, P12312, DOI 10.1073/pnas.0703944104; Segel IH, 1975, ENZYME KINETICS BEHA; STONE JR, 1994, BIOCHEMISTRY-US, V33, P5636, DOI 10.1021/bi00184a036; STONE JR, 1995, BIOCHEM BIOPH RES CO, V207, P572, DOI 10.1006/bbrc.1995.1226; Stone JR, 1996, BIOCHEMISTRY-US, V35, P1093, DOI 10.1021/bi9519718; Stone JR, 1995, BIOCHEMISTRY-US, V34, P16397, DOI 10.1021/bi00050a021; SZABO A, 1976, BIOCHEMISTRY-US, V15, P4427, DOI 10.1021/bi00665a013; Ubbink M, 2002, ANNU REV BIOPH BIOM, V31, P393, DOI 10.1146/annurev.biophys.31.091701.171000; WEDEL B, 1994, P NATL ACAD SCI USA, V91, P2592, DOI 10.1073/pnas.91.7.2592; Winger JA, 2005, BIOCHEMISTRY-US, V44, P4083, DOI 10.1021/bi047601d; Winger JA, 2007, J BIOL CHEM, V282, P897, DOI 10.1074/jbc.M606327200; Zhao Y, 1999, P NATL ACAD SCI USA, V96, P14753, DOI 10.1073/pnas.96.26.14753; Zhao YD, 1998, BIOCHEMISTRY-US, V37, P12458, DOI 10.1021/bi9811563	37	25	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35741	35748		10.1074/jbc.M705557200	http://dx.doi.org/10.1074/jbc.M705557200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17916555	hybrid			2022-12-25	WOS:000251458100035
J	Donini, S; Clerici, M; Wengel, J; Vester, B; Peracchi, A				Donini, Stefano; Clerici, Marcello; Wengel, Jesper; Vester, Birte; Peracchi, Alessio			The advantages of being locked - Assessing the cleavage of short and long RNAs by locked nucleic acid-containing 8-17 deoxyribozymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; CLEAVING DNA ENZYME; IN-VITRO SELECTION; DUPLEX FORMATION; CATALYTIC DNA; MESSENGER-RNA; LNA; DNAZYMES; RECOGNITION; STABILITY	RNA-cleaving deoxyribozymes can be used for the sequence-specific knockdown of mRNAs. It was previously shown that activity of these deoxyribozymes is enhanced when their substrate-binding arms include some locked nucleic acid (LNA) residues, but the mechanistic basis of this enhancement was not explored. Here we dissected the kinetics and thermodynamics underlying the reaction of LNA-containing 8-17 deoxyribozymes. Four 8-17 constructs were designed to target sequences within the E6 mRNA from human papillomavirus type 16. When one of these deoxyribozymes (DNAzymes) and the corresponding LNA-armed enzyme (LNAzyme) were tested against a minimal RNA substrate, they showed similar rates of substrate binding and similar rates of intramolecular cleavage, but the LNAzyme released its substrate more slowly. The superior thermodynamic stability of the LNAzyme-substrate complex led to improved performances in reactions carried out at low catalyst concentrations. The four DNAzymes and the corresponding LNAzymes were then tested against extended E6 transcripts (> 500 nucleotides long). With these structured substrates, the LNAzymes retained full activity, whereas the DNAzymes cleaved extremely poorly, unless they were allowed to pre-anneal to their targets. These results imply that LNAzymes can easily overcome the kinetic barrier represented by local RNA structure and bind to folded targets with a faster association rate as compared with DNAzymes. Such faster annealing to structured targets can be explained by a model whereby LNA monomers favor the initial hybridization to short stretches of unpaired residues ("nucleation"), which precedes disruption of the local mRNA structure and completion of the binding process.	Univ So Denmark, Dept Biochem & Mol Biol, Nucle Acid Ctr, DK-5230 Odense M, Denmark; Univ Parma, Dept Biochem & Mol Biol, I-43100 Parma, Italy; Univ So Denmark, Dept Chem, Nucle Acid Ctr, DK-5230 Odense M, Denmark	University of Southern Denmark; University of Parma; University of Southern Denmark	Vester, B (corresponding author), Univ So Denmark, Dept Biochem & Mol Biol, Nucle Acid Ctr, DK-5230 Odense M, Denmark.	b.vester@bmb.sdu.dk; peracchi@unipr.it	Peracchi, Alessio/G-5167-2012; Peracchi, Alessio/Q-5173-2019; wengel, jesper/K-1177-2013	Peracchi, Alessio/0000-0003-3254-4099; Peracchi, Alessio/0000-0003-3254-4099; Vester, Birte/0000-0002-5368-0500; Wengel, Jesper/0000-0001-9835-1009				Bonaccio M, 2004, NUCLEIC ACIDS RES, V32, P916, DOI 10.1093/nar/gkh250; Bondensgaard K, 2000, CHEM-EUR J, V6, P2687, DOI 10.1002/1521-3765(20000804)6:15<2687::AID-CHEM2687>3.0.CO;2-U; Cairns MJ, 1999, NAT BIOTECHNOL, V17, P480, DOI 10.1038/8658; Cairns MJ, 2002, CURR DRUG TARGETS, V3, P269, DOI 10.2174/1389450023347722; Cairns Murray J, 2004, Methods Mol Biol, V252, P267; CANTOR CR, 1970, BIOPOLYMERS, V9, P1059, DOI 10.1002/bip.1970.360090909; Christensen U, 2001, BIOCHEM J, V354, P481, DOI 10.1042/0264-6021:3540481; Dass C, 2006, DRUG DEV IND PHARM, V32, P1, DOI 10.1080/03639040500387872; Dass CR, 2004, TRENDS PHARMACOL SCI, V25, P395, DOI 10.1016/j.tips.2004.06.001; Fahmy RG, 2004, NUCLEIC ACIDS RES, V32, P2281, DOI 10.1093/nar/gkh543; Ferrari D, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf111; FERSHT A, 1985, ENZYME STRUCTURE MEC, P137; Fluiter K, 2005, OLIGONUCLEOTIDES, V15, P246, DOI 10.1089/oli.2005.15.246; Jakobsen MR, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-29; Joyce GF, 2001, METHOD ENZYMOL, V341, P503, DOI 10.1016/S0076-6879(01)41173-6; Kaur H, 2006, BIOCHEMISTRY-US, V45, P7347, DOI 10.1021/bi060307w; Kurreck J, 2002, J BIOL CHEM, V277, P7099, DOI 10.1074/jbc.M107206200; Li J, 2000, NUCLEIC ACIDS RES, V28, P481, DOI 10.1093/nar/28.2.481; Liu Y, 2004, J MOL BIOL, V341, P887, DOI 10.1016/j.jmb.2004.06.060; Long D, 2007, NAT STRUCT MOL BIOL, V14, P287, DOI 10.1038/nsmb1226; McTigue PM, 2004, BIOCHEMISTRY-US, V43, P5388, DOI 10.1021/bi035976d; Mouritzen P, 2003, EXPERT REV MOL DIAGN, V3, P27, DOI 10.1586/14737159.3.1.27; Nakano S, 1999, NUCLEIC ACIDS RES, V27, P2957, DOI 10.1093/nar/27.14.2957; Ormond TK, 2006, J BIOMOL STRUCT DYN, V24, P171, DOI 10.1080/07391102.2006.10507110; Pan WH, 2003, MOL THER, V7, P129, DOI 10.1016/S0000-000X(00)00000-0; Peracchi A, 2005, J MOL BIOL, V352, P783, DOI 10.1016/j.jmb.2005.07.059; Reynaldo LP, 2000, J MOL BIOL, V297, P511, DOI 10.1006/jmbi.2000.3573; Santoro SW, 1998, BIOCHEMISTRY-US, V37, P13330, DOI 10.1021/bi9812221; Santoro SW, 1997, P NATL ACAD SCI USA, V94, P4262, DOI 10.1073/pnas.94.9.4262; Schubert S, 2003, NUCLEIC ACIDS RES, V31, P5982, DOI 10.1093/nar/gkg791; Schubert S, 2004, J MOL BIOL, V339, P355, DOI 10.1016/j.jmb.2004.03.064; Silverman SK, 2005, NUCLEIC ACIDS RES, V33, P6151, DOI 10.1093/nar/gki930; Singh SK, 1998, CHEM COMMUN, P1247, DOI 10.1039/a801571f; Singh SK, 1998, CHEM COMMUN, P455, DOI 10.1039/a708608c; Venturini F, 1999, NUCLEIC ACIDS RES, V27, P1585, DOI 10.1093/nar/27.7.1585; Vester B, 2002, J AM CHEM SOC, V124, P13682, DOI 10.1021/ja0276220; Vester B, 2004, BIOCHEMISTRY-US, V43, P13233, DOI 10.1021/bi0485732; Vester B, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-19; Walton SP, 2002, BIOPHYS J, V82, P366, DOI 10.1016/S0006-3495(02)75401-5; Wengel J, 1999, ACCOUNTS CHEM RES, V32, P301, DOI 10.1021/ar980051p; You Y, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl175; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	42	23	25	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35510	35518		10.1074/jbc.M706993200	http://dx.doi.org/10.1074/jbc.M706993200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17908692	hybrid			2022-12-25	WOS:000251458100010
J	Guay, C; Madiraju, SRM; Aumais, A; Joly, E; Prentki, M				Guay, Claudiane; Madiraju, S. R. Murthy; Aumais, Alexandre; Joly, Erik; Prentki, Marc			A role for ATP-citrate lyase, malic enzyme, and pyruvate/citrate cycling in glucose-induced insulin secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; CHAIN ACYL-COA; PALMITOYLTRANSFERASE-I INTERACTION; HORMONE-SENSITIVE LIPASE; FATTY-ACID SYNTHESIS; MALONYL-COA; TRICARBOXYLATE CARRIER; REGULATED ANAPLEROSIS; ISLETS; SHUTTLE	In pancreatic beta-cells, metabolic coupling factors generated during glucose metabolism and pyruvate cycling through anaplerosis/cataplerosis processes contribute to the regulation of insulin secretion. Pyruvate/citrate cycling across the mitochondrial membrane leads to the production of malonyl-CoA and NADPH, two candidate coupling factors. To examine the implication of pyruvate/citrate cycling in glucose-induced insulin secretion (GIIS), different steps of the cycle were inhibited in INS 832/13 cells by pharmacological inhibitors and/or RNA interference (RNAi) technology: mitochondrial citrate export, ATP-citrate lyase (ACL), and cytosolic malic enzyme (ME1). The inhibitors of the di- and tri-carboxylate carriers, n-butylmalonate and 1,2,3-benzenetricarboxylate, respectively, reduced GIIS, indicating the importance of transmitochondrial transport of tri-and dicarboxylates in the action of glucose. To directly test the role of ACL and ME1 in GIIS, small hairpinRNA (shRNA) were used to selectively decrease ACL or ME1 expression in transfected INS 832/13 cells. shRNA-ACL reduced ACL protein levels by 67%, and this was accompanied by a reduction in GIIS. The amplification/K-ATP-independent pathway of GIIS was affected by RNAi knockdown of ACL. The ACL inhibitor radicicol also curtailed GIIS. shRNA-ME1 reduced ME1 activity by 62% and decreased GIIS. RNAi suppression of either ACL or ME1 did not affect glucose oxidation. However, because ACL is required for malonyl-CoA formation, inhibition of ACL expression by shRNA-ACL decreased glucose incorporation into palmitate and increased fatty acid oxidation in INS 832/13 cells. Taken together, the results underscore the importance of pyruvate/citrate cycling in pancreatic beta-cell metabolic signaling and the regulation of GIIS.	Ctr Hosp Univ Montreal, Ctr Rech, Mol Nutr Unit, Montreal, PQ H1W 4A4, Canada; Ctr Hosp Univ Montreal, Ctr Rech, Montreal Diabet Res Ctr, Montreal, PQ H1W 4A4, Canada; Univ Montreal, Dept Nutr, Montreal, PQ H1W 4A4, Canada; Univ Montreal, Dept Biochem, Montreal, PQ H1W 4A4, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Prentki, M (corresponding author), MDRC CR CHUM, Technopole Angus,Rm 401,2901 Rachel St, Montreal, PQ H1W 4A4, Canada.	marc.prentki@umontreal.ca	Guay, Claudiane/AAF-5381-2019	Guay, Claudiane/0000-0002-6478-8744				AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; ASHCROFT F M, 1991, Current Opinion in Cell Biology, V3, P671, DOI 10.1016/0955-0674(91)90040-6; ASHCROFT FM, 1984, NATURE, V312, P446, DOI 10.1038/312446a0; AZZI A, 1993, J BIOENERG BIOMEMBR, V25, P515, DOI 10.1007/BF01108408; Bauer DE, 2005, ONCOGENE, V24, P6314, DOI 10.1038/sj.onc.1208773; BEST L, 1988, BIOCHEM PHARMACOL, V37, P2019, DOI 10.1016/0006-2952(88)90550-3; BISACCIA F, 1993, BIOCHIM BIOPHYS ACTA, V1142, P139, DOI 10.1016/0005-2728(93)90095-W; Brun T, 1996, DIABETES, V45, P190, DOI 10.2337/diabetes.45.2.190; CHEN SY, 1994, DIABETES, V43, P878, DOI 10.2337/diabetes.43.7.878; CORKEY BE, 1989, J BIOL CHEM, V264, P21608; Dabrowski M, 2003, J PHYSIOL-LONDON, V550, P357, DOI 10.1113/jphysiol.2003.041715; Fahien LA, 2002, DIABETES, V51, P2669, DOI 10.2337/diabetes.51.9.2669; Farfari S, 2000, DIABETES, V49, P718, DOI 10.2337/diabetes.49.5.718; Flamez D, 2002, DIABETES, V51, P2018, DOI 10.2337/diabetes.51.7.2018; Fransson U, 2006, DIABETOLOGIA, V49, P1578, DOI 10.1007/s00125-006-0263-y; Fulgencio JP, 1996, DIABETES, V45, P1556, DOI 10.2337/diabetes.45.11.1556; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; HEDESKOV CJ, 1987, BIOCHEM J, V241, P161, DOI 10.1042/bj2410161; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Herrero L, 2005, DIABETES, V54, P462, DOI 10.2337/diabetes.54.2.462; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Ivarsson R, 2005, DIABETES, V54, P2132, DOI 10.2337/diabetes.54.7.2132; Joseph JW, 2006, J BIOL CHEM, V281, P35624, DOI 10.1074/jbc.M602606200; Khan A, 1996, J BIOL CHEM, V271, P2539, DOI 10.1074/jbc.271.5.2539; Ki SW, 2000, J BIOL CHEM, V275, P39231, DOI 10.1074/jbc.M006192200; Lajoix AD, 2001, DIABETES, V50, P1311, DOI 10.2337/diabetes.50.6.1311; Liu YQ, 2004, J BIOL CHEM, V279, P7470, DOI 10.1074/jbc.M307921200; Liu YQ, 2002, J BIOL CHEM, V277, P39163, DOI 10.1074/jbc.M207157200; Lu DH, 2002, P NATL ACAD SCI USA, V99, P2708, DOI 10.1073/pnas.052005699; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; MACDONALD MJ, 1993, METABOLISM, V42, P1229, DOI 10.1016/0026-0495(93)90118-8; MACDONALD MJ, 1992, HORM METAB RES, V24, P158, DOI 10.1055/s-2007-1003284; MacDonald MJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE302, DOI 10.1152/ajpendo.00041.2002; MACDONALD MJ, 1995, J BIOL CHEM, V270, P20051; MacDonald PE, 2003, DIABETOLOGIA, V46, P1046, DOI 10.1007/s00125-003-1159-8; Maechler P, 1999, NATURE, V402, P685, DOI 10.1038/45280; Mizuarai S, 2005, J BIOL CHEM, V280, P32434, DOI 10.1074/jbc.M503152200; Nolan CJ, 2006, DIABETES, V55, pS16, DOI 10.2337/db06-S003; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Peyot ML, 2004, DIABETES, V53, P1733, DOI 10.2337/diabetes.53.7.1733; Pi JB, 2007, DIABETES, V56, P1783, DOI 10.2337/db06-1601; Pongratz RL, 2007, J BIOL CHEM, V282, P200, DOI 10.1074/jbc.M602954200; PRENTKI M, 1992, J BIOL CHEM, V267, P5802; PRENTKI M, 1987, PHYSIOL REV, V67, P1185, DOI 10.1152/physrev.1987.67.4.1185; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Roduit R, 2004, DIABETES, V53, P1007, DOI 10.2337/diabetes.53.4.1007; Roduit R, 2001, DIABETES, V50, P1970, DOI 10.2337/diabetes.50.9.1970; Roduit R, 2000, J BIOL CHEM, V275, P35799, DOI 10.1074/jbc.M006001200; Ronnebaum SM, 2006, J BIOL CHEM, V281, P30593, DOI 10.1074/jbc.M511908200; Salehi A, 1996, AM J PHYSIOL-CELL PH, V270, pC1634, DOI 10.1152/ajpcell.1996.270.6.C1634; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; SENER A, 1991, BIOCHIMIE, V73, P1287, DOI 10.1016/0300-9084(91)90090-N; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329	53	119	125	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35657	35665		10.1074/jbc.M707294200	http://dx.doi.org/10.1074/jbc.M707294200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17928289	hybrid			2022-12-25	WOS:000251458100026
J	Hatta, M; Cirillo, LA				Hatta, Mitsutoki; Cirillo, Lisa Ann			Chromatin opening and stable perturbation of core histone: DNA contacts by FoxO1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-BINDING PROTEIN-1; TRANSCRIPTION FACTOR FKHR; INSULIN-RESPONSE SEQUENCES; RAT HEPATOMA-CELLS; FORKHEAD TRANSCRIPTION; CRYSTAL-STRUCTURE; MMTV PROMOTER; ALVEOLAR RHABDOMYOSARCOMA; GENE-EXPRESSION; KINASE-B	FoxO1, a member of the forkhead rabdomyosarcoma (FoxO) subfamily of transcription factors, binds DNA via a highly conserved winged-helix "forkhead box" motif used by other regulatory proteins to mediate their effects through chromatin binding and remodeling. To examine how FoxO1 regulates target genes in chromatin, we studied the binding of purified recombinant FoxO1 protein to nucleosome particles and chromatin arrays containing the insulin-like growth factor-binding protein 1 promoter. We found that FoxO1 is able to bind to its cognate sites within the insulin-like growth factor-binding protein 1 promoter on a nucleosome. This binding stably perturbs core histone: DNA contacts extending up- and downstream from sites of FoxO1 binding without disrupting the underlying core particle. FoxO1 is able to harness these capabilities to bind to and de-condense linker histone-compacted chromatin arrays. Chromatin opening by FoxO1 requires both the N and C termini of the protein, which are also required for high affinity core histone binding and, in the case of the N terminus, nucleosome perturbation. We suggest that the chromatin binding and remodeling functions revealed here for FoxO1 endow all FoxO factors with the ability to initiate and dynamically modulate active chromatin states, enabling their diverse roles as gene regulatory factors in metabolism, cell survival, apoptosis, cell cycle progression, DNA repair, and protection against oxidative stress.	Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Cirillo, LA (corresponding author), Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	lcirillo@mcw.edu	HATTA, MOCHAMMAD/D-3742-2019	HATTA, MOCHAMMAD/0000-0002-8456-4203				ADAMS CC, 1995, MOL CELL BIOL, V15, P1405; ARCHER TK, 1992, SCIENCE, V255, P1573, DOI 10.1126/science.1347958; Ayala JE, 1999, DIABETES, V48, P1885, DOI 10.2337/diabetes.48.9.1885; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; BAXEVANIS AD, 1991, BIOCHEMISTRY-US, V30, P8817, DOI 10.1021/bi00100a013; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Bednar J, 1998, P NATL ACAD SCI USA, V95, P14173, DOI 10.1073/pnas.95.24.14173; Belikov S, 2001, EMBO J, V20, P2802, DOI 10.1093/emboj/20.11.2802; Bennicelli JL, 1996, P NATL ACAD SCI USA, V93, P5455, DOI 10.1073/pnas.93.11.5455; BENNICELLI JL, 1995, ONCOGENE, V11, P119; Berger SL, 2001, ONCOGENE, V20, P3007, DOI 10.1038/sj.onc.1204324; Biggs WH, 2001, MAMM GENOME, V12, P416, DOI 10.1007/s003350020002; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Birkenkamp KU, 2003, BIOCHEM SOC T, V31, P292, DOI 10.1042/bst0310292; Boura E, 2007, J BIOL CHEM, V282, P8265, DOI 10.1074/jbc.M605682200; Boyes J, 1998, J MOL BIOL, V279, P529, DOI 10.1006/jmbi.1998.1783; Cirillo LA, 1999, MOL CELL, V4, P961, DOI 10.1016/S1097-2765(00)80225-7; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Cirillo LA, 1998, EMBO J, V17, P244, DOI 10.1093/emboj/17.1.244; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; CORDINGLEY MG, 1987, CELL, V48, P261, DOI 10.1016/0092-8674(87)90429-6; Crissey MAS, 1999, HEPATOLOGY, V30, P1187, DOI 10.1002/hep.510300520; Daitoku H, 2003, DIABETES, V52, P642, DOI 10.2337/diabetes.52.3.642; Furuyama T, 2004, J BIOL CHEM, V279, P34741, DOI 10.1074/jbc.M314214200; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Hollenhorst PC, 2000, GENETICS, V154, P1533; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Kaestner KH, 2000, GENE DEV, V14, P142; Karantza V, 1996, BIOCHEMISTRY-US, V35, P2037, DOI 10.1021/bi9518858; Katoh M, 2004, INT J ONCOL, V25, P1495; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Koranda M, 2000, NATURE, V406, P94, DOI 10.1038/35017589; Lee CS, 2005, NATURE, V435, P944, DOI 10.1038/nature03649; LEE JY, 1994, HEPATOLOGY, V19, P656, DOI 10.1002/hep.1840190317; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; McPherson CE, 1996, NUCLEIC ACIDS RES, V24, P397, DOI 10.1093/nar/24.3.397; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Nasrin N, 2000, P NATL ACAD SCI USA, V97, P10412, DOI 10.1073/pnas.190326997; ORLOWSKI CC, 1991, MOL ENDOCRINOL, V5, P1180, DOI 10.1210/mend-5-8-1180; ORLOWSKI CC, 1990, MOL ENDOCRINOL, V4, P1592, DOI 10.1210/mend-4-10-1592; OwenHughes T, 1996, SCIENCE, V273, P513, DOI 10.1126/science.273.5274.513; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; RAMAKRISHNAN V, 1993, NATURE, V362, P219, DOI 10.1038/362219a0; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; SCHULLER AGP, 1993, ENDOCRINOLOGY, V132, P2544, DOI 10.1210/en.132.6.2544; Schwarz PM, 1996, BIOCHEMISTRY-US, V35, P4009, DOI 10.1021/bi9525684; SIMPSON RT, 1985, CELL, V42, P799, DOI 10.1016/0092-8674(85)90276-4; So CW, 2003, BLOOD, V101, P633, DOI 10.1182/blood-2002-06-1785; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; SVAREN J, 1994, EMBO J, V13, P4856, DOI 10.1002/j.1460-2075.1994.tb06812.x; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Tomizawa M, 2000, J BIOL CHEM, V275, P7289, DOI 10.1074/jbc.275.10.7289; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; TRUSS M, 1995, EMBO J, V14, P1737, DOI 10.1002/j.1460-2075.1995.tb07163.x; Usachenko SI, 1996, J BIOL CHEM, V271, P3831; Vander Kooi BT, 2003, J BIOL CHEM, V278, P11782, DOI 10.1074/jbc.M212570200; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Weigelt J, 2001, BIOCHEMISTRY-US, V40, P5861, DOI 10.1021/bi001663w; White CL, 2004, J MOL BIOL, V342, P1391, DOI 10.1016/j.jmb.2004.07.080; WORKMAN JL, 1992, SCIENCE, V258, P1780, DOI 10.1126/science.1465613; Yan JZ, 2006, MOL CELL BIOL, V26, P155, DOI 10.1128/MCB.26.1.155-168.2006; Yeagley D, 2001, J BIOL CHEM, V276, P33705, DOI 10.1074/jbc.M101215200; Zaret K, 1999, DEV BIOL, V209, P1, DOI 10.1006/dbio.1999.9228; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200	66	83	85	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35583	35593		10.1074/jbc.M704735200	http://dx.doi.org/10.1074/jbc.M704735200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17923482	hybrid			2022-12-25	WOS:000251458100018
J	Bhat, N; Joe, A; PereiraPerrin, M; Ward, HD				Bhat, Najma; Joe, Angela; PereiraPerrin, Mercio; Ward, Honorine D.			Cryptosporidium p30, a galactose/N-acetylgalactosamine-specific lectin, mediates infection in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOXOPLASMA-GONDII; PARVUM SPOROZOITES; MICRONEME PROTEINS; CELL INVASION; HOST; PARASITE; IDENTIFICATION; GLYCOPROTEIN; ATTACHMENT; EXPRESSION	Cryptosporidium sp. cause human and animal diarrheal disease worldwide. The molecular mechanisms underlying Cryptosporidium attachment to, and invasion of, host cells are poorly understood. Previously, we described a surface-associated Gal/GalNAc-specific lectin activity in sporozoites of Cryptosporidium parvum. Here we describe p30, a 30-kDa Gal/GalNAc-specific lectin isolated from C. parvum and Cryptosporidium hominis sporozoites by Gal-affinity chromatography. p30 is encoded by a single copy gene containing a 906-bp open reading frame, the deduced amino acid sequence of which predicts a 302-amino acid, 31.8-kDa protein with a 22-amino acid N-terminal signal sequence. The p30 gene is expressed at 24-72 h after infection of intestinal epithelial cells. Antisera to recombinant p30 expressed in Escherichia coli react with an similar to 30-kDa protein in C. parvum and C. hominis. p30 is localized to the apical region of sporozoites and is predominantly intracellular in both sporozoites and intracellular stages of the parasite. p30 associates with gp900 and gp40, Gal/GalNAc-containing mucin-like glycoproteins that are also implicated in mediating infection. Native and recombinant p30 bind to Caco-2A cells in a dose-dependent, saturable, and Gal-inhibitable manner. Recombinant p30 inhibits C. parvum attachment to and infection of Caco-2A cells, whereas antisera to the recombinant protein also inhibit infection. Taken together, these findings suggest that p30 mediates C. parvum infection in vitro and raise the possibility that this protein may serve as a target for intervention.	Tufts Univ, New England Med Ctr, Div Geog Med & Infect Dis, Boston, MA 02111 USA; Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA	Tufts Medical Center; Tufts University; Tufts University	Ward, HD (corresponding author), Tufts Univ, New England Med Ctr, Div Geog Med & Infect Dis, Box 041,750 Washington St, Boston, MA 02111 USA.	hward@tufts-nemc.org			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R42AI045194, R41AI045194, R01AI052786] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040574] Funding Source: NIH RePORTER; NIAID NIH HHS [AI52786, AI45194] Funding Source: Medline; NIDDK NIH HHS [P30 DK34928] Funding Source: Medline; NINDS NIH HHS [NS40574] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abrahamsen MS, 2004, SCIENCE, V304, P441, DOI 10.1126/science.1094786; ANDREWS P, 1965, BIOCHEM J, V96, P595, DOI 10.1042/bj0960595; Bahl A, 2003, NUCLEIC ACIDS RES, V31, P212, DOI 10.1093/nar/gkg081; Barnes DA, 1998, MOL BIOCHEM PARASIT, V96, P93, DOI 10.1016/S0166-6851(98)00119-4; BHAT N, 2000, LECTINS PATHOLOGY, P173; Brecht S, 2001, J BIOL CHEM, V276, P4119, DOI 10.1074/jbc.M008294200; Carruthers VB, 2000, INFECT IMMUN, V68, P4005, DOI 10.1128/IAI.68.7.4005-4011.2000; Cevallos AM, 2000, INFECT IMMUN, V68, P4108, DOI 10.1128/IAI.68.7.4108-4116.2000; Cevallos AM, 2000, INFECT IMMUN, V68, P5167, DOI 10.1128/IAI.68.9.5167-5175.2000; Chen XM, 2000, GASTROENTEROLOGY, V118, P368, DOI 10.1016/S0016-5085(00)70219-8; Dubremetz JF, 1998, TRENDS MICROBIOL, V6, P27, DOI 10.1016/S0966-842X(97)01165-7; FAYER R, 1990, INFECT IMMUN, V58, P2962, DOI 10.1128/IAI.58.9.2962-2965.1990; Frederick JR, 2005, GLYCOBIOLOGY, V15, p53R, DOI 10.1093/glycob/cwj007; GOLDHAR J, 1994, METHOD ENZYMOL, V236, P211; HAMER DH, 1994, INFECT IMMUN, V62, P2208, DOI 10.1128/IAI.62.6.2208-2213.1994; Hashim A, 2006, INFECT IMMUN, V74, P99, DOI 10.1128/IAI.74.1.99-107.2006; Heiges M, 2006, NUCLEIC ACIDS RES, V34, pD419, DOI 10.1093/nar/gkj078; Houzelstein D, 2004, MOL BIOL EVOL, V21, P1177, DOI 10.1093/molbev/msh082; JOE A, 1994, J EUKARYOT MICROBIOL, V41, pS44; Joe A, 1998, INFECT IMMUN, V66, P3429, DOI 10.1128/IAI.66.7.3429-3432.1998; Keller N, 2004, INFECT IMMUN, V72, P4791, DOI 10.1128/IAI.72.8.4791-4800.2004; Klein H, 2003, PARASITOL RES, V90, P84, DOI 10.1007/s00436-002-0600-0; Leav BA, 2003, CLIN INFECT DIS, V36, P903, DOI 10.1086/368194; Lourenco EV, 2001, GLYCOBIOLOGY, V11, P541, DOI 10.1093/glycob/11.7.541; LUMB R, 1988, PARASITOL RES, V74, P531, DOI 10.1007/BF00531630; Meissner M, 2002, J CELL SCI, V115, P563; O'Connor RM, 2003, INFECT IMMUN, V71, P6027, DOI 10.1128/IAI.71.10.6027-6034.2003; O'Connor RM, 2002, MOL BIOCHEM PARASIT, V119, P203, DOI 10.1016/S0166-6851(01)00416-9; O'Connor RM, 2007, MOL BIOCHEM PARASIT, V156, P80, DOI 10.1016/j.molbiopara.2007.07.010; Petri WA, 2002, ANNU REV MICROBIOL, V56, P39, DOI 10.1146/annurev.micro.56.012302.160959; Priest JW, 2001, MOL BIOCHEM PARASIT, V113, P117, DOI 10.1016/S0166-6851(00)00386-8; Puiu D, 2004, NUCLEIC ACIDS RES, V32, pD329, DOI 10.1093/nar/gkh050; Reiss M, 2001, J CELL BIOL, V152, P563, DOI 10.1083/jcb.152.3.563; Rotz LD, 2002, EMERG INFECT DIS, V8, P225, DOI 10.3201/eid0802.010164; Saouros S, 2005, J BIOL CHEM, V280, P38583, DOI 10.1074/jbc.C500365200; Sharon N, 1998, PROTEIN SCI, V7, P2042, DOI 10.1002/pro.5560070922; Silber AM, 2002, EXP PARASITOL, V100, P217, DOI 10.1016/S0014-4894(02)00013-9; Soldati D, 2001, INT J PARASITOL, V31, P1293, DOI 10.1016/S0020-7519(01)00257-0; THEA DM, 1992, J PARASITOL, V78, P886, DOI 10.2307/3283323; Tosini F, 2004, MOL BIOCHEM PARASIT, V134, P137, DOI 10.1016/j.molbiopara.2003.11.014; Tzipori S, 2002, MICROBES INFECT, V4, P1047, DOI 10.1016/S1286-4579(02)01629-5; UPTON SJ, 1994, FEMS MICROBIOL LETT, V118, P233, DOI 10.1016/0378-1097(94)90509-6; Verdon R, 1997, J INFECT DIS, V175, P1268, DOI 10.1086/593695; Wanyiri J, 2006, FUTURE MICROBIOL, V1, P201, DOI 10.2217/17460913.1.2.201; Wanyiri JW, 2007, INFECT IMMUN, V75, P184, DOI 10.1128/IAI.00944-06; Ward H, 1998, ADV PARASIT, V40, P151, DOI 10.1016/S0065-308X(08)60120-7; Xiao LH, 2004, CLIN MICROBIOL REV, V17, P72, DOI 10.1128/CMR.17.1.72-97.2004; Xu P, 2004, NATURE, V431, P1107, DOI 10.1038/nature02977; Yu Jae-Ran, 2000, Korean Journal of Parasitology, V38, P59, DOI 10.3347/kjp.2000.38.2.59; Zardi EM, 2005, CHEMOTHERAPY, V51, P193, DOI 10.1159/000086920	50	37	44	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34877	34887		10.1074/jbc.M706950200	http://dx.doi.org/10.1074/jbc.M706950200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17905738	hybrid			2022-12-25	WOS:000251155200030
J	Cadieux, N; Barekzi, N; Bradbeer, C				Cadieux, Nathalie; Barekzi, Nazir; Bradbeer, Clive			Observations on the calcium dependence and reversibility of cobalamin transport across the outer membrane Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENERGY TRANSDUCTION; BTUB AFFECT; TONB; PROTEIN; VITAMIN-B12; GENE; FEPA; MUTATIONS; SEQUENCE; BINDING	The calcium dependence of cobalamin (Cbl) binding to the BtuB protein of Escherichia coli and the reversibility of its function in the transport of Cbl across the outer membrane have been examined. The results show that the two calcium-binding sites in BtuB that were identified previously by others are responsible for the calcium dependence of high affinity Cbl binding. The affinity of the pure BtuB protein for Cbl was similar to 1000-fold higher in the presence of saturating levels of calcium than in its absence. The affinities of BtuB for both Cbl and calcium were decreased by insertion of alanine residues at position 51 of the mature protein and were increased by several mutations and deletions in the TonB box. Experiments on the uptake of Cbl into the periplasmic space showed that this process is reversible and that the exit of Cbl back into the medium does not require the protonmotive force. Our interpretation of these results is that the role of the TonB-ExbB-ExbD complex, potentiated by the protonmotive force, is to reduce the affinity of the Cbl-binding site, thus increasing the rate of Cbl release into the periplasmic space. The evidence also indicates that access of the Cbl-binding site of BtuB to the periplasmic space does not require removal of the hatch domain from the barrel.	Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Bradbeer, C (corresponding author), Univ Virginia, Dept Biochem & Mol Genet, POB 800733, Charlottesville, VA 22908 USA.	cb7f@virginia.edu			NIGMS NIH HHS [GM019078] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Boyd D, 2000, J BACTERIOL, V182, P842, DOI 10.1128/JB.182.3.842-847.2000; Bradbeer C., 1999, Chemistry and biochemistry of B12., P489; BRADBEER C, 1978, J BIOL CHEM, V253, P1347; BRADBEER C, 1990, J BACTERIOL, V172, P4919, DOI 10.1128/jb.172.9.4919-4926.1990; BRADBEER C, 1976, J BACTERIOL, V128, P99, DOI 10.1128/JB.128.1.99-104.1976; BRADBEER C, 1986, J BIOL CHEM, V261, P2520; BRADBEER C, 1993, J BACTERIOL, V175, P3146, DOI 10.1128/JB.175.10.3146-3150.1993; Cadieux N, 1999, P NATL ACAD SCI USA, V96, P10673, DOI 10.1073/pnas.96.19.10673; Cadieux N, 2000, J BACTERIOL, V182, P5954, DOI 10.1128/JB.182.21.5954-5961.2000; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Cascales E, 2001, MOL MICROBIOL, V42, P795, DOI 10.1046/j.1365-2958.2001.02673.x; Chimento DP, 2003, J MOL BIOL, V332, P999, DOI 10.1016/j.jmb.2003.07.005; DAVIS BD, 1950, J BACTERIOL, V60, P17, DOI 10.1128/JB.60.1.17-28.1950; GUDMUNDSDOTTIR A, 1989, J BACTERIOL, V171, P6526, DOI 10.1128/jb.171.12.6526-6533.1989; HELLER K, 1985, J BACTERIOL, V161, P904, DOI 10.1128/JB.161.3.904-908.1985; HELLER KJ, 1988, GENE, V64, P147, DOI 10.1016/0378-1119(88)90488-X; Higgs PI, 2002, MOL MICROBIOL, V44, P271, DOI 10.1046/j.1365-2958.2002.02880.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma L, 2007, J BIOL CHEM, V282, P397, DOI 10.1074/jbc.M605333200; PORTZEHL H, 1964, BIOCHIM BIOPHYS ACTA, V79, P581, DOI 10.1016/0926-6577(64)90224-4; Postle K, 2002, SCIENCE, V295, P1658; REYNOLDS PR, 1980, J BIOL CHEM, V255, P4313; Shultis DD, 2006, SCIENCE, V312, P1396, DOI 10.1126/science.1127694; SKARE JT, 1993, J BIOL CHEM, V268, P16302	24	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34921	34928		10.1074/jbc.M707426200	http://dx.doi.org/10.1074/jbc.M707426200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17908684	hybrid			2022-12-25	WOS:000251155200035
J	Dustin, ML; Starr, T; Coombs, D; Majeau, GR; Meier, W; Hochman, PS; Douglass, A; Vale, R; Goldstein, B; Whitty, A				Dustin, Michael L.; Starr, Toby; Coombs, Daniel; Majeau, Gerard R.; Meier, Werner; Hochman, Paula S.; Douglass, Adam; Vale, Ron; Goldstein, Byron; Whitty, Adrian			Quantification and modeling of tripartite CD2-, CD58FC chimera (Alefacept)-, and CD16-mediated cell adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTION-ASSOCIATED ANTIGEN-3; 2-DIMENSIONAL DISSOCIATION-CONSTANT; FC-GAMMA-RIII; T-LYMPHOCYTES; LOW-AFFINITY; MONOCLONAL-ANTIBODY; FUSION PROTEINS; LEUKEMIA-CELLS; MOLECULE CD2; RECEPTOR	Alefacept is a chimeric protein combining CD58 immuno-globulin-like domain 1 with human IgG1 Fc. Alefacept mediates adhesion by bridging CD2 on T cells to activating Fc receptors on effector cells, but the equilibrium binding parameters have not been determined. Alefacept mediated T cell killing by NK cells and adhesion between CD2- and CD16-expressing cells at an optimum concentration of 100 nM. We introduce novel measurements with supported planer bilayers, from which key two-dimensional and three-dimensional parameters can be determined by data fitting. Alefacept competitively inhibited cell bilayer adhesion mediated by the CD2-CD58 interaction. Alefacept mediated maximal adhesion of CD2(+) T cells to CD16B, an Fc receptor, in planar bilayers at 500 nM. A mechanistic model for alefacept-mediated cell-bilayer adhesion allowed fitting of the data and determination of two-dimensional binding parameters. These included the density of bonds in the adhesion area, which grew to maintain a consistent average bond density of 200 molecules/mu m(2) and two-dimensional association constants of 3.1 and 630 mu m(2) for bivalently and monovalently bound forms of alefacept, respectively. The maximum number of CD16 bound and the fit value of 4,350 CD2 per cell are much lower than the 40,000 CD2 per cell measured with anti-CD2 Fab. These results suggest that additional information is needed to correctly predict Alefacept-mediated bridge formation.	NYU, Sch Med, Ctr Med Biol, Skirball Inst Biomol Med,Dept Pathol, New York, NY 10016 USA; Univ British Columbia, Dept Math, Vancouver, BC V6T 1Z2, Canada; Biogen Inc, Cambridge, MA 02142 USA; Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA	New York University; University of British Columbia; Biogen; University of California System; University of California San Francisco; United States Department of Energy (DOE); Los Alamos National Laboratory	Dustin, ML (corresponding author), NYU, Sch Med, Ctr Med Biol, Skirball Inst Biomol Med,Dept Pathol, New York, NY 10016 USA.	dustin@saturn.med.nyu.edu	Dustin, Michael/AAM-4611-2020	Dustin, Michael/0000-0003-4983-6389; Coombs, Daniel/0000-0002-8038-6278	NIAID NIH HHS [R37-1 AI043542] Funding Source: Medline; NIGMS NIH HHS [R37 GM035556] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI043542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM035556] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baselga J, 2001, SEMIN ONCOL, V28, P4, DOI 10.1053/sonc.2001.28544; BELL GI, 1984, BIOPHYS J, V45, P1051, DOI 10.1016/S0006-3495(84)84252-6; Bromley SK, 2001, NAT IMMUNOL, V2, P1159, DOI 10.1038/ni737; BYRN RA, 1990, NATURE, V344, P667, DOI 10.1038/344667a0; Cartron G, 2002, BLOOD, V99, P754, DOI 10.1182/blood.V99.3.754; CROTHERS DM, 1972, IMMUNOCHEMISTRY, V9, P341, DOI 10.1016/0019-2791(72)90097-3; da Silva AJ, 2002, J IMMUNOL, V168, P4462, DOI 10.4049/jimmunol.168.9.4462; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Dustin ML, 1997, J BIOL CHEM, V272, P15782, DOI 10.1074/jbc.272.25.15782; Dustin ML, 1997, J BIOL CHEM, V272, P30889, DOI 10.1074/jbc.272.49.30889; DUSTIN ML, 1987, J EXP MED, V165, P677, DOI 10.1084/jem.165.3.677; Dustin ML, 1996, J CELL BIOL, V132, P465, DOI 10.1083/jcb.132.3.465; DUSTIN ML, 1989, J EXP MED, V169, P503, DOI 10.1084/jem.169.2.503; Ellis CN, 2001, NEW ENGL J MED, V345, P248, DOI 10.1056/NEJM200107263450403; Galon J, 1997, EUR J IMMUNOL, V27, P1928, DOI 10.1002/eji.1830270816; Gong Q, 2005, J IMMUNOL, V174, P817, DOI 10.4049/jimmunol.174.2.817; Green JM, 1997, J CELL BIOL, V139, P1209, DOI 10.1083/jcb.139.5.1209; HIBBS ML, 1989, SCIENCE, V246, P1608, DOI 10.1126/science.2531918; KATO K, 1992, J EXP MED, V176, P1241, DOI 10.1084/jem.176.5.1241; Klopfenstein DR, 2002, CELL, V109, P347, DOI 10.1016/S0092-8674(02)00708-0; LIU SJ, 1995, BIOPHYS J, V68, P459, DOI 10.1016/S0006-3495(95)80207-9; Louis E, 2004, ALIMENT PHARM THER, V19, P511, DOI 10.1111/j.1365-2036.2004.01871.x; Majeau GR, 1999, CELL ADHES COMMUN, V7, P267, DOI 10.3109/15419069909010808; MAJEAU GR, 1994, J IMMUNOL, V152, P2753; MEUER SC, 1984, CELL, V36, P897, DOI 10.1016/0092-8674(84)90039-4; MILLER GT, 1993, J EXP MED, V178, P211, DOI 10.1084/jem.178.1.211; POSNER RG, 1992, BIOCHEMISTRY-US, V31, P5350, DOI 10.1021/bi00138a015; SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111; SANDERS ME, 1988, J IMMUNOL, V140, P1401; SCHLESSINGER J, 1977, P NATL ACAD SCI USA, V74, P1110, DOI 10.1073/pnas.74.3.1110; Shao JY, 2005, ANN BIOMED ENG, V33, P483, DOI 10.1007/s10439-005-2504-5; Uchida JJ, 2004, J EXP MED, V199, P1659, DOI 10.1084/jem.20040119; VANDERMERWE PA, 1994, BIOCHEMISTRY-US, V33, P10149, DOI 10.1021/bi00199a043; WEIS RM, 1982, J BIOL CHEM, V257, P6440; WELLS AF, 1966, APPL MICROBIOL, V14, P271, DOI 10.1128/AEM.14.2.271-275.1966; Williams TE, 2001, J BIOL CHEM, V276, P13283, DOI 10.1074/jbc.M010427200; Winckler B, 1999, NATURE, V397, P698, DOI 10.1038/17789; ZETTLMEISSL G, 1990, DNA CELL BIOL, V9, P347, DOI 10.1089/dna.1990.9.347; Zhang Z, 2003, CANCER RES, V63, P6453; Zhu DM, 2007, BIOPHYS J, V92, P1022, DOI 10.1529/biophysj.106.089649	40	21	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34748	34757		10.1074/jbc.M705616200	http://dx.doi.org/10.1074/jbc.M705616200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17911103	hybrid			2022-12-25	WOS:000251155200017
J	Pilecka, I; Patrignani, C; Pescini, R; Curchod, ML; Perrin, D; Xue, Y; Yasenchak, J; Clark, A; Magnone, MC; Zaratin, P; Valenzuela, D; Rommel, C; van Huijsduijnen, RH				Pilecka, Iwona; Patrignani, Claudia; Pescini, Rosanna; Curchod, Marie-Laure; Perrin, Dominique; Xue, Yingzi; Yasenchak, Jason; Clark, Ann; Magnone, Maria Chiara; Zaratin, Paola; Valenzuela, David; Rommel, Christian; van Huijsduijnen, Rob Hooft			Protein-tyrosine phosphatase H1 controls growth hormone receptor signaling and systemic growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; SUBSTRATE-TRAPPING MUTANTS; MOTH-EATEN MICE; INSULIN-RECEPTOR; FACTOR-I; NEGATIVE REGULATOR; STAT5 ACTIVATION; ADIPOSE-TISSUE; FOCAL ADHESION; BETA-RECEPTOR	Several protein-tyrosine phosphatases (PTPs) have been implicated in the control of growth hormone receptor (GHR) signaling, but none have been shown to affect growth in vivo. We have applied a battery of molecular and cellular approaches to test a family-wide panel of PTPs for interference with GHR signaling. Among the subset of PTPs that showed activity in multiple readouts, we selected PTP-H1/PTPN3 for further in vivo studies and found that mice lacking the PTP-H1 catalytic domain show significantly enhanced growth over their wild type littermates. In addition, PTP-H1 mutant animals had enhanced plasma and liver mRNA expression of insulin-like growth factor 1, as well as increased bone density and mineral content. These observations point to a controlling role for PTP-H1 in modulating GHR signaling and systemic growth through insulin-like growth factor 1 secretion.	Merck Serono Int, CH-1211 Geneva, Switzerland; Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; EMD Serono Res Inst, Rockland, MA 02370 USA	Merck KGaA; EMD Serono Inc.; Regeneron	van Huijsduijnen, RH (corresponding author), Merck Serono Int, CH-1211 Geneva, Switzerland.	rob.hooft@merckserono.net	Pilecka, Iwona/AAT-9114-2021; van Huijsduijnen, Rob A.M. Hooft/B-3653-2009	Pilecka, Iwona/0000-0002-5057-346X; van Huijsduijnen, Rob A.M. Hooft/0000-0002-2261-9424				Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; AHMAD F, 1995, J CLIN INVEST, V95, P2806, DOI 10.1172/JCI117985; Aoki N, 2002, MOL ENDOCRINOL, V16, P58, DOI 10.1210/me.16.1.58; Aoki N, 2000, J BIOL CHEM, V275, P39718, DOI 10.1074/jbc.M005615200; Arrandale JM, 1996, J BIOL CHEM, V271, P21353, DOI 10.1074/jbc.271.35.21353; AYLING CM, 1989, J ENDOCRINOL, V123, P429, DOI 10.1677/joe.0.1230429; Bauler TJ, 2007, J IMMUNOL, V178, P3680, DOI 10.4049/jimmunol.178.6.3680; Baum HBA, 1996, ANN INTERN MED, V125, P883, DOI 10.7326/0003-4819-125-11-199612010-00003; Ben-Yair L, 2002, PROTEIN EXPRES PURIF, V25, P456, DOI 10.1016/S1046-5928(02)00044-X; Berneis K, 1996, BAILLIERE CLIN ENDOC, V10, P337, DOI 10.1016/S0950-351X(96)80470-8; Blair ER, 2006, BIOORGAN MED CHEM, V14, P464, DOI 10.1016/j.bmc.2005.08.025; Bluher S, 2005, BEST PRACT RES CL EN, V19, P577, DOI 10.1016/j.beem.2005.07.011; Chase K, 2005, GENOME RES, V15, P1820, DOI 10.1101/gr.3712705; Cheng A, 2002, DEV CELL, V2, P497, DOI 10.1016/S1534-5807(02)00149-1; Chiarugi P, 2002, J BIOL CHEM, V277, P37331, DOI 10.1074/jbc.M205203200; Chiarugi P, 1997, BIOCHEM BIOPH RES CO, V238, P676, DOI 10.1006/bbrc.1997.7355; Cook WS, 2002, DEV CELL, V2, P385, DOI 10.1016/S1534-5807(02)00158-2; Elchebly M, 2000, J MOL MED-JMM, V78, P473, DOI 10.1007/s001090000141; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Engstrom BE, 2002, SCAND J CLIN LAB INV, V62, P25, DOI 10.1080/003655102753517172; Engstrom BE, 2000, J INTERN MED, V247, P570, DOI 10.1046/j.1365-2796.2000.00672.x; Espanel X, 2002, PROTEIN SCI, V11, P2326, DOI 10.1110/ps.0213402; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Flores-Morales A, 2006, MOL ENDOCRINOL, V20, P241, DOI 10.1210/me.2005-0170; Gjorloff-Wingren A, 2000, EUR J IMMUNOL, V30, P2412, DOI 10.1002/1521-4141(2000)30:8<2412::AID-IMMU2412>3.0.CO;2-J; GORDON JA, 1991, METHOD ENZYMOL, V201, P477; Govers R, 1999, EMBO J, V18, P28, DOI 10.1093/emboj/18.1.28; Gu F, 2003, MOL CELL BIOL, V23, P3753, DOI 10.1128/MCB.23.11.3753-3762.2003; Hackett RH, 1997, J BIOL CHEM, V272, P11128; Han SL, 2000, EUR J IMMUNOL, V30, P1318, DOI 10.1002/(SICI)1521-4141(200005)30:5<1318::AID-IMMU1318>3.0.CO;2-G; Hansen LH, 1996, J BIOL CHEM, V271, P12669, DOI 10.1074/jbc.271.21.12669; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Heinonen KM, 2004, BLOOD, V103, P3457, DOI 10.1182/blood-2003-09-3153; Herrington J, 2000, ONCOGENE, V19, P2585, DOI 10.1038/sj.onc.1203526; Jespersen T, 2006, BIOCHEM BIOPH RES CO, V348, P1455, DOI 10.1016/j.bbrc.2006.08.014; Jing M, 2007, J VIROL, V81, P2231, DOI 10.1128/JVI.01979-06; Johansson A. G., 1999, Journal of Endocrinological Investigation, V22, P58; Kappert K, 2007, FASEB J, V21, P523, DOI 10.1096/fj.06-6219com; Karlsson S, 2006, MOL BIOL CELL, V17, P4846, DOI 10.1091/mbc.E06-04-0306; Kasuga M, 1996, DIABETIC MED, V13, pS87; Kaszubska W, 2002, MOL CELL ENDOCRINOL, V195, P109, DOI 10.1016/S0303-7207(02)00178-8; Katsumata M, 2000, J NUTR, V130, P2482, DOI 10.1093/jn/130.10.2482; KHARITONENKOV A, 1995, J BIOL CHEM, V270, P29189, DOI 10.1074/jbc.270.49.29189; Kim SO, 1998, J BIOL CHEM, V273, P2344, DOI 10.1074/jbc.273.4.2344; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; KOZLOWSKI M, 1993, J EXP MED, V178, P2157, DOI 10.1084/jem.178.6.2157; KULAS DT, 1995, J BIOL CHEM, V270, P2435, DOI 10.1074/jbc.270.6.2435; Lammers R, 1997, FEBS LETT, V404, P37, DOI 10.1016/S0014-5793(97)00080-X; Lavoie C, 2000, P NATL ACAD SCI USA, V97, P13637, DOI 10.1073/pnas.240278097; Li PM, 1996, CELL SIGNAL, V8, P467, DOI 10.1016/S0898-6568(96)00101-5; LOBIE PE, 1995, J BIOL CHEM, V270, P21745, DOI 10.1074/jbc.270.37.21745; MOLLER NPH, 1995, J BIOL CHEM, V270, P23126, DOI 10.1074/jbc.270.39.23126; Mooney RA, 1997, BIOCHEM BIOPH RES CO, V235, P709, DOI 10.1006/bbrc.1997.6889; Morinville A, 1998, TRENDS PHARMACOL SCI, V19, P452, DOI 10.1016/S0165-6147(98)01257-7; Nakashima N, 2000, J BIOL CHEM, V275, P12889, DOI 10.1074/jbc.275.17.12889; OGUNKOLADE B, 2005, END ABSTR, V9, P85; Ouwens DM, 1996, BIOCHEM J, V318, P609, DOI 10.1042/bj3180609; PALMITER RD, 1982, NATURE, V300, P611, DOI 10.1038/300611a0; Pasquali C, 2003, MOL ENDOCRINOL, V17, P2228, DOI 10.1210/me.2003-0011; Persson C, 2004, MOL CELL BIOL, V24, P2190, DOI 10.1128/MCB.24.5.2190-2201.2004; Pilecka I, 2007, TRENDS ENDOCRIN MET, V18, P12, DOI 10.1016/j.tem.2006.11.004; Rocchi S, 1996, ENDOCRINOLOGY, V137, P4944, DOI 10.1210/en.137.11.4944; Saxton TM, 2000, NAT GENET, V24, P420, DOI 10.1038/74279; Sotiropoulos A, 1996, MOL ENDOCRINOL, V10, P998, DOI 10.1210/me.10.8.998; Sozio MS, 2004, J BIOL CHEM, V279, P7760, DOI 10.1074/jbc.M309994200; Stofega MR, 2000, MOL ENDOCRINOL, V14, P1338, DOI 10.1210/me.14.9.1338; Strous GJ, 1997, J BIOL CHEM, V272, P40; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; ten Hoeve J, 2002, MOL CELL BIOL, V22, P5662, DOI 10.1128/MCB.22.16.5662-5668.2002; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; TSUI HW, 1993, NAT GENET, V4, P124, DOI 10.1038/ng0693-124; Umeda S, 1999, AM J PATHOL, V155, P223, DOI 10.1016/S0002-9440(10)65116-4; VACARESSE N, 2006, APMIS, V114, P163; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; van Huijsduijnen RH, 2002, DRUG DISCOV TODAY, V7, P1013, DOI 10.1016/S1359-6446(02)02438-8; VANDERKUUR JA, 1995, J BIOL CHEM, V270, P21738, DOI 10.1074/jbc.270.37.21738; Walchli S, 2000, J BIOL CHEM, V275, P9792, DOI 10.1074/jbc.275.13.9792; Walenkamp MJE, 2006, HORM RES, V66, P221, DOI 10.1159/000095161; Wang XZ, 1996, MOL ENDOCRINOL, V10, P1249, DOI 10.1210/me.10.10.1249; WANG YD, 1995, J BIOL CHEM, V270, P7021, DOI 10.1074/jbc.270.13.7021; Warabi M, 2000, EXP MOL PATHOL, V68, P187, DOI 10.1006/exmp.2000.2303; YouTen KE, 1997, J EXP MED, V186, P683, DOI 10.1084/jem.186.5.683; Yu DH, 1998, J BIOL CHEM, V273, P21125, DOI 10.1074/jbc.273.33.21125; Zabolotny JM, 2002, DEV CELL, V2, P489, DOI 10.1016/S1534-5807(02)00148-X; Zheng YF, 2002, J BIOL CHEM, V277, P42463, DOI 10.1074/jbc.M207459200	85	34	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35405	35415		10.1074/jbc.M705814200	http://dx.doi.org/10.1074/jbc.M705814200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17921143	hybrid			2022-12-25	WOS:000251155200083
J	Jain, P; Mostoller, K; Flaig, KE; Ahuja, J; Lepoutre, V; Alefantis, T; Khan, ZK; Wigdahl, B				Jain, Pooja; Mostoller, Kate; Flaig, Katherine E.; Ahuja, Jaya; Lepoutre, Veronique; Alefantis, Timothy; Khan, Zafar K.; Wigdahl, Brian			Identification of human T cell leukemia virus type 1 tax amino acid signals and cellular factors involved in secretion of the viral oncoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HTLV-I TAX; NF-KAPPA-B; TRANSACTIVATOR PROTEIN TAX; CARRIER MEMBRANE-PROTEINS; CYTOTOXIC LYMPHOCYTES-T; APICAL PLASMA-MEMBRANE; NUCLEAR-PORE COMPLEX; CANINE KIDNEY-CELLS; ENDOPLASMIC-RETICULUM; CEREBROSPINAL-FLUID	Human T cell leukemia virus type 1 (HTLV-1) is the etiologic agent of a number of pathologic abnormalities, including adult T cell leukemia (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). The viral oncoprotein Tax has been implicated in the pathogenesis of these diseases. Recently, cell-free Tax was detected in the cerebrospinal fluid of HAM/TSP patients, implying that extracellular Tax may be relevant to neurologic disease. Additionally, the presence of a nuclear export signal within Tax and its active secretion has been demonstrated in vitro. However, the mechanism of Tax secretion remains to be established. Studies reported herein elucidate the process of Tax secretion and identify domains of Tax critical to its subcellular localization and secretion. Tax was shown to interact with a number of cellular secretory pathway proteins in both the model cell line BHK (baby hamster kidney)-21 and an HTLV-1-infected T cell line, C8166, physiologically relevant to HTLV-1-induced disease. Silencing of selected components of the secretory pathway affected Tax secretion, further confirming regulated secretion of Tax. Additionally, mutations in two putative secretory signals within Tax DHE and YTNI resulted in aberrant subcellular localization of Tax and significantly altered protein secretion. Together, these studies demonstrate that Tax secretion is a regulated event facilitated by its interactions with proteins of the cellular secretory pathway and the presence of secretory signals within the carboxyl-terminal domain of the protein.	Drexel Univ, Coll Med, Dept Microbiol & Immunol, Ctr Mol Virol & Neuroimmunol,Ctr Canc Biol, Philadelphia, PA 19129 USA; Drexel Univ, Coll Med, Inst Mol Med & Infect Dis, Philadelphia, PA 19129 USA; Penn State Univ, Coll Med, Dept Pediat, Hershey, PA 17033 USA; Vital Probes Inc, Mayfield, PA 18433 USA	Drexel University; Drexel University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Wigdahl, B (corresponding author), Drexel Univ, Coll Med, Dept Microbiol & Immunol, Ctr Mol Virol & Neuroimmunol,Ctr Canc Biol, 2900 Queen Ln, Philadelphia, PA 19129 USA.	bwigdahl@drexelmed.edu			NCI NIH HHS [2R01 CA 054559-13A1] Funding Source: Medline; NINDS NIH HHS [NS 044801] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA054559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS044801] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahuja J, 2006, J NEUROVIROL, V12, P47, DOI 10.1080/13550280600614981; Alefantis T, 2005, J BIOMED SCI, V12, P961, DOI 10.1007/s11373-005-9026-x; Alefantis T, 2003, J BIOL CHEM, V278, P21814, DOI 10.1074/jbc.M211576200; Alefantis T, 2005, J BIOL CHEM, V280, P17353, DOI 10.1074/jbc.M409851200; Alefantis T, 2007, BIOMED PHARMACOTHER, V61, P194, DOI 10.1016/j.biopha.2007.02.005; Azimi N, 1998, P NATL ACAD SCI USA, V95, P2452, DOI 10.1073/pnas.95.5.2452; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Barlowe C, 1998, BBA-MOL CELL RES, V1404, P67, DOI 10.1016/S0167-4889(98)00047-0; Barmak K, 2003, VIROLOGY, V308, P1, DOI 10.1016/S0042-6822(02)00091-0; BRADY JN, 1992, AIDS RES HUM RETROV, V8, P724; Burton M, 2000, J VIROL, V74, P2351, DOI 10.1128/JVI.74.5.2351-2364.2000; Cartier L, 2005, ARCH VIROL, V150, P743, DOI 10.1007/s00705-004-0443-3; Chen D, 2000, BLOOD, V95, P921, DOI 10.1182/blood.V95.3.921.003k17_921_929; Chu ZL, 1999, J BIOL CHEM, V274, P15297, DOI 10.1074/jbc.274.22.15297; Cowan EP, 1997, J VIROL, V71, P6982, DOI 10.1128/JVI.71.9.6982-6989.1997; CRENON I, 1993, ONCOGENE, V8, P867; Darsow T, 1998, J CELL BIOL, V142, P913, DOI 10.1083/jcb.142.4.913; DHIBJALBUT S, 1994, ANN NEUROL, V36, P787, DOI 10.1002/ana.410360516; Foster LJ, 1999, AM J PHYSIOL-CELL PH, V276, pC1108, DOI 10.1152/ajpcell.1999.276.5.C1108; Galli T, 1998, MOL BIOL CELL, V9, P1437, DOI 10.1091/mbc.9.6.1437; Gaynor EC, 1998, BBA-MOL CELL RES, V1404, P33, DOI 10.1016/S0167-4889(98)00045-7; Good LF, 1996, EMBO J, V15, P3744, DOI 10.1002/j.1460-2075.1996.tb00744.x; Grant C, 2002, J CELL PHYSIOL, V190, P133, DOI 10.1002/JCP.10053; Greten TF, 1998, P NATL ACAD SCI USA, V95, P7568, DOI 10.1073/pnas.95.13.7568; GROSSMAN WJ, 1995, P NATL ACAD SCI USA, V92, P1057, DOI 10.1073/pnas.92.4.1057; Guo ZH, 2002, J BIOL CHEM, V277, P35357, DOI 10.1074/jbc.M202259200; Guo ZH, 1998, CELL, V94, P537, DOI 10.1016/S0092-8674(00)81594-9; Harhaj EW, 1999, ONCOGENE, V18, P1341, DOI 10.1038/sj.onc.1202405; Holaska JM, 1998, P NATL ACAD SCI USA, V95, P14739, DOI 10.1073/pnas.95.25.14739; Holaska JM, 2001, J CELL BIOL, V152, P127, DOI 10.1083/jcb.152.1.127; JACOBSON S, 1990, NATURE, V348, P245, DOI 10.1038/348245a0; JACOBSON S, 1992, ANN NEUROL, V32, P651, DOI 10.1002/ana.410320508; JACOBSON S, 1988, ANN NEUROL S, V23, P196; Jain P, 2007, J LEUKOCYTE BIOL, V82, P44, DOI 10.1189/jlb.1006641; Jin DY, 1999, J BIOL CHEM, V274, P17402, DOI 10.1074/jbc.274.25.17402; Kubota R, 2002, J NEUROVIROL, V8, P53, DOI 10.1080/135502802317247811; Kubota R, 2000, AIDS RES HUM RETROV, V16, P1705, DOI 10.1089/08892220050193182; Lafont F, 1999, P NATL ACAD SCI USA, V96, P3734, DOI 10.1073/pnas.96.7.3734; Leung SM, 1998, J BIOL CHEM, V273, P17732, DOI 10.1074/jbc.273.28.17732; LINDHOLM P F, 1990, New Biologist, V2, P1034; Low SH, 1998, J CELL BIOL, V141, P1503, DOI 10.1083/jcb.141.7.1503; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Marks MS, 1996, J CELL BIOL, V135, P341, DOI 10.1083/jcb.135.2.341; MARRIOTT SJ, 1991, NEW BIOL, V3, P678; Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; Mostoller K, 2004, J NEUROVIROL, V10, P358, DOI 10.1080/13550280490521104; Ng PWP, 2001, ONCOGENE, V20, P4484, DOI 10.1038/sj.onc.1204513; Nishimura N, 1999, J BIOL CHEM, V274, P15937, DOI 10.1074/jbc.274.22.15937; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227; SALAHUDDIN SZ, 1983, VIROLOGY, V129, P51, DOI 10.1016/0042-6822(83)90395-1; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; SEMMES OJ, 1992, J VIROL, V66, P7183, DOI 10.1128/JVI.66.12.7183-7192.1992; Semmes OJ, 1996, J VIROL, V70, P6347, DOI 10.1128/JVI.70.9.6347-6357.1996; Sevier CS, 2000, MOL BIOL CELL, V11, P13, DOI 10.1091/mbc.11.1.13; Singleton DR, 1997, J CELL SCI, V110, P2099; SMITH MR, 1990, GENE DEV, V4, P1875, DOI 10.1101/gad.4.11.1875; SMITH MR, 1992, VIROLOGY, V187, P316, DOI 10.1016/0042-6822(92)90320-O; TANAKA A, 1990, P NATL ACAD SCI USA, V87, P1071, DOI 10.1073/pnas.87.3.1071; Votsmeier C, 2001, EMBO J, V20, P6742, DOI 10.1093/emboj/20.23.6742; WILKEN N, 1995, EUR J CELL BIOL, V68, P211; WU J, 1995, J BIOL CHEM, V270, P14209, DOI 10.1074/jbc.270.23.14209; Wu TT, 1997, J CELL SCI, V110, P1533; Xiao GT, 2000, J BIOL CHEM, V275, P34060, DOI 10.1074/jbc.M002970200; YOKOYAMA N, 1995, NATURE, V376, P184, DOI 10.1038/376184a0; ZHAO LJ, 1991, P NATL ACAD SCI USA, V88, P11445, DOI 10.1073/pnas.88.24.11445	67	20	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34581	34593		10.1074/jbc.M707317200	http://dx.doi.org/10.1074/jbc.M707317200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17897946	hybrid			2022-12-25	WOS:000251145700072
J	Segers, K; Dahlback, B; Bock, PE; Tans, G; Rosing, J; Nicolaes, GAF				Segers, Kenneth; Dahlbaeck, Bjoern; Bock, Paul E.; Tans, Guido; Rosing, Jan; Nicolaes, Gerry A. F.			The role of thrombin exosites I and II in the activation of human coagulation factor V	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RUSSELLS VIPER VENOM; BOVINE FACTOR-V; DNA APTAMER; FACTOR-XA; CATALYZED ACTIVATION; STUART FACTOR; CLEAVAGE REQUIREMENTS; BINDING EXOSITE; SNAKE-VENOM; LIGHT-CHAIN	Human blood coagulation Factor V(FV) is a plasma protein with little procoagulant activity. Limited proteolysis at Arg(709), Arg(1018), and Arg(1545) by thrombin or Factor Xa (FXa) results in the generation of activated FV, which serves as a cofactor of FXa in prothrombin activation. Both thrombin exosites I and II have been reported to be involved in FV activation, but the relative importance of these regions in the individual cleavages remains unclear. To investigate the role of each exosite in FV activation, we have used recombinant FV molecules with only one of the three activation cleavage sites available, in combination with exosite I- or II-specific aptamers. In addition, structural requirements for exosite interactions located in the B-domain of FV were probed using FV B-domain deletion mutants and comparison with FV activating enzymes from the venom of Russell's viper(RVV-V) and of Levant's viper (LVV-V) known to activate FV by specific cleavage at Arg(1545). Our results indicate that thrombin exosite II is not involved in cleavage at Arg(709) and that both thrombin exosites are important for recognition and cleavage at Arg(1545). Efficient thrombin- catalyzed FV activation requires both the N- and C-terminal regions of the B-domain, whereas only the latter is required by RVV-V and LVV-V. This indicates that proteolysis of FV by thrombin at Arg(709), Arg(1018), and Arg(1545) show different cleavage requirements with respect to interactions mediated by thrombin exosites and areas that surround the respective cleavage sites. In addition, interactions between exosite I of thrombin and FV are primarily responsible for the different cleavage site specificity as compared with activation by RVV-V or LVV-V.	Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Biochem, NL-6200 MD Maastricht, Netherlands; Lund Univ, Univ Hosp, Dept Lab Med, Wallenberg Lab, SE-20502 Malmo, Sweden; Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37232 USA	Maastricht University; Lund University; Skane University Hospital; Vanderbilt University	Nicolaes, GAF (corresponding author), Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Biochem, NL-6200 MD Maastricht, Netherlands.	G.Nicolaes@bioch.unimaas.nl	Nicolaes, Gerry A.F./A-8421-2016	Nicolaes, Gerry A.F./0000-0002-2482-0412; Dahlback, Bjorn/0000-0003-1546-0328	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL038779, R01HL038779] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL038779-21, HL 038779, R01 HL038779] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arocas V, 1998, THROMB HAEMOSTASIS, V79, P1157, DOI 10.1055/s-0037-1615033; Bode W, 2006, SEMIN THROMB HEMOST, V32, P16, DOI 10.1055/s-2006-939551; Bukys MA, 2006, J BIOL CHEM, V281, P18569, DOI 10.1074/jbc.M600752200; Carter WJ, 2005, J BIOL CHEM, V280, P2745, DOI 10.1074/jbc.M411606200; DAHLBACK B, 1980, J CLIN INVEST, V66, P583, DOI 10.1172/JCI109890; Dharmawardana KR, 1999, J BIOL CHEM, V274, P18635, DOI 10.1074/jbc.274.26.18635; Dharmawardana KR, 1998, BIOCHEMISTRY-US, V37, P13143, DOI 10.1021/bi9812165; DISCIPIO RG, 1977, BIOCHEMISTRY-US, V16, P698, DOI 10.1021/bi00623a022; ESMON CT, 1979, J BIOL CHEM, V254, P964; Esmon CT, 1996, J BIOL CHEM, V271, P13882, DOI 10.1074/jbc.271.23.13882; Fernandez JA, 1999, THROMB HAEMOSTASIS, V82, P1462; FUJIKAWA K, 1972, BIOCHEMISTRY-US, V11, P4892, DOI 10.1021/bi00776a003; FUJIKAWA K, 1972, BIOCHEMISTRY-US, V11, P4882, DOI 10.1021/bi00776a002; HIBBARD LS, 1980, J BIOL CHEM, V255, P638; HORTIN GL, 1990, BLOOD, V76, P946; Huntington JA, 2005, J THROMB HAEMOST, V3, P1861, DOI 10.1111/j.1538-7836.2005.01363.x; JENNY RJ, 1987, P NATL ACAD SCI USA, V84, P4846, DOI 10.1073/pnas.84.14.4846; KANE WH, 1990, BIOCHEMISTRY-US, V29, P6762, DOI 10.1021/bi00481a003; KAUFMAN RJ, 1990, METHOD ENZYMOL, V185, P487, DOI 10.1016/0076-6879(90)85041-L; KELLER FG, 1995, BIOCHEMISTRY-US, V34, P4118, DOI 10.1021/bi00012a030; KISIEL W, 1979, J BIOL CHEM, V254, P2230; MACAYA RF, 1993, P NATL ACAD SCI USA, V90, P3745, DOI 10.1073/pnas.90.8.3745; MARQUETTE KA, 1995, BLOOD, V86, P3026; MONKOVIC DD, 1990, BIOCHEMISTRY-US, V29, P1118, DOI 10.1021/bi00457a004; Myles T, 2001, J BIOL CHEM, V276, P25143, DOI 10.1074/jbc.M011324200; NESHEIM ME, 1979, J BIOL CHEM, V254, P952; NICOLAES GAF, 1995, J BIOL CHEM, V270, P21158, DOI 10.1074/jbc.270.36.21158; PADMANABHAN K, 1993, J BIOL CHEM, V268, P17651; PITTMAN DD, 1994, BIOCHEMISTRY-US, V33, P6952, DOI 10.1021/bi00188a026; ROSING J, 1980, J BIOL CHEM, V255, P274; SCHULTZE P, 1994, J MOL BIOL, V235, P1532, DOI 10.1006/jmbi.1994.1105; Segers K, 2006, PROTEINS, V64, P968, DOI 10.1002/prot.21051; SHEEHAN JP, 1994, P NATL ACAD SCI USA, V91, P5518, DOI 10.1073/pnas.91.12.5518; Siigur E, 1999, BIOCHEM BIOPH RES CO, V262, P328, DOI 10.1006/bbrc.1999.1200; Steen M, 2002, J BIOL CHEM, V277, P38424, DOI 10.1074/jbc.M204972200; SUZUKI K, 1982, J BIOL CHEM, V257, P6556; TANS G, 1994, J BIOL CHEM, V269, P15969; TANS G, 1991, J BIOL CHEM, V266, P21864; Tasset DM, 1997, J MOL BIOL, V272, P688, DOI 10.1006/jmbi.1997.1275; Thorelli E, 1997, EUR J BIOCHEM, V247, P12, DOI 10.1111/j.1432-1033.1997.00012.x; Thorelli E, 1998, THROMB HAEMOSTASIS, V80, P92, DOI 10.1055/s-0037-1615145; Toso R, 2004, J BIOL CHEM, V279, P21643, DOI 10.1074/jbc.M402107200; TRACY PB, 1982, BLOOD, V60, P59; TSIANG M, 1995, J BIOL CHEM, V270, P16854, DOI 10.1074/jbc.270.28.16854; van der Neut Kolfschoten M, 2003, THROMB HAEMOSTASIS, V89, P429; WANG KY, 1993, BIOCHEMISTRY-US, V32, P11285, DOI 10.1021/bi00093a004; Zhu H, 2007, J BIOL CHEM, V282, P15033, DOI 10.1074/jbc.M701315200	47	29	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					33915	33924		10.1074/jbc.M701123200	http://dx.doi.org/10.1074/jbc.M701123200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17878169	Green Accepted, hybrid			2022-12-25	WOS:000251145700004
J	Waditee, R; Bhuiyan, NH; Hirata, E; Hibino, T; Tanaka, Y; Shikata, M; Takabe, T				Waditee, Rungaroon; Bhuiyan, Nazmul H.; Hirata, Emi; Hibino, Takashi; Tanaka, Yoshito; Shikata, Masamitsu; Takabe, Teruhiro			Metabolic engineering for betaine accumulation in microbes and plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYANOBACTERIUM APHANOTHECE-HALOPHYTICA; GLYCINE BETAINE; ESCHERICHIA-COLI; 3-PHOSPHOGLYCERATE DEHYDROGENASE; FUNCTIONAL-CHARACTERIZATION; ALDEHYDE DEHYDROGENASE; CHOLINE MONOOXYGENASE; ABIOTIC-STRESS; ARABIDOPSIS; BIOSYNTHESIS	Plants accumulate a variety of osmoprotectants that improve their ability to combat abiotic stresses. Among them, betaine appears to play an important role in conferring resistance to stresses. Betaine is synthesized via either choline oxidation or glycine methylation. An increased betaine level in transgenic plants is one of the potential strategies to generate stress-tolerant crop plants. Here, we showed that an exogenous supply of serine or glycine to a halotolerant cyanobacterium Aphanothece halophytica, which synthesizes betaine from glycine by a three-step methylation, elevated intracellular accumulation of betaine under salt stress. The gene encoding 3-phosphoglycerate dehydrogenase (PGDH), which catalyzes the first step of the phosphorylated pathway of serine biosynthesis, was isolated from A. halophytica. Expression of the Aphanothece PGDH gene in Escherichia coli caused an increase in levels of betaine as well as glycine and serine. Expression of the Aphanothece PGDH gene in Arabidopsis plants, in which the betaine synthetic pathway was introduced via glycine methylation, further increased betaine levels and improved the stress tolerance. These results demonstrate that PGDH enhances the levels of betaine by providing the precursor serine for both choline oxidation and glycine methylation pathways.	Meijo Univ, Res Inst, Tenpaku Ku, Nagoya, Aichi 4688502, Japan; Meijo Univ, Grad Sch Environm & Human Sci, Nagoya, Aichi 4688502, Japan; Shimadzu Co, Nakagyou Ku, Kyoto 6408511, Japan	Meijo University; Meijo University; Shimadzu Corporation	Takabe, T (corresponding author), Meijo Univ, Res Inst, Tenpaku Ku, Nagoya, Aichi 4688502, Japan.	takabe@ccmfs.meijo-u.ac.jp						Achouri Y, 1997, BIOCHEM J, V323, P365, DOI 10.1042/bj3230365; Albers E, 2003, J BIOL CHEM, V278, P10264, DOI 10.1074/jbc.M211692200; Ali V, 2004, EUR J BIOCHEM, V271, P2670, DOI 10.1111/j.1432-1033.2004.04195.x; APPLING DR, 1991, FASEB J, V5, P2645, DOI 10.1096/fasebj.5.12.1916088; BALLOU CE, 1956, J AM CHEM SOC, V78, P3718, DOI 10.1021/ja01596a045; Bauwe H, 2003, J EXP BOT, V54, P1523, DOI 10.1093/jxb/erg171; Boch J, 1996, J BACTERIOL, V178, P5121, DOI 10.1128/jb.178.17.5121-5129.1996; Chen THH, 2002, CURR OPIN PLANT BIOL, V5, P250, DOI 10.1016/S1369-5266(02)00255-8; CHERN MK, 1995, BIOCHEM BIOPH RES CO, V213, P561, DOI 10.1006/bbrc.1995.2168; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Colman B, 1997, PHYSIOL PLANTARUM, V100, P133, DOI 10.1034/j.1399-3054.1997.1000114.x; Dey S, 2005, J BIOL CHEM, V280, P14884, DOI 10.1074/jbc.M414488200; Hanson AD, 2002, CURR OPIN PLANT BIOL, V5, P244, DOI 10.1016/S1369-5266(02)00249-2; HANSON AD, 1994, P NATL ACAD SCI USA, V91, P306, DOI 10.1073/pnas.91.1.306; Hayashi H, 1997, PLANT J, V12, P133, DOI 10.1046/j.1365-313X.1997.12010133.x; Hibino T, 2002, J BIOL CHEM, V277, P41352, DOI 10.1074/jbc.M205965200; Hibino T, 1999, PLANT MOL BIOL, V40, P409, DOI 10.1023/A:1006273124726; Ho CL, 1999, J BIOL CHEM, V274, P397, DOI 10.1074/jbc.274.1.397; Ho CL, 2001, AMINO ACIDS, V20, P243, DOI 10.1007/s007260170042; Kempf B, 1998, ARCH MICROBIOL, V170, P319, DOI 10.1007/s002030050649; LAMARK T, 1991, MOL MICROBIOL, V5, P1049, DOI 10.1111/j.1365-2958.1991.tb01877.x; McNeil SD, 2001, P NATL ACAD SCI USA, V98, P10001, DOI 10.1073/pnas.171228998; Moreno JI, 2005, PLANT J, V41, P451, DOI 10.1111/j.1365-313X.2004.02311.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nuccio ML, 2000, METAB ENG, V2, P300, DOI 10.1006/mben.2000.0158; Nuccio ML, 1998, PLANT J, V16, P487, DOI 10.1046/j.1365-313x.1998.00316.x; Rathinasabapathi B, 1997, P NATL ACAD SCI USA, V94, P3454, DOI 10.1073/pnas.94.7.3454; RHODES D, 1993, ANNU REV PLANT PHYS, V44, P357, DOI 10.1146/annurev.pp.44.060193.002041; Rontein D, 2002, METAB ENG, V4, P49, DOI 10.1006/mben.2001.0208; SOMERVILLE CR, 1981, PLANT SCI LETT, V21, P89, DOI 10.1016/0304-4211(81)90073-0; SOROKIN A, 1993, MOL MICROBIOL, V10, P385, DOI 10.1111/j.1365-2958.1993.tb02670.x; Tasseva G, 2004, FEBS LETT, V566, P115, DOI 10.1016/j.febslet.2004.04.015; TOBEY KL, 1986, J BIOL CHEM, V261, P2179; Waditee R, 2005, P NATL ACAD SCI USA, V102, P1318, DOI 10.1073/pnas.0409017102; Waditee R, 2003, J BIOL CHEM, V278, P4932, DOI 10.1074/jbc.M210970200; Waditee R, 2001, J BIOL CHEM, V276, P36931, DOI 10.1074/jbc.M103650200; WERETILNYK EA, 1990, P NATL ACAD SCI USA, V87, P2745, DOI 10.1073/pnas.87.7.2745; YAMADA H, 1979, AGR BIOL CHEM TOKYO, V43, P2173, DOI 10.1080/00021369.1979.10863769; Youssefian S, 2001, PLANT PHYSIOL, V126, P1001, DOI 10.1104/pp.126.3.1001; Zhao GS, 1996, J BACTERIOL, V178, P232, DOI 10.1128/jb.178.1.232-239.1996; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	41	50	53	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34185	34193		10.1074/jbc.M704939200	http://dx.doi.org/10.1074/jbc.M704939200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17884813	hybrid			2022-12-25	WOS:000251145700033
J	Zhang, WW; Wu, YD; Wu, CY; Gunst, SJ				Zhang, Wenwu; Wu, Yidi; Wu, Chuanyue; Gunst, Susan J.			Integrin-linked kinase regulates N-WASp-mediated actin polymerization and tension development in tracheal smooth muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARP2/3 COMPLEX; CELL-ADHESION; EXTRACELLULAR-MATRIX; TYROSINE PHOSPHORYLATION; CONTRACTILE STIMULATION; SIGNAL-TRANSDUCTION; FOCAL ADHESIONS; CH-ILKBP; PROTEIN; PINCH	The contractile stimulation of smooth muscle tissues stimulates the recruitment of proteins to membrane adhesion complexes and the initiation of actin polymerization. We hypothesized that integrin-linked kinase (ILK), a beta-integrin-binding scaffolding protein and serine/threonine kinase, and its binding proteins, PINCH, and alpha-parvin may be recruited to membrane adhesion sites during contractile stimulation of tracheal smooth muscle to mediate cytoskeletal processes required for tension development. Immunoprecipitation analysis indicted that ILK, PINCH, and alpha-parvin form a stable cytosolic complex and that the ILK.PINCH.alpha-parvin complex is recruited to integrin adhesion complexes in response to acetylcholine (ACh) stimulation where it associates with paxillin and vinculin. Green fluorescent protein (GFP)-ILK and GFP-PINCH were expressed in tracheal muscle tissues and both endogenous and recombinant ILK and PINCH were recruited to the membrane in response to ACh stimulation. The N-terminal LIM1 domain of PINCH binds to ILK and is required for the targeting of the ILK-PINCH complex to focal adhesion sites in fibroblasts during cell adhesion. We expressed the GFP-PINCH LIM1-2 fragment, consisting only of LIM1-2 domains, in tracheal smooth muscle tissues to competitively inhibit the interaction of ILK with PINCH. The PINCH LIM1-2 fragment inhibited the recruitment of endogenous ILK and PINCH to integrin adhesion sites and prevented their association of ILK with beta-integrins, paxillin, and vinculin. The PINCH LIM1-2 fragment also inhibited tension development, actin polymerization, and activation of the actin nucleation initiator, N-WASp. We conclude that the recruitment of the ILK.PINCH.alpha-parvin complex to membrane adhesion complexes is required to initiate cytoskeletal processes required for tension development in smooth muscle.	Indiana Univ, Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA; Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gunst, SJ (corresponding author), 635 Barnhill Dr,MS313, Indianapolis, IN 46202 USA.	sgunst@iupui.edu		Gunst, Susan/0000-0001-9836-4782	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R23HL029289, R01HL074099, R01HL029289] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065188] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL074099, R01 HL074099-04, R01 HL029289, R01 HL029289-21A2, HL 29289, HL 074099] Funding Source: Medline; NIGMS NIH HHS [GM 65188] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		An SS, 2002, AM J PHYSIOL-CELL PH, V283, pC792, DOI 10.1152/ajpcell.00425.2001; Attwell S, 2003, MOL BIOL CELL, V14, P4813, DOI 10.1091/mbc.E03-05-0308; Barany M, 2001, J BIOL CHEM, V276, P48398, DOI 10.1074/jbc.M106227200; BARNES PJ, 1990, J APPL PHYSIOL, V68, P1777, DOI 10.1152/jappl.1990.68.5.1777; Brakebusch C, 2003, EMBO J, V22, P2324, DOI 10.1093/emboj/cdg245; Calderwood DA, 2000, J BIOL CHEM, V275, P22607, DOI 10.1074/jbc.R900037199; Cipolla MJ, 2002, FASEB J, V16, P72, DOI 10.1096/cj.01-0104hyp; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; Cooper JA, 2000, CURR OPIN CELL BIOL, V12, P97, DOI 10.1016/S0955-0674(99)00062-9; Dedhar S, 1996, CURR OPIN CELL BIOL, V8, P657, DOI 10.1016/S0955-0674(96)80107-4; Deng JT, 2002, BIOCHEM J, V367, P517, DOI 10.1042/BJ20020522; Deng JT, 2001, J BIOL CHEM, V276, P16365, DOI 10.1074/jbc.M011634200; Gunst SJ, 2003, RESP PHYSIOL NEUROBI, V137, P151, DOI 10.1016/S1569-9048(03)00144-7; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Herrera AM, 2004, AM J PHYSIOL-LUNG C, V286, pL1161, DOI 10.1152/ajplung.00298.2003; Higgs HN, 1999, J BIOL CHEM, V274, P32531, DOI 10.1074/jbc.274.46.32531; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Hirshman CA, 1999, AM J PHYSIOL-LUNG C, V277, pL653, DOI 10.1152/ajplung.1999.277.3.L653; Jones KA, 1999, J PHYSIOL-LONDON, V519, P527, DOI 10.1111/j.1469-7793.1999.0527m.x; Kim HR, 2004, AM J PHYSIOL-CELL PH, V287, pC1375, DOI 10.1152/ajpcell.00100.2004; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Li FG, 1999, J CELL SCI, V112, P4589; Luttrell LM, 1999, CURR OPIN CELL BIOL, V11, P177, DOI 10.1016/S0955-0674(99)80023-4; Mehta D, 1999, J PHYSIOL-LONDON, V519, P829, DOI 10.1111/j.1469-7793.1999.0829n.x; Millard TH, 2004, BIOCHEM J, V380, P1, DOI 10.1042/BJ20040176; Mishima W, 2004, GENES CELLS, V9, P193, DOI 10.1111/j.1356-9597.2004.00717.x; Muranyi A, 2002, BIOCHEM J, V366, P211, DOI 10.1042/BJ20020401; Nikolopoulos SN, 2002, J BIOL CHEM, V277, P1568, DOI 10.1074/jbc.M108612200; Nikolopoulos SN, 2001, J BIOL CHEM, V276, P23499, DOI 10.1074/jbc.M102163200; PAVALKO FM, 1995, AM J PHYSIOL-CELL PH, V268, pC563, DOI 10.1152/ajpcell.1995.268.3.C563; Saez AO, 2004, AM J PHYSIOL-CELL PH, V286, pC433, DOI 10.1152/ajpcell.00030.2003; SCHMEICHEL KL, 1994, CELL, V79, P211, DOI 10.1016/0092-8674(94)90191-0; Slack BE, 1998, P NATL ACAD SCI USA, V95, P7281, DOI 10.1073/pnas.95.13.7281; Tang D, 1999, AM J PHYSIOL-CELL PH, V276, pC250, DOI 10.1152/ajpcell.1999.276.1.C250; Tang DD, 2005, J BIOL CHEM, V280, P23380, DOI 10.1074/jbc.M413390200; Tang DD, 2004, J BIOL CHEM, V279, P51722, DOI 10.1074/jbc.M408351200; Tang DD, 2003, J PHYSIOL-LONDON, V553, P21, DOI 10.1113/jphysiol.2003.045047; Tu YZ, 2001, J CELL BIOL, V153, P585, DOI 10.1083/jcb.153.3.585; Tu YZ, 1999, MOL CELL BIOL, V19, P2425; Wang ZL, 1996, AM J PHYSIOL-CELL PH, V271, pC1594, DOI 10.1152/ajpcell.1996.271.5.C1594; Wilson DP, 2005, BIOCHEM J, V392, P641, DOI 10.1042/BJ20051173; Wu CY, 2005, TRENDS CELL BIOL, V15, P460, DOI 10.1016/j.tcb.2005.07.002; Wu CY, 1999, J CELL SCI, V112, P4485; Wu CY, 2001, J CELL BIOL, V155, P505, DOI 10.1083/jcb.200108077; Wu XY, 2004, J BIOL CHEM, V279, P9565, DOI 10.1074/jbc.M310739200; Zervas CG, 2001, J CELL BIOL, V152, P1007, DOI 10.1083/jcb.152.5.1007; Zhan Y, 2002, J BIOL CHEM, V277, P4512, DOI 10.1074/jbc.M109520200; ZHANG W, 2008, IN PRESS P AM THORAC; Zhang WW, 2006, J PHYSIOL-LONDON, V572, P659, DOI 10.1113/jphysiol.2006.106518; Zhang WW, 2005, AM J PHYSIOL-CELL PH, V288, pC1145, DOI 10.1152/ajpcell.00387.2004; Zhang YJ, 2002, J CELL SCI, V115, P4777, DOI 10.1242/jcs.00166	51	43	45	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34568	34580		10.1074/jbc.M704966200	http://dx.doi.org/10.1074/jbc.M704966200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17897939	hybrid			2022-12-25	WOS:000251145700071
J	Monterroso, B; Minton, AP				Monterroso, Begona; Minton, Allen P.			Effect of high concentration of inert cosolutes on the refolding of an enzyme - Carbonic anhydrase B in sucrose and Ficoll 70	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELF-ASSOCIATION; PROTEIN STABILITY; DEXTRAN; STATE; DNA	The kinetics of refolding of carbonic anhydrase II following transfer from a buffer containing 5 M guanidinium chloride to a buffer containing 0.5 M guanidinium chloride were studied by measuring the time-dependent recovery of enzymatic activity. Experiments were carried out in buffer containing concentrations of two "inert" cosolutes, sucrose and Ficoll 70, a sucrose polymer, at concentrations up to 150 g/liter. Data analysis indicates that both cosolutes significantly accelerate the rate of refolding to native or compact near-native conformations, but decrease the fraction of catalytically active enzyme recovered in the limit of long time. According to the simplest model that fits the data, both cosolutes accelerate a competing side reaction yielding inactive compact species. Acceleration of the side reaction by Ficoll is significantly greater than that of sucrose at equal w/v concentrations.	NIDDK, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Monterroso, B (corresponding author), NIDDK, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA.	monterrosob@niddk.nih.gov	Monterroso, Begoña/J-9748-2014	Monterroso, Begoña/0000-0003-2538-084X; Minton, Allen/0000-0001-8459-1247	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK024957, Z01DK024957] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bookchin RM, 1999, J BIOL CHEM, V274, P6689, DOI 10.1074/jbc.274.10.6689; Cheung MS, 2005, P NATL ACAD SCI USA, V102, P4753, DOI 10.1073/pnas.0409630102; Derham BK, 2006, BBA-PROTEINS PROTEOM, V1764, P1000, DOI 10.1016/j.bbapap.2006.01.005; Galan A, 2001, J BIOL CHEM, V276, P957, DOI 10.1074/jbc.M006861200; Gudiksen KL, 2004, ANAL CHEM, V76, P7151, DOI 10.1021/ac0488560; Hall D, 2003, BBA-PROTEINS PROTEOM, V1649, P127, DOI 10.1016/S1570-9639(03)00167-5; JARVIS TC, 1990, J BIOL CHEM, V265, P15160; JOHNSON WC, 1984, OPTICAL ACTIVITY STR, P245; Li J, 2001, J BIOL CHEM, V276, P34396, DOI 10.1074/jbc.M103392200; LINDNER R, 1995, BIOPHYS CHEM, V57, P15, DOI 10.1016/0301-4622(95)00063-4; Lindner RA, 1997, BIOPHYS CHEM, V66, P57, DOI 10.1016/S0301-4622(97)00011-2; Miles AJ, 2006, CHEM SOC REV, V35, P39, DOI 10.1039/b316168b; Minton AP, 2005, J PHARM SCI-US, V94, P1668, DOI 10.1002/jps.20417; Minton AP, 2000, CURR OPIN STRUC BIOL, V10, P34, DOI 10.1016/S0959-440X(99)00045-7; Minton AP, 2005, BIOPHYS J, V88, P971, DOI 10.1529/biophysj.104.050351; MINTON AP, 1983, MOL CELL BIOCHEM, V55, P119, DOI 10.1007/BF00673707; POCKER Y, 1967, BIOCHEMISTRY-US, V6, P668, DOI 10.1021/bi00855a005; Ren GP, 2003, J PROTEIN CHEM, V22, P431, DOI 10.1023/B:JOPC.0000005458.08802.11; Rivas G, 1999, BIOCHEMISTRY-US, V38, P9379, DOI 10.1021/bi990355z; Rivas G, 2001, P NATL ACAD SCI USA, V98, P3150, DOI 10.1073/pnas.051634398; Safarian S, 2006, J BIOCHEM, V139, P1025, DOI 10.1093/jb/mvj115; Saito R, 2004, ACTA CRYSTALLOGR D, V60, P792, DOI 10.1107/S0907444904003166; Sasahara K, 2003, J MOL BIOL, V326, P1227, DOI 10.1016/S0022-2836(02)01443-2; Tokuriki N, 2004, PROTEIN SCI, V13, P125, DOI 10.1110/ps.03288104; van den Berg B, 1999, EMBO J, V18, P6927, DOI 10.1093/emboj/18.24.6927; WETLAUFER DB, 1995, PROTEIN SCI, V4, P1535, DOI 10.1002/pro.5560040811; Zhou BR, 2004, J BIOL CHEM, V279, P55109, DOI 10.1074/jbc.M409086200; ZIMMERMAN SB, 1987, P NATL ACAD SCI USA, V84, P1871, DOI 10.1073/pnas.84.7.1871; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331	29	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33452	33458		10.1074/jbc.M705157200	http://dx.doi.org/10.1074/jbc.M705157200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17878163	Green Published, hybrid			2022-12-25	WOS:000250840200025
J	Sipila, L; Ruotsalainen, H; Sormunen, R; Baker, NL; Lamande, SR; Vapola, M; Wang, C; Sado, Y; Aszodi, A; Myllyla, R				Sipilae, Laura; Ruotsalainen, Heli; Sormunen, Raija; Baker, Naomi L.; Lamande, Shireen R.; Vapola, Miia; Wang, Chunguang; Sado, Yoshikazu; Aszodi, Attila; Myllylae, Raili			Secretion and assembly of type IV and VI collagens depend on glycosylation of hydroxylysines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN LYSYL HYDROXYLASE; CONGENITAL MUSCULAR-DYSTROPHY; AMINO-ACID-SEQUENCE; ENDOPLASMIC-RETICULUM; BASEMENT-MEMBRANE; POSTTRANSLATIONAL MODIFICATIONS; LYSYL-HYDROXYLASE-3 LH3; EXTRACELLULAR-MATRIX; TISSUE DISTRIBUTION; MOLECULAR-CLONING	Most lysines in type IV and VI collagens are hydroxylated and glycosylated, but the functions of these unique galactosylhydroxylysyl and glucosylgalactosylhydroxylysyl residues are poorly understood. The formation of glycosylated hydroxy-lysines is catalyzed by multifunctional lysyl hydroxylase 3 (LH3) in vivo, and we have used LH3-manipulated mice and cells as models to study the function of these carbohydrates. These hydroxylysine-linked carbohydrates were shown recently to be indispensable for the formation of basement membranes (Ruotsalainen, H., Sipila , L., Vapola, M., Sormunen, R., Salo, A. M., Uitto, L., Mercer, D. K., Robins, S. P., Risteli, M., Aszodi, A., Fassler, R., and Myllyla, R. ( 2006) J. Cell Sci. 119, 625-635). Analysis of LH3 knock-out embryos and cells in this work indicated that loss of glycosylated hydroxylysines prevents the intracellular tetramerization of type VI collagen and leads to impaired secretion of type IV and VI collagens. Mice lacking the LH activity of LH3 produced slightly underglycosylated type IV and VI collagens with abnormal distribution. The altered distribution and aggregation of type VI collagen led to similar ultrastructural alterations in muscle to those detected in collagen VI knockout and some Ullrich congenital muscular dystrophy patients. Our results provide new information about the function of hydroxylysine-linked carbohydrates of collagens, indicating that they play an important role in the secretion, assembly, and distribution of highly glycosylated collagen types.	Univ Oulu, Dept Biochem, FI-90014 Oulu, Finland; Univ Oulu, Bioctr Oulu, FI-90014 Oulu, Finland; Univ Oulu, Dept Pathol, FI-90014 Oulu, Finland; Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Parkville, Vic 3052, Australia; Shigei Med Res Inst, Div Immunol, Okayama 7010202, Japan; Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany	Finland National Institute for Health & Welfare; University of Oulu; University of Oulu; University of Oulu; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Royal Children's Hospital Melbourne; University of Melbourne; Max Planck Society	Myllyla, R (corresponding author), Univ Oulu, Dept Biochem, POB 3000, FI-90014 Oulu, Finland.	raili.myllyla@oulu.fi	Wang, Chunguang/AAE-7054-2020; Wang, Chunguang/AAE-6997-2020	Wang, Chunguang/0000-0001-5569-321X; Ruotsalainen, Heli/0000-0003-4923-5196; Salo, Miia/0000-0003-2085-7880; Lamande, Shireen/0000-0003-2938-2711				ARMSTRONG LC, 1995, BBA-GENE STRUCT EXPR, V1264, P93, DOI 10.1016/0167-4781(95)00130-9; Baker NL, 2005, HUM MOL GENET, V14, P279, DOI 10.1093/hmg/ddi025; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; CHU ML, 1988, J BIOL CHEM, V263, P18601; ENGVALL E, 1986, J CELL BIOL, V102, P703, DOI 10.1083/jcb.102.3.703; Fisher LW, 1995, ACTA ORTHOP SCAND, V66, P61, DOI 10.3109/17453679509157649; HAUTALA T, 1992, GENOMICS, V13, P62, DOI 10.1016/0888-7543(92)90202-4; Heikkinen J, 2000, J BIOL CHEM, V275, P36158, DOI 10.1074/jbc.M006203200; Heise CT, 2000, J IMMUNOL, V165, P1403, DOI 10.4049/jimmunol.165.3.1403; HELENIUS A, 1994, MOL BIOL CELL, V5, P253, DOI 10.1091/mbc.5.3.253; Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270; Ishikawa H, 2004, NEUROLOGY, V62, P620, DOI 10.1212/01.WNL.0000113023.84421.00; KIELTY CM, 2002, CONNECTIVE TISSUE IT, P103; Kirschner J, 2005, AM J MED GENET A, V132A, P296, DOI 10.1002/ajmg.a.30443; Kivirikko K I, 1979, Int Rev Connect Tissue Res, V8, P23; Kivirikko K. I., 1992, POSTTRANSLATIONAL MO, P1; KIVIRIKKO KI, 1995, PRINCIPLES MED BIOL; Kuo HJ, 1997, J BIOL CHEM, V272, P26522, DOI 10.1074/jbc.272.42.26522; KUO HJ, 1995, EUR J BIOCHEM, V232, P364, DOI 10.1111/j.1432-1033.1995.364zz.x; Lamande SR, 2006, J BIOL CHEM, V281, P16607, DOI 10.1074/jbc.M510192200; LAMANDE SR, 1995, J BIOL CHEM, V270, P8642, DOI 10.1074/jbc.270.15.8642; Lamande SR, 1999, SEMIN CELL DEV BIOL, V10, P455, DOI 10.1006/scdb.1999.0317; LANGEVELD JPM, 1991, J BIOL CHEM, V266, P2622; Lauer-Fields JL, 2003, J BIOL CHEM, V278, P14321, DOI 10.1074/jbc.M212246200; Matsuoka Y, 2004, MOL BIOL CELL, V15, P4467, DOI 10.1091/mbc.E04-01-0050; Mercer DK, 2003, BIOCHEM BIOPH RES CO, V307, P803, DOI 10.1016/S0006-291X(03)01262-2; Minamitani T, 2004, EXP CELL RES, V298, P305, DOI 10.1016/j.yexcr.2004.04.030; MYLLYLA R, 1991, J BIOL CHEM, V266, P2805; Norman KR, 2000, DEV BIOL, V227, P690, DOI 10.1006/dbio.2000.9897; Notbohm H, 1999, J BIOL CHEM, V274, P8988, DOI 10.1074/jbc.274.13.8988; Passoja K, 1998, P NATL ACAD SCI USA, V95, P10482, DOI 10.1073/pnas.95.18.10482; Rautavuoma K, 2004, P NATL ACAD SCI USA, V101, P14120, DOI 10.1073/pnas.0404966101; Rautavuoma K, 2002, J BIOL CHEM, V277, P23084, DOI 10.1074/jbc.M112077200; Richards AA, 2006, MOL ENDOCRINOL, V20, P1673, DOI 10.1210/me.2005-0390; Robins SP, 2002, PRINCIPLES BONE BIOL, V1, P211; Ruotsalainen H, 2006, J CELL SCI, V119, P625, DOI 10.1242/jcs.02780; Ruotsalainen H, 1999, MATRIX BIOL, V18, P325, DOI 10.1016/S0945-053X(99)00016-5; Sabatelli P, 2001, MATRIX BIOL, V20, P475, DOI 10.1016/S0945-053X(01)00160-3; SADO Y, 1995, HISTOCHEM CELL BIOL, V104, P267, DOI 10.1007/BF01464322; Salo AM, 2006, J CELL PHYSIOL, V207, P644, DOI 10.1002/jcp.20596; Timpl R., 1994, EXTRACELLULAR MATRIX; TORREBLANCO A, 1992, J BIOL CHEM, V267, P2650; Valtavaara M, 1997, J BIOL CHEM, V272, P6831, DOI 10.1074/jbc.272.11.6831; Valtavaara M, 1998, J BIOL CHEM, V273, P12881, DOI 10.1074/jbc.273.21.12881; Van den Steen PE, 2004, BIOCHEMISTRY-US, V43, P10809, DOI 10.1021/bi0493665; Wang CG, 2002, MATRIX BIOL, V21, P559, DOI 10.1016/S0945-053X(02)00071-9; Wang CG, 2002, J BIOL CHEM, V277, P18568, DOI 10.1074/jbc.M201389200; Wang Y, 2006, J BIOL CHEM, V281, P16391, DOI 10.1074/jbc.M513907200	48	58	60	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33381	33388		10.1074/jbc.M704198200	http://dx.doi.org/10.1074/jbc.M704198200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17873278	hybrid			2022-12-25	WOS:000250840200017
J	Khanam, T; Raabe, CA; Kiefmann, M; Handel, S; Skryabin, BV; Brosius, J				Khanam, Tasneem; Raabe, Carsten A.; Kiefmann, Martin; Handel, Sergej; Skryabin, Boris V.; Brosius, Juergen			Can ID Repetitive Elements Serve as Cis-acting Dendritic Targeting Elements? An In Vivo Study	PLOS ONE			English	Article								Dendritic localization of mRNA/RNA involves interaction of cis-elements and trans-factors. Small, non-protein coding dendritic BC1 RNA is thought to regulate translation in dendritic microdomains. Following microinjections into cultured cells, BC1 RNA fused to larger mRNAs appeared to impart transport competence to these chimeras, and its 5' ID region was proposed as the cis-acting dendritic targeting element. As these ID elements move around rodent genomes and, if transcribed, form a long RNA stem-loop, they might, thereby, lead to new localizations for targeted gene products. To test their targeting ability in vivo we created transgenic mice expressing various ID elements fused to the 3' UTR of reporter mRNA for Enhanced Green Fluorescent Protein. In vivo, neither ID elements nor the BC1 RNA coding region were capable of transporting EGFP RNA to dendrites, although the 3' UTR of alpha-CaMKII mRNA, an established cis-acting element did produce positive results. Other mRNAs containing naturally inserted ID elements are also not found in neuronal dendrites. We conclude that the 5' ID domain from BC1 RNA is not a sufficient dendritic targeting element for mRNAs in vivo.	[Khanam, Tasneem; Raabe, Carsten A.; Kiefmann, Martin; Handel, Sergej; Skryabin, Boris V.; Brosius, Juergen] Univ Munster, Inst Expt Pathol, Munster, Germany	University of Munster	Khanam, T (corresponding author), Univ Munster, Inst Expt Pathol, Munster, Germany.	tasneem@uni-muenster.de; RNA.world@uni-muenster.de	Skryabin, Boris/AAL-3100-2020; Brosius, Jürgen/F-5029-2016	Skryabin, Boris/0000-0002-4392-185X; Brosius, Jürgen/0000-0003-1650-2059	Nationales Genomforschungsnetz (NGFN) [0313358A]	Nationales Genomforschungsnetz (NGFN)	This work was supported by Nationales Genomforschungsnetz (NGFN, 0313358A) to J.B.	Ainger K, 1997, J CELL BIOL, V138, P1077, DOI 10.1083/jcb.138.5.1077; Barbieri Marcello, 2003, ORGANIC CODES INTRO; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Blichenberg A, 1999, J NEUROSCI, V19, P8818, DOI 10.1523/JNEUROSCI.19-20-08818.1999; Blichenberg A, 2001, EUR J NEUROSCI, V13, P1881, DOI 10.1046/j.0953-816x.2001.01565.x; BODIAN D, 1965, P NATL ACAD SCI USA, V53, P418, DOI 10.1073/pnas.53.2.418; BROSIUS J, 1992, P NATL ACAD SCI USA, V89, P10706, DOI 10.1073/pnas.89.22.10706; BURGIN KE, 1990, J NEUROSCI, V10, P1788; Cristofanilli M, 2006, J MOL BIOL, V356, P1118, DOI 10.1016/j.jmb.2005.11.090; Czaplinski K, 2006, TRENDS BIOCHEM SCI, V31, P687, DOI 10.1016/j.tibs.2006.10.007; Du TG, 2007, SEMIN CELL DEV BIOL, V18, P171, DOI 10.1016/j.semcdb.2007.01.010; Eberwine J, 2002, NEUROCHEM RES, V27, P1065, DOI 10.1023/A:1020956805307; Ephrussi A, 2004, CELL, V116, P143, DOI 10.1016/S0092-8674(04)00037-6; Ferrigno O, 2001, NAT GENET, V28, P77, DOI 10.1038/ng0501-77; FREGIEN N, 1986, GENE, V48, P1, DOI 10.1016/0378-1119(86)90346-X; GARNER CC, 1988, NATURE, V336, P674, DOI 10.1038/336674a0; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; HOGAN B, 1986, MANIPULATING MOUSE E; Huang YS, 2002, EMBO J, V21, P2139, DOI 10.1093/emboj/21.9.2139; Inaba Y, 2004, J NEUROCHEM, V89, P1347, DOI 10.1111/j.1471-4159.2004.02440.x; Khanam T, 2007, NUCLEIC ACIDS RES, V35, P529, DOI 10.1093/nar/gkl1082; KIM J, 1995, NUCLEIC ACIDS RES, V23, P2245, DOI 10.1093/nar/23.12.2245; KIM JM, 1994, P NATL ACAD SCI USA, V91, P3607, DOI 10.1073/pnas.91.9.3607; Kindler S, 2005, ANNU REV CELL DEV BI, V21, P223, DOI 10.1146/annurev.cellbio.21.122303.120653; KLEIMAN R, 1993, MOL BRAIN RES, V20, P305, DOI 10.1016/0169-328X(93)90057-V; KOENIG E, 1965, J NEUROCHEM, V12, P357, DOI 10.1111/j.1471-4159.1965.tb04236.x; KOENIG E, 1965, J NEUROCHEM, V12, P343, DOI 10.1111/j.1471-4159.1965.tb04235.x; Kondrashov AV, 2005, J MOL BIOL, V353, P88, DOI 10.1016/j.jmb.2005.07.049; KRESS M, 1984, SCIENCE, V226, P974, DOI 10.1126/science.6095445; Krull M, 2005, MOL BIOL EVOL, V22, P1702, DOI 10.1093/molbev/msi164; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; Ludwig A, 2005, J MOL BIOL, V350, P200, DOI 10.1016/j.jmb.2005.03.058; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Mayford M, 1996, P NATL ACAD SCI USA, V93, P13250, DOI 10.1073/pnas.93.23.13250; Mori Y, 2000, NAT NEUROSCI, V3, P1079, DOI 10.1038/80591; Muslimov IA, 2004, J BIOL CHEM, V279, P52613, DOI 10.1074/jbc.M409240200; Muslimov IA, 1997, J NEUROSCI, V17, P4722; Muslimov IA, 2006, J CELL BIOL, V175, P427, DOI 10.1083/jcb.200607008; Rozhdestvensky TS, 2001, RNA, V7, P722, DOI 10.1017/S1355838201002485; RYSKOV A P, 1984, Molekulyarnaya Biologiya (Moscow), V18, P92; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Sorek R, 2002, GENOME RES, V12, P1060, DOI 10.1101/gr.229302; STEWARD O, 1982, J NEUROSCI, V2, P284; Suda S, 2002, BIOCHEM BIOPH RES CO, V291, P1265, DOI 10.1006/bbrc.2002.6592; TIEDGE H, 1991, P NATL ACAD SCI USA, V88, P2093, DOI 10.1073/pnas.88.6.2093; TIEDGE H, 1993, J NEUROSCI, V13, P2382, DOI 10.1523/JNEUROSCI.13-06-02382.1993; Tiedge H, 1996, J NEUROSCI, V16, P7171; Tiedge Henri, 2006, RNA Biol, V3, P133; Wang HD, 2005, J CELL BIOL, V171, P811, DOI 10.1083/jcb.200506006; Wang HD, 2002, J NEUROSCI, V22, P10232; WEINER AM, 1986, ANNU REV BIOCHEM, V55, P631, DOI 10.1146/annurev.bi.55.070186.003215	52	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e961	10.1371/journal.pone.0000961	http://dx.doi.org/10.1371/journal.pone.0000961			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17896001	gold, Green Published			2022-12-25	WOS:000207455800039
J	Clark, J; Attard, G; Jhavar, S; Flohr, P; Reid, A; De-Bono, J; Eeles, R; Scardino, P; Cuzick, J; Fisher, G; Parker, MD; Foster, CS; Berney, D; Kovacs, G; Cooper, CS				Clark, J.; Attard, G.; Jhavar, S.; Flohr, P.; Reid, A.; De-Bono, J.; Eeles, R.; Scardino, P.; Cuzick, J.; Fisher, G.; Parker, M. D.; Foster, C. S.; Berney, D.; Kovacs, G.; Cooper, C. S.			Complex patterns of ETS gene alteration arise during cancer development in the human prostate	ONCOGENE			English	Article						prostate cancer; ERG; TMPRSS2; ERG fusion transcripts	IN-SITU HYBRIDIZATION; INTRAEPITHELIAL NEOPLASIA; RADICAL PROSTATECTOMY; CHROMOSOMAL-ANOMALIES; INDEPENDENT ORIGIN; TMPRSS2-ERG FUSION; EXPRESSION; CARCINOMA; HETEROGENEITY; SPECIMENS	An ERG gene 'break-apart' fluorescence in situ hybridization (FISH) assay has been used to screen whole-mount prostatectomy specimens for rearrangements at the ERG locus. In cancers containing ERG alterations the observed pattern of changes was often complex. Different categories of ERG gene alteration were found either together in a single cancerous region or within separate foci of cancer in the same prostate slice. In some cases the juxtaposition of particular patterns of ERG alterations suggested possible mechanisms of tumour progression. Prostates harbouring ERG alterations commonly also contained cancer that lacked rearrangements of the ERG gene. A single trans-urethral resection of the prostate specimen examined harboured both ERG and ETV1 gene rearrangements demonstrating that the observed complexity may, at least in part, be explained by multiple ETS gene alterations arising independently in a single prostate. In a search for possible precursor lesions clonal ERG rearrangements were found both in high grade prostatic intraepithelial neoplasia (PIN) and in atypical in situ epithelial lesions consistent with the diagnosis of low grade PIN. Our observations support the view that ERG gene alterations represent an initiating event that promotes clonal expansion initially to form regions of epithelial atypia. The complex patterns of ERG alteration found in prostatectomy specimens have important implications for the design of experiments investigating the clinical significance and mechanism of development of individual prostate cancers.	[Clark, J.; Attard, G.; Jhavar, S.; Flohr, P.; Reid, A.; De-Bono, J.; Eeles, R.; Parker, M. D.; Cooper, C. S.] Male Urol Canc Res Ctr, Inst Canc Res, Sutton SM2 5NG, Surrey, England; [Attard, G.; Reid, A.; De-Bono, J.; Eeles, R.] Royal Marsden NHS Trust Fdn Hosp, Sutton, Surrey, England; [Scardino, P.] Mem Sloan Kettering Canc Ctr, Dept Urol, New York, NY 10021 USA; [Cuzick, J.; Fisher, G.] Univ London, Wolfson Inst Prevent Med, London, England; [Foster, C. S.] Univ Liverpool, Dept Pathol, Royal Liverpool Univ Hosp, Liverpool L69 3BX, Merseyside, England; [Berney, D.] St Bartholomews Hosp, Orchid Tissue Lab, London, England; [Kovacs, G.] Heidelberg Univ, Fac Med, Mol Oncol Lab, Heidelberg, Germany	University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Memorial Sloan Kettering Cancer Center; University of London; Queen Mary University London; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; University of London; Queen Mary University London; Ruprecht Karls University Heidelberg	Clark, J (corresponding author), Male Urol Canc Res Ctr, Inst Canc Res, 15 Cotswold Rd, Sutton SM2 5NG, Surrey, England.	jeremy.clark@icr.ac.uk		Berney, Daniel/0000-0001-5474-8696; Parker, Matthew/0000-0003-2999-3870; Eeles, Rosalind/0000-0002-3698-6241; de Bono, Johann S/0000-0002-2034-595X; Attard, Gerhardt/0000-0002-4811-7983	MRC [G0501019] Funding Source: UKRI; Cancer Research UK Funding Source: Medline; Medical Research Council [G0501019] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		AIHARA M, 1994, UROLOGY, V43, P60, DOI 10.1016/S0090-4295(94)80264-5; Arora R, 2004, CANCER-AM CANCER SOC, V100, P2362, DOI 10.1002/cncr.20243; ATTARD G, 2007, ONCOGENE        0716; Bostwick DG, 1998, CANCER, V83, P1995, DOI 10.1002/(SICI)1097-0142(19981101)83:9<1995::AID-CNCR16>3.0.CO;2-2; BRAWER MK, 1991, UROLOGY, V38, P103, DOI 10.1016/S0090-4295(05)80067-6; Cerveira N, 2006, NEOPLASIA, V8, P826, DOI 10.1593/neo.06427; Chen ME, 2000, CANCER, V89, P1800, DOI 10.1002/1097-0142(20001015)89:8<1800::AID-CNCR21>3.0.CO;2-D; Cheng L, 1998, J NATL CANCER I, V90, P233, DOI 10.1093/jnci/90.3.233; Chun FKH, 2007, EUR UROL, V51, P949, DOI 10.1016/j.eururo.2006.07.008; Clark J, 2007, ONCOGENE, V26, P2667, DOI 10.1038/sj.onc.1210070; Cuzick J, 2006, BRIT J CANCER, V95, P1186, DOI 10.1038/sj.bjc.6603411; Demichelis F, 2007, ONCOGENE, V26, P5692, DOI 10.1038/sj.onc.1210630; Djavan B, 1999, Tech Urol, V5, P139; Egevad L, 2006, MODERN PATHOL, V19, P180, DOI 10.1038/modpathol.3800522; EPSTEIN JI, 1995, AM J SURG PATHOL, V19, P873, DOI 10.1097/00000478-199508000-00002; Foster CS, 2000, PROSTATE, P4; Foster CS, 2004, ONCOGENE, V23, P5871, DOI 10.1038/sj.onc.1207800; Foster CS, 2000, SCAND J UROL NEPHROL, V34, P19, DOI 10.1080/003655900750169284; GREENE DR, 1995, SEMIN SURG ONCOL, V11, P9, DOI 10.1002/ssu.2980110104; GRIGNON DJ, 1994, J CELL BIOCHEM, P267; Hermans KG, 2006, CANCER RES, V66, P10658, DOI 10.1158/0008-5472.CAN-06-1871; Iljin K, 2006, CANCER RES, V66, P10242, DOI 10.1158/0008-5472.CAN-06-1986; Jenkins RB, 1997, CANCER RES, V57, P524; Jhavar SG, 2005, J CLIN PATHOL, V58, P504, DOI 10.1136/jcp.2004.021808; KONISHI N, 1995, AM J PATHOL, V147, P1112; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; MCNEAL JE, 1988, PROSTATE, V13, P91, DOI 10.1002/pros.2990130202; McNeal JE, 1996, AM J SURG PATHOL, V20, P802, DOI 10.1097/00000478-199607000-00003; MILLER GJ, 1994, J UROLOGY, V152, P1709, DOI 10.1016/S0022-5347(17)32368-6; MIRCHANDANI D, 1995, AM J PATHOL, V147, P92; NAM RK, 2003, CANCER BIOL THER, V6, P40; Perner S, 2007, AM J SURG PATHOL, V31, P882, DOI 10.1097/01.pas.0000213424.38503.aa; Perner S, 2006, CANCER RES, V66, P8337, DOI 10.1158/0008-5472.CAN-06-1482; QIAN JQ, 1995, CANCER RES, V55, P5408; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Sakai I, 2005, BJU INT, V96, P528, DOI 10.1111/j.1464-410X.2005.05678.x; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Srigley JR, 2000, ARCH PATHOL LAB MED, V124, P1034; Stephenson AJ, 2005, CANCER-AM CANCER SOC, V104, P290, DOI 10.1002/cncr.21157; Tomlins SA, 2006, CANCER RES, V66, P3396, DOI 10.1158/0008-5472.CAN-06-0168; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; VILLERS A, 1992, CANCER, V70, P2313, DOI 10.1002/1097-0142(19921101)70:9<2313::AID-CNCR2820700917>3.0.CO;2-T; Wang JH, 2006, CANCER RES, V66, P8347, DOI 10.1158/0008-5472.CAN-06-1966; Yoshimoto M, 2006, NEOPLASIA, V8, P465, DOI 10.1593/neo.06283; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158	47	109	120	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 27	2008	27	14					1993	2003		10.1038/sj.onc.1210843	http://dx.doi.org/10.1038/sj.onc.1210843			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	279MK	17922029				2022-12-25	WOS:000254359100004
J	Kanda, I; Nishimura, N; Nakatsuji, H; Yamamura, R; Nakanishi, H; Sasaki, T				Kanda, I.; Nishimura, N.; Nakatsuji, H.; Yamamura, R.; Nakanishi, H.; Sasaki, T.			Involvement of Rab13 and JRAB/MICAL-L2 in epithelial cell scattering	ONCOGENE			English	Article						Rab13; JRAB/MICAL-L2; cell scattering	SMALL G-PROTEINS; MDCK CELLS; ADHESION RECEPTORS; BINDING-PROTEINS; TIGHT JUNCTIONS; INTEGRIN BETA-1; OCCLUDIN; RHO; MEMBRANE; CADHERIN	Epithelial cell scattering recapitulates the first steps of carcinoma invasion/metastasis. While the balance between cell-cell adhesive activity and cell motility ultimately determines this process, its molecular mechanisms remain unclear. Adherence junctions and tight junctions (TJs) are primarily responsible for cell-cell adhesive activity and subjected to dynamic remodeling. We previously showed that Rab13 and its effector protein JRAB/MICAL-L2 mediate the endocytic recycling of the integral TJ protein occludin and the assembly of functional TJs. In this study, we examined the role of Rab13 and JRAB/MICAL-L2 in the scattering of Madin-Darby canine kidney (MDCK) cells in response to 12-O-tetradecanoylphorbol-13-acetate (TPA). Knockdown of Rab13 in canine MDCK cells suppressed the TPA-induced scattering, and this phenotype was restored by re-expression of human Rab13. During TPA-induced MDCK cell scattering, Rab13 was transiently activated and returned to its basal level, and both Rab13 and JRAB/MICAL-L2 were colocalized with F-actin at cell-cell contact sites and then accumulated at emerging lamellipodial structures. TPA-induced MDCK cell scattering was also inhibited by knockdown of canine JRAB/MICAL-L2 and rescued by re-expression of mouse JRAB/MICAL-L2. These results indicate that Rab13 and JRAB/MICAL-L2 are involved in epithelial cell scattering.	[Kanda, I.; Nishimura, N.; Nakatsuji, H.; Yamamura, R.; Sasaki, T.] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Biochem, Tokushima 7708503, Japan; [Kanda, I.; Nakanishi, H.] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Plast & Reconstruct Surg, Tokushima 7708503, Japan	Tokushima University; Tokushima University	Sasaki, T (corresponding author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Biochem, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	sasaki@basic.med.tokushima-u.ac.jp	Nakanishi, Hiroyuki/AAD-9324-2020	Nakanishi, Hiroyuki/0000-0003-3982-3314; Nakanishi, Hiroyuki/0000-0002-9765-0266				Aijaz S, 2005, DEV CELL, V8, P777, DOI 10.1016/j.devcel.2005.03.003; Ashida S, 2006, CLIN CANCER RES, V12, P2767, DOI 10.1158/1078-0432.CCR-05-1995; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Braga VMM, 1997, J CELL BIOL, V137, P1421, DOI 10.1083/jcb.137.6.1421; Braga VMM, 2005, CURR OPIN CELL BIOL, V17, P466, DOI 10.1016/j.ceb.2005.08.012; Bretscher MS, 1996, CELL, V85, P465, DOI 10.1016/S0092-8674(00)81246-5; Chen X, 2006, CURR OPIN CELL BIOL, V18, P572, DOI 10.1016/j.ceb.2006.07.002; Clarke H, 2000, J CELL SCI, V113, P3187; Comoglio PM, 2002, J CLIN INVEST, V109, P857, DOI 10.1172/JCI200215392; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Di Giovanni S, 2005, J BIOL CHEM, V280, P2084, DOI 10.1074/jbc.M411975200; Di Giovanni S, 2006, EMBO J, V25, P4084, DOI 10.1038/sj.emboj.7601292; Hickson GRX, 2003, MOL BIOL CELL, V14, P2908, DOI 10.1091/mbc.E03-03-0160; Imamura H, 1998, MOL BIOL CELL, V9, P2561, DOI 10.1091/mbc.9.9.2561; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Kimura Y, 1997, AM J PATHOL, V151, P45; Kodama A, 1999, ONCOGENE, V18, P3996, DOI 10.1038/sj.onc.1202773; Kusumi A, 1999, CURR OPIN CELL BIOL, V11, P582, DOI 10.1016/S0955-0674(99)00020-4; Li J, 2005, DEV CELL, V9, P663, DOI 10.1016/j.devcel.2005.09.012; Marzesco AM, 2002, MOL BIOL CELL, V13, P1819, DOI 10.1091/mbc.02-02-0029; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Morimoto S, 2005, J BIOL CHEM, V280, P2220, DOI 10.1074/jbc.M406906200; NAGAFUCHI A, 1994, J CELL BIOL, V127, P235, DOI 10.1083/jcb.127.1.235; Palacios F, 2003, J BIOL CHEM, V278, P17395, DOI 10.1074/jbc.M300998200; Palacios F, 2001, EMBO J, V20, P4973, DOI 10.1093/emboj/20.17.4973; Powelka AM, 2004, TRAFFIC, V5, P20, DOI 10.1111/j.1600-0854.2004.00150.x; Roberts M, 2001, CURR BIOL, V11, P1392, DOI 10.1016/S0960-9822(01)00442-0; Suzuki T, 2002, J BIOL CHEM, V277, P14933, DOI 10.1074/jbc.M111842200; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167; TAKAI Y, 1995, TRENDS BIOCHEM SCI, V20, P227, DOI 10.1016/S0968-0004(00)89022-2; Takaishi K, 1997, J CELL BIOL, V139, P1047, DOI 10.1083/jcb.139.4.1047; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Terai T, 2006, MOL BIOL CELL, V17, P2465, DOI 10.1091/mbc.E05-09-0826; Terman JR, 2002, CELL, V109, P887, DOI 10.1016/S0092-8674(02)00794-8; Tobioka H, 2004, HUM PATHOL, V35, P159, DOI 10.1016/j.humpath.2003.09.013; Troyanovsky RB, 2006, MOL BIOL CELL, V17, P3484, DOI 10.1091/mbc.E06-03-0190; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Vasioukhin V, 2001, CURR OPIN CELL BIOL, V13, P76, DOI 10.1016/S0955-0674(00)00177-0; Wells CD, 2006, CELL, V125, P535, DOI 10.1016/j.cell.2006.02.045; Yamamoto Y, 2003, BIOCHEM BIOPH RES CO, V308, P270, DOI 10.1016/S0006-291X(03)01358-5	42	27	27	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 13	2008	27	12					1687	1695		10.1038/sj.onc.1210812	http://dx.doi.org/10.1038/sj.onc.1210812			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	273WF	17891173				2022-12-25	WOS:000253962100004
J	Milliken, EL; Lozada, KL; Johnson, E; Landis, MD; Seachrist, DD; Whitten, I; Sutton, ALM; Abdul-Karim, FW; Keri, RA				Milliken, E. L.; Lozada, K. L.; Johnson, E.; Landis, M. D.; Seachrist, D. D.; Whitten, I.; Sutton, A. L. M.; Abdul-Karim, F. W.; Keri, R. A.			Ovarian hyperstimulation induces centrosome amplification and aneuploid mammary tumors independently of alterations in p53 in a transgenic mouse model of breast cancer	ONCOGENE			English	Article						breast cancer; mammary gland; ovarian steroids; p53; centrosome; aneuploidy	ELEVATED LUTEINIZING-HORMONE; CHROMOSOMAL INSTABILITY; GENOMIC INSTABILITY; RANDOMIZED-TRIALS; MENSTRUAL FACTORS; EPITHELIAL-CELLS; MICE DEFICIENT; TAMOXIFEN; RECEPTOR; RISK	Aneuploidy and genomic instability are common features of human cancers, including breast cancer; however, mechanisms by which such abnormalities develop are not understood. The exquisite dependence of the mammary gland on hormones for growth and development as well as hormonal contributions to breast cancer risk and progression suggest that tumorigenic mechanisms in the breast should be considered in the context of hormonal stimulation. We used transgenic mice that overexpress luteinizing hormone with subsequent ovarian hyperstimulation as a model to identify mechanisms involved in hormone-induced mammary cancer. Tumor pathology in these mice is highly variable, suggesting individual tumors undergo distinct initiating or promoting events. Supporting this notion, hormone-induced tumors display considerable chromosomal instability and aneuploidy, despite the presence of functional p53. The presence of extensive centrosome amplification in tumors and hyperplastic glands prior to tumor formation suggests that alterations in the ovarian hormonal milieu dysregulate the centrosome cycle in mammary epithelial cells, leading to aneuploidy and cancer.	[Milliken, E. L.; Lozada, K. L.; Johnson, E.; Landis, M. D.; Seachrist, D. D.; Whitten, I.; Sutton, A. L. M.; Keri, R. A.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Abdul-Karim, F. W.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Abdul-Karim, F. W.] Univ Hosp Cleveland, Dept Pathol, Cleveland, OH 44106 USA; [Keri, R. A.] Case Western Reserve Univ, Sch Med, Div Gen Med Sci Oncol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; Case Western Reserve University	Keri, RA (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 2109 Adelbert Rd,10900 Euclid Ave, Cleveland, OH 44106 USA.	keri@case.edu	Keri, Ruth/ABF-2209-2021	Keri, Ruth/0000-0002-1640-3088; Sutton, Amelia/0000-0003-0493-0670	NCI NIH HHS [R01 CA090398, R01 CA090398-06A1, T32CA059366, CA090398, P30 CA043703, T32 CA059366, R01 CA090398-07] Funding Source: Medline; NIGMS NIH HHS [T32GM08056, T32 GM008803, T32 GM008056, T32GM08803, T32 GM007250] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA059366, R01CA090398, P30CA043703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250, T32GM008056, T32GM008803] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Backlund MG, 2001, CANCER RES, V61, P6577; Baum M, 2002, LANCET, V359, P2131; Bonneterre J, 2001, CANCER, V92, P2247, DOI 10.1002/1097-0142(20011101)92:9<2247::AID-CNCR1570>3.0.CO;2-Y; Braakhuis BJM, 2003, CANCER RES, V63, P1727; BRINTON LA, 1988, CANCER INVEST, V6, P245, DOI 10.3109/07357908809080645; Buzdar AU, 2006, CANCER-AM CANCER SOC, V107, P472, DOI 10.1002/cncr.22042; Cardiff RD, 2000, ONCOGENE, V19, P968, DOI 10.1038/sj.onc.1203277; CHENG KC, 1993, ADV CANCER RES, V60, P121; Clarke M, 1998, LANCET, V351, P1451; Clarke RB, 2005, DEV BIOL, V277, P443, DOI 10.1016/j.ydbio.2004.07.044; D'Assoro AB, 2002, BREAST CANCER RES TR, V75, P25, DOI 10.1023/A:1016550619925; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; DONEHOWER LA, 1995, GENE DEV, V9, P882, DOI 10.1101/gad.9.7.882; Duesberg P, 2005, CELL ONCOL, V27, P293; Ewan KB, 2002, CANCER RES, V62, P5627; Fei PW, 2003, ONCOGENE, V22, P5774, DOI 10.1038/sj.onc.1206677; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Fukasawa K, 1997, ONCOGENE, V15, P1295, DOI 10.1038/sj.onc.1201482; Goepfert TM, 2002, CANCER RES, V62, P4115; HAMMOND SL, 1984, P NATL ACAD SCI-BIOL, V81, P5435, DOI 10.1073/pnas.81.17.5435; HSIEH CC, 1990, INT J CANCER, V46, P796, DOI 10.1002/ijc.2910460508; Hundley JE, 1997, MOL CELL BIOL, V17, P723, DOI 10.1128/MCB.17.2.723; IRWIN KL, 1988, AM J EPIDEMIOL, V127, P1192, DOI 10.1093/oxfordjournals.aje.a114912; Jerry DJ, 2000, ONCOGENE, V19, P1052, DOI 10.1038/sj.onc.1203270; Kero J, 2000, J CLIN INVEST, V105, P633, DOI 10.1172/JCI7716; Kinyamu HK, 2003, MOL CELL BIOL, V23, P5867, DOI 10.1128/MCB.23.16.5867-5881.2003; Kuperwasser C, 2000, AM J PATHOL, V157, P2151, DOI 10.1016/S0002-9440(10)64853-5; KVALE G, 1988, CANCER-AM CANCER SOC, V62, P1625, DOI 10.1002/1097-0142(19881015)62:8<1625::AID-CNCR2820620828>3.0.CO;2-K; Li BL, 1997, MOL CELL BIOL, V17, P3155, DOI 10.1128/MCB.17.6.3155; Li BL, 1998, ONCOGENE, V16, P997, DOI 10.1038/sj.onc.1201621; Lingle WL, 1999, AM J PATHOL, V155, P1941, DOI 10.1016/S0002-9440(10)65513-7; Lingle WL, 2002, P NATL ACAD SCI USA, V99, P1978, DOI 10.1073/pnas.032479999; Lingle WL, 1998, P NATL ACAD SCI USA, V95, P2950, DOI 10.1073/pnas.95.6.2950; Mann RJ, 1999, ENDOCRINOLOGY, V140, P2592, DOI 10.1210/en.140.6.2592; Mayo LD, 2002, TRENDS BIOCHEM SCI, V27, P462, DOI 10.1016/S0968-0004(02)02166-7; McDermott KM, 2006, PLOS BIOL, V4, P350, DOI 10.1371/journal.pbio.0040051; MILLER CW, 1993, ONCOGENE, V8, P1815; Milliken EL, 2002, ENDOCRINOLOGY, V143, P3671, DOI 10.1210/en.2002-220228; Mohammad HP, 2003, ENDOCRINOLOGY, V144, P4626, DOI 10.1210/en.2003-0357; Pati D, 2004, CANCER RES, V64, P5608, DOI 10.1158/0008-5472.CAN-03-0629; Pharoah PDP, 1999, BRIT J CANCER, V80, P1968, DOI 10.1038/sj.bjc.6690628; Pihan GA, 1999, SEMIN CANCER BIOL, V9, P289, DOI 10.1006/scbi.1999.0131; Pihan GA, 2003, CANCER RES, V63, P1398; Romanov SR, 2001, NATURE, V409, P633, DOI 10.1038/35054579; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; Yahagi N, 2003, J BIOL CHEM, V278, P25395, DOI 10.1074/jbc.M302364200; Zell JA, 2002, LIFE SCI, V71, P2331, DOI 10.1016/S0024-3205(02)02045-3	47	8	9	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 13	2008	27	12					1759	1766		10.1038/sj.onc.1210815	http://dx.doi.org/10.1038/sj.onc.1210815			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	273WF	17891171	Green Accepted			2022-12-25	WOS:000253962100011
J	Aachmann, FL; Fomenko, DE; Soragni, A; Gladyshev, VN; Dikiy, A				Aachmann, Finn L.; Fomenko, Dmitri E.; Soragni, Alice; Gladyshev, Vadim N.; Dikiy, Alexander			Solution structure of selenoprotein W and NMR analysis of its interaction with 14-3-3 proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; 14-3-3 PROTEINS; BACKBONE DYNAMICS; THIOREDOXIN; PURIFICATION; SPECTROSCOPY; DATABASE; PROGRAM; BIOLOGY; MUSCLE	Selenium is a trace element with significant biomedical potential. It is essential in mammals due to its occurrence in several proteins in the form of selenocysteine ( Sec). One of the most abundant mammalian Sec-containing proteins is selenoprotein W (SelW). This protein of unknown function has a broad expression pattern and contains a candidate CXXU ( where U represents Sec) redox motif. Here, we report the solution structure of the Sec(13)-> Cys variant of mouse SelW determined through high resolution NMR spectroscopy. The protein has a thioredoxin-like fold with the CXXU motif located in an exposed loop similarly to the redox-active site in thioredoxin. Protein dynamics studies revealed the rigidity of the protein backbone and mobility of two external loops and suggested a role of these loops in interaction with SelW partners. Molecular modeling of structures of other members of the Rdx family based on the SelW structure identified new conserved features in these proteins, including an aromatic cluster and interacting loops. Our previous study suggested an interaction between SelW and 14-3-3 proteins. In the present work, with the aid of NMR spectroscopy, we demonstrated specificity of this interaction and identified mobile loops in SelW as interacting surfaces. This finding suggests that 14-3-3 are redox-regulated proteins.	[Aachmann, Finn L.; Soragni, Alice; Dikiy, Alexander] Norwegian Univ Sci & Technol, Dept Biotechnol, N-7491 Trondheim, Norway; [Fomenko, Dmitri E.; Gladyshev, Vadim N.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA	Norwegian University of Science & Technology (NTNU); University of Nebraska System; University of Nebraska Lincoln	Dikiy, A (corresponding author), Norwegian Univ Sci & Technol, Dept Biotechnol, N-7491 Trondheim, Norway.	alex.dikiy@biotech.ntnu.no	Aachmann, Finn/G-4136-2015; Gladyshev, Vadim N/A-9894-2013; Gladyshev, Vadim N/J-6187-2013	Aachmann, Finn/0000-0003-1613-4663; Soragni, Alice/0000-0002-6634-2885; Gladyshev, Vadim/0000-0002-0372-7016	NIGMS NIH HHS [GM061603] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061603] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beilstein MA, 1996, J INORG BIOCHEM, V61, P117, DOI 10.1016/0162-0134(95)00045-3; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Darling DL, 2005, CURR TOP DEV BIOL, V68, P281, DOI 10.1016/S0070-2153(05)68010-6; DeLano WL, 2002, PYMOL USERS MANUAL; Dikiy A, 2007, BIOCHEMISTRY-US, V46, P6871, DOI 10.1021/bi602462q; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Ferguson AD, 2006, J BIOL CHEM, V281, P3536, DOI 10.1074/jbc.M511386200; Flohe L, 2005, DEV OPHTHALMOL, V38, P89, DOI 10.1159/000082770; Fomenko DE, 2007, SCIENCE, V315, P387, DOI 10.1126/science.1133114; Gu QP, 2000, MOL CELL BIOCHEM, V204, P49, DOI 10.1023/A:1007065829068; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; GUNTERT P, 1991, J MOL BIOL, V217, P531, DOI 10.1016/0022-2836(91)90755-U; Halliwell B, 2006, PLANT PHYSIOL, V141, P312, DOI 10.1104/pp.106.077073; HATFIELD DL, 2006, SELENIUM MOL BIOL RO; Homans SW, 2004, ANGEW CHEM INT EDIT, V43, P290, DOI 10.1002/anie.200300581; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; KELLER R, 2004, THESIS SWISSS FEDERA; KLINE AD, 1988, J MOL BIOL, V204, P675, DOI 10.1016/0022-2836(88)90364-6; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Loflin J, 2006, J INORG BIOCHEM, V100, P1679, DOI 10.1016/j.jinorgbio.2006.05.018; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; Novoselov SV, 2007, J BIOL CHEM, V282, P11960, DOI 10.1074/jbc.M701605200; Pellecchia M, 2002, NAT REV DRUG DISCOV, V1, P211, DOI 10.1038/nrd748; Qi Y, 2005, PROTEINS, V58, P376, DOI 10.1002/prot.20329; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; Stadtman TC, 1996, ANNU REV BIOCHEM, V65, P83, DOI 10.1146/annurev.bi.65.070196.000503; Sun Y, 2001, J INORG BIOCHEM, V84, P151, DOI 10.1016/S0162-0134(00)00219-1; van Heusden GPH, 2005, IUBMB LIFE, V57, P623, DOI 10.1080/15216540500252666; VENDELAND SC, 1993, J BIOL CHEM, V268, P17103; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Zhang HY, 2003, J BIOMOL NMR, V25, P173, DOI 10.1023/A:1022836027055	36	71	80	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37036	37044		10.1074/jbc.M705410200	http://dx.doi.org/10.1074/jbc.M705410200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17928294	hybrid, Green Published			2022-12-25	WOS:000251646000030
J	Phelps, CB; Gaudet, R				Phelps, Christopher B.; Gaudet, Rachelle			The role of the N terminus and transmembrane domain of TRPM8 in channel localization and tetramerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MENTHOL RECEPTOR TRPM8; COLD RECEPTOR; CATION CHANNELS; ION-CHANNEL; ACTIVATION; REVEALS; TRPV1; THERMOSENSATION; DESENSITIZATION; TRAFFICKING	Transient receptor potential (TRP) channels are a family of cation channels involved in diverse cellular functions. They are composed of a transmembrane domain of six putative transmembrane segments flanked by large N- and C-terminal cytoplasmic domains. The melastatin subfamily (TRPM) channels have N- terminal domains of similar to 700 amino acids with four regions of shared homology and C-terminal domains containing the conserved TRP domain followed by a coiled-coil region. Here we investigated the effects of N- and C-terminal deletions on the cold and menthol receptor, TRPM8, expressed heterologously in Sf21 insect cells. Patch-clamp electrophysiology was used to study channel activity and revealed that only deletion of the first 39 amino acids was tolerated by the channel. Further N- terminal truncation or any C-terminal deletions prevented proper TRPM8 function. Confocal microscopy with immunofluorescence revealed that amino acids 40-86 are required for localization to the plasma membrane. Furthermore, analysis of deletion mutant oligomerization shows that the transmembrane domain is sufficient for TPRM8 assembly into tetramers. TRPM8 channels with C-terminal deletions tetramerize and localize properly but are inactive, indicating that although not essential for tetramerization and localization, the C terminus is critical for proper function of the channel sensor and/or gate.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Phelps, CB (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 7 Divinity Ave, Cambridge, MA 02138 USA.	gaudet@mcb.harvard.edu	Gaudet, Rachelle/I-4133-2014; Gaudet, Rachelle/Y-3985-2019	Gaudet, Rachelle/0000-0002-9177-054X; Gaudet, Rachelle/0000-0002-9177-054X				Andersson DA, 2004, J NEUROSCI, V24, P5364, DOI 10.1523/JNEUROSCI.0890-04.2004; Bandell M, 2006, NAT NEUROSCI, V9, P493, DOI 10.1038/nn1665; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Brauchi S, 2006, J NEUROSCI, V26, P4835, DOI 10.1523/JNEUROSCI.5080-05.2006; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Brauchi S, 2007, P NATL ACAD SCI USA, V104, P10246, DOI 10.1073/pnas.0703420104; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chuang HH, 2004, NEURON, V43, P859, DOI 10.1016/j.neuron.2004.08.038; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Dragoni I, 2006, J BIOL CHEM, V281, P37353, DOI 10.1074/jbc.M607227200; Erler I, 2006, J BIOL CHEM, V281, P38396, DOI 10.1074/jbc.M607756200; Fleig A, 2004, TRENDS PHARMACOL SCI, V25, P633, DOI 10.1016/j.tips.2004.10.004; Harteneck C, 2005, N-S ARCH PHARMACOL, V371, P307, DOI 10.1007/s00210-005-1034-x; Hui KY, 2005, BIOCHEM BIOPH RES CO, V333, P374, DOI 10.1016/j.bbrc.2005.05.123; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Kraft R, 2005, PFLUG ARCH EUR J PHY, V451, P204, DOI 10.1007/s00424-005-1428-0; Kwon Y, 2007, MOL CELL, V25, P491, DOI 10.1016/j.molcel.2007.01.021; Launay P, 2004, SCIENCE, V306, P1374, DOI 10.1126/science.1098845; Lis A, 2005, N-S ARCH PHARMACOL, V371, P315, DOI 10.1007/s00210-005-1050-x; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Liu BY, 2005, J NEUROSCI, V25, P4835, DOI 10.1523/JNEUROSCI.1296-05.2005; Liu BY, 2005, J NEUROSCI, V25, P1674, DOI 10.1523/JNEUROSCI.3632-04.2005; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Mei ZZ, 2006, J BIOL CHEM, V281, P38748, DOI 10.1074/jbc.M607591200; Minor DL, 2000, CELL, V102, P657, DOI 10.1016/S0092-8674(00)00088-X; MONTELL C, 2005, SCI STKE, P1; MONTELL C, 2001, SCI STKE, V90, P1; Nilius B, 2006, EMBO J, V25, P467, DOI 10.1038/sj.emboj.7600963; Nilius B, 2005, PFLUG ARCH EUR J PHY, V451, P1, DOI 10.1007/s00424-005-1462-y; Nilius B, 2005, J BIOL CHEM, V280, P6423, DOI 10.1074/jbc.M411089200; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Perraud AL, 2003, CELL CALCIUM, V33, P519, DOI 10.1016/S0143-4160(03)00057-5; Phelps Christopher B, 2007, Channels (Austin), V1, P148; Reid G, 2005, PFLUG ARCH EUR J PHY, V451, P250, DOI 10.1007/s00424-005-1437-z; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Stein AT, 2006, J GEN PHYSIOL, V128, P509, DOI 10.1085/jgp.200609576; Tsuruda PR, 2006, NEURON, V51, P201, DOI 10.1016/j.neuron.2006.06.023; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Voets T, 2007, NAT CHEM BIOL, V3, P174, DOI 10.1038/nchembio862; Zerangue N, 2000, P NATL ACAD SCI USA, V97, P3591, DOI 10.1073/pnas.060016797; Zhang L, 2004, CANCER RES, V64, P8365, DOI 10.1158/0008-5472.CAN-04-2146	44	56	58	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36474	36480		10.1074/jbc.M707205200	http://dx.doi.org/10.1074/jbc.M707205200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17908685	hybrid, Green Published			2022-12-25	WOS:000251458300039
J	Abid, MR; Spokes, KC; Shih, SC; Aird, WC				Abid, Md. Ruhul; Spokes, Katherine C.; Shih, Shou-Ching; Aird, William C.			NADPH oxidase activity selectively modulates vascular endothelial growth factor signaling pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; OXYGEN SPECIES PRODUCTION; ACTIVATED PROTEIN-KINASE; FOCAL ADHESION KINASE; ANGIOTENSIN-II; NAD(P)H OXIDASE; FACTOR-RECEPTOR; FACTOR VEGF; TYROSINE PHOSPHORYLATION; SUPEROXIDE-PRODUCTION	Vascular endothelial growth factor (VEGF) and reactive oxygen species (ROS) play critical roles in vascular physiology and pathophysiology. We have demonstrated previously that NADPH oxidase-derived ROS are required for VEGF-mediated migration and proliferation of endothelial cells. The goal of this study was to determine the extent to which VEGF signaling is coupled to NADPH oxidase activity. Human umbilical vein endothelial cells and/or human coronary artery endothelial cells were transfected with short interfering RNA against the p(47phox) subunit of NADPH oxidase, treated in the absence or presence of VEGF, and assayed for signaling, gene expression, and function. We show that NADPH oxidase activity is required for VEGF activation of phosphoinositide 3-kinase-Akt-forkhead, and p38 MAPK, but not ERK1/2 or JNK. The permissive role of NADPH oxidase on phosphoinositide 3-kinase-Akt-forkhead signaling is mediated at post-VEGF receptor levels and involves the nonreceptor tyrosine kinase Src. DNA microarrays revealed the existence of two distinct classes of VEGF-responsive genes, one that is ROS-dependent and another that is independent of ROS levels. VEGF-induced, thrombomodulin-dependent activation of protein C was dependent on NADPH oxidase activity, whereas VEGF-induced decay-accelerating factor-mediated protection of endothelial cells against complement- mediated lysis was not. Taken together, these findings suggest that NADPH oxidase-derived ROS selectively modulate some but not all the effects of VEGF on endothelial cell phenotypes.	Beth Israel Deaconess Med Ctr, Harvard Med Sch, Dept Med, Div Mol & Vasc Med, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Harvard Med Sch, Dept Pathol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Abid, MR (corresponding author), Beth Israel Deaconess Med Ctr, Harvard Med Sch, Dept Med, Div Mol & Vasc Med, Boston, MA 02215 USA.	rabid@bidmc.harvard.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082927, R01HL077348] Funding Source: NIH RePORTER; NHLBI NIH HHS [5R01HL077348, 5R01HL082927] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abid MR, 2006, J BIOL CHEM, V281, P35544, DOI 10.1074/jbc.M608620200; Abid MR, 2004, J BIOL CHEM, V279, P44030, DOI 10.1074/jbc.M408285200; Abid MR, 2001, FASEB J, V15, P2548, DOI 10.1096/fj.01-0338fje; Abid MR, 2000, FEBS LETT, V486, P252, DOI 10.1016/S0014-5793(00)02305-X; Abid R, 2004, ARTERIOSCL THROM VAS, V24, P294, DOI 10.1161/01.ATV.0000110502.10593.06; Ago T, 2004, CIRCULATION, V109, P227, DOI 10.1161/01.CIR.0000105680.92873.70; Al-Mehdi AB, 1998, CIRC RES, V83, P730, DOI 10.1161/01.RES.83.7.730; Alavi A, 2003, SCIENCE, V301, P94, DOI 10.1126/science.1082015; Ashton AW, 2004, CIRC RES, V95, P372, DOI 10.1161/01.RES.0000138300.41642.15; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Barash Y, 2004, BIOINFORMATICS, V20, P839, DOI 10.1093/bioinformatics/btg487; Bayraktutan U, 1998, CARDIOVASC RES, V38, P256, DOI 10.1016/S0008-6363(98)00003-0; Brandes RP, 2001, THROMB HAEMOSTASIS, V85, P1104; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Calnek DS, 1998, EXP CELL RES, V238, P294, DOI 10.1006/excr.1997.3812; Catarzi S, 2005, BBA-MOL CELL RES, V1745, P166, DOI 10.1016/j.bbamcr.2005.03.004; Chen JX, 2007, AM J PHYSIOL-HEART C, V292, pH1664, DOI 10.1152/ajpheart.01138.2006; Chen JX, 2006, AM J PHYSIOL-HEART C, V291, pH1563, DOI 10.1152/ajpheart.01081.2005; Chen Y, 2004, NITRIC OXIDE-BIOL CH, V11, P121; Chen ZQ, 1997, CANCER RES, V57, P2013; Claesson-Welsh L, 2003, BIOCHEM SOC T, V31, P20, DOI 10.1042/bst0310020; Colavitti R, 2002, J BIOL CHEM, V277, P3101, DOI 10.1074/jbc.M107711200; DANGELO G, 1995, P NATL ACAD SCI USA, V92, P6374, DOI 10.1073/pnas.92.14.6374; De Keulenaer GW, 1998, CIRC RES, V82, P1094, DOI 10.1161/01.RES.82.10.1094; Djordjevic T, 2005, ARTERIOSCL THROM VAS, V25, P519, DOI 10.1161/01.ATV.0000154279.98244.eb; Duerrschmidt N, 2000, BIOCHEM BIOPH RES CO, V269, P713, DOI 10.1006/bbrc.2000.2354; Dvorak HF, 2000, SEMIN PERINATOL, V24, P75, DOI 10.1016/S0146-0005(00)80061-0; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Folkman J, 2004, APMIS, V112, P496, DOI 10.1111/j.1600-0463.2004.apm11207-0809.x; Gorlach A, 2000, CIRC RES, V87, P26, DOI 10.1161/01.RES.87.1.26; GRIENDLING KK, 1994, CIRC RES, V74, P1141, DOI 10.1161/01.RES.74.6.1141; GUO DQ, 1995, J BIOL CHEM, V270, P6729, DOI 10.1074/jbc.270.12.6729; Guzik TJ, 2000, CIRC RES, V86, pE85, DOI 10.1161/01.RES.86.9.e85; Harfouche R, 2005, FASEB J, V19, P1728, DOI 10.1096/fj.04-3621fje; Heeneman S, 2000, J BIOL CHEM, V275, P15926, DOI 10.1074/jbc.M909616199; Holland JA, 1998, ENDOTHELIUM-NEW YORK, V6, P113, DOI 10.3109/10623329809072198; Holmqvist K, 2004, J BIOL CHEM, V279, P22267, DOI 10.1074/jbc.M312729200; HOWARD AB, 1997, AM J PHYSIOL, V272, pC4221; Hu TS, 2005, AM J PHYSIOL-RENAL, V289, pF816, DOI 10.1152/ajprenal.00024.2005; HUNTER T, 1987, CELL, V49, P1, DOI 10.1016/0092-8674(87)90745-8; Johnson EN, 2003, J BIOL CHEM, V278, P1686, DOI 10.1074/jbc.M210250200; Jones SA, 1996, AM J PHYSIOL-HEART C, V271, pH1626, DOI 10.1152/ajpheart.1996.271.4.H1626; Kanno S, 2000, ONCOGENE, V19, P2138, DOI 10.1038/sj.onc.1203533; Kerlin BA, 2003, BLOOD, V102, P3085, DOI 10.1182/blood-2003-06-1789; Korpelainen EI, 1999, ONCOGENE, V18, P1, DOI 10.1038/sj.onc.1202288; Kroll J, 1997, J BIOL CHEM, V272, P32521, DOI 10.1074/jbc.272.51.32521; Landmesser U, 2003, J CLIN INVEST, V111, P1201, DOI 10.1172/JCI200314172; Li JM, 2005, MOL CELL BIOL, V25, P2320, DOI 10.1128/MCB.25.6.2320-2330.2005; Li JM, 2004, CIRCULATION, V109, P1307, DOI 10.1161/01.CIR.0000118463.23388.B9; Li JM, 2003, J AM SOC NEPHROL, V14, pS221, DOI 10.1097/01.ASN.0000077406.67663.E7; Li JM, 2003, J BIOL CHEM, V278, P12094, DOI 10.1074/jbc.M209793200; Li JM, 2004, AM J PHYSIOL-REG I, V287, pR1014, DOI 10.1152/ajpregu.00124.2004; Li JM, 2001, CARDIOVASC RES, V52, P477, DOI 10.1016/S0008-6363(01)00407-2; Lin MT, 2003, MOL PHARMACOL, V64, P1029, DOI 10.1124/mol.64.5.1029; Mahadev K, 2001, J BIOL CHEM, V276, P21938, DOI 10.1074/jbc.C100109200; Marumo T, 1999, DIABETES, V48, P1131, DOI 10.2337/diabetes.48.5.1131; Mason JC, 2004, J BIOL CHEM, V279, P41611, DOI 10.1074/jbc.M407981200; Matsumoto T, 2005, EMBO J, V24, P2342, DOI 10.1038/sj.emboj.7600709; Matsumoto T, 2001, Sci STKE, V2001, pre21, DOI 10.1126/stke.2001.112.re21; Matsumoto T, 2006, J ATHEROSCLER THROMB, V13, P130, DOI 10.5551/jat.13.130; Mechtcheriakova D, 1999, BLOOD, V93, P3811, DOI 10.1182/blood.V93.11.3811.411k40_3811_3823; Mukhopadhyay D, 2004, MOL CELL BIOCHEM, V264, P51, DOI 10.1023/B:MCBI.0000044374.85095.df; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Osawa M, 2004, J BIOL CHEM, V279, P29691, DOI 10.1074/jbc.M309371200; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; SCHLAEPFER DD, 1994, NATURE, V372, P786; Shih SC, 2002, AM J PATHOL, V161, P35, DOI 10.1016/S0002-9440(10)64154-5; Simoncini T, 2000, CIRC RES, V87, P19, DOI 10.1161/01.RES.87.1.19; Stupack DG, 2004, CURR TOP DEV BIOL, V64, P207, DOI 10.1016/S0070-2153(04)64009-9; Tanimoto T, 2002, J BIOL CHEM, V277, P42997, DOI 10.1074/jbc.M204764200; Tojo T, 2005, CIRCULATION, V111, P2347, DOI 10.1161/01.CIR.0000164261.62586.14; Ushio-Fukai M, 2002, CIRC RES, V91, P1160, DOI 10.1161/01.RES.0000046227.65158.F8; Ushio-Fukai M, 2001, ARTERIOSCL THROM VAS, V21, P489, DOI 10.1161/01.ATV.21.4.489; Van Buul JD, 2005, ANTIOXID REDOX SIGN, V7, P308, DOI 10.1089/ars.2005.7.308; Wada Y, 2005, FASEB J, V19, P1914, DOI 10.1096/fj.05-4037fje; Wu RF, 2003, J BIOL CHEM, V278, P36830, DOI 10.1074/jbc.M302251200; Xia P, 1996, J CLIN INVEST, V98, P2018, DOI 10.1172/JCI119006; Xie ZL, 2001, J CELL PHYSIOL, V188, P132, DOI 10.1002/jcp.1104; Yamaoka-Tojo M, 2004, CIRC RES, V95, P276, DOI 10.1161/01.RES.0000136522.58649.60; Zachary I, 2000, ARTERIOSCL THROM VAS, V20, P1512, DOI 10.1161/01.ATV.20.6.1512; Zelzer E, 2005, CURR TOP DEV BIOL, V65, P169; Zhang JJ, 2004, KIDNEY INT, V66, P722, DOI 10.1111/j.1523-1755.2004.00794.x; Zhuo L, 1997, DEV BIOL, V187, P36, DOI 10.1006/dbio.1997.8601	83	123	127	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35373	35385		10.1074/jbc.M702175200	http://dx.doi.org/10.1074/jbc.M702175200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17908694	hybrid			2022-12-25	WOS:000251155200080
J	Li, JL; Wei, H; Chesley, A; Moon, C; Krawczyk, M; Volkova, M; Ziman, B; Margulies, KB; Talan, M; Crow, MT; Boheler, KR				Li, Jinliang; Wei, Hong; Chesley, Alan; Moon, Chanil; Krawczyk, Melissa; Volkova, Maria; Ziman, Bruce; Margulies, Kenneth B.; Talan, Mark; Crow, Michael T.; Boheler, Kenneth R.			The pro-angiogenic cytokine pleiotrophin potentiates cardiomyocyte apoptosis through inhibition of endogenous AKT/PKB activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-ASSOCIATED MOLECULE; ANAPLASTIC LYMPHOMA KINASE; GENE-EXPRESSION; PROTEIN-KINASE; BREAST-CANCER; IN-VITRO; HB-GAM; BINDING; RECEPTOR; CELLS	Pleiotrophin is a development-regulated cytokine and growth factor that can promote angiogenesis, cell proliferation, or differentiation, and it has been reported to have neovasculogenic effects in damaged heart. Developmentally, it is prominently expressed in fetal and neonatal hearts, but it is minimally expressed in normal adult heart. Conversely, we show in a rat model of myocardial infarction and in human dilated cardiomyopathy that pleiotrophin is markedly up-regulated. To elucidate the effects of pleiotrophin on cardiac contractile cells, we employed primary cultures of rat neonatal and adult cardiomyocytes. We show that pleiotrophin is released from cardiomyocytes in vitro in response to hypoxia and that the addition of recombinant pleiotrophin promotes caspase-mediated genomic DNA fragmentation in a dose-and time-dependent manner. Functionally, it potentiates the apoptotic response of neonatal cardiomyocytes to hypoxic stress and to ultraviolet irradiation and of adult cardiomyocytes to hypoxia-reoxygenation. Moreover, UV-induced apoptosis in neonatal cardiomyocytes can be partially inhibited by small interfering RNA-mediated knockdown of endogenous pleiotrophin. Mechanistically, pleiotrophin antagonizes IGF-1 associated Ser-473 phosphorylation of AKT/PKB, and it concomitantly decreases both BAD and GSK3 beta phosphorylation. Adenoviral expression of constitutively active AKT and lithium chloride-mediated inhibition of GSK3 beta reduce the potentiated programmed cell death elicited by pleiotrophin. These latter data indicate that pleiotrophin potentiates cardiomyocyte cell death, at least partially, through inhibition of AKT signaling. In conclusion, we have uncovered a novel function for pleiotrophin on heart cells following injury. It fosters cardiomyocyte programmed cell death in response to pro-apoptotic stress, which may be critical to myocardial injury repair.	NIA, NIH, GRC LCS, Cardiovasc Sci Lab, Baltimore, MD 21224 USA; Johns Hopkins Univ, Dept Med, Baltimore, MD 21224 USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University; University of Pennsylvania	Boheler, KR (corresponding author), NIA, NIH, GRC LCS, Cardiovasc Sci Lab, 5600 Nathan Shock Dr, Baltimore, MD 21224 USA.	bohelerk@grc.nia.nih.gov		Li, Jinliang/0000-0002-3018-0570	NHLBI NIH HHS [HL-073935] Funding Source: Medline; NIA NIH HHS [R01-AG017022] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000283, Z01AG000867, R01AG017022] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Anisimov SV, 2002, MECH DEVELOP, V117, P25, DOI 10.1016/S0925-4773(02)00177-6; Bao XF, 2005, J BIOL CHEM, V280, P9180, DOI 10.1074/jbc.M413423200; Bastias J, 2002, ANTICANCER RES, V22, P1603; Bernard-Pierrot I, 2002, J BIOL CHEM, V277, P32071, DOI 10.1074/jbc.M202747200; Boheler KR, 2003, P NATL ACAD SCI USA, V100, P2754, DOI 10.1073/pnas.0436564100; Bowden ET, 2002, J BIOL CHEM, V277, P35862, DOI 10.1074/jbc.M203963200; Chang YC, 2007, P NATL ACAD SCI USA, V104, P10888, DOI 10.1073/pnas.0704366104; Chen HW, 2004, HEART, V90, P927, DOI 10.1136/hrt.2002.006734; Chesley A, 2000, CIRC RES, V87, P1172, DOI 10.1161/01.RES.87.12.1172; Choudhuri R, 1997, CANCER RES, V57, P1814; Christman KL, 2005, BIOCHEM BIOPH RES CO, V332, P1146, DOI 10.1016/j.bbrc.2005.04.174; Christman KL, 2005, BIOMATERIALS, V26, P1139, DOI 10.1016/j.biomaterials.2004.04.025; Communal C, 1998, CIRCULATION, V98, P1329, DOI 10.1161/01.CIR.98.13.1329; Czubayko F, 1996, P NATL ACAD SCI USA, V93, P14753, DOI 10.1073/pnas.93.25.14753; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Deuel TF, 2002, ARCH BIOCHEM BIOPHYS, V397, P162, DOI 10.1006/abbi.2001.2705; FANG WJ, 1992, J BIOL CHEM, V267, P25889; HAMPTON BS, 1992, MOL BIOL CELL, V3, P85, DOI 10.1091/mbc.3.1.85; Hida H, 2003, EUR J NEUROSCI, V17, P2127, DOI 10.1046/j.1460-9568.2003.02661.x; IWAKI K, 1990, J BIOL CHEM, V265, P13809; Li JA, 1997, CIRC RES, V81, P785; Maeda N, 1996, J BIOL CHEM, V271, P21446, DOI 10.1074/jbc.271.35.21446; Margulies KB, 2005, CIRC RES, V96, P592, DOI 10.1161/01.RES.0000159390.03503.c3; Milev P, 1998, J BIOL CHEM, V273, P6998, DOI 10.1074/jbc.273.12.6998; MITSIADIS TA, 1995, DEVELOPMENT, V121, P37; Moon C, 2003, P NATL ACAD SCI USA, V100, P11612, DOI 10.1073/pnas.1930406100; Powers C, 2002, J BIOL CHEM, V277, P14153, DOI 10.1074/jbc.M112354200; Pufe T, 2003, ARTHRITIS RHEUM, V48, P660, DOI 10.1002/art.10839; RAUVALA H, 1989, EMBO J, V8, P2933, DOI 10.1002/j.1460-2075.1989.tb08443.x; RIEGEL AT, 1994, BREAST CANCER RES TR, V31, P309; Sato M, 1997, BIOCHEM BIOPH RES CO, V238, P831, DOI 10.1006/bbrc.1997.7403; Souttou B, 1997, J BIOL CHEM, V272, P19588, DOI 10.1074/jbc.272.31.19588; Souttou B, 2001, J CELL PHYSIOL, V187, P59, DOI 10.1002/1097-4652(2001)9999:9999<00::AID-JCP1051>3.0.CO;2-F; Spinale FG, 1996, J MOL CELL CARDIOL, V28, P1591, DOI 10.1006/jmcc.1996.0150; Stoica GE, 2001, J BIOL CHEM, V276, P16772, DOI 10.1074/jbc.M010660200; Taravini IRE, 2005, BRAIN RES, V1066, P196, DOI 10.1016/j.brainres.2005.10.055; TEZUKA K, 1990, BIOCHEM BIOPH RES CO, V173, P246, DOI 10.1016/S0006-291X(05)81048-4; Wang DJ, 2003, HYPERTENSION, V42, P88, DOI 10.1161/01.HYP.0000074905.22908.A6; Wu H, 2005, J CUTAN PATHOL, V32, P125, DOI 10.1111/j.0303-6987.2005.00282.x; Yeh HJ, 1998, J NEUROSCI, V18, P3699; Yin H, 2005, J BIOL CHEM, V280, P8022, DOI 10.1074/jbc.M407179200; Zhang YF, 2003, AM J PHYSIOL-HEART C, V284, pH2078, DOI 10.1152/ajpheart.00942.2001	43	32	33	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34984	34993		10.1074/jbc.M703513200	http://dx.doi.org/10.1074/jbc.M703513200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17925408	hybrid			2022-12-25	WOS:000251155200043
J	Mans, J; Natarajan, K; Balbo, A; Schuck, P; Eikel, D; Hess, S; Robinson, H; Simic, H; Jonjic, S; Tiemessen, CT; Margulies, DH				Mans, Janet; Natarajan, Kannan; Balbo, Andrea; Schuck, Peter; Eikel, Daniel; Hess, Sonja; Robinson, Howard; Simic, Hrvoje; Jonjic, Stipan; Tiemessen, Caroline T.; Margulies, David H.			Cellular expression and crystal structure of the murine cytomegalovirus major histocompatibility complex class I-like glycoprotein, m153	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLETE DNA-SEQUENCE; NATURAL-KILLER-CELLS; MOUSE CYTOMEGALOVIRUS; IMMUNOGLOBULIN SUPERFAMILY; IMMUNE EVASION; MOLECULES; RECEPTOR; LIGAND; ACTIVATION; HOMOLOG	Mouse cytomegalovirus (MCMV), a beta-herpesvirus that establishes latent and persistent infections in mice, is a valuable model for studying complex virus-host interactions. MCMV encodes the m145 family of putative immunoevasins with predicted major histocompatibility complex, class I (MHC-I) structure. Functions attributed to some family members include down-regulation of host MHC-I (m152) and NKG2D ligands (m145, m152, and m155) and interaction with inhibitory or activating NK receptors (m157). We present the cellular, biochemical, and structural characterization of m153, which is a heavily glycosylated homodimer, that does not require beta 2m or peptide and is expressed at the surface of MCMV-infected cells. Its 2.4-angstrom crystal structure confirms that this compact molecule preserves an MHC-I-like fold and reveals a novel mode of dimerization, confirmed by site-directed mutagenesis, and a distinctive disulfide-stabilized extended N terminus. The structure provides a useful framework for comparative analysis of the divergent members of the m145 family.	NIAID, Immunol Lab, Mol Biol Sect, Bethesda, MD 20892 USA; NIH, Off Director, Bethesda, MD 20892 USA; Prod Appl Lab, Ithaca, NY 14850 USA; CALTECH, Beckman Inst, Proteome Explorat Lab, Pasadena, CA 91125 USA; Brookhaven Natl Lab, Upton, NY 11973 USA; Univ Rijeka, Dept Histol & Embryol, Fac Med, Rijeka 51000, Croatia; Univ Witwatersrand, Dept Virol, ZA-2050 Johannesburg, South Africa; Natl Inst Communicable Dis, ZA-2131 Johannesburg, South Africa	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; California Institute of Technology; United States Department of Energy (DOE); Brookhaven National Laboratory; University of Rijeka; University of Witwatersrand; National Institute for Communicable Diseases (NICD)	Margulies, DH (corresponding author), NIAID, Immunol Lab, Mol Biol Sect, 10 Ctr Dr, Bethesda, MD 20892 USA.	dhm@nih.gov	Jonjic, Stipan/C-5657-2016; Hess, Sonja/K-4842-2013; Schuck, Peter/AAA-6888-2020; Simic, Hrvoje/S-8491-2018	Jonjic, Stipan/0000-0001-5003-3108; Hess, Sonja/0000-0002-5904-9816; Schuck, Peter/0000-0002-8859-6966; Simic, Hrvoje/0000-0001-8477-3198; Tiemessen, Caroline/0000-0002-0991-1690; Margulies, David/0000-0001-8530-7375; Mans, Janet/0000-0001-6721-1177	Intramural NIH HHS [Z01 AI000622-16] Funding Source: Medline; Wellcome Trust [076352] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI001028, Z01AI000622] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [Z01EB000008] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Adams EJ, 2007, P NATL ACAD SCI USA, V104, P10128, DOI 10.1073/pnas.0703735104; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alcami A, 2000, TRENDS MICROBIOL, V8, P410, DOI 10.1016/S0966-842X(00)01830-8; ALLEN H, 1986, P NATL ACAD SCI USA, V83, P7447, DOI 10.1073/pnas.83.19.7447; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; BECK S, 1988, NATURE, V331, P269, DOI 10.1038/331269a0; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BJORKMAN PJ, 1990, ANNU REV BIOCHEM, V59, P253, DOI 10.1146/annurev.bi.59.070190.001345; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; Bowness P, 2002, RHEUMATOLOGY, V41, P857, DOI 10.1093/rheumatology/41.8.857; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURMEISTER WP, 1994, NATURE, V372, P336, DOI 10.1038/372336a0; Chapman TL, 1998, J VIROL, V72, P460, DOI 10.1128/JVI.72.1.460-466.1998; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cosman D, 1997, IMMUNITY, V7, P273, DOI 10.1016/S1074-7613(00)80529-4; DeLano WL, 2002, PYMOL USERS MANUAL; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farrell HE, 1997, NATURE, V386, P510, DOI 10.1038/386510a0; FREMONT DH, 1992, SCIENCE, V257, P919, DOI 10.1126/science.1323877; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Halaby DM, 1998, J MOL EVOL, V46, P389, DOI 10.1007/PL00006318; Hasan M, 2005, J VIROL, V79, P2920, DOI 10.1128/JVI.79.5.2920-2930.2005; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Krmpotic A, 2005, J EXP MED, V201, P211, DOI 10.1084/jem.20041617; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Li PW, 2002, IMMUNITY, V16, P77, DOI 10.1016/S1074-7613(02)00258-3; Lodoen M, 2003, J EXP MED, V197, P1245, DOI 10.1084/jem.20021973; Lodoen MB, 2004, J EXP MED, V200, P1075, DOI 10.1084/jem.20040583; MARGULIES DH, IN PRESS FUNDAMENTAL; Mathys S, 2003, J INFECT DIS, V187, P988, DOI 10.1086/368094; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Natarajan K, 2006, J MOL BIOL, V358, P157, DOI 10.1016/j.jmb.2006.01.068; Natarajan K, 1999, Rev Immunogenet, V1, P32; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2005, ACTA CRYSTALLOGR D, V61, P465, DOI 10.1107/S0907444905001897; Rawlinson WD, 1996, J VIROL, V70, P8833, DOI 10.1128/JVI.70.12.8833-8849.1996; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shiroishi M, 2006, J BIOL CHEM, V281, P10439, DOI 10.1074/jbc.M512305200; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Smith LM, 2006, VIROLOGY, V352, P450, DOI 10.1016/j.virol.2006.04.031; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; TOWNSEND A, 1989, COLD SH Q B, V54, P299; Vink C, 2000, J VIROL, V74, P7656, DOI 10.1128/JVI.74.16.7656-7665.2000; Voigt V, 2003, P NATL ACAD SCI USA, V100, P13483, DOI 10.1073/pnas.2233572100; Wills MR, 2005, J IMMUNOL, V175, P7457, DOI 10.4049/jimmunol.175.11.7457	49	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35247	35258		10.1074/jbc.M706782200	http://dx.doi.org/10.1074/jbc.M706782200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17897947	hybrid, Green Accepted			2022-12-25	WOS:000251155200069
J	Nelson, MR; Luo, H; Vari, HK; Cox, BJ; Simmonds, AJ; Krause, HM; Lipshitz, HD; Smibert, CA				Nelson, Meryl R.; Luo, Hua; Vari, Heli K.; Cox, Brian J.; Simmonds, Andrew J.; Krause, Henry M.; Lipshitz, Howard D.; Smibert, Craig A.			A multiprotein complex that mediates translational enhancement in drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NANOS MESSENGER-RNA; KH-DOMAIN PROTEIN; BINDING PROTEIN; HNRNPA/B HOMOLOG; AFFINITY TAGS; IN-VITRO; YEAST; SCP160P; HRP48; SMAUG	Modulating the efficiency of translation plays an important role in a wide variety of cellular processes and is often mediated by trans-acting factors that interact with cis-acting sequences within the mRNA. Here we show that a cis-acting element, the Hsp83 degradation element (HDE), within the 3'-untranslated region of the Drosophila Hsp83 mRNA functions as a translational enhancer. We show that this element is bound by a multiprotein complex, and we identify components using a novel affinity-based method called tandem RNA affinity purification tagging. Three proteins (DDP1, Hrp48, and poly(A)-binding protein) are components of the HDE-binding complex and function in translational enhancement. Our data support a model whereby the HDE is composed of several cis-acting subelements that represent binding sites for trans-acting factors, and the combined action of these trans-acting factors underlies the ability of the HDE to stimulate translation.	Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada; Hosp Sick Children, Res Inst, Program Dev & Stem Cell Biol, Toronto, ON M5G 1L7, Canada; Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Alberta	Smibert, CA (corresponding author), 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	c.smibert@utoronto.ca	Simmonds, Andrew J/D-3675-2009	Krause, Henry/0000-0002-6182-7074; Simmonds, Andrew/0000-0001-7165-9302; Lipshitz, Howard/0000-0002-7372-4419				Bashirullah A, 1999, EMBO J, V18, P2610, DOI 10.1093/emboj/18.9.2610; Chagnovich D, 2001, P NATL ACAD SCI USA, V98, P11359, DOI 10.1073/pnas.201284398; CHOU TB, 1992, GENETICS, V131, P643; Chou TB, 1996, GENETICS, V144, P1673; Cortes A, 1999, EMBO J, V18, P3820, DOI 10.1093/emboj/18.13.3820; Cunningham KS, 2000, P NATL ACAD SCI USA, V97, P12498, DOI 10.1073/pnas.220425497; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Gallie DR, 2002, NUCLEIC ACIDS RES, V30, P3401, DOI 10.1093/nar/gkf457; Goodrich JS, 2004, DEVELOPMENT, V131, P1949, DOI 10.1242/dev.01078; Hammond LE, 1997, MOL CELL BIOL, V17, P7260, DOI 10.1128/MCB.17.12.7260; Hentze MW, 2007, TRANSLATIONAL CONTRO, P269; Hirao I, 1998, MOL DIVERS, V4, P75, DOI 10.1023/A:1026401917416; Huynh JR, 2004, DEV CELL, V6, P625, DOI 10.1016/S1534-5807(04)00130-3; Jaeger S, 2005, BIOCHIMIE, V87, P827, DOI 10.1016/j.biochi.2005.03.012; Kanamori H, 1998, MOL CELL BIOL, V18, P3991, DOI 10.1128/MCB.18.7.3991; Kosturko LD, 2006, MOL BIOL CELL, V17, P3521, DOI 10.1091/mbc.E05-10-0946; Kwon S, 1999, J CELL BIOL, V147, P247, DOI 10.1083/jcb.147.2.247; Lang BD, 2000, NUCLEIC ACIDS RES, V28, P1576, DOI 10.1093/nar/28.7.1576; Li AM, 2003, NUCLEIC ACIDS RES, V31, P1830, DOI 10.1093/nar/gkg284; Nelson MR, 2004, EMBO J, V23, P150, DOI 10.1038/sj.emboj.7600026; Roy G, 2004, MOL CELL BIOL, V24, P1143, DOI 10.1128/MCB.24.3.1143-1154.2004; SIEBEL CW, 1994, GENE DEV, V8, P1713, DOI 10.1101/gad.8.14.1713; Skabkina OV, 2003, J BIOL CHEM, V278, P18191, DOI 10.1074/jbc.M209073200; Smibert CA, 1999, RNA, V5, P1535, DOI 10.1017/S1355838299991392; Smibert CA, 1996, GENE DEV, V10, P2600, DOI 10.1101/gad.10.20.2600; Srisawat C, 2002, METHODS, V26, P156, DOI 10.1016/S1046-2023(02)00018-X; Srisawat C, 2001, RNA, V7, P632, DOI 10.1017/S135583820100245X; Wells DR, 1998, GENE DEV, V12, P3236, DOI 10.1101/gad.12.20.3236; Yano T, 2004, DEV CELL, V6, P637, DOI 10.1016/S1534-5807(04)00132-7	29	23	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34031	34038		10.1074/jbc.M706363200	http://dx.doi.org/10.1074/jbc.M706363200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17890223	hybrid			2022-12-25	WOS:000251145700017
J	Chae, K; Zhang, K; Zhang, L; Morikis, D; Kim, ST; Mollet, JC; de la Rosa, N; Tan, K; Lord, EM				Chae, Keun; Zhang, Kangling; Zhang, Li; Morikis, Dimitrios; Kim, Sun Tae; Mollet, Jean-Claude; de la Rosa, Noelle; Tan, Kimberly; Lord, Elizabeth M.			Two SCA (stigma/style cysteine-rich adhesin) Isoforms show structural differences that correlate with their levels of in vitro pollen tube adhesion activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-TRANSFER PROTEIN; ANTIMICROBIAL PROTEIN; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; ACYL-BINDING; SWISS-MODEL; MAIZE; FLUORESCENCE; EXPRESSION; ELECTROSTATICS	Lily pollen tubes grow adhering to an extracellular matrix produced by the transmitting tract epidermis in a hollow style. SCA, a small (similar to 9.4 kDa), basic protein plus low esterified pectin from this extracellular matrix are involved in the pollen tube adhesion event. The mode of action for this adhesion event is unknown. We partially separated three SCA iso-forms from the lily stigma in serial size exclusion column fractions (SCA1, 9370 Da; SCA2, 9384 Da; SCA3, 9484 Da). Peptide sequencing analysis allowed us to determine two amino acid variations in SCA3, compared with SCA1. For SCA2, however, there are more sequence variations yet to be identified. Our structural homology and molecular dynamics modeling results show that SCA isoforms have the plant nonspecific lipid transfer protein-like structure: a globular shape of the orthogonal 4-helix bundle architecture, four disulfide bonds, an internal hydrophobic and solvent-inaccessible cavity, and a long C-terminal tail. The Ala(71) in SCA3, replacing the Gly(71) in SCA1, has no predictable effect on structure. The Arg(26) in SCA3, replacing the Gly(26) in SCA1, is predicted to cause structural changes that result in a significantly reduced volume for the internal hydrophobic cavity in SCA3. The volume of the internal cavity fluctuates slightly during the molecular dynamics simulation, but overall, SCA1 displays a larger cavity than SCA3. SCA1 displays higher activity than SCA3 in the in vitro pollen tube adhesion assay. No differences were found between the two SCAs in a binding assay with pectin. The larger size of the hydrophobic cavity in SCA1 correlates with its higher adhesion activity.	Univ Calif Riverside, Ctr Plant Cell Biol, Dept Bot & Plant Sci, Riverside, CA 92521 USA; Univ Calif Riverside, Mass Spectrometry Facil, Riverside, CA 92521 USA; Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA; Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA; Gyeongsang Natl Univ, Environm Biotechnol Natl Core Res Ctr, Jinju 660701, South Korea; Univ Rouen, CNRS, UMR 6037, IRFPM 23,Lab Glycobiol & Transports Chez Vegetaux, F-76821 Mont St Aignan, France	University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; Gyeongsang National University; Centre National de la Recherche Scientifique (CNRS); Universite de Rouen Normandie	Lord, EM (corresponding author), Univ Calif Riverside, Ctr Plant Cell Biol, Dept Bot & Plant Sci, Riverside, CA 92521 USA.	lord@ucr.edu	Morikis, Dimitrios/L-8527-2013	Morikis, Dimitrios/0000-0003-0083-4665; Mollet, Jean-Claude/0000-0001-8717-0034				Adcock SA, 2006, CHEM REV, V106, P1589, DOI 10.1021/cr040426m; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Antosiewicz J, 1996, BIOCHEMISTRY-US, V35, P7819, DOI 10.1021/bi9601565; Arondel V, 2000, PLANT SCI, V157, P1, DOI 10.1016/S0168-9452(00)00232-6; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BERNHARD WR, 1991, PLANT PHYSIOL, V95, P164, DOI 10.1104/pp.95.1.164; BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; CAMMUE BRUNO PA, 1995, PLANT PHYSIOL, V109, P445, DOI 10.1104/pp.109.2.445; Capocchi A, 2005, J AGR FOOD CHEM, V53, P7976, DOI 10.1021/jf0580465; Castro MS, 2003, J CHROMATOGR B, V794, P109, DOI 10.1016/S1570-0232(03)00423-9; Charvolin D, 1999, EUR J BIOCHEM, V264, P562, DOI 10.1046/j.1432-1327.1999.00667.x; Da Silva P, 2005, PROTEINS, V59, P356, DOI 10.1002/prot.20405; Dominy BN, 1999, J PHYS CHEM B, V103, P3765, DOI 10.1021/jp984440c; Dong J, 2005, PLANT PHYSIOL, V138, P778, DOI 10.1104/pp.105.063388; Douliez JP, 2000, BBA-BIOMEMBRANES, V1467, P65, DOI 10.1016/S0005-2736(00)00197-8; Douliez JP, 2001, EUR J BIOCHEM, V268, P384, DOI 10.1046/j.1432-1033.2001.01889.x; Douliez JP, 2001, EUR J BIOCHEM, V268, P1400, DOI 10.1046/j.1432-1327.2001.02007.x; Douliez JP, 2000, J CEREAL SCI, V32, P1, DOI 10.1006/jcrs.2000.0315; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; GILSON MK, 1993, PROTEINS, V15, P266, DOI 10.1002/prot.340150305; Gomar J, 1996, PROTEIN SCI, V5, P565; Gomar J, 1997, FOLD DES, V2, P183, DOI 10.1016/S1359-0278(97)00025-4; Gomar J, 1998, PROTEINS, V31, P160, DOI 10.1002/(SICI)1097-0134(19980501)31:2<160::AID-PROT6>3.0.CO;2-Q; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hamilton JA, 2004, PROG LIPID RES, V43, P177, DOI 10.1016/j.plipres.2003.09.002; Han GW, 2001, J MOL BIOL, V308, P263, DOI 10.1006/jmbi.2001.4559; Heinemann B, 1996, PROTEIN SCI, V5, P13; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Jauh GY, 1997, SEX PLANT REPROD, V10, P173, DOI 10.1007/s004970050085; Kader JC, 1997, TRENDS PLANT SCI, V2, P66, DOI 10.1016/S1360-1385(97)82565-4; Kader JC, 1996, ANNU REV PLANT PHYS, V47, P627, DOI 10.1146/annurev.arplant.47.1.627; Kim S, 2003, P NATL ACAD SCI USA, V100, P16125, DOI 10.1073/pnas.2533800100; Kim ST, 2006, PLANT PHYSIOL, V142, P1397, DOI 10.1104/pp.106.086801; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lerche MH, 1998, PROTEIN SCI, V7, P2490, DOI 10.1002/pro.5560071202; Lin KF, 2005, BIOCHEMISTRY-US, V44, P5703, DOI 10.1021/bi047608v; Liu YJ, 2002, BIOCHEM BIOPH RES CO, V294, P535, DOI 10.1016/S0006-291X(02)00509-0; Lord E, 2000, TRENDS PLANT SCI, V5, P368, DOI 10.1016/S1360-1385(00)01744-1; Lord EM, 2003, J EXP BOT, V54, P47, DOI 10.1093/jxb/54.380.47; Lord EM, 2002, ANNU REV CELL DEV BI, V18, P81, DOI 10.1146/annurev.cellbio.18.012502.083438; Lord EM, 2001, SEX PLANT REPROD, V14, P57, DOI 10.1007/s004970100076; MADURA JD, 1995, COMPUT PHYS COMMUN, V91, P57, DOI 10.1016/0010-4655(95)00043-F; Maldonado AM, 2002, NATURE, V419, P399, DOI 10.1038/nature00962; Molina A, 1997, PLANT J, V12, P669, DOI 10.1046/j.1365-313X.1997.00669.x; Mollet JC, 2000, PLANT CELL, V12, P1737, DOI 10.1105/tpc.12.9.1737; Mollet Jean-Claude, 2007, V25, P69, DOI 10.1002/9780470988824.ch4; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nieuwland J, 2005, PLANT CELL, V17, P2009, DOI 10.1105/tpc.105.032094; OSTERGAARD J, 1995, BBA-LIPID LIPID MET, V1254, P169, DOI 10.1016/0005-2760(94)00180-7; Park SY, 2003, PLANT MOL BIOL, V51, P183, DOI 10.1023/A:1021139502947; Park SY, 2000, PLANT CELL, V12, P151, DOI 10.1105/tpc.12.1.151; Petsko G., 2004, PROTEIN STRUCTURE FU; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SHIN DH, 1995, STRUCTURE, V3, P189, DOI 10.1016/S0969-2126(01)00149-6; Sitkoff D, 1996, J PHYS CHEM-US, V100, P2744, DOI 10.1021/jp952986i; Sodano P, 1997, FEBS LETT, V416, P130, DOI 10.1016/S0014-5793(97)01185-X; Tassin S, 1998, BIOCHEMISTRY-US, V37, P3623, DOI 10.1021/bi9723515; THOMA S, 1994, PLANT PHYSIOL, V105, P35, DOI 10.1104/pp.105.1.35; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VIGNOLS F, 1994, GENE, V142, P265, DOI 10.1016/0378-1119(94)90272-0; Wu JZ, 2006, FLUID PHASE EQUILIBR, V241, P317, DOI 10.1016/j.fluid.2005.12.044; YANG AS, 1993, J MOL BIOL, V231, P459, DOI 10.1006/jmbi.1993.1294; Zachowski A, 1998, EUR J BIOCHEM, V257, P443, DOI 10.1046/j.1432-1327.1998.2570443.x	65	27	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33845	33858		10.1074/jbc.M703997200	http://dx.doi.org/10.1074/jbc.M703997200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17878166	Green Published, hybrid			2022-12-25	WOS:000250840200066
J	Kurimoto, E; Suzuki, M; Amemiya, E; Yamaguchi, Y; Nirasawa, S; Shimba, N; Xu, N; Kashiwagi, T; Kawai, M; Suzuki, E; Kato, K				Kurimoto, Eiji; Suzuki, Maiko; Amemiya, Eiko; Yamaguchi, Yoshiki; Nirasawa, Satoru; Shimba, Nobuhisa; Xu, Ningchun; Kashiwagi, Tatsuki; Kawai, Misako; Suzuki, Ei-ichiro; Kato, Koichi			Curculin exhibits sweet-tasting and taste-modifying activities through its distinct molecular surfaces	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOTECHNOLOGICAL PRODUCTION; PROTEIN; NEOCULIN; PURIFICATION; BRAZZEIN; RECEPTOR; MONELLIN; REGIONS; SYSTEM; FRUIT	Curculin isolated from Curculigo latifolia, a plant grown in Malaysia, has an intriguing property of modifying sour taste into sweet taste. In addition to this taste-modifying activity, curculin itself elicits a sweet taste. Although these activities have been attributed to the heterodimeric isoform and not homodimers of curculin, the underlying mechanisms for the dual action of this protein have been largely unknown. To identify critical sites for these activities, we performed a mutational and structural study of recombinant curculin. Based on the comparison of crystal structures of curculin homo- and heterodimers, a series of mutants was designed and subjected to tasting assays. Mapping of amino acid residues on the three-dimensional structure according to their mutational effects revealed that the curculin heterodimer exhibits sweet-tasting and taste-modifying activities through its partially overlapping but distinct molecular surfaces. These findings suggest that the two activities of the curculin heterodimer are expressed through its two different modes of interactions with the T1R2-T1R3 heterodimeric sweet taste receptor.	Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi 4678603, Japan; Natl Food Res Inst, Enzyme Lab, Tsukuba, Ibaraki 3058642, Japan; Ajinomoto Co Inc, Inst Life Sci, Kawasaki Ku, Kawasaki, Kanagawa 2108681, Japan; Natl Inst Nat Sci, Inst Mol Sci, Aichi 4448787, Japan	Nagoya City University; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan; Ajinomoto Co Inc; National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS)	Kato, K (corresponding author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, 3-1 Tanabe Dori, Nagoya, Aichi 4678603, Japan.	kkato@phar.nagoya-cu.ac.jp	Yamaguchi, Yoshiki/N-5246-2015	Yamaguchi, Yoshiki/0000-0003-0100-5439; Kato, Koichi/0000-0001-7187-9612				ABE K, 1992, BIOCHIM BIOPHYS ACTA, V1130, P232, DOI 10.1016/0167-4781(92)90537-A; ARIYOSHI Y, 1994, J SYN ORG CHEM JPN, V52, P359, DOI 10.5059/yukigoseikyokaishi.52.359; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Faus I, 2000, APPL MICROBIOL BIOT, V53, P145, DOI 10.1007/s002530050001; Jiang PH, 2005, J BIOL CHEM, V280, P15238, DOI 10.1074/jbc.M414287200; Jiang PH, 2004, J BIOL CHEM, V279, P45068, DOI 10.1074/jbc.M406779200; Jin ZY, 2003, FEBS LETT, V544, P33, DOI 10.1016/S0014-5793(03)00383-1; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Masuda T, 2006, J BIOSCI BIOENG, V102, P375, DOI 10.1263/jbb.102.375; Nakajima K, 2006, NEUROREPORT, V17, P1241, DOI 10.1097/01.wnr.0000230513.01339.3b; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Shimizu-Ibuka A, 2006, J MOL BIOL, V359, P148, DOI 10.1016/j.jmb.2006.03.030; Shirasuka Y, 2004, BIOSCI BIOTECH BIOCH, V68, P1403, DOI 10.1271/bbb.68.1403; SOMOZA JR, 1995, CHEM SENSES, V20, P61, DOI 10.1093/chemse/20.1.61; Suzuki M, 2004, FEBS LETT, V573, P135, DOI 10.1016/j.febslet.2004.07.073; Temussi PA, 2006, CELL MOL LIFE SCI, V63, P1876, DOI 10.1007/s00018-006-6077-8; THEERASILP S, 1988, J BIOL CHEM, V263, P11536; Walters DE, 2006, J AGR FOOD CHEM, V54, P10129, DOI 10.1021/jf062359y; YAMASHITA H, 1990, J BIOL CHEM, V265, P15770; YAMASHITA H, 1995, CHEM SENSES, V20, P239, DOI 10.1093/chemse/20.2.239	24	24	26	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33252	33256		10.1074/jbc.C700174200	http://dx.doi.org/10.1074/jbc.C700174200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17895249	hybrid			2022-12-25	WOS:000250840200004
J	Scanzano, R; Segall, L; Blostein, R				Scanzano, Rosemarie; Segall, Laura; Blostein, Rhoda			Specific sites in the cytoplasmic N terminus modulate conformational transitions of the Na,K-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-ALPHA-1 NA,K-ATPASE; ALANINE MUTAGENESIS; CATALYTIC SUBUNIT; CLUSTERED CHARGE; EXPRESSION; SUBSTITUTIONS; CA2+-ATPASE; ALPHA-2	The cytoplasmic N terminus of the Na,K-ATPase is a highly charged and flexible structure that comprises three predicted helical regions including H1 spanning residues 27 to 33 and H2 spanning residues 42 to 50. Previous deletion mutagenesis experiments showed that deletion of residues up to and including most of H2 shifts the E-1/E-2 conformational equilibrium toward E-1. The present study describes a clustered charge-to-alanine mutagenesis approach designed to delineate specific sites within the N terminus that modulate the steady-state E-1 <-> E-2 and E1P <-> E2P poise. Criteria to assess shifts in poise include (i) sensitivity to inhibition by inorganic orthovanadate to assess overall poise; (ii) K+- sensitivity of Na-ATPase measured at micromolar ATP to assess changes in the E-2(K) + ATP -> E-1 center dot ATP + K+ rate; (iii) K'(ATP) for low-affinity ATP binding at the latter step; (iv) overall catalytic turnover, and (v) the E1P -> E2P transition. The results of alanine replacements in H1 (31KKE) suggest that this site stabilizes E2P and to a lesser extent E2. In H2, residues within 47HRK have a role in stabilizing E2 but not E2P as revealed with double mutants 31KKE 3 AAA/47H -> A and 31KKE -> AAA/47HRK -> AAA. Taken together, these observations suggest that sites 31KKE in H1 and 47HRK in H2 have distinct roles in modulating the enzyme's conformational transitions during the catalytic cycle of the enzyme.	McGill Univ, Dept Biochem, Montreal, PQ H3G 1A4, Canada; McGill Univ, Dept Med, Montreal, PQ H3G 1A4, Canada	McGill University; McGill University	Blostein, R (corresponding author), Montreal Gen Hosp, Res Inst, 1650 Cedar Ave,Rm L11-132, Montreal, PQ H3G 1A4, Canada.	Rhoda.Blostein@mcgill.ca						BENNETT WF, 1991, J BIOL CHEM, V266, P5191; Boxenbaum N, 1998, J BIOL CHEM, V273, P23086, DOI 10.1074/jbc.273.36.23086; DALY SE, 1994, J BIOL CHEM, V269, P23944; Daly SE, 1996, J BIOL CHEM, V271, P23683, DOI 10.1074/jbc.271.39.23683; DeMasi J, 2000, J VIROL, V74, P2393, DOI 10.1128/JVI.74.5.2393-2405.2000; FORBUSH B, 1983, ANAL BIOCHEM, V128, P159, DOI 10.1016/0003-2697(83)90356-1; Huang KN, 1997, MOL CELL BIOL, V17, P4654, DOI 10.1128/MCB.17.8.4654; JEWELL EA, 1991, J BIOL CHEM, V266, P16925; Jorgensen PL, 2003, ANNU REV PHYSIOL, V65, P817, DOI 10.1146/annurev.physiol.65.092101.142558; JORGENSEN PL, 1988, J MEMBRANE BIOL, V103, P95, DOI 10.1007/BF01870942; JORGENSEN PL, 1975, BIOCHIM BIOPHYS ACTA, V401, P399, DOI 10.1016/0005-2736(75)90239-4; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; KLODOS I, 1994, J BIOL CHEM, V269, P1734; LANE LK, 1993, J BIOL CHEM, V268, P17930; LANE LK, 1993, BIOCHEM MOL BIOL INT, V31, P817; Mahmmoud YA, 2003, J BIOL CHEM, V278, P37427, DOI 10.1074/jbc.M305126200; Markwell M A, 1981, Methods Enzymol, V72, P296; Miyakawa-Naito A, 2003, J BIOL CHEM, V278, P50355, DOI 10.1074/jbc.M305378200; MUNZER JS, 1994, J BIOL CHEM, V269, P16668; Palmgren MG, 1998, BBA-BIOENERGETICS, V1365, P37, DOI 10.1016/S0005-2728(98)00041-3; Segall L, 2002, J BIOL CHEM, V277, P35202, DOI 10.1074/jbc.M206115200; SHANBAKY NM, 1994, AM J PHYSIOL, V267, pC590, DOI 10.1152/ajpcell.1994.267.2.C590; SILENCE K, 1995, J BIOL CHEM, V270, P27192, DOI 10.1074/jbc.270.45.27192; Sweadner KJ, 2001, BIOCHEM J, V356, P685, DOI 10.1042/0264-6021:3560685; Toyoshima C, 2003, ANN NY ACAD SCI, V986, P1, DOI 10.1111/j.1749-6632.2003.tb07131.x; TOYOSHIMA C, 2004, ANN REV BOCHEM, V277, P35202; Vilsen B, 1997, BIOCHEMISTRY-US, V36, P13312, DOI 10.1021/bi971030q; Zhang SB, 2006, J BIOL CHEM, V281, P21954, DOI 10.1074/jbc.M601578200; [No title captured]	29	8	8	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46							33691	10.1074/jbc.M705899200	http://dx.doi.org/10.1074/jbc.M705899200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17881356	hybrid			2022-12-25	WOS:000250840200050
J	Louie, GV; Baiga, TJ; Bowman, ME; Koeduka, T; Taylor, JH; Spassova, SM; Pichersky, E; Noel, JP				Louie, Gordon V.; Baiga, Thomas J.; Bowman, Marianne E.; Koeduka, Takao; Taylor, John H.; Spassova, Snejina M.; Pichersky, Eran; Noel, Joseph P.			Structure and Reaction Mechanism of Basil Eugenol Synthase	PLOS ONE			English	Article							BENZYLIC ETHER REDUCTASES; PINORESINOL-LARICIRESINOL; BIOSYNTHESIS; CHAIN; COENZYME; PROGRAM	Phenylpropenes, a large group of plant volatile compounds that serve in multiple roles in defense and pollinator attraction, contain a propenyl side chain. Eugenol synthase (EGS) catalyzes the reductive displacement of acetate from the propenyl side chain of the substrate coniferyl acetate to produce the allyl-phenylpropene eugenol. We report here the structure determination of EGS from basil (Ocimum basilicum) by protein x-ray crystallography. EGS is structurally related to the short-chain dehydrogenase/reductases (SDRs), and in particular, enzymes in the isoflavone-reductase-like subfamily. The structure of a ternary complex of EGS bound to the cofactor NADP(H) and a mixed competitive inhibitor EMDF ((7S,8S)-ethyl (7,8-methylene)-dihydroferulate) provides a detailed view of the binding interactions within the EGS active site and a starting point for mutagenic examination of the unusual reductive mechanism of EGS. The key interactions between EMDF and the EGS-holoenzyme include stacking of the phenyl ring of EMDF against the cofactor's nicotinamide ring and a water-mediated hydrogen-bonding interaction between the EMDF 4-hydroxy group and the side-chain amino moiety of a conserved lysine residue, Lys132. The C4 carbon of nicotinamide resides immediately adjacent to the site of hydride addition, the C7 carbon of cinnamyl acetate substrates. The inhibitor-bound EGS structure suggests a two-step reaction mechanism involving the formation of a quinone-methide prior to reduction. The formation of this intermediate is promoted by a hydrogen-bonding network that favors deprotonation of the substrate's 4-hydroxyl group and disfavors binding of the acetate moiety, akin to a push-pull catalytic mechanism. Notably, the catalytic involvement in EGS of the conserved Lys132 in preparing the phenolic substrate for quinone methide formation through the proton-relay network appears to be an adaptation of the analogous role in hydrogen bonding played by the equivalent lysine residue in other enzymes of the SDR family.	[Louie, Gordon V.; Baiga, Thomas J.; Bowman, Marianne E.; Taylor, John H.; Spassova, Snejina M.; Noel, Joseph P.] Salk Inst Biol Studies, Howard Hughes Med Inst, Jack H Skirball Ctr Chem Biol & Prote, La Jolla, CA 92037 USA; [Koeduka, Takao; Pichersky, Eran] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	Howard Hughes Medical Institute; Salk Institute; University of Michigan System; University of Michigan	Noel, JP (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, Jack H Skirball Ctr Chem Biol & Prote, La Jolla, CA 92037 USA.	noel@salk.edu	Noel, Joseph P/A-9459-2009		National Science Foundation [0331353, 0312466, 0718152, 0236027, 0718064]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation grants 0331353, 0312466 and 0718152 to EP and 0236027 and 0718064 to JNP. JPN is an investigator of the Howard Hughes Medical Institute.	Akashi T, 2006, FEBS LETT, V580, P5666, DOI 10.1016/j.febslet.2006.09.016; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carugo O, 1997, PROTEINS, V28, P10, DOI 10.1002/(SICI)1097-0134(199705)28:1<10::AID-PROT2>3.3.CO;2-R; Dexter R, 2007, PLANT J, V49, P265, DOI 10.1111/j.1365-313X.2006.02954.x; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; Fujita M, 1999, J BIOL CHEM, V274, P618, DOI 10.1074/jbc.274.2.618; Gang DR, 2001, PLANT PHYSIOL, V125, P539, DOI 10.1104/pp.125.2.539; Gang DR, 1999, J BIOL CHEM, V274, P7516, DOI 10.1074/jbc.274.11.7516; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kallberg Y, 2002, EUR J BIOCHEM, V269, P4409, DOI 10.1046/j.1432-1033.2002.03130.x; Koeduka T, 2006, P NATL ACAD SCI USA, V103, P10128, DOI 10.1073/pnas.0603732103; Kolappan S, 2007, BIOCHEMISTRY-US, V46, P946, DOI 10.1021/bi0608515; Koumanov A, 2003, PROTEINS, V51, P289, DOI 10.1002/prot.10354; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Min TP, 2003, J BIOL CHEM, V278, P50714, DOI 10.1074/jbc.M308493200; Pichersky E, 2006, SCIENCE, V311, P808, DOI 10.1126/science.1118510; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shi R, 2004, J BIOL CHEM, V279, P16778, DOI 10.1074/jbc.M313156200; Tanaka M, 2005, PLOS BIOL, V3, P764, DOI 10.1371/journal.pbio.0030128; Tanner GJ, 2003, J BIOL CHEM, V278, P31647, DOI 10.1074/jbc.M302783200; Thoden JB, 1997, BIOCHEMISTRY-US, V36, P6294, DOI 10.1021/bi970025j; Toteva MM, 2003, J AM CHEM SOC, V125, P8814, DOI 10.1021/ja029588v; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vassao DG, 2006, ORG BIOMOL CHEM, V4, P2733, DOI 10.1039/b605407b; Wang XQ, 2006, J MOL BIOL, V358, P1341, DOI 10.1016/j.jmb.2006.03.022	30	35	36	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e993	10.1371/journal.pone.0000993	http://dx.doi.org/10.1371/journal.pone.0000993			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912370	Green Published, gold			2022-12-25	WOS:000207455900029
J	Beck, CW; Promislow, DEL				Beck, Christopher W.; Promislow, Daniel E. L.			Evolution of Female Preference for Younger Males	PLOS ONE			English	Article							SONG REPERTOIRE SIZE; SEXUAL SELECTION; MATE CHOICE; MALE AGE; OLDER MALES; GOOD GENES; SPONTANEOUS MUTATION; PARENTAL AGE; ORNAMENTATION; MAINTENANCE	Previous theoretical work has suggested that females should prefer to mate with older males, as older males should have higher fitness than the average fitness of the cohort into which they were born. However, studies in humans and model organisms have shown that as males age, they accumulate deleterious mutations in their germ-line at an ever-increasing rate, thereby reducing the quality of genes passed on to the next generation. Thus, older males may produce relatively poor-quality offspring. To better understand how male age influences female mate preference and offspring quality, we used a genetic algorithm model to study the effect of age-related increases in male genetic load on female mate preference. When we incorporate age-related increases in mutation load in males into our model, we find that females evolve a preference for younger males. Females in this model could determine a male's age, but not his inherited genotype nor his mutation load. Nevertheless, females evolved age-preferences that led them to mate with males that had low mutation loads, but showed no preference for males with respect to their somatic quality. These results suggest that germ-line quality, rather than somatic quality, should be the focus of female preference in good genes models.	[Beck, Christopher W.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Promislow, Daniel E. L.] Univ Georgia, Dept Genet, Athens, GA 30602 USA	Emory University; University System of Georgia; University of Georgia	Beck, CW (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	christopher.beck@emory.edu		Promislow, Daniel/0000-0001-7088-4495; Beck, Christopher/0000-0002-1073-1363	Ellison Medical Foundation	Ellison Medical Foundation(Lawrence Ellison Foundation)	Daniel Promislow was supported by a Senior Scholar Award from the Ellison Medical Foundation.	Agrawal AF, 2001, NATURE, V411, P692, DOI 10.1038/35079590; Andersson Malte, 1994; Beck CW, 2000, EVOL ECOL RES, V2, P107; Beck CW, 2002, EVOL ECOL RES, V4, P275; Bertram SM, 2000, ANIM BEHAV, V60, P333, DOI 10.1006/anbe.2000.1473; Brooks R, 2001, TRENDS ECOL EVOL, V16, P308, DOI 10.1016/S0169-5347(01)02147-4; Charlesworth B, 2001, J THEOR BIOL, V210, P47, DOI 10.1006/jtbi.2001.2296; Charlesworth B, 1987, SEXUAL SELECTION TES, P21; COSENS SE, 1986, CAN J ZOOL, V64, P1926, DOI 10.1139/z86-289; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Crow JF, 2006, J RADIAT RES, V47, pB75, DOI 10.1269/jrr.47.B75; Crow JF, 1997, P NATL ACAD SCI USA, V94, P8380, DOI 10.1073/pnas.94.16.8380; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Dean R, 2007, SCIENCE, V316, P383, DOI 10.1126/science.1142201; Ellegren H, 2007, P ROY SOC B-BIOL SCI, V274, P1, DOI 10.1098/rspb.2006.3720; Felton A, 2006, BEHAV ECOL SOCIOBIOL, V59, P786, DOI 10.1007/s00265-005-0124-6; Fuller RC, 2005, AM NAT, V166, P437, DOI 10.1086/444443; Gavrilov LA, 1997, MUTAT RES-FUND MOL M, V377, P61, DOI 10.1016/S0027-5107(97)00058-4; Gil D, 2001, ANIM BEHAV, V62, P689, DOI 10.1006/anbe.2001.1812; GLASER RL, 2004, SCI AGING KNOWLEDGE, pRE1, DOI DOI 10.1126/SAGEKE.2004.3.RE1; Goriely A, 2003, SCIENCE, V301, P643, DOI 10.1126/science.1085710; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; Hadfield JD, 2006, P ROY SOC B-BIOL SCI, V273, P1347, DOI 10.1098/rspb.2005.3459; Haldane JBS, 1937, AM NAT, V71, P337, DOI 10.1086/280722; Hansen TF, 1995, J EVOLUTION BIOL, V8, P759, DOI 10.1046/j.1420-9101.1995.8060759.x; Hansen TF, 1999, GENETICA, V106, P251, DOI 10.1023/A:1003988101586; Houle D, 2002, P ROY SOC B-BIOL SCI, V269, P97, DOI 10.1098/rspb.2001.1823; Hunt J, 2004, TRENDS ECOL EVOL, V19, P329, DOI 10.1016/j.tree.2004.03.035; IWASA Y, 1991, EVOLUTION, V45, P1431, DOI 10.1111/j.1558-5646.1991.tb02646.x; Jones TM, 2007, BEHAV ECOL, V18, P251, DOI 10.1093/beheco/arl077; Jones TM, 2004, P ROY SOC B-BIOL SCI, V271, P1311, DOI 10.1098/rspb.2004.2723; Jones TM, 2000, P ROY SOC B-BIOL SCI, V267, P681, DOI 10.1098/rspb.2000.1056; Kirkpatrick M, 2004, EVOLUTION, V58, P683; Kirkpatrick M, 1996, EVOLUTION, V50, P2125, DOI [10.2307/2410684, 10.1111/j.1558-5646.1996.tb03603.x]; KIRKPATRICK M, 1987, ANNU REV ECOL SYST, V18, P43, DOI 10.1146/annurev.es.18.110187.000355; Kokko H, 1998, EVOL ECOL, V12, P739, DOI 10.1023/A:1006541701002; Kokko H, 1997, BEHAV ECOL SOCIOBIOL, V41, P99, DOI 10.1007/s002650050369; Kokko H, 1996, P ROY SOC B-BIOL SCI, V263, P1533, DOI 10.1098/rspb.1996.0224; Komdeur J, 2005, BEHAV ECOL, V16, P805, DOI 10.1093/beheco/ari059; Linder JE, 2005, J EVOLUTION BIOL, V18, P568, DOI 10.1111/j.1420-9101.2004.00872.x; Lopez P, 2003, BEHAV ECOL SOCIOBIOL, V55, P73, DOI 10.1007/s00265-003-0675-3; Madsen V, 2007, AM NAT, V169, pS93, DOI 10.1086/510096; Mank JE, 2006, P ROY SOC B-BIOL SCI, V273, P233, DOI 10.1098/rspb.2005.3334; MANNING JT, 1985, J THEOR BIOL, V116, P349, DOI 10.1016/S0022-5193(85)80273-3; MANNING JT, 1984, J THEOR BIOL, V108, P215, DOI 10.1016/S0022-5193(84)80067-3; Martin Joyce A, 2005, Natl Vital Stat Rep, V54, P1; MCLEAN KR, 1985, J THEOR BIOL, V116, P369, DOI 10.1016/S0022-5193(85)80275-7; Medawar P., 1952, UNSOLVED PROBLEM BIO; Miller LK, 2005, EVOLUTION, V59, P2414; Moller AP, 2001, NATURWISSENSCHAFTEN, V88, P401, DOI 10.1007/s001140100255; NOTTEBOHM F, 1978, Z TIERPSYCHOL, V46, P298; O'Loghlen AL, 2003, BEHAV ECOL SOCIOBIOL, V53, P102, DOI 10.1007/s00265-002-0551-6; Oneal E, 2007, BIOL LETTERS, V3, P29, DOI 10.1098/rsbl.2006.0565; Osada K, 2003, P ROY SOC B-BIOL SCI, V270, P929, DOI 10.1098/rspb.2002.2308; Poesel A, 2006, ANIM BEHAV, V72, P531, DOI 10.1016/j.anbehav.2005.10.022; POMIANKOWSKI A, 1987, J THEOR BIOL, V128, P195, DOI 10.1016/S0022-5193(87)80169-8; Price DK, 1998, BEHAV GENET, V28, P395, DOI 10.1023/A:1021677804038; Priest NK, 2002, EVOLUTION, V56, P927, DOI 10.1111/j.0014-3820.2002.tb01405.x; Promislow D, 2003, BEHAV GENET, V33, P191, DOI 10.1023/A:1022562103669; Promislow DEL, 1998, GENETICA, V102-3, P299, DOI 10.1023/A:1017047212008; Radwan J, 2003, ECOL LETT, V6, P581, DOI 10.1046/j.1461-0248.2003.00484.x; RICE WR, 1988, EVOLUTION, V42, P817, DOI [10.2307/2408873, 10.1111/j.1558-5646.1988.tb02500.x]; RISCH N, 1987, AM J HUM GENET, V41, P218; SEARCY WA, 1985, CONDOR, V87, P222, DOI 10.2307/1366886; Siefferman L, 2005, J AVIAN BIOL, V36, P428, DOI 10.1111/j.0908-8857.2005.03401.x; Siller S, 2001, NATURE, V411, P689, DOI 10.1038/35079578; Sloter E, 2004, FERTIL STERIL, V81, P925, DOI 10.1016/j.fertnstert.2003.07.043; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Wyrobek AJ, 2006, P NATL ACAD SCI USA, V103, P9601, DOI 10.1073/pnas.0506468103; ZAHAVI A, 1977, J THEOR BIOL, V67, P603, DOI 10.1016/0022-5193(77)90061-3; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	71	42	42	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e939	10.1371/journal.pone.0000939	http://dx.doi.org/10.1371/journal.pone.0000939			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895980	Green Published, Green Submitted, gold			2022-12-25	WOS:000207455800018
J	Thuiller, W; Slingsby, JA; Privett, SDJ; Cowling, RM				Thuiller, Wilfried; Slingsby, Jasper A.; Privett, Sean D. J.; Cowling, Richard M.			Stochastic Species Turnover and Stable Coexistence in a Species-Rich, Fire-Prone Plant Community	PLOS ONE			English	Article								Understanding the mechanisms that maintain diversity is important for managing ecosystems for species persistence. Here we used a long-term data set to understand mechanisms of coexistence at the local and regional scales in the Cape Floristic Region, a global hotspot of plant diversity. We used a dataset comprising 81 monitoring sites, sampled in 1966 and again in 1996, and containing 422 species for which growth form, regeneration mode, dispersal distance and abundances at both the local (site) and meta-community scales are known. We found that species presence and abundance were stable at the meta-community scale over the 30 year period but highly unstable at the local scale, and were not influenced by species' biological attributes. Moreover, rare species were no more likely to go extinct at the local scale than common species, and that alpha diversity in local communities was strongly influenced by habitat. We conclude that stochastic environmental fluctuations associated with recurrent fire buffer populations from extinction, thereby ensuring stable coexistence at the meta-community scale by creating a "neutral-like" pattern maintained by niche-differentiation.	[Thuiller, Wilfried] Univ Grenoble 1, CNRS, Lab Ecol Alpine, UMR 5553, Grenoble, France; [Slingsby, Jasper A.; Privett, Sean D. J.] Univ Cape Town, Dept Bot, ZA-7700 Rondebosch, South Africa; [Cowling, Richard M.] Nelson Mandela Metropolitan Univ, Dept Bot, Port Elizabeth, South Africa	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie; University of Cape Town; Nelson Mandela University	Thuiller, W (corresponding author), Univ Grenoble 1, CNRS, Lab Ecol Alpine, UMR 5553, Grenoble, France.	wilfried.thuiller@ujf-grenoble.fr	Slingsby, Jasper/AAU-7259-2021; Cowling, Richard/AFU-6261-2022; Thuiller, Wilfried/G-3283-2010	Slingsby, Jasper/0000-0003-1246-1181; Thuiller, Wilfried/0000-0002-5388-5274	National Research Foundation; Nelson Mandela Metropolitan University; University of Cape Town; International Research Network	National Research Foundation; Nelson Mandela Metropolitan University; University of Cape Town; International Research Network	Funding for this research was provided by the National Research Foundation (RMC, JAS), the Nelson Mandela Metropolitan University (RMC) and the University of Cape Town (JAS). Funding for the publication cost came from the International Research Network (GDRI) project France South Africa-Dynamics of biodiversity in Southern African ecosystems and sustainable use in the context of global change: processes and mechanisms involved.	Adler PB, 2006, P NATL ACAD SCI USA, V103, P12793, DOI 10.1073/pnas.0600599103; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bell G, 2005, ECOLOGY, V86, P1757, DOI 10.1890/04-1028; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Bond W. J., 1992, ECOLOGY FYNBOS NUTR, P206; Bond W. J., 1996, FIRE PLANTS, DOI DOI 10.2307/2404797; Bond WJ, 2001, TRENDS ECOL EVOL, V16, P45, DOI 10.1016/S0169-5347(00)02033-4; BOND WJ, 1995, ECOSCIENCE, V2, P252, DOI 10.1080/11956860.1995.11682291; BOND WJ, 1984, J ECOL, V72, P209, DOI 10.2307/2260014; BOND WJ, 1990, S AFR J BOT, V56, P326, DOI 10.1016/S0254-6299(16)31060-2; Bond WJ, 1999, OECOLOGIA, V120, P132, DOI 10.1007/s004420050841; Brook BW, 2006, ECOLOGY, V87, P1445, DOI 10.1890/0012-9658(2006)87[1445:SOEFDD]2.0.CO;2; Brook BW, 2006, ECOL LETT, V9, P375, DOI 10.1111/j.1461-0248.2006.00883.x; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Chave J, 2004, ECOL LETT, V7, P241, DOI 10.1111/j.1461-0248.2003.00566.x; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CHESSON PL, 1981, AM NAT, V117, P923, DOI 10.1086/283778; CHESSON PL, 1989, J MATH BIOL, V27, P117, DOI 10.1007/BF00276099; COWLING RM, 1987, S AFR J SCI, V83, P106; Cowling RM, 1996, TRENDS ECOL EVOL, V11, P362, DOI 10.1016/0169-5347(96)10044-6; Cowling RM, 2002, DIVERS DISTRIB, V8, P163, DOI 10.1046/j.1472-4642.2002.00143.x; COWLING RM, 1990, S AFR J ECOL, V1, P1; DOAK DF, 1994, ECOLOGY, V75, P615, DOI 10.2307/1941720; Dornelas M, 2006, NATURE, V440, P80, DOI 10.1038/nature04534; Facelli JM, 2005, ECOLOGY, V86, P2998, DOI 10.1890/05-0304; Goldblatt P., 2000, CAPE PLANTS CONSPECT; Grigulis K, 2005, GLOBAL CHANGE BIOL, V11, P1042, DOI 10.1111/j.1365-2486.2005.00980.x; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; Hubbell Stephen P., 2001, V32, pi; Ives AR, 2006, ECOL APPL, V16, P20, DOI 10.1890/04-0702; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; LAURIE H, 1995, J VEG SCI, V6, P161, DOI 10.2307/3236210; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Linder R, 1992, ECOLOGY FYNBOS; Link WA, 2006, ECOLOGY, V87, P2626, DOI 10.1890/0012-9658(2006)87[2626:MWATFO]2.0.CO;2; MANDERS PT, 1992, FOREST ECOL MANAG, V48, P277, DOI 10.1016/0378-1127(92)90150-8; Midgley GF, 2006, DIVERS DISTRIB, V12, P555, DOI 10.1111/j.1366-9516.2006.00273.x; Midgley GF, 2003, BIOL CONSERV, V112, P87, DOI 10.1016/S0006-3207(02)00414-7; Pake CE, 1996, ECOLOGY, V77, P1427, DOI 10.2307/2265540; Pinheiro J, 2001, MIXED EFFECTS MODELS; Privett SDJ, 2001, BOTHALIA, V31, P99, DOI 10.4102/abc.v31i1.509; Richards MB, 1997, OIKOS, V79, P394, DOI 10.2307/3546024; Rozdilsky ID, 2001, ECOL RES, V16, P983, DOI 10.1046/j.1440-1703.2001.00446.x; Silvertown J, 2004, TRENDS ECOL EVOL, V19, P605, DOI 10.1016/j.tree.2004.09.003; Simmons MT, 1996, BIODIVERS CONSERV, V5, P551, DOI 10.1007/BF00137609; TAYLOR H C, 1984, Bothalia, V15, P259; Thuiller W, 2004, ECOLOGY, V85, P1688, DOI 10.1890/03-0148; Thuiller W, 2006, ECOGRAPHY, V29, P733, DOI 10.1111/j.0906-7590.2006.04674.x; van Wilgen B.W., 1992, P345; VANWILGEN BW, 1985, J APPL ECOL, V22, P207, DOI 10.2307/2403338; VANWILGEN BW, 1985, J APPL ECOL, V22, P955, DOI 10.2307/2403243; Vlok J. H. J., 2000, Diversity and Distributions, V6, P273, DOI 10.1046/j.1472-4642.2000.00090.x; WARNER RR, 1985, AM NAT, V125, P769, DOI 10.1086/284379; WHITTAKER RH, 1965, SCIENCE, V147, P250, DOI 10.1126/science.147.3655.250; Wilgen B. W. van, 1981, South African Forestry Journal, P42; [No title captured]	56	68	70	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2007	2	9							e938	10.1371/journal.pone.0000938	http://dx.doi.org/10.1371/journal.pone.0000938			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HT	17895979	Green Published, gold			2022-12-25	WOS:000207455800017
